Citrus Sinensis ID: 003065

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-
Protein Sequence
MAKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHccccccccccccccccccccccccEEcccccccEEEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccEEEEccccccccccHHccccccccEEEccccccccccccHHHcccccccEEcccccccEEcccHHHHccccccEEEccccccccccccccccccccccEEcccccccccccccccccccccEEcccccccEEcccHHHHccccccEEEcccccccccccHHHHcccccccEEcccccccccccccccccccccEEEccccEEEEcccHHHHcccccccccccccEEEEEccccccccccccEEEcccccccccccHHccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHcccccccEEcccccccccccHHHcccccccccccccccccccccHHHHcccccccccccccccccccHHHHHcccccccccccccccccccccccccccccEEEcccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEccHHHHHHHHccccccEEEcccccEEEEEEEcccccEEEEEEcccccccccHHHHHHHHccccccccccEEEEEEccccEEEEEcccccccHHHHHccccccccccccHHHHHHHHHHHHHHccccccccccccEEEccccccccccccccEEEccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccHHHHHHHHHHHHHHHHHHccHHccccHHHHHHHHHHHHccccccccccccccccccccccEEEEcccccEEEEEEEccccccccccHHHcccccccEEEcccccccccccHHHHcccccEEEEccccccccccccccccHccEEEEEccccccccccHHHccccccEEEEccccccccccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEcccccccccccHHHHccHcccEEEcccccccccccHHHcccccccEEEEEcccccccccHHHccccccEEEEEccccccccccHHHHcccccEEEEEEcccccccccccHcccccEEEEEEccccccccccHHHccccccEEEEEccccccccccHHccccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccccEEEccHHHccccEEEEEEcccccccccccHHHHHcccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccEEEccccccccHHHHHcccHHcEEEcccccEEEEEEEcccccEEEEEEccccccccHHHHHHHHHHHccHHHHHHHHHEcccccccEEEEEEcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHcccHcccccccccHHHEEEcccccEEEcccccccHEccccccccccEEEccccEcccc
Coil and Loop (DISEMBL)
MAKIPFLCFHLLALLCFILVsvfppslslnVETQALIQFKSklkdphgvldswkesadspcgfsgitcdsvtgrvteisfdnkslsgEISSSISALQSLTvlslpfnvlsgklplelsncsnlkvlnvtgnamvgsvpdlsalknleifdLSINYFTGRFPRWVVNLTQLVSlsigdnvydeaeipesignlkNLTYLFLAHCNLRGRIPESISELRelgtldicrnkisgefPRSIRKLQKLWKIELYANnltgelpaelgnltllqefdissnqmygklpeeignlknlTVFQcfknnfsgefpsgfgdmRKLFAFSIygnrfsgpfpenlgrytaltdvdisenqfsgsfpkyLCEKRKLLNLLALSnnfsgevpnsyadcktiqrlrisdnhlsgkipdglwalpnvgmldfgdndftggispliGLSTSLSQLVLQNnrfsgelpselgrltnLERLILtnnnfsgkiPSALGALRQLsslhleenaltgsipnemgdcaRIVDLNLarnslsgniprSLSLLSSLNAlnlsgnkltgsipdnLMKLKLSSidlsenqlsgsvpldflrmggdgafagneglcldqsTKMLMNskltacpaiqkqkggfkdKLVLFCIIAVALAAFLAGLLLVSYKNfklsadmengekevsskwklasfhhididAEQIcnleednligsggtgkvYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFlvleympngnlFQALHKRVkegkpeldWFRRYKIALGAAKGIAylhhdcsppiihrdikssnilldedyepkiadfgvakiaenspkvsdyscfagthgyiapg
Flexible Loop (DISEMBL)
MAKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWkesadspcGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRelgtldicrnkisgefprsIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGtvavkqlwkgdgVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAkiaenspkvsdyscFAGTHGYIAPG
Low Complexity Region (SEG)
MAKIPflcfhllallcfilVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKslsgeisssisalqslTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKllnllalsnnFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRslsllsslnalnlsgnklTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKlvlfciiavalaaflaglllVSYKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG
Disordered region (IsUnstruct)
***IPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSL***ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT**I**NLMKLKL***********GSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSAD*******VSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI***
Disordered Region (DISOPRED)
*AKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTK************************VLFCIIAVALAAFLAGLLLVSYK**********************SFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP***DYSCFAGTHGYIAPG
Disordered Region (DISEMBL)
MAKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADM*********KWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG
Disordered Region (DISPRO)
**KIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLM**************GGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKL***********SSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	851	2.2.26 [Sep-21-2011]
Q9SGP2	996	Receptor-like protein kin	no	no	0.949	0.811	0.396	1e-161
Q9LJM4	991	Receptor-like protein kin	no	no	0.938	0.806	0.410	1e-159
C0LGX3	993	LRR receptor-like serine/	no	no	0.925	0.793	0.388	1e-154
P47735	999	Receptor-like protein kin	no	no	0.954	0.812	0.384	1e-150
Q9SYQ8	980	Receptor protein kinase C	no	no	0.935	0.812	0.374	1e-147
O49545	1003	Leucine-rich repeat recep	no	no	0.937	0.795	0.371	1e-139
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.936	0.795	0.367	1e-138
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.945	0.794	0.35	1e-135
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.955	0.737	0.335	1e-131
Q9FRS6	1029	Leucine-rich repeat recep	no	no	0.958	0.793	0.336	1e-129

>sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1

 Score =  570 bits (1469), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 345/871 (39%), Positives = 493/871 (56%), Gaps = 63/871 (7%)

Query: 24  PPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNK 83
           P   SLN +   L Q K  L DP   L SW  +  SPC +SG++C      VT +   + 
Sbjct: 11  PTVFSLNQDGFILQQVKLSLDDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSA 70

Query: 84  SLSGEISS------------------------SISALQSLTVLSLPFNVLSGKLPLELSN 119
           +L+G   S                        +I+A +SL  L L  N+L+G+LP  L++
Sbjct: 71  NLAGPFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLAD 130

Query: 120 CSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN 178
              L  L++TGN   G +P      +NLE+  L  N   G  P ++ N++ L  L++  N
Sbjct: 131 IPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYN 190

Query: 179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR 238
            +  + IP   GNL NL  ++L  C+L G+IP+S+ +L +L  LD+  N + G  P S+ 
Sbjct: 191 PFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLG 250

Query: 239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298
            L  + +IELY N+LTGE+P ELGNL  L+  D S NQ+ GK+P+E+  +  L     ++
Sbjct: 251 GLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYE 309

Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
           NN  GE P+       L+   I+GNR +G  P++LG  + L  +D+SEN+FSG  P  LC
Sbjct: 310 NNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLC 369

Query: 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
            K +L  LL + N+FSG +P S ADC+++ R+R++ N  SG +P G W LP+V +L+  +
Sbjct: 370 AKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVN 429

Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALG 478
           N F+G IS  IG +++LS L+L NN F+G LP E+G L NL +L  + N FSG +P +L 
Sbjct: 430 NSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLM 489

Query: 479 ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538
           +L +L +L L  N  +G + + +    ++ +LNLA N  +G IP  +  LS LN L+LSG
Sbjct: 490 SLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSG 549

Query: 539 NKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMN 598
           N  +G IP +L  LKL+ ++LS N+LSG +P    +     +F GN GLC D   K L  
Sbjct: 550 NMFSGKIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLCGD--IKGLCG 607

Query: 599 SKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSS 658
           S+  A     K++G       +F + A+ L A +A      Y+ FK +  ME       S
Sbjct: 608 SENEA-----KKRGYVWLLRSIFVLAAMVLLAGVAWFYF-KYRTFKKARAMER------S 655

Query: 659 KWKLASFHHIDIDAEQIC-NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---- 713
           KW L SFH +     +I  +L+EDN+IG+G +GKVY++ L  N  TVAVK+LW G     
Sbjct: 656 KWTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVL-TNGETVAVKRLWTGSVKET 714

Query: 714 -----------GVK--VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
                      GV+   F AE+E LGKIRH+NI+KL+ C        LV EYMPNG+L  
Sbjct: 715 GDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGD 774

Query: 761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820
            LH   K G   L W  R+KI L AA+G++YLHHD  PPI+HRDIKS+NIL+D DY  ++
Sbjct: 775 LLHSS-KGGM--LGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARV 831

Query: 821 ADFGVAKIAENSPKV-SDYSCFAGTHGYIAP 850
           ADFGVAK  + + K     S  AG+ GYIAP
Sbjct: 832 ADFGVAKAVDLTGKAPKSMSVIAGSCGYIAP 862

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LJM4|IKU2_ARATH Receptor-like protein kinase HAIKU2 OS=Arabidopsis thaliana GN=IKU2 PE=1 SV=1

 Score =  564 bits (1453), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 352/857 (41%), Positives = 497/857 (57%), Gaps = 58/857 (6%)

Query: 32  ETQALIQFKSKLKDPHG--VLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSL---- 85
           E + L++ KS   +     V  +W    +S C F+GI C+S  G V EI+  ++SL    
Sbjct: 26  EVENLLKLKSTFGETKSDDVFKTWTHR-NSACEFAGIVCNS-DGNVVEINLGSRSLINRD 83

Query: 86  -SGEISS----SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDL 140
             G  +     SI  L+ L  L L  N L G++   L  C+ L+ L++  N   G  P +
Sbjct: 84  DDGRFTDLPFDSICDLKLLEKLVLGNNSLRGQIGTNLGKCNRLRYLDLGINNFSGEFPAI 143

Query: 141 SALKNLEIFDLSINYFTGRFPRW--VVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
            +L+ LE   L+ +  +G FP W  + +L +L  LS+GDN +     P  I NL  L ++
Sbjct: 144 DSLQLLEFLSLNASGISGIFP-WSSLKDLKRLSFLSVGDNRFGSHPFPREILNLTALQWV 202

Query: 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
           +L++ ++ G+IPE I  L  L  L++  N+ISGE P+ I +L+ L ++E+Y+N+LTG+LP
Sbjct: 203 YLSNSSITGKIPEGIKNLVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIYSNDLTGKLP 262

Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
               NLT L+ FD S+N + G L  E+  LKNL     F+N  +GE P  FGD + L A 
Sbjct: 263 LGFRNLTNLRNFDASNNSLEGDL-SELRFLKNLVSLGMFENRLTGEIPKEFGDFKSLAAL 321

Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP 378
           S+Y N+ +G  P  LG +TA   +D+SEN   G  P Y+C+K  + +LL L N F+G+ P
Sbjct: 322 SLYRNQLTGKLPRRLGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQNRFTGQFP 381

Query: 379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQL 438
            SYA CKT+ RLR+S+N LSG IP G+W LPN+  LD   N F G ++  IG + SL  L
Sbjct: 382 ESYAKCKTLIRLRVSNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIGNAKSLGSL 441

Query: 439 VLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
            L NNRFSG LP ++    +L  + L  N FSG +P + G L++LSSL L++N L+G+IP
Sbjct: 442 DLSNNRFSGSLPFQISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQNNLSGAIP 501

Query: 499 NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSID 558
             +G C  +VDLN A NSLS  IP SL  L  LN+LNLSGNKL+G IP  L  LKLS +D
Sbjct: 502 KSLGLCTSLVDLNFAGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLSALKLSLLD 561

Query: 559 LSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKL 618
           LS NQL+GSVP   +     G+F GN GLC   S+K+     L  CP  +    G +  L
Sbjct: 562 LSNNQLTGSVPESLV----SGSFEGNSGLC---SSKI---RYLRPCPLGKPHSQGKRKHL 611

Query: 619 --VLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQIC 676
             V  C I   +AA LA   L SY  FK+  D  N   +  + W+++SF  ++ +  +I 
Sbjct: 612 SKVDMCFI---VAAILALFFLFSYVIFKIRRDKLNKTVQKKNDWQVSSFRLLNFNEMEII 668

Query: 677 N-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---------------KGDGVKV--- 717
           + ++ +N+IG GG G VY++ L ++  T+AVK +W                 DG      
Sbjct: 669 DEIKSENIIGRGGQGNVYKVSL-RSGETLAVKHIWCPESSHESFRSSTAMLSDGNNRSNN 727

Query: 718 --FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDW 775
             F AE+  L  I+H N++KL+  +    S  LV EYMPNG+L++ LH+R   G+ E+ W
Sbjct: 728 GEFEAEVATLSNIKHINVVKLFCSITCEDSKLLVYEYMPNGSLWEQLHER--RGEQEIGW 785

Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835
             R  +ALGAAKG+ YLHH    P+IHRD+KSSNILLDE++ P+IADFG+AKI +     
Sbjct: 786 RVRQALALGAAKGLEYLHHGLDRPVIHRDVKSSNILLDEEWRPRIADFGLAKIIQADSVQ 845

Query: 836 SDYSC--FAGTHGYIAP 850
            D+S     GT GYIAP
Sbjct: 846 RDFSAPLVKGTLGYIAP 862

Modulates the seed size by negatively regulating the cellularization of syncytial endosperm.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  547 bits (1409), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 332/855 (38%), Positives = 475/855 (55%), Gaps = 67/855 (7%)

Query: 40  KSKLKDPHGVLDSWKESAD--SPCGFSGITCDSVTGR---VTEISFDNKSLSGEISSSIS 94
           K++L DP G L  W  + D  SPC ++GITC    G    VT I     ++SG       
Sbjct: 36  KTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPYGFC 95

Query: 95  ALQSLTVLSLPFNVLSGKL---PLELSNCSNLKVLNVTGNAMVGSVPDLSA-LKNLEIFD 150
            +++L  ++L  N L+G +   PL L  CS L+ L +  N   G +P+ S   + L + +
Sbjct: 96  RIRTLINITLSQNNLNGTIDSAPLSL--CSKLQNLILNQNNFSGKLPEFSPEFRKLRVLE 153

Query: 151 LSINYFTGRFPR--------WVVNL----------------TQLVSLSIGDNVYDEAEIP 186
           L  N FTG  P+         V+NL                T+L  L +    +D + IP
Sbjct: 154 LESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAYISFDPSPIP 213

Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKI 246
            ++GNL NLT L L H NL G IP+SI  L  L  LD+  N ++GE P SI +L+ +++I
Sbjct: 214 STLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQI 273

Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP 306
           ELY N L+G+LP  +GNLT L+ FD+S N + G+LPE+I  L+ L  F    N F+G  P
Sbjct: 274 ELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQ-LISFNLNDNFFTGGLP 332

Query: 307 SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL 366
                   L  F I+ N F+G  P NLG+++ +++ D+S N+FSG  P YLC +RKL  +
Sbjct: 333 DVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKI 392

Query: 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
           +  SN  SGE+P SY DC ++  +R++DN LSG++P   W LP   +    +N   G I 
Sbjct: 393 ITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELANNNQLQGSIP 452

Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486
           P I  +  LSQL +  N FSG +P +L  L +L  + L+ N+F G IPS +  L+ L  +
Sbjct: 453 PSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERV 512

Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
            ++EN L G IP+ +  C  + +LNL+ N L G IP  L  L  LN L+LS N+LTG IP
Sbjct: 513 EMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIP 572

Query: 547 DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPA 606
             L++LKL+  ++S+N+L G +P  F +     +F GN  LC      +         P 
Sbjct: 573 AELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIR--------PC 624

Query: 607 IQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSSKWKLASFH 666
             K++  +   + + CI  VAL   L  L + +   FK      N         K+  F 
Sbjct: 625 RSKRETRYILPISILCI--VALTGALVWLFIKTKPLFKRKPKRTN---------KITIFQ 673

Query: 667 HIDIDAEQIC-NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAA 720
            +    E I   L EDN+IGSGG+G VYR+ L K+  T+AVK+LW   G K     VF +
Sbjct: 674 RVGFTEEDIYPQLTEDNIIGSGGSGLVYRVKL-KSGQTLAVKKLWGETGQKTESESVFRS 732

Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH-KRVKEGKPELDWFRRY 779
           E+E LG++RH NI+KL  C       FLV E+M NG+L   LH ++       LDW  R+
Sbjct: 733 EVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRF 792

Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI--AENSPKVSD 837
            IA+GAA+G++YLHHD  PPI+HRD+KS+NILLD + +P++ADFG+AK    E++  VSD
Sbjct: 793 SIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSD 852

Query: 838 --YSCFAGTHGYIAP 850
              SC AG++GYIAP
Sbjct: 853 VSMSCVAGSYGYIAP 867

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1

 Score =  534 bits (1376), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 336/873 (38%), Positives = 490/873 (56%), Gaps = 61/873 (6%)

Query: 21  SVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESAD-SPCGFSGITCDSVTGRVT--- 76
           S + PSLSLN +   L Q K  L DP   L SW ++ D +PC + G++CD+ +  V+   
Sbjct: 13  STYLPSLSLNQDATILRQAKLGLSDPAQSLSSWSDNNDVTPCKWLGVSCDATSNVVSVDL 72

Query: 77  --------------------EISFDNKSLSGEISSS-ISALQSLTVLSLPFNVLSGKLPL 115
                                +S  N S++G +S+       +L  L L  N+L G +P 
Sbjct: 73  SSFMLVGPFPSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPK 132

Query: 116 ELS-NCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSL 173
            L  N  NLK L ++GN +  ++P      + LE  +L+ N+ +G  P  + N+T L  L
Sbjct: 133 SLPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKEL 192

Query: 174 SIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF 233
            +  N++  ++IP  +GNL  L  L+LA CNL G IP S+S L  L  LD+  N+++G  
Sbjct: 193 KLAYNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSI 252

Query: 234 PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTV 293
           P  I +L+ + +IEL+ N+ +GELP  +GN+T L+ FD S N++ GK+P+ +  L   ++
Sbjct: 253 PSWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLLNLESL 312

Query: 294 FQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSF 353
              F+N   G  P      + L    ++ NR +G  P  LG  + L  VD+S N+FSG  
Sbjct: 313 NL-FENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEI 371

Query: 354 PKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGM 413
           P  +C + KL  L+ + N+FSGE+ N+   CK++ R+R+S+N LSG+IP G W LP + +
Sbjct: 372 PANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSL 431

Query: 414 LDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKI 473
           L+  DN FTG I   I  + +LS L +  NRFSG +P+E+G L  +  +    N+FSG+I
Sbjct: 432 LELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEI 491

Query: 474 PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNA 533
           P +L  L+QLS L L +N L+G IP E+     + +LNLA N LSG IP+ + +L  LN 
Sbjct: 492 PESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNY 551

Query: 534 LNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQST 593
           L+LS N+ +G IP  L  LKL+ ++LS N LSG +P  +        F GN GLC+D   
Sbjct: 552 LDLSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCVDLD- 610

Query: 594 KMLMNSKLTACPAIQKQKG-GFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENG 652
                     C  I + K  G+    +L  I  +A   F+ G+++   K  KL A     
Sbjct: 611 --------GLCRKITRSKNIGY--VWILLTIFLLAGLVFVVGIVMFIAKCRKLRA--LKS 658

Query: 653 EKEVSSKWKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK 711
               +SKW+  SFH +     +I + L+E N+IG G +GKVY+++L +    VAVK+L K
Sbjct: 659 STLAASKWR--SFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVEL-RGGEVVAVKKLNK 715

Query: 712 ----GD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLF 759
               GD           VFAAE+E LG IRH++I++L+ C   G    LV EYMPNG+L 
Sbjct: 716 SVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLA 775

Query: 760 QALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPK 819
             LH   ++G   L W  R +IAL AA+G++YLHHDC PPI+HRD+KSSNILLD DY  K
Sbjct: 776 DVLHGD-RKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAK 834

Query: 820 IADFGVAKIAE--NSPKVSDYSCFAGTHGYIAP 850
           +ADFG+AK+ +   S      S  AG+ GYIAP
Sbjct: 835 VADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAP 867

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3

 Score =  522 bits (1345), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 323/862 (37%), Positives = 480/862 (55%), Gaps = 66/862 (7%)

Query: 31  VETQALIQFKSKLKDP--HGVLDSWKESA--DSPCGFSGITCDSVTGRVTEISFDNKSLS 86
            + + L+  KS +  P  HG+ D W  S+  D+ C FSG++CD    RV  ++     L 
Sbjct: 26  TDMEVLLNLKSSMIGPKGHGLHD-WIHSSSPDAHCSFSGVSCDD-DARVISLNVSFTPLF 83

Query: 87  GEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNA-MVGSVPD--LSAL 143
           G IS  I  L  L  L+L  N  +G+LPLE+ + ++LKVLN++ N  + G+ P   L A+
Sbjct: 84  GTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAM 143

Query: 144 KNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC 203
            +LE+ D   N F G+ P  +  L +L  LS G N +   EIPES G++++L YL L   
Sbjct: 144 VDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFS-GEIPESYGDIQSLEYLGLNGA 202

Query: 204 NLRGRIPESISELR-------------------------ELGTLDICRNKISGEFPRSIR 238
            L G+ P  +S L+                         +L  LD+    ++GE P S+ 
Sbjct: 203 GLSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLS 262

Query: 239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298
            L+ L  + L+ NNLTG +P EL  L  L+  D+S NQ+ G++P+   NL N+T+   F+
Sbjct: 263 NLKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFR 322

Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
           NN  G+ P   G++ KL  F ++ N F+   P NLGR   L  +D+S+N  +G  PK LC
Sbjct: 323 NNLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLC 382

Query: 359 EKRKLLNLLALSNN-FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417
              K L +L LSNN F G +P     CK++ ++RI  N L+G +P GL+ LP V +++  
Sbjct: 383 RGEK-LEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELT 441

Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL 477
           DN F+G + P+      L Q+ L NN FSGE+P  +G   NL+ L L  N F G IP  +
Sbjct: 442 DNFFSGEL-PVTMSGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREI 500

Query: 478 GALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLS 537
             L+ LS ++   N +TG IP+ +  C+ ++ ++L+RN ++G IP+ ++ + +L  LN+S
Sbjct: 501 FELKHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNIS 560

Query: 538 GNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPL--DFLRMGGDGAFAGNEGLCLDQSTK 594
           GN+LTGSIP  +  +  L+++DLS N LSG VPL   FL    + +FAGN  LCL     
Sbjct: 561 GNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVF-NETSFAGNTYLCLPHR-- 617

Query: 595 MLMNSKLTACPAIQKQKGGFKDKLVLFCI--IAVALAAFLAGLLLVSYKNFKLSADMENG 652
                   +CP    Q     +   LF    I + + A + GL+L+S         M   
Sbjct: 618 -------VSCPTRPGQTSD-HNHTALFSPSRIVITVIAAITGLILISVA----IRQMNKK 665

Query: 653 EKEVSSKWKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW- 710
           + + S  WKL +F  +D  +E +   L+E+N+IG GG G VYR  +  N   VA+K+L  
Sbjct: 666 KNQKSLAWKLTAFQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNV-DVAIKRLVG 724

Query: 711 --KGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE 768
              G     F AE++ LG+IRHR+I++L   +    ++ L+ EYMPNG+L + LH   K 
Sbjct: 725 RGTGRSDHGFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGS-KG 783

Query: 769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           G   L W  R+++A+ AAKG+ YLHHDCSP I+HRD+KS+NILLD D+E  +ADFG+AK 
Sbjct: 784 G--HLQWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKF 841

Query: 829 AENSPKVSDYSCFAGTHGYIAP 850
             +       S  AG++GYIAP
Sbjct: 842 LVDGAASECMSSIAGSYGYIAP 863

Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  498 bits (1281), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 321/863 (37%), Positives = 463/863 (53%), Gaps = 65/863 (7%)

Query: 32  ETQALIQFKSKLK----DPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSG 87
           E +AL+  K+ L     D +  L SWK S  S C + G+TCD     VT +     +LSG
Sbjct: 25  EFRALLSLKTSLTGAGDDKNSPLSSWKVST-SFCTWIGVTCDVSRRHVTSLDLSGLNLSG 83

Query: 88  EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKN 145
            +S  +S L+ L  LSL  N++SG +P E+S+ S L+ LN++ N   GS PD   S L N
Sbjct: 84  TLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVN 143

Query: 146 LEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE----------------------- 182
           L + D+  N  TG  P  V NLTQL  L +G N +                         
Sbjct: 144 LRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELV 203

Query: 183 AEIPESIGNLKNLTYLFLAHCN-LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQ 241
            +IP  IGNL  L  L++ + N     +P  I  L EL   D     ++GE P  I KLQ
Sbjct: 204 GKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQ 263

Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
           KL  + L  N  +G L  ELG L+ L+  D+S+N   G++P     LKNLT+   F+N  
Sbjct: 264 KLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKL 323

Query: 302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
            GE P   GD+ +L    ++ N F+G  P+ LG    L  VD+S N+ +G+ P  +C   
Sbjct: 324 HGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGN 383

Query: 362 KLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDF 421
           KL  L+ L N   G +P+S   C+++ R+R+ +N L+G IP GL+ LP +  ++  DN  
Sbjct: 384 KLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYL 443

Query: 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALR 481
           +G +    G+S +L Q+ L NN+ SG LP  +G  T +++L+L  N F G IPS +G L+
Sbjct: 444 SGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQ 503

Query: 482 QLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKL 541
           QLS +    N  +G I  E+  C  +  ++L+RN LSG IP  ++ +  LN LNLS N L
Sbjct: 504 QLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHL 563

Query: 542 TGSIPDNLMKLK-LSSIDLSENQLSGSVP-------LDFLRMGGDGAFAGNE-GLCLDQS 592
            GSIP ++  ++ L+S+D S N LSG VP        ++    G+    G   G C D  
Sbjct: 564 VGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDGV 623

Query: 593 TKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENG 652
            K    S  +  P     K       +L C IA A+ A      ++  ++ K +++    
Sbjct: 624 AKGGHQSH-SKGPLSASMK-LLLVLGLLVCSIAFAVVA------IIKARSLKKASE---- 671

Query: 653 EKEVSSKWKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW- 710
               S  W+L +F  +D   + + + L+EDN+IG GG G VY+  +  N   VAVK+L  
Sbjct: 672 ----SRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYK-GVMPNGDLVAVKRLAA 726

Query: 711 --KGDGVKV-FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK 767
             +G      F AE++ LG+IRHR+I++L        ++ LV EYMPNG+L + LH + K
Sbjct: 727 MSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK-K 785

Query: 768 EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            G   L W  RYKIAL AAKG+ YLHHDCSP I+HRD+KS+NILLD ++E  +ADFG+AK
Sbjct: 786 GG--HLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAK 843

Query: 828 IAENSPKVSDYSCFAGTHGYIAP 850
             ++S      S  AG++GYIAP
Sbjct: 844 FLQDSGTSECMSAIAGSYGYIAP 866

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  494 bits (1272), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 316/860 (36%), Positives = 456/860 (53%), Gaps = 63/860 (7%)

Query: 31  VETQALIQFKSKLK-DPHG-VLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGE 88
            E  AL+  KS    D H  +L SW  S  + C ++G+TCD     VT +     +LSG 
Sbjct: 26  TELHALLSLKSSFTIDEHSPLLTSWNLST-TFCSWTGVTCDVSLRHVTSLDLSGLNLSGT 84

Query: 89  ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNL 146
           +SS ++ L  L  LSL  N +SG +P ++SN   L+ LN++ N   GS PD   S L NL
Sbjct: 85  LSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNL 144

Query: 147 EIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYD-----------------------EA 183
            + DL  N  TG  P  + NLTQL  L +G N +                          
Sbjct: 145 RVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTG 204

Query: 184 EIPESIGNLKNLTYLFLAHCN-LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
           +IP  IGNL  L  L++ + N     +P  I  L EL   D     ++GE P  I KLQK
Sbjct: 205 KIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQK 264

Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
           L  + L  N  TG +  ELG ++ L+  D+S+N   G++P     LKNLT+   F+N   
Sbjct: 265 LDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLY 324

Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRK 362
           G  P   G+M +L    ++ N F+G  P+ LG    L  +D+S N+ +G+ P  +C   +
Sbjct: 325 GAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNR 384

Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422
           L+ L+ L N   G +P+S   C+++ R+R+ +N L+G IP  L+ LP +  ++  DN  T
Sbjct: 385 LMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLT 444

Query: 423 GGISPLI--GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480
           G + P+   G+S  L Q+ L NN+ SG LP+ +G L+ +++L+L  N FSG IP  +G L
Sbjct: 445 GEL-PISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRL 503

Query: 481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
           +QLS L    N  +G I  E+  C  +  ++L+RN LSG+IP  L+ +  LN LNLS N 
Sbjct: 504 QQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNH 563

Query: 541 LTGSIPDNLMKLK-LSSIDLSENQLSGSVP-LDFLRMGGDGAFAGNEGLC---LDQSTKM 595
           L GSIP  +  ++ L+S+D S N LSG VP           +F GN  LC   L    K 
Sbjct: 564 LVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKG 623

Query: 596 LMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKE 655
              S +    A  K         +LFC +  A+ A +             +  + N  + 
Sbjct: 624 THQSHVKPLSATTKLL---LVLGLLFCSMVFAIVAIIK------------ARSLRNASE- 667

Query: 656 VSSKWKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--- 711
            +  W+L +F  +D   + + + L+EDN+IG GG G VY+  + K    VAVK+L     
Sbjct: 668 -AKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPK-GDLVAVKRLATMSH 725

Query: 712 -GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK 770
                  F AE++ LG+IRHR+I++L        ++ LV EYMPNG+L + LH + K G 
Sbjct: 726 GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK-KGG- 783

Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
             L W  RYKIAL AAKG+ YLHHDCSP I+HRD+KS+NILLD ++E  +ADFG+AK  +
Sbjct: 784 -HLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQ 842

Query: 831 NSPKVSDYSCFAGTHGYIAP 850
           +S      S  AG++GYIAP
Sbjct: 843 DSGTSECMSAIAGSYGYIAP 862

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  481 bits (1239), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 301/860 (35%), Positives = 458/860 (53%), Gaps = 55/860 (6%)

Query: 32  ETQALIQFKSKLKDPHGVLDSWKESADSP-CGFSGITCDSVTGRVTEISFDNKSLSGEIS 90
           E   L+  KS L DP   L  WK S  S  C ++G+ C+S  G V ++     +L+G+IS
Sbjct: 30  ELSVLLSVKSTLVDPLNFLKDWKLSDTSDHCNWTGVRCNS-NGNVEKLDLAGMNLTGKIS 88

Query: 91  SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKV---------------------LNVT 129
            SIS L SL   ++  N     LP  +    ++ +                     LN +
Sbjct: 89  DSISQLSSLVSFNISCNGFESLLPKSIPPLKSIDISQNSFSGSLFLFSNESLGLVHLNAS 148

Query: 130 GNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSI-GDNVYDEAEIPE 187
           GN + G++  DL  L +LE+ DL  N+F G  P    NL +L  L + G+N+    E+P 
Sbjct: 149 GNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNL--TGELPS 206

Query: 188 SIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIE 247
            +G L +L    L +   +G IP     +  L  LD+   K+SGE P  + KL+ L  + 
Sbjct: 207 VLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLL 266

Query: 248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPS 307
           LY NN TG +P E+G++T L+  D S N + G++P EI  LKNL +    +N  SG  P 
Sbjct: 267 LYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPP 326

Query: 308 GFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367
               + +L    ++ N  SG  P +LG+ + L  +D+S N FSG  P  LC K  L  L+
Sbjct: 327 AISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLI 386

Query: 368 ALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP 427
             +N F+G++P + + C+++ R+R+ +N L+G IP G   L  +  L+   N  +GGI  
Sbjct: 387 LFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPG 446

Query: 428 LIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLH 487
            I  S SLS +    N+    LPS +  + NL+  ++ +N  SG++P        LS+L 
Sbjct: 447 DISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLD 506

Query: 488 LEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPD 547
           L  N LTG+IP+ +  C ++V LNL  N+L+G IPR ++ +S+L  L+LS N LTG +P+
Sbjct: 507 LSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPE 566

Query: 548 NL-MKLKLSSIDLSENQLSGSVPLD-FLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACP 605
           ++     L  +++S N+L+G VP++ FL+        GN GLC            L  C 
Sbjct: 567 SIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLC---------GGVLPPCS 617

Query: 606 AIQKQKGGFKD----KLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSSK-- 659
             Q+           ++V   +I +A    L  L +V+   +K          E +SK  
Sbjct: 618 KFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGE 677

Query: 660 --WKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---- 712
             W+L +FH +   A  I   ++E N+IG G TG VY+ ++ +++  +AVK+LW+     
Sbjct: 678 WPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADI 737

Query: 713 -DGVK-VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK 770
            DG    F  E+ +LGK+RHRNI++L   L    +  +V E+M NGNL  A+H +   G+
Sbjct: 738 EDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGR 797

Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
             +DW  RY IALG A G+AYLHHDC PP+IHRDIKS+NILLD + + +IADFG+A++  
Sbjct: 798 LLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM- 856

Query: 831 NSPKVSDYSCFAGTHGYIAP 850
            + K    S  AG++GYIAP
Sbjct: 857 -ARKKETVSMVAGSYGYIAP 875

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  468 bits (1204), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 322/960 (33%), Positives = 467/960 (48%), Gaps = 147/960 (15%)

Query: 29  LNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTG--RVTEISFDNKSLS 86
           LN+E Q L++ KSK  D    L +W  +   PCG++G+ C + +    V  ++  +  LS
Sbjct: 27  LNLEGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLS 86

Query: 87  GEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP----DLSA 142
           G++S SI  L  L  L L +N LSGK+P E+ NCS+L++L +  N   G +P     L +
Sbjct: 87  GKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVS 146

Query: 143 LKNLEIFDLSI---------------------NYFTGRFPRWVVNLTQLVSLSIGDNVYD 181
           L+NL I++  I                     N  +G+ PR + NL +L S   G N+  
Sbjct: 147 LENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMIS 206

Query: 182 -----------------------EAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRE 218
                                    E+P+ IG LK L+ + L      G IP  IS    
Sbjct: 207 GSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTS 266

Query: 219 LGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY 278
           L TL + +N++ G  P+ +  LQ L  + LY N L G +P E+GNL+   E D S N + 
Sbjct: 267 LETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALT 326

Query: 279 GKLPEEIGNLKNLTVFQCFKNNFSGEFPS------------------------GFGDMRK 314
           G++P E+GN++ L +   F+N  +G  P                         GF  +R 
Sbjct: 327 GEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRG 386

Query: 315 LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFS 374
           LF   ++ N  SG  P  LG Y+ L  +D+S+N  SG  P YLC    ++ L   +NN S
Sbjct: 387 LFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLS 446

Query: 375 GEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTS 434
           G +P     CKT+ +LR++ N+L G+ P  L    NV  ++ G N F G I   +G  ++
Sbjct: 447 GNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSA 506

Query: 435 LSQLVLQNNRFSGELPSELGRLTN------------------------LERLILTNNNFS 470
           L +L L +N F+GELP E+G L+                         L+RL +  NNFS
Sbjct: 507 LQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFS 566

Query: 471 GKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSS 530
           G +PS +G+L QL  L L  N L+G+IP  +G+ +R+ +L +  N  +G+IPR L  L+ 
Sbjct: 567 GTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTG 626

Query: 531 LN-ALNLSGNKLTGSIPDNLMKL----------------------KLSSI---DLSENQL 564
           L  ALNLS NKLTG IP  L  L                       LSS+   + S N L
Sbjct: 627 LQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSL 686

Query: 565 SGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCII 624
           +G +PL  LR     +F GNEGLC     + +         +  K  G    K++     
Sbjct: 687 TGPIPL--LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAA 744

Query: 625 AVALAAFLAGLLLVSYKNFKLSADMENGEKEVSSKWKL-------ASFHHIDIDAEQICN 677
            +   + +   L+V      +     + +    S+  L         F   D+ A    N
Sbjct: 745 VIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVA-ATDN 803

Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKV---FAAEMEILGKIRH 730
            +E  ++G G  G VY+  L     T+AVK+L      G+   V   F AE+  LG IRH
Sbjct: 804 FDESFVVGRGACGTVYKAVLPAGY-TLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRH 862

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
           RNI+KL+      GS+ L+ EYMP G+L + LH    +    LDW +R+KIALGAA+G+A
Sbjct: 863 RNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH----DPSCNLDWSKRFKIALGAAQGLA 918

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           YLHHDC P I HRDIKS+NILLD+ +E  + DFG+AK+ +  P     S  AG++GYIAP
Sbjct: 919 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-MPHSKSMSAIAGSYGYIAP 977

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1

 Score =  462 bits (1190), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 313/930 (33%), Positives = 462/930 (49%), Gaps = 114/930 (12%)

Query: 1   MAKIPFLCFHL-LALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADS 59
           + ++ FL +++  AL  F+    F      N E + L+ FKS L DP   L  WK   ++
Sbjct: 3   IPRLFFLFYYIGFALFPFVSSETFQ-----NSEQEILLAFKSDLFDPSNNLQDWKRPENA 57

Query: 60  P-------CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGK 112
                   C ++G+ CD+  G V ++   N +LSG +S  I +  SL  L L  N     
Sbjct: 58  TTFSELVHCHWTGVHCDA-NGYVAKLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESS 116

Query: 113 LPLELSNCSNLKVLNVTGNAMVGSVP-------------------------DLSALKNLE 147
           LP  LSN ++LKV++V+ N+  G+ P                         DL     LE
Sbjct: 117 LPKSLSNLTSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLE 176

Query: 148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG 207
           + D    YF G  P    NL  L  L +  N +   ++P+ IG L +L  + L +    G
Sbjct: 177 VLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNNFG-GKVPKVIGELSSLETIILGYNGFMG 235

Query: 208 RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLL 267
            IPE   +L  L  LD+    ++G+ P S+ +L++L  + LY N LTG+LP ELG +T L
Sbjct: 236 EIPEEFGKLTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSL 295

Query: 268 QEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG 327
              D+S NQ+ G++P E+G LKNL +    +N  +G  PS   ++  L    ++ N   G
Sbjct: 296 VFLDLSDNQITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMG 355

Query: 328 PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTI 387
             P +LG+ + L  +D+S N+ SG  P  LC  R L  L+  +N+FSG++P     C T+
Sbjct: 356 SLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTL 415

Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS----------- 436
            R+RI  NH+SG IP G   LP +  L+   N+ TG I   I LSTSLS           
Sbjct: 416 VRVRIQKNHISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDISFNHLSS 475

Query: 437 ------------QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS 484
                         +  +N F+G++P+++    +L  L L+ N+FSG IP  + +  +L 
Sbjct: 476 LSSSIFSSPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKLV 535

Query: 485 SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGS 544
           SL+L+ N L G IP  +     +  L+L+ NSL+GNIP  L    +L  LN+S NKL G 
Sbjct: 536 SLNLKSNQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGP 595

Query: 545 IPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLC---LDQSTKMLMNSKL 601
           IP N++    ++ID          P D +         GN GLC   L   +K L  S  
Sbjct: 596 IPSNML---FAAID----------PKDLV---------GNNGLCGGVLPPCSKSLALSAK 633

Query: 602 TACPA-IQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVS----YKNFKLSADMENGEKEV 656
              P  I      F   +    I+A+ +  FLAG  + +    Y NF          +E 
Sbjct: 634 GRNPGRIHVNHAVFGFIVGTSVIVAMGM-MFLAGRWIYTRWDLYSNFAREYIFCKKPRE- 691

Query: 657 SSKWKLASFHHIDIDAEQI-CNLEEDNLIGSGGTGKVYRLD-LKKNAGTVAVKQLWKGDG 714
              W+L +F  +   A  I  +++E N+IG G  G VY+ + +++   TVAVK+LW+   
Sbjct: 692 EWPWRLVAFQRLCFTAGDILSHIKESNIIGMGAIGIVYKAEVMRRPLLTVAVKKLWRSPS 751

Query: 715 VK--------------VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
            +                  E+ +LG +RHRNI+K+   +       +V EYMPNGNL  
Sbjct: 752 PQNDIEDHHQEEDEEDDILREVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGT 811

Query: 761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820
           ALH +  E     DW  RY +A+G  +G+ YLH+DC PPIIHRDIKS+NILLD + E +I
Sbjct: 812 ALHSK-DEKFLLRDWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARI 870

Query: 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           ADFG+AK+  +  K    S  AG++GYIAP
Sbjct: 871 ADFGLAKMMLH--KNETVSMVAGSYGYIAP 898

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	851
224146319	977	predicted protein [Populus trichocarpa]	0.997	0.868	0.688	0.0
359493408	974	PREDICTED: receptor-like protein kinase	0.995	0.869	0.686	0.0
359807055	955	receptor-like protein kinase HSL1-like [	0.982	0.875	0.652	0.0
449494090	976	PREDICTED: LRR receptor-like serine/thre	0.969	0.845	0.645	0.0
449446347	976	PREDICTED: LRR receptor-like serine/thre	0.969	0.845	0.645	0.0
297839079	977	hypothetical protein ARALYDRAFT_476351 [	0.982	0.855	0.590	0.0
255561534	919	Receptor protein kinase CLAVATA1 precurs	0.938	0.869	0.615	0.0
296089466	892	unnamed protein product [Vitis vinifera]	0.898	0.857	0.617	0.0
15218385	977	leucine-rich receptor-like protein kinas	0.972	0.847	0.579	0.0
110738078	977	putative leucine-rich receptor-like prot	0.972	0.847	0.579	0.0

>gi|224146319|ref|XP_002325963.1| predicted protein [Populus trichocarpa] gi|222862838|gb|EEF00345.1| predicted protein [Populus trichocarpa]

 Score = 1149 bits (2971), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 589/855 (68%), Positives = 701/855 (81%), Gaps = 6/855 (0%)

Query: 1   MAKIPFLCFH-LLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADS 59
           MAK   L    ++ ++C + +S FPPSLSL+VETQAL+ FKS+LKDP  VL SWKES +S
Sbjct: 1   MAKTSVLSLQFIITVICLLSLSSFPPSLSLDVETQALLDFKSQLKDPLNVLKSWKES-ES 59

Query: 60  PCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSN 119
           PC FSGITCD ++G+VT ISFDN+SLSG IS SISAL+SL  L LP N +SGKLP  + N
Sbjct: 60  PCEFSGITCDPLSGKVTAISFDNQSLSGVISPSISALESLMSLWLPSNAISGKLPDGVIN 119

Query: 120 CSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV 179
           CS L+VLN+TGN MVG +PDLS+L+NLEI DLS NYF+GRFP W+ NL+ L++L +G N 
Sbjct: 120 CSKLRVLNLTGNKMVGVIPDLSSLRNLEILDLSENYFSGRFPSWIGNLSGLLALGLGTNE 179

Query: 180 YDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRK 239
           Y   EIPESIGNLKNLT+LFLA+ +LRG IPESI EL  L TLDI RNKISG+FP+SI K
Sbjct: 180 YHVGEIPESIGNLKNLTWLFLANSHLRGEIPESIFELENLQTLDISRNKISGQFPKSISK 239

Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
           L+KL KIEL+ NNLTGE+P EL NLTLLQEFD+SSNQ+YGKLPE IG+LK+LTVFQ  +N
Sbjct: 240 LRKLTKIELFYNNLTGEIPPELANLTLLQEFDVSSNQLYGKLPEGIGSLKSLTVFQGHQN 299

Query: 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
           NFSGE P+GFG+MR L  FSIY N FSG FP N GR++ L  +DISENQFSGSFP++LCE
Sbjct: 300 NFSGEIPAGFGEMRYLNGFSIYQNNFSGEFPTNFGRFSPLNSIDISENQFSGSFPRFLCE 359

Query: 360 KRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN 419
            ++L  LLAL N FSG +P+SYA+CKT+ R R++ N L+GKIP+G+WA+P   ++DF DN
Sbjct: 360 SKQLQYLLALGNRFSGVLPDSYAECKTLWRFRVNKNQLTGKIPEGVWAMPLASIIDFSDN 419

Query: 420 DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA 479
           DFTG +SP I LSTSL+QL+LQNNRFSG+LPSELG+L NLE+L L NNNFSG IPS +G+
Sbjct: 420 DFTGEVSPQIRLSTSLNQLILQNNRFSGQLPSELGKLMNLEKLYLNNNNFSGVIPSDIGS 479

Query: 480 LRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN 539
           L+QLSSLHLEEN+LTGSIP+E+GDCAR+VDLN+A NSLSG IP +++L+SSLN+LNLS N
Sbjct: 480 LQQLSSLHLEENSLTGSIPSELGDCARVVDLNIASNSLSGRIPSTITLMSSLNSLNLSRN 539

Query: 540 KLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNS 599
           K+TG IP+ L KLKLSSIDLSENQLSG VP   L MGGD AF GN+ LC+D+++K ++NS
Sbjct: 540 KITGLIPEGLEKLKLSSIDLSENQLSGRVPSVLLTMGGDRAFIGNKELCVDENSKTIINS 599

Query: 600 KLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKL-SADMEN---GEKE 655
            +  C   Q Q+  F DKLVLF IIA  L   L G+LL+SY+NFK   A+M+N   G+KE
Sbjct: 600 GIKVCLGRQDQERKFGDKLVLFSIIACVLVFVLTGMLLLSYRNFKHGQAEMKNDLEGKKE 659

Query: 656 VSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV 715
              KW+++SFH +DIDA++IC+LEEDNLIG GGTGKVYRLDLKKN G VAVKQLWKGDG+
Sbjct: 660 GDPKWQISSFHQLDIDADEICDLEEDNLIGCGGTGKVYRLDLKKNRGAVAVKQLWKGDGL 719

Query: 716 KVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDW 775
           K   AEMEILGKIRHRNILKLYA LLKG SSFLV EYMPNGNLFQALH R+K+G+PELDW
Sbjct: 720 KFLEAEMEILGKIRHRNILKLYASLLKGESSFLVFEYMPNGNLFQALHTRIKDGQPELDW 779

Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835
            +RYKIALGAAKGIAYLHHDCSPPI+HRDIKSSNILLDED EPKIADFGVAK+AE S K 
Sbjct: 780 NQRYKIALGAAKGIAYLHHDCSPPILHRDIKSSNILLDEDNEPKIADFGVAKLAEMSLKG 839

Query: 836 SDYSCFAGTHGYIAP 850
            D S F GTHGYIAP
Sbjct: 840 CDNSSFTGTHGYIAP 854

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493408|ref|XP_003634589.1| PREDICTED: receptor-like protein kinase HSL1-like [Vitis vinifera]

 Score = 1124 bits (2908), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 586/854 (68%), Positives = 671/854 (78%), Gaps = 7/854 (0%)

Query: 1   MAKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSP 60
           MAK P    H L   CF    +       +VE +AL+QFK +LKDP   LDSWK+S DSP
Sbjct: 1   MAKHPLSFLHFLLCCCFFSTLLS--PSLSSVEVEALLQFKKQLKDPLHRLDSWKDS-DSP 57

Query: 61  CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNC 120
           C F G++CD +TG V E+S DNKSLSGEISSS+SAL+SLT L LP N LSG LP EL+ C
Sbjct: 58  CKFFGVSCDPITGLVNELSLDNKSLSGEISSSLSALRSLTHLVLPSNSLSGYLPSELNKC 117

Query: 121 SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVY 180
           SNL+VLNVT N ++G+VPDLS L NL   DLSINYF+G FP WV NLT LVSLS+G+N Y
Sbjct: 118 SNLQVLNVTCNNLIGTVPDLSELSNLRTLDLSINYFSGPFPSWVTNLTGLVSLSLGENHY 177

Query: 181 DEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKL 240
           DE EIPESIGNLKNL+Y+F AH  LRG IPES  E+  + +LD   N ISG FP+SI KL
Sbjct: 178 DEGEIPESIGNLKNLSYIFFAHSQLRGEIPESFFEITAMESLDFSGNNISGNFPKSIAKL 237

Query: 241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
           QKL+KIEL+ N LTGE+P EL NLTLLQE DIS NQ+YGKLPEEIG LK L VF+ + NN
Sbjct: 238 QKLYKIELFDNQLTGEIPPELANLTLLQEIDISENQLYGKLPEEIGRLKKLVVFESYDNN 297

Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
           FSGE P+ FGD+  L  FSIY N FSG FP N GR++ L   DISENQFSG+FPKYLCE 
Sbjct: 298 FSGEIPAAFGDLSNLTGFSIYRNNFSGEFPANFGRFSPLNSFDISENQFSGAFPKYLCEN 357

Query: 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDND 420
            +LL LLAL N FSGE P+SYA CK++QRLRI++N LSG+IP+G+WALPNV M+DFGDN 
Sbjct: 358 GRLLYLLALGNRFSGEFPDSYAKCKSLQRLRINENQLSGEIPNGIWALPNVQMIDFGDNG 417

Query: 421 FTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480
           F+G ISP IG ++SL+QL+L NNRFSG+LPSELG L NL +L L  N FSGKIPS LGAL
Sbjct: 418 FSGRISPDIGTASSLNQLILANNRFSGKLPSELGSLANLGKLYLNGNEFSGKIPSELGAL 477

Query: 481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
           +QLSSLHLEEN+LTGSIP E+G CAR+VDLNLA NSLSGNIP S SLL+ LN+LNLSGNK
Sbjct: 478 KQLSSLHLEENSLTGSIPAELGKCARLVDLNLAWNSLSGNIPDSFSLLTYLNSLNLSGNK 537

Query: 541 LTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSK 600
           LTGS+P NL KLKLSSIDLS NQLSG V  D L+MGGD AF GN+GLC++QS K+ ++S 
Sbjct: 538 LTGSLPVNLRKLKLSSIDLSRNQLSGMVSSDLLQMGGDQAFLGNKGLCVEQSYKIQLHSG 597

Query: 601 LTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGE----KEV 656
           L  C      K   K+KL LFCIIA AL   L GLL+VSY+NFK +      E    KE 
Sbjct: 598 LDVCTGNNDPKRVAKEKLFLFCIIASALVILLVGLLVVSYRNFKHNESYAENELEGGKEK 657

Query: 657 SSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK 716
             KWKL SFH ++  AE +CNLEEDNLIGSGGTGKVYRLDLK+N G VAVKQLWKG GVK
Sbjct: 658 DLKWKLESFHPVNFTAEDVCNLEEDNLIGSGGTGKVYRLDLKRNGGPVAVKQLWKGSGVK 717

Query: 717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF 776
           VF AE+EIL KIRHRNI+KLYACL KGGSSFLVLEYM NGNLFQALH+++KEG PELDW 
Sbjct: 718 VFTAEIEILRKIRHRNIMKLYACLKKGGSSFLVLEYMSNGNLFQALHRQIKEGVPELDWH 777

Query: 777 RRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           +RYKIALGAAKGIAYLHHDCSPPIIHRDIKS+NILLDE+YEPKIADFGVAKIA+NS   S
Sbjct: 778 QRYKIALGAAKGIAYLHHDCSPPIIHRDIKSTNILLDEEYEPKIADFGVAKIADNSSTES 837

Query: 837 DYSCFAGTHGYIAP 850
             SCFAGTHGYIAP
Sbjct: 838 YSSCFAGTHGYIAP 851

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359807055|ref|NP_001241340.1| receptor-like protein kinase HSL1-like [Glycine max] gi|223452422|gb|ACM89538.1| leucine-rich repeat transmembrane protein kinase [Glycine max]

 Score = 1103 bits (2854), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 547/838 (65%), Positives = 659/838 (78%), Gaps = 2/838 (0%)

Query: 14  LLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTG 73
           +L     S+FPP +SL +ETQAL+QFK+ LKD    L SW ES DSPC F GITCD V+G
Sbjct: 1   MLLLTSYSIFPPCVSLTLETQALLQFKNHLKDSSNSLASWNES-DSPCKFYGITCDPVSG 59

Query: 74  RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
           RVTEIS DNKSLSG+I  S+S LQSL VLSLP N++SGKLP E+S C++L+VLN+TGN +
Sbjct: 60  RVTEISLDNKSLSGDIFPSLSILQSLQVLSLPSNLISGKLPSEISRCTSLRVLNLTGNQL 119

Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           VG++PDLS L++L++ DLS NYF+G  P  V NLT LVSL +G+N Y+E EIP ++GNLK
Sbjct: 120 VGAIPDLSGLRSLQVLDLSANYFSGSIPSSVGNLTGLVSLGLGENEYNEGEIPGTLGNLK 179

Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
           NL +L+L   +L G IPES+ E++ L TLDI RNKISG   RSI KL+ L+KIEL++NNL
Sbjct: 180 NLAWLYLGGSHLIGDIPESLYEMKALETLDISRNKISGRLSRSISKLENLYKIELFSNNL 239

Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
           TGE+PAEL NLT LQE D+S+N MYG+LPEEIGN+KNL VFQ ++NNFSGE P+GF DMR
Sbjct: 240 TGEIPAELANLTNLQEIDLSANNMYGRLPEEIGNMKNLVVFQLYENNFSGELPAGFADMR 299

Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF 373
            L  FSIY N F+G  P N GR++ L  +DISENQFSG FPK+LCE RKL  LLAL NNF
Sbjct: 300 HLIGFSIYRNSFTGTIPGNFGRFSPLESIDISENQFSGDFPKFLCENRKLRFLLALQNNF 359

Query: 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST 433
           SG  P SY  CK+++R RIS N LSGKIPD +WA+P V ++D   NDFTG +   IGLST
Sbjct: 360 SGTFPESYVTCKSLKRFRISMNRLSGKIPDEVWAIPYVEIIDLAYNDFTGEVPSEIGLST 419

Query: 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
           SLS +VL  NRFSG+LPSELG+L NLE+L L+NNNFSG+IP  +G+L+QLSSLHLEEN+L
Sbjct: 420 SLSHIVLTKNRFSGKLPSELGKLVNLEKLYLSNNNFSGEIPPEIGSLKQLSSLHLEENSL 479

Query: 494 TGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK 553
           TGSIP E+G CA +VDLNLA NSLSGNIP+S+SL+SSLN+LN+SGNKL+GSIP+NL  +K
Sbjct: 480 TGSIPAELGHCAMLVDLNLAWNSLSGNIPQSVSLMSSLNSLNISGNKLSGSIPENLEAIK 539

Query: 554 LSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGG 613
           LSS+D SENQLSG +P     +GG+ AF GN+GLC++ + K  MNS L  C     Q   
Sbjct: 540 LSSVDFSENQLSGRIPSGLFIVGGEKAFLGNKGLCVEGNLKPSMNSDLKICAKNHGQPSV 599

Query: 614 FKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADME-NGEKEVSSKWKLASFHHIDIDA 672
             DK VLF  IA      LAGL+ +S ++ K  A+    G+KEVS KWKLASFH +DIDA
Sbjct: 600 SADKFVLFFFIASIFVVILAGLVFLSCRSLKHDAEKNLQGQKEVSQKWKLASFHQVDIDA 659

Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN 732
           ++IC L+EDNLIGSGGTGKVYR++L+KN   VAVKQL K DGVK+ AAEMEILGKIRHRN
Sbjct: 660 DEICKLDEDNLIGSGGTGKVYRVELRKNGAMVAVKQLGKVDGVKILAAEMEILGKIRHRN 719

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           ILKLYA LLKGGS+ LV EYMPNGNLFQALH+++K+GKP LDW +RYKIALGA KGIAYL
Sbjct: 720 ILKLYASLLKGGSNLLVFEYMPNGNLFQALHRQIKDGKPNLDWNQRYKIALGAGKGIAYL 779

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           HHDC+PP+IHRDIKSSNILLDEDYE KIADFG+A+ AE S K   YSC AGT GYIAP
Sbjct: 780 HHDCNPPVIHRDIKSSNILLDEDYESKIADFGIARFAEKSDKQLGYSCLAGTLGYIAP 837

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449494090|ref|XP_004159444.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Cucumis sativus]

 Score = 1051 bits (2719), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 536/830 (64%), Positives = 661/830 (79%), Gaps = 5/830 (0%)

Query: 25  PSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKS 84
           PS+ L  ETQAL++FK  LKDP G L+SW +S +SPCGFSGITCD  +G+V EIS +NKS
Sbjct: 24  PSMPLPTETQALLRFKENLKDPTGFLNSWIDS-ESPCGFSGITCDRASGKVVEISLENKS 82

Query: 85  LSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALK 144
           LSGEIS SIS LQ LT LSL  N +SG+LP +L NCSNL+VLN+T N MV  +PDLS L+
Sbjct: 83  LSGEISPSISVLQWLTTLSLASNHISGELPNQLINCSNLRVLNLTDNEMVKRIPDLSQLR 142

Query: 145 NLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN 204
            LE+ DLSIN+F+G+FP WV NLT LVSL +G N ++  EIPESIGNLKNLT+L+LA+  
Sbjct: 143 KLEVLDLSINFFSGQFPIWVGNLTGLVSLGLGQNEFEAGEIPESIGNLKNLTWLYLANAQ 202

Query: 205 LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNL 264
           LRG IPES+ EL+ L TLD+ RN++SG+  +SI KLQ L K+EL+ N LTGE+P E+ NL
Sbjct: 203 LRGEIPESLFELKALKTLDLSRNELSGKISKSISKLQNLNKLELFVNKLTGEIPPEISNL 262

Query: 265 TLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324
           TLLQE DIS+N +YG+LPEE+GNL+NL VFQ ++NNFSG+ P GFG+M+ L AFSIY N 
Sbjct: 263 TLLQEIDISANSLYGQLPEEVGNLRNLVVFQLYENNFSGKLPEGFGNMQNLIAFSIYRNN 322

Query: 325 FSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADC 384
           FSG FP N GR++ L+ +DISENQFSGSFP++LCE RKL  LLAL N FSGE+P + A+C
Sbjct: 323 FSGDFPVNFGRFSPLSSIDISENQFSGSFPQFLCENRKLEFLLALENRFSGELPFALAEC 382

Query: 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNR 444
           K++QR RI++N +SG IPDG+WALPN  M+DF DN+F G ISP IGLSTSLSQLVL NN+
Sbjct: 383 KSLQRFRINNNQMSGSIPDGVWALPNAKMIDFSDNEFIGIISPNIGLSTSLSQLVLPNNK 442

Query: 445 FSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC 504
           FSG LPSELG+LTNLERL L+NN F+G+IPS +G LRQLSS HLE N+L GSIP E+G+C
Sbjct: 443 FSGNLPSELGKLTNLERLYLSNNEFNGEIPSEIGFLRQLSSFHLEVNSLNGSIPLEIGNC 502

Query: 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQL 564
            R+VD+N A+NSLSG+IP S SL+SSLN+LNLS NKL+G IP++L K+KLSSIDLS NQL
Sbjct: 503 ERLVDVNFAQNSLSGSIPSSFSLISSLNSLNLSSNKLSGIIPESLEKMKLSSIDLSGNQL 562

Query: 565 SGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCII 624
            G VP   L M GD AF  N+ LC+D++ +  +N+ L  C      KG   D+++ F II
Sbjct: 563 FGRVPSSLLAMSGDKAFLDNKELCVDENYRDRINTTLVTCTGKNSHKGVLNDEILFFSII 622

Query: 625 AVALAAFLAGLLLVSYKNFKLS-ADME---NGEKEVSSKWKLASFHHIDIDAEQICNLEE 680
              L   LAGL LVS    K+S  D E    G+++ + +WK+ASFH ++IDA++IC+ EE
Sbjct: 623 VSILVCVLAGLALVSCNCLKISQTDPEASWEGDRQGAPQWKIASFHQVEIDADEICSFEE 682

Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           +NLIGSGGTGKVYRLDLKKN  TVAVKQLWKGD +KV AAEMEILGKIRHRNILKLYACL
Sbjct: 683 ENLIGSGGTGKVYRLDLKKNGYTVAVKQLWKGDAMKVLAAEMEILGKIRHRNILKLYACL 742

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           ++ GSS+LV EYM NGNL++AL +++K G+PEL+W++RYKIALGAA+GIAYLHHDCSPPI
Sbjct: 743 MREGSSYLVFEYMTNGNLYEALQRQIKSGQPELNWYQRYKIALGAARGIAYLHHDCSPPI 802

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS+NILLD DYEPKIADFGVAK+A+     S++S  AGTHGYIAP
Sbjct: 803 IHRDIKSTNILLDGDYEPKIADFGVAKVADQFQSASEHSSLAGTHGYIAP 852

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446347|ref|XP_004140933.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Cucumis sativus]

 Score = 1050 bits (2716), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 536/830 (64%), Positives = 660/830 (79%), Gaps = 5/830 (0%)

Query: 25  PSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKS 84
           PS+ L  ETQAL++FK  LKDP G L+SW +S +SPCGFSGITCD  +G+V EIS +NKS
Sbjct: 24  PSMPLPTETQALLRFKENLKDPTGFLNSWIDS-ESPCGFSGITCDRASGKVVEISLENKS 82

Query: 85  LSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALK 144
           LSGEIS SIS LQ LT LSL  N +SG+LP +L NCSNL+VLN+T N MV  +PDLS L+
Sbjct: 83  LSGEISPSISVLQWLTTLSLASNHISGELPNQLINCSNLRVLNLTDNEMVKRIPDLSQLR 142

Query: 145 NLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN 204
            LE+ DLSIN+F+G+FP WV NLT LVSL +G N ++  EIPESIGNLKNLT+L+LA+  
Sbjct: 143 KLEVLDLSINFFSGQFPIWVGNLTGLVSLGLGQNEFEAGEIPESIGNLKNLTWLYLANAQ 202

Query: 205 LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNL 264
           LRG IPES+ EL+ L TLD+ RN++SG+   SI KLQ L K+EL+ N LTGE+P E+ NL
Sbjct: 203 LRGEIPESLFELKALKTLDLSRNELSGKISNSISKLQNLNKLELFVNKLTGEIPPEISNL 262

Query: 265 TLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324
           TLLQE DIS+N +YG+LPEE+GNL+NL VFQ ++NNFSG+ P GFG+M+ L AFSIY N 
Sbjct: 263 TLLQEIDISANSLYGQLPEEVGNLRNLVVFQLYENNFSGKLPEGFGNMQNLIAFSIYRNN 322

Query: 325 FSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADC 384
           FSG FP N GR++ L+ +DISENQFSGSFP++LCE RKL  LLAL N FSGE+P + A+C
Sbjct: 323 FSGDFPVNFGRFSPLSSIDISENQFSGSFPQFLCENRKLEFLLALENRFSGELPFALAEC 382

Query: 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNR 444
           K++QR RI++N +SG IPDG+WALPN  M+DF DN+F G ISP IGLSTSLSQLVL NN+
Sbjct: 383 KSLQRFRINNNQMSGSIPDGVWALPNAKMIDFSDNEFIGIISPNIGLSTSLSQLVLPNNK 442

Query: 445 FSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC 504
           FSG LPSELG+LTNLERL L+NN F+G+IPS +G LRQLSS HLE N+L GSIP E+G+C
Sbjct: 443 FSGNLPSELGKLTNLERLYLSNNEFNGEIPSEIGFLRQLSSFHLEVNSLNGSIPLEIGNC 502

Query: 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQL 564
            R+VD+N A+NSLSG+IP S SL+SSLN+LNLS NKL+G IP++L K+KLSSIDLS NQL
Sbjct: 503 ERLVDVNFAQNSLSGSIPSSFSLISSLNSLNLSSNKLSGIIPESLEKMKLSSIDLSGNQL 562

Query: 565 SGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCII 624
            G VP   L M GD AF  N+ LC+D++ +  +N+ L  C      KG   D+++ F II
Sbjct: 563 FGRVPSSLLAMSGDKAFLDNKELCVDENYRDRINTTLVTCTGKNSHKGVLNDEILFFSII 622

Query: 625 AVALAAFLAGLLLVSYKNFKLS-ADME---NGEKEVSSKWKLASFHHIDIDAEQICNLEE 680
              L   LAGL LVS    K+S  D E    G+++ + +WK+ASFH ++IDA++IC+ EE
Sbjct: 623 VSILVCVLAGLALVSCNCLKISQTDPEASWEGDRQGAPQWKIASFHQVEIDADEICSFEE 682

Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           +NLIGSGGTGKVYRLDLKKN  TVAVKQLWKGD +KV AAEMEILGKIRHRNILKLYACL
Sbjct: 683 ENLIGSGGTGKVYRLDLKKNGYTVAVKQLWKGDAMKVLAAEMEILGKIRHRNILKLYACL 742

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           ++ GSS+LV EYM NGNL++AL +++K G+PEL+W++RYKIALGAA+GIAYLHHDCSPPI
Sbjct: 743 MREGSSYLVFEYMTNGNLYEALQRQIKSGQPELNWYQRYKIALGAARGIAYLHHDCSPPI 802

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS+NILLD DYEPKIADFGVAK+A+     S++S  AGTHGYIAP
Sbjct: 803 IHRDIKSTNILLDGDYEPKIADFGVAKVADQFQSASEHSSLAGTHGYIAP 852

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297839079|ref|XP_002887421.1| hypothetical protein ARALYDRAFT_476351 [Arabidopsis lyrata subsp. lyrata] gi|297333262|gb|EFH63680.1| hypothetical protein ARALYDRAFT_476351 [Arabidopsis lyrata subsp. lyrata]

 Score =  990 bits (2560), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 501/849 (59%), Positives = 630/849 (74%), Gaps = 13/849 (1%)

Query: 11  LLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDS 70
           L  +   IL S+FPP++   VE QAL +FK+ L DPH +L SWK S DSPC F G+TCD 
Sbjct: 13  LATVAATILFSMFPPNVESTVEKQALFRFKNHLDDPHNILQSWKPS-DSPCVFRGVTCDP 71

Query: 71  VTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTG 130
           ++G V  IS  N +LSG IS SISAL  L+ LSLP N +SG++P E+ NC+NLKVLN+T 
Sbjct: 72  LSGEVIGISLGNANLSGTISPSISALTKLSTLSLPSNFISGRIPPEIVNCTNLKVLNLTS 131

Query: 131 NAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIG 190
           N + G++P+LS LKNLEI D+S N+ TG F  W+ N+TQL SL +G+N Y+E  IPESIG
Sbjct: 132 NRISGTIPNLSPLKNLEILDISGNFLTGEFQSWIGNMTQLFSLGLGNNHYEEGMIPESIG 191

Query: 191 NLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYA 250
            LK LT+LFLA  NL G+IP SI +L  L T DI  N ISG+FP  I +   L KIEL+ 
Sbjct: 192 GLKKLTWLFLARSNLTGKIPNSIFDLNALDTFDIANNAISGDFPVLITRFVNLTKIELFN 251

Query: 251 NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFG 310
           N LTG++P E+ NLT L+E D+SSNQ+ G LPEE+GNLK L VF C +NNF+GEFPSG G
Sbjct: 252 NRLTGKIPPEIKNLTRLREIDVSSNQLSGALPEELGNLKELRVFHCHENNFTGEFPSGLG 311

Query: 311 DMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALS 370
           D+R L + SIY N FSG FP N+GR++ L  VDISEN+F+G FP++LC+ +KL  LLAL 
Sbjct: 312 DLRHLTSLSIYRNNFSGEFPVNIGRFSPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQ 371

Query: 371 NNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIG 430
           NNFSGE+P SYADCK++ RLRI+ N LSG + +G WALP   MLD  DN+ TG ISP IG
Sbjct: 372 NNFSGEIPRSYADCKSLLRLRINKNRLSGHVTEGFWALPLAKMLDLSDNELTGEISPQIG 431

Query: 431 LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE 490
           LST LSQL+LQNNRFSG++P ELGRLTN+ER+ L+NN  SG+IP  +G L++LSSLHLE 
Sbjct: 432 LSTELSQLILQNNRFSGKIPRELGRLTNIERIYLSNNKISGEIPMEVGDLKELSSLHLEN 491

Query: 491 NALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLM 550
           N+LTG IP E+ +C ++VDLNLA+N L+G IP SLS ++SLN+L+ SGNKLTG IP +L+
Sbjct: 492 NSLTGFIPVELTNCVKLVDLNLAKNFLTGEIPNSLSQIASLNSLDFSGNKLTGEIPASLV 551

Query: 551 KLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD-QSTKMLMNSKLTACPAIQK 609
           KLKLS IDLS NQLSG +P D L +GG  AF+ NE LC+D Q+ K   N +L+ C   Q 
Sbjct: 552 KLKLSFIDLSGNQLSGRIPPDLLAVGGSTAFSRNEKLCVDKQNAKTSQNLRLSICSGDQH 611

Query: 610 -QKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSA-DMENGE-KEVSSKWKLASFH 666
            Q+ G  D  +LF  +A+ +   + GL  + Y+  K+   D ENG+  +  +KWK+ASFH
Sbjct: 612 VQRNGSLDGTLLFLALAIVVVVLVTGLFALRYRVLKIRELDSENGDINKADAKWKIASFH 671

Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAE 721
            +++DAE+IC L+ED++IG+G  GKVYR+DLKK  GTVAVK L +      DG +V  AE
Sbjct: 672 QMELDAEEICRLDEDHVIGAGSAGKVYRVDLKKGGGTVAVKWLKRAGGEEVDGTEVSVAE 731

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
           MEILGKIRHRN+LKLYACL+  GS +LV E+M NGNL+QAL   +K G PELDW +RYKI
Sbjct: 732 MEILGKIRHRNVLKLYACLVGRGSRYLVFEFMENGNLYQALRNNIKGGLPELDWLKRYKI 791

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
           A+GAAKGIAYLHHDC PPIIHRDIKSSNILLD DYE KIADFGVAK+A+   K  ++SC 
Sbjct: 792 AVGAAKGIAYLHHDCCPPIIHRDIKSSNILLDGDYESKIADFGVAKVAD---KGYEWSCV 848

Query: 842 AGTHGYIAP 850
           AGTHGY+AP
Sbjct: 849 AGTHGYMAP 857

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255561534|ref|XP_002521777.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223538990|gb|EEF40587.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis]

 Score =  981 bits (2537), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 525/853 (61%), Positives = 620/853 (72%), Gaps = 54/853 (6%)

Query: 1   MAKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSP 60
           MA+  FL    L+LL  ++ SV  PS  LN+ETQAL+QFK +LKDP  VL SWKES  SP
Sbjct: 1   MARKCFLSVQFLSLLSILVFSVCLPSFGLNIETQALLQFKRQLKDPLNVLGSWKESESSP 60

Query: 61  CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNC 120
           C FSGITCDS++G+VT ISFDNKSLSGEIS SISAL+SLT LSLP N LSGKLP EL NC
Sbjct: 61  CKFSGITCDSISGKVTAISFDNKSLSGEISPSISALESLTTLSLPSNALSGKLPYELINC 120

Query: 121 SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVY 180
           SNLKVLN+TGN M+G +PDLS+L+NLEI DL+ NYF+GRFP WV NLT LV+L+IG N +
Sbjct: 121 SNLKVLNLTGNQMIGVLPDLSSLRNLEILDLTKNYFSGRFPAWVGNLTGLVALAIGQNEF 180

Query: 181 DEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKL 240
           D+ EIPESIGNLKNLTYLFLA  +L+G IPESI  L EL TLDI RNKISG FP+SI KL
Sbjct: 181 DDGEIPESIGNLKNLTYLFLADAHLKGEIPESIFGLWELETLDISRNKISGHFPKSISKL 240

Query: 241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
           +KL+KIEL+ NNLTGE+P EL NLTLL+E DISSNQ+YGKLPE IG LKNL VFQ + N 
Sbjct: 241 KKLYKIELFLNNLTGEIPPELANLTLLREIDISSNQLYGKLPEGIGKLKNLVVFQMYNNR 300

Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
           FSGE P+GFG M  L  FSIYGN FSG FP N GR++ L   DISENQFSGSFPK+LCE 
Sbjct: 301 FSGELPAGFGQMHNLNGFSIYGNNFSGEFPANFGRFSPLNSFDISENQFSGSFPKFLCEG 360

Query: 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDND 420
           +KL  LLAL N FSGE+  SYA CKT++R RI++N +SG+IPDG+WALP V +LDF +N 
Sbjct: 361 KKLQYLLALGNRFSGELSYSYAKCKTLERFRINNNMMSGQIPDGVWALPLVLLLDFSNNA 420

Query: 421 FTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480
           F+G ISP IGLS                        T+L +LIL NN FSG++PS LG L
Sbjct: 421 FSGQISPNIGLS------------------------TSLTQLILQNNRFSGQLPSELGKL 456

Query: 481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
             L  L+L+ N+ +G IP+E+G   ++  L+L +NSL+G IP  L   + L  LNL+ N 
Sbjct: 457 MNLQKLYLDNNSFSGEIPSEIGALKQLSSLHLVQNSLTGAIPSELGECARLVDLNLASNS 516

Query: 541 LTGSIPDNL-MKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNS 599
           L+G IP +  +   L+S++LS N+L+G +P                        + L   
Sbjct: 517 LSGHIPHSFSLMTSLNSLNLSHNRLTGLIP------------------------EYLEKL 552

Query: 600 KLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNF-KLSADMENG-EKEVS 657
           KL+   +  +  G   DK        + L   L GLLL SY+NF    AD EN  E    
Sbjct: 553 KLSXXHSQDRTIG---DKWCCSPSSYLPLVIILVGLLLASYRNFINGKADRENDLEARRD 609

Query: 658 SKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV 717
           +KWKLASFH +D+DA++ICNLEE NLIGSGGTGKVYRL+LK++  TVAVKQLWKGD +KV
Sbjct: 610 TKWKLASFHQLDVDADEICNLEEGNLIGSGGTGKVYRLELKRSGCTVAVKQLWKGDYLKV 669

Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR 777
             AEMEILGKIRHRNILKLYA LLKGGSS+LVLEYM  GNLFQAL +R+K+ KPELDW +
Sbjct: 670 SEAEMEILGKIRHRNILKLYASLLKGGSSYLVLEYMAKGNLFQALQRRIKDEKPELDWLQ 729

Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
           RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK+ E S K  D
Sbjct: 730 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKLVEVSYKGCD 789

Query: 838 YSCFAGTHGYIAP 850
            S  AGTHGYIAP
Sbjct: 790 SSSVAGTHGYIAP 802

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296089466|emb|CBI39285.3| unnamed protein product [Vitis vinifera]

 Score =  957 bits (2475), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 527/854 (61%), Positives = 604/854 (70%), Gaps = 89/854 (10%)

Query: 1   MAKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSP 60
           MAK P    H L   CF    +       +VE +AL+QFK +LKDP   LDSWK+S DSP
Sbjct: 1   MAKHPLSFLHFLLCCCFFSTLLS--PSLSSVEVEALLQFKKQLKDPLHRLDSWKDS-DSP 57

Query: 61  CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNC 120
           C F G++CD +TG V E+S DNKSLSGEISSS+SAL+SLT L LP N LSG LP EL+ C
Sbjct: 58  CKFFGVSCDPITGLVNELSLDNKSLSGEISSSLSALRSLTHLVLPSNSLSGYLPSELNKC 117

Query: 121 SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVY 180
           SNL+VLNVT N ++G+VPDLS L NL   DLSINYF+G FP WV NLT LVSLS+G+N Y
Sbjct: 118 SNLQVLNVTCNNLIGTVPDLSELSNLRTLDLSINYFSGPFPSWVTNLTGLVSLSLGENHY 177

Query: 181 DEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKL 240
           DE EIPESIGNLKNL+Y+F AH  LRG IPES  E+  + +LD   N ISG FP+SI KL
Sbjct: 178 DEGEIPESIGNLKNLSYIFFAHSQLRGEIPESFFEITAMESLDFSGNNISGNFPKSIAKL 237

Query: 241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
           QKL+KIEL+ N LTGE+P EL NLTLLQE DIS NQ+YGKLPEEIG LK L VF+ + NN
Sbjct: 238 QKLYKIELFDNQLTGEIPPELANLTLLQEIDISENQLYGKLPEEIGRLKKLVVFESYDNN 297

Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
           FSGE P+ FGD+  L  FSIY N FSG FP N GR++ L   DISENQFSG+FPKYLCE 
Sbjct: 298 FSGEIPAAFGDLSNLTGFSIYRNNFSGEFPANFGRFSPLNSFDISENQFSGAFPKYLCEN 357

Query: 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDND 420
            +LL LLAL N FSGE P+SYA CK++QRLRI++N LSG+IP+G+WALPNV M+DFGDN 
Sbjct: 358 GRLLYLLALGNRFSGEFPDSYAKCKSLQRLRINENQLSGEIPNGIWALPNVQMIDFGDNG 417

Query: 421 FTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480
           F+G ISP IG ++SL+QL+L NNRFSG+LPSELG L NL +L L  N FSGKIPS LGAL
Sbjct: 418 FSGRISPDIGTASSLNQLILANNRFSGKLPSELGSLANLGKLYLNGNEFSGKIPSELGAL 477

Query: 481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
           +QLSSLHLEEN+LTGSIP E+G CAR+VDLNLA NSLSGNIP S SLL+ LN+LNLSGNK
Sbjct: 478 KQLSSLHLEENSLTGSIPAELGKCARLVDLNLAWNSLSGNIPDSFSLLTYLNSLNLSGNK 537

Query: 541 LTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSK 600
           LTGS+P NL KLKLSSIDLS NQLSG V  D L+MGGD AF GN+GLC++Q         
Sbjct: 538 LTGSLPVNLRKLKLSSIDLSRNQLSGMVSSDLLQMGGDQAFLGNKGLCVEQK-------- 589

Query: 601 LTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGE----KEV 656
                           KL LFCIIA AL   L GLL+VSY+NFK +      E    KE 
Sbjct: 590 ----------------KLFLFCIIASALVILLVGLLVVSYRNFKHNESYAENELEGGKEK 633

Query: 657 SSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK 716
             KWKL SFH ++  AE +CNLEEDNLIGSGGTGKVYRLDLK+N G VAVKQLWKG GVK
Sbjct: 634 DLKWKLESFHPVNFTAEDVCNLEEDNLIGSGGTGKVYRLDLKRNGGPVAVKQLWKGSGVK 693

Query: 717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF 776
           VF AE+EIL KIRHRNI+KLYACL KGGSSFLVLEYM NGNLFQALH+++KEG       
Sbjct: 694 VFTAEIEILRKIRHRNIMKLYACLKKGGSSFLVLEYMSNGNLFQALHRQIKEG------- 746

Query: 777 RRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
                                                      IAD        NS   S
Sbjct: 747 -------------------------------------------IAD--------NSSTES 755

Query: 837 DYSCFAGTHGYIAP 850
             SCFAGTHGYIAP
Sbjct: 756 YSSCFAGTHGYIAP 769

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15218385|ref|NP_177363.1| leucine-rich receptor-like protein kinase [Arabidopsis thaliana] gi|12323667|gb|AAG51800.1|AC067754_16 leucine-rich receptor-like protein kinase, putative; 28019-31149 [Arabidopsis thaliana] gi|224589477|gb|ACN59272.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332197165|gb|AEE35286.1| leucine-rich receptor-like protein kinase [Arabidopsis thaliana]

 Score =  952 bits (2461), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 487/841 (57%), Positives = 625/841 (74%), Gaps = 13/841 (1%)

Query: 19  LVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEI 78
           L+ +FPP++   VE QAL +FK++L D H +L SWK S DSPC F GITCD ++G V  I
Sbjct: 21  LLFIFPPNVESTVEKQALFRFKNRLDDSHNILQSWKPS-DSPCVFRGITCDPLSGEVIGI 79

Query: 79  SFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP 138
           S  N +LSG IS SISAL  L+ LSLP N +SG++P E+ NC NLKVLN+T N + G++P
Sbjct: 80  SLGNVNLSGTISPSISALTKLSTLSLPSNFISGRIPPEIVNCKNLKVLNLTSNRLSGTIP 139

Query: 139 DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
           +LS LK+LEI D+S N+  G F  W+ N+ QLVSL +G+N Y+E  IPESIG LK LT+L
Sbjct: 140 NLSPLKSLEILDISGNFLNGEFQSWIGNMNQLVSLGLGNNHYEEGIIPESIGGLKKLTWL 199

Query: 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
           FLA  NL G+IP SI +L  L T DI  N IS +FP  I +L  L KIEL+ N+LTG++P
Sbjct: 200 FLARSNLTGKIPNSIFDLNALDTFDIANNAISDDFPILISRLVNLTKIELFNNSLTGKIP 259

Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
            E+ NLT L+EFDISSNQ+ G LPEE+G LK L VF C +NNF+GEFPSGFGD+  L + 
Sbjct: 260 PEIKNLTRLREFDISSNQLSGVLPEELGVLKELRVFHCHENNFTGEFPSGFGDLSHLTSL 319

Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP 378
           SIY N FSG FP N+GR++ L  VDISEN+F+G FP++LC+ +KL  LLAL N FSGE+P
Sbjct: 320 SIYRNNFSGEFPVNIGRFSPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQNEFSGEIP 379

Query: 379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQL 438
            SY +CK++ RLRI++N LSG++ +G W+LP   M+D  DN+ TG +SP IGLST LSQL
Sbjct: 380 RSYGECKSLLRLRINNNRLSGQVVEGFWSLPLAKMIDLSDNELTGEVSPQIGLSTELSQL 439

Query: 439 VLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
           +LQNNRFSG++P ELGRLTN+ER+ L+NNN SG+IP  +G L++LSSLHLE N+LTG IP
Sbjct: 440 ILQNNRFSGKIPRELGRLTNIERIYLSNNNLSGEIPMEVGDLKELSSLHLENNSLTGFIP 499

Query: 499 NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSID 558
            E+ +C ++VDLNLA+N L+G IP SLS ++SLN+L+ SGN+LTG IP +L+KLKLS ID
Sbjct: 500 KELKNCVKLVDLNLAKNFLTGEIPNSLSQIASLNSLDFSGNRLTGEIPASLVKLKLSFID 559

Query: 559 LSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD-QSTKMLMNSKLTACPAIQK-QKGGFKD 616
           LS NQLSG +P D L +GG  AF+ NE LC+D ++ K   N  L+ C   Q  ++    D
Sbjct: 560 LSGNQLSGRIPPDLLAVGGSTAFSRNEKLCVDKENAKTNQNLGLSICSGYQNVKRNSSLD 619

Query: 617 KLVLFCIIAVALAAFLAGLLLVSYKNFKLSA-DMENGE-KEVSSKWKLASFHHIDIDAEQ 674
             +LF  +A+ +   ++GL  + Y+  K+   D EN +  +  +KWK+ASFH +++D ++
Sbjct: 620 GTLLFLALAIVVVVLVSGLFALRYRVVKIRELDSENRDINKADAKWKIASFHQMELDVDE 679

Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIR 729
           IC L+ED++IGSG  GKVYR+DLKK  GTVAVK L +     GDG +V  AEMEILGKIR
Sbjct: 680 ICRLDEDHVIGSGSAGKVYRVDLKKGGGTVAVKWLKRGGGEEGDGTEVSVAEMEILGKIR 739

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           HRN+LKLYACL+  GS +LV E+M NGNL+QAL   +K G PELDW +RYKIA+GAAKGI
Sbjct: 740 HRNVLKLYACLVGRGSRYLVFEFMENGNLYQALGNNIKGGLPELDWLKRYKIAVGAAKGI 799

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
           AYLHHDC PPIIHRDIKSSNILLD DYE KIADFGVAK+A+   K  ++SC AGTHGY+A
Sbjct: 800 AYLHHDCCPPIIHRDIKSSNILLDGDYESKIADFGVAKVAD---KGYEWSCVAGTHGYMA 856

Query: 850 P 850
           P
Sbjct: 857 P 857

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110738078|dbj|BAF00973.1| putative leucine-rich receptor-like protein kinase [Arabidopsis thaliana]

 Score =  952 bits (2460), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 487/841 (57%), Positives = 625/841 (74%), Gaps = 13/841 (1%)

Query: 19  LVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEI 78
           L+ +FPP++   VE QAL +FK++L D H +L SWK S DSPC F GITCD ++G V  I
Sbjct: 21  LLFIFPPNVESTVEKQALFRFKNRLDDSHNILQSWKPS-DSPCVFRGITCDPLSGEVIGI 79

Query: 79  SFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP 138
           S  N +LSG IS SISAL  L+ LSLP N +SG++P E+ NC NLKVLN+T N + G++P
Sbjct: 80  SLGNVNLSGTISPSISALTKLSTLSLPSNFISGRIPPEIVNCKNLKVLNLTSNRLSGTIP 139

Query: 139 DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
           +LS LK+LEI D+S N+  G F  W+ N+ QLVSL +G+N Y+E  IPESIG LK LT+L
Sbjct: 140 NLSPLKSLEILDISGNFLNGEFQSWIGNMNQLVSLGLGNNHYEEGIIPESIGGLKKLTWL 199

Query: 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
           FLA  NL G+IP SI +L  L T DI  N IS +FP  I +L  L KIEL+ N+LTG++P
Sbjct: 200 FLARSNLTGKIPNSIFDLNALDTFDIANNAISDDFPILISRLVNLTKIELFNNSLTGKIP 259

Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
            E+ NLT L+EFDISSNQ+ G LPEE+G LK L VF C +NNF+GEFPSGFGD+  L + 
Sbjct: 260 PEIKNLTRLREFDISSNQLSGVLPEELGVLKELRVFHCHENNFTGEFPSGFGDLSHLTSL 319

Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP 378
           SIY N FSG FP N+GR++ L  VDISEN+F+G FP++LC+ +KL  LLAL N FSGE+P
Sbjct: 320 SIYRNNFSGEFPVNIGRFSPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQNEFSGEIP 379

Query: 379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQL 438
            SY +CK++ RLRI++N LSG++ +G W+LP   M+D  DN+ TG +SP IGLST LSQL
Sbjct: 380 RSYGECKSLLRLRINNNRLSGQVVEGFWSLPLAKMIDLSDNELTGEVSPQIGLSTELSQL 439

Query: 439 VLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
           +LQNNRFSG++P ELGRLTN+ER+ L+NNN SG+IP  +G L++LSSLHLE N+LTG IP
Sbjct: 440 ILQNNRFSGKIPRELGRLTNIERIYLSNNNLSGEIPMEVGDLKELSSLHLENNSLTGFIP 499

Query: 499 NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSID 558
            E+ +C ++VDLNLA+N L+G IP SLS ++SLN+L+ SGN+LTG IP +L+KLKLS ID
Sbjct: 500 KELENCVKLVDLNLAKNFLTGEIPNSLSQIASLNSLDFSGNRLTGEIPASLVKLKLSFID 559

Query: 559 LSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD-QSTKMLMNSKLTACPAIQK-QKGGFKD 616
           LS NQLSG +P D L +GG  AF+ NE LC+D ++ K   N  L+ C   Q  ++    D
Sbjct: 560 LSGNQLSGRIPPDLLAVGGSTAFSRNEKLCVDKENAKTNQNLGLSICSGYQNVKRNSSLD 619

Query: 617 KLVLFCIIAVALAAFLAGLLLVSYKNFKLSA-DMENGE-KEVSSKWKLASFHHIDIDAEQ 674
             +LF  +A+ +   ++GL  + Y+  K+   D EN +  +  +KWK+ASFH +++D ++
Sbjct: 620 GTLLFLALAIVVVVLVSGLFALRYRVVKIRELDSENRDINKADAKWKIASFHQMELDVDE 679

Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIR 729
           IC L+ED++IGSG  GKVYR+DLKK  GTVAVK L +     GDG +V  AEMEILGKIR
Sbjct: 680 ICRLDEDHVIGSGSAGKVYRVDLKKGGGTVAVKWLKRGGGEEGDGTEVSVAEMEILGKIR 739

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           HRN+LKLYACL+  GS +LV E+M NGNL+QAL   +K G PELDW +RYKIA+GAAKGI
Sbjct: 740 HRNVLKLYACLVGRGSRYLVFEFMENGNLYQALGNNIKGGLPELDWLKRYKIAVGAAKGI 799

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
           AYLHHDC PPIIHRDIKSSNILLD DYE KIADFGVAK+A+   K  ++SC AGTHGY+A
Sbjct: 800 AYLHHDCCPPIIHRDIKSSNILLDGDYESKIADFGVAKVAD---KGYEWSCVAGTHGYMA 856

Query: 850 P 850
           P
Sbjct: 857 P 857

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	851
TAIR|locus:2207036	977	AT1G72180 [Arabidopsis thalian	0.969	0.844	0.541	4.6e-240
TAIR|locus:2024432	977	LRR XI-23 [Arabidopsis thalian	0.648	0.564	0.396	1.8e-146
TAIR|locus:2091206	991	IKU2 "HAIKU2" [Arabidopsis tha	0.941	0.808	0.374	4e-138
TAIR|locus:2032553	996	HSL1 "HAESA-like 1" [Arabidops	0.857	0.732	0.388	4.2e-134
TAIR|locus:2005540	999	HAE "HAESA" [Arabidopsis thali	0.573	0.488	0.380	2.9e-133
TAIR|locus:2169975	993	HSL2 "HAESA-like 2" [Arabidops	0.571	0.489	0.377	6.8e-132
TAIR|locus:2204350	980	CLV1 "AT1G75820" [Arabidopsis	0.921	0.8	0.348	1.3e-123
TAIR|locus:2180617	1005	AT5G25930 [Arabidopsis thalian	0.864	0.732	0.344	7.7e-119
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.564	0.473	0.335	3.7e-118
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.571	0.484	0.341	6.8e-117

TAIR|locus:2207036 AT1G72180 [Arabidopsis thaliana (taxid:3702)]

 Score = 2314 (819.6 bits), Expect = 4.6e-240, P = 4.6e-240
 Identities = 454/838 (54%), Positives = 577/838 (68%)

Query:    22 VFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFD 81
             +FPP++   VE QAL +FK++L D H +L SWK S DSPC F GITCD ++G V  IS  
Sbjct:    24 IFPPNVESTVEKQALFRFKNRLDDSHNILQSWKPS-DSPCVFRGITCDPLSGEVIGISLG 82

Query:    82 NKXXXXXXXXXXXXXXXXTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLS 141
             N                 + LSLP N +SG++P E+ NC NLKVLN+T N + G++P+LS
Sbjct:    83 NVNLSGTISPSISALTKLSTLSLPSNFISGRIPPEIVNCKNLKVLNLTSNRLSGTIPNLS 142

Query:   142 ALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLA 201
              LK+LEI D+S N+  G F  W+ N+ QLVSL +G+N Y+E  IPESIG LK LT+LFLA
Sbjct:   143 PLKSLEILDISGNFLNGEFQSWIGNMNQLVSLGLGNNHYEEGIIPESIGGLKKLTWLFLA 202

Query:   202 HCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL 261
               NL G+IP SI +L  L T DI  N IS +FP  I +L  L KIEL+ N+LTG++P E+
Sbjct:   203 RSNLTGKIPNSIFDLNALDTFDIANNAISDDFPILISRLVNLTKIELFNNSLTGKIPPEI 262

Query:   262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIY 321
              NLT L+EFDISSNQ+ G LPEE+G LK L VF C +NNF+GEFPSGFGD+  L + SIY
Sbjct:   263 KNLTRLREFDISSNQLSGVLPEELGVLKELRVFHCHENNFTGEFPSGFGDLSHLTSLSIY 322

Query:   322 GNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSY 381
              N FSG FP N+GR++ L  VDISEN+F+G FP++LC+ +K          FSGE+P SY
Sbjct:   323 RNNFSGEFPVNIGRFSPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQNEFSGEIPRSY 382

Query:   382 ADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQ 441
              +CK++ RLRI++N LSG++ +G W+LP   M+D  DN+ TG +SP IGLST LSQL+LQ
Sbjct:   383 GECKSLLRLRINNNRLSGQVVEGFWSLPLAKMIDLSDNELTGEVSPQIGLSTELSQLILQ 442

Query:   442 NNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501
             NNRFSG++P ELGRLTN+ER+ L+NNN SG+IP  +G L++LSSLHLE N+LTG IP E+
Sbjct:   443 NNRFSGKIPRELGRLTNIERIYLSNNNLSGEIPMEVGDLKELSSLHLENNSLTGFIPKEL 502

Query:   502 GDCARIVDLNLARNSLSGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSE 561
              +C ++VDLNLA+N L+G IP                   TG IP +L+KLKLS IDLS 
Sbjct:   503 KNCVKLVDLNLAKNFLTGEIPNSLSQIASLNSLDFSGNRLTGEIPASLVKLKLSFIDLSG 562

Query:   562 NQLSGSVPLDFLRMGGDGAFAGNEGLCLD-QSTKMLMNSKLTACPAIQKQKGGFK-DKXX 619
             NQLSG +P D L +GG  AF+ NE LC+D ++ K   N  L+ C   Q  K     D   
Sbjct:   563 NQLSGRIPPDLLAVGGSTAFSRNEKLCVDKENAKTNQNLGLSICSGYQNVKRNSSLDGTL 622

Query:   620 XXXXXXXXXXXXXXXXXXVSYKNFKL-SADMENGE-KEVSSKWKLASFHHIDIDAEQICN 677
                               + Y+  K+   D EN +  +  +KWK+ASFH +++D ++IC 
Sbjct:   623 LFLALAIVVVVLVSGLFALRYRVVKIRELDSENRDINKADAKWKIASFHQMELDVDEICR 682

Query:   678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRN 732
             L+ED++IGSG  GKVYR+DLKK  GTVAVK L +G     DG +V  AEMEILGKIRHRN
Sbjct:   683 LDEDHVIGSGSAGKVYRVDLKKGGGTVAVKWLKRGGGEEGDGTEVSVAEMEILGKIRHRN 742

Query:   733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
             +LKLYACL+  GS +LV E+M NGNL+QAL   +K G PELDW +RYKIA+GAAKGIAYL
Sbjct:   743 VLKLYACLVGRGSRYLVFEFMENGNLYQALGNNIKGGLPELDWLKRYKIAVGAAKGIAYL 802

Query:   793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             HHDC PPIIHRDIKSSNILLD DYE KIADFGVAK+A+   K  ++SC AGTHGY+AP
Sbjct:   803 HHDCCPPIIHRDIKSSNILLDGDYESKIADFGVAKVAD---KGYEWSCVAGTHGYMAP 857

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2024432 LRR XI-23 [Arabidopsis thaliana (taxid:3702)]

 Score = 1058 (377.5 bits), Expect = 1.8e-146, Sum P(2) = 1.8e-146
 Identities = 223/563 (39%), Positives = 325/563 (57%)

Query:    32 ETQALIQFKSKLKDPH-GVLDSWK-ESADSPCGFSGITCDSVTGRVTEISFDNKXXXXXX 89
             + Q L++ KS   D +  V DSWK  S   PC F G+TC+S  G VTEI    +      
Sbjct:    30 DLQVLLKLKSSFADSNLAVFDSWKLNSGIGPCSFIGVTCNS-RGNVTEIDLSRRGLSGNF 88

Query:    90 XXXXX-XXXXXTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEI 148
                          LSL FN LSG +P +L NC++LK L++  N   G+ P+ S+L  L+ 
Sbjct:    89 PFDSVCEIQSLEKLSLGFNSLSGIIPSDLKNCTSLKYLDLGNNLFSGAFPEFSSLNQLQF 148

Query:   149 FDLSINYFTGRFPRW--VVNLTQLVSLSIGDNVYDE-AEIPESIGNLKNLTYLFLAHCNL 205
               L+ + F+G FP W  + N T LV LS+GDN +D  A+ P  + +LK L++L+L++C++
Sbjct:   149 LYLNNSAFSGVFP-WKSLRNATSLVVLSLGDNPFDATADFPVEVVSLKKLSWLYLSNCSI 207

Query:   206 RGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLT 265
              G+IP +I +L EL  L+I  + ++GE P  I KL  LW++ELY N+LTG+LP   GNL 
Sbjct:   208 AGKIPPAIGDLTELRNLEISDSGLTGEIPSEISKLTNLWQLELYNNSLTGKLPTGFGNLK 267

Query:   266 LLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325
              L   D S+N + G L  E+ +L NL   Q F+N FSGE P  FG+ + L   S+Y N+ 
Sbjct:   268 NLTYLDASTNLLQGDL-SELRSLTNLVSLQMFENEFSGEIPLEFGEFKDLVNLSLYTNKL 326

Query:   326 SGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCK 385
             +G  P+ LG       +D SEN  +G  P  +C+  K           +G +P SYA+C 
Sbjct:   327 TGSLPQGLGSLADFDFIDASENLLTGPIPPDMCKNGKMKALLLLQNNLTGSIPESYANCL 386

Query:   386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF 445
             T+QR R+S+N+L+G +P GLW LP + ++D   N+F G I+  I     L  L L  N+ 
Sbjct:   387 TLQRFRVSENNLNGTVPAGLWGLPKLEIIDIEMNNFEGPITADIKNGKMLGALYLGFNKL 446

Query:   446 SGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA 505
             S ELP E+G   +L ++ L NN F+GKIPS++G L+ LSSL ++ N  +G IP+ +G C+
Sbjct:   447 SDELPEEIGDTESLTKVELNNNRFTGKIPSSIGKLKGLSSLKMQSNGFSGEIPDSIGSCS 506

Query:   506 RIVDLNLARNSLSGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSENQLS 565
              + D+N+A+NS+SG IP                   +G IP++L  L+LS +DLS N+LS
Sbjct:   507 MLSDVNMAQNSISGEIPHTLGSLPTLNALNLSDNKLSGRIPESLSSLRLSLLDLSNNRLS 566

Query:   566 GSVPLDFLRMGGDGAFAGNEGLC 588
             G +PL       +G+F GN GLC
Sbjct:   567 GRIPLSLSSY--NGSFNGNPGLC 587

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0006979 "response to oxidative stress" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

GO:0070825 "micropyle" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2091206 IKU2 "HAIKU2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1352 (481.0 bits), Expect = 4.0e-138, P = 4.0e-138
 Identities = 320/855 (37%), Positives = 459/855 (53%)

Query:    32 ETQALIQFKSKLKDPHG--VLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKXXXXXX 89
             E + L++ KS   +     V  +W    +S C F+GI C+S  G V EI+  ++      
Sbjct:    26 EVENLLKLKSTFGETKSDDVFKTWTHR-NSACEFAGIVCNS-DGNVVEINLGSRSLINRD 83

Query:    90 XXXXXXXX-XXTVLSLPF--------NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDL 140
                        ++  L          N L G++   L  C+ L+ L++  N   G  P +
Sbjct:    84 DDGRFTDLPFDSICDLKLLEKLVLGNNSLRGQIGTNLGKCNRLRYLDLGINNFSGEFPAI 143

Query:   141 SALKNLEIFDLSINYFTGRFPRW--VVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
              +L+ LE   L+ +  +G FP W  + +L +L  LS+GDN +     P  I NL  L ++
Sbjct:   144 DSLQLLEFLSLNASGISGIFP-WSSLKDLKRLSFLSVGDNRFGSHPFPREILNLTALQWV 202

Query:   199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
             +L++ ++ G+IPE I  L  L  L++  N+ISGE P+ I +L+ L ++E+Y+N+LTG+LP
Sbjct:   203 YLSNSSITGKIPEGIKNLVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIYSNDLTGKLP 262

Query:   259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
                 NLT L+ FD S+N + G L  E+  LKNL     F+N  +GE P  FGD + L A 
Sbjct:   263 LGFRNLTNLRNFDASNNSLEGDL-SELRFLKNLVSLGMFENRLTGEIPKEFGDFKSLAAL 321

Query:   319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVP 378
             S+Y N+ +G  P  LG +TA   +D+SEN   G  P Y+C+K            F+G+ P
Sbjct:   322 SLYRNQLTGKLPRRLGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQNRFTGQFP 381

Query:   379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQL 438
              SYA CKT+ RLR+S+N LSG IP G+W LPN+  LD   N F G ++  IG + SL  L
Sbjct:   382 ESYAKCKTLIRLRVSNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIGNAKSLGSL 441

Query:   439 VLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
              L NNRFSG LP ++    +L  + L  N FSG +P + G L++LSSL L++N L+G+IP
Sbjct:   442 DLSNNRFSGSLPFQISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQNNLSGAIP 501

Query:   499 NEMGDCARIVDLNLARNSLSGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSID 558
               +G C  +VDLN A NSLS  IP                   +G IP  L  LKLS +D
Sbjct:   502 KSLGLCTSLVDLNFAGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLSALKLSLLD 561

Query:   559 LSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKX 618
             LS NQL+GSVP   +     G+F GN GLC   S+K+     L  CP  +    G K K 
Sbjct:   562 LSNNQLTGSVPESLV----SGSFEGNSGLC---SSKIRY---LRPCPLGKPHSQG-KRKH 610

Query:   619 XXXXXXXXXXXXXXXXXXXVSYKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQICN- 677
                                 SY  FK+  D  N   +  + W+++SF  ++ +  +I + 
Sbjct:   611 LSKVDMCFIVAAILALFFLFSYVIFKIRRDKLNKTVQKKNDWQVSSFRLLNFNEMEIIDE 670

Query:   678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---------------KGDGVK-----V 717
             ++ +N+IG GG G VY++ L+    T+AVK +W                 DG        
Sbjct:   671 IKSENIIGRGGQGNVYKVSLRSGE-TLAVKHIWCPESSHESFRSSTAMLSDGNNRSNNGE 729

Query:   718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR 777
             F AE+  L  I+H N++KL+  +    S  LV EYMPNG+L++ LH+R   G+ E+ W  
Sbjct:   730 FEAEVATLSNIKHINVVKLFCSITCEDSKLLVYEYMPNGSLWEQLHER--RGEQEIGWRV 787

Query:   778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
             R  +ALGAAKG+ YLHH    P+IHRD+KSSNILLDE++ P+IADFG+AKI +      D
Sbjct:   788 RQALALGAAKGLEYLHHGLDRPVIHRDVKSSNILLDEEWRPRIADFGLAKIIQADSVQRD 847

Query:   838 YSC--FAGTHGYIAP 850
             +S     GT GYIAP
Sbjct:   848 FSAPLVKGTLGYIAP 862

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009960 "endosperm development" evidence=IMP

TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1314 (467.6 bits), Expect = 4.2e-134, P = 4.2e-134
 Identities = 299/769 (38%), Positives = 427/769 (55%)

Query:   102 LSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRF 160
             L L  N+L+G+LP  L++   L  L++TGN   G +P      +NLE+  L  N   G  
Sbjct:   113 LDLSQNLLTGELPQTLADIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTI 172

Query:   161 PRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELG 220
             P ++ N++ L  L++  N +  + IP   GNL NL  ++L  C+L G+IP+S+ +L +L 
Sbjct:   173 PPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLV 232

Query:   221 TLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK 280
              LD+  N + G  P S+  L  + +IELY N+LTGE+P ELGNL  L+  D S NQ+ GK
Sbjct:   233 DLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGK 292

Query:   281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALT 340
             +P+E+  +  L     ++NN  GE P+       L+   I+GNR +G  P++LG  + L 
Sbjct:   293 IPDELCRVP-LESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLR 351

Query:   341 DVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLSGK 400
              +D+SEN+FSG  P  LC K +          FSG +P S ADC+++ R+R++ N  SG 
Sbjct:   352 WLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGS 411

Query:   401 IPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE 460
             +P G W LP+V +L+  +N F+G IS  IG +++LS L+L NN F+G LP E+G L NL 
Sbjct:   412 VPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLN 471

Query:   461 RLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGN 520
             +L  + N FSG +P +L +L +L +L L  N  +G + + +    ++ +LNLA N  +G 
Sbjct:   472 QLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGK 531

Query:   521 IPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGA 580
             IP                   +G IP +L  LKL+ ++LS N+LSG +P    +     +
Sbjct:   532 IPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNS 591

Query:   581 FAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKXXXXXXXXXXXXXXXXXXXXVSY 640
             F GN GLC D   K L  S+  A      +K G+                         Y
Sbjct:   592 FIGNPGLCGD--IKGLCGSENEA------KKRGYVWLLRSIFVLAAMVLLAGVAWFYFKY 643

Query:   641 KNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQIC-NLEEDNLIGSGGTGKVYRLDLKK 699
             + FK +  ME       SKW L SFH +     +I  +L+EDN+IG+G +GKVY++ L  
Sbjct:   644 RTFKKARAMER------SKWTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVLT- 696

Query:   700 NAGTVAVKQLWKGD---------------GVK--VFAAEMEILGKIRHRNILKLYACLLK 742
             N  TVAVK+LW G                GV+   F AE+E LGKIRH+NI+KL+ C   
Sbjct:   697 NGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCST 756

Query:   743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
                  LV EYMPNG+L   LH   K G   L W  R+KI L AA+G++YLHHD  PPI+H
Sbjct:   757 RDCKLLVYEYMPNGSLGDLLHSS-KGGM--LGWQTRFKIILDAAEGLSYLHHDSVPPIVH 813

Query:   803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKV-SDYSCFAGTHGYIAP 850
             RDIKS+NIL+D DY  ++ADFGVAK  + + K     S  AG+ GYIAP
Sbjct:   814 RDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAP 862

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)]

 Score = 878 (314.1 bits), Expect = 2.9e-133, Sum P(2) = 2.9e-133
 Identities = 187/491 (38%), Positives = 274/491 (55%)

Query:   102 LSLPFNVLSGKLPLELS-NCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGR 159
             L L  N+L G +P  L  N  NLK L ++GN +  ++P      + LE  +L+ N+ +G 
Sbjct:   119 LDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGT 178

Query:   160 FPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL 219
              P  + N+T L  L +  N++  ++IP  +GNL  L  L+LA CNL G IP S+S L  L
Sbjct:   179 IPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSL 238

Query:   220 GTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG 279
               LD+  N+++G  P  I +L+ + +IEL+ N+ +GELP  +GN+T L+ FD S N++ G
Sbjct:   239 VNLDLTFNQLTGSIPSWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTG 298

Query:   280 KLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTAL 339
             K+P+ + NL NL     F+N   G  P      + L    ++ NR +G  P  LG  + L
Sbjct:   299 KIPDNL-NLLNLESLNLFENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPL 357

Query:   340 TDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLSG 399
               VD+S N+FSG  P  +C + K          FSGE+ N+   CK++ R+R+S+N LSG
Sbjct:   358 QYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSG 417

Query:   400 KIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459
             +IP G W LP + +L+  DN FTG I   I  + +LS L +  NRFSG +P+E+G L  +
Sbjct:   418 QIPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGI 477

Query:   460 ERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSG 519
               +    N+FSG+IP +L  L+QLS L L +N L+G IP E+     + +LNLA N LSG
Sbjct:   478 IEISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSG 537

Query:   520 NIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDG 579
              IP+                  +G IP  L  LKL+ ++LS N LSG +P  +       
Sbjct:   538 EIPKEVGILPVLNYLDLSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAH 597

Query:   580 AFAGNEGLCLD 590
              F GN GLC+D
Sbjct:   598 DFIGNPGLCVD 608

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 860 (307.8 bits), Expect = 6.8e-132, Sum P(2) = 6.8e-132
 Identities = 184/488 (37%), Positives = 268/488 (54%)

Query:   102 LSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRF 160
             L L  N  SGKLP        L+VL +  N   G +P     L  L++ +L+ N  +G  
Sbjct:   128 LILNQNNFSGKLPEFSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIV 187

Query:   161 PRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELG 220
             P ++  LT+L  L +    +D + IP ++GNL NLT L L H NL G IP+SI  L  L 
Sbjct:   188 PAFLGYLTELTRLDLAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLE 247

Query:   221 TLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK 280
              LD+  N ++GE P SI +L+ +++IELY N L+G+LP  +GNLT L+ FD+S N + G+
Sbjct:   248 NLDLAMNSLTGEIPESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGE 307

Query:   281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALT 340
             LPE+I  L+ L  F    N F+G  P        L  F I+ N F+G  P NLG+++ ++
Sbjct:   308 LPEKIAALQ-LISFNLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEIS 366

Query:   341 DVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLSGK 400
             + D+S N+FSG  P YLC +RK           SGE+P SY DC ++  +R++DN LSG+
Sbjct:   367 EFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGE 426

Query:   401 IPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE 460
             +P   W LP   +    +N   G I P I  +  LSQL +  N FSG +P +L  L +L 
Sbjct:   427 VPARFWELPLTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLR 486

Query:   461 RLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGN 520
              + L+ N+F G IPS +  L+ L  + ++EN L G IP+ +  C  + +LNL+ N L G 
Sbjct:   487 VIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGG 546

Query:   521 IPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGA 580
             IP                   TG IP  L++LKL+  ++S+N+L G +P  F +     +
Sbjct:   547 IPPELGDLPVLNYLDLSNNQLTGEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPS 606

Query:   581 FAGNEGLC 588
             F GN  LC
Sbjct:   607 FLGNPNLC 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)]

 Score = 1215 (432.8 bits), Expect = 1.3e-123, P = 1.3e-123
 Identities = 293/840 (34%), Positives = 435/840 (51%)

Query:    47 HGVLD-SWKESADSPCGFSGITCDSVTGRVTEISFDNKXXXXXXXXXXXXXXXXTVLSLP 105
             HG+ D     S D+ C FSG++CD    RV  ++                      L+L 
Sbjct:    44 HGLHDWIHSSSPDAHCSFSGVSCDD-DARVISLNVSFTPLFGTISPEIGMLTHLVNLTLA 102

Query:   106 FNVLSGKLPLELSNCSNLKVLNVTGNA-MVGSVPD--LSALKNLEIFDLSINYFTGRFPR 162
              N  +G+LPLE+ + ++LKVLN++ N  + G+ P   L A+ +LE+ D   N F G+ P 
Sbjct:   103 ANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAMVDLEVLDTYNNNFNGKLPP 162

Query:   163 WVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL-------------FLAHC-NLR-- 206
              +  L +L  LS G N +   EIPES G++++L YL             FL+   NLR  
Sbjct:   163 EMSELKKLKYLSFGGNFFS-GEIPESYGDIQSLEYLGLNGAGLSGKSPAFLSRLKNLREM 221

Query:   207 ---------GRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
                      G +P     L +L  LD+    ++GE P S+  L+ L  + L+ NNLTG +
Sbjct:   222 YIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKHLHTLFLHINNLTGHI 281

Query:   258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFA 317
             P EL  L  L+  D+S NQ+ G++P+   NL N+T+   F+NN  G+ P   G++ KL  
Sbjct:   282 PPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRNNLYGQIPEAIGELPKLEV 341

Query:   318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEV 377
             F ++ N F+   P NLGR   L  +D+S+N  +G  PK LC   K          F G +
Sbjct:   342 FEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCRGEKLEMLILSNNFFFGPI 401

Query:   378 PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQ 437
             P     CK++ ++RI  N L+G +P GL+ LP V +++  DN F+G + P+      L Q
Sbjct:   402 PEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFSGEL-PVTMSGDVLDQ 460

Query:   438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI 497
             + L NN FSGE+P  +G   NL+ L L  N F G IP  +  L+ LS ++   N +TG I
Sbjct:   461 IYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFELKHLSRINTSANNITGGI 520

Query:   498 PNEMGDCARIVDLNLARNSLSGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKL-KLSS 556
             P+ +  C+ ++ ++L+RN ++G IP+                  TGSIP  +  +  L++
Sbjct:   521 PDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTGIGNMTSLTT 580

Query:   557 IDLSENQLSGSVPL--DFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGF 614
             +DLS N LSG VPL   FL +  + +FAGN  LCL             +CP    Q    
Sbjct:   581 LDLSFNDLSGRVPLGGQFL-VFNETSFAGNTYLCLPHRV---------SCPTRPGQTSDH 630

Query:   615 KDKXXXXXXXXXXXXXXXXXXXXVSYKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQ 674
                                    +     +    M   + + S  WKL +F  +D  +E 
Sbjct:   631 NHTALFSPSRIVITVIAAITGLILISVAIR---QMNKKKNQKSLAWKLTAFQKLDFKSED 687

Query:   675 ICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKV--FAAEMEILGKIRH 730
             +   L+E+N+IG GG G VYR  +  N   VA+K+L  +G G     F AE++ LG+IRH
Sbjct:   688 VLECLKEENIIGKGGAGIVYRGSMPNNVD-VAIKRLVGRGTGRSDHGFTAEIQTLGRIRH 746

Query:   731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
             R+I++L   +    ++ L+ EYMPNG+L + LH   K G   L W  R+++A+ AAKG+ 
Sbjct:   747 RHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGS-KGG--HLQWETRHRVAVEAAKGLC 803

Query:   791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             YLHHDCSP I+HRD+KS+NILLD D+E  +ADFG+AK   +       S  AG++GYIAP
Sbjct:   804 YLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYIAP 863

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0007172 "signal complex assembly" evidence=IDA

GO:0016021 "integral to membrane" evidence=TAS

GO:0030154 "cell differentiation" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

GO:0009934 "regulation of meristem structural organization" evidence=IMP

GO:0016020 "membrane" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

TAIR|locus:2180617 AT5G25930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1170 (416.9 bits), Expect = 7.7e-119, P = 7.7e-119
 Identities = 263/764 (34%), Positives = 409/764 (53%)

Query:   102 LSLPFNVLSGKLPLELSNCS-NLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGR 159
             L L  N+L+G LP+++   S  L  L++  N   G +P  L  +  L++ +L  + + G 
Sbjct:   116 LDLSQNLLNGSLPVDIDRLSPELDYLDLAANGFSGDIPKSLGRISKLKVLNLYQSEYDGT 175

Query:   160 FPRWVVNLTQLVSLSIGDN-VYDEAEIPESIGNLKNLTYLFLAHCNLRGRI-PESISELR 217
             FP  + +L++L  L +  N  +  A+IP   G LK L Y++L   NL G I P     + 
Sbjct:   176 FPSEIGDLSELEELRLALNDKFTPAKIPIEFGKLKKLKYMWLEEMNLIGEISPVVFENMT 235

Query:   218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQM 277
             +L  +D+  N ++G  P  +  L+ L +  L+AN LTGE+P  + + T L   D+S+N +
Sbjct:   236 DLEHVDLSVNNLTGRIPDVLFGLKNLTEFYLFANGLTGEIPKSI-SATNLVFLDLSANNL 294

Query:   278 YGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYT 337
              G +P  IGNL  L V   F N  +GE P   G +  L  F I+ N+ +G  P  +G ++
Sbjct:   295 TGSIPVSIGNLTKLQVLNLFNNKLTGEIPPVIGKLPGLKEFKIFNNKLTGEIPAEIGVHS 354

Query:   338 ALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHL 397
              L   ++SENQ +G  P+ LC+  K           +GE+P S  DC T+  +++ +N  
Sbjct:   355 KLERFEVSENQLTGKLPENLCKGGKLQGVVVYSNNLTGEIPESLGDCGTLLTVQLQNNDF 414

Query:   398 SGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLT 457
             SGK P  +W   ++  L   +N FTG +     ++ ++S++ + NNRFSGE+P ++G  +
Sbjct:   415 SGKFPSRIWNASSMYSLQVSNNSFTGELPE--NVAWNMSRIEIDNNRFSGEIPKKIGTWS 472

Query:   458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSL 517
             +L      NN FSG+ P  L +L  L S+ L+EN LTG +P+E+     ++ L+L++N L
Sbjct:   473 SLVEFKAGNNQFSGEFPKELTSLSNLISIFLDENDLTGELPDEIISWKSLITLSLSKNKL 532

Query:   518 SGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGG 577
             SG IPR                  +G IP  +  LKL++ ++S N+L+G +P     +  
Sbjct:   533 SGEIPRALGLLPRLLNLDLSENQFSGGIPPEIGSLKLTTFNVSSNRLTGGIPEQLDNLAY 592

Query:   578 DGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKXXXXXXXXXXXXXXXXXXXX 637
             + +F  N  LC D     L +     C   ++   GF  K                    
Sbjct:   593 ERSFLNNSNLCADNPVLSLPD-----CRKQRRGSRGFPGKILAMILVIAVLLLTITL--- 644

Query:   638 VSYKNFKLSADMENGEKEVSSK-WKLASFHHIDI-DAEQICNLEEDNLIGSGGTGKVYRL 695
               +  F +  D    ++    + WKL SFH +D  +++ + NL E  +IGSGG+GKVY++
Sbjct:   645 --FVTFFVVRDYTRKQRRRGLETWKLTSFHRVDFAESDIVSNLMEHYVIGSGGSGKVYKI 702

Query:   696 DLKKNAGTVAVKQLWKGDGV-----KVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750
              ++ +   VAVK++W    +     K F AE+EILG IRH NI+KL  C+ +  S  LV 
Sbjct:   703 FVESSGQCVAVKRIWDSKKLDQKLEKEFIAEVEILGTIRHSNIVKLLCCISREDSKLLVY 762

Query:   751 EYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
             EY+   +L Q LH + K G  E   L W +R  IA+GAA+G+ Y+HHDC+P IIHRD+KS
Sbjct:   763 EYLEKRSLDQWLHGKKKGGTVEANNLTWSQRLNIAVGAAQGLCYMHHDCTPAIIHRDVKS 822

Query:   808 SNILLDEDYEPKIADFGVAKIA-ENSPKVSDYSCFAGTHGYIAP 850
             SNILLD ++  KIADFG+AK+  + + +    S  AG+ GYIAP
Sbjct:   823 SNILLDSEFNAKIADFGLAKLLIKQNQEPHTMSAVAGSFGYIAP 866

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 730 (262.0 bits), Expect = 3.7e-118, Sum P(2) = 3.7e-118
 Identities = 163/486 (33%), Positives = 250/486 (51%)

Query:   107 NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVV 165
             N  SG L L  +    L  LN +GN + G++  DL  L +LE+ DL  N+F G  P    
Sbjct:   126 NSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFK 185

Query:   166 NLTQLVSLSI-GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDI 224
             NL +L  L + G+N+    E+P  +G L +L    L +   +G IP     +  L  LD+
Sbjct:   186 NLQKLRFLGLSGNNL--TGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDL 243

Query:   225 CRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEE 284
                K+SGE P  + KL+ L  + LY NN TG +P E+G++T L+  D S N + G++P E
Sbjct:   244 AIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPME 303

Query:   285 IGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDI 344
             I  LKNL +    +N  SG  P     + +L    ++ N  SG  P +LG+ + L  +D+
Sbjct:   304 ITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDV 363

Query:   345 SENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLSGKIPDG 404
             S N FSG  P  LC K            F+G++P + + C+++ R+R+ +N L+G IP G
Sbjct:   364 SSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIG 423

Query:   405 LWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLIL 464
                L  +  L+   N  +GGI   I  S SLS +    N+    LPS +  + NL+  ++
Sbjct:   424 FGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLV 483

Query:   465 TNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRX 524
              +N  SG++P        LS+L L  N LTG+IP+ +  C ++V LNL  N+L+G IPR 
Sbjct:   484 ADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQ 543

Query:   525 XXXXXXXXXXXXXXXXXTGSIPDNL-MKLKLSSIDLSENQLSGSVPLD-FLRMGGDGAFA 582
                              TG +P+++     L  +++S N+L+G VP++ FL+        
Sbjct:   544 ITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLR 603

Query:   583 GNEGLC 588
             GN GLC
Sbjct:   604 GNSGLC 609

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 734 (263.4 bits), Expect = 6.8e-117, Sum P(2) = 6.8e-117
 Identities = 168/492 (34%), Positives = 251/492 (51%)

Query:   102 LSLPFNVLSGKLPLELSN-CSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGR 159
             L+L  NV +G  P E+S+   NL+VL+V  N + G +P  ++ L  L    L  NYF G+
Sbjct:   122 LNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGK 181

Query:   160 FPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN-LRGRIPESISELRE 218
              P    +   +  L++  N     +IP  IGNL  L  L++ + N     +P  I  L E
Sbjct:   182 IPPSYGSWPVIEYLAVSGNEL-VGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSE 240

Query:   219 LGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY 278
             L   D     ++GE P  I KLQKL  + L  N  +G L  ELG L+ L+  D+S+N   
Sbjct:   241 LVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFT 300

Query:   279 GKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338
             G++P     LKNLT+   F+N   GE P   GD+ +L    ++ N F+G  P+ LG    
Sbjct:   301 GEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGK 360

Query:   339 LTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLS 398
             L  VD+S N+ +G+ P  +C   K            G +P+S   C+++ R+R+ +N L+
Sbjct:   361 LNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLN 420

Query:   399 GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458
             G IP GL+ LP +  ++  DN  +G +    G+S +L Q+ L NN+ SG LP  +G  T 
Sbjct:   421 GSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTG 480

Query:   459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
             +++L+L  N F G IPS +G L+QLS +    N  +G I  E+  C  +  ++L+RN LS
Sbjct:   481 VQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELS 540

Query:   519 GNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLK-LSSIDLSENQLSGSVP-LDFLRMG 576
             G IP                    GSIP ++  ++ L+S+D S N LSG VP        
Sbjct:   541 GEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYF 600

Query:   577 GDGAFAGNEGLC 588
                +F GN  LC
Sbjct:   601 NYTSFLGNPDLC 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00190700 hypothetical protein (977 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	851
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-142
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-38
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-33
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-27
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-09
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	1e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
PRK15387	788	PRK15387, PRK15387, E3 ubiquitin-protein ligase Ss	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.002
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	0.002
PLN03210	1153	PLN03210, PLN03210, Resistant to P	0.003
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  445 bits (1146), Expect = e-142
 Identities = 288/883 (32%), Positives = 450/883 (50%), Gaps = 72/883 (8%)

Query: 2   AKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPC 61
            K P  C +L+ +L F+ ++    S+    E + L+ FKS + DP   L +W  SAD  C
Sbjct: 3   KKGPQHCPYLIFMLFFLFLNF---SMLHAEELELLLSFKSSINDPLKYLSNWNSSADV-C 58

Query: 62  GFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLP------- 114
            + GITC++ + RV  I    K++SG+ISS+I  L  +  ++L  N LSG +P       
Sbjct: 59  LWQGITCNNSS-RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117

Query: 115 -----LELSN-----------CSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFT 157
                L LSN             NL+ L+++ N + G +P D+ +  +L++ DL  N   
Sbjct: 118 SSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177

Query: 158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELR 217
           G+ P  + NLT L  L++  N     +IP  +G +K+L +++L + NL G IP  I  L 
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQL-VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236

Query: 218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQM 277
            L  LD+  N ++G  P S+  L+ L  + LY N L+G +P  + +L  L   D+S N +
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296

Query: 278 YGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYT 337
            G++PE +  L+NL +   F NNF+G+ P     + +L    ++ N+FSG  P+NLG++ 
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356

Query: 338 ALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHL 397
            LT +D+S N  +G  P+ LC    L  L+  SN+  GE+P S   C++++R+R+ DN  
Sbjct: 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF 416

Query: 398 SGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLT 457
           SG++P     LP V  LD  +N+  G I+       SL  L L  N+F G LP   G   
Sbjct: 417 SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-K 475

Query: 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSL 517
            LE L L+ N FSG +P  LG+L +L  L L EN L+G IP+E+  C ++V L+L+ N L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535

Query: 518 SGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLD--FLR 574
           SG IP S S +  L+ L+LS N+L+G IP NL  ++ L  +++S N L GS+P    FL 
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA 595

Query: 575 MGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAG 634
           +    A AGN  LC   +T     S L  C  ++K    +     + C +   L   L  
Sbjct: 596 INAS-AVAGNIDLCGGDTT-----SGLPPCKRVRKTPSWW---FYITCTLGAFLVLALVA 646

Query: 635 LLLVSYKNFKLSADMENGEKEVSSKWKLASFH-----HIDIDAEQICNLEEDNLIGSGGT 689
              V  +      +++  E E    W+L  F       I I+   + +L+E+N+I  G  
Sbjct: 647 FGFVFIRGRNNL-ELKRVENE-DGTWELQFFDSKVSKSITIND-ILSSLKEENVISRGKK 703

Query: 690 GKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIRHRNILKLYACLLKGGSSF 747
           G  Y+    KN     VK++   + +       EI  +GK++H NI+KL         ++
Sbjct: 704 GASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759

Query: 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
           L+ EY+   NL + L          L W RR KIA+G AK + +LH  CSP ++  ++  
Sbjct: 760 LIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811

Query: 808 SNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I++D   EP +      +++      +D  CF  +  Y+AP
Sbjct: 812 EKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AYVAP 847

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  141 bits (359), Expect = 2e-38
 Identities = 60/171 (35%), Positives = 86/171 (50%), Gaps = 13/171 (7%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           +G GG G VY    KK    VA+K +        ++    E+EIL K+ H NI+KLY   
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
                 +LV+EY   G+L   L +     + +L      +I L   +G+ YLH   S  I
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKEN----EGKLSEDEILRILLQILEGLEYLH---SNGI 113

Query: 801 IHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRD+K  NILLD D  + K+ADFG++K+  +   +       GT  Y+AP
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  142 bits (361), Expect = 4e-38
 Identities = 66/171 (38%), Positives = 85/171 (49%), Gaps = 14/171 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
           +GSG  G VY+   K     VAVK L K        +    E+ IL ++ H NI++L   
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                  +LV+EY   G+LF  L +        L      KIAL   +G+ YLH   S  
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGGP-----LSEDEAKKIALQILRGLEYLH---SNG 118

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+K  NILLDE+   KIADFG+AK    S   S  + F GT  Y+AP
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMAP 167

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  136 bits (345), Expect = 6e-36
 Identities = 65/172 (37%), Positives = 88/172 (51%), Gaps = 14/172 (8%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYA 738
             +G G  GKVY    KK    VA+K + K    K       E++IL K++H NI++LY 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +LV+EY   G+LF  L KR   G+   D  R Y         + YLH   S 
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEARFY--LRQILSALEYLH---SK 116

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRD+K  NILLDED   K+ADFG+A+  +   K++    F GT  Y+AP
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  131 bits (333), Expect = 2e-34
 Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 16/158 (10%)

Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGD----GVKVFAAEMEILGKIR 729
           L     +G G  G+VY+  LK   G     VAVK L K D     ++ F  E  I+ K+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLD 59

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           H N++KL     +    ++V+EYM  G+    L   +++ +P+L        AL  A+G+
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGD----LLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            YL    S   IHRD+ + N L+ E+   KI+DFG+++
Sbjct: 116 EYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  129 bits (328), Expect = 1e-33
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 13/157 (8%)

Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKG---DGVKVFAAEMEILGKIRH 730
           L     +G G  G+VY+  LK         VAVK L +      ++ F  E  I+ K+ H
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI+KL     +     +V+EYMP G+L   L K       EL        AL  A+G+ 
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN---RPKELSLSDLLSFALQIARGME 117

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           YL    S   IHRD+ + N L+ E+   KI+DFG+++
Sbjct: 118 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  125 bits (316), Expect = 4e-32
 Identities = 53/157 (33%), Positives = 75/157 (47%), Gaps = 15/157 (9%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG----VKVFAAEMEILGKIRHRNIL 734
             +G G  G+VY+  LK   G    VAVK L K D      K F  E  ++ K+ H N++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKR----VKEGKPELDWFRRYKIALGAAKGIA 790
           +L     +    +LVLEYM  G+L   L K         K  L        A+  AKG+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           YL    S   +HRD+ + N L+ ED   KI+DFG+++
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  119 bits (301), Expect = 5e-30
 Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 14/157 (8%)

Query: 678 LEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           LE    +G G  G+VY+     D +     VAVK L +G   +    F  E  I+ K+ H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L     +G   ++V EYMP G+L   L K       +L      ++AL  AKG+ 
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH----GEKLTLKDLLQMALQIAKGME 116

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           YL    S   +HRD+ + N L+ E+   KI+DFG+++
Sbjct: 117 YLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  112 bits (282), Expect = 1e-27
 Identities = 56/172 (32%), Positives = 85/172 (49%), Gaps = 18/172 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLW--KGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG GG G+VY+   K+    VA+K +     +  +    E++IL K +H NI+K Y   L
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA---LGAAKGIAYLHHDCSP 798
           K    ++V+E+   G+L   L    +            +IA       KG+ YLH   S 
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQT-------LTESQIAYVCKELLKGLEYLH---SN 117

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            IIHRDIK++NILL  D E K+ DFG++    ++   +      GT  ++AP
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  109 bits (275), Expect = 1e-26
 Identities = 57/175 (32%), Positives = 82/175 (46%), Gaps = 14/175 (8%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLY 737
            L+G G  G VY    K     +AVK +       + ++    E+ IL  ++H NI++ Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 738 ACLLKGGSSFL--VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
                   + L   LEY+  G+L   L K    GK      R+Y   +   +G+AYLH  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQI--LEGLAYLH-- 118

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  I+HRDIK +NIL+D D   K+ADFG AK   +           GT  ++AP
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  109 bits (275), Expect = 1e-26
 Identities = 61/179 (34%), Positives = 92/179 (51%), Gaps = 22/179 (12%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQL-WKG--DGVKVFA-AEMEILGKIRHRNILKLY 737
             IG G  GKVY +  K +     +K++      +  +  A  E++IL K+ H NI+K Y
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAKGIAYL 792
               + G   +V+EY   G+L Q + K+ KEGK  PE   LDWF   ++ L     + YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCLA----LKYL 119

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC-FAGTHGYIAP 850
           H   S  I+HRDIK  NI L  +   K+ DFG++K+  ++    D +    GT  Y++P
Sbjct: 120 H---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VDLAKTVVGTPYYLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (274), Expect = 2e-26
 Identities = 63/180 (35%), Positives = 91/180 (50%), Gaps = 18/180 (10%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVF----AAEMEILGKIRHRN 732
           +LE   ++G G +G VY++  K      A+K++   DG + F      E++ L       
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           ++K Y    K G   +VLEYM  G+L   L K  K  +P L       IA    KG+ YL
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYL 115

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS--PKVSDYSCFAGTHGYIAP 850
           H      IIHRDIK SN+L++   E KIADFG++K+ EN+     +    F GT  Y++P
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT----FVGTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 9e-25
 Identities = 58/175 (33%), Positives = 95/175 (54%), Gaps = 18/175 (10%)

Query: 682 NLIGSGGTGKVYR-LDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKL 736
           +LIG G  G VY+ L+  +    VA+KQ+     K + +K    E+++L  ++H NI+K 
Sbjct: 6   DLIGRGAFGVVYKGLN-LETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
              +    S +++LEY  NG+L Q + K     +  +  +  Y++     +G+AYLH   
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV-YQVL----QGLAYLH--- 116

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
              +IHRDIK++NIL  +D   K+ADFGVA K+ + S   +      GT  ++AP
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 2e-22
 Identities = 69/177 (38%), Positives = 89/177 (50%), Gaps = 25/177 (14%)

Query: 684 IGSGGTGKVYRLDLKKNAGTV-AVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
           +G G  GKV  L  KK+ G + A+K L K        V+    E  IL +I H  I+KL+
Sbjct: 1   LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRY--KIALGAAKGIAYLH- 793
                    +LVLEY P G LF  L K   EG+  E +  R Y  +I L     + YLH 
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSE-ERARFYAAEIVLA----LEYLHS 111

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                 II+RD+K  NILLD D   K+ DFG+AK  E S + S  + F GT  Y+AP
Sbjct: 112 LG----IIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 17/181 (9%)

Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN 732
           E++ ++ E   +G G  G VY+   K+    VA+K +   + ++    E+ IL +     
Sbjct: 2   EEVFDILE--KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPY 59

Query: 733 ILKLYACLLKGGSSFLVLEYMPNG---NLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           I+K Y    K    ++V+EY   G   ++ +  +K + E +          I     KG+
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKGL 112

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
            YLH   S   IHRDIK+ NILL+E+ + K+ADFGV+    ++  ++  +   GT  ++A
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMA 167

Query: 850 P 850
           P
Sbjct: 168 P 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 61/181 (33%), Positives = 88/181 (48%), Gaps = 22/181 (12%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA--EMEILGKIRHRNIL 734
           E  N IG G  G V+++  K +    A+KQ  L K +  +   A  E  +L K+    I+
Sbjct: 3   EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE-LDWFRRYKIALGAAKGIAYLH 793
           + Y   L  G   +V+EY  NG+L + L  +     PE   W    +  +    G+A+LH
Sbjct: 63  RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLH 118

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA----GTHGYIA 849
              S  I+HRDIKS N+ LD     KI D GVAK+      +SD + FA    GT  Y++
Sbjct: 119 ---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL------LSDNTNFANTIVGTPYYLS 169

Query: 850 P 850
           P
Sbjct: 170 P 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 98.3 bits (243), Expect = 8e-22
 Identities = 64/179 (35%), Positives = 87/179 (48%), Gaps = 19/179 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-----WKGDGVKVFAAEMEILGKIRH-RNILKL 736
            +G G  G+VY   L ++   VA+K L      K   V+ F  E++IL  + H  NI+KL
Sbjct: 7   KLGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y      GS +LV+EY+  G+L   L K  ++G             +     + YLH   
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI--LSALEYLH--- 118

Query: 797 SPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIA----ENSPKVSDYSCFAGTHGYIAP 850
           S  IIHRDIK  NILLD D    K+ DFG+AK+       S   +  S   GT GY+AP
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.1 bits (240), Expect = 1e-21
 Identities = 57/177 (32%), Positives = 94/177 (53%), Gaps = 15/177 (8%)

Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKIRHRNIL 734
            NLE+   IG G +G+VY+   +     VA+K++  +    ++   E+ I+   +H NI+
Sbjct: 22  KNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIV 78

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
             Y   L G   ++V+EYM  G+L   +    V+  +P++ +     +     +G+ YLH
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQGLEYLH 133

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  +IHRDIKS NILL +D   K+ADFG A  A+ + + S  +   GT  ++AP
Sbjct: 134 ---SQNVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRNSVVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 95.3 bits (238), Expect = 1e-21
 Identities = 58/155 (37%), Positives = 73/155 (47%), Gaps = 20/155 (12%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKI-RHRNILKL 736
           +IG G    V     K+     A+K     QL K   VK    E E+L ++  H  I+KL
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA---KGIAYLH 793
           Y       + + VLEY PNG L Q + K    G  +    R Y     AA     + YLH
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFY-----AAEILLALEYLH 119

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
              S  IIHRD+K  NILLD+D   KI DFG AK+
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKV 151

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.3 bits (238), Expect = 2e-21
 Identities = 51/158 (32%), Positives = 78/158 (49%), Gaps = 30/158 (18%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
           IG G  G+VY+   KK    VA+K++    + +G  + A  E+++L K+RH NI++L   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 740 LL--KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK--------GI 789
           +     GS ++V EYM +      L    +            K      K        G+
Sbjct: 67  VTSKGKGSIYMVFEYMDHD--LTGLLDSPE-----------VKFTESQIKCYMKQLLEGL 113

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            YLH +    I+HRDIK SNIL++ D   K+ADFG+A+
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 93.4 bits (233), Expect = 8e-21
 Identities = 60/177 (33%), Positives = 84/177 (47%), Gaps = 28/177 (15%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G+G  G+V  +  K +    A+K L K   VK+        E  IL  IRH  ++ LY 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHDC 796
                 + +LV+EY+P G LF  L    K G+      R Y  ++ L     + YLH   
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARFYAAQVVLA----LEYLHS-L 120

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD--YS-CFAGTHGYIAP 850
              I++RD+K  N+LLD D   KI DFG AK      +V    Y+ C  GT  Y+AP
Sbjct: 121 D--IVYRDLKPENLLLDSDGYIKITDFGFAK------RVKGRTYTLC--GTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 11/150 (7%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHRNILKLYACL 740
            IG G  G V   D +     VAVK L K D    + F AE  ++  +RH N+++L   +
Sbjct: 13  TIGKGEFGDVMLGDYRGQ--KVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           L+G   ++V EYM  G+L   L  R   G+  +   ++   AL   +G+ YL        
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLE---EKNF 123

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
           +HRD+ + N+L+ ED   K++DFG+AK A 
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 60/172 (34%), Positives = 90/172 (52%), Gaps = 17/172 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IGSG  G VY+         VA+K   L  GD  ++   E+ +L + RH NI+  +   L
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLHHDCSP 798
           +    ++V+EY   G+L Q +++  +    EL      +IA       KG+AYLH     
Sbjct: 71  RRDKLWIVMEYCGGGSL-QDIYQVTRGPLSEL------QIAYVCRETLKGLAYLHET--- 120

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             IHRDIK +NILL ED + K+ADFGV+  A+ +  ++    F GT  ++AP
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATIAKRKSFIGTPYWMAP 170

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 57/178 (32%), Positives = 84/178 (47%), Gaps = 17/178 (9%)

Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---EMEILGKIRHRNIL 734
           LE    +G+G +G V ++  +     +AVK +       +      E++IL K     I+
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYL 792
             Y      G   + +EYM  G+L   + K V+   PE     R   KIA+   KG+ YL
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPE-----RILGKIAVAVLKGLTYL 116

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      IIHRD+K SNIL++   + K+ DFGV+    NS   +    F GT  Y+AP
Sbjct: 117 HEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT----FVGTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 2e-19
 Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 12/148 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
           +G G  G VY+   KK    VA+K++    + +G+   A  E+ +L +++H NI+KL   
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           +      +LV EY    +L + L KR   G    +  +     L   +G+AY H      
Sbjct: 67  IHTERKLYLVFEYCDM-DLKKYLDKR--PGPLSPNLIKSIMYQL--LRGLAYCHSHR--- 118

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAK 827
           I+HRD+K  NIL++ D   K+ADFG+A+
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 51/177 (28%), Positives = 78/177 (44%), Gaps = 22/177 (12%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA-----EMEILGKIRHRNILKL 736
            +IG G  GKV  +  +      A+K + K   V+  +      E  IL ++ H  ++ L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK---GIAYLH 793
           +       + +LV++ +  G+L   L ++VK        F   ++     +    + YLH
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVK--------FSEEQVKFWICEIVLALEYLH 117

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  IIHRDIK  NILLDE     I DF +A         +  S   GT GY+AP
Sbjct: 118 ---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 13/158 (8%)

Query: 681 DNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG--DGVKV-FAAEMEILGKIRHRNIL 734
           + +IG G  G+V R  LK        VA+K L  G  D  ++ F  E  I+G+  H NI+
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           +L   + K     ++ EYM NG+L + L  R  +GK      +   +  G A G+ YL  
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGK--FTVGQLVGMLRGIASGMKYLSE 124

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
                 +HRD+ + NIL++ +   K++DFG+++  E+S
Sbjct: 125 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 61/182 (33%), Positives = 83/182 (45%), Gaps = 26/182 (14%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-QLWKGDGVKVFAAEMEILGKI-RHRNILKLYACL 740
           +IG G  GKVY+   KK    VA+K      D  +    E  IL K   H NI   Y   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 741 LKGGSS------FLVLEYMPNG---NLFQALHKRVKEGKPELDWFRRYKIAL---GAAKG 788
           +K          +LV+E    G   +L + L K+ K  K E        IA       +G
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-------IAYILRETLRG 125

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           +AYLH      +IHRDIK  NILL ++ E K+ DFGV+  A+    +   + F GT  ++
Sbjct: 126 LAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRRNTFIGTPYWM 180

Query: 849 AP 850
           AP
Sbjct: 181 AP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 59/177 (33%), Positives = 88/177 (49%), Gaps = 18/177 (10%)

Query: 682 NLIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKL 736
           N IG G  GKVY  ++L      +AVK++   D     +K  A EM++L  ++H N++K 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTG-ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE-LDWFRRYKIALGAAKGIAYLHHD 795
           Y   +     ++ +EY   G L + L      G+       R Y + L   +G+AYLH  
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQL--LEGLAYLH-- 116

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENS-PKVSDYSCFAGTHGYIAP 850
            S  I+HRDIK +NI LD +   K+ DFG A  +  N+     +    AGT  Y+AP
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 52/147 (35%), Positives = 81/147 (55%), Gaps = 9/147 (6%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +GSG  G+V+   L KN   VA+K L   D +K   F  E++ L ++RH++++ L+A   
Sbjct: 14  LGSGYFGEVWE-GLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
            G   +++ E M  G+L   L  R  EG+  L       +A   A+G+AYL        I
Sbjct: 73  VGEPVYIITELMEKGSLLAFL--RSPEGQ-VLPVASLIDMACQVAEGMAYLE---EQNSI 126

Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + NIL+ ED   K+ADFG+A++
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARL 153

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 54/171 (31%), Positives = 81/171 (47%), Gaps = 25/171 (14%)

Query: 678 LEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKI 728
           L     +G G  G+V +     LD      TVAVK L K D     +    +EME++  I
Sbjct: 14  LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMI 72

Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG---KPELDWFRRYKI--- 781
            +H+NI+ L     + G  ++V+EY  +GNL   L  R   G    P+        +   
Sbjct: 73  GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 782 -----ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                A   A+G+ +L    S   IHRD+ + N+L+ ED+  KIADFG+A+
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 84.4 bits (209), Expect = 7e-18
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 26/175 (14%)

Query: 679 EEDNL-----IGSGGTGKVY--RLDLKKNAGT--VAVKQLWKGDGVKV----FAAEMEIL 725
           E+ +L     +G G  GKV   R D   +     VAVK L    G +     F  E+EIL
Sbjct: 2   EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEIL 60

Query: 726 GKIRHRNILKL-YACLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
             + H NI+K    C   GG S  L++EY+P+G+L   L +     + +++  R    + 
Sbjct: 61  RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSS 116

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
              KG+ YL    S   IHRD+ + NIL++ +   KI+DFG+AK+        DY
Sbjct: 117 QICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED---KDY 165

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.9 bits (210), Expect = 8e-18
 Identities = 65/195 (33%), Positives = 97/195 (49%), Gaps = 41/195 (21%)

Query: 671 DAEQI-CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL----------WKGDGVKVFA 719
           D E++  +L E   IG G  G VY     +    VA+K++          W+ D +K   
Sbjct: 12  DPEKLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ-DIIK--- 64

Query: 720 AEMEILGKIRHRNILKLYACLLKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRR 778
            E+  L ++RH N ++   C L+  +++LV+EY + + +    +HK     KP     + 
Sbjct: 65  -EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-----KP----LQE 114

Query: 779 YKIA---LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835
            +IA    GA +G+AYLH       IHRDIK+ NILL E    K+ADFG A +   SP  
Sbjct: 115 VEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV--SPAN 169

Query: 836 SDYSCFAGTHGYIAP 850
           S    F GT  ++AP
Sbjct: 170 S----FVGTPYWMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.4 bits (209), Expect = 9e-18
 Identities = 62/179 (34%), Positives = 87/179 (48%), Gaps = 13/179 (7%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAAEMEILGKIRHRNI 733
            + E + +G G  G V +  LK      A+K +      D  K    E+EI    +   I
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61

Query: 734 LKLY-ACLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +K Y A L +  SS  + +EY   G+L  +++K+VK+    +      KIA    KG++Y
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH   S  IIHRDIK SNILL    + K+ DFGV+    NS        F GT  Y+AP
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAP 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 52/161 (32%), Positives = 77/161 (47%), Gaps = 20/161 (12%)

Query: 684 IGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILK 735
           +G G  GKV+      L+ + +   VAVK L +    D  K F  E E+L   +H NI+K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQAL--HKR-----VKEGKP--ELDWFRRYKIALGAA 786
            Y    +G    +V EYM +G+L + L  H            P  EL   +  +IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            G+ YL    S   +HRD+ + N L+  D   KI DFG+++
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 53/174 (30%), Positives = 87/174 (50%), Gaps = 19/174 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGV-KVFAAEMEILGKIRHRNILKLYAC 739
           IG G  G V++   ++   TVA+K++       G+      E++ L   +H  ++KL   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK---PELDWFRRYKIALGAAKGIAYLHHDC 796
              G    LV+EYMP+      L + +++ +   PE    + Y   L   KG+AY+H   
Sbjct: 68  FPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQ-VKSYMRML--LKGVAYMH--- 116

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +  I+HRD+K +N+L+  D   KIADFG+A++  +  +   YS    T  Y AP
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 60/185 (32%), Positives = 88/185 (47%), Gaps = 25/185 (13%)

Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKG-DGVKVFAAEMEILGKIR 729
           E    LE    IG G  G+VY+   K+    VA+K   L +  D ++    E++ L + R
Sbjct: 1   ELFTLLEC---IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR 57

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA---LGAA 786
              I K Y   LKG   ++++EY   G+    L    K GK          IA       
Sbjct: 58  SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGK-----LDETYIAFILREVL 108

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTH 845
            G+ YLH +     IHRDIK++NILL E+ + K+ADFGV+ ++     K +    F GT 
Sbjct: 109 LGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT---FVGTP 162

Query: 846 GYIAP 850
            ++AP
Sbjct: 163 FWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 51/150 (34%), Positives = 79/150 (52%), Gaps = 16/150 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+   L  N   VAVK L  G    K F AE +I+ K+RH  +++LYA    
Sbjct: 14  LGAGQFGEVWE-GLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V E M  G+L + L      G+    P+L       +A   A G+AYL    + 
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQL-----IDMAAQVASGMAYLE---AQ 122

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + N+L+ E+   K+ADFG+A++
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARV 152

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 50/158 (31%), Positives = 86/158 (54%), Gaps = 13/158 (8%)

Query: 683 LIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKL 736
           +IG+G  G+V+R  LK   +    VA+K L  G   K    F +E  I+G+  H NI++L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
              + K   + ++ EYM NG    AL K +++   E   ++   +  G A G+ YL    
Sbjct: 72  EGVVTKFKPAMIITEYMENG----ALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---S 124

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
               +HRD+ + NIL++ + E K++DFG++++ E+ P+
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 80.5 bits (199), Expect = 9e-17
 Identities = 56/179 (31%), Positives = 84/179 (46%), Gaps = 26/179 (14%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-------VKVFAAEMEILGKIRHRNILK 735
           L+GSG  G VY      +    AVK++   D        VK    E+ +L K++H NI++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA---KGIAYL 792
                 +  + ++ LE +P G+L + L K           F    I L       G+ YL
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKK--------YGSFPEPVIRLYTRQILLGLEYL 118

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
           H       +HRDIK +NIL+D +   K+ADFG+AK + E S   S    F G+  ++AP
Sbjct: 119 H---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS----FKGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 59/175 (33%), Positives = 83/175 (47%), Gaps = 16/175 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IG G T  VY      N   VA+K++     +   V     E++ + +  H N++K Y  
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
            + G   +LV+ Y+  G+L   +      G   LD      +     KG+ YLH   S  
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLH---SNG 122

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGV-AKIAEN---SPKVSDYSCFAGTHGYIAP 850
            IHRDIK+ NILL ED   KIADFGV A +A+    + KV     F GT  ++AP
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR--KTFVGTPCWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 54/154 (35%), Positives = 82/154 (53%), Gaps = 16/154 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L  G    + F  E +I+ K+RH  +++LYA   +
Sbjct: 14  LGAGQFGEVW-MGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L     EGK    P+L       +A   A+G+AYL    S 
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQL-----VDMAAQIAEGMAYLE---SR 122

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             IHRD+ + NIL+ E+   KIADFG+A++ E+ 
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 22/160 (13%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK--------QLWKGDGVKVFAAEMEILGKIRHRNIL 734
            +G G  G VY++    +    A+K        Q  + D V     E+ IL  + H NI+
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN----EIRILASVNHPNII 62

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP---ELDWFRRYKIALGAAKGIAY 791
                 L G    +V+EY P G+L +A+ KR K+ K    +  W    +I +   +G+  
Sbjct: 63  SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQA 118

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
           LH      I+HRD+KS+NILL  +   KI D G++K+ + 
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 59/181 (32%), Positives = 84/181 (46%), Gaps = 25/181 (13%)

Query: 684 IGSGGTGKVYRLDLKKNAG-TVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLY 737
           I  G  G+V+ L  KK+ G   A+K + K D      V     E +IL + +   ++KLY
Sbjct: 1   ISKGAYGRVF-LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
                  + +LV+EY+P G+L   L      G  + D  R Y  +I L     + YLH  
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVARIYIAEIVLA----LEYLH-- 110

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI-----AENSPKVSDYSC-FAGTHGYIA 849
            S  IIHRD+K  NIL+D +   K+ DFG++K+       N            GT  YIA
Sbjct: 111 -SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 850 P 850
           P
Sbjct: 170 P 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 51/172 (29%), Positives = 89/172 (51%), Gaps = 17/172 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           +G G  GKVY+   K+     A K  Q+   + ++ F  E++IL + +H NI+ LY    
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 742 KGGSSFLVLEYMPNG---NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                ++++E+   G   ++   L + + E  P++ +  R  +     + + +LH   S 
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTE--PQIRYVCRQML-----EALNFLH---SH 122

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRD+K+ NILL  D + K+ADFGV+  A+N   +     F GT  ++AP
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVS--AKNKSTLQKRDTFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 78.4 bits (193), Expect = 6e-16
 Identities = 44/149 (29%), Positives = 79/149 (53%), Gaps = 9/149 (6%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYAC 739
           + +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L   
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
             +    +++ E+M  GNL   L    +  + E++      +A   +  + YL       
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLR---ECNRQEVNAVVLLYMATQISSAMEYLE---KKN 124

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKI 828
            IHRD+ + N L+ E++  K+ADFG++++
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRL 153

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.0 bits (193), Expect = 8e-16
 Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 16/172 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYA 738
           +G GG G+V  + +K    T A+K + K         +   +E EIL +  H  I+KLY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   ++++EY   G L+  L  R    +    +  R+ IA        YLH+    
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIA-CVVLAFEYLHNR--- 112

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            II+RD+K  N+LLD +   K+ DFG AK  ++  K   ++ F GT  Y+AP
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT--WT-FCGTPEYVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 79.5 bits (196), Expect = 8e-16
 Identities = 59/179 (32%), Positives = 87/179 (48%), Gaps = 17/179 (9%)

Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKV-FAAEMEILGKIRHR 731
           +  LE  N IGSG  G VY++  +      A+K ++    D V+     E+EIL  + H 
Sbjct: 73  LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHP 132

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           N++K +      G   ++LE+M  G+L         EG    D      +A     GIAY
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSL---------EGTHIADEQFLADVARQILSGIAY 183

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH      I+HRDIK SN+L++     KIADFGV++I   +    + S   GT  Y++P
Sbjct: 184 LH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSP 237

Length = 353

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 14/171 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFA-AEMEILGKIRHRNILKLYAC 739
           IG G  G VY+   K     VA+K++      +G+   A  E+++L ++ H NI+KL   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
               G  +LV E+M + +L++ +  R +     L     Y++     +G+A+ H   S  
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLL----QGLAFCH---SHG 118

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           I+HRD+K  N+L++ +   K+ADFG+A+       V  Y+ +  T  Y AP
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAP 167

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 46/150 (30%), Positives = 86/150 (57%), Gaps = 9/150 (6%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VA+K L +G    + F AE  ++ +++H  +++LYA + +
Sbjct: 14  LGAGQFGEVW-MGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +  EG  +L   +   +A   A+G+A++        IH
Sbjct: 73  E-PIYIITEYMENGSLVDFL--KTPEGI-KLTINKLIDMAAQIAEGMAFIERKNY---IH 125

Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ E    KIADFG+A++ E++
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.8 bits (191), Expect = 2e-15
 Identities = 62/178 (34%), Positives = 90/178 (50%), Gaps = 31/178 (17%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----------WKGDGVKVFAAEMEILGKIRHRNI 733
           IG G  G VY          VAVK++          W+ D +K    E++ L +++H N 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ-DIIK----EVKFLQQLKHPNT 83

Query: 734 LKLYACLLKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           ++   C LK  +++LV+EY + + +    +HK     KP L       I  GA +G+AYL
Sbjct: 84  IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK-----KP-LQEVEIAAITHGALQGLAYL 137

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      +IHRDIK+ NILL E  + K+ADFG A  +  SP  S    F GT  ++AP
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS--SPANS----FVGTPYWMAP 186

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 60/160 (37%), Positives = 82/160 (51%), Gaps = 20/160 (12%)

Query: 678 LEEDNLIGSGGTGKV--YRLDLKKNAGT---VAVKQLWKGDGVKV---FAAEMEILGKIR 729
           L++  ++G G  GKV  Y  D   N GT   VAVK L +  G +    +  E+ IL  + 
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYD-PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64

Query: 730 HRNILKLYACLLKGG--SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           H NI+K   C  + G     L++EY+P G+L   L K  K    +L  F     A    +
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLF-----AQQICE 118

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           G+AYLH   S   IHRD+ + N+LLD D   KI DFG+AK
Sbjct: 119 GMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 58/173 (33%), Positives = 84/173 (48%), Gaps = 15/173 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAA-EMEILGKIRHRNILKLYA 738
           ++G G  G V +   K     VA+K+  + +    VK  A  E+++L ++RH NI+ L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-HDCS 797
              + G  +LV EY+    L + L +    G P  D  R Y   L   + IAY H H+  
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELL-EASPGGLPP-DAVRSYIWQL--LQAIAYCHSHN-- 120

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             IIHRDIK  NIL+ E    K+ DFG A+ A  +   S  + +  T  Y AP
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAP 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 76.8 bits (190), Expect = 3e-15
 Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 39/190 (20%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFAA--EMEILGKIRH 730
           E+   +G G    VY+   K+    VA+K++  G      DG+  F A  E+++L +++H
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN-FTALREIKLLQELKH 61

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA---- 786
            NI+ L        +  LV E+M   +L + +              +   I L  A    
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFME-TDL-EKV-------------IKDKSIVLTPADIKS 106

Query: 787 ------KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
                 +G+ YLH +    I+HRD+K +N+L+  D   K+ADFG+A+   +  +    + 
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTH 161

Query: 841 FAGTHGYIAP 850
              T  Y AP
Sbjct: 162 QVVTRWYRAP 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 16/182 (8%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIR 729
           N     L+G G  G+VY          +AVKQ+            V     E+++L  ++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           H  I++ Y CL    +  + +EYMP G    ++  ++K      +   R K      +G+
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGG----SVKDQLKAYGALTETVTR-KYTRQILEGV 117

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYI 848
            YLH   S  I+HRDIK +NIL D     K+ DFG +K +       +      GT  ++
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174

Query: 849 AP 850
           +P
Sbjct: 175 SP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.6 bits (188), Expect = 5e-15
 Identities = 55/171 (32%), Positives = 84/171 (49%), Gaps = 20/171 (11%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGDGVKVFAAEMEILGKI-RH 730
           +++  ++IG G  G+V +  +KK+     A    +K+    D  + FA E+E+L K+  H
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYKIALGA---- 785
            NI+ L       G  +L +EY P+GNL   L K RV E  P           L +    
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 786 ------AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
                 A+G+ YL        IHRD+ + NIL+ E+Y  KIADFG+++  E
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE 175

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.3 bits (187), Expect = 6e-15
 Identities = 64/178 (35%), Positives = 93/178 (52%), Gaps = 31/178 (17%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----------WKGDGVKVFAAEMEILGKIRHRNI 733
           IG G  G VY     +    VA+K++          W+ D +K    E++ L +I+H N 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ-DIIK----EVKFLQRIKHPNS 87

Query: 734 LKLYACLLKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           ++   C L+  +++LV+EY + + +    +HK     KP L       I  GA +G+AYL
Sbjct: 88  IEYKGCYLREHTAWLVMEYCLGSASDLLEVHK-----KP-LQEVEIAAITHGALQGLAYL 141

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  +IHRDIK+ NILL E  + K+ADFG A IA  SP  S    F GT  ++AP
Sbjct: 142 H---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA--SPANS----FVGTPYWMAP 190

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.9 bits (186), Expect = 8e-15
 Identities = 59/178 (33%), Positives = 91/178 (51%), Gaps = 31/178 (17%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----------WKGDGVKVFAAEMEILGKIRHRNI 733
           IG G  G VY     +N+  VA+K++          W+ D +K    E+  L K+RH N 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIK----EVRFLQKLRHPNT 77

Query: 734 LKLYACLLKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           ++   C L+  +++LV+EY + + +    +HK     KP L       +  GA +G+AYL
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KP-LQEVEIAAVTHGALQGLAYL 131

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  +IHRD+K+ NILL E    K+ DFG A I      ++  + F GT  ++AP
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 8e-15
 Identities = 56/175 (32%), Positives = 80/175 (45%), Gaps = 19/175 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRH---RNILKL 736
           LIG G  G VYR         VA+K +      D V     E+ +L ++R     NI K 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y   LKG   ++++EY   G++   +       K      R   +AL       Y+H   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVAL------KYIHKV- 120

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGV-AKIAENSPKVSDYSCFAGTHGYIAP 850
              +IHRDIK++NIL+      K+ DFGV A + +NS K    S F GT  ++AP
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK---RSTFVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.0 bits (188), Expect = 9e-15
 Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY 737
             IGSG  G V     K+    VA+K++       + A     E+++L  +RH NI+ L 
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 738 ACLL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
             L       F    +V E M        LHK +K  +P  D   +Y       +G+ YL
Sbjct: 66  DILRPPSPEDFNDVYIVTELMETD-----LHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
           H   S  +IHRD+K SNIL++ + + KI DFG+A+  +    
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 56/178 (31%), Positives = 77/178 (43%), Gaps = 25/178 (14%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAE--------MEILGKIRHRNILK 735
           +G G  GKV   + KK     A+K L KGD +     E         E     RH  ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK---GIAYL 792
           L+AC         V+EY   G+L   +H  V         F   +    AA    G+ YL
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTDV---------FSEPRAVFYAACVVLGLQYL 117

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H +    I++RD+K  N+LLD +   KIADFG+ K  E        S F GT  ++AP
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAP 170

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 52/149 (34%), Positives = 76/149 (51%), Gaps = 13/149 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK----QLWKGDGVKVFAAEMEILGKIRHRNILKLYA 738
            IG G  G VY+  LK N   VAVK     L      K F  E EIL +  H NI+KL  
Sbjct: 2   KIGKGNFGDVYKGVLKGN-TEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIG 59

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
             ++    ++V+E +P G+L   L K+    K  L   +  +++L AA G+ YL      
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKNC- 114

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             IHRD+ + N L+ E+   KI+DFG+++
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 20/174 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL------WKGDGVKVFAAEMEILGKI-RHRNILKL 736
           +G G  G VY    K+    VA+K++      W+ + + +   E++ L K+  H NI+KL
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEHPNIVKL 63

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                +    + V EYM  GNL+Q +  R  +GKP         I     +G+A++H   
Sbjct: 64  KEVFRENDELYFVFEYM-EGNLYQLMKDR--KGKP-FSESVIRSIIYQILQGLAHIHKH- 118

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                HRD+K  N+L+      KIADFG+A+   + P  +DY     T  Y AP
Sbjct: 119 --GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY---VSTRWYRAP 167

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 56/166 (33%), Positives = 82/166 (49%), Gaps = 20/166 (12%)

Query: 682 NLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILK 735
           ++IG G  G+V +  +KK     +A    +K+    D  + FA E+E+L K+  H NI+ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP----------ELDWFRRYKIALG 784
           L       G  +L +EY P+GNL   L K RV E  P           L   +    A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
            A+G+ YL        IHRD+ + NIL+ E+Y  KIADFG+++  E
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE 163

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.2 bits (190), Expect = 1e-14
 Identities = 44/127 (34%), Positives = 61/127 (48%), Gaps = 20/127 (15%)

Query: 462 LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNI 521
           L L N    G IP+ +  LR L S++L  N++ G+IP  +G    +  L+L+ NS +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 522 PRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAF 581
           P SL  L+SL  LNL+GN L+G +P  L                G   L          F
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL----------------GGRLLHRASFN----F 522

Query: 582 AGNEGLC 588
             N GLC
Sbjct: 523 TDNAGLC 529

Length = 623

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 22/181 (12%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQL------------WKGDGVKVFAAEMEILGKIR 729
           LIG G  G+VY L L    G + AVKQ+             + D VK   +E+E L  + 
Sbjct: 8   LIGKGTYGRVY-LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           H NI++            + LEY+P G++   L    +  +  + +F    +     +G+
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGL 121

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
           AYLH   S  I+HRD+K+ N+L+D D   KI+DFG++K +++           G+  ++A
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 850 P 850
           P
Sbjct: 179 P 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 12/159 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID  ++  L+E   +GSG  G V  L   +    VA+K + +G      F  E +++ K+
Sbjct: 1   IDPSELTFLKE---LGSGQFGVV-HLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL 56

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H N+++LY    K    F+V EYM NG L   L +R  +   E        +     + 
Sbjct: 57  SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW----LLDMCSDVCEA 112

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           + YL  +     IHRD+ + N L+ ED   K++DFG+A+
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 49/160 (30%), Positives = 82/160 (51%), Gaps = 12/160 (7%)

Query: 677 NLEEDNL---IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNI 733
           N++E  L   IG G  G V   D + N   VAVK +      + F AE  ++ ++RH N+
Sbjct: 4   NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLRHSNL 61

Query: 734 LKLYACLLK-GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           ++L   +++  G  ++V EYM  G+L   L  R   G+  L      K +L   + + YL
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYL 118

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
               +   +HRD+ + N+L+ ED   K++DFG+ K A ++
Sbjct: 119 E---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.5 bits (183), Expect = 3e-14
 Identities = 58/175 (33%), Positives = 92/175 (52%), Gaps = 17/175 (9%)

Query: 683 LIGSGGTGKVY--RLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILK 735
           ++G G  GKV+  R     +AG +   ++ K   +KV        E +IL ++ H  I+K
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           L+      G  +L+L+++  G+LF  L K V   + ++  F   ++AL        L H 
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK-FYLAELALA-------LDHL 114

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  II+RD+K  NILLDE+   K+ DFG++K + +  K + YS F GT  Y+AP
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YS-FCGTVEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 55/174 (31%), Positives = 79/174 (45%), Gaps = 22/174 (12%)

Query: 684 IGSGGTGKVYRLDLKKNAGT-VAVKQLWKGD-----GVKVFAAEMEILGKIRHR-NILKL 736
           I  G  G VY L  K++ G   A+K L K D      V    AE  I+        + KL
Sbjct: 4   ISKGAFGSVY-LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y         +LV+EY+  G+   +L K +  G    DW ++Y   +    G+  LH   
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDC-ASLIKTL--GGLPEDWAKQYIAEV--VLGVEDLHQR- 116

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              IIHRDIK  N+L+D+    K+ DFG+++    + K      F GT  Y+AP
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAP 162

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 74.5 bits (183), Expect = 3e-14
 Identities = 62/204 (30%), Positives = 87/204 (42%), Gaps = 33/204 (16%)

Query: 653 EKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG 712
            K  +S WKL+ F             E    +G+G  G+V     K      A+K L K 
Sbjct: 8   TKPDTSSWKLSDF-------------EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR 54

Query: 713 DGVKV-----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK 767
           + +K+      A E  IL ++ H  I+ +          + +LE++  G LF  L K   
Sbjct: 55  EILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK--- 111

Query: 768 EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            G+   D  + Y   L  A    YLH   S  II+RD+K  N+LLD     K+ DFG AK
Sbjct: 112 AGRFPNDVAKFYHAELVLA--FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Query: 828 IAENSPKVSDYS-CFAGTHGYIAP 850
                 KV D +    GT  Y+AP
Sbjct: 167 ------KVPDRTFTLCGTPEYLAP 184

Length = 329

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 20/182 (10%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRN 732
             E+  ++G G  G V+    K +   V +KQ+       D       E ++L  + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGI 789
           I++ Y   L+  +  +V+EY P G L + + KR      E   L +F +  +A       
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------- 113

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             LHH  +  I+HRD+K+ NILLD+     KI DFG++KI  +  K        GT  YI
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYI 168

Query: 849 AP 850
           +P
Sbjct: 169 SP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 54/167 (32%), Positives = 81/167 (48%), Gaps = 20/167 (11%)

Query: 681 DNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNIL 734
           +++IG G  G+V R  +KK     NA    +K+    +  + FA E+E+L K+  H NI+
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPE----------LDWFRRYKIAL 783
            L       G  ++ +EY P GNL   L K RV E  P           L   +  + A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
             A G+ YL        IHRD+ + N+L+ E+   KIADFG+++  E
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE 170

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 25/178 (14%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEME-------ILGKIRHRNILKL 736
           IG G  GK+Y    K ++    +K++   D  K+   E E       +L K++H NI+  
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEI---DLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKR---VKEGKPELDWFRRYKIALGAAKGIAYLH 793
           +A   + G  F+V+EY   G+L + ++++   +      L WF   +I+LG       L 
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLG-------LK 115

Query: 794 HDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H     I+HRDIKS NI L ++    K+ DFG+A+   +S +++ Y+C  GT  Y++P
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA-YTC-VGTPYYLSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 48/150 (32%), Positives = 84/150 (56%), Gaps = 8/150 (5%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +    N+  VAVK L  G   V+ F  E  ++  ++H  +++LYA + K
Sbjct: 14  LGAGQFGEVW-MGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM  G+L   L K  + GK  L   +    +   A+G+AY+        IH
Sbjct: 73  EEPIYIITEYMAKGSLLDFL-KSDEGGKVLLP--KLIDFSAQIAEGMAYIERK---NYIH 126

Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++N+L+ E    KIADFG+A++ E++
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDN 156

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 53/162 (32%), Positives = 71/162 (43%), Gaps = 19/162 (11%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGT------VAVKQLWKGDGV---KVFAAEMEILGKIRHRN 732
           N +GSG  G+VY        G       VAVK L KG      K F  E  ++    H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPELDWFRRYKIALGAAKGIA 790
           I+KL    L     ++++E M  G+L   L   +  + G P L       I L  AKG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 791 YLHHDCSPPIIHRDIKSSNILLDE-DYEP----KIADFGVAK 827
           YL        IHRD+ + N L+ E  Y+     KI DFG+A+
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 45/145 (31%), Positives = 77/145 (53%), Gaps = 9/145 (6%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG 743
           IG G  G V + +       VAVK +      + F  E  ++ K+ H+N+++L   +L  
Sbjct: 14  IGEGEFGAVLQGEYTGQ--KVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71

Query: 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHR 803
           G  ++V+E M  GNL   L  R   G+  +   +  + +L  A+G+ YL    S  ++HR
Sbjct: 72  GL-YIVMELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124

Query: 804 DIKSSNILLDEDYEPKIADFGVAKI 828
           D+ + NIL+ ED   K++DFG+A++
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV 149

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 58/187 (31%), Positives = 86/187 (45%), Gaps = 19/187 (10%)

Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEIL 725
             D   + NL E   IGSG  G+VY++  KK    +AVKQ+ +       K    +++++
Sbjct: 11  PADLNDLENLGE---IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV 67

Query: 726 GKIRHR--NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
            K  H    I+K Y   +     F+ +E M        L KR++   PE       K+ +
Sbjct: 68  LK-SHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPE---DILGKMTV 121

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
              K + YL       +IHRD+K SNILLD     K+ DFG++    +S K    S  AG
Sbjct: 122 AIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAKTRS--AG 176

Query: 844 THGYIAP 850
              Y+AP
Sbjct: 177 CAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 35/185 (18%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---------EMEILGKIRHRNIL 734
           IGSG  G V      ++   VA+K++        F           E++IL   +H NI+
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKI-----PHAFDVPTLAKRTLRELKILRHFKHDNII 67

Query: 735 KLYACLLKGGSSF----LVLEYMPNGNLFQALHKRVKEGKP-ELDWFRR--YKIALGAAK 787
            +   L   G+ F    +V++ M + +L   +H      +P   +  R   Y++     +
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD----QPLTEEHIRYFLYQLL----R 118

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY--SCFAGTH 845
           G+ Y+H   S  +IHRD+K SN+L++ED E +I DFG+A+   +SP    Y  + +  T 
Sbjct: 119 GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 846 GYIAP 850
            Y AP
Sbjct: 176 WYRAP 180

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 52/171 (30%), Positives = 86/171 (50%), Gaps = 15/171 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           +G G  GKVY+   K+     A K  +    + ++ +  E+EIL    H  I+KL     
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEG--KPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
             G  ++++E+ P G +  A+   +  G  +P++    R  +     + + YLH   S  
Sbjct: 80  WDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQML-----EALQYLH---SMK 130

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+K+ N+LL  D + K+ADFGV+  A+N   +     F GT  ++AP
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAP 179

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 22/187 (11%)

Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAA-EMEILGKIR 729
           ++ + E    +G G  G+VY+    K    VA+K++    + DG  + A  E++IL K++
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 730 HRNILKLY--------ACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYK 780
           H N++ L             K GS ++V  YM + +L   L    VK  + ++       
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIK-----C 119

Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
             L   +GI YLH      I+HRDIK++NIL+D     KIADFG+A+  +  P       
Sbjct: 120 YMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 841 FAGTHGY 847
             GT  Y
Sbjct: 177 GGGTRKY 183

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.3 bits (180), Expect = 3e-13
 Identities = 48/130 (36%), Positives = 67/130 (51%), Gaps = 9/130 (6%)

Query: 378 PNSYADC---KTIQRLRIS----DNH-LSGKIPDGLWALPNVGMLDFGDNDFTGGISPLI 429
           P S ADC    T  +  I     DN  L G IP+ +  L ++  ++   N   G I P +
Sbjct: 403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL 462

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA-LRQLSSLHL 488
           G  TSL  L L  N F+G +P  LG+LT+L  L L  N+ SG++P+ALG  L   +S + 
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522

Query: 489 EENALTGSIP 498
            +NA    IP
Sbjct: 523 TDNAGLCGIP 532

Length = 623

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 50/162 (30%), Positives = 84/162 (51%), Gaps = 14/162 (8%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNIL 734
            L+    IG G TG V     K     VAVK+  L K    ++   E+ I+   +H NI+
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           ++Y+  L G   ++V+E++  G L   + H R+ E   ++       + L   K +++LH
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE--EQIA-----TVCLAVLKALSFLH 132

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFG-VAKIAENSPK 834
              +  +IHRDIKS +ILL  D   K++DFG  A++++  P+
Sbjct: 133 ---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 36/133 (27%), Positives = 64/133 (48%), Gaps = 14/133 (10%)

Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFR 777
           E+ IL  ++H NI+  Y   +   +  + +EY   G L+  + ++  +   E   L +  
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL- 107

Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
            ++I       ++Y+H      I+HRDIK+ NI L +    K+ DFG++KI   S     
Sbjct: 108 -FQIV----SAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMA 158

Query: 838 YSCFAGTHGYIAP 850
            +   GT  Y++P
Sbjct: 159 ETV-VGTPYYMSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 60/177 (33%), Positives = 80/177 (45%), Gaps = 22/177 (12%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILG-KIRHRNILKL 736
           ++G G  GKV+  +LK      A+K L K      D V+    E  +L     H  +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLF---QALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           Y       + F V+EY+  G+L    Q+ HK         D  R    A     G+ +LH
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--------FDLPRATFYAAEIICGLQFLH 113

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  I++RD+K  NILLD D   KIADFG+ K  EN    +    F GT  YIAP
Sbjct: 114 ---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 58/176 (32%), Positives = 82/176 (46%), Gaps = 20/176 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
           ++G G  GKV   +LK      AVK L K      D V+    E  +L    +H  + +L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK--RVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           ++C       F V+EY+  G+L   + +  R  E +     F   +I LG    + +LH 
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRAR---FYAAEIVLG----LQFLH- 113

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                II+RD+K  N+LLD +   KIADFG+ K  E        S F GT  YIAP
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 54/149 (36%), Positives = 80/149 (53%), Gaps = 13/149 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKV-FAAEMEILGKIRHRNILKLYA 738
           L+G G  G+V++  LK     VAVK   K D    +K+ F +E  IL +  H NI+KL  
Sbjct: 2   LLGKGNFGEVFKGTLKDKT-PVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              +    ++V+E +P G+    L K+    K EL   +  K AL AA G+AYL    S 
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLE---SK 112

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             IHRD+ + N L+ E+   KI+DFG+++
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 15/170 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V     K     VAVK+  L K    ++   E+ I+    H N++ +Y   L
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++V+E++  G L   + H R+ E +          + L   + ++YLH   +  +
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLH---NQGV 139

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS +ILL  D   K++DFG    A+ S +V       GT  ++AP
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAP 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.1 bits (172), Expect = 7e-13
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 18/168 (10%)

Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAA-EMEILGKIRH 730
           +   E+ N IG G  G VYR     +   VA+K++    + DG+ + +  E+ +L  +RH
Sbjct: 6   VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65

Query: 731 RNILKLYACLL--KGGSSFLVLEYMPN--GNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
            NI++L   ++     S FLV+EY      +L   +     E + +        + L   
Sbjct: 66  PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-------LMLQLL 118

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
           +G+ YLH +    IIHRD+K SN+LL +    KIADFG+A+      K
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.7 bits (168), Expect = 9e-13
 Identities = 41/133 (30%), Positives = 74/133 (55%), Gaps = 14/133 (10%)

Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFR 777
           E+ +L  ++H NI++      + G+ ++V++Y   G+L++ ++ +     PE   LDWF 
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF- 107

Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
             +I L        L H     I+HRDIKS NI L +D   K+ DFG+A++  ++ +++ 
Sbjct: 108 -VQICLA-------LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159

Query: 838 YSCFAGTHGYIAP 850
            +C  GT  Y++P
Sbjct: 160 -TCI-GTPYYLSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 18/159 (11%)

Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKL 736
           +G G  GKV     Y L  +++   VAVK L     +  K F  E E+L  ++H +I+K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKR------VKEGKP--ELDWFRRYKIALGAAKG 788
           Y   ++G    +V EYM +G+L + L         + EG    EL   +   IA   A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           + YL    S   +HRD+ + N L+ E+   KI DFG+++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 21/163 (12%)

Query: 678 LEEDNLIGSGGTGKVY----RLDLKKNAGTVAVKQLWKGDGVKVFAA---EMEILGKIRH 730
           LE+  ++GSG  G VY      + +K    VA+K L +    K       E  ++  + H
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 731 RNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
            ++++L   CL       L+ + MP G L       V+  K  +         +  AKG+
Sbjct: 69  PHVVRLLGICL--SSQVQLITQLMPLGCLLD----YVRNHKDNIGSQYLLNWCVQIAKGM 122

Query: 790 AYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
           +YL         ++HRD+ + N+L+      KI DFG+AK+ +
Sbjct: 123 SYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 53/156 (33%), Positives = 75/156 (48%), Gaps = 20/156 (12%)

Query: 682 NLIGSGGTGKVYR---LDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILK 735
            +IG G  G VY    +D        AVK L +    + V+ F  E  I+    H N+L 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 736 LYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP---ELDWFRRYKIALGAAKGIAY 791
           L   CL   GS  +VL YM +G+L   +  R +   P   +L  F      L  AKG+ Y
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGF-----GLQVAKGMEY 113

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           L    S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 12/169 (7%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           +GSG  G VY+          AVK  +L  GD   +   E+ ++ + +H NI+  +   L
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
                ++ +EY   G+L    H      + ++ +  R  +     +G+AYLH   S   +
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH---SKGKM 128

Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           HRDIK +NILL ++ + K+ADFGVA  A+ +  ++    F GT  ++AP
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 47/148 (31%), Positives = 65/148 (43%), Gaps = 13/148 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKL 736
            +G G  G V R +   + G    VAVK L      D +  F  E  I+  + H N+++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y  +L      +V E  P G+L   L K   +             A+  A G+ YL    
Sbjct: 62  YGVVLTH-PLMMVTELAPLGSLLDRLRK---DALGHFLISTLCDYAVQIANGMRYLE--- 114

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFG 824
           S   IHRD+ + NILL  D + KI DFG
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFG 142

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 29/171 (16%)

Query: 678 LEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIR 729
           LEE   +G G  GKVY+ +L     + +A +VA+K L +    KV   F  E E++  ++
Sbjct: 10  LEE---LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----------VKEGKPELDWFRR 778
           H NI+ L     K   + ++ EY+ +G+L + L +             +  K  LD    
Sbjct: 67  HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 779 YKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             IA+  A G+ YL  HH      +HRD+ + N L+ E    KI+DFG+++
Sbjct: 127 LHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 54/154 (35%), Positives = 79/154 (51%), Gaps = 15/154 (9%)

Query: 683 LIGSGGTGKVY--RLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKL 736
            +G G  G V   R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 737 YA-CLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
              C   G  +  LV+EY+P G+L   L K     +  LD  +    A    KG+ YL  
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLG- 125

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             S   +HRD+ + NIL++ +   KI DFG+ K+
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKV 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 21/185 (11%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV----KVFAAEMEILGKIRHRNIL 734
           E    IG G  G V ++  K +   +  K++  G+      +   +E+ IL +++H NI+
Sbjct: 3   EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 735 KLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAK 787
           + Y  ++   +   ++V+EY   G+L Q + K  KE K   E        +  +AL    
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL---- 118

Query: 788 GIAYLHH--DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
                H+  D    ++HRD+K +NI LD +   K+ DFG+AKI  +    S    + GT 
Sbjct: 119 --YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTP 174

Query: 846 GYIAP 850
            Y++P
Sbjct: 175 YYMSP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 53/170 (31%), Positives = 85/170 (50%), Gaps = 15/170 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V    +K +   VAVK+  L K    ++   E+ I+   +H N++++Y   L
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++V+E++  G L   + H R+ E +          + L   K ++ LH   +  +
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKALSVLH---AQGV 137

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS +ILL  D   K++DFG    A+ S +V       GT  ++AP
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 19/183 (10%)

Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG---DGVKVFAAE 721
           ID+   +I   EE  +IG+G  G+V R  LK   K    VA+K L  G      + F +E
Sbjct: 1   IDVSCVKI---EE--VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 55

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
             I+G+  H NI+ L   + K     ++ E+M NG L   L  R  +G  +    +   +
Sbjct: 56  ASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDG--QFTVIQLVGM 111

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SC 840
             G A G+ YL        +HRD+ + NIL++ +   K++DFG+++  E+      Y S 
Sbjct: 112 LRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168

Query: 841 FAG 843
             G
Sbjct: 169 LGG 171

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.5 bits (170), Expect = 4e-12
 Identities = 33/91 (36%), Positives = 52/91 (57%)

Query: 435 LSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT 494
           +  L L N    G +P+++ +L +L+ + L+ N+  G IP +LG++  L  L L  N+  
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 495 GSIPNEMGDCARIVDLNLARNSLSGNIPRSL 525
           GSIP  +G    +  LNL  NSLSG +P +L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 16/173 (9%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEME 723
           IDA  I   + + +IG+G  G+V    LK   K    VA+K L  G   K    F +E  
Sbjct: 1   IDASCI---KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEAS 57

Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           I+G+  H NI+ L   + K     +V EYM NG+L   L K       +    +   +  
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH----DGQFTVIQLVGMLR 113

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           G A G+ YL  D     +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 114 GIASGMKYL-SDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 68.8 bits (168), Expect = 4e-12
 Identities = 70/242 (28%), Positives = 119/242 (49%), Gaps = 10/242 (4%)

Query: 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN-LLALSNNFSGEVPNSYADCKTIQR 389
           ENL     L  +D++ N+   +  +    +   L  L   +NN +   P        ++ 
Sbjct: 87  ENLLNLLPLPSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKE 144

Query: 390 LRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGEL 449
           L +SDN +   +P  L  LPN+  LD   ND +  +  L+   ++L+ L L  N+ S +L
Sbjct: 145 LDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DL 201

Query: 450 PSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD 509
           P E+  L+ LE L L +NN   ++ S+L  L+ LS L L  N L   +P  +G+ + +  
Sbjct: 202 PPEIELLSALEELDL-SNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLET 259

Query: 510 LNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVP 569
           L+L+ N +S     SL  L++L  L+LSGN L+ ++P   + L L  + L+      ++ 
Sbjct: 260 LDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALE 317

Query: 570 LD 571
           L 
Sbjct: 318 LK 319

Length = 394

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 54/150 (36%), Positives = 77/150 (51%), Gaps = 11/150 (7%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKI-RHRNILKLYACLL 741
           IG G  GKVY++  KK+    AVK L    D  +   AE  IL  +  H N++K Y    
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 742 K-----GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           K     GG  +LVLE    G++ + +   +  G+  LD      I  GA  G+ +LH++ 
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYGALLGLQHLHNN- 147

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
              IIHRD+K +NILL  +   K+ DFGV+
Sbjct: 148 --RIIHRDVKGNNILLTTEGGVKLVDFGVS 175

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 18/172 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGT-----VAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYA 738
           IGSG  G VY+    +N  T     + V +L  G+   V   E+ ++   +H NI+  + 
Sbjct: 17  IGSGTYGDVYK---ARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
             L+    ++ +E+   G+L    H      + ++ +  R  +     +G+ YLH   S 
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH---SK 125

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             +HRDIK +NILL ++   K+ADFGV+  A+ +  ++    F GT  ++AP
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 16/164 (9%)

Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNA--GTVAVKQLWKGDGVK---VFAAEMEILGKI 728
            +     +G G  G VY      + K      VA+K + +   ++    F  E  ++ + 
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF 66

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDWFRRYKIAL 783
              ++++L   +  G  + +V+E M  G+L   L  R  E     G       +  ++A 
Sbjct: 67  NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             A G+AYL    +   +HRD+ + N ++ ED   KI DFG+ +
Sbjct: 127 EIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 6e-12
 Identities = 62/183 (33%), Positives = 88/183 (48%), Gaps = 31/183 (16%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT-----VAVKQLWKGDGV---KVFA---AEMEILGKIRHR 731
           ++G GG GKV+++  +K  G       A+K L K   V   K  A   AE  IL  ++H 
Sbjct: 3   VLGKGGYGKVFQV--RKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG--KPELDWFRRYKIALGAAKGI 789
            I+ L      GG  +L+LEY+  G LF  L    +EG    +   F   +I+L     +
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLE---REGIFMEDTACFYLSEISL----AL 113

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK--IAENSPKVSDYSCFAGTHGY 847
            +LH      II+RD+K  NILLD     K+ DFG+ K  I E +   +    F GT  Y
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT----FCGTIEY 166

Query: 848 IAP 850
           +AP
Sbjct: 167 MAP 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 66.5 bits (162), Expect = 6e-12
 Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 9/146 (6%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           IGSG  G V+ L        VA+K + +G    + F  E +++ K+ H  +++LY    +
Sbjct: 12  IGSGQFGLVW-LGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
                LV E+M +G L   L  R + GK   +      + L   +G+AYL       +IH
Sbjct: 71  RSPICLVFEFMEHGCLSDYL--RAQRGKFSQETL--LGMCLDVCEGMAYLESSN---VIH 123

Query: 803 RDIKSSNILLDEDYEPKIADFGVAKI 828
           RD+ + N L+ E+   K++DFG+ + 
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF 149

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 7e-12
 Identities = 55/200 (27%), Positives = 84/200 (42%), Gaps = 38/200 (19%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
           L+G G  G+V+ + LK      A+K     ++ K + VK    E EIL  + H  +  LY
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
           A         LV++Y P G LF+ L ++  +   E +  R Y   +  A  + YLH    
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSE-EVARFYAAEVLLA--LEYLH---L 121

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS------------------ 839
             I++RD+K  NILL E     ++DF ++K ++  P     +                  
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 840 ---------CFAGTHGYIAP 850
                     F GT  YIAP
Sbjct: 182 SEEPSFRSNSFVGTEEYIAP 201

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 54/162 (33%), Positives = 80/162 (49%), Gaps = 25/162 (15%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQL-----------WKGDGVKVFAAEMEILGKI 728
           LIGSG  G VY   L  NA +   +AVKQ+            K   +   A E+ +L ++
Sbjct: 7   LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
           +H NI++     L      + LEY+P G++   L+      +  +  F R  +     KG
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-----KG 118

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
           + YLH   +  IIHRDIK +NIL+D     KI+DFG++K  E
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.2 bits (164), Expect = 7e-12
 Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 20/153 (13%)

Query: 703 TVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYACLLKGGSS-FLVLEYMPNGN 757
            VA+K++ K     V A     E+++L  +RH NI+ L    +      + V E +    
Sbjct: 37  NVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTD- 95

Query: 758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE 817
               LH R+   +P    F +Y       +G+ Y+H   S  ++HRD+K SNIL++E+ +
Sbjct: 96  ----LH-RLLTSRPLEKQFIQY-FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCD 146

Query: 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            KI DFG+A+I +  P+++ Y     T  Y AP
Sbjct: 147 LKICDFGLARIQD--PQMTGY---VSTRYYRAP 174

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 34/187 (18%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKGDGVKV-----FAAEMEILGKIRH 730
           +LE    +G+G  G+V+ L   + +    A+K +   + +++        E  +L ++ H
Sbjct: 2   DLERIKTVGTGTFGRVH-LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG---AAK 787
             I++L+         ++++EY+P G LF  L               R+  + G   A++
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-----------GRFSNSTGLFYASE 109

Query: 788 ---GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS-CFAG 843
               + YLH   S  I++RD+K  NILLD++   K+ DFG AK      K+ D +    G
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCG 160

Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 161 TPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 16/171 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           IG G  G+V++    +    VA+K +      D ++    E+ +L +     + K Y   
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           LKG   ++++EY+  G+    L        P  D F+   +     KG+ YLH   S   
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL-----RAGP-FDEFQIATMLKEILKGLDYLH---SEKK 122

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIK++N+LL E  + K+ADFGVA ++ +   K    + F GT  ++AP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 55/174 (31%), Positives = 81/174 (46%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIR-HRNILKL 736
           ++G G  GKV    LK++    AVK L K      D V+    E  IL   R H  + +L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y C       F V+E++  G+L   + K  +  +    ++     A      + +LH   
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY-----AAEITSALMFLH--- 113

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD +   K+ADFG+ K    + K +  S F GT  YIAP
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 52/166 (31%), Positives = 75/166 (45%), Gaps = 29/166 (17%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-------VKVFAAEMEILGKIR 729
           N     L+G G  G+VY          +AVKQ+            V     E+++L  +R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 730 HRNILKLYACLLKGGSSFLVL--EYMPNGNL------FQALHKRVKEGKPELDWFRRYKI 781
           H  I++ Y CL       L +  EYMP G++      + AL + V          RRY  
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT---------RRYTR 113

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            +   +G++YLH   S  I+HRDIK +NIL D     K+ DFG +K
Sbjct: 114 QI--LQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 52/182 (28%), Positives = 89/182 (48%), Gaps = 23/182 (12%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEME---------ILGKIRHRN 732
            ++G G  G VY   L      +AVKQ+ + D   V AAE E         +L  ++H N
Sbjct: 6   EVLGKGAYGTVY-CGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I++     L   +  + +E++P G++   L++      PE   F +Y   +    G+AYL
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRF--GPLPEP-VFCKYTKQI--LDGVAYL 118

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHG---YI 848
           H++C   ++HRDIK +N++L  +   K+ DFG A ++A      +  +     HG   ++
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 849 AP 850
           AP
Sbjct: 176 AP 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 56/158 (35%), Positives = 74/158 (46%), Gaps = 29/158 (18%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKL 736
           +IG G  G+V  L   K+ G V A+K L K D +K        AE +IL       I+KL
Sbjct: 8   VIGRGAFGEV-WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66

Query: 737 YACLLKGGSSF-------LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           Y        SF       LV+EYMP G+L   L   +++     +  R Y   L  A  +
Sbjct: 67  YY-------SFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYIAELVLA--L 114

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             +H       IHRDIK  NIL+D D   K+ADFG+ K
Sbjct: 115 DSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 48/145 (33%), Positives = 72/145 (49%), Gaps = 20/145 (13%)

Query: 703 TVAVKQLWKGDG----VKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNGN 757
           TVAVK L K D     +    +EME++  I +H+NI+ L     + G  ++++EY   GN
Sbjct: 46  TVAVKML-KDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104

Query: 758 LFQALHKRVKEG-----------KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIK 806
           L + L  R   G           + +L +      A   A+G+ YL    S   IHRD+ 
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLA 161

Query: 807 SSNILLDEDYEPKIADFGVAKIAEN 831
           + N+L+ ED   KIADFG+A+   N
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHN 186

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 11/155 (7%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIP-LPLIKSYLFQL--LQGLAFC 116

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+
Sbjct: 117 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 55/176 (31%), Positives = 85/176 (48%), Gaps = 16/176 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKI-RHRNILKLYACL 740
           L+G+G  G+VY+    K     A+K +   GD  +    E+ +L K   HRNI   Y   
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 741 LKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           +K          +LV+E+   G++   L K  K    + +W     I     +G+++LH 
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ 129

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                +IHRDIK  N+LL E+ E K+ DFGV+  A+    V   + F GT  ++AP
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAP 180

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 53/170 (31%), Positives = 87/170 (51%), Gaps = 15/170 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V     K +   VAVK   L K    ++   E+ I+   +H+N++++Y   L
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
            G   ++++E++  G    AL   V + +  L+  +   +     + + YLH   S  +I
Sbjct: 89  VGEELWVLMEFLQGG----ALTDIVSQTR--LNEEQIATVCESVLQALCYLH---SQGVI 139

Query: 802 HRDIKSSNILLDEDYEPKIADFG-VAKIAENSPKVSDYSCFAGTHGYIAP 850
           HRDIKS +ILL  D   K++DFG  A+I+++ PK        GT  ++AP
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAP 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 20/152 (13%)

Query: 696 DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750
           D  K A TVAVK L K D  +       +EME++  I +H+NI+ L     + G  ++++
Sbjct: 42  DKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 100

Query: 751 EYMPNGNLFQALHKRVKEG-----------KPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           EY   GNL + L  R   G             ++ +          A+G+ YL    S  
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQK 157

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
            IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 158 CIHRDLAARNVLVTENNVMKIADFGLARDVNN 189

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 23/188 (12%)

Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEIL 725
           D+  E +  + +   +G+G  G V ++        +A K +  G    V      E++I+
Sbjct: 1   DLRNEDLETISD---LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM 57

Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
            + R   I+  Y   L   +  + +E+M  G+L   ++K+      E+      KIA+  
Sbjct: 58  HECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEI----LGKIAVAV 112

Query: 786 AKGIAYL---HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
            +G+ YL   H      I+HRDIK SNIL++   + K+ DFGV+    NS  ++D   F 
Sbjct: 113 VEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IAD--TFV 163

Query: 843 GTHGYIAP 850
           GT  Y++P
Sbjct: 164 GTSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 48/176 (27%), Positives = 88/176 (50%), Gaps = 20/176 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHRNILKLYACL 740
           ++G G  G VY          +A+K++ + D   V+    E+ +   ++HRNI++     
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKR---VKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
            + G   + +E +P G+L   L  +   +K+ +  + ++ +  +     +G+ YLH +  
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDN-- 127

Query: 798 PPIIHRDIKSSNILLDEDYEP--KIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
             I+HRDIK  N+L++  Y    KI+DFG +K +A  +P       F GT  Y+AP
Sbjct: 128 -QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCT---ETFTGTLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 58/174 (33%), Positives = 78/174 (44%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILK-L 736
           ++G G  GKV   +LK      AVK L K      D V+    E  +L        L  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y         F V+E++  G+L   +     + K   D +R    A     G+ +LH   
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHI-----QDKGRFDLYRATFYAAEIVCGLQFLH--- 113

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  II+RD+K  N++LD D   KIADFG+ K  EN    +  S F GT  YIAP
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 57/176 (32%), Positives = 76/176 (43%), Gaps = 20/176 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIR-HRNILKL 736
           ++G G  GKV   +LK      A+K L K      D V     E  IL     H  +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNL-FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-H 794
           + C       F V+EY+  G+L FQ    R      + D  R    A      + +LH H
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH 115

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                +I+RD+K  NILLD +   K+ADFG+ K  E        + F GT  YIAP
Sbjct: 116 G----VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 55/176 (31%), Positives = 85/176 (48%), Gaps = 16/176 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKI-RHRNILKLYACL 740
           ++G+G  G+VY+    K     A+K +    D  +    E+ +L K   HRNI   Y   
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 741 LKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           +K          +LV+E+   G++   L K  K    + DW     I     +G+A+LH 
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAY--ICREILRGLAHLH- 138

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             +  +IHRDIK  N+LL E+ E K+ DFGV+  A+    V   + F GT  ++AP
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAP 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 4e-11
 Identities = 36/104 (34%), Positives = 61/104 (58%), Gaps = 5/104 (4%)

Query: 63  FSGITC--DSVTGR--VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELS 118
           +SG  C  DS  G+  +  +  DN+ L G I + IS L+ L  ++L  N + G +P  L 
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463

Query: 119 NCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFP 161
           + ++L+VL+++ N+  GS+P+ L  L +L I +L+ N  +GR P
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 29/166 (17%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW-------KGDGVKVFAAEMEILGKIR 729
           N     L+G G  G+VY          +A KQ+            V     E+++L  ++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 730 HRNILKLYACLLKGGSSFLV--LEYMPNGNL------FQALHKRVKEGKPELDWFRRYKI 781
           H  I++ Y CL       L   +EYMP G++      + AL + V          R+Y  
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT---------RKYTR 113

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            +   +G++YLH +    I+HRDIK +NIL D     K+ DFG +K
Sbjct: 114 QI--LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.3 bits (157), Expect = 5e-11
 Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 22/184 (11%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTV-AVKQLWK---GDGVKVFAAEMEILGKIRH-R 731
           +L++   IG G  G V ++ L K +GT+ AVK++         K    +++++ +     
Sbjct: 5   DLKDLGEIGRGAFGTVNKM-LHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 732 NILKLYACLLKGGSSFLVLEYMPNG--NLFQALHKRVKEGKPE--LDWFRRYKIALGAAK 787
            I+K Y  L + G  ++ +E M       ++ +++ +K   PE  L      KIA+   K
Sbjct: 64  YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVK 118

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS-PKVSDYSCFAGTHG 846
            + YL  +    IIHRD+K SNILLD +   K+ DFG++    +S  K  D    AG   
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD----AGCRP 172

Query: 847 YIAP 850
           Y+AP
Sbjct: 173 YMAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 56/177 (31%), Positives = 78/177 (44%), Gaps = 22/177 (12%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILG-KIRHRNILKL 736
           ++G G  GKV   +LK      A+K L K      D V+    E  +L     H  +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK---GIAYLH 793
           +         F V+EY+  G+L   +    +        F   +    AA+   G+ +LH
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--------FDEARARFYAAEIICGLQFLH 113

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                 II+RD+K  N+LLD+D   KIADFG+ K  EN       S F GT  YIAP
Sbjct: 114 ---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 29/181 (16%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT-VAVKQLW------------KGDGVKVFAAEMEILGK-I 728
            +GSG  G VY++  K N    +A+K++             +   +    +E+ I+ + +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 729 RHRNILKLYACLLKGGSSFLVLEYM---PNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
           RH NI++ Y   L+    ++V++ +   P G  F +L    KE K      R + I +  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL----KEKKQRFTEERIWNIFVQM 122

Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD------YS 839
              + YLH +    I+HRD+  +NI+L ED +  I DFG+AK  +   K++       YS
Sbjct: 123 VLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180

Query: 840 C 840
           C
Sbjct: 181 C 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 6e-11
 Identities = 29/80 (36%), Positives = 43/80 (53%)

Query: 231 GEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKN 290
           G  P  I KL+ L  I L  N++ G +P  LG++T L+  D+S N   G +PE +G L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 291 LTVFQCFKNNFSGEFPSGFG 310
           L +     N+ SG  P+  G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.7 bits (160), Expect = 6e-11
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 8/105 (7%)

Query: 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
           LVL+Y   G+L Q +  R K  +     FR ++  L   + +  +HH  S  +IHRDIKS
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRT----FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKS 171

Query: 808 SNILLDEDYEPKIADFGVAKIAENSPKVSD--YSCFAGTHGYIAP 850
           +NILL  +   K+ DFG +K+   +  VSD     F GT  Y+AP
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAAT--VSDDVGRTFCGTPYYVAP 214

Length = 496

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.6 bits (157), Expect = 6e-11
 Identities = 54/180 (30%), Positives = 93/180 (51%), Gaps = 31/180 (17%)

Query: 684 IGSGGTGKV-YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY- 737
           +GSG  G V   LD +  A  VA+K+L++    ++FA     E+ +L  ++H N++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGA-KVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81

Query: 738 -----ACLLKGGSSFLVLEYMPN--GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                  L +    +LV+ +M    G L +  H+++ E + +   F  Y++     KG+ 
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQ---FLVYQML----KGLK 132

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           Y+H   +  IIHRD+K  N+ ++ED E KI DFG+A+  +     S+ + +  T  Y AP
Sbjct: 133 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-----SEMTGYVVTRWYRAP 184

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 17/154 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+      N   VAVK L  G    + F  E +I+ K+RH  +++LYA ++ 
Sbjct: 14  LGNGQFGEVWMGTWNGNT-KVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVS 71

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L  +  EG+    P L       +A   A G+AY+      
Sbjct: 72  EEPIYIVTEYMSKGSLLDFL--KDGEGRALKLPNL-----VDMAAQVAAGMAYIER---M 121

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             IHRD++S+NIL+ +    KIADFG+A++ E++
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 54/174 (31%), Positives = 82/174 (47%), Gaps = 18/174 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKL-Y 737
           +G GG G+V    +K      A K+L K       G ++   E +IL K+  R I+ L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDW-FRRYKIALGAAKGIAYLHHDC 796
           A   K     LV+  M  G+L   ++   + G PE    F   +I  G    + +LH   
Sbjct: 61  AFETKDDLC-LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQR- 114

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I++RD+K  N+LLD+    +I+D G+A   +   K+      AGT GY+AP
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 54/171 (31%), Positives = 84/171 (49%), Gaps = 16/171 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           IG G  G+VY+    +    VA+K +      D ++    E+ +L +     I + Y   
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           LKG   ++++EY+  G+    L    K G  E  +     I     KG+ YLH   S   
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIA--TILREILKGLDYLH---SERK 122

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIK++N+LL E  + K+ADFGVA ++ +   K    + F GT  ++AP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 63.3 bits (154), Expect = 7e-11
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 19/160 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG-----VKVFAAEMEILGKIRHRNIL 734
           ++G G  G V    L ++ G+   VAVK + K D      ++ F +E   +    H N++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 735 KLYACLLKGGSS------FLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAK 787
           KL     +  S        ++L +M +G+L   L + R+     +L      K  +  A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           G+ YL    +   IHRD+ + N +L ED    +ADFG++K
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 25/166 (15%)

Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKVFA---AEMEILGKI-RHRN 732
           +G G  G+V R               TVAVK L      K  A   +EME++  I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----------VKEGKPELDWFRRYKI 781
           I+ L     + G  ++++EY   GNL + L  R            K  + +L +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           A   A+G+ YL    S   IHRD+ + N+L+ ED   KIADFG+A+
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 21/162 (12%)

Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKL 736
           +G G  GKV     Y L   K+   VAVK L        K F  E E+L  ++H +I+K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKR------VKEGKP-----ELDWFRRYKIALGA 785
           Y     G    +V EYM +G+L + L         + +G+P     EL   +   IA   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           A G+ YL    S   +HRD+ + N L+  +   KI DFG+++
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.8 bits (155), Expect = 8e-11
 Identities = 54/174 (31%), Positives = 76/174 (43%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
           +IG G  GKV     K +    AVK L K   +K      + A    +L  ++H  ++ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           +         + VL+Y+  G LF  L +     +P   ++     A   A  I YLH   
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY-----AAEVASAIGYLH--- 113

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  II+RD+K  NILLD      + DFG+ K  E        S F GT  Y+AP
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 63.5 bits (154), Expect = 8e-11
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)

Query: 704 VAVKQLWKGDGVKV----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLF 759
           VAVK L + D  K     F  E++I+ ++++ NI++L    +      ++ EYM NG+L 
Sbjct: 47  VAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 760 QALHKRVKEGK-------PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812
           Q L +R  E         P +       +A+  A G+ YL    S   +HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162

Query: 813 DEDYEPKIADFGVAK 827
              Y  KIADFG+++
Sbjct: 163 GNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 64.2 bits (157), Expect = 8e-11
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 29/181 (16%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY 737
           + +GSG  G+V      K    VA+K+L +     + A     E+ +L  + H N++ L 
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 738 ACLLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGI 789
                  S       +LV   M        L+  VK  K   D   F  Y+I     +G+
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLMG-----ADLNNIVKCQKLSDDHIQFLVYQIL----RGL 131

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
            Y+H   S  IIHRD+K SNI ++ED E KI DFG+A+  ++  +++ Y     T  Y A
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD--EMTGY---VATRWYRA 183

Query: 850 P 850
           P
Sbjct: 184 P 184

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.2 bits (153), Expect = 8e-11
 Identities = 50/158 (31%), Positives = 86/158 (54%), Gaps = 11/158 (6%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV-KVFAAEMEILGKIRHRNILK 735
           +L  D  +G G  G+V+ +        VA+K L  G  + + F  E +I+ K+RH  ++ 
Sbjct: 7   SLRLDVKLGQGCFGEVW-MGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP 65

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE-LDWFRRYKIALGAAKGIAYLHH 794
           LYA ++     ++V E+M  G+L   L    KEG  + L   +   +A   A G+AY+  
Sbjct: 66  LYA-VVSEEPIYIVTEFMGKGSLLDFL----KEGDGKYLKLPQLVDMAAQIADGMAYIER 120

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
                 IHRD++++NIL+ ++   KIADFG+A++ E++
Sbjct: 121 ---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.4 bits (154), Expect = 9e-11
 Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 15/170 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK--VFAAEMEILGKIRHRNILKLYACLL 741
           IG G +G VY          VA+KQ+      K  +   E+ ++ + +H NI+      L
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 742 KGGSSFLVLEYMPNGNLFQALHKR-VKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++V+EY+  G+L   + +  + EG+          +     + + +LH   S  +
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEFLH---SNQV 136

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS NILL  D   K+ DFG    A+ +P+ S  S   GT  ++AP
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 54/171 (31%), Positives = 84/171 (49%), Gaps = 16/171 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           IG G  G+V++    +    VA+K +      D ++    E+ +L +     + K Y   
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           LK    ++++EY+  G+    L     E  P LD  +   I     KG+ YLH   S   
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLL-----EPGP-LDETQIATILREILKGLDYLH---SEKK 122

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIK++N+LL E  E K+ADFGVA ++ +   K    + F GT  ++AP
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 17/154 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+          VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 14  LGQGCFGEVWM-GTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L  + + GK    P+L       +A   A G+AY+      
Sbjct: 72  EEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQL-----VDMAAQIASGMAYVER---M 121

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 53/157 (33%), Positives = 84/157 (53%), Gaps = 16/157 (10%)

Query: 684 IGSGGTGKVY--RLDLK-KNAGT-VAVKQLWKGDGVKVFA---AEMEILGKIRHRNILKL 736
           +G G  GKV   R D +  N G  VAVK L    G    A    E+EIL  + H NI+K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 737 YA-CLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
              C   GG+   L++E++P+G+L + L +     K +++  ++ K A+   KG+ YL  
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLG- 126

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
             S   +HRD+ + N+L++ +++ KI DFG+ K  E 
Sbjct: 127 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 1e-10
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 39/175 (22%)

Query: 684 IGSGGTGKVYRLDLKKNAGT--VAVKQL----WKGDGVKVFAA-EMEILGKIRHRNILKL 736
           IG G  G+VY+   K        A+K+      +  G+   A  E+ +L +++H N++ L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 737 YACLL--KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK---IALGAAK---- 787
               L     S +L+ +Y  + +L+Q +            + R+ K   I     K    
Sbjct: 68  VEVFLEHADKSVYLLFDYAEH-DLWQIIK-----------FHRQAKRVSIPPSMVKSLLW 115

Query: 788 ----GIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPK 834
               G+ YLH   S  ++HRD+K +NIL+     E    KI D G+A++     K
Sbjct: 116 QILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 60/183 (32%), Positives = 80/183 (43%), Gaps = 34/183 (18%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG 743
           IG G  G+VY++  K      A+K L K    K   A+ E+   I  RNIL      L  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK----KEIVAKKEVAHTIGERNIL---VRTLLD 53

Query: 744 GSSF---------------LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            S F               LV +YM  G LF  L K   EG+   D  + Y   L  A  
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK---EGRFSEDRAKFYIAELVLA-- 108

Query: 789 IAYLH-HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
           + +LH +D    I++RD+K  NILLD      + DFG++K   N       + F GT  Y
Sbjct: 109 LEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEY 162

Query: 848 IAP 850
           +AP
Sbjct: 163 LAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNIL-KL 736
           ++G G  GKV   + K      A+K L K      D V+    E  +L        L +L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       + V+EY+  G+L   + +  K  +P+  ++     A   + G+ +LH   
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY-----AAEISVGLFFLHRR- 120

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N++LD +   KIADFG+ K  E+         F GT  YIAP
Sbjct: 121 --GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 63.4 bits (155), Expect = 1e-10
 Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 58/196 (29%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA------------EMEILGKIR-H 730
           +G G  G V++   ++    VA+K        K+F A            E+  L ++  H
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALK--------KIFDAFRNATDAQRTFREIMFLQELGDH 66

Query: 731 RNILKLYACLLKGGSS---FLVLEYMPN-------GNLFQALHKRVKEGKPELDWFRRYK 780
            NI+KL   ++K  +    +LV EYM          N+ + +HKR          +  Y+
Sbjct: 67  PNIVKLLN-VIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR----------YIMYQ 115

Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK------IAENSPK 834
           +     K + Y+H   S  +IHRD+K SNILL+ D   K+ADFG+A+          +P 
Sbjct: 116 LL----KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 835 VSDYSCFAGTHGYIAP 850
           ++DY     T  Y AP
Sbjct: 169 LTDY---VATRWYRAP 181

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 55/173 (31%), Positives = 75/173 (43%), Gaps = 16/173 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGK-IRHRNILKLY 737
           IG G  GKV     K +    AVK L K         K   AE  +L K ++H  ++ L+
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    + VL+Y+  G LF  L +     +P   ++     A   A  + YLH   S
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY-----AAEIASALGYLH---S 114

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             II+RD+K  NILLD      + DFG+ K  E        S F GT  Y+AP
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 16/150 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAA-EMEILGKIRHRNILKLYAC 739
           IG G  G V++   ++    VA+K++   D   GV   A  E+ +L +++H+NI++LY  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVK--EGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
           L       LV EY       Q L K      G  + +  + +   L   KG+A+ H   S
Sbjct: 68  LHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQL--LKGLAFCH---S 117

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             ++HRD+K  N+L++++ E K+ADFG+A+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 23/155 (14%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
           IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H NI++L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRR------YKIALGAAKGIAYLH 793
           +      +LV E+     L   L K+  +  P             Y++     +GIAY H
Sbjct: 67  VHSENKLYLVFEF-----LDLDL-KKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCH 116

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
              S  ++HRD+K  N+L+D +   K+ADFG+A+ 
Sbjct: 117 ---SHRVLHRDLKPQNLLIDREGALKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 53/183 (28%), Positives = 78/183 (42%), Gaps = 36/183 (19%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAA-EMEILGKIRHRNILKLYA 738
           L+G G  G V +   K+    VA+K+  +      VK  A  E+ +L ++RH N++ L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 739 CLLKGGSSFLVLEYM-----------PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
              +    +LV E++           PNG                LD  R  K      +
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----------------LDESRVRKYLFQILR 111

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
           GI + H   S  IIHRDIK  NIL+ +    K+ DFG A+    +P    Y+ +  T  Y
Sbjct: 112 GIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPG-EVYTDYVATRWY 166

Query: 848 IAP 850
            AP
Sbjct: 167 RAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 19/170 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G VY+         +AVK +     V++     +E+EIL K     I+  Y   
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
                  +  E+M  G+L   +++++ E    L      +IA+   KG+ YL    S  I
Sbjct: 69  FVENRISICTEFMDGGSL--DVYRKIPE--HVLG-----RIAVAVVKGLTYL---WSLKI 116

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +HRD+K SN+L++   + K+ DFGV+    NS   +    + GT+ Y+AP
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 15/160 (9%)

Query: 677 NLEEDNLIGSGGTGKV-----YRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKI 728
           NL     +G+G  GKV     Y L        VAVK L         +   +E++I+  +
Sbjct: 36  NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95

Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
             H NI+ L      GG   ++ EY   G+L   L ++ +E    L+    +  +   AK
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSF--SYQVAK 152

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           G+A+L    S   IHRD+ + N+LL      KI DFG+A+
Sbjct: 153 GMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 16/134 (11%)

Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFR 777
           E  +L K++H NI+         G  ++V+EY   G+L Q +  +  +  PE   L WF 
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF- 106

Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
             ++ LG       + H     ++HRDIKS NI L ++ + K+ DFG A++  +      
Sbjct: 107 -VQMCLG-------VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GA 155

Query: 838 YSC-FAGTHGYIAP 850
           Y+C + GT  Y+ P
Sbjct: 156 YACTYVGTPYYVPP 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 29/82 (35%), Positives = 48/82 (58%)

Query: 205 LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNL 264
           LRG IP  IS+LR L ++++  N I G  P S+  +  L  ++L  N+  G +P  LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 265 TLLQEFDISSNQMYGKLPEEIG 286
           T L+  +++ N + G++P  +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 21/163 (12%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIR---HR 731
           EE   IG G  G VY+         VA+K++      +G+ +    E+ +L ++    H 
Sbjct: 2   EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP 61

Query: 732 NILKLY-ACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK-IALGA 785
           NI++L   C            LV E++ + +L   L K  K G P        K +    
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPP----ETIKDLMRQL 116

Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
            +G+ +LH   S  I+HRD+K  NIL+  D + KIADFG+A+I
Sbjct: 117 LRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 48/165 (29%), Positives = 89/165 (53%), Gaps = 17/165 (10%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILK 735
           +L+ +  +G+G  G+V+     K+   VAVK +  G   V+ F AE  ++  ++H  ++K
Sbjct: 7   SLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAY 791
           L+A + K    +++ E+M  G+L   L  +  EG     P+L  F     +   A+G+A+
Sbjct: 66  LHAVVTKE-PIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDF-----SAQIAEGMAF 117

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           +        IHRD++++NIL+      KIADFG+A++ E++   +
Sbjct: 118 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)

Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWKGDGVKVFAA---EMEILGKIRH 730
           L +  L+GSG  G V++        +    VA+K +    G + F      M  +G + H
Sbjct: 9   LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE--LDWFRRYKIALGAAKG 788
             I++L   +  G S  LV +  P G+L   + +      P+  L+W       +  AKG
Sbjct: 69  AYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKG 121

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           + YL       ++HR++ + NILL  D   +IADFGVA +
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 16/172 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGV--KVFAAEMEILGKIRHRNILKLYAC 739
           IG G  G V++   ++    VA+K+  +   D V  K+   E+ +L +++H N++ L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-HDCSP 798
             +     LV EY  +  +   L K  + G PE       KI     + + + H H+C  
Sbjct: 69  FRRKRKLHLVFEYCDH-TVLNELEKNPR-GVPEH---LIKKIIWQTLQAVNFCHKHNC-- 121

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             IHRD+K  NIL+ +  + K+ DFG A+I   +    DY+ +  T  Y AP
Sbjct: 122 --IHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 19/179 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-----WKGDGVKVFAA---EMEILGKIRHRNIL 734
            +G+G     Y+    K    +AVKQ+        +  +V  A   E+ ++ ++ H +I+
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           ++     +     L +E+M  G++   L K    G  +      Y   L   +G++YLH 
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQL--LRGLSYLHE 121

Query: 795 DCSPPIIHRDIKSSNILLDED-YEPKIADFGVA-KIAENSPKVSDYSC-FAGTHGYIAP 850
           +    IIHRD+K +N+L+D      +IADFG A ++A       ++     GT  ++AP
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 50/164 (30%), Positives = 67/164 (40%), Gaps = 16/164 (9%)

Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKI 728
           ++     +G G  G+VY       D       VAVK L           F  E  I+ K 
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKP-ELDWFRRYKIALGAA 786
            H+NI++L     +    F++LE M  G+L   L   R +  +P  L        A   A
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
           KG  YL        IHRDI + N LL         KIADFG+A+
Sbjct: 127 KGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 11/130 (8%)

Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+++L +     I+  Y      G   + +E+M  G+L Q L K  +  +  L      K
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----K 103

Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
           I++   +G+ YL       I+HRD+K SNIL++   E K+ DFGV+    +S   S    
Sbjct: 104 ISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---- 157

Query: 841 FAGTHGYIAP 850
           F GT  Y++P
Sbjct: 158 FVGTRSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 29/160 (18%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLW-------KGDGVKVFAAEMEILGKIRHRNILK 735
           L+G G  G+VY          +AVKQ+            V     E+++L  + H  I++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 736 LYACLLKGGSSFL--VLEYMPNGNL------FQALHKRVKEGKPELDWFRRYKIALGAAK 787
            Y CL       L   +E+MP G++      + AL + V          R+Y   +   +
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT---------RKYTRQI--LE 117

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           G++YLH   S  I+HRDIK +NIL D     K+ DFG +K
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 17/172 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL--WKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           +G G  GKVY+   K+     A K +     + ++ +  E++IL    H NI+KL     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 742 KGGSSFLVLEYMPNGNL---FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              + ++++E+   G +      L + + E +  +       +     + + YLH +   
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-------VCKQTLEALNYLHEN--- 122

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            IIHRD+K+ NIL   D + K+ADFGV+  A+N+  +     F GT  ++AP
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 15/174 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYA 738
           +G GG G+V    ++      A K+L K       G +    E  IL K+  R I+ L A
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 739 CLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
              +  +   LV+  M  G+L   ++  V E  P     R          G+ +LH    
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
             II+RD+K  N+LLD D   +I+D G+A ++ +   K   Y   AGT G++AP
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY---AGTPGFMAP 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 41/130 (31%), Positives = 59/130 (45%), Gaps = 12/130 (9%)

Query: 704 VAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
           VAVK L           F  E++IL ++   NI +L           +++EYM NG+L Q
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 761 ALHKRV------KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814
            L K V            L +     +A   A G+ YL    S   +HRD+ + N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165

Query: 815 DYEPKIADFG 824
           +Y  KIADFG
Sbjct: 166 NYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.9 bits (147), Expect = 6e-10
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 13/169 (7%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G +G V+          VA+KQ  L K    ++   E+ ++ ++++ NI+      L
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
            G   F+V+EY+  G+L   + +        +D  +   +     + + +LH +    +I
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETC------MDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           HRDIKS N+LL  D   K+ DFG    A+ +P+ S  S   GT  ++AP
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNIL-KL 736
           ++G G  GKV   + K      A+K L K      D V+    E  +L        L +L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       + V+EY+  G+L   + +  K  +P   ++     A   A G+ +LH   
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY-----AAEIAIGLFFLH--- 118

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  II+RD+K  N++LD +   KIADFG+ K      K +    F GT  YIAP
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT--RTFCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 60.7 bits (147), Expect = 7e-10
 Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 30/178 (16%)

Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAG--TVAVKQLWKGDG---VKVFAAEMEILGKI 728
           NL     +G G  GKV +     LK  AG  TVAVK L +      ++   +E  +L ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNL--FQALHKRVKEGKPELDWFRRYK------ 780
            H +++KLY    + G   L++EY   G+L  F    ++V       D  R         
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 781 -----------IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                       A   ++G+ YL       ++HRD+ + N+L+ E  + KI+DFG+++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 61.3 bits (149), Expect = 8e-10
 Identities = 58/181 (32%), Positives = 82/181 (45%), Gaps = 32/181 (17%)

Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA-----EMEILGKIRHRNILK 735
           IGSG  G V   Y     +N   VA+K+L +     V  A     E+ ++  + H+NI+ 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQN---VAIKKLSR-PFQNVTHAKRAYRELVLMKLVNHKNIIG 79

Query: 736 LYACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           L        S       +LV+E M + NL Q +         +LD  R   +      GI
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM-------DLDHERMSYLLYQMLCGI 131

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
            +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y A
Sbjct: 132 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRA 185

Query: 850 P 850
           P
Sbjct: 186 P 186

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.2 bits (146), Expect = 8e-10
 Identities = 52/171 (30%), Positives = 86/171 (50%), Gaps = 13/171 (7%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKV--FAAEMEILGKIRHRNILKLYACL 740
           +G G  G VY++  +    T+A+K++  + D  K      E++IL K     I+  Y   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVK-EGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
              G+ ++ +EYM  G+L +     V  EG PE D  RR  I     KG+ +L  + +  
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRR--ITYAVVKGLKFLKEEHN-- 123

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+K +N+L++ + + K+ DFGV+     S   ++  C      Y+AP
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGC----QSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.4 bits (149), Expect = 1e-09
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 2/103 (1%)

Query: 367 LALSNN-FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGI 425
           L L N    G +PN  +  + +Q + +S N + G IP  L ++ ++ +LD   N F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 426 SPLIGLSTSLSQLVLQNNRFSGELPSELG-RLTNLERLILTNN 467
              +G  TSL  L L  N  SG +P+ LG RL +      T+N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 48/140 (34%), Positives = 70/140 (50%), Gaps = 20/140 (14%)

Query: 704 VAVKQLWKGDGVKV----FAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL 758
           VAVK L K D  +       +EME++  I +H+NI+ L     + G  ++++EY   GNL
Sbjct: 53  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111

Query: 759 FQALHKRVKEG---------KPE--LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
            + L  R   G          PE  L +      A   A+G+ YL    S   IHRD+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168

Query: 808 SNILLDEDYEPKIADFGVAK 827
            N+L+ ED   KIADFG+A+
Sbjct: 169 RNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 12/159 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID + +  L+E   +G+G  G V +    +    VA+K + +G      F  E +++ K+
Sbjct: 1   IDPKDLTFLKE---LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL 56

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY    K    ++V EYM NG L   L    +E        +  ++     +G
Sbjct: 57  SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEG 112

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL    S   IHRD+ + N L+D+    K++DFG+++
Sbjct: 113 MAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 53.9 bits (130), Expect = 1e-09
 Identities = 21/42 (50%), Positives = 27/42 (64%), Gaps = 1/42 (2%)

Query: 29 LNVETQALIQFKSKL-KDPHGVLDSWKESADSPCGFSGITCD 69
          LN +  AL+ FKS L  DP G L SW  S+  PC ++G+TCD
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 48/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAA-EMEILGKIRHRNILKLY 737
           N I  G  G VYR   KK    VA+K+L    + +G  + +  E+ IL K++H NI+ + 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 738 ACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
             ++  GS+    ++V+EY+ +      L   ++  K          + L    G+A+LH
Sbjct: 71  EVVV--GSNLDKIYMVMEYVEH-----DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH 123

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            +    I+HRD+K+SN+LL+     KI DFG+A+
Sbjct: 124 DNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.2 bits (146), Expect = 2e-09
 Identities = 45/175 (25%), Positives = 72/175 (41%), Gaps = 25/175 (14%)

Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVK------------VFAAEMEI 724
              +G G  GKV +         VA+K++       D  K                E++I
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG 784
           + +I+H NI+ L    ++G    LV++ M   +L     K+V + K  L   +   I L 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDL-----KKVVDRKIRLTESQVKCILLQ 127

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
              G+  LH       +HRD+  +NI ++     KIADFG+A+     P     S
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Length = 335

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.2 bits (146), Expect = 2e-09
 Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 32/173 (18%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA--EMEILGKIRHRNILKLYACLL 741
           +G G  G V+          VAVK++   D   V  A  E++I+ ++ H NI+K+Y  L 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 742 KGGSS--------------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
             GS               ++V EYM        L   +++G    +  R +   L   +
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQL--LR 125

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYS 839
           G+ Y+H   S  ++HRD+K +N+ ++ ED   KI DFG+A+I +       YS
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD-----PHYS 170

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 28/157 (17%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
           IG G  G VY+   +    T+A+K++    + +GV   A  E+ +L +++H NI++L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 740 LLKGGSSFLVLEY--------MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +      +LV EY        M +   F    + +K           Y+I     +GIAY
Sbjct: 70  VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT--------YLYQI----LRGIAY 117

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK 827
            H   S  ++HRD+K  N+L+D      K+ADFG+A+
Sbjct: 118 CH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 26/178 (14%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY- 737
            +GSG  G V     K+    VA+K+L +    ++FA     E+ +L  ++H N++ L  
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 738 ----ACLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
               A        F LV+ YM   +L + +   + E K +   +  Y++      G+ Y+
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQ---YLVYQML----CGLKYI 133

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K  N+ ++ED E KI DFG+A+ A+     ++ + +  T  Y AP
Sbjct: 134 H---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYRAP 183

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 16/175 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNIL-KL 736
           ++G G  GKV   + K      A+K L K      D V+    E  +L        L +L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       + V+EY+  G+L   + +  +  +P   ++     A   A G+ +LH   
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY-----AAEIAIGLFFLH--- 118

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG 851
           S  II+RD+K  N++LD +   KIADFG+ K  EN         F GT  YIAP 
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPE 171

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 4/131 (3%)

Query: 720 AEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY 779
           +E+  L    H  I+K +          L++EY   G+L + + +R+KE  P    F+ Y
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP----FQEY 169

Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
           ++ L   + +  L    S  ++HRD+KS+NI L      K+ DFG +K   +S  +   S
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229

Query: 840 CFAGTHGYIAP 850
            F GT  Y+AP
Sbjct: 230 SFCGTPYYLAP 240

Length = 478

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 58/182 (31%), Positives = 83/182 (45%), Gaps = 24/182 (13%)

Query: 679 EEDNLIGSGGTGKVYRLDLKK----NAGTVAVKQLWKGDGVK------VFAAEMEILGKI 728
           E+ N I + GTG   R+ L      +   VA+K+  K   +K      VF+ E +IL  I
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNYI 88

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H   + LY         +LVLE++  G  F  L +R K    ++  F   +I L     
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFYAAQIVLI---- 143

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YL    S  I++RD+K  N+LLD+D   K+ DFG AK+ +            GT  YI
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-----LCGTPEYI 195

Query: 849 AP 850
           AP
Sbjct: 196 AP 197

Length = 340

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 20/161 (12%)

Query: 684 IGSGGTGKVY-----RLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKL 736
           +G G  GKV+      L  +++   VAVK L +      + F  E E+L  ++H++I++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALH------KRVKEGKP----ELDWFRRYKIALGAA 786
           Y    +G    +V EYM +G+L + L       K +  G+     +L   +   IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            G+ YL    S   +HRD+ + N L+ +    KI DFG+++
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.0 bits (145), Expect = 3e-09
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 14/220 (6%)

Query: 75  VTEISFDNKSLSGEISSSISALQS-LTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
           +T +  DN +++ +I   I  L+S L  L L  N +   LP  L N  NLK L+++ N +
Sbjct: 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL 175

Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
                 LS L NL   DLS N  +   P  +  L+ L  L + +N     E+  S+ NLK
Sbjct: 176 SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN--SIIELLSSLSNLK 232

Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
           NL+ L L++ N    +PESI  L  L TLD+  N+IS     S+  L  L +++L  N+L
Sbjct: 233 NLSGLELSN-NKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSL 289

Query: 254 TGELPAE-LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLT 292
           +  LP   L  L L    ++           E+     L 
Sbjct: 290 SNALPLIALLLLLLELLLNLLLT----LKALELKLNSILL 325

Length = 394

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 54/185 (29%), Positives = 85/185 (45%), Gaps = 20/185 (10%)

Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAAEMEIL 725
           D D E+I  L      G+G  G V ++  K +   +A K +    K         E+++L
Sbjct: 4   DDDFERISEL------GAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57

Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
            +     I+  Y      G   + +E+M  G+L Q L K  K    E+      K+++  
Sbjct: 58  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEI----LGKVSIAV 112

Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
            +G+AYL       I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT 
Sbjct: 113 LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTR 166

Query: 846 GYIAP 850
            Y++P
Sbjct: 167 SYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.0 bits (142), Expect = 3e-09
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 15/170 (8%)

Query: 684 IGSGGTGKVYR-LDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           IG G +G VY  +D+      VA+KQ  L +    ++   E+ ++ + ++ NI+      
Sbjct: 27  IGQGASGTVYTAIDIA-TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           L G   ++V+EY+  G+L   + +        +D  +   +     + + +LH   S  +
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALDFLH---SNQV 136

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS NILL  D   K+ DFG    A+ +P+ S  S   GT  ++AP
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 43/178 (24%), Positives = 79/178 (44%), Gaps = 23/178 (12%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA-----------AEMEILGKIRHRN 732
           IG G    VY+     +   VA+K+      V++F             E+++L ++ H N
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKK------VQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           ++K  A  ++     +VLE    G+L + + K  K+ K  +     +K  +     + ++
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  I+HRDIK +N+ +      K+ D G+ +    S K +      GT  Y++P
Sbjct: 123 H---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 19/152 (12%)

Query: 684 IGSGGTGKV----YRLDLKKNAG-TVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILK 735
           +G G  G V    Y +  K      VAVK L +     G K F  E  ++ ++ H  I++
Sbjct: 3   LGHGNFGSVVKGVYLM--KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           L   + KG    LV+E  P G L + L KR      E+      ++A   A G+AYL   
Sbjct: 61  LIG-VCKGEPLMLVMELAPLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE-- 112

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            S   +HRD+ + N+LL   ++ KI+DFG+++
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSR 143

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 54/174 (31%), Positives = 79/174 (45%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNIL-KL 736
           +IG G   KV  + LKKN    A+K + K      + +     E  +  +      L  L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       FLV+EY+  G+L    H + +   PE +  R Y   +  A  + +LH   
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLPE-EHARFYAAEICIA--LNFLHER- 115

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD D   K+ D+G+ K  E        S F GT  YIAP
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 47/176 (26%), Positives = 86/176 (48%), Gaps = 21/176 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL--WKGDGVKVFAAEME--ILGKIRHRNILKLYAC 739
           +G G  G+V  +  + +     +K+L        +  AAE E  +L +++H NI+  Y  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYRE 66

Query: 740 LLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGIAYLHH 794
             +G     ++V+ +   G+L+  L ++  +  PE   ++WF +  +AL       YLH 
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYLHE 120

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                I+HRD+K+ N+ L      K+ D G+A++ EN   ++  S   GT  Y++P
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STLIGTPYYMSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 52/174 (29%), Positives = 76/174 (43%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
           +IG G  GKV     K      AVK L K   +K      + +    +L  ++H  ++ L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           +         + VL+Y+  G LF  L +     +P   ++     A   A  + YLH   
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-----AAEIASALGYLH--- 113

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  I++RD+K  NILLD      + DFG+ K  EN       S F GT  Y+AP
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 51/176 (28%), Positives = 78/176 (44%), Gaps = 20/176 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--------DGVKVFAAEMEILGKIRHRNIL 734
           +IG G   KV  ++LKK     A+K + K         D V+      E      H  ++
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN--HPFLV 59

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
            L++C       F V+E++  G+L    H + +   PE +  R Y     +A+    L+ 
Sbjct: 60  GLHSCFQTESRLFFVIEFVSGGDLM--FHMQRQRKLPE-EHARFY-----SAEISLALNF 111

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                II+RD+K  N+LLD +   K+ D+G+ K  E        S F GT  YIAP
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.0 bits (143), Expect = 4e-09
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 17/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  +  K +    A+K L K + +K      F  E +I+       I++L+
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    ++V+EYMP G+L   +        PE  W R Y   +  A  +  +H   S
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPE-KWARFYTAEVVLA--LDAIH---S 160

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
              IHRD+K  N+LLD+    K+ADFG   K+  N     D +   GT  YI+P
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISP 212

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 47/150 (31%), Positives = 72/150 (48%), Gaps = 15/150 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAG-TVAVKQ-----LWKGDGVKVFAAEMEILGKIRHRNILKLY 737
           +G GG G+V+ L  KK+ G  VA+K+     L+K + V+    E +IL   +   ++KL 
Sbjct: 9   VGQGGYGQVF-LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    +L +EY+P G+ F+ L      G    D  R Y   +  A  +  LH    
Sbjct: 68  YAFQDDEYLYLAMEYVPGGD-FRTL--LNNLGVLSEDHARFYMAEMFEA--VDALHE--- 119

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              IHRD+K  N L+D     K+ DFG++K
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 5e-09
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 35/186 (18%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY 737
           + IG G  G V     K     VA+K++   +  + F      E++IL + +H NI+ + 
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGIL 69

Query: 738 ACLLKGGS--SF----LVLEYMPNGNLFQALHKRVKEGKPELD---WFRRYKIALGAAKG 788
             +++  S  SF    +V E M        L+K +K      D   +F  Y+I     +G
Sbjct: 70  D-IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFL-YQIL----RG 118

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF----AGT 844
           + Y+H   S  ++HRD+K SN+LL+ + + KI DFG+A+IA+      D++ F      T
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE---HDHTGFLTEYVAT 172

Query: 845 HGYIAP 850
             Y AP
Sbjct: 173 RWYRAP 178

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.0 bits (140), Expect = 6e-09
 Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 14/134 (10%)

Query: 704 VAVKQLWKGDGVKV----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLF 759
           VAVK L + D  K     F  E++I+ +++  NI++L A  +      ++ EYM NG+L 
Sbjct: 49  VAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 760 QALHKR------VKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813
           Q L +        K     + +     +A   A G+ YL    S   +HRD+ + N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 814 EDYEPKIADFGVAK 827
           ++Y  KIADFG+++
Sbjct: 165 KNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.9 bits (140), Expect = 7e-09
 Identities = 55/173 (31%), Positives = 74/173 (42%), Gaps = 15/173 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
           L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                      V+EY   G LF  L +   E     D  R Y   + +A G  YLH   S
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALG--YLH---S 113

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             +++RD+K  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.4 bits (138), Expect = 8e-09
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 13/169 (7%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G +G VY          VA++Q  L +    ++   E+ ++ + ++ NI+      L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
            G   ++V+EY+  G+L   + +        +D  +   +     + + +LH   S  +I
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           HRDIKS NILL  D   K+ DFG    A+ +P+ S  S   GT  ++AP
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 57.5 bits (139), Expect = 8e-09
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 24/162 (14%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAA-EMEILGKIRHRNILKLY 737
             IG G  G+VY+   K     VA+K++    + +G  + A  E++IL ++ HRNI+ L 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 738 ACLL----------KGGSSFLVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIALGAA 786
             +             G+ +LV EYM + +L   L    V   +  +  F +  +     
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQLL----- 126

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           +G+ Y H       +HRDIK SNILL+   + K+ADFG+A++
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 58.7 bits (142), Expect = 9e-09
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 6/105 (5%)

Query: 162 RWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGT 221
           +W ++   L      DN      IP  I  L++L  + L+  ++RG IP S+  +  L  
Sbjct: 417 KWFIDGLGL------DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV 470

Query: 222 LDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTL 266
           LD+  N  +G  P S+ +L  L  + L  N+L+G +PA LG   L
Sbjct: 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 10/151 (6%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK---QLWKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           IG G  G+V+   L+ +   VAVK   +    D    F  E  IL +  H NI++L    
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +    ++V+E +  G+    L     EG P L      ++   AA G+ YL        
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRT---EG-PRLKVKELIQMVENAAAGMEYLESKHC--- 115

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
           IHRD+ + N L+ E    KI+DFG+++  E+
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEED 146

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.7 bits (139), Expect = 9e-09
 Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 22/186 (11%)

Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEI 724
           D D E+I  L      G+G  G V+++   K +G +  ++L     K         E+++
Sbjct: 4   DDDFEKISEL------GAGNGGVVFKV-SHKPSGLIMARKLIHLEIKPAIRNQIIRELQV 56

Query: 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG 784
           L +     I+  Y      G   + +E+M  G+L Q L K  +  +  L      K+++ 
Sbjct: 57  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIA 111

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
             KG+ YL       I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT
Sbjct: 112 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGT 165

Query: 845 HGYIAP 850
             Y++P
Sbjct: 166 RSYMSP 171

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 54/184 (29%), Positives = 88/184 (47%), Gaps = 28/184 (15%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYA- 738
           IG G  G+V++   KK    VA+K++   +  + F      E++IL  ++H N++ L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 739 CLLKG-------GSSFLVLEYMPN--GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           C  K        GS +LV E+  +    L    +K VK    E+      K+      G+
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEHDLAGLLS--NKNVKFTLSEIK-----KVMKMLLNGL 132

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG---THG 846
            Y+H      I+HRD+K++NIL+ +D   K+ADFG+A+ A +  K S  + +     T  
Sbjct: 133 YYIH---RNKILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNSKPNRYTNRVVTLW 188

Query: 847 YIAP 850
           Y  P
Sbjct: 189 YRPP 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKL 736
           +IG G  GKV     K +    AVK L K       +   + A    +L  ++H  ++ L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           +         + VL+++  G LF  L +     +P   ++     A   A  + YLH   
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFY-----AAEIASALGYLH--- 113

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  I++RD+K  NILLD      + DFG+ K  E   +    + F GT  Y+AP
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 55/179 (30%), Positives = 80/179 (44%), Gaps = 30/179 (16%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIR-------HRNIL 734
           IG G   +V +   +K     A+K +      K F +  ++  L +I+       H NIL
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM-----KKHFKSLEQVNNLREIQALRRLSPHPNIL 61

Query: 735 KLYACLL--KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           +L   L   K G   LV E M + NL++ +  R K   PE    + Y   L   K + ++
Sbjct: 62  RLIEVLFDRKTGRLALVFELM-DMNLYELIKGR-KRPLPEKR-VKSYMYQL--LKSLDHM 116

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
           H +    I HRDIK  NIL+  D   K+ADFG  + I    P    Y+ +  T  Y AP
Sbjct: 117 HRN---GIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPP----YTEYISTRWYRAP 167

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 56/174 (32%), Positives = 84/174 (48%), Gaps = 13/174 (7%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIR-HRNILKLYACLL 741
           IG G  GKV+++  KKN    AVK L    D  +   AE  IL  +  H N++K Y    
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 742 K-----GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           K     G   +LVLE    G++   +   +K G+   +    Y I   A  G+ +LH + 
Sbjct: 86  KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-ILHEALMGLQHLHVNK 144

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +   IHRD+K +NILL  +   K+ DFGV+    ++    + S   GT  ++AP
Sbjct: 145 T---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAP 193

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 30/151 (19%)

Query: 691 KVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750
           K+ R D  KNA         + D    F  E++IL +++  NI++L    +      ++ 
Sbjct: 52  KILRPDANKNA---------RND----FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMIT 98

Query: 751 EYMPNGNLFQALHKRVKEGK--------------PELDWFRRYKIALGAAKGIAYLHHDC 796
           EYM NG+L Q L     + K              P + +     +AL  A G+ YL    
Sbjct: 99  EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---S 155

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           S   +HRD+ + N L+ E+   KIADFG+++
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 58/177 (32%), Positives = 80/177 (45%), Gaps = 24/177 (13%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           IGSG  G V           VAVK+L +    +  A     E+ +L  + H+NI+ L   
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 740 LLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                S       +LV+E M + NL Q +H        ELD  R   +      GI +LH
Sbjct: 89  FTPQKSLEEFQDVYLVMELM-DANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH 140

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  IIHRD+K SNI++  D   KI DFG+A+ A  +  ++ Y     T  Y AP
Sbjct: 141 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV---TRYYRAP 191

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 55/173 (31%), Positives = 76/173 (43%), Gaps = 15/173 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLY 737
           L+G G  GKV  +  K +    A+K L K      D V     E  +L   RH  +  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                      V+EY+  G LF  L +   E     D  R Y   + +A  + YLH   S
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSR---ERVFSEDRTRFYGAEIVSA--LDYLH---S 113

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I++RD+K  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 55/184 (29%), Positives = 84/184 (45%), Gaps = 19/184 (10%)

Query: 677 NLEEDNLIGSGGTGKVY--RLDLKKNAGTV-AVKQLWKGDGVKV------FAAEMEILGK 727
           N E   ++G+G  GKV+  R     +AG + A+K L K   V+          E ++L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 728 IRHRNIL-KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
           +R    L  L+          L+L+Y+  G LF  L++R          F   ++ +  A
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--------FTESEVRVYIA 112

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
           + +  L H     II+RDIK  NILLD +    + DFG++K      +   YS F GT  
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIE 171

Query: 847 YIAP 850
           Y+AP
Sbjct: 172 YMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 44/148 (29%), Positives = 79/148 (53%), Gaps = 10/148 (6%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
           IG G  G VY+   KK    VA+K++    + +GV   A  E+ +L +++H NI+ L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           L++    +L+ E++ + +L + L    K    + +  + Y   +   +GI + H   S  
Sbjct: 68  LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQI--LQGILFCH---SRR 121

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAK 827
           ++HRD+K  N+L+D     K+ADFG+A+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 54/174 (31%), Positives = 79/174 (45%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKN----AGTVAVKQLWKGD-GVKVFAAEMEILGKI-RHRNILKL 736
           +IG G   KV  + LKK     A  V  K+L   D  +     E  +  +   H  ++ L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       F V+EY+  G+L    H + +   PE +  R Y   +  A  + YLH   
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPE-EHARFYSAEISLA--LNYLHER- 115

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD +   K+ D+G+ K  E        S F GT  YIAP
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 15/163 (9%)

Query: 689 TGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNIL-KLYACLLKGGSSF 747
           +GK+Y + + K A  V      K    +    E ++L  IR    L  L+          
Sbjct: 27  SGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81

Query: 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
           L+L+Y+  G LF  L +R +        F+  ++ + + + +  L H     II+RDIK 
Sbjct: 82  LILDYINGGELFTHLSQRER--------FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKL 133

Query: 808 SNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            NILLD +    + DFG++K          YS F GT  Y+AP
Sbjct: 134 ENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 17/184 (9%)

Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA-----AEMEILGKIR 729
           + N   +  IG G   +VYR     +   VA+K++   D +   A      E+++L ++ 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPELD-WFRRYKIALGAA 786
           H N++K YA  ++     +VLE    G+L + +   K+ K   PE   W  +Y + L +A
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCSA 118

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
                L H  S  ++HRDIK +N+ +      K+ D G+ +    S K +      GT  
Sbjct: 119 -----LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPY 171

Query: 847 YIAP 850
           Y++P
Sbjct: 172 YMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 23/155 (14%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKL 736
           +IG G  G+V RL  KK+ G + A+K+L K + ++        AE +IL +  +  ++KL
Sbjct: 8   VIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR----RYKIALGAAKGIAYL 792
           Y         +L++EY+P G++   L K+        D F     R+ IA      I  +
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLMKK--------DTFTEEETRFYIA-ETILAIDSI 117

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           H       IHRDIK  N+LLD     K++DFG+  
Sbjct: 118 H---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 41/147 (27%), Positives = 77/147 (52%), Gaps = 9/147 (6%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G    VY+   +     VA+K+  L   +G    A  E+ ++ +++H NI++L+  +
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
                  LV EYM + +L + +      G  + +  + +   L   KGIA+ H +    +
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCHEN---RV 121

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAK 827
           +HRD+K  N+L+++  E K+ADFG+A+
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 46/147 (31%), Positives = 68/147 (46%), Gaps = 13/147 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           IG G  G+V  +         A+K L K D +         AE +IL +  +  ++KLY 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                 + + V++Y+P G++   L   ++ G  E D  R Y   L  A  I  +H     
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIAELTCA--IESVH---KM 120

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGV 825
             IHRDIK  NIL+D D   K+ DFG+
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 15/159 (9%)

Query: 686 SGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGS 745
            G  G+V+          V +K   KG  +     E  +L  + H +++++   L+ G  
Sbjct: 76  PGSEGRVFVATKPGQPDPVVLKIGQKGTTL----IEAMLLQNVNHPSVIRMKDTLVSGAI 131

Query: 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDI 805
           + +VL +  + +L+  L KR +     L   +   I     +G+ YLH   +  IIHRD+
Sbjct: 132 TCMVLPHY-SSDLYTYLTKRSRP----LPIDQALIIEKQILEGLRYLH---AQRIIHRDV 183

Query: 806 KSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
           K+ NI +++  +  I D G A+    +P    +   AGT
Sbjct: 184 KTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGT 219

Length = 357

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 15/172 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYA 738
           IG G  GKV ++  +      A+K + K        V    AE  +L ++    I+ L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +LVL ++  G LF  L +   EG+     F   +     A+ +  L +    
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQR---EGR-----FDLSRARFYTAELLCALENLHKF 112

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +I+RD+K  NILLD      + DFG+ K+  N       + F GT  Y+AP
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.9 bits (134), Expect = 4e-08
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)

Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81

Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 133

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 134 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 187

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 50/176 (28%), Positives = 73/176 (41%), Gaps = 28/176 (15%)

Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
           N+E    IG G  G+V++     L   +    VAVK L +    D    F  E  ++ + 
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK-----------------EGKP 771
            H NI+KL      G    L+ EYM  G+L + L  R                       
Sbjct: 66  DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 772 ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            L    +  IA   A G+AYL        +HRD+ + N L+ E+   KIADFG+++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 15/168 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNIL-KLYACLLK 742
           +    TGK+Y + + + A  V      K   V+    E  +L  +R    L  L+     
Sbjct: 22  VTGHDTGKLYAMKVLQKAALVQ-----KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
                L+L+Y+  G +F  L++R        D F   ++   + + I  L H     I++
Sbjct: 77  EAKLHLILDYVSGGEMFTHLYQR--------DNFSEDEVRFYSGEIILALEHLHKLGIVY 128

Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           RDIK  NILLD +    + DFG++K   +  K   YS F GT  Y+AP
Sbjct: 129 RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 15/173 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  +  K      A+K L K + +K      F  E +I+       +++L+
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    ++V+EYMP G+L   +       K    W R Y      A+ +  L    S
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHS 160

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              IHRD+K  N+LLD+    K+ADFG   +  N   +       GT  YI+P
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 26/180 (14%)

Query: 684 IGSGGTGKVYRL-DLKKNAGT-------VAVKQLWKGDGVKVFAAEMEILGKIRHRNILK 735
           +G G  G VY + D K  A         + V +L   + V+    E ++L K+ H  I+K
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAKGIA 790
            +A  L+  +  ++ EY    +L   L +    GK   E    +WF +  +      G+ 
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVH 120

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           Y+H      I+HRD+K+ NI L  +   KI DFGV+++   S  ++  + F GT  Y++P
Sbjct: 121 YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA--TTFTGTPYYMSP 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 15/173 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VK-VFAAEMEILGKIRHRNILKLYA 738
           ++G G  G V +   K+    VA+K+    +    VK     E+++L  ++  NI++L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              + G  +LV EY+   N+ + L +      P  +  R Y   L   K I + H +   
Sbjct: 68  AFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP--EKVRSYIYQL--IKAIHWCHKN--- 119

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
            I+HRDIK  N+L+  +   K+ DFG A+ ++E S   ++Y+ +  T  Y +P
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYRSP 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.4 bits (133), Expect = 7e-08
 Identities = 70/314 (22%), Positives = 123/314 (39%), Gaps = 16/314 (5%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
            +P S+  L +L  L  +  +      E++  L  L +LD+  N++       + +L  L
Sbjct: 61  LLPSSLSRLLSLDLLSPSGISSLD-GSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNL 118

Query: 244 WKIELYANNLTGELPAELGNLTL-LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
             ++L  NN+T ++P  +G L   L+E D+S N+    LP  + NL NL        N  
Sbjct: 119 TSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNL-DLSFNDL 175

Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRK 362
            + P    ++  L    + GN+ S   P  +   +AL ++D+S N              K
Sbjct: 176 SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSL--SNLK 232

Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422
            L+ L LSNN   ++P S  +   ++ L +S+N +S      L +L N+  LD   N  +
Sbjct: 233 NLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLS 290

Query: 423 GGISPLIGLSTSLSQL---VLQNNRFSGELPS--ELGRLTNLERLILTNNNFSGKIPSAL 477
             +  +  L   L  L   +L       +L S      + +             +  + L
Sbjct: 291 NALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNL 350

Query: 478 GALRQLSSLHLEEN 491
             L           
Sbjct: 351 WTLDNALDESNLNR 364

Length = 394

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 54/173 (31%), Positives = 74/173 (42%), Gaps = 15/173 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLY 737
           L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                      V+EY   G LF  L +   E     +  R Y   + +A  + YLH   S
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSA--LEYLH---S 113

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             +++RDIK  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 54.4 bits (131), Expect = 8e-08
 Identities = 28/72 (38%), Positives = 42/72 (58%), Gaps = 7/72 (9%)

Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS-PKVSDY 838
           KIA+   K + YLH   S  +IHRD+K SN+L++ + + K+ DFG++    +S  K  D 
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID- 163

Query: 839 SCFAGTHGYIAP 850
              AG   Y+AP
Sbjct: 164 ---AGCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 17/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  +  K +    A+K L K + +K      F  E +I+       +++L+
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    ++V+EYMP G+L   +        PE  W + Y      A+ +  L    S
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPE-KWAKFY-----TAEVVLALDAIHS 160

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
             +IHRD+K  N+LLD+    K+ADFG   K+ E      D +   GT  YI+P
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 15/168 (8%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT-----VAVKQLWKGDGVKV---FAAEMEILGKI 728
           NL+E   +G G  G+V+    K          V VK L K     +   F  E+++  K+
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL---HKRVKEGKPE-LDWFRRYKIALG 784
            H+N+++L     +    +++LEY   G+L Q L     + ++ KP  L   ++  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
            A G+ +L    +   +HRD+ + N L+    E K++   ++K   NS
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 18/174 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL-----WKGDGVKVFAAEMEILGKIRHRNILKLYA 738
           +G GG G+V  + +K      A K+L      K  G K+   E EIL K+    I+ L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 739 CLLKGGSSFLVLEYMPNGNL-FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    LV+  M  G+L +   +     G+  L+  R    +     GI +LH   S
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNV----GERGLEMERVIHYSAQITCGILHLH---S 113

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
             I++RD+K  N+LLD+    +++D G+A ++ +           AGT+GY+AP
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR----AGTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 49/163 (30%), Positives = 73/163 (44%), Gaps = 16/163 (9%)

Query: 689 TGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748
           TG +Y + + K +  +A +       V  F  E +IL       I +L        + +L
Sbjct: 25  TGDIYAMKVMKKSVLLAQET------VSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78

Query: 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSS 808
           V+EY P G+L   L++   E + + D  + Y   L  A  I  +H       +HRDIK  
Sbjct: 79  VMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLA--IHSVH---QMGYVHRDIKPE 131

Query: 809 NILLDEDYEPKIADFG-VAKIAENSPKVSDYSCFAGTHGYIAP 850
           N+L+D     K+ADFG  A++  N    S      GT  YIAP
Sbjct: 132 NVLIDRTGHIKLADFGSAARLTANKMVNSKLP--VGTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 19/166 (11%)

Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTV----AVKQLWKGDGVKV---FAAEMEILGKIRH 730
           L+   ++GSG  G VY+        TV    A+K L +  G K    F  E  I+  + H
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPEL--DWFRRYKIALGAAKG 788
            ++++L    L      LV + MP+G L   +H+       +L  +W       +  AKG
Sbjct: 69  PHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKG 121

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
           + YL       ++HRD+ + N+L+      KI DFG+A++ E   K
Sbjct: 122 MMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 17/156 (10%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTV-AVKQLWKGD-----GVKVFAAEMEILGKIRH 730
           + E   +IG G  G+V RL  KK+ G + A+K L K D      V    AE +IL +   
Sbjct: 2   DFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF-RRYKIALGAAKGI 789
             ++K++       + +L++E++P G++   L K+    +    ++     +A+ A   +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825
            +         IHRDIK  N+LLD     K++DFG+
Sbjct: 121 GF---------IHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 25/188 (13%)

Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---------KGDGVKVFAAEMEIL 725
           + N + +  IG G   +VYR     +   VA+K++          + D VK    E+++L
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK----EIDLL 56

Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPELD-WFRRYKIA 782
            ++ H N++K     ++     +VLE    G+L Q +   K+ K   PE   W  +Y + 
Sbjct: 57  KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW--KYFVQ 114

Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
           L +A     + H  S  ++HRDIK +N+ +      K+ D G+ +    S K +      
Sbjct: 115 LCSA-----VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 167

Query: 843 GTHGYIAP 850
           GT  Y++P
Sbjct: 168 GTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 17/175 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  + LK      A+K L K + +K      F  E ++L    ++ I  L+
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA-KGIAYLHHDC 796
                  + +LV++Y   G+L   L K  ++  PE D  R Y   +  A   +  LH+  
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSK-FEDRLPE-DMARFYLAEMVIAIDSVHQLHY-- 123

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
               +HRDIK  NIL+D +   ++ADFG   K+ E+    S  S   GT  YI+P
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS--SVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)

Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88

Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 140

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
           ++G GG G+V    ++      A K+L K       G  +   E +IL K+  R ++ L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 738 ACLLKGGSSFLVLEYMPNGNL-FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                  +  LVL  M  G+L F   H     G+   +  R    A     G+  LH + 
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHM----GEAGFEEGRAVFYAAEICCGLEDLHQE- 121

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I++RD+K  NILLD+    +I+D G   +A + P+        GT GY+AP
Sbjct: 122 --RIVYRDLKPENILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 53.7 bits (129), Expect = 3e-07
 Identities = 27/78 (34%), Positives = 41/78 (52%)

Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRK 362
           G  P+    +R L + ++ GN   G  P +LG  T+L  +D+S N F+GS P+ L +   
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 363 LLNLLALSNNFSGEVPNS 380
           L  L    N+ SG VP +
Sbjct: 492 LRILNLNGNSLSGRVPAA 509

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 53.7 bits (129), Expect = 3e-07
 Identities = 26/78 (33%), Positives = 44/78 (56%), Gaps = 2/78 (2%)

Query: 78  ISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV 137
           I+    S+ G I  S+ ++ SL VL L +N  +G +P  L   ++L++LN+ GN++ G V
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506

Query: 138 PDLSALKNLEIFDLSINY 155
           P  +AL    +   S N+
Sbjct: 507 P--AALGGRLLHRASFNF 522

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 53/143 (37%), Positives = 77/143 (53%), Gaps = 7/143 (4%)

Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL-RQ 482
             S  +     L  L L  NR      SEL  LTNL  L L NNN +  IP  +G L   
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSN 141

Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
           L  L L +N +  S+P+ + +   + +L+L+ N LS ++P+ LS LS+LN L+LSGNK++
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199

Query: 543 GSIPDNLMKL-KLSSIDLSENQL 564
             +P  +  L  L  +DLS N +
Sbjct: 200 -DLPPEIELLSALEELDLSNNSI 221

Length = 394

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 54/179 (30%), Positives = 81/179 (45%), Gaps = 29/179 (16%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 740 LLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAY 791
                S       +LV   M        L+  VK  K   D   F  Y+I     +G+ Y
Sbjct: 85  FTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQIL----RGLKY 135

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 136 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 186

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 14/158 (8%)

Query: 681 DNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNIL 734
              IG G  G VY+   +  +     VAVK           + F  E  I+ +  H +I+
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           KL   ++     ++V+E  P G L   L       K  LD       +   +  +AYL  
Sbjct: 71  KLIG-VITENPVWIVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLE- 124

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             S   +HRDI + N+L+      K+ DFG+++  E+ 
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 3e-07
 Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 15/151 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTV-AVKQLWKGDG-----VKVFAAEMEILGKIRHRNILKLY 737
           I  G  GKVY L  KKN   + AVK + K D      V    AE + L   +   I+ LY
Sbjct: 12  ISRGAFGKVY-LGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
             L    + +LV+EY+  G++   LH     G  + +   +Y I+   A  + YLH    
Sbjct: 71  YSLQSANNVYLVMEYLIGGDVKSLLHIY---GYFDEEMAVKY-IS-EVALALDYLHRH-- 123

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IIHRD+K  N+L+  +   K+ DFG++K+
Sbjct: 124 -GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 27/161 (16%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTV-AVKQLWKGDGVKVFAAEMEILGKIR-HRNIL 734
           + E   +IG G  G+V RL  KK+ G V A+K L K D +     E E +G IR  R+IL
Sbjct: 2   DFESLKVIGRGAFGEV-RLVQKKDTGHVYAMKILRKADML-----EKEQVGHIRAERDIL 55

Query: 735 ---------KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF-RRYKIALG 784
                    K++       + +L++E++P G++   L K+    + E  ++     +A+ 
Sbjct: 56  VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825
           +   + +         IHRDIK  N+LLD     K++DFG+
Sbjct: 116 SIHQLGF---------IHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 44/147 (29%), Positives = 76/147 (51%), Gaps = 11/147 (7%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G    VY+   K N   VA+K  +L + +G    A  E  +L  ++H NI+ L+  +
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
               +  LV EY+ + +L Q + K    G    +  + +   L   +G++Y+H      I
Sbjct: 73  HTKETLTLVFEYV-HTDLCQYMDKH--PGGLHPENVKLFLFQL--LRGLSYIHQRY---I 124

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAK 827
           +HRD+K  N+L+ +  E K+ADFG+A+
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.2 bits (126), Expect = 3e-07
 Identities = 40/124 (32%), Positives = 61/124 (49%), Gaps = 19/124 (15%)

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           + N +KLY  +       L+++Y+ +G+LF  L    KEGK      +  KI     + +
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVK--KIIRQLVEAL 122

Query: 790 AYLH-HDCSPPIIHRDIKSSNILLDEDYEPKI--ADFGVAKIAENSPKVSDYSCFAGTHG 846
             LH H+    IIH DIK  N+L D   + +I   D+G+ KI   +P     SC+ GT  
Sbjct: 123 NDLHKHN----IIHNDIKLENVLYDR-AKDRIYLCDYGLCKI-IGTP-----SCYDGTLD 171

Query: 847 YIAP 850
           Y +P
Sbjct: 172 YFSP 175

Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
           ++G GG G+V    ++      A K+L K       G  +   E +IL K+  + ++ L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                  +  LVL  M  G+L   ++     G P  +  R    A     G+  LH +  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHRE-- 121

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
              ++RD+K  NILLD+    +I+D G+A KI    P+        GT GY+AP
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLAVKI----PEGESIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 5e-07
 Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 27/156 (17%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQL-----WKGDGVKVFAAEMEILGKIRHRNILKL 736
           +IG G  G+V RL  KK+ G + A+K L     +K D +    AE ++L +     ++ L
Sbjct: 8   VIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR----RYKIA--LGAAKGIA 790
           Y         +L++E++P G+L   L K         D F     R+ +A  + A + + 
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLIK--------YDTFSEDVTRFYMAECVLAIEAVH 118

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
            L        IHRDIK  NIL+D     K++DFG++
Sbjct: 119 KLG------FIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 9/145 (6%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-FAAEMEILGKIRHRNILKLYACLLK 742
           +GSG  G V  L   +    VA+K + +G   +  F  E +++ K+ H  +++LY    +
Sbjct: 12  LGSGQFG-VVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               ++V E+M NG L   L  R ++GK   D      +     +G+ YL  +     IH
Sbjct: 71  QKPLYIVTEFMENGCLLNYL--RQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFIH 123

Query: 803 RDIKSSNILLDEDYEPKIADFGVAK 827
           RD+ + N L+      K++DFG+ +
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 34/138 (24%), Positives = 52/138 (37%), Gaps = 18/138 (13%)

Query: 685 GSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDG--VKVFAAEMEILGKIRHRNILKLYACL 740
                  + +   K     VAVK+  L       +K+   E+    +++H NIL      
Sbjct: 11  EDLMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLHHDCS 797
           +     ++V   M  G+    L     EG PEL       IA         + Y+H    
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSK-- 120

Query: 798 PPIIHRDIKSSNILLDED 815
              IHR +K+S+ILL  D
Sbjct: 121 -GFIHRSVKASHILLSGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 8e-07
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 15/174 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  + +K      A+K L K + +K      F  E ++L     R I  L+
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                  + +LV++Y   G+L   L K       ++  F   ++ L A   +  L +   
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL-AIDSVHQLGY--- 123

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
              +HRDIK  N+LLD++   ++ADFG   ++  +    S  +   GT  YI+P
Sbjct: 124 ---VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS--NVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 9e-07
 Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 19/174 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      +    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 740 LLKGGSSFLVLEYMPNGNLFQA-LHKRVKEGKPELD--WFRRYKIALGAAKGIAYLHHDC 796
                S     E     NL  A L+  VK  K   +   F  Y++     +G+ Y+H   
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL----RGLKYIH--- 135

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  IIHRD+K SN+ ++ED E +I DFG+A+ A++     + + +  T  Y AP
Sbjct: 136 SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 37/163 (22%), Positives = 62/163 (38%), Gaps = 23/163 (14%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNIL--KLYACL 740
           L+  G T +VY L  K       +K     +       E+ IL  +  + +   K+ A  
Sbjct: 5   LLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG 62

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKP--ELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G S+L++E++              EG+   E+    +  IA   A+ +A LH     
Sbjct: 63  ESDGWSYLLMEWI--------------EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
            + H D+   NIL+D+     I D+  A      P   D +  
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYG---PPAFDLAAA 148

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 24/164 (14%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---------EMEILGKIR 729
           E D  IG G  G V+ +   ++   VA+K++       VF           E+++L   +
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM-----PNVFQNLVSCKRVFRELKMLCFFK 57

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRR---YKIALGAA 786
           H N+L     L           Y+    +   LHK +   +P      +   Y+I     
Sbjct: 58  HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---- 113

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
           +G+ YLH   S  I+HRDIK  N+L++ +   KI DFG+A++ E
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 13/150 (8%)

Query: 681 DNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVK---VFAAEMEILGKIRHRNIL 734
           + ++G+G  G++ R  LK   K    VA+  L  G   K    F AE   LG+  H NI+
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           +L   + +G +  +V EYM NG L   L K   EG  +L   +   +  G A G+ YL  
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKH--EG--QLVAGQLMGMLPGLASGMKYL-- 123

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFG 824
                 +H+ + +  +L++ D   KI+ F 
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 16/152 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGT----VAVKQLWKGDGVK---VFAAEMEILGKIRHRNILKL 736
           IG+G  GKV   +   + G     V VK+L          +F  E++   ++ H N+L+ 
Sbjct: 3   IGNGWFGKVLLGEA--HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK-RVKE-GKPELDWFRRYKIALGAAKGIAYLHH 794
               ++     LVLE+ P G+L   L   R       + D  +R  +A   A G+ +LH 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLHQ 118

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
                 IH D+   N  L  D   KI D+G+A
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 24/178 (13%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKL- 736
           ++G GG G+V    ++      A K+L K       G  +   E +IL K+  R ++ L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           YA   K     LVL  M  G+L   ++     G P  D  R    A     G+  LH   
Sbjct: 67  YAYETKDALC-LVLTLMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLH--- 119

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSP---KVSDYSCFAGTHGYIAP 850
              I++RD+K  NILLD+    +I+D G+A +I E      +V       GT GY+AP
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-------GTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGD-----GVKVFAAEMEILGKIRHRNIL 734
           ++G G  G V    LK   G+   VAVK L K D      ++ F  E   + +  H N++
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 735 KLYACLLKGGSS------FLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKIALGAAK 787
           KL    L+  +        ++L +M +G+L    L  R+ E    L      +  +  A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           G+ YL    S   IHRD+ + N +L+E+    +ADFG++K
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 53/173 (30%), Positives = 75/173 (43%), Gaps = 14/173 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLY 737
           L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                      V+EY   G LF  L +   E     D  R Y   + +A  + YLH + +
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSA--LDYLHSEKN 116

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             +++RD+K  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.1 bits (119), Expect = 3e-06
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 21/182 (11%)

Query: 684 IGSGGTGKVYRLDLK--KNAGTVAVKQLWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G  G VY+   K  K+    A+KQ+ +G G+ + A  E+ +L +++H N++ L    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 741 LKGGSS--FLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIAL--GAAKGIAYLHH 794
           L       +L+ +Y  + +L+  +  H+  K  K  +   R    +L      GI YLH 
Sbjct: 68  LSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 795 DCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSP--KVSDYSCFAGTHGYI 848
           +    ++HRD+K +NIL+     E    KIAD G A++  NSP   ++D      T  Y 
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWYR 182

Query: 849 AP 850
           AP
Sbjct: 183 AP 184

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 36/184 (19%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +IG GG G+VY           A+K L   D  ++   + E L  +  R +L L +    
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLA-LNERIMLSLVS---T 53

Query: 743 GGSSFLV---------------LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           G   F+V               L+ M  G+L   L +     + E+ ++        A +
Sbjct: 54  GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY--------ATE 105

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHG 846
            I  L H  +  +++RD+K +NILLDE    +I+D G+A   ++  P  S      GTHG
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHG 160

Query: 847 YIAP 850
           Y+AP
Sbjct: 161 YMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 13/148 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G    V++   K     VA+K+  L   +G    A  E+ +L  ++H NI+ L+  +
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL-GAAKGIAYLHHDCSPP 799
                  LV EY+ + +L Q L     +    L      KI +    +G++Y H      
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYL-----DNCGNLMSMHNVKIFMFQLLRGLSYCHKR---K 123

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAK 827
           I+HRD+K  N+L++E  E K+ADFG+A+
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 13/155 (8%)

Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRH 730
               +   +G G  G+V            A+K L K D      V    AE +IL +  +
Sbjct: 1   SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
             +++LY       + + V++Y+P G++   L   ++ G    D  R Y   L  A  + 
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFPEDLARFYIAELTCA--VE 115

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825
            +H       IHRDIK  NIL+D D   K+ DFG+
Sbjct: 116 SVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 20/162 (12%)

Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAA-EMEILGKI 728
           A    NLE+   +G G    VY+   + N   VA+K   +   +GV   A  E  +L  +
Sbjct: 4   ATSYLNLEK---LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GA 785
           +H NI+ L+  +    +   V EYM + +L Q + +      P       Y + L     
Sbjct: 61  KHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHP-------YNVRLFMFQL 112

Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            +G+AY+H      I+HRD+K  N+L+    E K+ADFG+A+
Sbjct: 113 LRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 13/179 (7%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHR 731
           + E   +IG G  G+V  + +K      A+K L K + +K      F  E  +L     +
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
            I  L+         +LV++Y   G+L   L K       ++  F   ++ L A   I  
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL-AIHSIHQ 120

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH+      +HRDIK  N+LLD +   ++ADFG + +  N       S   GT  YI+P
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 7/99 (7%)

Query: 728 IRHRNILK-LYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPE-LDWFRRYKIAL 783
           + H+NIL  L+ C+  G   F++  YM  GNL   L   +  +   P+ L   +   +A+
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD 822
             A G++YLH      +IH+DI + N ++DE+ + KI D
Sbjct: 125 QIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.8 bits (119), Expect = 5e-06
 Identities = 30/113 (26%), Positives = 52/113 (46%), Gaps = 26/113 (23%)

Query: 126 LNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAE 184
           L +    + G +P D+S L++L+  +LS N   G                          
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG-------------------------N 457

Query: 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSI 237
           IP S+G++ +L  L L++ +  G IPES+ +L  L  L++  N +SG  P ++
Sbjct: 458 IPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 21/182 (11%)

Query: 684 IGSGGTGKVYRLDLK--KNAGTVAVKQLWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G  G VY+   K  K+    A+KQ+ +G G+ + A  E+ +L +++H N++ L    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 741 LKGGSS--FLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIAL--GAAKGIAYLHH 794
           L       +L+ +Y  + +L+  +  H+  K  K  +   R    +L      GI YLH 
Sbjct: 68  LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 795 DCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSP--KVSDYSCFAGTHGYI 848
           +    ++HRD+K +NIL+     E    KIAD G A++  NSP   ++D      T  Y 
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWYR 182

Query: 849 AP 850
           AP
Sbjct: 183 AP 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 19/172 (11%)

Query: 669 DIDAEQICNLEEDNLIGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAA 720
           ++  E+I  L E   +G G  G VY    R  +K  A T VAVK + +   ++    F  
Sbjct: 2   EVSREKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 58

Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDW 775
           E  ++      ++++L   + KG  + +V+E M +G+L   L     E     G+P    
Sbjct: 59  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 118

Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               ++A   A G+AYL+   +   +HRD+ + N ++  D+  KI DFG+ +
Sbjct: 119 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 8e-06
 Identities = 45/166 (27%), Positives = 68/166 (40%), Gaps = 49/166 (29%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G    VY+   K     VA+K+  L   +G    A  E  +L  ++H NI+ L+  +
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 741 LKGGSSFLVLEYM-----------PNG----N----LFQALHKRVKEGKPELDWFRRYKI 781
               +  LV EY+             G    N    LFQ L                   
Sbjct: 73  HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL------------------- 113

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                +G+AY H      ++HRD+K  N+L+ E  E K+ADFG+A+
Sbjct: 114 -----RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 32/123 (26%), Positives = 61/123 (49%), Gaps = 11/123 (8%)

Query: 715 VKVFAAEMEILGKIRHRNILKLYACLLKGGSSF----LVLEYMPNGNLFQALHKRVKEGK 770
           + +   E++ L +I   NILK+Y  ++          L+LEY   G L + L K     +
Sbjct: 62  IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-----E 116

Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
            +L +  +  +A+   KG+  L+   + P  ++++ S + L+ E+Y+ KI   G+ KI  
Sbjct: 117 KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILS 174

Query: 831 NSP 833
           + P
Sbjct: 175 SPP 177

Length = 283

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 49/173 (28%), Positives = 74/173 (42%), Gaps = 14/173 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
           ++G GG G+V    ++      A K+L K       G  +   E  IL K+  R ++ L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                  +  LVL  M  G+L   ++     G P  D  R    A     G+  L  +  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRE-- 121

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I++RD+K  NILLD+    +I+D G   +A   P+        GT GY+AP
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLG---LAVQIPEGETVRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 27/67 (40%), Positives = 40/67 (59%), Gaps = 6/67 (8%)

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAG 843
           AA+ I  L H  +  +++RD+K +NILLDE    +I+D G+A   ++  P  S      G
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VG 157

Query: 844 THGYIAP 850
           THGY+AP
Sbjct: 158 THGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.7 bits (116), Expect = 1e-05
 Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 1/81 (1%)

Query: 275 NQ-MYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENL 333
           NQ + G +P +I  L++L       N+  G  P   G +  L    +  N F+G  PE+L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 334 GRYTALTDVDISENQFSGSFP 354
           G+ T+L  ++++ N  SG  P
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 15/148 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTV-AVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLY 737
           +G G  G+V  L  K +   + A+K L K D      V    AE +IL +  +  ++KLY
Sbjct: 9   LGIGAFGEVC-LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                  + + V++Y+P G++   L +   E  PE+    R+ IA      I  +H    
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIR--MEVFPEV--LARFYIA-ELTLAIESVH---K 119

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGV 825
              IHRDIK  NIL+D D   K+ DFG+
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 22/163 (13%)

Query: 684 IGSGGTGKVYRLDL----KKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKL 736
           +G    GK+Y+  L      +A  VA+K L   +  +    F  E  ++ ++ H NI+ L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQAL-----HKRV-----KEG--KPELDWFRRYKIALG 784
              + +     ++ EY+  G+L + L     H  V     ++G  K  LD      IA+ 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            A G+ YL    S   +H+D+ + NIL+ E    KI+D G+++
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 13/148 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G    V++   K     VA+K+  L   +G    A  E+ +L  ++H NI+ L+  +
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL-GAAKGIAYLHHDCSPP 799
               S  LV EY+ + +L     K+  +    +      KI L    +G+AY H      
Sbjct: 74  HTDKSLTLVFEYL-DKDL-----KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAK 827
           ++HRD+K  N+L++E  E K+ADFG+A+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 55/210 (26%), Positives = 81/210 (38%), Gaps = 69/210 (32%)

Query: 684 IGSGGTGKVYR---LDLKKNAG--TVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  GKV +     ++K+A   TVAVK L +G      K    E++IL  I  H N++
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQAL------------------------------- 762
            L  AC   GG   +++EY   GNL   L                               
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 763 ---------------HKRVKEGKPELDWFRRYKIAL----------GAAKGIAYLHHDCS 797
                           K + + + + +    YK  L            A+G+ +L    S
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              IHRD+ + NILL E+   KI DFG+A+
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 41/147 (27%), Positives = 70/147 (47%), Gaps = 11/147 (7%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G    VY+   K     VA+K+  L   +G    A  E+ +L  ++H NI+ L+  +
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
               S  LV EY     L + L + + +    ++            +G+ Y H      +
Sbjct: 74  HTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125

Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAK 827
           +HRD+K  N+L++E  E K+ADFG+A+
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 66/270 (24%), Positives = 93/270 (34%), Gaps = 46/270 (17%)

Query: 339 LTDVDISENQFSGSFPKYLCEK---RKLLNLLALSNNFSGEVPNSYADC-----KT--IQ 388
           L  + +  N       K L      +  L  L LS N +G +P           K   +Q
Sbjct: 25  LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQ 84

Query: 389 RLRISDNHLSGKIPDGLWAL---PNVGMLDFGDNDFTGGISPLIG-----LSTSLSQLVL 440
            L +SDN L       L +L    ++  L   +N        L+      L  +L +LVL
Sbjct: 85  ELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL 144

Query: 441 QNNRFSGE----LPSELGRLTNLERLILTNNNFSG----KIPSALGALRQLSSLHLEENA 492
             NR  G     L   L    +L+ L L NN         +   L A   L  L L  N 
Sbjct: 145 GRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG 204

Query: 493 LT--GSIPNEMG--DCARIVDLNLARNSLSGNI-----PRSLSLLSSLNALNLSGNKLT- 542
           LT  G+            +  LNL  N+L+           LS   SL  L+LS N +T 
Sbjct: 205 LTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITD 264

Query: 543 -------GSIPDNLMKLKLSSIDLSENQLS 565
                    + +    L+L   DL  N+  
Sbjct: 265 DGAKDLAEVLAEKESLLEL---DLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 19/160 (11%)

Query: 678 LEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
            ++  ++GSG  G VY+     + +K    VA+K+L +    K       E  ++  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKG 788
            ++ +L    L      L+ + MP G L   +  HK     +  L+W       +  AKG
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           + YL       ++HRD+ + N+L+      KI DFG+AK+
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 20/158 (12%)

Query: 684 IGSGGTGKVYRL-DLKKNAGTVAVKQL---WKGDGVKVFA----AEMEILGKIRHRNILK 735
           IG G  GKV++  DLK     VA+K++      +G+ +      A +  L    H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 736 LY-ACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
           L+  C +    +     LV E++ + +L   L K  + G P  +  +     L   +G+ 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT-ETIKDMMFQL--LRGLD 124

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           +LH   S  ++HRD+K  NIL+    + K+ADFG+A+I
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 32/117 (27%), Positives = 56/117 (47%), Gaps = 10/117 (8%)

Query: 718 FAAEMEILGKIRHRNILKLYACLLKGG------SSFLVLEYMPNGNLFQ-ALHKRVKEGK 770
           F +E   + +  H N+++L    L+        S  ++L +M +G+L    L+ R+ +  
Sbjct: 47  FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP 106

Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             L      K     A G+ YL    S   IHRD+ + N +L+E+    +ADFG++K
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 4e-05
 Identities = 41/142 (28%), Positives = 61/142 (42%), Gaps = 14/142 (9%)

Query: 704 VAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH 763
           V VK +  G   K    E++IL  I HR I+ L        +  +V+      +LF  + 
Sbjct: 122 VIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYV- 176

Query: 764 KRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823
               +    L   +   I     + +AYLH      IIHRD+K+ NI LDE     + DF
Sbjct: 177 ----DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDF 229

Query: 824 GVA-KIAENSPKVSDYSCFAGT 844
           G A K+  +      Y  ++GT
Sbjct: 230 GAACKLDAHPDTPQCYG-WSGT 250

Length = 392

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 46.2 bits (110), Expect = 4e-05
 Identities = 18/41 (43%), Positives = 30/41 (73%), Gaps = 3/41 (7%)

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +G+ Y+H   S  ++HRD+K SN+LL+ + + KI DFG+A+
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 46.6 bits (110), Expect = 5e-05
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 22/171 (12%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNI--LKLY-- 737
           N+IG+G  G VY       +  VA+K++ +    K    E+ I+  + H NI  LK Y  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK--NRELLIMKNLNHINIIFLKDYYY 129

Query: 738 -ACLLKGGSSF---LVLEYMPNGNLFQALHKRVK---EGKPELDWFRRYKIALGAAKGIA 790
             C  K   +    +V+E++P     Q +HK +K        L  F     +    + +A
Sbjct: 130 TECFKKNEKNIFLNVVMEFIP-----QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 791 YLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSC 840
           Y+H   S  I HRD+K  N+L+D + +  K+ DFG AK      +   Y C
Sbjct: 185 YIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232

Length = 440

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 5e-05
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 16/149 (10%)

Query: 704 VAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL-EYMPNGNLFQAL 762
           V VK  W    V     E  +L ++ H  +L L    + GG + LVL +Y    +L+  L
Sbjct: 197 VVVKAGWYASSVH----EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYL 250

Query: 763 HKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821
             R++  G  ++    R    L A   I Y+H +    IIHRDIK+ N+L++   +  + 
Sbjct: 251 GARLRPLGLAQVTAVARQ--LLSA---IDYIHGE---GIIHRDIKTENVLVNGPEDICLG 302

Query: 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           DFG A  A  S     +   AGT    AP
Sbjct: 303 DFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Length = 461

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 25/68 (36%), Positives = 39/68 (57%), Gaps = 11/68 (16%)

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-----IAENSPKVSDYSCFA 842
           G+ Y+H   S  ++HRD+K  N+L++ D E KI DFG+A+       EN+  +++Y    
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY---V 170

Query: 843 GTHGYIAP 850
            T  Y AP
Sbjct: 171 ATRWYRAP 178

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 45.7 bits (108), Expect = 5e-05
 Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 12/150 (8%)

Query: 684 IGSGGTGKVY--RLDLKKNAGTVAVKQLWKGDGVK---VFAAEMEILGKIRHRNILKLYA 738
           IG+G  GKV    ++       V VK+L     V+    F  E +    ++H N+L+   
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHK-RVKEG-KPELDWFRRYKIALGAAKGIAYLHHDC 796
              +     LV+E+ P G+L   L   R  E   P+    +R  +A   A G+ +LH + 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLHLHKN- 119

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
               IH D+   N LL  D   KI D+G++
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 27/182 (14%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLY 737
           +IG G  G V           VA+K++        D  ++   E+++L  +RH +I+++ 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEIK 65

Query: 738 ACLLKGGSS-----FLVLEYMPNGNLFQALHKRVKEG---KPELDWFRRYKIALGAAKGI 789
             +L          ++V E M +      LH+ +K      PE   F  Y++     + +
Sbjct: 66  HIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQLL----RAL 116

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN-SPKVSDYSCFAGTHGYI 848
            Y+H   +  + HRD+K  NIL + D + KI DFG+A++A N +P    ++ +  T  Y 
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 849 AP 850
           AP
Sbjct: 174 AP 175

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 22/54 (40%), Positives = 33/54 (61%), Gaps = 12/54 (22%)

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
           +G+ +LH +C   I+HRD+K  NIL+    + K+ADFG+A+I         YSC
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI---------YSC 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 38/157 (24%), Positives = 75/157 (47%), Gaps = 16/157 (10%)

Query: 684 IGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    +  +K    T VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPEL---DWFRRYKIALGAAKGIA 790
           L   + +G  + +++E M  G+L   L   +   E  P        +  ++A   A G+A
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           YL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.2 bits (107), Expect = 9e-05
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 19/157 (12%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFA-AEMEILGKIRHRN-ILKLYA 738
           IG G  GKVY+   K     VA+K+       +G+   A  E+ +L  +     I++L  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 739 CL---LKGGSS--FLVLEYMPNGNL--FQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
                 K G    +LV EY+ + +L  F   + R           + +   L   KG+A+
Sbjct: 69  VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--LKGVAH 125

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK 827
            H      ++HRD+K  N+L+D+     KIAD G+ +
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.8 bits (94), Expect = 2e-04
 Identities = 19/60 (31%), Positives = 26/60 (43%)

Query: 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSL 517
           NL+ L L+NN  +     A   L  L  L L  N LT   P        +  L+L+ N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 34/126 (26%), Positives = 52/126 (41%), Gaps = 20/126 (15%)

Query: 721 EMEILGKIRHRNILKL--------YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE 772
           E+  LG++ H NILK+           ++     F +  +M +            + +P 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-------KDRPL 265

Query: 773 LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           L   R     L  A  + Y+H      +IHRDIK  NI L+ D +  + DFG A   E  
Sbjct: 266 LKQTRAIMKQLLCA--VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 833 PKVSDY 838
            +  DY
Sbjct: 321 REAFDY 326

Length = 501

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 39/170 (22%)

Query: 678 LEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRN 732
           L++  ++GSG  G VY+     D +     VA+K L +    K   A  EIL +      
Sbjct: 9   LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK---ANKEILDEAYVMAG 65

Query: 733 ILKLYACLLKG----GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA--- 785
           +   Y C L G     +  LV + MP G L              LD+ R  K  +G+   
Sbjct: 66  VGSPYVCRLLGICLTSTVQLVTQLMPYGCL--------------LDYVRENKDRIGSQDL 111

Query: 786 -------AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
                  AKG++YL       ++HRD+ + N+L+      KI DFG+A++
Sbjct: 112 LNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 29/101 (28%), Positives = 46/101 (45%), Gaps = 6/101 (5%)

Query: 715 VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELD 774
           +K    E+ +    RH NI+  +     G   +++  +M  G+    L     EG  E  
Sbjct: 43  LKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEA- 101

Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED 815
                 I  GA +G+ YLH +     IHR+IK+S+IL+  D
Sbjct: 102 --LIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|185285 PRK15387, PRK15387, E3 ubiquitin-protein ligase SspH2; Provisional

 Score = 42.1 bits (98), Expect = 0.001
 Identities = 77/304 (25%), Positives = 125/304 (41%), Gaps = 89/304 (29%)

Query: 251 NNLTG--ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG 308
           NNLT    LP EL  L      ++S NQ+   LP     L  L++F     +     PSG
Sbjct: 232 NNLTSLPALPPELRTL------EVSGNQL-TSLPVLPPGLLELSIFSNPLTHLPA-LPSG 283

Query: 309 FGDMRKLFAFSIYGNRFSG--PFPENLGRYTALTDVDISENQFSG--SFPKYLCEKRKLL 364
                 L    I+GN+ +     P        L ++ +S+NQ +   + P  LC+     
Sbjct: 284 ------LCKLWIFGNQLTSLPVLP------PGLQELSVSDNQLASLPALPSELCK----- 326

Query: 365 NLLALSNNFSG--EVPNSYADCKTIQRLRISDNHLSG--KIPDGLWALPNVGMLDFGDND 420
            L A +N  +    +P+       +Q L +SDN L+    +P  L+ L            
Sbjct: 327 -LWAYNNQLTSLPTLPSG------LQELSVSDNQLASLPTLPSELYKLWA---------- 369

Query: 421 FTGGISPLIGLSTSLSQLVLQNNRFSG--ELPSELGRLTNLERLILTNNNFSGKIPSALG 478
           +   ++ L  L + L +L++  NR +    LPSEL      + L+++ N           
Sbjct: 370 YNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSEL------KELMVSGN----------- 412

Query: 479 ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538
              +L+SL +  + L              + L++ RN L+  +P SL  LSS   +NL G
Sbjct: 413 ---RLTSLPMLPSGL--------------LSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454

Query: 539 NKLT 542
           N L+
Sbjct: 455 NPLS 458

Length = 788

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 17/60 (28%), Positives = 26/60 (43%)

Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
           NL  L L++  L      +   L  L  LD+  N ++   P +   L  L  ++L  NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 27/110 (24%), Positives = 54/110 (49%), Gaps = 15/110 (13%)

Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           ++ ++ H++++KLY   ++  +  +V EY+  G L   LH+  ++    L W     +A 
Sbjct: 54  LMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHR--EKNNVSLHWK--LDVAK 108

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILL-----DEDYEP--KIADFGVA 826
             A  + YL       ++H ++   NIL+     +E Y P  K++D G+ 
Sbjct: 109 QLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 21/153 (13%)

Query: 684 IGSGGTGKVYR--LDLKKNAGTVAVKQLWKGDGVKVFAAEM----EILGKIRHRNILKLY 737
           +GSG  G V +    +KK+  TVAVK L   +       E+     ++ ++ +  I+++ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 738 ACLLKGGSSFLVLEYMPNG--NLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHH 794
             + +  S  LV+E    G  N F   +K V E    EL     +++++G    + YL  
Sbjct: 63  G-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL----VHQVSMG----MKYLEE 113

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                 +HRD+ + N+LL   +  KI+DFG++K
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSK 143

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 41.0 bits (96), Expect = 0.003
 Identities = 51/181 (28%), Positives = 73/181 (40%), Gaps = 24/181 (13%)

Query: 123 LKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
           L+ +++ G+  +  +PDLS   NLE   LS        P  +  L +L  L +      E
Sbjct: 636 LRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLE 695

Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR---- 238
             +P  I NLK+L  L L+ C+ R +    IS    +  LD+    I  EFP ++R    
Sbjct: 696 I-LPTGI-NLKSLYRLNLSGCS-RLKSFPDIST--NISWLDLDETAIE-EFPSNLRLENL 749

Query: 239 --------KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKN 290
                   K +KLW+       L   L   L  L L      S      +LP  I NL  
Sbjct: 750 DELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFL------SDIPSLVELPSSIQNLHK 803

Query: 291 L 291
           L
Sbjct: 804 L 804

syringae 6; Provisional. Length = 1153

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 40.2 bits (94), Expect = 0.004
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 15/152 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV------KVFAAEMEILGKIRHRNILKL 736
           LI +G  G VY +  K+     A+K++ K + +      +VF  E +IL    +  ++ +
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSM 66

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           +          +V+EY+  G+    L K +  G   +D  R Y      A  + YLH   
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDC-ATLLKNI--GALPVDMARMYFAETVLA--LEYLH--- 118

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           +  I+HRD+K  N+L+      K+ DFG++KI
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	851
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.98
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.97
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.96
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.96
KOG0605	550	consensus NDR and related serine/threonine kinases	99.96
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0198	313	consensus MEKK and related serine/threonine protei	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.95
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.95
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.95
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.95
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.94
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.94
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.94
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.94
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.94
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.94
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.94
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.94
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.94
KOG0589	426	consensus Serine/threonine protein kinase [General	99.94
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.94
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.94
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.94
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.94
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.94
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.94
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.94
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.94
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.94
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.94
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.94
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.94
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.93
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.93
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.93
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.93
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.93
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.93
KOG0610	459	consensus Putative serine/threonine protein kinase	99.93
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.93
PTZ00267	478	NIMA-related protein kinase; Provisional	99.93
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.93
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.93
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.93
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.93
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.93
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.93
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.93
PHA03212	391	serine/threonine kinase US3; Provisional	99.93
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.93
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.93
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.93
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.93
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.93
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.93
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.93
KOG0586	596	consensus Serine/threonine protein kinase [General	99.93
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.93
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.93
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.93
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.93
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.93
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.93
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.93
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.93
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.93
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.93
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.93
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.93
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.93
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.92
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.92
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.92
KOG0584	632	consensus Serine/threonine protein kinase [General	99.92
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.92
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.92
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.92
PTZ00283	496	serine/threonine protein kinase; Provisional	99.92
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.92
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.92
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.92
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.92
PHA03211	461	serine/threonine kinase US3; Provisional	99.92
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.92
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.92
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.92
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.92
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.92
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.92
PTZ00036	440	glycogen synthase kinase; Provisional	99.92
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.92
KOG1152	772	consensus Signal transduction serine/threonine kin	99.92
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.92
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.92
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.92
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.92
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.92
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.92
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.92
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.91
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.91
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.91
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.91
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.91
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.91
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.91
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.91
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.91
PHA03209	357	serine/threonine kinase US3; Provisional	99.91
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.91
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.91
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.91
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.91
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.91
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.91
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.91
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.91
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.91
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.91
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.91
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.91
PHA03207	392	serine/threonine kinase US3; Provisional	99.91
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.91
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.91
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.91
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.91
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.91
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.91
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.91
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.91
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.91
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.91
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.91
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.91
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.91
PHA02988	283	hypothetical protein; Provisional	99.91
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.91
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.9
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.9
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.9
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.9
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.9
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.9
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.9
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.9
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.9
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.9
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.9
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.9
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.9
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.9
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.9
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.9
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.9
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.9
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.9
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.9
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.9
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.9
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.9
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.9
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.9
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.9
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.9
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.9
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.9
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.9
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.9
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.9
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.9
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.9
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.9
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.9
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.9
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.9
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.9
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.9
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.9
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.9
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.9
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.9
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.9
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.9
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.9
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.9
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.9
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.9
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.9
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.9
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.9
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.9
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.9
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.9
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.9
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.9
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.9
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.9
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.9
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.9
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.89
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.89
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.89
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.89
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.89
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.89
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.89
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.89
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.89
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.89
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.89
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.89
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.89
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.89
PHA03210	501	serine/threonine kinase US3; Provisional	99.89
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.89
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.89
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.89
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.89
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.89
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.89
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.89
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.89
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.89
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.89
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.89
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.89
PTZ00284	467	protein kinase; Provisional	99.89
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.89
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.89
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.89
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.89
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.89
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.89
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.89
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.89
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.89
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.89
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.89
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.89
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.89
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.89
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.89
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.89
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.89
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.89
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.89
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.89
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.89
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.89
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.89
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.89
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.89
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.89
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.89
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.88
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.88
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.88
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.88
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.88
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.88
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.88
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.88
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.88
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.88
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.88
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.88
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.88
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.88
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.88
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.88
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.88
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.88
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.88
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.88
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.88
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.88
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.88
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.88
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.88
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.88
PLN00009	294	cyclin-dependent kinase A; Provisional	99.88
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.88
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.88
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.88
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.88
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.88
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.88
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.88
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.88
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.88
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.88
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.88
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.88
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.88
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.88
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.88
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.88
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.88
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.88
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.87
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.87
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.87
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.87
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.87
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.87
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.87
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.87
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.87
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.87
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.87
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.87
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.87
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.87
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.87
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.87
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.87
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.87
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.87
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.86
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.86
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.86
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.86
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.86
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.86
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.86
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.86
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.86
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.86
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.86
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.86
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.86
PHA02882	294	putative serine/threonine kinase; Provisional	99.86
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.86
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.85
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.85
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.85
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.85
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.85
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.85
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.85
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.85
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.85
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.85
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.85
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.84
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.84
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.82
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.82
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.8
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.8
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.8
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.8
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.8
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.78
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
PRK10345	210	hypothetical protein; Provisional	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.75
smart00090	237	RIO RIO-like kinase.	99.74
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.72
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.72
PRK12274	218	serine/threonine protein kinase; Provisional	99.72
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PLN03150	623	hypothetical protein; Provisional	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.58
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.53
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.51
PLN03150	623	hypothetical protein; Provisional	99.5
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.49
PLN00181	793	protein SPA1-RELATED; Provisional	99.46
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.45
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.44
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.38
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.36
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.31
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.26
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.26
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.2
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.19
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.19
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.19
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.17
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.14
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.14
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.13
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.13
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.1
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
KOG3087	229	consensus Serine/threonine protein kinase [General	99.09
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	99.04
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.03
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.02
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.0
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.97
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.88
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.87
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.86
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.83
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.8
KOG1243	690	consensus Protein kinase [General function predict	98.8
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.78
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.73
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.71
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.63
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.56
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.52
PRK09902	216	hypothetical protein; Provisional	98.47
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.46
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.46
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.46
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.46
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.46
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.37
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.36
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.35

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.1e-105  Score=990.68  Aligned_cols=790  Identities=34%  Similarity=0.582  Sum_probs=571.3

Q ss_pred             chhhHHHHHHHHHhcCCCCCCCCCCCCCCCCCcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCc
Q 003065           29 LNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNV  108 (851)
Q Consensus        29 ~~~~~~aLl~fk~~~~~~~~~l~sW~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~  108 (851)
                      .++|++||++||+++.+|.+.+.+|+.. +|||.|.||+|++ .++|+.|||++++++|.+++++..+++|++|+|++|+
T Consensus        27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~  104 (968)
T PLN00113         27 HAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ  104 (968)
T ss_pred             CHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence            5789999999999999898889999865 7899999999986 4699999999999999999999999999999999999


Q ss_pred             ccCccCcccc-cCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcc
Q 003065          109 LSGKLPLELS-NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE  187 (851)
Q Consensus       109 l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~  187 (851)
                      ++|.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|||++|.+++.+|..+.++++|++|+|++|.+. +.+|.
T Consensus       105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~-~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~-~~~p~  182 (968)
T PLN00113        105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR-GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV-GKIPN  182 (968)
T ss_pred             cCCcCChHHhccCCCCCEEECcCCccccccCc-cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccc-ccCCh
Confidence            9999998765 888888888888888765553 34556666666666666556666666666666666666554 44555


Q ss_pred             cccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcc
Q 003065          188 SIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLL  267 (851)
Q Consensus       188 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  267 (851)
                      .++++++|++|+|++|++.+.+|..++++++|++|+|++|++++.+|..+.++++|++|++++|++++.+|..++++++|
T Consensus       183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  262 (968)
T PLN00113        183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL  262 (968)
T ss_pred             hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCC
Confidence            55555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             cEEecccccccCCCCccccCcCCccEEEccCCccCC------------------------CCCCCCCCcccccEEEeccC
Q 003065          268 QEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG------------------------EFPSGFGDMRKLFAFSIYGN  323 (851)
Q Consensus       268 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~------------------------~~p~~~~~l~~L~~L~l~~N  323 (851)
                      ++|++++|++.+.+|..+.++++|+.|++++|++++                        .+|..++.+++|+.|++++|
T Consensus       263 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n  342 (968)
T PLN00113        263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN  342 (968)
T ss_pred             CEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCC
Confidence            555555555554455545455555555555555444                        44444455555555555555


Q ss_pred             cCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCC
Q 003065          324 RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD  403 (851)
Q Consensus       324 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  403 (851)
                      .+++.+|..++.+++|+.|++++|++++.+|.+++...+++.+++.+|++.+.+|..+..+++|+.|++++|++++.+|.
T Consensus       343 ~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~  422 (968)
T PLN00113        343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS  422 (968)
T ss_pred             CCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECCh
Confidence            55555555555555555555555555555555555555566666666666666666677777788888888888777787


Q ss_pred             cccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcc
Q 003065          404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL  483 (851)
Q Consensus       404 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  483 (851)
                      .+..+++|+.|++++|++++.++..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|++++.+|..+..+++|
T Consensus       423 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L  501 (968)
T PLN00113        423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSEL  501 (968)
T ss_pred             hHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhcc
Confidence            78788888888888888888888777788888888888888888877755 45789999999999999999999999999


Q ss_pred             cEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCC
Q 003065          484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSEN  562 (851)
Q Consensus       484 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N  562 (851)
                      +.|+|++|++++.+|..++.+++|+.|+|++|.++|.+|..+..+++|+.|||++|+++|.+|..+..+ .|+.+|+++|
T Consensus       502 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N  581 (968)
T PLN00113        502 MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN  581 (968)
T ss_pred             CEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999998 8999999999


Q ss_pred             cccccCCcccccCCC-CccccCCCCCCCCcccccccccCCCCCccccccCCCccccceeEEeeehH-HHHHHHHhhhhhh
Q 003065          563 QLSGSVPLDFLRMGG-DGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVA-LAAFLAGLLLVSY  640 (851)
Q Consensus       563 ~l~~~~p~~~~~~~~-~~~~~gn~~lc~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  640 (851)
                      ++.|.+|...++..+ +.+|.||+++|+.+.+.     ..++|...    .....+++++++++++ +++++++++++++
T Consensus       582 ~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~-----~~~~c~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  652 (968)
T PLN00113        582 HLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS-----GLPPCKRV----RKTPSWWFYITCTLGAFLVLALVAFGFVFI  652 (968)
T ss_pred             cceeeCCCcchhcccChhhhcCCccccCCcccc-----CCCCCccc----cccceeeeehhHHHHHHHHHHHHHHHHHHH
Confidence            999999988777666 78899999999864221     13355421    1111111211111111 1112222222222


Q ss_pred             cccccccccccCcccccccceeeecccc---cccH-HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHH
Q 003065          641 KNFKLSADMENGEKEVSSKWKLASFHHI---DIDA-EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK  716 (851)
Q Consensus       641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~  716 (851)
                      ++++. ...+..+.+. ..|....+...   .+.. +....|+..+.||+|+||.||+|++..++..||||++...... 
T Consensus       653 ~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-  729 (968)
T PLN00113        653 RGRNN-LELKRVENED-GTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-  729 (968)
T ss_pred             Hhhhc-cccccccccc-ccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-
Confidence            22211 1111111111 11221111110   1111 2245688889999999999999999889999999998654332 


Q ss_pred             HHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 003065          717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC  796 (851)
Q Consensus       717 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  796 (851)
                       ...|++++++++|||||++++++.+++..|+||||+++|+|.++++.        ++|..+.+++.|+|+|++|||+.+
T Consensus       730 -~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~  800 (968)
T PLN00113        730 -PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRC  800 (968)
T ss_pred             -cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCC
Confidence             23578999999999999999999999999999999999999999852        688999999999999999999777


Q ss_pred             CCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       797 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++|+|||+||+||+++.++.+++. ||.+......      ....||++|||||
T Consensus       801 ~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE  848 (968)
T PLN00113        801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPE  848 (968)
T ss_pred             CCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcc
Confidence            7899999999999999999888876 7766543221      1236899999999

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-61  Score=603.72  Aligned_cols=491  Identities=36%  Similarity=0.585  Sum_probs=437.5

Q ss_pred             ceEEEecccCCcceecCcccc-CCccCcEEeCCCC----------------------cccCccCcccccCCCCceEeccc
Q 003065           74 RVTEISFDNKSLSGEISSSIS-ALQSLTVLSLPFN----------------------VLSGKLPLELSNCSNLKVLNVTG  130 (851)
Q Consensus        74 ~v~~l~l~~~~l~g~i~~~l~-~l~~L~~L~L~~n----------------------~l~~~~p~~~~~l~~L~~L~Ls~  130 (851)
                      +++.|+|+++.++|.+|..+. .+++|++|+|++|                      .+++.+|..|+++++|++|+|++
T Consensus        94 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~  173 (968)
T PLN00113         94 YIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG  173 (968)
T ss_pred             CCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECcc
Confidence            567778888888777776554 5555555555555                      45556667777888888888888


Q ss_pred             CcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccC
Q 003065          131 NAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI  209 (851)
Q Consensus       131 n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~  209 (851)
                      |.+.+..|. ++++++|++|+|++|.+.+.+|..+.++++|++|+|++|.+. +.+|..++++++|++|++++|++++.+
T Consensus       174 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~  252 (968)
T PLN00113        174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS-GEIPYEIGGLTSLNHLDLVYNNLTGPI  252 (968)
T ss_pred             CcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC-CcCChhHhcCCCCCEEECcCceecccc
Confidence            888776665 788888888888888888888888888888888888888887 677888888888888888888888888


Q ss_pred             CcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcC
Q 003065          210 PESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLK  289 (851)
Q Consensus       210 p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  289 (851)
                      |..++++++|++|++++|++++.+|..+.++++|++|++++|.+.+.+|..+.++++|+.|++++|.+.+.+|..+..++
T Consensus       253 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~  332 (968)
T PLN00113        253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP  332 (968)
T ss_pred             ChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCC
Confidence            88888888899999999998888888888999999999999999988999999999999999999999999999999999


Q ss_pred             CccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhc
Q 003065          290 NLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL  369 (851)
Q Consensus       290 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~  369 (851)
                      +|+.|++++|++++.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.+.+.
T Consensus       333 ~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~  412 (968)
T PLN00113        333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQ  412 (968)
T ss_pred             CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeC
Q 003065          370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGEL  449 (851)
Q Consensus       370 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~  449 (851)
                      +|++.+.+|..|..+++|+.|++++|.+++.+|..++.+++|+.|++++|++.+.+|..+. .++|+.|++++|++++.+
T Consensus       413 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~  491 (968)
T PLN00113        413 DNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAV  491 (968)
T ss_pred             CCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCcc
Confidence            9999999999999999999999999999999999999999999999999999999888764 589999999999999999


Q ss_pred             CcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccc
Q 003065          450 PSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLS  529 (851)
Q Consensus       450 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  529 (851)
                      |..+..+++|+.|+|++|++++.+|..++.+++|++|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+..++
T Consensus       492 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  571 (968)
T PLN00113        492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE  571 (968)
T ss_pred             ChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCeEeCCCCccccccCcccccccceEEeCcCCcccc
Q 003065          530 SLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSG  566 (851)
Q Consensus       530 ~L~~L~Ls~N~l~g~ip~~l~~l~L~~l~ls~N~l~~  566 (851)
                      +|+.|++++|+++|.+|..-.-..+....+.+|+..|
T Consensus       572 ~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc  608 (968)
T PLN00113        572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC  608 (968)
T ss_pred             ccCEEeccCCcceeeCCCcchhcccChhhhcCCcccc
Confidence            9999999999999999975322244455667887443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.2e-47  Score=385.13  Aligned_cols=475  Identities=27%  Similarity=0.382  Sum_probs=402.2

Q ss_pred             eEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCc
Q 003065           75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSIN  154 (851)
Q Consensus        75 v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N  154 (851)
                      .+.+++++|.+. .+.+.+.+|..|++|++++|+++ .+|++++.+.+++.|+.++|.++..++.++.+.+|..|++++|
T Consensus        47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n  124 (565)
T KOG0472|consen   47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSN  124 (565)
T ss_pred             hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccc
Confidence            456788888887 56778999999999999999998 7999999999999999999999999999999999999999999


Q ss_pred             ccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccccccccccc
Q 003065          155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP  234 (851)
Q Consensus       155 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p  234 (851)
                      .+. ..|+.++.+..|+.|+..+|+++  .+|+.++++.+|..|++.+|++....|+.+. ++.|++||...|-++ .+|
T Consensus       125 ~~~-el~~~i~~~~~l~dl~~~~N~i~--slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP  199 (565)
T KOG0472|consen  125 ELK-ELPDSIGRLLDLEDLDATNNQIS--SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP  199 (565)
T ss_pred             cee-ecCchHHHHhhhhhhhccccccc--cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence            998 78889999999999999999997  7899999999999999999999955555554 999999999999997 889


Q ss_pred             ccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccc-cCcCCccEEEccCCccCCCCCCCCCCcc
Q 003065          235 RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFPSGFGDMR  313 (851)
Q Consensus       235 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~l~~N~l~~~~p~~~~~l~  313 (851)
                      ..++.+.+|..|+|..|+|. .+| .|.+++.|++|+++.|+|. .+|.+. .+++++.+||+.+|++. ..|+.++-++
T Consensus       200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr  275 (565)
T KOG0472|consen  200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR  275 (565)
T ss_pred             hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence            99999999999999999999 677 8999999999999999998 667665 48999999999999999 8899999999


Q ss_pred             cccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhc---chHHHHh------ccCCccc-----c-cc
Q 003065          314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR---KLLNLLA------LSNNFSG-----E-VP  378 (851)
Q Consensus       314 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~---~L~~l~l------~~n~~~~-----~-~p  378 (851)
                      +|++||+++|.|+ ..|..++++ .|+.|-+.+|.+. .+-..+-+..   -|++|..      .++.-.|     . .+
T Consensus       276 sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~  352 (565)
T KOG0472|consen  276 SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPS  352 (565)
T ss_pred             hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCC
Confidence            9999999999999 578889999 9999999999997 3333332211   1233322      0111111     1 11


Q ss_pred             cc---ccCccccceeccccCccccccCCcccCccc---cceEEecCCcCCCCCCcccccCCC-CCeEecCCCcceeeCCc
Q 003065          379 NS---YADCKTIQRLRISDNHLSGKIPDGLWALPN---VGMLDFGDNDFTGGISPLIGLSTS-LSQLVLQNNRFSGELPS  451 (851)
Q Consensus       379 ~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~~~~~-L~~L~Ls~N~l~~~~p~  451 (851)
                      ..   ...+.+.+.|++++-+++ .+|+..+....   ...++++.|++...+ ..+..+.. ++.+.+++|.++ .+|.
T Consensus       353 ~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~elP-k~L~~lkelvT~l~lsnn~is-fv~~  429 (565)
T KOG0472|consen  353 ESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCELP-KRLVELKELVTDLVLSNNKIS-FVPL  429 (565)
T ss_pred             Ccccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhhhh-hhhHHHHHHHHHHHhhcCccc-cchH
Confidence            11   223457899999999998 78877766555   788999999998544 43333333 345677777776 8899


Q ss_pred             ccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccC
Q 003065          452 ELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL  531 (851)
Q Consensus       452 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  531 (851)
                      .++.+++|..|+|++|.+. .+|..++.+..|+.||+|.|+|. .+|..+..+..++.+-.++|++....|+.+.+|.+|
T Consensus       430 ~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL  507 (565)
T KOG0472|consen  430 ELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNL  507 (565)
T ss_pred             HHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhc
Confidence            9999999999999999997 78999999999999999999997 889888888888888888899997777779999999


Q ss_pred             CeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcc
Q 003065          532 NALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLD  571 (851)
Q Consensus       532 ~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~  571 (851)
                      ..|||.+|.+. .||+.++++ +++.|++.+|++.  .|+.
T Consensus       508 ~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr~  545 (565)
T KOG0472|consen  508 TTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPRH  545 (565)
T ss_pred             ceeccCCCchh-hCChhhccccceeEEEecCCccC--CCHH
Confidence            99999999999 899999999 9999999999999  5543

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=5.7e-46  Score=376.03  Aligned_cols=455  Identities=26%  Similarity=0.374  Sum_probs=379.5

Q ss_pred             ceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccC
Q 003065           74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI  153 (851)
Q Consensus        74 ~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~  153 (851)
                      -.+.+++.++.++ ++|++++.+..+..|+.++|+++ ++|.+++.+.+|+.|+++.|.+...+++++.+..|+.||..+
T Consensus        69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~  146 (565)
T KOG0472|consen   69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDATN  146 (565)
T ss_pred             ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhhccc
Confidence            3567888999998 78999999999999999999998 899999999999999999999999999999999999999999


Q ss_pred             cccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccc
Q 003065          154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF  233 (851)
Q Consensus       154 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~  233 (851)
                      |+++ ..|..+.++.+|..|++.+|++.  ++|+..-+++.|++||..+|-++ .+|+.++.+.+|+.|+|.+|+|. ..
T Consensus       147 N~i~-slp~~~~~~~~l~~l~~~~n~l~--~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~l  221 (565)
T KOG0472|consen  147 NQIS-SLPEDMVNLSKLSKLDLEGNKLK--ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FL  221 (565)
T ss_pred             cccc-cCchHHHHHHHHHHhhccccchh--hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cC
Confidence            9998 78889999999999999999997  67777666999999999999998 89999999999999999999998 66


Q ss_pred             cccccCCCcccEEEeeccCccCcCCcCcC-CCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCc
Q 003065          234 PRSIRKLQKLWKIELYANNLTGELPAELG-NLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM  312 (851)
Q Consensus       234 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l  312 (851)
                      | .|.+++.|++|.++.|+|. .+|++.. ++++|..|||.+|++. ..|++++-+++|++||+|+|.|+ .+|..+++|
T Consensus       222 P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl  297 (565)
T KOG0472|consen  222 P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL  297 (565)
T ss_pred             C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence            7 8999999999999999999 7777655 8999999999999999 88999999999999999999999 678899999


Q ss_pred             ccccEEEeccCcCCCCCCCccCCCC--ccceee-------ccCCc---------ccccCchhhhhhcchHHHHhccCCcc
Q 003065          313 RKLFAFSIYGNRFSGPFPENLGRYT--ALTDVD-------ISENQ---------FSGSFPKYLCEKRKLLNLLALSNNFS  374 (851)
Q Consensus       313 ~~L~~L~l~~N~l~~~~p~~l~~l~--~L~~L~-------Ls~N~---------l~~~~p~~~~~~~~L~~l~l~~n~~~  374 (851)
                       +|+.|.+.||.+...--+.+..=+  -|++|.       +|.-.         ..+.+|+ .......+.|..+.-+++
T Consensus       298 -hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~-~~~~i~tkiL~~s~~qlt  375 (565)
T KOG0472|consen  298 -HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPD-IYAIITTKILDVSDKQLT  375 (565)
T ss_pred             -eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccc-hhhhhhhhhhcccccccc
Confidence             999999999998632111111100  011111       11110         0111111 122334556666666665


Q ss_pred             cccccc-ccCcc--ccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCc
Q 003065          375 GEVPNS-YADCK--TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPS  451 (851)
Q Consensus       375 ~~~p~~-~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~  451 (851)
                       .+|+. |....  -....+++.|++. .+|..+..+..+++.-+.+|+..+-+|..+..+++|..|+|++|-+. .+|.
T Consensus       376 -~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~  452 (565)
T KOG0472|consen  376 -LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPE  452 (565)
T ss_pred             -cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcch
Confidence             34443 33322  2789999999998 88988877776665444444444578888999999999999999998 8999


Q ss_pred             ccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccC
Q 003065          452 ELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL  531 (851)
Q Consensus       452 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  531 (851)
                      .++.+..|+.||+|.|+|. .+|.++..+..++.+-.++|++....|..+.++.+|..|||.+|.+. .||..+++|++|
T Consensus       453 e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL  530 (565)
T KOG0472|consen  453 EMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNL  530 (565)
T ss_pred             hhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccce
Confidence            9999999999999999998 88999988888888888889998777777999999999999999999 899999999999


Q ss_pred             CeEeCCCCccccccCcc
Q 003065          532 NALNLSGNKLTGSIPDN  548 (851)
Q Consensus       532 ~~L~Ls~N~l~g~ip~~  548 (851)
                      +.|+|+||+|+  .|..
T Consensus       531 ~hLeL~gNpfr--~Pr~  545 (565)
T KOG0472|consen  531 RHLELDGNPFR--QPRH  545 (565)
T ss_pred             eEEEecCCccC--CCHH
Confidence            99999999999  4543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-42  Score=361.39  Aligned_cols=366  Identities=20%  Similarity=0.209  Sum_probs=284.5

Q ss_pred             CCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccc
Q 003065          146 LEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC  225 (851)
Q Consensus       146 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  225 (851)
                      -+.||+|+|+++.+.+..|.++++|+.+++..|.++  .||...+...+|+.|+|.+|.|+..-.+.+..++.|++||||
T Consensus        80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt--~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT--RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             eeeeeccccccccCcHHHHhcCCcceeeeeccchhh--hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            467999999999999999999999999999999997  889888888889999999999998888889999999999999


Q ss_pred             cccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCC
Q 003065          226 RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEF  305 (851)
Q Consensus       226 ~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~  305 (851)
                      .|.|+.+.-.+|..-.++++|+|++|.|+..-...|..+.+|..|.|+.|+++...+..|.+|++|+.|+|..|+|.-.-
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive  237 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE  237 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence            99999666678888899999999999999888889999999999999999999777778889999999999999998443


Q ss_pred             CCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCcc
Q 003065          306 PSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCK  385 (851)
Q Consensus       306 p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~  385 (851)
                      --.|.+|++|+.|.|..|.++..-...|-.+.++++|+|+.|+++..--.|+.+                        ++
T Consensus       238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfg------------------------Lt  293 (873)
T KOG4194|consen  238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFG------------------------LT  293 (873)
T ss_pred             hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccc------------------------cc
Confidence            457999999999999999999888888999999999999999998554444444                        45


Q ss_pred             ccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEecc
Q 003065          386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT  465 (851)
Q Consensus       386 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  465 (851)
                      .|+.|+||+|.|....+++..-.++|+.|+|++|+|+...+..|..+..|+.|+|++|+++..-...|..+.+|+.|||+
T Consensus       294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr  373 (873)
T KOG4194|consen  294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR  373 (873)
T ss_pred             hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence            55555555555555555555555555555555555555555556666666666666666665555566666666666666


Q ss_pred             CccccCCCcc---ccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCC
Q 003065          466 NNNFSGKIPS---ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG  538 (851)
Q Consensus       466 ~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  538 (851)
                      +|.++..+.+   .|.+|+.|+.|+|.+|+|..+...+|..+..|+.|||.+|.|...-|++|..| +|+.|-++.
T Consensus       374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            6666655543   45666777777777777765555567777777777777777776777777776 666665543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=359.44  Aligned_cols=379  Identities=20%  Similarity=0.236  Sum_probs=286.3

Q ss_pred             eEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEeccccc
Q 003065          197 YLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQ  276 (851)
Q Consensus       197 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  276 (851)
                      .|++++|++....+..|.++++|+.+++.+|.++ .+|.......+|+.|+|.+|.|+..-.+++.-++.|+.||||.|.
T Consensus        82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~  160 (873)
T KOG4194|consen   82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL  160 (873)
T ss_pred             eeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch
Confidence            3444444444444444444555555555555444 344433334445555555555554444445555555555555555


Q ss_pred             ccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchh
Q 003065          277 MYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKY  356 (851)
Q Consensus       277 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~  356 (851)
                      |+...-..|..-.++++|+|++|+|+..-...|.++.+|.+|.|+.|+++...+..|.++++|+.|||..|+|.-.---.
T Consensus       161 is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt  240 (873)
T KOG4194|consen  161 ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT  240 (873)
T ss_pred             hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence            55333334444455666666666666555556666666666666666666555566666777777777777765322445


Q ss_pred             hhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCC
Q 003065          357 LCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS  436 (851)
Q Consensus       357 ~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~  436 (851)
                      |..+++|+.+.+.+|+++..-...|-.+.++++|+|+.|+++..-..++.+++.|+.|+||+|.|..+-+..+...++|+
T Consensus       241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~  320 (873)
T KOG4194|consen  241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK  320 (873)
T ss_pred             hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence            66777777777778887777778899999999999999999988889999999999999999999999888889999999


Q ss_pred             eEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCC---Ccccccccceeecc
Q 003065          437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPN---EMGDCARIVDLNLA  513 (851)
Q Consensus       437 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls  513 (851)
                      +|+|++|+|+...+.+|..+..|++|.|++|+++..-...|..+++|+.|||++|.|++.|.+   .|..+++|+.|+|.
T Consensus       321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~  400 (873)
T KOG4194|consen  321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLT  400 (873)
T ss_pred             eEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeec
Confidence            999999999988889999999999999999999988888999999999999999999876654   47789999999999


Q ss_pred             CcccccccCCCccccccCCeEeCCCCccccccCcccccccceEEeCcCCcccccCCcccccCC
Q 003065          514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMG  576 (851)
Q Consensus       514 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~L~~l~ls~N~l~~~~p~~~~~~~  576 (851)
                      +|+|......+|..+..|+.|||.+|.+...-|..|..+.|+.|-+..-.+-|+|...|..++
T Consensus       401 gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qW  463 (873)
T KOG4194|consen  401 GNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQW  463 (873)
T ss_pred             CceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHHHHHH
Confidence            999996666799999999999999999998889999999999999999999999987776543

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.5e-39  Score=342.92  Aligned_cols=370  Identities=26%  Similarity=0.403  Sum_probs=275.2

Q ss_pred             CCCCeEeccCcccC-CCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcc
Q 003065          144 KNLEIFDLSINYFT-GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTL  222 (851)
Q Consensus       144 ~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  222 (851)
                      +-.+-.|+++|.|+ +.+|..+..+++++.|.|...++.  .+|+.++.+.+|++|.+++|++. .+-..+..|+.|+.+
T Consensus         7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~--~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE--QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh--hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            34455677777777 567778888888888888777775  67888888888888888888887 555667777777777


Q ss_pred             ccccccccc-cccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCc-cccCcCCccEEEccCCc
Q 003065          223 DICRNKISG-EFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPE-EIGNLKNLTVFQCFKNN  300 (851)
Q Consensus       223 ~L~~N~i~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~l~~N~  300 (851)
                      ++..|++.. -+|..+..+..|+.||||+|+++ ..|..+..-.++-.|+||+|+|. .+|. .|.+|+.|-+||||+|+
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~Nr  161 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNR  161 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccch
Confidence            777777742 34555556666666666666666 55655655666666666666665 3333 34455555566666665


Q ss_pred             cCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCC-ccccccc
Q 003065          301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNN-FSGEVPN  379 (851)
Q Consensus       301 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~-~~~~~p~  379 (851)
                      +. .+|+.+..+..|++|.|++|.+...--..+..+                        ++|..|.+++.+ -...+|.
T Consensus       162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsm------------------------tsL~vLhms~TqRTl~N~Pt  216 (1255)
T KOG0444|consen  162 LE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSM------------------------TSLSVLHMSNTQRTLDNIPT  216 (1255)
T ss_pred             hh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccc------------------------hhhhhhhcccccchhhcCCC
Confidence            55 344444445555555555554432222223333                        344444444432 2346788


Q ss_pred             cccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCC
Q 003065          380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL  459 (851)
Q Consensus       380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L  459 (851)
                      ++..+.+|..+|+|.|.+. .+|+++..+++|+.|+||+|+|+.. ....+...+|++|+||.|+++ .+|.+++.++.|
T Consensus       217 sld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL-~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL  293 (1255)
T KOG0444|consen  217 SLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL-NMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKL  293 (1255)
T ss_pred             chhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee-eccHHHHhhhhhhccccchhc-cchHHHhhhHHH
Confidence            8999999999999999998 8999999999999999999999853 334566788999999999998 899999999999


Q ss_pred             cEEeccCcccc-CCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCC
Q 003065          460 ERLILTNNNFS-GKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG  538 (851)
Q Consensus       460 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  538 (851)
                      +.|++.+|+++ .-+|+.++.|.+|+.+..++|.+. .+|..+..|..|+.|.|++|+|- .+|..+.-++.|+.|||..
T Consensus       294 ~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre  371 (1255)
T KOG0444|consen  294 TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE  371 (1255)
T ss_pred             HHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence            99999999997 458999999999999999999997 89999999999999999999998 7999999999999999999


Q ss_pred             CccccccCccc
Q 003065          539 NKLTGSIPDNL  549 (851)
Q Consensus       539 N~l~g~ip~~l  549 (851)
                      |.=- ..|+.-
T Consensus       372 NpnL-VMPPKP  381 (1255)
T KOG0444|consen  372 NPNL-VMPPKP  381 (1255)
T ss_pred             CcCc-cCCCCc
Confidence            9755 455443

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=3.3e-39  Score=341.95  Aligned_cols=364  Identities=25%  Similarity=0.382  Sum_probs=232.0

Q ss_pred             ceEEEecccCCcc-eecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEecc
Q 003065           74 RVTEISFDNKSLS-GEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLS  152 (851)
Q Consensus        74 ~v~~l~l~~~~l~-g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls  152 (851)
                      -|..+|+++|.++ +..|++...+++++.|.|...++. .+|++++.|.+|++|.+++|++......++.|+.|+.+++.
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R   86 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVR   86 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhh
Confidence            5777888888887 456777888888888888777776 67888888888888888887777666666666666666666


Q ss_pred             CcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccccccccc
Q 003065          153 INYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGE  232 (851)
Q Consensus       153 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~  232 (851)
                      +|++.                        ...+|..+.+|..|+.||||+|+++ ..|..+..-+++.+|+||+|+|..+
T Consensus        87 ~N~LK------------------------nsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetI  141 (1255)
T KOG0444|consen   87 DNNLK------------------------NSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETI  141 (1255)
T ss_pred             ccccc------------------------cCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccC
Confidence            66654                        3445555555555555555555555 4555555555555555555555532


Q ss_pred             ccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccC-CCCCCCCCC
Q 003065          233 FPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS-GEFPSGFGD  311 (851)
Q Consensus       233 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~-~~~p~~~~~  311 (851)
                      ....|.+++.|-+||||+|++. .+|..+..+..|++|+|++|.+...--..+..+++|++|.+++.+=+ ..+|.++..
T Consensus       142 Pn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~  220 (1255)
T KOG0444|consen  142 PNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDD  220 (1255)
T ss_pred             CchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhh
Confidence            2233455555555555555555 44445555555555555555544322223333444444444443322 234444444


Q ss_pred             cccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceec
Q 003065          312 MRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLR  391 (851)
Q Consensus       312 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~  391 (851)
                      |.+|..++++.|.+. .+|+.+-.+.+|+.|+||+|+|+                         ++........+|+.|+
T Consensus       221 l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-------------------------eL~~~~~~W~~lEtLN  274 (1255)
T KOG0444|consen  221 LHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-------------------------ELNMTEGEWENLETLN  274 (1255)
T ss_pred             hhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-------------------------eeeccHHHHhhhhhhc
Confidence            444444444444444 44555555555555555555554                         1122233445677777


Q ss_pred             cccCccccccCCcccCccccceEEecCCcCC-CCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCcccc
Q 003065          392 ISDNHLSGKIPDGLWALPNVGMLDFGDNDFT-GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFS  470 (851)
Q Consensus       392 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  470 (851)
                      ||.|+++ .+|++++.+++|+.|.+.+|+++ ..+|..++.+..|+.+..++|.+. .+|+.++.+..|+.|.|+.|++.
T Consensus       275 lSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi  352 (1255)
T KOG0444|consen  275 LSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI  352 (1255)
T ss_pred             cccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee
Confidence            7777777 77777778888888888888775 346777788888888888888887 78888888888888888888887


Q ss_pred             CCCccccccCCcccEEEecCCcc
Q 003065          471 GKIPSALGALRQLSSLHLEENAL  493 (851)
Q Consensus       471 ~~~p~~~~~l~~L~~L~Ls~N~l  493 (851)
                       ..|+++--|+.|+.|||..|.-
T Consensus       353 -TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  353 -TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             -echhhhhhcCCcceeeccCCcC
Confidence             6788888888888888888843

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-39  Score=354.74  Aligned_cols=463  Identities=24%  Similarity=0.319  Sum_probs=320.3

Q ss_pred             eEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCc
Q 003065           75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSIN  154 (851)
Q Consensus        75 v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N  154 (851)
                      ++.+++..|.+-..--+.+..--+|+.|||++|++. ..|..+..+.+|+.|+++.|.|...+-+++++++|++|.|.+|
T Consensus        23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n  101 (1081)
T KOG0618|consen   23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNN  101 (1081)
T ss_pred             HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccc
Confidence            555555555543211122223333777777777775 5677777777777777777777766655777777777777777


Q ss_pred             ccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccccccccccc
Q 003065          155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP  234 (851)
Q Consensus       155 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p  234 (851)
                      .+. ..|..+..+.+|++|+++.|.+.  .+|..+..++.++.+..++|....    .++... .+.+++..|.+.+.++
T Consensus       102 ~l~-~lP~~~~~lknl~~LdlS~N~f~--~~Pl~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~~  173 (1081)
T KOG0618|consen  102 RLQ-SLPASISELKNLQYLDLSFNHFG--PIPLVIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSFL  173 (1081)
T ss_pred             hhh-cCchhHHhhhcccccccchhccC--CCchhHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccchh
Confidence            766 66777777777777777777774  667777777777777777772221    222222 6677777777777777


Q ss_pred             ccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCccc
Q 003065          235 RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK  314 (851)
Q Consensus       235 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  314 (851)
                      ..+..++.  .|||.+|.+. .  ..+.++.+|+.|....|++...    --..++|+.|+.++|.++...+.  ..-.+
T Consensus       174 ~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~--p~p~n  242 (1081)
T KOG0618|consen  174 IDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVH--PVPLN  242 (1081)
T ss_pred             cchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeeccc--ccccc
Confidence            66666666  6777777776 2  2355677777777777776521    12346778888888877733222  22357


Q ss_pred             ccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceecccc
Q 003065          315 LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISD  394 (851)
Q Consensus       315 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~  394 (851)
                      |++++++.|+++ .+|++++.+.+|+.|+..+|+++ .+|..+...++|..+....|.+. .+|.....++.|+.|||..
T Consensus       243 l~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~  319 (1081)
T KOG0618|consen  243 LQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQS  319 (1081)
T ss_pred             ceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehh
Confidence            888888888888 45688888888888888888885 78888888888888888888776 4566677788888888888


Q ss_pred             CccccccCCcccC-cc-ccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCC
Q 003065          395 NHLSGKIPDGLWA-LP-NVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGK  472 (851)
Q Consensus       395 N~l~~~~p~~~~~-l~-~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  472 (851)
                      |.|. ..|+.+.. +. .|..|+.+.|++...+...=..++.|+.|++.+|.++...-..+.++..|+.|+|++|++...
T Consensus       320 N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f  398 (1081)
T KOG0618|consen  320 NNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF  398 (1081)
T ss_pred             cccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence            8887 55554332 22 266677777777655533334456678888888888776666677778888888888888755


Q ss_pred             CccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCcccc-ccCccccc
Q 003065          473 IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG-SIPDNLMK  551 (851)
Q Consensus       473 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~l~~  551 (851)
                      ....+.++..|+.|+||+|+|+ .+|..+.++..|+.|...+|+|. ..| .+..++.|+.+|+|.|+|+- .+|.....
T Consensus       399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~  475 (1081)
T KOG0618|consen  399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS  475 (1081)
T ss_pred             CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence            5567778888888888888886 67788888888888888888887 666 77788888888888888863 33444333


Q ss_pred             ccceEEeCcCCcc
Q 003065          552 LKLSSIDLSENQL  564 (851)
Q Consensus       552 l~L~~l~ls~N~l  564 (851)
                      -.|++|||++|.+
T Consensus       476 p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  476 PNLKYLDLSGNTR  488 (1081)
T ss_pred             cccceeeccCCcc
Confidence            4678888888874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-36  Score=305.06  Aligned_cols=167  Identities=32%  Similarity=0.488  Sum_probs=149.3

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+.+|...+.||+|+||.||+|+++.++..||||.+.+..    ..+-+..|+++++.++|||||+++++++.++..|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            4568899999999999999999999999999999986653    455678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC------CceEEeee
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED------YEPKIADF  823 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~------~~~kl~DF  823 (851)
                      ||||.||+|.+|++++     ..+++.....++.|+|.|+++||   +++||||||||+|||++..      -.+||+||
T Consensus        88 MEyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             EEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            9999999999999975     36888899999999999999999   8899999999999999754      45899999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+.......   ..+.+|+|.|||||
T Consensus       160 GfAR~L~~~~~---a~tlcGSplYMAPE  184 (429)
T KOG0595|consen  160 GFARFLQPGSM---AETLCGSPLYMAPE  184 (429)
T ss_pred             chhhhCCchhH---HHHhhCCccccCHH
Confidence            99998875433   34478999999998

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=351.80  Aligned_cols=482  Identities=27%  Similarity=0.338  Sum_probs=398.2

Q ss_pred             EecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccC
Q 003065           78 ISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFT  157 (851)
Q Consensus        78 l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~  157 (851)
                      +|.+..++. .||..+..-..++.|+++.|-+-..--+.+.+.-+|+.||+++|++..-+-.+..+++|+.|.++.|.+.
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~   81 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIR   81 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccccCCchhhhHHHHhhcccchhhHh
Confidence            455555555 5777777778899999999987532223455566699999999999887777999999999999999998


Q ss_pred             CCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccc
Q 003065          158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSI  237 (851)
Q Consensus       158 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~  237 (851)
                       ..|.+..++.+|++|+|..|.+.  .+|.++..+++|++|+++.|++. .+|..+..++.++.++.++|.-....+   
T Consensus        82 -~vp~s~~~~~~l~~lnL~~n~l~--~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg---  154 (1081)
T KOG0618|consen   82 -SVPSSCSNMRNLQYLNLKNNRLQ--SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG---  154 (1081)
T ss_pred             -hCchhhhhhhcchhheeccchhh--cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhc---
Confidence             77889999999999999999996  78999999999999999999998 889999999999999999992222222   


Q ss_pred             cCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccE
Q 003065          238 RKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFA  317 (851)
Q Consensus       238 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  317 (851)
                       ... ++.++|..|.+.+.++..+..++.  .|||++|.+.   --.+.++.+|+.+.+..|+++...    -..++|+.
T Consensus       155 -~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~  223 (1081)
T KOG0618|consen  155 -QTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTA  223 (1081)
T ss_pred             -ccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchhe
Confidence             222 888999999999999988888877  8999999987   345778899999999999987432    23578999


Q ss_pred             EEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCcc
Q 003065          318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHL  397 (851)
Q Consensus       318 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l  397 (851)
                      |+.++|.++...+.  ..-.+|+.+|+|.|+++ .+|+|++.+.+++.+...+|++ ..+|..+...++|+.|++..|.+
T Consensus       224 L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l-~~lp~ri~~~~~L~~l~~~~nel  299 (1081)
T KOG0618|consen  224 LYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRL-VALPLRISRITSLVSLSAAYNEL  299 (1081)
T ss_pred             eeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhH-HhhHHHHhhhhhHHHHHhhhhhh
Confidence            99999999843332  23467999999999999 6789999999999999999999 67888899999999999999999


Q ss_pred             ccccCCcccCccccceEEecCCcCCCCCCcccccCCC-CCeEecCCCcceeeCCc-ccccCCCCcEEeccCccccCCCcc
Q 003065          398 SGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTS-LSQLVLQNNRFSGELPS-ELGRLTNLERLILTNNNFSGKIPS  475 (851)
Q Consensus       398 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~-L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~  475 (851)
                      + .+|....+++.|+.|||..|+|...++..+.-+.. |..|+.+.|++. ..|. .=..+..|+.|++.+|.++...-.
T Consensus       300 ~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p  377 (1081)
T KOG0618|consen  300 E-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFP  377 (1081)
T ss_pred             h-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchh
Confidence            8 78888888999999999999999887777666555 888999999998 4442 222457899999999999987666


Q ss_pred             ccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cc
Q 003065          476 ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KL  554 (851)
Q Consensus       476 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L  554 (851)
                      .+.+.+.|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|.++..++.|++|...+|++. ..| .+..+ .|
T Consensus       378 ~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL  454 (1081)
T KOG0618|consen  378 VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQL  454 (1081)
T ss_pred             hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcc
Confidence            7888999999999999998555566889999999999999999 89999999999999999999999 889 77788 99


Q ss_pred             eEEeCcCCcccccC-CcccccCCC-CccccCCCCC
Q 003065          555 SSIDLSENQLSGSV-PLDFLRMGG-DGAFAGNEGL  587 (851)
Q Consensus       555 ~~l~ls~N~l~~~~-p~~~~~~~~-~~~~~gn~~l  587 (851)
                      +.+|+|.|+|+--. |........ .-.+.||..+
T Consensus       455 ~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  455 KVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             eEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            99999999986433 322220111 2345677653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-34  Score=290.14  Aligned_cols=165  Identities=35%  Similarity=0.448  Sum_probs=144.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  746 (851)
                      +.|.+.+.||+|+||.|-+|..+.+++.||||++.+..         .....++|+++|++++||+||+++++|+..+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45788999999999999999999999999999996541         223467999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC---CceEEeee
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKIADF  823 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DF  823 (851)
                      ||||||++||+|++++-..     ..+....-..+++|++.|+.|||   ++||+||||||+|||+..+   ..+||+||
T Consensus       252 YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             EEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999764     23455555788999999999999   8999999999999999765   78999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+..+..   ..+.+++|||.|.|||
T Consensus       324 GlAK~~g~~---sfm~TlCGTpsYvAPE  348 (475)
T KOG0615|consen  324 GLAKVSGEG---SFMKTLCGTPSYVAPE  348 (475)
T ss_pred             chhhccccc---eehhhhcCCccccChh
Confidence            999988744   3355689999999999

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=284.73  Aligned_cols=164  Identities=35%  Similarity=0.508  Sum_probs=147.2

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCe-eEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS-SFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~  752 (851)
                      +.+..+.||+|..|.||+|.++.+++.+|+|++...   ...+++.+|++++++++||+||++|++|..++. .+++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            456788999999999999999999999999999433   346788999999999999999999999999994 9999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      |++|+|.+++...     ..+++....+|+.+|++||.|||+  +++||||||||+|||++..|++||||||.++.....
T Consensus       160 MDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             cCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            9999999998763     458888899999999999999995  489999999999999999999999999999887665


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                          ...+++||..|||||
T Consensus       233 ----~a~tfvGT~~YMsPE  247 (364)
T KOG0581|consen  233 ----IANTFVGTSAYMSPE  247 (364)
T ss_pred             ----hcccccccccccChh
Confidence                224579999999999

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=285.51  Aligned_cols=167  Identities=35%  Similarity=0.467  Sum_probs=149.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ..+|+..++||+|+||+||.++.+++++.||+|++++.     .+.+...+|..++.+++||+||+++..|++++..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            45899999999999999999999999999999998765     3456778999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      +||+.||+|..++++.     ..+++..+.-++..|+.||.|||   +++|||||+||+|||+|.+|+++|+|||+|+..
T Consensus       104 ld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            9999999999999863     45777778888999999999999   899999999999999999999999999999965


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  +.+++||+.|||||
T Consensus       176 ~~~~~~--t~tfcGT~eYmAPE  195 (357)
T KOG0598|consen  176 LKDGDA--TRTFCGTPEYMAPE  195 (357)
T ss_pred             ccCCCc--cccccCCccccChH
Confidence            544332  34589999999998

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=298.48  Aligned_cols=172  Identities=53%  Similarity=0.882  Sum_probs=149.9

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc--HHHHHHHHHHHHcCCCCccccEEEEEEeCC-eeEEE
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHRNILKLYACLLKGG-SSFLV  749 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv  749 (851)
                      ...++|...+.||+|+||.||+|... ++..||||++.....  .++|.+|++++.+++|||+|+++|||.+.+ ..++|
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            34578999999999999999999994 448999998866544  567999999999999999999999999988 59999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      +|||++|+|.++++....  . .++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++++||+|||+|+..
T Consensus       151 YEym~nGsL~d~L~~~~~--~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKG--E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG  227 (361)
T ss_pred             EEccCCCCHHHHhCCCCC--C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence            999999999999987421  1 7899999999999999999999988889999999999999999999999999999765


Q ss_pred             CC-CCCccccccc-ccccccccCC
Q 003065          830 EN-SPKVSDYSCF-AGTHGYIAPG  851 (851)
Q Consensus       830 ~~-~~~~~~~~~~-~gt~~Y~APE  851 (851)
                      .. ....   ... .||.+|+|||
T Consensus       228 ~~~~~~~---~~~~~gt~gY~~PE  248 (361)
T KOG1187|consen  228 PEGDTSV---STTVMGTFGYLAPE  248 (361)
T ss_pred             Cccccce---eeecCCCCccCChh
Confidence            54 2211   112 7999999998

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=2.4e-32  Score=293.76  Aligned_cols=171  Identities=30%  Similarity=0.464  Sum_probs=154.1

Q ss_pred             ccHHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecc-----cccHHHHHHHHHHHHcCCCCccccEEEEEEeCC
Q 003065          670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGG  744 (851)
Q Consensus       670 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  744 (851)
                      .+.+. ..|+..+.||+|+|+.||.+++..+|..||+|++.+     ....+.+.+||++.+.++|||||+++++|++..
T Consensus        13 ~D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   13 EDPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ecCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            44445 679999999999999999999999999999999865     345677889999999999999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      .+|+|.|+|+.++|.++++++     .++++..+..+++||+.|+.|||   +.+|+|||||..|++++++.++||+|||
T Consensus        92 nVYivLELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccc
Confidence            999999999999999998853     46888999999999999999999   8899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|.....+....  .+.+|||.|+|||
T Consensus       164 LAt~le~~~Erk--~TlCGTPNYIAPE  188 (592)
T KOG0575|consen  164 LATQLEYDGERK--KTLCGTPNYIAPE  188 (592)
T ss_pred             eeeeecCccccc--ceecCCCcccChh
Confidence            999887653332  3478999999999

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.1e-33  Score=274.93  Aligned_cols=174  Identities=25%  Similarity=0.407  Sum_probs=150.8

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEE-EEEeCCe-eE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYA-CLLKGGS-SF  747 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~  747 (851)
                      .+.+|++.+.||+|.||+||++.+..+|..+|.|.++-+    ...++...|+.++++++|||||++++ .|.++.. .+
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            345789999999999999999999999999999998633    34567889999999999999999988 5555555 89


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEECCCCceEEeeecC
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      +|||||++|+|.+.++.. +.....+++..+|++..|++.||..+|... +.  |+||||||.||+++.+|.+|++|||+
T Consensus        97 ivmE~c~~GDLsqmIk~~-K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHF-KKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             HHHHhhcccCHHHHHHHH-HhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchh
Confidence            999999999999999875 445667999999999999999999999432 44  99999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.......  ...+++|||+||+||
T Consensus       175 ~r~l~s~~t--fA~S~VGTPyYMSPE  198 (375)
T KOG0591|consen  175 GRFLSSKTT--FAHSLVGTPYYMSPE  198 (375)
T ss_pred             HhHhcchhH--HHHhhcCCCcccCHH
Confidence            998876543  335689999999998

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.97  E-value=1.5e-32  Score=269.77  Aligned_cols=166  Identities=26%  Similarity=0.395  Sum_probs=144.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc----HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +.|+...++|+|+||.||+|+++++|+.||||++...++    .+-..+|++++++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            468888999999999999999999999999999865533    3446799999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      ||+. ++.+-+.+.    ...++...+..+++|+++|+.|+|   ++++|||||||+|||++.+|.+|+||||+|+....
T Consensus        82 ~~dh-TvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   82 YCDH-TVLHELERY----PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             ecch-HHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            9965 555555543    345788889999999999999999   88999999999999999999999999999998875


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.  ..++.++.|.+|+|||
T Consensus       154 pg--d~YTDYVATRWYRaPE  171 (396)
T KOG0593|consen  154 PG--DNYTDYVATRWYRAPE  171 (396)
T ss_pred             Cc--chhhhhhhhhhccChh
Confidence            32  2345578899999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=261.04  Aligned_cols=164  Identities=32%  Similarity=0.457  Sum_probs=148.9

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +.+|+..+.||.|+||+|..++.+.++..||+|++.+++     ..+...+|..+++.+.||+++++++.+.+.+..|||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            458899999999999999999999999999999987653     345567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||++||.|+.++++.     ..++...+.-+|.+|+.|++|||   +.+|++||+||+|||+|.+|.+||+|||+|+.+
T Consensus       123 meyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EeccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            9999999999999874     35777888889999999999999   789999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...     +-+.+|||.|+|||
T Consensus       195 ~~r-----T~TlCGTPeYLAPE  211 (355)
T KOG0616|consen  195 SGR-----TWTLCGTPEYLAPE  211 (355)
T ss_pred             cCc-----EEEecCCccccChH
Confidence            643     34478999999998

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.1e-31  Score=277.86  Aligned_cols=168  Identities=32%  Similarity=0.394  Sum_probs=146.3

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  748 (851)
                      ...|+..++||+|.||.||+|++..+|+.||+|++....    ......+||.+|++++||||+++.+...+.  +.+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            346888999999999999999999999999999986542    344567999999999999999999988765  78999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+|||+. ||.-++..    ....++..++..++.|++.||+|+|   .++|+|||||.+|||||.+|.+||+|||+|+.
T Consensus       196 VFeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceee
Confidence            9999964 78776654    3456899999999999999999999   89999999999999999999999999999998


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +...... .++..+-|.+|+|||
T Consensus       268 y~~~~~~-~~T~rVvTLWYRpPE  289 (560)
T KOG0600|consen  268 YTPSGSA-PYTSRVVTLWYRPPE  289 (560)
T ss_pred             ccCCCCc-ccccceEEeeccChH
Confidence            7765433 356678899999998

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-31  Score=278.74  Aligned_cols=169  Identities=37%  Similarity=0.492  Sum_probs=150.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  748 (851)
                      ..+|.+.+.||+|+|++|++|+.+++++.||||++.++     ...+.+.+|-++|.+| .||.|++++..|++....|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            35799999999999999999999999999999998654     3456678899999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+||+++|+|.++|++.     ..+++.....++.+|+.|++|||   +.|||||||||+|||+|.+|++||+|||.|+.
T Consensus       152 vLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999975     45788888899999999999999   89999999999999999999999999999998


Q ss_pred             cCCCCCc---------cc--ccccccccccccCC
Q 003065          829 AENSPKV---------SD--YSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~---------~~--~~~~~gt~~Y~APE  851 (851)
                      +......         ..  ..+++||..|.+||
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPE  257 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPE  257 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHH
Confidence            7654222         11  14689999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=5.9e-31  Score=254.54  Aligned_cols=166  Identities=30%  Similarity=0.418  Sum_probs=147.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc----HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .+|...+.+|+|.||.||+|++..+++.||||+++....    .....+||+.++.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            368889999999999999999999999999999975532    2346799999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      ||+ .+|...++.    ....++..++..++.++++|++|+|   ++.|+|||+||.|+|++.+|.+||+|||+|+.+..
T Consensus        82 fm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             ecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            996 589888875    3567899999999999999999999   88999999999999999999999999999999886


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  .+-|.+|+|||
T Consensus       154 p~~~~~~--~V~TRWYRAPE  171 (318)
T KOG0659|consen  154 PNRIQTH--QVVTRWYRAPE  171 (318)
T ss_pred             CCccccc--ceeeeeccChH
Confidence            6554433  26799999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-30  Score=278.35  Aligned_cols=164  Identities=41%  Similarity=0.608  Sum_probs=141.2

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcE-EEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCC-eeEEEEe
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGG-SSFLVLE  751 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  751 (851)
                      ....+.+|+|+||+||+|.++  |.. ||||++...+    ..+.|.+|+.++.+++|||||+++|++.... ..++|||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            345566999999999999994  445 9999986542    2558999999999999999999999998876 7899999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEEeCCCCCCEEECCCC-ceEEeeecCcccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP-IIHRDIKSSNILLDEDY-EPKIADFGVAKIA  829 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrDlkp~NILl~~~~-~~kl~DFGla~~~  829 (851)
                      |+++|+|.++++..   ....+++..+++++.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++..
T Consensus       121 y~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             eCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            99999999999874   3567999999999999999999999   667 99999999999999998 9999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  ...+...||+.|||||
T Consensus       195 ~~~~--~~~~~~~GT~~wMAPE  214 (362)
T KOG0192|consen  195 VISK--TSMTSVAGTYRWMAPE  214 (362)
T ss_pred             cccc--ccccCCCCCccccChh
Confidence            6432  2233367999999999

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=278.43  Aligned_cols=166  Identities=29%  Similarity=0.405  Sum_probs=148.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHH--HHHHHHHHHcCC-CCccccEEEEEEeCC-eeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKV--FAAEMEILGKIR-HRNILKLYACLLKGG-SSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  749 (851)
                      +++|...+.||.|.||.||+|+...++..||||+++++ ...++  -.||+..+++++ |||||++.+++.+.+ ..|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            46899999999999999999999999999999999765 23333  358999999998 999999999999888 89999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ||||+ .+|++.++++    ...++...+..|+.||++||+|+|   .+|++|||+||+|||+.....+||+|||+||.+
T Consensus        89 fE~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             HHhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccc
Confidence            99995 6999999875    567999999999999999999999   889999999999999998889999999999988


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......   +.++.|.+|+|||
T Consensus       161 ~SkpPY---TeYVSTRWYRAPE  179 (538)
T KOG0661|consen  161 RSKPPY---TEYVSTRWYRAPE  179 (538)
T ss_pred             ccCCCc---chhhhcccccchH
Confidence            776554   4468899999998

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=269.60  Aligned_cols=168  Identities=35%  Similarity=0.533  Sum_probs=147.1

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHc--CCCCccccEEEEEEeCC----eeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLLKGG----SSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l  748 (851)
                      +......+++|+|+||.||+|+.  .++.||||++. ..+.+.|+.|-++++.  ++|+||+++++.-....    .+|+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp-~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP-EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecC-HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34556788999999999999998  45899999874 4456678888888776  58999999999877655    7899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD------CSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      |+||.+.|+|.+|++.+      .++|....+|+..+++||+|||+.      ++++|+|||||.+|||+..|+++.|+|
T Consensus       286 Vt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             EeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            99999999999999875      689999999999999999999964      357899999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|..+..+....+....+||.+|||||
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPE  388 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPE  388 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHH
Confidence            99999988777666666789999999998

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.96  E-value=1.7e-30  Score=258.66  Aligned_cols=168  Identities=32%  Similarity=0.374  Sum_probs=146.6

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHH----HHHHHHHHHHcCCCCccccEEEEEEe--CCeeE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK----VFAAEMEILGKIRHRNILKLYACLLK--GGSSF  747 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  747 (851)
                      .+++|+..+.|++|+||.||+|+++.+++.||+|+++.+.+..    .-.+||.++.+++|||||.+-.+...  -+.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            4567899999999999999999999999999999997764433    34799999999999999999887654  46799


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +|||||+ .+|...++..    ..++....+..++.|+++|++|||   ...|+|||+||+|+|+.+.|.+||+|||+|+
T Consensus       154 ~VMe~~E-hDLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  154 IVMEYVE-HDLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             eeHHHHH-hhHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhh
Confidence            9999996 4898888764    356888889999999999999999   7899999999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++...+  .++..+-|.+|+|||
T Consensus       226 ~ygsp~k--~~T~lVVTLWYRaPE  247 (419)
T KOG0663|consen  226 EYGSPLK--PYTPLVVTLWYRAPE  247 (419)
T ss_pred             hhcCCcc--cCcceEEEeeecCHH
Confidence            9887643  345567899999998

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.96  E-value=2.1e-30  Score=273.47  Aligned_cols=165  Identities=30%  Similarity=0.459  Sum_probs=148.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+.    .+.+.+.+|++++++++|||||.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5788889999999999999999999999999998654    344568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+.| +|+.++..     ...+++..+..++.+++.|+.|||   +.+|+|||+||.|||++..|.+|+||||+|+.+..
T Consensus        82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            9976 99999976     346889999999999999999999   88999999999999999999999999999998876


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ..+.+.|||.|||||
T Consensus       153 ~t~--vltsikGtPlYmAPE  170 (808)
T KOG0597|consen  153 NTS--VLTSIKGTPLYMAPE  170 (808)
T ss_pred             Cce--eeeeccCcccccCHH
Confidence            433  234578999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.96  E-value=2.3e-29  Score=266.46  Aligned_cols=146  Identities=28%  Similarity=0.412  Sum_probs=134.4

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+++|+..+.||+|+||+||.|+-+.+|..+|+|++++.     ...+.+..|-.+|....+|+||+++..|++.+..|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            356899999999999999999999999999999999765     356678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      ||||++||++..+|.+.     ..++...+..++.+++-|+..+|   +.|+|||||||+|+|||..|++||+|||+++
T Consensus       219 iMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             EEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccc
Confidence            99999999999999763     46777778888999999999999   8899999999999999999999999999985

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-29  Score=271.25  Aligned_cols=167  Identities=31%  Similarity=0.466  Sum_probs=147.1

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-------ccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCe
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGS  745 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  745 (851)
                      ....|...+.||+|+||+|+.|++..++..||+|++.++       ...+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            346899999999999999999999999999999976553       23455678999999999 9999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-CceEEeeec
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFG  824 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG  824 (851)
                      .|+||||+.||+|++++.+.     ..+.+....+++.|++.|++|+|   +++|+||||||+|||++.+ +++||+|||
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            99999999999999999863     34666888899999999999999   8899999999999999999 999999999


Q ss_pred             CccccC-CCCCcccccccccccccccCC
Q 003065          825 VAKIAE-NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~-~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.... .+.   ...+.+||+.|+|||
T Consensus       167 ~s~~~~~~~~---~l~t~cGsp~Y~aPE  191 (370)
T KOG0583|consen  167 LSAISPGEDG---LLKTFCGSPAYAAPE  191 (370)
T ss_pred             cccccCCCCC---cccCCCCCcccCCHH
Confidence            999874 222   234578999999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=6.4e-30  Score=259.33  Aligned_cols=165  Identities=27%  Similarity=0.458  Sum_probs=149.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      -+|++.+.||+|.||+|-+|.....|+.||||.+++.     .+.-.+.+||++|..++||||+++|++|+..+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            3788999999999999999999899999999988654     23445789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||..+|.|+||+.++     ..++.....++++||..|+.|+|   ..+++|||+|.+|||+|.++++||+|||++-.+.
T Consensus       133 EYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  133 EYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999875     46888899999999999999999   8899999999999999999999999999998776


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...-   .++++|+|-|.+||
T Consensus       205 ~~kf---LqTFCGSPLYASPE  222 (668)
T KOG0611|consen  205 DKKF---LQTFCGSPLYASPE  222 (668)
T ss_pred             cccH---HHHhcCCcccCCcc
Confidence            6543   34589999999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-29  Score=256.61  Aligned_cols=170  Identities=27%  Similarity=0.425  Sum_probs=150.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +.|+..+.||.|..+.||+|++..++..||||++.-+   ...+.+++|+..|+.++||||++++.+|..+...|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            4799999999999999999999999999999998544   3467889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      |.+|++.+.++.....   .+++..+..|.+++++||.|||   .+|.||||||+.||||+.+|.+||+|||.+..+...
T Consensus       106 Ma~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999987554   3788889999999999999999   789999999999999999999999999987655443


Q ss_pred             CCcc--cccccccccccccCC
Q 003065          833 PKVS--DYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~--~~~~~~gt~~Y~APE  851 (851)
                      ....  +...++||++|||||
T Consensus       180 G~R~~~rf~tfvgtp~wmAPE  200 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPE  200 (516)
T ss_pred             CceeeEeeccccCcccccChH
Confidence            3222  225678999999998

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3e-29  Score=260.56  Aligned_cols=172  Identities=35%  Similarity=0.437  Sum_probs=143.7

Q ss_pred             HHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----------------cHHHHHHHHHHHHcCCCCcccc
Q 003065          672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------------GVKVFAAEMEILGKIRHRNILK  735 (851)
Q Consensus       672 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~  735 (851)
                      ...+++|+..+.||+|.||+|-+|++..+++.||||++.+..                ..+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            456789999999999999999999999999999999985431                1346789999999999999999


Q ss_pred             EEEEEEeC--CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          736 LYACLLKG--GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       736 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      ++++..+.  +.+|||+|||..|.+...     ....+.+...+++++.+++..||+|||   .++||||||||+|+|++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS  244 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence            99998764  678999999998876421     223344889999999999999999999   78999999999999999


Q ss_pred             CCCceEEeeecCccccCCCCC---cccccccccccccccCC
Q 003065          814 EDYEPKIADFGVAKIAENSPK---VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 ~~~~~kl~DFGla~~~~~~~~---~~~~~~~~gt~~Y~APE  851 (851)
                      ++|++||+|||.+........   .......+|||.|||||
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE  285 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPE  285 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchH
Confidence            999999999999976633211   11223468999999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2e-28  Score=254.83  Aligned_cols=169  Identities=34%  Similarity=0.496  Sum_probs=144.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCC--eeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGG--SSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  751 (851)
                      .++...+.||+|+||.||++...+++...|||.+....  ..+.+.+|+.+|++++|||||+++|......  ..++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            46788899999999999999999889999999885542  2456889999999999999999999755444  6889999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-CCceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~  830 (851)
                      |+++|+|.+++.+.   +. .++...+.++++|+++||+|||   +++||||||||+|||++. ++.+||+|||+|+...
T Consensus        97 y~~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             ccCCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            99999999999875   22 5899999999999999999999   899999999999999999 7999999999998766


Q ss_pred             CC-CCcccccccccccccccCC
Q 003065          831 NS-PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~-~~~~~~~~~~gt~~Y~APE  851 (851)
                      .. ........+.||+.|||||
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPE  191 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPE  191 (313)
T ss_pred             cccccccccccccCCccccCch
Confidence            41 1112233468999999998

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=9.5e-29  Score=252.08  Aligned_cols=170  Identities=26%  Similarity=0.368  Sum_probs=145.3

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCc-cccEEEEEEeCC-----
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRN-ILKLYACLLKGG-----  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  744 (851)
                      +..|+..++||+|+||.||+|+.+.+|+.||+|++.-+.    ......+|+.++++++|+| ||.+++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            456788888999999999999999999999999986542    2345689999999999999 999999998766     


Q ss_pred             -eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          745 -SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       745 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                       ..++|+||+ .-+|.+++....... ..++...+..+++|+++|++|||   +++|+||||||+|||++++|.+||+||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeecc
Confidence             789999999 469999998753221 34666788999999999999999   889999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+...-+..  .++..++|.+|+|||
T Consensus       165 GlAra~~ip~~--~yt~evvTlWYRaPE  190 (323)
T KOG0594|consen  165 GLARAFSIPMR--TYTPEVVTLWYRAPE  190 (323)
T ss_pred             chHHHhcCCcc--cccccEEEeeccCHH
Confidence            99996654332  245568999999998

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.3e-29  Score=240.10  Aligned_cols=169  Identities=34%  Similarity=0.490  Sum_probs=149.2

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      -.+++|++.+.||+|-||.||.|+.++++..||+|++.++     ...+++.+|+++-+.++||||+++|++|.+....|
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy   98 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY   98 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence            3456899999999999999999999999999999998665     34567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +++||..+|+++..++..   ....++......++.|+|.|+.|+|   .++|+||||||+|+|++..+.+||+|||-+.
T Consensus        99 LilEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             EEEEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            999999999999999854   2345677778889999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......    ..+.+||..|.|||
T Consensus       173 ~~p~~k----R~tlcgt~dyl~pE  192 (281)
T KOG0580|consen  173 HAPSNK----RKTLCGTLDYLPPE  192 (281)
T ss_pred             ecCCCC----ceeeecccccCCHh
Confidence            554322    23478999999998

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.96  E-value=3.3e-29  Score=254.58  Aligned_cols=165  Identities=33%  Similarity=0.517  Sum_probs=138.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCC---ee--EEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGG---SS--FLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~--~lv~e  751 (851)
                      .|...+++|.|+||.||+|....++++||||++......+  .+|.++|+++.|||||++..+|....   ..  .+|||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            5678899999999999999999999999999997665433  47999999999999999988876432   23  48999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-CceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~  830 (851)
                      ||+ .+|.++++.... ....++...+.-+++|+.+|+.|||   +.+|+||||||.|+|+|.+ |.+||||||.|+...
T Consensus       103 ymP-~tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  103 YMP-ETLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             hch-HHHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            996 499999886432 3445666777789999999999999   7899999999999999966 899999999999887


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++....   +..|..|+|||
T Consensus       178 ~~epniS---YicSRyYRaPE  195 (364)
T KOG0658|consen  178 KGEPNIS---YICSRYYRAPE  195 (364)
T ss_pred             cCCCcee---EEEeccccCHH
Confidence            7655433   56699999998

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=262.62  Aligned_cols=165  Identities=30%  Similarity=0.438  Sum_probs=147.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ..|..-+.||+|+.|.||.|....+++.||||++...  ...+-+.+|+.+|+..+|+|||.+++.|...+..|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4678888999999999999999999999999998554  33455789999999999999999999998889999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      +||+|.|.+...      .+++.++..|++++++||+|||   .++|+|||||.+|||++.+|.+||+|||++..+....
T Consensus       353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            999999998764      4889999999999999999999   8899999999999999999999999999998877654


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ..+.+|||+|||||
T Consensus       424 ~K--R~TmVGTPYWMAPE  439 (550)
T KOG0578|consen  424 SK--RSTMVGTPYWMAPE  439 (550)
T ss_pred             Cc--cccccCCCCccchh
Confidence            32  24478999999998

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=268.20  Aligned_cols=166  Identities=33%  Similarity=0.501  Sum_probs=146.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  748 (851)
                      +.+|...++||+|+||+|+.+..+.+++.||||++++.     ++.+..+.|.+|+... +||.++.++.+|++.++.|.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            45889999999999999999999999999999998765     5667788899998877 59999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+.||++..+.+      ...+++..+.-++..|+.||+|||   +++|||||||.+|||+|.+|.+||+|||+++.
T Consensus       447 vmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccc
Confidence            999999999554433      346888899999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .-...  ..+.+++|||.|||||
T Consensus       518 ~m~~g--~~TsTfCGTpey~aPE  538 (694)
T KOG0694|consen  518 GMGQG--DRTSTFCGTPEFLAPE  538 (694)
T ss_pred             cCCCC--CccccccCChhhcChh
Confidence            54222  2456789999999998

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-29  Score=248.33  Aligned_cols=166  Identities=27%  Similarity=0.419  Sum_probs=152.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      -|++.+.||+|+||.||+|.++.+|+.+|+|++.-+.+.+++.+|+.+|++++.|++|++||.+......|+|||||..|
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            47889999999999999999999999999999988888999999999999999999999999998888999999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  836 (851)
                      +..|.++.+    ..++....+..+.+..++||+|||   ...-+|||||+.|||++.+|.+|++|||.|....+...  
T Consensus       114 SiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--  184 (502)
T KOG0574|consen  114 SISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--  184 (502)
T ss_pred             cHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence            999999875    557888899999999999999999   67889999999999999999999999999987765432  


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      ...+++|||.|||||
T Consensus       185 KRNTVIGTPFWMAPE  199 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPE  199 (502)
T ss_pred             hhCccccCcccccHH
Confidence            234578999999998

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.95  E-value=1.1e-28  Score=238.58  Aligned_cols=167  Identities=32%  Similarity=0.476  Sum_probs=148.6

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc------cc----HHHHHHHHHHHHcC-CCCccccEEEEEEe
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DG----VKVFAAEMEILGKI-RHRNILKLYACLLK  742 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~  742 (851)
                      ....|+..+.+|+|..+.|.+|.++.+++.+|+|++...      ..    .+.-.+|+.+++++ .||+|+++.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            345788899999999999999999999999999998432      11    23456799999998 69999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      +...++|+|.|+.|.|+|++...     -.+++....+|++|+.+|+.|||   ...|||||+||+|||+|++.++||+|
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEec
Confidence            99999999999999999999864     46888899999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|+....+.+..   ..+|||+|.|||
T Consensus       167 FGFa~~l~~GekLr---elCGTPgYLAPE  192 (411)
T KOG0599|consen  167 FGFACQLEPGEKLR---ELCGTPGYLAPE  192 (411)
T ss_pred             cceeeccCCchhHH---HhcCCCcccChh
Confidence            99999988776544   378999999998

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7e-29  Score=262.63  Aligned_cols=161  Identities=35%  Similarity=0.507  Sum_probs=143.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .|...+.||.|+||.||-|++..+...||||++.-.     ..+.++.+|+..+++++|||+|.+-|||-.....|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            477888999999999999999999999999998532     346778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      || -|+-.|.+.-+    ..++....+..|+.+.+.||.|||   +.+.||||||+.|||+++.|.||++|||.|..+..
T Consensus       107 YC-lGSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             HH-hccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            99 56888887664    346778888999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .      .+++|||+|||||
T Consensus       179 A------nsFvGTPywMAPE  192 (948)
T KOG0577|consen  179 A------NSFVGTPYWMAPE  192 (948)
T ss_pred             h------hcccCCccccchh
Confidence            3      3489999999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=255.31  Aligned_cols=166  Identities=34%  Similarity=0.494  Sum_probs=142.0

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      +...+.||+|-||+||.|.+. ....||+|.++.. ...++|.+|+++|++++|++||++++++..++..|||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            467789999999999999994 3447999998774 45688999999999999999999999999988999999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  836 (851)
                      +|.+|++..   ....+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+|||+|+...++....
T Consensus       287 sLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  287 SLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             cHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            999999873   3456888899999999999999999   8899999999999999999999999999999655443222


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      . ....-...|.|||
T Consensus       361 ~-~~~kfPIkWtAPE  374 (468)
T KOG0197|consen  361 S-EGGKFPIKWTAPE  374 (468)
T ss_pred             c-CCCCCCceecCHH
Confidence            1 1112245699998

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=243.34  Aligned_cols=166  Identities=29%  Similarity=0.410  Sum_probs=144.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecc----cccHHHHHHHHHHHHcCCCCccccEEEEEEe-----CCeeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLK-----GGSSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~  747 (851)
                      .|...+.||+|+||.|+.|.++.+++.||||++..    ....++..+|+++++.++|+||+.+.+.+..     -...|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            45557899999999999999999999999999863    2456778899999999999999999998865     34689


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +|+|+| +.+|.+.++.     ...+.......++.|+++|++|+|   +.+|+|||+||+|++++.+..+||+|||+|+
T Consensus       103 iV~elM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  103 LVFELM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             EehhHH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccccee
Confidence            999999 5799888875     344888889999999999999999   8899999999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...........+.++.|.+|+|||
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPE  197 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPE  197 (359)
T ss_pred             eccccCcccchhcceeeeeecCHH
Confidence            886543344456678999999998

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-27  Score=245.37  Aligned_cols=168  Identities=33%  Similarity=0.442  Sum_probs=139.9

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHc--CCCCccccEEEEEEeC----CeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLLKG----GSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~l  748 (851)
                      .++....+.||+|+||+||+|.+  .|+.||||++...++ +.+.+|.++++.  ++|+||+.+++.-..+    ...|+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE-~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDE-RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             hheeEEEEEecCccccceeeccc--cCCceEEEEecccch-hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            34567889999999999999999  578999999866554 445688888876  4999999999875433    24799


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH-----DCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      |++|.+.|||+||+.+.      .++....++++..+|.||++||.     +..+.|.|||||..|||+.++|.+.|+|+
T Consensus       287 vTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             eeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            99999999999999864      68888999999999999999995     35688999999999999999999999999


Q ss_pred             cCccccCCCCC--cccccccccccccccCC
Q 003065          824 GVAKIAENSPK--VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~--~~~~~~~~gt~~Y~APE  851 (851)
                      |+|-.......  .......+||.+|||||
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPE  390 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPE  390 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChH
Confidence            99976554421  12233468999999998

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.94  E-value=6e-27  Score=259.17  Aligned_cols=146  Identities=27%  Similarity=0.398  Sum_probs=132.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|+..+.||+|+||+||+|++..+++.||||++.+.     .....+.+|++++++++|++|+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            688999999999999999999999999999998653     233567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |+++|+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          82 FLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999998753     35788899999999999999999   7899999999999999999999999999997543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=2e-27  Score=256.44  Aligned_cols=167  Identities=31%  Similarity=0.424  Sum_probs=148.9

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+..|+.++.||.|+-|.|..|++..+|+.+|||++.+.     .....+.+|+.+|+-+.||||+++|++|+.+.++|+
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            355688999999999999999999999999999998654     234568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |.||+++|.|++++.++     ..++...+.++++||+.|+.|+|   ..+|+|||+||+|+|+|..+++||+|||+|..
T Consensus        90 vlEyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsL  161 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASL  161 (786)
T ss_pred             EEEecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeec
Confidence            99999999999999874     45778888899999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...+.-.   .+.+|+|.|.|||
T Consensus       162 e~~gklL---eTSCGSPHYA~PE  181 (786)
T KOG0588|consen  162 EVPGKLL---ETSCGSPHYAAPE  181 (786)
T ss_pred             ccCCccc---cccCCCcccCCch
Confidence            6554332   3358999999998

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.94  E-value=9.1e-27  Score=252.60  Aligned_cols=164  Identities=30%  Similarity=0.420  Sum_probs=146.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  749 (851)
                      ..|+..+.||+|.||.||+|+.+.+|+.+|+|++.+..     ..+.+.+|+++|+++. |||||.+++.|++....++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            46888899999999999999999999999999986542     3467899999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC----CCceEEeeecC
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE----DYEPKIADFGV  825 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGl  825 (851)
                      ||++.||.|++.+.+.      .+++.....++.|++.|++|||   +.||+|||+||+|+|+..    ++.+|++|||+
T Consensus       115 mEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            9999999999999874      2888899999999999999999   789999999999999963    35799999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |......   ......+||++|+|||
T Consensus       186 a~~~~~~---~~~~~~~Gtp~y~APE  208 (382)
T KOG0032|consen  186 AKFIKPG---ERLHTIVGTPEYVAPE  208 (382)
T ss_pred             ceEccCC---ceEeeecCCccccCch
Confidence            9988762   2344578999999998

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-28  Score=235.21  Aligned_cols=165  Identities=28%  Similarity=0.419  Sum_probs=144.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecc----cccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +.|++.+.||+|+|+.||++.++.+|+.+|+|++..    ..+.+.+.+|+++.+.++|||||++++.+.+.+..|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            468888999999999999999999999999998743    3567889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC---CCCceEEeeecCccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAKI  828 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~  828 (851)
                      +|+|++|..-+-.+     ...++..+-..++||++|+.|+|   .++|||||+||+|+++.   ....+|++|||+|..
T Consensus        91 ~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             cccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            99999998777654     23566777789999999999999   88999999999999995   344699999999998


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   .....++|||+|||||
T Consensus       163 l~~g---~~~~G~~GtP~fmaPE  182 (355)
T KOG0033|consen  163 VNDG---EAWHGFAGTPGYLSPE  182 (355)
T ss_pred             eCCc---cccccccCCCcccCHH
Confidence            8733   2345678999999998

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.94  E-value=9.8e-27  Score=257.30  Aligned_cols=166  Identities=25%  Similarity=0.370  Sum_probs=144.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|++.+.||+|+||.||+|++..+++.||+|++.+.     ...+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4789999999999999999999999999999998542     23445778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++...      .++...+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus       123 Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         123 EYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             cCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999988642      3677788899999999999999   7899999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .... .......||+.|||||
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE  213 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPE  213 (370)
T ss_pred             cCCc-eecccCCCCcccCCHH
Confidence            3322 1123457999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.94  E-value=9.8e-27  Score=253.77  Aligned_cols=164  Identities=29%  Similarity=0.413  Sum_probs=145.1

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +.+|++.+.||+|+||.||+|++..+++.||||++...     ...+.+.+|++++++++||||+++++++..++..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            45789999999999999999999999999999998643     2345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        97 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             EcCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            9999999999998753     34677788889999999999999   789999999999999999999999999999866


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....     ....||+.|+|||
T Consensus       169 ~~~~-----~~~~gt~~y~aPE  185 (329)
T PTZ00263        169 PDRT-----FTLCGTPEYLAPE  185 (329)
T ss_pred             CCCc-----ceecCChhhcCHH
Confidence            4332     2257999999998

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.94  E-value=1.3e-26  Score=258.20  Aligned_cols=144  Identities=26%  Similarity=0.354  Sum_probs=130.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .|+..+.||+|+||+||+|++..+++.||||++...     ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578899999999999999999999999999998653     234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+++|+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          82 YIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            99999999998753     34778888889999999999999   78999999999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-27  Score=253.25  Aligned_cols=171  Identities=33%  Similarity=0.506  Sum_probs=145.1

Q ss_pred             cccccHHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe
Q 003065          667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK  742 (851)
Q Consensus       667 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  742 (851)
                      ..++.++   +....+.||+|+||+||+|.+-   ..||||++...    +..+.|+.|+.++++-+|.||+-+.||+..
T Consensus       386 ~WeIp~~---ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  386 EWEIPPE---EVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccCHH---Hhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            3445444   3478899999999999999983   36999998544    356789999999999999999999999988


Q ss_pred             CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      ++. .+|+.+|+|.+|+.+++..    +..++..+...||.|||+||.|||   .++|||||+|..||+++++++|||+|
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             Cce-eeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEec
Confidence            877 8999999999999999874    456888999999999999999999   88999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|..-.............|...|||||
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPE  560 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPE  560 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHH
Confidence            99997544333333334456889999998

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.2e-26  Score=257.21  Aligned_cols=146  Identities=29%  Similarity=0.426  Sum_probs=132.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|+..+.||+|+||.||+|++..+++.||||++...     .....+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            688999999999999999999999999999998643     234557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          82 YLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            99999999998753     35788889999999999999999   7899999999999999999999999999987543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.94  E-value=2.2e-26  Score=250.49  Aligned_cols=160  Identities=31%  Similarity=0.401  Sum_probs=138.9

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      +.||+|+||.||+|++..+++.||||++...     .....+.+|++++++++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999999999999998643     23356778999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  836 (851)
                      +|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.......  
T Consensus        81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--  150 (323)
T cd05571          81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--  150 (323)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--
Confidence            999988753     35788889999999999999999   78999999999999999999999999999975432211  


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      .....+||+.|+|||
T Consensus       151 ~~~~~~gt~~y~aPE  165 (323)
T cd05571         151 TMKTFCGTPEYLAPE  165 (323)
T ss_pred             cccceecCccccChh
Confidence            123457999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=2e-27  Score=253.21  Aligned_cols=169  Identities=27%  Similarity=0.387  Sum_probs=151.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCe-eEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS-SFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  749 (851)
                      +++|...+++|+|+||.++.++++.+++.||+|++.-.    ...+...+|+.++++++|||||.+.+.|+.++. .++|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            45789999999999999999999999999999998543    334567899999999999999999999999888 9999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |+||+||++.+.+.+..   ...+++.++.+++.|++.|++|||   +..|+|||||+.||+++.++.+||+|||+|+..
T Consensus        83 m~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             EeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            99999999999998763   456889999999999999999999   789999999999999999999999999999998


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  ...+++|||.||+||
T Consensus       157 ~~~~~--~a~tvvGTp~YmcPE  176 (426)
T KOG0589|consen  157 NPEDS--LASTVVGTPYYMCPE  176 (426)
T ss_pred             CCchh--hhheecCCCcccCHH
Confidence            77642  234578999999998

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-26  Score=257.29  Aligned_cols=144  Identities=27%  Similarity=0.397  Sum_probs=130.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|++.+.||+|+||.||+|++..+++.||||++.+.     ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            688999999999999999999999999999988543     234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        82 ~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          82 FLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            99999999998753     34677888889999999999999   78999999999999999999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.94  E-value=2.6e-26  Score=245.30  Aligned_cols=165  Identities=29%  Similarity=0.384  Sum_probs=142.9

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      |+..+.||+|+||.||+|.+..+++.||||++...     .....+.+|++++++++|++|+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67788999999999999999999999999988543     2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++|+|.+++...   ....+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.....
T Consensus        82 ~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          82 MNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             cCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999998887653   2335788899999999999999999   789999999999999999999999999999875433


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..   .....||+.|||||
T Consensus       156 ~~---~~~~~g~~~y~aPE  171 (285)
T cd05631         156 ET---VRGRVGTVGYMAPE  171 (285)
T ss_pred             Ce---ecCCCCCCCccCHh
Confidence            22   22357999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2e-26  Score=252.06  Aligned_cols=162  Identities=26%  Similarity=0.387  Sum_probs=144.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|++.+.||+|+||.||+|++..+++.||||++...     ...+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            688999999999999999999999999999998643     234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++|+|.+++...     ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus        82 ~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          82 YVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999998753     35788888899999999999999   78999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .     .....||+.|+|||
T Consensus       154 ~-----~~~~~gt~~y~aPE  168 (333)
T cd05600         154 Y-----ANSVVGSPDYMAPE  168 (333)
T ss_pred             c-----cCCcccCccccChh
Confidence            1     22357999999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.94  E-value=2.2e-26  Score=256.12  Aligned_cols=144  Identities=26%  Similarity=0.365  Sum_probs=130.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|++.+.||+|+||.||+|++..+++.||||++.+.     ...+.+.+|++++++++||||+++++.+.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            688999999999999999999999999999998543     234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+++|+|.+++.+.     ..++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        82 ~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          82 YIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            99999999998753     34677788889999999999999   78999999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-26  Score=249.11  Aligned_cols=162  Identities=28%  Similarity=0.406  Sum_probs=143.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...     ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            688899999999999999999989999999998543     234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++|+|.+++...     ..+++.....++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          82 YVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999998753     35778888899999999999999   78999999999999999999999999999986643


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..     ....||+.|+|||
T Consensus       154 ~~-----~~~~gt~~y~aPE  168 (291)
T cd05612         154 RT-----WTLCGTPEYLAPE  168 (291)
T ss_pred             Cc-----ccccCChhhcCHH
Confidence            21     2246999999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.94  E-value=1.8e-26  Score=252.26  Aligned_cols=164  Identities=30%  Similarity=0.406  Sum_probs=143.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCC-cEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNA-GTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      ..+|++.+.||+|+||.||+|++..++ ..||+|++...     ...+.+.+|+++++.++||||+++++++.+++..|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            457999999999999999999876555 67999988542     334567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++|+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       109 v~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            99999999999998753     35788888999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....     ....||+.|||||
T Consensus       181 ~~~~~-----~~~~gt~~y~aPE  198 (340)
T PTZ00426        181 VDTRT-----YTLCGTPEYIAPE  198 (340)
T ss_pred             cCCCc-----ceecCChhhcCHH
Confidence            54321     2357999999998

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.94  E-value=3.5e-27  Score=257.45  Aligned_cols=167  Identities=32%  Similarity=0.434  Sum_probs=144.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC------eeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------SSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  747 (851)
                      .+...+.||+|+||.||+++++.+|+.||||.+...   ...+...+|++++++++|+|||++++.-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            356678899999999999999999999999998763   56777889999999999999999999876544      458


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC--CCC--ceEEeee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD--EDY--EPKIADF  823 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DF  823 (851)
                      +|||||.||||...+.+-  +....++....+.+..+++.||.|||   +.+|+||||||.||++-  .+|  .-||+||
T Consensus        94 lvmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             EEEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence            999999999999999763  44557899999999999999999999   78999999999999984  334  3699999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |.|+...++.   ...+++||+.|.|||
T Consensus       169 G~Arel~d~s---~~~S~vGT~~YLhPe  193 (732)
T KOG4250|consen  169 GAARELDDNS---LFTSLVGTEEYLHPE  193 (732)
T ss_pred             cccccCCCCC---eeeeecCchhhcChH
Confidence            9999888765   345689999999997

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.94  E-value=2.5e-26  Score=256.17  Aligned_cols=144  Identities=26%  Similarity=0.355  Sum_probs=130.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .|+..+.||+|+||.||+|++..+++.||||++....     ..+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788999999999999999999999999999986532     34567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+++|+|.+++.+.     ..++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus        82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            99999999998753     34677788889999999999999   78999999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-27  Score=247.40  Aligned_cols=165  Identities=36%  Similarity=0.507  Sum_probs=146.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .|...+.||+|+||.||+|.+..+++.||+|++.-+   ++.+++++|+.++..++++||.++|+.+..+...|++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            577789999999999999999999999999998654   45678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      .||++.+.++..     ..+++..+..|++++..|+.|+|   .++.+|||||+.||++..+|.+|++|||.+.......
T Consensus        94 ~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   94 GGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             cCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            999999998753     23355666678999999999999   7899999999999999999999999999998777654


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  .+++|||.|||||
T Consensus       166 ~rr--~tfvGTPfwMAPE  181 (467)
T KOG0201|consen  166 KRR--KTFVGTPFWMAPE  181 (467)
T ss_pred             hcc--ccccccccccchh
Confidence            433  5589999999998

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.3e-26  Score=248.94  Aligned_cols=168  Identities=27%  Similarity=0.330  Sum_probs=145.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+.     ...+.+.+|+.+++.++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            3688999999999999999999999999999998642     23455788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++.+.    ...++...+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            999999999998753    235788888899999999999999   7899999999999999999999999999997654


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...... .....||+.|||||
T Consensus       154 ~~~~~~-~~~~~gt~~y~aPE  173 (331)
T cd05597         154 ADGTVQ-SNVAVGTPDYISPE  173 (331)
T ss_pred             CCCCcc-ccceeccccccCHH
Confidence            432211 12246999999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.94  E-value=5.3e-26  Score=247.79  Aligned_cols=160  Identities=31%  Similarity=0.416  Sum_probs=139.1

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      +.||+|+||.||+|++..+++.||||++.+.     .....+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999999999999999998643     23456788999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  836 (851)
                      +|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--  150 (328)
T cd05593          81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--  150 (328)
T ss_pred             CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--
Confidence            998888652     35788899999999999999999   78999999999999999999999999999975432221  


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      ......||+.|+|||
T Consensus       151 ~~~~~~gt~~y~aPE  165 (328)
T cd05593         151 TMKTFCGTPEYLAPE  165 (328)
T ss_pred             ccccccCCcCccChh
Confidence            123357999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.94  E-value=3.4e-26  Score=253.29  Aligned_cols=167  Identities=26%  Similarity=0.365  Sum_probs=144.1

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+.     ...+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            35789999999999999999999999999999998542     2334577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++...      .++...+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       122 ~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         122 MEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            9999999999988652      3667778888999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...... ......||+.|||||
T Consensus       193 ~~~~~~-~~~~~~gt~~y~aPE  213 (370)
T cd05596         193 DANGMV-RCDTAVGTPDYISPE  213 (370)
T ss_pred             cCCCcc-cCCCCCCCcCeECHH
Confidence            433221 123357999999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.94  E-value=2e-26  Score=257.88  Aligned_cols=172  Identities=28%  Similarity=0.419  Sum_probs=144.8

Q ss_pred             CCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      +....+.||+|+||+||+|+..     +....||||.+++..   ..++|++|++.++.++|||||+++|.+..++..||
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            4467788999999999999864     234459999997653   46789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceE
Q 003065          749 VLEYMPNGNLFQALHKRVKEG---------KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPK  819 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  819 (851)
                      |+|||..|||.+||..+....         .++++..+.+.||.|||.||+||-   ++.+|||||..+|+||.++..+|
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence            999999999999998764322         234889999999999999999999   78999999999999999999999


Q ss_pred             EeeecCccccCCCCCcccccccccccccccCC
Q 003065          820 IADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       820 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|||++|.+.............=..+|||||
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppE  675 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE  675 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence            99999999776554333221122356899998

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=5e-26  Score=247.51  Aligned_cols=160  Identities=31%  Similarity=0.415  Sum_probs=138.5

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      +.||+|+||.||+|++..+++.||+|++...     .....+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4689999999999999999999999998653     23455678999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  836 (851)
                      +|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--  150 (323)
T cd05595          81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--  150 (323)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--
Confidence            998888652     35788899999999999999999   78999999999999999999999999999875432221  


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      ......||+.|+|||
T Consensus       151 ~~~~~~gt~~y~aPE  165 (323)
T cd05595         151 TMKTFCGTPEYLAPE  165 (323)
T ss_pred             ccccccCCcCcCCcc
Confidence            123357999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.94  E-value=4.4e-26  Score=252.37  Aligned_cols=166  Identities=27%  Similarity=0.365  Sum_probs=144.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...     ...+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            5899999999999999999999999999999998542     23445778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++...      .++...+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+...
T Consensus       123 Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         123 EYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             cCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            999999999988642      3677778889999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..... .....+||+.|||||
T Consensus       194 ~~~~~-~~~~~~gt~~y~aPE  213 (371)
T cd05622         194 KEGMV-RCDTAVGTPDYISPE  213 (371)
T ss_pred             cCCcc-cccCcccCccccCHH
Confidence            43221 123457999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.94  E-value=4.5e-26  Score=248.97  Aligned_cols=167  Identities=29%  Similarity=0.386  Sum_probs=146.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|++.+.||+|+||.||+|++..+++.||+|++...     ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            688999999999999999999999999999998653     234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++|+|.+++.+.    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus        82 ~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          82 YQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999998764    245788888999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .... ......||+.|+|||
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE  173 (330)
T cd05601         155 NKMV-NSKLPVGTPDYIAPE  173 (330)
T ss_pred             CCce-eeecccCCccccCHH
Confidence            3322 122346899999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=6.7e-26  Score=245.45  Aligned_cols=158  Identities=28%  Similarity=0.422  Sum_probs=137.7

Q ss_pred             ecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       684 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      ||+|+||.||+|++..+++.||+|++...     .....+.+|++++++++||||+++++++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999998542     2345678899999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      .+++...     ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~  150 (312)
T cd05585          81 FHHLQRE-----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KT  150 (312)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cc
Confidence            9998753     35788889999999999999999   78999999999999999999999999999975433221  12


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ....||+.|+|||
T Consensus       151 ~~~~gt~~y~aPE  163 (312)
T cd05585         151 NTFCGTPEYLAPE  163 (312)
T ss_pred             ccccCCcccCCHH
Confidence            3457999999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=9.4e-26  Score=245.78  Aligned_cols=160  Identities=31%  Similarity=0.402  Sum_probs=138.0

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      +.||+|+||.||+|++..+++.||+|++...     .....+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999999999999999998653     23455678999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      +|.+++...     ..+++..+..++.|++.||+|||   + .+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-  151 (325)
T cd05594          81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-  151 (325)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence            999888652     35788899999999999999999   5 6999999999999999999999999999875432221 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|||||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (325)
T cd05594         152 -TMKTFCGTPEYLAPE  166 (325)
T ss_pred             -ccccccCCcccCCHH
Confidence             123357999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.93  E-value=5.4e-26  Score=243.32  Aligned_cols=167  Identities=26%  Similarity=0.362  Sum_probs=143.0

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +++|+..+.||+|+||.||+|.+..++..||+|++...   .....+.+|++++++++||||+++++++..++..|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            45799999999999999999999999999999988643   234567799999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |++ ++|.+++...    ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        84 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          84 YLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             CCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            996 5998888653    234678888999999999999999   78999999999999999999999999999976543


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ......||+.|+|||
T Consensus       156 ~~~--~~~~~~~~~~y~aPE  173 (288)
T cd07871         156 PTK--TYSNEVVTLWYRPPD  173 (288)
T ss_pred             CCc--cccCceecccccChH
Confidence            221  122346899999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.93  E-value=6.5e-26  Score=250.69  Aligned_cols=145  Identities=28%  Similarity=0.405  Sum_probs=131.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|+..+.||+|+||.||+|++..+++.||||++...     .....+.+|++++..++||+|+++++++..++..|+|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            688899999999999999999999999999998643     234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |+++|+|.+++.+.     ..++...+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          82 FLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             CCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            99999999998753     35788888899999999999999   789999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.93  E-value=6.6e-26  Score=247.46  Aligned_cols=168  Identities=27%  Similarity=0.318  Sum_probs=145.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+.     .....+.+|+.+++.++|++|+++++++..++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3688999999999999999999999999999998542     23345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++.+.    ...+++..+..++.|++.||+|+|   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999763    235788888899999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...... .....||+.|+|||
T Consensus       154 ~~~~~~-~~~~~gt~~y~aPE  173 (331)
T cd05624         154 QDGTVQ-SSVAVGTPDYISPE  173 (331)
T ss_pred             CCCcee-eccccCCcccCCHH
Confidence            433221 22356999999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.93  E-value=3.6e-26  Score=250.71  Aligned_cols=173  Identities=30%  Similarity=0.398  Sum_probs=139.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeC-Ce
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKG-GS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  745 (851)
                      ++|++.+.||+|+||.||+|.+.     .++..||||++....   ..+.+.+|+++++.+ +||||+++++++... +.
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            36889999999999999999752     345679999986542   345688999999999 899999999987654 46


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhC---------------------------------------------------------
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKE---------------------------------------------------------  768 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------  768 (851)
                      .|+||||+++|+|.+++......                                                         
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            89999999999999999753210                                                         


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccc
Q 003065          769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI  848 (851)
Q Consensus       769 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~  848 (851)
                      ....+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++...............+++.||
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence            0134778888899999999999999   7899999999999999999999999999998664433222222345678899


Q ss_pred             cCC
Q 003065          849 APG  851 (851)
Q Consensus       849 APE  851 (851)
                      |||
T Consensus       244 aPE  246 (338)
T cd05102         244 APE  246 (338)
T ss_pred             CcH
Confidence            998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.93  E-value=6e-26  Score=245.04  Aligned_cols=173  Identities=27%  Similarity=0.350  Sum_probs=142.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC----------------CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK----------------NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKL  736 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l  736 (851)
                      .+|...+.||+|+||.||+|.+..                ++..||+|++....   ...++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            368889999999999999998632                33469999886542   34578899999999999999999


Q ss_pred             EEEEEeCCeeEEEEeccCCCCHHHHHHHhhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEE
Q 003065          737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKE--------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH  802 (851)
Q Consensus       737 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  802 (851)
                      ++++...+..++||||+++|+|.+++......              ....+++..+.+++.|++.|++|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            99999999999999999999999998754211              1134678888999999999999999   789999


Q ss_pred             eCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       803 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |||||+||+++.++.+||+|||+++...............++..|||||
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE  210 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE  210 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHH
Confidence            9999999999999999999999998654433222222334678899998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.93  E-value=3.6e-26  Score=239.05  Aligned_cols=163  Identities=28%  Similarity=0.397  Sum_probs=141.3

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      -..+.||.|.||.||-|+++++|+.||||++.+.    .....+++|+.+++.++||.||.+...|++.+..++|||-+ 
T Consensus       567 f~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-  645 (888)
T KOG4236|consen  567 FADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-  645 (888)
T ss_pred             hhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-
Confidence            3468899999999999999999999999998543    45677899999999999999999999999999999999999 


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC---CceEEeeecCccccCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKIADFGVAKIAEN  831 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~  831 (851)
                      .|+..+.+-..   ....++.....-++.||+.||+|||   .++|+|+|+||+|||+.+.   -++||||||.|+++++
T Consensus       646 ~GDMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  646 HGDMLEMILSS---EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             cchHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            56777777654   3456777777888899999999999   7899999999999999643   3799999999999987


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..-.   .+++|||.|.|||
T Consensus       720 ksFR---rsVVGTPAYLaPE  736 (888)
T KOG4236|consen  720 KSFR---RSVVGTPAYLAPE  736 (888)
T ss_pred             hhhh---hhhcCCccccCHH
Confidence            5432   3478999999998

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=4.8e-26  Score=233.78  Aligned_cols=146  Identities=29%  Similarity=0.368  Sum_probs=132.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +.|+..+.||.|.-|+||.|+.+.++..+|+|++.++     ....+.+.|.+||+.+.||.++.+|..|+.....|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            4678889999999999999999999999999999665     23456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      |||+||+|....+++   ....++...+.-++..|+-||+|||   -.|||+|||||+|||+.++|++.|+||.++.
T Consensus       157 eyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             ecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccc
Confidence            999999999888764   4556888888889999999999999   7899999999999999999999999999874

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-27  Score=267.25  Aligned_cols=167  Identities=30%  Similarity=0.360  Sum_probs=148.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecc-----cccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|++.++||+|+||.|..++++.+++.||+|++.+     ..+...|..|-.+|..-+.+.|+.++..|+++.+.|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            478999999999999999999999999999999865     345567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |||+||+|...+.+.    . .++...+.-++..|+-||.-+|   +.|+|||||||+|||+|..|++|++|||.+-.+.
T Consensus       155 dY~pGGDlltLlSk~----~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKF----D-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             ecccCchHHHHHhhc----C-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            999999999999874    1 4666666677889999999999   8999999999999999999999999999998887


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+..... ...+|||.|++||
T Consensus       227 ~dG~V~s-~~aVGTPDYISPE  246 (1317)
T KOG0612|consen  227 ADGTVRS-SVAVGTPDYISPE  246 (1317)
T ss_pred             CCCcEEe-ccccCCCCccCHH
Confidence            6655433 3458999999998

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=1.2e-25  Score=257.08  Aligned_cols=171  Identities=24%  Similarity=0.320  Sum_probs=145.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCC-CcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKN-AGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .|...+.||+|+||.||+|....+ +..||+|.+....  ....+.+|+++++.++|||||++++++..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            488899999999999999998777 6788998764432  3345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++|+|.+++..... ....+++..+..++.|++.||+|+|   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus       148 ~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        148 SGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            99999999876432 2345788888999999999999999   7899999999999999999999999999998765443


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ........+||+.|+|||
T Consensus       224 ~~~~~~~~~gt~~y~aPE  241 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPE  241 (478)
T ss_pred             ccccccccCCCccccCHh
Confidence            322234467999999998

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.93  E-value=1.3e-25  Score=242.28  Aligned_cols=166  Identities=28%  Similarity=0.356  Sum_probs=142.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++....   ....+.+|+++++.++||||+++++++..++..|+||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            47899999999999999999999899999999986432   234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++ +++.+++...    ...++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          85 VH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            95 6888887653    345778888999999999999999   789999999999999999999999999999754332


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ......||+.|+|||
T Consensus       157 ~~--~~~~~~~~~~y~aPE  173 (303)
T cd07869         157 SH--TYSNEVVTLWYRPPD  173 (303)
T ss_pred             Cc--cCCCCcccCCCCChH
Confidence            21  223356899999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.93  E-value=8.6e-27  Score=229.75  Aligned_cols=175  Identities=27%  Similarity=0.379  Sum_probs=146.6

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCc----EEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEe-C
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLK-G  743 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  743 (851)
                      +.+..|+....||+|.||.||+|..+.+..    .+|+|+++.+.    -....-+|+..++.++|||++.+..+|.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            345679999999999999999997655433    68999986652    23445799999999999999999998876 7


Q ss_pred             CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC----CceE
Q 003065          744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED----YEPK  819 (851)
Q Consensus       744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~----~~~k  819 (851)
                      ...|+++||.+. +|.+.++-+.......++......|+.||+.|+.|||   +.=|+|||+||+|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence            789999999964 9999998766555567888999999999999999999   7789999999999999876    8999


Q ss_pred             EeeecCccccCCCCCcc-cccccccccccccCC
Q 003065          820 IADFGVAKIAENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       820 l~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      |+|||+|+.+...-..- ....++-|.+|+|||
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE  209 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPE  209 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChH
Confidence            99999999887664332 334567899999998

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.93  E-value=1.5e-25  Score=244.81  Aligned_cols=167  Identities=28%  Similarity=0.336  Sum_probs=144.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|++.+.||+|+||.||++++..+++.||+|++.+.     .....+.+|+.++..++|++|+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            688899999999999999999999999999998542     223457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++|+|.+++.+.    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        82 y~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          82 YYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             ccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999763    235788888899999999999999   78999999999999999999999999999976543


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .... ......||+.|||||
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE  173 (332)
T cd05623         155 DGTV-QSSVAVGTPDYISPE  173 (332)
T ss_pred             CCcc-eecccccCccccCHH
Confidence            3221 122357999999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=7.2e-26  Score=249.65  Aligned_cols=167  Identities=31%  Similarity=0.437  Sum_probs=145.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            688999999999999999999989999999998643     344568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++++|.+++.+.     ..++...+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          82 YMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            99999999998763     45788889999999999999999   78999999999999999999999999999986654


Q ss_pred             CC---------------------------CcccccccccccccccCC
Q 003065          832 SP---------------------------KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~---------------------------~~~~~~~~~gt~~Y~APE  851 (851)
                      ..                           .........||+.|+|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  200 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE  200 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            32                           001122357999999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.93  E-value=2.2e-25  Score=242.84  Aligned_cols=165  Identities=30%  Similarity=0.401  Sum_probs=140.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCC-ccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHR-NILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  750 (851)
                      +|++.+.||+|+||.||+|++..+++.||||++.+.     ...+.+..|+++++.++|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            478889999999999999999999999999998643     3445678899999999765 5888999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05587          81 EYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI  152 (324)
T ss_pred             cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence            999999999988653     34778888999999999999999   7899999999999999999999999999987533


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  ......||+.|+|||
T Consensus       153 ~~~~--~~~~~~gt~~y~aPE  171 (324)
T cd05587         153 FGGK--TTRTFCGTPDYIAPE  171 (324)
T ss_pred             CCCC--ceeeecCCccccChh
Confidence            2211  123457999999998

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PLN03210 Resistant to P

Probab=99.93  E-value=7e-25  Score=273.79  Aligned_cols=338  Identities=20%  Similarity=0.261  Sum_probs=175.9

Q ss_pred             ccccCccccceeecccccCCC-----CCCcccccCCC-CCCeEecccccccccCCcccccccccCccccccccccccccc
Q 003065          162 RWVVNLTQLVSLSIGDNVYDE-----AEIPESIGNLK-NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPR  235 (851)
Q Consensus       162 ~~~~~l~~L~~L~L~~N~l~~-----~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~  235 (851)
                      ..|.++.+|+.|.+..+....     ..+|+.+..++ +|+.|++.++.+. .+|..| ...+|+.|++++|++. .++.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            345566666666665443210     23555555553 5777777777766 556665 3567777777777776 4566


Q ss_pred             cccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccc
Q 003065          236 SIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKL  315 (851)
Q Consensus       236 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  315 (851)
                      .+..+++|+.|+|++|.....+|. +..+++|+.|+|++|.....+|..+.++++|+.|++++|...+.+|..+ ++++|
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL  706 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL  706 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence            666777777777776654445553 6667777777777766555677777777777777777765444566544 56777


Q ss_pred             cEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCc-------cccccccccCccccc
Q 003065          316 FAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF-------SGEVPNSYADCKTIQ  388 (851)
Q Consensus       316 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~-------~~~~p~~~~~l~~L~  388 (851)
                      +.|++++|.....+|..   ..+|+.|++++|.+. .+|..+ .+++|.+|.+..+..       ....|..+...++|+
T Consensus       707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~  781 (1153)
T PLN03210        707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT  781 (1153)
T ss_pred             CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccch
Confidence            77777776655455543   345667777777665 444432 233333333332111       111111122223455


Q ss_pred             eeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCcc
Q 003065          389 RLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNN  468 (851)
Q Consensus       389 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  468 (851)
                      .|+|++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|+.|+|++|.....+|..   ..+|+.|+|++|.
T Consensus       782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~  857 (1153)
T PLN03210        782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTG  857 (1153)
T ss_pred             heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCC
Confidence            55555554444445444445555555554443222233322 3444444444444322222221   1334444444444


Q ss_pred             ccCCCccccccCCcccEEEecCC-cccCCCCCCcccccccceeeccCc
Q 003065          469 FSGKIPSALGALRQLSSLHLEEN-ALTGSIPNEMGDCARIVDLNLARN  515 (851)
Q Consensus       469 l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N  515 (851)
                      ++ .+|.++..+++|+.|+|++| +++ .+|..+..++.|+.++++++
T Consensus       858 i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        858 IE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             Cc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence            43 33444444444444444442 232 23333444444444444433

syringae 6; Provisional

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.93  E-value=2.1e-25  Score=241.83  Aligned_cols=160  Identities=34%  Similarity=0.488  Sum_probs=135.6

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|++..+++.||||++...     ...+.+..|.+++... +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999998643     2334556677777654 899999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+....... 
T Consensus        81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-  151 (316)
T cd05592          81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-  151 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-
Confidence            9999888653     35788888899999999999999   78999999999999999999999999999976433221 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (316)
T cd05592         152 -KASTFCGTPDYIAPE  166 (316)
T ss_pred             -ccccccCCccccCHH
Confidence             223457999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.93  E-value=2.2e-25  Score=243.17  Aligned_cols=160  Identities=28%  Similarity=0.447  Sum_probs=138.1

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|++..+++.||||++.+.     ...+.+.+|..+++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999999999999999998653     2345578899999998 799999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++.+.     ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-  151 (329)
T cd05588          81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-  151 (329)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence            9999888652     35888999999999999999999   78999999999999999999999999999975322211 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (329)
T cd05588         152 -TTSTFCGTPNYIAPE  166 (329)
T ss_pred             -ccccccCCccccCHH
Confidence             123357999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.93  E-value=1.9e-25  Score=243.30  Aligned_cols=163  Identities=33%  Similarity=0.484  Sum_probs=138.4

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHH---HcCCCCccccEEEEEEeCCeeEEE
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEIL---GKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      |++.+.||+|+||.||+|.+..+++.||||++.+.     ...+.+.+|++++   +.++||||+++++++..++..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56788999999999999999999999999998643     2334566776665   466899999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|..++.+      ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            999999999887753      35888999999999999999999   789999999999999999999999999998754


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  ......||+.|||||
T Consensus       152 ~~~~~--~~~~~~g~~~y~aPE  171 (324)
T cd05589         152 MGFGD--RTSTFCGTPEFLAPE  171 (324)
T ss_pred             CCCCC--cccccccCccccCHh
Confidence            32221  223467999999998

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=8.4e-28  Score=244.40  Aligned_cols=276  Identities=20%  Similarity=0.189  Sum_probs=223.1

Q ss_pred             CceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEeccc-CcccCCCCC-CCCCCCCCeEe
Q 003065           73 GRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTG-NAMVGSVPD-LSALKNLEIFD  150 (851)
Q Consensus        73 ~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-n~l~~~~~~-l~~l~~L~~L~  150 (851)
                      ...++|+|..|+|+..-+.+|+.++.|++||||+|+|+..-|++|..+.+|..|-+-+ |+|+..+.. |++|..|+.|.
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            5689999999999965567999999999999999999999999999999988887766 999988877 99999999999


Q ss_pred             ccCcccCCCCcccccCccccceeecccccCCCCCCcc-cccCCCCCCeEeccccc------------ccccCCccccccc
Q 003065          151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFLAHCN------------LRGRIPESISELR  217 (851)
Q Consensus       151 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~-~~~~l~~L~~L~L~~n~------------l~~~~p~~~~~l~  217 (851)
                      +.-|++.-+..+.|..|++|..|.+.+|.+.  .++. .|..+.+++.+.+..|.            +....|..++...
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q--~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgar  224 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQ--SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGAR  224 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhh--hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccce
Confidence            9999999888999999999999999999997  5666 78899999999999888            3334455556666


Q ss_pred             ccCccccccccccccccccccC-CCcccEEEeeccCccCcCC-cCcCCCCcccEEecccccccCCCCccccCcCCccEEE
Q 003065          218 ELGTLDICRNKISGEFPRSIRK-LQKLWKIELYANNLTGELP-AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQ  295 (851)
Q Consensus       218 ~L~~L~L~~N~i~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  295 (851)
                      -..-..+.++++..+-+..|.. +.++..=-.+.....+..| ..|..+++|+.|+|++|+++++-+.+|..+..++.|.
T Consensus       225 c~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~  304 (498)
T KOG4237|consen  225 CVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELY  304 (498)
T ss_pred             ecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhh
Confidence            6666666667766544444432 2222221223333444555 4588899999999999999988888999999999999


Q ss_pred             ccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCccc
Q 003065          296 CFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS  350 (851)
Q Consensus       296 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  350 (851)
                      |..|++...-...|.++..|++|+|++|+|+...|.+|..+.+|.+|+|-.|.+.
T Consensus       305 L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  305 LTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             cCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            9999988665567889999999999999999999999999999999999888775

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=229.57  Aligned_cols=168  Identities=30%  Similarity=0.370  Sum_probs=146.2

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+++|+..++||+|.||+|..|+.+.+++.||+|+++++     ++...-..|-++++..+||.+..+-..|+.+++.|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            456899999999999999999999999999999998765     233445679999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+.||.|+-++.+.     ..++.....-+...|+.||.|||   +++||.||+|.+|.|+|.+|++||+|||+++.
T Consensus       246 VMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             EEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh
Confidence            99999999998888753     35666667778889999999999   78999999999999999999999999999985


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      --..  ...+.+++|||.|.|||
T Consensus       318 ~I~~--g~t~kTFCGTPEYLAPE  338 (516)
T KOG0690|consen  318 EIKY--GDTTKTFCGTPEYLAPE  338 (516)
T ss_pred             cccc--cceeccccCChhhcCch
Confidence            3322  22345689999999998

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=2.6e-25  Score=247.33  Aligned_cols=162  Identities=25%  Similarity=0.318  Sum_probs=140.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      .+|++.+.||+|+||.||+|.+..+++.||+|+..    .+.+.+|++++++++||||+++++++..++..++|+|++ +
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-K  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-C
Confidence            47999999999999999999999999999999753    245678999999999999999999999999999999999 4


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++...     ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+....... 
T Consensus       167 ~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        167 TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            7898887653     35788889999999999999999   78999999999999999999999999999975432211 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                      .......||+.|+|||
T Consensus       238 ~~~~~~~gt~~y~aPE  253 (391)
T PHA03212        238 NKYYGWAGTIATNAPE  253 (391)
T ss_pred             cccccccCccCCCChh
Confidence            1223457999999998

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.93  E-value=2.7e-25  Score=241.49  Aligned_cols=160  Identities=35%  Similarity=0.501  Sum_probs=137.3

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|+++.+++.||||++.+.     ...+.+..|.++++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999999999999999998643     2345667888888876 699999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-  151 (320)
T cd05590          81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-  151 (320)
T ss_pred             chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence            9999888753     35788889999999999999999   78999999999999999999999999999875432221 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (320)
T cd05590         152 -TTSTFCGTPDYIAPE  166 (320)
T ss_pred             -cccccccCccccCHH
Confidence             123357999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.93  E-value=2.7e-25  Score=260.32  Aligned_cols=173  Identities=26%  Similarity=0.308  Sum_probs=144.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|++.+.||+|+||.||+|++..+++.||||++...     ...+++.+|++++++++||||+++++++.+++..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            5789999999999999999999999999999998643     12456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          751 EYMPNGNLFQALHKRVKE------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      ||++||+|.+++......      .....++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998753211      1223567778899999999999999   7899999999999999999999999999


Q ss_pred             CccccCCCCC----------------cccccccccccccccCC
Q 003065          825 VAKIAENSPK----------------VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~----------------~~~~~~~~gt~~Y~APE  851 (851)
                      +|+.......                .......+||+.|||||
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE  201 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE  201 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHH
Confidence            9986621110                01112357999999998

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=244.39  Aligned_cols=164  Identities=29%  Similarity=0.447  Sum_probs=137.3

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCc---E-EEEEEecc-----cccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAG---T-VAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~---~-vavK~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ...+.||+|+||+||+|+.+..+.   . ||||..+.     ....+++.+|+++|+.++|||||++||+.......|+|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            445899999999999999876533   3 89998764     24567899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ||+|.||+|.+++++.    ...++..++.+++.++|+||+|||   +++++||||.++|+|++.++.+||+|||+++..
T Consensus       240 mEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            9999999999999874    226899999999999999999999   889999999999999999999999999998755


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  ..-.-...|+|||
T Consensus       313 ~~~~~~~--~~~klPirWLAPE  332 (474)
T KOG0194|consen  313 SQYVMKK--FLKKLPIRWLAPE  332 (474)
T ss_pred             cceeecc--ccccCcceecChh
Confidence            3111110  0011246899998

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.93  E-value=3.5e-25  Score=241.06  Aligned_cols=160  Identities=34%  Similarity=0.460  Sum_probs=134.7

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHH-HHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEME-ILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||+||+|++..+++.||||++...     ...+.+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999999999999999998643     22334555555 46789999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  151 (323)
T cd05575          81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-  151 (323)
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-
Confidence            9999988752     35788888899999999999999   78999999999999999999999999999975432221 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (323)
T cd05575         152 -TTSTFCGTPEYLAPE  166 (323)
T ss_pred             -ccccccCChhhcChh
Confidence             223357999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.1e-27  Score=250.55  Aligned_cols=166  Identities=27%  Similarity=0.383  Sum_probs=145.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .|.+...||.|+||+||+|+.+.++...|.|++...  ...+++.-||+|+..+.||+||++++.|...+..|++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            467888899999999999999988888888988543  556789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      ||-+...+-+.    ...+...++..+++|+++||.|||   ++.|||||+|+.|||++-+|.++++|||.+......  
T Consensus       113 GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--  183 (1187)
T KOG0579|consen  113 GGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--  183 (1187)
T ss_pred             CchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--
Confidence            99998887764    456888999999999999999999   889999999999999999999999999987543322  


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .....+++|||+|||||
T Consensus       184 ~qkRDsFIGTPYWMAPE  200 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPE  200 (1187)
T ss_pred             HhhhccccCCcccccch
Confidence            22234589999999998

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.93  E-value=2.8e-25  Score=241.61  Aligned_cols=160  Identities=33%  Similarity=0.471  Sum_probs=137.0

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|++..+++.||||++...     ...+.+..|.++++.+ +||+|+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4689999999999999999999999998643     2345577899998866 799999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-  151 (321)
T cd05591          81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-  151 (321)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence            9999888653     35788888899999999999999   78999999999999999999999999999975433222 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (321)
T cd05591         152 -TTTTFCGTPDYIAPE  166 (321)
T ss_pred             -cccccccCccccCHH
Confidence             123357999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.93  E-value=3e-25  Score=242.73  Aligned_cols=166  Identities=27%  Similarity=0.359  Sum_probs=141.1

Q ss_pred             CCccCCeecccCcEEEEEEEEc---CCCcEEEEEEeccc------ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      +|++.+.||+|+||.||+|+..   .+++.||+|++.+.      ...+.+.+|+++++.+ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788899999999999998864   46788999998542      2245577899999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+++|+|.+++..+     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~  152 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLS  152 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence            9999999999999998753     35788888999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +........ ......||+.|||||
T Consensus       153 ~~~~~~~~~-~~~~~~gt~~y~aPE  176 (332)
T cd05614         153 KEFLSEEKE-RTYSFCGTIEYMAPE  176 (332)
T ss_pred             ccccccCCC-ccccccCCccccCHH
Confidence            865433222 123457999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=1.4e-25  Score=241.96  Aligned_cols=166  Identities=30%  Similarity=0.432  Sum_probs=146.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +..|.+.+.||+|.|+.|..|++..++..||||.+.+..    ....+.+|+++|+.++|||||+++.+.+.....|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            457899999999999999999999999999999987652    2344789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+.+|.+++++.++..     ........+..|+.+|++|+|   ++.|||||||++|||++.+.++||+|||++..+.
T Consensus       135 eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec
Confidence            99999999999987632     233566678899999999999   8899999999999999999999999999999887


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   .+++|++.|.|||
T Consensus       207 ~~~~l---qt~cgsppyAaPE  224 (596)
T KOG0586|consen  207 YGLML---QTFCGSPPYAAPE  224 (596)
T ss_pred             ccccc---cccCCCCCccChH
Confidence            55433   3478999999998

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.93  E-value=3.7e-25  Score=241.22  Aligned_cols=160  Identities=29%  Similarity=0.452  Sum_probs=137.2

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|++..+++.||+|++.+.     ...+.+.+|+.++.++ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999998653     2334577899888776 899999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-  151 (329)
T cd05618          81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-  151 (329)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence            9998887652     35788889999999999999999   78999999999999999999999999999975432211 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (329)
T cd05618         152 -TTSTFCGTPNYIAPE  166 (329)
T ss_pred             -ccccccCCccccCHH
Confidence             123357999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=4.2e-25  Score=240.36  Aligned_cols=160  Identities=31%  Similarity=0.452  Sum_probs=135.7

Q ss_pred             CeecccCcEEEEEEEEc---CCCcEEEEEEeccc------ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          682 NLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +.||+|+||.||+|+..   .+++.||||++...      .....+.+|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999864   46788999998643      2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++...     ..+.+..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            9999999988753     34677778889999999999999   789999999999999999999999999998754332


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ......||+.|+|||
T Consensus       154 ~~--~~~~~~gt~~y~aPE  170 (323)
T cd05584         154 GT--VTHTFCGTIEYMAPE  170 (323)
T ss_pred             CC--cccccCCCccccChh
Confidence            22  122357999999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=4.5e-26  Score=225.34  Aligned_cols=163  Identities=25%  Similarity=0.354  Sum_probs=139.9

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEeccCCCC
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEYMPNGN  757 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  757 (851)
                      .+.||+|+|+.|..|+...++..||||++.+.  ....++.+|++++..++ |+||++++++|+++..+|+|||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            46799999999999999999999999999765  34677889999999985 9999999999999999999999999999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC---ceEEeeecCccccCCCC-
Q 003065          758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---EPKIADFGVAKIAENSP-  833 (851)
Q Consensus       758 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~-  833 (851)
                      |..+++++     ..+.+..+-++..+|+.||.|||   .+||.|||+||+|||..+..   .+|||||.++.-+.... 
T Consensus       163 lLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  163 LLSHIQKR-----KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             HHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            99999875     35778888899999999999999   89999999999999997543   58999999875433221 


Q ss_pred             ----CcccccccccccccccCC
Q 003065          834 ----KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ----~~~~~~~~~gt~~Y~APE  851 (851)
                          ......+.+|+..|||||
T Consensus       235 ~spastP~L~tPvGSAEfMAPE  256 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPE  256 (463)
T ss_pred             CCCCCCccccCcccchhhcchh
Confidence                112234568999999998

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.93  E-value=3.2e-25  Score=241.34  Aligned_cols=165  Identities=30%  Similarity=0.398  Sum_probs=140.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +|.+.+.||+|+||.||+|++..+++.||||++.+.     ...+.+..|.+++..+ +|++|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            478889999999999999999999999999998643     2234566788888777 5899999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            999999999888653     34788889999999999999999   7899999999999999999999999999997543


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  ......||+.|+|||
T Consensus       153 ~~~~--~~~~~~gt~~y~aPE  171 (323)
T cd05616         153 WDGV--TTKTFCGTPDYIAPE  171 (323)
T ss_pred             CCCC--ccccCCCChhhcCHH
Confidence            2221  123457999999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.93  E-value=3.4e-25  Score=241.03  Aligned_cols=165  Identities=28%  Similarity=0.388  Sum_probs=140.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +|+..+.||+|+||.||+|+++.+++.||||++.+.     ...+.+..|.++++.+. |++|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            367789999999999999999999999999998643     23455778999998885 577888999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        81 Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          81 EYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            999999999988653     35788999999999999999999   7899999999999999999999999999997543


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  ......||+.|+|||
T Consensus       153 ~~~~--~~~~~~gt~~y~aPE  171 (323)
T cd05615         153 VDGV--TTRTFCGTPDYIAPE  171 (323)
T ss_pred             CCCc--cccCccCCccccCHH
Confidence            3221  123356999999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.93  E-value=3.9e-25  Score=240.53  Aligned_cols=160  Identities=33%  Similarity=0.444  Sum_probs=134.1

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHH-HHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEME-ILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|++..+++.||+|++.+.     .....+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999998543     22334555554 57889999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  151 (321)
T cd05603          81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-  151 (321)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-
Confidence            9998887642     35677788889999999999999   78999999999999999999999999999875432221 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (321)
T cd05603         152 -TTSTFCGTPEYLAPE  166 (321)
T ss_pred             -ccccccCCcccCCHH
Confidence             223457999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.93  E-value=2.2e-25  Score=247.37  Aligned_cols=173  Identities=29%  Similarity=0.405  Sum_probs=142.0

Q ss_pred             cCCccCCeecccCcEEEEEEEE-----cCCCcEEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      .+|++.+.||+|+||.||+|++     ..++..||||++...   ...+.+.+|+++++.+ +||||+++++++..++..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            3688999999999999999974     345668999998643   2345688999999999 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhh-----------------------------------------------------------
Q 003065          747 FLVLEYMPNGNLFQALHKRVK-----------------------------------------------------------  767 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  767 (851)
                      |+||||+++|+|.++++....                                                           
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            999999999999999975321                                                           


Q ss_pred             -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc
Q 003065          768 -----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       768 -----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  836 (851)
                                 .....+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                       01124788889999999999999999   7899999999999999999999999999998765433222


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      ......++..|+|||
T Consensus       272 ~~~~~~~~~~y~aPE  286 (375)
T cd05104         272 VKGNARLPVKWMAPE  286 (375)
T ss_pred             ccCCCCCCcceeChh
Confidence            222234567899998

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.93  E-value=4.1e-25  Score=240.74  Aligned_cols=160  Identities=31%  Similarity=0.437  Sum_probs=134.8

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHH-HHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEME-ILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||+||+|++..+++.||||++...     ...+.+.+|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4689999999999999999999999998643     22344555655 46779999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  151 (325)
T cd05604          81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-  151 (325)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence            9998887642     35788889999999999999999   78999999999999999999999999999875432211 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|||||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (325)
T cd05604         152 -TTTTFCGTPEYLAPE  166 (325)
T ss_pred             -CcccccCChhhCCHH
Confidence             123457999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.93  E-value=3.5e-25  Score=235.95  Aligned_cols=162  Identities=30%  Similarity=0.400  Sum_probs=139.1

Q ss_pred             ecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       684 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      ||+|+||+||+|++..+++.||+|++....     ..+.+..|+++++.++||||+++.+++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999999999999999985432     235567899999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      .+++.... .....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++........  .
T Consensus        81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~  154 (280)
T cd05608          81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--T  154 (280)
T ss_pred             HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--c
Confidence            98876432 23456889999999999999999999   789999999999999999999999999999766543221  2


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ....||+.|+|||
T Consensus       155 ~~~~g~~~y~aPE  167 (280)
T cd05608         155 KGYAGTPGFMAPE  167 (280)
T ss_pred             cccCCCcCccCHH
Confidence            3357899999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.93  E-value=2.4e-25  Score=246.69  Aligned_cols=173  Identities=29%  Similarity=0.402  Sum_probs=141.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC-----CcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      ++|++.+.||+|+||.||+|++...     +..||||++....   ..+.+.+|+++++.+ +|+|||++++++..++..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            4788999999999999999986433     3579999986542   345678999999999 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhh-----------------------------------------------------------
Q 003065          747 FLVLEYMPNGNLFQALHKRVK-----------------------------------------------------------  767 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  767 (851)
                      |+||||+++|+|.+++.....                                                           
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            999999999999999875321                                                           


Q ss_pred             ------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCccccccc
Q 003065          768 ------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF  841 (851)
Q Consensus       768 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  841 (851)
                            .....+++..+.+++.|++.|++|||   +++|+||||||+||++++++.+||+|||+++..............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                  01124678888999999999999999   789999999999999999999999999999866443222222223


Q ss_pred             ccccccccCC
Q 003065          842 AGTHGYIAPG  851 (851)
Q Consensus       842 ~gt~~Y~APE  851 (851)
                      .+++.|||||
T Consensus       275 ~~~~~y~aPE  284 (374)
T cd05106         275 RLPVKWMAPE  284 (374)
T ss_pred             CCccceeCHH
Confidence            4567899998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=4.5e-25  Score=235.82  Aligned_cols=166  Identities=30%  Similarity=0.387  Sum_probs=143.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .|+..+.||+|+||.||++.+..+++.||||++....     ....+.+|++++++++||||+++++++.+++..|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3778899999999999999998899999999985432     23456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++|+|.+++...   ....+++..+..++.|++.|++|||   +.+++||||||+||++++++.++|+|||+++....
T Consensus        81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            99999999888653   2345888999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...   .....|++.|+|||
T Consensus       155 ~~~---~~~~~~~~~y~aPE  171 (285)
T cd05605         155 GET---IRGRVGTVGYMAPE  171 (285)
T ss_pred             CCc---cccccCCCCccCcH
Confidence            322   12346899999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.93  E-value=5.8e-25  Score=240.12  Aligned_cols=165  Identities=27%  Similarity=0.398  Sum_probs=144.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ++|+..+.||+|+||.||+|++..++..||+|.+....   ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            47899999999999999999999999999999886542   345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++|+|.+++...     ..+++..+..++.|++.|+.|||+  ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          85 MDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            9999999998753     347888889999999999999993  236999999999999999999999999999765432


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      .    .....||+.|+|||
T Consensus       158 ~----~~~~~g~~~y~aPE  172 (331)
T cd06649         158 M----ANSFVGTRSYMSPE  172 (331)
T ss_pred             c----cccCCCCcCcCCHh
Confidence            2    12356999999998

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.93  E-value=5.1e-25  Score=238.81  Aligned_cols=160  Identities=34%  Similarity=0.502  Sum_probs=136.3

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|+++.+++.||+|++...     ...+....|.+++... +||+|+++++++.+++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999999999999999998653     2345567788888764 899999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  151 (316)
T cd05620          81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-  151 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-
Confidence            9999988653     35788888899999999999999   78999999999999999999999999999875322211 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (316)
T cd05620         152 -RASTFCGTPDYIAPE  166 (316)
T ss_pred             -ceeccCCCcCccCHH
Confidence             223457999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=4.5e-25  Score=239.75  Aligned_cols=160  Identities=32%  Similarity=0.428  Sum_probs=137.7

Q ss_pred             CeecccCcEEEEEEEEc---CCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          682 NLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      +.||+|+||.||++++.   .+++.||+|++....    ....+.+|++++++++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            67999999999998863   578899999986532    34456789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            99999988652     35788999999999999999999   78999999999999999999999999999986544322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                        ......||+.|+|||
T Consensus       154 --~~~~~~g~~~y~aPE  168 (318)
T cd05582         154 --KAYSFCGTVEYMAPE  168 (318)
T ss_pred             --ceecccCChhhcCHH
Confidence              223457999999998

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=5.8e-26  Score=206.66  Aligned_cols=165  Identities=27%  Similarity=0.378  Sum_probs=142.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..++||+|.||+||+|+.+++++.||+|.++-.+    ......+|+-+++.++|+|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            5677889999999999999999999999999986442    245678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      |. .+|..+....    ...++......++.|+++|+.|+|   ++.+.|||+||.|.+|+.+|++|++|||+|+..+-+
T Consensus        83 cd-qdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   83 CD-QDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             hh-HHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            94 5777776653    556888888999999999999999   889999999999999999999999999999977654


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      .  .-++..+-|.+|++|.
T Consensus       155 v--rcysaevvtlwyrppd  171 (292)
T KOG0662|consen  155 V--RCYSAEVVTLWYRPPD  171 (292)
T ss_pred             e--EeeeceeeeeeccCcc
Confidence            2  2234446789999984

>PLN03210 Resistant to P

Probab=99.93  E-value=8e-25  Score=273.27  Aligned_cols=336  Identities=22%  Similarity=0.304  Sum_probs=199.0

Q ss_pred             ccccccccCcccccccc------ccccccccccCCC-cccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCcc
Q 003065          212 SISELRELGTLDICRNK------ISGEFPRSIRKLQ-KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEE  284 (851)
Q Consensus       212 ~~~~l~~L~~L~L~~N~------i~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  284 (851)
                      +|.++++|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|+.|++++|++. .++..
T Consensus       553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~  629 (1153)
T PLN03210        553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG  629 (1153)
T ss_pred             HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence            34444555554443332      2223344444432 3555555555554 444444 3455555555555554 34444


Q ss_pred             ccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchH
Q 003065          285 IGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLL  364 (851)
Q Consensus       285 l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~  364 (851)
                      +..+++|+.|+++++.....+|. ++.+++|+.|++++|.....+|..+..+++|+.|++++|..-+.+|..+ ++++|+
T Consensus       630 ~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~  707 (1153)
T PLN03210        630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY  707 (1153)
T ss_pred             cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence            55555555555555443334442 4555555555555554444555555555555555555543333444433 444555


Q ss_pred             HHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcC-------CCCCCcccccCCCCCe
Q 003065          365 NLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDF-------TGGISPLIGLSTSLSQ  437 (851)
Q Consensus       365 ~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-------~~~~~~~~~~~~~L~~  437 (851)
                      .|.+.+|...+.+|..   .++|++|+|++|.+. .+|..+ .+++|+.|++.++..       ....+..+...++|+.
T Consensus       708 ~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~  782 (1153)
T PLN03210        708 RLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR  782 (1153)
T ss_pred             EEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchh
Confidence            5555555444444432   346777778877776 566554 467777777766322       1222223334567888


Q ss_pred             EecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCccc
Q 003065          438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSL  517 (851)
Q Consensus       438 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  517 (851)
                      |+|++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|+.|+|++|.....+|..   ..+|+.|+|++|.+
T Consensus       783 L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i  858 (1153)
T PLN03210        783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGI  858 (1153)
T ss_pred             eeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCC
Confidence            8888887777788888888888888888876555666655 6778888888887544455543   35677888888888


Q ss_pred             ccccCCCccccccCCeEeCCC-CccccccCcccccc-cceEEeCcCCc
Q 003065          518 SGNIPRSLSLLSSLNALNLSG-NKLTGSIPDNLMKL-KLSSIDLSENQ  563 (851)
Q Consensus       518 ~~~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~l~~l-~L~~l~ls~N~  563 (851)
                      + .+|.++..+++|+.|+|++ |+|. .+|.....+ .|+.++++++.
T Consensus       859 ~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        859 E-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             c-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            7 6777888888888888887 4565 577777666 77888877764

syringae 6; Provisional

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.92  E-value=6.3e-25  Score=238.00  Aligned_cols=160  Identities=34%  Similarity=0.497  Sum_probs=136.3

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||+||+|++..+++.||||++...     ...+.+..|..+++.. +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4689999999999999999999999998653     2345566788888764 899999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  151 (316)
T cd05619          81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-  151 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence            9999988753     35778888899999999999999   78999999999999999999999999999875432211 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (316)
T cd05619         152 -KTCTFCGTPDYIAPE  166 (316)
T ss_pred             -ceeeecCCccccCHH
Confidence             123357999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.92  E-value=5.4e-25  Score=239.87  Aligned_cols=160  Identities=30%  Similarity=0.450  Sum_probs=138.1

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||+||+|++..+++.||+|++.+.     ...+.+.+|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999998653     2345578899999888 699999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  151 (327)
T cd05617          81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-  151 (327)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence            9999888652     35888999999999999999999   78999999999999999999999999999975332211 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       .....+||+.|+|||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (327)
T cd05617         152 -TTSTFCGTPNYIAPE  166 (327)
T ss_pred             -ceecccCCcccCCHH
Confidence             123457999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.92  E-value=2.5e-25  Score=245.25  Aligned_cols=163  Identities=33%  Similarity=0.486  Sum_probs=139.3

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ..+|+..+.||+|+||.||+|++..+++.||||++....   ..+.+.+|+++++.++|+||+++++++..++..|+|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            346778899999999999999999899999999985442   24568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++|+|.+.         .......+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       153 ~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        153 FMDGGSLEGT---------HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             cCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            9999988542         12455667789999999999999   78999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ......||..|+|||
T Consensus       221 ~~~--~~~~~~gt~~y~aPE  238 (353)
T PLN00034        221 TMD--PCNSSVGTIAYMSPE  238 (353)
T ss_pred             ccc--cccccccCccccCcc
Confidence            321  123357999999998

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=7.2e-26  Score=244.39  Aligned_cols=163  Identities=27%  Similarity=0.441  Sum_probs=140.9

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEe------cccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCe--eEEEE
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL------WKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGS--SFLVL  750 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  750 (851)
                      +..++||+|+|-+||+|.+..+|..||.-.+      +.....++|..|+++|+.|+|||||++|++|.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4567899999999999999999998886544      233455789999999999999999999999987655  67899


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC-CCCceEEeeecCcccc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIA  829 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~  829 (851)
                      |.+..|+|.+|.+++     ...+......+++||++||.|||.+ .++|||||||.+||+|+ ..|.+||+|.|+|+..
T Consensus       123 EL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             ecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            999999999999886     3467778889999999999999987 78999999999999997 5689999999999987


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....    ..++|||.|||||
T Consensus       197 r~s~a----ksvIGTPEFMAPE  214 (632)
T KOG0584|consen  197 RKSHA----KSVIGTPEFMAPE  214 (632)
T ss_pred             hcccc----ceeccCccccChH
Confidence            65432    3378999999998

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.92  E-value=7.8e-25  Score=239.16  Aligned_cols=165  Identities=28%  Similarity=0.422  Sum_probs=143.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ++|+..+.||+|+||.||+|++..++..+|+|.+...   ...+.+.+|++++++++||||+++++++..++..|+||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            4789999999999999999999989999999988654   2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++|+|.+++...     ..+++.....++.|++.|+.|||+  ..+|+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          85 MDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            9999999998753     347788888999999999999993  247999999999999999999999999999765432


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      .    .....||+.|+|||
T Consensus       158 ~----~~~~~~~~~y~aPE  172 (333)
T cd06650         158 M----ANSFVGTRSYMSPE  172 (333)
T ss_pred             c----cccCCCCccccCHH
Confidence            1    12346899999998

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.92  E-value=6.2e-26  Score=248.39  Aligned_cols=166  Identities=30%  Similarity=0.532  Sum_probs=146.0

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCc---EEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .++.++||.|.||+||+|..+..++   .||||.++..   ....+|..|+.||.++.||||+++.|+.......++|+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            4678999999999999999986664   4999999765   456679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      ||++|+|..|++.+    +..+.+.+...+.++||.||+||-   +.++|||||.++|||++.+..+|++|||+++...+
T Consensus       711 yMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  711 YMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            99999999999875    456899999999999999999999   89999999999999999999999999999998876


Q ss_pred             CCCcccccccccc--cccccCC
Q 003065          832 SPKVSDYSCFAGT--HGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt--~~Y~APE  851 (851)
                      +. ...+++..|.  .+|.|||
T Consensus       784 d~-~~~ytt~GGKIPiRWTAPE  804 (996)
T KOG0196|consen  784 DP-EAAYTTLGGKIPIRWTAPE  804 (996)
T ss_pred             CC-CccccccCCccceeecChh
Confidence            65 3334444443  5799998

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-25  Score=252.71  Aligned_cols=171  Identities=26%  Similarity=0.416  Sum_probs=140.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCC-CCccccEEEE-EEe------CCee
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIR-HRNILKLYAC-LLK------GGSS  746 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~~  746 (851)
                      ++++.+.|.+|||+.||.|++...+..||+|++...  ...+.+.+||++|+.|+ |+|||.+++. ...      .-++
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            456789999999999999999888899999987544  44567889999999996 9999999993 221      1356


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      ++.||||+||.|-|++..+..   ..+.+..+++|+.++++|+.+||.. +++|||||||-+||||..+|+.||||||.|
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            899999999999999998743   3489999999999999999999965 788999999999999999999999999999


Q ss_pred             cccCCCCCcc-------cccccccccccccCC
Q 003065          827 KIAENSPKVS-------DYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~-------~~~~~~gt~~Y~APE  851 (851)
                      ...-......       .......|+.|+|||
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPE  225 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPE  225 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChH
Confidence            7543322110       001123699999998

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=4.6e-25  Score=252.22  Aligned_cols=172  Identities=28%  Similarity=0.287  Sum_probs=144.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC-------
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG-------  744 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  744 (851)
                      .+|.+.+.||+|+||.||+|++..+++.||||++...    .....+.+|+.++..++|+||+++++.+...+       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            4899999999999999999999999999999998543    23456788999999999999999988765432       


Q ss_pred             -eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          745 -SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       745 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                       ..++||||+++|+|.+++..+.. ....+++..+..++.|++.||+|+|   +++|+||||||+||+++.++.+||+||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEec
Confidence             36899999999999999976532 2346888889999999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++...............||+.|+|||
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE  215 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPE  215 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHH
Confidence            9998765432222233467999999998

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.92  E-value=4.4e-25  Score=236.20  Aligned_cols=166  Identities=24%  Similarity=0.388  Sum_probs=141.2

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|++.+.||+|+||.||+|+++.+++.||||++...    ...+.+.+|++++++++||||+++++++..++..|+||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            688999999999999999999999999999998643    2345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++++.+..+ ...    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~~~~~l~~~-~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          82 VEKNMLELL-EEM----PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             CCCCHHHHH-Hhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            988766543 321    235788889999999999999999   789999999999999999999999999999876433


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ... ......||+.|+|||
T Consensus       154 ~~~-~~~~~~~~~~y~aPE  171 (287)
T cd07848         154 SNA-NYTEYVATRWYRSPE  171 (287)
T ss_pred             ccc-cccccccccccCCcH
Confidence            221 223357899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.92  E-value=7.6e-25  Score=238.66  Aligned_cols=160  Identities=32%  Similarity=0.424  Sum_probs=133.2

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHH-HHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEME-ILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|++..+++.||+|++...     .....+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4689999999999999999999999998643     12233444444 56788999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+.......++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+....... 
T Consensus        81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-  151 (325)
T cd05602          81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-  151 (325)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence            9999988753     34667778889999999999999   78999999999999999999999999999975432221 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|||||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (325)
T cd05602         152 -TTSTFCGTPEYLAPE  166 (325)
T ss_pred             -CcccccCCccccCHH
Confidence             223457999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.92  E-value=5e-25  Score=241.72  Aligned_cols=166  Identities=25%  Similarity=0.404  Sum_probs=139.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC-----CeeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  747 (851)
                      +|++.+.||+|+||.||+|++..+++.||||++...    .....+.+|++++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478889999999999999999999999999988542    2345688999999999999999999987543     2479


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||++ ++|.+++...     ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence            9999994 7898888642     35788999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCC-cccccccccccccccCC
Q 003065          828 IAENSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      ....... ........||+.|+|||
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE  176 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPE  176 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHH
Confidence            6533221 11223457999999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.92  E-value=6.2e-26  Score=234.39  Aligned_cols=167  Identities=29%  Similarity=0.388  Sum_probs=148.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +.|..-++||+|+||+||-|+.+.+|+-||.|++.++     .+......|..++++++.+.||.+-..|++.+..++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            4577788999999999999999999999999987443     44555678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ..|.||+|.-+|...   +.+.++...+.-++.+|+.||++||   ..+||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus       265 tlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            999999998887654   4578999999999999999999999   7899999999999999999999999999999887


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   ...+||.+|||||
T Consensus       339 ~g~~~---~~rvGT~GYMAPE  356 (591)
T KOG0986|consen  339 EGKPI---RGRVGTVGYMAPE  356 (591)
T ss_pred             CCCcc---ccccCcccccCHH
Confidence            76543   2358999999998

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=6.3e-27  Score=238.08  Aligned_cols=364  Identities=20%  Similarity=0.297  Sum_probs=229.5

Q ss_pred             CCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeec-cCccCcCCcCcCCCCcccEEecc
Q 003065          195 LTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYA-NNLTGELPAELGNLTLLQEFDIS  273 (851)
Q Consensus       195 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls  273 (851)
                      -+.++|..|+|+.+.|.+|..+++|+.|||++|+|+.+-|++|.++++|..|-+.+ |+|+...-..|++|..|+.|.+.
T Consensus        69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN  148 (498)
T KOG4237|consen   69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN  148 (498)
T ss_pred             ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence            44555556666555555566666666666666666655556666665555544444 55554433455566666666666


Q ss_pred             cccccCCCCccccCcCCccEEEccCCccCCCCCC-CCCCcccccEEEeccCc------------CCCCCCCccCCCCccc
Q 003065          274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPS-GFGDMRKLFAFSIYGNR------------FSGPFPENLGRYTALT  340 (851)
Q Consensus       274 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~------------l~~~~p~~l~~l~~L~  340 (851)
                      -|++.-...+.|..+++|..|.+.+|.+. .++. .|..+..++.+.+..|.            +....|-.++...-..
T Consensus       149 an~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~  227 (498)
T KOG4237|consen  149 ANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS  227 (498)
T ss_pred             hhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence            66665555555556666666666666555 3333 55556666666665555            2223344455555555


Q ss_pred             eeeccCCcccccCchhh-hhhcchHHHHhccCCccccccc-cccCccccceeccccCccccccCCcccCccccceEEecC
Q 003065          341 DVDISENQFSGSFPKYL-CEKRKLLNLLALSNNFSGEVPN-SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD  418 (851)
Q Consensus       341 ~L~Ls~N~l~~~~p~~~-~~~~~L~~l~l~~n~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  418 (851)
                      -..+.++++..+-+..+ +....+..-..+..+..+..|. .|..+++|+.|+|++|+|+++-+.+|.++..++.|.|..
T Consensus       228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~  307 (498)
T KOG4237|consen  228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR  307 (498)
T ss_pred             hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence            55666666665444444 3333444444555556666663 489999999999999999999999999999999999999


Q ss_pred             CcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCcccc------------------CCCccccccC
Q 003065          419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFS------------------GKIPSALGAL  480 (851)
Q Consensus       419 N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~------------------~~~p~~~~~l  480 (851)
                      |++..+-...|..+..|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|.+.                  |..|-  ..=
T Consensus       308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~C--q~p  385 (498)
T KOG4237|consen  308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRC--QSP  385 (498)
T ss_pred             chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCC--CCC
Confidence            9999888889999999999999999999999999999999999999988762                  11110  011


Q ss_pred             CcccEEEecCCccc---CCCCCCcc---------cccccce-eeccCcccccccCCCccccccCCeEeCCCCccccccCc
Q 003065          481 RQLSSLHLEENALT---GSIPNEMG---------DCARIVD-LNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPD  547 (851)
Q Consensus       481 ~~L~~L~Ls~N~l~---~~~p~~~~---------~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~  547 (851)
                      ..++.++++.+.+.   -..|++.+         .++-+.+ ...|++.++ .+|..+..  .-..|++.+|.++ .+|.
T Consensus       386 ~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP~--d~telyl~gn~~~-~vp~  461 (498)
T KOG4237|consen  386 GFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIPV--DVTELYLDGNAIT-SVPD  461 (498)
T ss_pred             chhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCCc--hhHHHhcccchhc-ccCH
Confidence            23556666666543   11333222         1222222 233444444 44443322  3456778888888 7777


Q ss_pred             ccccc-cceEEeCcCCcccccC
Q 003065          548 NLMKL-KLSSIDLSENQLSGSV  568 (851)
Q Consensus       548 ~l~~l-~L~~l~ls~N~l~~~~  568 (851)
                      .  .+ .+ .+|+|+|+|+---
T Consensus       462 ~--~~~~l-~~dls~n~i~~Ls  480 (498)
T KOG4237|consen  462 E--LLRSL-LLDLSNNRISSLS  480 (498)
T ss_pred             H--HHhhh-hcccccCceehhh
Confidence            6  33 56 7788888876433

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.92  E-value=8.6e-25  Score=243.23  Aligned_cols=173  Identities=27%  Similarity=0.377  Sum_probs=142.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC-----CcEEEEEEecccc---cHHHHHHHHHHHHcCC-CCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGD---GVKVFAAEMEILGKIR-HRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  746 (851)
                      .+|.+.+.||+|+||.||+|++...     +..||||++....   ..+.+.+|+++++++. ||||+++++++...+..
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            4788999999999999999987432     3469999986542   3456889999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhC----------------------------------------------------------
Q 003065          747 FLVLEYMPNGNLFQALHKRVKE----------------------------------------------------------  768 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------------  768 (851)
                      |+|||||++|+|.+++......                                                          
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            9999999999999998764210                                                          


Q ss_pred             ---------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC
Q 003065          769 ---------------------------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED  815 (851)
Q Consensus       769 ---------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~  815 (851)
                                                       ....+++..+..++.|+++|++|||   +.+|+||||||+||+++.+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~  273 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCC
Confidence                                             0124677888899999999999999   7899999999999999999


Q ss_pred             CceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       816 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.+||+|||+++...............+++.|+|||
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  309 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE  309 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence            999999999998664433222223345778899998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=8.4e-25  Score=246.05  Aligned_cols=164  Identities=27%  Similarity=0.354  Sum_probs=141.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      .+|.+.+.||+|+||.||+|.+..+++.||||...    ...+.+|++++++++|+|||++++++..++..++|||++ .
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~  243 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R  243 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence            36899999999999999999999999999999643    234568999999999999999999999999999999999 4


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++...    ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       244 ~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        244 SDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            7898888653    236899999999999999999999   789999999999999999999999999999876443222


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                      .......||+.|||||
T Consensus       317 ~~~~~~~GT~~Y~APE  332 (461)
T PHA03211        317 PFHYGIAGTVDTNAPE  332 (461)
T ss_pred             ccccccCCCcCCcCHH
Confidence            2223457999999998

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-25  Score=237.12  Aligned_cols=167  Identities=29%  Similarity=0.388  Sum_probs=143.5

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ..+.++||+|-||+|..|+. ..+..||||+++..   ....+|.+|+++|.+++|||||+++++|..++..++|+|||+
T Consensus       540 L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  540 LRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             eehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            46788999999999999988 44688999999765   345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+|+.++..   +........+|+.|||.||+||.   +.++||||+.++|+|+|.++++||+|||+++.......
T Consensus       619 nGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  619 NGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             cCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999988632   22455667789999999999999   78999999999999999999999999999997665554


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .......+-..+|||||
T Consensus       693 y~vqgr~vlpiRwmawE  709 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWE  709 (807)
T ss_pred             eeeecceeeeeeehhHH
Confidence            43333344567899998

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.2e-24  Score=237.71  Aligned_cols=158  Identities=31%  Similarity=0.406  Sum_probs=133.4

Q ss_pred             ecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcC---CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKI---RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       684 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      ||+|+||.||+|++..+++.||||++....     ....+..|..++.+.   +||+|+++++++..++..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999999999999999985431     223345677777665   699999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++.+.     ..+++..+..++.|+++|++|||   +++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-  151 (330)
T cd05586          81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-  151 (330)
T ss_pred             ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence            9999888652     35788899999999999999999   78999999999999999999999999999975433221 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|||||
T Consensus       152 -~~~~~~gt~~y~aPE  166 (330)
T cd05586         152 -TTNTFCGTTEYLAPE  166 (330)
T ss_pred             -CccCccCCccccCHH
Confidence             123457999999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.92  E-value=1.2e-24  Score=230.19  Aligned_cols=168  Identities=26%  Similarity=0.362  Sum_probs=140.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEc---CCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|++.+.||+|+||.||+|++.   ..+..||+|.+....   ....+.+|+.++++++||||+++++++..++..|+|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46889999999999999999875   345679999986542   235688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++...    ...+++..++.++.|++.|++|||   +++++||||||+||+++.++.+|++|||.+...
T Consensus        85 ~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          85 TEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999998753    235789999999999999999999   789999999999999999999999999987654


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...... ......++..|+|||
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE  178 (266)
T cd05064         158 KSEAIY-TTMSGKSPVLWAAPE  178 (266)
T ss_pred             cccchh-cccCCCCceeecCHH
Confidence            322111 111234567899998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.92  E-value=1.6e-24  Score=235.33  Aligned_cols=160  Identities=34%  Similarity=0.486  Sum_probs=137.6

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|++..+++.||||++.+.     ...+.+.+|+++++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999998643     2345677899999888 799999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  151 (318)
T cd05570          81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-  151 (318)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence            9999888653     35889999999999999999999   78999999999999999999999999999875332221 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       152 -~~~~~~g~~~y~aPE  166 (318)
T cd05570         152 -TTSTFCGTPDYIAPE  166 (318)
T ss_pred             -cccceecCccccCHH
Confidence             123356999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.92  E-value=2.1e-24  Score=229.56  Aligned_cols=159  Identities=31%  Similarity=0.426  Sum_probs=136.7

Q ss_pred             ecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       684 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      ||+|+||.||+++.+.+++.||+|++...     ...+.+..|++++++++||||+++++++..+...|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999988542     1234456799999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      .+++...   ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++........   .
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~  151 (277)
T cd05607          81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---I  151 (277)
T ss_pred             HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---e
Confidence            9888653   2345788888999999999999999   78999999999999999999999999999986654322   1


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ....||+.|+|||
T Consensus       152 ~~~~~~~~y~aPE  164 (277)
T cd05607         152 TQRAGTNGYMAPE  164 (277)
T ss_pred             eccCCCCCccCHH
Confidence            2346899999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.92  E-value=1.5e-24  Score=231.59  Aligned_cols=173  Identities=27%  Similarity=0.395  Sum_probs=144.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC-----cEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA-----GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      .+|++.+.||+|+||.||+|.....+     ..||+|.+....   ....+.+|++++++++||||+++++++...+..|
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            47889999999999999999876544     679999886442   2456889999999999999999999999989999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGK-----------PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY  816 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~  816 (851)
                      ++|||+++++|.+++........           ..+++..+..++.|++.|+.|||   +.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            99999999999999986432221           45788889999999999999999   78999999999999999999


Q ss_pred             ceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       817 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+||+|||+++...............+++.|+|||
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  196 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPE  196 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHH
Confidence            99999999998654433222223345788999998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.92  E-value=1.5e-24  Score=245.04  Aligned_cols=166  Identities=25%  Similarity=0.371  Sum_probs=136.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeC--------CeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG--------GSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~  747 (851)
                      .+|+..+.||+|+||.||+|.+..+++.||||++....  ....+|+.+++.++|||||++++++...        ...+
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            46899999999999999999999999999999885443  2345799999999999999998876432        2467


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-ceEEeeecCc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVA  826 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla  826 (851)
                      +||||++ +++.+++..... ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+|
T Consensus       144 lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        144 VVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            9999996 578887765322 3456888899999999999999999   78999999999999998664 7999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.......   .....||+.|||||
T Consensus       219 ~~~~~~~~---~~~~~~t~~y~aPE  240 (440)
T PTZ00036        219 KNLLAGQR---SVSYICSRFYRAPE  240 (440)
T ss_pred             hhccCCCC---cccCCCCcCccCHH
Confidence            87654322   22357899999998

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.92  E-value=1.6e-24  Score=234.38  Aligned_cols=167  Identities=26%  Similarity=0.349  Sum_probs=142.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +.+|...+.||+|+||.||+|++..+++.||+|++...   .....+.+|++++++++||||+++++++..++..|+|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            35789999999999999999999989999999988643   233467789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |++ +++.+++...    ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          85 YLD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             CCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            996 5888887653    335788888899999999999999   78999999999999999999999999999976543


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ......+|+.|+|||
T Consensus       157 ~~~--~~~~~~~~~~y~aPE  174 (309)
T cd07872         157 PTK--TYSNEVVTLWYRPPD  174 (309)
T ss_pred             Ccc--ccccccccccccCCH
Confidence            321  122346899999998

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.92  E-value=1.5e-24  Score=235.46  Aligned_cols=168  Identities=23%  Similarity=0.349  Sum_probs=140.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcE----EEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|+..+.||+|+||.||+|++..++..    ||||++...   ...+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            4689999999999999999998665553    899988643   2346788999999999999999999988764 5789


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+||+++|+|.+++...    ...+++...+.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        86 v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          86 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccc
Confidence            99999999999998763    345788889999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..............++..|+|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE  181 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALE  181 (316)
T ss_pred             ccCCCcceeccCCccceeecChH
Confidence            65443322222233567899998

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.92  E-value=5.3e-25  Score=233.49  Aligned_cols=168  Identities=30%  Similarity=0.437  Sum_probs=147.4

Q ss_pred             HHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccH----------HHHHHHHHHHHcCC---CCccccEEE
Q 003065          672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV----------KVFAAEMEILGKIR---HRNILKLYA  738 (851)
Q Consensus       672 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~---h~niv~l~~  738 (851)
                      ...+.+|...+.+|+|+||+|+.|.++.....|+||.+.+++-.          -.+-.||.||.+++   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            34567899999999999999999999999999999998776321          12346999999997   999999999


Q ss_pred             EEEeCCeeEEEEecc-CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc
Q 003065          739 CLLKGGSSFLVLEYM-PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE  817 (851)
Q Consensus       739 ~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~  817 (851)
                      +|++++.+|++||-. ++.+|++++..     .+.+++.....|.+||+.|+++||   +++|||||||-+|+.++.+|-
T Consensus       637 fFEddd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  637 FFEDDDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             eeecCCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCe
Confidence            999999999999976 56799999975     356888889999999999999999   899999999999999999999


Q ss_pred             eEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       818 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +||+|||.|.....++    ...++||..|.|||
T Consensus       709 ~klidfgsaa~~ksgp----fd~f~gtv~~aape  738 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSGP----FDVFVGTVDYAAPE  738 (772)
T ss_pred             EEEeeccchhhhcCCC----cceeeeeccccchh
Confidence            9999999998766543    34589999999998

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.92  E-value=2.2e-25  Score=235.41  Aligned_cols=155  Identities=32%  Similarity=0.484  Sum_probs=135.8

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      ...+.||.|+.|.||+|+.  .++.||||+++.-     -..+|+.|++++||||+.+.|+|...-.+|||||||..|.|
T Consensus       127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el-----kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL-----KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhhccCcccceeeeec--cCceehhHHHhhh-----hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            4678899999999999998  4678999987432     23678899999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      +.+++..     ..+.....+.+..+||.||.|||   .++|||||||.-||||..+..+||+|||.++...+..   +.
T Consensus       200 ~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---Tk  268 (904)
T KOG4721|consen  200 YEVLKAG-----RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TK  268 (904)
T ss_pred             HHHHhcc-----CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hh
Confidence            9999863     45677778899999999999999   7899999999999999999999999999998776543   23


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ..++||..|||||
T Consensus       269 MSFaGTVaWMAPE  281 (904)
T KOG4721|consen  269 MSFAGTVAWMAPE  281 (904)
T ss_pred             hhhhhhHhhhCHH
Confidence            4589999999998

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.92  E-value=8.7e-25  Score=238.55  Aligned_cols=163  Identities=25%  Similarity=0.336  Sum_probs=143.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCC-C-----CccccEEEEEEeCCeeEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIR-H-----RNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv  749 (851)
                      +|++.+.||+|+||+|.+|++.++++.||||+++... -..+-..|+.+|..++ |     -|+|+++++|...++.|+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            7899999999999999999999999999999997764 3455678999999996 3     5899999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC--CceEEeeecCcc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED--YEPKIADFGVAK  827 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~  827 (851)
                      +|.+ ..+|+++++..   ....++...+..|+.||+.||.+||   +.+|||+||||+|||+.+.  ..+||+|||.|.
T Consensus       267 fELL-~~NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  267 FELL-STNLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             ehhh-hhhHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            9999 57999999875   4556889999999999999999999   8899999999999999643  379999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......     +++-+..|+|||
T Consensus       340 ~~~q~vy-----tYiQSRfYRAPE  358 (586)
T KOG0667|consen  340 FESQRVY-----TYIQSRFYRAPE  358 (586)
T ss_pred             ccCCcce-----eeeeccccccch
Confidence            7654432     356799999999

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.92  E-value=3.4e-24  Score=229.05  Aligned_cols=165  Identities=28%  Similarity=0.372  Sum_probs=142.3

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      |+..+.||+|+||+||+|++..+++.||+|.+....     ....+.+|++++++++|++|+++++++..++..|+||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999999999999999885432     234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++...   ....+++..+..++.|++.|+.|||   +.+|+||||||+||++++++.+||+|||++......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            9999999888653   2346899999999999999999999   789999999999999999999999999999765432


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..   .....|++.|+|||
T Consensus       156 ~~---~~~~~g~~~~~aPE  171 (285)
T cd05632         156 ES---IRGRVGTVGYMAPE  171 (285)
T ss_pred             Cc---ccCCCCCcCccChH
Confidence            21   12346899999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-25  Score=214.08  Aligned_cols=174  Identities=25%  Similarity=0.338  Sum_probs=145.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecc--cccHHHHHHHHHHHHcCCCCccccEEEEEE-----eCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLL-----KGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~~l  748 (851)
                      ++|.+.+.+|+|||+.||.++...+++.||+|++.-  .++.+..++|++..++++|||+++++++..     .....|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            379999999999999999999999999999999843  356777899999999999999999887653     2345899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      +++|+..|+|.+.+..... ....+++.+.++|+.++++|+++||.. .+++.||||||+||++.+++.+++.|||.++.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999999999999987643 445789999999999999999999954 34699999999999999999999999999976


Q ss_pred             cCCCCC-------cccccccccccccccCC
Q 003065          829 AENSPK-------VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~-------~~~~~~~~gt~~Y~APE  851 (851)
                      ..-...       .++...-..|..|+|||
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPE  208 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPE  208 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCch
Confidence            543211       11222334689999998

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.92  E-value=1.8e-24  Score=229.14  Aligned_cols=167  Identities=26%  Similarity=0.326  Sum_probs=133.9

Q ss_pred             CeecccCcEEEEEEEEcC--CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          682 NLIGSGGTGKVYRLDLKK--NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      +.||+|+||.||+|+...  ....+|+|.+....   ....+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997533  33468888775432   2456788999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  836 (851)
                      +|.+++...........++.....++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999997753322334567778899999999999999   7899999999999999999999999999987543322111


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      ......+++.|+|||
T Consensus       158 ~~~~~~~~~~y~aPE  172 (269)
T cd05042         158 TKDCHAVPLRWLAPE  172 (269)
T ss_pred             ccCCCCCcccccCHH
Confidence            122334677899998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.92  E-value=2.7e-24  Score=230.45  Aligned_cols=165  Identities=27%  Similarity=0.358  Sum_probs=135.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcC-CCcEEEEEEeccc----ccHHHHHHHHHHHHcC---CCCccccEEEEEE-----eC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKK-NAGTVAVKQLWKG----DGVKVFAAEMEILGKI---RHRNILKLYACLL-----KG  743 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~  743 (851)
                      +|++.+.||+|+||.||+|++.. ++..||+|++...    .....+.+|+++++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68899999999999999999854 4678999988543    2234566788887766   6999999999875     24


Q ss_pred             CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      ...++||||++ ++|.+++...   ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence            56899999995 6999988753   2345788899999999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++......   ......||+.|+|||
T Consensus       155 g~~~~~~~~~---~~~~~~~~~~y~aPE  179 (290)
T cd07862         155 GLARIYSFQM---ALTSVVVTLWYRAPE  179 (290)
T ss_pred             cceEeccCCc---ccccccccccccChH
Confidence            9998665432   223356899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.92  E-value=2.8e-24  Score=227.71  Aligned_cols=167  Identities=26%  Similarity=0.279  Sum_probs=136.9

Q ss_pred             CeecccCcEEEEEEEEcC--CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          682 NLIGSGGTGKVYRLDLKK--NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      +.||+|+||.||+|+...  ++..+|+|.+....   ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998643  44679999886543   2346888999999999999999999999988999999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  836 (851)
                      +|.+++...........++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||.++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997653333345667778889999999999999   7899999999999999999999999999997554332222


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      ......|++.|+|||
T Consensus       158 ~~~~~~~~~~y~aPE  172 (269)
T cd05087         158 TPDQLWVPLRWIAPE  172 (269)
T ss_pred             cCCCcCCcccccCHh
Confidence            223345788999998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.91  E-value=4.2e-24  Score=228.27  Aligned_cols=165  Identities=28%  Similarity=0.382  Sum_probs=142.0

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      |+..+.||+|+||.||+|.+..+++.||||.+....     ..+.+.+|+.++++++|++|+++++.+.+++..|+||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999999999999999885431     234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++...   ....+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.++|+|||++......
T Consensus        82 ~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          82 MNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             cCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999988653   2335788889999999999999999   789999999999999999999999999998765433


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..   .....||+.|+|||
T Consensus       156 ~~---~~~~~g~~~y~aPE  171 (285)
T cd05630         156 QT---IKGRVGTVGYMAPE  171 (285)
T ss_pred             cc---ccCCCCCccccChH
Confidence            22   12346899999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.91  E-value=3.4e-24  Score=232.84  Aligned_cols=167  Identities=27%  Similarity=0.389  Sum_probs=135.3

Q ss_pred             CCeecccCcEEEEEEEEc--CCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEe--CCeeEEEEeccCCC
Q 003065          681 DNLIGSGGTGKVYRLDLK--KNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLVLEYMPNG  756 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g  756 (851)
                      .+.||+|+||.||+|+++  .+++.||+|.+........+.+|++++++++||||+++++++..  +...|+||||++ +
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence            468999999999999975  36678999998766555667899999999999999999998854  456899999995 6


Q ss_pred             CHHHHHHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE----CCCCceEEeeecCccc
Q 003065          757 NLFQALHKRVKE----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKI  828 (851)
Q Consensus       757 sL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~  828 (851)
                      ++.+++......    ....++...+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+|+.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            888887643211    1235788889999999999999999   7899999999999999    4567899999999987


Q ss_pred             cCCCCC-cccccccccccccccCC
Q 003065          829 AENSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      ...... ........||+.|+|||
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE  185 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPE  185 (317)
T ss_pred             cCCCCccccccCCccccccccCCH
Confidence            654322 12233467899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.91  E-value=2.6e-24  Score=237.83  Aligned_cols=164  Identities=34%  Similarity=0.397  Sum_probs=138.0

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC-----
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG-----  744 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  744 (851)
                      ...+|+..+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999999999999999998543    33556789999999999999999999886543     


Q ss_pred             -eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          745 -SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       745 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                       ..|+||||++ +++.+.+..       .++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecC
Confidence             4799999996 467666542       3677788899999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++.......   .....||+.|+|||
T Consensus       168 g~a~~~~~~~~---~~~~~~t~~y~aPE  192 (359)
T cd07876         168 GLARTACTNFM---MTPYVVTRYYRAPE  192 (359)
T ss_pred             CCccccccCcc---CCCCcccCCCCCch
Confidence            99976543221   22356899999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.91  E-value=5.6e-24  Score=225.07  Aligned_cols=166  Identities=30%  Similarity=0.435  Sum_probs=144.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...  ...+.+.+|+.++++++||||+++++++..++..|+||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4799999999999999999999889999999988644  34456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.++++..     ..+++..+..++.|++.|++|||   +.+|+|||+||+||+++.++.+||+|||+++......
T Consensus        89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          89 GGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999988653     35788889999999999999999   7899999999999999999999999999998664322


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......|++.|+|||
T Consensus       161 ~--~~~~~~~~~~y~~PE  176 (267)
T cd06646         161 A--KRKSFIGTPYWMAPE  176 (267)
T ss_pred             c--ccCccccCccccCHh
Confidence            1  122346899999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.91  E-value=3.4e-24  Score=238.28  Aligned_cols=172  Identities=27%  Similarity=0.433  Sum_probs=140.7

Q ss_pred             CCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEecccc---cHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  747 (851)
                      +|.+.+.||+|+||.||+|++.     ..++.||||++....   ..+.+.+|+++++++. |||||++++++...+..+
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~  117 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY  117 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence            5778899999999999999864     344679999996542   2346889999999997 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhh------------------------------------------------------------
Q 003065          748 LVLEYMPNGNLFQALHKRVK------------------------------------------------------------  767 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------  767 (851)
                      +||||+++|+|.+++++...                                                            
T Consensus       118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (401)
T cd05107         118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG  197 (401)
T ss_pred             EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence            99999999999999976321                                                            


Q ss_pred             ---------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC
Q 003065          768 ---------------------------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE  814 (851)
Q Consensus       768 ---------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~  814 (851)
                                                       .....+++.....++.|++.|++|||   +++++||||||+||++++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~  274 (401)
T cd05107         198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICE  274 (401)
T ss_pred             hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeC
Confidence                                             01124677788899999999999999   789999999999999999


Q ss_pred             CCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       815 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.+||+|||+++...............+++.|||||
T Consensus       275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  311 (401)
T cd05107         275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE  311 (401)
T ss_pred             CCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence            9999999999998654332211122345788999998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.91  E-value=4.6e-24  Score=223.66  Aligned_cols=163  Identities=29%  Similarity=0.404  Sum_probs=136.5

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      +.||+|+||.||+|++..+++.||+|.+...   +....+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4689999999999999889999999987543   2345688999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      .+++...    ...+++..++.++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++...........
T Consensus        81 ~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          81 LTFLRTE----GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9998653    335788899999999999999999   789999999999999999999999999998765432111111


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ....++..|+|||
T Consensus       154 ~~~~~~~~y~aPE  166 (252)
T cd05084         154 GMKQIPVKWTAPE  166 (252)
T ss_pred             CCCCCceeecCch
Confidence            1112345799998

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.91  E-value=3.7e-24  Score=228.58  Aligned_cols=174  Identities=25%  Similarity=0.349  Sum_probs=142.9

Q ss_pred             HcCCccCCeecccCcEEEEEEEEc----CCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLK----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      +.+|++.+.||+|+||.||+|+..    ..+..||+|.+....   ....+.+|++++++++||||+++++++..++..|
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            356888999999999999999853    355789999986432   2356889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhh------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC
Q 003065          748 LVLEYMPNGNLFQALHKRVK------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED  815 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~  815 (851)
                      +||||+++++|.+++.....            .....+++.....++.|++.|++|||   +++++||||||+||+++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence            99999999999999864321            01234788888999999999999999   7899999999999999999


Q ss_pred             CceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       816 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.+||+|||+++...............++..|+|||
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  196 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE  196 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChH
Confidence            999999999998664433222223345677899998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.91  E-value=3.3e-24  Score=238.20  Aligned_cols=165  Identities=28%  Similarity=0.390  Sum_probs=140.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC-----eeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG-----SSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  747 (851)
                      +|+..+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999889999999988543    23456889999999999999999999998776     789


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+. ++|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus        81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecccccee
Confidence            9999995 688777753     345888899999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ........ ......+|+.|+|||
T Consensus       152 ~~~~~~~~-~~~~~~~~~~y~aPE  174 (372)
T cd07853         152 VEEPDESK-HMTQEVVTQYYRAPE  174 (372)
T ss_pred             ecccCccc-cCCCCCcCCCcCCHH
Confidence            65433221 222346899999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.91  E-value=4.7e-24  Score=227.00  Aligned_cols=173  Identities=21%  Similarity=0.323  Sum_probs=141.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|+..+.||+|+||.||+|.+..     ++..||||++....   ...++.+|+.+++.++||||+++++++..++..+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            468999999999999999998642     34679999885432   3456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEG-----KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      +||||+++++|.+++.......     ....++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECC
Confidence            9999999999999997632111     234678888999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++...............+++.|||||
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPE  191 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChh
Confidence            99997654432222112234578899998

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=4.4e-24  Score=235.48  Aligned_cols=161  Identities=26%  Similarity=0.395  Sum_probs=139.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      .+|++.+.||+|+||.||+|++..++..||+|+.....    ...|+.++++++||||+++++++..++..++||||+ .
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~  140 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT----TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-S  140 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc----cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-C
Confidence            47999999999999999999999889999999754332    356999999999999999999999999999999999 5


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      +++.+++...    ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  
T Consensus       141 ~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        141 SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            6898888653    346889999999999999999999   7899999999999999999999999999997543222  


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       212 -~~~~~~gt~~y~aPE  226 (357)
T PHA03209        212 -AFLGLAGTVETNAPE  226 (357)
T ss_pred             -ccccccccccccCCe
Confidence             122356999999998

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-24  Score=226.77  Aligned_cols=165  Identities=24%  Similarity=0.321  Sum_probs=147.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      -|+..+.||+|.|+.|-.|++.-+|..||||++.+..    ....+.+|++.|+-++|||||++|++...+...|+|+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            4788899999999999999999999999999996652    345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC-CCCceEEeeecCccccCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~  831 (851)
                      -++|+|+||+-++    +..+.+....+++.||+.|+.|+|   +..+||||+||+||.+- .-|-+|+.|||++-.+..
T Consensus        99 GD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             cCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999875    446788888899999999999999   78899999999999874 678999999999987766


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.+.   ++.+|+..|-|||
T Consensus       172 G~kL---~TsCGSLAYSAPE  188 (864)
T KOG4717|consen  172 GKKL---TTSCGSLAYSAPE  188 (864)
T ss_pred             cchh---hcccchhhccCch
Confidence            5543   4478999999998

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.91  E-value=4.1e-24  Score=224.97  Aligned_cols=164  Identities=38%  Similarity=0.555  Sum_probs=141.8

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHH----HHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK----VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      |+..+.||+|+||.||+|+...+++.||+|++.......    ...+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567889999999999999999999999999997664322    2345999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++...     ..+++..+..++.|+++||+|||   +.+++||||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             cccccccccccc-----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            999999999832     35789999999999999999999   6799999999999999999999999999997642221


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                        .......+|+.|+|||
T Consensus       153 --~~~~~~~~~~~y~aPE  168 (260)
T PF00069_consen  153 --ENFNPFVGTPEYMAPE  168 (260)
T ss_dssp             --SEBSSSSSSGGGSCHH
T ss_pred             --cccccccccccccccc
Confidence              2233457899999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.91  E-value=7.8e-24  Score=223.89  Aligned_cols=169  Identities=28%  Similarity=0.403  Sum_probs=142.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC---CcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|+..+.||+|+||.||+|++...   ...||||++....   ....+.+|+.++++++||||+++++++..++..|+|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            4688999999999999999998644   4579999886542   345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|.+++...    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          84 TEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999998753    236789999999999999999999   789999999999999999999999999999877


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .............+++.|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe  178 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPE  178 (266)
T ss_pred             cccccceeccCCCCCccccChh
Confidence            5222221112233567899998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=3.6e-24  Score=247.96  Aligned_cols=265  Identities=28%  Similarity=0.425  Sum_probs=145.7

Q ss_pred             CCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEec
Q 003065          193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI  272 (851)
Q Consensus       193 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  272 (851)
                      ..-..|+|++|+|+ .+|..+.  ++|+.|++++|+|+ .+|.   .+++|++|+|++|+|+ .+|..   .++|+.|++
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeec
Confidence            34556777777776 5666554  35667777777766 3443   2355666666666666 33432   245555555


Q ss_pred             ccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCccccc
Q 003065          273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGS  352 (851)
Q Consensus       273 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  352 (851)
                      ++|.++ .+|..+   ++|+.|++++|+++ .                        +|..   .++|+.|+|++|+|++ 
T Consensus       270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~------------------------LP~~---p~~L~~LdLS~N~L~~-  316 (788)
T PRK15387        270 FSNPLT-HLPALP---SGLCKLWIFGNQLT-S------------------------LPVL---PPGLQELSVSDNQLAS-  316 (788)
T ss_pred             cCCchh-hhhhch---hhcCEEECcCCccc-c------------------------cccc---ccccceeECCCCcccc-
Confidence            555554 233221   23444455555444 2                        2221   2345555555555542 


Q ss_pred             CchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccC
Q 003065          353 FPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS  432 (851)
Q Consensus       353 ~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  432 (851)
                      +|..                     |      .+|+.|++++|+|+ .+|..   ..+|+.|+|++|+|++.++ .   .
T Consensus       317 Lp~l---------------------p------~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~LP~-l---p  361 (788)
T PRK15387        317 LPAL---------------------P------SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLASLPT-L---P  361 (788)
T ss_pred             CCCC---------------------c------ccccccccccCccc-ccccc---ccccceEecCCCccCCCCC-C---C
Confidence            2210                     0      12444455555554 23321   1345555555555554322 1   2


Q ss_pred             CCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeec
Q 003065          433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL  512 (851)
Q Consensus       433 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  512 (851)
                      .+|+.|++++|+|+ .+|..   ..+|+.|++++|+|++ +|...   +.|+.|++++|+|++ +|...   .+|+.|++
T Consensus       362 ~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~L  429 (788)
T PRK15387        362 SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-LPMLP---SGLLSLSV  429 (788)
T ss_pred             cccceehhhccccc-cCccc---ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-CCcch---hhhhhhhh
Confidence            34566666666666 34432   2456777777777764 44322   457777777777763 55432   35667777


Q ss_pred             cCcccccccCCCccccccCCeEeCCCCccccccCccc
Q 003065          513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNL  549 (851)
Q Consensus       513 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l  549 (851)
                      ++|+|+ .+|..+..+++|+.|+|++|+|+|.+|..+
T Consensus       430 s~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        430 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             ccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            777777 677777777777777777777777777665

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.91  E-value=7.1e-24  Score=224.29  Aligned_cols=170  Identities=23%  Similarity=0.356  Sum_probs=145.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|++++++++||||+++++++...+..|+|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4789999999999999999999989999999987432     23456789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++..... ....++...+..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            99999999998875422 2345788889999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  ......|++.|+|||
T Consensus       158 ~~~~--~~~~~~~~~~~~aPE  176 (267)
T cd08228         158 SKTT--AAHSLVGTPYYMSPE  176 (267)
T ss_pred             chhH--HHhcCCCCccccChh
Confidence            4322  112346889999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.91  E-value=7.1e-24  Score=222.82  Aligned_cols=167  Identities=25%  Similarity=0.349  Sum_probs=140.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||.||+|+++ .+..+|+|.+... ...+.+.+|++++++++||||+++++++...+..|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            35788899999999999999885 4568999987644 345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++...    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.++.......
T Consensus        83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          83 NGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            99999988753    235788999999999999999999   78999999999999999999999999999986543322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .. .....++..|+|||
T Consensus       156 ~~-~~~~~~~~~y~aPE  171 (256)
T cd05114         156 TS-SSGAKFPVKWSPPE  171 (256)
T ss_pred             ec-cCCCCCchhhCChh
Confidence            11 12223567899998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.91  E-value=7.3e-24  Score=227.87  Aligned_cols=173  Identities=28%  Similarity=0.338  Sum_probs=144.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC----------------cEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA----------------GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKL  736 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l  736 (851)
                      .+|++.+.||+|+||.||+|++...+                ..||+|++....   ..+.+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            47899999999999999999875433                458999886542   35678899999999999999999


Q ss_pred             EEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCE
Q 003065          737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG------KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNI  810 (851)
Q Consensus       737 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NI  810 (851)
                      ++++..++..++||||+++++|.+++.+.....      ...+++..++.++.|++.|++|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence            999999999999999999999999998653211      236889999999999999999999   78999999999999


Q ss_pred             EECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          811 LLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       811 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++.++.+||+|||+++...............+++.|+|||
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  202 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE  202 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence            99999999999999998654433222222345678999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.91  E-value=3.9e-24  Score=236.18  Aligned_cols=164  Identities=33%  Similarity=0.398  Sum_probs=138.4

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC------
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------  743 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  743 (851)
                      .+.+|+..+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            456899999999999999999999889999999998643    2345677899999999999999999988643      


Q ss_pred             CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      ...|+||||++ +++.+.+..       .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeC
Confidence            34699999996 467776643       3678888899999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++.......   .....||+.|+|||
T Consensus       164 g~~~~~~~~~~---~~~~~~t~~y~aPE  188 (355)
T cd07874         164 GLARTAGTSFM---MTPYVVTRYYRAPE  188 (355)
T ss_pred             cccccCCCccc---cCCccccCCccCHH
Confidence            99986544322   22357899999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.91  E-value=6.5e-24  Score=226.28  Aligned_cols=173  Identities=28%  Similarity=0.392  Sum_probs=143.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      .+|.+.+.||+|+||.||+|++..     +++.||||++....   ..+.+.+|++++++++|+||+++++++..++..|
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468889999999999999998743     35789999986542   3467899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhh---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCce
Q 003065          748 LVLEYMPNGNLFQALHKRVK---------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP  818 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~  818 (851)
                      +||||+++++|.+++.....         .....+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            99999999999999976421         12345788889999999999999999   7899999999999999999999


Q ss_pred             EEeeecCccccCCCCCcccccccccccccccCC
Q 003065          819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       819 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|||+++...............+++.|+|||
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE  194 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE  194 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChh
Confidence            999999997654332211112234678899998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.91  E-value=9.7e-24  Score=226.16  Aligned_cols=162  Identities=34%  Similarity=0.473  Sum_probs=143.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|+..+.||+|+||.||+|.+..+++.||+|++...     ...+.+.+|++++++++||||+++++++..++..|+|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            688899999999999999999989999999988543     234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++++|.+++...     ..++...+..++.|++.|+.|||   +.+++||||+|+||+++.++.+||+|||+++....
T Consensus        82 ~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          82 YVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             cCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99999999998763     35788889999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .     .....|++.|+|||
T Consensus       154 ~-----~~~~~~~~~y~aPE  168 (290)
T cd05580         154 R-----TYTLCGTPEYLAPE  168 (290)
T ss_pred             C-----CCCCCCCccccChh
Confidence            3     12246899999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.91  E-value=8.8e-24  Score=226.25  Aligned_cols=173  Identities=28%  Similarity=0.408  Sum_probs=143.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|.+.+.||+|+||.||++...     .++..||+|.+...  ...+.+.+|++++++++||||+++++++...+..|+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            36888999999999999999853     34556999988654  235578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhh--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEE
Q 003065          749 VLEYMPNGNLFQALHKRVK--------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI  820 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl  820 (851)
                      ||||+++++|.+++.....        .....+++..+..++.|++.|++|||   +++++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            9999999999999976421        12235899999999999999999999   789999999999999999999999


Q ss_pred             eeecCccccCCCCCcccccccccccccccCC
Q 003065          821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|||+++...............+++.|+|||
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  192 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE  192 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHH
Confidence            9999998664432222222334678899998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.91  E-value=1.2e-23  Score=227.41  Aligned_cols=164  Identities=27%  Similarity=0.400  Sum_probs=142.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      +|++.+.||+|+||.||++++..++..||+|.+....   ...++.+|++++++++||||+++++++..++..|+||||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            6889999999999999999999999999999886442   2356789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++...     ..+++..+..++.|+++|+.|||.  ..+++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          82 DGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            999999998753     357788888999999999999993  2589999999999999999999999999987654322


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .    ....|++.|+|||
T Consensus       155 ~----~~~~~~~~~~aPE  168 (308)
T cd06615         155 A----NSFVGTRSYMSPE  168 (308)
T ss_pred             c----ccCCCCcCccChh
Confidence            1    2356899999998

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=6.6e-24  Score=228.06  Aligned_cols=173  Identities=27%  Similarity=0.356  Sum_probs=141.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC--------------CcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN--------------AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYA  738 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~  738 (851)
                      .+|++.+.||+|+||.||+|++...              ...||+|++...   .....+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4789999999999999999987542              235899988654   23456889999999999999999999


Q ss_pred             EEEeCCeeEEEEeccCCCCHHHHHHHhhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 003065          739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL  811 (851)
Q Consensus       739 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NIL  811 (851)
                      ++...+..|+||||+++++|.+++......       ....+++..+..++.|++.|++|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            999999999999999999999999653211       1134688889999999999999999   789999999999999


Q ss_pred             ECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          812 LDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       812 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++++.+||+|||+++...............++..|+|||
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  201 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE  201 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence            9999999999999997654332222222234577899998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.6e-23  Score=221.00  Aligned_cols=168  Identities=30%  Similarity=0.462  Sum_probs=143.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      ++|+..+.||+|++|.||+|.+..++++||+|.+....       ..+.+.+|++++++++||||+++++++..++..|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            36889999999999999999998899999999875431       23467889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+||+++++|.+++...     ..++.....+++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            99999999999988753     34778888899999999999999   78999999999999999999999999999976


Q ss_pred             cCCCCCcc-cccccccccccccCC
Q 003065          829 AENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ........ ......|+..|+|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE  177 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPE  177 (263)
T ss_pred             ccccccccccccCCCcCccccCcc
Confidence            54322111 112346889999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=5.5e-24  Score=237.76  Aligned_cols=164  Identities=27%  Similarity=0.374  Sum_probs=139.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC--CCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK--NAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|.+.+.||+|+||.||+|....  ++..||+|.+...   +...+|++++++++||||+++++++...+..|+|||++
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~  168 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY  168 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence            368999999999999999997643  4577999987554   23468999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      . +++.+++..     ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus       169 ~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        169 K-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             C-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            5 688888843     346889999999999999999999   7899999999999999999999999999998665443


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .........||+.|+|||
T Consensus       240 ~~~~~~~~~gt~~y~aPE  257 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPE  257 (392)
T ss_pred             ccccccccccccCccCHh
Confidence            332333467999999998

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.91  E-value=6.5e-24  Score=249.61  Aligned_cols=174  Identities=22%  Similarity=0.349  Sum_probs=143.6

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe--CCeeE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSF  747 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  747 (851)
                      .+.+|.+.+.||+|+||.||+|++..++..||+|++...    .....+..|+.++++++|||||+++++|..  ....|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            356899999999999999999999999999999988543    235668899999999999999999998854  45689


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCcEEeCCCCCCEEECCC--------
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC----SPPIIHRDIKSSNILLDED--------  815 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~ivHrDlkp~NILl~~~--------  815 (851)
                      +||||+++|+|.+++..... ....+++..++.|+.||+.||+|||...    ..+||||||||+|||++.+        
T Consensus        91 IVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999999976432 2346899999999999999999999432    1469999999999999642        


Q ss_pred             ---------CceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          816 ---------YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       816 ---------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                               +.+||+|||+++.......   .....||+.|+|||
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPE  211 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPE  211 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHH
Confidence                     3489999999986644322   22357999999998

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.91  E-value=9e-24  Score=222.98  Aligned_cols=168  Identities=26%  Similarity=0.406  Sum_probs=143.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            5788899999999999999998889999999886543 356788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++...   ....+++..+..++.|+++|++|||   +.+++||||||+||++++++.+||+|||.++........
T Consensus        87 ~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          87 GNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999998753   2345788899999999999999999   789999999999999999999999999999876543221


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......++..|+|||
T Consensus       161 -~~~~~~~~~~y~aPE  175 (263)
T cd05052         161 -AHAGAKFPIKWTAPE  175 (263)
T ss_pred             -ccCCCCCccccCCHH
Confidence             111223466899998

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=6.5e-24  Score=245.80  Aligned_cols=265  Identities=25%  Similarity=0.352  Sum_probs=190.7

Q ss_pred             ccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEecc
Q 003065          243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYG  322 (851)
Q Consensus       243 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~  322 (851)
                      -..|+|+.|.++ .+|..+.  ++|+.|++++|+++ .+|..   .++|++|++++|+|+. +|..   .++|+.|++++
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~  271 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFS  271 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeeccC
Confidence            345566666665 4555443  35666666666665 34432   3566666666666663 3432   24566677777


Q ss_pred             CcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccC
Q 003065          323 NRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP  402 (851)
Q Consensus       323 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  402 (851)
                      |+++ .+|..   ..+|+.|++++|+++ .+|                        .   ..++|++|+|++|+|++ +|
T Consensus       272 N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP------------------------~---~p~~L~~LdLS~N~L~~-Lp  318 (788)
T PRK15387        272 NPLT-HLPAL---PSGLCKLWIFGNQLT-SLP------------------------V---LPPGLQELSVSDNQLAS-LP  318 (788)
T ss_pred             Cchh-hhhhc---hhhcCEEECcCCccc-ccc------------------------c---cccccceeECCCCcccc-CC
Confidence            7766 33432   245777888888877 222                        2   12579999999999995 56


Q ss_pred             CcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCc
Q 003065          403 DGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ  482 (851)
Q Consensus       403 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  482 (851)
                      ..   ..+|+.|++++|++++.+ .   ...+|+.|+|++|+|+ .+|..   ..+|+.|++++|+|++ +|...   .+
T Consensus       319 ~l---p~~L~~L~Ls~N~L~~LP-~---lp~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l~---~~  383 (788)
T PRK15387        319 AL---PSELCKLWAYNNQLTSLP-T---LPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPALP---SG  383 (788)
T ss_pred             CC---cccccccccccCcccccc-c---cccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Ccccc---cc
Confidence            53   346889999999998744 2   2358999999999999 46653   3578899999999995 66543   57


Q ss_pred             ccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcC
Q 003065          483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSE  561 (851)
Q Consensus       483 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~  561 (851)
                      |+.|+|++|+|++ +|...   ..|+.|++++|+|++ +|...   .+|+.|+|++|+|+ .+|..+..+ .|+.|+|++
T Consensus       384 L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~  454 (788)
T PRK15387        384 LKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  454 (788)
T ss_pred             cceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence            8999999999984 66543   578999999999994 77543   46889999999999 899999988 899999999


Q ss_pred             CcccccCCcccccC
Q 003065          562 NQLSGSVPLDFLRM  575 (851)
Q Consensus       562 N~l~~~~p~~~~~~  575 (851)
                      |+|+|.+|..+...
T Consensus       455 N~Ls~~~~~~L~~l  468 (788)
T PRK15387        455 NPLSERTLQALREI  468 (788)
T ss_pred             CCCCchHHHHHHHH
Confidence            99999998766443

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=7.5e-24  Score=225.39  Aligned_cols=173  Identities=23%  Similarity=0.313  Sum_probs=143.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC-----cEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA-----GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|.+.+.||+|+||.||+|.+....     ..||+|.+....   ....+.+|+.+++.++||||+++++++...+..|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            46888999999999999999886433     789999986443   2446789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEG-----KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      +||||+++|+|.+++.......     ...+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence            9999999999999997643211     224688889999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++...............++..|+|||
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPE  191 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHH
Confidence            99998665433222222345788999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.91  E-value=7.5e-24  Score=224.10  Aligned_cols=166  Identities=28%  Similarity=0.412  Sum_probs=144.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|+..+.||+|+||.||+|++..+++.||+|.+....  ....+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            36888899999999999999999999999999886542  3456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++...     ..+++.....++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          89 GGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            999999988653     35788899999999999999999   7899999999999999999999999999987654322


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......|++.|+|||
T Consensus       161 ~--~~~~~~~~~~y~aPE  176 (267)
T cd06645         161 A--KRKSFIGTPYWMAPE  176 (267)
T ss_pred             c--ccccccCcccccChh
Confidence            1  123356899999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.91  E-value=9.3e-24  Score=227.61  Aligned_cols=167  Identities=27%  Similarity=0.366  Sum_probs=143.0

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +++|...+.||+|+||.||+|++..+++.||+|.+...   .....+.+|++++++++||||+++++++..++..|+|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            46799999999999999999999889999999988543   234567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |++ ++|.+++...    ...+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          85 YLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            996 6898888653    335788889999999999999999   78999999999999999999999999999976543


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ......+++.|+|||
T Consensus       157 ~~~--~~~~~~~~~~y~~PE  174 (301)
T cd07873         157 PTK--TYSNEVVTLWYRPPD  174 (301)
T ss_pred             CCC--cccccceeecccCcH
Confidence            221  122345789999998

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.91  E-value=1.2e-23  Score=224.09  Aligned_cols=168  Identities=29%  Similarity=0.377  Sum_probs=138.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc----EEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|+..+.||+|+||.||+|.+..++.    +||+|.+....   ...++..|+..++++.||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            467888999999999999999877665    47777765432   2356777888999999999999999875 455789


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ++||+++|+|.+++...    ...+++..+..++.|++.|++|+|   +++++||||||+||+++.++.+||+|||+++.
T Consensus        86 i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            99999999999999753    345789999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..............|+..|+|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE  181 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALE  181 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHH
Confidence            65433222233345778899998

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=2.4e-24  Score=230.07  Aligned_cols=143  Identities=27%  Similarity=0.393  Sum_probs=127.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      -|..++.||-|+||+|.++...++...||+|.+++.+     .......|.+||.....+.||++|..|++.+..|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            3677889999999999999998998899999987653     33456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      |++||++..++.+.     ..+.+..+.-++..+..|+++.|   ..|+|||||||+|||||.+|++||+|||+++
T Consensus       710 YIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             ccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccc
Confidence            99999999998764     34556666667889999999999   8899999999999999999999999999985

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.91  E-value=1.4e-23  Score=220.47  Aligned_cols=167  Identities=31%  Similarity=0.449  Sum_probs=145.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|++|.||+|++..+++.||+|.+...    ...+.+.+|++++++++||||+++++++..++..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477889999999999999999999999999987532    3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++...   ....+++..++.++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999999764   2346788899999999999999999   789999999999999999999999999999876544


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  .....|++.|+|||
T Consensus       155 ~~~--~~~~~~~~~y~aPE  171 (256)
T cd08529         155 TNF--ANTIVGTPYYLSPE  171 (256)
T ss_pred             cch--hhccccCccccCHH
Confidence            322  23356899999998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.91  E-value=1.8e-23  Score=219.55  Aligned_cols=167  Identities=23%  Similarity=0.388  Sum_probs=144.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      +|++.+.||+|+||.||++++..+++.||+|.+...   ...+.+.+|+.+++.++|+||+++++++..++..|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            477889999999999999999999999999987543   24466788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      +++++.+++...   ....++......++.|++.|+.|||   +.+|+|+||||+||++++++.++++|||.++......
T Consensus        81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            999999988653   2334678888999999999999999   7899999999999999999999999999997664432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  .....|++.|+|||
T Consensus       155 ~~--~~~~~~~~~~~aPE  170 (255)
T cd08219         155 AY--ACTYVGTPYYVPPE  170 (255)
T ss_pred             cc--cccccCCccccCHH
Confidence            21  12356899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.91  E-value=8.8e-24  Score=231.93  Aligned_cols=173  Identities=31%  Similarity=0.407  Sum_probs=138.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEe-CCe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLK-GGS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~  745 (851)
                      ++|++.+.||+|+||.||+|.+.     .+++.||||++....   ....+.+|++++.++ +||||+++++++.. +..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            37899999999999999999852     456789999986532   345678999999999 68999999997765 456


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhC---------------------------------------------------------
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKE---------------------------------------------------------  768 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------  768 (851)
                      .++||||+++|+|.+++......                                                         
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            78999999999999998753110                                                         


Q ss_pred             -----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCccccccccc
Q 003065          769 -----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG  843 (851)
Q Consensus       769 -----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  843 (851)
                           ....+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++...............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                 0123678888899999999999999   78999999999999999999999999999986543322222222345


Q ss_pred             ccccccCC
Q 003065          844 THGYIAPG  851 (851)
Q Consensus       844 t~~Y~APE  851 (851)
                      ++.|+|||
T Consensus       244 ~~~y~aPE  251 (343)
T cd05103         244 PLKWMAPE  251 (343)
T ss_pred             CcceECcH
Confidence            67899998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.91  E-value=1.2e-23  Score=225.18  Aligned_cols=173  Identities=24%  Similarity=0.364  Sum_probs=140.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      .+|++.+.||+|+||.||+|..++     .+..||+|.+....   ....+.+|+.++++++||||+++++++..++..|
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            478999999999999999997642     34579999875443   2345778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          748 LVLEYMPNGNLFQALHKRVKE-----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      +||||+++|+|.+++......     ......+..+..++.|++.|+.|||   +++|+||||||+||+++.++.+|++|
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECc
Confidence            999999999999999764221     1234567778899999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++...............++..|+|||
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE  191 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPE  191 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHH
Confidence            99998654432222222234577899998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.91  E-value=1.4e-23  Score=228.16  Aligned_cols=167  Identities=26%  Similarity=0.386  Sum_probs=135.2

Q ss_pred             CCeecccCcEEEEEEEEcC--CCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEe--CCeeEEEEeccCCC
Q 003065          681 DNLIGSGGTGKVYRLDLKK--NAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLVLEYMPNG  756 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g  756 (851)
                      ...||+|+||.||+|+...  ++..||+|.+........+.+|++++++++||||+++++++..  +...|+||||++ +
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence            4679999999999999754  5578999998766556678899999999999999999998854  567899999995 5


Q ss_pred             CHHHHHHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE----CCCCceEEeeecCccc
Q 003065          757 NLFQALHKRVKE----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKI  828 (851)
Q Consensus       757 sL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~  828 (851)
                      ++.+++......    ....+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+|+.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            888887643211    1235788889999999999999999   7899999999999999    5667899999999987


Q ss_pred             cCCCCC-cccccccccccccccCC
Q 003065          829 AENSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      ...... ........||+.|+|||
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE  185 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPE  185 (317)
T ss_pred             cCCCcccccccCcceecccccCcH
Confidence            654322 12233457899999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.91  E-value=1.3e-23  Score=226.93  Aligned_cols=173  Identities=29%  Similarity=0.420  Sum_probs=142.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-------CCCcEEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-------KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGG  744 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  744 (851)
                      .+|.+.+.||+|+||.||+|++.       .++..||+|.+...   ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            46889999999999999999753       23447999988643   2345688999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      ..|+||||+++|+|.+++......           ....+++..+..++.|++.|++|||   +.+++||||||+||+++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~  171 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVT  171 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEc
Confidence            999999999999999999864221           1235788889999999999999999   78999999999999999


Q ss_pred             CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++.+||+|||.++...............+++.|+|||
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE  209 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE  209 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCch
Confidence            99999999999998765433222222334678899998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.91  E-value=7.7e-24  Score=231.49  Aligned_cols=172  Identities=31%  Similarity=0.418  Sum_probs=139.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEe-CCee
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLK-GGSS  746 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~~  746 (851)
                      +|++.+.||+|+||.||+|....     +++.||+|++....   ..+.+.+|+++++++ +|+||+++++++.. +...
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            68899999999999999997543     34789999986432   345677899999999 89999999998764 4568


Q ss_pred             EEEEeccCCCCHHHHHHHhhhC--------------------------------------------------------CC
Q 003065          747 FLVLEYMPNGNLFQALHKRVKE--------------------------------------------------------GK  770 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~~  770 (851)
                      +++|||+++++|.+++......                                                        ..
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            8999999999999998653210                                                        01


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccccC
Q 003065          771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP  850 (851)
Q Consensus       771 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP  850 (851)
                      ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence            25789999999999999999999   789999999999999999999999999999876543322222334567889999


Q ss_pred             C
Q 003065          851 G  851 (851)
Q Consensus       851 E  851 (851)
                      |
T Consensus       245 E  245 (337)
T cd05054         245 E  245 (337)
T ss_pred             H
Confidence            8

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PHA02988 hypothetical protein; Provisional

Probab=99.91  E-value=1.7e-23  Score=223.11  Aligned_cols=158  Identities=24%  Similarity=0.346  Sum_probs=134.1

Q ss_pred             cCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--c---HHHHHHHHHHHHcCCCCccccEEEEEEe----CCeeEEEE
Q 003065          680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--G---VKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFLVL  750 (851)
Q Consensus       680 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  750 (851)
                      ....||+|++|.||+|+.  +++.||||++....  .   .+.+.+|++++++++||||+++++++.+    ....++||
T Consensus        24 ~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         24 TSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             CCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            346799999999999998  68899999986532  1   3567899999999999999999999876    34679999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++...     ..+++.....++.+++.|+.|+|.  ..+++||||||+||++++++.+||+|||+++...
T Consensus       102 Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        102 EYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             EeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            999999999998753     357888999999999999999993  2488899999999999999999999999998654


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...     ....||+.|+|||
T Consensus       175 ~~~-----~~~~~~~~y~aPE  190 (283)
T PHA02988        175 SPP-----FKNVNFMVYFSYK  190 (283)
T ss_pred             ccc-----ccccCcccccCHH
Confidence            332     1246899999998

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.91  E-value=1.3e-23  Score=224.98  Aligned_cols=165  Identities=28%  Similarity=0.326  Sum_probs=136.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcC---CCCccccEEEEEEe-----CC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKI---RHRNILKLYACLLK-----GG  744 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  744 (851)
                      +|++.+.||+|+||.||+|+++.+++.||+|.+....    ....+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999999999999999886431    233566788877765   69999999998764     34


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      ..++||||++ +++.+++...   ....+++..+..++.|++.|++|+|   +.+|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccC
Confidence            5799999996 5898888753   2345789999999999999999999   7899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++.......   .....||+.|+|||
T Consensus       154 ~~~~~~~~~~---~~~~~~~~~y~aPE  177 (288)
T cd07863         154 LARIYSCQMA---LTPVVVTLWYRAPE  177 (288)
T ss_pred             ccccccCccc---CCCccccccccCch
Confidence            9986653322   12346899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.90  E-value=1.9e-23  Score=222.57  Aligned_cols=159  Identities=30%  Similarity=0.435  Sum_probs=138.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      +|+..+.||+|+||.||+|.+..+++.||+|++...   ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            578889999999999999999999999999988543   23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      +++++..+.         .+++.....++.|++.|++|||   +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          82 DGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             CCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence            999986542         3567778899999999999999   7899999999999999999999999999997654332


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                          .....||+.|+|||
T Consensus       150 ----~~~~~~~~~y~aPE  163 (279)
T cd06619         150 ----AKTYVGTNAYMAPE  163 (279)
T ss_pred             ----ccCCCCChhhcCce
Confidence                22357899999998

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.90  E-value=1.3e-23  Score=248.50  Aligned_cols=167  Identities=31%  Similarity=0.369  Sum_probs=145.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +.+|.+.+.||+|+||.||+|++..+++.||||++....     ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999999899999999986532     235688899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|.+++...     ..+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        83 mEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~  154 (669)
T cd05610          83 MEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT  154 (669)
T ss_pred             EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence            9999999999998753     24678888999999999999999   779999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  ......||+.|+|||
T Consensus       155 ~~~~~--~~~~~~~t~~~~~pe  174 (669)
T cd05610         155 LNREL--NMMDILTTPSMAKPK  174 (669)
T ss_pred             cCCcc--cccccccCccccCcc
Confidence            54322  223467899999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.90  E-value=7.2e-24  Score=232.95  Aligned_cols=162  Identities=28%  Similarity=0.403  Sum_probs=138.3

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC------C
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------G  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  744 (851)
                      .++|...+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|++++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            35789999999999999999999999999999998643    2345677899999999999999999887543      3


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      ..|+++|++ +++|.+++..      ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence            468999988 7899887653      35788899999999999999999   7899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++.....     .....||+.|+|||
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE  185 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPE  185 (343)
T ss_pred             cceecCCC-----cCCccccccccCch
Confidence            99865432     22357899999998

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.90  E-value=9.6e-24  Score=233.83  Aligned_cols=164  Identities=32%  Similarity=0.393  Sum_probs=138.4

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC------
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------  743 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  743 (851)
                      ...+|+..+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            356899999999999999999999999999999998643    2345678899999999999999999887543      


Q ss_pred             CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      ...|+||||++ +++.+++..       .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeC
Confidence            35799999996 577777643       3677888899999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+.......   .....||+.|+|||
T Consensus       171 G~a~~~~~~~~---~~~~~~t~~y~aPE  195 (364)
T cd07875         171 GLARTAGTSFM---MTPYVVTRYYRAPE  195 (364)
T ss_pred             CCccccCCCCc---ccCCcccCCcCCHH
Confidence            99986544321   22357899999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.90  E-value=1.9e-24  Score=209.76  Aligned_cols=166  Identities=27%  Similarity=0.411  Sum_probs=137.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++.+....||.|++|.|++++.+.++..+|||.+.+..   +.+++...++++...+ .|+||+.+|||..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            45567788999999999999999999999999997653   4556777777776665 8999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      .|. .-....+++.    ..++++...-++...++.||.||.+  .++|+|||+||+|||+|+.|++|+||||.+....+
T Consensus       172 lMs-~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHH-HHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec
Confidence            983 3444444432    3457777778899999999999997  56999999999999999999999999999987665


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   .-+|-+.|||||
T Consensus       245 SkAht---rsAGC~~YMaPE  261 (391)
T KOG0983|consen  245 SKAHT---RSAGCAAYMAPE  261 (391)
T ss_pred             ccccc---cccCCccccCcc
Confidence            53322   247999999998

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.90  E-value=1.4e-24  Score=248.88  Aligned_cols=171  Identities=26%  Similarity=0.437  Sum_probs=137.3

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEe--------
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLK--------  742 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  742 (851)
                      -+.+|+..+.||+||||.||+|+.+-+|+.||||++.-.   .....+.+|+..+++++|||||+++..|.+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            345788999999999999999999999999999998654   234457799999999999999999876520        


Q ss_pred             -----------------------------------------------C--------------------------------
Q 003065          743 -----------------------------------------------G--------------------------------  743 (851)
Q Consensus       743 -----------------------------------------------~--------------------------------  743 (851)
                                                                     .                                
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                           0                                


Q ss_pred             --------------------------------CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHH
Q 003065          744 --------------------------------GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY  791 (851)
Q Consensus       744 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  791 (851)
                                                      ...|+-||||+...+.+++++.....    .....++++++|++||.|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHH
Confidence                                            12478899998877777776532111    355678999999999999


Q ss_pred             HHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC----------------CCCCcccccccccccccccCC
Q 003065          792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE----------------NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       792 LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|   ++|||||||||.||++|++..+||+|||+|+...                ......+.+..+||.-|+|||
T Consensus       713 IH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE  785 (1351)
T KOG1035|consen  713 IH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE  785 (1351)
T ss_pred             HH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence            99   8899999999999999999999999999998621                011122456679999999998

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.90  E-value=1.2e-23  Score=225.78  Aligned_cols=173  Identities=29%  Similarity=0.399  Sum_probs=142.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC-----cEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA-----GTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      .+|+..+.||+|+||.||++......     ..+|+|.+....   ....+.+|+++++++ +|+||+++++++..++..
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            36888999999999999999886433     679999886542   234678899999999 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhh-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC
Q 003065          747 FLVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED  815 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~  815 (851)
                      |+||||+++|+|.+++..+..           .....+++..+..++.|++.|++|||   +.+|+||||||+||+++++
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCC
Confidence            999999999999999976421           22346888999999999999999999   7899999999999999999


Q ss_pred             CceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       816 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.+|++|||.++...............++..|+|||
T Consensus       169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  204 (293)
T cd05053         169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPE  204 (293)
T ss_pred             CeEEeCccccccccccccceeccCCCCCCccccCHH
Confidence            999999999998765433222222233567899998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.1e-23  Score=219.94  Aligned_cols=168  Identities=30%  Similarity=0.412  Sum_probs=141.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+... ...+.+.+|++++++++||||+++++++...+..|+||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            35888999999999999999974 4578999998654 345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...   ....+++..+..++.|++.|+.|||   +.+++||||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          85 YGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             CCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999998763   2345789999999999999999999   78999999999999999999999999999987653322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .. .....++..|+|||
T Consensus       159 ~~-~~~~~~~~~y~aPE  174 (261)
T cd05068         159 EA-REGAKFPIKWTAPE  174 (261)
T ss_pred             cc-cCCCcCceeccCcc
Confidence            11 11122345799998

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.90  E-value=1.6e-23  Score=220.84  Aligned_cols=168  Identities=27%  Similarity=0.445  Sum_probs=142.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||.||+|.. .++..||+|.+... ...+.+.+|+.++++++|+||+++++++...+..|+||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            4788999999999999999987 45678999987653 345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...   ....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          85 KGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999998764   2345788888999999999999999   78999999999999999999999999999987654322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......++..|+|||
T Consensus       159 ~-~~~~~~~~~~y~aPE  174 (261)
T cd05072         159 T-AREGAKFPIKWTAPE  174 (261)
T ss_pred             e-ccCCCccceecCCHH
Confidence            1 112234677899998

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.90  E-value=8.1e-24  Score=225.94  Aligned_cols=173  Identities=21%  Similarity=0.283  Sum_probs=142.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC-----CcEEEEEEeccccc---HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      .+|...+.||+|+||.||+|.+..+     ++.||+|++.....   .+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            3577888999999999999987543     46799999865432   356889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhh-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC
Q 003065          748 LVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY  816 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~  816 (851)
                      +++||+++++|.+++.....           .....+++..+..++.|++.|++|+|   +++|+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            99999999999999864311           11234788888999999999999999   78999999999999999999


Q ss_pred             ceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       817 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+||+|||+++...............+++.|+|||
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  196 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPE  196 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHH
Confidence            99999999988664433222223345678999998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.5e-24  Score=247.91  Aligned_cols=171  Identities=31%  Similarity=0.436  Sum_probs=141.9

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCc-----EEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAG-----TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+..+.||+|+||.||+|...+...     .||||.+.+.   .+..+|.+|..+|+.++|||||+++|.+.+.+..+++
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            4567889999999999999865443     3999988654   4567899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          750 LEYMPNGNLFQALHKRVKE--GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +|||++|+|..|+++.+..  ....+.....+.++.|||+|++||+   ++++|||||.++|+|++....+||+|||+|+
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhH
Confidence            9999999999999875322  2456888899999999999999999   8899999999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+.............=-..|||||
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PE  874 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPE  874 (1025)
T ss_pred             hhhhchheeccCccccceecCCHH
Confidence            554443222211111235899998

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.90  E-value=1.6e-23  Score=223.07  Aligned_cols=168  Identities=23%  Similarity=0.341  Sum_probs=139.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc----EEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|+..+.||+|+||.||+|++..++.    +||+|++....   ..+.+.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            468889999999999999999876665    48999886432   34567899999999999999999998875 45789


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ++||+++|+|.+++...    ...+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||+++.
T Consensus        86 ~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          86 VTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceee
Confidence            99999999999998753    345888899999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..............+++.|+|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE  181 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALE  181 (279)
T ss_pred             cccccceeecCCCccchhhCCHH
Confidence            65433222222234567899998

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.90  E-value=1.1e-23  Score=221.77  Aligned_cols=166  Identities=38%  Similarity=0.559  Sum_probs=136.5

Q ss_pred             cCCeecccCcEEEEEEEEc----CCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          680 EDNLIGSGGTGKVYRLDLK----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       680 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ..+.||+|+||.||+|.+.    ..+..|+||.+....   ..+.+.+|++.+++++||||+++++++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999997    345679999995532   357899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++|+|.+++...   ....+++..+..|+.|+++||.|||   +.+++|+||+++||+++.++.+||+|||+++.....
T Consensus        83 ~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   83 CPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             -TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             ccccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            9999999999874   3456899999999999999999999   679999999999999999999999999999877433


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..........+...|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~aPE  175 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPE  175 (259)
T ss_dssp             SSEEESTTSESGGGGS-HH
T ss_pred             ccccccccccccccccccc
Confidence            3222222345678899998

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.90  E-value=2.4e-25  Score=215.27  Aligned_cols=168  Identities=29%  Similarity=0.400  Sum_probs=140.4

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEecc
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+....||.|+||+|++-.++.+|+..|||+++..   .+.+++..|.++..+- +.|+||++||....++..|+.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            34567899999999999999999999999999654   4567788888875554 7999999999988888999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                       ..++..+.+....-.+..+++...-.|....++||.||.+  ...|||||+||+|||+|..|.+|+||||.+....++-
T Consensus       146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence             5788777665544455678888888889999999999997  5699999999999999999999999999997665442


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..   +.-+|-..|||||
T Consensus       223 Ak---T~daGCrpYmAPE  237 (361)
T KOG1006|consen  223 AK---TVDAGCRPYMAPE  237 (361)
T ss_pred             Hh---hhccCCccccChh
Confidence            22   2246899999998

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.90  E-value=1.3e-23  Score=226.52  Aligned_cols=171  Identities=32%  Similarity=0.472  Sum_probs=139.8

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcE--EEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGT--VAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  748 (851)
                      +++|++.+.||+|+||.||+|.+..++..  +|+|.+...   ...+.+.+|++++.++ +||||+++++++..++..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            45788999999999999999998777654  577776542   2345688999999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc
Q 003065          749 VLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE  817 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~  817 (851)
                      ||||+++++|.+++.+....           ....+++..++.++.|++.|++|||   +.+++||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            99999999999999764211           1235788899999999999999999   789999999999999999999


Q ss_pred             eEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       818 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +||+|||+++.......   .....++..|+|||
T Consensus       163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE  193 (303)
T cd05088         163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIE  193 (303)
T ss_pred             EEeCccccCcccchhhh---cccCCCcccccCHH
Confidence            99999999864322111   11123466799998

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.90  E-value=1.8e-23  Score=224.17  Aligned_cols=172  Identities=26%  Similarity=0.374  Sum_probs=139.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      +|.+.+.||+|+||.||+|+...     ....+|+|.+....   ..+.+.+|+.+++.++||||+++++++..++..|+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46788999999999999998743     22568888876543   24568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhh-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 003065          749 VLEYMPNGNLFQALHKRVK-------------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSN  809 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~N  809 (851)
                      |+||+++++|.+++.....                   .....+++..++.++.|++.|++|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            9999999999999875321                   11235788899999999999999999   7899999999999


Q ss_pred             EEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          810 ILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       810 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |++++++.+||+|||+++...............++..|+|||
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE  199 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE  199 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHH
Confidence            999999999999999998654332211122234577899998

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.90  E-value=2.2e-23  Score=222.77  Aligned_cols=167  Identities=27%  Similarity=0.350  Sum_probs=142.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|++|.||+|++..+++.||||++...    ...+.+.+|+.++++++||||+++++++..++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            478889999999999999999889999999988543    2346678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++ +++.+++....  ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          81 LS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             CC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            97 68988886532  2346888999999999999999999   789999999999999999999999999999765433


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ......+++.|+|||
T Consensus       155 ~~--~~~~~~~~~~y~aPE  171 (285)
T cd07861         155 VR--VYTHEVVTLWYRAPE  171 (285)
T ss_pred             cc--cccCCcccccccChH
Confidence            21  122235789999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.90  E-value=3.1e-23  Score=222.55  Aligned_cols=167  Identities=29%  Similarity=0.416  Sum_probs=144.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      +.|++.+.||+|+||.||+|++..+++.||+|.+....  ..+.+.+|+++++.++||||+++++++..++..|+||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            46889999999999999999999999999999986543  3567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      +++++..++.+.    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+.......
T Consensus        92 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          92 PGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            999998887653    235788999999999999999999   7899999999999999999999999999987543321


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                        .......|++.|+|||
T Consensus       165 --~~~~~~~~~~~y~aPE  180 (292)
T cd06644         165 --QRRDSFIGTPYWMAPE  180 (292)
T ss_pred             --cccceecCCccccCce
Confidence              1122346889999998

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.90  E-value=2.9e-23  Score=218.11  Aligned_cols=167  Identities=22%  Similarity=0.348  Sum_probs=145.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||.++...+++.+|+|++...    ...+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478899999999999999999999999999987543    3356688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++.+.   ....+++..+..++.|++.|+.|||   +.+++||||||+||++++++.+||+|||.++.....
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            9999999998764   1345788899999999999999999   789999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ......|++.|+|||
T Consensus       155 ~~--~~~~~~~~~~y~ape  171 (256)
T cd08221         155 YS--MAETVVGTPYYMSPE  171 (256)
T ss_pred             cc--cccccCCCccccCHh
Confidence            32  122356899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.90  E-value=2e-23  Score=224.96  Aligned_cols=170  Identities=28%  Similarity=0.388  Sum_probs=141.6

Q ss_pred             cCCccCCeecccCcEEEEEEEE-----cCCCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      ++|...+.||+|+||.||+|.+     ..++..||||++....   ..+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            3688999999999999999975     2345579999886542   345688999999999 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+++|+|.++++..   ....+++..+..++.|++.|++|||   +++|+|+||||+||+++.++.+|++|||++
T Consensus       115 ~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            9999999999999998753   1233789999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +...............+++.|+|||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE  213 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPE  213 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHh
Confidence            8665432211122234678899998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.90  E-value=2.3e-23  Score=223.98  Aligned_cols=165  Identities=27%  Similarity=0.392  Sum_probs=144.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|+..+.||+|+||.||+|.+..+++.||+|.+...  ...+.+.+|+.+++.++|+||+++++++..++..|+||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5799999999999999999999889999999988643  33466789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++.+      ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||.+.......
T Consensus        99 ~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            99999998864      24678888999999999999999   7899999999999999999999999999997654432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  .....|++.|+|||
T Consensus       170 ~~--~~~~~~~~~y~aPE  185 (297)
T cd06656         170 SK--RSTMVGTPYWMAPE  185 (297)
T ss_pred             cC--cCcccCCccccCHH
Confidence            21  12346899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.90  E-value=2e-23  Score=223.78  Aligned_cols=173  Identities=28%  Similarity=0.388  Sum_probs=143.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|...+.||+|+||.||+|++..     ++..+|+|.+....  ..+.+.+|++++++++|+||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            367888999999999999998642     44568999876543  34678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhh-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc
Q 003065          749 VLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE  817 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~  817 (851)
                      ||||+++++|.+++.....           .....+++..++.++.|++.|++|||   +++|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            9999999999999976421           11234789999999999999999999   789999999999999999999


Q ss_pred             eEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       818 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +||+|||+++...............|++.|+|||
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  195 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE  195 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChH
Confidence            9999999997655433222222345788999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.90  E-value=2e-23  Score=219.33  Aligned_cols=166  Identities=29%  Similarity=0.387  Sum_probs=139.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +|++.+.||+|+||.||+|++. ++..+|+|++... .....+.+|++++++++||||+++++++...+..|+||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            5788999999999999999885 5668999988654 3456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++...    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++........
T Consensus        84 ~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          84 GCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            9999998753    235788999999999999999999   789999999999999999999999999999866433221


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                      . .....++..|+|||
T Consensus       157 ~-~~~~~~~~~y~~Pe  171 (256)
T cd05059         157 S-SQGTKFPVKWAPPE  171 (256)
T ss_pred             c-cCCCCCCccccCHH
Confidence            1 11122445799998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.90  E-value=2.4e-23  Score=223.65  Aligned_cols=165  Identities=27%  Similarity=0.394  Sum_probs=143.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|+..+.||+|+||.||+|.+..+++.||+|.+...  ...+.+.+|+.+++.+.|+||+++++++..+...|+||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4788899999999999999999889999999988643  34567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++..      ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       100 ~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654         100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            99999998864      24678889999999999999999   7899999999999999999999999999987654332


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  .....|++.|+|||
T Consensus       171 ~~--~~~~~~~~~y~aPE  186 (296)
T cd06654         171 SK--RSTMVGTPYWMAPE  186 (296)
T ss_pred             cc--cCcccCCccccCHH
Confidence            11  12346899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.90  E-value=2.9e-23  Score=219.71  Aligned_cols=166  Identities=22%  Similarity=0.292  Sum_probs=132.6

Q ss_pred             CeecccCcEEEEEEEEcCCC--cEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNA--GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~--~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      +.||+|+||.||+|+....+  ..+++|.+...   ...+.+.+|+.+++.++||||+++++++......|+||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            35899999999999764332  34667766433   23567899999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  836 (851)
                      +|.+++.+... .....+...+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            99999976422 2334566777889999999999999   7899999999999999999999999999986433221111


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      ......|+..|+|||
T Consensus       157 ~~~~~~~~~~y~aPE  171 (268)
T cd05086         157 TEDDKCVPLRWLAPE  171 (268)
T ss_pred             cccCCcCcccccCch
Confidence            222346789999998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.90  E-value=2.3e-23  Score=220.35  Aligned_cols=169  Identities=29%  Similarity=0.451  Sum_probs=140.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC---cEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA---GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|++.+.||+|+||.||+|++..++   ..+|+|.+...   ...+.+.+|+.++++++||||+++++++..++..|+|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46888999999999999999886444   36999988643   2345788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|.+++...    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++..
T Consensus        84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          84 TEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            9999999999998753    235788899999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcc-cccccccccccccCC
Q 003065          830 ENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ....... ......++..|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe  179 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPE  179 (267)
T ss_pred             ccccceeeecCCCccceeecCHh
Confidence            5432211 111223456899998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.90  E-value=1.8e-23  Score=221.27  Aligned_cols=170  Identities=23%  Similarity=0.365  Sum_probs=146.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|++.+.||+|+||.||+|++..+++.||||.+...     ...+++.+|+++++.++||||+++++++..++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4788899999999999999999889999999987542     23457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++.... .....+++..++.++.|++.|+.|||   +.+++|+||||+||+++.++.++++|||++....
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            9999999999987532 23346889999999999999999999   7899999999999999999999999999987665


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  .....|+..|+|||
T Consensus       158 ~~~~~--~~~~~~~~~~~ape  176 (267)
T cd08229         158 SKTTA--AHSLVGTPYYMSPE  176 (267)
T ss_pred             cCCcc--cccccCCcCccCHH
Confidence            43221  12346899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.90  E-value=3.8e-24  Score=199.63  Aligned_cols=167  Identities=26%  Similarity=0.387  Sum_probs=140.2

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEecc
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ......||+|+||.|-+.++..+|...|+|.+...   +..++..+|+.+..+. .+|.+|.+||.....+..|+.||.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            35567899999999999999999999999998654   4566778899886554 7999999999988889999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                       ..||..+.++..+ ....+++...-+|+..+..||.|||+  +..++|||+||+||||+.+|++|+||||.+....++.
T Consensus       128 -~tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  128 -DTSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             -hhhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence             5688777765433 45568888888999999999999997  4689999999999999999999999999998776543


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..+   .-.|...|||||
T Consensus       204 Akt---~daGCkpYmaPE  218 (282)
T KOG0984|consen  204 AKT---MDAGCKPYMAPE  218 (282)
T ss_pred             HHH---HhcCCCccCChh
Confidence            222   135888999998

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.90  E-value=3.7e-23  Score=220.75  Aligned_cols=165  Identities=27%  Similarity=0.415  Sum_probs=142.6

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      |++.+.||+|+||.||+|.+..++..+|+|.+...  ...+.+.+|+++++.++||||+++++++..++..|+||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            67788999999999999999988999999988544  2356688999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      +++.+++.+.    ...+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+|++|||++........ 
T Consensus        87 ~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          87 GAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            9998887642    345889999999999999999999   78999999999999999999999999999876543221 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......||+.|+|||
T Consensus       159 -~~~~~~~~~~y~aPE  173 (282)
T cd06643         159 -RRDSFIGTPYWMAPE  173 (282)
T ss_pred             -ccccccccccccCHh
Confidence             122356899999998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.90  E-value=3.1e-23  Score=220.03  Aligned_cols=171  Identities=26%  Similarity=0.335  Sum_probs=136.4

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCc--EEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC------Ce
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAG--TVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------GS  745 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  745 (851)
                      |.+.+.||+|+||.||+|++..++.  .||+|.+...    ...+.+.+|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567889999999999999877665  5899987543    3356788999999999999999999876432      24


Q ss_pred             eEEEEeccCCCCHHHHHHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          746 SFLVLEYMPNGNLFQALHKRVK-EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      .++||||+++|+|.+++..... .....+++.....++.|++.|++|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999998854322 22345789999999999999999999   7899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++...............+++.|+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe  184 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIE  184 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHH
Confidence            998765433221112234577899997

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=2.4e-23  Score=223.89  Aligned_cols=158  Identities=21%  Similarity=0.198  Sum_probs=125.6

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcC-CCcEEEEEEeccc-------ccHHHHHHHHHHHHcCCCCcccc-EEEEEEeCCe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKK-NAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILK-LYACLLKGGS  745 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~  745 (851)
                      ..+|...+.||+|+||+||+|.+.. ++..||||++...       ...+.+.+|++++++++|+++++ ++++    +.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            3579999999999999999999876 6777899986432       12456889999999999999986 4432    46


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCC-CCCCEEECCCCceEEeeec
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDI-KSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFG  824 (851)
                      .|+||||++|++|... ..     ..      ...++.++++||.|+|   +++|+|||| ||+|||++.++.+||+|||
T Consensus        93 ~~LVmE~~~G~~L~~~-~~-----~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RP-----HG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             cEEEEEccCCCCHHHh-Cc-----cc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            7999999999999621 10     01      1356889999999999   789999999 9999999999999999999


Q ss_pred             CccccCCCCCcc------cccccccccccccCC
Q 003065          825 VAKIAENSPKVS------DYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~------~~~~~~gt~~Y~APE  851 (851)
                      +|+.........      ......+++.|+|||
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe  190 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD  190 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence            999776543221      123567899999998

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.8e-23  Score=222.90  Aligned_cols=167  Identities=28%  Similarity=0.418  Sum_probs=145.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+...  ...+.+.+|++++++++||||+++++.+..++..|+||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            4688999999999999999999888999999988644  34457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++.+.    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          85 DGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             CCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            999999988753    235888899999999999999999   7899999999999999999999999999987654332


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......||+.|+|||
T Consensus       158 ~--~~~~~~~~~~y~~PE  173 (280)
T cd06611         158 Q--KRDTFIGTPYWMAPE  173 (280)
T ss_pred             c--ccceeecchhhcCHH
Confidence            1  122356899999998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.90  E-value=2.2e-23  Score=222.96  Aligned_cols=167  Identities=26%  Similarity=0.422  Sum_probs=143.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...   .....+.+|++++++++||||+++++++..++..|+||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            678899999999999999999889999999988643   22457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++...  .....+++..+..++.|++.|+.|||+  +.+|+||||||+||+++.++.+||+|||.++......
T Consensus        82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          82 DAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             CCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            999998888652  123367899999999999999999994  2589999999999999999999999999997654332


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .    ....|++.|+|||
T Consensus       158 ~----~~~~~~~~y~aPE  171 (286)
T cd06622         158 A----KTNIGCQSYMAPE  171 (286)
T ss_pred             c----ccCCCccCccCcc
Confidence            1    2245888999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.90  E-value=2.1e-23  Score=224.34  Aligned_cols=173  Identities=25%  Similarity=0.343  Sum_probs=140.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC----------------CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK----------------NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKL  736 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l  736 (851)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|++....   ..+++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            368999999999999999986432                33469999886432   34678899999999999999999


Q ss_pred             EEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCE
Q 003065          737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG------KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNI  810 (851)
Q Consensus       737 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NI  810 (851)
                      ++++..++..|+||||+++++|.+++.......      ...+++..+..++.|++.|++|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999997643211      124678889999999999999999   78999999999999


Q ss_pred             EECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          811 LLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       811 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++.++.+|++|||+++...............+++.|+|||
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence            99999999999999998654432211112233467899997

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.90  E-value=3.7e-23  Score=221.19  Aligned_cols=171  Identities=30%  Similarity=0.348  Sum_probs=143.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcC-CCCccccEEEEEE-----eCCeeE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI-RHRNILKLYACLL-----KGGSSF  747 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~~  747 (851)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++++ +||||+++++++.     .++..|
T Consensus        17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   96 (286)
T cd06638          17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW   96 (286)
T ss_pred             ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence            357899999999999999999999999999999876543 345678899999999 6999999999874     345689


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++++|.+++..... ....+++..+..++.|+++|+.|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        97 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  172 (286)
T cd06638          97 LVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA  172 (286)
T ss_pred             EEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence            99999999999998875422 2345788889999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ........  .....|++.|+|||
T Consensus       173 ~~~~~~~~--~~~~~~~~~y~aPE  194 (286)
T cd06638         173 QLTSTRLR--RNTSVGTPFWMAPE  194 (286)
T ss_pred             ecccCCCc--cccccCCCcccChh
Confidence            66433211  12246899999998

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.90  E-value=2.1e-23  Score=225.43  Aligned_cols=173  Identities=29%  Similarity=0.404  Sum_probs=141.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-------CCcEEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGG  744 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  744 (851)
                      .+|.+.+.||+|+||.||+|++..       +...||+|.+...   .....+.+|+++++++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            468999999999999999998643       2346999988653   2345678899999999 7999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      ..|+||||+++|+|.+++......           ....+++..+..++.|++.|++|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            999999999999999999764221           1235788999999999999999999   78999999999999999


Q ss_pred             CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++.+||+|||.++...............+++.|+|||
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  212 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE  212 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChH
Confidence            99999999999997654322211122223457899998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.90  E-value=3.1e-23  Score=225.25  Aligned_cols=171  Identities=26%  Similarity=0.392  Sum_probs=143.2

Q ss_pred             CCccCCeecccCcEEEEEEEEcC--CCcEEEEEEecc-----cccHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKK--NAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  747 (851)
                      +|++.+.||+|+||.||+|++..  +++.||+|.+..     ....+.+.+|++++++++||||+++++++.+.  +..|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788899999999999999988  789999999876     23346678899999999999999999999887  7899


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC----CCceEEeee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE----DYEPKIADF  823 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DF  823 (851)
                      +||||++ +++.+++..........++...+..++.|++.|++|||   +.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999996 57888776553333346888899999999999999999   789999999999999999    899999999


Q ss_pred             cCccccCCCCC-cccccccccccccccCC
Q 003065          824 GVAKIAENSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      |+++....... ........+|+.|+|||
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE  185 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPE  185 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHH
Confidence            99987654322 11223356899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=3.8e-23  Score=220.30  Aligned_cols=168  Identities=25%  Similarity=0.369  Sum_probs=139.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc----EEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|+..+.||+|+||.||+|.+..++.    .||+|......   ....+.+|+.++++++||||+++++++.. +..++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            467889999999999999999876654    58999876543   34568899999999999999999999877 78899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++|+|.+++...    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++.
T Consensus        86 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence            99999999999998753    335889999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..............++..|+|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE  181 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALE  181 (279)
T ss_pred             ccCcccceecCCCcccccccCHH
Confidence            65433222111223466899998

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.90  E-value=4.4e-23  Score=218.15  Aligned_cols=170  Identities=22%  Similarity=0.338  Sum_probs=146.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ++|++.+.||+|+||.||+|....+++.||+|.++..     ...+.+.+|++++++++|++|+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4788999999999999999999889999999987532     23567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++.... .....+++..+..++.+++.|+.|||   +.+++||||||+||+++.++.++|+|||+++...
T Consensus        82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            9999999999987532 23445788999999999999999999   7899999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  .....|++.|+|||
T Consensus       158 ~~~~~--~~~~~~~~~y~apE  176 (267)
T cd08224         158 SKTTA--AHSLVGTPYYMSPE  176 (267)
T ss_pred             CCCcc--cceecCCccccCHH
Confidence            33211  12346889999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=8.6e-24  Score=227.79  Aligned_cols=163  Identities=27%  Similarity=0.407  Sum_probs=139.0

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCHH
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLF  759 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  759 (851)
                      -+||+|.||+||.|++.++...+|||.+..+  +..+-+..||..-++++|.|||+++|++.+++.+-+.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            3699999999999999999999999998554  33455788999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC-CCCceEEeeecCccccCCCCCcccc
Q 003065          760 QALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       760 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      +.++...  +.-.-.+..+--+.+||++||+|||   +..|||||||-+|||++ -.|.+||+|||.++....-..  .+
T Consensus       661 sLLrskW--GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~T  733 (1226)
T KOG4279|consen  661 SLLRSKW--GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CT  733 (1226)
T ss_pred             HHHHhcc--CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc--cc
Confidence            9998642  2222355666678899999999999   88999999999999996 578999999999987654332  23


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      .++.||..|||||
T Consensus       734 ETFTGTLQYMAPE  746 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPE  746 (1226)
T ss_pred             cccccchhhhChH
Confidence            4578999999998

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.90  E-value=4.1e-23  Score=219.10  Aligned_cols=171  Identities=25%  Similarity=0.342  Sum_probs=138.5

Q ss_pred             CccCCeecccCcEEEEEEEEcCC---CcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCe-----
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS-----  745 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  745 (851)
                      |++.+.||+|+||.||+|++..+   +..||+|++...    ...+.+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999998653   367999998643    224568899999999999999999998765443     


Q ss_pred             -eEEEEeccCCCCHHHHHHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          746 -SFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       746 -~~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                       .++||||+++|+|.+++...... ....+++.....++.|++.|+.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999998664322 2346888899999999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++...............++..|+|||
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe  185 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIE  185 (273)
T ss_pred             cceeeccccccccccccccCCccccCHh
Confidence            9998765433222112223567899998

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-24  Score=250.63  Aligned_cols=167  Identities=31%  Similarity=0.452  Sum_probs=142.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ++.....||.|.||.||.|...++|...|||.+.-.    ...+.+.+|..++..++|||+|+++|+-...+..++.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            456778899999999999999999999999987543    2345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      |++|+|.+.+....     -.++.....+..|++.|+.|||   +.|||||||||+||+++.+|.+|.+|||.|..+...
T Consensus      1316 C~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             hccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            99999999987532     2344455567889999999999   789999999999999999999999999999887655


Q ss_pred             CC--cccccccccccccccCC
Q 003065          833 PK--VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~--~~~~~~~~gt~~Y~APE  851 (851)
                      ..  .......+||+.|||||
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPE 1408 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPE 1408 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCch
Confidence            21  12234578999999998

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.90  E-value=3.5e-23  Score=217.52  Aligned_cols=163  Identities=29%  Similarity=0.473  Sum_probs=139.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEE-eCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL-KGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  754 (851)
                      .+|++.+.||+|+||.||++..  .+..||+|.+......+.+.+|+.++++++|++++++++++. .++..|+||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            4788999999999999999987  477899999877666778999999999999999999998754 5567899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...   ....+++.....++.|++.|++|||   +.+++||||||+||++++++.+|++|||+++.......
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  157 (256)
T cd05082          84 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD  157 (256)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence            99999998764   2335788899999999999999999   78999999999999999999999999999876543221


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                           ...++..|+|||
T Consensus       158 -----~~~~~~~y~aPE  169 (256)
T cd05082         158 -----TGKLPVKWTAPE  169 (256)
T ss_pred             -----CCccceeecCHH
Confidence                 123567899998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.90  E-value=4.3e-23  Score=218.07  Aligned_cols=168  Identities=29%  Similarity=0.426  Sum_probs=140.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-------ccHHHHHHHHHHHHcCCCCccccEEEEEEeC--Cee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  746 (851)
                      .+|+..+.||+|+||.||+|.+..+++.||||.+...       ...+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            3688899999999999999999999999999987432       1235678899999999999999999998763  467


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      ++||||+++++|.+++...     ..+++....+++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.+
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence            8999999999999998753     24677788899999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCC-cccccccccccccccCC
Q 003065          827 KIAENSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      +....... ........|+..|+|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE  179 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPE  179 (265)
T ss_pred             cccccccccccccccCCCCccccChh
Confidence            76543211 11122346899999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.90  E-value=2.8e-23  Score=218.24  Aligned_cols=167  Identities=25%  Similarity=0.363  Sum_probs=140.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+|++.+.||+|+||.||+|++. .+..||+|.+... ...+.+.+|+.++++++||||+++++++...+..|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            36788899999999999999874 3456999988654 335678999999999999999999999998888999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++...    ...+++..++.++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.++.......
T Consensus        83 ~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          83 NGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            99999998753    235789999999999999999999   78999999999999999999999999999986644322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......++..|+|||
T Consensus       156 ~-~~~~~~~~~~y~~pe  171 (256)
T cd05113         156 T-SSVGSKFPVRWSPPE  171 (256)
T ss_pred             e-ecCCCccChhhCCHH
Confidence            1 111234567899998

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.90  E-value=2.5e-23  Score=220.38  Aligned_cols=169  Identities=28%  Similarity=0.465  Sum_probs=140.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc---EEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|++.+.||+|+||.||+|.++.+++   .||||.+...   ...+++..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457889999999999999999876654   5999998654   2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|.+++...    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++..
T Consensus        84 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          84 TEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence            9999999999988753    345788999999999999999999   789999999999999999999999999999766


Q ss_pred             CCCCCccccc-ccc--cccccccCC
Q 003065          830 ENSPKVSDYS-CFA--GTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~-~~~--gt~~Y~APE  851 (851)
                      .......... ...  ++..|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE  181 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPE  181 (269)
T ss_pred             ccCccccccccccCCCcceeecCHh
Confidence            5432211111 111  245799998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-24  Score=220.75  Aligned_cols=168  Identities=29%  Similarity=0.386  Sum_probs=142.3

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  747 (851)
                      ...+|....+||+|+||+|..|..+.+.+.||||++++.     ++.+--+.|-++++-- +-|.+++++.||++-+..|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            345788999999999999999999999999999988664     3344445677777766 5789999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      .||||+.||+|.-+++...     .+.+..+.-+|..||-||-|||   ++||+.||+|.+||++|.+|++||+|||+++
T Consensus       427 FVMEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eEEEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccc
Confidence            9999999999999988753     3444566678999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .---+  ..++.+++|||.|+|||
T Consensus       499 Eni~~--~~TTkTFCGTPdYiAPE  520 (683)
T KOG0696|consen  499 ENIFD--GVTTKTFCGTPDYIAPE  520 (683)
T ss_pred             ccccC--CcceeeecCCCcccccc
Confidence            54333  23455689999999998

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.90  E-value=3.4e-23  Score=219.69  Aligned_cols=168  Identities=30%  Similarity=0.431  Sum_probs=142.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcC-CCCccccEEEEEEeC------CeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLLKG------GSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~~  747 (851)
                      ..|+..+.||+|+||.||+|....+++.||+|++... .....+.+|+.+++++ +||||+++++++...      ...|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            3578889999999999999999999999999998544 3456788999999998 799999999988653      4579


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++++|.+++...   ....+++..+..++.|++.|++|||   +++|+|||+||+||++++++.+||+|||+++
T Consensus        86 iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            999999999999998753   2345788889999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  ......|++.|+|||
T Consensus       160 ~~~~~~~--~~~~~~g~~~y~aPE  181 (272)
T cd06637         160 QLDRTVG--RRNTFIGTPYWMAPE  181 (272)
T ss_pred             ecccccc--cCCcccccccccCHh
Confidence            6543221  223457899999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.90  E-value=3.6e-23  Score=221.03  Aligned_cols=168  Identities=28%  Similarity=0.416  Sum_probs=140.1

Q ss_pred             CCccCCeecccCcEEEEEEEE----cCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDL----KKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  747 (851)
                      -|++.+.||+|+||.||+|+.    ..++..||+|.+....   ..+.+.+|++++++++||||+++++++...  ...|
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            468899999999999999985    3567789999986442   345788999999999999999999988765  5689


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++++|.+++.+.    ...+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+||+|||+++
T Consensus        85 lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence            999999999999998653    235788999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCc-ccccccccccccccCC
Q 003065          828 IAENSPKV-SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~-~~~~~~~gt~~Y~APE  851 (851)
                      ........ .......|+..|+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE  182 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPE  182 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHH
Confidence            66543221 1122345777899998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.90  E-value=1.9e-23  Score=220.13  Aligned_cols=167  Identities=30%  Similarity=0.422  Sum_probs=143.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|+..+.||+|+||.||+|.+.. +..+|+|++....  ....+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            368899999999999999999976 8889999986553  3567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++...   ....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+.......
T Consensus        85 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          85 EKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999763   2345788899999999999999999   7899999999999999999999999999998765432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ....++..|+|||
T Consensus       159 ~~~--~~~~~~~~~~~PE  174 (261)
T cd05148         159 YLS--SDKKIPYKWTAPE  174 (261)
T ss_pred             ccc--cCCCCceEecCHH
Confidence            211  1234677899997

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.90  E-value=5.1e-23  Score=216.71  Aligned_cols=167  Identities=31%  Similarity=0.452  Sum_probs=142.7

Q ss_pred             CeecccCcEEEEEEEEcCC---CcEEEEEEeccccc---HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|.....   +..||+|.+.....   .+.+.+|++.++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4689999999999999765   88899999876533   56788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          756 GNLFQALHKRVKE----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       756 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      ++|.+++......    ....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998764111    1356899999999999999999999   78999999999999999999999999999987765


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...........+++.|+|||
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE  177 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPE  177 (262)
T ss_pred             ccccccccCCCcCccccCHH
Confidence            43222223346788999998

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.90  E-value=5.9e-23  Score=215.89  Aligned_cols=167  Identities=24%  Similarity=0.381  Sum_probs=142.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe-CCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  751 (851)
                      +|++.+.||+|++|.||++++..+++.||+|++...    ...+.+.+|++++++++|+|++++++.+.. ....|+|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            478899999999999999999888999999998543    234567889999999999999999988764 446799999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++++|.+++...   ....+++.++..++.+++.|++|+|   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            99999999998763   2345789999999999999999999   78999999999999999999999999999987644


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ......|++.|+|||
T Consensus       155 ~~~--~~~~~~~~~~y~aPE  172 (257)
T cd08223         155 QCD--MASTLIGTPYYMSPE  172 (257)
T ss_pred             cCC--ccccccCCcCccChh
Confidence            322  122356899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.90  E-value=3.2e-23  Score=226.81  Aligned_cols=172  Identities=30%  Similarity=0.413  Sum_probs=140.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCC-------CcEEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKN-------AGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGS  745 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  745 (851)
                      +|++.+.||+|+||.||+|++...       ...||+|.+...   ...+.+.+|+++++++ +||||+++++++..++.
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   92 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence            588999999999999999986432       236899987643   2346788999999999 79999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHhhh-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE  814 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~  814 (851)
                      .|+||||+++|+|.+++.+...           .....+++..+..++.|++.|+.|||   +.+++||||||+||+++.
T Consensus        93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~  169 (334)
T cd05100          93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcC
Confidence            9999999999999999976421           12345788899999999999999999   789999999999999999


Q ss_pred             CCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       815 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.+||+|||+++...............++..|+|||
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  206 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE  206 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHH
Confidence            9999999999998665432222222233467899998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.90  E-value=5.4e-23  Score=219.89  Aligned_cols=166  Identities=30%  Similarity=0.396  Sum_probs=144.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|++.+.||+|+||.||+|++..++..||||++....    ..+.+.+|+.++++++||||+++++++..+...|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999998899999999986442    346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      + +++|.+++...    ...+++..+..++.|+++|++|||   +.+++|+||||+||+++.++.++++|||.+......
T Consensus        81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 99999998753    245889999999999999999999   789999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      .. .......|+.+|+|||
T Consensus       153 ~~-~~~~~~~~~~~y~aPE  170 (286)
T cd07832         153 EP-RLYSHQVATRWYRAPE  170 (286)
T ss_pred             CC-CccccccCcccccCce
Confidence            32 1223356899999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.90  E-value=4e-23  Score=217.88  Aligned_cols=167  Identities=28%  Similarity=0.438  Sum_probs=139.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+|++.+.||+|+||.||+|++..+ ..||+|++... ...+.+.+|++++++++||||+++++++.. +..|+||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            3688999999999999999988554 56999998754 345678999999999999999999988754 56799999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++.+.   ....+++..+..++.|++.||+|+|   +.+++||||||+||++++++.+||+|||.++.......
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          84 KGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999753   2335788899999999999999999   78999999999999999999999999999986654332


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .. .....++..|+|||
T Consensus       158 ~~-~~~~~~~~~y~~PE  173 (262)
T cd05071         158 TA-RQGAKFPIKWTAPE  173 (262)
T ss_pred             cc-ccCCcccceecCHh
Confidence            11 12234677899998

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.90  E-value=4.6e-23  Score=220.10  Aligned_cols=167  Identities=26%  Similarity=0.391  Sum_probs=139.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHH-HHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEI-LGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|++.+.||+|+||.||+|++..+++.||+|++....   ....+..|+.+ ++..+||||+++++++..++..|+||||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            6888999999999999999999999999999886542   23455566665 5667899999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      ++ |+|.+++..... ....+++..++.++.|++.|++|||   ++ +++||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          82 MD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            96 789888876432 2356899999999999999999999   55 899999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...   .....|+..|+|||
T Consensus       157 ~~~---~~~~~~~~~y~aPE  173 (283)
T cd06617         157 SVA---KTIDAGCKPYMAPE  173 (283)
T ss_pred             ccc---cccccCCccccChh
Confidence            221   12246889999998

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.90  E-value=3.9e-23  Score=224.16  Aligned_cols=173  Identities=31%  Similarity=0.415  Sum_probs=140.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-------CCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGG  744 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  744 (851)
                      .+|.+.+.||+|+||.||+|++..       ....||+|.+....   ....+.+|+++++++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            367899999999999999998632       34569999886542   345678899999999 6999999999999989


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhh-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      ..|+||||+++|+|.+++.....           .....+++..+..++.|++.|++|||   +.+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            99999999999999999976421           11245888899999999999999999   78999999999999999


Q ss_pred             CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++.+||+|||.++...............++..|||||
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  206 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE  206 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHH
Confidence            99999999999998665432221112223456799998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.90  E-value=8.5e-23  Score=215.92  Aligned_cols=167  Identities=29%  Similarity=0.457  Sum_probs=140.2

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-------ccHHHHHHHHHHHHcCCCCccccEEEEEEe--CCeeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  747 (851)
                      +|+..+.||+|+||.||+|.+..++..||+|++...       ...+.+.+|+.++++++||||+++++++..  ++..+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            688999999999999999999999999999987533       123467889999999999999999998865  36778


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +++||+++++|.+++...     ..+++.....++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        83 l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            999999999999998753     24678888899999999999999   7899999999999999999999999999997


Q ss_pred             ccCCCCC-cccccccccccccccCC
Q 003065          828 IAENSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      ....... ........|+..|+|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE  179 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPE  179 (266)
T ss_pred             ccccccccCCccccCCccccccCHH
Confidence            6543211 11122345899999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.90  E-value=6.3e-23  Score=215.70  Aligned_cols=164  Identities=30%  Similarity=0.426  Sum_probs=142.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +|+..+.||+|+||.||+|....++..||+|.+....       ..+.+.+|++++++++|+||+++++++..+...|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677899999999999999998889999999875432       346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      +||+++++|.+++.+.     ..+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||.+...
T Consensus        81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence            9999999999998753     34778888899999999999999   789999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   ......|++.|+|||
T Consensus       153 ~~~~---~~~~~~~~~~y~~pe  171 (258)
T cd06632         153 VEFS---FAKSFKGSPYWMAPE  171 (258)
T ss_pred             cccc---cccccCCCcceeCHH
Confidence            4432   122356899999998

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=9e-23  Score=215.11  Aligned_cols=167  Identities=32%  Similarity=0.474  Sum_probs=145.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ++|+..+.||+|+||.||+|.+..+++.+|+|++...  ...+.+.+|++++++++||||+++++++..++..|++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            4688899999999999999999888999999988654  34567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++...    ...++...+..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.+.......
T Consensus        83 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          83 GGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            999999988753    245788889999999999999999   7899999999999999999999999999997654332


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......|+..|+|||
T Consensus       156 ~--~~~~~~~~~~y~~Pe  171 (262)
T cd06613         156 A--KRKSFIGTPYWMAPE  171 (262)
T ss_pred             h--ccccccCCccccCch
Confidence            1  122356889999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.90  E-value=3.2e-23  Score=241.93  Aligned_cols=310  Identities=20%  Similarity=0.288  Sum_probs=186.7

Q ss_pred             CCchhhHHHHHHHHHhcCCCCCCCCC----CCCCCCCCcccce----------------eEecCCCCceEEEecccCCcc
Q 003065           27 LSLNVETQALIQFKSKLKDPHGVLDS----WKESADSPCGFSG----------------ITCDSVTGRVTEISFDNKSLS   86 (851)
Q Consensus        27 ~~~~~~~~aLl~fk~~~~~~~~~l~s----W~~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~l~   86 (851)
                      ...++|.+++++..+.+.-|. .+.+    |.+. +|+|--..                |.|.  .+.||.+..-+....
T Consensus        59 ~~~~~~~~~~~~~~~~l~~p~-~~~~~~~~~~~~-~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~~~  134 (754)
T PRK15370         59 TASPEEIKSKFECLRMLAFPA-YADNIQYSRGGA-DQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESEQA  134 (754)
T ss_pred             CCCHHHHHHHHHHHHHhcCCc-hhhccccccCCC-CcccccCCcchhhheeeecCCceEEecC--CCccccccccccccc
Confidence            345788999999999997663 3444    9887 78895544                5564  335666655442222


Q ss_pred             eecCccccCCccCcEEeCC-----CCcccCccC---ccc-----ccCCCCceEecccCcccCCCCCCCCCCCCCeEeccC
Q 003065           87 GEISSSISALQSLTVLSLP-----FNVLSGKLP---LEL-----SNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI  153 (851)
Q Consensus        87 g~i~~~l~~l~~L~~L~L~-----~n~l~~~~p---~~~-----~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~  153 (851)
                      ..-..+-.    -..-+..     .+.-.+.-+   .++     +-..+.+.|+++++.++..+..+.  ++|+.|+|++
T Consensus       135 ~~~~~~~~----~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~  208 (754)
T PRK15370        135 SSASGSKD----AVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACIP--EQITTLILDN  208 (754)
T ss_pred             ccCCCCCC----hhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCcccc--cCCcEEEecC
Confidence            11110000    0000000     000000000   001     111456677777777766544443  3677777777


Q ss_pred             cccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccc
Q 003065          154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF  233 (851)
Q Consensus       154 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~  233 (851)
                      |+++ .+|..+.  ++|++|++++|+++  .+|..+.  ++|+.|+|++|++. .+|..+.  ++|++|++++|+|+ .+
T Consensus       209 N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt--sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~L  277 (754)
T PRK15370        209 NELK-SLPENLQ--GNIKTLYANSNQLT--SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CL  277 (754)
T ss_pred             CCCC-cCChhhc--cCCCEEECCCCccc--cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-cc
Confidence            7776 3454443  46777777777775  5565443  46777777777777 5566554  46777788777777 45


Q ss_pred             cccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcc
Q 003065          234 PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR  313 (851)
Q Consensus       234 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~  313 (851)
                      |..+.  ++|+.|++++|+++ .+|..+.  ++|+.|++++|+++. +|..+.  ++|+.|++++|.+++ +|..+.  +
T Consensus       278 P~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~  346 (754)
T PRK15370        278 PENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--P  346 (754)
T ss_pred             ccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--C
Confidence            65543  47788888888887 3554442  467888888888873 454443  578888888888874 565553  6


Q ss_pred             cccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCcc
Q 003065          314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFS  374 (851)
Q Consensus       314 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~  374 (851)
                      +|+.|++++|+++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ..|+.|++++|++.
T Consensus       347 sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~  401 (754)
T PRK15370        347 ELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV  401 (754)
T ss_pred             cccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc
Confidence            7888888888887 4565543  57888999999888 4565443  23455555555544

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.90  E-value=5.9e-23  Score=219.41  Aligned_cols=168  Identities=30%  Similarity=0.418  Sum_probs=137.5

Q ss_pred             CCccCCeecccCcEEEEEEEE----cCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEe--CCeeEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDL----KKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFL  748 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  748 (851)
                      +|++.+.||+|+||.||+|..    ..++..||+|++....  ..+.+.+|++++++++||||+++++++..  ....|+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            678889999999999999984    3567889999986542  34578899999999999999999998754  346799


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++++|.+++.+.    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        85 v~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          85 VMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            99999999999998753    235788999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCccc-ccccccccccccCC
Q 003065          829 AENSPKVSD-YSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~-~~~~~gt~~Y~APE  851 (851)
                      ......... .....++..|+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE  181 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPE  181 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHH
Confidence            654322111 11122345699998

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.90  E-value=4.2e-23  Score=221.03  Aligned_cols=173  Identities=29%  Similarity=0.364  Sum_probs=141.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      .+|+..+.||+|+||.||+|.+..     ++..||+|++....   ..+.+.+|++++++++||||+++++++..++..|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            468899999999999999998743     56789999886543   2456889999999999999999999999989999


Q ss_pred             EEEeccCCCCHHHHHHHhhh-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCE
Q 003065          748 LVLEYMPNGNLFQALHKRVK-----------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNI  810 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NI  810 (851)
                      +||||+++|+|.+++.....                 .....+++..++.++.|++.|+.|+|   +.+++||||||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhhe
Confidence            99999999999999975421                 11234778888999999999999999   78999999999999


Q ss_pred             EECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          811 LLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       811 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++.++.+||+|||.++...............++..|+|||
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  202 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPE  202 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHH
Confidence            99999999999999987654332111111223567799998

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.90  E-value=4.6e-23  Score=219.38  Aligned_cols=173  Identities=28%  Similarity=0.299  Sum_probs=141.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|.+.+.||+|+||.||+|.+..     ++..||+|.+....   ....+.+|+.++++++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            468889999999999999999976     67789999875332   2456889999999999999999999999888999


Q ss_pred             EEEeccCCCCHHHHHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC---ceEEee
Q 003065          748 LVLEYMPNGNLFQALHKRVKE--GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---EPKIAD  822 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~D  822 (851)
                      +||||+++++|.+++......  ....+++..+.+++.|++.|++|||   +.+++||||||+||+++.++   .+|++|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEecc
Confidence            999999999999999765321  1235889999999999999999999   78999999999999998654   599999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++...............++..|+|||
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPE  191 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHH
Confidence            99998764322211111223456899998

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.90  E-value=5.2e-23  Score=220.66  Aligned_cols=167  Identities=27%  Similarity=0.366  Sum_probs=141.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +++|+..+.||+|++|.||+|+++.+++.||||.+....   ....+.+|++++++++|+||+++++++..++..|+|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            357899999999999999999998889999999885432   23456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |++ ++|.+++.+.    ...+++.....++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        84 ~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          84 YLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             cCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            997 5999988753    235788889999999999999999   78999999999999999999999999999875432


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  .....++..|+|||
T Consensus       156 ~~~~--~~~~~~~~~~~aPE  173 (291)
T cd07844         156 PSKT--YSNEVVTLWYRPPD  173 (291)
T ss_pred             CCcc--ccccccccccCCcH
Confidence            2111  12234688999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=6.7e-23  Score=222.58  Aligned_cols=148  Identities=31%  Similarity=0.434  Sum_probs=132.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+....     ..+.+.+|+++++.++||||+++++.+..++..|+|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            6888899999999999999998889999999986542     34568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |+++++|.+++...   ....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus        82 ~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          82 YCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             ecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            99999999998753   2346788889999999999999999   7899999999999999999999999999987543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.89  E-value=5.3e-23  Score=217.68  Aligned_cols=167  Identities=25%  Similarity=0.368  Sum_probs=142.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      +|+..+.||+|+||.||+|....+++.||+|++....        ..+.+.+|++++++++|+||+++++++..++..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999998999999999886432        24578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-ceEEeeecCcc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAK  827 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~  827 (851)
                      ||||+++++|.+++.+.     ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++ .+||+|||.+.
T Consensus        81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            99999999999998753     35778888999999999999999   78999999999999998776 59999999997


Q ss_pred             ccCCCCCcc--cccccccccccccCC
Q 003065          828 IAENSPKVS--DYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~--~~~~~~gt~~Y~APE  851 (851)
                      .........  ......||..|+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE  178 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPE  178 (268)
T ss_pred             ccccccccCCccccccccccceeCHh
Confidence            665432111  112346889999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.89  E-value=8.4e-23  Score=220.59  Aligned_cols=167  Identities=26%  Similarity=0.341  Sum_probs=141.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|+..+.||+|+||.||++.+..+++.||+|.+....     ..+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888999999999999999999999999999885432     34567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++++|.+++...     ..+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||+++....
T Consensus        82 ~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          82 YVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999998653     35788888899999999999999   78999999999999999999999999999874211


Q ss_pred             CCC-------------cccccccccccccccCC
Q 003065          832 SPK-------------VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~-------------~~~~~~~~gt~~Y~APE  851 (851)
                      ...             ........|+..|+|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  186 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE  186 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCch
Confidence            100             00111245788999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.89  E-value=6.8e-23  Score=219.75  Aligned_cols=166  Identities=27%  Similarity=0.329  Sum_probs=139.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      .+|...+.||+|+||.||+|.+..+++.||+|++...   .....+.+|+++++.++|+||+++++++..++..|+||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            4788999999999999999999989999999998543   2234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +. +++.+++...    ...+.+..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          85 MH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             cc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            95 7887776542    234677788889999999999999   789999999999999999999999999999764432


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  .....+++.|+|||
T Consensus       157 ~~~--~~~~~~~~~y~aPE  173 (291)
T cd07870         157 SQT--YSSEVVTLWYRPPD  173 (291)
T ss_pred             CCC--CCCccccccccCCc
Confidence            211  12245789999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.89  E-value=5.8e-23  Score=216.13  Aligned_cols=156  Identities=22%  Similarity=0.346  Sum_probs=132.6

Q ss_pred             CeecccCcEEEEEEEEcCCC----------cEEEEEEeccccc-HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          682 NLIGSGGTGKVYRLDLKKNA----------GTVAVKQLWKGDG-VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +.||+|+||.||+|.+..++          ..|++|.+..... ...+.+|+.++++++||||+++++++.. +..++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46899999999999997666          3478887654433 6778899999999999999999999887 7789999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-------ceEEeee
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-------EPKIADF  823 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~DF  823 (851)
                      ||+++|+|.+++...    ...+++..+..++.|++.|++|||   +++|+||||||+||+++.++       .+|++||
T Consensus        80 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          80 EYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence            999999999998764    225788889999999999999999   78999999999999999887       7999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++.....      ....++..|+|||
T Consensus       153 g~a~~~~~~------~~~~~~~~y~aPE  174 (259)
T cd05037         153 GIPITVLSR------EERVERIPWIAPE  174 (259)
T ss_pred             Ccccccccc------cccccCCCccChh
Confidence            999865431      1234677899998

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.89  E-value=9e-23  Score=216.49  Aligned_cols=167  Identities=29%  Similarity=0.396  Sum_probs=141.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc------------cHHHHHHHHHHHHcCCCCccccEEEEEEeCC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD------------GVKVFAAEMEILGKIRHRNILKLYACLLKGG  744 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  744 (851)
                      +|...+.||+|+||.||+|....+++.||+|.+....            ..+.+.+|++++++++|||++++++++..++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4678899999999999999998889999999874310            1245778999999999999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      ..++||||+++++|.+++.+.     ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+|++|||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence            999999999999999998753     35788888899999999999999   7899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++...............|+..|+|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE  180 (272)
T cd06629         154 ISKKSDDIYDNDQNMSMQGSVFWMAPE  180 (272)
T ss_pred             ccccccccccccccccccCCccccCHH
Confidence            997654332222223346889999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.89  E-value=7.5e-23  Score=218.77  Aligned_cols=165  Identities=26%  Similarity=0.405  Sum_probs=141.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||+|++..+++.||+|++....    ..+.+.+|++++++++||||+++++++..+...++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            6888999999999999999998889999999875432    235678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++++.+..++..     ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          82 CDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             cCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            998877766543     235789999999999999999999   789999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ......++..|+|||
T Consensus       154 ~~--~~~~~~~~~~~~aPE  170 (286)
T cd07847         154 GD--DYTDYVATRWYRAPE  170 (286)
T ss_pred             cc--cccCcccccccCCHH
Confidence            32  122346788999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.89  E-value=9.1e-23  Score=215.78  Aligned_cols=167  Identities=31%  Similarity=0.430  Sum_probs=141.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----------GVKVFAAEMEILGKIRHRNILKLYACLLKGGS  745 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  745 (851)
                      +|...+.||+|+||.||+|.+..+++.||+|.+....           ..+.+.+|++++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999998889999999875431           12457889999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .++||||+++++|.+++...     ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCC
Confidence            99999999999999999753     34678888899999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCc----ccccccccccccccCC
Q 003065          826 AKIAENSPKV----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~----~~~~~~~gt~~Y~APE  851 (851)
                      ++........    .......|+..|+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe  182 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPE  182 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChh
Confidence            9876532111    1112345889999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.89  E-value=7.2e-23  Score=223.34  Aligned_cols=166  Identities=18%  Similarity=0.217  Sum_probs=137.1

Q ss_pred             cCCeeccc--CcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          680 EDNLIGSG--GTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       680 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ..++||+|  +|++||++.++.+++.||||++...    ...+.+.+|+++++.++||||+++++++..++..|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999999999999999998653    22345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++|+|.+++..+.   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++|||.+.......
T Consensus        82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            9999999987542   234788899999999999999999   7899999999999999999999999998764432211


Q ss_pred             Ccc-----cccccccccccccCC
Q 003065          834 KVS-----DYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~-----~~~~~~gt~~Y~APE  851 (851)
                      ...     ......++..|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE  178 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPE  178 (327)
T ss_pred             ccccccccccccccceecccChH
Confidence            100     011235778899998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=4.7e-23  Score=229.52  Aligned_cols=168  Identities=30%  Similarity=0.433  Sum_probs=147.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcC-CCCccccEEEEEEe-----CCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLLK-----GGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~l  748 (851)
                      ..|++.+.||+|.+|+||+++.+++++.+|||+.... +..++++.|.++++.. .|||++.++++|..     ++..|+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            4578999999999999999999999999999988654 4566788899999887 69999999998853     578999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |||||.+|+..|.++...   ...+.|..+..|++.++.|+.+||   ...++|||||=.|||++.++.+|++|||.+..
T Consensus        99 VMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             EeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            999999999999998753   456889999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  ....+.+|||.|||||
T Consensus       173 ldsT~--grRnT~iGtP~WMAPE  193 (953)
T KOG0587|consen  173 LDSTV--GRRNTFIGTPYWMAPE  193 (953)
T ss_pred             eeccc--ccccCcCCCcccccce
Confidence            66543  3344578999999998

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.89  E-value=6.9e-23  Score=215.16  Aligned_cols=167  Identities=29%  Similarity=0.416  Sum_probs=147.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      ++|+..+.||+|+||.||+|....+++.||+|.+......+++.+|++++++++||||+++++++..+...|+++||+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            47889999999999999999998888999999987665577899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++...    ...+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.+||+|||++.........
T Consensus        83 ~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          83 GSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            9999998653    346789999999999999999999   789999999999999999999999999999876544321


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                        .....|+..|+|||
T Consensus       156 --~~~~~~~~~y~~PE  169 (256)
T cd06612         156 --RNTVIGTPFWMAPE  169 (256)
T ss_pred             --cccccCCccccCHH
Confidence              22345889999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=9.3e-23  Score=214.30  Aligned_cols=163  Identities=31%  Similarity=0.516  Sum_probs=141.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc-HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||.||+|..  .++.||+|.+..... .+++.+|+.++++++|+||+++++++...+..|+||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            4788999999999999999987  478899999876644 6778999999999999999999999998899999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...   ....+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||.++.......
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          84 KGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            99999998764   2235889999999999999999999   78999999999999999999999999999987643221


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                           ...++..|+|||
T Consensus       158 -----~~~~~~~~~ape  169 (256)
T cd05039         158 -----SGKLPVKWTAPE  169 (256)
T ss_pred             -----cCCCcccccCch
Confidence                 123466799998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.89  E-value=8.1e-23  Score=219.55  Aligned_cols=165  Identities=26%  Similarity=0.419  Sum_probs=143.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|+..+.||.|+||.||+|.+..+++.||+|.+...  ...+.+.+|+++++.++||||+++++++..++..|+|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3688899999999999999999899999999988543  34567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++...      .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          99 AGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            999999988642      4788999999999999999999   7899999999999999999999999999987654432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  .....|++.|+|||
T Consensus       170 ~~--~~~~~~~~~y~aPE  185 (296)
T cd06655         170 SK--RSTMVGTPYWMAPE  185 (296)
T ss_pred             cc--CCCcCCCccccCcc
Confidence            21  12246899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.89  E-value=6.8e-23  Score=218.43  Aligned_cols=173  Identities=25%  Similarity=0.372  Sum_probs=141.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      ++|...+.||+|+||.||+|...     .++..+|+|.+...  ...+.+.+|++++++++|+||+++++++..++..|+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            36788899999999999999753     34567999987543  335678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCce
Q 003065          749 VLEYMPNGNLFQALHKRVKE----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP  818 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~  818 (851)
                      ||||+++++|.+++......          ....+++..+..++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            99999999999999764210          1135788999999999999999999   7899999999999999999999


Q ss_pred             EEeeecCccccCCCCCcccccccccccccccCC
Q 003065          819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       819 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|||+++...............+++.|+|||
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  194 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE  194 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHH
Confidence            999999997654332211122234578899998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=2.3e-23  Score=238.97  Aligned_cols=175  Identities=22%  Similarity=0.309  Sum_probs=134.8

Q ss_pred             HHHHcCCccCCeecccCcEEEEEEEEcCCCcE-EEEE------------------Eeccc-ccHHHHHHHHHHHHcCCCC
Q 003065          672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT-VAVK------------------QLWKG-DGVKVFAAEMEILGKIRHR  731 (851)
Q Consensus       672 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK------------------~~~~~-~~~~~~~~E~~~l~~l~h~  731 (851)
                      .....+|++.+.||+|+||+||+|..+..... ++.|                  .+... .....+.+|++++++++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            34457899999999999999999876533221 1111                  11111 2345678999999999999


Q ss_pred             ccccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 003065          732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL  811 (851)
Q Consensus       732 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NIL  811 (851)
                      |||++++++...+..|+|+|++ ++++.+++..................++.|++.||+|||   +++||||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence            9999999999999999999999 568888876532221223345567789999999999999   789999999999999


Q ss_pred             ECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          812 LDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       812 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.++.+||+|||+|+......... .....||+.|+|||
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE  338 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPE  338 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCch
Confidence            9999999999999998765432221 22357999999998

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.89  E-value=7.6e-23  Score=220.20  Aligned_cols=165  Identities=28%  Similarity=0.381  Sum_probs=141.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +|+..+.||+|+||.||+|.+..+++.||||++....       ....+..|++++++++|+||+++++++.+++..|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999998889999999986442       134567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+ +++|.+++...    ...+++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            9999 89999998753    135889999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  .....+++.|+|||
T Consensus       153 ~~~~~~--~~~~~~~~~y~aPE  172 (298)
T cd07841         153 GSPNRK--MTHQVVTRWYRAPE  172 (298)
T ss_pred             cCCCcc--ccccccceeeeCHH
Confidence            543221  12235688999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.89  E-value=1.1e-22  Score=218.66  Aligned_cols=169  Identities=26%  Similarity=0.286  Sum_probs=140.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCC-CCccccEEEEEEeCCe-----e
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIR-HRNILKLYACLLKGGS-----S  746 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~  746 (851)
                      +|+..+.||+|+||.||+|.+..+++.||+|++....    ..+.+.+|+++++++. ||||+++++++...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6888999999999999999999999999999875432    2356788999999995 6999999999877665     7


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-CCceEEeeecC
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGV  825 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGl  825 (851)
                      |+||||+++ ++.+++..........+++..+..++.||+.||+|||   +++|+||||||+||+++. ++.+||+|||.
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999975 8999887653332346789999999999999999999   789999999999999998 88999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.......  ......+++.|+|||
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~aPE  181 (295)
T cd07837         158 GRAFSIPVK--SYTHEIVTLWYRAPE  181 (295)
T ss_pred             ceecCCCcc--ccCCcccccCCCChH
Confidence            986543221  122235788999998

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.89  E-value=7e-23  Score=220.96  Aligned_cols=168  Identities=27%  Similarity=0.399  Sum_probs=138.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc----EEEEEEeccccc---HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|+..+.||+|+||.||+|++..++.    .||+|.+.....   ...+.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            467888999999999999999876665    478888765432   33678999999999999999999988654 4679


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ++||+++|+|.+++...    ...+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus        86 v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccc
Confidence            99999999999998753    335788889999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..............++..|+|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE  181 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALE  181 (303)
T ss_pred             ccCcccccccCCCccccccCCHH
Confidence            65433222222334677899998

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.89  E-value=3.4e-23  Score=221.27  Aligned_cols=165  Identities=28%  Similarity=0.410  Sum_probs=140.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||+|++..+++.||+|++....    ....+.+|++++++++||||+++++++.+.+..|+|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999999999999999885432    234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++ +++.+++...    ...+++..+..++.|+++|++|||   +++++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          81 CD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            96 5888877653    345889999999999999999999   789999999999999999999999999999865433


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ......+++.|+|||
T Consensus       153 ~~--~~~~~~~~~~y~aPE  169 (284)
T cd07839         153 VR--CYSAEVVTLWYRPPD  169 (284)
T ss_pred             CC--CcCCCccccCCcChH
Confidence            21  122346789999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.89  E-value=9.8e-23  Score=214.87  Aligned_cols=157  Identities=22%  Similarity=0.325  Sum_probs=129.9

Q ss_pred             CeecccCcEEEEEEEEcCC------------CcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          682 NLIGSGGTGKVYRLDLKKN------------AGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~------------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      +.||+|+||.||+|+....            ...||+|.+...  .....+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4689999999999985322            235888887543  23456788999999999999999999999988999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc-------eEE
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-------PKI  820 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~-------~kl  820 (851)
                      +||||+++|+|..++...    ...+++..+..++.|+++|++|||   +++|+||||||+||+++.++.       +|+
T Consensus        81 lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence            999999999998887643    345788889999999999999999   889999999999999987664       899


Q ss_pred             eeecCccccCCCCCcccccccccccccccCC
Q 003065          821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|||++.......      ...|+..|+|||
T Consensus       154 ~d~g~~~~~~~~~------~~~~~~~y~aPE  178 (262)
T cd05077         154 SDPGIPITVLSRQ------ECVERIPWIAPE  178 (262)
T ss_pred             CCCCCCccccCcc------cccccccccChh
Confidence            9999987553321      235788999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.89  E-value=1e-22  Score=214.62  Aligned_cols=167  Identities=31%  Similarity=0.447  Sum_probs=139.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||.||+|.+. .+..||+|.+... ...+.+.+|+.++++++|++++++++++. .+..|+||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            36889999999999999999874 5667999988654 34567899999999999999999999875 456899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...   ....+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||.+........
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          84 KGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999998753   2345788999999999999999999   78999999999999999999999999999986654322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .. .....++..|+|||
T Consensus       158 ~~-~~~~~~~~~y~aPE  173 (260)
T cd05070         158 TA-RQGAKFPIKWTAPE  173 (260)
T ss_pred             cc-ccCCCCCccccChH
Confidence            11 11234567899998

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.89  E-value=1.5e-22  Score=214.26  Aligned_cols=168  Identities=26%  Similarity=0.357  Sum_probs=139.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+.....||+|+||.||+|.+..++..||+|.+...  ...+.+.+|++++++++|+||+++++++..++..++|+||++
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   88 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP   88 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence            344556899999999999999888999999987654  345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-CCceEEeeecCccccCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~  833 (851)
                      +++|.+++.....  ....+...+..++.|++.|++|||   +.+|+||||||+||+++. ++.+||+|||.+.......
T Consensus        89 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          89 GGSLSALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             CCCHHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            9999999876311  111267778889999999999999   789999999999999976 6799999999987654322


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......|++.|+|||
T Consensus       164 ~--~~~~~~~~~~~~aPE  179 (268)
T cd06624         164 P--CTETFTGTLQYMAPE  179 (268)
T ss_pred             C--ccccCCCCccccChh
Confidence            2  122345899999998

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.89  E-value=7.9e-23  Score=219.48  Aligned_cols=167  Identities=31%  Similarity=0.367  Sum_probs=142.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  748 (851)
                      +++|+..+.||+|+||.||+|++..+++.||+|.+....    ....+.+|++++++++||||+++++++...  +..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            457899999999999999999998889999999986432    233567899999999999999999998877  88999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||++ ++|.+++...    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||.++.
T Consensus        84 v~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~  155 (293)
T cd07843          84 VMEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLARE  155 (293)
T ss_pred             EehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence            999996 5998888753    235889999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  ......+++.|+|||
T Consensus       156 ~~~~~~--~~~~~~~~~~~~aPE  176 (293)
T cd07843         156 YGSPLK--PYTQLVVTLWYRAPE  176 (293)
T ss_pred             ccCCcc--ccccccccccccCch
Confidence            655422  122345789999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.89  E-value=8.8e-23  Score=219.52  Aligned_cols=170  Identities=31%  Similarity=0.443  Sum_probs=138.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc--EEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG--TVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ++|++.+.||+|+||.||+|+...++.  .+|+|.+...   ...+.+.+|+++++++ +||||+++++++...+..|+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            478899999999999999999877664  4788877532   2345688999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCce
Q 003065          750 LEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP  818 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~  818 (851)
                      |||+++++|.+++......           ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            9999999999999764211           1134788899999999999999999   7899999999999999999999


Q ss_pred             EEeeecCccccCCCCCcccccccccccccccCC
Q 003065          819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       819 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|||++........   ......+..|+|||
T Consensus       159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE  188 (297)
T cd05089         159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIE  188 (297)
T ss_pred             EECCcCCCccccceec---cCCCCcCccccCch
Confidence            9999999864322111   11112355799998

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.89  E-value=8.2e-23  Score=216.94  Aligned_cols=156  Identities=22%  Similarity=0.284  Sum_probs=127.8

Q ss_pred             eecccCcEEEEEEEEcCC------------------------CcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccE
Q 003065          683 LIGSGGTGKVYRLDLKKN------------------------AGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKL  736 (851)
Q Consensus       683 ~lg~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l  736 (851)
                      .||+|+||.||+|....+                        ...||+|++....  ....+.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            589999999999975321                        2348888875432  24567889999999999999999


Q ss_pred             EEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC
Q 003065          737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY  816 (851)
Q Consensus       737 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~  816 (851)
                      ++++..+...|+||||+++|+|.+++.+.    ...+++..+..++.|+++||+|||   +++|+||||||+||+++..+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccC
Confidence            99999999999999999999998888642    345788889999999999999999   78999999999999997644


Q ss_pred             -------ceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          817 -------EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       817 -------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                             .+|++|||.+.......      ...++..|+|||
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe  190 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPE  190 (274)
T ss_pred             cccCccceeeecCCcccccccccc------ccccCCcccCch
Confidence                   38999999986543221      135788899998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.89  E-value=9e-23  Score=214.15  Aligned_cols=162  Identities=29%  Similarity=0.507  Sum_probs=138.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      .+|++.+.||+|+||.||++..  +++.||+|++......+.+.+|+.++++++||||+++++++... ..|+||||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            4688999999999999999875  67789999987666667889999999999999999999998765 47999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++...   ....+++..+..++.|++.|+.|+|   +.+++||||||+||+++.++.+||+|||.++....... 
T Consensus        83 ~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-  155 (254)
T cd05083          83 GNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-  155 (254)
T ss_pred             CCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCC-
Confidence            9999998764   2335788889999999999999999   78999999999999999999999999999976433211 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                          ....+..|+|||
T Consensus       156 ----~~~~~~~y~~pe  167 (254)
T cd05083         156 ----NSKLPVKWTAPE  167 (254)
T ss_pred             ----CCCCCceecCHH
Confidence                123456799998

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.89  E-value=4.1e-23  Score=220.80  Aligned_cols=165  Identities=30%  Similarity=0.442  Sum_probs=142.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||+|.+..+++.||+|++....    ..+.+.+|++++++++||||+++++++..++..|+||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            6888999999999999999998889999999875432    245678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++++++.++...     ...+++..+..++.|++.|++|||   +.+++|||++|+||++++++.+||+|||+++.....
T Consensus        82 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          82 VDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             CCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            998888776543     234789999999999999999999   789999999999999999999999999999865443


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ......|+..|+|||
T Consensus       154 ~~--~~~~~~~~~~y~aPE  170 (286)
T cd07846         154 GE--VYTDYVATRWYRAPE  170 (286)
T ss_pred             cc--ccCcccceeeccCcH
Confidence            22  223356899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PTZ00284 protein kinase; Provisional

Probab=99.89  E-value=8.5e-23  Score=233.53  Aligned_cols=162  Identities=21%  Similarity=0.292  Sum_probs=132.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCC------CccccEEEEEEeC-CeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRH------RNILKLYACLLKG-GSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~~~  747 (851)
                      .+|++.+.||+|+||.||+|++..+++.||||++... ...+....|+++++.++|      .+++++++++... +..|
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            5799999999999999999999989999999998643 233456678888877754      4588888888764 5788


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCcEEeCCCCCCEEECCCC----------
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNILLDEDY----------  816 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrDlkp~NILl~~~~----------  816 (851)
                      +|||++ +++|.+++.+.     ..+++..+..++.|++.||+|||   + .+||||||||+|||++.++          
T Consensus       209 iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             EEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            999988 78999988753     35788899999999999999999   5 5999999999999998765          


Q ss_pred             ------ceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          817 ------EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       817 ------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                            .+||+|||.+......     ....+||+.|||||
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE  315 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPE  315 (467)
T ss_pred             cCCCCceEEECCCCccccCccc-----cccccCCccccCcH
Confidence                  4999999988643221     23367999999998

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=8e-23  Score=218.36  Aligned_cols=165  Identities=30%  Similarity=0.426  Sum_probs=143.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      .+|++.+.||+|+||+||+|++..+++.||+|++...   ...+.+.+|+++++.++||||+++++++...+..|+||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4688899999999999999999889999999987543   2356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++.+.     ..+++.....++.+++.|+.|||+  ..+++||||||+||++++++.++|+|||++......
T Consensus        85 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          85 MDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             CCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999888652     357888899999999999999994  258999999999999999999999999998754332


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..    ....|+..|+|||
T Consensus       158 ~~----~~~~~~~~~~aPE  172 (284)
T cd06620         158 IA----DTFVGTSTYMSPE  172 (284)
T ss_pred             cc----CccccCcccCCHH
Confidence            21    2346899999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.7e-22  Score=213.29  Aligned_cols=167  Identities=30%  Similarity=0.454  Sum_probs=140.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-------ccHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  747 (851)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...       ...+.+.+|++++++++|+||+++++++...  +..+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            688999999999999999999999999999987432       2235688999999999999999999998664  4678


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +|+||+++++|.+++...     ..+++.....++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||+++
T Consensus        83 ~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            999999999999988753     24678888899999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCC-cccccccccccccccCC
Q 003065          828 IAENSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      ....... ........|+..|+|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE  179 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPE  179 (264)
T ss_pred             ccccccccCccccccCCcccccCHh
Confidence            6543211 11122356899999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.89  E-value=1.8e-22  Score=212.03  Aligned_cols=166  Identities=31%  Similarity=0.446  Sum_probs=143.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||+|....+++.+|||.+...    ...+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999999999999999988543    2356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-CceEEeeecCccccCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAEN  831 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~  831 (851)
                      +++++|.+++...   ....+++..+..++.++++|++|+|   +++++||||||+||+++++ +.+|++|||.++....
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            9999999999764   2345788889999999999999999   7899999999999999855 4689999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   ....|+..|+|||
T Consensus       155 ~~~~---~~~~~~~~y~aPE  171 (256)
T cd08220         155 KSKA---YTVVGTPCYISPE  171 (256)
T ss_pred             Cccc---cccccCCcccCch
Confidence            3221   2246899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.89  E-value=1.3e-22  Score=214.83  Aligned_cols=168  Identities=30%  Similarity=0.487  Sum_probs=139.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCc---EEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +|+..+.||+|+||.||+|+...+++   .+|+|.+....   ..+.+.+|++++++++||||+++++++...+..|+||
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT   85 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence            67888999999999999999875554   69999886542   3456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++...    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||++....
T Consensus        86 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          86 EYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999998753    345788899999999999999999   7899999999999999999999999999997665


Q ss_pred             CCCCcccc-cccccccccccCC
Q 003065          831 NSPKVSDY-SCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~-~~~~gt~~Y~APE  851 (851)
                      ........ .....++.|+|||
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE  180 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPE  180 (268)
T ss_pred             cccccceeccCCCcCceecCHH
Confidence            43221111 1112345799998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.89  E-value=1.9e-22  Score=213.10  Aligned_cols=166  Identities=25%  Similarity=0.372  Sum_probs=139.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      +|+..+.||+|+||.||+|.. .+++.+|||.+....        ..+.+.+|++++++++|+||+++++++.+.+..|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            478889999999999999987 578899999875331        23457889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+||+++++|.+++.+.     ..+++..+..++.|++.|++|+|   +.+|+|+||||+||++++++.+||+|||+++.
T Consensus        80 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  151 (265)
T cd06631          80 FMEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARR  151 (265)
T ss_pred             EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence            99999999999998753     24678888899999999999999   78999999999999999999999999999876


Q ss_pred             cCCCCC----cccccccccccccccCC
Q 003065          829 AENSPK----VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~----~~~~~~~~gt~~Y~APE  851 (851)
                      ......    ........|+..|+|||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe  178 (265)
T cd06631         152 LAWVGLHGTHSNMLKSMHGTPYWMAPE  178 (265)
T ss_pred             hhhccccccccccccccCCCccccChh
Confidence            532111    11122356899999998

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.89  E-value=1.2e-22  Score=215.86  Aligned_cols=172  Identities=25%  Similarity=0.362  Sum_probs=142.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEeccccc---HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|+..+.||+|+||.||+|+.+.     +.+.||+|.+.....   .+.+.+|++++++++|+||+++++++...+..|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            468889999999999999999753     345699998865433   467899999999999999999999999988999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEG----KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      +||||+++|+|.+++.......    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+|++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997642111    125889999999999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++...... ........++..|+|||
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE  188 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPE  188 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChh
Confidence            9987543222 11222345678899998

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.89  E-value=1.6e-22  Score=212.55  Aligned_cols=161  Identities=25%  Similarity=0.311  Sum_probs=131.2

Q ss_pred             eecccCcEEEEEEEEc--CCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCC
Q 003065          683 LIGSGGTGKVYRLDLK--KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGN  757 (851)
Q Consensus       683 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  757 (851)
                      .||+|+||.||+|.+.  ..+..||+|++....   ..+.+.+|++++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999775  345569999886543   24568899999999999999999998764 56899999999999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc-
Q 003065          758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS-  836 (851)
Q Consensus       758 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-  836 (851)
                      |.+++...    ...+++..+.+++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++......... 
T Consensus        81 L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          81 LNKFLSGK----KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            99988753    346888999999999999999999   7899999999999999999999999999997654432211 


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      ......+++.|+|||
T Consensus       154 ~~~~~~~~~~y~aPE  168 (257)
T cd05115         154 ARSAGKWPLKWYAPE  168 (257)
T ss_pred             ccCCCCCCcccCCHH
Confidence            111123457899998

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.4e-22  Score=213.58  Aligned_cols=168  Identities=32%  Similarity=0.464  Sum_probs=142.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|.+.+.||+|+||.||+|... .++.||||.+... ...+++.+|++++++++|+||+++++++......++||||++
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            47889999999999999999974 5578999988654 446778999999999999999999999998889999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...   ....+++..+..++.+++.|++|||   +.+++|+||||+||++++++.+|++|||.++.......
T Consensus        85 ~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          85 KGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             CCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999763   2345788999999999999999999   78999999999999999999999999999987654221


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .. .....++..|+|||
T Consensus       159 ~~-~~~~~~~~~y~~PE  174 (261)
T cd05034         159 TA-REGAKFPIKWTAPE  174 (261)
T ss_pred             hh-hhccCCCccccCHH
Confidence            11 11223456899998

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.5e-23  Score=215.30  Aligned_cols=170  Identities=32%  Similarity=0.336  Sum_probs=142.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---------ccHHHHHHHHHHHHcCCCCccccEEEEEE-eCCe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---------DGVKVFAAEMEILGKIRHRNILKLYACLL-KGGS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~  745 (851)
                      ++|-...+||+|+|++||+|.+....+.||||+-.-.         .-.+...+|.++-+.+.||.||++|++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            3577788999999999999999888889999975322         12345678999999999999999999996 4577


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC---CCCceEEee
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIAD  822 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~D  822 (851)
                      +|-|+|||+|.+|.-|++.+     ..+++..+..|+.||+.||.||.+. +++|||-|+||.|||+.   ..|.+||+|
T Consensus       543 FCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            89999999999999888764     3567888889999999999999976 78999999999999995   457899999


Q ss_pred             ecCccccCCCCCcc-----cccccccccccccCC
Q 003065          823 FGVAKIAENSPKVS-----DYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~-----~~~~~~gt~~Y~APE  851 (851)
                      ||+++++.++....     -+...+||.+|.+||
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPE  650 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPE  650 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcc
Confidence            99999987654321     234568999999998

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.89  E-value=1.7e-22  Score=212.82  Aligned_cols=166  Identities=30%  Similarity=0.439  Sum_probs=137.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +|.+.+.||+|+||.||+|.+..+ ..+|+|++... ...+.+.+|++++++++|++++++++++. .+..|+||||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            578889999999999999988544 46999987654 34567889999999999999999998875 4568999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++...   ....+++..+..++.|++.|+.|||   +.+++||||||+||++++++.+||+|||.++........
T Consensus        85 ~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          85 GSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999753   2335788899999999999999999   789999999999999999999999999999866443221


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......++..|+|||
T Consensus       159 -~~~~~~~~~~y~~Pe  173 (260)
T cd05069         159 -ARQGAKFPIKWTAPE  173 (260)
T ss_pred             -ccCCCccchhhCCHH
Confidence             111234677899998

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.89  E-value=6e-23  Score=216.04  Aligned_cols=164  Identities=29%  Similarity=0.413  Sum_probs=143.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...     ...+.+.+|++++++++||||+++++++..+...|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            478889999999999999999889999999988643     235678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++++|.+++...     ..++...+..++.|+++|+.|||   +.+++|+||||+||++++++.++|+|||.+.....
T Consensus        81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            99999999998753     35788889999999999999999   78999999999999999999999999999876654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...   .....|+..|+|||
T Consensus       153 ~~~---~~~~~~~~~y~~PE  169 (258)
T cd05578         153 DTL---TTSTSGTPGYMAPE  169 (258)
T ss_pred             Ccc---ccccCCChhhcCHH
Confidence            321   22346888999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.89  E-value=2.3e-22  Score=211.33  Aligned_cols=167  Identities=32%  Similarity=0.444  Sum_probs=142.0

Q ss_pred             CccCCeecccCcEEEEEEEEcCCC----cEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNA----GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +++.+.||+|+||.||+|++...+    ..||+|++....   ..+.+.+|++.++.++|+||+++++++.+.+..|++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356789999999999999997766    889999986553   4667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++....   ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++++|||.++...
T Consensus        81 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       81 EYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            9999999999987642   112789999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ........ ...+++.|+|||
T Consensus       155 ~~~~~~~~-~~~~~~~y~~Pe  174 (258)
T smart00219      155 DDDYYKKK-GGKLPIRWMAPE  174 (258)
T ss_pred             cccccccc-cCCCcccccChH
Confidence            54222111 123678999998

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.89  E-value=2.3e-22  Score=215.63  Aligned_cols=171  Identities=33%  Similarity=0.403  Sum_probs=143.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcC-CCCccccEEEEEEeC-----CeeE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI-RHRNILKLYACLLKG-----GSSF  747 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~  747 (851)
                      ..+|++.+.||+|+||.||+|....+++.+|+|++.... ....+.+|+.+++++ +|||++++++++...     +..|
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            357999999999999999999999999999999986543 346678899999999 899999999988653     3589


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++++|.++++.... ....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus       101 lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            99999999999998875422 2345788899999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ........  .....|+..|+|||
T Consensus       177 ~~~~~~~~--~~~~~~~~~y~aPE  198 (291)
T cd06639         177 QLTSTRLR--RNTSVGTPFWMAPE  198 (291)
T ss_pred             hccccccc--ccCccCCccccChh
Confidence            65433211  12246889999998

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.5e-22  Score=214.96  Aligned_cols=164  Identities=32%  Similarity=0.461  Sum_probs=144.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      +|+..+.||.|+||.||+|.+..+++.||+|.+...   .....+.+|+++++.++|+||+++++++..+...|+|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            678889999999999999999989999999988544   23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++...      .+++..+..++.|++.|+.|||   +++++||||+|+||++++++.++++|||+++......
T Consensus        82 ~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          82 GGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            999999988652      6788999999999999999999   7899999999999999999999999999998775442


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......|++.|+|||
T Consensus       153 ~--~~~~~~~~~~y~~PE  168 (274)
T cd06609         153 S--KRNTFVGTPFWMAPE  168 (274)
T ss_pred             c--ccccccCCccccChh
Confidence            1  122356899999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.89  E-value=1.9e-22  Score=215.41  Aligned_cols=167  Identities=26%  Similarity=0.383  Sum_probs=142.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      +|+..+.||+|++|.||+|++..++..||||++...   ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            478899999999999999999989999999988643   23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      + +++.+++....  ....+++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|||+++......
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          81 D-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             C-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            7 58988887542  2345889999999999999999999   7899999999999999999999999999997654322


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......+++.|+|||
T Consensus       155 ~--~~~~~~~~~~y~~PE  170 (284)
T cd07836         155 N--TFSNEVVTLWYRAPD  170 (284)
T ss_pred             c--ccccccccccccChH
Confidence            1  112245788999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.89  E-value=1.7e-22  Score=215.65  Aligned_cols=165  Identities=32%  Similarity=0.407  Sum_probs=135.9

Q ss_pred             CccCCeecccCcEEEEEEEE----cCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeEE
Q 003065          678 LEEDNLIGSGGTGKVYRLDL----KKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFL  748 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  748 (851)
                      |+..+.||+|+||+||++..    ..+++.||+|.+....   ..+.+.+|++++++++||||+++++++...  ...|+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48889999999999987653    3567789999886542   356788999999999999999999987653  45789


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++++|.+++...      .+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.
T Consensus        86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence            99999999999998652      4889999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCccc-ccccccccccccCC
Q 003065          829 AENSPKVSD-YSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~-~~~~~gt~~Y~APE  851 (851)
                      ......... .....++..|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE  180 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVE  180 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHh
Confidence            654322111 11224567799998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.89  E-value=2.2e-22  Score=210.67  Aligned_cols=161  Identities=34%  Similarity=0.461  Sum_probs=134.3

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      +.||+|+||.||+|.. .++..||+|.+....   ....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            4689999999999986 467889999876542   234688999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      .+++...    ...+++..+..++.|++.|+.|+|   +++++||||||+||+++.++.+|++|||++.......... .
T Consensus        80 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~  151 (250)
T cd05085          80 LSFLRKK----KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-S  151 (250)
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccccc-C
Confidence            9988653    235788999999999999999999   7899999999999999999999999999997544332111 1


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ....++..|+|||
T Consensus       152 ~~~~~~~~y~aPE  164 (250)
T cd05085         152 GLKQIPIKWTAPE  164 (250)
T ss_pred             CCCCCcccccCHH
Confidence            1123467799998

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.89  E-value=1.6e-22  Score=214.37  Aligned_cols=164  Identities=33%  Similarity=0.494  Sum_probs=133.4

Q ss_pred             CeecccCcEEEEEEEEcCCCc--EEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAG--TVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|++.+++.  .+|+|.+...   ...+.+.+|+++++++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999987765  4688877542   3345788999999999 799999999999999999999999999


Q ss_pred             CCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          756 GNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       756 gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      |+|.+++......           ....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            9999999764211           1234788899999999999999999   7899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++........   ......+..|+|||
T Consensus       158 l~~~~~~~~~---~~~~~~~~~y~apE  181 (270)
T cd05047         158 LSRGQEVYVK---KTMGRLPVRWMAIE  181 (270)
T ss_pred             Cccccchhhh---ccCCCCccccCChH
Confidence            9863321111   11122356799998

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.89  E-value=1.8e-22  Score=212.17  Aligned_cols=167  Identities=23%  Similarity=0.398  Sum_probs=143.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||+++...+++.||+|++...    ...+++.+|++++++++||||+++++++...+..|+||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478899999999999999999999999999988532    2345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++...   ....+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||.+......
T Consensus        81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            9999999988753   2235688888999999999999999   789999999999999999999999999999866443


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  .....|++.|+|||
T Consensus       155 ~~~--~~~~~~~~~~~~pe  171 (256)
T cd08218         155 VEL--ARTCIGTPYYLSPE  171 (256)
T ss_pred             hhh--hhhccCCccccCHH
Confidence            221  12245889999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.89  E-value=1.9e-22  Score=214.84  Aligned_cols=157  Identities=27%  Similarity=0.334  Sum_probs=130.2

Q ss_pred             eecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHc---CCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGK---IRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       683 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .||+|+||.||++.+..+++.||+|.+....     ....+.+|..+++.   .+||+|+++++++..++..|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999998899999999885431     12234455444433   479999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+|++|||++........
T Consensus        81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~  152 (279)
T cd05633          81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (279)
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence            99999988653     35889999999999999999999   78999999999999999999999999999875543221


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                          ....||+.|+|||
T Consensus       153 ----~~~~~~~~y~aPE  165 (279)
T cd05633         153 ----HASVGTHGYMAPE  165 (279)
T ss_pred             ----cCcCCCcCccCHH
Confidence                2246899999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=206.64  Aligned_cols=163  Identities=26%  Similarity=0.352  Sum_probs=135.1

Q ss_pred             CCcc-CCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEe----CCeeEEEE
Q 003065          677 NLEE-DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLK----GGSSFLVL  750 (851)
Q Consensus       677 ~~~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~  750 (851)
                      +|.+ .++||-|-.|+|..|.++.+++++|+|++.+..   ..++|++.--.. .|||||.++++|+.    .....+||
T Consensus        62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~---KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm  138 (400)
T KOG0604|consen   62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP---KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM  138 (400)
T ss_pred             hheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH---HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence            4543 367999999999999999999999999986543   345788875554 69999999998753    34567999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---CCceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~  827 (851)
                      |.|+||.|+..++++   +...+++.++..|+.||+.|++|||   +.+|.||||||+|+|...   +..+|++|||+|+
T Consensus       139 E~meGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  139 ECMEGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             ecccchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccccc
Confidence            999999999999886   4567899999999999999999999   899999999999999964   4579999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......   ..+.+-||+|.|||
T Consensus       213 ~t~~~~~---L~TPc~TPyYvaPe  233 (400)
T KOG0604|consen  213 ETQEPGD---LMTPCFTPYYVAPE  233 (400)
T ss_pred             ccCCCcc---ccCCcccccccCHH
Confidence            7654332   33356799999998

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.89  E-value=2e-22  Score=212.32  Aligned_cols=167  Identities=28%  Similarity=0.438  Sum_probs=139.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+... ...+++.+|+.++++++|+||+++++++. .+..|+||||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            3688899999999999999987 45778999988654 34567899999999999999999998864 456899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...   ....+++..+..++.|++.|++|||   +.+++||||||+||++++++.++++|||++........
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          84 NGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999988653   2346788899999999999999999   78999999999999999999999999999976653221


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......++..|+|||
T Consensus       158 ~-~~~~~~~~~~y~~pe  173 (260)
T cd05067         158 T-AREGAKFPIKWTAPE  173 (260)
T ss_pred             c-cccCCcccccccCHH
Confidence            1 112234577899998

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.89  E-value=3e-22  Score=211.67  Aligned_cols=171  Identities=32%  Similarity=0.463  Sum_probs=146.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ++|++.+.||+|+||.||+|....++..+|+|++...   ...+.+.+|+++++.++|+||+++++.+..++..|+||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            3688999999999999999999888999999988543   2456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++.....  ...+++.....++.|++.|++|||   +.+++||||||+||++++++.+||+|||++......
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            999999999976421  245788899999999999999999   789999999999999999999999999998766544


Q ss_pred             CCcc--cccccccccccccCC
Q 003065          833 PKVS--DYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~--~~~~~~gt~~Y~APE  851 (851)
                      ....  ......|+..|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe  176 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPE  176 (267)
T ss_pred             ccccccccccccCChhhcChH
Confidence            3221  122346899999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.7e-22  Score=214.94  Aligned_cols=164  Identities=30%  Similarity=0.453  Sum_probs=142.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCC---CCccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIR---HRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+...   ...+++.+|++++++++   |||++++++++..+...|+||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477888999999999999999889999999988543   34567889999999996   999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++...      .+++.....++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||.+....
T Consensus        82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            999999999987542      5788899999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  ......|+..|+|||
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE  171 (277)
T cd06917         153 QNSS--KRSTFVGTPYWMAPE  171 (277)
T ss_pred             CCcc--ccccccCCcceeCHH
Confidence            4432  123346899999998

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.89  E-value=2.5e-22  Score=215.27  Aligned_cols=166  Identities=28%  Similarity=0.366  Sum_probs=140.5

Q ss_pred             CCccCCeecccCcEEEEEEEEc---CCCcEEEEEEeccc------ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      +|++.+.||+|+||.||+|+..   .+++.||+|++...      ...+.+.+|+++++++ +|++|++++++++.++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4778899999999999999874   47889999988543      2345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+++++|.+++...     ..+++..+..++.|+++|+.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  152 (290)
T cd05613          81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  152 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence            9999999999999998753     34678888889999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +........ ......|+..|+|||
T Consensus       153 ~~~~~~~~~-~~~~~~~~~~y~aPE  176 (290)
T cd05613         153 KEFHEDEVE-RAYSFCGTIEYMAPD  176 (290)
T ss_pred             eeccccccc-ccccccCCcccCChh
Confidence            865443221 122356899999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.89  E-value=2.6e-22  Score=213.62  Aligned_cols=164  Identities=30%  Similarity=0.446  Sum_probs=141.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      -|+..+.||+|+||.||+|.+..++..||+|.+....   ..+.+.+|++++++++||||+++++++..++..|+||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4778899999999999999998889999999875432   3456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++..      ..+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999988853      24788899999999999999999   7899999999999999999999999999987654332


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......|+..|+|||
T Consensus       156 ~--~~~~~~~~~~y~~PE  171 (277)
T cd06641         156 I--KRNTFVGTPFWMAPE  171 (277)
T ss_pred             h--hhccccCCccccChh
Confidence            1  122346889999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.89  E-value=2.7e-22  Score=211.71  Aligned_cols=165  Identities=35%  Similarity=0.523  Sum_probs=146.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      +|++.+.||+|++|.||+|++..+++.||||++....   ..+.+.+|++.+++++|+||+++++++..++..++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6788899999999999999999899999999986653   3677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++++|.+++...     ..++...+..++.|+++|++|+|   + .+++||||+|+||+++.++.++|+|||.+......
T Consensus        82 ~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          82 DGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            999999998753     45788899999999999999999   7 89999999999999999999999999999876544


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  ....|+..|+|||
T Consensus       154 ~~~~--~~~~~~~~y~~pE  170 (264)
T cd06623         154 LDQC--NTFVGTVTYMSPE  170 (264)
T ss_pred             CCcc--cceeecccccCHh
Confidence            3221  2346889999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.89  E-value=2.9e-22  Score=211.46  Aligned_cols=172  Identities=26%  Similarity=0.448  Sum_probs=144.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe--CCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  750 (851)
                      +|++.+.||.|+||.||+|.+..+++.||+|++...    ...+.+..|++++++++||||+++++++..  +...|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999999999999999988543    234567889999999999999999997754  45679999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC--SPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||+++++|.+++.... .....+++..++.++.|++.|++|+|..+  +.+++|+||||+||+++.++.+|++|||++..
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            9999999999997652 23456889999999999999999999543  57899999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  .....|++.|+|||
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~pE  180 (265)
T cd08217         160 LGHDSSF--AKTYVGTPYYMSPE  180 (265)
T ss_pred             ccCCccc--ccccccCCCccChh
Confidence            6544321  12346899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.88  E-value=1.6e-22  Score=216.52  Aligned_cols=166  Identities=31%  Similarity=0.398  Sum_probs=141.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|++++++++|+||+++++++..++..|+||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            688899999999999999999989999999987543    2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++++.+..+...     ...+++..+..++.|++.|+.|||   +.+++|||++|+||++++++.+||+|||.+......
T Consensus        82 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          82 VERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             CCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            987666544432     234788899999999999999999   789999999999999999999999999999876654


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      .. .......|+..|+|||
T Consensus       154 ~~-~~~~~~~~~~~~~~PE  171 (288)
T cd07833         154 PA-SPLTDYVATRWYRAPE  171 (288)
T ss_pred             cc-ccccCcccccCCcCCc
Confidence            32 1223356899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.88  E-value=2.8e-22  Score=214.12  Aligned_cols=169  Identities=31%  Similarity=0.403  Sum_probs=140.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC----CCcEEEEEEeccccc---HHHHHHHHHHHHcCCCCccccEEEEEEe--CCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK----NAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLK--GGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  746 (851)
                      +.|+..+.||+|+||.||+|+...    +++.||||++.....   .+.+.+|+++++.++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            357788999999999999998643    477899999875543   5678999999999999999999998877  5578


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      ++||||+++++|.+++...    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+
T Consensus        84 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            9999999999999999763    235888999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCcc-cccccccccccccCC
Q 003065          827 KIAENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      .......... ......++..|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe  182 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPE  182 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcH
Confidence            8765332211 111223456799997

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.88  E-value=1.1e-22  Score=218.78  Aligned_cols=164  Identities=29%  Similarity=0.424  Sum_probs=140.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .|+....||+|+||.||+|.+..+++.||+|.+...  ...+.+.+|+.+++.++||||+++++++..++..|+||||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            345566799999999999999888999999998543  345668899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++..      ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus       102 ~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         102 GGALTDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            9999887653      24788899999999999999999   78999999999999999999999999999876543322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .  .....|++.|+|||
T Consensus       173 ~--~~~~~~~~~y~aPE  187 (297)
T cd06659         173 K--RKSLVGTPYWMAPE  187 (297)
T ss_pred             c--ccceecCccccCHH
Confidence            1  22356899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.88  E-value=8e-23  Score=219.12  Aligned_cols=164  Identities=28%  Similarity=0.445  Sum_probs=140.2

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .|.....||+|+||.||++.+..++..||||++...  ...+.+.+|+.+++.++|+||+++++++..++..|+||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            345567799999999999999888999999987543  334568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++..      ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++........
T Consensus       103 ~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         103 GGALTDIVTH------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            9999988753      24778889999999999999999   78999999999999999999999999999876543322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                        ......|++.|+|||
T Consensus       174 --~~~~~~~~~~y~aPE  188 (292)
T cd06658         174 --KRKSLVGTPYWMAPE  188 (292)
T ss_pred             --cCceeecCccccCHH
Confidence              122356899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.88  E-value=2.1e-22  Score=214.27  Aligned_cols=159  Identities=31%  Similarity=0.419  Sum_probs=136.8

Q ss_pred             ecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       684 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      ||+|+||.||+|.+..+++.||+|.+...     .....+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999889999999988543     2344567899999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      .+++...   ....+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.+||+|||.+........   .
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~  151 (277)
T cd05577          81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---I  151 (277)
T ss_pred             HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---c
Confidence            9998764   2245788899999999999999999   78999999999999999999999999999876543221   1


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ....|+..|+|||
T Consensus       152 ~~~~~~~~y~~PE  164 (277)
T cd05577         152 KGRAGTPGYMAPE  164 (277)
T ss_pred             ccccCCCCcCCHH
Confidence            2345788999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=2.1e-22  Score=213.75  Aligned_cols=171  Identities=32%  Similarity=0.428  Sum_probs=144.8

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcC-CCCccccEEEEEEeCC------ee
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI-RHRNILKLYACLLKGG------SS  746 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~  746 (851)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+++++++ +|+||+++++++....      ..
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            358999999999999999999998888999999886543 356788999999999 7999999999987644      48


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+++++|.+++..... ....+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||.+
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            999999999999999876421 2346788899999999999999999   889999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ........  ......|++.|+|||
T Consensus       161 ~~~~~~~~--~~~~~~~~~~y~aPE  183 (275)
T cd06608         161 AQLDSTLG--RRNTFIGTPYWMAPE  183 (275)
T ss_pred             eecccchh--hhcCccccccccCHh
Confidence            76543322  122346899999998

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.88  E-value=2.1e-22  Score=214.59  Aligned_cols=173  Identities=23%  Similarity=0.273  Sum_probs=141.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC----CCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEe-CCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK----NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  747 (851)
                      ++|+..+.||+|+||.||+|.+..    .+..||+|++...   ...+.+.+|+.++++++||||+++++++.. +...+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            478899999999999999999865    2577999987643   234567899999999999999999998665 56789


Q ss_pred             EEEeccCCCCHHHHHHHhhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          748 LVLEYMPNGNLFQALHKRVKE---GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      +++||+++++|.+++......   ....+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g  162 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNA  162 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCC
Confidence            999999999999998764221   1146889999999999999999999   7899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++...............++..|+|||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE  189 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALE  189 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHH
Confidence            998654332211112234677899998

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.88  E-value=6.7e-23  Score=218.12  Aligned_cols=164  Identities=31%  Similarity=0.458  Sum_probs=141.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .|+..+.||+|+||.||+|.+..++..||+|.+...   ...+.+.+|++++++++||||+++++++..+...|+||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            466778899999999999999888999999987643   23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++..      ..+++..+..++.|+++|+.|||   +.+++|+||+|+||++++++.+|++|||+++......
T Consensus        85 ~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          85 GGGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999988753      35788888999999999999999   7899999999999999999999999999997655432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......|+..|+|||
T Consensus       156 ~--~~~~~~~~~~y~aPE  171 (277)
T cd06642         156 I--KRNTFVGTPFWMAPE  171 (277)
T ss_pred             h--hhhcccCcccccCHH
Confidence            1  122346889999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.88  E-value=6.8e-23  Score=215.61  Aligned_cols=157  Identities=20%  Similarity=0.310  Sum_probs=131.4

Q ss_pred             CeecccCcEEEEEEEEcCCCc-------EEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          682 NLIGSGGTGKVYRLDLKKNAG-------TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +.||+|+||.||+|.+...+.       +||+|.+...  ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999998865443       4888877543  2345678899999999999999999999998999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc--------eEEeeec
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE--------PKIADFG  824 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DFG  824 (851)
                      +++|+|.+++...    ...+++..+..++.|++.|++|||   +++|+||||||+||+++.++.        +|++|||
T Consensus        81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999998753    235788888999999999999999   789999999999999987765        6999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+......      ....+++.|+|||
T Consensus       154 ~~~~~~~~------~~~~~~~~y~aPE  174 (258)
T cd05078         154 ISITVLPK------EILLERIPWVPPE  174 (258)
T ss_pred             cccccCCc------hhccccCCccCch
Confidence            98654322      2245788999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2e-23  Score=207.43  Aligned_cols=167  Identities=26%  Similarity=0.417  Sum_probs=146.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  748 (851)
                      +.+|...++||+|+|++|..++++++.+.||+|+++++     ++.+..+.|-.+..+. +||.+|.++.||++....++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            45789999999999999999999999999999998764     3456678888888776 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |.||++||+|.-++++.     ..+++..+.-+...|.-|+.|||   ++|||.||+|.+|+|+|..|++|++|+|+++.
T Consensus       329 vieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhc
Confidence            99999999998888764     35777888888889999999999   89999999999999999999999999999985


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      --.+.  ..+++++|||.|+|||
T Consensus       401 ~l~~g--d~tstfcgtpnyiape  421 (593)
T KOG0695|consen  401 GLGPG--DTTSTFCGTPNYIAPE  421 (593)
T ss_pred             CCCCC--cccccccCCCcccchh
Confidence            43332  2345689999999998

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.88  E-value=1.8e-22  Score=215.69  Aligned_cols=166  Identities=26%  Similarity=0.382  Sum_probs=141.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|++|.||+|++..+++.||||++....    ..+.+.+|++++++++||||+++++++..++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999999899999999885432    235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +. ++|.+++...   ....+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||+++.....
T Consensus        81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            95 6898888653   2346788999999999999999999   789999999999999999999999999998765433


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ......+++.|+|||
T Consensus       154 ~~--~~~~~~~~~~y~aPE  170 (284)
T cd07860         154 VR--TYTHEVVTLWYRAPE  170 (284)
T ss_pred             cc--ccccccccccccCCe
Confidence            21  122345788999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.88  E-value=2.7e-22  Score=213.42  Aligned_cols=164  Identities=30%  Similarity=0.475  Sum_probs=142.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .|+..+.||+|+||.||+|.+..++..||+|.+...   ...+.+.+|+++++++.||||+++++++..+...|+||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            577888999999999999999888999999988643   23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++..      ..+++.....++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        85 ~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          85 GGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999998864      24677888899999999999999   7899999999999999999999999999997664432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......++..|+|||
T Consensus       156 ~--~~~~~~~~~~y~apE  171 (277)
T cd06640         156 I--KRNTFVGTPFWMAPE  171 (277)
T ss_pred             c--ccccccCcccccCHh
Confidence            1  122346888999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.88  E-value=1.5e-22  Score=214.36  Aligned_cols=167  Identities=33%  Similarity=0.440  Sum_probs=136.9

Q ss_pred             CeecccCcEEEEEEEEcCCC------cEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          682 NLIGSGGTGKVYRLDLKKNA------GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +.||+|+||.||+|++....      +.||+|.+...   .....+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999986433      67999987544   2456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-----ceEEeeecC
Q 003065          753 MPNGNLFQALHKRVKE--GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-----EPKIADFGV  825 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFGl  825 (851)
                      +++++|.+++......  ....+++..+..++.|++.|++|||   +.+++|+||||+||+++.++     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999764322  2234788899999999999999999   78999999999999999877     899999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++...............++..|+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE  183 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPE  183 (269)
T ss_pred             ccccccccccccCcccCCCccccCHH
Confidence            97654332222222234678899998

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.88  E-value=1.2e-22  Score=214.65  Aligned_cols=164  Identities=33%  Similarity=0.466  Sum_probs=143.2

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+...   ...+++.+|++++++++||||+++++++..++..|+|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            577889999999999999999989999999988654   23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++++|.+++...    ...++.....+++.|++.|+.|+|   + .+++||||||+||++++++.+||+|||.+......
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          82 DGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             CCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            999999998763    246788888999999999999999   6 89999999999999999999999999998765432


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...    ...|+..|+|||
T Consensus       155 ~~~----~~~~~~~y~~PE  169 (265)
T cd06605         155 LAK----TFVGTSSYMAPE  169 (265)
T ss_pred             Hhh----cccCChhccCHH
Confidence            211    156889999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=6e-25  Score=210.61  Aligned_cols=168  Identities=27%  Similarity=0.397  Sum_probs=138.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEE--------eC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLL--------KG  743 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~--------~~  743 (851)
                      ..|+....+|+|.||+||+|+.+.+++.||+|++..+.    -.....+|+++++.++|+|++.+++.+.        +.
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            46778889999999999999999999999999875432    2345679999999999999998877553        23


Q ss_pred             CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      ..+|+||++|+ .+|.-.+..    ....++...+.+++.++..||.|+|   ...|+|||+||+|+||+.+|.+||+||
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecc
Confidence            45899999996 478777754    2456888899999999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCC--cccccccccccccccCC
Q 003065          824 GVAKIAENSPK--VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~--~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+.......  ...++..+-|.+|++||
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppE  198 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPE  198 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHH
Confidence            99976654322  22355567799999998

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.88  E-value=2.7e-22  Score=217.10  Aligned_cols=171  Identities=27%  Similarity=0.388  Sum_probs=140.6

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCC----
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGG----  744 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  744 (851)
                      +.+++|+..+.||+|+||.||+|++..+++.||||++....    ....+.+|++++++++||||+++++++...+    
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            34568999999999999999999999999999999885432    2345678999999999999999999876543    


Q ss_pred             ----eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEE
Q 003065          745 ----SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI  820 (851)
Q Consensus       745 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl  820 (851)
                          ..|+||||+. +++.+++...    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEE
Confidence                4599999995 5888877642    235789999999999999999999   789999999999999999999999


Q ss_pred             eeecCccccCCCCCc--ccccccccccccccCC
Q 003065          821 ADFGVAKIAENSPKV--SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE  851 (851)
                      +|||++.........  .......++..|+|||
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  193 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE  193 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcH
Confidence            999999866443221  1122346788999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.88  E-value=2.4e-22  Score=211.29  Aligned_cols=163  Identities=29%  Similarity=0.400  Sum_probs=136.3

Q ss_pred             CeecccCcEEEEEEEEcC-CC--cEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKK-NA--GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|++|.||+|.+.. .+  ..||+|.+....   ..+.+.+|++++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 33  259999986653   35678899999999999999999999888 889999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++....   ...+++...+.++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          80 GSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99999997642   146789999999999999999999   789999999999999999999999999999876543221


Q ss_pred             -ccccccccccccccCC
Q 003065          836 -SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 -~~~~~~~gt~~Y~APE  851 (851)
                       .......++..|+|||
T Consensus       154 ~~~~~~~~~~~~y~~pE  170 (257)
T cd05040         154 YVMEEHLKVPFAWCAPE  170 (257)
T ss_pred             eecccCCCCCceecCHH
Confidence             1112245788999998

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.88  E-value=2.8e-22  Score=215.08  Aligned_cols=165  Identities=28%  Similarity=0.403  Sum_probs=143.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|+..+.||+|+||.||++....+++.||+|.+...  ...+.+.+|+.++++++||||+++++++...+..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5789999999999999999999888999999987543  34466889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++.+.      .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            999999988642      4678888999999999999999   7899999999999999999999999999987654332


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  .....|++.|+|||
T Consensus       170 ~~--~~~~~~~~~y~~PE  185 (293)
T cd06647         170 SK--RSTMVGTPYWMAPE  185 (293)
T ss_pred             cc--cccccCChhhcCch
Confidence            21  22346899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.88  E-value=3.3e-22  Score=210.28  Aligned_cols=160  Identities=25%  Similarity=0.296  Sum_probs=131.7

Q ss_pred             eecccCcEEEEEEEE--cCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          683 LIGSGGTGKVYRLDL--KKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       683 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      .||+|+||.||+|.+  ..+++.||+|++....    ..+.+.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999965  4567889999885442    2456889999999999999999999875 45678999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcc
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  836 (851)
                      +|.+++...     ..+++..+..++.|++.|++|+|   +++|+||||||+||++++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            999998652     35788899999999999999999   7899999999999999999999999999998765443211


Q ss_pred             -cccccccccccccCC
Q 003065          837 -DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 -~~~~~~gt~~Y~APE  851 (851)
                       ......+++.|+|||
T Consensus       153 ~~~~~~~~~~~y~aPE  168 (257)
T cd05116         153 KAKTHGKWPVKWYAPE  168 (257)
T ss_pred             eecCCCCCCccccCHh
Confidence             111223467899998

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.88  E-value=2.9e-22  Score=212.35  Aligned_cols=166  Identities=27%  Similarity=0.340  Sum_probs=137.2

Q ss_pred             CCccCCeecccCcEEEEEEEEcCC---CcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +|...+.||+|+||.||+|.+...   ...||||......   ..+.+.+|+.++++++||||+++++++.. +..|+||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~   85 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM   85 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence            578889999999999999987543   3468999876543   34578899999999999999999998875 4578999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++...    ...+++..+..++.+++.|++|+|   +.+++||||||+||+++.++.+|++|||+++...
T Consensus        86 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          86 ELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            999999999999753    235789999999999999999999   7899999999999999999999999999998665


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....... ....++..|+|||
T Consensus       159 ~~~~~~~-~~~~~~~~y~aPE  178 (270)
T cd05056         159 DESYYKA-SKGKLPIKWMAPE  178 (270)
T ss_pred             cccceec-CCCCccccccChh
Confidence            4322111 1223456899998

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.88  E-value=4.7e-22  Score=209.86  Aligned_cols=167  Identities=34%  Similarity=0.501  Sum_probs=143.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||+|....+++.||+|.+....    ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999998889999999986542    356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++...     ..+++..+..++.++++|++|||   +.+++|+||+|+||++++++.+||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            9999999998752     24677888899999999999999   789999999999999999999999999999876543


Q ss_pred             CCccc--ccccccccccccCC
Q 003065          833 PKVSD--YSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~--~~~~~gt~~Y~APE  851 (851)
                      .....  .....|++.|+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE  173 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPE  173 (264)
T ss_pred             CCcccccccCCcCCcCccChh
Confidence            22111  12346789999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.88  E-value=3.1e-22  Score=213.57  Aligned_cols=168  Identities=30%  Similarity=0.427  Sum_probs=141.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcC-CCCccccEEEEEEe------CCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLLK------GGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~  747 (851)
                      ..|++.+.||+|+||.||+|++..+++.||+|++... .....+..|+.+++++ +|+||+++++++..      ....|
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            5788999999999999999999999999999988554 3445678899999998 69999999998853      45789


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++|+|.+++....   ...+++..+..++.|++.|++|||   +.+|+|||+||+||++++++.+||+|||+++
T Consensus        96 iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             EEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            9999999999999987532   234677788899999999999999   7899999999999999999999999999987


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  ......|++.|+|||
T Consensus       170 ~~~~~~~--~~~~~~~~~~y~aPE  191 (282)
T cd06636         170 QLDRTVG--RRNTFIGTPYWMAPE  191 (282)
T ss_pred             hhhcccc--CCCcccccccccCHh
Confidence            6543211  123356899999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=7.5e-23  Score=216.77  Aligned_cols=165  Identities=25%  Similarity=0.384  Sum_probs=137.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .|++.++||+||.++||++... +.+.||+|++...    ...+.|..|+..|.+++ |.+||++++|...++..|||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            6899999999999999999884 4556777766322    34567899999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |= ..+|.++++.+.   .....| .+..+..||+.|+.++|   +.||||.||||.|+|+-+ |.+||+|||.|..+..
T Consensus       441 ~G-d~DL~kiL~k~~---~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKK---SIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             cc-cccHHHHHHhcc---CCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            76 679999998752   222334 56678899999999999   889999999999999975 5999999999998887


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.+.......+||+.|||||
T Consensus       512 DTTsI~kdsQvGT~NYMsPE  531 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPE  531 (677)
T ss_pred             cccceeeccccCcccccCHH
Confidence            76554445578999999998

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.88  E-value=3.6e-22  Score=210.39  Aligned_cols=167  Identities=26%  Similarity=0.443  Sum_probs=139.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|.+. .+..+|+|.+.... ..+.+.+|++++++++|+||+++++++.. ...|+||||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            47889999999999999999864 55679999886543 35678899999999999999999999877 77899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++.+.   .....++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++.......
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          84 KGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            99999998763   2345788888999999999999999   78999999999999999999999999999976544322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......++..|+|||
T Consensus       158 ~-~~~~~~~~~~y~~PE  173 (260)
T cd05073         158 T-AREGAKFPIKWTAPE  173 (260)
T ss_pred             c-cccCCcccccccCHh
Confidence            1 112234567799998

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.88  E-value=4.4e-22  Score=208.48  Aligned_cols=162  Identities=33%  Similarity=0.441  Sum_probs=135.5

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      +.||+|+||.||+|.+.. ++.||+|++....   ..+.+.+|++++++++|+||+++++++...+..|+||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            468999999999999976 8999999886543   345788999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      .+++...    ...+++.....++.+++.|++|||   +.+++||||||+||+++.++.+||+|||.++...........
T Consensus        80 ~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          80 LTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9998653    235788888999999999999999   789999999999999999999999999999865432211111


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ....++..|+|||
T Consensus       153 ~~~~~~~~y~~PE  165 (251)
T cd05041         153 GLKQIPIKWTAPE  165 (251)
T ss_pred             ccCcceeccCChH
Confidence            1123456799998

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.88  E-value=5.4e-22  Score=214.49  Aligned_cols=162  Identities=34%  Similarity=0.495  Sum_probs=139.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ..|+..+.||+|+||.||+|+...+++.||+|++...     ...+.+.+|+++++.++||||+++++++..++..|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            3588899999999999999999888999999988532     22356889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||++ |++.+++...    ...+++..+..++.|++.|+.|||   +.+|+||||+|+||+++.++.+||+|||++....
T Consensus        95 e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          95 EYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            9996 6787777543    235788999999999999999999   7899999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..      ....|++.|+|||
T Consensus       167 ~~------~~~~~~~~y~aPE  181 (307)
T cd06607         167 PA------NSFVGTPYWMAPE  181 (307)
T ss_pred             CC------CCccCCccccCce
Confidence            32      1246888999998

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.88  E-value=3.6e-22  Score=214.44  Aligned_cols=167  Identities=26%  Similarity=0.355  Sum_probs=138.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|+..+.||+|++|.||+|++..+++.||+|++...    ...+.+.+|++++++++||||+++++++..++..|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            4788999999999999999999889999999988543    223567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-CCceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~  830 (851)
                      |++ +++.+++...   .....++.....++.|++.|++|||   +++++||||||+||+++. ++.+||+|||+++...
T Consensus        82 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             ccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            995 6888877543   2233577788889999999999999   789999999999999985 5579999999997654


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  ......|++.|+|||
T Consensus       155 ~~~~--~~~~~~~~~~y~~PE  173 (294)
T PLN00009        155 IPVR--TFTHEVVTLWYRAPE  173 (294)
T ss_pred             CCcc--ccccCceeecccCHH
Confidence            3221  122346789999998

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.88  E-value=4.2e-22  Score=210.09  Aligned_cols=157  Identities=32%  Similarity=0.459  Sum_probs=137.5

Q ss_pred             ecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       684 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      ||+|+||.||+|++..+++.||+|++...     ...+.+.+|++++++++||||+++++++.++...|+||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            68999999999999888999999998543     2346788999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      .+++.+.     ..++...+..++.|++.|++|+|   +.+++|+||||+||+++.++.+||+|||.++......   ..
T Consensus        81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~  149 (262)
T cd05572          81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KT  149 (262)
T ss_pred             HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cc
Confidence            9999753     34788888999999999999999   7899999999999999999999999999998765432   11


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ....|++.|+|||
T Consensus       150 ~~~~~~~~~~~PE  162 (262)
T cd05572         150 WTFCGTPEYVAPE  162 (262)
T ss_pred             ccccCCcCccChh
Confidence            2346899999998

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=5.1e-22  Score=212.46  Aligned_cols=167  Identities=35%  Similarity=0.421  Sum_probs=141.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEe--CCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  751 (851)
                      +|+..+.||.|++|.||+|.+..+++.||+|.+....   ....+.+|++++++++||||+++++++..  .+..|+|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5788899999999999999998899999999886542   34668899999999999999999998864  346899999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++++|.+++..... ....++......++.|++.|+.|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        82 ~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          82 YCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             ecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999998875432 3445788889999999999999999   78999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...    ....++..|+|||
T Consensus       158 ~~~----~~~~~~~~y~~pE  173 (287)
T cd06621         158 SLA----GTFTGTSFYMAPE  173 (287)
T ss_pred             ccc----ccccCCccccCHH
Confidence            221    1245788999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.88  E-value=3.2e-22  Score=216.53  Aligned_cols=167  Identities=32%  Similarity=0.390  Sum_probs=140.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  748 (851)
                      +.+|++.+.||+|+||.||+|.+..+++.||+|++....    ....+.+|++++++++|+||+++++++...  +..|+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            458999999999999999999999999999999885432    123456899999999999999999998754  56899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||++ ++|.+++...    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++.
T Consensus        86 v~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          86 VMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence            999996 5888888653    245888999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  .....+++.|+|||
T Consensus       158 ~~~~~~~--~~~~~~~~~y~aPE  178 (309)
T cd07845         158 YGLPAKP--MTPKVVTLWYRAPE  178 (309)
T ss_pred             cCCccCC--CCcccccccccChh
Confidence            6543211  12234688899998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.88  E-value=4e-22  Score=210.23  Aligned_cols=163  Identities=30%  Similarity=0.403  Sum_probs=130.7

Q ss_pred             CeecccCcEEEEEEEEcC---CCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEE-eCCeeEEEEeccC
Q 003065          682 NLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLL-KGGSSFLVLEYMP  754 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  754 (851)
                      +.||+|+||.||+|++..   ....||+|++...   ...+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998753   3456999987543   23467888999999999999999999765 4566899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++.+.    .....+..+..++.|++.|+.|||   +.+++||||||+||++++++.+||+|||+++.......
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            99999998753    234567778889999999999999   78999999999999999999999999999976543221


Q ss_pred             c--ccccccccccccccCC
Q 003065          835 V--SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~--~~~~~~~gt~~Y~APE  851 (851)
                      .  .......++..|+|||
T Consensus       154 ~~~~~~~~~~~~~~y~aPE  172 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALE  172 (262)
T ss_pred             eeecccccCcCCccccChh
Confidence            1  1111234677899998

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.88  E-value=3.4e-22  Score=220.45  Aligned_cols=164  Identities=32%  Similarity=0.405  Sum_probs=138.4

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC------
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------  743 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  743 (851)
                      ...+|+..+.||+|+||.||+|.+..+++.||+|++...    ...+.+.+|++++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            346899999999999999999999999999999988542    2345677899999999999999999988643      


Q ss_pred             CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      ...|+||||++ +++.+.+..       .++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccC
Confidence            34699999995 588887753       2677888899999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++.......   .....||+.|+|||
T Consensus       163 g~~~~~~~~~~---~~~~~~~~~y~aPE  187 (353)
T cd07850         163 GLARTAGTSFM---MTPYVVTRYYRAPE  187 (353)
T ss_pred             ccceeCCCCCC---CCCCcccccccCHH
Confidence            99987654322   22346899999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.88  E-value=4.6e-22  Score=211.75  Aligned_cols=157  Identities=27%  Similarity=0.333  Sum_probs=130.1

Q ss_pred             eecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHH---HHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEME---ILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       683 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .||+|+||.||+|.+..+++.||+|.+....     ....+..|..   .++...||+|+++++++...+..|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4799999999999998899999999885431     1122334443   3444579999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++..     ...+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~  152 (278)
T cd05606          81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (278)
T ss_pred             CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence            9999988764     235889999999999999999999   78999999999999999999999999999875543221


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                          ....|+..|+|||
T Consensus       153 ----~~~~~~~~y~aPE  165 (278)
T cd05606         153 ----HASVGTHGYMAPE  165 (278)
T ss_pred             ----cCcCCCcCCcCcH
Confidence                2246899999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.88  E-value=4.6e-22  Score=208.96  Aligned_cols=167  Identities=25%  Similarity=0.382  Sum_probs=140.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|++... .....+.+|++++++++||+|+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            36788899999999999999884 4678999988654 345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...    ...+++..+..++.+++.|++|||   +.+++||||||+||+++.++.+||+|||.++.......
T Consensus        83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          83 HGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            99999988753    235788889999999999999999   78999999999999999999999999999876543321


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......++..|+|||
T Consensus       156 ~-~~~~~~~~~~~~aPe  171 (256)
T cd05112         156 T-SSTGTKFPVKWSSPE  171 (256)
T ss_pred             c-ccCCCccchhhcCHh
Confidence            1 111223567899998

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=6.4e-22  Score=208.09  Aligned_cols=161  Identities=29%  Similarity=0.405  Sum_probs=132.9

Q ss_pred             CeecccCcEEEEEEEEcCCC---cEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNA---GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|.....+   ..||+|.+....   ..+++.+|+++++++.|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46899999999999876554   689999986543   3567889999999999999999999876 4567999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+++..+..++.|++.|++|||   ..+++||||||+||+++.++.+||+|||.++........
T Consensus        80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999763     25788999999999999999999   789999999999999999999999999999866543322


Q ss_pred             cc-ccccccccccccCC
Q 003065          836 SD-YSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~-~~~~~gt~~Y~APE  851 (851)
                      .. .....++..|+|||
T Consensus       152 ~~~~~~~~~~~~y~aPE  168 (257)
T cd05060         152 YRATTAGRWPLKWYAPE  168 (257)
T ss_pred             cccccCccccccccCHH
Confidence            11 11122356799998

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.88  E-value=3.3e-22  Score=214.09  Aligned_cols=169  Identities=28%  Similarity=0.385  Sum_probs=138.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||++.+..+++.||+|++...   .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            566778899999999999999999999999998653   23456889999999996 99999999999988899999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++ +++.++...........+++.....++.+++.|++|||+  ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            85 566555433222233568889999999999999999994  358999999999999999999999999999765433


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...   ....|++.|+|||
T Consensus       162 ~~~---~~~~~~~~y~aPE  177 (288)
T cd06616         162 IAK---TRDAGCRPYMAPE  177 (288)
T ss_pred             Ccc---ccccCccCccCHH
Confidence            221   2235899999998

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=8.8e-22  Score=206.39  Aligned_cols=165  Identities=33%  Similarity=0.466  Sum_probs=145.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|++|.||+|++..+++.||+|.+....    ..+.+.+|++++++++||+++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999998889999999986543    456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++...     ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999998753     45789999999999999999999   789999999999999999999999999999876554


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  .....|+..|+|||
T Consensus       153 ~~~--~~~~~~~~~y~~pe  169 (254)
T cd06627         153 SKD--DASVVGTPYWMAPE  169 (254)
T ss_pred             ccc--ccccccchhhcCHh
Confidence            321  22346899999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.88  E-value=7.1e-22  Score=207.45  Aligned_cols=169  Identities=30%  Similarity=0.433  Sum_probs=146.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||++.+..+++.||+|++...    ...+.+.+|+++++.++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            477889999999999999999888999999998644    3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++.+... ....+++..+..++.+++.|+.|||   +.+++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999987521 2356899999999999999999999   789999999999999999999999999999876554


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  .....|++.|+|||
T Consensus       157 ~~~--~~~~~~~~~y~~pe  173 (258)
T cd08215         157 VDL--AKTVVGTPYYLSPE  173 (258)
T ss_pred             cce--ecceeeeecccChh
Confidence            311  22346899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.88  E-value=3.2e-22  Score=210.23  Aligned_cols=167  Identities=27%  Similarity=0.447  Sum_probs=143.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|+..+.||+|+||.||+|....++..||+|.+...    ...+.+.+|+++++.++|+||+++++++..++..|+|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            477889999999999999999999999999998543    3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-ceEEeeecCccccCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAEN  831 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~  831 (851)
                      +++++|.+++.+.   ....+++..+..++.|+++|+.|||   +.+++|+||||+||++++++ .+|++|||.+.....
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            9999999998753   2335788999999999999999999   78999999999999999875 469999999986654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  .....|++.|+|||
T Consensus       155 ~~~~--~~~~~~~~~~~ape  172 (257)
T cd08225         155 SMEL--AYTCVGTPYYLSPE  172 (257)
T ss_pred             Cccc--ccccCCCccccCHH
Confidence            3221  12245899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=6.2e-23  Score=218.54  Aligned_cols=168  Identities=26%  Similarity=0.393  Sum_probs=144.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.....+||-|.||.||.|.|++-...||||.++.. ...++|.+|+.+|+.++|||+|+++|+|...-.+|||+|||..
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y  347 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY  347 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence            345678899999999999999998999999998654 5678999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+|+++.   ....++....+.++.||+.||+||.   .+.+||||+.++|+|+.++..+||+|||+++.+..+...
T Consensus       348 GNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT  421 (1157)
T KOG4278|consen  348 GNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT  421 (1157)
T ss_pred             ccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence            9999999886   3445677778899999999999999   789999999999999999999999999999998765322


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                      .. ....-...|.|||
T Consensus       422 AH-AGAKFPIKWTAPE  436 (1157)
T KOG4278|consen  422 AH-AGAKFPIKWTAPE  436 (1157)
T ss_pred             cc-cCccCcccccCcc
Confidence            21 1112245699998

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.88  E-value=9.9e-22  Score=205.51  Aligned_cols=165  Identities=34%  Similarity=0.498  Sum_probs=146.2

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      +|+..+.||+|++|.||++.+..+++.+++|++....  ..+.+.+|++.+++++|++++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999998889999999987654  56788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...    ...+++..+..++.|++.|++|||   +.+++||||+|+||++++++.+||+|||.+........
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          81 GGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            99999988763    246889999999999999999999   78999999999999999999999999999987655432


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                         .....|+..|+|||
T Consensus       154 ---~~~~~~~~~~~~PE  167 (253)
T cd05122         154 ---RNTMVGTPYWMAPE  167 (253)
T ss_pred             ---ccceecCCcccCHH
Confidence               22356899999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.88  E-value=3.3e-22  Score=219.20  Aligned_cols=168  Identities=29%  Similarity=0.435  Sum_probs=140.1

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeC--Cee
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKI-RHRNILKLYACLLKG--GSS  746 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  746 (851)
                      ...+|+..+.||+|+||.||+|.+..+++.||||++...    .....+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            345789999999999999999999888999999987542    2345577899999999 999999999988653  367


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||++ ++|.+++...      .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+
T Consensus        85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence            99999996 5898887642      5678888899999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCc---ccccccccccccccCC
Q 003065          827 KIAENSPKV---SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~---~~~~~~~gt~~Y~APE  851 (851)
                      +........   .......||+.|+|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE  182 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPE  182 (337)
T ss_pred             hccccccccccCcchhcccccccccCce
Confidence            866443221   1223457899999998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.88  E-value=3.1e-22  Score=219.29  Aligned_cols=166  Identities=27%  Similarity=0.409  Sum_probs=138.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeC-----CeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  747 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++...   .....+.+|+.++++++||||+++++++...     ...|
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            4789999999999999999999999999999998532   2345678899999999999999999876543     3579


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +|+||++ +++.+++..      ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        85 lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          85 IVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECccccee
Confidence            9999996 588777643      35788889999999999999999   7899999999999999999999999999997


Q ss_pred             ccCCCCCcc-cccccccccccccCC
Q 003065          828 IAENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ......... ......||+.|+|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE  179 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPE  179 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChH
Confidence            654332211 122356899999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.88  E-value=2.1e-22  Score=215.17  Aligned_cols=164  Identities=28%  Similarity=0.376  Sum_probs=139.0

Q ss_pred             ccCCeecccCcEEEEEEEEcCC--C--cEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKN--A--GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~--~--~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ...+.||+|-||.||+|....-  |  -.||||.-+..   +..+.|..|.-+|+.++|||||+++|.+.+. ..|+|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence            5678999999999999987532  2  24899987653   4577899999999999999999999999765 5899999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      .++-|.|.+|++..    ...++......++.|++.||.|||   +..+|||||..+|||+....-+|++|||+++.+.+
T Consensus       471 L~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  471 LAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             cccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            99999999999874    456888888999999999999999   89999999999999999988999999999998877


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....... ...-...|||||
T Consensus       544 ~~yYkaS-~~kLPIKWmaPE  562 (974)
T KOG4257|consen  544 DAYYKAS-RGKLPIKWMAPE  562 (974)
T ss_pred             cchhhcc-ccccceeecCcc
Confidence            6544332 222345799998

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=7.6e-24  Score=221.38  Aligned_cols=166  Identities=29%  Similarity=0.422  Sum_probs=145.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +.+++....||-|+||.|-.++.......+|+|++++.     ...+.+..|-.+|..++.|.||++|..|.+..+.||+
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            45667888899999999999988666556899988654     3456678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ||-|-||.+...+.++     ..++.....-++..+.+|++|||   +++||+||+||+|.++|.+|.+||.|||+|+.+
T Consensus       499 mEaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  499 MEACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             HHhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence            9999999999999875     34666667778899999999999   889999999999999999999999999999998


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..+.+.   -+++|||.|.|||
T Consensus       571 ~~g~KT---wTFcGTpEYVAPE  589 (732)
T KOG0614|consen  571 GSGRKT---WTFCGTPEYVAPE  589 (732)
T ss_pred             ccCCce---eeecCCcccccch
Confidence            876543   3489999999998

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.87  E-value=2.7e-22  Score=213.66  Aligned_cols=167  Identities=36%  Similarity=0.529  Sum_probs=144.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +|...+.||+|+||.||+|+...+++.||+|++...     ...+.+.+|++++++++ ||||+++++++..++..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            688899999999999999999989999999988542     23456788999999998 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++.+.     ..+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++++|||++....
T Consensus        82 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          82 EYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999998753     36899999999999999999999   7899999999999999999999999999998655


Q ss_pred             CCCCc------------------ccccccccccccccCC
Q 003065          831 NSPKV------------------SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~------------------~~~~~~~gt~~Y~APE  851 (851)
                      .....                  .......|+..|+|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe  192 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE  192 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHH
Confidence            43221                  1223456889999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.87  E-value=8.6e-22  Score=210.11  Aligned_cols=162  Identities=30%  Similarity=0.357  Sum_probs=136.6

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCC-CCccccEEEEEEeC--CeeEEEEe
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIR-HRNILKLYACLLKG--GSSFLVLE  751 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  751 (851)
                      |++.+.||+|+||.||+|++..+++.||+|++...   .......+|+.+++++. |+||+++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56788999999999999999889999999988653   22234457999999885 99999999999887  88999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |++ +++.+++...    ...+++..+..++.|++.||+|||   +.+++||||||+||+++. +.+||+|||.++....
T Consensus        81 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            996 5888887653    245789999999999999999999   789999999999999999 9999999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   ....+++.|+|||
T Consensus       152 ~~~~---~~~~~~~~y~aPE  168 (282)
T cd07831         152 KPPY---TEYISTRWYRAPE  168 (282)
T ss_pred             CCCc---CCCCCCcccCChh
Confidence            3222   2246899999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.87  E-value=7.6e-22  Score=209.46  Aligned_cols=171  Identities=25%  Similarity=0.352  Sum_probs=135.9

Q ss_pred             CccCCeecccCcEEEEEEEEcC---CCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC------
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------  744 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  744 (851)
                      |.+.+.||+|+||.||+|.++.   +++.||||++...    ...+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5677899999999999998653   4678999988643    23456889999999999999999999876432      


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVK-EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      ..++++||+++|+|.+++..... .....+++.....++.|++.|++|||   +.+|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            24789999999999988764321 12235788889999999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |.++...............+++.|+|||
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe  185 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALE  185 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHh
Confidence            9998664433222222234567899997

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.87  E-value=1e-21  Score=208.10  Aligned_cols=169  Identities=27%  Similarity=0.450  Sum_probs=140.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcC-CCcEEEEEEeccc------------ccHHHHHHHHHHHHc-CCCCccccEEEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKK-NAGTVAVKQLWKG------------DGVKVFAAEMEILGK-IRHRNILKLYACLLK  742 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~------------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  742 (851)
                      +|++.+.||+|+||.||+|.+.. .++.+|+|.+...            ....++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999977 6788999987421            123456778888865 799999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      ++..|+||||+++++|.+++.... .....+++..++.++.|++.|+.|||.  ..+++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999886532 234468888999999999999999993  25899999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||.+.......   ......|+..|+|||
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe  183 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPE  183 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChh
Confidence            99998655433   223356899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.87  E-value=1.4e-21  Score=212.21  Aligned_cols=161  Identities=35%  Similarity=0.524  Sum_probs=139.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .|+..+.||+|+||.||+|++..++..||+|++...     ...+.+.+|++++++++|||++++++++..+...|+|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            477889999999999999999889999999988543     223568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |++ |++.+.+...    ...+++..+..++.|++.|+.|||   +.+|+||||+|+||+++.++.+||+|||++.....
T Consensus       106 ~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         106 YCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            996 5887777543    345889999999999999999999   78999999999999999999999999999875433


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .      ....|++.|+|||
T Consensus       178 ~------~~~~~~~~y~aPE  191 (317)
T cd06635         178 A------NSFVGTPYWMAPE  191 (317)
T ss_pred             c------ccccCCccccChh
Confidence            2      2246889999998

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.87  E-value=5.4e-22  Score=209.37  Aligned_cols=160  Identities=31%  Similarity=0.467  Sum_probs=137.4

Q ss_pred             ecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       684 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      ||+|+||.||+|++..+++.||+|++...     ...+.+.+|++++++++||||+++++++..+...|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999888999999988654     2345688899999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC----
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK----  834 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----  834 (851)
                      .+++.+.     ..+++..+..++.|+++||+|||   +.+++||||+|+||++++++.+||+|||++........    
T Consensus        81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            9998763     25788899999999999999999   78999999999999999999999999999876543321    


Q ss_pred             --cccccccccccccccCC
Q 003065          835 --VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 --~~~~~~~~gt~~Y~APE  851 (851)
                        ........++..|+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe  171 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPE  171 (265)
T ss_pred             cccccccCcccCccccCHH
Confidence              11223356888999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.87  E-value=1.2e-21  Score=205.72  Aligned_cols=167  Identities=32%  Similarity=0.430  Sum_probs=145.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  750 (851)
                      +|+..+.||+|++|.||+|.+..+++.|++|++....    ..+.+.+|++++++++||||+++++++...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999998889999999986553    367788999999999999999999999888  8899999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++...     ..+++..+..++.|+++|++|||   +.+++|+|++|+||+++.++.+||+|||.+....
T Consensus        81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            999999999998763     26889999999999999999999   7899999999999999999999999999998776


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ............++..|+|||
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE  173 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPE  173 (260)
T ss_pred             cccccccccCCCCCccccCHh
Confidence            553211122346889999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.87  E-value=1.2e-21  Score=209.51  Aligned_cols=168  Identities=30%  Similarity=0.470  Sum_probs=146.0

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ...|+..+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|++.++.++|+||+++++++...+..|+|+||+
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   97 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM   97 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence            346888899999999999999998889999999986554 3567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++....    ..+++..+..++.|++.|++|||   +.+++|+|+||+||+++.++.+||+|||.+.......
T Consensus        98 ~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          98 DGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             CCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999998742    36889999999999999999999   7899999999999999999999999999987654332


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......|++.|+|||
T Consensus       171 ~--~~~~~~~~~~y~~PE  186 (286)
T cd06614         171 S--KRNSVVGTPYWMAPE  186 (286)
T ss_pred             h--hhccccCCcccCCHh
Confidence            1  112345788999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.87  E-value=1.3e-21  Score=209.19  Aligned_cols=164  Identities=29%  Similarity=0.442  Sum_probs=140.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .|...+.||+|++|.||++.+..+++.||+|++...  ...+.+.+|+.++++++||||+++++++..++..|+|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            455667999999999999999888999999987543  334567899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++..      ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||.+........
T Consensus       100 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648         100 GGALTDIVTH------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             CCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            9999998865      24778888999999999999999   78999999999999999999999999999876543322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .  .....|++.|+|||
T Consensus       171 ~--~~~~~~~~~y~aPE  185 (285)
T cd06648         171 R--RKSLVGTPYWMAPE  185 (285)
T ss_pred             c--cccccCCccccCHH
Confidence            1  12346899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.87  E-value=1e-21  Score=209.68  Aligned_cols=165  Identities=28%  Similarity=0.374  Sum_probs=140.6

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      |+..+.||+|++|.||+|.+..++..||+|++....    ..+.+.+|++++++++|||++++++++..++..|+||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999998899999999886432    2356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      + ++|.+++...   ....+++..+..++.|+++|++|||   +++++||||+|+||++++++.+||+|||.++......
T Consensus        81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            4 6899988753   2245889999999999999999999   7899999999999999999999999999997654322


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......+++.|+|||
T Consensus       154 ~--~~~~~~~~~~~~aPE  169 (283)
T cd07835         154 R--TYTHEVVTLWYRAPE  169 (283)
T ss_pred             c--ccCccccccCCCCCc
Confidence            1  122235788999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.87  E-value=8.7e-22  Score=212.39  Aligned_cols=168  Identities=29%  Similarity=0.390  Sum_probs=139.8

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC------
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  744 (851)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...    .....+.+|++++++++||||+++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            45789999999999999999999988999999998643    22356778999999999999999999886644      


Q ss_pred             ----eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEE
Q 003065          745 ----SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI  820 (851)
Q Consensus       745 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl  820 (851)
                          ..|+|+||+++ ++.+.+...    ...+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEe
Confidence                78999999975 777776542    346889999999999999999999   789999999999999999999999


Q ss_pred             eeecCccccCCCCCcccccccccccccccCC
Q 003065          821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|||.+........ .......++..|+|||
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE  187 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPE  187 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChH
Confidence            99999986654332 1122234678899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.87  E-value=1.3e-23  Score=226.77  Aligned_cols=166  Identities=31%  Similarity=0.456  Sum_probs=147.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|+....+|.|.||.||||+++.+++..|||+++-+  ++.+..++|+-+++.++|||||.+++.+...+..|+.||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            4788999999999999999999999999999988654  66777889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      .+|+|.+..+-     ...+++.++..+++...+|++|+|   +++-+|||||=.||++++.|.+|++|||.+..+....
T Consensus        95 gggslQdiy~~-----TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   95 GGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             CCCcccceeee-----cccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence            99999887653     356788888899999999999999   8899999999999999999999999999987765432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                        .....++|||+|||||
T Consensus       167 --~KrksfiGtpywmapE  182 (829)
T KOG0576|consen  167 --AKRKSFIGTPYWMAPE  182 (829)
T ss_pred             --hhhhcccCCccccchh
Confidence              2234588999999998

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.87  E-value=7.1e-22  Score=216.86  Aligned_cols=161  Identities=28%  Similarity=0.427  Sum_probs=137.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCC------e
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGG------S  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  745 (851)
                      ++|++.+.||+|+||.||+|.+..++..||||++....    ..+.+.+|++++++++||||+++++++....      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            46889999999999999999999999999999885432    2356789999999999999999999887543      4


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .++||||+ ++++.+++..      ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||+
T Consensus        95 ~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            58999999 7799887753      25788899999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.......     ....+++.|+|||
T Consensus       165 ~~~~~~~~-----~~~~~~~~y~aPE  185 (343)
T cd07880         165 ARQTDSEM-----TGYVVTRWYRAPE  185 (343)
T ss_pred             ccccccCc-----cccccCCcccCHH
Confidence            98654322     2245789999998

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.87  E-value=1.8e-21  Score=205.88  Aligned_cols=160  Identities=28%  Similarity=0.378  Sum_probs=132.5

Q ss_pred             HcCCccCCee--cccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEe
Q 003065          675 ICNLEEDNLI--GSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .++|++.+.+  |+|+||.||+++.+.++..+|+|.+.......   .|+.....+ +||||+++++++..++..|+|||
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            4566676666  99999999999999999999999886542111   123222222 79999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-ceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~  830 (851)
                      |+++++|.+++...     ..+++..+..++.|+++|++|||   +.+++||||||+||+++.++ .++|+|||.++...
T Consensus        90 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         90 YIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            99999999998753     26889999999999999999999   78999999999999999988 99999999987654


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...      ...|+..|+|||
T Consensus       162 ~~~------~~~~~~~y~aPE  176 (267)
T PHA03390        162 TPS------CYDGTLDYFSPE  176 (267)
T ss_pred             CCc------cCCCCCcccChh
Confidence            322      235899999998

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.87  E-value=7e-22  Score=207.45  Aligned_cols=167  Identities=29%  Similarity=0.469  Sum_probs=144.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +|++.+.||+|+||.||++++..+++.+|+|.+...    .....+.+|++++++++|+||+++++++......|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            478889999999999999999889999999988643    2345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++.+.. .....+++..++.++.|++.|++|||   +.+++||||+|+||+++.++.+|++|||+++.....
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999999987743 23356788999999999999999999   789999999999999999999999999999876554


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..    ....|++.|+|||
T Consensus       157 ~~----~~~~~~~~~~~Pe  171 (256)
T cd08530         157 MA----KTQIGTPHYMAPE  171 (256)
T ss_pred             Cc----ccccCCccccCHH
Confidence            21    1245788999998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.87  E-value=1.2e-21  Score=209.61  Aligned_cols=165  Identities=33%  Similarity=0.439  Sum_probs=140.6

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeEEEEe
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFLVLE  751 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  751 (851)
                      |++.+.||+|+||.||+|.+..+++.||+|++....    ..+.+.+|++++++++|||++++++++...  +..|+|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999998889999999986542    345678999999999999999999999887  88999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |++ +++.+++...    ...+++..+..++.|+++|++|||   +.+++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            996 5888887643    246889999999999999999999   78999999999999999999999999999987655


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .... ......++..|+|||
T Consensus       153 ~~~~-~~~~~~~~~~y~~PE  171 (287)
T cd07840         153 RNSA-DYTNRVITLWYRPPE  171 (287)
T ss_pred             CCcc-cccccccccccCCce
Confidence            4321 122345788999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.87  E-value=4.7e-22  Score=217.62  Aligned_cols=167  Identities=29%  Similarity=0.405  Sum_probs=139.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe----CCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  747 (851)
                      .+|+..+.||+|+||.||+|....+++.||+|++...    ...+.+.+|+.++++++||||+++++++..    ....|
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            4788999999999999999999999999999998653    234567789999999999999999887753    35689


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+. ++|.+++..     ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++
T Consensus        85 lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          85 VVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence            9999995 688888754     234888999999999999999999   7899999999999999999999999999997


Q ss_pred             ccCCCCCc--ccccccccccccccCC
Q 003065          828 IAENSPKV--SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~--~~~~~~~gt~~Y~APE  851 (851)
                      ........  .......|+..|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE  181 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPE  181 (334)
T ss_pred             eecccCcCCCcccccccccccccChH
Confidence            65433211  1112357899999998

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=4.7e-22  Score=232.24  Aligned_cols=255  Identities=27%  Similarity=0.414  Sum_probs=192.5

Q ss_pred             cceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCC
Q 003065           63 FSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSA  142 (851)
Q Consensus        63 w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~  142 (851)
                      |.-..|-.  ..++.+++++.+++ .+|..+.  ++|+.|+|++|+++ .+|..+.  ++|++|+|++|.+++.+..+. 
T Consensus       170 ~r~~~Cl~--~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~-  240 (754)
T PRK15370        170 QRMRDCLK--NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP-  240 (754)
T ss_pred             HHHHhhcc--cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh-
Confidence            44345643  35788999998888 4676664  57999999999998 5787665  589999999999987655453 


Q ss_pred             CCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcc
Q 003065          143 LKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTL  222 (851)
Q Consensus       143 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  222 (851)
                       ++|+.|+|++|.+. .+|..+.  ++|+.|++++|++.  .+|..+.  ++|+.|++++|+|+ .+|..+.  ++|+.|
T Consensus       241 -~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~--~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L  309 (754)
T PRK15370        241 -DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS--CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHL  309 (754)
T ss_pred             -ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC--ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHH
Confidence             47999999999988 5676654  57999999999987  5777664  58999999999998 4565553  478899


Q ss_pred             ccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccC
Q 003065          223 DICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS  302 (851)
Q Consensus       223 ~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~  302 (851)
                      ++++|+++. +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|++++|+++
T Consensus       310 ~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt  380 (754)
T PRK15370        310 NVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT  380 (754)
T ss_pred             HhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC
Confidence            999999984 555443  678889999999884 666553  68899999999887 5676553  57888999998888


Q ss_pred             CCCCCCCCCcccccEEEeccCcCCCCCCCcc----CCCCccceeeccCCccc
Q 003065          303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENL----GRYTALTDVDISENQFS  350 (851)
Q Consensus       303 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l----~~l~~L~~L~Ls~N~l~  350 (851)
                       .+|..+.  ..|+.|++++|+++ .+|..+    +.++++..|++.+|.++
T Consensus       381 -~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        381 -NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             -CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence             4565543  36888888888887 445443    34467788888888876

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.87  E-value=1e-21  Score=210.57  Aligned_cols=163  Identities=28%  Similarity=0.444  Sum_probs=139.0

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      |+....||+|+||.||++....+++.||||++...  ...+.+.+|+.+++.++|+||+++++++..++..|+||||+++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            33446799999999999999999999999987543  3345688999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++..      ..+++.....++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++........ 
T Consensus       102 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-  171 (292)
T cd06657         102 GALTDIVTH------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  171 (292)
T ss_pred             CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence            999887653      24688888999999999999999   78999999999999999999999999999876543321 


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                       ......|++.|+|||
T Consensus       172 -~~~~~~~~~~y~~pE  186 (292)
T cd06657         172 -RRKSLVGTPYWMAPE  186 (292)
T ss_pred             -cccccccCccccCHH
Confidence             122356899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.87  E-value=1.2e-22  Score=223.53  Aligned_cols=165  Identities=25%  Similarity=0.363  Sum_probs=137.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCc----EEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ..+..++||+|+||+||+|.+...++    +||+|++...   ...+++..|+-+|.++.|||++++++++.... ..+|
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            34677899999999999999876654    4899987654   34577899999999999999999999987765 7899


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ++||+.|+|.||++.+    +..+.....+.+..|||+||+|||   ++++|||||..+|||+..-..+||.|||+|+..
T Consensus       776 tq~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHhcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            9999999999999875    456777888999999999999999   789999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccccc
Q 003065          830 ENSPKVSDYSCFAGTHGYIA  849 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~A  849 (851)
                      ..+..........-.+.|||
T Consensus       849 ~~d~~ey~~~~gK~pikwma  868 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMA  868 (1177)
T ss_pred             CcccccccccccccCcHHHH
Confidence            76654433222222344555

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.87  E-value=1.5e-21  Score=213.91  Aligned_cols=167  Identities=26%  Similarity=0.313  Sum_probs=138.0

Q ss_pred             cCCc-cCCeecccCcEEEEEEEEcCCCcEEEEEEecccccH----------------HHHHHHHHHHHcCCCCccccEEE
Q 003065          676 CNLE-EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV----------------KVFAAEMEILGKIRHRNILKLYA  738 (851)
Q Consensus       676 ~~~~-~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------~~~~~E~~~l~~l~h~niv~l~~  738 (851)
                      .+|. ..+.||+|+||.||+|.+..+++.||||++......                ..+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3554 457799999999999999889999999988543211                24678999999999999999999


Q ss_pred             EEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCce
Q 003065          739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP  818 (851)
Q Consensus       739 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~  818 (851)
                      ++..++..|+||||++ |+|.+++..     ...++......++.|++.|++|||   +.+++||||||+||+++.++.+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence            9999999999999996 689888864     235788889999999999999999   7899999999999999999999


Q ss_pred             EEeeecCccccCCCC------------CcccccccccccccccCC
Q 003065          819 KIADFGVAKIAENSP------------KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       819 kl~DFGla~~~~~~~------------~~~~~~~~~gt~~Y~APE  851 (851)
                      |++|||.++......            .........+++.|+|||
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  203 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPE  203 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCCh
Confidence            999999997654111            011112235788999998

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.4e-21  Score=204.12  Aligned_cols=156  Identities=29%  Similarity=0.403  Sum_probs=130.8

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHH-HcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEIL-GKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|.+..+++.||||.+....     ....+..|..++ ...+|+|++++++++..++..|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999998899999999986532     122344555544 445899999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++...     ..++...+..++.|++.||.|+|   +.+++||||+|+||++++++.+||+|||+++.....   
T Consensus        82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  150 (260)
T cd05611          82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---  150 (260)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc---
Confidence            9999998753     34778888899999999999999   789999999999999999999999999998754331   


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                         ....|++.|+|||
T Consensus       151 ---~~~~~~~~y~~pe  163 (260)
T cd05611         151 ---KKFVGTPDYLAPE  163 (260)
T ss_pred             ---ccCCCCcCccChh
Confidence               2245889999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.86  E-value=1.5e-21  Score=208.91  Aligned_cols=166  Identities=28%  Similarity=0.354  Sum_probs=139.2

Q ss_pred             CCccCCeecccCcEEEEEEEEc---CCCcEEEEEEeccc------ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      +|++.+.||+|+||.||+|+..   .++..||||.+...      ...+.+.+|+++++++ +||+|+++++++..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3678899999999999999864   35678999988543      2345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+++|+|.+++...     ..+++..+..++.|+++|++|||   +.+++||||||+||+++.++.++++|||++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~  152 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLS  152 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccc
Confidence            9999999999999988652     34778888899999999999999   789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +......... .....|+..|+|||
T Consensus       153 ~~~~~~~~~~-~~~~~~~~~y~aPE  176 (288)
T cd05583         153 KEFLAEEEER-AYSFCGTIEYMAPE  176 (288)
T ss_pred             cccccccccc-cccccCCccccCHH
Confidence            7654432211 12346899999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.86  E-value=4.6e-21  Score=207.71  Aligned_cols=160  Identities=35%  Similarity=0.510  Sum_probs=137.5

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      |...+.||+|+||.||+|++..+++.||+|++...     ...+.+.+|+++++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66778899999999999999889999999988542     2235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +. |++.+++...    ...+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus       103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~  174 (313)
T cd06633         103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA  174 (313)
T ss_pred             CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence            95 6888877643    345788899999999999999999   789999999999999999999999999998643221


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                            ....|+..|+|||
T Consensus       175 ------~~~~~~~~y~aPE  187 (313)
T cd06633         175 ------NSFVGTPYWMAPE  187 (313)
T ss_pred             ------CCccccccccChh
Confidence                  2346899999998

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=1.4e-21  Score=208.54  Aligned_cols=164  Identities=30%  Similarity=0.416  Sum_probs=140.2

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEecc
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      |++.+.||+|++|.||+|+...+++.||||++....   ......+|+..+++++ |+||+++++++..++..|+||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999998889999999886542   2234467999999999 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                       +|++.+++....   ...+++..+..++.|++.|+.|||   +.+++|+||||+||++++++.++|+|||.++......
T Consensus        81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence             889999887642   246789999999999999999999   7899999999999999999999999999998665432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..   ....|+..|+|||
T Consensus       154 ~~---~~~~~~~~~~aPE  168 (283)
T cd07830         154 PY---TDYVSTRWYRAPE  168 (283)
T ss_pred             Cc---CCCCCcccccCce
Confidence            21   2246889999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.86  E-value=1.9e-21  Score=213.66  Aligned_cols=161  Identities=29%  Similarity=0.406  Sum_probs=136.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeC------Ce
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG------GS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  745 (851)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++....    ..+.+.+|++++++++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            57899999999999999999998899999999986432    245677899999999999999999987543      34


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+++|++ +++|.+++..      ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        97 ~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~  166 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL  166 (345)
T ss_pred             EEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecccc
Confidence            68888887 7899887653      24788899999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.....     .....|++.|+|||
T Consensus       167 ~~~~~~~-----~~~~~~~~~y~aPE  187 (345)
T cd07877         167 ARHTDDE-----MTGYVATRWYRAPE  187 (345)
T ss_pred             ccccccc-----ccccccCCCccCHH
Confidence            9765332     12346899999998

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.86  E-value=1.1e-21  Score=214.97  Aligned_cols=165  Identities=25%  Similarity=0.375  Sum_probs=139.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC-----Cee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  746 (851)
                      .+|.+.+.||+|+||.||+|++..+++.||||.+...    ...+.+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4688999999999999999999999999999988542    2345677899999999999999999987644     347


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+|+||+. ++|.+++..     ...++......++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        85 ~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          85 YIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            99999995 788888764     235888899999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.......  ......|+..|+|||
T Consensus       156 ~~~~~~~~--~~~~~~~~~~y~aPE  178 (337)
T cd07858         156 RTTSEKGD--FMTEYVVTRWYRAPE  178 (337)
T ss_pred             cccCCCcc--cccccccccCccChH
Confidence            87654321  122346889999998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.86  E-value=2.1e-21  Score=212.27  Aligned_cols=166  Identities=28%  Similarity=0.350  Sum_probs=135.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCC--CcEEEEEEeccc----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeC----Ce
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKN--AGTVAVKQLWKG----DGVKVFAAEMEILGKI-RHRNILKLYACLLKG----GS  745 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  745 (851)
                      +|++.+.||+|+||.||+|++..+  +..||+|++...    ...+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477888999999999999999877  889999988542    2345678899999999 599999999875432    45


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+++||++ ++|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            789999985 689888754     245788999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCc--ccccccccccccccCC
Q 003065          826 AKIAENSPKV--SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~--~~~~~~~gt~~Y~APE  851 (851)
                      ++........  .......||+.|+|||
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE  179 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPE  179 (332)
T ss_pred             ceecccccccccccccCcccCccccCcH
Confidence            9865432211  1123357899999998

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.86  E-value=1.9e-21  Score=218.38  Aligned_cols=173  Identities=21%  Similarity=0.221  Sum_probs=129.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEc----------------CCCcEEEEEEecccc--cHH--------------HHHHHH
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLK----------------KNAGTVAVKQLWKGD--GVK--------------VFAAEM  722 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~--~~~--------------~~~~E~  722 (851)
                      .++|++.++||+|+||.||+|...                ..++.||||++....  ..+              ....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            458999999999999999999752                234679999985431  112              233477


Q ss_pred             HHHHcCCCCcc-----ccEEEEEEe--------CCeeEEEEeccCCCCHHHHHHHhhhC-------------------CC
Q 003065          723 EILGKIRHRNI-----LKLYACLLK--------GGSSFLVLEYMPNGNLFQALHKRVKE-------------------GK  770 (851)
Q Consensus       723 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~  770 (851)
                      .++.+++|.++     +++++++..        .+..|+||||+++++|.++++.....                   ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777776554     566676643        35689999999999999998753110                   11


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccccC
Q 003065          771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP  850 (851)
Q Consensus       771 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP  850 (851)
                      ...++..+..++.|++.|+.|+|   +.+|+||||||+||+++.++.+||+|||+++......... .....+|+.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeCh
Confidence            23567788899999999999999   7899999999999999999999999999997654332211 1122458999999


Q ss_pred             C
Q 003065          851 G  851 (851)
Q Consensus       851 E  851 (851)
                      |
T Consensus       380 E  380 (507)
T PLN03224        380 E  380 (507)
T ss_pred             h
Confidence            8

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.86  E-value=2.4e-21  Score=211.47  Aligned_cols=164  Identities=21%  Similarity=0.255  Sum_probs=133.2

Q ss_pred             Ceeccc--CcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSG--GTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|  +||+||+|++..+++.||||++....    ..+.+.+|+.+++.++||||+++++++..++..|+|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            345666  99999999999999999999986432    246678899999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      +++.+++....   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|++||+.+.........
T Consensus        84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            99999987642   235788888899999999999999   789999999999999999999999999865433221111


Q ss_pred             c-----cccccccccccccCC
Q 003065          836 S-----DYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~-----~~~~~~gt~~Y~APE  851 (851)
                      .     ......++..|||||
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE  178 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPE  178 (328)
T ss_pred             ccccccccccccCccCccChh
Confidence            0     001123567799998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.86  E-value=1.6e-21  Score=211.21  Aligned_cols=169  Identities=31%  Similarity=0.436  Sum_probs=138.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeC-------
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG-------  743 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  743 (851)
                      +++|++.+.||+|+||.||+|++..+++.||||++....    ....+.+|++++++++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            568999999999999999999999999999999885431    234567899999999999999999877443       


Q ss_pred             -CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          744 -GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       744 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                       ...|+||||++ +++.+.+...    ...+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence             34699999995 4777766542    346889999999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCc---------ccccccccccccccCC
Q 003065          823 FGVAKIAENSPKV---------SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~---------~~~~~~~gt~~Y~APE  851 (851)
                      ||+++........         .......|++.|+|||
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  196 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE  196 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChH
Confidence            9999765433211         1123346789999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.86  E-value=3.2e-21  Score=207.34  Aligned_cols=167  Identities=30%  Similarity=0.446  Sum_probs=137.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .++|++.+.||+|+||.||+|++..+++.||||.+....   ....+.+|++++.+.. ||||+++++++.+....|+||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            357889999999999999999998889999999986542   3345667887777775 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||++ +++.+++...    ...+++..+..++.|++.|++|||.  ..+|+||||+|+||++++++.+||+|||++....
T Consensus        94 e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          94 ELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            9984 5777766542    2368888899999999999999993  2589999999999999999999999999997654


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   ....|++.|+|||
T Consensus       167 ~~~~~---~~~~~~~~y~aPE  184 (296)
T cd06618         167 DSKAK---TRSAGCAAYMAPE  184 (296)
T ss_pred             CCCcc---cCCCCCccccCHh
Confidence            33222   1235788999998

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.86  E-value=4.3e-21  Score=209.20  Aligned_cols=161  Identities=28%  Similarity=0.415  Sum_probs=136.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe-CCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  750 (851)
                      ++|+..+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|++++++++||||+++++++.. ....|+|+
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            4789999999999999999999999999999987542    235677899999999999999999998876 55789999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+ +++|.+++..      ..++......++.|+++|++|||   +.+|+||||||+||++++++.+||+|||.++...
T Consensus        90 e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          90 ELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             ehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            999 6788877753      24677778889999999999999   7899999999999999999999999999997543


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...     ....+++.|+|||
T Consensus       160 ~~~-----~~~~~~~~y~aPE  175 (328)
T cd07856         160 PQM-----TGYVSTRYYRAPE  175 (328)
T ss_pred             CCc-----CCCcccccccCce
Confidence            321     2245788999998

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.86  E-value=2.9e-21  Score=206.14  Aligned_cols=164  Identities=29%  Similarity=0.428  Sum_probs=141.2

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      |+..+.||+|++|.||+|.+..+++.+|+|++....    ....+.+|++++++++|++|+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999998899999999885542    2456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      + +++.+++...    ...+++..+..++.|++.|+.|||   +.+|+|+||||+||+++.++.+||+|||.+.......
T Consensus        81 ~-~~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 D-TDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             C-CCHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            6 4888888763    246888999999999999999999   7899999999999999999999999999998765543


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                        .......++..|+|||
T Consensus       153 --~~~~~~~~~~~~~~PE  168 (283)
T cd05118         153 --RPYTHYVVTRWYRAPE  168 (283)
T ss_pred             --ccccCccCcccccCcH
Confidence              1222346888999998

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.86  E-value=4.6e-21  Score=205.71  Aligned_cols=167  Identities=24%  Similarity=0.238  Sum_probs=123.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC---CcEEEEEEecccccH-------------HHHHHHHHHHHcCCCCccccEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKGDGV-------------KVFAAEMEILGKIRHRNILKLYAC  739 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-------------~~~~~E~~~l~~l~h~niv~l~~~  739 (851)
                      .+|++.+.||+|+||.||+|++..+   +..+|+|+.......             .....+...+..+.|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4789999999999999999998776   566777754322110             111233445566789999999987


Q ss_pred             EEeCC----eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC
Q 003065          740 LLKGG----SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED  815 (851)
Q Consensus       740 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~  815 (851)
                      +....    ..++++|++. .++.+.+...     ...++..+..++.|++.|++|||   +.+|+||||||+|||++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCC
Confidence            65543    3478888873 4666666542     22456778899999999999999   7899999999999999999


Q ss_pred             CceEEeeecCccccCCCCCc-----ccccccccccccccCC
Q 003065          816 YEPKIADFGVAKIAENSPKV-----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       816 ~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE  851 (851)
                      +.+||+|||+|+........     .......||+.|+|||
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape  203 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD  203 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHH
Confidence            99999999999866432211     1112346999999997

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.86  E-value=6.9e-21  Score=203.65  Aligned_cols=164  Identities=31%  Similarity=0.353  Sum_probs=136.4

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcC---CCCccccEEEEEEeCCe-----
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKI---RHRNILKLYACLLKGGS-----  745 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  745 (851)
                      |++.+.||+|+||.||+|++..+++.||+|++....    ....+.+|+++++++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999998889999999986431    234566788877666   59999999999988776     


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .+++|||+. +++.+++...   ....+++..+..++.|+++|++|||   +.+++|+||||+||+++.++.+||+|||.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCc
Confidence            899999996 5898888753   2235889999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.........   ....++..|+|||
T Consensus       154 ~~~~~~~~~~---~~~~~~~~~~~PE  176 (287)
T cd07838         154 ARIYSFEMAL---TSVVVTLWYRAPE  176 (287)
T ss_pred             ceeccCCccc---ccccccccccChH
Confidence            9876543222   2235788999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.85  E-value=2.5e-21  Score=211.66  Aligned_cols=166  Identities=30%  Similarity=0.395  Sum_probs=141.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC-----eeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG-----SSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  747 (851)
                      +|++.+.||+|+||.||+|++..+++.||+|++...    ...+.+.+|+++++.++|+||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            478889999999999999999888999999988653    34567889999999999999999999887765     789


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||++ ++|.+++.+.     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||.+.
T Consensus        81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            9999996 5888887642     36889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCc-ccccccccccccccCC
Q 003065          828 IAENSPKV-SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~-~~~~~~~gt~~Y~APE  851 (851)
                      ........ .......+|+.|+|||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE  176 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPE  176 (330)
T ss_pred             eecccccccccccccccccCcCCce
Confidence            76554310 1123346899999998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.85  E-value=5.1e-21  Score=206.89  Aligned_cols=161  Identities=34%  Similarity=0.516  Sum_probs=138.2

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .|+..+.||+|+||.||+|++..++..||+|.+...     ...+++.+|+++++.++|+|++++++++......|+|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            477788999999999999999888999999987532     224567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+. |++.+++...    ...+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        96 ~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          96 YCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             ccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            996 6887777543    234788888999999999999999   78999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .      ....|++.|+|||
T Consensus       168 ~------~~~~~~~~y~aPE  181 (308)
T cd06634         168 A------NXFVGTPYWMAPE  181 (308)
T ss_pred             c------ccccCCccccCHH
Confidence            2      1246889999998

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.85  E-value=6.3e-21  Score=199.50  Aligned_cols=158  Identities=37%  Similarity=0.487  Sum_probs=137.4

Q ss_pred             ecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       684 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      ||+|+||.||++.+..+++.||+|++....     ..+.+..|++++++++||||+++++.+..++..|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999998889999999886542     345788999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY  838 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  838 (851)
                      .+++...     ..+++.....++.|++.|+.|+|   +.+++|+||||+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~  150 (250)
T cd05123          81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RT  150 (250)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cc
Confidence            9998753     25788899999999999999999   78999999999999999999999999999976654321  12


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ....|+..|+|||
T Consensus       151 ~~~~~~~~~~~Pe  163 (250)
T cd05123         151 NTFCGTPEYLAPE  163 (250)
T ss_pred             cCCcCCccccChH
Confidence            2356889999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.85  E-value=6.4e-21  Score=206.87  Aligned_cols=158  Identities=20%  Similarity=0.214  Sum_probs=129.2

Q ss_pred             CcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCHHHHHH
Q 003065          688 GTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH  763 (851)
Q Consensus       688 ~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~  763 (851)
                      ++|.||.++...+++.||||++...    ...+.+.+|++++++++|+||+++++++...+..|++|||+++|++.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4455566666668999999998543    344678899999999999999999999999999999999999999999998


Q ss_pred             HhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc-----ccc
Q 003065          764 KRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV-----SDY  838 (851)
Q Consensus       764 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-----~~~  838 (851)
                      ...   ...++......++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||.+.........     ...
T Consensus        92 ~~~---~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~  165 (314)
T cd08216          92 THF---PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP  165 (314)
T ss_pred             Hhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence            642   234778888899999999999999   789999999999999999999999999998755332111     111


Q ss_pred             cccccccccccCC
Q 003065          839 SCFAGTHGYIAPG  851 (851)
Q Consensus       839 ~~~~gt~~Y~APE  851 (851)
                      ....++..|+|||
T Consensus       166 ~~~~~~~~y~aPE  178 (314)
T cd08216         166 KSSVKNLPWLSPE  178 (314)
T ss_pred             ccccccccccCHH
Confidence            2345788999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.85  E-value=2.1e-21  Score=224.01  Aligned_cols=171  Identities=22%  Similarity=0.208  Sum_probs=121.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCC----CcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEE------EEeCC
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKN----AGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYAC------LLKGG  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~  744 (851)
                      .++|+..+.||+|+||.||+|++..+    +..||||++......+....|  .++...+.+++.+...      ...+.
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence            46899999999999999999999888    899999987654333222222  1222222233322211      23456


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKE---------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSN  809 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~N  809 (851)
                      ..|+||||+++++|.+++......               .........+..++.|++.||+|||   +++|+||||||+|
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~N  285 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQN  285 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHH
Confidence            789999999999999998753100               0001122345678999999999999   7899999999999


Q ss_pred             EEECC-CCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          810 ILLDE-DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       810 ILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||++. ++.+||+|||+|+........ ....+.||+.|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE  327 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPE  327 (566)
T ss_pred             EEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChH
Confidence            99985 579999999999865433221 123467899999998

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=7.8e-22  Score=213.46  Aligned_cols=166  Identities=29%  Similarity=0.417  Sum_probs=138.2

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCc---EEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ...+.||+|.||.|++|.|+..+.   .||||.+...   ...++|.+|+.+|.+++|||++++||...+ ....||||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            455689999999999999975433   3999998655   256889999999999999999999999877 568899999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++.|+|.+.+++   .....+-......++.|||.||+||.   .+++||||+..+|+++...-.+||+|||+.+.....
T Consensus       192 aplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  192 APLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             cccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            999999999987   24556778888899999999999999   889999999999999999889999999999987765


Q ss_pred             CCccccc-ccccccccccCC
Q 003065          833 PKVSDYS-CFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~-~~~gt~~Y~APE  851 (851)
                      +....+. ...--..|.|||
T Consensus       266 ed~Yvm~p~rkvPfAWCaPE  285 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPE  285 (1039)
T ss_pred             CcceEecCCCcCcccccCHh
Confidence            4432211 111244689998

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=4.9e-23  Score=199.46  Aligned_cols=164  Identities=27%  Similarity=0.420  Sum_probs=135.1

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC-----eeEE
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG-----SSFL  748 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  748 (851)
                      .+..+.||-|+||.||.+++..+|+.||.|++..-    ...+++.+|++++...+|.|++..++..+...     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            45678899999999999999999999999988443    34577889999999999999999887765432     4688


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+|.|. .+|.+.+-     +...++...+..+..||++|++|||   +.+|.||||||.|.|++.+..+||||||+|+.
T Consensus       135 ~TELmQ-SDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHH-hhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccc
Confidence            999884 57766654     3456777788889999999999999   88999999999999999999999999999997


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+.+... .++..+-|.+|+|||
T Consensus       206 ee~d~~~-hMTqEVVTQYYRAPE  227 (449)
T KOG0664|consen  206 WDQRDRL-NMTHEVVTQYYRAPE  227 (449)
T ss_pred             cchhhhh-hhHHHHHHHHhccHH
Confidence            6654432 233346789999998

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.85  E-value=4.8e-21  Score=204.29  Aligned_cols=164  Identities=32%  Similarity=0.413  Sum_probs=140.8

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      |+..+.||+|+||.||+|+...+++.||+|++...    ...+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            56678899999999999999989999999998653    23456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      + ++|.+++.+.    ...+++..+..++.|++.|++|||   +.+|+||||+|+||++++++.+||+|||.++......
T Consensus        81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            7 5999999764    145889999999999999999999   7899999999999999999999999999998665432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......++..|+|||
T Consensus       153 ~--~~~~~~~~~~~~aPE  168 (282)
T cd07829         153 R--TYTHEVVTLWYRAPE  168 (282)
T ss_pred             c--ccCccccCcCcCChH
Confidence            2  122235678899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.85  E-value=4.1e-21  Score=202.32  Aligned_cols=168  Identities=27%  Similarity=0.380  Sum_probs=138.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecc-------cccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-------GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +|.+.+.||+|+||.||++++...+..+++|+++.       .....++.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999999987776676666532       12334567899999999999999999999888899999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|.+++.... .....+++..++.++.|++.|+.|||   +.+++|+|+||+||++++ +.+|++|||.++..
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence            99999999999987642 23456899999999999999999999   789999999999999975 57999999999766


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  .....|++.|+|||
T Consensus       156 ~~~~~~--~~~~~~~~~~~~pe  175 (260)
T cd08222         156 MGSCDL--ATTFTGTPYYMSPE  175 (260)
T ss_pred             CCCccc--ccCCCCCcCccCHH
Confidence            443221  12345889999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.85  E-value=5.2e-21  Score=209.95  Aligned_cols=160  Identities=29%  Similarity=0.404  Sum_probs=133.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC------e
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------S  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  745 (851)
                      .+|...+.||+|+||.||+|++..+++.||||++...    .....+.+|++++++++||||+++++++....      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4788889999999999999999889999999988643    22355789999999999999999999886542      4


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+|+||+. .++.++..       ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+
T Consensus        95 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          95 FYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             EEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            689999995 46655432       24788889999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.....     .....||+.|+|||
T Consensus       164 ~~~~~~~-----~~~~~~~~~y~aPE  184 (342)
T cd07879         164 ARHADAE-----MTGYVVTRWYRAPE  184 (342)
T ss_pred             CcCCCCC-----CCCceeeecccChh
Confidence            9765332     12346789999998

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.85  E-value=8e-21  Score=197.06  Aligned_cols=149  Identities=24%  Similarity=0.222  Sum_probs=127.2

Q ss_pred             cCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhh
Q 003065          687 GGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV  766 (851)
Q Consensus       687 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  766 (851)
                      |.||.||+|++..+++.||+|++....   .+.+|...+....||||+++++++...+..|+||||+++|+|.+++.+. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-
Confidence            889999999999999999999986543   2345556666678999999999999999999999999999999998753 


Q ss_pred             hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccc
Q 003065          767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG  846 (851)
Q Consensus       767 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  846 (851)
                          ..+++..+..++.|+++|++|+|   +++|+||||||+||+++.++.++++|||.+.......     ....++..
T Consensus        80 ----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          80 ----LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             ----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence                24788899999999999999999   7899999999999999999999999999886654321     12346778


Q ss_pred             cccCC
Q 003065          847 YIAPG  851 (851)
Q Consensus       847 Y~APE  851 (851)
                      |+|||
T Consensus       148 y~aPE  152 (237)
T cd05576         148 YCAPE  152 (237)
T ss_pred             ccCCc
Confidence            99998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.84  E-value=3.7e-21  Score=211.20  Aligned_cols=161  Identities=30%  Similarity=0.418  Sum_probs=138.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCe------
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS------  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  745 (851)
                      ++|+..+.||+|+||.||+|++..+++.||||++...    ...+.+.+|+.++++++||||+++++++...+.      
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            4788999999999999999999989999999987543    234567789999999999999999887766554      


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+|+||+ +++|.+++..      ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        95 ~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence            89999999 6799888764      35788899999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +......     .....++..|+|||
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE  185 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPE  185 (343)
T ss_pred             ccccccc-----ccCCcccccccCHH
Confidence            9865433     12346788999998

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.84  E-value=6.7e-21  Score=209.10  Aligned_cols=166  Identities=28%  Similarity=0.405  Sum_probs=135.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeC----------
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKG----------  743 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  743 (851)
                      .+|...+.||+|+||.||+|.+..+++.||+|++...  ...+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            4788999999999999999999999999999988544  3456688999999999999999998776543          


Q ss_pred             ----CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-CCce
Q 003065          744 ----GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEP  818 (851)
Q Consensus       744 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-~~~~  818 (851)
                          ...|+||||++ ++|.+++..      ..+++..+..++.|++.|++|||   +.+|+||||||+||+++. ++.+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceE
Confidence                35789999996 588877753      24778889999999999999999   789999999999999974 5578


Q ss_pred             EEeeecCccccCCCCCcc-cccccccccccccCC
Q 003065          819 KIADFGVAKIAENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       819 kl~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      |++|||.++......... ......|+..|+|||
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  188 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR  188 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHH
Confidence            999999997654321111 112235788999998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.84  E-value=5.9e-21  Score=194.75  Aligned_cols=165  Identities=24%  Similarity=0.301  Sum_probs=139.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc-HHHHHHHHHHHHcCCC--C----ccccEEEEEEeCCeeE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-VKVFAAEMEILGKIRH--R----NILKLYACLLKGGSSF  747 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~~  747 (851)
                      ..+|.+...+|+|.||+|..|.+..++..||||+++.-.. .+...-|+++++++.+  |    -+|++.++|...++.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC  167 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC  167 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence            3589999999999999999999999989999999876533 4455679999999942  2    3677889999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-------------
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-------------  814 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-------------  814 (851)
                      +|+|.+ |-|+.+++...   +..+++...+..|+.|++++++|||   +.+++|-|+||+|||+.+             
T Consensus       168 ivfell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCcc
Confidence            999998 77999999864   4567888999999999999999999   889999999999999832             


Q ss_pred             -------CCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          815 -------DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       815 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                             +..+|++|||.|+...+..     ..++.|..|+|||
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPE  279 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPE  279 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCch
Confidence                   2358999999998766543     3467899999999

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.8e-20  Score=185.58  Aligned_cols=140  Identities=21%  Similarity=0.198  Sum_probs=107.8

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEecccc----c-------HH-----------------HHHHHHHHHHcCCCCc
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----G-------VK-----------------VFAAEMEILGKIRHRN  732 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~-------~~-----------------~~~~E~~~l~~l~h~n  732 (851)
                      .+.||+|+||.||+|.+. +|++||||+++...    .       ..                 ...+|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999996 89999999986431    1       11                 1234999999998887


Q ss_pred             cccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE
Q 003065          733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL  812 (851)
Q Consensus       733 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl  812 (851)
                      +.....+...  ..++||||++++++......     ...++......++.|++.++.|+||  +.+|+||||||+||++
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli  151 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEE
Confidence            7543333222  23899999988776544322     2357788899999999999999942  6799999999999999


Q ss_pred             CCCCceEEeeecCccccCC
Q 003065          813 DEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       813 ~~~~~~kl~DFGla~~~~~  831 (851)
                      + ++.++++|||+|.....
T Consensus       152 ~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         152 H-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             E-CCcEEEEEccccccCCC
Confidence            8 47899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.82  E-value=9.5e-21  Score=184.01  Aligned_cols=162  Identities=22%  Similarity=0.356  Sum_probs=133.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcC-CCCccccEEE-EEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYA-CLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lv~e~  752 (851)
                      +.|.+.+.+|+|.||.+-.|+++.+...+|+|.+..+ ...++|.+|...--.+ .|.||+.-|+ .|+..+..++++||
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            4689999999999999999999999999999998766 4567899999876666 5899998665 57888888899999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC--CCCceEEeeecCccccC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD--EDYEPKIADFGVAKIAE  830 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~  830 (851)
                      ++.|+|.+-+..      ..+.+....+++.|++.|+.|||   ++.+||||||.+||||-  +..++|+||||..+..+
T Consensus       104 aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  104 APRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             CccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999776543      34667777899999999999999   89999999999999993  34489999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......     .-+..|.|||
T Consensus       175 ~tV~~~-----~~~~~y~~pe  190 (378)
T KOG1345|consen  175 TTVKYL-----EYVNNYHAPE  190 (378)
T ss_pred             ceehhh-----hhhcccCCcH
Confidence            433221     2355677776

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.4e-19  Score=180.16  Aligned_cols=140  Identities=20%  Similarity=0.208  Sum_probs=109.9

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEeccccc----------------------------HHHHHHHHHHHHcCCCCc
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----------------------------VKVFAAEMEILGKIRHRN  732 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------------~~~~~~E~~~l~~l~h~n  732 (851)
                      .+.||+|+||.||+|++. +|+.||||++.....                            ...+.+|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999986 899999999865311                            112357899999999998


Q ss_pred             cccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCcEEeCCCCCCEE
Q 003065          733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNIL  811 (851)
Q Consensus       733 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrDlkp~NIL  811 (851)
                      +.....+....  .|+||||++|+++......     ...++.....+++.|++.++.++|   . .||+||||||+||+
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIl  150 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNIL  150 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEE
Confidence            86544433332  4899999988755433222     124567788899999999999999   5 79999999999999


Q ss_pred             ECCCCceEEeeecCccccCCC
Q 003065          812 LDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       812 l~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++ ++.++|+|||+|+.....
T Consensus       151 l~-~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         151 YH-DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             EE-CCCEEEEEcccceecCCC
Confidence            99 789999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.82  E-value=1.4e-20  Score=208.90  Aligned_cols=166  Identities=28%  Similarity=0.398  Sum_probs=131.5

Q ss_pred             CccCCeecccCcEE-EEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          678 LEEDNLIGSGGTGK-VYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       678 ~~~~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      |...+++|.|+-|+ ||+|..  .++.||||++..+ ..+...+|+..++.- +|||||++++...++...|+..|.| .
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e-~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE-FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH-hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence            44556789998885 899998  6789999987443 334557999999988 6999999999999999999999999 5


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---C--CceEEeeecCccccC
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---D--YEPKIADFGVAKIAE  830 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~--~~~kl~DFGla~~~~  830 (851)
                      .+|.+++.....+ .........+.+..|++.|+++||   +.+|||||+||.||||+.   +  ..++|+|||+++...
T Consensus       587 ~sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 CSLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            6999999874111 111111344577899999999999   789999999999999975   3  479999999999877


Q ss_pred             CCCC-cccccccccccccccCC
Q 003065          831 NSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      .+.. .....+..||-+|+|||
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE  684 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPE  684 (903)
T ss_pred             CCcchhhcccCCCCcccccCHH
Confidence            6543 23345678999999998

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.82  E-value=5.3e-21  Score=181.22  Aligned_cols=171  Identities=23%  Similarity=0.321  Sum_probs=139.6

Q ss_pred             ccccccHHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCC-CCccccEEEEEEeCC
Q 003065          666 HHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLKGG  744 (851)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  744 (851)
                      ....++....++|++.+.+|+|.|++||.|....+.++++||++++. ..+.+.+|+.+++.+. ||||+++++...++.
T Consensus        28 E~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~  106 (338)
T KOG0668|consen   28 ESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE  106 (338)
T ss_pred             hheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence            33445555667899999999999999999999889999999988554 4566889999999997 999999999887653


Q ss_pred             --eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-CceEEe
Q 003065          745 --SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIA  821 (851)
Q Consensus       745 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~  821 (851)
                        ...+|+||+.+.+......        .++...+...+.+++.||.|+|   ++||+|||+||.|++||.. -.++++
T Consensus       107 SktpaLiFE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlI  175 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLI  175 (338)
T ss_pred             ccCchhHhhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeee
Confidence              4579999998877655443        3566677788999999999999   8999999999999999965 469999


Q ss_pred             eecCccccCCCCCcccccccccccccccCC
Q 003065          822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       822 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+|..+.....   +...+.+.+|--||
T Consensus       176 DWGLAEFYHp~~e---YnVRVASRyfKGPE  202 (338)
T KOG0668|consen  176 DWGLAEFYHPGKE---YNVRVASRYFKGPE  202 (338)
T ss_pred             ecchHhhcCCCce---eeeeeehhhcCCch
Confidence            9999988766543   33345677777777

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.80  E-value=5e-19  Score=181.60  Aligned_cols=166  Identities=36%  Similarity=0.477  Sum_probs=142.4

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      |+..+.||+|++|.||++....+++.+|+|.+....   ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            566789999999999999998888999999986543   46778899999999999999999999998889999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++....    ..+++.....++.+++.++.|+|   +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       81 GGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            999999987641    11788889999999999999999   77999999999999999999999999999987755421


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......++..|++||
T Consensus       154 ~-~~~~~~~~~~~~~pe  169 (225)
T smart00221      154 A-LLKTVKGTPFYLAPE  169 (225)
T ss_pred             c-cccceeccCCcCCHh
Confidence            1 122346788899998

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.80  E-value=2e-19  Score=209.66  Aligned_cols=169  Identities=30%  Similarity=0.432  Sum_probs=137.8

Q ss_pred             ccCCeecccCcEEEEEEEEcC-------CCcEEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeE
Q 003065          679 EEDNLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  747 (851)
                      ++.+.+|+|+||+|++|....       ....||||..+..   .+.+.+..|+++|+.+ +|+||+.+.|++...+..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            455699999999999997531       1446999988654   3467889999999999 6999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhh---------hCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC
Q 003065          748 LVLEYMPNGNLFQALHKRV---------KEGK--PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY  816 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~  816 (851)
                      +|+||++.|+|.++++...         ....  ..+.....+.++.|||.|++||+   +.++||||+.++|||+.++.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence            9999999999999998865         1111  23888899999999999999999   78999999999999999999


Q ss_pred             ceEEeeecCccccCCCCCccccccccccc--ccccCC
Q 003065          817 EPKIADFGVAKIAENSPKVSDYSCFAGTH--GYIAPG  851 (851)
Q Consensus       817 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~--~Y~APE  851 (851)
                      .+||+|||+|+........... .-.|+.  .|||||
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApE  491 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPE  491 (609)
T ss_pred             EEEEccccceeccCCCCceEec-CCCCccceeecCHH
Confidence            9999999999976554333211 112223  499998

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=3.6e-19  Score=177.95  Aligned_cols=165  Identities=22%  Similarity=0.254  Sum_probs=143.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEeccCC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      .|.+.++||+|+||..+.|+..-++++||||.-..+.+..++..|.+..+.+. .+.|...+.+..++-+-.+|+|.+ |
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            68999999999999999999999999999998777777888999999999984 689999998888888889999998 8


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-----ceEEeeecCccccC
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-----EPKIADFGVAKIAE  830 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFGla~~~~  830 (851)
                      .+|.|...-.    ...++...+..+|.|++.-++|+|   ++.+|.|||||+|+||..-+     .+.++|||+|+.+.
T Consensus       108 PSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  108 PSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             cCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            8999887754    456899999999999999999999   88999999999999996443     58999999999887


Q ss_pred             CCCCcc-----ccccccccccccc
Q 003065          831 NSPKVS-----DYSCFAGTHGYIA  849 (851)
Q Consensus       831 ~~~~~~-----~~~~~~gt~~Y~A  849 (851)
                      +..+..     ......||.+||+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMS  204 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMS  204 (449)
T ss_pred             CccccccCccccccccccceeeeE
Confidence            765433     2345679999996

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.80  E-value=1.1e-18  Score=176.58  Aligned_cols=159  Identities=38%  Similarity=0.593  Sum_probs=137.9

Q ss_pred             ecccCcEEEEEEEEcCCCcEEEEEEeccccc---HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCHHH
Q 003065          684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ  760 (851)
Q Consensus       684 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  760 (851)
                      ||+|++|.||+++...+++.+++|++.....   .+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999987799999999876654   4788999999999999999999999999899999999999999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-CCceEEeeecCccccCCCCCccccc
Q 003065          761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIAENSPKVSDYS  839 (851)
Q Consensus       761 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~  839 (851)
                      ++...    ...+++..+..++.+++++++|||   +.+++|+||+|.||+++. ++.++|+|||.+........  ...
T Consensus        81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~  151 (215)
T cd00180          81 LLKEN----EGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLK  151 (215)
T ss_pred             HHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhh
Confidence            98753    145788899999999999999999   779999999999999999 89999999999986654421  112


Q ss_pred             ccccccccccCC
Q 003065          840 CFAGTHGYIAPG  851 (851)
Q Consensus       840 ~~~gt~~Y~APE  851 (851)
                      ...+...|++||
T Consensus       152 ~~~~~~~~~~pe  163 (215)
T cd00180         152 TIVGTPAYMAPE  163 (215)
T ss_pred             cccCCCCccChh
Confidence            245788899997

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=2.8e-19  Score=170.98  Aligned_cols=166  Identities=20%  Similarity=0.204  Sum_probs=139.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCC-CccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ..|...+.||.|+||.+|.|.....|..||||.-.......++..|.++.+.++| ..|+.+..+..+...-.+|||.. 
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-   93 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-   93 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence            5789999999999999999999999999999988777667778899999999975 67777888888888889999998 


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC---CCCceEEeeecCccccCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~  831 (851)
                      |.+|.+...-.    ...++..+.+-.+-|++.-++|+|   .+++|||||||+|+|+.   ....+.++|||+|+.+.+
T Consensus        94 GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   94 GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            88998887653    345788888889999999999999   78999999999999995   334699999999998765


Q ss_pred             CCCc-----cccccccccccccc
Q 003065          832 SPKV-----SDYSCFAGTHGYIA  849 (851)
Q Consensus       832 ~~~~-----~~~~~~~gt~~Y~A  849 (851)
                      ..+.     .......||..|.+
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYAS  189 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYAS  189 (341)
T ss_pred             ccccccCccccCCccceeeeehh
Confidence            4332     22334678988865

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.79  E-value=6.6e-20  Score=182.81  Aligned_cols=161  Identities=32%  Similarity=0.379  Sum_probs=136.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC------e
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------S  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  745 (851)
                      .+|...+.+|.|+- .|..|.+.-.+++||+|++..+    ...++..+|...+..++|+||++++.+|....      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            36777888999988 7778888888999999987543    34677789999999999999999999986543      4


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+||||| .++|.+.+..       +++-.....|..|++.|++|+|   +.+|+||||||+||++..++.+||.|||+
T Consensus        96 ~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchh
Confidence            69999999 5799998874       3677788899999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+.....   ...+.++.|..|.|||
T Consensus       165 ar~e~~~---~~mtpyVvtRyyrape  187 (369)
T KOG0665|consen  165 ARTEDTD---FMMTPYVVTRYYRAPE  187 (369)
T ss_pred             hcccCcc---cccCchhheeeccCch
Confidence            9866544   2234468899999998

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.2e-19  Score=197.36  Aligned_cols=160  Identities=27%  Similarity=0.329  Sum_probs=133.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ..|+....+|.|+|+.|-.+.+..+++..+||++.+.  ..+-.+|+.++... +||||+++++.+.++.+.|+|||++.
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            4677778899999999999999999999999998665  23345688776666 79999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE-CCCCceEEeeecCccccCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL-DEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~  833 (851)
                      |+-+.+.+...     +... ..+..|+.+|+.|+.|||   ++||||||+||+|||+ ++.++++|+|||.++.....-
T Consensus       400 g~ell~ri~~~-----~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~  470 (612)
T KOG0603|consen  400 GGELLRRIRSK-----PEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC  470 (612)
T ss_pred             ccHHHHHHHhc-----chhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence            99887776542     1222 566679999999999999   7899999999999999 588999999999998776551


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                           .+.+-|..|.|||
T Consensus       471 -----~tp~~t~~y~APE  483 (612)
T KOG0603|consen  471 -----DTPALTLQYVAPE  483 (612)
T ss_pred             -----cccchhhcccChh
Confidence                 1124588999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.78  E-value=2.8e-19  Score=185.31  Aligned_cols=142  Identities=27%  Similarity=0.381  Sum_probs=128.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcC---CCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ...|...++||+|.|+.||++.+..   .++.||+|.+.......++..|++.+..+ .+.||+++.+++..++...+|+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            3468899999999999999999877   67889999998888888999999999999 5899999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-CCceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~  827 (851)
                      ||++..+-.++...        ++...+..+++.+..||+++|   ..|||||||||+|++.+. .+.-.|+|||+|.
T Consensus       115 p~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  115 PYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             cccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            99999888887754        567788889999999999999   889999999999999984 4678999999997

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.78  E-value=1.3e-18  Score=180.57  Aligned_cols=153  Identities=39%  Similarity=0.546  Sum_probs=134.0

Q ss_pred             CcEEEEEEEEcCCCcEEEEEEeccccc---HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCHHHHHHH
Q 003065          688 GTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK  764 (851)
Q Consensus       688 ~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  764 (851)
                      +||.||+|+...+++.+|+|++.....   .+.+.+|++.+++++|++|+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999988899999999866533   67899999999999999999999999998999999999999999999875


Q ss_pred             hhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccc
Q 003065          765 RVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT  844 (851)
Q Consensus       765 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt  844 (851)
                      .     ..+++..+..++.++++++.|||   +.+++|+||+|+||+++.++.++++|||.+........   .....|+
T Consensus        81 ~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~  149 (244)
T smart00220       81 R-----GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVGT  149 (244)
T ss_pred             c-----cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccCC
Confidence            3     12788899999999999999999   77999999999999999999999999999987665421   2234688


Q ss_pred             cccccCC
Q 003065          845 HGYIAPG  851 (851)
Q Consensus       845 ~~Y~APE  851 (851)
                      ..|+|||
T Consensus       150 ~~~~~pE  156 (244)
T smart00220      150 PEYMAPE  156 (244)
T ss_pred             cCCCCHH
Confidence            8999998

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=3.2e-21  Score=174.77  Aligned_cols=166  Identities=30%  Similarity=0.494  Sum_probs=105.0

Q ss_pred             ccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccce
Q 003065           93 ISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVS  172 (851)
Q Consensus        93 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  172 (851)
                      +.++.+++.|-||+|+++ .+|..|+.+.+|++|++++|++...+++++.+++|+.|+++-|++.               
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~---------------   92 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN---------------   92 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh---------------
Confidence            444555555555555555 4555555555555555555555555555555555555555544443               


Q ss_pred             eecccccCCCCCCcccccCCCCCCeEeccccccc-ccCCcccccccccCccccccccccccccccccCCCcccEEEeecc
Q 003065          173 LSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLR-GRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYAN  251 (851)
Q Consensus       173 L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N  251 (851)
                                 .+|..|+.++.|+.|||..|++. ...|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|
T Consensus        93 -----------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn  160 (264)
T KOG0617|consen   93 -----------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN  160 (264)
T ss_pred             -----------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence                       45556666666666666666654 245666666666777777777776 66777777777777777777


Q ss_pred             CccCcCCcCcCCCCcccEEecccccccCCCCccccCc
Q 003065          252 NLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNL  288 (851)
Q Consensus       252 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  288 (851)
                      .+- .+|..++.++.|++|++.+|+++ .+|.+++++
T Consensus       161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l  195 (264)
T KOG0617|consen  161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL  195 (264)
T ss_pred             chh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence            776 67778888888888888888887 666666654

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=3.3e-18  Score=170.84  Aligned_cols=137  Identities=19%  Similarity=0.318  Sum_probs=106.7

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcC-----CCCccccEEEEEEeCC---eeE
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKI-----RHRNILKLYACLLKGG---SSF  747 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~  747 (851)
                      +...+.||+|+||.||.  +..++.. +||++...  ...+.+.+|+++++.+     .||||++++++++++.   ..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            45678999999999995  6666555 69987643  2456789999999999     5799999999998863   434


Q ss_pred             -EEEec--cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCcEEeCCCCCCEEECC----CCceE
Q 003065          748 -LVLEY--MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI-AYLHHDCSPPIIHRDIKSSNILLDE----DYEPK  819 (851)
Q Consensus       748 -lv~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivHrDlkp~NILl~~----~~~~k  819 (851)
                       +|+||  +++|+|.+++.+.      .++..  ..++.+++.++ +|||   +.+|+||||||+|||++.    ++.++
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEE
Confidence             78999  5579999999652      23333  34577888777 9999   789999999999999974    33799


Q ss_pred             Eee-ecCccc
Q 003065          820 IAD-FGVAKI  828 (851)
Q Consensus       820 l~D-FGla~~  828 (851)
                      |+| ||.+..
T Consensus       150 LiDg~G~~~~  159 (210)
T PRK10345        150 VCDNIGESTF  159 (210)
T ss_pred             EEECCCCcce
Confidence            999 555443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=6.9e-21  Score=207.12  Aligned_cols=59  Identities=17%  Similarity=0.167  Sum_probs=31.6

Q ss_pred             eEeccCcccC-CCCcccccCccccceeecccccCCCC---CCcccccCCCCCCeEeccccccc
Q 003065          148 IFDLSINYFT-GRFPRWVVNLTQLVSLSIGDNVYDEA---EIPESIGNLKNLTYLFLAHCNLR  206 (851)
Q Consensus       148 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~---~~p~~~~~l~~L~~L~L~~n~l~  206 (851)
                      .|+|+.+.++ ...+..+..+++|++|+++++.++..   .+++.+...++|++|+++++.+.
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~   64 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETG   64 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccC
Confidence            4566666665 23344445556666666666665321   23334445555666666655554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=1.1e-20  Score=171.27  Aligned_cols=165  Identities=27%  Similarity=0.459  Sum_probs=138.0

Q ss_pred             CCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCc
Q 003065          142 ALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGT  221 (851)
Q Consensus       142 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  221 (851)
                      ++++.+.|-||+|+++ .+|..++.+.+|+.|++++|++.  ++|..+++|++|++|++.-|++. ..|..|+.++.|+.
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie--~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE--ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh--hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            3444444555555554 44445555555666666666664  78999999999999999999998 89999999999999


Q ss_pred             ccccccccc-ccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCc
Q 003065          222 LDICRNKIS-GEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN  300 (851)
Q Consensus       222 L~L~~N~i~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~  300 (851)
                      |||.+|++. ..+|..|..++.|+.|+|++|.+. .+|..++++++||.|.+..|.+- .+|.+++.+++|+.|.+.+|+
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            999999996 467999999999999999999999 89999999999999999999998 789999999999999999999


Q ss_pred             cCCCCCCCCCCcc
Q 003065          301 FSGEFPSGFGDMR  313 (851)
Q Consensus       301 l~~~~p~~~~~l~  313 (851)
                      ++ .+|+.++++.
T Consensus       185 l~-vlppel~~l~  196 (264)
T KOG0617|consen  185 LT-VLPPELANLD  196 (264)
T ss_pred             ee-ecChhhhhhh
Confidence            99 6777666553

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=9.2e-21  Score=206.10  Aligned_cols=282  Identities=19%  Similarity=0.231  Sum_probs=160.3

Q ss_pred             eEecccCcccC-CCCC-CCCCCCCCeEeccCcccCCC----CcccccCccccceeecccccCCC-----CCCcccccCCC
Q 003065          125 VLNVTGNAMVG-SVPD-LSALKNLEIFDLSINYFTGR----FPRWVVNLTQLVSLSIGDNVYDE-----AEIPESIGNLK  193 (851)
Q Consensus       125 ~L~Ls~n~l~~-~~~~-l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~-----~~~p~~~~~l~  193 (851)
                      .|+|.++.+++ .... +..+++|+.|+++++.++..    ++..+...++|++|+++++.+..     ..++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            57888888874 3333 67788899999999998643    45566777889999999988752     12234566777


Q ss_pred             CCCeEecccccccccCCcccccccc---cCccccccccccc----cccccccCC-CcccEEEeeccCccCc----CCcCc
Q 003065          194 NLTYLFLAHCNLRGRIPESISELRE---LGTLDICRNKISG----EFPRSIRKL-QKLWKIELYANNLTGE----LPAEL  261 (851)
Q Consensus       194 ~L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~L~~N~i~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~  261 (851)
                      +|++|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++.    ++..+
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            8888888888887655555555555   7777777777762    222344444 5666666666666532    22233


Q ss_pred             CCCCcccEEecccccccCC----CCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCC
Q 003065          262 GNLTLLQEFDISSNQMYGK----LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYT  337 (851)
Q Consensus       262 ~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~  337 (851)
                      ..+++|++|++++|.+++.    ++..+..+++|+.|++++|.+++...                    ..++..+..++
T Consensus       162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~--------------------~~l~~~~~~~~  221 (319)
T cd00116         162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA--------------------SALAETLASLK  221 (319)
T ss_pred             HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH--------------------HHHHHHhcccC
Confidence            3444555555555555421    11222333345555555444432111                    01223344556


Q ss_pred             ccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCcccc----ccCCcccCccccce
Q 003065          338 ALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSG----KIPDGLWALPNVGM  413 (851)
Q Consensus       338 ~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~  413 (851)
                      +|+.|++++|++++.....++..                +   ....+.|++|++++|.++.    .+...+..+++|++
T Consensus       222 ~L~~L~ls~n~l~~~~~~~l~~~----------------~---~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~  282 (319)
T cd00116         222 SLEVLNLGDNNLTDAGAAALASA----------------L---LSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE  282 (319)
T ss_pred             CCCEEecCCCcCchHHHHHHHHH----------------H---hccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccE
Confidence            67777777776654222222110                0   0123456666776666651    22333444566777


Q ss_pred             EEecCCcCCCC----CCcccccC-CCCCeEecCCCcc
Q 003065          414 LDFGDNDFTGG----ISPLIGLS-TSLSQLVLQNNRF  445 (851)
Q Consensus       414 L~Ls~N~l~~~----~~~~~~~~-~~L~~L~Ls~N~l  445 (851)
                      +++++|.++..    ....+... +.|+.+++.+|.+
T Consensus       283 l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         283 LDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             EECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            77777776644    22222223 5677777766653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=4.2e-18  Score=178.54  Aligned_cols=156  Identities=22%  Similarity=0.344  Sum_probs=132.9

Q ss_pred             cccccccceeeecccccccHHHH-cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc-HHHHHHHHHHHHcCC-
Q 003065          653 EKEVSSKWKLASFHHIDIDAEQI-CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-VKVFAAEMEILGKIR-  729 (851)
Q Consensus       653 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~-  729 (851)
                      +++.+..|....||++.+..... .+|.+.++||-|.|++||+|++....+.||+|+++..+. .+....||+++++++ 
T Consensus        54 eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~  133 (590)
T KOG1290|consen   54 EQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVRE  133 (590)
T ss_pred             cccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHh
Confidence            34455677788899998887776 789999999999999999999999999999999976643 456678999999983 


Q ss_pred             -------CCccccEEEEEEe----CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 003065          730 -------HRNILKLYACLLK----GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP  798 (851)
Q Consensus       730 -------h~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  798 (851)
                             ..+||++++.|..    +.+++||+|++ |.+|..+|...   .-..++...+.+|++||+.||.|||+.|  
T Consensus       134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ec--  207 (590)
T KOG1290|consen  134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHREC--  207 (590)
T ss_pred             cCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhc--
Confidence                   3579999999965    45789999999 88999999875   3345788899999999999999999854  


Q ss_pred             CcEEeCCCCCCEEECC
Q 003065          799 PIIHRDIKSSNILLDE  814 (851)
Q Consensus       799 ~ivHrDlkp~NILl~~  814 (851)
                      +|||-||||+|||+..
T Consensus       208 gIIHTDlKPENvLl~~  223 (590)
T KOG1290|consen  208 GIIHTDLKPENVLLCS  223 (590)
T ss_pred             CccccCCCcceeeeec
Confidence            9999999999999954

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=1e-17  Score=171.68  Aligned_cols=142  Identities=19%  Similarity=0.179  Sum_probs=110.7

Q ss_pred             CccCCeecccCcEEEEEEE-EcCCCcEEEEEEeccccc--------------------------HHHHHHHHHHHHcCCC
Q 003065          678 LEEDNLIGSGGTGKVYRLD-LKKNAGTVAVKQLWKGDG--------------------------VKVFAAEMEILGKIRH  730 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~--------------------------~~~~~~E~~~l~~l~h  730 (851)
                      |++.+.||+|+||.||+|. +..+++.||||++.....                          ...+.+|+++++++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            7788999999999999998 667899999998864310                          1235689999999976


Q ss_pred             Cc--cccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEEeCCCC
Q 003065          731 RN--ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP-IIHRDIKS  807 (851)
Q Consensus       731 ~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrDlkp  807 (851)
                      ..  +++.+++    +..++||||++++++......     ...........++.|++.+++++|   +.+ |+|||+||
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp  177 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE  177 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence            33  3444432    235899999998887665422     123445556789999999999999   788 99999999


Q ss_pred             CCEEECCCCceEEeeecCccccCCC
Q 003065          808 SNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       808 ~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +||+++ ++.++++|||.|......
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccCCc
Confidence            999999 789999999999866554

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.72  E-value=2.3e-17  Score=178.74  Aligned_cols=167  Identities=25%  Similarity=0.313  Sum_probs=133.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCC-cEEEEEEeccccc--HHHHHHHHHHHHcCCC----CccccEEEEE-EeCCeeEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNA-GTVAVKQLWKGDG--VKVFAAEMEILGKIRH----RNILKLYACL-LKGGSSFL  748 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~--~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  748 (851)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|.......  ...+..|+.++..+..    +++.++++.. ..+...|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7899999999999999999987664 5688887755422  2267889999998873    6899999998 57788999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-----CceEEeee
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-----YEPKIADF  823 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DF  823 (851)
                      ||+.+ |.+|.++....   ....++.....+|+.|++.+|+++|   +.|++||||||+|+.+...     ..+.+.||
T Consensus        99 VM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            99988 88999977654   2467899999999999999999999   8899999999999999754     36999999


Q ss_pred             cCccccC--CCC-----Cccc-ccccccccccccC
Q 003065          824 GVAKIAE--NSP-----KVSD-YSCFAGTHGYIAP  850 (851)
Q Consensus       824 Gla~~~~--~~~-----~~~~-~~~~~gt~~Y~AP  850 (851)
                      |+|+...  ...     .... ...+.||..|+++
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~  206 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI  206 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccH
Confidence            9998322  111     1111 2345699999886

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.72  E-value=6.3e-18  Score=177.90  Aligned_cols=166  Identities=26%  Similarity=0.277  Sum_probs=139.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCC------CCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIR------HRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|.+....|+|-|+.|.+|.+...+..||||+|.... ..+.=++|+++|++++      .-|+++++..|....+.||
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            57889999999999999999999999999999997654 3455678999999995      3588999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-CceEEeeecCcc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAK  827 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~  827 (851)
                      |+|-+ ..+|.+++++...  ...+....+..++.|+.-||..|.   ..+|+|.||||+|||+++. ..+||||||.|.
T Consensus       512 VFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  512 VFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             Eehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcccc
Confidence            99988 5799999998643  445677778889999999999999   6799999999999999865 468999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+......    .+.-+..|.|||
T Consensus       586 ~~~eneit----PYLVSRFYRaPE  605 (752)
T KOG0670|consen  586 FASENEIT----PYLVSRFYRAPE  605 (752)
T ss_pred             cccccccc----HHHHHHhccCcc
Confidence            87765432    234567899998

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=6.8e-17  Score=157.69  Aligned_cols=133  Identities=17%  Similarity=0.194  Sum_probs=104.7

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc------HHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEe
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG------VKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .+...|++|+||+||.+..  .+.+++.+.+.....      ...+.+|+++++++. |+++++++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4678899999999997765  566777666643322      224789999999995 5889999886    34699999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCC-CCCCEEECCCCceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDI-KSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |++|.+|.+....            ....++.|++++++++|   +.||+|||| ||+|||++.++.++|+|||+|....
T Consensus        79 yI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         79 YLAGAAMYQRPPR------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             eecCccHHhhhhh------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            9999888654321            01246788999999999   789999999 7999999999999999999998655


Q ss_pred             CC
Q 003065          831 NS  832 (851)
Q Consensus       831 ~~  832 (851)
                      ..
T Consensus       144 ~~  145 (218)
T PRK12274        144 PR  145 (218)
T ss_pred             Cc
Confidence            43

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=4.3e-17  Score=162.93  Aligned_cols=136  Identities=14%  Similarity=0.195  Sum_probs=111.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHH---------HHHHHHHHHHcCCCCccccEEEEEEeC-
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVK---------VFAAEMEILGKIRHRNILKLYACLLKG-  743 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~-  743 (851)
                      .+|...+++|.|+||.||.+..  ++..+|||.+..+.  ...         .+.+|++.+.+++|++|+.+.+++... 
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            4799999999999999999755  46689999986542  111         257899999999999999998886543 


Q ss_pred             -------CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC
Q 003065          744 -------GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY  816 (851)
Q Consensus       744 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~  816 (851)
                             +..++||||++|.+|.++..         .+.    ....+++.++..+|   +.|++|||+||+||+++++|
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC
Confidence                   35789999999999977631         121    24568999999999   78999999999999999988


Q ss_pred             ceEEeeecCccccC
Q 003065          817 EPKIADFGVAKIAE  830 (851)
Q Consensus       817 ~~kl~DFGla~~~~  830 (851)
                       ++++|||..+...
T Consensus       173 -i~liDfg~~~~~~  185 (232)
T PRK10359        173 -LRIIDLSGKRCTA  185 (232)
T ss_pred             -EEEEECCCccccc
Confidence             9999999887654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1.7e-16  Score=161.34  Aligned_cols=134  Identities=20%  Similarity=0.302  Sum_probs=112.3

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEecccc----------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +.||+|++|.||+|.+  .+..|++|+.....          ....+.+|++++..+.|++++....++...+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5789999999999987  66789999764321          12357789999999999998877777777778899999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |++|++|.+++...        .. ....++.+++.++.++|   +.+++|||++|+||+++ ++.++++|||.++...
T Consensus        80 ~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         80 YIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             EeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            99999999988642        11 67789999999999999   78999999999999999 7899999999987643

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=1.8e-16  Score=159.16  Aligned_cols=135  Identities=21%  Similarity=0.189  Sum_probs=106.5

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc------------------------cHHHHHHHHHHHHcCCCCc-
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD------------------------GVKVFAAEMEILGKIRHRN-  732 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~E~~~l~~l~h~n-  732 (851)
                      |...+.||+|+||.||+|.. .+++.||||++....                        ......+|+.++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            67789999999999999987 478999999865321                        0113567899999998874 


Q ss_pred             -cccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 003065          733 -ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL  811 (851)
Q Consensus       733 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NIL  811 (851)
                       +++.++    .+..++||||++|+++.+....           .....++.+++.++.++|   +.+|+||||||+||+
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nil  157 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNIL  157 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEE
Confidence             444443    2456899999999988654320           134568889999999999   789999999999999


Q ss_pred             ECCCCceEEeeecCccccCC
Q 003065          812 LDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       812 l~~~~~~kl~DFGla~~~~~  831 (851)
                      +++++.++|+|||.|.....
T Consensus       158 l~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EcCCCcEEEEECCccccCCC
Confidence            99999999999999975544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PLN03150 hypothetical protein; Provisional

Probab=99.68  E-value=1.2e-16  Score=186.63  Aligned_cols=150  Identities=32%  Similarity=0.499  Sum_probs=125.9

Q ss_pred             CCCchhhHHHHHHHHHhcCCCCCCCCCCCCCCCCCc-----ccceeEecC--CC--CceEEEecccCCcceecCccccCC
Q 003065           26 SLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPC-----GFSGITCDS--VT--GRVTEISFDNKSLSGEISSSISAL   96 (851)
Q Consensus        26 ~~~~~~~~~aLl~fk~~~~~~~~~l~sW~~~~~~~c-----~w~gv~c~~--~~--~~v~~l~l~~~~l~g~i~~~l~~l   96 (851)
                      ..+.++|..||++||+++.++..  .+|.++   +|     .|.||+|+.  .+  .+|+.|+|++++++|.+|++++.+
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~---~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L  441 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL  441 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCccc--CCCCCC---CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence            45678899999999999977643  489753   34     799999953  22  269999999999999999999999


Q ss_pred             ccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCc-cccceee
Q 003065           97 QSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNL-TQLVSLS  174 (851)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~  174 (851)
                      ++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|. ++++++|++|||++|.++|.+|..+..+ .++..++
T Consensus       442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~  521 (623)
T PLN03150        442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN  521 (623)
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence            9999999999999999999999999999999999999988887 8999999999999999998888877653 4556666


Q ss_pred             cccccC
Q 003065          175 IGDNVY  180 (851)
Q Consensus       175 L~~N~l  180 (851)
                      +.+|..
T Consensus       522 ~~~N~~  527 (623)
T PLN03150        522 FTDNAG  527 (623)
T ss_pred             ecCCcc
Confidence            666654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=3.4e-16  Score=157.61  Aligned_cols=130  Identities=20%  Similarity=0.305  Sum_probs=105.8

Q ss_pred             eecccCcEEEEEEEEcCCCcEEEEEEecccc----------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       683 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      .||+|+||.||+|.+  ++..|++|+.....          ...++.+|+++++.++|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            379999999999985  56789999854321          124567899999999988766555555566677999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ++|++|.+++.....            .++.+++.++.++|   +.+++|||++|+||+++ ++.++++|||+++...
T Consensus        79 ~~g~~l~~~~~~~~~------------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        79 IEGKPLKDVIEEGND------------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             ECCccHHHHHhhcHH------------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            999999988754210            67899999999999   78999999999999999 7899999999987643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=5.2e-16  Score=179.70  Aligned_cols=136  Identities=21%  Similarity=0.290  Sum_probs=110.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----------ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  745 (851)
                      ..|...+.||+|+||.||++.+...  .+++|+....          ...+++.+|+++++.++|++++....++.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            3456789999999999999987443  3444432111          113457899999999999999988777777777


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .++||||+++++|.+++..             ...++.++++++.|+|   +.+++|||+||+||++ .++.++|+|||+
T Consensus       411 ~~lv~E~~~g~~L~~~l~~-------------~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLEG-------------NPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             CEEEEEecCCCcHHHHHHH-------------HHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence            8999999999999988752             3468899999999999   7899999999999999 577999999999


Q ss_pred             ccccC
Q 003065          826 AKIAE  830 (851)
Q Consensus       826 a~~~~  830 (851)
                      |+...
T Consensus       474 a~~~~  478 (535)
T PRK09605        474 GKYSD  478 (535)
T ss_pred             cccCC
Confidence            98654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.64  E-value=1.9e-15  Score=164.62  Aligned_cols=166  Identities=39%  Similarity=0.505  Sum_probs=137.6

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCC-ccccEEEEEEeCCeeEEEEe
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHR-NILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e  751 (851)
                      |...+.+|.|+||.||++.+.   ..+|+|.+....     ....+.+|+.+++.+.|+ +|+++.+.+...+..++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            567788999999999999986   788999886542     356788999999999988 79999999988777899999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-ceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~  830 (851)
                      |+.++++.+++......  ..+.......++.|++.+++|+|   +.+++|||+||+||+++..+ .++++|||.++...
T Consensus        79 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          79 YVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             cCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999999666543111  25778888899999999999999   78899999999999999888 79999999998655


Q ss_pred             CCCCcc----cccccccccccccCC
Q 003065          831 NSPKVS----DYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~----~~~~~~gt~~Y~APE  851 (851)
                      ......    ......||..|+|||
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe  178 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPE  178 (384)
T ss_pred             CCCccccccccccccccccccCCHH
Confidence            443221    234568999999998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=1.5e-15  Score=145.42  Aligned_cols=136  Identities=24%  Similarity=0.212  Sum_probs=113.0

Q ss_pred             cCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCC--CccccEEEEEEeCCeeEEEEeccCCCC
Q 003065          680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH--RNILKLYACLLKGGSSFLVLEYMPNGN  757 (851)
Q Consensus       680 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs  757 (851)
                      +.+.+|+|.++.||++....  +.+++|..........+.+|+.+++.++|  ..+++++.+...++..|++|||++++.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            45779999999999999843  78999988665445678899999999976  588999998888888999999998876


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       758 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      +..+            +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus        80 ~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          80 LDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            6432            34455678899999999999543358999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.59  E-value=4e-15  Score=152.02  Aligned_cols=172  Identities=18%  Similarity=0.185  Sum_probs=130.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCc-----EEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEE-eCCeeE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAG-----TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLL-KGGSSF  747 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~  747 (851)
                      ++...-.+-+|.||+||+|.+++.+.     .|-||.++..   .....+..|...+..+.|||+.++.+... +....+
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~  364 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF  364 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence            45566678999999999998765432     3566666443   23456788999999999999999988765 456778


Q ss_pred             EEEeccCCCCHHHHHHHhhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          748 LVLEYMPNGNLFQALHKRVK---EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      +++.++.-|+|..++.....   .....++..+...++.|++.|++|||   ..+|||.||..+|.+||+..++||+|=.
T Consensus       365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccch
Confidence            99999999999999985432   22345677788899999999999999   8899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++..-......-....-....||+||
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslE  468 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLE  468 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHH
Confidence            998653332111001111345788887

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.58  E-value=9.8e-15  Score=145.35  Aligned_cols=135  Identities=22%  Similarity=0.211  Sum_probs=97.6

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEeccccc----HHH----------------------HHHHHHHHHcCCCCc--
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKV----------------------FAAEMEILGKIRHRN--  732 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~----------------------~~~E~~~l~~l~h~n--  732 (851)
                      .+.||+|+||+||+|.+. +++.||||++.....    ...                      ...|.+.+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999985 788999998764311    111                      135666666665443  


Q ss_pred             cccEEEEEEeCCeeEEEEeccCCCCHHH-HHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCcEEeCCCCCCE
Q 003065          733 ILKLYACLLKGGSSFLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNI  810 (851)
Q Consensus       733 iv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrDlkp~NI  810 (851)
                      +.+.+++    ...++||||++++.+.. .+... .     .. .....++.+++.++.++|   . ++|+|||+||+||
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~-----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Ni  146 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R-----LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNI  146 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-h-----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhE
Confidence            4445543    23589999999854321 11111 0     00 456688999999999999   6 8999999999999


Q ss_pred             EECCCCceEEeeecCccccCC
Q 003065          811 LLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       811 Ll~~~~~~kl~DFGla~~~~~  831 (851)
                      +++ ++.++++|||.|.....
T Consensus       147 li~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EEE-CCcEEEEECcccccccC
Confidence            999 88999999999976655

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=4.9e-14  Score=144.93  Aligned_cols=136  Identities=19%  Similarity=0.272  Sum_probs=104.3

Q ss_pred             cCCeec-ccCcEEEEEEEEcCCCcEEEEEEeccc---------------ccHHHHHHHHHHHHcCCCCcc--ccEEEEEE
Q 003065          680 EDNLIG-SGGTGKVYRLDLKKNAGTVAVKQLWKG---------------DGVKVFAAEMEILGKIRHRNI--LKLYACLL  741 (851)
Q Consensus       680 ~~~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~---------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~  741 (851)
                      ....|| .|+.|+||.++.  .+..+|||.+...               .....+.+|++++.+++|++|  ++.+++..
T Consensus        35 ~~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         35 QARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             cCceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            346687 889999999877  3678999977431               122457789999999998885  66666643


Q ss_pred             eC-C---eeEEEEeccCC-CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC
Q 003065          742 KG-G---SSFLVLEYMPN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY  816 (851)
Q Consensus       742 ~~-~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~  816 (851)
                      .. +   ..++||||++| .+|.+++...      .++..    .+.+++.++.+||   +.||+||||||+|||++.++
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCC
Confidence            32 2   23599999997 6898887531      23332    3568999999999   88999999999999999988


Q ss_pred             ceEEeeecCccccC
Q 003065          817 EPKIADFGVAKIAE  830 (851)
Q Consensus       817 ~~kl~DFGla~~~~  830 (851)
                      .++|+|||.++...
T Consensus       180 ~v~LIDfg~~~~~~  193 (239)
T PRK01723        180 KFWLIDFDRGELRT  193 (239)
T ss_pred             CEEEEECCCcccCC
Confidence            99999999998654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=9.8e-15  Score=170.80  Aligned_cols=164  Identities=22%  Similarity=0.276  Sum_probs=121.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCC---CCccccEEEEEEeCCeeEEEEecc
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR---HRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .|.+.+.+|+|+||+||+|...+ ++.||+|+-++....+ |.-=.+++.+|+   -+.|..+..++...+..++|+||.
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~  776 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS  776 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence            57888999999999999999966 9999999865543222 222223344444   234555666666777789999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-------CCceEEeeecCc
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-------DYEPKIADFGVA  826 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-------~~~~kl~DFGla  826 (851)
                      +.|+|.+++.     .....+|...+.++.|+++.++.||   ..+|||+||||+|.|+..       ..-++|+|||.+
T Consensus       777 ~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  777 PYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             ccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            9999999987     3556888899999999999999999   789999999999999942       235899999999


Q ss_pred             cccCCCCCcccccccccccccccC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAP  850 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~AP  850 (851)
                      -.+.--.........++|-.+-++
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~  872 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCI  872 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhH
Confidence            765433333333344445444443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.51  E-value=3e-14  Score=159.51  Aligned_cols=200  Identities=31%  Similarity=0.531  Sum_probs=107.5

Q ss_pred             eEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCC-CCCeEecccc
Q 003065          125 VLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK-NLTYLFLAHC  203 (851)
Q Consensus       125 ~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~-~L~~L~L~~n  203 (851)
                      .|+++.|.+...+..+..++.++.|++.+|.++                          .+|.....++ +|+.|++++|
T Consensus        97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~--------------------------~i~~~~~~~~~nL~~L~l~~N  150 (394)
T COG4886          97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT--------------------------DIPPLIGLLKSNLKELDLSDN  150 (394)
T ss_pred             eeeccccccccCchhhhcccceeEEecCCcccc--------------------------cCccccccchhhccccccccc
Confidence            455555555444444444455555555555554                          3444444442 5555555555


Q ss_pred             cccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCc
Q 003065          204 NLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPE  283 (851)
Q Consensus       204 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  283 (851)
                      ++. .+|..+..+++|+.|++++|+++ .+|.....++.|+.|++++|+++ .+|.....+..|++|++++|++. ..+.
T Consensus       151 ~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~  226 (394)
T COG4886         151 KIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLS  226 (394)
T ss_pred             chh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecch
Confidence            554 33344555555555555555555 33433335555555555555555 44444444445666666666433 3445


Q ss_pred             cccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhh
Q 003065          284 EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYL  357 (851)
Q Consensus       284 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~  357 (851)
                      .+.+++++..+.+.+|++. .++..++.++++++|++++|+++...+  ++.+.+++.||+++|.+....|...
T Consensus       227 ~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             hhhhcccccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence            5556666666666666655 224555666666666666666663332  6666777777777777765555443

>PLN03150 hypothetical protein; Provisional

Probab=99.50  E-value=3.2e-14  Score=166.45  Aligned_cols=92  Identities=40%  Similarity=0.687  Sum_probs=57.7

Q ss_pred             CcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCC
Q 003065          459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG  538 (851)
Q Consensus       459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  538 (851)
                      ++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            45566666666666666666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             CccccccCcccc
Q 003065          539 NKLTGSIPDNLM  550 (851)
Q Consensus       539 N~l~g~ip~~l~  550 (851)
                      |+++|.+|..+.
T Consensus       500 N~l~g~iP~~l~  511 (623)
T PLN03150        500 NSLSGRVPAALG  511 (623)
T ss_pred             CcccccCChHHh
Confidence            666666665554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=1.9e-14  Score=165.68  Aligned_cols=164  Identities=24%  Similarity=0.362  Sum_probs=126.3

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEec----ccccHH----HHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVK----VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~----~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ...+.+|.|++|.|+.+......+..+.|...    ......    .+..|+.+-..+.|+|++.......+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            46788999999988888776666556665443    222222    2455777777889999988666555555555569


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |||++ +|+..+.+.     ..+....+..++.|+..|++|+|   +.||.|||+||+|++++.+|.+||+|||.+....
T Consensus       401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence            99998 999988763     24566667788999999999999   8899999999999999999999999999997665


Q ss_pred             CCCCc--ccccccccccccccCC
Q 003065          831 NSPKV--SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~--~~~~~~~gt~~Y~APE  851 (851)
                      .+...  .....++|+..|+|||
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE  494 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPE  494 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcc
Confidence            44333  3345678999999999

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.46  E-value=4e-14  Score=172.31  Aligned_cols=117  Identities=18%  Similarity=0.201  Sum_probs=84.2

Q ss_pred             cCCC-CccccEEEEE-------EeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 003065          727 KIRH-RNILKLYACL-------LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP  798 (851)
Q Consensus       727 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  798 (851)
                      .++| +||++++++|       .....++.++||+ +++|.+++...    ...+++..+..++.||++||.|||   ++
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~   99 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAH---SQ   99 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHH---hC
Confidence            3445 5777788877       2234567888988 67999999642    345889999999999999999999   78


Q ss_pred             CcEEeCCCCCCEEECC-------------------CCceEEeeecCccccCCCCC--------------ccccccccccc
Q 003065          799 PIIHRDIKSSNILLDE-------------------DYEPKIADFGVAKIAENSPK--------------VSDYSCFAGTH  845 (851)
Q Consensus       799 ~ivHrDlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~  845 (851)
                      +|+||||||+|||++.                   ++.+|++|||+++.......              .......+||+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            9999999999999954                   44566666666654221000              00011246899


Q ss_pred             ccccCC
Q 003065          846 GYIAPG  851 (851)
Q Consensus       846 ~Y~APE  851 (851)
                      +|||||
T Consensus       180 ~Y~APE  185 (793)
T PLN00181        180 WYTSPE  185 (793)
T ss_pred             ceEChh
Confidence            999999

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.45  E-value=8.2e-15  Score=156.77  Aligned_cols=192  Identities=30%  Similarity=0.525  Sum_probs=125.2

Q ss_pred             CccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEe
Q 003065          337 TALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDF  416 (851)
Q Consensus       337 ~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  416 (851)
                      .--...||+.|++. .+|..++.+-.|..+.+..|.+. .+|..++++..|.+|||+.|+++ ..|..++.++       
T Consensus        75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-------  144 (722)
T KOG0532|consen   75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-------  144 (722)
T ss_pred             cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-------
Confidence            33456778888887 66766666666666555555543 44555555555666666666655 4454444443       


Q ss_pred             cCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCC
Q 003065          417 GDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGS  496 (851)
Q Consensus       417 s~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  496 (851)
                                        |+.|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. -
T Consensus       145 ------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~  203 (722)
T KOG0532|consen  145 ------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-D  203 (722)
T ss_pred             ------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-h
Confidence                              666666667666 66777776677777777777776 56667777777777777777776 5


Q ss_pred             CCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc----cceEEeCcCC
Q 003065          497 IPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL----KLSSIDLSEN  562 (851)
Q Consensus       497 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l----~L~~l~ls~N  562 (851)
                      +|.++..| .|..||+|+|+++ .||-.|..|+.|++|-|.+|.|. ..|..+...    -.++|+..-.
T Consensus       204 lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  204 LPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             CCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence            56666633 4777777777777 77777777777777777777777 566554332    2345554443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.44  E-value=1.1e-13  Score=155.11  Aligned_cols=199  Identities=33%  Similarity=0.459  Sum_probs=156.6

Q ss_pred             EEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCC-CCCeEeccCcccCCCCcccccCccccceeeccccc
Q 003065          101 VLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALK-NLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV  179 (851)
Q Consensus       101 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  179 (851)
                      .|+++.|.+. ..+..+..++.++.|++.+|.++..++....++ +|+.|++++|.+. .+|..+..+++|+.|++++|+
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~  174 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND  174 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence            5777777774 234456667889999999999998888777775 8999999999987 556678888999999999998


Q ss_pred             CCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCc
Q 003065          180 YDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPA  259 (851)
Q Consensus       180 l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  259 (851)
                      +.  ++|...+.+++|+.|++++|+++ .+|........|++|++++|++. ..+..+.+++++..+.+.+|++. .++.
T Consensus       175 l~--~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~  249 (394)
T COG4886         175 LS--DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE  249 (394)
T ss_pred             hh--hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence            86  67777778888999999999998 67776666677889999988644 56677888888888888888887 4467


Q ss_pred             CcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCC
Q 003065          260 ELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG  308 (851)
Q Consensus       260 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~  308 (851)
                      .++.++++++|++++|+++. ++. ++.+.+++.|++++|.++...|..
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             hhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhh
Confidence            77788888888888888873 333 778888888888888887665553

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.43  E-value=7e-15  Score=157.29  Aligned_cols=185  Identities=30%  Similarity=0.513  Sum_probs=139.4

Q ss_pred             cCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCccc
Q 003065          165 VNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLW  244 (851)
Q Consensus       165 ~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~  244 (851)
                      ..++--...||+.|++.  ++|..++.+-.|+.+.|.+|.+. .+|..+.++..|..|||+.|+++ ..|..+..+ -|+
T Consensus        72 ~~ltdt~~aDlsrNR~~--elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLk  146 (722)
T KOG0532|consen   72 YDLTDTVFADLSRNRFS--ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLK  146 (722)
T ss_pred             ccccchhhhhccccccc--cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cce
Confidence            34555567788888886  77777777778888888888887 77888888888888888888887 667666665 377


Q ss_pred             EEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCc
Q 003065          245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR  324 (851)
Q Consensus       245 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~  324 (851)
                      .|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|..++.| .|..||++.|+
T Consensus       147 vli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNk  222 (722)
T KOG0532|consen  147 VLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNK  222 (722)
T ss_pred             eEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCc
Confidence            8888888887 67777788888888888888887 67777888888888888888877 456666644 47777777777


Q ss_pred             CCCCCCCccCCCCccceeeccCCcccccCchhhhhh
Q 003065          325 FSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK  360 (851)
Q Consensus       325 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~  360 (851)
                      ++ .+|-.|.+++.|++|-|.+|.+. .-|..+|..
T Consensus       223 is-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~k  256 (722)
T KOG0532|consen  223 IS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEK  256 (722)
T ss_pred             ee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhc
Confidence            77 67777777777777777777776 556656543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.38  E-value=2.4e-12  Score=143.98  Aligned_cols=140  Identities=19%  Similarity=0.181  Sum_probs=97.8

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEecccccH------------------------------------------HHH
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV------------------------------------------KVF  718 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------------------------------------~~~  718 (851)
                      .+.||.|++|+||+|+. .+|+.||||+.++....                                          -+|
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            47899999999999998 47899999987543100                                          023


Q ss_pred             HHHHHHHHcCC-----CCccccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 003065          719 AAEMEILGKIR-----HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK-GIAYL  792 (851)
Q Consensus       719 ~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~L  792 (851)
                      .+|++.+.+++     ++++.-..-++...+..++||||++|+++.++.....    ...+   +.+++..+++ .+..+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~~---~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGLD---RKALAENLARSFLNQV  273 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCCC---HHHHHHHHHHHHHHHH
Confidence            45666555552     3332211112233445799999999999988765321    1122   2346666665 46778


Q ss_pred             HhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       793 H~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |   ..|++|+|+||.||+++.++.++++|||++.....
T Consensus       274 ~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 L---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             H---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   68999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.36  E-value=6.6e-14  Score=153.09  Aligned_cols=154  Identities=29%  Similarity=0.345  Sum_probs=125.4

Q ss_pred             ecccCcEEEEEEEE---cCCCcEEEEEEecccc----cHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEeccCC
Q 003065          684 IGSGGTGKVYRLDL---KKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       684 lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +|+|+||+|+.+.-   .+.++.||+|+.++..    .......|..++..++ ||.+|+++..++.++..+++++|..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            69999999986542   3456779999876542    1224556888999997 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |++...+...     ..++..........++-|++++|   +.+|+|||+|++||+++.+|.+|+.|||+++..-.....
T Consensus        82 g~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   82 GDLFTRLSKE-----VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             chhhhccccC-----CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            9997766542     33455555667778888999999   889999999999999999999999999999876544322


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                            +||..|||||
T Consensus       154 ------cgt~eymApE  163 (612)
T KOG0603|consen  154 ------CGTYEYRAPE  163 (612)
T ss_pred             ------ccchhhhhhH
Confidence                  7999999998

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=6.8e-13  Score=136.27  Aligned_cols=113  Identities=28%  Similarity=0.416  Sum_probs=84.1

Q ss_pred             CCCccccEEEEEE---------------------------eCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHH
Q 003065          729 RHRNILKLYACLL---------------------------KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI  781 (851)
Q Consensus       729 ~h~niv~l~~~~~---------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i  781 (851)
                      +|||||++.+.|.                           ++...|+||..++ .+|.+++..+      ..+.....-|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~------~~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR------HRSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC------CCchHHHHHH
Confidence            5999999887763                           2235689999884 5899988753      3455566678


Q ss_pred             HHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE--CCCC--ceEEeeecCccccCCCCC----cccccccccccccccCC
Q 003065          782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILL--DEDY--EPKIADFGVAKIAENSPK----VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       782 ~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl--~~~~--~~kl~DFGla~~~~~~~~----~~~~~~~~gt~~Y~APE  851 (851)
                      ..|+++|+.|||   .+||.|||+|.+|||+  |+|+  .++|+|||++-..+...-    ........|...-||||
T Consensus       347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE  421 (598)
T KOG4158|consen  347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE  421 (598)
T ss_pred             HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence            899999999999   7899999999999999  3444  579999998854333211    12223345778899998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.31  E-value=4e-12  Score=143.49  Aligned_cols=146  Identities=18%  Similarity=0.155  Sum_probs=94.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc------------------------------------HH--
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG------------------------------------VK--  716 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------------------------~~--  716 (851)
                      ...|+. +.||.|++|+||+|+.+++|+.||||+.++...                                    .+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999987799999999864310                                    01  


Q ss_pred             ----HHHHHHHHHHcCC----CCccccEEEEE-EeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 003065          717 ----VFAAEMEILGKIR----HRNILKLYACL-LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK  787 (851)
Q Consensus       717 ----~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~  787 (851)
                          ++.+|+..+.+++    +...+.+-..+ ......++||||++|+.+.++-.-. .   ...+..   .++...++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~---~g~d~~---~la~~~v~  270 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-A---AGTDMK---LLAERGVE  270 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-h---cCCCHH---HHHHHHHH
Confidence                1344555555442    33333333333 2345678999999999997753211 0   111211   12222111


Q ss_pred             H-HHHHHhCCCCCcEEeCCCCCCEEECCCC----ceEEeeecCccccCC
Q 003065          788 G-IAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIADFGVAKIAEN  831 (851)
Q Consensus       788 ~-l~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~~  831 (851)
                      . +..++   ..|++|+|+||.||+++.++    .++++|||++.....
T Consensus       271 ~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        271 VFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            1 22233   56999999999999999888    999999999976644

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.26  E-value=1.7e-11  Score=119.80  Aligned_cols=131  Identities=22%  Similarity=0.187  Sum_probs=95.7

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCCCCccc-cEEEEEEeCCeeEEEEeccCCCCH
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNIL-KLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      .+.++.|.++.||+++.  .++.|++|...... ....+.+|+++++.+.+..++ +++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            35688999999999987  37789999875543 234567899999998765544 4555433  345899999999876


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC--SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       759 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      .+.  .        .   ....++.+++++++.||...  ..+++|+|++|.||+++ ++.++++|||.|...
T Consensus        79 ~~~--~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          79 LTE--D--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             ccc--c--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            532  0        0   11235678999999999421  12359999999999999 668999999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.26  E-value=1.2e-11  Score=127.82  Aligned_cols=165  Identities=22%  Similarity=0.300  Sum_probs=103.5

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCC----------CCccccEEEE---
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIR----------HRNILKLYAC---  739 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~----------h~niv~l~~~---  739 (851)
                      +...+.||.|+++.||.+++.++++++|||+....     ...+++.+|.-....+.          |-.++..++.   
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            45678899999999999999999999999987432     24556666665544432          2122221121   


Q ss_pred             ------EEeC---C-----eeEEEEeccCCCCHHHHHHHhhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEe
Q 003065          740 ------LLKG---G-----SSFLVLEYMPNGNLFQALHKRVKEGK--PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHR  803 (851)
Q Consensus       740 ------~~~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr  803 (851)
                            +...   .     ..+++|+-+ .++|.+++..-.....  ..+....+..+..|+++.++++|   ..|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                  1111   1     135678877 5788887654222112  12344455677789999999999   7899999


Q ss_pred             CCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          804 DIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       804 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||||+|++++.+|.++|+||+.....+.....     ...+..|.+||
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe  212 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPE  212 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChh
Confidence            99999999999999999999987655442211     12356677776

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.20  E-value=2.2e-12  Score=148.06  Aligned_cols=163  Identities=28%  Similarity=0.343  Sum_probs=122.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHH---HHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVF---AAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +|...+.||+++|=+|.+|++. .| .|+||++.+++   ..+.|   .+|++ ..-++|||++.+..........|||=
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            5677889999999999999983 34 58999986553   22333   34555 55669999999888777777788999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      +|.. -+|+|.+..+     +-+.....+.|++|++.|+..+|   ..||+|+|||.+||||+.-..+.|+||..-+...
T Consensus       101 qyvk-hnLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY  171 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTY  171 (1431)
T ss_pred             HHHh-hhhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCcc
Confidence            9984 5888888653     44666777889999999999999   7899999999999999999899999998765432


Q ss_pred             CCC-Ccccccccc----cccccccCC
Q 003065          831 NSP-KVSDYSCFA----GTHGYIAPG  851 (851)
Q Consensus       831 ~~~-~~~~~~~~~----gt~~Y~APE  851 (851)
                      -++ ...++.-+.    .-..|+|||
T Consensus       172 LPeDNPadf~fFFDTSrRRtCYiAPE  197 (1431)
T KOG1240|consen  172 LPEDNPADFTFFFDTSRRRTCYIAPE  197 (1431)
T ss_pred             CCCCCcccceEEEecCCceeeecChH
Confidence            111 111222121    234699998

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.19  E-value=2.5e-12  Score=134.20  Aligned_cols=207  Identities=23%  Similarity=0.255  Sum_probs=135.4

Q ss_pred             ccCCCCceEecccCcccCCCC--CCCCCCCCCeEeccCcccCCCCc--ccccCccccceeecccccCCCCCCcccccCCC
Q 003065          118 SNCSNLKVLNVTGNAMVGSVP--DLSALKNLEIFDLSINYFTGRFP--RWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK  193 (851)
Q Consensus       118 ~~l~~L~~L~Ls~n~l~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~  193 (851)
                      .++++|+...|.+........  ....|++++.||||.|-|....+  .-...|++|+.|+|+.|++....-...-..++
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            467788888888877655442  36788888899999888874322  33467888888889888886322112224578


Q ss_pred             CCCeEecccccccccC-CcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCC--cCcCCCCcccEE
Q 003065          194 NLTYLFLAHCNLRGRI-PESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP--AELGNLTLLQEF  270 (851)
Q Consensus       194 ~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L  270 (851)
                      .|+.|.|+.|.++..- -.....+++|+.|+|..|...........-+..|+.|||++|++.. .+  ...+.++.|..|
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~L  276 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQL  276 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhh
Confidence            8889999999887432 2234567888888888886433444556667788888888888763 33  346678888888


Q ss_pred             ecccccccCC-CCcc-----ccCcCCccEEEccCCccCCCCCC--CCCCcccccEEEeccCcCC
Q 003065          271 DISSNQMYGK-LPEE-----IGNLKNLTVFQCFKNNFSGEFPS--GFGDMRKLFAFSIYGNRFS  326 (851)
Q Consensus       271 ~Ls~N~l~~~-~p~~-----l~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~  326 (851)
                      +++.+.+... .|+.     ...+++|++|+++.|++.. .+.  .+..+++|+.|.+..|.+.
T Consensus       277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             hccccCcchhcCCCccchhhhcccccceeeecccCcccc-ccccchhhccchhhhhhccccccc
Confidence            8888877643 2222     2446677777777777752 111  2333444455555555554

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.19  E-value=2.5e-12  Score=134.16  Aligned_cols=209  Identities=20%  Similarity=0.203  Sum_probs=160.2

Q ss_pred             cCCccCcEEeCCCCcccCccC--cccccCCCCceEecccCcccCCCCC---CCCCCCCCeEeccCcccCCCCcccc-cCc
Q 003065           94 SALQSLTVLSLPFNVLSGKLP--LELSNCSNLKVLNVTGNAMVGSVPD---LSALKNLEIFDLSINYFTGRFPRWV-VNL  167 (851)
Q Consensus        94 ~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~Ls~n~l~~~~~~---l~~l~~L~~L~Ls~N~l~~~~~~~~-~~l  167 (851)
                      .+++.|+...|.+..+. ..+  .....|++++.||||+|-+..-.+-   +..|++|+.|+||.|++.-...... ..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            46889999999998875 233  3678899999999999988764443   5789999999999999864333222 367


Q ss_pred             cccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccccccccccc--ccccCCCcccE
Q 003065          168 TQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP--RSIRKLQKLWK  245 (851)
Q Consensus       168 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p--~~~~~l~~L~~  245 (851)
                      ++|+.|.|+.+.++..++-.....+++|+.|+|..|.....-.....-+..|+.|||++|++- ..+  ...+.++.|..
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence            899999999999986666555677899999999999644344445566788999999999986 344  45788999999


Q ss_pred             EEeeccCccCc-CCcC-----cCCCCcccEEecccccccCC-CCccccCcCCccEEEccCCccCCC
Q 003065          246 IELYANNLTGE-LPAE-----LGNLTLLQEFDISSNQMYGK-LPEEIGNLKNLTVFQCFKNNFSGE  304 (851)
Q Consensus       246 L~L~~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~  304 (851)
                      |+++.+.++.. .|+.     ....++|++|+++.|++... .-..+..+++|+.|.+..|.++.+
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e  341 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE  341 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence            99999998743 2222     35688999999999999632 123466678888888888888743

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.19  E-value=6e-12  Score=122.96  Aligned_cols=161  Identities=23%  Similarity=0.344  Sum_probs=122.9

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .....+|.+...|+.|+|++.  |..+++|++.-.    ...++|..|.-.++-..||||+.+++.+.......++..||
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            345567888999999999994  445667766433    33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      +.|+|+..+++.   .....+..+..+++.++|+|++|||.. ++-|..--+....+++|++.+++|.- +-++..-.. 
T Consensus       270 p~gslynvlhe~---t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe-  343 (448)
T KOG0195|consen  270 PFGSLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQE-  343 (448)
T ss_pred             cchHHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeec-
Confidence            999999999874   344577888999999999999999964 33344457889999999998887652 111111000 


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                           ....-.|.||+||
T Consensus       344 -----~gr~y~pawmspe  356 (448)
T KOG0195|consen  344 -----VGRAYSPAWMSPE  356 (448)
T ss_pred             -----cccccCcccCCHH
Confidence                 1123478899998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.17  E-value=4.1e-10  Score=110.45  Aligned_cols=136  Identities=15%  Similarity=0.150  Sum_probs=97.0

Q ss_pred             CeecccCcEEEEEEEEcC------CCcEEEEEEeccc-------------c-----------cHHHH----HHHHHHHHc
Q 003065          682 NLIGSGGTGKVYRLDLKK------NAGTVAVKQLWKG-------------D-----------GVKVF----AAEMEILGK  727 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~-------------~-----------~~~~~----~~E~~~l~~  727 (851)
                      ..||.|--+.||.|...+      .+..+|||+.+..             +           ..+.+    ++|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998643      3578999976311             0           01222    379999999


Q ss_pred             CCC--CccccEEEEEEeCCeeEEEEeccCCCCHHH-HHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEEe
Q 003065          728 IRH--RNILKLYACLLKGGSSFLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKIALGAAKGIAYL-HHDCSPPIIHR  803 (851)
Q Consensus       728 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHr  803 (851)
                      +..  -.+++.+++    ...++||||+.+..+.. .++.      ..++......+..+++.++.++ |   ..++||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            853  456666764    45689999997643321 1221      1233445567788999999999 6   6799999


Q ss_pred             CCCCCCEEECCCCceEEeeecCccccCC
Q 003065          804 DIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       804 Dlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++.||++++ +.+.++|||.|.....
T Consensus       150 DLs~~NIL~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         150 DLSEYNMLWHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCCHHHEEEEC-CcEEEEECCCceeCCC
Confidence            99999999974 6899999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.14  E-value=7.1e-12  Score=140.59  Aligned_cols=250  Identities=28%  Similarity=0.323  Sum_probs=177.8

Q ss_pred             cCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCcccccee
Q 003065           94 SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSL  173 (851)
Q Consensus        94 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  173 (851)
                      ..+..++.++++.|.+.. +-..+..+++|+.|++.+|.|......+..+++|++||+++|.|+...  .+..++.|+.|
T Consensus        69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L  145 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL  145 (414)
T ss_pred             HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheecccccccccc--chhhccchhhh
Confidence            456777777788888863 444578888899999999988876555788889999999999887543  35667778889


Q ss_pred             ecccccCCCCCCcccccCCCCCCeEecccccccccCC-cccccccccCccccccccccccccccccCCCcccEEEeeccC
Q 003065          174 SIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP-ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN  252 (851)
Q Consensus       174 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~  252 (851)
                      ++++|.+..  + ..+..+++|+.+++++|++...-+ . ...+.+|+.+++.+|.+..  ...+..+..+..+++..|.
T Consensus       146 ~l~~N~i~~--~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~  219 (414)
T KOG0531|consen  146 NLSGNLISD--I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK  219 (414)
T ss_pred             eeccCcchh--c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence            999998862  2 456668889999999999885433 2 5677888889999998863  3345555666666888888


Q ss_pred             ccCcCCcCcCCCCc--ccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCC--
Q 003065          253 LTGELPAELGNLTL--LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGP--  328 (851)
Q Consensus       253 l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--  328 (851)
                      ++..-+  +..+..  |+.+++++|++. .++..+..+.++..|++.+|++...  ..+.....+..+....|.+...  
T Consensus       220 i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  294 (414)
T KOG0531|consen  220 ISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEA  294 (414)
T ss_pred             ceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhh
Confidence            873322  223333  888999999887 4446777888888889988888743  2345556667777777776521  


Q ss_pred             -CCCc-cCCCCccceeeccCCcccccCchhh
Q 003065          329 -FPEN-LGRYTALTDVDISENQFSGSFPKYL  357 (851)
Q Consensus       329 -~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~  357 (851)
                       .... ......++.+.+..|.+....+.+.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
T KOG0531|consen  295 ISQEYITSAAPTLVTLTLELNPIRKISSLDL  325 (414)
T ss_pred             hhccccccccccccccccccCcccccccccH
Confidence             1121 4566778888888888776555443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.14  E-value=1.3e-11  Score=138.38  Aligned_cols=247  Identities=26%  Similarity=0.295  Sum_probs=122.6

Q ss_pred             ccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEE
Q 003065          216 LRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQ  295 (851)
Q Consensus       216 l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  295 (851)
                      +..++.+++..|.|.. +-..+..+++|..|++.+|+|.. +...+..+++|++|++++|+|+..  ..+..++.|+.|+
T Consensus        71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~  146 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELN  146 (414)
T ss_pred             hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhhe
Confidence            3444445555555542 22234455555555555555552 222244566666666666666533  2344455566666


Q ss_pred             ccCCccCCCCCCCCCCcccccEEEeccCcCCCCCC-CccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCcc
Q 003065          296 CFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP-ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFS  374 (851)
Q Consensus       296 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~  374 (851)
                      +++|.|+..  ..+..+..|+.+++++|++...-+ . ...+.+++.+++.+|.+.  ...++.....+..+.+..|.+.
T Consensus       147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccce
Confidence            666666522  234445666666666666653333 1 355666677777777665  2223333333444444455444


Q ss_pred             ccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccc
Q 003065          375 GEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELG  454 (851)
Q Consensus       375 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~  454 (851)
                      ..-+.....+..|+.+++++|++. .++..+..+.++..|++.+|++...-                          .+.
T Consensus       222 ~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--------------------------~~~  274 (414)
T KOG0531|consen  222 KLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--------------------------GLE  274 (414)
T ss_pred             eccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--------------------------ccc
Confidence            332211111112666666666665 33333444455555555555444221                          122


Q ss_pred             cCCCCcEEeccCccccCC---Ccc-ccccCCcccEEEecCCcccCCCC
Q 003065          455 RLTNLERLILTNNNFSGK---IPS-ALGALRQLSSLHLEENALTGSIP  498 (851)
Q Consensus       455 ~l~~L~~L~Ls~N~l~~~---~p~-~~~~l~~L~~L~Ls~N~l~~~~p  498 (851)
                      ....+..+.+..|.+...   ... .....+.++.+.+..|.+....+
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  275 RLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            333444455555554411   111 14455677777777777765444

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.13  E-value=2e-12  Score=131.54  Aligned_cols=233  Identities=18%  Similarity=0.257  Sum_probs=131.5

Q ss_pred             CceEEEecccCCccee----cCccccCCccCcEEeCCC---CcccCccCcc-------cccCCCCceEecccCcccCCC-
Q 003065           73 GRVTEISFDNKSLSGE----ISSSISALQSLTVLSLPF---NVLSGKLPLE-------LSNCSNLKVLNVTGNAMVGSV-  137 (851)
Q Consensus        73 ~~v~~l~l~~~~l~g~----i~~~l~~l~~L~~L~L~~---n~l~~~~p~~-------~~~l~~L~~L~Ls~n~l~~~~-  137 (851)
                      ..+++|+|++|.+.-+    +.+.|.+.++|+..++|+   -++..++|+.       +-.+++|++||||+|.|...- 
T Consensus        30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~  109 (382)
T KOG1909|consen   30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI  109 (382)
T ss_pred             CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence            3688999999998643    556788888999999986   2334456654       345678999999999885432 


Q ss_pred             CC----CCCCCCCCeEeccCcccCCCCccc-------------ccCccccceeecccccCCCCC---CcccccCCCCCCe
Q 003065          138 PD----LSALKNLEIFDLSINYFTGRFPRW-------------VVNLTQLVSLSIGDNVYDEAE---IPESIGNLKNLTY  197 (851)
Q Consensus       138 ~~----l~~l~~L~~L~Ls~N~l~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~~---~p~~~~~l~~L~~  197 (851)
                      +.    +.+++.|++|.|.+|.+...-...             ...-++|+++..++|++..+.   +...|...+.|+.
T Consensus       110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee  189 (382)
T KOG1909|consen  110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEE  189 (382)
T ss_pred             HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccce
Confidence            22    677888888888888875221111             223356666777766665321   1223455566666


Q ss_pred             Eeccccccccc----CCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecc
Q 003065          198 LFLAHCNLRGR----IPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS  273 (851)
Q Consensus       198 L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  273 (851)
                      +.++.|.|...    +-..|..+++|+.|||.+|-++.....                    .+...+..+++|++|+++
T Consensus       190 vr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~--------------------~LakaL~s~~~L~El~l~  249 (382)
T KOG1909|consen  190 VRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV--------------------ALAKALSSWPHLRELNLG  249 (382)
T ss_pred             EEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH--------------------HHHHHhcccchheeeccc
Confidence            66666666421    112344555555555555555422111                    111233334444444444


Q ss_pred             cccccCCCCccc-----cCcCCccEEEccCCccCCC----CCCCCCCcccccEEEeccCcC
Q 003065          274 SNQMYGKLPEEI-----GNLKNLTVFQCFKNNFSGE----FPSGFGDMRKLFAFSIYGNRF  325 (851)
Q Consensus       274 ~N~l~~~~p~~l-----~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l  325 (851)
                      +|.+...-...|     ...++|++|.+.+|.++..    +...+...+.|+.|+|++|++
T Consensus       250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            444433222221     1234555555555555421    112334466667777777776

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.13  E-value=9.3e-12  Score=123.41  Aligned_cols=127  Identities=22%  Similarity=0.310  Sum_probs=58.9

Q ss_pred             ccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEcc
Q 003065          218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF  297 (851)
Q Consensus       218 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~  297 (851)
                      .|++||||+|.|+ .+..+..-+++++.|++|+|.|...  +.+..+++|+.||||+|.++ .+..+=..|-+.+.|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            3444444444444 3444444444555555555544421  12444455555555555444 233333344444555555


Q ss_pred             CCccCCCCCCCCCCcccccEEEeccCcCCCC-CCCccCCCCccceeeccCCccc
Q 003065          298 KNNFSGEFPSGFGDMRKLFAFSIYGNRFSGP-FPENLGRYTALTDVDISENQFS  350 (851)
Q Consensus       298 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~  350 (851)
                      .|.+..  -.++..+-+|..|++.+|+|... --+.+++++-|+.+.|.+|.+.
T Consensus       361 ~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  361 QNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             hhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence            554431  12334444455555555555421 1234555555666666666665

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.10  E-value=1.5e-11  Score=121.98  Aligned_cols=131  Identities=26%  Similarity=0.354  Sum_probs=91.6

Q ss_pred             cceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecC
Q 003065          411 VGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE  490 (851)
Q Consensus       411 L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  490 (851)
                      |+.+|||+|.|+ .+.+.....+.++.|++|+|.|.. +. .+..+++|+.||||+|.++ .+..+-..|-+++.|.|++
T Consensus       286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~  361 (490)
T KOG1259|consen  286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ  361 (490)
T ss_pred             hhhccccccchh-hhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence            444444444443 233344455667777777777763 22 3777888888888888887 4555566677888899999


Q ss_pred             CcccCCCCCCcccccccceeeccCccccccc-CCCccccccCCeEeCCCCccccccCcc
Q 003065          491 NALTGSIPNEMGDCARIVDLNLARNSLSGNI-PRSLSLLSSLNALNLSGNKLTGSIPDN  548 (851)
Q Consensus       491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~ip~~  548 (851)
                      |.+..  -..++.+-+|..||+++|+|.... ...+++++-|+.+.|.+|++++ +|+-
T Consensus       362 N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~-~vdY  417 (490)
T KOG1259|consen  362 NKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG-SVDY  417 (490)
T ss_pred             hhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc-cchH
Confidence            98853  245677888899999999887432 3478899999999999999994 5553

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=6.2e-11  Score=113.87  Aligned_cols=110  Identities=25%  Similarity=0.265  Sum_probs=27.0

Q ss_pred             ccCCccCcEEeCCCCcccCccCcccc-cCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccc-cCcccc
Q 003065           93 ISALQSLTVLSLPFNVLSGKLPLELS-NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWV-VNLTQL  170 (851)
Q Consensus        93 l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L  170 (851)
                      +.+...+++|+|++|.|+. + +.++ .+.+|+.|||++|.|+.. +.+..+++|+.|++++|+++... ..+ ..+++|
T Consensus        15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~i~-~~l~~~lp~L   90 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISSIS-EGLDKNLPNL   90 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-C-HHHHHH-TT-
T ss_pred             ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCccc-cchHHhCCcC
Confidence            3344456666666666652 2 2344 456666666666666542 34555666666666666665322 222 245555


Q ss_pred             ceeecccccCCCCCCcccccCCCCCCeEeccccccc
Q 003065          171 VSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLR  206 (851)
Q Consensus       171 ~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~  206 (851)
                      ++|++++|++....--..+..+++|+.|+|.+|.++
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            555555555543222233444555555555555544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.09  E-value=2.1e-09  Score=100.53  Aligned_cols=143  Identities=22%  Similarity=0.274  Sum_probs=105.6

Q ss_pred             cCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----------ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       680 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ....+-+|+-+.|+++.+  .|+.+.||.-..+          -..++..+|++.+.++.--.|....-++.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567899999999999987  6777788853222          1234567899999998755555544455555566789


Q ss_pred             EeccCC-CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC---ceEEeeecC
Q 003065          750 LEYMPN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---EPKIADFGV  825 (851)
Q Consensus       750 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGl  825 (851)
                      |||++| .++.+++.....   .+.........+..+-+.+.-||   ..+|+|+|+..+||++.+++   .+.++|||+
T Consensus        89 ME~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             EEeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecc
Confidence            999976 478888877532   22222233577888889999999   88999999999999997655   458999999


Q ss_pred             ccccC
Q 003065          826 AKIAE  830 (851)
Q Consensus       826 a~~~~  830 (851)
                      +....
T Consensus       163 s~~s~  167 (229)
T KOG3087|consen  163 SSVSR  167 (229)
T ss_pred             hhccc
Confidence            87543

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.05  E-value=8.4e-11  Score=112.97  Aligned_cols=109  Identities=30%  Similarity=0.437  Sum_probs=25.8

Q ss_pred             cccCCCCceEecccCcccCCCCCCC-CCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccc-cCCCC
Q 003065          117 LSNCSNLKVLNVTGNAMVGSVPDLS-ALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKN  194 (851)
Q Consensus       117 ~~~l~~L~~L~Ls~n~l~~~~~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~-~~l~~  194 (851)
                      +.+..++++|+|++|.|+. +..++ .+.+|+.||||+|.++..  ..+..++.|++|++++|+++  .+++.+ ..+++
T Consensus        15 ~~n~~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~--~i~~~l~~~lp~   89 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS--SISEGLDKNLPN   89 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS-----S-CHHHHHH-TT
T ss_pred             ccccccccccccccccccc-ccchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC--ccccchHHhCCc
Confidence            3445567777777777765 33454 466777777777776632  23455555666666666554  333333 23555


Q ss_pred             CCeEecccccccccCC-cccccccccCcccccccccc
Q 003065          195 LTYLFLAHCNLRGRIP-ESISELRELGTLDICRNKIS  230 (851)
Q Consensus       195 L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~i~  230 (851)
                      |++|+|++|+|...-- ..+..+++|++|+|.+|.++
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            5555555555542110 22333444444444444443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=2.1e-09  Score=101.33  Aligned_cols=132  Identities=24%  Similarity=0.328  Sum_probs=99.3

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEe-cccc---------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGD---------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~-~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ..+++|+-+.+|.+.+  -|.++++|.- .+..         ...+-.+|++++.+++--.|....-++.+.+...++||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3578999999999977  3445666643 2211         12345689999999876666665556667777889999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |++|..|.+.+...            ...++..+-.-+.-||   ..+|+|+|+.++||++..+ .+.++|||++.....
T Consensus        80 ~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s~~  143 (204)
T COG3642          80 YIEGELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSDE  143 (204)
T ss_pred             EeCChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCC-cEEEEECCccccccc
Confidence            99998888888653            1346677777788899   7899999999999999876 499999999985443

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=99.04  E-value=1.9e-10  Score=83.10  Aligned_cols=40  Identities=55%  Similarity=1.107  Sum_probs=31.5

Q ss_pred             hhhHHHHHHHHHhcC-CCCCCCCCCCCCC-CCCcccceeEec
Q 003065           30 NVETQALIQFKSKLK-DPHGVLDSWKESA-DSPCGFSGITCD   69 (851)
Q Consensus        30 ~~~~~aLl~fk~~~~-~~~~~l~sW~~~~-~~~c~w~gv~c~   69 (851)
                      ++|++||++||+++. +|.+.+.+|+... .+||+|.||+||
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            689999999999998 5779999999874 789999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.03  E-value=1.9e-11  Score=124.45  Aligned_cols=244  Identities=23%  Similarity=0.324  Sum_probs=122.7

Q ss_pred             CcCCCCcccEEecccccccCC----CCccccCcCCccEEEccCCccCC----CCCCCCCCcccccEEEeccCcCCCCCCC
Q 003065          260 ELGNLTLLQEFDISSNQMYGK----LPEEIGNLKNLTVFQCFKNNFSG----EFPSGFGDMRKLFAFSIYGNRFSGPFPE  331 (851)
Q Consensus       260 ~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~  331 (851)
                      .+..+.+++.++||+|.+...    +...+.+.++|+..++++- ++|    .+|+.+.                 .+.+
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~-----------------~l~~   86 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALK-----------------MLSK   86 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHH-----------------HHHH
Confidence            445677888899999887532    2334556667777776643 222    2222110                 1122


Q ss_pred             ccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCC--------
Q 003065          332 NLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD--------  403 (851)
Q Consensus       332 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--------  403 (851)
                      ++...+.|++||||.|.|.-..+..+..+                    +..+.+|++|.|.+|.+.-.-..        
T Consensus        87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~l--------------------l~s~~~L~eL~L~N~Glg~~ag~~l~~al~~  146 (382)
T KOG1909|consen   87 ALLGCPKLQKLDLSDNAFGPKGIRGLEEL--------------------LSSCTDLEELYLNNCGLGPEAGGRLGRALFE  146 (382)
T ss_pred             HHhcCCceeEeeccccccCccchHHHHHH--------------------HHhccCHHHHhhhcCCCChhHHHHHHHHHHH
Confidence            33455677788888887764444433221                    22345555666665555311101        


Q ss_pred             -----cccCccccceEEecCCcCCCCCC----cccccCCCCCeEecCCCcceee----CCcccccCCCCcEEeccCcccc
Q 003065          404 -----GLWALPNVGMLDFGDNDFTGGIS----PLIGLSTSLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFS  470 (851)
Q Consensus       404 -----~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  470 (851)
                           -...-++|+++..++|++.....    ..|...+.|+.+.++.|.|...    +...|..+++|+.|||..|-|+
T Consensus       147 l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft  226 (382)
T KOG1909|consen  147 LAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFT  226 (382)
T ss_pred             HHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhh
Confidence                 11223456666666666653322    2344445666666666665411    1234555666666666666665


Q ss_pred             CC----CccccccCCcccEEEecCCcccCCCCCCcc-----cccccceeeccCccccc----ccCCCccccccCCeEeCC
Q 003065          471 GK----IPSALGALRQLSSLHLEENALTGSIPNEMG-----DCARIVDLNLARNSLSG----NIPRSLSLLSSLNALNLS  537 (851)
Q Consensus       471 ~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls  537 (851)
                      ..    +...+..+++|+.|+++++.++..-...|.     ..++|+.|.+.+|.++-    .+...+...+.|+.|+|+
T Consensus       227 ~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLn  306 (382)
T KOG1909|consen  227 LEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLN  306 (382)
T ss_pred             hHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCC
Confidence            22    223445555666666666665432222211     13445555555555442    122223334455555555


Q ss_pred             CCcc
Q 003065          538 GNKL  541 (851)
Q Consensus       538 ~N~l  541 (851)
                      +|++
T Consensus       307 gN~l  310 (382)
T KOG1909|consen  307 GNRL  310 (382)
T ss_pred             cccc
Confidence            5555

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.02  E-value=1.3e-09  Score=111.71  Aligned_cols=141  Identities=22%  Similarity=0.304  Sum_probs=104.0

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCC--ccccEEEEEEeC---CeeEEEEecc
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHR--NILKLYACLLKG---GSSFLVLEYM  753 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~  753 (851)
                      +.++.|..+.||+++.. +|+.+++|......   ....+.+|+++++.+.+.  .+++++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            56899999999999874 35789999876543   356788999999999764  456777776553   3568999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD--------------------------------------  795 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------  795 (851)
                      +|.++.+.+..      ..++......++.++++++.+||+.                                      
T Consensus        83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            98877554310      1345555556667777777777631                                      


Q ss_pred             ---------------CCCCcEEeCCCCCCEEECC--CCceEEeeecCcccc
Q 003065          796 ---------------CSPPIIHRDIKSSNILLDE--DYEPKIADFGVAKIA  829 (851)
Q Consensus       796 ---------------~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~  829 (851)
                                     ....++|+|++|.||+++.  ++.+.|+||+.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                           1246899999999999998  667899999988643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.00  E-value=1.5e-10  Score=133.37  Aligned_cols=133  Identities=29%  Similarity=0.364  Sum_probs=90.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      .+|+.++.|..|+||.||.++++.+.+.+|+| +.++..   +.+-  ++.....|.+|                     
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l---ilRn--ilt~a~npfvv---------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL---ILRN--ILTFAGNPFVV---------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccch---hhhc--cccccCCccee---------------------
Confidence            47889999999999999999999999999995 433211   1111  22223333333                     


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC-
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK-  834 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-  834 (851)
                      |+-...++.     ...++.        +++.+++|+|   ..+|+|||+||+|.+|+.-|++|+.|||+.+..-.... 
T Consensus       136 gDc~tllk~-----~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 GDCATLLKN-----IGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             chhhhhccc-----CCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence            333333322     112222        2267899999   88999999999999999999999999999875321110 


Q ss_pred             -------c-----ccccccccccccccCC
Q 003065          835 -------V-----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 -------~-----~~~~~~~gt~~Y~APE  851 (851)
                             .     -....++|||.|+|||
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPe  228 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPE  228 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChh
Confidence                   0     0113468999999998

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.97  E-value=6.7e-11  Score=136.55  Aligned_cols=170  Identities=27%  Similarity=0.326  Sum_probs=132.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-CCcEEEEEEeccc----ccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-NAGTVAVKQLWKG----DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  749 (851)
                      ..|...+.||+|+|+.|-.+.... ....+|+|.+...    ...+....|..+-+.+. |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            367888889999999998877633 3445777766433    22344455777777776 99999999999999999999


Q ss_pred             EeccCCCCHHHHH-HHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-ceEEeeecCcc
Q 003065          750 LEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAK  827 (851)
Q Consensus       750 ~e~~~~gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~  827 (851)
                      +||.+++++.+.+ +..    ....+......+..|+..++.|+|.  ..++.|||+||+|.+++..+ ..|++|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCcccccccccccccCC----ccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999998877 321    1123344455788999999999994  35899999999999999999 99999999998


Q ss_pred             ccCC-CCCccccccccc-ccccccCC
Q 003065          828 IAEN-SPKVSDYSCFAG-THGYIAPG  851 (851)
Q Consensus       828 ~~~~-~~~~~~~~~~~g-t~~Y~APE  851 (851)
                      .+.. ..........+| ++.|+|||
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E  199 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPE  199 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcc
Confidence            7766 444444445678 99999998

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.88  E-value=1.6e-09  Score=129.74  Aligned_cols=131  Identities=20%  Similarity=0.261  Sum_probs=94.0

Q ss_pred             cCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcc--cCCCCcccccCccccceeecccccCCCCCCcccccCCCCCC
Q 003065          119 NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINY--FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLT  196 (851)
Q Consensus       119 ~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~  196 (851)
                      +....+...+-+|.+.....+. ..++|++|=+..|.  +.......|..++.|++|||++|.=- +.+|+.++.|-+|+
T Consensus       521 ~~~~~rr~s~~~~~~~~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l-~~LP~~I~~Li~Lr  598 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIEHIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSL-SKLPSSIGELVHLR  598 (889)
T ss_pred             chhheeEEEEeccchhhccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCcc-CcCChHHhhhhhhh
Confidence            3366777777777775443332 23368888888885  55444555777888888888875433 67888888888888


Q ss_pred             eEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccC
Q 003065          197 YLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN  252 (851)
Q Consensus       197 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~  252 (851)
                      +|+|++..+. .+|..+.+|+.|.+|++..+.-...+|.....|++|++|.+....
T Consensus       599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            8888888887 778888888888888888777655666666778888888776654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.87  E-value=3.9e-08  Score=102.27  Aligned_cols=139  Identities=17%  Similarity=0.115  Sum_probs=98.9

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccccc-------------HHHHHHHHHHHHcCCCCcc--ccEEEEEEe----
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-------------VKVFAAEMEILGKIRHRNI--LKLYACLLK----  742 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~E~~~l~~l~h~ni--v~l~~~~~~----  742 (851)
                      +.+-+.....|++++.  .|+.|.||.......             ...+.+|.+.+.++...+|  ++.+++.+.    
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            4444444455777665  567899996633221             1147789999988854444  344555543    


Q ss_pred             -CCeeEEEEeccCCC-CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC------
Q 003065          743 -GGSSFLVLEYMPNG-NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE------  814 (851)
Q Consensus       743 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~------  814 (851)
                       ....++|||++++. +|.+++....   ....+......++.+++..+.-||   ..||+|+|++++|||++.      
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~  179 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGRE  179 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCC
Confidence             23578999999876 7988876431   123345566788999999999999   789999999999999975      


Q ss_pred             -CCceEEeeecCccc
Q 003065          815 -DYEPKIADFGVAKI  828 (851)
Q Consensus       815 -~~~~kl~DFGla~~  828 (851)
                       ++.+.++||+.++.
T Consensus       180 ~~~~~~LIDl~r~~~  194 (268)
T PRK15123        180 EDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCceEEEEECCcccc
Confidence             46899999998864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.86  E-value=5e-09  Score=102.96  Aligned_cols=74  Identities=24%  Similarity=0.213  Sum_probs=62.5

Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.++++.+    ...+++..++.++.|++.||+|||   +.+      ||+||+++.++.+|+  ||.++......  
T Consensus         1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--   63 (176)
T smart00750        1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--   63 (176)
T ss_pred             CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc--
Confidence            6899998763    345899999999999999999999   444      999999999999999  99998765422  


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                           ..||+.|||||
T Consensus        64 -----~~g~~~y~aPE   74 (176)
T smart00750       64 -----SRVDPYFMAPE   74 (176)
T ss_pred             -----CCCcccccChH
Confidence                 25899999998

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.84  E-value=3e-09  Score=127.33  Aligned_cols=149  Identities=21%  Similarity=0.295  Sum_probs=88.0

Q ss_pred             CCCCeEecccccccccCCcccccccccCcccccccc--ccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEE
Q 003065          193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNK--ISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF  270 (851)
Q Consensus       193 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~--i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  270 (851)
                      ...+...+-+|.+. .++....+ +.|++|-+..|.  +....+..|..++.|++|||++|.=-+.+|..++++-+|++|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            45556666666665 33433332 356666666664  443333446667777777777665555677777777777777


Q ss_pred             ecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcC--CCCCCCccCCCCccceeec
Q 003065          271 DISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF--SGPFPENLGRYTALTDVDI  344 (851)
Q Consensus       271 ~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l--~~~~p~~l~~l~~L~~L~L  344 (851)
                      ++++..+. .+|..+.+|+.|.+|++..+.-...+|.....|++|++|.+..-..  ....-..+..+.+|+.+..
T Consensus       601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~  675 (889)
T KOG4658|consen  601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI  675 (889)
T ss_pred             cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence            77777776 6677777777777777776655445555555677777776655432  1222223344444544444

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.83  E-value=3.9e-09  Score=116.26  Aligned_cols=121  Identities=29%  Similarity=0.469  Sum_probs=97.3

Q ss_pred             HHcCCCCccccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeC
Q 003065          725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRD  804 (851)
Q Consensus       725 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrD  804 (851)
                      |+.+.|.|+.+++|.+..+...+.|.+||..|+|.|.+..    ....+++.....++++++.|++|+|.  ++-..|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeee
Confidence            3568899999999999999999999999999999999976    35678999999999999999999995  33349999


Q ss_pred             CCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          805 IKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       805 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++.|.++|....+|++|||+.................-..-|.|||
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPe  121 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPE  121 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHH
Confidence            99999999999999999999987664311111111112244577876

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.83  E-value=4.8e-10  Score=120.90  Aligned_cols=99  Identities=25%  Similarity=0.366  Sum_probs=82.2

Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      +.|+.|++|+-.+|.+|+.++..  ....++.....++.|++.|++|      ++.+|||+||.||+...+..+||.|||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence            57899999999999999986532  3345677888999999999999      489999999999999999999999999


Q ss_pred             CccccCCCC----CcccccccccccccccCC
Q 003065          825 VAKIAENSP----KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~----~~~~~~~~~gt~~Y~APE  851 (851)
                      +........    ..+..+..+||..||+||
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPE  432 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPE  432 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHH
Confidence            998776554    222344568999999998

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.80  E-value=4.3e-09  Score=83.08  Aligned_cols=59  Identities=37%  Similarity=0.523  Sum_probs=30.3

Q ss_pred             CCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCc
Q 003065          434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA  492 (851)
Q Consensus       434 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  492 (851)
                      +|+.|++++|+++...+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34455555555554444455555555555555555554444455555555555555554

...

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.80  E-value=2.6e-08  Score=110.66  Aligned_cols=126  Identities=18%  Similarity=0.228  Sum_probs=105.0

Q ss_pred             EEEEcCCCcEEEEEEeccccc--HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCC
Q 003065          694 RLDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP  771 (851)
Q Consensus       694 ~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~  771 (851)
                      .|..+.++.+|.|.......+  .....+-++.++.++||+|+++++.++..+..|+|+|.+.  .|..++++..     
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence            466677888999988866554  4556788899999999999999999999999999999984  6777777642     


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          772 ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       772 ~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                         .......++||+.||.|||+  +.+++|++|.-+.|+++..|..||++|-++.....
T Consensus       103 ---~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~  157 (690)
T KOG1243|consen  103 ---KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG  157 (690)
T ss_pred             ---HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence               33455678899999999996  56999999999999999999999999988765443

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.78  E-value=5.3e-09  Score=82.55  Aligned_cols=59  Identities=34%  Similarity=0.491  Sum_probs=29.5

Q ss_pred             cccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCc
Q 003065          482 QLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK  540 (851)
Q Consensus       482 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  540 (851)
                      +|++|++++|+++...+..|..+++|+.|++++|+++...|.+|..+++|+.|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34445555555544444444455555555555555554444455555555555555554

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.73  E-value=5.6e-08  Score=95.12  Aligned_cols=125  Identities=26%  Similarity=0.266  Sum_probs=79.5

Q ss_pred             EEEEEEEcCCCcEEEEEEeccc---------------c-------------cHHHHHHHHHHHHcCCCC--ccccEEEEE
Q 003065          691 KVYRLDLKKNAGTVAVKQLWKG---------------D-------------GVKVFAAEMEILGKIRHR--NILKLYACL  740 (851)
Q Consensus       691 ~Vy~~~~~~~~~~vavK~~~~~---------------~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~  740 (851)
                      .||.|.. .++..+|||+.+..               .             ......+|.+.|.++..-  ++++.+++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899987 56779999976321               0             022357899999999765  456666542


Q ss_pred             EeCCeeEEEEeccC--CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCcEEeCCCCCCEEECCCCc
Q 003065          741 LKGGSSFLVLEYMP--NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY-LHHDCSPPIIHRDIKSSNILLDEDYE  817 (851)
Q Consensus       741 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivHrDlkp~NILl~~~~~  817 (851)
                          ..++||||++  |..+.. +....      +.......+..+++..+.. +|   ..||+|+|+.+.||+++++ .
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~~------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDVD------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHCG------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-C
T ss_pred             ----CCEEEEEecCCCccchhh-HHhcc------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-e
Confidence                3479999998  544433 33211      0012234566677775555 46   6799999999999999987 9


Q ss_pred             eEEeeecCccccCC
Q 003065          818 PKIADFGVAKIAEN  831 (851)
Q Consensus       818 ~kl~DFGla~~~~~  831 (851)
                      +.++|||.|.....
T Consensus       145 ~~iIDf~qav~~~~  158 (188)
T PF01163_consen  145 VYIIDFGQAVDSSH  158 (188)
T ss_dssp             EEE--GTTEEETTS
T ss_pred             EEEEecCcceecCC
Confidence            99999999876553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.71  E-value=8.8e-09  Score=113.51  Aligned_cols=167  Identities=23%  Similarity=0.197  Sum_probs=129.9

Q ss_pred             CCccCCeecc--cCcEEEEEEEE--cCCCcEEEEEEeccc----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeE
Q 003065          677 NLEEDNLIGS--GGTGKVYRLDL--KKNAGTVAVKQLWKG----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       677 ~~~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  747 (851)
                      .+...+.+|.  |.+|.||.+..  ..++..+|+|+-+..    .....-.+|+...+++ .|++.++.+..++..+..|
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4667788999  99999999998  888899999974222    2233345677777777 4999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCcEEeCCCCCCEEECCC-CceEEee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK----GIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIAD  822 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~D  822 (851)
                      +-+|++ +.++.++.+..    ...++....+.+..+..+    |+.++|   ...++|-|+||+||+...+ ...+++|
T Consensus       195 iqtE~~-~~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             eeeccc-cchhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCC
Confidence            999999 57888877653    223455566677777777    999999   8899999999999999988 8899999


Q ss_pred             ecCccccCCCCCcccc---cccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDY---SCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~---~~~~gt~~Y~APE  851 (851)
                      ||+...+....-....   ....|...|+|||
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke  298 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE  298 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChh
Confidence            9999887765422111   1224777899997

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.63  E-value=1e-09  Score=97.03  Aligned_cols=137  Identities=20%  Similarity=0.271  Sum_probs=105.7

Q ss_pred             CCCeEecCCCcceeeCCccc---ccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCccccccccee
Q 003065          434 SLSQLVLQNNRFSGELPSEL---GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL  510 (851)
Q Consensus       434 ~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  510 (851)
                      .+..++|+++++- .+++..   .....|+..+|++|.+....+..-...+.++.|+|++|+|+ .+|.++..++.|+.|
T Consensus        28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            4566778888775 445443   44567778899999998555544455568899999999997 788889999999999


Q ss_pred             eccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCccccc
Q 003065          511 NLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR  574 (851)
Q Consensus       511 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~~  574 (851)
                      |++.|.+. ..|..+..+.+|..||..+|.+. .||..+-.- .....++.+++|.+.+|...|.
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa  168 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQA  168 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccccc
Confidence            99999998 78888888999999999999998 777653222 3444567888999999877663

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.56  E-value=3.5e-09  Score=117.00  Aligned_cols=126  Identities=29%  Similarity=0.315  Sum_probs=74.3

Q ss_pred             cceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecC
Q 003065          411 VGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE  490 (851)
Q Consensus       411 L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  490 (851)
                      |...+.+.|++. .....+..++.|+.|+|++|+++..-  .+..++.|+.|||++|.++...--...++. |+.|.|++
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn  241 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN  241 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence            444444555444 22233445556666666666665322  566667777777777777632222333433 77777777


Q ss_pred             CcccCCCCCCcccccccceeeccCcccccccCC-CccccccCCeEeCCCCccc
Q 003065          491 NALTGSIPNEMGDCARIVDLNLARNSLSGNIPR-SLSLLSSLNALNLSGNKLT  542 (851)
Q Consensus       491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~  542 (851)
                      |.++..  ..+.++.+|+.||+++|-|++.--- -++.+..|+.|+|.||++-
T Consensus       242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            776532  2456677777777777777653222 2356677788888888876

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.52  E-value=3.3e-09  Score=117.27  Aligned_cols=181  Identities=29%  Similarity=0.306  Sum_probs=126.3

Q ss_pred             cccccCccccceeccccCccccccCCcccCc-cccceEEecCCcCC----------CCCCcccccCCCCCeEecCCCcce
Q 003065          378 PNSYADCKTIQRLRISDNHLSGKIPDGLWAL-PNVGMLDFGDNDFT----------GGISPLIGLSTSLSQLVLQNNRFS  446 (851)
Q Consensus       378 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~----------~~~~~~~~~~~~L~~L~Ls~N~l~  446 (851)
                      |-.+..+.+|++|.|.+..|..  -..+..+ ..|+.|-- .|.+.          |.+...+ ..-.|...+.+.|++.
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~-~Wn~L~~a~fsyN~L~  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSP-VWNKLATASFSYNRLV  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccch-hhhhHhhhhcchhhHH
Confidence            4456677788888888888763  1111111 12222211 11111          1111111 1235888899999998


Q ss_pred             eeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCcc
Q 003065          447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS  526 (851)
Q Consensus       447 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  526 (851)
                       .+..++.-++.|+.|||++|+++...  .+..++.|++|||++|.|+...--....+. |+.|++++|.++..  ..+.
T Consensus       178 -~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie  251 (1096)
T KOG1859|consen  178 -LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIE  251 (1096)
T ss_pred             -hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHH
Confidence             77788888999999999999998654  889999999999999999844434455555 99999999999844  3467


Q ss_pred             ccccCCeEeCCCCccccccCcc-cccc-cceEEeCcCCcccccC
Q 003065          527 LLSSLNALNLSGNKLTGSIPDN-LMKL-KLSSIDLSENQLSGSV  568 (851)
Q Consensus       527 ~l~~L~~L~Ls~N~l~g~ip~~-l~~l-~L~~l~ls~N~l~~~~  568 (851)
                      ++++|+.|||++|-|++.---. +..+ .|..|+|.+|++.|..
T Consensus       252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            8999999999999998532111 1223 7899999999998854

>PRK09902 hypothetical protein; Provisional

Probab=98.47  E-value=3e-06  Score=83.32  Aligned_cols=136  Identities=14%  Similarity=0.087  Sum_probs=99.7

Q ss_pred             cccCcEEEEEEEEcCCCcEEEEEEecc--------cccHHHHHHHHHHHHcCCCCc--cccEEEEEEe--C--CeeEEEE
Q 003065          685 GSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRN--ILKLYACLLK--G--GSSFLVL  750 (851)
Q Consensus       685 g~G~~g~Vy~~~~~~~~~~vavK~~~~--------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~--~--~~~~lv~  750 (851)
                      |+||.+-|++...  .|+.+=+|+-..        .-+...|.+|+..++++...+  +++...+...  +  -..++|+
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            6788899999876  344677886531        235678999999999985433  4444422211  1  2357999


Q ss_pred             eccCC-CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc--eEEeeecCcc
Q 003065          751 EYMPN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE--PKIADFGVAK  827 (851)
Q Consensus       751 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~  827 (851)
                      |-++| .+|.+++...   ...+.+...+..+..+++.++.-||   +.|+.|+|+-+.||+++.++.  ++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97753 5888887553   2234566667789999999999999   889999999999999986666  9999998775


Q ss_pred             c
Q 003065          828 I  828 (851)
Q Consensus       828 ~  828 (851)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.46  E-value=2.3e-06  Score=87.31  Aligned_cols=142  Identities=15%  Similarity=0.177  Sum_probs=87.8

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCc--cccEEEEEEeCCeeEEEEeccCCCC-H
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN--ILKLYACLLKGGSSFLVLEYMPNGN-L  758 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-L  758 (851)
                      ..||+|..+.||+.    .+..+++|............+|.++++.+..-.  +++.+++....+...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            57899999999984    244678898776555667789999999986443  4567777777777889999998863 1


Q ss_pred             HHH--------------HHH----hhhCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHh-CCCCCcEEeCCCC
Q 003065          759 FQA--------------LHK----RVKEGKPELDWFRRY-KIAL----------GAAK-GIAYLHH-DCSPPIIHRDIKS  807 (851)
Q Consensus       759 ~~~--------------l~~----~~~~~~~~l~~~~~~-~i~~----------~i~~-~l~~LH~-~~~~~ivHrDlkp  807 (851)
                      .+.              +.+    -..-........... ++-.          .+.+ ...+|.. .....++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            111              111    000000011111100 0000          0001 1122221 1134678999999


Q ss_pred             CCEEECCCCceEEeeecCccc
Q 003065          808 SNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       808 ~NILl~~~~~~kl~DFGla~~  828 (851)
                      .||++++++ +.++||+.+..
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CcEEEcCCC-cEEEechhcCc
Confidence            999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=8.2e-07  Score=100.01  Aligned_cols=139  Identities=21%  Similarity=0.220  Sum_probs=93.1

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEecccc-----------------------c---------HH----------HHH
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----------------------G---------VK----------VFA  719 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------------------~---------~~----------~~~  719 (851)
                      +.|+.++-|+||+|+.. +|+.||||+.++.-                       .         .+          ++.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67899999999999994 59999999874320                       0         00          134


Q ss_pred             HHHHHHHcCC-----CCccccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHH-HHHHH
Q 003065          720 AEMEILGKIR-----HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG-IAYLH  793 (851)
Q Consensus       720 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~-l~~LH  793 (851)
                      +|...+.+++     .+.+.--.-|++..+...++|||++|..+.+......    ...+..   .++..++++ ++.+-
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k---~ia~~~~~~f~~q~~  282 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRK---ELAELLVRAFLRQLL  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHH---HHHHHHHHHHHHHHH
Confidence            5666665552     3444333334455667899999999998888753321    223322   233333332 12222


Q ss_pred             hCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       794 ~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                         ..|++|.|.+|.||+++.+|++.+.|||+.....+
T Consensus       283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               35999999999999999999999999999876554

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.46  E-value=1.2e-06  Score=87.88  Aligned_cols=136  Identities=23%  Similarity=0.194  Sum_probs=94.2

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecc----------cc--------------cHHHHHHHHHHHHcCCCC--
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GD--------------GVKVFAAEMEILGKIRHR--  731 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----------~~--------------~~~~~~~E~~~l~~l~h~--  731 (851)
                      +.+...||.|--+.||.|.. ..|.++|||.=+-          ..              .....++|.++|+++...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            35678999999999999998 4788999994210          00              122356899999999755  


Q ss_pred             ccccEEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 003065          732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL  811 (851)
Q Consensus       732 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NIL  811 (851)
                      .+++.+++    +...+||||++|-.|...-          ++....-.++..|++-+.-.-   ..||||+|+.+=||+
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIl  234 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNIL  234 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEE
Confidence            66666653    4568999999886654321          111222233444444444333   469999999999999


Q ss_pred             ECCCCceEEeeecCccccCC
Q 003065          812 LDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       812 l~~~~~~kl~DFGla~~~~~  831 (851)
                      ++++|.+.++||--+.....
T Consensus       235 V~~dg~~~vIDwPQ~v~~~h  254 (304)
T COG0478         235 VTEDGDIVVIDWPQAVPISH  254 (304)
T ss_pred             EecCCCEEEEeCcccccCCC
Confidence            99999999999987765443

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.46  E-value=3.4e-08  Score=98.56  Aligned_cols=185  Identities=20%  Similarity=0.249  Sum_probs=81.0

Q ss_pred             CccCcEEeCCCCcccC--ccCcccccCCCCceEecccCcccCCCCCC-CCCCCCCeEeccCcccCCCC-cccccCccccc
Q 003065           96 LQSLTVLSLPFNVLSG--KLPLELSNCSNLKVLNVTGNAMVGSVPDL-SALKNLEIFDLSINYFTGRF-PRWVVNLTQLV  171 (851)
Q Consensus        96 l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l-~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~  171 (851)
                      .++++.|||.+|.++.  ++-.-+.+|+.|++|+|+.|.+...+..+ ..+++|++|-|.+..+...- ...+..++.++
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            3455555555555542  22223345555555555555555444443 24445555555554443222 12223444444


Q ss_pred             eeecccccCCCCCCcccccCCCCCCeEecccccccccCCc--ccccccccCccccccccccccccccccCCCcccEEEee
Q 003065          172 SLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE--SISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELY  249 (851)
Q Consensus       172 ~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~  249 (851)
                      .|.+|.|.+.               .+++..|-++...|+  .+..++.++.+.++-|++...+|       ++..+-+.
T Consensus       150 elHmS~N~~r---------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fp-------nv~sv~v~  207 (418)
T KOG2982|consen  150 ELHMSDNSLR---------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFP-------NVNSVFVC  207 (418)
T ss_pred             hhhhccchhh---------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcc-------cchheeee
Confidence            4444444221               111111111111110  12223334444444555543333       34444555


Q ss_pred             ccCccCcC-CcCcCCCCcccEEecccccccCCC-CccccCcCCccEEEccCCccC
Q 003065          250 ANNLTGEL-PAELGNLTLLQEFDISSNQMYGKL-PEEIGNLKNLTVFQCFKNNFS  302 (851)
Q Consensus       250 ~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~  302 (851)
                      .|.+...- ...+..++.+..|+|+.|+|...- -+.+..+++|..|.+++|.+.
T Consensus       208 e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~  262 (418)
T KOG2982|consen  208 EGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS  262 (418)
T ss_pred             cCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence            55443211 123444555556666666664321 124555566666666666554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.46  E-value=1.5e-06  Score=87.45  Aligned_cols=108  Identities=27%  Similarity=0.289  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHHcCCCCcc--ccEEEEEEeC----CeeEEEEeccCCC-CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 003065          715 VKVFAAEMEILGKIRHRNI--LKLYACLLKG----GSSFLVLEYMPNG-NLFQALHKRVKEGKPELDWFRRYKIALGAAK  787 (851)
Q Consensus       715 ~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~  787 (851)
                      .....+|...+.++....|  ++.+++.+..    ...++|+|++++. +|.+++....     ..+......++.+++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR  129 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence            4457789998888854443  4466665542    2458999999874 7888887531     1444556788999999


Q ss_pred             HHHHHHhCCCCCcEEeCCCCCCEEECCCC---ceEEeeecCccccC
Q 003065          788 GIAYLHHDCSPPIIHRDIKSSNILLDEDY---EPKIADFGVAKIAE  830 (851)
Q Consensus       788 ~l~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~  830 (851)
                      .+.-||   +.||+|+|++|.|||++.++   .+.++||+-++...
T Consensus       130 ~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  130 LIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            999999   78999999999999999886   89999999887644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.41  E-value=2.6e-07  Score=93.77  Aligned_cols=99  Identities=25%  Similarity=0.359  Sum_probs=82.4

Q ss_pred             HHHHHcCCCCccccEEEEEEeC-----CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 003065          722 MEILGKIRHRNILKLYACLLKG-----GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC  796 (851)
Q Consensus       722 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  796 (851)
                      ..-+-.+.|.|+|+++.||.+.     .+..+++|||+.|++.+++++..+ ....+....+.+++.||..||.|||.+ 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            3445566799999999988653     346789999999999999988644 344567777889999999999999976 


Q ss_pred             CCCcEEeCCCCCCEEECCCCceEEee
Q 003065          797 SPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       797 ~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      +++|+|+++..+-|++..+|-+|+.-
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~  221 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGS  221 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecc
Confidence            89999999999999999998888753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.37  E-value=1.7e-07  Score=103.47  Aligned_cols=145  Identities=20%  Similarity=0.250  Sum_probs=114.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-CCCcEEEEEEecccc--cHHH--HHHHHHHHHcC-CCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-KNAGTVAVKQLWKGD--GVKV--FAAEMEILGKI-RHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|..+..||.|.|+.|+.+... .++..|++|......  ...+  -..|+-+...+ .|.+++.++..|......|+-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            46788899999999999998766 677889999775431  1111  23566666665 588999988888887788899


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-CceEEeeecCccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKI  828 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~  828 (851)
                      -|||++++......-     ...++...++++..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||.++.
T Consensus       345 ~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             hhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            999999988766522     223556667788999999999999   8999999999999999876 7889999999864

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.36  E-value=1.9e-08  Score=89.04  Aligned_cols=107  Identities=26%  Similarity=0.319  Sum_probs=68.5

Q ss_pred             cccceeccccCccccccCCccc---CccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcE
Q 003065          385 KTIQRLRISDNHLSGKIPDGLW---ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLER  461 (851)
Q Consensus       385 ~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  461 (851)
                      ..+..+||+.+++- .+++...   ....|..++|++|.|...++..-...+.++.|+|++|+|+ .+|.++..++.|+.
T Consensus        27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~  104 (177)
T KOG4579|consen   27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS  104 (177)
T ss_pred             HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence            34677888888775 4555443   3445566677777777655555555556667777777776 56666666667777


Q ss_pred             EeccCccccCCCccccccCCcccEEEecCCccc
Q 003065          462 LILTNNNFSGKIPSALGALRQLSSLHLEENALT  494 (851)
Q Consensus       462 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  494 (851)
                      |+++.|.+. ..|..+..|.+|..||..+|.+.
T Consensus       105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             cccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            777777666 45555555666666666666654

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.35  E-value=3.2e-08  Score=97.51  Aligned_cols=181  Identities=17%  Similarity=0.204  Sum_probs=112.2

Q ss_pred             ceEEEecccCCccee----cCccccCCccCcEEeCCCC---cccCccCc-------ccccCCCCceEecccCcccCCCCC
Q 003065           74 RVTEISFDNKSLSGE----ISSSISALQSLTVLSLPFN---VLSGKLPL-------ELSNCSNLKVLNVTGNAMVGSVPD  139 (851)
Q Consensus        74 ~v~~l~l~~~~l~g~----i~~~l~~l~~L~~L~L~~n---~l~~~~p~-------~~~~l~~L~~L~Ls~n~l~~~~~~  139 (851)
                      .++++||++|.+..+    +...|.+-.+|+..+++.-   .....+|+       ++-+|++|+..+||+|.+....|.
T Consensus        31 ~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~~e  110 (388)
T COG5238          31 ELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFPE  110 (388)
T ss_pred             ceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcccch
Confidence            578899999988654    4456777788888888763   22233443       456788999999999988655443


Q ss_pred             -----CCCCCCCCeEeccCcccCCCC----ccc---------ccCccccceeecccccCCCCCCcc---cccCCCCCCeE
Q 003065          140 -----LSALKNLEIFDLSINYFTGRF----PRW---------VVNLTQLVSLSIGDNVYDEAEIPE---SIGNLKNLTYL  198 (851)
Q Consensus       140 -----l~~l~~L~~L~Ls~N~l~~~~----~~~---------~~~l~~L~~L~L~~N~l~~~~~p~---~~~~l~~L~~L  198 (851)
                           +++-+.|++|.|++|.+..+-    ..+         ..+-+.|++...+.|++..++--.   .+..-.+|+.+
T Consensus       111 ~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~v  190 (388)
T COG5238         111 ELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHENLKEV  190 (388)
T ss_pred             HHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcCceeE
Confidence                 677788899999888875222    211         223467888888888886433211   23333577788


Q ss_pred             ecccccccccCC-----cccccccccCcccccccccccccc----ccccCCCcccEEEeeccCcc
Q 003065          199 FLAHCNLRGRIP-----ESISELRELGTLDICRNKISGEFP----RSIRKLQKLWKIELYANNLT  254 (851)
Q Consensus       199 ~L~~n~l~~~~p-----~~~~~l~~L~~L~L~~N~i~~~~p----~~~~~l~~L~~L~L~~N~l~  254 (851)
                      .+..|.|.-..-     ..+..+.+|+.|||..|-++-...    .++...+.|+.|.+.+|-++
T Consensus       191 ki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls  255 (388)
T COG5238         191 KIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLS  255 (388)
T ss_pred             EeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhc
Confidence            888887762211     122345566777777776653222    23334444555555555554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	851
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		8e-49
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-34
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-48
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		9e-35
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-30
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-30
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-21
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-19
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-18
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-18
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-17
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-13
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		6e-11
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-11
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		9e-11
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		2e-05
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		1e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		1e-05
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		2e-10
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		9e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-10
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		4e-10
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		9e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-10
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		4e-10
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		6e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-10
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		5e-10
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		5e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		9e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-05
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		1e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-05
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		1e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-05
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-05
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-05
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		5e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-05
3soa_A	444	Full-Length Human Camkii Length = 444		9e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-04
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		6e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-04
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		8e-04
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		8e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-04

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  192 bits (487), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 175/559 (31%), Positives = 248/559 (44%), Gaps = 70/559 (12%)
Query: 25  PSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNK- 83
           PS SL  E   LI FK  L D + +L  W  S  +PC F G+TC     +VT I   +K 
Sbjct: 6   PSQSLYREIHQLISFKDVLPDKN-LLPDW-SSNKNPCTFDGVTCRD--DKVTSIDLSSKP 61
Query: 84  -------------------------XXXXXXXXXXXXXXXXTVLSLPFNVLSGKLPL--E 116
                                                    T L L  N LSG +     
Sbjct: 62  LNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 117 LSNCSNLKVLNVTGNAM--VGSVPDLSALKNLEIFDLSINYFTG-RFPRWVVN--LTQLV 171
           L +CS LK LNV+ N +   G V     L +LE+ DLS N  +G     WV++    +L 
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 172 SLSI-GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKIS 230
            L+I G+ +  + ++   +    NL +L ++  N    IP  + +   L  LDI  NK+S
Sbjct: 182 HLAISGNKISGDVDVSRCV----NLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLS 236
Query: 231 GEFPRSIRK----------------------LQKLWKIELYANNLTGELPAEL-GNLTLL 267
           G+F R+I                        L+ L  + L  N  TGE+P  L G    L
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTL 296
Query: 268 QEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP-SGFGDMRKLFAFSIYGNRFS 326
              D+S N  YG +P   G+   L       NNFSGE P      MR L    +  N FS
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 327 GPFPENLGRYTA-LTDVDISENQFSGSFPKYLCE--KRKXXXXXXXXXXFSGEVPNSYAD 383
           G  PE+L   +A L  +D+S N FSG     LC+  K            F+G++P + ++
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 416
Query: 384 CKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNN 443
           C  +  L +S N+LSG IP  L +L  +  L    N   G I   +    +L  L+L  N
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476
Query: 444 RFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGD 503
             +GE+PS L   TNL  + L+NN  +G+IP  +G L  L+ L L  N+ +G+IP E+GD
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 504 CARIVDLNLARNSLSGNIP 522
           C  ++ L+L  N  +G IP
Sbjct: 537 CRSLIWLDLNTNLFNGTIP 555

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  145 bits (365), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 141/536 (26%), Positives = 225/536 (41%), Gaps = 81/536 (15%)
Query: 107 NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVN 166
           N LSG     +S C+ LK+LN++ N  VG +P L  LK+L+   L+ N FTG  P ++  
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSG 291
Query: 167 LTQ-LVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP-ESISELRELGTLDI 224
               L  L +  N +  A +P   G+   L  L L+  N  G +P +++ ++R L  LD+
Sbjct: 292 ACDTLTGLDLSGNHFYGA-VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350
Query: 225 CRNKISGEFPRSIRKLQ-KLWKIELYANNL--------------------------TGEL 257
             N+ SGE P S+  L   L  ++L +NN                           TG++
Sbjct: 351 SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410
Query: 258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFA 317
           P  L N + L    +S N + G +P  +G+L  L   + + N   GE P     ++ L  
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470
Query: 318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEV 377
             +  N  +G  P  L   T L  + +S N+ +G  PK++               FSG +
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 378 PNSYADCKTIQRLRISDNHLSGKIPDGLWA-----------------LPNVGMLDFGDND 420
           P    DC+++  L ++ N  +G IP  ++                  + N GM    +  
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK--ECH 588
Query: 421 FTGGISPLIGL-STSLSQLVLQN------NRFSGELPSELGRLTNLERLILTNNNFSGKI 473
             G +    G+ S  L++L  +N        + G          ++  L ++ N  SG I
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648
Query: 474 PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRXXXXXXXXXX 533
           P  +G++  L  L+L  N ++GSIP+E+GD   +  L+L+ N L G IP+          
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM--- 705
Query: 534 XXXXXXXXTGSIPDNLMKLKLSSIDLSENQLSGSVP-LDFLRMGGDGAFAGNEGLC 588
                               L+ IDLS N LSG +P +          F  N GLC
Sbjct: 706 --------------------LTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  190 bits (482), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 174/558 (31%), Positives = 247/558 (44%), Gaps = 70/558 (12%)
Query: 26  SLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNK-- 83
           S SL  E   LI FK  L D + +L  W  S  +PC F G+TC     +VT I   +K  
Sbjct: 4   SQSLYREIHQLISFKDVLPDKN-LLPDW-SSNKNPCTFDGVTCRD--DKVTSIDLSSKPL 59
Query: 84  ------------------------XXXXXXXXXXXXXXXXTVLSLPFNVLSGKLPL--EL 117
                                                   T L L  N LSG +     L
Sbjct: 60  NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSL 119
Query: 118 SNCSNLKVLNVTGNAM--VGSVPDLSALKNLEIFDLSINYFTG-RFPRWVVN--LTQLVS 172
            +CS LK LNV+ N +   G V     L +LE+ DLS N  +G     WV++    +L  
Sbjct: 120 GSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 179
Query: 173 LSI-GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISG 231
           L+I G+ +  + ++   +    NL +L ++  N    IP  + +   L  LDI  NK+SG
Sbjct: 180 LAISGNKISGDVDVSRCV----NLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSG 234
Query: 232 EFPRSIRK----------------------LQKLWKIELYANNLTGELPAEL-GNLTLLQ 268
           +F R+I                        L+ L  + L  N  TGE+P  L G    L 
Sbjct: 235 DFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLT 294
Query: 269 EFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP-SGFGDMRKLFAFSIYGNRFSG 327
             D+S N  YG +P   G+   L       NNFSGE P      MR L    +  N FSG
Sbjct: 295 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 354
Query: 328 PFPENLGRYTA-LTDVDISENQFSGSFPKYLCE--KRKXXXXXXXXXXFSGEVPNSYADC 384
             PE+L   +A L  +D+S N FSG     LC+  K            F+G++P + ++C
Sbjct: 355 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 414
Query: 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNR 444
             +  L +S N+LSG IP  L +L  +  L    N   G I   +    +L  L+L  N 
Sbjct: 415 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 474
Query: 445 FSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC 504
            +GE+PS L   TNL  + L+NN  +G+IP  +G L  L+ L L  N+ +G+IP E+GDC
Sbjct: 475 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 534
Query: 505 ARIVDLNLARNSLSGNIP 522
             ++ L+L  N  +G IP
Sbjct: 535 RSLIWLDLNTNLFNGTIP 552

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  145 bits (366), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 141/536 (26%), Positives = 225/536 (41%), Gaps = 81/536 (15%)
Query: 107 NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVN 166
           N LSG     +S C+ LK+LN++ N  VG +P L  LK+L+   L+ N FTG  P ++  
Sbjct: 230 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSG 288
Query: 167 LTQ-LVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP-ESISELRELGTLDI 224
               L  L +  N +  A +P   G+   L  L L+  N  G +P +++ ++R L  LD+
Sbjct: 289 ACDTLTGLDLSGNHFYGA-VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 347
Query: 225 CRNKISGEFPRSIRKLQ-KLWKIELYANNL--------------------------TGEL 257
             N+ SGE P S+  L   L  ++L +NN                           TG++
Sbjct: 348 SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 407
Query: 258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFA 317
           P  L N + L    +S N + G +P  +G+L  L   + + N   GE P     ++ L  
Sbjct: 408 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 467
Query: 318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEV 377
             +  N  +G  P  L   T L  + +S N+ +G  PK++               FSG +
Sbjct: 468 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 527
Query: 378 PNSYADCKTIQRLRISDNHLSGKIPDGLWA-----------------LPNVGMLDFGDND 420
           P    DC+++  L ++ N  +G IP  ++                  + N GM    +  
Sbjct: 528 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK--ECH 585
Query: 421 FTGGISPLIGL-STSLSQLVLQN------NRFSGELPSELGRLTNLERLILTNNNFSGKI 473
             G +    G+ S  L++L  +N        + G          ++  L ++ N  SG I
Sbjct: 586 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 645
Query: 474 PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRXXXXXXXXXX 533
           P  +G++  L  L+L  N ++GSIP+E+GD   +  L+L+ N L G IP+          
Sbjct: 646 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM--- 702
Query: 534 XXXXXXXXTGSIPDNLMKLKLSSIDLSENQLSGSVP-LDFLRMGGDGAFAGNEGLC 588
                               L+ IDLS N LSG +P +          F  N GLC
Sbjct: 703 --------------------LTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 738

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 74/177 (41%), Positives = 105/177 (59%), Gaps = 6/177 (3%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNI 733
           N    N++G GG GKVY+  L  +   VAVK+L +     G   F  E+E++    HRN+
Sbjct: 39  NFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNL 97
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           L+L    +      LV  YM NG++   L +R  E +P LDW +R +IALG+A+G+AYLH
Sbjct: 98  LRLRGFCMTPTERLLVYPYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLH 156
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             C P IIHRD+K++NILLDE++E  + DFG+AK+  +           GT G+IAP
Sbjct: 157 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXHVXXAVRGTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  129 bits (323), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 73/177 (41%), Positives = 104/177 (58%), Gaps = 6/177 (3%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNI 733
           N    N++G GG GKVY+  L  +   VAVK+L +     G   F  E+E++    HRN+
Sbjct: 31  NFXNKNILGRGGFGKVYKGRLA-DGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 89
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           L+L    +      LV  YM NG++   L +R  E +P LDW +R +IALG+A+G+AYLH
Sbjct: 90  LRLRGFCMTPTERLLVYPYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             C P IIHRD+K++NILLDE++E  + DFG+AK+  +           G  G+IAP
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXHVXXAVRGXIGHIAP 204

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/175 (40%), Positives = 96/175 (54%), Gaps = 13/175 (7%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV------FAAEMEILGKIRHRNILK 735
           N +G GG G VY+  +  N  TVAVK+L     +        F  E++++ K +H N+++
Sbjct: 37  NKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           L      G    LV  YMPNG+L   L     +G P L W  R KIA GAA GI +LH +
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                IHRDIKS+NILLDE +  KI+DFG+A+ +E   +    S   GT  Y+AP
Sbjct: 153 HH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/175 (40%), Positives = 95/175 (54%), Gaps = 13/175 (7%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV------FAAEMEILGKIRHRNILK 735
           N +G GG G VY+  +  N  TVAVK+L     +        F  E++++ K +H N+++
Sbjct: 37  NKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           L      G    LV  YMPNG+L   L     +G P L W  R KIA GAA GI +LH +
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                IHRDIKS+NILLDE +  KI+DFG+A+ +E   +        GT  Y+AP
Sbjct: 153 HH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/175 (40%), Positives = 95/175 (54%), Gaps = 13/175 (7%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV------FAAEMEILGKIRHRNILK 735
           N +G GG G VY+  +  N  TVAVK+L     +        F  E++++ K +H N+++
Sbjct: 31  NKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 88
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           L      G    LV  YMPNG+L   L     +G P L W  R KIA GAA GI +LH +
Sbjct: 89  LLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCKIAQGAANGINFLHEN 146
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                IHRDIKS+NILLDE +  KI+DFG+A+ +E   +        GT  Y+AP
Sbjct: 147 HH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (263), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 70/175 (40%), Positives = 92/175 (52%), Gaps = 13/175 (7%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV------FAAEMEILGKIRHRNILK 735
           N  G GG G VY+  +  N  TVAVK+L     +        F  E+++  K +H N+++
Sbjct: 28  NKXGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVE 85
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           L      G    LV  Y PNG+L   L     +G P L W  R KIA GAA GI +LH +
Sbjct: 86  LLGFSSDGDDLCLVYVYXPNGSLLDRL--SCLDGTPPLSWHXRCKIAQGAANGINFLHEN 143
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                IHRDIKS+NILLDE +  KI+DFG+A+ +E   +    S   GT  Y AP
Sbjct: 144 HH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/179 (35%), Positives = 102/179 (56%), Gaps = 11/179 (6%)
Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHR 731
           C+L     IG+G  G V+R +   +   VAVK L + D     V  F  E+ I+ ++RH 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           NI+     + +  +  +V EY+  G+L++ LHK     + +LD  RR  +A   AKG+ Y
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNY 152
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH+  +PPI+HRD+KS N+L+D+ Y  K+ DFG++++  +    S  +  AGT  ++AP
Sbjct: 153 LHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA--AGTPEWMAP 208

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 64/179 (35%), Positives = 104/179 (58%), Gaps = 11/179 (6%)
Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHR 731
           C+L     IG+G  G V+R +   +   VAVK L + D     V  F  E+ I+ ++RH 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           NI+     + +  +  +V EY+  G+L++ LHK     + +LD  RR  +A   AKG+ Y
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNY 152
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH+  +PPI+HR++KS N+L+D+ Y  K+ DFG++++ + S  +S  S  AGT  ++AP
Sbjct: 153 LHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSA-AGTPEWMAP 208

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/184 (36%), Positives = 99/184 (53%), Gaps = 8/184 (4%)
Query: 670 IDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW--KGDGVKVFAAEMEILG 726
           +D E+  N  +   LIG G  GKVY+  L+  A  VA+K+       G++ F  E+E L 
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA-KVALKRRTPESSQGIEEFETEIETLS 90
Query: 727 KIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
             RH +++ L     +     L+ +YM NGNL + L+         + W +R +I +GAA
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAA 149
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
           +G+ YLH   +  IIHRD+KS NILLDE++ PKI DFG++K      +        GT G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 847 YIAP 850
           YI P
Sbjct: 207 YIDP 210

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/184 (36%), Positives = 99/184 (53%), Gaps = 8/184 (4%)
Query: 670 IDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW--KGDGVKVFAAEMEILG 726
           +D E+  N  +   LIG G  GKVY+  L+  A  VA+K+       G++ F  E+E L 
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA-KVALKRRTPESSQGIEEFETEIETLS 90
Query: 727 KIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
             RH +++ L     +     L+ +YM NGNL + L+         + W +R +I +GAA
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAA 149
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
           +G+ YLH   +  IIHRD+KS NILLDE++ PKI DFG++K      +        GT G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 847 YIAP 850
           YI P
Sbjct: 207 YIDP 210

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 140/305 (45%), Gaps = 24/305 (7%)
Query: 32  ETQALIQFKSKLKDPHGVLDSWKESADSPCGFS--GITCDSVTGRVTEISFDNKXXXXXX 89
           + QAL+Q K  L +P   L SW  + D  C  +  G+ CD+ T    +    N       
Sbjct: 7   DKQALLQIKKDLGNPT-TLSSWLPTTDC-CNRTWLGVLCDTDT----QTYRVNNLDLSGL 60
Query: 90  XXXXXXXXXXTVLSLPF---------NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD- 139
                     ++ +LP+         N L G +P  ++  + L  L +T   + G++PD 
Sbjct: 61  NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 140 LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNL-TYL 198
           LS +K L   D S N  +G  P  + +L  LV ++   N    A IP+S G+   L T +
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA-IPDSYGSFSKLFTSM 179
Query: 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
            ++   L G+IP + + L  L  +D+ RN + G+        +   KI L  N+L  +L 
Sbjct: 180 TISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL- 237
Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
            ++G    L   D+ +N++YG LP+ +  LK L       NN  GE P G G++++ F  
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQR-FDV 295
Query: 319 SIYGN 323
           S Y N
Sbjct: 296 SAYAN 300

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 7/235 (2%)
Query: 160 FPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL 219
            P  + NL  L  L IG        IP +I  L  L YL++ H N+ G IP+ +S+++ L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 220 GTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLT-LLQEFDISSNQMY 278
            TLD   N +SG  P SI  L  L  I    N ++G +P   G+ + L     IS N++ 
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 279 GKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338
           GK+P    NL NL      +N   G+    FG  +      +  N  +    + +G    
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKN 245
Query: 339 LTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRIS 393
           L  +D+  N+  G+ P+ L + +             GE+P        +QR  +S
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG----GNLQRFDVS 296

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 94/241 (39%), Gaps = 26/241 (10%)
Query: 281 LPEEIGNLKNLT-VFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTAL 339
           +P  + NL  L  ++    NN  G  P     + +L    I     SG  P+ L +   L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 340 TDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYAD-CKTIQRLRISDNHLS 398
             +D S N  SG+ P  +                SG +P+SY    K    + IS N L+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISPL-----------------------IGLSTSL 435
           GKIP     L N+  +D   N   G  S L                       +GLS +L
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246
Query: 436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTG 495
           + L L+NNR  G LP  L +L  L  L ++ NN  G+IP      R   S +     L G
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
Query: 496 S 496
           S
Sbjct: 307 S 307

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 15/222 (6%)
Query: 375 GEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTS 434
           G +P + A    +  L I+  ++SG IPD L  +  +  LDF  N  +G + P I    +
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 435 LSQLVLQNNRFSGELPSELGRLTNL-ERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
           L  +    NR SG +P   G  + L   + ++ N  +GKIP     L  L+ + L  N L
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209
Query: 494 TGSIPNEMGDCARIVDLNLARNSLSGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLK 553
            G      G       ++LA+NSL+ ++ +                   G++P  L +LK
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY-GTLPQGLTQLK 268
Query: 554 -LSSIDLSENQLSGSVPLDFLRMGGD------GAFAGNEGLC 588
            L S+++S N L G +P      GG+       A+A N+ LC
Sbjct: 269 FLHSLNVSFNNLCGEIP-----QGGNLQRFDVSAYANNKCLC 305

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 98/187 (52%), Gaps = 26/187 (13%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---------VKVFAAEMEILGKI 728
           +E +  IG GG G V++  L K+   VA+K L  GD           + F  E+ I+  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H NI+KLY   L      +V+E++P G+L+   H+ + +  P + W  + ++ L  A G
Sbjct: 81  NHPNIVKLYG--LMHNPPRMVMEFVPCGDLY---HRLLDKAHP-IKWSVKLRLMLDIALG 134
Query: 789 IAYLHHDCSPPIIHRDIKSSNIL---LDEDYE--PKIADFGVAKIAENSPKVSDYSCFAG 843
           I Y+ +  +PPI+HRD++S NI    LDE+     K+ADFG+++ +     V   S   G
Sbjct: 135 IEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLLG 188
Query: 844 THGYIAP 850
              ++AP
Sbjct: 189 NFQWMAP 195

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 97/187 (51%), Gaps = 26/187 (13%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---------VKVFAAEMEILGKI 728
           +E +  IG GG G V++  L K+   VA+K L  GD           + F  E+ I+  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H NI+KLY   L      +V+E++P G+L+   H+ + +  P + W  + ++ L  A G
Sbjct: 81  NHPNIVKLYG--LMHNPPRMVMEFVPCGDLY---HRLLDKAHP-IKWSVKLRLMLDIALG 134
Query: 789 IAYLHHDCSPPIIHRDIKSSNIL---LDEDYE--PKIADFGVAKIAENSPKVSDYSCFAG 843
           I Y+ +  +PPI+HRD++S NI    LDE+     K+ADFG ++ +     V   S   G
Sbjct: 135 IEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-----VHSVSGLLG 188
Query: 844 THGYIAP 850
              ++AP
Sbjct: 189 NFQWMAP 195

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 97/187 (51%), Gaps = 26/187 (13%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---------VKVFAAEMEILGKI 728
           +E +  IG GG G V++  L K+   VA+K L  GD           + F  E+ I+  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H NI+KLY   L      +V+E++P G+L+   H+ + +  P + W  + ++ L  A G
Sbjct: 81  NHPNIVKLYG--LMHNPPRMVMEFVPCGDLY---HRLLDKAHP-IKWSVKLRLMLDIALG 134
Query: 789 IAYLHHDCSPPIIHRDIKSSNIL---LDEDYE--PKIADFGVAKIAENSPKVSDYSCFAG 843
           I Y+ +  +PPI+HRD++S NI    LDE+     K+ADF +++ +     V   S   G
Sbjct: 135 IEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-----VHSVSGLLG 188
Query: 844 THGYIAP 850
              ++AP
Sbjct: 189 NFQWMAP 195

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 646 SADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVA 705
           SA   N E+E++SK K           E   + E    +G G  G VY    K++   +A
Sbjct: 7   SAPENNPEEELASKQKNEESKKRQWALE---DFEIGRPLGKGKFGNVYLAREKQSKFILA 63
Query: 706 VKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
           +K L+K    K         E+EI   +RH NIL+LY         +L+LEY P G +++
Sbjct: 64  LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 123
Query: 761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820
            L K  K      D  R        A  ++Y H   S  +IHRDIK  N+LL    E KI
Sbjct: 124 ELQKLSK-----FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKI 175
Query: 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           ADFG +  A +S + +      GT  Y+ P
Sbjct: 176 ADFGWSVHAPSSRRTT----LCGTLDYLPP 201

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSK-----FDEQRTATYITELANALSYCH---SK 132
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 180

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 144
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 145 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 192

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 51/208 (24%)
Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA------- 720
           ++ID  ++  LEE  +IG GG GKVYR               W GD V V AA       
Sbjct: 2   LEIDFAEL-TLEE--IIGIGGFGKVYR-------------AFWIGDEVAVKAARHDPDED 45
Query: 721 ----------EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK 770
                     E ++   ++H NI+ L    LK  +  LV+E+   G L + L  +     
Sbjct: 46  ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPD 105
Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP--------KIAD 822
             ++W      A+  A+G+ YLH +   PIIHRD+KSSNIL+ +  E         KI D
Sbjct: 106 ILVNW------AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159
Query: 823 FGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           FG+A+    + K+S     AG + ++AP
Sbjct: 160 FGLAREWHRTTKMSA----AGAYAWMAP 183

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 130
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 178

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 127
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 175

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 646 SADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVA 705
           SA   N E+E++SK K           E   + E    +G G  G VY    K++   +A
Sbjct: 7   SAPENNPEEELASKQKNEESKKRQWALE---DFEIGRPLGKGKFGNVYLAREKQSKFILA 63
Query: 706 VKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
           +K L+K    K         E+EI   +RH NIL+LY         +L+LEY P G +++
Sbjct: 64  LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 123
Query: 761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820
            L K  K      D  R        A  ++Y H   S  +IHRDIK  N+LL    E KI
Sbjct: 124 ELQKLSK-----FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKI 175
Query: 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           ADFG +  A +S +  D  C  GT  Y+ P
Sbjct: 176 ADFGWSVHAPSSRR--DDLC--GTLDYLPP 201

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 132
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 180

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 128
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +     +GT  Y+ P
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTT----LSGTLDYLPP 176

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 132
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 180

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 130
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +    +   GT  Y+ P
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPP 178

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 127
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +        GT  Y+ P
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTE----LCGTLDYLPP 175

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 130
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 178

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSK-----FDEQRTATYITELANALSYCH---SK 132
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +        GT  Y+ P
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX----LXGTLDYLPP 180

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 126
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 127 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 174

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 131
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 132 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 179

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 128
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +  D  C  GT  Y+ P
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--DTLC--GTLDYLPP 176

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K+    +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 124
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 125 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 172

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 128
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +        GT  Y+ P
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPP 176

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 127
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +        GT  Y+ P
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPP 175

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 127
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +    +   GT  Y+ P
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPP 175

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 132
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +        GT  Y+ P
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPP 180

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 127
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +        GT  Y+ P
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPP 175

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 127
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +    +   GT  Y+ P
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLDYLPP 175

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 129
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +        GT  Y+ P
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX----LCGTLDYLPP 177

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K +   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 127
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +    +   GT  Y+ P
Sbjct: 128 KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPP 175

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 130
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +  D  C  GT  Y+ P
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--DDLC--GTLDYLPP 178

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    +++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  +      D  R        A  ++Y H   S 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-----FDEQRTATYITELANALSYCH---SK 131
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL  + E KIADFG +  A +S + +      GT  Y+ P
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 179

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 129
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIA+FG +  A +S + +      GT  Y+ P
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT----LCGTLDYLPP 177

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 130
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +        GT  Y+ P
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX----LCGTLDYLPP 178

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 85/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 16  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 71
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH  + E K E+   +   IA   A+G+ YLH   +  
Sbjct: 72  YSTAPQLAIVTQWCEGSSLYHHLH--IIETKFEM--IKLIDIARQTAQGMDYLH---AKS 124
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A +         +   +G+  ++AP
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 127
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIADFG +  A +S +        GT  Y+ P
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX----LCGTLDYLPP 175

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 90/184 (48%), Gaps = 16/184 (8%)
Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ-----LWKGDGVKVFAAEMEILGK 727
           E+I + +  NL+G G    VYR +       VA+K      ++K   V+    E++I  +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAA 786
           ++H +IL+LY         +LVLE   NG + + L  RVK   + E   F    I     
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT---- 123
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
            G+ YLH   S  I+HRD+  SN+LL  +   KIADFG+A   +  P    Y+   GT  
Sbjct: 124 -GMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK-MPHEKHYT-LCGTPN 177
Query: 847 YIAP 850
           YI+P
Sbjct: 178 YISP 181

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 102/194 (52%), Gaps = 19/194 (9%)
Query: 666 HHIDIDAEQI--CNLEEDNLIGSGGTGKVY--RLDLKKNAGTVAVKQLWKGDGVKV---- 717
           HH+   +E+    + E   ++G G  GKV+  R   + ++G +   ++ K   +KV    
Sbjct: 16  HHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRV 75
Query: 718 -FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF 776
               E +IL  + H  ++KL+      G  +L+L+++  G+LF  L K V   + ++ ++
Sbjct: 76  RTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY 135
Query: 777 RRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
              ++ALG       L H  S  II+RD+K  NILLDE+   K+ DFG++K A +  K +
Sbjct: 136 LA-ELALG-------LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKA 187
Query: 837 DYSCFAGTHGYIAP 850
            YS F GT  Y+AP
Sbjct: 188 -YS-FCGTVEYMAP 199

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  K      D  R        A  ++Y H   S 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH---SK 130
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL    E KIA+FG +  A +S + +      GT  Y+ P
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT----LCGTLDYLPP 178

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    +++   +A+K L+K    K         E+EI   +RH NIL+LY 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LEY P G +++ L K  +      D  R        A  ++Y H   S 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-----FDEQRTATYITELANALSYCH---SK 131
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+LL  + E KIADFG +  A +S +  D  C  GT  Y+ P
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR--DTLC--GTLDYLPP 179

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 682 NLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILK 735
           ++IG G  G+V +  +KK+     A    +K+    D  + FA E+E+L K+  H NI+ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPE----------LDWFRRYKIALG 784
           L       G  +L +EY P+GNL   L K RV E  P           L   +    A  
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
            A+G+ YL        IHRD+ + NIL+ E+Y  KIADFG+++  E
Sbjct: 141 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE 183

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 682 NLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILK 735
           ++IG G  G+V +  +KK+     A    +K+    D  + FA E+E+L K+  H NI+ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPE----------LDWFRRYKIALG 784
           L       G  +L +EY P+GNL   L K RV E  P           L   +    A  
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
            A+G+ YL        IHRD+ + NIL+ E+Y  KIADFG+++  E
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE 193

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 87/166 (52%), Gaps = 14/166 (8%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           +    +IG+G  G+VY+  LK ++G     VA+K L  G   K    F  E  I+G+  H
Sbjct: 46  VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     ++ EYM NG    AL K ++E   E    +   +  G A G+ 
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENG----ALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL    +   +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 85/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 43  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 98
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH  + E K E+   +   IA   A+G+ YLH   +  
Sbjct: 99  YSTKPQLAIVTQWCEGSSLYHHLH--IIETKFEM--IKLIDIARQTAQGMDYLH---AKS 151
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A +         +   +G+  ++AP
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 85/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 21  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 76
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH  + E K E+   +   IA   A+G+ YLH   +  
Sbjct: 77  YSTKPQLAIVTQWCEGSSLYHHLH--IIETKFEM--IKLIDIARQTAQGMDYLH---AKS 129
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A +         +   +G+  ++AP
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 85/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 44  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 99
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH  + E K E+   +   IA   A+G+ YLH   +  
Sbjct: 100 YSTKPQLAIVTQWCEGSSLYHHLH--IIETKFEM--IKLIDIARQTAQGMDYLH---AKS 152
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A +         +   +G+  ++AP
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 85/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 16  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 71
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH  + E K E+   +   IA   A+G+ YLH   +  
Sbjct: 72  YSTKPQLAIVTQWCEGSSLYHHLH--IIETKFEM--IKLIDIARQTAQGMDYLH---AKS 124
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A +         +   +G+  ++AP
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 85/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 21  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 76
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH  + E K E+   +   IA   A+G+ YLH   +  
Sbjct: 77  YSTKPQLAIVTQWCEGSSLYHHLH--IIETKFEM--IKLIDIARQTAQGMDYLH---AKS 129
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A +         +   +G+  ++AP
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 85/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 18  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 73
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH  + E K E+   +   IA   A+G+ YLH   +  
Sbjct: 74  YSTKPQLAIVTQWCEGSSLYHHLH--IIETKFEM--IKLIDIARQTAQGMDYLH---AKS 126
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A +         +   +G+  ++AP
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 87/171 (50%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L   D      + F  E+ +L K RH NIL L+  
Sbjct: 44  IGSGSFGTVYK---GKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFMG 99
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
            +   +  +V ++    +L++ LH  V+E K ++  F+   IA   A+G+ YLH   +  
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYKHLH--VQETKFQM--FQLIDIARQTAQGMDYLH---AKN 152
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L E    KI DFG+A +              G+  ++AP
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/165 (35%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 664 SFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEME 723
           S H ID        +E + ++G G  G V +   K  A  VA+KQ+      K F  E+ 
Sbjct: 2   SLHMIDYK-----EIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAFIVELR 54
Query: 724 ILGKIRHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            L ++ H NI+KLY ACL       LV+EY   G+L+  LH    E  P           
Sbjct: 55  QLSRVNHPNIVKLYGACL---NPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWC 109
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVA 826
           L  ++G+AYLH      +IHRD+K  N+LL       KI DFG A
Sbjct: 110 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 84/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 20  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 75
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH    E K E+   +   IA   A+G+ YLH   +  
Sbjct: 76  YSTKPQLAIVTQWCEGSSLYHHLH--ASETKFEMK--KLIDIARQTARGMDYLH---AKS 128
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A +         +   +G+  ++AP
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/165 (35%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 664 SFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEME 723
           S H ID        +E + ++G G  G V +   K  A  VA+KQ+      K F  E+ 
Sbjct: 1   SLHMIDYK-----EIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAFIVELR 53
Query: 724 ILGKIRHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            L ++ H NI+KLY ACL       LV+EY   G+L+  LH    E  P           
Sbjct: 54  QLSRVNHPNIVKLYGACL---NPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWC 108
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVA 826
           L  ++G+AYLH      +IHRD+K  N+LL       KI DFG A
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 91/178 (51%), Gaps = 31/178 (17%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----------WKGDGVKVFAAEMEILGKIRHRNI 733
           IG G  G VY     +N+  VA+K++          W+ D +K    E+  L K+RH N 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIK----EVRFLQKLRHPNT 77
Query: 734 LKLYACLLKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           ++   C L+  +++LV+EY + + +    +HK     KP L       +  GA +G+AYL
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KP-LQEVEIAAVTHGALQGLAYL 131
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  +IHRD+K+ NILL E    K+ DFG A I      ++  + F GT  ++AP
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAP 180

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 91/178 (51%), Gaps = 31/178 (17%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----------WKGDGVKVFAAEMEILGKIRHRNI 733
           IG G  G VY     +N+  VA+K++          W+ D +K    E+  L K+RH N 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIK----EVRFLQKLRHPNT 116
Query: 734 LKLYACLLKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           ++   C L+  +++LV+EY + + +    +HK     KP L       +  GA +G+AYL
Sbjct: 117 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KP-LQEVEIAAVTHGALQGLAYL 170
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  +IHRD+K+ NILL E    K+ DFG A I      ++  + F GT  ++AP
Sbjct: 171 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAP 219

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/166 (33%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 682 NLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILK 735
           ++IG G  G+V +  +KK+     A    +K+    D  + FA E+E+L K+  H NI+ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPE----------LDWFRRYKIALG 784
           L       G  +L +EY P+GNL   L K RV E  P           L   +    A  
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
            A+G+ YL        IHR++ + NIL+ E+Y  KIADFG+++  E
Sbjct: 148 VARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQE 190

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 84/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 36  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 91
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH  + E K E+   +   IA   A+G+ YLH   +  
Sbjct: 92  YSTKPQLAIVTQWCEGSSLYHHLH--IIETKFEM--IKLIDIARQTAQGMDYLH---AKS 144
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A           +   +G+  ++AP
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 84/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 44  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 99
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH  + E K E+   +   IA   A+G+ YLH   +  
Sbjct: 100 YSTKPQLAIVTQWCEGSSLYHHLH--IIETKFEM--IKLIDIARQTAQGMDYLH---AKS 152
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A           +   +G+  ++AP
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 84/171 (49%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 16  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 71
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH  + E K E+   +   IA   A+G+ YLH   +  
Sbjct: 72  YSTKPQLAIVTQWCEGSSLYHHLH--IIETKFEM--IKLIDIARQTAQGMDYLH---AKS 124
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A           +   +G+  ++AP
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 83/171 (48%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 32  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 87
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH    E K E+   +   IA   A+G+ YLH   +  
Sbjct: 88  YSTAPQLAIVTQWCEGSSLYHHLH--ASETKFEMK--KLIDIARQTARGMDYLH---AKS 140
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A           +   +G+  ++AP
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 84/175 (48%), Gaps = 18/175 (10%)
Query: 683 LIGSGGTGKVY----RLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYA 738
           ++G G  G+V     R+  ++ A  V  K   K         E+E+L K+ H NI+KL+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
            L    S ++V E    G LF  + KR +    E D  R  K       GI Y+H     
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFS---GITYMH---KH 140
Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRD+K  NILL   ++D + KI DFG++   + + K+ D     GT  YIAP
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAP 192

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI 728
           +I + E   ++G G  GKV+  + KK     A+K L K      D V+    E  +L   
Sbjct: 16  KIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 729 RHRNILKLYACLLKGGSS-FLVLEYMPNGNLF---QALHKRVKEGKPELDWFRRYKIALG 784
                L    C  +   + F V+EY+  G+L    Q+ HK         D  R    A  
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--------FDLSRATFYAAE 127
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
              G+ +LH   S  I++RD+K  NILLD+D   KIADFG+ K  EN    +  + F GT
Sbjct: 128 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGT 182
Query: 845 HGYIAP 850
             YIAP
Sbjct: 183 PDYIAP 188

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 18/172 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEME-----ILGKIRHRNILKLYA 738
           +G+G  G+V+ +  + N    A+K L K   V++   E       +L  + H  I++++ 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   F++++Y+  G LF  L K  +   P   ++     A      + YLH   S 
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALEYLH---SK 125
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            II+RD+K  NILLD++   KI DFG AK     P V+   C  GT  YIAP
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYXLC--GTPDYIAP 172

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 83/171 (48%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IGSG  G VY+    K  G VAVK L         ++ F  E+ +L K RH NIL L+  
Sbjct: 32  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 87
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                   +V ++    +L+  LH    E K E+   +   IA   A+G+ YLH   +  
Sbjct: 88  YSTKPQLAIVTQWCEGSSLYHHLH--ASETKFEMK--KLIDIARQTARGMDYLH---AKS 140
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+KS+NI L ED   KI DFG+A           +   +G+  ++AP
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V EYM NG+L   L K       +    +   +  G A G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 161
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG+A++ E+ P+ +
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 81/177 (45%), Gaps = 22/177 (12%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
           ++G G  GKV+  + KK     A+K L K      D V+    E  +L        L   
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 738 ACLLKGGSS-FLVLEYMPNGNLF---QALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            C  +   + F V+EY+  G+L    Q+ HK         D  R    A     G+ +LH
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--------FDLSRATFYAAEIILGLQFLH 135
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  I++RD+K  NILLD+D   KIADFG+ K  EN    +  + F GT  YIAP
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAP 187

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V     K     VAVK+  L K    ++   E+ I+    H N++ +Y+  L
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++V+E++  G L   + H R+ E +          + L   + ++YLH+     +
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLHNQG---V 162
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS +ILL  D   K++DFG    A+ S +V       GT  ++AP
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKXLVGTPYWMAP 210

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 661 KLASFHHIDIDAEQI--CNLEEDNLIGSGGTGKVYRLDLKKNAGT-----VAVKQLWKG- 712
           ++A  HH+    E+      E   ++G G  GKV+ +  KK +G+      A+K L K  
Sbjct: 7   EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLV--KKISGSDARQLYAMKVLKKAT 64
Query: 713 ----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE 768
               D V+    E +IL ++ H  I+KL+      G  +L+L+++  G+LF  L K V  
Sbjct: 65  LKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-- 121
Query: 769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
                  F    +    A+    L H  S  II+RD+K  NILLDE+   K+ DFG++K 
Sbjct: 122 ------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175
Query: 829 AENSPKVSDYSCFAGTHGYIAP 850
           + +  K + YS F GT  Y+AP
Sbjct: 176 SIDHEKKA-YS-FCGTVEYMAP 195

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 661 KLASFHHIDIDAEQI--CNLEEDNLIGSGGTGKVYRLDLKKNAGT-----VAVKQLWKG- 712
           ++A  HH+    E+      E   ++G G  GKV+ +  KK +G+      A+K L K  
Sbjct: 7   EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLV--KKISGSDARQLYAMKVLKKAT 64
Query: 713 ----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE 768
               D V+    E +IL ++ H  I+KL+      G  +L+L+++  G+LF  L K V  
Sbjct: 65  LKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-- 121
Query: 769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
                  F    +    A+    L H  S  II+RD+K  NILLDE+   K+ DFG++K 
Sbjct: 122 ------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175
Query: 829 AENSPKVSDYSCFAGTHGYIAP 850
           + +  K + YS F GT  Y+AP
Sbjct: 176 SIDHEKKA-YS-FCGTVEYMAP 195

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V EYM NG+L   L K       +    +   +  G A G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 161
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 162 YL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 84/150 (56%), Gaps = 8/150 (5%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +    N+  VAVK L  G   V+ F  E  ++  ++H  +++LYA + +
Sbjct: 21  LGAGQFGEVW-MGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM  G+L   L K  + GK  L   +    +   A+G+AY+        IH
Sbjct: 80  EEPIYIITEYMAKGSLLDFL-KSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIH 133
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++N+L+ E    KIADFG+A++ E++
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDN 163

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 661 KLASFHHIDIDAEQI--CNLEEDNLIGSGGTGKVYRLDLKKNAGT-----VAVKQLWKG- 712
           ++A  HH+    E+      E   ++G G  GKV+ +  KK +G+      A+K L K  
Sbjct: 8   EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLV--KKISGSDARQLYAMKVLKKAT 65
Query: 713 ----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE 768
               D V+    E +IL ++ H  I+KL+      G  +L+L+++  G+LF  L K V  
Sbjct: 66  LKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-- 122
Query: 769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
                  F    +    A+    L H  S  II+RD+K  NILLDE+   K+ DFG++K 
Sbjct: 123 ------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 176
Query: 829 AENSPKVSDYSCFAGTHGYIAP 850
           + +  K + YS F GT  Y+AP
Sbjct: 177 SIDHEKKA-YS-FCGTVEYMAP 196

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 18/175 (10%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYA 738
           ++G G  G+V +   +      AVK + K             E+E+L K+ H NI+KL+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
            L    S ++V E    G LF  + KR +  + +       +I      GI Y+H     
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----RIIKQVFSGITYMH---KH 140
Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRD+K  NILL   ++D + KI DFG++   + + K+ D     GT  YIAP
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAP 192

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 18/175 (10%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYA 738
           ++G G  G+V +   +      AVK + K             E+E+L K+ H NI+KL+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
            L    S ++V E    G LF  + KR +  + +       +I      GI Y+H     
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----RIIKQVFSGITYMH---KH 140
Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRD+K  NILL   ++D + KI DFG++   + + K+ D     GT  YIAP
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAP 192

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V EYM NG+L   L K       +    +   +  G A G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 161
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 84/150 (56%), Gaps = 8/150 (5%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +    N+  VAVK L  G   V+ F  E  ++  ++H  +++LYA + K
Sbjct: 20  LGAGQFGEVW-MGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ E+M  G+L   L K  + GK  L   +    +   A+G+AY+        IH
Sbjct: 79  EEPIYIITEFMAKGSLLDFL-KSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIH 132
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++N+L+ E    KIADFG+A++ E++
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDN 162

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V EYM NG+L   L K       +    +   +  G A G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 161
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V EYM NG+L   L K       +    +   +  G A G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 161
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +G   K    E++I+ K+ H
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK--NRELQIMRKLDH 72
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 131
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVSDYSCF 841
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS Y C 
Sbjct: 132 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC- 184
Query: 842 AGTHGYIAP 850
             +  Y AP
Sbjct: 185 --SRYYRAP 191

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V EYM NG+L   L K       +    +   +  G A G+ 
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 149
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 150 YLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +G   K    E++I+ K+ H
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK--NRELQIMRKLDH 72
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 131
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVSDYSCF 841
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS Y C 
Sbjct: 132 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC- 184
Query: 842 AGTHGYIAP 850
             +  Y AP
Sbjct: 185 --SRYYRAP 191

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V EYM NG+L   L K       +    +   +  G A G+ 
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 132
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 133 YLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V EYM NG+L   L K       +    +   +  G A G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 161
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V EYM NG+L   L K       +    +   +  G A G+ 
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 159
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 160 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V EYM NG+L   L K       +    +   +  G A G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 161
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG+ ++ E+ P+ +
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 71/146 (48%), Gaps = 13/146 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVK-VFAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K+N   +A+K L+K     +GV+     E+EI   +RH NIL++Y 
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LE+ P G L++ L K  +      D  R        A  + Y H     
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGR-----FDEQRSATFMEELADALHYCHER--- 134
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFG 824
            +IHRDIK  N+L+    E KIADFG
Sbjct: 135 KVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVK-VFAAEMEILGKIRHRNILKLYA 738
           +G G  G VY    K+N   +A+K L+K     +GV+     E+EI   +RH NIL++Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                   +L+LE+ P G L++ L K  +      D  R        A  + Y H     
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGR-----FDEQRSATFMEELADALHYCHER--- 133
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIK  N+L+    E KIADFG +  A +  +        GT  Y+ P
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGTLDYLPP 181

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY C       +  L Y  NG L + + K  
Sbjct: 73  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKI- 131
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 132 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 184
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 185 KVLSPESKQARANXFVGTAQYVSP 208

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/177 (34%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
            E ++ +G G T  VYR   K      A+K L K    K+   E+ +L ++ H NI+KL 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-KPELDWFRRYKIALGAAKGIAYLHHDC 796
                     LVLE +  G LF  +   V++G   E D     K  L A   +AYLH + 
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRI---VEKGYYSERDAADAVKQILEA---VAYLHENG 168
Query: 797 SPPIIHRDIKSSNILLDE---DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I+HRD+K  N+L      D   KIADFG++KI E+   +       GT GY AP
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAP 219

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 86/175 (49%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +G   K    E++I+ K+ H
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK--NRELQIMRKLDH 72
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI-YVKLYMYQL 131
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 132 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNIL 734
           +L    ++G G  G+  ++  ++    + +K+L + D    + F  E++++  + H N+L
Sbjct: 11  DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           K    L K      + EY+  G L       +K    +  W +R   A   A G+AYLH 
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGI----IKSMDSQYPWSQRVSFAKDIASGMAYLH- 125
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             S  IIHRD+ S N L+ E+    +ADFG+A++
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKL 736
           +G G  GKV     Y L  +++   VAVK L     +  K F  E E+L  ++H +I+K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKR------VKEGKP--ELDWFRRYKIALGAAKG 788
           Y   ++G    +V EYM +G+L + L         + EG P  EL   +   IA   A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           + YL    S   +HRD+ + N L+ E+   KI DFG+++
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 87/176 (49%), Gaps = 20/176 (11%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKL 736
           + +G G  GKV   + +     VAVK L +      D V     E++ L   RH +I+KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           Y  +      F+V+EY+  G LF  +  H RV+E    ++  R ++  L A   + Y H 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE----MEARRLFQQILSA---VDYCHR 129
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                ++HRD+K  N+LLD     KIADFG++ +  +   + D SC  G+  Y AP
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRD-SC--GSPNYAAP 179

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 15/170 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V    ++ +   VAVK+  L K    ++   E+ I+   +H N++++Y   L
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++V+E++  G L   + H R+ E +          + L   + ++ LH      +
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQG---V 146
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS +ILL  D   K++DFG    A+ S +V       GT  ++AP
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAP 194

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 15/170 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V    ++ +   VAVK+  L K    ++   E+ I+   +H N++++Y   L
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++V+E++  G L   + H R+ E +          + L   + ++ LH      +
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQG---V 137
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS +ILL  D   K++DFG    A+ S +V       GT  ++AP
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAP 185

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 15/170 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V    ++ +   VAVK+  L K    ++   E+ I+   +H N++++Y   L
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++V+E++  G L   + H R+ E +          + L   + ++ LH      +
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQG---V 148
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS +ILL  D   K++DFG    A+ S +V       GT  ++AP
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAP 196

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 15/170 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V    ++ +   VAVK+  L K    ++   E+ I+   +H N++++Y   L
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++V+E++  G L   + H R+ E +          + L   + ++ LH      +
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQG---V 141
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS +ILL  D   K++DFG    A+ S +V       GT  ++AP
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAP 189

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 665 FHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEM 722
           F  +D    +  ++   + +G G  G+VY    KK + TVAVK L K D ++V  F  E 
Sbjct: 21  FQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTMEVEEFLKEA 79
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            ++ +I+H N+++L          ++V EYMP GNL   L +  +E   E+       +A
Sbjct: 80  AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE---EVTAVVLLYMA 136
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
              +  + YL        IHRD+ + N L+ E++  K+ADFG++++
Sbjct: 137 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRL 179

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 15/170 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V    ++ +   VAVK+  L K    ++   E+ I+   +H N++++Y   L
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++V+E++  G L   + H R+ E +          + L   + ++ LH      +
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTRMNEEQ-------IAAVCLAVLQALSVLHAQG---V 268
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS +ILL  D   K++DFG    A+ S +V       GT  ++AP
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAP 316

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 124
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 15/170 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V    ++ +   VAVK+  L K    ++   E+ I+   +H N++++Y   L
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++V+E++  G L   + H R+ E +          + L   + ++ LH      +
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTRMNEEQ-------IAAVCLAVLQALSVLHAQG---V 191
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS +ILL  D   K++DFG    A+ S +V       GT  ++AP
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAP 239

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 108/381 (28%), Positives = 158/381 (41%), Gaps = 38/381 (9%)
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           + S+  +  L NL   + S N  T   P  + NLT+LV + + +N    A+I   + NL 
Sbjct: 53  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADI-TPLANLT 107
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
           NLT L L +  +    P  +  L  L  L++  N IS     ++  L  L ++   +N +
Sbjct: 108 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFSSNQV 163
Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
           T   P  L NLT L+  DISSN++       +  L NL       N  S   P   G + 
Sbjct: 164 TDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILT 217
Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXF 373
            L   S+ GN+        L   T LTD+D++ NQ S   P  L    K           
Sbjct: 218 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 273
Query: 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST 433
           S   P   A    +  L +++N L    P  +  L N+  L    N+    ISP+  L T
Sbjct: 274 SNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI-SDISPVSSL-T 327
Query: 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
            L +L   NN+ S    S L  LTN+  L   +N  S   P  L  L +++ L L + A 
Sbjct: 328 KLQRLFFSNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 383
Query: 494 TG---------SIPNEMGDCA 505
           T          SIPN + +  
Sbjct: 384 TNAPVNYKANVSIPNTVKNVT 404

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 67/139 (48%), Gaps = 16/139 (11%)
Query: 387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
           + RL +S N +S      L  L ++  L F  N  T  + PL  L+T L +L + +N+ S
Sbjct: 131 LNRLELSSNTISDI--SALSGLTSLQQLSFSSNQVTD-LKPLANLTT-LERLDISSNKVS 186
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA- 505
               S L +LTNLE LI TNN  S   P  LG L  L  L L  N L      ++G  A 
Sbjct: 187 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL-----KDIGTLAS 237
Query: 506 --RIVDLNLARNSLSGNIP 522
              + DL+LA N +S   P
Sbjct: 238 LTNLTDLDLANNQISNLAP 256

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
           +G G  G+V     +     VAVK +     V        E+ I   + H N++K Y   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +G   +L LEY   G LF  +   +  G PE D  R +   +    G+ YLH      I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 91/174 (52%), Gaps = 16/174 (9%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG---DGVKVFAAEM 722
           +I+A +I     + +IGSG +G+V    L+   +    VA+K L  G      + F +E 
Sbjct: 45  EIEASRI---HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            I+G+  H NI++L   + +G  + +V EYM NG+L   L  R  +G+  +   +   + 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTI--MQLVGML 157
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
            G   G+ YL        +HRD+ + N+L+D +   K++DFG++++ E+ P  +
Sbjct: 158 RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 94/181 (51%), Gaps = 17/181 (9%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG---DGVKVFAAEM 722
           +I+A +I     + +IGSG +G+V    L+   +    VA+K L  G      + F +E 
Sbjct: 45  EIEASRI---HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            I+G+  H NI++L   + +G  + +V EYM NG+L   L  R  +G+  +   +   + 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTI--MQLVGML 157
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
            G   G+ YL        +HRD+ + N+L+D +   K++DFG++++ E+ P  + Y+   
Sbjct: 158 RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-YTTTG 213
Query: 843 G 843
           G
Sbjct: 214 G 214

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIR 729
           I N E   ++G G  GKV    +K+     AVK L K      D V+    E  IL   R
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 730 -HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  + +L+ C       F V+E++  G+L   + K  +        F   +    AA+ 
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--------FDEARARFYAAEI 133
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           I+ L       II+RD+K  N+LLD +   K+ADFG+ K  E        + F GT  YI
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYI 191
Query: 849 AP 850
           AP
Sbjct: 192 AP 193

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 164
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKV 194

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V E M NG+L   L K       +    +   +  G A G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 161
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL    +   +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 162 YLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 20  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 79
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 80  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 132
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKV 162

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 84  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 136
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKV 166

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 26  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 85
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 86  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 138
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKV 168

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKV 163

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 39  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 98
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 99  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 151
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKV 181

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 28  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 87
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 88  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 140
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKV 170

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKV 163

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 39  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 98
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 99  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 151
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKV 181

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 108/381 (28%), Positives = 158/381 (41%), Gaps = 38/381 (9%)
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           + S+  +  L NL   + S N  T   P  + NLT+LV + + +N    A+I   + NL 
Sbjct: 53  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADI-TPLANLT 107
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
           NLT L L +  +    P  +  L  L  L++  N IS     ++  L  L ++   +N +
Sbjct: 108 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFSSNQV 163
Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
           T   P  L NLT L+  DISSN++       +  L NL       N  S   P   G + 
Sbjct: 164 TDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILT 217
Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXF 373
            L   S+ GN+        L   T LTD+D++ NQ S   P  L    K           
Sbjct: 218 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 273
Query: 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST 433
           S   P   A    +  L +++N L    P  +  L N+  L    N+    ISP+  L T
Sbjct: 274 SNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI-SDISPVSSL-T 327
Query: 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
            L +L   NN+ S    S L  LTN+  L   +N  S   P  L  L +++ L L + A 
Sbjct: 328 KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 383
Query: 494 TG---------SIPNEMGDCA 505
           T          SIPN + +  
Sbjct: 384 TNAPVNYKANVSIPNTVKNVT 404

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 67/139 (48%), Gaps = 16/139 (11%)
Query: 387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
           + RL +S N +S      L  L ++  L F  N  T  + PL  L+T L +L + +N+ S
Sbjct: 131 LNRLELSSNTISDI--SALSGLTSLQQLSFSSNQVTD-LKPLANLTT-LERLDISSNKVS 186
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA- 505
               S L +LTNLE LI TNN  S   P  LG L  L  L L  N L      ++G  A 
Sbjct: 187 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL-----KDIGTLAS 237
Query: 506 --RIVDLNLARNSLSGNIP 522
              + DL+LA N +S   P
Sbjct: 238 LTNLTDLDLANNQISNLAP 256

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKV 163

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 43  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 100
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 159
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVSDYSCF 841
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS Y C 
Sbjct: 160 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC- 212
Query: 842 AGTHGYIAP 850
             +  Y AP
Sbjct: 213 --SRYYRAP 219

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 84/189 (44%), Gaps = 22/189 (11%)
Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVK-VFAAE 721
           H  ID     + E    +G G  G VY    KK+   VA+K L+K     +GV+     E
Sbjct: 19  HFTID-----DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
           +EI   + H NIL+LY         +L+LEY P G L++ L K         D  R   I
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT-----FDEQRTATI 128
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
               A  + Y H      +IHRDIK  N+LL    E KIADFG +  A +  +       
Sbjct: 129 MEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR----KTM 181
Query: 842 AGTHGYIAP 850
            GT  Y+ P
Sbjct: 182 CGTLDYLPP 190

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 25  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 84
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 85  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 137
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKV 167

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 22/190 (11%)
Query: 674 QICNLEEDNL-------------IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA 720
           Q+  L+ED+L             +G G  G VY+   K+    VA+KQ+     ++    
Sbjct: 14  QLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK 73
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ I+ +    +++K Y    K    ++V+EY   G++   +  R K     L       
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIAT 129
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
           I     KG+ YLH       IHRDIK+ NILL+ +   K+ADFGVA   + +  ++  + 
Sbjct: 130 ILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNX 184
Query: 841 FAGTHGYIAP 850
             GT  ++AP
Sbjct: 185 VIGTPFWMAP 194

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 108/381 (28%), Positives = 158/381 (41%), Gaps = 38/381 (9%)
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           + S+  +  L NL   + S N  T   P  + NLT+LV + + +N    A+I   + NL 
Sbjct: 53  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADI-TPLANLT 107
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
           NLT L L +  +    P  +  L  L  L++  N IS     ++  L  L ++   +N +
Sbjct: 108 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFSSNQV 163
Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
           T   P  L NLT L+  DISSN++       +  L NL       N  S   P   G + 
Sbjct: 164 TDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILT 217
Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXF 373
            L   S+ GN+        L   T LTD+D++ NQ S   P  L    K           
Sbjct: 218 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 273
Query: 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST 433
           S   P   A    +  L +++N L    P  +  L N+  L    N+    ISP+  L T
Sbjct: 274 SNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI-SDISPVSSL-T 327
Query: 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
            L +L   NN+ S    S L  LTN+  L   +N  S   P  L  L +++ L L + A 
Sbjct: 328 KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 383
Query: 494 TG---------SIPNEMGDCA 505
           T          SIPN + +  
Sbjct: 384 TNAPVNYKANVSIPNTVKNVT 404

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 68/139 (48%), Gaps = 16/139 (11%)
Query: 387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
           + RL +S N +S      L  L ++  L+F  N  T  + PL  L+T L +L + +N+ S
Sbjct: 131 LNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTD-LKPLANLTT-LERLDISSNKVS 186
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA- 505
               S L +LTNLE LI TNN  S   P  LG L  L  L L  N L      ++G  A 
Sbjct: 187 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL-----KDIGTLAS 237
Query: 506 --RIVDLNLARNSLSGNIP 522
              + DL+LA N +S   P
Sbjct: 238 LTNLTDLDLANNQISNLAP 256

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 19  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 78
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 79  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 131
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKV 161

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 27  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 86
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 87  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 139
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKV 169

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V E M NG+L   L K       +    +   +  G A G+ 
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 132
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 133 YLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 49  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 106
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 165
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVSDYSCF 841
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS Y C 
Sbjct: 166 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC- 218
Query: 842 AGTHGYIAP 850
             +  Y AP
Sbjct: 219 --SRYYRAP 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 94  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 151
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 210
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVSDYSCF 841
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS Y C 
Sbjct: 211 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC- 263
Query: 842 AGTHGYIAP 850
             +  Y AP
Sbjct: 264 --SRYYRAP 270

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 51  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 108
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 167
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVSDYSCF 841
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS Y C 
Sbjct: 168 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC- 220
Query: 842 AGTHGYIAP 850
             +  Y AP
Sbjct: 221 --SRYYRAP 227

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK- 742
           IG G  G V   D + N   VAVK +      + F AE  ++ ++RH N+++L   +++ 
Sbjct: 20  IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 77
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
            G  ++V EYM  G+L   L  R   G+  L      K +L   + + YL  +     +H
Sbjct: 78  KGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 131
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD+ + N+L+ ED   K++DFG+ K A ++
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASST 161

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
           N+  D ++G+G  G+V    LK   K   +VA+K L  G   K    F  E  I+G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            NI++L   + K     +V E M NG+L   L K       +    +   +  G A G+ 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMK 161
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
           YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 20  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 77
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 136
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVSDYSCF 841
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS Y C 
Sbjct: 137 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC- 189
Query: 842 AGTHGYIAP 850
             +  Y AP
Sbjct: 190 --SRYYRAP 196

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 28  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 85
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 144
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVSDYSCF 841
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS Y C 
Sbjct: 145 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC- 197
Query: 842 AGTHGYIAP 850
             +  Y AP
Sbjct: 198 --SRYYRAP 204

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 53  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 110
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 169
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVSDYSCF 841
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS Y C 
Sbjct: 170 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC- 222
Query: 842 AGTHGYIAP 850
             +  Y AP
Sbjct: 223 --SRYYRAP 229

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 87/174 (50%), Gaps = 9/174 (5%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV----KVFAAEMEILGKIRHRNILKLYAC 739
           IG+G  G+  ++  K +   +  K+L  G       ++  +E+ +L +++H NI++ Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 740 LLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKP-ELDWFRRYKIALGAAKGIAYLHHDC 796
           ++   ++  ++V+EY   G+L   + K  KE +  + ++  R    L  A    +   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              ++HRD+K +N+ LD     K+ DFG+A+I  +    +    F GT  Y++P
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSP 185

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 87/174 (50%), Gaps = 9/174 (5%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV----KVFAAEMEILGKIRHRNILKLYAC 739
           IG+G  G+  ++  K +   +  K+L  G       ++  +E+ +L +++H NI++ Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 740 LLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKP-ELDWFRRYKIALGAAKGIAYLHHDC 796
           ++   ++  ++V+EY   G+L   + K  KE +  + ++  R    L  A    +   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              ++HRD+K +N+ LD     K+ DFG+A+I  +    +    F GT  Y++P
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTPYYMSP 185

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 72
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 131
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVSDYSCF 841
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS Y C 
Sbjct: 132 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC- 184
Query: 842 AGTHGYIAP 850
             +  Y AP
Sbjct: 185 --SRYYRAP 191

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVK------VFAAEMEILGKIRHRN 732
            ++G GG GKV+++     A T    A+K L K   V+         AE  IL +++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+ L      GG  +L+LEY+  G LF  L    +EG    D    Y   +  A G  +L
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALG--HL 137
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      II+RD+K  NI+L+     K+ DFG+ K + +   V+    F GT  Y+AP
Sbjct: 138 HQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--HTFCGTIEYMAP 190

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK- 742
           IG G  G V   D + N   VAVK +      + F AE  ++ ++RH N+++L   +++ 
Sbjct: 29  IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
            G  ++V EYM  G+L   L  R   G+  L      K +L   + + YL  +     +H
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 140
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD+ + N+L+ ED   K++DFG+ K A ++
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASST 170

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 16/176 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKI-RHRNILKLYACL 740
           L+G+G  G+VY+    K     A+K +   GD  +    E+ +L K   HRNI   Y   
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 741 LKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           +K          +LV+E+   G++   + K  K    + +W     I     +G+++LH 
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAY--ICREILRGLSHLHQ 147
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                +IHRDIK  N+LL E+ E K+ DFGV+  A+    V   + F GT  ++AP
Sbjct: 148 H---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAP 198

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK- 742
           IG G  G V   D + N   VAVK +      + F AE  ++ ++RH N+++L   +++ 
Sbjct: 14  IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
            G  ++V EYM  G+L   L  R   G+  L      K +L   + + YL  +     +H
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 125
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD+ + N+L+ ED   K++DFG+ K A ++
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASST 155

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 683 LIGSGGTGKVYRL---DLKKN-AGTVAVKQLW-KGDGVKVFAAEMEILGKIRHRNILKLY 737
            +G GG  K + +   D K+  AG +  K L  K    +  + E+ I   + H++++  +
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDC 796
                    F+VLE     +L + LHKR K   +PE  ++ R +I LG      YLH + 
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 136
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              +IHRD+K  N+ L+ED E KI DFG+A   E   +     C  GT  YIAP
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAP 186

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVK------VFAAEMEILGKIRHRN 732
            ++G GG GKV+++     A T    A+K L K   V+         AE  IL +++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+ L      GG  +L+LEY+  G LF  L    +EG    D    Y   +  A G  +L
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALG--HL 137
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      II+RD+K  NI+L+     K+ DFG+ K + +   V+   C  GT  Y+AP
Sbjct: 138 HQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC--GTIEYMAP 190

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK- 742
           IG G  G V   D + N   VAVK +      + F AE  ++ ++RH N+++L   +++ 
Sbjct: 201 IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
            G  ++V EYM  G+L   L  R   G+  L      K +L   + + YL  +     +H
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 312
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD+ + N+L+ ED   K++DFG+ K A ++
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASST 342

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++E++P G+L + L K     K  +D  +  +      KG+ YL    + 
Sbjct: 84  YSAGRRNLKLIMEFLPYGSLREYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 136
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKV 166

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 93/182 (51%), Gaps = 16/182 (8%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRH 730
           +I +LE    +GSG  G+V+++  +K    +AVKQ+ +    +  K    +++++ K   
Sbjct: 23  EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 731 -RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
              I++ +   +     F+ +E M  G   + L KR++   PE       K+ +   K +
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILG---KMTVAIVKAL 137
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYI 848
            YL       +IHRD+K SNILLDE  + K+ DFG++ ++ ++  K  D S  AG   Y+
Sbjct: 138 YYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--KAKDRS--AGCAAYM 191
Query: 849 AP 850
           AP
Sbjct: 192 AP 193

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 683 LIGSGGTGKVYRL---DLKKN-AGTVAVKQLW-KGDGVKVFAAEMEILGKIRHRNILKLY 737
            +G GG  K + +   D K+  AG +  K L  K    +  + E+ I   + H++++  +
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDC 796
                    F+VLE     +L + LHKR K   +PE  ++ R +I LG      YLH + 
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 158
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              +IHRD+K  N+ L+ED E KI DFG+A   E   +     C  GT  YIAP
Sbjct: 159 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAP 208

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 86/172 (50%), Gaps = 23/172 (13%)
Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNIL 734
            + EE  ++G G  G+V +     ++   A+K++   +  +    +E+ +L  + H+ ++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 735 KLYACLL-------------KGGSSFLVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYK 780
           + YA  L             K  + F+ +EY  NG L+  +H + + + + E  ++R ++
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE--YWRLFR 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             L A   ++Y+H   S  IIHRD+K  NI +DE    KI DFG+AK    S
Sbjct: 124 QILEA---LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 21  LGAGQAGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 80  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDA 162

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 683 LIGSGGTGKVYRL---DLKKN-AGTVAVKQLW-KGDGVKVFAAEMEILGKIRHRNILKLY 737
            +G GG  K + +   D K+  AG +  K L  K    +  + E+ I   + H++++  +
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDC 796
                    F+VLE     +L + LHKR K   +PE  ++ R +I LG      YLH + 
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 140
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              +IHRD+K  N+ L+ED E KI DFG+A   E   +     C  GT  YIAP
Sbjct: 141 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAP 190

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 683 LIGSGGTGKVYRL---DLKKN-AGTVAVKQLW-KGDGVKVFAAEMEILGKIRHRNILKLY 737
            +G GG  K + +   D K+  AG +  K L  K    +  + E+ I   + H++++  +
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDC 796
                    F+VLE     +L + LHKR K   +PE  ++ R +I LG      YLH + 
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 136
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              +IHRD+K  N+ L+ED E KI DFG+A   E   +     C  GT  YIAP
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAP 186

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 683 LIGSGGTGKVYRL---DLKKN-AGTVAVKQLW-KGDGVKVFAAEMEILGKIRHRNILKLY 737
            +G GG  K + +   D K+  AG +  K L  K    +  + E+ I   + H++++  +
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDC 796
                    F+VLE     +L + LHKR K   +PE  ++ R +I LG      YLH + 
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 160
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              +IHRD+K  N+ L+ED E KI DFG+A   E   +     C  GT  YIAP
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAP 210

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-FAAEMEIL 725
           H+ ID  ++  ++E   IGSG  G V+ L    N   VA+K + +G   +  F  E E++
Sbjct: 21  HMVIDPSELTFVQE---IGSGQFGLVH-LGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVM 76
Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
            K+ H  +++LY   L+     LV E+M +G L   L  R + G    +      + L  
Sbjct: 77  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAE--TLLGMCLDV 132
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
            +G+AYL   C   +IHRD+ + N L+ E+   K++DFG+ +  
Sbjct: 133 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 173

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 16/157 (10%)
Query: 684 IGSGGTGKV----YRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKL 736
           +G G  GKV    Y  +       VAVK L     G+ +     E+EIL  + H NI+K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 737 YA-CLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
              C   GG+   L++E++P+G+L + L K     K +++  ++ K A+   KG+ YL  
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLG- 143
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
             S   +HRD+ + N+L++ +++ KI DFG+ K  E 
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 683 LIGSGGTGKVYRL---DLKKN-AGTVAVKQLW-KGDGVKVFAAEMEILGKIRHRNILKLY 737
            +G GG  K + +   D K+  AG +  K L  K    +  + E+ I   + H++++  +
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDC 796
                    F+VLE     +L + LHKR K   +PE  ++ R +I LG      YLH + 
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 134
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              +IHRD+K  N+ L+ED E KI DFG+A   E   +     C  GT  YIAP
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAP 184

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 16/157 (10%)
Query: 684 IGSGGTGKV----YRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKL 736
           +G G  GKV    Y  +       VAVK L     G+ +     E+EIL  + H NI+K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 737 YA-CLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
              C   GG+   L++E++P+G+L + L K     K +++  ++ K A+   KG+ YL  
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLG- 131
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
             S   +HRD+ + N+L++ +++ KI DFG+ K  E 
Sbjct: 132 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 166

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
           +GSG  G+V     +K    VA+K + K           D       E+EIL K+ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +K+          ++VLE M  G LF  +  +KR+KE   +L +F  Y++ L     + Y
Sbjct: 78  IKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YF--YQMLLA----VQY 129
Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           LH +    IIHRD+K  N+LL   +ED   KI DFG +KI   +   S      GT  Y+
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYL 183
Query: 849 AP 850
           AP
Sbjct: 184 AP 185

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 66  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 124
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 125 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 177
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 178 KVLSPESKQARANAFVGTAQYVSP 201

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
           +GSG  G+V     +K    VA+K + K           D       E+EIL K+ H  I
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +K+          ++VLE M  G LF  +  +KR+KE   +L +F  Y++ L     + Y
Sbjct: 77  IKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YF--YQMLLA----VQY 128
Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           LH +    IIHRD+K  N+LL   +ED   KI DFG +KI   +   S      GT  Y+
Sbjct: 129 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYL 182
Query: 849 AP 850
           AP
Sbjct: 183 AP 184

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 86/176 (48%), Gaps = 20/176 (11%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKL 736
           + +G G  GKV   + +     VAVK L +      D V     E++ L   RH +I+KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           Y  +      F+V+EY+  G LF  +  H RV+E    ++  R ++  L A   + Y H 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE----MEARRLFQQILSA---VDYCHR 129
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                ++HRD+K  N+LLD     KIADFG++ +  +   +   SC  G+  Y AP
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SC--GSPNYAAP 179

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
           +GSG  G+V     +K    VA+K + K           D       E+EIL K+ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +K+          ++VLE M  G LF  +  +KR+KE   +L +F  Y++ L     + Y
Sbjct: 78  IKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YF--YQMLLA----VQY 129
Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           LH +    IIHRD+K  N+LL   +ED   KI DFG +KI   +   S      GT  Y+
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYL 183
Query: 849 AP 850
           AP
Sbjct: 184 AP 185

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 49  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 106
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 165
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 166 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
           +GSG  G+V     +K    VA+K + K           D       E+EIL K+ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +K+          ++VLE M  G LF  +  +KR+KE   +L +F  Y++ L     + Y
Sbjct: 78  IKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YF--YQMLLA----VQY 129
Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           LH +    IIHRD+K  N+LL   +ED   KI DFG +KI   +   S      GT  Y+
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYL 183
Query: 849 AP 850
           AP
Sbjct: 184 AP 185

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 72
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 131
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 132 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 16  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 73
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 132
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 133 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 182

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 65  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 123
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 124 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 176
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 177 KVLSPESKQARANSFVGTAQYVSP 200

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 72
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 131
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 132 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 69  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 127
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 128 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 180
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 181 KVLSPESKQARANSFVGTAQYVSP 204

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/154 (38%), Positives = 80/154 (51%), Gaps = 20/154 (12%)
Query: 684 IGSGGTGKV--YRLDLKKNAGT---VAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  GKV  Y  D   N GT   VAVK L +G G ++   +  E+EIL  + H +I+K
Sbjct: 17  LGEGHFGKVSLYCYD-PTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 736 LYACLLKGG--SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
              C    G  S  LV+EY+P G+L   L +    G  +L  F     A    +G+AYLH
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCV-GLAQLLLF-----AQQICEGMAYLH 129
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              +   IHR + + N+LLD D   KI DFG+AK
Sbjct: 130 ---AQHYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 27  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 84
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 143
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 144 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 193

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
           +GSG  G+V     +K    VA+K + K           D       E+EIL K+ H  I
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +K+          ++VLE M  G LF  +  +KR+KE   +L +F  Y++ L     + Y
Sbjct: 84  IKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YF--YQMLLA----VQY 135
Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           LH +    IIHRD+K  N+LL   +ED   KI DFG +KI   +   S      GT  Y+
Sbjct: 136 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYL 189
Query: 849 AP 850
           AP
Sbjct: 190 AP 191

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 85/178 (47%), Gaps = 24/178 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVK-----QLWKGDGVKVFAAEMEILGKIRHRNIL 734
           L+ + G G   ++ L ++  T   VAVK     QL      K+F  E+ I+  + H NI+
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           KL+  +    + +LV+EY   G +F  L  H R+KE +     FR+          + Y 
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK-FRQ------IVSAVQYC 129
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      I+HRD+K+ N+LLD D   KIADFG +       K+     F G+  Y AP
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DTFCGSPPYAAP 181

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 34  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 91
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 150
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 151 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 200

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 23  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 80
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 139
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 140 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 189

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 19  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 76
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 135
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 136 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 185

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 72
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 131
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 132 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 110/382 (28%), Positives = 159/382 (41%), Gaps = 41/382 (10%)
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           + S+  +  L NL   + S N  T   P  + NLT+LV + + +N    A+I   + NL 
Sbjct: 57  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADI-TPLANLT 111
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS-IRKLQKLWKIELYANN 252
           NLT L L +  +    P  +  L  L  L++  N IS     S +  LQ+L     + N 
Sbjct: 112 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLS----FGNQ 165
Query: 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
           +T   P  L NLT L+  DISSN++       +  L NL       N  S   P   G +
Sbjct: 166 VTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGIL 219
Query: 313 RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXX 372
             L   S+ GN+        L   T LTD+D++ NQ S   P  L    K          
Sbjct: 220 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 275
Query: 373 FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS 432
            S   P   A    +  L +++N L    P  +  L N+  L    N+ +  ISP+  L 
Sbjct: 276 ISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS-DISPVSSL- 329
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
           T L +L   NN+ S    S L  LTN+  L   +N  S   P  L  L +++ L L + A
Sbjct: 330 TKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 385
Query: 493 LTG---------SIPNEMGDCA 505
            T          SIPN + +  
Sbjct: 386 WTNAPVNYKANVSIPNTVKNVT 407

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 67/139 (48%), Gaps = 17/139 (12%)
Query: 387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
           + RL +S N +S      L  L ++  L FG+      + PL  L+T L +L + +N+ S
Sbjct: 135 LNRLELSSNTISDI--SALSGLTSLQQLSFGNQ--VTDLKPLANLTT-LERLDISSNKVS 189
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA- 505
               S L +LTNLE LI TNN  S   P  LG L  L  L L  N L      ++G  A 
Sbjct: 190 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL-----KDIGTLAS 240
Query: 506 --RIVDLNLARNSLSGNIP 522
              + DL+LA N +S   P
Sbjct: 241 LTNLTDLDLANNQISNLAP 259

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 66  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 124
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 125 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 177
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 178 KVLSPESKQARANXFVGTAQYVSP 201

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 85/178 (47%), Gaps = 24/178 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVK-----QLWKGDGVKVFAAEMEILGKIRHRNIL 734
           L+ + G G   ++ L ++  T   VAVK     QL      K+F  E+ I+  + H NI+
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           KL+  +    + +LV+EY   G +F  L  H R+KE +     FR+          + Y 
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK-FRQ------IVSAVQYC 129
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      I+HRD+K+ N+LLD D   KIADFG +       K+     F G+  Y AP
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DTFCGSPPYAAP 181

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 19/173 (10%)
Query: 684 IGSGGTGKV----YRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IG G   KV    + L  K+ A  +  K       ++    E+ I+  + H NI+KL+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 740 LLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
           +    + +LV+EY   G +F  L  H R+KE +     FR+          + Y H    
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK-FRQ------IVSAVQYCHQKF- 133
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K+ N+LLD D   KIADFG +       K+ +   F G+  Y AP
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE---FCGSPPYAAP 181

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 66  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 124
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 125 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 177
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 178 KVLSPESKQARANXFVGTAQYVSP 201

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ KIRH  +++LYA ++ 
Sbjct: 26  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYA-VVS 83
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L   +  GK    P+L       +A   A G+AY+      
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQL-----VDMAAQIASGMAYVERMN-- 134
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 66  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 124
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 125 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 177
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 178 KVLSPESKQARANXFVGTAQYVSP 201

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 84/154 (54%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 26  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V+EYM  G+L   L   +  GK    P+L       +A   A G+AY+      
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEM--GKYLRLPQL-----VDMAAQIASGMAYVERMN-- 134
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 68  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 126
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 127 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 179
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 180 KVLSPESKQARANXFVGTAQYVSP 203

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 79/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    ++++E+M  GNL   L +     + E++      +A   +  + YL        I
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFI 134
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRL 161

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/154 (38%), Positives = 80/154 (51%), Gaps = 20/154 (12%)
Query: 684 IGSGGTGKV--YRLDLKKNAGT---VAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  GKV  Y  D   N GT   VAVK L +G G ++   +  E+EIL  + H +I+K
Sbjct: 16  LGEGHFGKVSLYCYD-PTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 736 LYACLLKGG--SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
              C    G  S  LV+EY+P G+L   L +    G  +L  F     A    +G+AYLH
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCV-GLAQLLLF-----AQQICEGMAYLH 128
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              +   IHR + + N+LLD D   KI DFG+AK
Sbjct: 129 ---AQHYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 68  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 126
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 127 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 179
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 180 KVLSPESKQARANXFVGTAQYVSP 203

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 50  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 108
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 109 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 161
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 162 KVLSPESKQARANXFVGTAQYVSP 185

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 84/154 (54%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 26  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V+EYM  G+L   L   +  GK    P+L       +A   A G+AY+      
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEM--GKYLRLPQL-----VDMAAQIASGMAYVERMN-- 134
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 87/174 (50%), Gaps = 9/174 (5%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV----KVFAAEMEILGKIRHRNILKLYAC 739
           IG+G  G+  ++  K +   +  K+L  G       ++  +E+ +L +++H NI++ Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 740 LLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKP-ELDWFRRYKIALGAAKGIAYLHHDC 796
           ++   ++  ++V+EY   G+L   + K  KE +  + ++  R    L  A    +   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              ++HRD+K +N+ LD     K+ DFG+A+I  +    +    F GT  Y++P
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSP 185

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 68  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 126
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 127 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 179
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 180 KVLSPESKQARANXFVGTAQYVSP 203

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 68  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 126
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 127 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 179
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 180 KVLSPESKQARANXFVGTAQYVSP 203

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 71  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 129
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 130 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 182
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 183 KVLSPESKQARANXFVGTAQYVSP 206

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 68  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 126
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 127 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 179
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 180 KVLSPESKQARANXFVGTAQYVSP 203

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH 730
           D  Q  +  +  +IG+G  G VY+  L  +   VA+K++ +    K    E++I+ K+ H
Sbjct: 27  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDH 84
Query: 731 RNILKLYACLLKGGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIAL 783
            NI++L       G         LVL+Y+P      A H  R K+  P + + + Y   L
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL 143
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAK-IAENSPKVS 836
              + +AY+H   S  I HRDIK  N+LLD D    K+ DFG AK +    P VS
Sbjct: 144 --FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 193

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 65  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 123
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 124 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 176
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 177 KVLSPESKQARANXFVGTAQYVSP 200

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKL 736
            ++G G  G+V     K      AVK     Q+ +    +    E+++L ++ H NI+KL
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y      G  +LV E    G LF  +  R +    E+D  R  +  L    GI Y+H + 
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLS---GITYMHKN- 145
Query: 797 SPPIIHRDIKSSNILLD---EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I+HRD+K  N+LL+   +D   +I DFG++   E S K+ D     GT  YIAP
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAP 197

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 43  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 101
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 102 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 154
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 155 KVLSPESKQARANXFVGTAQYVSP 178

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 44  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 102
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 103 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 155
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 156 KVLSPESKQARANXFVGTAQYVSP 179

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 93/176 (52%), Gaps = 19/176 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVK-VFAAEMEILGKIRHRNILKLYA 738
           +++G+G   +V   + K+    VA+K + K   +G +     E+ +L KI+H NI+ L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-KPELDWFRRYKIALGAAKGIAYLHHDCS 797
               GG  +L+++ +  G LF  +   V++G   E D  R     L A K   YLH    
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVK---YLH---D 134
Query: 798 PPIIHRDIKSSNIL---LDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K  N+L   LDED +  I+DFG++K+ E+   V   +C  GT GY+AP
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTAC--GTPGYVAP 187

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 74/133 (55%), Gaps = 14/133 (10%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR---VKEGKPELDWFR 777
           E+ +L  ++H NI++      + GS ++V++Y   G+LF+ ++ +   + +    LDWF 
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
           +  +AL          H     I+HRDIKS NI L +D   ++ DFG+A++  ++ +++ 
Sbjct: 133 QICLAL---------KHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
Query: 838 YSCFAGTHGYIAP 850
            +C  GT  Y++P
Sbjct: 184 -ACI-GTPYYLSP 194

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 69  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 127
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 128 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 180
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 181 KVLSPESKQARANXFVGTAQYVSP 204

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 45  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 103
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 104 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 156
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 157 KVLSPESKQARANXFVGTAQYVSP 180

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 46  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 104
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 105 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 157
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 158 KVLSPESKQARANXFVGTAQYVSP 181

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKL 736
            ++G G  G+V     K      AVK     Q+ +    +    E+++L ++ H NI+KL
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y      G  +LV E    G LF  +  R +    E+D  R  +  L    GI Y+H + 
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLS---GITYMHKN- 168
Query: 797 SPPIIHRDIKSSNILLD---EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I+HRD+K  N+LL+   +D   +I DFG++   E S K+ D     GT  YIAP
Sbjct: 169 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAP 220

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 44/147 (29%), Positives = 80/147 (54%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    ++++E+M  GNL   L +  ++   E++      +A   +  + YL        I
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKL 736
            ++G G  G+V     K      AVK     Q+ +    +    E+++L ++ H NI+KL
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y      G  +LV E    G LF  +  R +    E+D  R  +  L    GI Y+H + 
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLS---GITYMHKN- 169
Query: 797 SPPIIHRDIKSSNILLD---EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I+HRD+K  N+LL+   +D   +I DFG++   E S K+ D     GT  YIAP
Sbjct: 170 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAP 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 84/178 (47%), Gaps = 24/178 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVK-----QLWKGDGVKVFAAEMEILGKIRHRNIL 734
           L+ + G G   ++ L ++  T   VAVK     QL      K+F  E+ I+  + H NI+
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           KL+  +    + +LV+EY   G +F  L  H R+KE +     FR+          + Y 
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK-FRQ------IVSAVQYC 129
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      I+HRD+K+ N+LLD D   KIADFG +       K+     F G   Y AP
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DAFCGAPPYAAP 181

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G TG V     K +   VAVK   L K    ++   E+ I+   +H N++++Y   L
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 742 KGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            G   ++++E++  G L   + + R+ E +          +     + +AYLH   +  +
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-------TVCEAVLQALAYLH---AQGV 162
Query: 801 IHRDIKSSNILLDEDYEPKIADFG-VAKIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIKS +ILL  D   K++DFG  A+I+++ PK        GT  ++AP
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKXLVGTPYWMAP 210

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKL 736
           + +G G  GKV     +     VAVK L +      D V     E++ L   RH +I+KL
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y  +      F+V+EY+  G LF  +    K G+  LD     ++      G+ Y H   
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI---CKNGR--LDEKESRRLFQQILSGVDYCHRHM 136
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              ++HRD+K  N+LLD     KIADFG++ +  +  +    SC  G+  Y AP
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRXSC--GSPNYAAP 184

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 17/153 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 192 LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L  + + GK    P+L       +A   A G+AY+      
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQL-----VDMAAQIASGMAYVER---M 299
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
             +HRD++++NIL+ E+   K+ADFG+A++ E+
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIED 332

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 93/176 (52%), Gaps = 19/176 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVK-VFAAEMEILGKIRHRNILKLYA 738
           +++G+G   +V   + K+    VA+K + K   +G +     E+ +L KI+H NI+ L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-KPELDWFRRYKIALGAAKGIAYLHHDCS 797
               GG  +L+++ +  G LF  +   V++G   E D  R     L A K   YLH    
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVK---YLH---D 134
Query: 798 PPIIHRDIKSSNIL---LDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K  N+L   LDED +  I+DFG++K+ E+   V   +C  GT GY+AP
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTAC--GTPGYVAP 187

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 22  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 81
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L K     K  +D  +  +      KG+ YL    + 
Sbjct: 82  YSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL---GTK 134
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHR++ + NIL++ +   KI DFG+ K+
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKV 164

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 93/176 (52%), Gaps = 19/176 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVK-VFAAEMEILGKIRHRNILKLYA 738
           +++G+G   +V   + K+    VA+K + K   +G +     E+ +L KI+H NI+ L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-KPELDWFRRYKIALGAAKGIAYLHHDCS 797
               GG  +L+++ +  G LF  +   V++G   E D  R     L A K   YLH    
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVK---YLH---D 134
Query: 798 PPIIHRDIKSSNIL---LDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K  N+L   LDED +  I+DFG++K+ E+   V   +C  GT GY+AP
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTAC--GTPGYVAP 187

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 17/153 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 192 LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L  + + GK    P+L       +A   A G+AY+      
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQL-----VDMAAQIASGMAYVER---M 299
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
             +HRD++++NIL+ E+   K+ADFG+A++ E+
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIED 332

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    ++++E+M  GNL   L +     + E+       +A   +  + YL        I
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRL 158

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 684 IGSGGTGKV----YRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           IG G   KV    + L  K+ A  +  K       ++    E+ I+  + H NI+KL+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 740 LLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
           +    + +LV+EY   G +F  L  H R+KE +     FR+          + Y H    
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK-FRQ------IVSAVQYCHQKF- 133
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K+ N+LLD D   KIADFG +       K+     F G+  Y AP
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DTFCGSPPYAAP 181

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    ++++E+M  GNL   L +     + E+       +A   +  + YL        I
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 80/183 (43%), Gaps = 19/183 (10%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIR 729
            I N      IG G   KV           VAVK + K       ++    E+ I+  + 
Sbjct: 13  HIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAK 787
           H NI+KL+  +    + +LV+EY   G +F  L  H R+KE +     FR+         
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK-FRQ------IVS 125
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
            + Y H      I+HRD+K+ N+LLD D   KIADFG +       K+     F G+  Y
Sbjct: 126 AVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKL---DTFCGSPPY 179
Query: 848 IAP 850
            AP
Sbjct: 180 AAP 182

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 110/382 (28%), Positives = 159/382 (41%), Gaps = 41/382 (10%)
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           + S+  +  L NL   + S N  T   P  + NLT+LV + + +N    A+I   + NL 
Sbjct: 58  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADI-TPLANLT 112
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS-IRKLQKLWKIELYANN 252
           NLT L L +  +    P  +  L  L  L++  N IS     S +  LQ+L     + N 
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLS----FGNQ 166
Query: 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
           +T   P  L NLT L+  DISSN++       +  L NL       N  S   P   G +
Sbjct: 167 VTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGIL 220
Query: 313 RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXX 372
             L   S+ GN+        L   T LTD+D++ NQ S   P  L    K          
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 276
Query: 373 FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS 432
            S   P   A    +  L +++N L    P  +  L N+  L    N+ +  ISP+  L 
Sbjct: 277 ISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS-DISPVSSL- 330
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
           T L +L   NN+ S    S L  LTN+  L   +N  S   P  L  L +++ L L + A
Sbjct: 331 TKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 386
Query: 493 LTG---------SIPNEMGDCA 505
            T          SIPN + +  
Sbjct: 387 WTNAPVNYKANVSIPNTVKNVT 408

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 67/139 (48%), Gaps = 17/139 (12%)
Query: 387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
           + RL +S N +S      L  L ++  L FG+      + PL  L+T L +L + +N+ S
Sbjct: 136 LNRLELSSNTISDI--SALSGLTSLQQLSFGNQ--VTDLKPLANLTT-LERLDISSNKVS 190
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA- 505
               S L +LTNLE LI TNN  S   P  LG L  L  L L  N L      ++G  A 
Sbjct: 191 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL-----KDIGTLAS 241
Query: 506 --RIVDLNLARNSLSGNIP 522
              + DL+LA N +S   P
Sbjct: 242 LTNLTDLDLANNQISNLAP 260

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 93/176 (52%), Gaps = 19/176 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVK-VFAAEMEILGKIRHRNILKLYA 738
           +++G+G   +V   + K+    VA+K + K   +G +     E+ +L KI+H NI+ L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-KPELDWFRRYKIALGAAKGIAYLHHDCS 797
               GG  +L+++ +  G LF  +   V++G   E D  R     L A K   YLH    
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVK---YLH---D 134
Query: 798 PPIIHRDIKSSNIL---LDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K  N+L   LDED +  I+DFG++K+ E+   V   +C  GT GY+AP
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTAC--GTPGYVAP 187

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 110/382 (28%), Positives = 158/382 (41%), Gaps = 41/382 (10%)
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           + S+  +  L NL   + S N  T   P  + NLT+LV + + +N    A+I   + NL 
Sbjct: 53  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADI-TPLANLT 107
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS-IRKLQKLWKIELYANN 252
           NLT L L +  +    P  +  L  L  L++  N IS     S +  LQ+L     + N 
Sbjct: 108 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLN----FGNQ 161
Query: 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
           +T   P  L NLT L+  DISSN++       +  L NL       N  S   P G   +
Sbjct: 162 VTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGI--L 215
Query: 313 RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXX 372
             L   S+ GN+        L   T LTD+D++ NQ S   P  L    K          
Sbjct: 216 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 271
Query: 373 FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS 432
            S   P   A    +  L +++N L    P  +  L N+  L    N+    ISP+  L 
Sbjct: 272 ISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI-SDISPVSSL- 325
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
           T L +L   NN+ S    S L  LTN+  L   +N  S   P  L  L +++ L L + A
Sbjct: 326 TKLQRLFFSNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 381
Query: 493 LTG---------SIPNEMGDCA 505
            T          SIPN + +  
Sbjct: 382 WTNAPVNYKANVSIPNTVKNVT 403

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
           + RL +S N +S      L  L ++  L+FG+      + PL  L+T L +L + +N+ S
Sbjct: 131 LNRLELSSNTISDI--SALSGLTSLQQLNFGNQ--VTDLKPLANLTT-LERLDISSNKVS 185
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA- 505
               S L +LTNLE LI TNN  S   P  LG L  L  L L  N L      ++G  A 
Sbjct: 186 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL-----KDIGTLAS 236
Query: 506 --RIVDLNLARNSLSGNIP 522
              + DL+LA N +S   P
Sbjct: 237 LTNLTDLDLANNQISNLAP 255

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           + + K + V     E +++ ++ H   +KLY         +  L Y  NG L + + K  
Sbjct: 68  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKI- 126
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G  +    R Y   + +A  + YLH      IIHRD+K  NILL+ED   +I DFG A
Sbjct: 127 --GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA 179
Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
           K+     K +  + F GT  Y++P
Sbjct: 180 KVLSPESKQARANSFVGTAQYVSP 203

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    ++++E+M  GNL   L +     + E+       +A   +  + YL        I
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 655 EVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-D 713
           E S K K++   H D  AE + +L E   IG G  G V ++  K +   +AVK++    D
Sbjct: 4   ESSGKLKISPEQHWDFTAEDLKDLGE---IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD 60
Query: 714 GVKVFAAEMEILGKIRHRN---ILKLYACLLKGGSSFLVLEYMPNG--NLFQALHKRVKE 768
             +     M++   +R  +   I++ Y  L + G  ++ +E M       ++ ++  + +
Sbjct: 61  EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD 120
Query: 769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-K 827
             PE       KI L   K + +L  +    IIHRDIK SNILLD     K+ DFG++ +
Sbjct: 121 VIPEEILG---KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175
Query: 828 IAENSPKVSDYSCFAGTHGYIAP 850
           + ++  K  D    AG   Y+AP
Sbjct: 176 LVDSIAKTRD----AGCRPYMAP 194

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 19/196 (9%)
Query: 661 KLASFHHI--DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVK 716
           K   + H+  D+D  ++  +  +  +G G  GKVY+   K+     A K  +    + ++
Sbjct: 4   KSREYEHVRRDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 61
Query: 717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG--KPELD 774
            +  E+EIL    H  I+KL       G  ++++E+ P G +  A+   +  G  +P++ 
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQ 120
Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
              R  +     + + +LH   S  IIHRD+K+ N+L+  + + ++ADFGV+  A+N   
Sbjct: 121 VVCRQML-----EALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKT 170
Query: 835 VSDYSCFAGTHGYIAP 850
           +     F GT  ++AP
Sbjct: 171 LQKRDSFIGTPYWMAP 186

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 110/382 (28%), Positives = 158/382 (41%), Gaps = 41/382 (10%)
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           + S+  +  L NL   + S N  T   P  + NLT+LV + + +N    A+I   + NL 
Sbjct: 53  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADI-TPLANLT 107
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS-IRKLQKLWKIELYANN 252
           NLT L L +  +    P  +  L  L  L++  N IS     S +  LQ+L     + N 
Sbjct: 108 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLN----FGNQ 161
Query: 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
           +T   P  L NLT L+  DISSN++       +  L NL       N  S   P G   +
Sbjct: 162 VTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGI--L 215
Query: 313 RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXX 372
             L   S+ GN+        L   T LTD+D++ NQ S   P  L    K          
Sbjct: 216 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 271
Query: 373 FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS 432
            S   P   A    +  L +++N L    P  +  L N+  L    N+    ISP+  L 
Sbjct: 272 ISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI-SDISPVSSL- 325
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
           T L +L   NN+ S    S L  LTN+  L   +N  S   P  L  L +++ L L + A
Sbjct: 326 TKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 381
Query: 493 LTG---------SIPNEMGDCA 505
            T          SIPN + +  
Sbjct: 382 WTNAPVNYKANVSIPNTVKNVT 403

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
           + RL +S N +S      L  L ++  L+FG+      + PL  L+T L +L + +N+ S
Sbjct: 131 LNRLELSSNTISDI--SALSGLTSLQQLNFGNQ--VTDLKPLANLTT-LERLDISSNKVS 185
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA- 505
               S L +LTNLE LI TNN  S   P  LG L  L  L L  N L      ++G  A 
Sbjct: 186 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL-----KDIGTLAS 236
Query: 506 --RIVDLNLARNSLSGNIP 522
              + DL+LA N +S   P
Sbjct: 237 LTNLTDLDLANNQISNLAP 255

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 26  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V+EYM  G L   L   +  GK    P+L       +A   A G+AY+      
Sbjct: 84  EEPIYIVMEYMSKGCLLDFLKGEM--GKYLRLPQL-----VDMAAQIASGMAYVERM--- 133
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 86/182 (47%), Gaps = 29/182 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
           +GSG  G+V     +K    VA++ + K           D       E+EIL K+ H  I
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +K+          ++VLE M  G LF  +  +KR+KE   +L +   Y++ L     + Y
Sbjct: 217 IKI-KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLA----VQY 268
Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           LH +    IIHRD+K  N+LL   +ED   KI DFG +KI   +   S      GT  Y+
Sbjct: 269 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYL 322
Query: 849 AP 850
           AP
Sbjct: 323 AP 324

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 17/153 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 275 LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 332
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L  + + GK    P+L       +A   A G+AY+      
Sbjct: 333 EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQL-----VDMAAQIASGMAYVERMN-- 383
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
             +HRD++++NIL+ E+   K+ADFG+A++ E+
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIED 415

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E++      +A   +  + YL        I
Sbjct: 93  REPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFI 146
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRL 173

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 86/182 (47%), Gaps = 29/182 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
           +GSG  G+V     +K    VA++ + K           D       E+EIL K+ H  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +K+          ++VLE M  G LF  +  +KR+KE   +L +   Y++ L     + Y
Sbjct: 203 IKI-KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLA----VQY 254
Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           LH +    IIHRD+K  N+LL   +ED   KI DFG +KI   +   S      GT  Y+
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYL 308
Query: 849 AP 850
           AP
Sbjct: 309 AP 310

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 47/154 (30%), Positives = 84/154 (54%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 19  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 76
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L  + + GK    P+L       +A   A G+AY+      
Sbjct: 77  EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQL-----VDMAAQIASGMAYVER---M 126
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 127 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 160

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 26  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L   +  GK    P+L       +A   A G+AY+      
Sbjct: 84  EEPIYIVCEYMSKGSLLDFLKGEM--GKYLRLPQL-----VDMAAQIASGMAYVERM--- 133
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E++      +A   +  + YL        I
Sbjct: 81  REPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRL 161

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 30  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 89  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 141
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDN 171

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 29  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 88  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 140
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDN 170

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E++      +A   +  + YL        I
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFI 135
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRL 162

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 15  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 72
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY----KIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L       K E+  + R      +A   A G+AY+      
Sbjct: 73  EEPIYIVTEYMSKGSLLDFL-------KGEMGKYLRLPQLVDMAAQIASGMAYVER---M 122
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 123 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 156

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 12/171 (7%)
Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEIL 725
           H+++  E+I  L+E   +GSG  G V +L   K    VAVK + +G      F  E + +
Sbjct: 2   HMELKREEITLLKE---LGSGQFG-VVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTM 57
Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
            K+ H  ++K Y    K    ++V EY+ NG L   L    K  +P     +  ++    
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPS----QLLEMCYDV 113
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
            +G+A+L    S   IHRD+ + N L+D D   K++DFG+ +   +   VS
Sbjct: 114 CEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 27  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 86  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDN 168

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 17  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 74
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY----KIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L       K E+  + R      +A   A G+AY+      
Sbjct: 75  EEPIYIVTEYMSKGSLLDFL-------KGEMGKYLRLPQLVDMAAQIASGMAYVER---M 124
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 125 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 158

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 26  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L   +  GK    P+L       +A   A G+AY+      
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQL-----VDMAAQIASGMAYVERMN-- 134
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E++      +A   +  + YL        I
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 68/155 (43%), Gaps = 23/155 (14%)
Query: 707 KQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS----FLVLEYMPNGNLFQAL 762
           KQ W+ +       E+  L  ++H NIL+      +G S     +L+  +   G+L   L
Sbjct: 60  KQSWQNE------YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL 113
Query: 763 HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC-------SPPIIHRDIKSSNILLDED 815
              V      + W     IA   A+G+AYLH D         P I HRDIKS N+LL  +
Sbjct: 114 KANV------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167
Query: 816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
               IADFG+A   E      D     GT  Y+AP
Sbjct: 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E++      +A   +  + YL        I
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFI 135
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRL 162

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 15/171 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           +G G  GKVY+   K+     A K  +    + ++ +  E+EIL    H  I+KL     
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEG--KPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
             G  ++++E+ P G +  A+   +  G  +P++    R  +     + + +LH   S  
Sbjct: 79  HDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQML-----EALNFLH---SKR 129
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           IIHRD+K+ N+L+  + + ++ADFGV+  A+N   +     F GT  ++AP
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAP 178

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E++      +A   +  + YL        I
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFI 135
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRL 162

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 16  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 75  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 127
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDN 157

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKL 736
            ++G G  G+V     K      AVK     Q+ +    +    E+++L ++ H NI+KL
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           Y      G  +LV E    G LF  +  R +    E+D  R   I      GI Y+H + 
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS--EVDAAR---IIRQVLSGITYMHKN- 151
Query: 797 SPPIIHRDIKSSNILLD---EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I+HRD+K  N+LL+   +D   +I DFG++   E S K+ D     GT  YIAP
Sbjct: 152 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAP 203

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 31  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 90  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 142
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDN 172

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ YL 
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKYL- 167
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 168 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 27  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 86  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDN 168

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 44/147 (29%), Positives = 79/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +  ++   E++      +A   +  + YL        I
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 44/147 (29%), Positives = 79/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +  ++   E++      +A   +  + YL        I
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 44/147 (29%), Positives = 79/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +  ++   E++      +A   +  + YL        I
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYLE---KKNFI 137
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRL 164

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 44/147 (29%), Positives = 79/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +  ++   E++      +A   +  + YL        I
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 44/147 (29%), Positives = 79/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +  ++   E++      +A   +  + YL        I
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 21  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 80  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDN 162

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKN-AGTVAVK-QLWKGDGVKVFAAEMEI 724
           +D   +        +G GG  K Y    +D K+  AG V  K  L K    +  + E+ I
Sbjct: 20  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 79
Query: 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIAL 783
              + + +++  +         ++VLE     +L + LHKR K   +PE  +F R  I  
Sbjct: 80  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-- 136
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFA 842
              +G+ YLH++    +IHRD+K  N+ L++D + KI DFG+A KI  +  +  D     
Sbjct: 137 ---QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD---LC 187
Query: 843 GTHGYIAP 850
           GT  YIAP
Sbjct: 188 GTPNYIAP 195

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 17/185 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEIL 725
           D   I N +    +G G  GKV           VA+K      L K D       E+  L
Sbjct: 8   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 67
Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
             +RH +I+KLY  +       +V+EY  N  LF  + +R K  + E   F +  I+   
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIIS--- 123
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
              + Y H      I+HRD+K  N+LLDE    KIADFG++ I  +   +   SC  G+ 
Sbjct: 124 --AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT-SC--GSP 175
Query: 846 GYIAP 850
            Y AP
Sbjct: 176 NYAAP 180

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 23  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 82  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 134
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDN 164

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 26  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 85  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 137
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDN 167

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKN-AGTVAVK-QLWKGDGVKVFAAEMEI 724
           +D   +        +G GG  K Y    +D K+  AG V  K  L K    +  + E+ I
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIAL 783
              + + +++  +         ++VLE     +L + LHKR K   +PE  +F R  I  
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-- 152
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFA 842
              +G+ YLH++    +IHRD+K  N+ L++D + KI DFG+A KI  +  +  D     
Sbjct: 153 ---QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD---LC 203
Query: 843 GTHGYIAP 850
           GT  YIAP
Sbjct: 204 GTPNYIAP 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 17/185 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEIL 725
           D   I N +    +G G  GKV           VA+K      L K D       E+  L
Sbjct: 9   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 68
Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
             +RH +I+KLY  +       +V+EY  N  LF  + +R K  + E   F +  I+   
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIIS--- 124
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
              + Y H      I+HRD+K  N+LLDE    KIADFG++ I  +   +   SC  G+ 
Sbjct: 125 --AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT-SC--GSP 176
Query: 846 GYIAP 850
            Y AP
Sbjct: 177 NYAAP 181

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 21  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 80  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDN 162

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ YL 
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKYL- 148
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V          D  K A TVAVK L K D  +       +EME++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYK 780
           NI+ L     + G  ++++EY   GNL + L  R   G           + ++ +     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
                A+G+ YL    S   IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 17/187 (9%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKN-AGTVAVK-QLWKGDGVKVFAAEMEI 724
           +D   +        +G GG  K Y    +D K+  AG V  K  L K    +  + E+ I
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIAL 783
              + + +++  +         ++VLE     +L + LHKR K   +PE  +F R  I  
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-- 152
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
              +G+ YLH++    +IHRD+K  N+ L++D + KI DFG+A   E   +     C  G
Sbjct: 153 ---QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC--G 204
Query: 844 THGYIAP 850
           T  YIAP
Sbjct: 205 TPNYIAP 211

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 22  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 81  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 133
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDN 163

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 77/147 (52%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E+       +A   +  + YL        I
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 59/209 (28%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAA--------E 721
           A Q+  +E    +G G  G+V+R              LW G+   VK+F++        E
Sbjct: 7   ARQVALVE---CVGKGRYGEVWR-------------GLWHGESVAVKIFSSRDEQSWFRE 50
Query: 722 MEILGKI--RHRNILKLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDW 775
            EI   +  RH NIL   A  +   +S    +L+  Y  +G+L+  L ++  E    L  
Sbjct: 51  TEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLAL-- 108
Query: 776 FRRYKIALGAAKGIAYLHHDC-----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
               ++A+ AA G+A+LH +       P I HRD KS N+L+  + +  IAD G+A +  
Sbjct: 109 ----RLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHS 164
Query: 831 ---------NSPKVSDYSCFAGTHGYIAP 850
                    N+P+V       GT  Y+AP
Sbjct: 165 QGSDYLDIGNNPRV-------GTKRYMAP 186

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 17/185 (9%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEIL 725
           D   I N +    +G G  GKV           VA+K      L K D       E+  L
Sbjct: 3   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 62
Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
             +RH +I+KLY  +       +V+EY  N  LF  + +R K  + E   F +  I+   
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIIS--- 118
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
              + Y H      I+HRD+K  N+LLDE    KIADFG++ I  +   +   SC  G+ 
Sbjct: 119 --AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT-SC--GSP 170
Query: 846 GYIAP 850
            Y AP
Sbjct: 171 NYAAP 175

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 17/153 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 192 LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L  + + GK    P+L       +A   A G+AY+      
Sbjct: 250 EEPIYIVGEYMSKGSLLDFL--KGETGKYLRLPQL-----VDMAAQIASGMAYVER---M 299
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
             +HRD++++NIL+ E+   K+ADFG+A++ E+
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIED 332

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 17/187 (9%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKN-AGTVAVK-QLWKGDGVKVFAAEMEI 724
           +D   +        +G GG  K Y    +D K+  AG V  K  L K    +  + E+ I
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIAL 783
              + + +++  +         ++VLE     +L + LHKR K   +PE  +F R  I  
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-- 152
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
              +G+ YLH++    +IHRD+K  N+ L++D + KI DFG+A   E   +     C  G
Sbjct: 153 ---QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC--G 204
Query: 844 THGYIAP 850
           T  YIAP
Sbjct: 205 TPNYIAP 211

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 20/173 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLL 741
           IGSG  G    +  K++   VAVK + +G+ +     + EI+    +RH NI++    +L
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAA-NVKREIINHRSLRHPNIVRFKEVIL 85
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
                 +V+EY   G LF+ +    +  + E  +F +  I+     G++Y H   +  + 
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVC 137
Query: 802 HRDIKSSNILLDEDYEP--KIADFGVAK--IAENSPKVSDYSCFAGTHGYIAP 850
           HRD+K  N LLD    P  KI DFG +K  +  + PK +      GT  YIAP
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAP 185

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 83/154 (53%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G+   + F  E +++ K+RH  +++LYA ++ 
Sbjct: 193 LGQGCFGEVW-MGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 250
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L   +  GK    P+L       +A   A G+AY+      
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQL-----VDMAAQIASGMAYVER---M 300
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+ ++ E++
Sbjct: 301 NYVHRDLRAANILVGENLVCKVADFGLGRLIEDN 334

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V          D  K A TVAVK L K D  +       +EME++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYK 780
           NI+ L     + G  ++++EY   GNL + L  R   G           + ++ +     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
                A+G+ YL    S   IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID  ++  ++E   IGSG  G V+ L    N   VA+K + +G    + F  E E++ K+
Sbjct: 2   IDPSELTFVQE---IGSGQFGLVH-LGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 57
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY   L+     LV E+M +G L   L  R + G    +      + L   +G
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAE--TLLGMCLDVCEG 113
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
           +AYL   C   +IHRD+ + N L+ E+   K++DFG+ +  
Sbjct: 114 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 151

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L+ N G  VAVK+L     + ++ F  E+EIL  ++H NI+K     
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     L++EY+P G+L   L    +     +D  +  +      KG+ YL    + 
Sbjct: 84  YSAGRRNLKLIMEYLPYGSLRDYLQAHAER----IDHIKLLQYTSQICKGMEYL---GTK 136
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+ + NIL++ +   KI DFG+ K+
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKV 166

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 21  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 80  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++++NIL+ +    KIADFG+A++ E++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDN 162

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ YL 
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKYL- 168
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 169 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID  ++  ++E   IGSG  G V+ L    N   VA+K + +G    + F  E E++ K+
Sbjct: 4   IDPSELTFVQE---IGSGQFGLVH-LGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 59
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY   L+     LV E+M +G L   L  R + G    +      + L   +G
Sbjct: 60  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAE--TLLGMCLDVCEG 115
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
           +AYL   C   +IHRD+ + N L+ E+   K++DFG+ +  
Sbjct: 116 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 153

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 77/147 (52%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E+       +A   +  + YL        I
Sbjct: 78  REPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRL 158

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ YL 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKYL- 149
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V          D  K A TVAVK L K D  +       +EME++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYK 780
           NI+ L     + G  ++++EY   GNL + L  R   G           + ++ +     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
                A+G+ YL    S   IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 77/147 (52%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E+       +A   +  + YL        I
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 22/178 (12%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGD----GVKVFAAEMEILGKIRHRNIL 734
            L+ + G G   ++ L ++  T   VA+K + K       ++    E+ I+  + H NI+
Sbjct: 15  RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 74
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           KL+  +    + +L++EY   G +F  L  H R+KE K     FR+          + Y 
Sbjct: 75  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-KEARSKFRQ------IVSAVQYC 127
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      I+HRD+K+ N+LLD D   KIADFG +       K+     F G+  Y AP
Sbjct: 128 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DTFCGSPPYAAP 179

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ YL 
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKYL- 147
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 77/147 (52%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E+       +A   +  + YL        I
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ YL 
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKYL- 148
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID  ++  ++E   IGSG  G V+ L    N   VA+K + +G    + F  E E++ K+
Sbjct: 7   IDPSELTFVQE---IGSGQFGLVH-LGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 62
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY   L+     LV E+M +G L   L  R + G    +      + L   +G
Sbjct: 63  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAE--TLLGMCLDVCEG 118
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
           +AYL   C   +IHRD+ + N L+ E+   K++DFG+ +  
Sbjct: 119 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 156

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL--WKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           +G G  GKVY+   K+ +   A K +     + ++ +  E++IL    H NI+KL     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 742 KGGSSFLVLEYMPNGNL---FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              + ++++E+   G +      L + + E + ++       +       + YLH +   
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------VCKQTLDALNYLHDN--- 154
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            IIHRD+K+ NIL   D + K+ADFGV+  A+N+  +     F GT  ++AP
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAP 204

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ YL 
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKYL- 146
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 147 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ YL 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKYL- 149
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ YL 
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKYL- 141
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 142 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V          D  K A TVAVK L K D  +       +EME++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSDLVSEMEMMKMIGKHK 101
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYK 780
           NI+ L     + G  ++++EY   GNL + L  R   G           + ++ +     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
                A+G+ YL    S   IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V          D  K A TVAVK L K D  +       +EME++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYK 780
           NI+ L     + G  ++++EY   GNL + L  R   G           + ++ +     
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
                A+G+ YL    S   IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V          D  K A TVAVK L K D  +       +EME++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYK 780
           NI+ L     + G  ++++EY   GNL + L  R   G           + ++ +     
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
                A+G+ YL    S   IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G +G VY          VA++Q  L +    ++   E+ ++ + ++ NI+      L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
            G   ++V+EY+  G+L   + +        +D  +   +     + + +LH   S  +I
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           HRDIKS NILL  D   K+ DFG    A+ +P+ S  S   GT  ++AP
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAP 185

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL--WKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           +G G  GKVY+   K+ +   A K +     + ++ +  E++IL    H NI+KL     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 742 KGGSSFLVLEYMPNGNL---FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              + ++++E+   G +      L + + E + ++       +       + YLH +   
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------VCKQTLDALNYLHDN--- 154
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            IIHRD+K+ NIL   D + K+ADFGV+  A+N+  +     F GT  ++AP
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDSFIGTPYWMAP 204

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 85/172 (49%), Gaps = 23/172 (13%)
Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNIL 734
            + EE  ++G G  G+V +     ++   A+K++   +  +    +E+ +L  + H+ ++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 735 KLYACLL-------------KGGSSFLVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYK 780
           + YA  L             K  + F+ +EY  N  L+  +H + + + + E  ++R ++
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE--YWRLFR 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             L A   ++Y+H   S  IIHRD+K  NI +DE    KI DFG+AK    S
Sbjct: 124 QILEA---LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 87/158 (55%), Gaps = 13/158 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILK 735
           +L+ +  +G+G  G+V+     K+   VAVK +  G   V+ F AE  ++  ++H  ++K
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           L+A + K    +++ E+M  G+L   L   +  K+  P+L  F     +   A+G+A++ 
Sbjct: 248 LHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-----SAQIAEGMAFIE 301
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
                  IHRD++++NIL+      KIADFG+A++ E+
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ YL 
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKYL- 144
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 79/154 (51%), Gaps = 20/154 (12%)
Query: 684 IGSGGTGKV--YRLDLKKNAGT---VAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  GKV  Y  D   N GT   VAVK L    G +    +  E++IL  + H +I+K
Sbjct: 39  LGEGHFGKVSLYCYD-PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 736 LYACLLKGGSSFL--VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
              C    G++ L  V+EY+P G+L   L  R   G  +L  F     A    +G+AYLH
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLF-----AQQICEGMAYLH 151
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              +   IHRD+ + N+LLD D   KI DFG+AK
Sbjct: 152 ---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 77/147 (52%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +     + E+       +A   +  + YL        I
Sbjct: 78  REPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HRD+ + N L+ E++  K+ADFG++++
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRL 158

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGD----GVKVFAAEMEILGKIRHRNIL 734
            L+ + G G   ++ L ++  T   VA+K + K       ++    E+ I+  + H NI+
Sbjct: 18  RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           KL+  +    + +L++EY   G +F  L  H R+KE K     FR+          + Y 
Sbjct: 78  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-KEARSKFRQ------IVSAVQYC 130
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      I+HRD+K+ N+LLD D   KIADFG +       K+     F G   Y AP
Sbjct: 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAP 182

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 20/152 (13%)
Query: 696 DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750
           D  K A TVAVK L K D  +       +EME++  I +H+NI+ L     + G  ++++
Sbjct: 108 DKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 166
Query: 751 EYMPNGNLFQALHKRVKEG-----------KPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           EY   GNL + L  R   G           + ++ +          A+G+ YL    S  
Sbjct: 167 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQK 223
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
            IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 224 CIHRDLAARNVLVTENNVMKIADFGLARDINN 255

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 26  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G L   L   +  GK    P+L       +A   A G+AY+      
Sbjct: 84  EEPIYIVTEYMSKGCLLDFLKGEM--GKYLRLPQL-----VDMAAQIASGMAYVERM--- 133
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 16/171 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           IG G  G+V++    +    VA+K +      D ++    E+ +L +     + K Y   
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           LKG   ++++EY+  G+    L           D F+   +     KG+ YLH   S   
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLH---SEKK 141
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIK++N+LL E  + K+ADFGVA ++ +   K    + F GT  ++AP
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAP 189

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 88/159 (55%), Gaps = 13/159 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILK 735
           +L+ +  +G+G  G+V+     K+   VAVK +  G   V+ F AE  ++  ++H  ++K
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 74
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           L+A + K    +++ E+M  G+L   L   +  K+  P+L  F     +   A+G+A++ 
Sbjct: 75  LHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-----SAQIAEGMAFIE 128
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
                  IHRD++++NIL+      KIADFG+A++ E++
Sbjct: 129 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 164

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 681 DNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNIL 734
           + +IG+G  G+V    LK   K    VA+K L  G   K    F  E  I+G+  H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
            L   + +G    +V+E+M NG    AL   +++   +    +   +  G A G+ YL  
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENG----ALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYL-- 161
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
                 +HRD+ + NIL++ +   K++DFG++++ E+ P+
Sbjct: 162 -ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL--WKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           +G G  GKVY+   K+ +   A K +     + ++ +  E++IL    H NI+KL     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 742 KGGSSFLVLEYMPNGNL---FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              + ++++E+   G +      L + + E + ++       +       + YLH +   
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------VCKQTLDALNYLHDN--- 154
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            IIHRD+K+ NIL   D + K+ADFGV+  A+N+  +     F GT  ++AP
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAP 204

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 662 LASFHHIDIDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWK---GDGV 715
           LA    + I  E++     D +IG G  G VY    +D  +N    A+K L +      V
Sbjct: 8   LAEVKDVLIPHERVVT-HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV 66
Query: 716 KVFAAEMEILGKIRHRNILKLYACLLKG-GSSFLVLEYMPNGNLFQALHKRVKEGKPELD 774
           + F  E  ++  + H N+L L   +L   G   ++L YM +G+L Q +  R  +  P + 
Sbjct: 67  EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVK 124
Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                   L  A+G+ YL        +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 125 DL--ISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 14/179 (7%)
Query: 664 SFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV--- 717
           + H    + E  C +  + +IG+G  G+V    LK   K    VA+K L  G   K    
Sbjct: 11  AVHEFAKEIEASC-ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRD 69
Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR 777
           F  E  I+G+  H NI+ L   + K     +V EYM NG+L   L    K+   +    +
Sbjct: 70  FLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL----KKNDGQFTVIQ 125
Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
              +  G + G+ YL        +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 126 LVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 181

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 26  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L   +  GK    P+L       +A   A G+AY+      
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQL-----VDMAAQIASGMAYVERMN-- 134
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD+ ++NIL+ E+   K+ADFG+A++ E++
Sbjct: 135 -YVHRDLAAANILVGENLVCKVADFGLARLIEDN 167

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 20/152 (13%)
Query: 696 DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750
           D  K A TVAVK L K D  +       +EME++  I +H+NI+ L     + G  ++++
Sbjct: 49  DKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 107
Query: 751 EYMPNGNLFQALHKRVKEG-----------KPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           EY   GNL + L  R   G           + ++ +          A+G+ YL    S  
Sbjct: 108 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQK 164
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
            IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 165 CIHRDLTARNVLVTENNVMKIADFGLARDINN 196

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G +G VY          VA++Q  L +    ++   E+ ++ + ++ NI+      L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
            G   ++V+EY+  G+L   + +        +D  +   +     + + +LH   S  +I
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           HRDIKS NILL  D   K+ DFG    A+ +P+ S  S   GT  ++AP
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSXMVGTPYWMAP 185

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 20/152 (13%)
Query: 696 DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750
           D  K A TVAVK L K D  +       +EME++  I +H+NI+ L     + G  ++++
Sbjct: 54  DKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 112
Query: 751 EYMPNGNLFQALHKRVKEG-----------KPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           EY   GNL + L  R   G           + ++ +          A+G+ YL    S  
Sbjct: 113 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQK 169
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
            IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 170 CIHRDLAARNVLVTENNVMKIADFGLARDINN 201

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G +G VY          VA++Q  L +    ++   E+ ++ + ++ NI+      L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
            G   ++V+EY+  G+L   + +        +D  +   +     + + +LH   S  +I
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLH---SNQVI 139
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           HRDIKS NILL  D   K+ DFG    A+ +P+ S  S   GT  ++AP
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSXMVGTPYWMAP 186

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 14/170 (8%)
Query: 681 DNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNIL 734
           + +IG+G  G+V R  LK   K    VA+K L  G      + F +E  I+G+  H NI+
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           +L   +       ++ E+M NG L   L  R+ +G  +    +   +  G A G+ YL  
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFL--RLNDG--QFTVIQLVGMLRGIASGMRYLAE 136
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAG 843
                 +HRD+ + NIL++ +   K++DFG+++ + ENS   ++ S   G
Sbjct: 137 MS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGG 183

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 20/152 (13%)
Query: 696 DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750
           D  K A TVAVK L K D  +       +EME++  I +H+NI+ L     + G  ++++
Sbjct: 51  DKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 109
Query: 751 EYMPNGNLFQALHKRVKEG-----------KPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           EY   GNL + L  R   G           + ++ +          A+G+ YL    S  
Sbjct: 110 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQK 166
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
            IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 167 CIHRDLAARNVLVTENNVMKIADFGLARDINN 198

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 86/160 (53%), Gaps = 13/160 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILK 735
           +L+ +  +G+G  G+V+     K+   VAVK +  G   V+ F AE  ++  ++H  ++K
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 241
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           L+A + K    +++ E+M  G+L   L   +  K+  P+L  F     +   A+G+A++ 
Sbjct: 242 LHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-----SAQIAEGMAFIE 295
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
                  IHRD++++NIL+      KIADFG+A++    P
Sbjct: 296 QRN---YIHRDLRAANILVSASLVCKIADFGLARVGAKFP 332

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/133 (35%), Positives = 68/133 (51%), Gaps = 14/133 (10%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ +L  + H NI+KLY       + +LV+E    G LF  +  R+K    E+D     K
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN--EVDAAVIIK 143
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSD 837
             L    G+ YLH      I+HRD+K  N+LL   ++D   KI DFG++ + EN  K+ +
Sbjct: 144 QVLS---GVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE 197
Query: 838 YSCFAGTHGYIAP 850
                GT  YIAP
Sbjct: 198 R---LGTAYYIAP 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 77/174 (44%), Gaps = 16/174 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
           +IG G  GKV     K      AVK L K   +K      + +    +L  ++H  ++ L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           +         + VL+Y+  G LF  L +     +P   ++     A   A  + YLH   
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-----AAEIASALGYLH--- 156
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  I++RD+K  NILLD      + DFG+ K  EN    S  S F GT  Y+AP
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAP 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 46/154 (29%), Positives = 84/154 (54%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 23  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L  + + GK    P+L       ++   A G+AY+      
Sbjct: 81  EEPIYIVTEYMNKGSLLDFL--KGETGKYLRLPQL-----VDMSAQIASGMAYVER---M 130
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 164

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 46/154 (29%), Positives = 84/154 (54%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 23  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
               ++V EYM  G+L   L  + + GK    P+L       ++   A G+AY+      
Sbjct: 81  EEPIYIVTEYMNKGSLLDFL--KGETGKYLRLPQL-----VDMSAQIASGMAYVER---M 130
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 164

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID  ++  ++E   IGSG  G V+ L    N   VA+K + +G    + F  E E++ K+
Sbjct: 5   IDPSELTFVQE---IGSGQFGLVH-LGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 60
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY   L+     LV E+M +G L   L  R + G    +      + L   +G
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAE--TLLGMCLDVCEG 116
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
           +AYL   C   +IHRD+ + N L+ E+   K++DFG+ +  
Sbjct: 117 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 154

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 20/173 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLL 741
           IGSG  G    +  K++   VAVK + +G+ +     + EI+    +RH NI++    +L
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE-NVKREIINHRSLRHPNIVRFKEVIL 84
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
                 +V+EY   G LF+ +    +  + E  +F +  I+     G++Y H   +  + 
Sbjct: 85  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVC 136
Query: 802 HRDIKSSNILLDEDYEP--KIADFGVAK--IAENSPKVSDYSCFAGTHGYIAP 850
           HRD+K  N LLD    P  KI DFG +K  +  + PK +      GT  YIAP
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAP 184

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V          D  K A TVAVK L K D  +       +EME++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYK 780
           NI+ L     + G  ++++EY   GNL + L  R   G           + ++ +     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
                A+G+ YL    S   IHRD+ + N+L+ E+   +IADFG+A+   N
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINN 209

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 89/174 (51%), Gaps = 16/174 (9%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEM 722
           +IDA  I   + + +IG G  G+V    LK   K    VA+K L  G   K    F +E 
Sbjct: 25  EIDASCI---KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 81
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            I+G+  H NI+ L   + K     ++ EYM NG+L   L K   +G+  +   +   + 
Sbjct: 82  SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTV--IQLVGML 137
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
            G   G+ YL  D S   +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 138 RGIGSGMKYLS-DMSA--VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA 188

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 17/154 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G+V+ +        VA+K L  G    + F  E +++ K+RH  +++LYA ++ 
Sbjct: 16  LGQGCFGEVW-MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 73
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
                +V EYM  G+L   L  + + GK    P+L       +A   A G+AY+      
Sbjct: 74  EEPIXIVTEYMSKGSLLDFL--KGETGKYLRLPQL-----VDMAAQIASGMAYVER---M 123
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 124 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 157

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ +L 
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKFL- 150
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ +L 
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKFL- 150
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--R 729
           A+QI  +++   IG G  G+V+    K     VAVK  +  +    F  E EI   +  R
Sbjct: 36  AKQIQMVKQ---IGKGRYGEVWMG--KWRGEKVAVKVFFTTEEASWFR-ETEIYQTVLMR 89
Query: 730 HRNILKLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
           H NIL   A  +KG  S    +L+ +Y  NG+L+  L     + K  L      K+A  +
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSML------KLAYSS 143
Query: 786 AKGIAYLHHDC-----SPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             G+ +LH +       P I HRD+KS NIL+ ++    IAD G+A
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ +L 
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKFL- 154
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 155 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ +L 
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKFL- 208
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ +L 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKFL- 149
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ +L 
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKFL- 147
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 79/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +  ++   E++      +A   +  + YL        I
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYLEKKN---FI 379
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HR++ + N L+ E++  K+ADFG++++
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRL 406

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+ +        VAVK L +G      F AE  ++ +++H+ +++LYA + +
Sbjct: 17  LGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               +++ EYM NG+L   L  +   G  +L   +   +A   A+G+A++        IH
Sbjct: 76  E-PIYIITEYMENGSLVDFL--KTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIH 128
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           R+++++NIL+ +    KIADFG+A++ E++
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDN 158

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G +G VY          VA++Q  L +    ++   E+ ++ + ++ NI+      L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
            G   ++V+EY+  G+L   + +        +D  +   +     + + +LH   S  +I
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           HRDIKS NILL  D   K+ DFG    A+ +P+ S  S   GT  ++AP
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSEMVGTPYWMAP 185

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 89/174 (51%), Gaps = 16/174 (9%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEM 722
           +IDA  I   + + +IG G  G+V    LK   K    VA+K L  G   K    F +E 
Sbjct: 4   EIDASCI---KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 60
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            I+G+  H NI+ L   + K     ++ EYM NG+L   L K   +G+  +   +   + 
Sbjct: 61  SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTV--IQLVGML 116
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
            G   G+ YL  D S   +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 117 RGIGSGMKYLS-DMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA 167

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG---VKVFAAEMEILGKIRHRNIL 734
           + +IG G  G VY   L  N G     AVK L +      V  F  E  I+    H N+L
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 735 KLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
            L   CL   GS  +VL YM +G+L   +  R +   P +     +   L  AKG+ +L 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGF--GLQVAKGMKFL- 149
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 84/178 (47%), Gaps = 24/178 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVK-----QLWKGDGVKVFAAEMEILGKIRHRNIL 734
           L+ + G G   ++ L ++  T   VAVK     QL      K+F  E+ I+  + H NI+
Sbjct: 11  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 69
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           KL+  +    + +LV+EY   G +F  L  H  +KE +     FR+          + Y 
Sbjct: 70  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAK-FRQ------IVSAVQYC 122
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      I+HRD+K+ N+LLD D   KIADFG +       K+     F G+  Y AP
Sbjct: 123 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DTFCGSPPYAAP 174

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 89/174 (51%), Gaps = 16/174 (9%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEM 722
           +IDA  I   + + +IG G  G+V    LK   K    VA+K L  G   K    F +E 
Sbjct: 10  EIDASCI---KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 66
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            I+G+  H NI+ L   + K     ++ EYM NG+L   L K   +G+  +   +   + 
Sbjct: 67  SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTV--IQLVGML 122
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
            G   G+ YL  D S   +HRD+ + NIL++ +   K++DFG++++ E+ P+ +
Sbjct: 123 RGIGSGMKYLS-DMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA 173

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
           +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +I+H N+++L     
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +    +++ E+M  GNL   L +  ++   E+       +A   +  + YL        I
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKN---FI 340
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKI 828
           HR++ + N L+ E++  K+ADFG++++
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRL 367

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 27/190 (14%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKL 736
           + +E  LIGSGG G+V++   + +  T  +K++ K +  K    E++ L K+ H NI+  
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-KYNNEKA-EREVKALAKLDHVNIVHY 69
Query: 737 YACL----------------LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
             C                  K    F+ +E+   G L Q + KR  E   +LD     +
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLALE 126
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
           +     KG+ Y+H   S  +I+RD+K SNI L +  + KI DFG+    +N  K      
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK- 182
Query: 841 FAGTHGYIAP 850
             GT  Y++P
Sbjct: 183 --GTLRYMSP 190

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--R 729
           A QI  LE    +G G  G+V+R   +     VAVK ++     K +  E E+   +  R
Sbjct: 36  ARQITLLE---CVGKGRYGEVWRGSWQ--GENVAVK-IFSSRDEKSWFRETELYNTVMLR 89
Query: 730 HRNILKLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
           H NIL   A  +    S    +L+  Y   G+L+  L          LD     +I L  
Sbjct: 90  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSI 143
Query: 786 AKGIAYLHHDC-----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-- 838
           A G+A+LH +       P I HRD+KS NIL+ ++ +  IAD G+A +   S    D   
Sbjct: 144 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 203
Query: 839 SCFAGTHGYIAP 850
           +   GT  Y+AP
Sbjct: 204 NPRVGTKRYMAP 215

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 86/174 (49%), Gaps = 22/174 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGT-VAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACL 740
           IG+G  G V RL   K A   VAVK + +G+ +     + EI+    +RH NI++    +
Sbjct: 27  IGAGNFG-VARLMRDKQANELVAVKYIERGEKIDE-NVKREIINHRSLRHPNIVRFKEVI 84
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           L      +V+EY   G LF+ +    +  + E  +F +  I+     G++Y H   +  +
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYAH---AMQV 136
Query: 801 IHRDIKSSNILLDEDYEP--KIADFGVAK--IAENSPKVSDYSCFAGTHGYIAP 850
            HRD+K  N LLD    P  KIADFG +K  +  + PK +      GT  YIAP
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA-----VGTPAYIAP 185

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKI 728
            I N +    +G G  GKV           VA+K      L K D       E+  L  +
Sbjct: 2   HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 61
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
           RH +I+KLY  +       +V+EY  N  LF  + +R K  + E   F +  I+      
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIIS-----A 115
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           + Y H      I+HRD+K  N+LLDE    KIADFG++ I  +   +   SC  G+  Y 
Sbjct: 116 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT-SC--GSPNYA 169
Query: 849 AP 850
           AP
Sbjct: 170 AP 171

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 18/173 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKLY 737
           IG G  GKV  +         A+K + K   V+      VF  E++I+  + H  ++ L+
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFLVNLW 81
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    F+V++ +  G+L   L + V         F+   + L   + +  L +  +
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVH--------FKEETVKLFICELVMALDYLQN 133
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             IIHRD+K  NILLDE     I DF +A +    P+ +  +  AGT  Y+AP
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGTKPYMAP 183

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 81/176 (46%), Gaps = 19/176 (10%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
           ++G G  G+V     K      AVK     Q+ +    +    E+++L ++ H NI KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                 G  +LV E    G LF  +  R +    E+D  R  +  L    GI Y H +  
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLS---GITYXHKN-- 145
Query: 798 PPIIHRDIKSSNILLD---EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K  N+LL+   +D   +I DFG++   E S K  D     GT  YIAP
Sbjct: 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGTAYYIAP 197

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 684 IGSGGTGKVYR-----LDLKK--NAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V       LD  K      VAVK L K D  +       +EME++  I +H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG---------KPELDWFRR--YK 780
           NI+ L     + G  ++++EY   GNL + L  R   G          PE     +    
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            A   A+G+ YL    S   IHRD+ + N+L+ ED   KIADFG+A+
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 69/140 (49%), Gaps = 20/140 (14%)
Query: 704 VAVKQLWKGDGVKV----FAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL 758
           VAVK L K D  +       +EME++  I +H+NI+ L     + G  ++++EY   GNL
Sbjct: 104 VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 759 FQALHKRVKEG---------KPELDWFRR--YKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
            + L  R   G          PE     +     A   A+G+ YL    S   IHRD+ +
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 219
Query: 808 SNILLDEDYEPKIADFGVAK 827
            N+L+ ED   KIADFG+A+
Sbjct: 220 RNVLVTEDNVMKIADFGLAR 239

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G +G VY          VA++Q  L +    ++   E+ ++ + ++ NI+      L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
            G   ++V+EY+  G+L   + +        +D  +   +     + + +LH   S  +I
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLH---SNQVI 139
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           HR+IKS NILL  D   K+ DFG    A+ +P+ S  S   GT  ++AP
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAP 186

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 84/171 (49%), Gaps = 16/171 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           IG G  G+V++    +    VA+K +      D ++    E+ +L +     + K Y   
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           LK    ++++EY+  G+    L     E  P LD  +   I     KG+ YLH +     
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLL-----EPGP-LDETQIATILREILKGLDYLHSEKK--- 145
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
           IHRDIK++N+LL E  E K+ADFGVA ++ +   K    + F GT  ++AP
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAP 193

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK----QLWKGDGVKV-FAAEMEILGKIRHRNILKLYA 738
           +G G  GKV      K    VA+K    QL K   + +    E+  L  +RH +I+KLY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
            +       +V+EY   G LF  +   V++ +   D  RR+   +  A  I Y H     
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYI---VEKKRMTEDEGRRFFQQIICA--IEYCHRH--- 127
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRD+K  N+LLD++   KIADFG++ I  +   +   SC  G+  Y AP
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SC--GSPNYAAP 176

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLL 741
           IGSG  G    +  K     VAVK + +G  +     + EI+    +RH NI++    +L
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRFKEVIL 86
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
                 +++EY   G L++ +    +  + E  +F +  ++     G++Y H   S  I 
Sbjct: 87  TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GVSYCH---SMQIC 138
Query: 802 HRDIKSSNILLDEDYEP--KIADFGVAK--IAENSPKVSDYSCFAGTHGYIAP 850
           HRD+K  N LLD    P  KI DFG +K  +  + PK +      GT  YIAP
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAP 186

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 684 IGSGGTGKVYR-----LDLKK--NAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V       LD  K      VAVK L K D  +       +EME++  I +H+
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG---------KPELDWFRR--YK 780
           NI+ L     + G  ++++EY   GNL + L  R   G          PE     +    
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            A   A+G+ YL    S   IHRD+ + N+L+ ED   KIADFG+A+
Sbjct: 140 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 81/178 (45%), Gaps = 24/178 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVK-----QLWKGDGVKVFAAEMEILGKIRHRNIL 734
           L+ + G G   ++ L ++  T   VAVK     QL      K+F  E+ I   + H NI+
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIV 76
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           KL+  +    + +LV EY   G +F  L  H R KE +     FR+          + Y 
Sbjct: 77  KLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAK-FRQ------IVSAVQYC 129
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      I+HRD+K+ N+LLD D   KIADFG +       K+     F G   Y AP
Sbjct: 130 HQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKL---DAFCGAPPYAAP 181

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY-------KIALGAA 786
            L  AC   GG   +++E+   GNL   L  +  E  P  D ++ +         +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
           KG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDP 198

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--R 729
           A QI  LE    +G G  G+V+R   +     VAVK ++     K +  E E+   +  R
Sbjct: 7   AHQITLLE---CVGKGRYGEVWRGSWQ--GENVAVK-IFSSRDEKSWFRETELYNTVMLR 60
Query: 730 HRNILKLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
           H NIL   A  +    S    +L+  Y   G+L+  L          LD     +I L  
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSI 114
Query: 786 AKGIAYLHHDC-----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-- 838
           A G+A+LH +       P I HRD+KS NIL+ ++ +  IAD G+A +   S    D   
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 839 SCFAGTHGYIAP 850
           +   GT  Y+AP
Sbjct: 175 NPRVGTKRYMAP 186

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/154 (38%), Positives = 78/154 (50%), Gaps = 20/154 (12%)
Query: 684 IGSGGTGKV--YRLDLKKNAGT---VAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  GKV  Y  D   N GT   VAVK L    G +    +  E++IL  + H +I+K
Sbjct: 22  LGEGHFGKVSLYCYD-PTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 736 LYACLLKGG--SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
              C    G  S  LV+EY+P G+L   L  R   G  +L  F     A    +G+AYLH
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLF-----AQQICEGMAYLH 134
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              S   IHR++ + N+LLD D   KI DFG+AK
Sbjct: 135 ---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 681 DNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNIL 734
           + +IG+G  G+V R  LK   K    VA+K L  G      + F +E  I+G+  H NI+
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           +L   +       ++ E+M NG L   L  R+ +G  +    +   +  G A G+ YL  
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFL--RLNDG--QFTVIQLVGMLRGIASGMRYLAE 134
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                 +HRD+ + NIL++ +   K++DFG+++  E +     Y+   G
Sbjct: 135 MS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 12/183 (6%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNI 733
           + E   +IGSG T  V           VA+K++        +     E++ + +  H NI
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGIA 790
           +  Y   +     +LV++ +  G++   +   V +G+ +   LD      I     +G+ 
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD---YSCFAGTHGY 847
           YLH +     IHRD+K+ NILL ED   +IADFGV+        ++       F GT  +
Sbjct: 136 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 848 IAP 850
           +AP
Sbjct: 193 MAP 195

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 684 IGSGGTGKVYR-----LDLKK--NAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V       LD  K      VAVK L K D  +       +EME++  I +H+
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 83
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG---------KPELDWFRR--YK 780
           NI+ L     + G  ++++EY   GNL + L  R   G          PE     +    
Sbjct: 84  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            A   A+G+ YL    S   IHRD+ + N+L+ ED   KIADFG+A+
Sbjct: 144 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 684 IGSGGTGKVYR-----LDLKK--NAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V       LD  K      VAVK L K D  +       +EME++  I +H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG---------KPELDWFRR--YK 780
           NI+ L     + G  ++++EY   GNL + L  R   G          PE     +    
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            A   A+G+ YL    S   IHRD+ + N+L+ ED   KIADFG+A+
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 684 IGSGGTGKVYR-----LDLKK--NAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V       LD  K      VAVK L K D  +       +EME++  I +H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYK 780
           NI+ L     + G  ++++EY   GNL + L  R   G           + +L       
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            A   A+G+ YL    S   IHRD+ + N+L+ ED   KIADFG+A+
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 69/140 (49%), Gaps = 20/140 (14%)
Query: 704 VAVKQLWKGDGVKV----FAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL 758
           VAVK L K D  +       +EME++  I +H+NI+ L     + G  ++++EY   GNL
Sbjct: 55  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 113
Query: 759 FQALHKRVKEG---------KPELDWFRR--YKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
            + L  R   G          PE     +     A   A+G+ YL    S   IHRD+ +
Sbjct: 114 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 170
Query: 808 SNILLDEDYEPKIADFGVAK 827
            N+L+ ED   KIADFG+A+
Sbjct: 171 RNVLVTEDNVMKIADFGLAR 190

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 684 IGSGGTGKVYR-----LDLKK--NAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V       LD  K      VAVK L K D  +       +EME++  I +H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG---------KPELDWFRR--YK 780
           NI+ L     + G  ++++EY   GNL + L  R   G          PE     +    
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            A   A+G+ YL    S   IHRD+ + N+L+ ED   KIADFG+A+
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 684 IGSGGTGKVYR-----LDLKK--NAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V       LD  K      VAVK L K D  +       +EME++  I +H+
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 87
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG---------KPELDWFRR--YK 780
           NI+ L     + G  ++++EY   GNL + L  R   G          PE     +    
Sbjct: 88  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            A   A+G+ YL    S   IHRD+ + N+L+ ED   KIADFG+A+
Sbjct: 148 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V          D  K A TVAVK L K D  +       +EME++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYK 780
           NI+ L     + G  ++++ Y   GNL + L  R   G           + ++ +     
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
                A+G+ YL    S   IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNIL-KL 736
           ++G G  GKV   D K      A+K L K      D V+    E  +L  +     L +L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       + V+EY+  G+L   + +  K  +P+  ++     A   + G+ +LH   
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY-----AAEISIGLFFLHKRG 140
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N++LD +   KIADFG+ K  E+         F GT  YIAP
Sbjct: 141 ---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAP 189

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 87/180 (48%), Gaps = 23/180 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           IG+G  G V     +     VA+K++     V   A     E++IL   +H NI+ +   
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 740 LL------KGGSSFLVLEYMPNGNLFQALHKRVKEGKP-ELDWFRRYKIALGAAKGIAYL 792
           L       +  S ++VL+ M +      LH+ +   +P  L+  R +   L   +G+ Y+
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESD-----LHQIIHSSQPLTLEHVRYFLYQL--LRGLKYM 174
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY--SCFAGTHGYIAP 850
           H   S  +IHRD+K SN+L++E+ E KI DFG+A+    SP    Y  + +  T  Y AP
Sbjct: 175 H---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 12/183 (6%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNI 733
           + E   +IGSG T  V           VA+K++        +     E++ + +  H NI
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGIA 790
           +  Y   +     +LV++ +  G++   +   V +G+ +   LD      I     +G+ 
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD---YSCFAGTHGY 847
           YLH +     IHRD+K+ NILL ED   +IADFGV+        ++       F GT  +
Sbjct: 131 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 848 IAP 850
           +AP
Sbjct: 188 MAP 190

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 22/180 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--RHRNILKLYACLL 741
           IG G  G+V+R   K     VAVK ++     + +  E EI   +  RH NIL   A   
Sbjct: 50  IGKGRFGEVWRG--KWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 742 KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC- 796
           K   ++    LV +Y  +G+LF  L++     +  +      K+AL  A G+A+LH +  
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHMEIV 160
Query: 797 ----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS--CFAGTHGYIAP 850
                P I HRD+KS NIL+ ++    IAD G+A   +++    D +     GT  Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI-------ALGAA 786
            L  AC   GG   +++E+   GNL   L  +  E  P  D ++ +         +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
           KG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 198

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 23/180 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           IG+G  G V     +     VA+K++     V   A     E++IL   +H NI+ +   
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 740 LLKG------GSSFLVLEYMPNGNLFQALHKRVKEGKP-ELDWFRRYKIALGAAKGIAYL 792
           L          S ++VL+ M +      LH+ +   +P  L+  R +   L   +G+ Y+
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESD-----LHQIIHSSQPLTLEHVRYFLYQL--LRGLKYM 175
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY--SCFAGTHGYIAP 850
           H   S  +IHRD+K SN+L++E+ E KI DFG+A+    SP    Y  + +  T  Y AP
Sbjct: 176 H---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYA 738
           L+G G  G V +   K     VA+K+  + D      K+   E+++L ++RH N++ L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 739 CLLKGGSSFLVLEYM-----------PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
              K    +LV E++           PNG  +Q + K +                     
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL----------------FQIIN 135
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
           GI + H   S  IIHRDIK  NIL+ +    K+ DFG A+      +V D      T  Y
Sbjct: 136 GIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWY 190
Query: 848 IAP 850
            AP
Sbjct: 191 RAP 193

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 35/201 (17%)
Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNIL 734
            + EE  ++G G  G+V +     ++   A+K++   +  +    +E+ +L  + H+ ++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVV 65
Query: 735 KLYACLL-------------KGGSSFLVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYK 780
           + YA  L             K  + F+  EY  N  L+  +H + + + + E  ++R ++
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE--YWRLFR 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-----------IA 829
             L A   ++Y+H   S  IIHR++K  NI +DE    KI DFG+AK            +
Sbjct: 124 QILEA---LSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 830 ENSPKVSD-YSCFAGTHGYIA 849
           +N P  SD  +   GT  Y+A
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVA 198

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 22/180 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--RHRNILKLYACLL 741
           IG G  G+V+R   K     VAVK ++     + +  E EI   +  RH NIL   A   
Sbjct: 37  IGKGRFGEVWRG--KWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 93
Query: 742 KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC- 796
           K   ++    LV +Y  +G+LF  L++     +  +      K+AL  A G+A+LH +  
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHMEIV 147
Query: 797 ----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS--CFAGTHGYIAP 850
                P I HRD+KS NIL+ ++    IAD G+A   +++    D +     GT  Y+AP
Sbjct: 148 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEI 724
           + +D E++    E   IG G  G+V++    +    VA+K +      D ++    E+ +
Sbjct: 1   MSLDPEELFTKLEK--IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 58
Query: 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG 784
           L +     + K Y   LK    ++++EY+  G+    L     E  P LD  +   I   
Sbjct: 59  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGP-LDETQIATILRE 112
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAG 843
             KG+ YLH +     IHRDIK++N+LL E  E K+ADFGVA ++ +   K    + F G
Sbjct: 113 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVG 166
Query: 844 THGYIAP 850
           T  ++AP
Sbjct: 167 TPFWMAP 173

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 22/180 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--RHRNILKLYACLL 741
           IG G  G+V+R   K     VAVK ++     + +  E EI   +  RH NIL   A   
Sbjct: 12  IGKGRFGEVWRG--KWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 68
Query: 742 KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC- 796
           K   ++    LV +Y  +G+LF  L++     +  +      K+AL  A G+A+LH +  
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHMEIV 122
Query: 797 ----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS--CFAGTHGYIAP 850
                P I HRD+KS NIL+ ++    IAD G+A   +++    D +     GT  Y+AP
Sbjct: 123 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 25/177 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      +    VA+K+L++    ++FA     E+ +L  +RH N++ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 740 LLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                +       +LV+ +M  G     L K  K G+  +  F  Y++     KG+ Y+H
Sbjct: 93  FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQ-FLVYQML----KGLRYIH 145
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              +  IIHRD+K  N+ ++ED E KI DFG+A+ A+     S+      T  Y AP
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMXGXVVTRWYRAP 194

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKL 736
           +G G  GKV     Y L   K+   VAVK L        K F  E E+L  ++H +I+K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK-----------RVKEGKPELDWFRRYKIALGA 785
           Y     G    +V EYM +G+L + L             + ++ K EL   +   IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           A G+ YL    S   +HRD+ + N L+  +   KI DFG+++
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 662 LASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVF 718
           L    ++  D E++    E   IG G  G+V++    +    VA+K +      D ++  
Sbjct: 10  LPGMQNLKADPEELFTKLEK--IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI 67
Query: 719 AAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRR 778
             E+ +L +     + K Y   LK    ++++EY+  G+    L     E  P LD  + 
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGP-LDETQI 121
Query: 779 YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSD 837
             I     KG+ YLH +     IHRDIK++N+LL E  E K+ADFGVA ++ +   K   
Sbjct: 122 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--- 175
Query: 838 YSCFAGTHGYIAP 850
            + F GT  ++AP
Sbjct: 176 RNXFVGTPFWMAP 188

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVK---QLWKGDGVKVFAAEMEILGKIRHRNILKLYA 738
           +++G G T  V+R   KK     A+K    +     V V   E E+L K+ H+NI+KL+A
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 739 CLLKGGS--SFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHD 795
              +  +    L++E+ P G+L+  L +     G PE ++    +  +G       ++H 
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG------MNHL 128
Query: 796 CSPPIIHRDIKSSNIL--LDEDYEP--KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
               I+HR+IK  NI+  + ED +   K+ DFG A+  E+  +   +    GT  Y+ P
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHP 184

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHR 731
           +G G  G+V          D  K A TVAVK L K D  +       +EME++  I +H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYK 780
           NI+ L     + G  ++++ Y   GNL + L  R   G           + ++ +     
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
                A+G+ YL    S   IHRD+ + N+L+ E+   KIADFG+A+   N
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 88/190 (46%), Gaps = 42/190 (22%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAA--------EMEILGKI--RHR 731
           IG G  G+V+R               W+G+   VK+F++        E EI   +  RH 
Sbjct: 17  IGKGRFGEVWRGK-------------WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHE 63
Query: 732 NILKLYACLLKGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           NIL   A   K   ++    LV +Y  +G+LF  L++     +  +      K+AL  A 
Sbjct: 64  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTAS 117
Query: 788 GIAYLHHDC-----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS--C 840
           G+A+LH +       P I HRD+KS NIL+ ++    IAD G+A   +++    D +   
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 841 FAGTHGYIAP 850
             GT  Y+AP
Sbjct: 178 RVGTKRYMAP 187

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 22/180 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--RHRNILKLYACLL 741
           IG G  G+V+R   K     VAVK ++     + +  E EI   +  RH NIL   A   
Sbjct: 11  IGKGRFGEVWRG--KWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 742 KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC- 796
           K   ++    LV +Y  +G+LF  L++     +  +      K+AL  A G+A+LH +  
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHMEIV 121
Query: 797 ----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS--CFAGTHGYIAP 850
                P I HRD+KS NIL+ ++    IAD G+A   +++    D +     GT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 40/203 (19%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKL 736
           + +E  LIGSGG G+V++   + +  T  ++++ K +  K    E++ L K+ H NI+  
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV-KYNNEKA-EREVKALAKLDHVNIVHY 70
Query: 737 YACL-----------------------------LKGGSSFLVLEYMPNGNLFQALHKRVK 767
             C                               K    F+ +E+   G L Q + KR  
Sbjct: 71  NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 768 EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           E   +LD     ++     KG+ Y+H   S  +IHRD+K SNI L +  + KI DFG+  
Sbjct: 131 E---KLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 828 IAENSPKVSDYSCFAGTHGYIAP 850
             +N  K +      GT  Y++P
Sbjct: 185 SLKNDGKRTRSK---GTLRYMSP 204

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVK---QLWKGDGVKVFAAEMEILGKIRHRNILKLYA 738
           +++G G T  V+R   KK     A+K    +     V V   E E+L K+ H+NI+KL+A
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 739 CLLKGGS--SFLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHD 795
              +  +    L++E+ P G+L+  L +     G PE ++    +  +G       ++H 
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG------MNHL 128
Query: 796 CSPPIIHRDIKSSNIL--LDEDYEP--KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
               I+HR+IK  NI+  + ED +   K+ DFG A+  E+  +   +    GT  Y+ P
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVXLYGTEEYLHP 184

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 22/180 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--RHRNILKLYACLL 741
           IG G  G+V+R   K     VAVK ++     + +  E EI   +  RH NIL   A   
Sbjct: 14  IGKGRFGEVWRG--KWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 70
Query: 742 KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC- 796
           K   ++    LV +Y  +G+LF  L++     +  +      K+AL  A G+A+LH +  
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHMEIV 124
Query: 797 ----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS--CFAGTHGYIAP 850
                P I HRD+KS NIL+ ++    IAD G+A   +++    D +     GT  Y+AP
Sbjct: 125 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID  ++  ++E   IGSG  G V+ L    N   VA+K + +G    + F  E E++ K+
Sbjct: 4   IDPSELTFVQE---IGSGQFGLVH-LGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 59
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY   L+     LV E+M +G L   L  R + G    +      + L   +G
Sbjct: 60  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAE--TLLGMCLDVCEG 115
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
           +AYL       +IHRD+ + N L+ E+   K++DFG+ +  
Sbjct: 116 MAYLEE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRFV 153

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 18/182 (9%)
Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAE 721
           IDI   +I     + +IG+G  G+V    LK   K    VA+K L  G   K    F +E
Sbjct: 30  IDISCVKI-----EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 84
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
             I+G+  H N++ L   + K     ++ E+M NG+L   L    ++   +    +   +
Sbjct: 85  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL----RQNDGQFTVIQLVGM 140
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
             G A G+ YL        +HRD+ + NIL++ +   K++DFG+++  E+      Y+  
Sbjct: 141 LRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 842 AG 843
            G
Sbjct: 198 LG 199

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEI 724
           + +D E++    E   IG G  G+V++    +    VA+K +      D ++    E+ +
Sbjct: 1   MSLDPEELFTKLEK--IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 58
Query: 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG 784
           L +     + K Y   LK    ++++EY+  G+    L     E  P LD  +   I   
Sbjct: 59  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGP-LDETQIATILRE 112
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAG 843
             KG+ YLH +     IHRDIK++N+LL E  E K+ADFGVA ++ +   K    + F G
Sbjct: 113 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNXFVG 166
Query: 844 THGYIAP 850
           T  ++AP
Sbjct: 167 TPFWMAP 173

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 81/150 (54%), Gaps = 9/150 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G+G  G+V+      N   VA+K L  G    + F  E +I+ K++H  +++LYA ++ 
Sbjct: 17  LGNGQFGEVWMGTWNGNT-KVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYA-VVS 74
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
               ++V EYM  G+L   L  +  EG+  L       +A   A G+AY+        IH
Sbjct: 75  EEPIYIVTEYMNKGSLLDFL--KDGEGR-ALKLPNLVDMAAQVAAGMAYIERMN---YIH 128
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           RD++S+NIL+      KIADFG+A++ E++
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDN 158

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 78/154 (50%), Gaps = 20/154 (12%)
Query: 684 IGSGGTGKV--YRLDLKKNAGT---VAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  GKV  Y  D   N GT   VAVK L    G +    +  E++IL  + H +I+K
Sbjct: 22  LGEGHFGKVSLYCYD-PTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 736 LYACLLKGG--SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
              C    G  S  LV+EY+P G+L   L  R   G  +L  F     A    +G+AYLH
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLF-----AQQICEGMAYLH 134
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              +   IHR++ + N+LLD D   KI DFG+AK
Sbjct: 135 ---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 19/170 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNIL-KLYACLLK 742
           I    TGK+Y + + K A  V      K    +    E ++L  IR    L  L+     
Sbjct: 76  ISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
                L+L+Y+  G LF  L +R +        F  +++ +   + +  L H     II+
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRER--------FTEHEVQIYVGEIVLALEHLHKLGIIY 182
Query: 803 RDIKSSNILLDEDYEPKIADFGVAK--IAENSPKVSDYSCFAGTHGYIAP 850
           RDIK  NILLD +    + DFG++K  +A+ + +  D   F GT  Y+AP
Sbjct: 183 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD---FCGTIEYMAP 229

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 20/173 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLL 741
           IGSG  G    +  K++   VAVK + +G+ +     + EI+    +RH NI++    +L
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE-NVKREIINHRSLRHPNIVRFKEVIL 85
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
                 +V+EY   G LF+ +    +  + E  +F +  I+     G++Y H   +  + 
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVC 137
Query: 802 HRDIKSSNILLDEDYEP--KIADFGVAK--IAENSPKVSDYSCFAGTHGYIAP 850
           HRD+K  N LLD    P  KI  FG +K  +  + PK +      GT  YIAP
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST-----VGTPAYIAP 185

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQM-------ELDHERMSYLLYQMLXGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EYMP G++F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    K+ADFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 677 NLEEDNLIGSGGTGKV-----YRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKI 728
           NL+    +G+G  GKV     + L  +     VAVK L      D  +   +E++I+  +
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 98
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK------EGKPELDWFRRYKI 781
            +H NI+ L      GG   ++ EY   G+L   L ++ +      +G+P L+       
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP-LELRDLLHF 157
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +   A+G+A+L    S   IHRD+ + N+LL   +  KI DFG+A+
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 200

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--RHRNILKLYACLL 741
           +G G  G+V+R   +     VAVK ++     K +  E E+   +  RH NIL   A  +
Sbjct: 16  VGKGRYGEVWRGSWQ--GENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 742 KGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC- 796
               S    +L+  Y   G+L+  L          LD     +I L  A G+A+LH +  
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 797 ----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY--SCFAGTHGYIAP 850
                P I HRD+KS NIL+ ++ +  IAD G+A +   S    D   +   GT  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EYMP G++F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    K+ADFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 683 LIGSGGTGKVYRLDLKKN----AGTVAVKQLWKGD-GVKVFAAEMEILGKI-RHRNILKL 736
           +IG G   KV  + LKK     A  V  K+L   D  +     E  +  +   H  ++ L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       F V+EY+  G+L    H + +   PE +  R Y   +  A  + YLH   
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPE-EHARFYSAEISLA--LNYLHERG 173
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD +   K+ D+G+ K  E        S F GT  YIAP
Sbjct: 174 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 222

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEILGKIRHRN 732
           + E+ + +G+G  G V+++   K +G V  ++L     K         E+++L +     
Sbjct: 7   DFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+  Y      G   + +E+M  G+L Q L K  +  +  L      K+++   KG+ YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                  I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT  Y++P
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSP 172

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEILGKIRHRN 732
           + E+ + +G+G  G V+++   K +G V  ++L     K         E+++L +     
Sbjct: 69  DFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+  Y      G   + +E+M  G+L Q L K  +  +  L      K+++   KG+ YL
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 182
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                  I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT  Y++P
Sbjct: 183 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSP 234

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKI-RHRNILKL 736
           +IG G   KV  + LKK     A+K + K      + +     E  +  +   H  ++ L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       F V+EY+  G+L    H + +   PE +  R Y   +  A  + YLH   
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPE-EHARFYSAEISLA--LNYLHERG 141
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD +   K+ D+G+ K  E        S F GT  YIAP
Sbjct: 142 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 190

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEILGKIRHRN 732
           + E+ + +G+G  G V+++   K +G V  ++L     K         E+++L +     
Sbjct: 7   DFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+  Y      G   + +E+M  G+L Q L K  +  +  L      K+++   KG+ YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                  I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT  Y++P
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSP 172

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEILGKIRHRN 732
           + E+ + +G+G  G V+++   K +G V  ++L     K         E+++L +     
Sbjct: 7   DFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+  Y      G   + +E+M  G+L Q L K  +  +  L      K+++   KG+ YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                  I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT  Y++P
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSP 172

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEILGKIRHRN 732
           + E+ + +G+G  G V+++   K +G V  ++L     K         E+++L +     
Sbjct: 7   DFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+  Y      G   + +E+M  G+L Q L K  +  +  L      K+++   KG+ YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                  I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT  Y++P
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSP 172

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEILGKIRHRN 732
           + E+ + +G+G  G V+++   K +G V  ++L     K         E+++L +     
Sbjct: 7   DFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+  Y      G   + +E+M  G+L Q L K  +  +  L      K+++   KG+ YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                  I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT  Y++P
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSP 172

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEILGKIRHRN 732
           + E+ + +G+G  G V+++   K +G V  ++L     K         E+++L +     
Sbjct: 26  DFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+  Y      G   + +E+M  G+L Q L K  +  +  L      K+++   KG+ YL
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 139
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                  I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT  Y++P
Sbjct: 140 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSP 191

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 20/173 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLL 741
           IGSG  G    +  K++   VAVK + +G+ +     + EI+    +RH NI++    +L
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE-NVKREIINHRSLRHPNIVRFKEVIL 85
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
                 +V+EY   G LF+ +    +  + E  +F +  I+     G++Y H   +  + 
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVC 137
Query: 802 HRDIKSSNILLDEDYEP--KIADFGVAK--IAENSPKVSDYSCFAGTHGYIAP 850
           HRD+K  N LLD    P  KI  FG +K  +  + PK +      GT  YIAP
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT-----VGTPAYIAP 185

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKI-RHRNILKL 736
           +IG G   KV  + LKK     A+K + K      + +     E  +  +   H  ++ L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       F V+EY+  G+L    H + +   PE +  R Y   +  A  + YLH   
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPE-EHARFYSAEISLA--LNYLHERG 126
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD +   K+ D+G+ K  E        S F GT  YIAP
Sbjct: 127 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 175

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 677 NLEEDNLIGSGGTGKV-----YRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKI 728
           NL+    +G+G  GKV     + L  +     VAVK L      D  +   +E++I+  +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK------EGKPELDWFRRYKI 781
            +H NI+ L      GG   ++ EY   G+L   L ++ +      +G+P L+       
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP-LELRDLLHF 165
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +   A+G+A+L    S   IHRD+ + N+LL   +  KI DFG+A+
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 208

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 86/177 (48%), Gaps = 26/177 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V     K++   VA+K+L +    ++FA     E+ +L  ++H N++ L   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 740 LLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                S       +LV+ +M   +L + +  +  E K +        +     KG+ Y+H
Sbjct: 92  FTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQY-------LVYQMLKGLKYIH 143
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  ++HRD+K  N+ ++ED E KI DFG+A+ A+     ++ + +  T  Y AP
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYRAP 192

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIRHRNILKLYAC 739
            ++GSG   +V+ +  +      A+K + K    +  + E EI  L KI+H NI+ L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                  +LV++ +  G LF  + +R      E D     +  L A K   YLH +    
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVK---YLHEN---G 126
Query: 800 IIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           I+HRD+K  N+L    +E+ +  I DFG++K+ +N   +   +C  GT GY+AP
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTAC--GTPGYVAP 176

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEILGKIRHRN 732
           + E+ + +G+G  G V+++   K +G V  ++L     K         E+++L +     
Sbjct: 34  DFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+  Y      G   + +E+M  G+L Q L K  +  +  L      K+++   KG+ YL
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 147
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                  I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT  Y++P
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSP 199

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKI-RHRNILKL 736
           +IG G   KV  + LKK     A+K + K      + +     E  +  +   H  ++ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       F V+EY+  G+L    H + +   PE +  R Y   +  A  + YLH   
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPE-EHARFYSAEISLA--LNYLHERG 130
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD +   K+ D+G+ K  E        S F GT  YIAP
Sbjct: 131 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 179

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 76/150 (50%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAGT-VAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L  N G  VAVKQL     D  + F  E++IL  +    I+K     
Sbjct: 21  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 80
Query: 741 LKGG--SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G  S  LV+EY+P+G L   L +     +  LD  R    +    KG+ YL    S 
Sbjct: 81  YGPGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLG---SR 133
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             +HRD+ + NIL++ +   KIADFG+AK+
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKL 163

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 76/150 (50%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAGT-VAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L  N G  VAVKQL     D  + F  E++IL  +    I+K     
Sbjct: 34  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93
Query: 741 LKGG--SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G  S  LV+EY+P+G L   L +     +  LD  R    +    KG+ YL    S 
Sbjct: 94  YGPGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLG---SR 146
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             +HRD+ + NIL++ +   KIADFG+AK+
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKL 176

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 76/150 (50%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAGT-VAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L  N G  VAVKQL     D  + F  E++IL  +    I+K     
Sbjct: 22  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 81
Query: 741 LKGG--SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G  S  LV+EY+P+G L   L +     +  LD  R    +    KG+ YL    S 
Sbjct: 82  YGPGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLG---SR 134
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             +HRD+ + NIL++ +   KIADFG+AK+
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKL 164

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 85/172 (49%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAG-TVAVKQLW---KGDGV-KVFAAEMEILGKIRHRNILKLYA 738
           IG G  G VY+   + N G T A+K++    + +G+      E+ IL +++H NI+KLY 
Sbjct: 10  IGEGTYGVVYKA--QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
            +       LV E++      Q L K +   +  L+        L    GIAY H     
Sbjct: 68  VIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            ++HRD+K  N+L++ + E KIADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIP-VRKYTHEVVTLWYRAP 169

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 83/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +        K    E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQM-------ELDHERMSYLLYQMLXGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 85/172 (49%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAG-TVAVKQLW---KGDGV-KVFAAEMEILGKIRHRNILKLYA 738
           IG G  G VY+   + N G T A+K++    + +G+      E+ IL +++H NI+KLY 
Sbjct: 10  IGEGTYGVVYKA--QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
            +       LV E++      Q L K +   +  L+        L    GIAY H     
Sbjct: 68  VIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            ++HRD+K  N+L++ + E KIADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIP-VRKYTHEVVTLWYRAP 169

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 81/187 (43%), Gaps = 25/187 (13%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAE------------MEI 724
           N E   ++G G +  V R   K      AVK +    G   F+AE            ++I
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVK-IIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 725 LGKIR-HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           L K+  H NI++L          FLV + M  G LF  L ++V   + E       KI  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-----KIMR 118
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
              + I  LH      I+HRD+K  NILLD+D   K+ DFG +   +   K+ +     G
Sbjct: 119 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCG 172
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 173 TPSYLAP 179

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 26/177 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V     K++   VA+K+L +    ++FA     E+ +L  ++H N++ L   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 740 LLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                S       +LV+ +M   +L + +     E K +        +     KG+ Y+H
Sbjct: 110 FTPASSLRNFYDFYLVMPFM-QTDLQKIMGMEFSEEKIQY-------LVYQMLKGLKYIH 161
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  ++HRD+K  N+ ++ED E KI DFG+A+ A+     ++ + +  T  Y AP
Sbjct: 162 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYRAP 210

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQM-------ELDHERMSYLLYQMLXGIK 133
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 134 HLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 187

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 15/173 (8%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  +  K      A+K L K + +K      F  E +I+       +++L+
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    ++V+EYMP G+L   +        PE  W R Y      A+ +  L    S
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPE-KWARFY-----TAEVVLALDAIHS 186
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              IHRD+K  N+LLD+    K+ADFG   +  N   +       GT  YI+P
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 238

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 654 KEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD 713
           K  +SK K    H  D +  ++        IG G  G+V  + LK      A+K L K +
Sbjct: 60  KPFTSKVKQMRLHREDFEILKV--------IGRGAFGEVAVVKLKNADKVFAMKILNKWE 111
Query: 714 GVK-----VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE 768
            +K      F  E ++L     + I  L+       + +LV++Y   G+L   L K    
Sbjct: 112 MLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR 171
Query: 769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-K 827
              E+  F   ++ + A   +  LH+      +HRDIK  NIL+D +   ++ADFG   K
Sbjct: 172 LPEEMARFYLAEMVI-AIDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 828 IAENSPKVSDYSCFAGTHGYIAP 850
           + E+    S  S   GT  YI+P
Sbjct: 225 LMEDGTVQS--SVAVGTPDYISP 245

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 15/173 (8%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  +  K      A+K L K + +K      F  E +I+       +++L+
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    ++V+EYMP G+L   +        PE  W R Y      A+ +  L    S
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPE-KWARFY-----TAEVVLALDAIHS 191
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              IHRD+K  N+LLD+    K+ADFG   +  N   +       GT  YI+P
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 243

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 15/173 (8%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  +  K      A+K L K + +K      F  E +I+       +++L+
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    ++V+EYMP G+L   +        PE  W R Y      A+ +  L    S
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPE-KWARFY-----TAEVVLALDAIHS 191
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              IHRD+K  N+LLD+    K+ADFG   +  N   +       GT  YI+P
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 243

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 83/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +        K    E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 81/187 (43%), Gaps = 25/187 (13%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAE------------MEI 724
           N E   ++G G +  V R   K      AVK +    G   F+AE            ++I
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVK-IIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 725 LGKIR-HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           L K+  H NI++L          FLV + M  G LF  L ++V   + E       KI  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-----KIMR 131
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
              + I  LH      I+HRD+K  NILLD+D   K+ DFG +   +   K+ +     G
Sbjct: 132 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCG 185
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 186 TPSYLAP 192

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 85/172 (49%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAG-TVAVKQLW---KGDGV-KVFAAEMEILGKIRHRNILKLYA 738
           IG G  G VY+   + N G T A+K++    + +G+      E+ IL +++H NI+KLY 
Sbjct: 10  IGEGTYGVVYKA--QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
            +       LV E++      Q L K +   +  L+        L    GIAY H     
Sbjct: 68  VIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            ++HRD+K  N+L++ + E KIADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIP-VRKYTHEIVTLWYRAP 169

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 92/182 (50%), Gaps = 13/182 (7%)
Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKI 728
           E + N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H NI+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQG 122
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           +A+ H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y 
Sbjct: 123 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYR 177
Query: 849 AP 850
           AP
Sbjct: 178 AP 179

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 663 ASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM 722
           AS   +D+D     NL+   LIG G  G VY+  L +    VAVK ++     + F  E 
Sbjct: 5   ASEPSLDLD-----NLKLLELIGRGRYGAVYKGSLDERP--VAVK-VFSFANRQNFINEK 56
Query: 723 EI--LGKIRHRNILKLYA----CLLKGGSSFL-VLEYMPNGNLFQALHKRVKEGKPELDW 775
            I  +  + H NI +           G   +L V+EY PNG+L + L           DW
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DW 110
Query: 776 FRRYKIALGAAKGIAYLHHDC------SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KI 828
               ++A    +G+AYLH +        P I HRD+ S N+L+  D    I+DFG++ ++
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 829 AEN---SPKVSDYSCFA--GTHGYIAP 850
             N    P   D +  +  GT  Y+AP
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAP 197

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 80/170 (47%), Gaps = 24/170 (14%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKE---GKPELDWFRRY-------KIAL 783
            L  AC   GG   +++E+   GNL   L  +  E    KPE D ++ +         + 
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE-DLYKDFLTLEHLIXYSF 155
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
             AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 156 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKI 728
           D  Q   LE  N IG G  G+V     K      A K++ K   + V  F  E+EI+  +
Sbjct: 23  DINQYYTLE--NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 80
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKIALGAAK 787
            H NI++LY         +LV+E    G LF+  +HKRV     E D  R  K  L A  
Sbjct: 81  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR---ESDAARIMKDVLSA-- 135
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVA 826
            +AY H      + HRD+K  N L      D   K+ DFG+A
Sbjct: 136 -VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 173

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 684 IGSGGTGKVYR-LDLKKNAGTVA--------VKQLWKGD-GVKVFAAEMEILGKIRHRNI 733
           +GSG  G V+  +D +KN   V         ++  W  D  +     E+ IL ++ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 734 LKLYACLLKGGSSFLVLEYMPNG-NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           +K+       G   LV+E   +G +LF  + +  +  +P   +  R  ++      + YL
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-----AVGYL 146
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                  IIHRDIK  NI++ ED+  K+ DFG A   E       +  F GT  Y AP
Sbjct: 147 RLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCAP 198

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 92/182 (50%), Gaps = 13/182 (7%)
Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKI 728
           E + N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H NI+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQG 122
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           +A+ H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y 
Sbjct: 123 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYR 177
Query: 849 AP 850
           AP
Sbjct: 178 AP 179

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 59/133 (44%), Gaps = 14/133 (10%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ +L  + H NI+KL+         +LV E+   G LF+ +  R K      D      
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-----FDECDAAN 150
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKIADFGVAKIAENSPKVSD 837
           I      GI YLH      I+HRDIK  NILL+        KI DFG++       K+ D
Sbjct: 151 IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 838 YSCFAGTHGYIAP 850
                GT  YIAP
Sbjct: 208 R---LGTAYYIAP 217

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKI 728
           D  Q   LE  N IG G  G+V     K      A K++ K   + V  F  E+EI+  +
Sbjct: 6   DINQYYTLE--NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKIALGAAK 787
            H NI++LY         +LV+E    G LF+  +HKRV     E D  R  K  L A  
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR---ESDAARIMKDVLSA-- 118
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVA 826
            +AY H      + HRD+K  N L      D   K+ DFG+A
Sbjct: 119 -VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 77/185 (41%), Gaps = 33/185 (17%)
Query: 685 GSGGTGKVYRLDLKKNAGTVAV-----KQLWKGDGVKVFAAEMEILGK--IRHRNILKLY 737
             G  G V++  L  +   V +     KQ W+        +E EI     ++H N+L+  
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQ--------SEREIFSTPGMKHENLLQFI 75
Query: 738 ACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           A   +G +     +L+  +   G+L   L   +      + W     +A   ++G++YLH
Sbjct: 76  AAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI------ITWNELCHVAETMSRGLSYLH 129
Query: 794 HDC--------SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
            D          P I HRD KS N+LL  D    +ADFG+A   E      D     GT 
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 846 GYIAP 850
            Y+AP
Sbjct: 190 RYMAP 194

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAP 173

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAP 172

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 118
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAP 171

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 118
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAP 171

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAP 172

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/135 (39%), Positives = 68/135 (50%), Gaps = 19/135 (14%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKP-ELDWFR 777
           E+ IL K+ H N++KL   L        ++V E +  G + +     V   KP   D  R
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPTLKPLSEDQAR 140
Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
            Y   L   KGI YLH+     IIHRDIK SN+L+ ED   KIADFGV+    N  K SD
Sbjct: 141 FYFQDL--IKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS----NEFKGSD 191
Query: 838 --YSCFAGTHGYIAP 850
              S   GT  ++AP
Sbjct: 192 ALLSNTVGTPAFMAP 206

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 685 GSGGTGKVYRLD-LKKNAGT-VAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACL 740
           G+ G+ ++ R D L  N G  VAVKQL     D  + F  E++IL  +    I+K     
Sbjct: 18  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 77
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              G     LV+EY+P+G L   L +     +  LD  R    +    KG+ YL    S 
Sbjct: 78  YGPGRPELRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLG---SR 130
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             +HRD+ + NIL++ +   KIADFG+AK+
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKL 160

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEIL 725
           +D E    +E+   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L
Sbjct: 4   VDMENFQKVEK---IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
            ++ H NI+KL   +      +LV E++ + +L + +      G P L   + Y   L  
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL-- 116
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
            +G+A+ H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T 
Sbjct: 117 LQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTL 171
Query: 846 GYIAP 850
            Y AP
Sbjct: 172 WYRAP 176

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAP 172

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 65/130 (50%), Gaps = 11/130 (8%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+++L +     I+  Y      G   + +E+M  G+L Q L K  K    E+      K
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEI----LGK 118
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
           +++   +G+AYL       I+HRD+K SNIL++   E K+ DFGV+    +S   S    
Sbjct: 119 VSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---- 172
Query: 841 FAGTHGYIAP 850
           F GT  Y+AP
Sbjct: 173 FVGTRSYMAP 182

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 178
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 179 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAP 232

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 92/174 (52%), Gaps = 16/174 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGT-VAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
           +G+G    VY+  L K  G  VA+K+  L   +G    A  E+ ++ +++H NI++LY  
Sbjct: 13  LGNGTYATVYK-GLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP---ELDWFRRYKIALGAAKGIAYLHHDC 796
           +       LV E+M N +L + +  R     P   EL+  + ++  L   +G+A+ H + 
Sbjct: 72  IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQGLAFCHEN- 127
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I+HRD+K  N+L+++  + K+ DFG+A+ A   P V+ +S    T  Y AP
Sbjct: 128 --KILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIP-VNTFSSEVVTLWYRAP 177

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 90/189 (47%), Gaps = 18/189 (9%)
Query: 666 HHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEM 722
            H  +D E++    + + IG G  G+VY+         VA+K +      D ++    E+
Sbjct: 11  QHSRVDPEEL--FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEI 68
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            +L +     I + +   LK    ++++EY+  G+    L    K G  E  +     I 
Sbjct: 69  TVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIA--TIL 122
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCF 841
               KG+ YLH +     IHRDIK++N+LL E  + K+ADFGVA ++ +   K    + F
Sbjct: 123 REILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNXF 176
Query: 842 AGTHGYIAP 850
            GT  ++AP
Sbjct: 177 VGTPFWMAP 185

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 81/177 (45%), Gaps = 24/177 (13%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY-- 737
           IGSG  G V           VAVK+L +    +  A     E+ +L  + H+NI+ L   
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 738 ----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                 L +    +LV+E M + NL Q +H        ELD  R   +      GI +LH
Sbjct: 90  FTPQKTLEEFQDVYLVMELM-DANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH 141
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  IIHRD+K SNI++  D   KI DFG+A+ A  +  ++ Y     T  Y AP
Sbjct: 142 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVV---TRYYRAP 192

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 17/174 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  +  K +    A+K L K + +K      F  E +I+       +++L+
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    ++V+EYMP G+L   +        PE  W + Y      A+ +  L    S
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPE-KWAKFY-----TAEVVLALDAIHS 192
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
             +IHRD+K  N+LLD+    K+ADFG   K+ E      D +   GT  YI+P
Sbjct: 193 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA--VGTPDYISP 244

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 80/187 (42%), Gaps = 25/187 (13%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAE------------MEI 724
           N E   ++G G +  V R   K      AVK +    G   F+AE            ++I
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVK-IIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 725 LGKIR-HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           L K+  H NI++L          FLV + M  G LF  L ++V   + E       KI  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-----KIMR 131
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
              + I  LH      I+HRD+K  NILLD+D   K+ DFG +   +   K+       G
Sbjct: 132 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS---VCG 185
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 186 TPSYLAP 192

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 650 ENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK-- 707
           ENGE   SS WK  +      D ++I   +E   +G+G   +V   + K      AVK  
Sbjct: 5   ENGES--SSSWKKQA-----EDIKKIFEFKE--TLGTGAFSEVVLAEEKATGKLFAVKCI 55
Query: 708 --QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR 765
             +  KG    +   E+ +L KI+H NI+ L          +LV++ +  G LF  +   
Sbjct: 56  PKKALKGKESSI-ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI--- 111
Query: 766 VKEG-KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIA 821
           V++G   E D     +  L A   + YLH      I+HRD+K  N+L    DE+ +  I+
Sbjct: 112 VEKGFYTEKDASTLIRQVLDA---VYYLHR---MGIVHRDLKPENLLYYSQDEESKIMIS 165
Query: 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           DFG++K+ E    V   +C  GT GY+AP
Sbjct: 166 DFGLSKM-EGKGDVMSTAC--GTPGYVAP 191

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 76/170 (44%), Gaps = 23/170 (13%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK----------IAL 783
            L  AC   GG   +++E+   GNL   L  +  E  P       YK           + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
             AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM-------ELDHERMSYLLYQMLVGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM-------ELDHERMSYLLYQMLVGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
                       V+EY   G LF  L + RV         F   +     A+ ++ L + 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYL 121
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  +++RDIK  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 174

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 173

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 85/174 (48%), Gaps = 15/174 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACL 740
           +GSG  G V+ ++ + +     +K + K      ++   AE+E+L  + H NI+K++   
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
               + ++V+E    G L + +      GK   + +   ++       +AY H   S  +
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFH---SQHV 145
Query: 801 IHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +H+D+K  NIL  +D  P    KI DFG+A++ ++    ++    AGT  Y+AP
Sbjct: 146 VHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAP 195

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 18/182 (9%)
Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAE 721
           IDI   +I     + +IG+G  G+V    LK   K    VA+K L  G   K    F +E
Sbjct: 4   IDISCVKI-----EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 58
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
             I+G+  H N++ L   + K     ++ E+M NG+L   L    ++   +    +   +
Sbjct: 59  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL----RQNDGQFTVIQLVGM 114
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
             G A G+ YL        +HR + + NIL++ +   K++DFG+++  E+      Y+  
Sbjct: 115 LRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 171
Query: 842 AG 843
            G
Sbjct: 172 LG 173

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    K+ADFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +        K    E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVVAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM-------ELDHERMSYLLYQMLVGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 172

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 15/189 (7%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA-----AEME 723
           D+    + N   +  IG G   +VYR     +   VA+K++   D +   A      E++
Sbjct: 25  DMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEID 84
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPELDWFRRYKI 781
           +L ++ H N++K YA  ++     +VLE    G+L + +   K+ K   PE   + +Y +
Sbjct: 85  LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW-KYFV 143
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
            L +A     L H  S  ++HRDIK +N+ +      K+ D G+ +    S K +     
Sbjct: 144 QLCSA-----LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSL 196
Query: 842 AGTHGYIAP 850
            GT  Y++P
Sbjct: 197 VGTPYYMSP 205

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFA-AEMEILGKIRHR 731
           E+ + +G G    VY+   K     VA+K++  G      DG+   A  E+++L ++ H 
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           NI+ L        +  LV ++M        L   +K+    L         L   +G+ Y
Sbjct: 73  NIIGLLDAFGHKSNISLVFDFMETD-----LEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH      I+HRD+K +N+LLDE+   K+ADFG+AK +  SP  + Y     T  Y AP
Sbjct: 128 LHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRA-YXHQVVTRWYRAP 181

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNIL-KL 736
           ++G G  GKV   + K      AVK L K      D V+    E  +L        L +L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       + V+EY+  G+L   + +  +  +P   ++     A   A G+ +L    
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-----AAEIAIGLFFLQ--- 138
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  II+RD+K  N++LD +   KIADFG+ K  EN         F GT  YIAP
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAP 190

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 121
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 174

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
                       V+EY   G LF  L + RV         F   +     A+ ++ L + 
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYL 124
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  +++RDIK  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 177

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
                       V+EY   G LF  L + RV         F   +     A+ ++ L + 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYL 121
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  +++RDIK  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 174

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 122
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 175

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 121
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 174

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 20/180 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEILGKIRHRN 732
           + E+ + +G+G  G V+++   K +G V  ++L     K         E+++L +     
Sbjct: 10  DFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+  Y      G   + +E+M  G+L Q L K  +  +  L      K+++   KG+ YL
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 123
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK--IAENSPKVSDYSCFAGTHGYIAP 850
                  I+HRD+K SNIL++   E K+ DFGV+   I E + +      F GT  Y++P
Sbjct: 124 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE------FVGTRSYMSP 175

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 141
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 195

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 122
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 175

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 123
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 176

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 172

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 118
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 171

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 87
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 139
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 140 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 193

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 121
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 122 H---SHRVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 174

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 172

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 141
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 195

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 172

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 77/178 (43%), Gaps = 38/178 (21%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA----------- 782
            L  AC   GG   +++E+   GNL   L  +  E  P       YK+A           
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-------YKVAPEDLYKDFLTL 147
Query: 783 -------LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
                     AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 148 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 178
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 179 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 232

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 118
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 171

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 121 H---SHRVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 173

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNIL-KL 736
           ++G G  GKV   + K      AVK L K      D V+    E  +L        L +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           ++C       + V+EY+  G+L   + +  +  +P   ++     A   A G+ +L    
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-----AAEIAIGLFFLQ--- 459
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  II+RD+K  N++LD +   KIADFG+ K  EN         F GT  YIAP
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAP 511

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 134
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 135 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 188

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 134
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 135 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 188

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 173

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L +N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                    L +    +LV+E M + NL Q +         ELD  R   +      GI 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 133
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 134 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 187

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 12/131 (9%)
Query: 721 EMEILGKIR-HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY 779
           E  IL ++  H +I+ L          FLV + M  G LF  L ++V   + E       
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET-----R 203
Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
            I     + +++LH +    I+HRD+K  NILLD++ + +++DFG +   E   K+ +  
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-- 258
Query: 840 CFAGTHGYIAP 850
              GT GY+AP
Sbjct: 259 -LCGTPGYLAP 268

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
                       V+EY   G LF  L + RV         F   +     A+ ++ L + 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYL 121
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  +++RDIK  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+++ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLSFC 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAP 172

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
                       V+EY   G LF  L + RV         F   +     A+ ++ L + 
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYL 126
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  +++RDIK  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 179

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 77/175 (44%), Gaps = 19/175 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +GSG  G+V     K      A+K + K              E+ +L ++ H NI+KLY 
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
                 + +LV+E    G LF  +  R K    E+D     K  L    G  YLH     
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMKQVLS---GTTYLH---KH 123
Query: 799 PIIHRDIKSSNILLD---EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRD+K  N+LL+    D   KI DFG++   E   K+ +     GT  YIAP
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER---LGTAYYIAP 175

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 677 NLEEDNLIGSGGTGKV-----YRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKI 728
           NL+    +G+G  GKV     + L  +     VAVK L      D  +   +E++I+  +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK--RVKEGKPE-------LDWFRR 778
            +H NI+ L      GG   ++ EY   G+L   L +  RV E  P        L     
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 779 YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              +   A+G+A+L    S   IHRD+ + N+LL   +  KI DFG+A+
Sbjct: 167 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
                       V+EY   G LF  L + RV         F   +     A+ ++ L + 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYL 121
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  +++RDIK  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 77/178 (43%), Gaps = 38/178 (21%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA----------- 782
            L  AC   GG   +++E+   GNL   L  +  E  P       YK+A           
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-------YKVAPEDLYKDFLTL 138
Query: 783 -------LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
                     AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 139 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +        K    E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 77/178 (43%), Gaps = 38/178 (21%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA----------- 782
            L  AC   GG   +++E+   GNL   L  +  E  P       YK+A           
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-------YKVAPEDLYKDFLTL 147
Query: 783 -------LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
                     AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 148 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L   +      G P L   + Y   L   +G+A+ 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 122
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 175

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 121 H---SHRVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 173

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 122
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 123 H---SHRVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 175

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 77/178 (43%), Gaps = 38/178 (21%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA----------- 782
            L  AC   GG   +++E+   GNL   L  +  E  P       YK+A           
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-------YKVAPEDLYKDFLTL 184
Query: 783 -------LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
                     AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 185 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 239

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 80/177 (45%), Gaps = 24/177 (13%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLY-- 737
           IGSG  G V           VAVK+L +        K    E+ +L  + H+NI+ L   
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 738 ----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                 L +    +LV+E M + NL Q +H        ELD  R   +      GI +LH
Sbjct: 92  FTPQKTLEEFQDVYLVMELM-DANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH 143
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  IIHRD+K SNI++  D   KI DFG+A+ A  +  ++ Y     T  Y AP
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY---VVTRYYRAP 194

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 37  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 145
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 146 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 199

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
                       V+EY   G LF  L + RV         F   +     A+ ++ L + 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYL 121
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  +++RDIK  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +        K    E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 77/178 (43%), Gaps = 38/178 (21%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA----------- 782
            L  AC   GG   +++E+   GNL   L  +  E  P       YK+A           
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-------YKVAPEDLYKDFLTL 147
Query: 783 -------LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
                     AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 148 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L   +      G P L   + Y   L   +G+A+ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 118
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAP 171

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L   +      G P L   + Y   L   +G+A+ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 120 H---SHRVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 172

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +        K    E+ ++  + H+NI+ L
Sbjct: 33  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 141
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 195

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 26  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 82
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 134
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 135 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 188

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +        K    E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAA 720
           ++  E+I  L E   +G G  G VY    R  +K  A T VAVK + +   ++    F  
Sbjct: 13  EVSREKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDW 775
           E  ++      ++++L   + KG  + +V+E M +G+L   L     E     G+P    
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               ++A   A G+AYL+   +   +HRD+ + N ++  D+  KI DFG+ +
Sbjct: 130 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAA 720
           ++  E+I  L E   +G G  G VY    R  +K  A T VAVK + +   ++    F  
Sbjct: 13  EVSREKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDW 775
           E  ++      ++++L   + KG  + +V+E M +G+L   L     E     G+P    
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               ++A   A G+AYL+   +   +HRD+ + N ++  D+  KI DFG+ +
Sbjct: 130 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L   +      G P L   + Y   L   +G+A+ 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 122
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 175

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAA 720
           ++  E+I  L E   +G G  G VY    R  +K  A T VAVK + +   ++    F  
Sbjct: 10  EVSREKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 66
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDW 775
           E  ++      ++++L   + KG  + +V+E M +G+L   L     E     G+P    
Sbjct: 67  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 126
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               ++A   A G+AYL+   +   +HRD+ + N ++  D+  KI DFG+ +
Sbjct: 127 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 67  IVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 122
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 175

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 23/171 (13%)
Query: 677 NLEEDNLIGSGGTGKV-----YRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKI 728
           NL+    +G+G  GKV     + L  +     VAVK L      D  +   +E++I+  +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG---------KPELDWFRR 778
            +H NI+ L      GG   ++ EY   G+L   L ++   G          PE     R
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 779 YKIALGA--AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             +   +  A+G+A+L    S   IHRD+ + N+LL   +  KI DFG+A+
Sbjct: 167 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 214

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAA 720
           ++  E+I  L E   +G G  G VY    R  +K  A T VAVK + +   ++    F  
Sbjct: 13  EVSREKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDW 775
           E  ++      ++++L   + KG  + +V+E M +G+L   L     E     G+P    
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               ++A   A G+AYL+   +   +HRD+ + N ++  D+  KI DFG+ +
Sbjct: 130 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 33/169 (19%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIR-HRNILKLY 737
           +G G  G V++   ++    VAVK+++       D  + F  E+ IL ++  H NI+ L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 738 ACLLKGGSS--FLVLEYMPN-------GNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
             L        +LV +YM          N+ + +HK+               +     K 
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY--------------VVYQLIKV 121
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
           I YLH   S  ++HRD+K SNILL+ +   K+ADFG+++   N  +V++
Sbjct: 122 IKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 21/169 (12%)
Query: 677 NLEEDNLIGSGGTGKV-----YRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKI 728
           NL+    +G+G  GKV     + L  +     VAVK L      D  +   +E++I+  +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK--RVKEGKPELDWFRR------- 778
            +H NI+ L      GG   ++ EY   G+L   L +  RV E  P              
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 779 YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              +   A+G+A+L    S   IHRD+ + N+LL   +  KI DFG+A+
Sbjct: 167 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+ ++    + +GV   A  E+ +L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAP 172

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+ ++    + +GV   A  E+ +L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G P L   + Y   L   +G+A+ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 118
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAP 171

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
            +   E    +G+G  G+V  +  K+     A+K L K   VK+   E       IL  +
Sbjct: 32  HLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 91
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A      
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 146
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 147 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 198
Query: 849 AP 850
           AP
Sbjct: 199 AP 200

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAA 720
           ++  E+I  L E   +G G  G VY    R  +K  A T VAVK + +   ++    F  
Sbjct: 13  EVSREKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDW 775
           E  ++      ++++L   + KG  + +V+E M +G+L   L     E     G+P    
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               ++A   A G+AYL+   +   +HRD+ + N ++  D+  KI DFG+ +
Sbjct: 130 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L   +      G P L   + Y   L   +G+A+ 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIP-LPLIKSYLFQL--LQGLAFC 121
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRD+K  N+L++ +   K+ADFG+A+ A   P V  Y     T  Y AP
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYXHEVVTLWYRAP 174

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 76/178 (42%), Gaps = 38/178 (21%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA----------- 782
            L  AC   GG   ++ E+   GNL   L  +  E  P       YK+A           
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP-------YKVAPEDLYKDFLTL 138
Query: 783 -------LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
                     AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 139 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
            +   E    +G+G  G+V  +  K+     A+K L K   VK+   E       IL  +
Sbjct: 39  HLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAA 720
           ++  E+I  L E   +G G  G VY    R  +K  A T VAVK + +   ++    F  
Sbjct: 12  EVSREKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 68
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDW 775
           E  ++      ++++L   + KG  + +V+E M +G+L   L     E     G+P    
Sbjct: 69  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 128
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               ++A   A G+AYL+   +   +HRD+ + N ++  D+  KI DFG+ +
Sbjct: 129 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
            +   E    +G+G  G+V  +  K+     A+K L K   VK+   E       IL  +
Sbjct: 39  HLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 78/182 (42%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
            +   E    +G+G  G+V  +  K+     A+K L K   VK+   E       I   +
Sbjct: 40  HLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAV 99
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++VLEY P G +F  L +  +  +P   ++     A      
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 154
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    K+ADFG AK  +            GT  Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT-----WXLCGTPEYL 206
Query: 849 AP 850
           AP
Sbjct: 207 AP 208

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
            +   E    +G+G  G+V  +  K+     A+K L K   VK+   E       IL  +
Sbjct: 39  HLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFA-AEMEILGKIRHRNILKLYAC 739
           IG G  G V++   ++    VA+K++   D   GV   A  E+ +L +++H+NI++L+  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           L       LV E+       Q L K       +LD            KG+ + H   S  
Sbjct: 70  LHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAK 827
           ++HRD+K  N+L++ + E K+ADFG+A+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 13/175 (7%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKL 736
            ++G GG G+V+   +K      A K+L K       G +    E +IL K+  R I+ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                      LV+  M  G++   ++  V E  P    F+  +     A+ ++ L H  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPG---FQEPRAIFYTAQIVSGLEHLH 306
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD+D   +I+D G+A ++     K   Y   AGT G++AP
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY---AGTPGFMAP 358

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 13/175 (7%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKL 736
            ++G GG G+V+   +K      A K+L K       G +    E +IL K+  R I+ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                      LV+  M  G++   ++  V E  P    F+  +     A+ ++ L H  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPG---FQEPRAIFYTAQIVSGLEHLH 306
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD+D   +I+D G+A ++     K   Y   AGT G++AP
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY---AGTPGFMAP 358

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 13/175 (7%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKL 736
            ++G GG G+V+   +K      A K+L K       G +    E +IL K+  R I+ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                      LV+  M  G++   ++  V E  P    F+  +     A+ ++ L H  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPG---FQEPRAIFYTAQIVSGLEHLH 306
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD+D   +I+D G+A ++     K   Y   AGT G++AP
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY---AGTPGFMAP 358

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 76/178 (42%), Gaps = 38/178 (21%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA----------- 782
            L  AC   GG   ++ E+   GNL   L  +  E  P       YK+A           
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP-------YKVAPEDLYKDFLTL 138
Query: 783 -------LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
                     AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 139 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 13/175 (7%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKL 736
            ++G GG G+V+   +K      A K+L K       G +    E +IL K+  R I+ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                      LV+  M  G++   ++  V E  P    F+  +     A+ ++ L H  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPG---FQEPRAIFYTAQIVSGLEHLH 306
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
              II+RD+K  N+LLD+D   +I+D G+A ++     K   Y   AGT G++AP
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY---AGTPGFMAP 358

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
           +GSG  G+V     K      A+K + K              E+ +L ++ H NI+KLY 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-HDCS 797
                 + +LV+E    G LF  +  R K    E+D     K  L    G  YLH H+  
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQKFS--EVDAAVIMKQVLS---GTTYLHKHN-- 141
Query: 798 PPIIHRDIKSSNILLD---EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K  N+LL+    D   KI DFG++   E   K+ +     GT  YIAP
Sbjct: 142 --IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER---LGTAYYIAP 192

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 18/179 (10%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKIRHR 731
             E    +G+G  G+V  +  K+     A+K L K   VK+   E       IL  +   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
            ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A        Y
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AAQIVLTFEY 157
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+AP
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYLAP 208

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
            +   E    +G+G  G+V  +  K+     A+K L K   VK+   E       IL  +
Sbjct: 60  HLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A      
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 174
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 226
Query: 849 AP 850
           AP
Sbjct: 227 AP 228

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 76/178 (42%), Gaps = 38/178 (21%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA----------- 782
            L  AC   GG   ++ E+   GNL   L  +  E  P       YK+A           
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP-------YKVAPEDLYKDFLTL 138
Query: 783 -------LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
                     AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 139 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
            +   E    +G+G  G+V  +  K+     A+K L K   VK+   E       IL  +
Sbjct: 32  HLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 91
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A      
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY-----AAQIVLT 146
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 147 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 198
Query: 849 AP 850
           AP
Sbjct: 199 AP 200

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 24/171 (14%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
           +G G  G+V     + +D      TVAVK L +G      +   +E++IL  I  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP----ELDWFRRYKI-------A 782
            L  AC   GG   +++E+   GNL   L  +  E  P      D ++ +         +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
              AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+     P
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 204

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 18/179 (10%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKIRHR 731
             E    +G+G  G+V  +  K+     A+K L K   VK+   E       IL  +   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
            ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A        Y
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AAQIVLTFEY 157
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+AP
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYLAP 208

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 18/179 (10%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKIRHR 731
             E    +G+G  G+V  +  K+     A+K L K   VK+   E       IL  +   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
            ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A        Y
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AAQIVLTFEY 157
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+AP
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYLAP 208

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
            +   E    +G+G  G+V  +  K+     A+K L K   VK+   E       IL  +
Sbjct: 40  HLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY P G +F  L +  +  +P   ++     A      
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 154
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+++D+    K+ DFG AK  +            GT  Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-----WXLCGTPEYL 206
Query: 849 AP 850
           AP
Sbjct: 207 AP 208

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 20  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 79
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A 
Sbjct: 80  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AA 134
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            G
Sbjct: 135 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCG 186
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 187 TPEYLAP 193

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYAC 739
           IG G  G V++   +     VA+K+  + +      K+   E+ +L +++H N++ L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-HDCSP 798
             +     LV EY  +  L +    R + G PE        I     + + + H H+C  
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPE---HLVKSITWQTLQAVNFCHKHNC-- 123
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
             IHRD+K  NIL+ +    K+ DFG A++
Sbjct: 124 --IHRDVKPENILITKHSVIKLCDFGFARL 151

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 30/180 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 34  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 90
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 142
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S  +     F  T  Y AP
Sbjct: 143 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVP---FVVTRYYRAP 196

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AA 149
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            G
Sbjct: 150 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCG 201
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 202 TPEYLAP 208

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAG---TVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILK 735
           +G G  G V R +    +G   +VAVK      L + + +  F  E+  +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           LY  +L      +V E  P G+L   L K   +G   L    RY  A+  A+G+ YL   
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKH--QGHFLLGTLSRY--AVQVAEGMGYLE-- 128
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            S   IHRD+ + N+LL      KI DFG+ +
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAG---TVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILK 735
           +G G  G V R +    +G   +VAVK      L + + +  F  E+  +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           LY  +L      +V E  P G+L   L K   +G   L    RY  A+  A+G+ YL   
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKH--QGHFLLGTLSRY--AVQVAEGMGYLE-- 128
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            S   IHRD+ + N+LL      KI DFG+ +
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAG---TVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILK 735
           +G G  G V R +    +G   +VAVK      L + + +  F  E+  +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           LY  +L      +V E  P G+L   L K   +G   L    RY  A+  A+G+ YL   
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKH--QGHFLLGTLSRY--AVQVAEGMGYLE-- 128
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            S   IHRD+ + N+LL      KI DFG+ +
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + F  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAGFVATRWYRAP 191

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + F  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAGFVATRWYRAP 191

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 17/154 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +IG+G  G V++  L + +  VA+K++ +    K    E++I+  ++H N++ L A    
Sbjct: 47  VIGNGSFGVVFQAKLVE-SDEVAIKKVLQDKRFK--NRELQIMRIVKHPNVVDLKAFFYS 103
Query: 743 GGSSF------LVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
            G         LVLEY+P      + H  ++K+  P L   + Y   L   + +AY+H  
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML-LIKLYMYQL--LRSLAYIH-- 158
Query: 796 CSPPIIHRDIKSSNILLDEDYEP-KIADFGVAKI 828
            S  I HRDIK  N+LLD      K+ DFG AKI
Sbjct: 159 -SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 32/179 (17%)
Query: 677 NLEEDNLIGSGGTGKV-----YRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKI 728
           NL+    +G+G  GKV     + L  +     VAVK L      D  +   +E++I+  +
Sbjct: 32  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 91
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK-------------------E 768
            +H NI+ L      GG   ++ EY   G+L   L ++ +                   +
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           G+P L+       +   A+G+A+L    S   IHRD+ + N+LL   +  KI DFG+A+
Sbjct: 152 GRP-LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 206

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 27/162 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +           AGT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLAGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 76/178 (42%), Gaps = 30/178 (16%)
Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKI 728
           N+E    IG G  G+V++     L   +    VAVK L +    D    F  E  ++ + 
Sbjct: 48  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK------------------RVKE-G 769
            + NI+KL      G    L+ EYM  G+L + L                    RV   G
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            P L    +  IA   A G+AYL        +HRD+ + N L+ E+   KIADFG+++
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 26  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 85
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 86  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 140
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+DE    ++ DFG AK  +            GT  Y+
Sbjct: 141 FEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 192
Query: 849 AP 850
           AP
Sbjct: 193 AP 194

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+++D+    K+ DFG+AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 76/162 (46%), Gaps = 27/162 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +        K    E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 86  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 137
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + F  T  Y AP
Sbjct: 138 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAGFVATRWYRAP 187

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY-----AA 149
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            G
Sbjct: 150 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCG 201
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 202 TPEYLAP 208

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 27/162 (16%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           IGSG  G V   Y   L++N   VA+K+L +    +  A     E+ ++  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
                   S       ++V+E M + NL Q +         ELD  R   +      GI 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           +LH   S  IIHRD+K SNI++  D   KI DFG+A+ A  S
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+++D+    K+ DFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAA 720
           ++  E+I  L E   +G G  G VY    R  +K  A T VAVK + +   ++    F  
Sbjct: 14  EVSREKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 70
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDW 775
           E  ++      ++++L   + KG  + +V+E M +G+L   L     E     G+P    
Sbjct: 71  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 130
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               ++A   A G+AYL+   +   +HR++ + N ++  D+  KI DFG+ +
Sbjct: 131 QEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAA 720
           ++  E+I  L E   +G G  G VY    R  +K  A T VAVK + +   ++    F  
Sbjct: 13  EVSREKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDW 775
           E  ++      ++++L   + KG  + +V+E M +G+L   L     E     G+P    
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               ++A   A G+AYL+   +   +HR++ + N ++  D+  KI DFG+ +
Sbjct: 130 QEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 81/182 (44%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 60  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 174
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  + +          GT  Y+
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGAT-----WTLCGTPEYL 226
Query: 849 AP 850
           AP
Sbjct: 227 AP 228

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY-----AA 149
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            G
Sbjct: 150 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCG 201
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 202 TPEYLAP 208

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 14/172 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLW-----KGDGVKVFAAEMEILGKIRHRNILKLYA 738
           +G GG   VY  +       VA+K ++     K + +K F  E+    ++ H+NI+ +  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
              +    +LV+EY+    L + +      G   +D    +   +    GI + H     
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQI--LDGIKHAH---DM 130
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRDIK  NIL+D +   KI DFG+AK A +   ++  +   GT  Y +P
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSP 181

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTV----AVKQLWKGDGVKV---FAAEMEILGKIR 729
            L+   ++GSG  G VY+        TV    A+K L +  G K    F  E  I+  + 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPEL--DWFRRYKIALGAAK 787
           H ++++L    L   +  LV + MP+G L + +H+       +L  +W       +  AK
Sbjct: 99  HPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAK 151
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
           G+ YL       ++HRD+ + N+L+      KI DFG+A++ E   K
Sbjct: 152 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 195

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTV----AVKQLWKGDGVKV---FAAEMEILGKIR 729
            L+   ++GSG  G VY+        TV    A+K L +  G K    F  E  I+  + 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPEL--DWFRRYKIALGAAK 787
           H ++++L    L   +  LV + MP+G L + +H+       +L  +W       +  AK
Sbjct: 76  HPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAK 128
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
           G+ YL       ++HRD+ + N+L+      KI DFG+A++ E   K
Sbjct: 129 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 172

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L K     + A     E+ +L  ++H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 102 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 153
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 154 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 203

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           IGSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 95  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 146
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 147 H---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVATRWYRAP 196

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK---QLWKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           IG G  G+V+   L+ +   VAVK   +    D    F  E  IL +  H NI++L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +    ++V+E +  G+    L     EG   L      ++   AA G+ YL   C    
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGA-RLRVKTLLQMVGDAAAGMEYLESKCC--- 234
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAK 827
           IHRD+ + N L+ E    KI+DFG+++
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAG---TVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILK 735
           +G G  G V R +    +G   +VAVK      L + + +  F  E+  +  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           LY  +L      +V E  P G+L   L K   +G   L    RY  A+  A+G+ YL   
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKH--QGHFLLGTLSRY--AVQVAEGMGYLE-- 132
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            S   IHRD+ + N+LL      KI DFG+ +
Sbjct: 133 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 163

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 86  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQIL----RGLKYI 137
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 138 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 187

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK---QLWKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
           IG G  G+V+   L+ +   VAVK   +    D    F  E  IL +  H NI++L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
            +    ++V+E +  G+    L     EG   L      ++   AA G+ YL   C    
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGA-RLRVKTLLQMVGDAAAGMEYLESKCC--- 234
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAK 827
           IHRD+ + N L+ E    KI+DFG+++
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFA-AEMEILGKIRHRNILKLYAC 739
           IG G  G V++   ++    VA+K++   D   GV   A  E+ +L +++H+NI++L+  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           L       LV E+       Q L K       +LD            KG+ + H   S  
Sbjct: 70  LHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAK 827
           ++HRD+K  N+L++ + E K+A+FG+A+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 91/178 (51%), Gaps = 29/178 (16%)
Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFA-AEMEILGKI 728
           +++   E+   IG G  G+V++   +K    VA+K++    + +G  + A  E++IL  +
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 729 RHRNILKLYA-CLLKG-------GSSFLVLEYMPN---GNLFQALHKRVKEGKPELDWFR 777
           +H N++ L   C  K        GS +LV ++  +   G L   L   VK    E+    
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIK--- 128
Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK---IAENS 832
             ++      G+ Y+H +    I+HRD+K++N+L+  D   K+ADFG+A+   +A+NS
Sbjct: 129 --RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 688 GTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747
           GTGK Y     K     + +   +G   +    E+ IL +IRH NI+ L+          
Sbjct: 49  GTGKEYAAKFIKKRRLXSSR---RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 105
Query: 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
           L+LE +  G LF  L ++    + E   F +  +      G+ YLH   S  I H D+K 
Sbjct: 106 LILELVSGGELFDFLAEKESLTEDEATQFLKQIL-----DGVHYLH---SKRIAHFDLKP 157
Query: 808 SNILLDEDYEP----KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            NI+L +   P    K+ DFG+A   E     +++    GT  ++AP
Sbjct: 158 ENIMLLDKNVPNPRIKLIDFGIAHKIEAG---NEFKNIFGTPEFVAP 201

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAG---TVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILK 735
           +G G  G V R +    +G   +VAVK      L + + +  F  E+  +  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           LY  +L      +V E  P G+L   L K   +G   L    RY  A+  A+G+ YL   
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKH--QGHFLLGTLSRY--AVQVAEGMGYLE-- 138
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            S   IHRD+ + N+LL      KI DFG+ +
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 17/175 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  + +K      A+K L K + +K      F  E ++L     + I  L+
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 140
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
                    +LV++Y   G+L   L K  ++  PE D  R Y  ++ L A   I  LH+ 
Sbjct: 141 YAFQDENHLYLVMDYYVGGDLLTLLSK-FEDKLPE-DMARFYIGEMVL-AIDSIHQLHY- 196
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                +HRDIK  N+LLD +   ++ADFG + +  N       S   GT  YI+P
Sbjct: 197 -----VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 245

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+++D+    K+ DFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAG---TVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILK 735
           +G G  G V R +    +G   +VAVK      L + + +  F  E+  +  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           LY  +L      +V E  P G+L   L K   +G   L    RY  A+  A+G+ YL   
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKH--QGHFLLGTLSRY--AVQVAEGMGYLE-- 132
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            S   IHRD+ + N+LL      KI DFG+ +
Sbjct: 133 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 163

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 17/175 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  + +K      A+K L K + +K      F  E ++L     + I  L+
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 156
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
                    +LV++Y   G+L   L K  ++  PE D  R Y  ++ L A   I  LH+ 
Sbjct: 157 YAFQDENHLYLVMDYYVGGDLLTLLSK-FEDKLPE-DMARFYIGEMVL-AIDSIHQLHY- 212
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                +HRDIK  N+LLD +   ++ADFG + +  N       S   GT  YI+P
Sbjct: 213 -----VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 261

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 14/133 (10%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E  I  K++H NI++L+  + +    +LV + +  G LF+ +  R  E   E D     +
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQ 135
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAKIAENSPKVSD 837
             L   + IAY H   S  I+HR++K  N+LL    +    K+ADFG+A    +S     
Sbjct: 136 QIL---ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EA 186
Query: 838 YSCFAGTHGYIAP 850
           +  FAGT GY++P
Sbjct: 187 WHGFAGTPGYLSP 199

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAG---TVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILK 735
           +G G  G V R +    +G   +VAVK      L + + +  F  E+  +  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           LY  +L      +V E  P G+L   L K   +G   L    RY  A+  A+G+ YL   
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKH--QGHFLLGTLSRY--AVQVAEGMGYLE-- 138
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            S   IHRD+ + N+LL      KI DFG+ +
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 110 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 161
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 162 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 211

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 109 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 160
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 161 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 210

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 100 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 151
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 152 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 201

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 95  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 146
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 147 H---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVATRWYRAP 196

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 24/175 (13%)
Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAG--TVAVKQLWKGDG---VKVFAAEMEILGKI 728
           NL     +G G  GKV +     LK  AG  TVAVK L +      ++   +E  +L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFR 777
            H +++KLY    + G   L++EY   G+L   L +  K G              LD   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 778 RYKIALGAAKGIAY-----LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              + +G     A+     + +     ++HRD+ + NIL+ E  + KI+DFG+++
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 87/193 (45%), Gaps = 28/193 (14%)
Query: 665 FHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI 724
           + H D+D +       D  +G G      +   KK+    AVK + K    ++ A   + 
Sbjct: 7   YQHYDLDLK-------DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKE 55
Query: 725 LGKIR----HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           +  ++    H NI+KL+        +FLV+E +  G LF+ + K+    + E  +  R  
Sbjct: 56  ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL 115
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSD 837
           ++      ++++H      ++HRD+K  N+L    +++ E KI DFG A++     +   
Sbjct: 116 VS-----AVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 838 YSCFAGTHGYIAP 850
             CF  T  Y AP
Sbjct: 168 TPCF--TLHYAAP 178

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 101 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 152
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 153 H---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVATRWYRAP 202

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 24/175 (13%)
Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAG--TVAVKQLWKGDG---VKVFAAEMEILGKI 728
           NL     +G G  GKV +     LK  AG  TVAVK L +      ++   +E  +L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFR 777
            H +++KLY    + G   L++EY   G+L   L +  K G              LD   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 778 RYKIALGAAKGIAY-----LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              + +G     A+     + +     ++HRD+ + NIL+ E  + KI+DFG+++
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+++D+    ++ DFG+AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 91/179 (50%), Gaps = 29/179 (16%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFA-AEMEILGK 727
            +++   E+   IG G  G+V++   +K    VA+K++    + +G  + A  E++IL  
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 72
Query: 728 IRHRNILKLYA-CLLKG-------GSSFLVLEYMPN---GNLFQALHKRVKEGKPELDWF 776
           ++H N++ L   C  K        GS +LV ++  +   G L   L   VK    E+   
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIK-- 127
Query: 777 RRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK---IAENS 832
              ++      G+ Y+H +    I+HRD+K++N+L+  D   K+ADFG+A+   +A+NS
Sbjct: 128 ---RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 24/175 (13%)
Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAG--TVAVKQLWKGDG---VKVFAAEMEILGKI 728
           NL     +G G  GKV +     LK  AG  TVAVK L +      ++   +E  +L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFR 777
            H +++KLY    + G   L++EY   G+L   L +  K G              LD   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 778 RYKIALGAAKGIAY-----LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              + +G     A+     + +     ++HRD+ + NIL+ E  + KI+DFG+++
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 92  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 143
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 144 H---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMTGYVATRWYRAP 193

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    + KL        + ++V+EY P G +F  L +  +  +P   ++     A 
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY-----AA 149
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+++D+    K+ DFG AK  +            G
Sbjct: 150 QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-----WXLCG 201
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 202 TPEYLAP 208

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 86  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 137
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 138 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 187

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 688 GTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747
           GTGK Y     K     + +   +G   +    E+ IL +IRH NI+ L+          
Sbjct: 35  GTGKEYAAKFIKKRRLSSSR---RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 91
Query: 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
           L+LE +  G LF  L ++    + E   F +  +      G+ YLH   S  I H D+K 
Sbjct: 92  LILELVSGGELFDFLAEKESLTEDEATQFLKQIL-----DGVHYLH---SKRIAHFDLKP 143
Query: 808 SNILLDEDYEP----KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            NI+L +   P    K+ DFG+A   E     +++    GT  ++AP
Sbjct: 144 ENIMLLDKNVPNPRIKLIDFGIAHKIEAG---NEFKNIFGTPEFVAP 187

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 688 GTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747
           GTGK Y     K     + +   +G   +    E+ IL +IRH NI+ L+          
Sbjct: 28  GTGKEYAAKFIKKRRLSSSR---RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84
Query: 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
           L+LE +  G LF  L ++    + E   F +  +      G+ YLH   S  I H D+K 
Sbjct: 85  LILELVSGGELFDFLAEKESLTEDEATQFLKQIL-----DGVHYLH---SKRIAHFDLKP 136
Query: 808 SNILLDEDYEP----KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            NI+L +   P    K+ DFG+A   E     +++    GT  ++AP
Sbjct: 137 ENIMLLDKNVPNPRIKLIDFGIAHKIEAG---NEFKNIFGTPEFVAP 180

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                       V+EY   G LF  L +   E     D  R Y   + +A  + YLH + 
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSA--LDYLHSEK 268
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +  +++RD+K  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 269 N--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 318

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 20/179 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
           ++G GG  +V+     ++   VAVK L + D  +       F  E +    + H  I+ +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 737 Y----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           Y    A    G   ++V+EY+    L   +H    EG   +   R  ++   A + + + 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGP--MTPKRAIEVIADACQALNFS 132
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
           H +    IIHRD+K +NIL+      K+ DFG+A+ IA++   V   +   GT  Y++P
Sbjct: 133 HQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSP 188

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    + KL        + ++V+EY P G +F  L +  +  +P   ++     A 
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY-----AA 149
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+++D+    K+ DFG AK  +            G
Sbjct: 150 QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-----WXLCG 201
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 202 TPEYLAP 208

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 96  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 147
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 148 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 197

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                       V+EY   G LF  L +   E     D  R Y   + +A  + YLH + 
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSA--LDYLHSEK 271
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +  +++RD+K  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 272 N--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 321

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 88/176 (50%), Gaps = 20/176 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHRNILKLYACL 740
           ++G G  G VY      N   +A+K++ + D    +    E+ +   ++H+NI++     
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKR---VKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
            + G   + +E +P G+L   L  +   +K+ +  + ++ +  +     +G+ YLH +  
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN-- 141
Query: 798 PPIIHRDIKSSNILLDEDYEP--KIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
             I+HRDIK  N+L++  Y    KI+DFG +K +A  +P       F GT  Y+AP
Sbjct: 142 -QIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCT---ETFTGTLQYMAP 192

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 102 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 153
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 154 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 203

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 102 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 153
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 154 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 203

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 18/183 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 APG 851
           AP 
Sbjct: 206 APA 208

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 96  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 147
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 148 H---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMTGYVATRWYRAP 197

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 92  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 143
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 144 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 193

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 95  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 146
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 147 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 196

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 113 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 164
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 165 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 214

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 91/179 (50%), Gaps = 29/179 (16%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFA-AEMEILGK 727
            +++   E+   IG G  G+V++   +K    VA+K++    + +G  + A  E++IL  
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 73
Query: 728 IRHRNILKLYA-CLLKG-------GSSFLVLEYMPN---GNLFQALHKRVKEGKPELDWF 776
           ++H N++ L   C  K        GS +LV ++  +   G L   L   VK    E+   
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIK-- 128
Query: 777 RRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK---IAENS 832
              ++      G+ Y+H +    I+HRD+K++N+L+  D   K+ADFG+A+   +A+NS
Sbjct: 129 ---RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 92  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 143
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 144 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 193

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY P G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+++D+    ++ DFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 96  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 147
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 148 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 197

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 95  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 146
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 147 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 196

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 89  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 140
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 141 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 190

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 97  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 148
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 198

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 101 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 152
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 153 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 202

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 73
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                       V+EY   G LF  L +   E     D  R Y   + +A  + YLH + 
Sbjct: 74  KYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSA--LDYLHSEK 128
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +  +++RD+K  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 129 N--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 178

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 92  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 143
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 144 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 193

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
           ++G GG  +V+     ++   VAVK L + D  +       F  E +    + H  I+ +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 737 Y----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           Y    A    G   ++V+EY+    L   +H    EG   +   R  ++   A + + + 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGP--MTPKRAIEVIADACQALNFS 132
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
           H +    IIHRD+K +NI++      K+ DFG+A+ IA++   V+  +   GT  Y++P
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 40  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 154
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 206
Query: 849 AP 850
           AP
Sbjct: 207 AP 208

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 110 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 161
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 162 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 211

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 87  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 138
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 139 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 188

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 86  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 137
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 138 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 187

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 88  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 139
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 140 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 189

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLXGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 87  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 138
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 139 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 188

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLL 741
           +G GG G V+          VA+K++   D   VK    E++I+ ++ H NI+K++  L 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 742 KGGSS--------------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
             GS               ++V EYM            V E  P L+   R        +
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDL------ANVLEQGPLLEEHARL-FMYQLLR 131
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAE 830
           G+ Y+H   S  ++HRD+K +N+ ++ ED   KI DFG+A+I +
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 109 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 160
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 161 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 210

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
           ++G GG  +V+     ++   VAVK L + D  +       F  E +    + H  I+ +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 737 Y----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           Y    A    G   ++V+EY+    L   +H    EG   +   R  ++   A + + + 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGP--MTPKRAIEVIADACQALNFS 132
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
           H +    IIHRD+K +NI++      K+ DFG+A+ IA++   V+  +   GT  Y++P
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                       V+EY   G LF  L +   E     D  R Y   + +A  + YLH + 
Sbjct: 76  KYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSA--LDYLHSEK 130
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +  +++RD+K  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 131 N--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 180

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    + KL        + ++V+EY P G +F  L +  +  +P   ++     A 
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFY-----AA 149
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+++D+    K+ DFG AK  +            G
Sbjct: 150 QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-----WXLCG 201
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 202 TPEYLAP 208

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+ +  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD-----EMTGYVATRWYRAP 191

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 34  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 93
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 94  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY-----AAQIVLT 148
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 149 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 200
Query: 849 AP 850
           AP
Sbjct: 201 AP 202

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKL 736
            L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                       V+EY   G LF  L +   E     D  R Y   + +A  + YLH + 
Sbjct: 75  KYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSA--LDYLHSEK 129
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +  +++RD+K  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 130 N--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 179

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 96  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 147
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 148 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 197

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 113 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 164
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     +   +  T  Y AP
Sbjct: 165 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMXGYVATRWYRAP 214

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 88/176 (50%), Gaps = 20/176 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHRNILKLYACL 740
           ++G G  G VY      N   +A+K++ + D    +    E+ +   ++H+NI++     
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKR---VKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
            + G   + +E +P G+L   L  +   +K+ +  + ++ +  +     +G+ YLH +  
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN-- 127
Query: 798 PPIIHRDIKSSNILLDEDYEP--KIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
             I+HRDIK  N+L++  Y    KI+DFG +K +A  +P       F GT  Y+AP
Sbjct: 128 -QIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCT---ETFTGTLQYMAP 178

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 60  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY-----AAQIVLT 174
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 226
Query: 849 AP 850
           AP
Sbjct: 227 AP 228

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK----QLWKGDGVKVFAAEMEI 724
           DI  EQ   LE   LIG G  G+VY     +  G VA++    +    D +K F  E+  
Sbjct: 29  DIPFEQ---LEIGELIGKGRFGQVYH---GRWHGEVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 725 LGKIRHRNI-LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
             + RH N+ L + AC+        ++  +  G   + L+  V++ K  LD  +  +IA 
Sbjct: 83  YRQTRHENVVLFMGACM--SPPHLAIITSLCKG---RTLYSVVRDAKIVLDVNKTRQIAQ 137
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
              KG+ YLH   +  I+H+D+KS N+  D + +  I DFG+  I+
Sbjct: 138 EIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 14/133 (10%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E  I  K++H NI++L+  + +    +LV + +  G LF+ +  R  E   E D     +
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQ 112
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAKIAENSPKVSD 837
             L   + IAY H   S  I+HR++K  N+LL    +    K+ADFG+A    +S     
Sbjct: 113 QIL---ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EA 163
Query: 838 YSCFAGTHGYIAP 850
           +  FAGT GY++P
Sbjct: 164 WHGFAGTPGYLSP 176

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 14/133 (10%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E  I  K++H NI++L+  + +    +LV + +  G LF+ +  R  E   E D     +
Sbjct: 54  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQ 111
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAKIAENSPKVSD 837
             L   + IAY H   S  I+HR++K  N+LL    +    K+ADFG+A    +S     
Sbjct: 112 QIL---ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EA 162
Query: 838 YSCFAGTHGYIAP 850
           +  FAGT GY++P
Sbjct: 163 WHGFAGTPGYLSP 175

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKGDGV---KVFAAEMEILGKI-RHRNIL 734
           +G+G  GKV     Y L     A TVAVK L     +   +   +E+++L  +  H NI+
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----VKEGKPEL--------DWFRRYKI 781
            L      GG + ++ EY   G+L   L ++       +  P +        D       
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
           +   AKG+A+L    S   IHRD+ + NILL      KI DFG+A+  +N
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 14/133 (10%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E  I  K++H NI++L+  + +    +LV + +  G LF+ +  R  E   E D     +
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQ 112
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAKIAENSPKVSD 837
             L   + IAY H   S  I+HR++K  N+LL    +    K+ADFG+A    +S     
Sbjct: 113 QIL---ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EA 163
Query: 838 YSCFAGTHGYIAP 850
           +  FAGT GY++P
Sbjct: 164 WHGFAGTPGYLSP 176

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKGDGV---KVFAAEMEILGKI-RHRNIL 734
           +G+G  GKV     Y L     A TVAVK L     +   +   +E+++L  +  H NI+
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----VKEGKPEL--------DWFRRYKI 781
            L      GG + ++ EY   G+L   L ++       +  P +        D       
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
           +   AKG+A+L    S   IHRD+ + NILL      KI DFG+A+  +N
Sbjct: 167 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 213

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 97  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 148
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+   +     + + +  T  Y AP
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAP 198

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 97  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 148
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+   +     + + +  T  Y AP
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAP 198

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             YLH   S  +I+RD+K  N+++D+    ++ DFG AK  +            GT  Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRT-----WXLCGTPEYL 205
Query: 849 AP 850
           AP
Sbjct: 206 AP 207

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 97  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 148
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+   +     + + +  T  Y AP
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAP 198

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 677 NLEEDNLIGSGGTGKV-----YRLDLKKNAGTVAVKQL-WKGDGVK--VFAAEMEILGKI 728
           NLE   ++GSG  GKV     Y +     +  VAVK L  K D  +     +E++++ ++
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKI----- 781
             H NI+ L       G  +L+ EY   G+L   L  KR K  + E+++  + ++     
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 782 ------------ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                       A   AKG+ +L        +HRD+ + N+L+      KI DFG+A+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKGDGV---KVFAAEMEILGKI-RHRNIL 734
           +G+G  GKV     Y L     A TVAVK L     +   +   +E+++L  +  H NI+
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----VKEGKPEL--------DWFRRYKI 781
            L      GG + ++ EY   G+L   L ++       +  P +        D       
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
           +   AKG+A+L    S   IHRD+ + NILL      KI DFG+A+  +N
Sbjct: 169 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 20/179 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
           ++G GG  +V+     +    VAVK L + D  +       F  E +    + H  I+ +
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 737 YAC----LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           YA        G   ++V+EY+    L   +H    EG   +   R  ++   A + + + 
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGP--MTPKRAIEVIADACQALNFS 132
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
           H +    IIHRD+K +NI++      K+ DFG+A+ IA++   V+  +   GT  Y++P
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K+   +AVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 119 FTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 170
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 171 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKGDGV---KVFAAEMEILGKI-RHRNIL 734
           +G+G  GKV     Y L     A TVAVK L     +   +   +E+++L  +  H NI+
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----VKEGKPEL--------DWFRRYKI 781
            L      GG + ++ EY   G+L   L ++       +  P +        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
           +   AKG+A+L    S   IHRD+ + NILL      KI DFG+A+  +N
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKN 220

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI D+G+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKGDGV---KVFAAEMEILGKI-RHRNIL 734
           +G+G  GKV     Y L     A TVAVK L     +   +   +E+++L  +  H NI+
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----VKEGKPEL--------DWFRRYKI 781
            L      GG + ++ EY   G+L   L ++       +  P +        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
           +   AKG+A+L    S   IHRD+ + NILL      KI DFG+A+  +N
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 220

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 45/97 (46%), Gaps = 6/97 (6%)
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
           G + FL+L  +  G L + L K    G    D     KI     + + ++H    PPIIH
Sbjct: 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV--LKIFYQTCRAVQHMHRQ-KPPIIH 161
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
           RD+K  N+LL      K+ DFG A    + P   DYS
Sbjct: 162 RDLKVENLLLSNQGTIKLCDFGSATTISHYP---DYS 195

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEM-----EILGKI 728
           Q+   +    +G+G  G+V  +  K++    A+K L K   VK+   E       IL  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLT 153
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             YLH   S  +I+RD+K  N+L+D+    ++ DFG AK
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G    VY+   K     VA+K+  L   +G    A  E+ +L  ++H NI+ L+  +
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
               S  LV EY+      + L + + +    ++            +G+AY H      +
Sbjct: 70  HTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
           +HRD+K  N+L++E  E K+ADFG+A+      K  D
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-VFAAEMEILGK 727
           +ID + +  L+E   +G+G  G V +    +    VA+K + +G   +  F  E +++  
Sbjct: 20  EIDPKDLTFLKE---LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 75
Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           + H  +++LY    K    F++ EYM NG L   L    +E +      +  ++     +
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCE 131
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
            + YL    S   +HRD+ + N L+++    K++DFG+++   +  + S
Sbjct: 132 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS 177

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-VFAAEMEILGK 727
           +ID + +  L+E   +G+G  G V +    +    VA+K + +G   +  F  E +++  
Sbjct: 20  EIDPKDLTFLKE---LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 75
Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           + H  +++LY    K    F++ EYM NG L   L    +E +      +  ++     +
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCE 131
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            + YL    S   +HRD+ + N L+++    K++DFG+++
Sbjct: 132 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + +    T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGXVATRWYRAP 191

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 90/179 (50%), Gaps = 29/179 (16%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFA-AEMEILGK 727
            +++   E+   IG G  G+V++   +K    VA+K++    + +G  + A  E++IL  
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 73
Query: 728 IRHRNILKLYA-CLLKG-------GSSFLVLEYMPN---GNLFQALHKRVKEGKPELDWF 776
           ++H N++ L   C  K         S +LV ++  +   G L   L   VK    E+   
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL---VKFTLSEIK-- 128
Query: 777 RRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK---IAENS 832
              ++      G+ Y+H +    I+HRD+K++N+L+  D   K+ADFG+A+   +A+NS
Sbjct: 129 ---RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-VFAAEMEILGK 727
           +ID + +  L+E   +G+G  G V +    +    VA+K + +G   +  F  E +++  
Sbjct: 4   EIDPKDLTFLKE---LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 59
Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           + H  +++LY    K    F++ EYM NG L   L    +E +      +  ++     +
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCE 115
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            + YL    S   +HRD+ + N L+++    K++DFG+++
Sbjct: 116 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 152

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-VFAAEMEILGK 727
           +ID + +  L+E   +G+G  G V +    +    VA+K + +G   +  F  E +++  
Sbjct: 5   EIDPKDLTFLKE---LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 60
Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           + H  +++LY    K    F++ EYM NG L   L    +E +      +  ++     +
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCE 116
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            + YL    S   +HRD+ + N L+++    K++DFG+++
Sbjct: 117 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-VFAAEMEILGK 727
           +ID + +  L+E   +G+G  G V +    +    VA+K + +G   +  F  E +++  
Sbjct: 5   EIDPKDLTFLKE---LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 60
Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           + H  +++LY    K    F++ EYM NG L   L    +E +      +  ++     +
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCE 116
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            + YL    S   +HRD+ + N L+++    K++DFG+++
Sbjct: 117 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 21/187 (11%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAAEM-----E 723
           A+   +L++   I + GTG   R+ L K+  T    A+K L K   VK+   E       
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           IL  +    ++KL        + ++V+EY+  G +F  L +  +  +P   ++     A 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AA 148
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                  YLH   S  +I+RD+K  N+L+D+    ++ DFG AK  +            G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WXLCG 200
Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHR 731
           + E   +IG G   +V  + +K+     A+K + K D +K      F  E ++L     R
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
            I +L+         +LV+EY   G+L   L K  +    E+  F   +I + A   +  
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM-AIDSVHR 180
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824
           L +      +HRDIK  NILLD     ++ADFG
Sbjct: 181 LGY------VHRDIKPDNILLDRCGHIRLADFG 207

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-VFAAEMEILGK 727
           +ID + +  L+E   +G+G  G V +    +    VA+K + +G   +  F  E +++  
Sbjct: 11  EIDPKDLTFLKE---LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 66
Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           + H  +++LY    K    F++ EYM NG L   L    +E +      +  ++     +
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCE 122
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            + YL    S   +HRD+ + N L+++    K++DFG+++
Sbjct: 123 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 159

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELDW--FRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 110 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 161
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     +      T  Y AP
Sbjct: 162 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMXGXVATRWYRAP 211

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 80/174 (45%), Gaps = 19/174 (10%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
           +GSG  G V   Y   L++    VAVK+L +     + A     E+ +L  ++H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                   S     E      L  A    + + +   D   ++ +     +G+ Y+H   
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH--- 148
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  IIHRD+K SN+ ++ED E +I DFG+A+ A+      + + +  T  Y AP
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRWYRAP 197

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 20/179 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
           ++G GG  +V+     +    VAVK L + D  +       F  E +    + H  I+ +
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 737 Y----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           Y    A    G   ++V+EY+    L   +H    EG   +   R  ++   A + + + 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGP--MTPKRAIEVIADACQALNFS 132
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
           H +    IIHRD+K +NI++      K+ DFG+A+ IA++   V+  +   GT  Y++P
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILK----L 736
           IG G  G V           VA+K++   +     +    E++IL + RH N++     L
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  L+      +++ +   +L++ L K  +     + +F  Y+I     +G+ Y+H   
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLL-KSQQLSNDHICYFL-YQIL----RGLKYIH--- 161
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF----AGTHGYIAP 850
           S  ++HRD+K SN+L++   + KI DFG+A+IA+      D++ F      T  Y AP
Sbjct: 162 SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPE---HDHTGFLTEXVATRWYRAP 216

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DF +A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDD-----EMTGYVATRWYRAP 191

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-VFAAEMEILGKI 728
           ID + +  L+E   +G+G  G V +    +    VA+K + +G   +  F  E +++  +
Sbjct: 1   IDPKDLTFLKE---LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL 56
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY    K    F++ EYM NG L   L    +E +      +  ++     + 
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEA 112
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           + YL    S   +HRD+ + N L+++    K++DFG+++
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      ++ ++   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 161
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 162 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 32/183 (17%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKL----- 736
            +IG GG G+VY           A+K L   D  ++   + E L  +  R +L L     
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLA-LNERIMLSLVSTGD 250
Query: 737 --------YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
                   YA       SF +L+ M  G+L   L +     + ++ ++        AA+ 
Sbjct: 251 CPFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEADMRFY--------AAEI 301
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGY 847
           I  L H  +  +++RD+K +NILLDE    +I+D G+A   ++  P  S      GTHGY
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGY 356
Query: 848 IAP 850
           +AP
Sbjct: 357 MAP 359

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 32/183 (17%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKL----- 736
            +IG GG G+VY           A+K L   D  ++   + E L  +  R +L L     
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLA-LNERIMLSLVSTGD 250
Query: 737 --------YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
                   YA       SF +L+ M  G+L   L +     + ++ ++        AA+ 
Sbjct: 251 CPFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEADMRFY--------AAEI 301
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGY 847
           I  L H  +  +++RD+K +NILLDE    +I+D G+A   ++  P  S      GTHGY
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGY 356
Query: 848 IAP 850
           +AP
Sbjct: 357 MAP 359

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 20/161 (12%)
Query: 684 IGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKL 736
           +G G  GKV+  +      +++   VAVK L +      + F  E E+L  ++H++I++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK----------PELDWFRRYKIALGAA 786
           +    +G    +V EYM +G+L + L     + K            L   +   +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            G+ YL        +HRD+ + N L+ +    KI DFG+++
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 23/176 (13%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY-- 737
           +GSG  G V      +    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 738 ---ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
              A  ++  S   ++  +   +L   +  + +    E   F  Y++     +G+ Y+H 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIV--KCQALSDEHVQFLVYQLL----RGLKYIH- 148
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             S  IIHRD+K SN+ ++ED E +I DFG+A+ A+      + + +  T  Y AP
Sbjct: 149 --SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRWYRAP 197

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 32/183 (17%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKL----- 736
            +IG GG G+VY           A+K L   D  ++   + E L  +  R +L L     
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLA-LNERIMLSLVSTGD 250
Query: 737 --------YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
                   YA       SF +L+ M  G+L   L +     + ++ ++        AA+ 
Sbjct: 251 CPFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEADMRFY--------AAEI 301
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGY 847
           I  L H  +  +++RD+K +NILLDE    +I+D G+A   ++  P  S      GTHGY
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGY 356
Query: 848 IAP 850
           +AP
Sbjct: 357 MAP 359

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 32/183 (17%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKL----- 736
            +IG GG G+VY           A+K L   D  ++   + E L  +  R +L L     
Sbjct: 194 RIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLA-LNERIMLSLVSTGD 249
Query: 737 --------YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
                   YA       SF +L+ M  G+L   L +     + ++ ++        AA+ 
Sbjct: 250 CPFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEADMRFY--------AAEI 300
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGY 847
           I  L H  +  +++RD+K +NILLDE    +I+D G+A   ++  P  S      GTHGY
Sbjct: 301 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGY 355
Query: 848 IAP 850
           +AP
Sbjct: 356 MAP 358

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 688 GTGKVYRLDLKKN------AGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           G   V R  +KK       A  +  K+L   D  K+   E  I   ++H NI++L+  + 
Sbjct: 42  GAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL-EREARICRLLKHPNIVRLHDSIS 100
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           + G  +LV + +  G LF+ +  R        +++     +    + +  ++H     I+
Sbjct: 101 EEGFHYLVFDLVTGGELFEDIVAR--------EYYSEADASHCIHQILESVNHIHQHDIV 152
Query: 802 HRDIKSSNILLDEDYE---PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           HRD+K  N+LL    +    K+ADFG+A   E   +   +  FAGT GY++P
Sbjct: 153 HRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLSP 202

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 141
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG-----VKVFAAEMEILGKIRHRNI 733
            ++G G  G V   +LK+  GT   VAVK + K D      ++ F +E   +    H N+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 734 LKLYACLLKGGSS-----FLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAK 787
           ++L    ++  S       ++L +M  G+L   L + R++ G   +      K  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           G+ YL +      +HRD+ + N +L +D    +ADFG++K
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 19/172 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWKGDGVKVFAA---EMEILGKIR 729
            L +  ++GSG  G V++        +    V +K +    G + F A    M  +G + 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPEL--DWFRRYKIALGAAK 787
           H +I++L   L  G S  LV +Y+P G+L   + +      P+L  +W       +  AK
Sbjct: 92  HAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAK 144
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
           G+ YL       ++HR++ + N+LL    + ++ADFGVA +     K   YS
Sbjct: 145 GMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 193

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 83/180 (46%), Gaps = 7/180 (3%)
Query: 100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV--PDLSALKNLEIFDLSINYFT 157
           T+L L  NVL+       +  + L+ L+++ NA + SV       L  L    L      
Sbjct: 59  TILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
Query: 158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE-SISEL 216
              P     L  L  L + DN   +A   ++  +L NLT+LFL H N    +PE +   L
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFL-HGNRISSVPERAFRGL 176
Query: 217 RELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDISSN 275
             L  L + +N+++   P + R L +L  + L+ANNL+  LP E L  L  LQ   ++ N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDN 235

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 20/179 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
           ++G GG  +V+     +    VAVK L + D  +       F  E +    + H  I+ +
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 94
Query: 737 Y----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           Y    A    G   ++V+EY+    L   +H    EG   +   R  ++   A + + + 
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGP--MTPKRAIEVIADACQALNFS 149
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
           H +    IIHRD+K +NI++      K+ DFG+A+ IA++   V+  +   GT  Y++P
Sbjct: 150 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 205

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 83/180 (46%), Gaps = 7/180 (3%)
Query: 100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV--PDLSALKNLEIFDLSINYFT 157
           T+L L  NVL+       +  + L+ L+++ NA + SV       L  L    L      
Sbjct: 58  TILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 117
Query: 158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE-SISEL 216
              P     L  L  L + DN   +A   ++  +L NLT+LFL H N    +PE +   L
Sbjct: 118 ELGPGLFRGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFL-HGNRISSVPERAFRGL 175
Query: 217 RELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDISSN 275
             L  L + +N+++   P + R L +L  + L+ANNL+  LP E L  L  LQ   ++ N
Sbjct: 176 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDN 234

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 19/172 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWKGDGVKVFAA---EMEILGKIR 729
            L +  ++GSG  G V++        +    V +K +    G + F A    M  +G + 
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPEL--DWFRRYKIALGAAK 787
           H +I++L   L  G S  LV +Y+P G+L   + +      P+L  +W       +  AK
Sbjct: 74  HAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAK 126
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
           G+ YL       ++HR++ + N+LL    + ++ADFGVA +     K   YS
Sbjct: 127 GMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 20/161 (12%)
Query: 684 IGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKL 736
           +G G  GKV+  +      +++   VAVK L +      + F  E E+L  ++H++I++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK----------PELDWFRRYKIALGAA 786
           +    +G    +V EYM +G+L + L     + K            L   +   +A   A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            G+ YL        +HRD+ + N L+ +    KI DFG+++
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 141
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 20/161 (12%)
Query: 684 IGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKL 736
           +G G  GKV+  +      +++   VAVK L +      + F  E E+L  ++H++I++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK----------PELDWFRRYKIALGAA 786
           +    +G    +V EYM +G+L + L     + K            L   +   +A   A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            G+ YL        +HRD+ + N L+ +    KI DFG+++
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 23/176 (13%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY-- 737
           +GSG  G V      +    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 738 ---ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
              A  ++  S   ++  +   +L   +  + +    E   F  Y++     +G+ Y+H 
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIV--KCQALSDEHVQFLVYQLL----RGLKYIH- 140
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             S  IIHRD+K SN+ ++ED E +I DFG+A+ A+      + + +  T  Y AP
Sbjct: 141 --SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADE-----EMTGYVATRWYRAP 189

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 149
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 150 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 141
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 143
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI  FG+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 145
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 141
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 141
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 139
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---EMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +          E++IL + RH NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 145
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 161
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 162 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 146
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 19/161 (11%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGD-----GVKVFAAEMEILGKIRHRNI 733
            ++G G  G V    LK+  G+   VAVK L K D      ++ F  E   + +  H ++
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 734 LKLYACLLKGGSS------FLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKIALGAA 786
            KL    L+  +        ++L +M +G+L    L  R+ E    L      +  +  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            G+ YL    S   IHRD+ + N +L ED    +ADFG+++
Sbjct: 148 CGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 147
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 148 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 138
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 139 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 145
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI D G+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 139
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI D G+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 19/173 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAG-TVAVKQLW---KGDGVKVFAA-EMEILGKIRHRNILKLYA 738
           +G G  G VY+   K + G  VA+K++    + +G+   A  E+ +L ++ H NI+ L  
Sbjct: 29  VGEGTYGVVYKA--KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL-GAAKGIAYLHHDCS 797
            +       LV E+M      + L K + E K  L    + KI L    +G+A+ H    
Sbjct: 87  VIHSERCLTLVFEFME-----KDLKKVLDENKTGLQ-DSQIKIYLYQLLRGVAHCHQH-- 138
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K  N+L++ D   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIP-VRSYTHEVVTLWYRAP 188

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 678 LEEDNLIGSGGTGKVYR-LDLKKNAGTVAV----KQLWKGDGVKVFAAEMEILGKIRHRN 732
           L+ D  IG G    VY+ LD +            ++L K +  + F  E E L  ++H N
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEXLKGLQHPN 86
Query: 733 ILKLY---ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPEL--DWFRRYKIALGAAK 787
           I++ Y      +KG    +++  +      +   KR K  K ++   W R+        K
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILK 140
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
           G+ +LH   +PPIIHRD+K  NI +       KI D G+A +     + S      GT  
Sbjct: 141 GLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPE 195
Query: 847 YIAP 850
           + AP
Sbjct: 196 FXAP 199

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L  + +    +   +  Y+I     +G+ Y+H   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL--KCQHLSNDHICYFLYQIL----RGLKYIH--- 145
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 31/195 (15%)
Query: 674 QICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK---VFAAEMEILGKIR 729
           Q C   E    +G+GG G V R   +     VA+KQ  +    K    +  E++I+ K+ 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 730 HRNILKLYAC------LLKGGSSFLVLEYMPNGNLFQALHK-----RVKEGKPELDWFRR 778
           H N++           L       L +EY   G+L + L++      +KEG       R 
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-----IRT 125
Query: 779 YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAKIAENSPKV 835
               + +A  + YLH +    IIHRD+K  NI+L    +    KI D G AK  +     
Sbjct: 126 LLSDISSA--LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 836 SDYSCFAGTHGYIAP 850
           ++   F GT  Y+AP
Sbjct: 181 TE---FVGTLQYLAP 192

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 31/195 (15%)
Query: 674 QICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK---VFAAEMEILGKIR 729
           Q C   E    +G+GG G V R   +     VA+KQ  +    K    +  E++I+ K+ 
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 730 HRNILKLYAC------LLKGGSSFLVLEYMPNGNLFQALHK-----RVKEGKPELDWFRR 778
           H N++           L       L +EY   G+L + L++      +KEG       R 
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-----IRT 126
Query: 779 YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAKIAENSPKV 835
               + +A  + YLH +    IIHRD+K  NI+L    +    KI D G AK  +     
Sbjct: 127 LLSDISSA--LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 181
Query: 836 SDYSCFAGTHGYIAP 850
           ++   F GT  Y+AP
Sbjct: 182 TE---FVGTLQYLAP 193

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 19/173 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAG-TVAVKQLW---KGDGVKVFAA-EMEILGKIRHRNILKLYA 738
           +G G  G VY+   K + G  VA+K++    + +G+   A  E+ +L ++ H NI+ L  
Sbjct: 29  VGEGTYGVVYKA--KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL-GAAKGIAYLHHDCS 797
            +       LV E+M      + L K + E K  L    + KI L    +G+A+ H    
Sbjct: 87  VIHSERCLTLVFEFME-----KDLKKVLDENKTGLQ-DSQIKIYLYQLLRGVAHCHQH-- 138
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K  N+L++ D   K+ADFG+A+ A   P V  Y+    T  Y AP
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIP-VRSYTHEVVTLWYRAP 188

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 14/157 (8%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNIL 734
           + ++G G  G+VY      + G    VAVK   K    D  + F +E  I+  + H +I+
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           KL   +++   +++++E  P G L   L +     K  L        +L   K +AYL  
Sbjct: 89  KLIG-IIEEEPTWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLE- 142
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
             S   +HRDI   NIL+      K+ DFG+++  E+
Sbjct: 143 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 177

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E  I   ++H NI++L+  + + G  +L+ + +  G LF+ +  R        +++    
Sbjct: 71  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--------EYYSEAD 122
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAKIAENSPKVSD 837
            +    + +  + H     ++HRD+K  N+LL    +    K+ADFG+A   E   +   
Sbjct: 123 ASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-- 180
Query: 838 YSCFAGTHGYIAP 850
           +  FAGT GY++P
Sbjct: 181 WFGFAGTPGYLSP 193

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 14/174 (8%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKL 736
            ++G GG G+V    ++      A K+L K       G  +   E +IL K+  R ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                   +  LVL  M  G+L   ++   + G PE    R    A     G+  LH + 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRE- 305
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I++RD+K  NILLD+    +I+D G   +A + P+        GT GY+AP
Sbjct: 306 --RIVYRDLKPENILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGYMAP 354

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 14/174 (8%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKL 736
            ++G GG G+V    ++      A K+L K       G  +   E +IL K+  R ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                   +  LVL  M  G+L   ++   + G PE    R    A     G+  LH + 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRE- 305
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I++RD+K  NILLD+    +I+D G   +A + P+        GT GY+AP
Sbjct: 306 --RIVYRDLKPENILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGYMAP 354

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 18/181 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA----AEMEILGKIRHRNILKLY 737
           +L+G G  G V     K     VA+K++   D   +FA     E++IL   +H NI+ ++
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIF 75
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                         Y+    +   LH+ +       D  + +       + +  LH    
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAVKVLH---G 130
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKI-----AENSPKVSDYSC---FAGTHGYIA 849
             +IHRD+K SN+L++ + + K+ DFG+A+I     A+NS      S    F  T  Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 850 P 850
           P
Sbjct: 191 P 191

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNIL 734
           + ++G G  G+VY      + G    VAVK   K    D  + F +E  I+  + H +I+
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           KL   +++   +++++E  P G L   L +     K  L        +L   K +AYL  
Sbjct: 77  KLIG-IIEEEPTWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLE- 130
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             S   +HRDI   NIL+      K+ DFG+++  E+ 
Sbjct: 131 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNIL 734
           + ++G G  G+VY      + G    VAVK   K    D  + F +E  I+  + H +I+
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           KL   +++   +++++E  P G L   L +     K  L        +L   K +AYL  
Sbjct: 73  KLIG-IIEEEPTWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLE- 126
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             S   +HRDI   NIL+      K+ DFG+++  E+ 
Sbjct: 127 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 162

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 740 LLKGGSSFLVLE-----YMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAYL 792
                S    LE     Y+    +   L+  VK  K   D   F  Y+I     +G+ Y+
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----RGLKYI 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI D G+A+  ++     + + +  T  Y AP
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDD-----EMTGYVATRWYRAP 191

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA++++   +     +    E++IL + RH NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 145
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 145
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF----AGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+      D++ F      T  Y AP
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD---HDHTGFLXEXVATRWYRAP 200

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 146
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF----AGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+      D++ F      T  Y AP
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD---HDHTGFLXEXVATRWYRAP 201

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 701 AGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
           A  +  K+L   D  K+   E  I   ++H NI++L+  + + G  +LV + +  G LF+
Sbjct: 34  AKIINTKKLSARDHQKL-EREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE 92
Query: 761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYE 817
            +  R        +++     +    + +  ++H     I+HRD+K  N+LL    +   
Sbjct: 93  DIVAR--------EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAA 144
Query: 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            K+ADFG+A   +   +   +  FAGT GY++P
Sbjct: 145 VKLADFGLAIEVQGDQQA--WFGFAGTPGYLSP 175

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 684 IGSGGTGKVYRL-DLKKNAGTVAVKQLWKGDGVKVF-------AAEMEILGKIRHRNILK 735
           IG G  GKV++  DLK     VA+K++    G +          A +  L    H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 736 LY-ACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
           L+  C +    +     LV E++ + +L   L K  + G P         +     +G+ 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI---KDMMFQLLRGLD 134
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           +LH   S  ++HRD+K  NIL+    + K+ADFG+A+I
Sbjct: 135 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 25/200 (12%)
Query: 663 ASFHHIDIDAEQ-----ICNLEEDNLIGSGGTGKVYRLD-----LKKNAGTVAVKQLWKG 712
           A F H  + A+Q        + +  ++G G  G+V++ +     LK  A  +  + +   
Sbjct: 71  APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK 130
Query: 713 DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE 772
           + VK    E+ ++ ++ H N+++LY          LV+EY+  G LF     R+ +    
Sbjct: 131 EEVK---NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD----RIIDESYN 183
Query: 773 LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL-LDEDYEP-KIADFGVAKIAE 830
           L             +GI ++H      I+H D+K  NIL ++ D +  KI DFG+A+  +
Sbjct: 184 LTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
Query: 831 NSPKVSDYSCFAGTHGYIAP 850
              K+       GT  ++AP
Sbjct: 241 PREKL---KVNFGTPEFLAP 257

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPAFVAP 186

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL   RH NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 143
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKL---- 736
           IG G  G V       N   VA+K++   +     +    E++IL   RH NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
            A  ++      +++ +   +L++ L K        + +F  Y+I     +G+ Y+H   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFL-YQIL----RGLKYIH--- 143
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAP 850
           S  ++HRD+K SN+LL+   + KI DFG+A++A+     + + + +  T  Y AP
Sbjct: 144 SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAG-TVAVKQLWKG----DGVKVFAAEMEILGKIRHR 731
           N E  +LIG G  G VY L   KNA   VA+K++ +        K    E+ IL +++  
Sbjct: 29  NYEIKHLIGRGSYGYVY-LAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 732 NILKLYAC-----LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
            I++L+       LLK    ++VLE + + +L +     +   +  +     Y + LG  
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTIL-YNLLLGEK 145
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               ++H      IIHRD+K +N LL++D   KI DFG+A+
Sbjct: 146 ----FIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGV--KVFAAEMEILGKIRHRNILKLY 737
           +LIG G  G VY    K     VA+K++ +   D +  K    E+ IL +++   I++LY
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 738 AC-----LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
                  LLK    ++VLE + + +L +     +   +  +     Y + LG      ++
Sbjct: 92  DLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTIL-YNLLLGEN----FI 145
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           H      IIHRD+K +N LL++D   K+ DFG+A+
Sbjct: 146 HESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 78/181 (43%), Gaps = 18/181 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA----AEMEILGKIRHRNILKLY 737
           +L+G G  G V     K     VA+K++   D   +FA     E++IL   +H NI+ ++
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIF 75
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                         Y+    +   LH+ +       D  + +       + +  LH    
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAVKVLH---G 130
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP--------KVSDYSCFAGTHGYIA 849
             +IHRD+K SN+L++ + + K+ DFG+A+I + S         + S  + +  T  Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 850 P 850
           P
Sbjct: 191 P 191

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 68/157 (43%), Gaps = 16/157 (10%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILK 735
           +G G  G+VY   +       +   VAVK L   +       F  E  I+ K  H+NI++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYLH 793
                L+    F++LE M  G+L   L + R +  +P  L       +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 794 HDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
            +     IHRDI + N LL         KI DFG+A+
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 701 AGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
           A  +  K+L   D  K+   E  I   ++H NI++L+  + + G  +LV + +  G LF+
Sbjct: 34  AKIINTKKLSARDHQKL-EREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE 92
Query: 761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYE 817
            +  R        +++     +    + +  ++H     I+HRD+K  N+LL    +   
Sbjct: 93  DIVAR--------EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAA 144
Query: 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            K+ADFG+A   +   +   +  FAGT GY++P
Sbjct: 145 VKLADFGLAIEVQGDQQA--WFGFAGTPGYLSP 175

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEI-LGKIRHRN 732
           +LE    +G G  G V ++    +   +AVK++         K    +++I +  +    
Sbjct: 52  DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 111
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
            +  Y  L + G  ++ +E M         +K+V +    +      KIA+   K + +L
Sbjct: 112 TVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 169
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  +IHRD+K SN+L++   + K+ DFG++  + ++  K  D    AG   Y+AP
Sbjct: 170 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTID----AGCKPYMAP 222

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 57/121 (47%), Gaps = 12/121 (9%)
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           ++ L+          L+LEY   G +F      + E   E D  R  K  L   +G+ YL
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL---EGVYYL 147
Query: 793 HHDCSPPIIHRDIKSSNILLDEDY---EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
           H +    I+H D+K  NILL   Y   + KI DFG+++   ++ ++ +     GT  Y+A
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLA 201
Query: 850 P 850
           P
Sbjct: 202 P 202

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 5/107 (4%)
Query: 142 ALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLA 201
           +L+NL   D+S  +    F      L+ L  L +  N + E  +P+    L+NLT+L L+
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 202 HCNLRGRIPESISELRELGTLDICRNKIS----GEFPRSIRKLQKLW 244
            C L    P + + L  L  L++  N++     G F R +  LQK+W
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR-LTSLQKIW 524

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 76/172 (44%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLK 742
           IG G   +  R   K      AVK + K    +  + E+EIL +  +H NI+ L      
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSK--RDPSEEIEILLRYGQHPNIITLKDVYDD 92
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
           G   +LV E M  G L   + ++    + E  +     +     K + YLH   S  ++H
Sbjct: 93  GKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLH---SQGVVH 144
Query: 803 RDIKSSNIL-LDEDYEP---KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           RD+K SNIL +DE   P   +I DFG AK       +    C+  T  ++AP
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--TANFVAP 194

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA----AEMEILGKIRHRNILKLY 737
           +L+G G  G V     K     VA+K++   D   +FA     E++IL   +H NI+ ++
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIF 75
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                         Y+    +   LH+ +       D  + +       + +  LH    
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAVKVLH---G 130
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +IHRD+K SN+L++ + + K+ DFG+A+I + S
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 18/158 (11%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNIL 734
           +G G  G+VY   +       +   VAVK L     + D +  F  E  I+ K+ H+NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKLNHQNIV 97
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYL 792
           +     L+    F++LE M  G+L   L + R +  +P  L       +A   A G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 793 HHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
             +     IHRDI + N LL         KI DFG+A+
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 684 IGSGGTGKVYRL-DLKKNAGTVAVKQLWKGDGVKVF-------AAEMEILGKIRHRNILK 735
           IG G  GKV++  DLK     VA+K++    G +          A +  L    H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 736 LY-ACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
           L+  C +    +     LV E++ + +L   L K  + G P         +     +G+ 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI---KDMMFQLLRGLD 134
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           +LH   S  ++HRD+K  NIL+    + K+ADFG+A+I
Sbjct: 135 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 76/172 (44%), Gaps = 17/172 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLK 742
           IG G   +  R   K      AVK + K    +  + E+EIL +  +H NI+ L      
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSK--RDPSEEIEILLRYGQHPNIITLKDVYDD 92
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
           G   +LV E M  G L   + ++    + E  +     +     K + YLH   S  ++H
Sbjct: 93  GKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLH---SQGVVH 144
Query: 803 RDIKSSNIL-LDEDYEP---KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           RD+K SNIL +DE   P   +I DFG AK       +    C+  T  ++AP
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--TANFVAP 194

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G+VY   +       +   VAVK L +    +    F  E  I+ K+ H+NI++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYLH 793
                L+    F++LE M  G+L   L + R +  +P  L       +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 794 HDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
            +     IHRDI + N LL         KI DFG+A+
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 684 IGSGGTGKVYRL-DLKKNAGTVAVKQLWKGDGVKVF-------AAEMEILGKIRHRNILK 735
           IG G  GKV++  DLK     VA+K++    G +          A +  L    H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 736 LY-ACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
           L+  C +    +     LV E++ + +L   L K  + G P         +     +G+ 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI---KDMMFQLLRGLD 134
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           +LH   S  ++HRD+K  NIL+    + K+ADFG+A+I
Sbjct: 135 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKG 788
           L   + +G  + +++E M  G+L   L     E         P L   +  ++A   A G
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 144
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 84/178 (47%), Gaps = 29/178 (16%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAE--MEILGKIRHRNILKLYACLL 741
           +G G  G+V+R++ K+     AVK++     ++VF AE  M   G    R I+ LY  + 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPR-IVPLYGAVR 155
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGK--PELDWFRRYKIALGAA-KGIAYLHHDCSP 798
           +G    + +E +  G+L Q     VKE    PE     R    LG A +G+ YLH   S 
Sbjct: 156 EGPWVNIFMELLEGGSLGQL----VKEQGCLPE----DRALYYLGQALEGLEYLH---SR 204
Query: 799 PIIHRDIKSSNILLDED-YEPKIADFGVAKIAE-----NSPKVSDYSCFAGTHGYIAP 850
            I+H D+K+ N+LL  D     + DFG A   +      S    DY    GT  ++AP
Sbjct: 205 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY--IPGTETHMAP 260

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKG 788
           L   + +G  + +++E M  G+L   L     E         P L   +  ++A   A G
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 135
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 136 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
           +G G  G+VY+        TVA+K++    + +GV   A  E+ +L +++HRNI++L + 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           +       L+ EY  N        K+  +  P++              G+ + H   S  
Sbjct: 102 IHHNHRLHLIFEYAENDL------KKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRR 152
Query: 800 IIHRDIKSSNILL---DEDYEP--KIADFGVAK 827
            +HRD+K  N+LL   D    P  KI DFG+A+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKG 788
           L   + +G  + +++E M  G+L   L     E         P L   +  ++A   A G
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 150
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKG 788
           L   + +G  + +++E M  G+L   L     E         P L   +  ++A   A G
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 143
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E  I   ++H NI++L+  + + G  +LV + +  G LF+ +  R        +++    
Sbjct: 53  EARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--------EYYSEAD 104
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAKIAENSPKVSD 837
            +    + +  + H     ++HRD+K  N+LL    +    K+ADFG+A   +   +   
Sbjct: 105 ASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQA-- 162
Query: 838 YSCFAGTHGYIAP 850
           +  FAGT GY++P
Sbjct: 163 WFGFAGTPGYLSP 175

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 123 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 171
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 172 EFKNIFGTPEFVAP 185

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNIL 734
           +G G  G+VY   +       +   VAVK L     + D +  F  E  I+ K  H+NI+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 137
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYL 792
           +     L+    F++LE M  G+L   L + R +  +P  L       +A   A G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 793 HHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
             +     IHRDI + N LL         KI DFG+A+
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E  I   ++H NI++L+  + + G  +L+ + +  G LF+ +  R        +++    
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--------EYYSEAD 111
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAKIAENSPKVSD 837
            +    + +  + H     ++HR++K  N+LL    +    K+ADFG+A   E   +   
Sbjct: 112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-- 169
Query: 838 YSCFAGTHGYIAP 850
           +  FAGT GY++P
Sbjct: 170 WFGFAGTPGYLSP 182

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKG 788
           L   + +G  + +++E M  G+L   L     E         P L   +  ++A   A G
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 144
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNIL 734
           +G G  G+VY   +       +   VAVK L     + D +  F  E  I+ K  H+NI+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 113
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYL 792
           +     L+    F++LE M  G+L   L + R +  +P  L       +A   A G  YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 793 HHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
             +     IHRDI + N LL         KI DFG+A+
Sbjct: 174 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNIL 734
           +G G  G+VY   +       +   VAVK L     + D +  F  E  I+ K  H+NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 97
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYL 792
           +     L+    F++LE M  G+L   L + R +  +P  L       +A   A G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 793 HHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
             +     IHRDI + N LL         KI DFG+A+
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKG 788
           L   + +G  + +++E M  G+L   L     E         P L   +  ++A   A G
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 141
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 142 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 123 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 171
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 172 EFKNIFGTPEFVAP 185

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G+VY   +       +   VAVK L +    +    F  E  I+ K  H+NI++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYLH 793
                L+    F++LE M  G+L   L + R +  +P  L       +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 794 HDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
            +     IHRDI + N LL         KI DFG+A+
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKG 788
           L   + +G  + +++E M  G+L   L     E         P L   +  ++A   A G
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 137
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 138 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKG 788
           L   + +G  + +++E M  G+L   L     E         P L   +  ++A   A G
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 143
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDW 775
           F  E  I+ K  H+NI++     L+    F++LE M  G+L   L + R +  +P  L  
Sbjct: 98  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 157
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
                +A   A G  YL  +     IHRDI + N LL         KI DFG+A+
Sbjct: 158 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDW 775
           F  E  I+ K  H+NI++     L+    F++LE M  G+L   L + R +  +P  L  
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 131
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
                +A   A G  YL  +     IHRDI + N LL         KI DFG+A+
Sbjct: 132 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNIL 734
           +G G  G+VY   +       +   VAVK L     + D +  F  E  I+ K  H+NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 97
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYL 792
           +     L+    F++LE M  G+L   L + R +  +P  L       +A   A G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 793 HHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
             +     IHRDI + N LL         KI DFG+A+
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDW 775
           F  E  I+ K  H+NI++     L+    F++LE M  G+L   L + R +  +P  L  
Sbjct: 87  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 146
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
                +A   A G  YL  +     IHRDI + N LL         KI DFG+A+
Sbjct: 147 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 25/160 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVF-------AAEMEILGKIRHRNILKL 736
           IG G  G VY+     +   VA+K +   +G +          A +  L    H N+++L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 737 YACLLKGGSS-----FLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKG 788
                   +       LV E++ + +L   L K    G P     D  R++       +G
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQF------LRG 124
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           + +LH +C   I+HRD+K  NIL+      K+ADFG+A+I
Sbjct: 125 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNIL 734
           +G G  G+VY   +       +   VAVK L     + D +  F  E  I+ K  H+NI+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 123
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYL 792
           +     L+    F++LE M  G+L   L + R +  +P  L       +A   A G  YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 793 HHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
             +     IHRDI + N LL         KI DFG+A+
Sbjct: 184 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKG 788
           L   + +G  + +++E M  G+L   L     E         P L   +  ++A   A G
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 172
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 173 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 25/160 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVF-------AAEMEILGKIRHRNILKL 736
           IG G  G VY+     +   VA+K +   +G +          A +  L    H N+++L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 737 YACLLKGGSS-----FLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKG 788
                   +       LV E++ + +L   L K    G P     D  R++       +G
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQF------LRG 124
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           + +LH +C   I+HRD+K  NIL+      K+ADFG+A+I
Sbjct: 125 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 25/160 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVF-------AAEMEILGKIRHRNILKL 736
           IG G  G VY+     +   VA+K +   +G +          A +  L    H N+++L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 737 YACLLKGGSS-----FLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKG 788
                   +       LV E++ + +L   L K    G P     D  R++       +G
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQF------LRG 124
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
           + +LH +C   I+HRD+K  NIL+      K+ADFG+A+I
Sbjct: 125 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 58/118 (49%), Gaps = 9/118 (7%)
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           +  Y  L + G  ++ +E M         +K+V +    +      KIA+   K + +LH
Sbjct: 69  VTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAP 850
              S  +IHRD+K SN+L++   + K+ DFG++  + ++  K  D    AG   Y+AP
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID----AGCKPYMAP 178

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL ++ H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   +  I H D+K  NI+L +   P    K+ DFG+A   E+     
Sbjct: 125 L-----DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---V 173
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 174 EFKNIFGTPEFVAP 187

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 74/149 (49%), Gaps = 22/149 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAE--MEILGKIRHRNILKLYACLL 741
           +G G  G+V+R++ K+     AVK++     ++VF AE  M   G    R I+ LY  + 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPR-IVPLYGAVR 136
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGK--PELDWFRRYKIALGAA-KGIAYLHHDCSP 798
           +G    + +E +  G+L Q     VKE    PE     R    LG A +G+ YLH   S 
Sbjct: 137 EGPWVNIFMELLEGGSLGQL----VKEQGCLPE----DRALYYLGQALEGLEYLH---SR 185
Query: 799 PIIHRDIKSSNILLDED-YEPKIADFGVA 826
            I+H D+K+ N+LL  D     + DFG A
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHA 214

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G+VY   +       +   VAVK L +    +    F  E  I+ K  H+NI++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYLH 793
                L+    F+++E M  G+L   L + R +  +P  L       +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 794 HDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
            +     IHRDI + N LL         KI DFG+A+
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G+VY   +       +   VAVK L +    +    F  E  I+ K  H+NI++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP-ELDWFRRYKIALGAAKGIAYLH 793
                L+    F+++E M  G+L   L + R +  +P  L       +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 794 HDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
            +     IHRDI + N LL         KI DFG+A+
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL ++ H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   +  I H D+K  NI+L +   P    K+ DFG+A   E+     
Sbjct: 125 L-----DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---V 173
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 174 EFKNIFGTPEFVAP 187

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL ++ H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   +  I H D+K  NI+L +   P    K+ DFG+A   E+     
Sbjct: 125 L-----DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---V 173
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 174 EFKNIFGTPEFVAP 187

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL ++ H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   +  I H D+K  NI+L +   P    K+ DFG+A   E+     
Sbjct: 125 L-----DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---V 173
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 174 EFKNIFGTPEFVAP 187

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL ++ H N++ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   +  I H D+K  NI+L +   P    K+ DFG+A   E+     
Sbjct: 125 L-----DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---V 173
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 174 EFKNIFGTPEFVAP 187

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL ++ H NI+ L+          L+LE +  G LF  L ++    + E   F +  
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   +  I H D+K  NI+L +   P    K+ DFG+A   E+     
Sbjct: 125 L-----DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---V 173
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 174 EFKNIFGTPEFVAP 187

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGV--KVFAAEMEILGKIRHRNILKLY 737
           +LIG+G  G V     K     VA+K++ +   D +  K    E+ IL ++ H +++K+ 
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 738 ACLL-----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
             ++     K    ++VLE      +  +  K++      L       +      G+ Y+
Sbjct: 119 DIVIPKDVEKFDELYVVLE------IADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
           H   S  I+HRD+K +N L+++D   K+ DFG+A+  +
Sbjct: 173 H---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 72/159 (45%), Gaps = 20/159 (12%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKG 788
           L   + +G  + +++E M  G+L   L     E         P L   +  ++A   A G
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 137
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +AYL+ +     +HRD+ + N  + ED+  KI DFG+ +
Sbjct: 138 MAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 660 WKLASFHHIDIDAEQICNLEE-DNLIGSGGTGKVYRLDLKKNAGTVAVKQLW--KGDGVK 716
           WK      ++I  + + +  +    +G+G  G V+R+  +      A K +        +
Sbjct: 34  WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 93
Query: 717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL---HKRVKEGKPEL 773
               E++ +  +RH  ++ L+          ++ E+M  G LF+ +   H ++ E +  +
Sbjct: 94  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE-AV 152
Query: 774 DWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPKIADFGVAKIAEN 831
           ++ R+        KG+ ++H +     +H D+K  NI+       E K+ DFG+   A  
Sbjct: 153 EYMRQ------VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT--AHL 201
Query: 832 SPKVSDYSCFAGTHGYIAP 850
            PK S      GT  + AP
Sbjct: 202 DPKQS-VKVTTGTAEFAAP 219

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 61/122 (50%), Gaps = 11/122 (9%)
Query: 721 EMEILGKIRHRNILKLYACLL--KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRR 778
           E+++L ++RH+N+++L   L   +    ++V+EY   G   Q +   V E +  +     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG--MQEMLDSVPEKRFPVCQAHG 113
Query: 779 YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
           Y   L    G+ YLH   S  I+H+DIK  N+LL      KI+  GVA+     P  +D 
Sbjct: 114 YFCQL--IDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH--PFAADD 166
Query: 839 SC 840
           +C
Sbjct: 167 TC 168

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPEL---DWFRRYKIALGAAKGIA 790
           L   + +G  + +++E M  G+L   L   +      P L      +  ++A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           YL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 660 WKLASFHHIDIDAEQICNLEE-DNLIGSGGTGKVYRLDLKKNAGTVAVKQLW--KGDGVK 716
           WK      ++I  + + +  +    +G+G  G V+R+  +      A K +        +
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL---HKRVKEGKPEL 773
               E++ +  +RH  ++ L+          ++ E+M  G LF+ +   H ++ E +  +
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE-AV 258
Query: 774 DWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPKIADFGVAKIAEN 831
           ++ R+        KG+ ++H +     +H D+K  NI+       E K+ DFG+   A  
Sbjct: 259 EYMRQ------VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT--AHL 307
Query: 832 SPKVSDYSCFAGTHGYIAP 850
            PK S      GT  + AP
Sbjct: 308 DPKQS-VKVTTGTAEFAAP 325

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 66/137 (48%), Gaps = 19/137 (13%)
Query: 721 EMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY 779
           E+EIL +  +H NI+ L      G   ++V E M  G L   + ++    + E       
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS----- 119
Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL-LDEDYEP---KIADFGVAKI--AENSP 833
            +     K + YLH   +  ++HRD+K SNIL +DE   P   +I DFG AK   AEN  
Sbjct: 120 AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 834 KVSDYSCFAGTHGYIAP 850
            ++   C+  T  ++AP
Sbjct: 177 LMT--PCY--TANFVAP 189

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL--WKGDGVKVFAAEMEI 724
           H  ID +Q+  L + N      +G++++   + N   V V ++  W     + F  E   
Sbjct: 4   HSGIDFKQLNFLTKLN---ENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 725 LGKIRHRNILK-LYACL-LKGGSSFLVLEYMPNGNLFQALHKRVKEGKP-ELDWFRRYKI 781
           L    H N+L  L AC         L+  +MP G+L+  LH    EG    +D  +  K 
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH----EGTNFVVDQSQAVKF 116
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821
           AL  A+G+A+L H   P I    + S ++++DED   +I+
Sbjct: 117 ALDMARGMAFL-HTLEPLIPRHALNSRSVMIDEDMTARIS 155

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 35/164 (21%)
Query: 682 NLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNIL 734
            ++GSG  G VY+     + +K    VA+K+L +    K       E  ++  + + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA--------- 785
           +L    L      L+++ MP G L              LD+ R +K  +G+         
Sbjct: 82  RLLGICLTSTVQ-LIMQLMPFGXL--------------LDYVREHKDNIGSQYLLNWCVQ 126
Query: 786 -AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
            AKG+ YL       ++HRD+ + N+L+      KI DFG+AK+
Sbjct: 127 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 83/199 (41%), Gaps = 26/199 (13%)
Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAAEMEILGKIRHR 731
           + + E    +G GG G V+    K +    A+K++    +    +    E++ L K+ H 
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRR---YKI 781
            I++ +   L+  ++  +    P   L+  +    KE       G+  ++   R     I
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS--------- 832
            L  A+ + +LH   S  ++HRD+K SNI    D   K+ DFG+    +           
Sbjct: 124 FLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 833 -PKVSDYSCFAGTHGYIAP 850
            P  + ++   GT  Y++P
Sbjct: 181 MPAYARHTGQVGTKLYMSP 199

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 684 IGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           +G G  G VY    K     +    VA+K + +   ++    F  E  ++ +    ++++
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPEL---DWFRRYKIALGAAKGIA 790
           L   + +G  + +++E M  G+L   L   +      P L      +  ++A   A G+A
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           YL+ +     +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 143 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 87/182 (47%), Gaps = 21/182 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGT--VAVKQLWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G  G VY+   K        A+KQ+ +G G+ + A  E+ +L +++H N++ L    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 741 LKGGSS--FLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIAL--GAAKGIAYLHH 794
           L       +L+ +Y  + +L+  +  H+  K  K  +   R    +L      GI YLH 
Sbjct: 88  LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 795 DCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSP--KVSDYSCFAGTHGYI 848
           +    ++HRD+K +NIL+     E    KIAD G A++  NSP   ++D      T  Y 
Sbjct: 147 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWYR 202
Query: 849 AP 850
           AP
Sbjct: 203 AP 204

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 35/164 (21%)
Query: 682 NLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNIL 734
            ++GSG  G VY+     + +K    VA+K+L +    K       E  ++  + + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA--------- 785
           +L    L      L+++ MP G L              LD+ R +K  +G+         
Sbjct: 85  RLLGICLTSTVQ-LIMQLMPFGCL--------------LDYVREHKDNIGSQYLLNWCVQ 129
Query: 786 -AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
            AKG+ YL       ++HRD+ + N+L+      KI DFG+AK+
Sbjct: 130 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 170

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 35/164 (21%)
Query: 682 NLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNIL 734
            ++GSG  G VY+     + +K    VA+K+L +    K       E  ++  + + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA--------- 785
           +L    L      L+++ MP G L              LD+ R +K  +G+         
Sbjct: 82  RLLGICLTSTVQ-LIMQLMPFGCL--------------LDYVREHKDNIGSQYLLNWCVQ 126
Query: 786 -AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
            AKG+ YL       ++HRD+ + N+L+      KI DFG+AK+
Sbjct: 127 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIR 729
           E +  L+ED ++G G   +V        +   AVK + K  G    +VF  E+E+L + +
Sbjct: 11  EDVYQLQED-VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR-EVEMLYQCQ 68
Query: 730 -HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            HRN+L+L     +    +LV E M  G++   +HKR    + E        +    A  
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-----VVVQDVASA 123
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGV 825
           + +LH+     I HRD+K  NIL +   +    KI DFG+
Sbjct: 124 LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGL 160

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 35/164 (21%)
Query: 682 NLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNIL 734
            ++GSG  G VY+     + +K    VA+K+L +    K       E  ++  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA--------- 785
           +L    L      L+++ MP G L              LD+ R +K  +G+         
Sbjct: 81  RLLGICLTSTVQ-LIMQLMPFGCL--------------LDYVREHKDNIGSQYLLNWCVQ 125
Query: 786 -AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
            AKG+ YL       ++HRD+ + N+L+      KI DFG+AK+
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 35/164 (21%)
Query: 682 NLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNIL 734
            ++GSG  G VY+     + +K    VA+K+L +    K       E  ++  + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA--------- 785
           +L    L      L+++ MP G L              LD+ R +K  +G+         
Sbjct: 84  RLLGICLTSTVQ-LIMQLMPFGCL--------------LDYVREHKDNIGSQYLLNWCVQ 128
Query: 786 -AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
            AKG+ YL       ++HRD+ + N+L+      KI DFG+AK+
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 35/164 (21%)
Query: 682 NLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNIL 734
            ++GSG  G VY+     + +K    VA+K+L +    K       E  ++  + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA--------- 785
           +L    L      L+++ MP G L              LD+ R +K  +G+         
Sbjct: 83  RLLGICLTSTVQ-LIMQLMPFGCL--------------LDYVREHKDNIGSQYLLNWCVQ 127
Query: 786 -AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
            AKG+ YL       ++HRD+ + N+L+      KI DFG+AK+
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 84/181 (46%), Gaps = 9/181 (4%)
Query: 100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV--PDLSALKNLEIFDLSINYFT 157
           T+L L  N L+G      +  + L+ L+++ NA +  V       L +L    L      
Sbjct: 58  TILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRVVDPTTFRGLGHLHTLHLDRCGLQ 117
Query: 158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFLAHCNLRGRIPE-SISE 215
              P     L  L  L + DN  +   +P+ +  +L NLT+LFL H N    +PE +   
Sbjct: 118 ELGPGLFRGLAALQYLYLQDN--NLQALPDNTFRDLGNLTHLFL-HGNRIPSVPEHAFRG 174
Query: 216 LRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDISS 274
           L  L  L + +N ++   P + R L +L  + L+ANNL+  LPAE L  L  LQ   ++ 
Sbjct: 175 LHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLS-MLPAEVLVPLRSLQYLRLND 233
Query: 275 N 275
           N
Sbjct: 234 N 234

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 26/181 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---------DGVKVFAAEMEILGKIR--HR 731
           L+GSGG G VY      +   VA+K + K          +G +V   E+ +L K+     
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV-PMEVVLLKKVSSGFS 73
Query: 732 NILKLYACLLKGGSSFLVLEYM-PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            +++L     +  S  L+LE M P  +LF  + +R   G  + +  R +   +  A    
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHC 130
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
              H+C   ++HRDIK  NIL+D +  E K+ DFG   + +++     Y+ F GT  Y  
Sbjct: 131 ---HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 181
Query: 850 P 850
           P
Sbjct: 182 P 182

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 83/343 (24%), Positives = 129/343 (37%), Gaps = 68/343 (19%)
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           V S+  +  L NLE  +L+ N  T   P  + NL +L +L IG N   +     ++ NL 
Sbjct: 56  VASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDIS---ALQNLT 110
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
           NL  L+L   N+    P                          +  L K + + L AN+ 
Sbjct: 111 NLRELYLNEDNISDISP--------------------------LANLTKXYSLNLGANHN 144
Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
             +L + L N T L    ++ +++    P  I NL +L       N    E  S    + 
Sbjct: 145 LSDL-SPLSNXTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI--EDISPLASLT 199
Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXF 373
            L  F+ Y N+ +   P  +   T L  + I  N+ +   P                   
Sbjct: 200 SLHYFTAYVNQITDITP--VANXTRLNSLKIGNNKITDLSP------------------- 238
Query: 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST 433
                   A+   +  L I  N +S    + +  L  +  L+ G N  +  IS L  LS 
Sbjct: 239 -------LANLSQLTWLEIGTNQISD--INAVKDLTKLKXLNVGSNQISD-ISVLNNLS- 287
Query: 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSA 476
            L+ L L NN+   E    +G LTNL  L L+ N+ +   P A
Sbjct: 288 QLNSLFLNNNQLGNEDXEVIGGLTNLTTLFLSQNHITDIRPLA 330

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 236 SIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQ 295
           +I K   L ++ L  N+LT ELPAE+ NL+ L+  D+S N++   LP E+G+   L  F 
Sbjct: 242 NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL-TSLPAELGSCFQLKYFY 299
Query: 296 CFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPF 329
            F +N     P  FG++  L    + GN     F
Sbjct: 300 FF-DNMVTTLPWEFGNLCNLQFLGVEGNPLEKQF 332

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E+ IL +I+H N++ L+          L+ E +  G LF  L ++    + E   F +  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVS 836
           +      G+ YLH   S  I H D+K  NI+L +   P    KI DFG+A   +     +
Sbjct: 124 L-----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---N 172
Query: 837 DYSCFAGTHGYIAP 850
           ++    GT  ++AP
Sbjct: 173 EFKNIFGTPEFVAP 186

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 45/211 (21%)
Query: 684 IGSGGTGKVYRLDLKKNAGTV-AVKQLWKGD-------GVKVFAAEMEILGKIRHRNILK 735
           IG G  G V R+ ++     + A+K + K          V+    E+ ++ K+ H NI +
Sbjct: 34  IGQGSYG-VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 736 LYACLLKGGSSFLVLEYMPNGNLF-------------------------------QALHK 764
           LY          LV+E    G+L                                +A++ 
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 765 RVKEGKPELDWFRRYKIALGAAKGI-AYLHHDCSPPIIHRDIKSSNILL--DEDYEPKIA 821
            +   +  LD+ +R K+     + I + LH+  +  I HRDIK  N L   ++ +E K+ 
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 822 DFGVAK--IAENSPKVSDYSCFAGTHGYIAP 850
           DFG++K     N+ +    +  AGT  ++AP
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	851
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-139
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-128
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-95
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-79
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-65
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-79
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-73
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-63
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-48
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-74
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-50
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-41
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-73
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-73
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-70
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-59
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-58
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-54
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-68
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-66
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-64
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-52
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-67
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-63
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-61
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-48
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-44
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-61
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-60
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-26
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-04
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-59
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-53
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-50
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-50
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-48
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-41
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-32
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-48
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-47
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-37
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-14
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-46
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-46
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-39
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-19
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-46
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-45
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-45
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-45
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-34
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-34
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-28
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-22
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-44
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-37
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-33
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-23
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-38
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-32
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-32
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-16
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-06
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-23
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-08
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-30
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-30
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-19
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-26
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-17
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-29
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-28
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-27
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-07
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-28
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-28
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-27
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-22
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-26
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-13
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-24
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-24
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-14
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-22
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-16
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-09
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-08
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-14
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-18
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-07
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-06
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-10
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-12
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-12
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-06
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-09
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	9e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-06
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  429 bits (1105), Expect = e-139
 Identities = 172/558 (30%), Positives = 260/558 (46%), Gaps = 41/558 (7%)

Query: 23  FPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDN 82
             PS SL  E   LI FK  L D   +L  W  + + PC F G+TC     +VT I   +
Sbjct: 4   ASPSQSLYREIHQLISFKDVLPDK-NLLPDWSSNKN-PCTFDGVTCRD--DKVTSIDLSS 59

Query: 83  KSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSA 142
           K L+                          +   L + + L+ L ++ + + GSV     
Sbjct: 60  KPLNVGF---------------------SAVSSSLLSLTGLESLFLSNSHINGSVSGFKC 98

Query: 143 LKNLEIFDLSINYFTGRFP--RWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL 200
             +L   DLS N  +G       + + + L  L++  N  D          L +L  L L
Sbjct: 99  SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158

Query: 201 AHCNLRGRIPESI---SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
           +  ++ G             EL  L I  NKISG+    + +   L  +++ +NN +  +
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI 216

Query: 258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFA 317
           P  LG+ + LQ  DIS N++ G     I     L +     N F G  P     ++ L  
Sbjct: 217 P-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQY 273

Query: 318 FSIYGNRFSGPFPENL-GRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGE 376
            S+  N+F+G  P+ L G    LT +D+S N F G+ P +      L +L   SNNFSGE
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333

Query: 377 VPNSY-ADCKTIQRLRISDNHLSGKIPDGLWAL-PNVGMLDFGDNDFTGGISPLIG--LS 432
           +P       + ++ L +S N  SG++P+ L  L  ++  LD   N+F+G I P +     
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393

Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
            +L +L LQNN F+G++P  L   + L  L L+ N  SG IPS+LG+L +L  L L  N 
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453

Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552
           L G IP E+     +  L L  N L+G IP  LS  ++LN ++LS N+LTG IP  + +L
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513

Query: 553 -KLSSIDLSENQLSGSVP 569
             L+ + LS N  SG++P
Sbjct: 514 ENLAILKLSNNSFSGNIP 531

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  402 bits (1036), Expect = e-128
 Identities = 137/541 (25%), Positives = 233/541 (43%), Gaps = 53/541 (9%)

Query: 76  TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
             +      LSG+ S +IS    L +L++  N   G +P       +L+ L++  N   G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTG 283

Query: 136 SVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP-ESIGNL 192
            +PD    A   L   DLS N+F G  P +  + + L SL++  N     E+P +++  +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN-NFSGELPMDTLLKM 342

Query: 193 KNLTYLFLAHCNLRGRIPESISELR-ELGTLDICRNKISGEFPRSI--RKLQKLWKIELY 249
           + L  L L+     G +PES++ L   L TLD+  N  SG    ++       L ++ L 
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402

Query: 250 ANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGF 309
            N  TG++P  L N + L    +S N + G +P  +G+L  L   + + N   GE P   
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462

Query: 310 GDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL 369
             ++ L    +  N  +G  P  L   T L  + +S N+ +G  PK++     L  L   
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522

Query: 370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKI--------------------PDGLWALP 409
           +N+FSG +P    DC+++  L ++ N  +G I                       +    
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 582

Query: 410 NVGMLDFGDND--FTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN 467
                    N   F G  S  +   ++ +   + +  + G          ++  L ++ N
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642

Query: 468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL 527
             SG IP  +G++  L  L+L  N ++GSIP+E+GD   +  L+L+ N L G IP+++S 
Sbjct: 643 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702

Query: 528 LSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
           L+ L  ++LS N L+G IP+     +  +   +                    F  N GL
Sbjct: 703 LTMLTEIDLSNNNLSGPIPEM---GQFETFPPA-------------------KFLNNPGL 740

Query: 588 C 588
           C
Sbjct: 741 C 741

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 94.2 bits (235), Expect = 6e-20
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 5/127 (3%)

Query: 454 GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513
            ++T+++      N     + S+L +L  L SL L  + + GS+       A +  L+L+
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108

Query: 514 RNSLSGNIP--RSLSLLSSLNALNLSGNKLTGSIPD-NLMKL-KLSSIDLSENQLSGSVP 569
           RNSLSG +    SL   S L  LN+S N L         +KL  L  +DLS N +SG+  
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168

Query: 570 LDFLRMG 576
           + ++   
Sbjct: 169 VGWVLSD 175

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 87.7 bits (218), Expect = 6e-18
 Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 26/139 (18%)

Query: 75  VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
               +  ++   G  S +     S+  L + +N+LSG +P E+ +   L +LN+  N + 
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669

Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           GS+PD +  L+ L I DLS N   G                          IP+++  L 
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDG-------------------------RIPQAMSALT 704

Query: 194 NLTYLFLAHCNLRGRIPES 212
            LT + L++ NL G IPE 
Sbjct: 705 MLTEIDLSNNNLSGPIPEM 723

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  310 bits (795), Expect = 7e-95
 Identities = 83/613 (13%), Positives = 188/613 (30%), Gaps = 78/613 (12%)

Query: 21  SVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSP-CGFS--------------- 64
           +V   +L+ +      +   ++    +  L    ++ +                      
Sbjct: 6   TVKDNALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKE 65

Query: 65  --------GITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSG----K 112
                   G++ +S  GRVT +S +    SG +  +I  L  L VL+L  +         
Sbjct: 66  LDMWGAQPGVSLNS-NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124

Query: 113 LPLELSNCSNLKVLNVTGNAMVGSVPDLSA---LKNLEIFDLSINYFTGRFPRWVVNLTQ 169
            P  +S   + +           +  D        +L    ++ +       +      +
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184

Query: 170 LVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKI 229
              +    N  +   + +++  L  L   ++ +            E            + 
Sbjct: 185 DTQIGQLSN--NITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQ 237

Query: 230 SGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQM--------YGKL 281
                     L+ L  +E+Y      +LP  L  L  +Q  +++ N+           + 
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297

Query: 282 PEEIGNLKNLTVFQCFKNNF-SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALT 340
             +    + + +     NN  +    +    M+KL       N+  G  P   G    L 
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLA 356

Query: 341 DVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYA--DCKTIQRLRISDNHLS 398
            ++++ NQ +   P   C   + +  L+ ++N    +PN +       +  +  S N + 
Sbjct: 357 SLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIG 415

Query: 399 G-------KIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG---- 447
                    +    +   NV  ++  +N  +     L    + LS + L  N  +     
Sbjct: 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475

Query: 448 ---ELPSELGRLTNLERLILTNNNFSGKIPSALGA--LRQLSSLHLEENALTGSIPNEMG 502
              +          L  + L  N  +  +     A  L  L  + L  N+ +   P +  
Sbjct: 476 SLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533

Query: 503 DCARIVDL------NLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSS 556
           + + +         +   N      P  ++L  SL  L +  N +   + + +    +S 
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP-NISV 591

Query: 557 IDLSENQLSGSVP 569
           +D+ +N       
Sbjct: 592 LDIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  266 bits (682), Expect = 9e-79
 Identities = 63/518 (12%), Positives = 144/518 (27%), Gaps = 57/518 (11%)

Query: 84  SLSGEISSSISALQ--SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLS 141
                            L    +  +     +            +    N +      + 
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVM 203

Query: 142 ALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLA 201
            L  L  F +  + F                                  NLK+LT + + 
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT------EDLKWDNLKDLTDVEVY 257

Query: 202 HCNLRGRIPESISELRELGTLDICRNKI--------SGEFPRSIRKLQKLWKIELYANNL 253
           +C    ++P  +  L E+  +++  N+           +        +K+  I +  NNL
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317

Query: 254 T-GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
               +   L  +  L   +   NQ+ G      G+   L       N  +    +  G  
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFT 376

Query: 313 RKLFAFSIYGNRFSG-PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSN 371
            ++   S   N+    P   +    + ++ +D S N+                    +  
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS-----------------VDG 419

Query: 372 NFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG-------G 424
                +  +      +  + +S+N +S    +       +  ++   N  T         
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479

Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSEL--GRLTNLERLILTNNNFSGKIPSALGALRQ 482
            +     +  L+ + L+ N+ +  L  +     L  L  + L+ N+FS   P+       
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537

Query: 483 LSSLHLEE------NALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNL 536
           L    +        N      P  +  C  +  L +  N +   +   +    +++ L++
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDI 594

Query: 537 SGNKLTGSIPDNLMK-LKLSSIDLSENQLSGSVPLDFL 573
             N         +   ++     L  ++       D L
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDAL 632

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  229 bits (587), Expect = 2e-65
 Identities = 72/489 (14%), Positives = 162/489 (33%), Gaps = 51/489 (10%)

Query: 74  RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
            + +   ++      I  S       T +    N ++  +   +   + L+   +  +  
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218

Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
           V         +  E  +               NL  L  + + +   +  ++P  +  L 
Sbjct: 219 VAENI----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC-PNLTKLPTFLKALP 273

Query: 194 NLTYLFLAHCNLR--------GRIPESISELRELGTLDICRNKI-SGEFPRSIRKLQKLW 244
            +  + +A              +         ++  + I  N + +     S++K++KL 
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333

Query: 245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSG 303
            +E   N L G+LP   G+   L   +++ NQ+  ++P    G  + +       N    
Sbjct: 334 MLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI-TEIPANFCGFTEQVENLSFAHNKLK- 390

Query: 304 EFPSGF--GDMRKLFAFSIYGNRFSG-------PFPENLGRYTALTDVDISENQFSGSFP 354
             P+ F    +  + A     N           P      +   ++ +++S NQ S  FP
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK-FP 449

Query: 355 KYLCEKRKLLNLLALSNN--------FSGEVPNSYADCKTIQRLRISDNHLSGKIPD--G 404
           K L      L+ + L  N           +   ++ +   +  + +  N L+  + D   
Sbjct: 450 KELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFR 508

Query: 405 LWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN------NRFSGELPSELGRLTN 458
              LP +  +D   N F+         S++L    ++N      NR   E P  +    +
Sbjct: 509 ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567

Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
           L +L + +N+    +   +     +S L +++N       + +          L  +   
Sbjct: 568 LTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

Query: 519 GNIPRSLSL 527
            +I    +L
Sbjct: 625 -DIRGCDAL 632

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  108 bits (273), Expect = 1e-24
 Identities = 23/154 (14%), Positives = 52/154 (33%), Gaps = 8/154 (5%)

Query: 429 IGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSG----KIPSALGALRQLS 484
           +  +  ++ L L+    SG +P  +G+LT LE L L ++          P  + A     
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 485 SLHLEENALTGSIPNEMG--DCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
                      +  +     D + ++   +  +    +I +S  +      +    N +T
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196

Query: 543 GSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRM 575
             +   +M+L KL    +  +        +    
Sbjct: 197 -FVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  268 bits (687), Expect = 1e-79
 Identities = 94/540 (17%), Positives = 185/540 (34%), Gaps = 44/540 (8%)

Query: 75  VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
              +      L    S S  +   L VL L    +         + S+L  L +TGN + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
                  S L +L+                + +L  L  L++  N+    ++PE   NL 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 194 NLTYLFLAHCNLRGRIPESISELRELG----TLDICRNKISGEFPRSIRKLQKLWKIELY 249
           NL +L L+   ++      +  L ++     +LD+  N ++   P + +++ +L K+ L 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLR 208

Query: 250 ANNLTGELPAE-LGNLTLLQEFDISSNQM--YGKLPE-EIGNLKNLTVFQCFKNNFS--- 302
            N  +  +    +  L  L+   +   +    G L + +   L+ L      +   +   
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 303 ---GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
               +    F  +  + +FS+          ++         +++   +F       L  
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326

Query: 360 KRKL------------------LNLLALSNN---FSGEVPNSYADCKTIQRLRISDNHLS 398
            ++L                  L  L LS N   F G    S     +++ L +S N + 
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386

Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISP-LIGLSTSLSQLVLQNNRFSGELPSELGRLT 457
             +      L  +  LDF  ++        +     +L  L + +             L+
Sbjct: 387 T-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445

Query: 458 NLERLILTNNNFSGKI-PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS 516
           +LE L +  N+F     P     LR L+ L L +  L    P      + +  LN++ N+
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505

Query: 517 LSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGSVPLDFLR 574
                      L+SL  L+ S N +  S    L      L+ ++L++N  + +       
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 565

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  251 bits (643), Expect = 1e-73
 Identities = 98/520 (18%), Positives = 173/520 (33%), Gaps = 55/520 (10%)

Query: 98  SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYF 156
           S   L L FN L         +   L+VL+++   +         +L +L    L+ N  
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 157 TGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG-RIPESISE 215
                     L+ L  L   +     +     IG+LK L  L +AH  ++  ++PE  S 
Sbjct: 89  QSLALGAFSGLSSLQKLVAVET-NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 216 LRELGTLDICRNKISGEFPRSIRKLQKL----WKIELYANNLTGELPAELGNLTLLQEFD 271
           L  L  LD+  NKI   +   +R L ++      ++L  N +    P     +  L +  
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLT 206

Query: 272 ISSNQMYGKLPEE-IGNLKNLTVFQCFKNNFSG--------------------------- 303
           + +N     + +  I  L  L V +     F                             
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 304 ------EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYL 357
                 +    F  +  + +FS+          ++         +++   +F   FP   
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQ-FPTLK 323

Query: 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS--GKIPDGLWALPNVGMLD 415
            +  K L       +  G    S  D  +++ L +S N LS  G      +   ++  LD
Sbjct: 324 LKSLKRLTF----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 416 FGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIP 474
              N     +S        L  L  Q++        S    L NL  L +++ +      
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 475 SALGALRQLSSLHLEENALTGSI-PNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNA 533
                L  L  L +  N+   +  P+   +   +  L+L++  L    P + + LSSL  
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498

Query: 534 LNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDF 572
           LN+S N            L  L  +D S N +  S   + 
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  222 bits (567), Expect = 6e-63
 Identities = 93/510 (18%), Positives = 175/510 (34%), Gaps = 37/510 (7%)

Query: 76  TEISFDNKSLSGEISSSISALQSLTVLSLPFNVL-SGKLPLELSNCSNLKVLNVTGNAMV 134
            ++     +L+   +  I  L++L  L++  N++ S KLP   SN +NL+ L+++ N + 
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 135 GSVP-DLSALKNLEIF----DLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI 189
                DL  L  + +     DLS+N              +L  L++ +N      +   I
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221

Query: 190 GNLKNLTYLFLAHCNLRGRI---PESISELRELGTLDICRNKIS------GEFPRSIRKL 240
             L  L    L     R          S L  L  L I   +++       +       L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281

Query: 241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
             +    L +  +              Q  ++ + +       ++ +LK LT       +
Sbjct: 282 TNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TS 334

Query: 301 FSGEFPSGFGDMRKLFAFSIYGNR--FSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
             G       D+  L    +  N   F G   ++    T+L  +D+S N        +L 
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL- 393

Query: 359 EKRKLLNLLAL---SNNFSGEVPNSY-ADCKTIQRLRISDNHLSGKIPDGLWALPNVGML 414
               L  L  L    +N       S     + +  L IS  H           L ++ +L
Sbjct: 394 ---GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450

Query: 415 DFGDNDFTGGISP-LIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKI 473
               N F     P +     +L+ L L   +     P+    L++L+ L +++NNF    
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510

Query: 474 PSALGALRQLSSLHLEENALTGSIPNEMGDCAR-IVDLNLARNSLSGNIPRS--LSLLSS 530
                 L  L  L    N +  S   E+      +  LNL +N  +        L  +  
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKD 570

Query: 531 LNALNLSGNKLTGSIPDNLMKLKLSSIDLS 560
              L +   ++  + P +   + + S++++
Sbjct: 571 QRQLLVEVERMECATPSDKQGMPVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  179 bits (457), Expect = 4e-48
 Identities = 81/414 (19%), Positives = 139/414 (33%), Gaps = 39/414 (9%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
           +IP+++    +   L L+   LR     S     EL  LD+ R +I      + + L  L
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF-S 302
             + L  N +          L+ LQ+       +       IG+LK L       N   S
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDV----DISENQFSGSFPKYLC 358
            + P  F ++  L    +  N+    +  +L     +  +    D+S N  +   P    
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF- 197

Query: 359 EKRKLLNLLAL---SNNFSGEVPNSYADCKTIQRLRISD---------NHLSGKIPDGLW 406
              K + L  L   +N  S  V  +    + +  L +            +L       L 
Sbjct: 198 ---KEIRLHKLTLRNNFDSLNVMKT--CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252

Query: 407 ALPNVGMLDFGDN---DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463
            L N+ + +F       +   I  L    T++S   L +                 + L 
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLE 310

Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS--GNI 521
           L N  F       L +L++L+          G       D   +  L+L+RN LS  G  
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365

Query: 522 PRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR 574
            +S    +SL  L+LS N +   +  N + L +L  +D   + L          
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  128 bits (324), Expect = 5e-31
 Identities = 53/202 (26%), Positives = 72/202 (35%), Gaps = 17/202 (8%)

Query: 377 VPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS 436
           VPN    C         + +   KIPD L    +   LD   N      S        L 
Sbjct: 7   VPNITYQC--------MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQ 55

Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGS 496
            L L               L++L  LILT N        A   L  L  L   E  L   
Sbjct: 56  VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115

Query: 497 IPNEMGDCARIVDLNLARNSL-SGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-- 553
               +G    + +LN+A N + S  +P   S L++L  L+LS NK+      +L  L   
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175

Query: 554 ---LSSIDLSENQLSGSVPLDF 572
                S+DLS N ++   P  F
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAF 197

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 21/121 (17%), Positives = 43/121 (35%), Gaps = 7/121 (5%)

Query: 61  CGFSGITCDSVTG--RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELS 118
           C    ++  +      +  ++  + +     +     L SL VL    N +      EL 
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539

Query: 119 NC-SNLKVLNVTGNAMVGSVPD---LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174
           +  S+L  LN+T N    +      L  +K+     + +       P     +  ++SL+
Sbjct: 540 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLN 598

Query: 175 I 175
           I
Sbjct: 599 I 599

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  259 bits (664), Expect = 2e-74
 Identities = 89/598 (14%), Positives = 179/598 (29%), Gaps = 74/598 (12%)

Query: 38  QFKSKLKDPHGVLDSWKESA--DSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISA 95
           ++ S   +      +W  +   D      G+  D+  GRVT +S       G +  +I  
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPDAIGQ 345

Query: 96  LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSI 153
           L  L VLS   +  +    L         +     + +        L   + L + DL  
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405

Query: 154 NYFTGR---FPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC------- 203
           +         P    +   L    IG+       I ++I  L  L  ++ A+        
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI 465

Query: 204 ------------NLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYAN 251
                               S S L++L  +++       + P  +  L +L  + +  N
Sbjct: 466 AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525

Query: 252 NLTG---------ELPAELGNLTLLQEFDISSNQMYGKLPEE--IGNLKNLTVFQCFKNN 300
                         L  +      +Q F +  N +    P    +  +  L +  C  N 
Sbjct: 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNK 584

Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYT-ALTDVDISENQFSGSFPKYLCE 359
                 + FG   KL    +  N+     PE+   +T  +  +  S N+     P     
Sbjct: 585 VR-HLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIF-N 639

Query: 360 KRKLLNLLAL---SNNFSGEVPN-----SYADCKTIQRLRISDNHLSGKIPDGLWALPNV 411
            + +  + ++    N    E  N               + +S N +     +       +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699

Query: 412 GMLDFGDNDFT-------GGISPLIGLSTSLSQLVLQNNRFSGELPSEL--GRLTNLERL 462
             +   +N  T                +  L+ + L+ N+ +  L  +     L  L  +
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758

Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEE------NALTGSIPNEMGDCARIVDLNLARNS 516
            ++ N FS   P+      QL +  +        N +    P  +  C  ++ L +  N 
Sbjct: 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817

Query: 517 LSGNIPRSLSLLSSLNALNLSGNKLT-GSIPDNLMKLKLSSIDLSENQLSGSVPLDFL 573
           +   +   L     L  L+++ N      +      ++     L  ++       D L
Sbjct: 818 IR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDAL 872

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  189 bits (481), Expect = 4e-50
 Identities = 80/503 (15%), Positives = 155/503 (30%), Gaps = 47/503 (9%)

Query: 90  SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNL-EI 148
               S L++ +V    F V+  KL  +         + +        + D  ALK + E 
Sbjct: 228 GIKRSELETQSVRGESFTVIDNKLTKD-------ANVPIQLKETAEYIKDYKALKAIWEA 280

Query: 149 FDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR 208
            D     +        ++          D   D+  +   + N   +T L LA    +GR
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGV--DLDNNGRVTGLSLAGFGAKGR 338

Query: 209 IPESISELRELGTLDICRNKISGEFP-------RSIRKLQKLWKIELYANNLTGELPAEL 261
           +P++I +L EL  L    +  +                 ++  +I ++   +  +    L
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398

Query: 262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIY 321
               LLQ+    + +M     +   +LK+  +      N           + KL      
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL--TNRITFISKAIQRLTKLQIIYFA 456

Query: 322 GNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSY 381
            + F+              D +    +   +        + L ++   +     ++P+  
Sbjct: 457 NSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511

Query: 382 ADCKTIQRLRISDNHLSG---------KIPDGLWALPNVGMLDFGDNDFTG-GISPLIGL 431
            D   +Q L I+ N             ++ D     P + +   G N+      S  +  
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQK 571

Query: 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA-LRQLSSLHLEE 490
              L  L   +N+         G    L  L L  N     IP    A   Q+  L    
Sbjct: 572 MVKLGLLDCVHNKVRH--LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSH 628

Query: 491 NALTGSIPN--EMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNA-----LNLSGNKLTG 543
           N L   IPN         +  ++ + N +          +          + LS N++  
Sbjct: 629 NKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK 687

Query: 544 SIPDNLMKL-KLSSIDLSENQLS 565
              +       +S+I LS N ++
Sbjct: 688 FPTELFATGSPISTIILSNNLMT 710

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  161 bits (409), Expect = 4e-41
 Identities = 43/360 (11%), Positives = 100/360 (27%), Gaps = 39/360 (10%)

Query: 227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG 286
           +    +    +    ++  + L      G +P  +G LT L+     ++           
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
                 + +  K+     +   F D                   + L   + L    I+ 
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDY-----------------DQRL-NLSDLLQDAINR 410

Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
           N       K      K   +  L+N  +  +  +      +Q +  +++  +       W
Sbjct: 411 NPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDW 469

Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
                   +                   L+ + L N     +LP  L  L  L+ L +  
Sbjct: 470 ED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524

Query: 467 NNFSG---------KIPSALGALRQLSSLHLEENALTG-SIPNEMGDCARIVDLNLARNS 516
           N             ++        ++   ++  N L        +    ++  L+   N 
Sbjct: 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK 584

Query: 517 LSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGSVPLDFLR 574
           +      +      L  L L  N++   IP++      ++  +  S N+L     +   +
Sbjct: 585 VR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAK 641

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  253 bits (649), Expect = 1e-73
 Identities = 104/525 (19%), Positives = 185/525 (35%), Gaps = 34/525 (6%)

Query: 75  VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
           +T ++  +  L    +++ +    LT L + FN +S   P        LKVLN+  N + 
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
                  +   NL    L  N          V    L++L +  N         +   L+
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST-KLGTQVQLE 145

Query: 194 NLTYLFLAHCNLRGRIPESIS--ELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYAN 251
           NL  L L++  ++    E +       L  L++  N+I    P     + +L+ + L   
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 252 NLTGELPAELG---NLTLLQEFDISSNQMYGKLPEEIGNLK--NLTVFQCFKNNFSGEFP 306
            L   L  +L      T ++   +S++Q+          LK  NLT+     NN +    
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 307 SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK------ 360
             F  + +L  F +  N     F  +L     +  +++  +    S       K      
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

Query: 361 RKLLNL--LALSNN-FSGEVPNSYADCKTIQRLRISDNHLSGK--IPDGLWALPNVG--M 413
           + L  L  L + +N   G   N +     ++ L +S++  S +    +   +L +    +
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385

Query: 414 LDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGK 472
           L+   N  +   S        L  L L  N    EL   E   L N+  + L+ N +   
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445

Query: 473 IPSALGALRQLSSLHLEENALTG--SIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSS 530
             ++   +  L  L L   AL    S P+       +  L+L+ N+++      L  L  
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505

Query: 531 LNALNLSGNKLT--------GSIPDNLMKL-KLSSIDLSENQLSG 566
           L  L+L  N L         G     L  L  L  ++L  N    
Sbjct: 506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  252 bits (646), Expect = 3e-73
 Identities = 95/526 (18%), Positives = 174/526 (33%), Gaps = 35/526 (6%)

Query: 76  TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
           TE+   + S+    ++     ++L  L L  N LS           NL+ L ++ N +  
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159

Query: 136 SVPD---LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIG-- 190
              +   + A  +L+  +LS N      P     + +L  L + +       + E +   
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV-QLGPSLTEKLCLE 218

Query: 191 -NLKNLTYLFLAHCNLRGRIPESISELR--ELGTLDICRNKISGEFPRSIRKLQKLWKIE 247
               ++  L L++  L      +   L+   L  LD+  N ++     S   L +L    
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFF 278

Query: 248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKL---------PEEIGNLKNLTVFQCFK 298
           L  NN+       L  L  ++  ++  +     +               LK L       
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338

Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLG----RYTALTDVDISENQFSGSFP 354
           N+  G   + F  +  L   S+  +  S     N       ++ L  +++++N+ S    
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398

Query: 355 KYLCEKRKLLNLLALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGM 413
                   L  L    N    E+    +   + I  + +S N       +    +P++  
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR 458

Query: 414 LDFGDNDFTG--GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFS- 470
           L                     +L+ L L NN  +      L  L  LE L L +NN + 
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518

Query: 471 -------GKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
                  G     L  L  L  L+LE N           D   +  ++L  N+L+     
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578

Query: 524 SLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGS 567
             +   SL +LNL  N +T             L+ +D+  N    +
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  243 bits (622), Expect = 7e-70
 Identities = 99/495 (20%), Positives = 166/495 (33%), Gaps = 26/495 (5%)

Query: 96  LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSIN 154
             ++TVL+L  N L        +  S L  L+V  N +    P+    L  L++ +L  N
Sbjct: 24  PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83

Query: 155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESIS 214
             +    +     T L  L +  N   +          KNL  L L+H  L      +  
Sbjct: 84  ELSQLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142

Query: 215 ELRELGTLDICRNKISGEFPR--SIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI 272
           +L  L  L +  NKI         I     L K+EL +N +    P     +  L    +
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFL 202

Query: 273 SSNQMYGKLPEEIG---NLKNLTVFQCFKNNFSGEFPSGFGDMR--KLFAFSIYGNRFSG 327
           ++ Q+   L E++       ++       +  S    + F  ++   L    +  N  + 
Sbjct: 203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262

Query: 328 PFPENLGRYTALTDVDISENQFSGSFP---------KYLCEKRKLLNLLALSNNFSGEVP 378
              ++      L    +  N     F          +YL  KR          +      
Sbjct: 263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322

Query: 379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS----TS 434
            S+   K ++ L + DN + G   +    L N+  L   ++  +              + 
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382

Query: 435 LSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIP-SALGALRQLSSLHLEENAL 493
           L  L L  N+ S         L +LE L L  N    ++       L  +  ++L  N  
Sbjct: 383 LHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY 442

Query: 494 TGSIPNEMGDCARIVDLNLARNSLSG--NIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK 551
                N       +  L L R +L    + P     L +L  L+LS N +     D L  
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502

Query: 552 L-KLSSIDLSENQLS 565
           L KL  +DL  N L+
Sbjct: 503 LEKLEILDLQHNNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  212 bits (543), Expect = 5e-59
 Identities = 88/524 (16%), Positives = 169/524 (32%), Gaps = 38/524 (7%)

Query: 74  RVTEISFDNKSLSGEISSSISALQ--SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGN 131
            + E+   N  +    S  +      SL  L L  N +    P        L  L +   
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 132 AMVGSVPD----LSALKNLEIFDLSINYFTGRFPRWVVNL--TQLVSLSIGDNVYDEAEI 185
            +  S+ +      A  ++    LS +  +       + L  T L  L +  N       
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN-NLNVVG 264

Query: 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRN---------KISGEFPRS 236
            +S   L  L Y FL + N++     S+  L  +  L++ R+          +      S
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324

Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG----NLKNLT 292
            + L+ L  + +  N++ G        L  L+   +S++    +              L 
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384

Query: 293 VFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPEN-LGRYTALTDVDISENQFSG 351
           +    KN  S      F  +  L    +  N                + ++ +S N++  
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444

Query: 352 SFPKYLCEKRKLLNLLALSNNFSG--EVPNSYADCKTIQRLRISDNHLSGKIPDGLWALP 409
                      L  L+            P+ +   + +  L +S+N+++    D L  L 
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504

Query: 410 NVGMLDFGDN--------DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLER 461
            + +LD   N           GG    +   + L  L L++N F          L  L+ 
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564

Query: 462 LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR-IVDLNLARNSLSGN 520
           + L  NN +    S       L SL+L++N +T       G   R + +L++  N     
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624

Query: 521 IPRSLSLLSSLNALNLSGNKLTGSI----PDNLMKLKLSSIDLS 560
                  ++ +N  + +  +L+       P +     +   D S
Sbjct: 625 CESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  210 bits (536), Expect = 4e-58
 Identities = 84/412 (20%), Positives = 141/412 (34%), Gaps = 23/412 (5%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
           ++P+ +    N+T L L H  LR     + +   +L +LD+  N IS   P   +KL  L
Sbjct: 18  QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75

Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG 303
             + L  N L+          T L E  + SN +           KNL       N  S 
Sbjct: 76  KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135

Query: 304 EFPSGFGDMRKLFAFSIYGNRFSGPFPENLG--RYTALTDVDISENQFSGSFPKYLCEKR 361
                   +  L    +  N+      E L     ++L  +++S NQ     P       
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195

Query: 362 KLLNLLALSNNFSGEVPNS---YADCKTIQRLRISDNHLSGKIPDGLWALPNVG--MLDF 416
           +L  L   +      +           +I+ L +S++ LS         L      MLD 
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255

Query: 417 GDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN--------- 467
             N+     +        L    L+ N         L  L N+  L L  +         
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315

Query: 468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL 527
           +       +   L+ L  L++E+N + G   N       +  L+L+ +  S     + + 
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375

Query: 528 ----LSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLR 574
                S L+ LNL+ NK++    D    L  L  +DL  N++   +     R
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  198 bits (506), Expect = 5e-54
 Identities = 66/405 (16%), Positives = 140/405 (34%), Gaps = 26/405 (6%)

Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
           +      +H  L  ++P+ +     +  L++  N++      +  +  +L  +++  N +
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
           +   P     L +L+  ++  N++     +      NLT      N+      + F   +
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL---S 370
            L    +  N  S        +   L ++ +S N+          +     +L  L   S
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEELDIFANSSLKKLELSS 180

Query: 371 NNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL---WALPNVGMLDFGDNDFTGGISP 427
           N      P  +     +  L +++  L   + + L    A  ++  L   ++  +   + 
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 428 LIGL--STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSS 485
                  T+L+ L L  N  +         L  LE   L  NN       +L  L  +  
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300

Query: 486 LHLEEN---------ALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNL 536
           L+L+ +         +L             +  LN+  N + G      + L +L  L+L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360

Query: 537 SGNK-----LTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMG 576
           S +      LT     +L    L  ++L++N++S      F  +G
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  228 bits (583), Expect = 3e-68
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 10/273 (3%)

Query: 323 NRFSGPFPENLGRYTALTDVDISENQFSGSF--PKYLCEKRKLLNL-LALSNNFSGEVPN 379
             + G   +   +   + ++D+S       +  P  L     L  L +   NN  G +P 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLV 439
           + A    +  L I+  ++SG IPD L  +  +  LDF  N  +G + P I    +L  + 
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 440 LQNNRFSGELPSELGRLTNLER-LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
              NR SG +P   G  + L   + ++ N  +GKIP     L  L+ + L  N L G   
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDAS 214

Query: 499 NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSI 557
              G       ++LA+NSL+ ++   + L  +LN L+L  N++ G++P  L +LK L S+
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273

Query: 558 DLSENQLSGSVP--LDFLRMGGDGAFAGNEGLC 588
           ++S N L G +P   +  R     A+A N+ LC
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVS-AYANNKCLC 305

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  223 bits (572), Expect = 1e-66
 Identities = 94/401 (23%), Positives = 143/401 (35%), Gaps = 102/401 (25%)

Query: 32  ETQALIQFKSKLKDPHGVLDSWKESAD-SPCGFSGITCDSVT--GRVTEISFDNKSLSGE 88
           + QAL+Q K  L +P   L SW  + D     + G+ CD+ T   RV  +     +L   
Sbjct: 7   DKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK- 64

Query: 89  ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEI 148
                                   +P  L+N   L  L + G                  
Sbjct: 65  ---------------------PYPIPSSLANLPYLNFLYIGGI----------------- 86

Query: 149 FDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR 208
                N   G                          IP +I  L  L YL++ H N+ G 
Sbjct: 87  -----NNLVG-------------------------PIPPAIAKLTQLHYLYITHTNVSGA 116

Query: 209 IPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLT-LL 267
           IP+ +S+++ L TLD   N +SG  P SI  L  L  I    N ++G +P   G+ + L 
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176

Query: 268 QEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG 327
               IS N++ GK+P    NL NL      +N   G+    FG  +      +  N  + 
Sbjct: 177 TSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235

Query: 328 PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTI 387
              + +G    L  +D+  N+  G+ P+ L                           K +
Sbjct: 236 DLGK-VGLSKNLNGLDLRNNRIYGTLPQGL------------------------TQLKFL 270

Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPL 428
             L +S N+L G+IP G   L    +  + +N    G SPL
Sbjct: 271 HSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCG-SPL 309

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  217 bits (556), Expect = 2e-64
 Identities = 71/324 (21%), Positives = 115/324 (35%), Gaps = 54/324 (16%)

Query: 251 NNLTGELPAELGNLTLLQEFDISSNQMYG--KLPEEIGNLKNLTVFQCFK-NNFSGEFPS 307
               G L         +   D+S   +     +P  + NL  L        NN  G  P 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 308 GFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367
               + +L    I     SG  P+ L +                                
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQ-------------------------------- 123

Query: 368 ALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP 427
                            KT+  L  S N LSG +P  + +LPN+  + F  N  +G I  
Sbjct: 124 ----------------IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

Query: 428 LIGLSTSLSQ-LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486
             G  + L   + +  NR +G++P     L NL  + L+ N   G      G+ +    +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
           HL +N+L   +  ++G    +  L+L  N + G +P+ L+ L  L++LN+S N L G IP
Sbjct: 227 HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

Query: 547 DNLMKLKLSSIDLSENQLSGSVPL 570
                 +      + N+     PL
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSPL 309

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  183 bits (466), Expect = 6e-52
 Identities = 54/184 (29%), Positives = 82/184 (44%), Gaps = 4/184 (2%)

Query: 393 SDNHLSGKIPDGLWALPNVGMLDFGDNDFTG--GISPLIGLSTSLSQLVLQN-NRFSGEL 449
            +    G + D       V  LD    +      I   +     L+ L +   N   G +
Sbjct: 34  CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI 93

Query: 450 PSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD 509
           P  + +LT L  L +T+ N SG IP  L  ++ L +L    NAL+G++P  +     +V 
Sbjct: 94  PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153

Query: 510 LNLARNSLSGNIPRSLSLLSSL-NALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSV 568
           +    N +SG IP S    S L  ++ +S N+LTG IP     L L+ +DLS N L G  
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA 213

Query: 569 PLDF 572
            + F
Sbjct: 214 SVLF 217

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  225 bits (576), Expect = 4e-67
 Identities = 75/182 (41%), Positives = 109/182 (59%), Gaps = 16/182 (8%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL--WKGDGVKV-FAAEMEILGKIRHRNI 733
           N    N++G GG GKVY+  L  +   VAVK+L   +  G ++ F  E+E++    HRN+
Sbjct: 31  NFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 89

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           L+L    +      LV  YM NG++   L +R  E +P LDW +R +IALG+A+G+AYLH
Sbjct: 90  LRLRGFCMTPTERLLVYPYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLH 148

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN-----SPKVSDYSCFAGTHGYI 848
             C P IIHRD+K++NILLDE++E  + DFG+AK+ +      +  V       GT G+I
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV------RGTIGHI 202

Query: 849 AP 850
           AP
Sbjct: 203 AP 204

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  222 bits (568), Expect = 5e-63
 Identities = 91/539 (16%), Positives = 168/539 (31%), Gaps = 43/539 (7%)

Query: 75  VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
              + F    L    +++ S L +LT L L    +         +   L  L +T N ++
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
                 LS  K L+         +      + N   L SL +G N              +
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI-KLPKGFPTE 153

Query: 194 NLTYLFLAHCNLRGRIPESISELRELG--TLDICRNKISGEFPRSIRKLQKLWKIELYAN 251
            L  L   +  +     E +S L++    +L++  N I+               +     
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGT 212

Query: 252 NLTGELPAELGNLTL----------------------------LQEFDISSNQMYGKLPE 283
                +   L N T+                            ++  ++  +  +     
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272

Query: 284 EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD 343
                  L        + S E PSG   +  L    +  N+F      +   + +LT + 
Sbjct: 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331

Query: 344 ISENQFSGSFPKYLCEKRKLLNLLALSNN---FSGEVPNSYADCKTIQRLRISDNHLSGK 400
           I  N           E  + L  L LS++    S        +   +Q L +S N     
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391

Query: 401 IPDGLWALPNVGMLDFGDNDFTGGISP-LIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459
             +     P + +LD          +         L  L L ++            L  L
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451

Query: 460 ERLILTNNNFSGKI---PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS 516
           + L L  N+F        ++L  L +L  L L    L+    +       +  ++L+ N 
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511

Query: 517 LSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLR 574
           L+ +   +LS L  +  LNL+ N ++  +P  L  L    +I+L +N L  +    +  
Sbjct: 512 LTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFL 569

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  217 bits (556), Expect = 2e-61
 Identities = 104/532 (19%), Positives = 171/532 (32%), Gaps = 29/532 (5%)

Query: 56  SADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPL 115
           S+D  C         V       + +N  L+ EI  ++    S   L   FNVL      
Sbjct: 3   SSDQKC-----IEKEVN---KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNT 51

Query: 116 ELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174
             S   NL  L++T   +     D   +   L+   L+ N         +     L  L 
Sbjct: 52  TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111

Query: 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP 234
                   +     + N K L  L+L   ++            +L  LD   N I     
Sbjct: 112 FIQT-GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170

Query: 235 RSIRKLQKLWKIELY-ANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGN--LKNL 291
             +  LQ+   + L    N    +     +  + Q  +    Q    + + + N  +++L
Sbjct: 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230

Query: 292 TVFQCFKNNFSGEFPSGFGDMRK--LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQF 349
            +      +     P+ F  + +  + + ++  + F          ++ L ++D++    
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290

Query: 350 SGSFPKYLCEKRKLLNLLALSNN-FSGEVPNSYADCKTIQRLRISDNHLSGKIPDG-LWA 407
           S   P  L      L  L LS N F      S ++  ++  L I  N    ++  G L  
Sbjct: 291 S-ELPSGLVGLST-LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348

Query: 408 LPNVGMLDFGDNDFTGGISPLIGLS--TSLSQLVLQNNRFSGELPSELGRLTNLERLILT 465
           L N+  LD   +D        + L   + L  L L  N               LE L L 
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408

Query: 466 NNNFSGKIP-SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNI--- 521
                 K   S    L  L  L+L  + L  S          +  LNL  N         
Sbjct: 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK 468

Query: 522 PRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDF 572
             SL  L  L  L LS   L+         L  ++ +DLS N+L+ S     
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  181 bits (462), Expect = 1e-48
 Identities = 71/401 (17%), Positives = 131/401 (32%), Gaps = 14/401 (3%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
           EIP ++    +   L  +   L      + S L  L  LD+ R +I      + +   +L
Sbjct: 26  EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG 303
             + L AN L       L     L+        +       + N K L       N+ S 
Sbjct: 84  DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143

Query: 304 EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALT--DVDISENQFSGSFPKYLCEKR 361
                     KL       N       E++      T   ++++ N  +        +  
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSA 202

Query: 362 KLLNLLALSNNFSGEVPNSYADCK--TIQRLRISDNHLSGKIPDGLWALP--NVGMLDFG 417
              +L          +     +    ++      D       P     L   +V  ++  
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262

Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL 477
            + F    S      + L +L L     S ELPS L  L+ L++L+L+ N F      + 
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA 321

Query: 478 GALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSL--SGNIPRSLSLLSSLNAL 534
                L+ L ++ N     +      +   + +L+L+ + +  S      L  LS L +L
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381

Query: 535 NLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR 574
           NLS N+      +   +  +L  +DL+  +L         +
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  167 bits (425), Expect = 6e-44
 Identities = 75/439 (17%), Positives = 141/439 (32%), Gaps = 14/439 (3%)

Query: 74  RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKV--LNVTGN 131
            +  +   +  +S          + L VL    N +      ++S+        LN+ GN
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189

Query: 132 AMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVN--LTQLVSLSIGDN-VYDEAEIPES 188
            + G  P        +  +           + + N  +  L   +  D    D +     
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249

Query: 189 IGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIEL 248
                ++  + L           +      L  LD+    +S E P  +  L  L K+ L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308

Query: 249 YANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEE-IGNLKNLTVFQCFKNN--FSGEF 305
            AN           N   L    I  N    +L    + NL+NL       ++   S   
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368

Query: 306 PSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN 365
                ++  L + ++  N       E       L  +D++  +      +   +   LL 
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428

Query: 366 LLALSNN-FSGEVPNSYADCKTIQRLRISDNHLSGKI---PDGLWALPNVGMLDFGDNDF 421
           +L LS++         +     +Q L +  NH         + L  L  + +L     D 
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488

Query: 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALR 481
           +            ++ + L +NR +      L  L  +  L L +N+ S  +PS L  L 
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILS 547

Query: 482 QLSSLHLEENALTGSIPNE 500
           Q  +++L +N L  +  N 
Sbjct: 548 QQRTINLRQNPLDCTCSNI 566

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  207 bits (530), Expect = 7e-61
 Identities = 71/183 (38%), Positives = 98/183 (53%), Gaps = 17/183 (9%)

Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD------GVKVFAAEMEILGKIR 729
                 N +G GG G VY+  +  N  TVAVK+L            + F  E++++ K +
Sbjct: 31  PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           H N+++L      G    LV  YMPNG+L   L     +G P L W  R KIA GAA GI
Sbjct: 89  HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGI 146

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK--VSDYSCFAGTHGY 847
            +LH +     IHRDIKS+NILLDE +  KI+DFG+A+ +E   +  ++  S   GT  Y
Sbjct: 147 NFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT--SRIVGTTAY 201

Query: 848 IAP 850
           +AP
Sbjct: 202 MAP 204

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  214 bits (546), Expect = 4e-60
 Identities = 99/519 (19%), Positives = 172/519 (33%), Gaps = 29/519 (5%)

Query: 75  VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
              I      L    S S S    L  L L    +            +L  L +TGN + 
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
              P   S L +LE                +  L  L  L++  N     ++P    NL 
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153

Query: 194 NLTYLFLAHCNLRGRIPESISELRELG----TLDICRNKISGEFPRSIRKLQKLWKIELY 249
           NL ++ L++  ++      +  LRE      +LD+  N I         +  KL ++ L 
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLR 212

Query: 250 ANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI------GNLKNLTV--FQCFKNN 300
            N  +  +    L NL  L    +   +   +   EI        L ++T+  F+    N
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272

Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
              +    F  +  + A S+ G      + E++ ++     + I   Q        L   
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIK--YLEDVPKHFKWQSLSIIRCQLKQFPTLDL--- 327

Query: 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW--ALPNVGMLDFGD 418
              L  L L+ N  G +        ++  L +S N LS             ++  LD   
Sbjct: 328 -PFLKSLTLTMN-KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385

Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPSAL 477
           N     +S        L  L  Q++        S    L  L  L ++  N         
Sbjct: 386 NGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444

Query: 478 GALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNL 536
             L  L++L +  N+   +  + +  +   +  L+L++  L          L  L  LN+
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504

Query: 537 SGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLR 574
           S N L      +  +L  LS++D S N++  +       
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQH 542

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  187 bits (478), Expect = 8e-51
 Identities = 82/506 (16%), Positives = 159/506 (31%), Gaps = 48/506 (9%)

Query: 84  SLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSA 142
            +      +   L  L+ L L  N +    P   S  ++L+ L      +       +  
Sbjct: 67  EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126

Query: 143 LKNLEIFDLSINYFTG-RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLT----Y 197
           L  L+  +++ N+    + P +  NLT LV + +  N          +  L+        
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNLS 185

Query: 198 LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPR-SIRKLQKLWKIELYANNLTGE 256
           L ++   +   I +   +  +L  L +  N  S    +  ++ L  L    L       E
Sbjct: 186 LDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244

Query: 257 LPAELGNLTLLQ--------EFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG 308
              E+   ++++        EF ++    +     +   L N++       +        
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP 304

Query: 309 FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL-- 366
                K  + SI   +       +L     L  + ++ N+ S SF K        L+L  
Sbjct: 305 K--HFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSISFKKVALPSLSYLDLSR 359

Query: 367 ---------------------LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL 405
                                L LS N +  +  ++   + +Q L    + L        
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSA 419

Query: 406 WA-LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLI 463
           +  L  +  LD    +       +    TSL+ L +  N F     S      TNL  L 
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479

Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
           L+              L +L  L++  N L     +       +  L+ + N +  +   
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539

Query: 524 SLSLLSSLNALNLSGNKLTGSIPDNL 549
                 SL   NL+ N +   I ++ 
Sbjct: 540 LQHFPKSLAFFNLTNNSVA-CICEHQ 564

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  113 bits (286), Expect = 2e-26
 Identities = 36/194 (18%), Positives = 65/194 (33%), Gaps = 5/194 (2%)

Query: 386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF 445
           + + + +S N L             +  LD    +              LS L+L  N  
Sbjct: 33  STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92

Query: 446 SGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTG-SIPNEMGDC 504
               P     LT+LE L+      +      +G L  L  L++  N +    +P    + 
Sbjct: 93  QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152

Query: 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNA----LNLSGNKLTGSIPDNLMKLKLSSIDLS 560
             +V ++L+ N +       L  L         L++S N +          +KL  + L 
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212

Query: 561 ENQLSGSVPLDFLR 574
            N  S ++    L+
Sbjct: 213 GNFNSSNIMKTCLQ 226

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  102 bits (256), Expect = 1e-22
 Identities = 29/145 (20%), Positives = 48/145 (33%), Gaps = 2/145 (1%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
            + +S   + L  N             + L+ L L+          A   L  LS+L L 
Sbjct: 29  DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88

Query: 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG-SIPDN 548
            N +    P        + +L      L+      +  L +L  LN++ N +    +P  
Sbjct: 89  GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148

Query: 549 LMKL-KLSSIDLSENQLSGSVPLDF 572
              L  L  +DLS N +      D 
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDL 173

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 20/105 (19%), Positives = 36/105 (34%), Gaps = 6/105 (5%)

Query: 74  RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
            +T +      L          L  L +L++  N L        +   +L  L+ + N +
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533

Query: 134 VGSVPD-LSALKNLEIFDLSINYFT-----GRFPRWVVNLTQLVS 172
             S        K+L  F+L+ N         +F +WV    Q + 
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLV 578

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  203 bits (520), Expect = 3e-59
 Identities = 67/178 (37%), Positives = 97/178 (54%), Gaps = 11/178 (6%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNIL 734
           N +   LIG G  GKVY+  L+  A  VA+K+       G++ F  E+E L   RH +++
Sbjct: 40  NFDHKFLIGHGVFGKVYKGVLRDGA-KVALKRRTPESSQGIEEFETEIETLSFCRHPHLV 98

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
            L     +     L+ +YM NGNL + L+         + W +R +I +GAA+G+ YLH 
Sbjct: 99  SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLHT 157

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA--ENSPKVSDYSCFAGTHGYIAP 850
                IIHRD+KS NILLDE++ PKI DFG++K     +   +S  +   GT GYI P
Sbjct: 158 RA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS--TVVKGTLGYIDP 210

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  188 bits (479), Expect = 1e-53
 Identities = 58/187 (31%), Positives = 80/187 (42%), Gaps = 22/187 (11%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIRHRNIL 734
            L+   +   G  G V++  L      VAVK     D  + +  E E+  L  ++H NIL
Sbjct: 25  PLQLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENIL 81

Query: 735 KLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
           +      +G S     +L+  +   G+L   L   V      + W     IA   A+G+A
Sbjct: 82  QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV------VSWNELCHIAETMARGLA 135

Query: 791 YLHHD-------CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
           YLH D         P I HRDIKS N+LL  +    IADFG+A   E      D     G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195

Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 196 TRRYMAP 202

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  179 bits (455), Expect = 2e-50
 Identities = 64/187 (34%), Positives = 103/187 (55%), Gaps = 16/187 (8%)

Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKGD----GVKVFAAEME 723
           DI       L     IG+G  G V+R +     G+ VAVK L + D     V  F  E+ 
Sbjct: 33  DIPWCD---LNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVA 86

Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           I+ ++RH NI+     + +  +  +V EY+  G+L++ LHK     + +LD  RR  +A 
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAY 144

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
             AKG+ YLH+  +PPI+HR++KS N+L+D+ Y  K+ DFG++++  ++   S     AG
Sbjct: 145 DVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAG 201

Query: 844 THGYIAP 850
           T  ++AP
Sbjct: 202 TPEWMAP 208

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  182 bits (465), Expect = 4e-50
 Identities = 98/442 (22%), Positives = 171/442 (38%), Gaps = 34/442 (7%)

Query: 123 LKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
           L    +T +  +  +   +AL       L     T        +L Q+ +L         
Sbjct: 3   LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL---G 57

Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
            +  + +  L NLT +  ++  L    P  +  L +L  + +  N+I+   P  +  L  
Sbjct: 58  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113

Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
           L  + L+ N +T   P  L NLT L   ++SSN +       +  L +L     F N  +
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLS-FGNQVT 168

Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRK 362
                   ++  L    I  N+ S      L + T L  +  + NQ S   P  +     
Sbjct: 169 D--LKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTN-- 222

Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422
            L+ L+L+ N   +   + A    +  L +++N +S   P  L  L  +  L  G N  +
Sbjct: 223 -LDELSLNGN-QLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278

Query: 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ 482
             ISPL GL T+L+ L L  N+      S +  L NL  L L  NN S   P  + +L +
Sbjct: 279 N-ISPLAGL-TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTK 332

Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
           L  L    N ++    + + +   I  L+   N +S   P  L+ L+ +  L L+    T
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388

Query: 543 GSIPDNLMKLKLSSIDLSENQL 564
            +  +    + + +   +    
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGA 410

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  176 bits (448), Expect = 7e-48
 Identities = 93/491 (18%), Positives = 182/491 (37%), Gaps = 36/491 (7%)

Query: 59  SPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELS 118
                + I  D+      +      +++  +S   + L  +T L      +       + 
Sbjct: 10  QDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVE 65

Query: 119 NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN 178
             +NL  +N + N  +  +  L  L  L    ++ N      P  + NLT L  L++ +N
Sbjct: 66  YLNNLTQINFSNN-QLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122

Query: 179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR 238
              +    + + NL NL  L L+   +      ++S L  L  L    N+++   P  + 
Sbjct: 123 ---QITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LA 174

Query: 239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298
            L  L ++++ +N ++    + L  LT L+    ++NQ+       +G L NL       
Sbjct: 175 NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNG 230

Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
           N            +  L    +  N+ S      L   T LT++ +  NQ S   P  L 
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISP--LA 284

Query: 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
               L NL    N       +  ++ K +  L +  N++S   P  + +L  +  L F +
Sbjct: 285 GLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340

Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALG 478
           N  +  +S L  L T+++ L   +N+ S    + L  LT + +L L +  ++    +   
Sbjct: 341 NKVSD-VSSLANL-TNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKA 396

Query: 479 ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538
            +   +++     AL    P  + D     + ++  N  S          S    +    
Sbjct: 397 NVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYT-NEVSYTFSQPVTIGKGT 453

Query: 539 NKLTGSIPDNL 549
              +G++   L
Sbjct: 454 TTFSGTVTQPL 464

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  155 bits (395), Expect = 7e-41
 Identities = 97/387 (25%), Positives = 146/387 (37%), Gaps = 52/387 (13%)

Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKI 246
            +   L       L   N+   +    ++L ++ TL   R  I       +  L  L +I
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 73

Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP 306
               N LT   P  L NLT L +  +++NQ+       + NL NLT    F N  +    
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQITD--- 126

Query: 307 SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL 366
                                   + L   T L  +++S N  S      L     L   
Sbjct: 127 -----------------------IDPLKNLTNLNRLELSSNTISD--ISALSGLTSL-QQ 160

Query: 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
           L+  N  +   P +     T++RL IS N +S      L  L N+  L   +N  +  I+
Sbjct: 161 LSFGNQVTDLKPLAN--LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-IT 215

Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486
           PL  L T+L +L L  N+        L  LTNL  L L NN  S   P  L  L +L+ L
Sbjct: 216 PLGIL-TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270

Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
            L  N ++   P  +     + +L L  N L    P  +S L +L  L L  N ++   P
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326

Query: 547 DNLMKLKLSSIDLSENQLSGSVPLDFL 573
            + +  KL  +    N++S    L  L
Sbjct: 327 VSSLT-KLQRLFFYNNKVSDVSSLANL 352

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  129 bits (326), Expect = 7e-32
 Identities = 91/357 (25%), Positives = 142/357 (39%), Gaps = 51/357 (14%)

Query: 219 LGTLDICR-NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQM 277
           LG+  I +   I+  F      L +  K  L   N+T  +     +L  +          
Sbjct: 3   LGSATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG- 57

Query: 278 YGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYT 337
             K  + +  L NLT      N  +    +   ++ KL    +  N+ +      L   T
Sbjct: 58  -IKSIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADI--TPLANLT 112

Query: 338 ALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHL 397
            LT + +  NQ +              ++  L N               + RL +S N +
Sbjct: 113 NLTGLTLFNNQIT--------------DIDPLKN------------LTNLNRLELSSNTI 146

Query: 398 SGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLT 457
           S      L  L ++  L FG+      + PL  L T+L +L + +N+ S    S L +LT
Sbjct: 147 SD--ISALSGLTSLQQLSFGNQVT--DLKPLANL-TTLERLDISSNKVSD--ISVLAKLT 199

Query: 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSL 517
           NLE LI TNN  S   P  LG L  L  L L  N L       +     + DL+LA N +
Sbjct: 200 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 255

Query: 518 SGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLR 574
           S   P  LS L+ L  L L  N+++   P   +   L++++L+ENQL    P+  L+
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISPLAGLT-ALTNLELNENQLEDISPISNLK 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  177 bits (452), Expect = 5e-50
 Identities = 57/188 (30%), Positives = 83/188 (44%), Gaps = 17/188 (9%)

Query: 664 SFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEME 723
           S H ID        +E + ++G G  G V +   +     VA+KQ+      K F  E+ 
Sbjct: 1   SLHMIDYK-----EIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQIESESERKAFIVELR 53

Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
            L ++ H NI+KLY   L      LV+EY   G+L+  LH    E  P           L
Sbjct: 54  QLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCL 109

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-PKIADFGVAKIAENSPKVSDYSCFA 842
             ++G+AYLH      +IHRD+K  N+LL       KI DFG A   +        +   
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNK 164

Query: 843 GTHGYIAP 850
           G+  ++AP
Sbjct: 165 GSAAWMAP 172

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  172 bits (437), Expect = 3e-48
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 31/196 (15%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---------VKVFAA 720
           +   +   +E +  IG GG G V++  L K+   VA+K L  GD           + F  
Sbjct: 16  LADNE---IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72

Query: 721 EMEILGKIRHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY 779
           E+ I+  + H NI+KLY           +V+E++P G+L+  L  +       + W  + 
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH---NPPRMVMEFVPCGDLYHRLLDK----AHPIKWSVKL 125

Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-----PKIADFGVAKIAENSPK 834
           ++ L  A GI Y+ +  +PPI+HRD++S NI L    E      K+ADFG+++       
Sbjct: 126 RLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----S 179

Query: 835 VSDYSCFAGTHGYIAP 850
           V   S   G   ++AP
Sbjct: 180 VHSVSGLLGNFQWMAP 195

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  174 bits (444), Expect = 2e-47
 Identities = 90/485 (18%), Positives = 170/485 (35%), Gaps = 73/485 (15%)

Query: 88  EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLE 147
           E+      ++S T     ++      P        + V  +               +   
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC----------LDRQAH 74

Query: 148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG 207
             +L+    +   P        L SL    N     E+PE   +LK+L         L  
Sbjct: 75  ELELNNLGLS-SLPE---LPPHLESLVASCN--SLTELPELPQSLKSLLVDNNNLKAL-- 126

Query: 208 RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLL 267
              +    L     L +  N++  + P  ++    L  I++  N+L  +LP    +L  +
Sbjct: 127 --SDLPPLLEY---LGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI 178

Query: 268 QEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG 327
                 +NQ+  +LP E+ NL  LT      N+   + P     +  +       N    
Sbjct: 179 ---AAGNNQL-EELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE- 228

Query: 328 PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTI 387
                L     LT +    N    + P         L  L + +N+  ++P      +++
Sbjct: 229 -ELPELQNLPFLTTIYADNNLLK-TLPDLPPS----LEALNVRDNYLTDLPEL---PQSL 279

Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG 447
             L +S+N  S  + +     PN+  L+   N+    I  L  L  SL +L + NN+   
Sbjct: 280 TFLDVSENIFS-GLSEL---PPNLYYLNASSNE----IRSLCDLPPSLEELNVSNNKLI- 330

Query: 448 ELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARI 507
           ELP+       LERLI + N+ + ++P     L+    LH+E N L    P+        
Sbjct: 331 ELPALPP---RLERLIASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPE----- 377

Query: 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567
              ++    ++ ++     L  +L  L++  N L    PD    ++   + ++  ++   
Sbjct: 378 ---SVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVE--DLRMNSERVVDP 431

Query: 568 VPLDF 572
                
Sbjct: 432 YEFAH 436

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  157 bits (398), Expect = 2e-41
 Identities = 88/477 (18%), Positives = 166/477 (34%), Gaps = 70/477 (14%)

Query: 76  TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCS---------NLKVL 126
           TE                   + + V  L   +      LEL+N           +L+ L
Sbjct: 37  TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESL 96

Query: 127 NVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI 185
             + N++   +P+   +LK+L + + ++   +            L  L + +N     ++
Sbjct: 97  VASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNN--QLEKL 146

Query: 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWK 245
           PE + N   L  + + + +L+ ++P+    L  +       N++  E P  ++ L  L  
Sbjct: 147 PE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELP-ELQNLPFLTA 199

Query: 246 IELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEF 305
           I    N+L  +LP    +L  +      +N +  +   E+ NL  LT      N      
Sbjct: 200 IYADNNSLK-KLPDLPLSLESI---VAGNNIL--EELPELQNLPFLTTIYADNNLLK-TL 252

Query: 306 PSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN 365
           P     +  L    +  N  +   PE       LT +D+SEN FS    +        L 
Sbjct: 253 PDLPPSLEALN---VRDNYLTD-LPELPQS---LTFLDVSENIFS-GLSELPPN----LY 300

Query: 366 LLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGI 425
            L  S+N    + +      +++ L +S+N L  ++P      P +  L    N     +
Sbjct: 301 YLNASSNEIRSLCDL---PPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAE-V 352

Query: 426 SPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSS 485
             L     +L QL ++ N    E P     + +L       N+   ++P     L+    
Sbjct: 353 PELPQ---NLKQLHVEYNPLR-EFPDIPESVEDL-----RMNSHLAEVPELPQNLK---Q 400

Query: 486 LHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
           LH+E N L    P+       + DL +    +      +      L       +   
Sbjct: 401 LHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  144 bits (366), Expect = 4e-37
 Identities = 82/422 (19%), Positives = 150/422 (35%), Gaps = 59/422 (13%)

Query: 73  GRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNA 132
             +  +     SL+ E+     +L+SL V +     LS            L+ L V+ N 
Sbjct: 91  PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-------DLPPLLEYLGVSNNQ 142

Query: 133 MVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNL 192
           +   +P+L     L+I D+  N    + P        L  ++ G+N  +E  +PE + NL
Sbjct: 143 LE-KLPELQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLEE--LPE-LQNL 194

Query: 193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN 252
             LT ++  + +L+ ++P+    L  +       N +       ++ L  L  I    N 
Sbjct: 195 PFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPELQNLPFLTTIYADNNL 248

Query: 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
           L   LP    +L  L   D         LPE   +L  L V +   +  S   P+     
Sbjct: 249 LK-TLPDLPPSLEALNVRDNYLTD----LPELPQSLTFLDVSENIFSGLSELPPN----- 298

Query: 313 RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNN 372
             L+  +   N       +       L ++++S N+     P         L  L  S N
Sbjct: 299 --LYYLNASSNEIRS-LCDLPPS---LEELNVSNNKLI-ELPALPPR----LERLIASFN 347

Query: 373 FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS 432
              EVP      + +++L +  N L  + PD   ++ +   L    +     ++ +  L 
Sbjct: 348 HLAEVPEL---PQNLKQLHVEYNPLR-EFPDIPESVED---LRMNSH-----LAEVPELP 395

Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
            +L QL ++ N    E P     + +L    + +         A     +L     E + 
Sbjct: 396 QNLKQLHVETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHH 451

Query: 493 LT 494
             
Sbjct: 452 HH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 88.9 bits (221), Expect = 1e-18
 Identities = 43/208 (20%), Positives = 73/208 (35%), Gaps = 29/208 (13%)

Query: 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417
                L   L  S+N + E+P    + K+      + +      P G      + +    
Sbjct: 8   VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66

Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL 477
           D            L     +L L N   S  LP       +LE L+ + N+ + ++P   
Sbjct: 67  DC-----------LDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELP 110

Query: 478 GALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLS 537
            +L+ L   +    AL+   P        +  L ++ N L   +P  L   S L  +++ 
Sbjct: 111 QSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVD 161

Query: 538 GNKLTGSIPDNLMKLKLSSIDLSENQLS 565
            N L   +PD    L+   I    NQL 
Sbjct: 162 NNSLK-KLPDLPPSLE--FIAAGNNQLE 186

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 33/154 (21%), Positives = 55/154 (35%), Gaps = 25/154 (16%)

Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALR--- 481
           I+P    +T L + +  ++  + E+P E   + +        + +    P   G  R   
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 482 ----------QLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL 531
                     Q   L L    L+ S+P        +  L  + NSL+  +P     L SL
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSL 116

Query: 532 NALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLS 565
              N +   L+  +P  L  L      +S NQL 
Sbjct: 117 LVDNNNLKALS-DLPPLLEYL-----GVSNNQLE 144

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  166 bits (423), Expect = 1e-46
 Identities = 42/190 (22%), Positives = 78/190 (41%), Gaps = 22/190 (11%)

Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEM 722
           H  ID +Q   L     +    +G++++   + N   + VK L    W     + F  E 
Sbjct: 4   HSGIDFKQ---LNFLTKLNENHSGELWKGRWQGN--DIVVKVLKVRDWSTRKSRDFNEEC 58

Query: 723 EILGKIRHRNILKLYACLLKGGSSFL--VLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
             L    H N+L +        +     +  +MP G+L+  LH+        +D  +  K
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG---TNFVVDQSQAVK 115

Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
            AL  A+G+A+LH    P I    + S ++++DED   +I+   V    ++  ++     
Sbjct: 116 FALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----- 169

Query: 841 FAGTHGYIAP 850
                 ++AP
Sbjct: 170 --YAPAWVAP 177

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  167 bits (425), Expect = 1e-46
 Identities = 60/192 (31%), Positives = 84/192 (43%), Gaps = 25/192 (13%)

Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIR 729
           A  I  LE    +G G  G+V+R   +     VAVK     D  K +  E E+     +R
Sbjct: 7   ARDITLLE---CVGKGRYGEVWRGSWQGE--NVAVKIFSSRD-EKSWFRETELYNTVMLR 60

Query: 730 HRNILKLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
           H NIL   A  +    S    +L+  Y   G+L+  L          LD     +I L  
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSI 114

Query: 786 AKGIAYLHHD-----CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
           A G+A+LH +       P I HRD+KS NIL+ ++ +  IAD G+A +   S    D   
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 841 --FAGTHGYIAP 850
               GT  Y+AP
Sbjct: 175 NPRVGTKRYMAP 186

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  166 bits (423), Expect = 2e-46
 Identities = 61/197 (30%), Positives = 92/197 (46%), Gaps = 31/197 (15%)

Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKG------DGVKVFAAE 721
           +ID  +   L  + +IG GG GKVYR       G  VAVK             ++    E
Sbjct: 3   EIDFAE---LTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQE 56

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
            ++   ++H NI+ L    LK  +  LV+E+   G L + L  +       +        
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNW 110

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP--------KIADFGVAKIAENSP 833
           A+  A+G+ YLH +   PIIHRD+KSSNIL+ +  E         KI DFG+A+    + 
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT 170

Query: 834 KVSDYSCFAGTHGYIAP 850
           K+S     AG + ++AP
Sbjct: 171 KMS----AAGAYAWMAP 183

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  168 bits (427), Expect = 2e-46
 Identities = 56/193 (29%), Positives = 82/193 (42%), Gaps = 28/193 (14%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIRHRNIL 734
           NL+   LIG G  G VY+  L +    VAVK     +  + F  E  I  +  + H NI 
Sbjct: 14  NLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANR-QNFINEKNIYRVPLMEHDNIA 70

Query: 735 KLYACLLKGGSS-----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           +      +  +       LV+EY PNG+L + L           DW    ++A    +G+
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGL 124

Query: 790 AYLHHD------CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC--- 840
           AYLH +        P I HRD+ S N+L+  D    I+DFG++     +  V        
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 841 ---FAGTHGYIAP 850
                GT  Y+AP
Sbjct: 185 AISEVGTIRYMAP 197

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  166 bits (423), Expect = 2e-46
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 26/204 (12%)

Query: 651 NGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW 710
           +G ++ +  W        +I   Q   +     IGSG  G VY+       G VAVK L 
Sbjct: 10  HGSRDAADDW--------EIPDGQ---ITVGQRIGSGSFGTVYKGKWH---GDVAVKMLN 55

Query: 711 KGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
                   ++ F  E+ +L K RH NIL           + +V ++    +L+  LH   
Sbjct: 56  VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHAS- 113

Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
              + + +  +   IA   A+G+ YLH   +  IIHRD+KS+NI L ED   KI DFG+A
Sbjct: 114 ---ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167

Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
                      +   +G+  ++AP
Sbjct: 168 TEKSRWSGSHQFEQLSGSILWMAP 191

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  173 bits (441), Expect = 3e-46
 Identities = 97/523 (18%), Positives = 188/523 (35%), Gaps = 34/523 (6%)

Query: 75  VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
              +      L    S S  +   L VL L    +         + S+L  L +TGN + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
                  S L +L+                + +L  L  L++  N+    ++PE   NL 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 194 NLTYLFLAHCNLRGRIPESISELREL----GTLDICRNKISGEFPRSIRKLQKLWKIELY 249
           NL +L L+   ++      +  L ++     +LD+  N ++        K  +L K+ L 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208

Query: 250 ANNLTGELPAE-LGNLTLLQEFDI------SSNQMYGKLPEEIGNLKNLTVFQ---CFKN 299
            N  +  +    +  L  L+   +      +   +       +  L NLT+ +    + +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
            +  +    F  +  + +FS+          ++         +++   +F       L  
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKS 326

Query: 360 KRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS--GKIPDGLWALPNVGMLDFG 417
               L  L  ++N  G   +   D  +++ L +S N LS  G      +   ++  LD  
Sbjct: 327 ----LKRLTFTSNKGGNAFSE-VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE--LGRLTNLERLILTNNNFSGKIPS 475
            N     +S        L  L  Q++    ++        L NL  L +++ +       
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439

Query: 476 ALGALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNAL 534
               L  L  L +  N+   +   ++  +   +  L+L++  L    P + + LSSL  L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499

Query: 535 NLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGSVP-LDFLR 574
           N++ N+L  S+PD +      L  I L  N    S P +D+L 
Sbjct: 500 NMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 541

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  152 bits (385), Expect = 7e-39
 Identities = 79/460 (17%), Positives = 154/460 (33%), Gaps = 44/460 (9%)

Query: 145 NLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN 204
           + +  DLS N           +  +L  L +        E   +  +L +L+ L L    
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE-DGAYQSLSHLSTLILTGNP 87

Query: 205 LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT-GELPAELGN 263
           ++     + S L  L  L      ++      I  L+ L ++ +  N +   +LP    N
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 264 LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC---FKNNFSGEFPSGFGDMRKLFAFSI 320
           LT L+  D+SSN++      ++  L  + +         N       G     +L   ++
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207

Query: 321 YGNRFSGPFPENLGRY-TALTDVDISENQFSG---------SFPKYLCEKRKLLNLLALS 370
             N  S    +   +    L    +   +F           S  + LC        LA  
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267

Query: 371 NNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDG--LWALPNVGMLDFGDNDFT------ 422
           + +  ++ + +     +    +    +  ++ D    +   ++ +++     F       
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326

Query: 423 -----------GGISPLIGLSTSLSQLVLQNNR--FSGELPSELGRLTNLERLILTNNNF 469
                      G     + L  SL  L L  N   F G         T+L+ L L+ N  
Sbjct: 327 LKRLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385

Query: 470 SGKIPSALGALRQLSSLHLEENALTGSIPNE--MGDCARIVDLNLARNSLSGNIPRSLSL 527
              + S    L QL  L  + + L   +           ++ L+++            + 
Sbjct: 386 I-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443

Query: 528 LSSLNALNLSGNKLTGSIPDN-LMKL-KLSSIDLSENQLS 565
           LSSL  L ++GN    +   +   +L  L+ +DLS+ QL 
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 90.2 bits (224), Expect = 8e-19
 Identities = 30/145 (20%), Positives = 49/145 (33%), Gaps = 2/145 (1%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
            L  S   L L  N               L+ L L+          A  +L  LS+L L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT-GSIPDN 548
            N +           + +  L     +L+      +  L +L  LN++ N +    +P+ 
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 549 LMKL-KLSSIDLSENQLSGSVPLDF 572
              L  L  +DLS N++      D 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDL 169

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  166 bits (422), Expect = 9e-46
 Identities = 57/195 (29%), Positives = 83/195 (42%), Gaps = 25/195 (12%)

Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LG 726
              A+QI   +    IG G  G+V+    +     VAVK  +  +    +  E EI    
Sbjct: 33  RTIAKQI---QMVKQIGKGRYGEVWMGKWRGE--KVAVKVFFTTE-EASWFRETEIYQTV 86

Query: 727 KIRHRNILKLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            +RH NIL   A  +KG  S    +L+ +Y  NG+L+  L          LD     K+A
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT------LDAKSMLKLA 140

Query: 783 LGAAKGIAYLH-----HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
             +  G+ +LH         P I HRD+KS NIL+ ++    IAD G+A    +     D
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200

Query: 838 YSC--FAGTHGYIAP 850
                  GT  Y+ P
Sbjct: 201 IPPNTRVGTKRYMPP 215

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  163 bits (414), Expect = 9e-45
 Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 23/190 (12%)

Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEI 724
           DI  EQ   LE   LIG G  G+VY        G VA++ +         +K F  E+  
Sbjct: 29  DIPFEQ---LEIGELIGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMA 82

Query: 725 LGKIRHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
             + RH N++    AC+       ++        L+  +       K  LD  +  +IA 
Sbjct: 83  YRQTRHENVVLFMGACM-SPPHLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQ 137

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI---AENSPKVSDYSC 840
              KG+ YLH   +  I+H+D+KS N+  D   +  I DFG+  I    +   +      
Sbjct: 138 EIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRI 193

Query: 841 FAGTHGYIAP 850
             G   ++AP
Sbjct: 194 QNGWLCHLAP 203

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  169 bits (429), Expect = 9e-45
 Identities = 94/488 (19%), Positives = 185/488 (37%), Gaps = 31/488 (6%)

Query: 98  SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYF 156
           ++  L L FN ++     +L  C+NL+VL +  + +     D   +L +LE  DLS N+ 
Sbjct: 27  AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 157 TGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE-SISE 215
           +     W   L+ L  L++  N Y    +     NL NL  L + +      I     + 
Sbjct: 87  SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146

Query: 216 LRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSN 275
           L  L  L+I    +     +S++ ++ +  + L+ +     L      L+ ++  ++   
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206

Query: 276 QMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGR 335
            +       +   +  +  +      S      F ++ KL  + +  +     F +    
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE--FDDC--T 262

Query: 336 YTALTDVDISENQFSGSFPKYLCEKRKLLNLLALS---NNFSGEVPNSYADCKTIQRLRI 392
              L D + SE+       K      + + +  L         ++   Y+  + ++R+ +
Sbjct: 263 LNGLGDFNPSESDVVSELGKV-----ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317

Query: 393 SDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGI---SPLIGLSTSLSQLVLQNNRFS-- 446
            ++ +   +P      L ++  LD  +N         S   G   SL  LVL  N     
Sbjct: 318 ENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376

Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR 506
            +    L  L NL  L ++ N F   +P +     ++  L+L    +   +   +     
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--T 432

Query: 507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSG 566
           +  L+++ N+L  +       L  L  L +S NKL  ++PD  +   L  + +S NQL  
Sbjct: 433 LEVLDVSNNNLD-SFSLF---LPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLK- 486

Query: 567 SVPLDFLR 574
           SVP     
Sbjct: 487 SVPDGIFD 494

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  137 bits (348), Expect = 2e-34
 Identities = 66/418 (15%), Positives = 137/418 (32%), Gaps = 32/418 (7%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
            IP  +     +  L L+   +       +     L  L +  ++I+     +   L  L
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG-KLPEEIGNLKNLTVFQCFKNNFS 302
             ++L  N+L+    +  G L+ L+  ++  N      +     NL NL   +       
Sbjct: 77  EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136

Query: 303 GEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
            E     F  +  L    I          ++L     +  + +  ++ +    +   +  
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADIL 195

Query: 362 KLLNLLALSNN---------FSGEVPNSYADCKTIQRLRISDNHLSG--KIPDGLWALPN 410
             +  L L +             +  +S       +   ++D   +   K+   +  L  
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255

Query: 411 VGMLDFGDNDFT-------GGISPLIGLST-SLSQLVLQNNRFSGELPSELGRLTNLERL 462
           V   D   N            +S L  + T ++ +L +       +L +    L  ++R+
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315

Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM---GDCARIVDLNLARNSLS- 518
            + N+       S    L+ L  L L EN +           G    +  L L++N L  
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375

Query: 519 -GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR 574
                  L  L +L +L++S N     +PD+     K+  ++LS   +   V     +
Sbjct: 376 MQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ 431

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  136 bits (344), Expect = 8e-34
 Identities = 82/455 (18%), Positives = 150/455 (32%), Gaps = 27/455 (5%)

Query: 96  LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGN--AMVGSVPDLSALKNLEIFDLSI 153
           L SL  L L  N LS          S+LK LN+ GN    +G       L NL+   +  
Sbjct: 73  LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132

Query: 154 NYFTGRFPRWV-VNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPES 212
                   R     LT L  L I        +  +S+ +++++ +L L        +   
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQ-SQSLKSIRDIHHLTLHLSESAFLLEIF 191

Query: 213 ISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI 272
              L  +  L++    ++      +   +    ++  A   +         L  L  + +
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251

Query: 273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPEN 332
             ++    +  +   L  L  F   +++   E      +   +    I            
Sbjct: 252 ELSE----VEFDDCTLNGLGDFNPSESDVVSELG--KVETVTIRRLHIPQFYLFYDLSTV 305

Query: 333 LGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEV----PNSYADCKTIQ 388
                 +  + +  ++     P    +  K L  L LS N   E             ++Q
Sbjct: 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364

Query: 389 RLRISDNHLS--GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
            L +S NHL    K  + L  L N+  LD   N F   +         +  L L +    
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR 423

Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR 506
             + + +     LE L ++NNN        L  L+    L++  N L  ++P+       
Sbjct: 424 -VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK-TLPDASL-FPV 474

Query: 507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKL 541
           ++ + ++RN L          L+SL  + L  N  
Sbjct: 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  119 bits (300), Expect = 3e-28
 Identities = 70/428 (16%), Positives = 141/428 (32%), Gaps = 37/428 (8%)

Query: 90  SSSISALQSLTVLSLPFNVLSG-KLPLELSNCSNLKVLNVTGNAMVGSVP--DLSALKNL 146
           SS    L SL  L+L  N      +     N +NL+ L +        +   D + L +L
Sbjct: 91  SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150

Query: 147 EIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLR 206
              ++          + + ++  +  L++  +             L ++ YL L   NL 
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL-EIFADILSSVRYLELRDTNLA 209

Query: 207 GRIPESISELRELGTLDICRNKIS-------GEFPRSIRKLQKLWKIELYANNLTG---- 255
                 +        +     + S        E  + +R + +L ++E     L G    
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269

Query: 256 -----ELPAELGNLTL--LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG 308
                ++ +ELG +    ++   I    ++  L      L+ +       +       S 
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329

Query: 309 FGDMRKLFAFSIYGNRFSGPFPEN---LGRYTALTDVDISENQFSGSFPKYLCEKRKLLN 365
              ++ L    +  N     + +N    G + +L  + +S+N    S  K       L N
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKN 388

Query: 366 L--LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
           L  L +S N    +P+S    + ++ L +S   +   +   +     + +LD  +N+   
Sbjct: 389 LTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS 445

Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483
               L      L +L +  N+    LP        L  + ++ N            L  L
Sbjct: 446 FSLFL----PRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499

Query: 484 SSLHLEEN 491
             + L  N
Sbjct: 500 QKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  100 bits (251), Expect = 4e-22
 Identities = 70/412 (16%), Positives = 141/412 (34%), Gaps = 57/412 (13%)

Query: 81  DNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV----GS 136
           + ++ S       + L SL  L +    L       L +  ++  L +  +         
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191

Query: 137 VPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE---AEIPESIGNLK 193
              LS+++ LE+ D ++  F           + +  L+   +V  +    E+ + +  + 
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251

Query: 194 NLTYLFLAHCNLRG------RIPESISELRELGT-----LDICRNKISGEFPRSIRKLQK 242
            L+ +    C L G         + +SEL ++ T     L I +  +  +       L+K
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311

Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQM---YGKLPEEIGNLKNLTVFQCFKN 299
           + +I +  + +     +   +L  L+  D+S N M   Y K     G   +L      +N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371

Query: 300 NFS--GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYL 357
           +     +       ++ L +  I  N F  P P++      +  +++S           +
Sbjct: 372 HLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI 429

Query: 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417
            +    L +L +SNN              +Q L IS N L   +PD              
Sbjct: 430 PQT---LEVLDVSNNNLDSFSLFL---PRLQELYISRNKLK-TLPDA------------- 469

Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNF 469
                        L   L  + +  N+          RLT+L+++ L  N +
Sbjct: 470 ------------SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  162 bits (412), Expect = 2e-44
 Identities = 59/194 (30%), Positives = 88/194 (45%), Gaps = 25/194 (12%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGK 727
             A  I   E    IG G  G+V+R   +     VAVK     +  + +  E EI     
Sbjct: 39  TIARTIVLQE---SIGKGRFGEVWRGKWRGE--EVAVKIFSSRE-ERSWFREAEIYQTVM 92

Query: 728 IRHRNILKLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           +RH NIL   A   K   +    +LV +Y  +G+LF  L++        +      K+AL
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLAL 146

Query: 784 GAAKGIAYLHHD-----CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
             A G+A+LH +       P I HRD+KS NIL+ ++    IAD G+A   +++    D 
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206

Query: 839 SC--FAGTHGYIAP 850
           +     GT  Y+AP
Sbjct: 207 APNHRVGTKRYMAP 220

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  160 bits (407), Expect = 6e-44
 Identities = 48/201 (23%), Positives = 84/201 (41%), Gaps = 24/201 (11%)

Query: 664 SFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG--VKVFAAE 721
           S  H       +    E  ++G G  G+  ++  ++    + +K+L + D    + F  E
Sbjct: 1   SMPHRIFRPSDL-IHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
           ++++  + H N+LK    L K      + EY+  G L   +         +  W +R   
Sbjct: 58  VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSF 113

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC- 840
           A   A G+AYLH   S  IIHRD+ S N L+ E+    +ADFG+A++  +     +    
Sbjct: 114 AKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170

Query: 841 -----------FAGTHGYIAP 850
                        G   ++AP
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAP 191

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  159 bits (404), Expect = 4e-43
 Identities = 78/399 (19%), Positives = 149/399 (37%), Gaps = 57/399 (14%)

Query: 170 LVSLSIGDNVYDEAEIP--ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRN 227
             +L+          I       +L       L   ++      +  EL  +  L +   
Sbjct: 2   AATLATLPA-----PINQIFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGE 54

Query: 228 KISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGN 287
           K++    + I  L  L  + L  N +T   P  L NL  L    I +N++       + N
Sbjct: 55  KVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQN 108

Query: 288 LKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISEN 347
           L NL      ++N S    S   ++ K+++ ++  N         L   T L  + ++E+
Sbjct: 109 LTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTES 165

Query: 348 QFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA 407
           +                ++  ++N               +  L ++ N +    P  L +
Sbjct: 166 KVK--------------DVTPIAN------------LTDLYSLSLNYNQIEDISP--LAS 197

Query: 408 LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN 467
           L ++       N  T  I+P+  + T L+ L + NN+ +    S L  L+ L  L +  N
Sbjct: 198 LTSLHYFTAYVNQITD-ITPVANM-TRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTN 253

Query: 468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL 527
             S    +A+  L +L  L++  N ++  I   + + +++  L L  N L       +  
Sbjct: 254 QISD--INAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGG 309

Query: 528 LSSLNALNLSGNKLTGSIP-DNLMKLKLSSIDLSENQLS 565
           L++L  L LS N +T   P  +L K+   S D +   + 
Sbjct: 310 LTNLTTLFLSQNHITDIRPLASLSKMD--SADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  155 bits (393), Expect = 1e-41
 Identities = 76/420 (18%), Positives = 144/420 (34%), Gaps = 75/420 (17%)

Query: 123 LKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
              L       +  +   + L       L     T         L  +  L +      +
Sbjct: 2   AATLATLPAP-INQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE---K 55

Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
               + I  L NL YL L    +    P  +S L +L  L I  NKI+     +++ L  
Sbjct: 56  VASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTN 111

Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
           L ++ L  +N++    + L NLT +   ++ +N         + N+  L      ++   
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVK 168

Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRK 362
               +   ++  L++ S+  N+        L   T+L       NQ +            
Sbjct: 169 D--VTPIANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQIT------------ 212

Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422
             ++  ++N               +  L+I +N ++      L  L  +  L+ G N  +
Sbjct: 213 --DITPVAN------------MTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQIS 256

Query: 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ 482
             I+ +  L T L  L + +N+ S    S L  L+ L  L L NN    +    +G L  
Sbjct: 257 D-INAVKDL-TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312

Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
           L++L L +N +T   P                          L+ LS +++ + +   + 
Sbjct: 313 LTTLFLSQNHITDIRP--------------------------LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  153 bits (389), Expect = 4e-41
 Identities = 79/356 (22%), Positives = 145/356 (40%), Gaps = 26/356 (7%)

Query: 219 LGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY 278
             TL      I+  FP     L +  +  L   ++T  +      L  + +  ++  ++ 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56

Query: 279 GKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338
               + I  L NL       N  +    S   ++ KL    I  N+ +      L   T 
Sbjct: 57  -ASIQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDI--SALQNLTN 111

Query: 339 LTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS 398
           L ++ ++E+  S   P  L    K+ +L  L  N +    +  ++   +  L ++++ + 
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSL-NLGANHNLSDLSPLSNMTGLNYLTVTESKVK 168

Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458
              P  +  L ++  L    N     ISPL  L TSL       N+ +    + +  +T 
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIED-ISPLASL-TSLHYFTAYVNQITD--ITPVANMTR 222

Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
           L  L + NN  +    S L  L QL+ L +  N ++    N + D  ++  LN+  N +S
Sbjct: 223 LNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278

Query: 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL 573
                 L+ LS LN+L L+ N+L     + +  L  L+++ LS+N ++   PL  L
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASL 332

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  143 bits (364), Expect = 1e-37
 Identities = 75/388 (19%), Positives = 136/388 (35%), Gaps = 49/388 (12%)

Query: 59  SPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELS 118
            P   + I  D+             S++  ++     L+S+T L +    ++  +   + 
Sbjct: 8   LPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIE 63

Query: 119 NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN 178
             +NL+ LN+ GN  +  +  LS L  L    +  N  T      + NLT L  L + ++
Sbjct: 64  YLTNLEYLNLNGNQ-ITDISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNED 120

Query: 179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR 238
                     + NL  +  L L   +        +S +  L  L +  +K+    P  I 
Sbjct: 121 ---NISDISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IA 174

Query: 239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298
            L  L+ + L  N +    P  L +LT L  F    NQ+       + N+  L   +   
Sbjct: 175 NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGN 230

Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
           N  +    S   ++ +L    I  N+ S      +   T L  +++  NQ S        
Sbjct: 231 NKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS-------- 278

Query: 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
                 ++  L+N               +  L +++N L  +  + +  L N+  L    
Sbjct: 279 ------DISVLNN------------LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320

Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFS 446
           N  T  I PL  L + +      N    
Sbjct: 321 NHIT-DIRPLASL-SKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 86.1 bits (214), Expect = 3e-18
 Identities = 40/188 (21%), Positives = 78/188 (41%), Gaps = 14/188 (7%)

Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG 447
             L      ++   PD    L             T  +     L  S+++LV+   + + 
Sbjct: 3   ATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTD-VVTQEEL-ESITKLVVAGEKVAS 58

Query: 448 ELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARI 507
                +  LTNLE L L  N  +   P  L  L +L++L++  N +T    + + +   +
Sbjct: 59  --IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNL 112

Query: 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSG 566
            +L L  +++S   P  L+ L+ + +LNL  N    S    L  +  L+ + ++E+++  
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169

Query: 567 SVPLDFLR 574
             P+  L 
Sbjct: 170 VTPIANLT 177

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.8 bits (107), Expect = 7e-05
 Identities = 21/94 (22%), Positives = 40/94 (42%), Gaps = 9/94 (9%)

Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
            ++L      +    P+   D A  +   L + S++  +      L S+  L ++G K+ 
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 543 GSIPD--NLMKLKLSSIDLSENQLSGSVPLDFLR 574
            SI     L  L+   ++L+ NQ++   PL  L 
Sbjct: 58  -SIQGIEYLTNLE--YLNLNGNQITDISPLSNLV 88

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  156 bits (396), Expect = 3e-42
 Identities = 48/370 (12%), Positives = 99/370 (26%), Gaps = 54/370 (14%)

Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
                   +      L+           + +S+ +     D  R   +            
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 243 LWKIELYANNLTGELPAELGNLTL--LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
                     L       L + T       ++ S  +  + P++   L +L         
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115

Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
              E P        L   ++  N      P ++     L ++ I         P+ L   
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDND 420
                   L N               +Q LR+    +   +P  +  L            
Sbjct: 174 DASGEHQGLVN---------------LQSLRLEWTGIR-SLPASIANL------------ 205

Query: 421 FTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480
                        +L  L ++N+  S  L   +  L  LE L L         P   G  
Sbjct: 206 ------------QNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252

Query: 481 RQLSSLHLEE-NALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN 539
             L  L L++ + L  ++P ++    ++  L+L        +P  ++ L +   + +  +
Sbjct: 253 APLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

Query: 540 KLTGSIPDNL 549
                +  + 
Sbjct: 312 LQA-QLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  134 bits (340), Expect = 7e-35
 Identities = 54/329 (16%), Positives = 104/329 (31%), Gaps = 29/329 (8%)

Query: 96  LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINY 155
                 L    +         LS        +           + +   N +I   +   
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSN---NPQIETRTGRA 67

Query: 156 FTGRFPRWVVNLTQ--LVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESI 213
                   + + TQ   V+L +        + P+    L +L ++ +    L   +P+++
Sbjct: 68  LK-ATADLLEDATQPGRVALELRSV--PLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123

Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTL------- 266
            +   L TL + RN +    P SI  L +L ++ + A     ELP  L +          
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182

Query: 267 --LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324
             LQ   +    +   LP  I NL+NL   +   +  S         + KL    + G  
Sbjct: 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCT 240

Query: 325 FSGPFPENLGRYTALTDVDISE-NQFSGSFPKYLCEKRKLLNL--LALSNNFS-GEVPNS 380
               +P   G    L  + + + +    + P  +    +L  L  L L    +   +P+ 
Sbjct: 241 ALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIH---RLTQLEKLDLRGCVNLSRLPSL 296

Query: 381 YADCKTIQRLRISDNHLSGKIPDGLWALP 409
            A       + +  +  +        A P
Sbjct: 297 IAQLPANCIILVPPHLQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  129 bits (326), Expect = 6e-33
 Identities = 43/216 (19%), Positives = 74/216 (34%), Gaps = 38/216 (17%)

Query: 88  EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-------- 139
           E+  ++     L  L+L  N L   LP  +++ + L+ L++     +  +P+        
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 140 --LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTY 197
                L NL+   L         P  + NL  L SL I ++    + +  +I +L  L  
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL--SALGPAIHHLPKLEE 233

Query: 198 LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
           L L  C      P        L  L +                          +NL   L
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDC-----------------------SNLL-TL 269

Query: 258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTV 293
           P ++  LT L++ D+       +LP  I  L    +
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 99.2 bits (248), Expect = 9e-23
 Identities = 38/184 (20%), Positives = 66/184 (35%), Gaps = 14/184 (7%)

Query: 88  EISSSISALQSLTVL---------SLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP 138
            + +SI++L  L  L          LP  + S     E     NL+ L +    +  S+P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199

Query: 139 D-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTY 197
             ++ L+NL+   +  +  +      + +L +L  L +          P   G    L  
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKR 257

Query: 198 LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
           L L  C+    +P  I  L +L  LD+         P  I +L     I +   +L  +L
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQL 316

Query: 258 PAEL 261
               
Sbjct: 317 DQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 14/81 (17%), Positives = 29/81 (35%), Gaps = 3/81 (3%)

Query: 76  TEISFDNKSLSGEISSSISALQSLTVLSLP-FNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
            E+     +              L  L L   + L   LPL++   + L+ L++ G   +
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNL 290

Query: 135 GSVPD-LSALKNLEIFDLSIN 154
             +P  ++ L    I  +  +
Sbjct: 291 SRLPSLIAQLPANCIILVPPH 311

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  152 bits (386), Expect = 3e-38
 Identities = 98/517 (18%), Positives = 169/517 (32%), Gaps = 49/517 (9%)

Query: 94  SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDL 151
             L +   L L FN +             L++L +       ++       L NL I DL
Sbjct: 21  QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80

Query: 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRG-RI 209
             +      P     L  L  L +      +A + +    NLK LT L L+   +R   +
Sbjct: 81  GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140

Query: 210 PESISELRELGTLDICRNKISGEFPRSIRKLQ--KLWKIELYANNLTGELPAELGNL--- 264
             S  +L  L ++D   N+I       +  LQ   L    L AN+L   +  + G     
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200

Query: 265 ---TLLQEFDISSNQMYGKLPEEIGN------------LKNLTVFQCFKNNFSGEFPSGF 309
               +L+  D+S N     +     N              ++       +N      + F
Sbjct: 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260

Query: 310 GDMRK--LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367
             + +  +    +                  L  ++++ N+ +    +        L +L
Sbjct: 261 AGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN-LQVL 319

Query: 368 ALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
            LS N  GE+  +++     +  + +  NH++         L  +  LD  DN  T    
Sbjct: 320 NLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT--- 376

Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSG-KIPSALGALRQLSS 485
             I    S+  + L  N+    LP           + L+ N      I   L  +  L  
Sbjct: 377 --IHFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQI 430

Query: 486 LHLEENALTGSIPNEM--GDCARIVDLNLARNSLSGNIPRSLSL-----LSSLNALNLSG 538
           L L +N  + S   +    +   +  L L  N L       L       LS L  L L+ 
Sbjct: 431 LILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489

Query: 539 NKLTGSIPDNLMK--LKLSSIDLSENQLSGSVPLDFL 573
           N L  S+P  +      L  + L+ N+L+     D  
Sbjct: 490 NYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP 525

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  133 bits (335), Expect = 5e-32
 Identities = 98/466 (21%), Positives = 156/466 (33%), Gaps = 56/466 (12%)

Query: 116 ELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSI 175
            ++        N+T       VP +  L   E   LS NY           L QL  L +
Sbjct: 7   RIAFYRFC---NLT------QVPQV--LNTTERLLLSFNYIRTVTASSFPFLEQLQLLEL 55

Query: 176 GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF-- 233
           G          E+  NL NL  L L    +    P++   L  L  L +    +S     
Sbjct: 56  GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115

Query: 234 PRSIRKLQKLWKIELYANNLTG-ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNL--KN 290
               R L+ L +++L  N +    L    G L  L+  D SSNQ++     E+  L  K 
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175

Query: 291 LTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS 350
           L+ F    N+        +G     F                  R   L  +D+S N ++
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPF------------------RNMVLEILDVSGNGWT 217

Query: 351 GSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPN 410
                              SN  S     S      I       +++     +    L  
Sbjct: 218 VDITG------------NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR 265

Query: 411 VGM--LDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNN 468
             +  LD          S +      L  L L  N+ +         L NL+ L L+ N 
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325

Query: 469 FSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL 528
                 S    L +++ + L++N +            ++  L+L  N+L+     ++  +
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFI 380

Query: 529 SSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLR 574
            S+  + LSGNKL  ++P   +      I LSEN+L     L FL 
Sbjct: 381 PSIPDIFLSGNKLV-TLPKINLTAN--LIHLSENRLENLDILYFLL 423

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  133 bits (335), Expect = 6e-32
 Identities = 112/621 (18%), Positives = 191/621 (30%), Gaps = 91/621 (14%)

Query: 76  TEISFDNKSLSGEI-SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
             +   ++     I   +   L +L +L L  + +    P       +L  L +    + 
Sbjct: 51  QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110

Query: 135 GSVPD---LSALKNLEIFDLSINYFTGRFPRWV-VNLTQLVSLSIGDNVYDEAEIPESIG 190
            +V        LK L   DLS N     +       L  L S+    N          + 
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC-EHELE 169

Query: 191 NL--KNLTYLFLAHCNLRGRIPESISELRE------LGTLDICRNKIS----GEFPRSIR 238
            L  K L++  LA  +L  R+     +         L  LD+  N  +    G F  +I 
Sbjct: 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS 229

Query: 239 KLQ--------KLWKIELYANNLTGELPAELGNLTL--LQEFDISSNQMYGKLPEEIGNL 288
           K Q         +       +N+          L    ++  D+S   ++         L
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289

Query: 289 KNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
           K+L V     N  +      F  +  L   ++  N     +  N      +  +D+ +N 
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349

Query: 349 FSGSFPKYLCEKRKLLNLLALSNNFSGEVPN---------SYADCKTI-------QRLRI 392
            +        +  + L  L L +N    +           S     T+         + +
Sbjct: 350 IA-IIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHL 408

Query: 393 SDNHLSG-KIPDGLWALPNVGMLDFGDNDFTGGISP-LIGLSTSLSQLVLQNNRFSGELP 450
           S+N L    I   L  +P++ +L    N F+          + SL QL L  N       
Sbjct: 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468

Query: 451 SELGR-----LTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA 505
           +EL       L++L+ L L +N  +   P     L  L  L L  N LT  + +      
Sbjct: 469 TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHN----- 522

Query: 506 RIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLS 565
                                L ++L  L++S N+L    PD  + L    +D++ N+  
Sbjct: 523 --------------------DLPANLEILDISRNQLLAPNPDVFVSLS--VLDITHNKFI 560

Query: 566 GSVPLDFLRMGGDGAFAGNEGL--------CLDQSTKMLMNSKLTACPAIQKQKGGFKDK 617
               L       +       G             S   L +     C   +  K      
Sbjct: 561 CECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLK--- 617

Query: 618 LVLFCIIAVALAAFLAGLLLV 638
             LF +  V L  FL  +L V
Sbjct: 618 FSLFIVCTVTLTLFLMTILTV 638

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 80.2 bits (198), Expect = 1e-15
 Identities = 57/309 (18%), Positives = 106/309 (34%), Gaps = 25/309 (8%)

Query: 75  VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
           V  +   +  +    S     L+ L VL+L +N ++           NL+VLN++ N ++
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN-LL 326

Query: 135 GSVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNL 192
           G +       L  +   DL  N+      +    L +L +L + DN         +I  +
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL------TTIHFI 380

Query: 193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSI-RKLQKLWKIELYAN 251
            ++  +FL+   L      +++       + +  N++          ++  L  + L  N
Sbjct: 381 PSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQN 436

Query: 252 NLTG-ELPAELGNLTLLQEFDISSNQMYGKLPEEI-----GNLKNLTVFQCFKNNFSGEF 305
             +             L++  +  N +      E+       L +L V     N  +   
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP 496

Query: 306 PSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN 365
           P  F  +  L   S+  NR +     +L     L  +DIS NQ     P        L  
Sbjct: 497 PGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVF---VSLSV 551

Query: 366 LLALSNNFS 374
           L    N F 
Sbjct: 552 LDITHNKFI 560

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  141 bits (358), Expect = 6e-36
 Identities = 66/482 (13%), Positives = 150/482 (31%), Gaps = 26/482 (5%)

Query: 74  RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
           R       + SL   ++S   +  ++  L L  N LS     +L+  + L++LN++ N +
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNL 192
                DL +L  L   DL+ NY        ++    + +L   +N      I   S    
Sbjct: 71  Y-ETLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANN-----NISRVSCSRG 119

Query: 193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISG-EFPRSIRKLQKLWKIELYAN 251
           +    ++LA+  +             +  LD+  N+I    F         L  + L  N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 252 NLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGD 311
            +  ++  ++     L+  D+SSN++   +  E  +   +T      N            
Sbjct: 180 FIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235

Query: 312 MRKLFAFSIYGNRFS-GPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALS 370
            + L  F + GN F  G   +   +   +  V     +          E+  +  L    
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYG 292

Query: 371 NNFSGEVPNSYAD-CKTIQRLRISDNHLSG----KIPDGLWALPNVGMLDFGDNDFTGGI 425
                ++P  +AD    ++R   +     G    ++            +D     +   I
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352

Query: 426 SPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSS 485
             +     +   L  +      ++ +       L+  +           +          
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLL 412

Query: 486 LHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI 545
             + +      +  +      I D ++ ++  +     +  L       +L+      ++
Sbjct: 413 RAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATL 472

Query: 546 PD 547
            +
Sbjct: 473 QE 474

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  140 bits (355), Expect = 1e-35
 Identities = 56/397 (14%), Positives = 119/397 (29%), Gaps = 21/397 (5%)

Query: 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLW 244
           I E   N        +   +L+  +         +  LD+  N +S      +    KL 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGE 304
            + L +N L      +L +L+ L+  D+++N +     +E+    ++       NN S  
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114

Query: 305 FPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLL 364
             S     + +    +  N+ +     + G  + +  +D+  N+        L      L
Sbjct: 115 SCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 365 NLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGG 424
             L L  NF  +V         ++ L +S N L+  +     +   V  +   +N     
Sbjct: 172 EHLNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228

Query: 425 ISPLIGLSTSLSQLVLQNNRFS-GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483
           I   +  S +L    L+ N F  G L     +   ++   +                   
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVKKLTGQNEEECTVP 286

Query: 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL----LSSLNALNLSGN 539
           +  H                   +     A  S  G+    L       +    ++    
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346

Query: 540 KLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRM 575
           +    I    ++ +   +++  +  L   V       
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 82.6 bits (204), Expect = 1e-16
 Identities = 26/152 (17%), Positives = 56/152 (36%), Gaps = 9/152 (5%)

Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483
            I  +           + ++     L S      N++ L L+ N  S    + L    +L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543
             L+L  N L      ++   + +  L+L  N +       L +  S+  L+ + N ++ 
Sbjct: 61  ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 544 SIPDNLMKLKLSSIDLSENQLSGSVPLDFLRM 575
            +  +  +    +I L+ N+++    LD    
Sbjct: 113 RVSCSRGQ-GKKNIYLANNKITMLRDLDEGCR 143

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  140 bits (353), Expect = 9e-35
 Identities = 75/369 (20%), Positives = 130/369 (35%), Gaps = 49/369 (13%)

Query: 167 LTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICR 226
                 L++G++      +P+ +    ++T L +   NL   +P    ELR   TL++  
Sbjct: 39  NNGNAVLNVGES--GLTTLPDCLP--AHITTLVIPDNNLT-SLPALPPELR---TLEVSG 90

Query: 227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG 286
           N+++   P     L +L             LPA    L  L    I  NQ+   LP    
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCKL---WIFGNQL-TSLPVLPP 141

Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
            L+ L+V     +N     P+   ++ KL     Y N+ +   P        L ++ +S+
Sbjct: 142 GLQELSVS----DNQLASLPALPSELCKL---WAYNNQLTS-LPMLPS---GLQELSVSD 190

Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
           NQ + S P       +L  L A +N  +  +P        ++ L +S N L+  +P    
Sbjct: 191 NQLA-SLPTLPS---ELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVLPS 241

Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
            L     L    N  T  +  L      L  L +  N+ +  LP  L  L++   + L  
Sbjct: 242 ELKE---LMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293

Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL-NLARNSLSGNIPRSL 525
           N  S +      ALR+++S       +                L   A + L        
Sbjct: 294 NPLSERTLQ---ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350

Query: 526 SLLSSLNAL 534
           +     +  
Sbjct: 351 APADRWHMF 359

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  139 bits (352), Expect = 1e-34
 Identities = 75/378 (19%), Positives = 126/378 (33%), Gaps = 46/378 (12%)

Query: 115 LELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174
           +     +   VLNV  + +  ++PD     ++    +  N  T   P       +L +L 
Sbjct: 34  MRACLNNGNAVLNVGESGL-TTLPD-CLPAHITTLVIPDNNLT-SLPA---LPPELRTLE 87

Query: 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP 234
           +  N      +P     L  L+       +L    P   S L +   L I  N+++   P
Sbjct: 88  VSGN--QLTSLPVLPPGLLELSIFSNPLTHL----PALPSGLCK---LWIFGNQLT-SLP 137

Query: 235 RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVF 294
                LQ+L    +  N L   LPA    L  L      +NQ+   LP     L+ L+V 
Sbjct: 138 VLPPGLQELS---VSDNQLA-SLPALPSELCKL---WAYNNQL-TSLPMLPSGLQELSVS 189

Query: 295 QCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFP 354
               +N     P+   ++ KL     Y NR +   P        L ++ +S N+ + S P
Sbjct: 190 ----DNQLASLPTLPSELYKL---WAYNNRLT-SLPALPS---GLKELIVSGNRLT-SLP 237

Query: 355 KYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGML 414
               E    L  L +S N    +P        +  L +  N L+ ++P+ L  L +   +
Sbjct: 238 VLPSE----LKELMVSGNRLTSLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTV 289

Query: 415 DFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIP 474
           +   N  +      +   TS         RF     S       L       +       
Sbjct: 290 NLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA--ADWLVPARE 347

Query: 475 SALGALRQLSSLHLEENA 492
                  +      E+NA
Sbjct: 348 GEPAPADRWHMFGQEDNA 365

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  136 bits (344), Expect = 1e-33
 Identities = 80/386 (20%), Positives = 132/386 (34%), Gaps = 96/386 (24%)

Query: 181 DEAEIPESIGN--LKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR 238
             A + + +          L +    L   +P+ +     + TL I  N ++   P    
Sbjct: 26  GRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP 81

Query: 239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298
           +L+ L   E+  N LT  LP     L  L  F          LP     L  L +F    
Sbjct: 82  ELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTH----LPALPSGLCKLWIF---- 129

Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
            N     P     +++L                            +S+NQ + S P    
Sbjct: 130 GNQLTSLPVLPPGLQEL---------------------------SVSDNQLA-SLPALPS 161

Query: 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
              +L  L A +N  +  +P        +Q L +SDN L+  +P                
Sbjct: 162 ---ELCKLWAYNNQLT-SLPML---PSGLQELSVSDNQLA-SLPTLP------------- 200

Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALG 478
                         + L +L   NNR +  LP+       L+ LI++ N  +  +P    
Sbjct: 201 --------------SELYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLTS-LPVLPS 241

Query: 479 ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538
            L+    L +  N LT S+P           L++ RN L+  +P SL  LSS   +NL G
Sbjct: 242 ELK---ELMVSGNRLT-SLPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEG 293

Query: 539 NKLTGSIPDNLMKLKLSSIDLSENQL 564
           N L+       ++ +++S       +
Sbjct: 294 NPLS-ERTLQALR-EITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  127 bits (321), Expect = 1e-30
 Identities = 65/303 (21%), Positives = 122/303 (40%), Gaps = 45/303 (14%)

Query: 264 LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323
                  ++  + +   LP+ +    ++T      NN +   P+   ++R L    + GN
Sbjct: 39  NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91

Query: 324 RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYAD 383
           + +   P        L+           + P  LC+       L +  N    +P     
Sbjct: 92  QLTS-LPVLPPGLLELSIFSNPLTHLP-ALPSGLCK-------LWIFGNQLTSLPVL--- 139

Query: 384 CKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNN 443
              +Q L +SDN L+  +P     L     L   +N  T  +  L      L +L + +N
Sbjct: 140 PPGLQELSVSDNQLA-SLPALPSELCK---LWAYNNQLTS-LPMLPS---GLQELSVSDN 191

Query: 444 RFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGD 503
           + +  LP+    L  L      NN  +  +P+    L+    L +  N LT S+P     
Sbjct: 192 QLA-SLPTLPSELYKLW---AYNNRLT-SLPALPSGLK---ELIVSGNRLT-SLPVLPS- 241

Query: 504 CARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSEN 562
              + +L ++ N L+ ++P    L S L +L++  N+LT  +P++L+ L   ++++L  N
Sbjct: 242 --ELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294

Query: 563 QLS 565
            LS
Sbjct: 295 PLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  125 bits (314), Expect = 7e-30
 Identities = 84/418 (20%), Positives = 135/418 (32%), Gaps = 70/418 (16%)

Query: 69  DSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNV 128
           D +   +T +   + +L+  + +       L  L +  N L+  LP+       L + + 
Sbjct: 57  DCLPAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSN 111

Query: 129 TGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPES 188
                   +P L     L    +  N  T   P        L  LS+ DN    A +P  
Sbjct: 112 PLT----HLPAL--PSGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDN--QLASLPAL 159

Query: 189 IGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIEL 248
              L  L      +  L   +P   S L+E   L +  N+++   P    +L KLW    
Sbjct: 160 PSELCKLW---AYNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPTLPSELYKLW---A 208

Query: 249 YANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG 308
           Y N LT  LPA    L  L    +S N++   LP     LK L V      N     P  
Sbjct: 209 YNNRLT-SLPALPSGLKEL---IVSGNRL-TSLPVLPSELKELMV----SGNRLTSLPML 259

Query: 309 FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLA 368
              +  L   S+Y N+ +   PE+L   ++ T V++  N  S          R++ +   
Sbjct: 260 PSGLLSL---SVYRNQLTR-LPESLIHLSSETTVNLEGNPLS-ERTLQAL--REITSAPG 312

Query: 369 LSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPL 428
            S                     I  +      P    AL                    
Sbjct: 313 YSGP------------------IIRFDMAGASAPRETRALHLAAADWLVPAREG-----E 349

Query: 429 IGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486
              +        ++N  +      L RL+  E   + +  F  +I S L  L +  +L
Sbjct: 350 PAPADRWHMFGQEDN--ADAFSLFLDRLSETENF-IKDAGFKAQISSWLAQLAEDEAL 404

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  131 bits (330), Expect = 3e-32
 Identities = 95/511 (18%), Positives = 164/511 (32%), Gaps = 62/511 (12%)

Query: 82  NKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-- 139
              L   +   +S     T+L++  N +S     ++ + S L++L ++ N +   +    
Sbjct: 9   KNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISV 64

Query: 140 LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLF 199
               + LE  DLS N               L  L +  N +D   I +  GN+  L +L 
Sbjct: 65  FKFNQELEYLDLSHNKLVKISCHP---TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121

Query: 200 LAHCNLRGRIPESISELRELG-TLDICRNKISGEFPRSIRKL--QKLWKIELYANNLTGE 256
           L+  +L       I+ L      L +       E P  ++    + L  +          
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181

Query: 257 LPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLF 316
           L   +  +  L+  +I       K    +  L  L       N               L 
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL-------------TLN 228

Query: 317 AFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGE 376
                 N F       L  +T +    IS  +  G                  S      
Sbjct: 229 NIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLD---------FRDFDYSGT---- 273

Query: 377 VPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS 436
                   K +   ++  +              N+ + +F  +             +   
Sbjct: 274 ------SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327

Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFS--GKIPSALGALRQLSSLHLEENALT 494
            L   NN  +  +    G LT LE LIL  N      KI      ++ L  L + +N+++
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVS 387

Query: 495 GSIPNEMGDC-ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL- 552
                        ++ LN++ N L+  I R   L   +  L+L  NK+  SIP  ++KL 
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLHSNKIK-SIPKQVVKLE 444

Query: 553 KLSSIDLSENQLSGSVPLDFLRMGGDGAFAG 583
            L  ++++ NQL  SVP        DG F  
Sbjct: 445 ALQELNVASNQLK-SVP--------DGIFDR 466

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 81.8 bits (202), Expect = 3e-16
 Identities = 64/403 (15%), Positives = 127/403 (31%), Gaps = 51/403 (12%)

Query: 89  ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEI 148
           I      +  L  L L    L     L +++ +  KVL V G        D   L++   
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG-EKEDPEGLQDFNT 165

Query: 149 FDLSINYFTGRFPRWVVN----------LTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
             L I + T +   ++++          L+ +  +   +       I   +     L+ L
Sbjct: 166 ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225

Query: 199 FLAHCNLRGRIPESISEL---RELGTLDICRNKISG-----EFPRSIRKLQKLWKIELYA 250
            L +          I +L     +    I   K+ G     +F  S   L+ L   ++ +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285

Query: 251 NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFG 310
           +             + +   + + +            +          N  +       G
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345

Query: 311 DMRKLFAFSIYGNRFS--GPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLA 368
            + +L    +  N+        E   +  +L  +DIS+N  S    K  C   K L  L 
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405

Query: 369 LSNNFSGEVPNSYADC--KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
           +S+N    + ++   C    I+ L +  N +   IP  +  L                  
Sbjct: 406 MSSN---ILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKL------------------ 443

Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNF 469
                  +L +L + +N+          RLT+L+++ L  N +
Sbjct: 444 ------EALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.5 bits (170), Expect = 2e-12
 Identities = 40/231 (17%), Positives = 84/231 (36%), Gaps = 32/231 (13%)

Query: 75  VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
           ++     +       S       ++ + +   +       L  S  S    L+ + N + 
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337

Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
            +V +    L  LE   L +N              QL  LS    +            +K
Sbjct: 338 DTVFENCGHLTELETLILQMN--------------QLKELSKIAEMTT---------QMK 374

Query: 194 NLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKI-SGEFPRSIRKLQKLWKIELYAN 251
           +L  L ++  ++     +   S  + L +L++  N +    F     +++ L    L++N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLD---LHSN 431

Query: 252 NLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
            +   +P ++  L  LQE +++SNQ+   +P+ I   L +L       N +
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 38/210 (18%), Positives = 64/210 (30%), Gaps = 48/210 (22%)

Query: 66  ITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKV 125
           + C S       + F N  L+  +  +   L  L  L L  N L                
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK--------------- 361

Query: 126 LNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI 185
                      +  ++     E+                  +  L  L I  N     E 
Sbjct: 362 ----------ELSKIA-----EMTT---------------QMKSLQQLDISQNSVSYDEK 391

Query: 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWK 245
                  K+L  L ++   L   I   +     +  LD+  NKI    P+ + KL+ L +
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQE 448

Query: 246 IELYANNLTGELPAELGNLTLLQEFDISSN 275
           + + +N L          LT LQ+  + +N
Sbjct: 449 LNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  123 bits (311), Expect = 4e-31
 Identities = 41/192 (21%), Positives = 77/192 (40%), Gaps = 27/192 (14%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNIL 734
           +      +G GG   V  ++   +    A+K++   +    +    E ++     H NIL
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 735 KLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGA 785
           +L A  L+   +    +L+L +   G L+  + +   +G    E   L          G 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL------GI 143

Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK-------VSDY 838
            +G+  +H   +    HRD+K +NILL ++ +P + D G    A    +       + D+
Sbjct: 144 CRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 839 SCFAGTHGYIAP 850
           +    T  Y AP
Sbjct: 201 AAQRCTISYRAP 212

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  124 bits (312), Expect = 1e-30
 Identities = 66/425 (15%), Positives = 125/425 (29%), Gaps = 70/425 (16%)

Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
                  + I     D     E I  L N   +   +  +R      +   R++  L++ 
Sbjct: 19  YDCVFYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77

Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEE 284
             +I      +      + K+ +  N +   LP     N+ LL    +  N +   LP  
Sbjct: 78  DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRG 135

Query: 285 I-GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD 343
           I  N   LT      NN        F     L    +  NR +                 
Sbjct: 136 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT----------------H 179

Query: 344 ISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403
           +  +                L    +S N    +    A    ++ L  S N ++  +  
Sbjct: 180 VDLSLIPS------------LFHANVSYNLLSTLAIPIA----VEELDASHNSIN-VVRG 222

Query: 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463
            +                          +  L+ L LQ+N  + +    L     L  + 
Sbjct: 223 PV--------------------------NVELTILKLQHNNLT-DTAW-LLNYPGLVEVD 254

Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
           L+ N     +      +++L  L++  N L  ++         +  L+L+ N L  ++ R
Sbjct: 255 LSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 312

Query: 524 SLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAG 583
           +      L  L L  N +  ++  +     L ++ LS N    +      R     A   
Sbjct: 313 NQPQFDRLENLYLDHNSIV-TLKLSTHH-TLKNLTLSHNDWDCNSLRALFRNVARPAVDD 370

Query: 584 NEGLC 588
            +  C
Sbjct: 371 ADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  102 bits (256), Expect = 2e-23
 Identities = 65/387 (16%), Positives = 129/387 (33%), Gaps = 52/387 (13%)

Query: 96  LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSI 153
           L +  +++   + +       L +   +++LN+    +   +     +    ++   +  
Sbjct: 44  LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102

Query: 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPES 212
           N      P    N+  L  L +  N    + +P  I  N   LT L +++ NL  RI + 
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDL--SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 159

Query: 213 I-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD 271
                  L  L +  N+++     S+  +  L+   +  N L+      L     ++E D
Sbjct: 160 TFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELD 211

Query: 272 ISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPE 331
            S N +   +   +     LT+ +   NN +    +   +                    
Sbjct: 212 ASHNSI-NVVRGPV--NVELTILKLQHNNLTD--TAWLLNY------------------- 247

Query: 332 NLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLR 391
                  L +VD+S N+       +   K + L  L +SNN    +        T++ L 
Sbjct: 248 -----PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLD 301

Query: 392 ISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPS 451
           +S NHL   +         +  L    N     +        +L  L L +N +      
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLR 357

Query: 452 ELGRLTNLERLILTNNNFSGKIPSALG 478
            L    N+ R  + + +   KI   L 
Sbjct: 358 AL--FRNVARPAVDDADQHCKIDYQLE 382

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 89.3 bits (222), Expect = 4e-19
 Identities = 50/291 (17%), Positives = 96/291 (32%), Gaps = 35/291 (12%)

Query: 90  SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLE 147
           + + +   ++  L + FN +    P    N   L VL +  N +  S+P         L 
Sbjct: 86  TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 144

Query: 148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFLAHCNLR 206
              +S N             T L +L +  N      +    +  + +L +  +++  L 
Sbjct: 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSN-----RLTHVDLSLIPSLFHANVSYNLL- 198

Query: 207 GRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTL 266
                +++    +  LD   N I+      +    +L  ++L  NNLT +    L N   
Sbjct: 199 ----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPG 249

Query: 267 LQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325
           L E D+S N++  K+       ++ L       N            +  L    +  N  
Sbjct: 250 LVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307

Query: 326 SGPFPENLGRYTALTDVDISENQFS----GSFPKYLCEKRKLLNLLALSNN 372
                 N  ++  L ++ +  N        +           L  L LS+N
Sbjct: 308 LH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHT--------LKNLTLSHN 349

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 89.3 bits (222), Expect = 5e-19
 Identities = 50/242 (20%), Positives = 89/242 (36%), Gaps = 22/242 (9%)

Query: 330 PENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKT 386
             NL       DV I        F     E   L N   +   N+   ++P       + 
Sbjct: 14  DSNLQYDCVFYDVHIDMQTQDVYFGF---EDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70

Query: 387 IQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFTGGISPLIGLS-TSLSQLVLQNNR 444
           ++ L ++D  +  +I          +  L  G N     + P +  +   L+ LVL+ N 
Sbjct: 71  VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERND 128

Query: 445 FSGELPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGD 503
            S  LP  +      L  L ++NNN          A   L +L L  N LT  +   +  
Sbjct: 129 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSL 184

Query: 504 CARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQ 563
              +   N++ N LS     +L++  ++  L+ S N +   +   +   +L+ + L  N 
Sbjct: 185 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV-ELTILKLQHNN 237

Query: 564 LS 565
           L+
Sbjct: 238 LT 239

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 79.7 bits (197), Expect = 7e-16
 Identities = 37/187 (19%), Positives = 74/187 (39%), Gaps = 17/187 (9%)

Query: 92  SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDL 151
            +S + SL   ++ +N+LS      L+    ++ L+ + N++   V        L I  L
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG-PVNVELTILKL 233

Query: 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIP 210
             N  T     W++N   LV + +  N  +  +I       ++ L  L++++  L   + 
Sbjct: 234 QHNNLTD--TAWLLNYPGLVEVDLSYN--ELEKIMYHPFVKMQRLERLYISNNRLV-ALN 288

Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
                +  L  LD+  N +     R+  +  +L  + L  N++   L   L     L+  
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNL 344

Query: 271 DISSNQM 277
            +S N  
Sbjct: 345 TLSHNDW 351

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 20/142 (14%), Positives = 45/142 (31%), Gaps = 14/142 (9%)

Query: 449 LPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM-GDCARI 507
           + S L        + +               L     +  + + +   +P  +     ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLS 565
             LNL    +      + +   ++  L +  N +   +P ++ +    L+ + L  N LS
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 566 GSVPLDFLRMGGDGAFAGNEGL 587
            S+P         G F     L
Sbjct: 131 -SLP--------RGIFHNTPKL 143

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  120 bits (304), Expect = 2e-30
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 33/200 (16%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR 729
           +D     + +E  LIGSGG G+V++   + +  T  +K++   +  +    E++ L K+ 
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLD 62

Query: 730 HRNILKLYAC----------------LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE- 772
           H NI+    C                  K    F+ +E+   G L Q + KR  E   + 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 773 --LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
             L+ F +        KG+ Y+H   S  +I+RD+K SNI L +  + KI DFG+    +
Sbjct: 123 LALELFEQ------ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173

Query: 831 NSPKVSDYSCFAGTHGYIAP 850
           N       +   GT  Y++P
Sbjct: 174 ND---GKRTRSKGTLRYMSP 190

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  124 bits (312), Expect = 3e-30
 Identities = 76/482 (15%), Positives = 143/482 (29%), Gaps = 76/482 (15%)

Query: 94  SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153
               S    +           +     + L  L+   ++ +  +  +  L  L     + 
Sbjct: 18  DNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSS-ITDMTGIEKLTGLTKLICTS 73

Query: 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFLAHCNLRGRIPES 212
           N  T      +   T L  L+   N     ++    +  L  LTYL      L       
Sbjct: 74  NNITT-LD--LSQNTNLTYLACDSN-----KLTNLDVTPLTKLTYLNCDTNKLT---KLD 122

Query: 213 ISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI 272
           +S+   L  L+  RN ++ E    +    +L +++ + N    +L   +   T L   D 
Sbjct: 123 VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177

Query: 273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPEN 332
           S N++      ++   K L    C  NN + +         +L       N+        
Sbjct: 178 SFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNK-------- 223

Query: 333 LGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRI 392
                 LT++D++                  L     S N   E+  S      +  L  
Sbjct: 224 ------LTEIDVTPL--------------TQLTYFDCSVNPLTELDVS--TLSKLTTLHC 261

Query: 393 SDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE 452
               L  +I   L     +                 +  +T L  L  Q    + EL   
Sbjct: 262 IQTDLL-EID--LTHNTQLIYFQAEGCRKI--KELDVTHNTQLYLLDCQAAGIT-ELD-- 313

Query: 453 LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512
           L +   L  L L N   + ++   +    +L SL      +       +G    + +   
Sbjct: 314 LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFE 368

Query: 513 ARNSLSGNIP-----RSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567
           A               SL++  S + L+  GN +    P +      ++  ++   LS  
Sbjct: 369 AEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQATNTITWENLSTD 427

Query: 568 VP 569
            P
Sbjct: 428 NP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 90.5 bits (225), Expect = 3e-19
 Identities = 64/366 (17%), Positives = 120/366 (32%), Gaps = 42/366 (11%)

Query: 92  SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDL 151
            ++ L  LT L+   N L+    L++S    L  LN   N +  +  D+S    L   D 
Sbjct: 101 DVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTL--TEIDVSHNTQLTELDC 155

Query: 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFLAHCNLRGRIP 210
            +N    +    V   TQL +L    N     +I E  +   K L  L     N+  ++ 
Sbjct: 156 HLNKKITKLD--VTPQTQLTTLDCSFN-----KITELDVSQNKLLNRLNCDTNNIT-KLD 207

Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
             +++  +L  LD   NK++ E    +  L +L   +   N LT EL   +  L+ L   
Sbjct: 208 --LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTL 259

Query: 271 DISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP 330
                 +  ++   + +   L  FQ        E         +L+         +    
Sbjct: 260 HCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---E 311

Query: 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRL 390
            +L +   L  + ++  + +         K   L  L+  N    +  +       +   
Sbjct: 312 LDLSQNPKLVYLYLNNTELT-ELDVSHNTK---LKSLSCVNAHIQDFSSV-GKIPALNNN 366

Query: 391 RISDNHLSGKIPDG-----LWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF 445
             ++        +      L    +  +LD   N     I P  G     +   +     
Sbjct: 367 FEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENL 424

Query: 446 SGELPS 451
           S + P+
Sbjct: 425 STDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 32/141 (22%), Positives = 62/141 (43%), Gaps = 13/141 (9%)

Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
            +L+ L   N+  + ++   + +LT L +LI T+NN +  +   L     L+ L  + N 
Sbjct: 42  ATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNK 96

Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552
           LT ++   +    ++  LN   N L+  +   +S    L  LN + N LT  I  +    
Sbjct: 97  LT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EIDVSHNT- 148

Query: 553 KLSSIDLSENQLSGSVPLDFL 573
           +L+ +D   N+    + +   
Sbjct: 149 QLTELDCHLNKKITKLDVTPQ 169

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  120 bits (304), Expect = 3e-30
 Identities = 52/381 (13%), Positives = 109/381 (28%), Gaps = 66/381 (17%)

Query: 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLW 244
           I E   N        +   +L+  +         +  LD+  N +S      +    KL 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGE 304
            + L +N L  E   +L +L+ L+  D+++N +     +E+    ++       NN S  
Sbjct: 62  LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114

Query: 305 FPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLL 364
             S     + ++   +  N+ +     + G  + +  +D+  N+                
Sbjct: 115 SCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEID-------------- 157

Query: 365 NLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGG 424
                    +       A   T++ L +  N +                           
Sbjct: 158 ---------TVNFAELAASSDTLEHLNLQYNFIY-------------------------D 183

Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS 484
           +   +     L  L L +N+ +  +  E      +  + L NN     I  AL   + L 
Sbjct: 184 VKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240

Query: 485 SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGS 544
              L  N                    +A+ ++   +        ++  L   G      
Sbjct: 241 HFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGA-YCCE 297

Query: 545 IPDNLMKLKLSSIDLSENQLS 565
                   +L  I L  +   
Sbjct: 298 DLPAPFADRL--IALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  120 bits (304), Expect = 3e-30
 Identities = 56/327 (17%), Positives = 115/327 (35%), Gaps = 23/327 (7%)

Query: 74  RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
           R       + SL   ++S   +  ++  L L  N LS     +L+  + L++LN++ N +
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
                DL +L  L   DL+ NY        ++    + +L   +N    + +  S    +
Sbjct: 71  Y-ETLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNI--SRVSCSR--GQ 120

Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISG-EFPRSIRKLQKLWKIELYANN 252
               ++LA+  +             +  LD+  N+I    F         L  + L  N 
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180

Query: 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
           +  ++  ++     L+  D+SSN++   +  E  +   +T      N             
Sbjct: 181 IY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236

Query: 313 RKLFAFSIYGNRFS-GPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSN 371
           + L  F + GN F  G   +   +   +  V     +      +  C    +  L     
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC---TVPTLGHYGA 293

Query: 372 NFSGEVPNSYADCKTIQRLRISDNHLS 398
               ++P  +AD    + + +  +H  
Sbjct: 294 YCCEDLPAPFAD----RLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  120 bits (302), Expect = 6e-30
 Identities = 51/313 (16%), Positives = 98/313 (31%), Gaps = 19/313 (6%)

Query: 281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALT 340
           + E   N     + +   ++      S       +    + GN  S     +L  +T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 341 DVDISENQFSGSFPKYLCEKRKLLNL--LALSNNFSGEVPNSYADCKTIQRLRISDNHLS 398
            +++S N           +   L  L  L L+NN+  E+        +I+ L  ++N++S
Sbjct: 62  LLNLSSNVLYE-----TLDLESLSTLRTLDLNNNYVQELLV----GPSIETLHAANNNIS 112

Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG-ELPSELGRLT 457
            ++            +   +N  T       G  + +  L L+ N               
Sbjct: 113 -RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSL 517
            LE L L  N     +   +    +L +L L  N L   +  E    A +  ++L  N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

Query: 518 SGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGG 577
              I ++L    +L   +L GN        +          +++  +      +      
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 578 DGAFAGNEGLCLD 590
                     C D
Sbjct: 286 PTLGHYGAYCCED 298

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  110 bits (277), Expect = 1e-26
 Identities = 42/293 (14%), Positives = 97/293 (33%), Gaps = 19/293 (6%)

Query: 89  ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLE 147
           I           +  +  + L   L     +  N+K L+++GN +       L+    LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG 207
           + +LS N         + +L+ L +L + +N      + + +    ++  L  A+ N+  
Sbjct: 62  LLNLSSNVLYETLD--LESLSTLRTLDLNNN-----YV-QELLVGPSIETLHAANNNIS- 112

Query: 208 RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTG-ELPAELGNLTL 266
           R+  S    +    + +  NKI+           ++  ++L  N +          +   
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 267 LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFS 326
           L+  ++  N +Y  +  ++     L       N  +      F     +   S+  N+  
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 327 GPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPN 379
               + L     L   D+  N F     +      K   +  ++     ++  
Sbjct: 228 L-IEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTG 277

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 26/149 (17%), Positives = 56/149 (37%), Gaps = 9/149 (6%)

Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483
            I  +           + ++     L S      N++ L L+ N  S    + L    +L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543
             L+L  N L      ++   + +  L+L  N +       L +  S+  L+ + N ++ 
Sbjct: 61  ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 544 SIPDNLMKLKLSSIDLSENQLSGSVPLDF 572
            +  +  +    +I L+ N+++    LD 
Sbjct: 113 RVSCSRGQ-GKKNIYLANNKITMLRDLDE 140

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  119 bits (300), Expect = 8e-30
 Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 37/200 (18%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-VKVFAAEMEILGKIRHRNILKLY 737
           EE  ++G G  G+V +     ++   A+K++   +  +    +E+ +L  + H+ +++ Y
Sbjct: 9   EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYY 68

Query: 738 ACLLKGGSS-------------FLVLEYMPNGNLFQALHKRVKEGKPE--LDWFRRYKIA 782
           A  L+  +              F+ +EY  NG L+  +H      + +     FR  +I 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QIL 126

Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC-- 840
                 ++Y+H   S  IIHRD+K  NI +DE    KI DFG+AK    S  +       
Sbjct: 127 EA----LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 841 ----------FAGTHGYIAP 850
                       GT  Y+A 
Sbjct: 180 LPGSSDNLTSAIGTAMYVAT 199

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  120 bits (304), Expect = 1e-29
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 13/166 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILG 726
           ++ E +   E+   IG G  G+V+   L+ +   VAVK   +    D    F  E  IL 
Sbjct: 111 LNHEDLVLGEQ---IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167

Query: 727 KIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
           +  H NI++L     +    ++V+E +  G+    L          L      ++   AA
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAA 223

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
            G+ YL    S   IHRD+ + N L+ E    KI+DFG+++   + 
Sbjct: 224 AGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  118 bits (297), Expect = 1e-29
 Identities = 52/182 (28%), Positives = 77/182 (42%), Gaps = 25/182 (13%)

Query: 681 DNLIGSGGTGKVYR-LDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILK 735
           D  IG G    VY+ LD +     VA  +L          + F  E E+L  ++H NI++
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTV-EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 736 LYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGI 789
            Y              LV E M +G L   L +       ++   R +  +I     KG+
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQIL----KGL 142

Query: 790 AYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
            +LH   +PPIIHRD+K  NI +       KI D G+A +   S   +      GT  ++
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFM 197

Query: 849 AP 850
           AP
Sbjct: 198 AP 199

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  118 bits (298), Expect = 4e-29
 Identities = 45/175 (25%), Positives = 86/175 (49%), Gaps = 18/175 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYA 738
            IG G  GK   +   ++     +K++          +    E+ +L  ++H NI++   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGIAYLHHD 795
              + GS ++V++Y   G+LF+ ++ +      E   LDWF   +I L     + ++H  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF--VQICLA----LKHVH-- 142

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
               I+HRDIKS NI L +D   ++ DFG+A++  ++ +++      GT  Y++P
Sbjct: 143 -DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGTPYYLSP 194

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  120 bits (303), Expect = 7e-29
 Identities = 44/165 (26%), Positives = 81/165 (49%), Gaps = 12/165 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGK 727
           ++   I    +   +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +
Sbjct: 217 MERTDITMKHK---LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKE 272

Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           I+H N+++L     +    +++ E+M  GNL   L +     + E+       +A   + 
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISS 329

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
            + YL        IHR++ + N L+ E++  K+ADFG++++    
Sbjct: 330 AMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  121 bits (304), Expect = 1e-28
 Identities = 69/402 (17%), Positives = 124/402 (30%), Gaps = 53/402 (13%)

Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
                  + I     D     E I  L N   +   +  +R      +   R++  L++ 
Sbjct: 25  YDCVFYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 83

Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEE 284
             +I      +      + K+ +  N +   LP     N+ LL    +  N +   LP  
Sbjct: 84  DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRG 141

Query: 285 I-GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD 343
           I  N   LT      NN        F     L    +  NR +                 
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT----------------H 185

Query: 344 ISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403
           +  +                L    +S N    +    A    ++ L  S N ++  +  
Sbjct: 186 VDLSLIPS------------LFHANVSYNLLSTLAIPIA----VEELDASHNSIN-VVRG 228

Query: 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERL 462
                  + +L    N+ T   + L+     L ++ L  N    ++      ++  LERL
Sbjct: 229 P--VNVELTILKLQHNNLT-DTAWLLNY-PGLVEVDLSYNELE-KIMYHPFVKMQRLERL 283

Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIP 522
            ++NN     +      +  L  L L  N L   +        R+ +L L  NS+   + 
Sbjct: 284 YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK 340

Query: 523 RSLSLLSSLNALNLSGNKLTGS----IPDNLMKLKLSSIDLS 560
             LS   +L  L LS N    +    +  N+ +  +   D  
Sbjct: 341 --LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  118 bits (296), Expect = 1e-27
 Identities = 76/474 (16%), Positives = 151/474 (31%), Gaps = 38/474 (8%)

Query: 88  EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKN 145
            I S++        + +           E    +N K++    + M   +P   L + + 
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 146 LEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCN 204
           +E+ +L+                 +  L +G N      +P  +  N+  LT L L   +
Sbjct: 77  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI--RYLPPHVFQNVPLLTVLVLERND 134

Query: 205 LRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGN 263
           L   +P  I     +L TL +  N +      + +    L  ++L +N LT  +   L  
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSL 190

Query: 264 LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323
           +  L   ++S N +       +     +       N+ +        ++  L    +  N
Sbjct: 191 IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHN 242

Query: 324 RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYAD 383
             +      L  Y  L +VD+S N+       +   K + L  L +SNN    +      
Sbjct: 243 NLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQP 299

Query: 384 CKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNN 443
             T++ L +S NHL   +         +  L    N     +        +L  L L +N
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHN 355

Query: 444 RFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA----------LRQLSSLHLEENAL 493
            +     S      N+ R  + + +   KI   L                   ++   ++
Sbjct: 356 DWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSV 413

Query: 494 TGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPD 547
              +    G C+    +N  ++       +    L     L    N+L   +  
Sbjct: 414 VEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQ 467

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 89.6 bits (222), Expect = 1e-18
 Identities = 82/479 (17%), Positives = 147/479 (30%), Gaps = 55/479 (11%)

Query: 96  LQSLTVLSLPFNVLSGKLPLEL-SNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLS 152
           +  LTVL L  N LS  LP  +  N   L  L+++ N +   + D    A  +L+   LS
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179

Query: 153 INYFT----GRFPR------------WVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLT 196
            N  T       P              +     +  L    N      +   +     LT
Sbjct: 180 SNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN--SINVVRGPV--NVELT 235

Query: 197 YLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE 256
            L L H NL       +     L  +D+  N++         K+Q+L ++ +  N L   
Sbjct: 236 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 292

Query: 257 LPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLF 316
           L      +  L+  D+S N +   +         L       N+      S    ++ L 
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL- 350

Query: 317 AFSIYGNRFSG----PFPENLGRYTALTDVDISENQFSGSFPKYLCEKR------KLLNL 366
             ++  N +          N+ R  A+ D D              C++       +LL  
Sbjct: 351 --TLSHNDWDCNSLRALFRNVAR-PAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQY 407

Query: 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
           +AL+ +   +V  +   C     +    +        G   L     L+   N+    + 
Sbjct: 408 IALT-SVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV- 465

Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486
                   L+   +Q  +    L +E+   TNL R  L  +  +    +       L   
Sbjct: 466 ------QQLTNEQIQQEQLLQGLHAEI--DTNLRRYRLPKDGLARSSDNLNKVFTHLKER 517

Query: 487 HLEENALTGSIPNEMGDCARIV-DLNLARNSLSGNI-PRSLSLLSSLNALNLSGNKLTG 543
              +   T +   E     +   DL     +L   +  +           +L   K+  
Sbjct: 518 QAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 68.0 bits (166), Expect = 6e-12
 Identities = 26/136 (19%), Positives = 48/136 (35%), Gaps = 5/136 (3%)

Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
                + +           E   L N + +   N+       + L + RQ+  L+L +  
Sbjct: 27  CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86

Query: 493 LTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK 551
           +   I          I  L +  N++    P     +  L  L L  N L+ S+P  +  
Sbjct: 87  IE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144

Query: 552 --LKLSSIDLSENQLS 565
              KL+++ +S N L 
Sbjct: 145 NTPKLTTLSMSNNNLE 160

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 21/160 (13%), Positives = 47/160 (29%), Gaps = 14/160 (8%)

Query: 431 LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE 490
           +       V         + S L        + +               L     +  + 
Sbjct: 1   VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60

Query: 491 NALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNL 549
           + +   +P  +     ++  LNL    +      + +   ++  L +  N +   +P ++
Sbjct: 61  STMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 118

Query: 550 MK--LKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
            +    L+ + L  N LS S+P         G F     L
Sbjct: 119 FQNVPLLTVLVLERNDLS-SLP--------RGIFHNTPKL 149

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  115 bits (290), Expect = 1e-28
 Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 12/164 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGK 727
           ++   I    +   +G G  G+VY    KK + TVAVK L K D ++V  F  E  ++ +
Sbjct: 10  MERTDITMKHK---LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKE 65

Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           I+H N+++L     +    +++ E+M  GNL   L +     + E+       +A   + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISS 122

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
            + YL        IHRD+ + N L+ E++  K+ADFG++++   
Sbjct: 123 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  115 bits (290), Expect = 2e-28
 Identities = 51/191 (26%), Positives = 77/191 (40%), Gaps = 19/191 (9%)

Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAE 721
            + +D            +G GG  K + +         A K      L K    +  + E
Sbjct: 6   EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRY 779
           + I   + H++++  +         F+VLE     +L +     K + E  PE    R Y
Sbjct: 66  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEA---RYY 120

Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
              +    G  YLH +    +IHRD+K  N+ L+ED E KI DFG+A   E   +     
Sbjct: 121 LRQI--VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL 175

Query: 840 CFAGTHGYIAP 850
           C  GT  YIAP
Sbjct: 176 C--GTPNYIAP 184

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  114 bits (289), Expect = 2e-28
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 12/159 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR 729
           ++ +++  L+    IG G  G V   D + N   VAVK +      + F AE  ++ ++R
Sbjct: 18  LNMKELKLLQT---IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR 72

Query: 730 HRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
           H N+++L    + + G  ++V EYM  G+L   L  R   G+  L      K +L   + 
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEA 129

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           + YL        +HRD+ + N+L+ ED   K++DFG+ K
Sbjct: 130 MEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  118 bits (297), Expect = 2e-28
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 14/160 (8%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR 729
           ++ +++  L+    IG G  G V   D + N   VAVK +      + F AE  ++ ++R
Sbjct: 190 LNMKELKLLQT---IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR 244

Query: 730 HRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
           H N+++L    + + G  ++V EYM  G+L   L  R   G+  L      K +L   + 
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEA 301

Query: 789 IAYL-HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           + YL  ++     +HRD+ + N+L+ ED   K++DFG+ K
Sbjct: 302 MEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (287), Expect = 3e-28
 Identities = 58/176 (32%), Positives = 81/176 (46%), Gaps = 21/176 (11%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKL 736
             +G G  G VY    K++   +A+K     QL K         E+EI   +RH NIL+L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           Y         +L+LEY P G +++ L    +  E +        Y   L  A  ++Y H 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT-----ATYITEL--ANALSYCH- 126

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             S  +IHRDIK  N+LL    E KIADFG +  A +S +     C  GT  Y+ P
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLC--GTLDYLPP 176

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  115 bits (290), Expect = 4e-28
 Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 19/175 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
            +G GG  K + +         A K      L K    +  + E+ I   + H++++  +
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
                    F+VLE     +L +     K + E  PE    R Y   +    G  YLH +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEA---RYYLRQI--VLGCQYLHRN 160

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
               +IHRD+K  N+ L+ED E KI DFG+A   E   +     C  GT  YIAP
Sbjct: 161 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAP 210

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  114 bits (288), Expect = 4e-28
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 19/180 (10%)

Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLY 737
            +++G G T  V+R   KK     A+K          V V   E E+L K+ H+NI+KL+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 738 ACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHH 794
           A   +  +    L++E+ P G+L+  L +       PE + F      +    G+ +L  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE-FLIVLRDV--VGGMNHLR- 129

Query: 795 DCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                I+HR+IK  NI+     D     K+ DFG A+  E+  +        GT  Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHP 184

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  113 bits (286), Expect = 4e-28
 Identities = 56/174 (32%), Positives = 83/174 (47%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
           L+G G    VYR +       VA+K      ++K   V+    E++I  +++H +IL+LY
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDC 796
                    +LVLE   NG + + L  RVK     E    R +   +    G+ YLH   
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA---RHFMHQI--ITGMLYLH--- 129

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           S  I+HRD+  SN+LL  +   KIADFG+A   +   +     C  GT  YI+P
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISP 181

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (286), Expect = 7e-28
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 21/175 (12%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
             +G G  G VY+   K+    VA+KQ+     ++    E+ I+ +    +++K Y    
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94

Query: 742 KGGSSFLVLEYMPNG---NLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLHHD 795
           K    ++V+EY   G   ++ +  +K + E           +IA       KG+ YLH  
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTED----------EIATILQSTLKGLEYLH-- 142

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                IHRDIK+ NILL+ +   K+ADFGVA   + +  ++  +   GT  ++AP
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVIGTPFWMAP 194

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  113 bits (285), Expect = 7e-28
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 16/164 (9%)

Query: 677 NLEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIR 729
            L+    +G G  GKV       +       VAVK L    G         E+EIL  + 
Sbjct: 22  FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81

Query: 730 HRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
           H NI+K      + G +   L++E++P+G+L + L K     K +++  ++ K A+   K
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICK 137

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
           G+ YL    S   +HRD+ + N+L++ +++ KI DFG+ K  E 
Sbjct: 138 GMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  112 bits (283), Expect = 8e-28
 Identities = 46/181 (25%), Positives = 86/181 (47%), Gaps = 21/181 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFA-AEMEILGKIRHRNILKLYA 738
            IG+G  G+  ++  K +   +  K+L  G   +  K    +E+ +L +++H NI++ Y 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 739 CLL--KGGSSFLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAKGIAY 791
            ++     + ++V+EY   G+L   + K  KE +   E   L      ++ L     +  
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM--TQLTLA----LKE 126

Query: 792 LH--HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
            H   D    ++HRD+K +N+ LD     K+ DFG+A+I  +    +    F GT  Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTPYYMS 184

Query: 850 P 850
           P
Sbjct: 185 P 185

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  113 bits (284), Expect = 1e-27
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 19/179 (10%)

Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWKGDGVKV---FAA 720
            + I  E++     D +IG G  G VY    +D  +N    A+K L +   ++    F  
Sbjct: 13  DVLIPHERV-VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR 71

Query: 721 EMEILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY 779
           E  ++  + H N+L L    L   G   ++L YM +G+L Q +    +  +         
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLI 127

Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
              L  A+G+ YL        +HRD+ + N +LDE +  K+ADFG+A+   +     +Y
Sbjct: 128 SFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD----REY 179

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (286), Expect = 1e-27
 Identities = 35/192 (18%), Positives = 71/192 (36%), Gaps = 36/192 (18%)

Query: 684 IGSGGTGKVYRLDLKKNAGT-VAVKQLWKGDGVKVFAA-------------------EME 723
           +  G   K+    L +      A+K+  K    K                       E++
Sbjct: 39  LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF-----RR 778
           I+  I++   L     +      +++ EYM N ++ +         K    +      + 
Sbjct: 96  IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 779 YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
                      +Y+H++ +  I HRD+K SNIL+D++   K++DFG ++   +       
Sbjct: 156 I--IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKI 207

Query: 839 SCFAGTHGYIAP 850
               GT+ ++ P
Sbjct: 208 KGSRGTYEFMPP 219

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (283), Expect = 1e-27
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 27/200 (13%)

Query: 661 KLASFHHI--DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVK 716
           K   + H+  D+D  ++  +     +G G  GKVY+   K+     A K       + ++
Sbjct: 4   KSREYEHVRRDLDPNEVWEIVG--ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 61

Query: 717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG---NLFQALHKRVKEGKPEL 773
            +  E+EIL    H  I+KL       G  ++++E+ P G    +   L + + E +   
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ--- 118

Query: 774 DWFRRYKIAL---GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
                  I +      + + +LH   S  IIHRD+K+ N+L+  + + ++ADFGV+  A+
Sbjct: 119 -------IQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AK 166

Query: 831 NSPKVSDYSCFAGTHGYIAP 850
           N   +     F GT  ++AP
Sbjct: 167 NLKTLQKRDSFIGTPYWMAP 186

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  113 bits (284), Expect = 2e-27
 Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 20/168 (11%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAG--TVAVKQLWKG---DGVKVFAAEMEILGKI-RH 730
           +++  ++IG G  G+V +  +KK+      A+K++ +    D  + FA E+E+L K+  H
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRY---------- 779
            NI+ L       G  +L +EY P+GNL   L K RV E  P                  
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             A   A+G+ YL        IHRD+ + NIL+ E+Y  KIADFG+++
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  112 bits (282), Expect = 2e-27
 Identities = 51/167 (30%), Positives = 70/167 (41%), Gaps = 17/167 (10%)

Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
           I   +  +   E    IG G  G VY    LD        AVK L +   +     F  E
Sbjct: 20  IGPSSLIVHFNEV---IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76

Query: 722 MEILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
             I+    H N+L L   CL   GS  +VL YM +G+L   +                  
Sbjct: 77  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIG 132

Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             L  AKG+ YL    S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 133 FGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  112 bits (283), Expect = 2e-27
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 21/178 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA-----AEMEILGKIRHRNILKLY 737
            IG G   +VYR     +   VA+K++   D +   A      E+++L ++ H N++K Y
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAKGIAYL 792
           A  ++     +VLE    G+L + +    K+ +  PE     +F   ++       + ++
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QLCSA----LEHM 152

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  ++HRDIK +N+ +      K+ D G+ +   +  K +      GT  Y++P
Sbjct: 153 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSP 205

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  111 bits (281), Expect = 2e-27
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 18/171 (10%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGT-VAVKQLWKG--DGVKVFAAEME 723
            +   +  L++   +G G  G V       L+ N G  VAVK+L     + ++ F  E+E
Sbjct: 7   FEERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63

Query: 724 ILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
           IL  ++H NI+K        G     L++EY+P G+L   L K     K  +D  +  + 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQY 119

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
                KG+ YL    +   IHRD+ + NIL++ +   KI DFG+ K+    
Sbjct: 120 TSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  114 bits (287), Expect = 2e-27
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 19/180 (10%)

Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLY 737
            +++G G T  V+R   KK     A+K          V V   E E+L K+ H+NI+KL+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 738 ACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHH 794
           A   +  +    L++E+ P G+L+  L +       PE + F      +    G+ +L  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE-FLIVLRDV--VGGMNHLR- 129

Query: 795 DCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                I+HR+IK  NI+     D     K+ DFG A+  E+  +        GT  Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHP 184

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  112 bits (282), Expect = 3e-27
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGT-VAVKQLWKG--DGVKVFAAEME 723
            +   +  L++   +G G  G V       L+ N G  VAVK+L     + ++ F  E+E
Sbjct: 38  FEERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94

Query: 724 ILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
           IL  ++H NI+K        G     L++EY+P G+L   L K     K  +D  +  + 
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQY 150

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
                KG+ YL    +   IHRD+ + NIL++ +   KI DFG+ K+        +Y
Sbjct: 151 TSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEY 201

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  112 bits (281), Expect = 4e-27
 Identities = 51/168 (30%), Positives = 76/168 (45%), Gaps = 20/168 (11%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGT-VAVKQLWKGDGVKV---FAAEM 722
            +   +  + +   +G G  G V       L  N G  VAVKQL +  G      F  E+
Sbjct: 20  FEERHLKYISQ---LGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREI 75

Query: 723 EILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           +IL  +    I+K        G     LV+EY+P+G L   L +     +  LD  R   
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLL 131

Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
            +    KG+ YL    S   +HRD+ + NIL++ +   KIADFG+AK+
Sbjct: 132 YSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKL 176

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  110 bits (277), Expect = 5e-27
 Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 16/176 (9%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           +  E+I  L+E   +GSG  G V     K     VAVK + +G      F  E + + K+
Sbjct: 5   LKREEITLLKE---LGSGQFGVVKLGKWKGQY-DVAVKMIKEGSMSEDEFFQEAQTMMKL 60

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  ++K Y    K    ++V EY+ NG L   L          L+  +  ++     +G
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEG 116

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
           +A+L    S   IHRD+ + N L+D D   K++DFG+ +   +      Y    GT
Sbjct: 117 MAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGT 165

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (281), Expect = 7e-27
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 17/206 (8%)

Query: 648 DMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK 707
           +++  +++    +        ++  +    + E   +G+G  G V+++  K +   +A K
Sbjct: 8   ELDEQQRKRLEAFLTQKQKVGELKDDDFEKISE---LGAGNGGVVFKVSHKPSGLVMARK 64

Query: 708 QLW---KGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK 764
            +    K         E+++L +     I+  Y      G   + +E+M  G+L Q L K
Sbjct: 65  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124

Query: 765 RVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824
             +  +  L      K+++   KG+ YL       I+HRD+K SNIL++   E K+ DFG
Sbjct: 125 AGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 177

Query: 825 VAKIAENSPKVSDYSCFAGTHGYIAP 850
           V+    +S   S    F GT  Y++P
Sbjct: 178 VSGQLIDSMANS----FVGTRSYMSP 199

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  109 bits (275), Expect = 7e-27
 Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 20/178 (11%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID  ++  ++E   IGSG  G V+          VA+K + +G    + F  E E++ K+
Sbjct: 5   IDPSELTFVQE---IGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIEEAEVMMKL 60

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY   L+     LV E+M +G L   L    +  +          + L   +G
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEG 116

Query: 789 IAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
           +AYL         +IHRD+ + N L+ E+   K++DFG+ +   +      Y+   GT
Sbjct: 117 MAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGT 165

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  110 bits (277), Expect = 7e-27
 Identities = 55/173 (31%), Positives = 79/173 (45%), Gaps = 17/173 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
            +G G  G VY    K+N   +A+K     QL K         E+EI   +RH NIL++Y
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    +L+LE+ P G L++ L    K G+ +      +   L  A  + Y H    
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEEL--ADALHYCH---E 132

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             +IHRDIK  N+L+    E KIADFG +  A +  +     C  GT  Y+ P
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMC--GTLDYLPP 181

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  114 bits (286), Expect = 8e-27
 Identities = 61/333 (18%), Positives = 110/333 (33%), Gaps = 34/333 (10%)

Query: 225 CRNK----ISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK 280
           C  K    +    P   R L       L  N +      E  +   L+E +++ N +   
Sbjct: 18  CHRKRFVAVPEGIPTETRLLD------LGKNRIKTLNQDEFASFPHLEELELNENIV-SA 70

Query: 281 LPEEI-GNLKNLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338
           +      NL NL       N      P G F  +  L    I  N+              
Sbjct: 71  VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129

Query: 339 LTDVDISENQFS----GSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKTIQRLR 391
           L  +++ +N        +F         L +L  L L       +P  + +    +  LR
Sbjct: 130 LKSLEVGDNDLVYISHRAF-------SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR 182

Query: 392 ISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP 450
           +   +++  I D  +  L  + +L+     +   ++P      +L+ L + +   +  +P
Sbjct: 183 LRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP 240

Query: 451 SE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM-GDCARIV 508
              +  L  L  L L+ N  S    S L  L +L  + L    L   +          + 
Sbjct: 241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLR 299

Query: 509 DLNLARNSLSGNIPRSLSLLSSLNALNLSGNKL 541
            LN++ N L+         + +L  L L  N L
Sbjct: 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  100 bits (250), Expect = 3e-22
 Identities = 63/303 (20%), Positives = 108/303 (35%), Gaps = 9/303 (2%)

Query: 74  RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
               +      +        ++   L  L L  N++S   P   +N  NL+ L +  N +
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92

Query: 134 VGSVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-G 190
              +P    + L NL   D+S N           +L  L SL +GDN  D   I      
Sbjct: 93  K-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN--DLVYISHRAFS 149

Query: 191 NLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYA 250
            L +L  L L  CNL     E++S L  L  L +    I+     S ++L +L  +E+  
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209

Query: 251 NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEE-IGNLKNLTVFQCFKNNFSGEFPSGF 309
                 +         L    I+   +   +P   + +L  L       N  S    S  
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPISTIEGSML 268

Query: 310 GDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL 369
            ++ +L    + G + +   P        L  +++S NQ + +  + +      L  L L
Sbjct: 269 HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLIL 327

Query: 370 SNN 372
            +N
Sbjct: 328 DSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 92.9 bits (231), Expect = 7e-20
 Identities = 53/270 (19%), Positives = 96/270 (35%), Gaps = 32/270 (11%)

Query: 329 FPENLGRYTALTDVDISENQFS----GSFPKYLCEKRKLLNLLALSNNFSGEV-PNSYAD 383
            PE +   T    +D+ +N+        F  +       L  L L+ N    V P ++ +
Sbjct: 26  VPEGIPTET--RLLDLGKNRIKTLNQDEFASF-----PHLEELELNENIVSAVEPGAFNN 78

Query: 384 CKTIQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFTGGISPLI--GLSTSLSQLVL 440
              ++ L +  N L   IP G    L N+  LD  +N     +   +   L  +L  L +
Sbjct: 79  LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDL-YNLKSLEV 135

Query: 441 QNNRFSGELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPN 499
            +N     +       L +LE+L L   N +     AL  L  L  L L    +      
Sbjct: 136 GDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194

Query: 500 EMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN-LMKLK-LSSI 557
                 R+  L ++       +  +     +L +L+++   LT ++P   +  L  L  +
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL 253

Query: 558 DLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
           +LS N +S ++                  L
Sbjct: 254 NLSYNPIS-TIE--------GSMLHELLRL 274

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  110 bits (277), Expect = 1e-26
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 25/174 (14%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKGDG-----VKVFAAE 721
           ID   +   +    +G G  G V   +LK+  G    VAVK + K D      ++ F +E
Sbjct: 31  IDRNLLILGKI---LGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSE 86

Query: 722 MEILGKIRHRNILKLYACLLKGGSS-----FLVLEYMPNGNLFQAL-HKRVKEGKPELDW 775
              +    H N+++L    ++  S       ++L +M  G+L   L + R++ G   +  
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146

Query: 776 FRRYKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               K  +  A G+ YL   +      +HRD+ + N +L +D    +ADFG++K
Sbjct: 147 QTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSK 195

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  110 bits (276), Expect = 1e-26
 Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 19/172 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G +G VY          VA++Q  L +    ++   E+ ++ + ++ NI+      L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLHHDCSP 798
            G   ++V+EY+  G+L   + +               +IA       + + +LH   S 
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC---------MDEGQIAAVCRECLQALEFLH---SN 135

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +IHRDIKS NILL  D   K+ DFG    A+ +P+ S  S   GT  ++AP
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAP 185

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  109 bits (275), Expect = 1e-26
 Identities = 40/178 (22%), Positives = 80/178 (44%), Gaps = 20/178 (11%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID + +  L+E   +G+G  G V     +     VA+K + +G      F  E +++  +
Sbjct: 21  IDPKDLTFLKE---LGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSEDEFIEEAKVMMNL 76

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY    K    F++ EYM NG L   L    +E +      +  ++     + 
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEA 132

Query: 789 IAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
           + YL          +HRD+ + N L+++    K++DFG+++   +     +Y+   G+
Sbjct: 133 MEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGS 181

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  110 bits (278), Expect = 2e-26
 Identities = 40/176 (22%), Positives = 76/176 (43%), Gaps = 19/176 (10%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRH--RNILK 735
             IGSGG+ KV+++ L +     A+K +   +     +  +  E+  L K++     I++
Sbjct: 15  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-H 794
           LY   +     ++V+E   N +L   L K+      +    + Y   +   + +  +H H
Sbjct: 74  LYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNM--LEAVHTIHQH 127

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                I+H D+K +N L+ +    K+ DFG+A   +            GT  Y+ P
Sbjct: 128 G----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  109 bits (275), Expect = 2e-26
 Identities = 40/176 (22%), Positives = 76/176 (43%), Gaps = 19/176 (10%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRN--ILK 735
             IGSGG+ KV+++ L +     A+K +         +  +  E+  L K++  +  I++
Sbjct: 34  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-H 794
           LY   +     ++V+E   N +L   L K+      +    + Y   +   + +  +H H
Sbjct: 93  LYDYEITDQYIYMVMECG-NIDLNSWLKKK---KSIDPWERKSYWKNM--LEAVHTIHQH 146

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                I+H D+K +N L+ +    K+ DFG+A   +            GT  Y+ P
Sbjct: 147 G----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  109 bits (275), Expect = 2e-26
 Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 15/190 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILG 726
           I+ +     E    IGSG T  V           VA+K++        +     E++ + 
Sbjct: 12  INRDDYELQEV---IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS 68

Query: 727 KIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL--- 783
           +  H NI+  Y   +     +LV++ +  G++   +   V +G+ +        IA    
Sbjct: 69  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV-AKIAENSPKVSDYS--C 840
              +G+ YLH       IHRD+K+ NILL ED   +IADFGV A +A       +     
Sbjct: 129 EVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185

Query: 841 FAGTHGYIAP 850
           F GT  ++AP
Sbjct: 186 FVGTPCWMAP 195

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  109 bits (274), Expect = 2e-26
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
           ++G G  G VY   DL  N   +A+K+         +    E+ +   ++H+NI++    
Sbjct: 29  VLGKGTYGIVYAGRDLS-NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY-KIALGAAKGIAYLHHDCSP 798
             + G   + +E +P G+L   L  +    K        Y K  L   +G+ YLH +   
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---EGLKYLHDNQ-- 142

Query: 799 PIIHRDIKSSNILLD-EDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
            I+HRDIK  N+L++      KI+DFG +K +A  +P       F GT  Y+AP
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQYMAP 192

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  109 bits (275), Expect = 2e-26
 Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 24/178 (13%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGT-VAVKQLWKGDGVKV---FAAEM 722
                +  + +   +G G  GKV            G  VAVK L    G +    +  E+
Sbjct: 28  FHKRYLKKIRD---LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84

Query: 723 EILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           +IL  + H +I+K   C    G++   LV+EY+P G+L   L +        +   +   
Sbjct: 85  DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLL 138

Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
            A    +G+AYLH   +   IHRD+ + N+LLD D   KI DFG+AK         +Y
Sbjct: 139 FAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEY 190

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (275), Expect = 2e-26
 Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 21/179 (11%)

Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILK 735
           L+    IG G TG V     K +   VAVK   L K    ++   E+ I+   +H N+++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIAL---GAAKGIAY 791
           +Y   L G   ++++E++  G L   +   R+ E +          IA       + +AY
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ----------IATVCEAVLQALAY 156

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH   +  +IHRDIKS +ILL  D   K++DFG    A+ S  V       GT  ++AP
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAP 210

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  108 bits (273), Expect = 3e-26
 Identities = 45/189 (23%), Positives = 89/189 (47%), Gaps = 18/189 (9%)

Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEI 724
           +++ A+ +  + E   +G G  G V ++    +   +AVK++         K    +++I
Sbjct: 2   MEVKADDLEPIME---LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58

Query: 725 LGK-IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK--PELDWFRRYKI 781
             + +     +  Y  L + G  ++ +E M + +L +   + + +G+  PE D     KI
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPE-DILG--KI 114

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
           A+   K + +LH   S  +IHRD+K SN+L++   + K+ DFG++    +          
Sbjct: 115 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDID 169

Query: 842 AGTHGYIAP 850
           AG   Y+AP
Sbjct: 170 AGCKPYMAP 178

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  109 bits (274), Expect = 3e-26
 Identities = 43/174 (24%), Positives = 67/174 (38%), Gaps = 21/174 (12%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIR-HRNI 733
            L    ++  GG   VY      +    A+K+L   +    +    E+  + K+  H NI
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 734 LKLYACLLKGGSS-------FLVLEYMPNGNLFQALHKRVKEGK-PE---LDWFRRYKIA 782
           ++  +    G          FL+L  +  G L + L K    G       L  F      
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY----- 143

Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
               + + ++H    PPIIHRD+K  N+LL      K+ DFG A    + P  S
Sbjct: 144 -QTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  113 bits (283), Expect = 4e-26
 Identities = 68/433 (15%), Positives = 133/433 (30%), Gaps = 42/433 (9%)

Query: 89  ISSSISALQSLTVLSLPFNVLSGKLPLELSNC-SNLKVLNVTGN--AMVGSVPDLSALKN 145
           I   I+   SL+  S  +N +S     +  +     +   + G       S+     +  
Sbjct: 3   IMLPINNNFSLSQNSF-YNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60

Query: 146 LEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNL 205
                L+    +   P  +    Q+  L I  N      +PE   +L+ L         L
Sbjct: 61  FSELQLNRLNLS-SLPDNL--PPQITVLEITQNALIS--LPELPASLEYLD---ACDNRL 112

Query: 206 RGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLT 265
              +PE  + L+    LD+  N+++   P     L+ +       N LT  LP    +L 
Sbjct: 113 S-TLPELPASLKH---LDVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPELPTSLE 163

Query: 266 LLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKL----FAFSIY 321
           +L    + +NQ+   LPE   +L+ L V      N     P+              F   
Sbjct: 164 VL---SVRNNQL-TFLPELPESLEALDV----STNLLESLPAVPVRNHHSEETEIFFRCR 215

Query: 322 GNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSY 381
            NR +   PEN+        + + +N  S S  +    ++           +        
Sbjct: 216 ENRITH-IPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

Query: 382 ADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQ 441
                     ++           +  + +    +   N F+  +  L   + S       
Sbjct: 274 NTLHRPLADAVTAW-FPENKQSDVSQIWHAFEHEEHANTFSAFLDRL-SDTVSARNTSGF 331

Query: 442 NNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501
             +    + + L +L+    L   +   +     +      L+  +L +  L       +
Sbjct: 332 REQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGL 387

Query: 502 GDCARIVDLNLAR 514
            D      L+L R
Sbjct: 388 FDNDTGALLSLGR 400

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  112 bits (282), Expect = 5e-26
 Identities = 56/347 (16%), Positives = 112/347 (32%), Gaps = 53/347 (15%)

Query: 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC---RNKISGEFPRSIRKLQ 241
           I   I N  +L+     +  + G   +  S   +     +    RN+        +  + 
Sbjct: 3   IMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59

Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
           +  +++L   NL+  LP  L     +   +I+ N +   LPE   +L+ L       +N 
Sbjct: 60  QFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLEYLDA----CDNR 111

Query: 302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
               P     ++ L    +  N+ +   PE       L  ++   NQ +   P+      
Sbjct: 112 LSTLPELPASLKHL---DVDNNQLTM-LPELPAL---LEYINADNNQLT-MLPELPTS-- 161

Query: 362 KLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDF 421
             L +L++ NN    +P      ++++ L +S N L   +P       +           
Sbjct: 162 --LEVLSVRNNQLTFLPEL---PESLEALDVSTNLLES-LPAVPVRNHH----------- 204

Query: 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALR 481
                       +      + NR +  +P  +  L     +IL +N  S +I  +L    
Sbjct: 205 ---------SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254

Query: 482 QLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL 528
                H      + S   +      + D          N    +S +
Sbjct: 255 AQPDYHGPRIYFSMSDGQQNTLHRPLAD--AVTAWFPENKQSDVSQI 299

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 98.9 bits (246), Expect = 1e-21
 Identities = 56/286 (19%), Positives = 101/286 (35%), Gaps = 33/286 (11%)

Query: 285 IGNLKNLTV--FQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDV 342
           I N  +L+   F    +    ++ S +    K        N       E L      +++
Sbjct: 7   INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSEL 64

Query: 343 DISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP 402
            ++    S S P  L      + +L ++ N    +P   A    ++ L   DN LS  +P
Sbjct: 65  QLNRLNLS-SLPDNLP---PQITVLEITQNALISLPELPAS---LEYLDACDNRLS-TLP 116

Query: 403 DGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERL 462
           +   +L +   LD  +N  T  +  L      L  +   NN+ +  LP      T+LE L
Sbjct: 117 ELPASLKH---LDVDNNQLTM-LPELPA---LLEYINADNNQLT-MLPELP---TSLEVL 165

Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR----IVDLNLARNSLS 518
            + NN  +  +P    +L  L    +  N L  S+P             +      N ++
Sbjct: 166 SVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT 220

Query: 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQL 564
            +IP ++  L     + L  N L+  I ++L +             
Sbjct: 221 -HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 97.3 bits (242), Expect = 4e-21
 Identities = 57/345 (16%), Positives = 97/345 (28%), Gaps = 72/345 (20%)

Query: 227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG 286
           +    ++  +  K +K        N     L   L  +    E  ++   +   LP+ + 
Sbjct: 23  SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNL-SSLPDNLP 79

Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
               +TV +  +N      P     +  L       NR S   PE       L  +D+  
Sbjct: 80  --PQITVLEITQNALI-SLPELPASLEYL---DACDNRLST-LPELPAS---LKHLDVDN 129

Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
           NQ +   P+       LL  +   NN    +P       +++ L + +N L+  +P+   
Sbjct: 130 NQLT-MLPELPA----LLEYINADNNQLTMLPEL---PTSLEVLSVRNNQLT-FLPELP- 179

Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
                                      SL  L +  N     LP+   R  + E      
Sbjct: 180 --------------------------ESLEALDVSTNLLE-SLPAVPVRNHHSEET---- 208

Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526
                                  EN +T  IP  +        + L  N LS  I  SLS
Sbjct: 209 ----------------EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251

Query: 527 LLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLD 571
             ++    +      + S       L     D        +   D
Sbjct: 252 QQTAQPDYHGPRIYFSMSDG-QQNTLHRPLADAVTAWFPENKQSD 295

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  110 bits (276), Expect = 4e-26
 Identities = 51/167 (30%), Positives = 71/167 (42%), Gaps = 17/167 (10%)

Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKGDGVKV---FAAE 721
           I   +  +   E    IG G  G VY   L  N G     AVK L +   +     F  E
Sbjct: 84  IGPSSLIVHFNEV---IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140

Query: 722 MEILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
             I+    H N+L L   CL   GS  +VL YM +G+L   +                  
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIG 196

Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             L  AKG+ +L    S   +HRD+ + N +LDE +  K+ADFG+A+
Sbjct: 197 FGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (273), Expect = 4e-26
 Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 17/188 (9%)

Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEME 723
               +   + NL E   +GSG  G+V+++  +K    +AVKQ+      +  K    +++
Sbjct: 19  RYQAEINDLENLGE---MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75

Query: 724 ILGK-IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
           ++ K      I++ +   +     F+ +E M  G   + L KR++   PE       K+ 
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPE-RILG--KMT 130

Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
           +   K + YL       +IHRD+K SNILLDE  + K+ DFG++    +          A
Sbjct: 131 VAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSA 185

Query: 843 GTHGYIAP 850
           G   Y+AP
Sbjct: 186 GCAAYMAP 193

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  108 bits (273), Expect = 5e-26
 Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 16/170 (9%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEME 723
           I+A +I   +    IGSG +G+V    L+        VA+K L  G      + F +E  
Sbjct: 46  IEASRIHIEKI---IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102

Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           I+G+  H NI++L   + +G  + +V EYM NG+L   L    +    +    +   +  
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLR 158

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
           G   G+ YL        +HRD+ + N+L+D +   K++DFG++++ E+ P
Sbjct: 159 GVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  108 bits (271), Expect = 5e-26
 Identities = 43/201 (21%), Positives = 80/201 (39%), Gaps = 38/201 (18%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
           E    +G GG G V+    K +    A+K++   +          E++ L K+ H  I++
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 67

Query: 736 LYACLLKGGSS------------FLVLEYMPNGNLFQALHKRVKEGKPE----LDWFRRY 779
            +   L+  ++            ++ ++     NL   ++ R    + E    L  F   
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL-- 125

Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS------- 832
           +IA      + +LH   S  ++HRD+K SNI    D   K+ DFG+    +         
Sbjct: 126 QIAEA----VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 833 ---PKVSDYSCFAGTHGYIAP 850
              P  + ++   GT  Y++P
Sbjct: 179 TPMPAYARHTGQVGTKLYMSP 199

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  108 bits (273), Expect = 5e-26
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 17/169 (10%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGDGVKV---FAAEM 722
           I    +   +    IG+G  G+VY+  LK ++G     VA+K L  G   K    F  E 
Sbjct: 41  IHPSCVTRQKV---IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97

Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            I+G+  H NI++L   + K     ++ EYM NG L + L    +E   E    +   + 
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGML 153

Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
            G A G+ YL    +   +HRD+ + NIL++ +   K++DFG++++ E+
Sbjct: 154 RGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  108 bits (273), Expect = 6e-26
 Identities = 38/164 (23%), Positives = 71/164 (43%), Gaps = 19/164 (11%)

Query: 677 NLEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIR 729
             ++  ++GSG  G VY+     + +K    VA+K+L +    K       E  ++  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           + ++ +L    L   +  L+ + MP G L   + +     K  +         +  AKG+
Sbjct: 76  NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGM 130

Query: 790 AYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
            YL         ++HRD+ + N+L+      KI DFG+AK+   
Sbjct: 131 NYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  108 bits (272), Expect = 6e-26
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 19/200 (9%)

Query: 662 LASFHHIDIDAEQICNLEEDNL-----IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGD 713
           + S   + I  EQ  +   ++L     IG G  G V ++  K +   +AVK++       
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62

Query: 714 GVKVFAAEMEILGK-IRHRNILKLYACLLKGGSSFLVLEYMPNG--NLFQALHKRVKEGK 770
             K    +++++ +      I++ Y  L + G  ++ +E M       ++ ++  + +  
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVI 122

Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
           PE +     KI L   K + +L  +    IIHRDIK SNILLD     K+ DFG++    
Sbjct: 123 PE-EILG--KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177

Query: 831 NSPKVSDYSCFAGTHGYIAP 850
           +S      +  AG   Y+AP
Sbjct: 178 DS---IAKTRDAGCRPYMAP 194

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  108 bits (271), Expect = 8e-26
 Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 20/172 (11%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG----DGVKVFAAEM 722
           I  +Q         +G G  G V    LK+  G    VAVK L         ++ F  E 
Sbjct: 20  IPEQQFTLGRM---LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76

Query: 723 EILGKIRHRNILKLYACLLKGGSS------FLVLEYMPNGNLFQAL-HKRVKEGKPELDW 775
             + +  H ++ KL    L+  +        ++L +M +G+L   L   R+ E    L  
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136

Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
               +  +  A G+ YL    S   IHRD+ + N +L ED    +ADFG+++
Sbjct: 137 QTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  108 bits (272), Expect = 8e-26
 Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 23/177 (12%)

Query: 682 NLIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVFAA---EMEILGKIRHRNILKLY 737
             +G G  G+V+R  D K+     AVK+      V++      E+     +    I+ LY
Sbjct: 64  PRVGRGSFGEVHRMKD-KQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLY 116

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
             + +G    + +E +  G+L Q + +     +    ++     AL   +G+ YLH    
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ--AL---EGLEYLHTRR- 170

Query: 798 PPIIHRDIKSSNILLDED-YEPKIADFGVAK-IAENSPKVSDYSC--FAGTHGYIAP 850
             I+H D+K+ N+LL  D     + DFG A  +  +    S  +     GT  ++AP
Sbjct: 171 --ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (269), Expect = 1e-25
 Identities = 54/196 (27%), Positives = 87/196 (44%), Gaps = 22/196 (11%)

Query: 661 KLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKV 717
            L    ++  D E++    E   IG G  G+V++    +    VA+K +      D ++ 
Sbjct: 9   GLPGMQNLKADPEELFTKLE--KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED 66

Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR 777
              E+ +L +     + K Y   LK    ++++EY+  G+    L               
Sbjct: 67  IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---------LD 117

Query: 778 RYKIAL---GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
             +IA       KG+ YLH   S   IHRDIK++N+LL E  E K+ADFGVA   + +  
Sbjct: 118 ETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDT 172

Query: 835 VSDYSCFAGTHGYIAP 850
               + F GT  ++AP
Sbjct: 173 QIKRNTFVGTPFWMAP 188

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  106 bits (268), Expect = 1e-25
 Identities = 39/178 (21%), Positives = 72/178 (40%), Gaps = 29/178 (16%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
           I    +  +EE   +G    GKVY+         +    VA+K L       +   F  E
Sbjct: 6   ISLSAVRFMEE---LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----------VKEGK 770
             +  +++H N++ L   + K     ++  Y  +G+L + L  R            +  K
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 771 PELDWFRRYKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             L+      +    A G+ YL  HH     ++H+D+ + N+L+ +    KI+D G+ 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLF 175

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  109 bits (273), Expect = 1e-25
 Identities = 39/176 (22%), Positives = 75/176 (42%), Gaps = 19/176 (10%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRH--RNILK 735
             IGSGG+ KV+++ L +     A+K +   +     +  +  E+  L K++     I++
Sbjct: 62  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-H 794
           LY   +     ++V+E   N +L   L K+      +    + Y   +   + +  +H H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNM--LEAVHTIHQH 174

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                I+H D+K +N L+ +    K+ DFG+A   +            G   Y+ P
Sbjct: 175 G----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  107 bits (270), Expect = 1e-25
 Identities = 37/171 (21%), Positives = 75/171 (43%), Gaps = 19/171 (11%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
           +  E+I    E   +G G  G VY      +   +    VA+K + +   ++    F  E
Sbjct: 22  VAREKITMSRE---LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDWF 776
             ++ +    ++++L   + +G  + +++E M  G+L   L                   
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 777 RRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +  ++A   A G+AYL+   +   +HRD+ + N ++ ED+  KI DFG+ +
Sbjct: 139 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  106 bits (267), Expect = 1e-25
 Identities = 46/164 (28%), Positives = 88/164 (53%), Gaps = 12/164 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           +  E +  +E    +G+G  G+V+      +   VAVK L +G      F AE  ++ ++
Sbjct: 10  VPRETLKLVER---LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQL 65

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
           +H+ +++LYA + +    +++ EYM NG+L   L         +L   +   +A   A+G
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEG 121

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           +A++        IHRD++++NIL+ +    KIADFG+A++ E++
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  108 bits (271), Expect = 2e-25
 Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEME 723
           +DA  I   +    +G+G  G+V    LK   K   +VA+K L  G   K    F  E  
Sbjct: 42  LDATNISIDKV---VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98

Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
           I+G+  H NI++L   + K     +V EYM NG+L   L K       +    +   +  
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLR 154

Query: 784 GAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
           G A G+ YL          +HRD+ + NIL++ +   K++DFG+ ++ E+ P
Sbjct: 155 GIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  106 bits (267), Expect = 2e-25
 Identities = 52/178 (29%), Positives = 76/178 (42%), Gaps = 30/178 (16%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
           I    I    E   +G G  GKV+      L   K+   VAVK L K   +     F  E
Sbjct: 12  IKRRDIVLKRE---LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQRE 67

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----------VKEGK 770
            E+L  ++H +I+K Y     G    +V EYM +G+L + L               ++ K
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 771 PELDWFRRYKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
            EL   +   IA   A G+ YL   H      +HRD+ + N L+  +   KI DFG++
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMS 180

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  110 bits (275), Expect = 5e-25
 Identities = 49/183 (26%), Positives = 77/183 (42%), Gaps = 22/183 (12%)

Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLY 737
              +G+GG G V R   +     VA+KQ  +       + +  E++I+ K+ H N++   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 738 AC------LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIA 790
                   L       L +EY   G+L + L++        E    R     + +A  + 
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-IRTLLSDISSA--LR 135

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEP---KIADFGVAKIAENSPKVSDYSCFAGTHGY 847
           YLH      IIHRD+K  NI+L    +    KI D G AK  +     ++   F GT  Y
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTLQY 189

Query: 848 IAP 850
           +AP
Sbjct: 190 LAP 192

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  108 bits (271), Expect = 5e-25
 Identities = 73/416 (17%), Positives = 132/416 (31%), Gaps = 46/416 (11%)

Query: 136 SVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNL 195
            VP+L A  ++   DLS+N            L  L  L +            +   L +L
Sbjct: 24  QVPELPA--HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 196 TYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEF--PRSIRKLQKLWKIELYANN 252
             L L +     ++     + L  L  L + +  + G        + L  L  + L  NN
Sbjct: 82  IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140

Query: 253 LTGELPAEL-GNLTLLQEFDISSNQMYGKLPEEI---GNLKNLTVFQCFKNNFSGEFPSG 308
           +    PA    N+      D++ N++   + EE       K+ T+ +             
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITLQ------ 193

Query: 309 FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLA 368
                      +           N  + T++T +D+S N F  S  K        +    
Sbjct: 194 ----------DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF---DAIAGTK 240

Query: 369 LSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPL 428
           + +       N  +           +    G    G+         D   +     +   
Sbjct: 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK------TCDLSKSKIFA-LLKS 293

Query: 429 I--GLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSS 485
           +     T L QL L  N  + ++       LT+L +L L+ N            L +L  
Sbjct: 294 VFSHF-TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV 351

Query: 486 LHLEENALTGSIPNEMGD-CARIVDLNLARNSLSGNIPRS-LSLLSSLNALNLSGN 539
           L L  N +  ++ ++       + +L L  N L  ++P      L+SL  + L  N
Sbjct: 352 LDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 98.3 bits (245), Expect = 1e-21
 Identities = 74/412 (17%), Positives = 120/412 (29%), Gaps = 55/412 (13%)

Query: 98  SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSINY 155
            +  + L  N ++       S   +L+ L V        + +     L +L I  L  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPESI- 213
           F          L  L  L++     D A +  +    L +L  L L   N++   P S  
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELY----------ANNLTGELPAELGN 263
             +R    LD+  NK+       +   Q      L              L  E       
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 264 LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323
            T +   D+S N     + +   +    T  Q    + S    S FG             
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG-----------HT 259

Query: 324 RFSGPFPENLGR--YTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP-NS 380
            F  P          + +   D+S+++   +  K +      L  L L+ N   ++  N+
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318

Query: 381 YADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVL 440
           +     + +L +S N L   I   +               F             L  L L
Sbjct: 319 FWGLTHLLKLNLSQNFLG-SIDSRM---------------FEN--------LDKLEVLDL 354

Query: 441 QNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491
             N     L  +    L NL+ L L  N            L  L  + L  N
Sbjct: 355 SYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 31/155 (20%), Positives = 54/155 (34%), Gaps = 11/155 (7%)

Query: 431 LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLE 489
           L   ++ + L  N  +    +   RL +L+ L +        I +     L  L  L L+
Sbjct: 28  LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87

Query: 490 ENALTGSIPNEM-GDCARIVDLNLARNSL-SGNIPR-SLSLLSSLNALNLSGNKLT---- 542
            N     +        A +  L L + +L    +       L+SL  L L  N +     
Sbjct: 88  YNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146

Query: 543 GSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGG 577
            S   N+ +     +DL+ N++      D L   G
Sbjct: 147 ASFFLNMRRFH--VLDLTFNKVKSICEEDLLNFQG 179

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  105 bits (265), Expect = 6e-25
 Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 23/173 (13%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
           +  + I  +     +G G  G+VY      +    +   VAVK L +    +    F  E
Sbjct: 27  VPRKNITLIRG---LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 83

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRY 779
             I+ K  H+NI++     L+    F+++E M  G+L   L   +        L      
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143

Query: 780 KIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
            +A   A G  YL  +H      IHRDI + N LL         KI DFG+A+
Sbjct: 144 HVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  105 bits (265), Expect = 6e-25
 Identities = 38/169 (22%), Positives = 72/169 (42%), Gaps = 18/169 (10%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEM 722
               ++  L+    +GSG  G V++     + +     V +K +    G +        M
Sbjct: 10  FKETELRKLKV---LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 66

Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
             +G + H +I++L        S  LV +Y+P G+L   + +     +  L         
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQH----RGALGPQLLLNWG 121

Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
           +  AKG+ YL       ++HR++ + N+LL    + ++ADFGVA +   
Sbjct: 122 VQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  105 bits (264), Expect = 8e-25
 Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 27/176 (15%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG--DGVKVFAAEM 722
           I    I    E   +G G  GKV+      L  +++   VAVK L +      + F  E 
Sbjct: 38  IKRRDIVLKWE---LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94

Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR----------VKEGKPE 772
           E+L  ++H++I++ +    +G    +V EYM +G+L + L                    
Sbjct: 95  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154

Query: 773 LDWFRRYKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
           L   +   +A   A G+ YL   H      +HRD+ + N L+ +    KI DFG++
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMS 205

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (265), Expect = 8e-25
 Identities = 57/177 (32%), Positives = 88/177 (49%), Gaps = 29/177 (16%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL-----WKGDGVKVFAAEMEILGKIRHRNILKLYA 738
           IG G  G VY     +N+  VA+K++        +  +    E+  L K+RH N ++   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 739 CLLKGGSSFLVLEYMPNG--NLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLH 793
           C L+  +++LV+EY      +L +   K ++E +          IA    GA +G+AYLH
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE----------IAAVTHGALQGLAYLH 171

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  +IHRD+K+ NILL E    K+ DFG A  +  +P  S    F GT  ++AP
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA--SIMAPANS----FVGTPYWMAP 219

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  105 bits (263), Expect = 1e-24
 Identities = 38/162 (23%), Positives = 71/162 (43%), Gaps = 15/162 (9%)

Query: 677 NLEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIR 729
             ++  ++GSG  G VY+     + +K    VA+K+L +    K       E  ++  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           + ++ +L    L   +  L+ + MP G L   + +     K  +         +  AKG+
Sbjct: 76  NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGM 130

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
            YL       ++HRD+ + N+L+      KI DFG+AK+   
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  104 bits (262), Expect = 1e-24
 Identities = 55/178 (30%), Positives = 84/178 (47%), Gaps = 22/178 (12%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKI-RHRNILKLYACLL 741
           +G+G  G+VY+    K     A+K +   GD  +    E+ +L K   HRNI   Y   +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91

Query: 742 KGGSSF------LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYL 792
           K           LV+E+   G++   L K  K    + +W     IA       +G+++L
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEW-----IAYICREILRGLSHL 145

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      +IHRDIK  N+LL E+ E K+ DFGV+  A+    V   + F GT  ++AP
Sbjct: 146 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAP 198

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (265), Expect = 1e-24
 Identities = 34/181 (18%), Positives = 64/181 (35%), Gaps = 23/181 (12%)

Query: 684 IGSG--GTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLY 737
           IG G      V     K     V V+++       + V     E+ +     H NI+   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLHH 794
           A  +     ++V  +M  G+    +     +G  EL       IA    G  K + Y+HH
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL------AIAYILQGVLKALDYIHH 146

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGV-AKIAENSPK----VSDYSCFAGTHGYIA 849
                 +HR +K+S+IL+  D +  ++       +  +  +                +++
Sbjct: 147 M---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 850 P 850
           P
Sbjct: 204 P 204

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  107 bits (268), Expect = 1e-24
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 12/164 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           I  E +   ++   +G+G  G+V+     K+   VAVK +  G   V+ F AE  ++  +
Sbjct: 185 IPRESLKLEKK---LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVEAFLAEANVMKTL 240

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
           +H  ++KL+A + K    +++ E+M  G+L   L         +    +    +   A+G
Sbjct: 241 QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEG 296

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           +A++        IHRD++++NIL+      KIADFG+A++ E++
Sbjct: 297 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  104 bits (262), Expect = 2e-24
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 21/168 (12%)

Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
           NL+    +G+G  GKV       L  +     VAVK L      D  +   +E++I+  +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106

Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR---------VKEGKPELDWFRR 778
            +H NI+ L      GG   ++ EY   G+L   L ++                      
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 779 YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
              +   A+G+A+L    S   IHRD+ + N+LL   +  KI DFG+A
Sbjct: 167 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  104 bits (262), Expect = 2e-24
 Identities = 47/173 (27%), Positives = 70/173 (40%), Gaps = 23/173 (13%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
           +  + I  +     +G G  G+VY      +    +   VAVK L +    +    F  E
Sbjct: 68  VPRKNITLIRG---LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 124

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRY 779
             I+ K  H+NI++     L+    F++LE M  G+L   L   +        L      
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184

Query: 780 KIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK 827
            +A   A G  YL  +H      IHRDI + N LL         KI DFG+A+
Sbjct: 185 HVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  102 bits (257), Expect = 3e-24
 Identities = 35/182 (19%), Positives = 76/182 (41%), Gaps = 31/182 (17%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-------LDLKKNAGTVAVKQLWKG--DGVKVFAA 720
           I  E +   E    +G G   K+++          + +   V +K L K   +  + F  
Sbjct: 5   IRNEDLIFNES---LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61

Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
              ++ K+ H++++  Y   + G  + LV E++  G+L   L    K+ K  ++   + +
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLE 117

Query: 781 IALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEP--------KIADFGVAKIAE 830
           +A   A  + +L  +      +IH ++ + NILL  + +         K++D G++    
Sbjct: 118 VAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172

Query: 831 NS 832
             
Sbjct: 173 PK 174

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  102 bits (257), Expect = 4e-24
 Identities = 47/172 (27%), Positives = 69/172 (40%), Gaps = 25/172 (14%)

Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKI 728
            L     +G+G  GKV       L     A TVAVK L     +       +E+++L  +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK------- 780
             H NI+ L      GG + ++ EY   G+L   L ++              +       
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 781 ------IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
                  +   AKG+A+L    S   IHRD+ + NILL      KI DFG+A
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 192

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  102 bits (256), Expect = 5e-24
 Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 25/176 (14%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG-----DGVKVFAAE 721
           I  + +  LE+   +G G  G V R +    +G    VAVK L        + +  F  E
Sbjct: 15  IGEKDLRLLEK---LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71

Query: 722 MEILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           +  +  + HRN+++LY   L       +V E  P G+L      R+++ +         +
Sbjct: 72  VNAMHSLDHRNLIRLYGVVL--TPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSR 125

Query: 781 IALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
            A+  A+G+ YL          IHRD+ + N+LL      KI DFG+ +    +  
Sbjct: 126 YAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  103 bits (258), Expect = 5e-24
 Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 25/173 (14%)

Query: 677 NLEEDNLIGSGGTGKVYR-------LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILG 726
            L     +G G  G+V          D  K A TVAVK L        +    +EME++ 
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95

Query: 727 KI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL-----------FQALHKRVKEGKPELD 774
            I +H+NI+ L     + G  ++++EY   GNL            +  +   +  + ++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +          A+G+ YL    S   IHRD+ + N+L+ E+   KIADFG+A+
Sbjct: 156 FKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  102 bits (256), Expect = 6e-24
 Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 30/178 (16%)

Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAG--TVAVKQLWKG---DGVKVFAAEMEILGKI 728
           NL     +G G  GKV +     LK  AG  TVAVK L +      ++   +E  +L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--------- 779
            H +++KLY    + G   L++EY   G+L   L +  K G   L               
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 780 ----------KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                       A   ++G+ YL       ++HRD+ + NIL+ E  + KI+DFG+++
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (262), Expect = 7e-24
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 12/164 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           I  E +    +   +G G  G+V+          VA+K L  G    + F  E +++ K+
Sbjct: 181 IPRESLRLEVK---LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL 236

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
           RH  +++LYA + +    ++V EYM  G+L   L          L   +   +A   A G
Sbjct: 237 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASG 292

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           +AY+        +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 293 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  103 bits (258), Expect = 7e-24
 Identities = 39/190 (20%), Positives = 63/190 (33%), Gaps = 21/190 (11%)

Query: 679 EEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHR 731
              +L+G G   +VY      L+  KN     +K     +     +    ME L      
Sbjct: 68  YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQH 127

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
             +K Y+  L    S LV E    G L  A++      +  +        A+     I  
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEP-----------KIADFGVAKIAENSPKVSDYSC 840
           +H      IIH DIK  N +L   +              + D G +   +  PK + ++ 
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 841 FAGTHGYIAP 850
              T G+   
Sbjct: 245 KCETSGFQCV 254

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  101 bits (253), Expect = 9e-24
 Identities = 40/171 (23%), Positives = 68/171 (39%), Gaps = 21/171 (12%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR--LDLKKNAGT-VAVKQLWKG---DGVKVFAAEME 723
           I  E+I        IG G  G V++      +N    VA+K           + F  E  
Sbjct: 12  IQRERIELGRC---IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68

Query: 724 ILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
            + +  H +I+KL           ++++E    G L       ++  K  LD       A
Sbjct: 69  TMRQFDHPHIVKLIGVIT--ENPVWIIMELCTLGEL----RSFLQVRKYSLDLASLILYA 122

Query: 783 LGAAKGIAYL-HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
              +  +AYL         +HRDI + N+L+  +   K+ DFG+++  E+S
Sbjct: 123 YQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  101 bits (253), Expect = 9e-24
 Identities = 45/172 (26%), Positives = 71/172 (41%), Gaps = 23/172 (13%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG---DGVKVFAAEME 723
           I  E +        +G G  G+VY      + G    VAVK   K    D  + F +E  
Sbjct: 9   IAREDVVLNRI---LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65

Query: 724 ILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
           I+  + H +I+KL          +++++E  P G L   L    +  K  L        +
Sbjct: 66  IMKNLDHPHIVKLIGIIE--EEPTWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYS 119

Query: 783 LGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           L   K +AYL   +      +HRDI   NIL+      K+ DFG+++  E+ 
Sbjct: 120 LQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  106 bits (265), Expect = 9e-24
 Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 26/177 (14%)

Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQL-WKGD--GVKVFAAEMEILGKIRHRNILKLY- 737
            I  GG G +Y  LD   N   V +K L   GD     +  AE + L ++ H +I++++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 738 ----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                        ++V+EY+   +L ++  ++       L         L     ++YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYLH 199

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  +++ D+K  NI+L E+ + K+ D G         +++ +    GT G+ AP
Sbjct: 200 ---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAP 246

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  105 bits (264), Expect = 9e-24
 Identities = 87/530 (16%), Positives = 170/530 (32%), Gaps = 72/530 (13%)

Query: 65  GITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLK 124
           G          + + + N++L+  +   +        LSL  N +S     ++S  S L+
Sbjct: 23  GSMTPFSNELESMVDYSNRNLT-HVPKDLPP--RTKALSLSQNSISELRMPDISFLSELR 79

Query: 125 VLNVTGNAMVGSVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
           VL ++ N  + S+        ++LE  D+S N            +  L  L +  N +D 
Sbjct: 80  VLRLSHN-RIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCP---MASLRHLDLSFNDFDV 135

Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELG-TLDICRNKISGEFPRSIRKLQ 241
             + +  GNL  LT+L L+    R      ++ L      LD+    I G    S++   
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195

Query: 242 KLWKIELYANNLTGELPAELGNLTL----LQEFDISSNQMYGKLPEEIGNLKNLTVFQCF 297
                 ++  N    +   +    L    L    ++       +       +  T+    
Sbjct: 196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255

Query: 298 KNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYL 357
             +    +       +  +                      +  ++I     +    +  
Sbjct: 256 LQHIETTWKCSVKLFQFFW-------------------PRPVEYLNIYNLTITERIDREE 296

Query: 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417
               +                      K++    + +                + +    
Sbjct: 297 FTYSETAL-------------------KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337

Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL 477
            +D            +S + L    N F+  +      L  L+ LIL  N          
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVA 396

Query: 478 GALRQLSSLHLEENALTGSIPNEMGDC-----ARIVDLNLARNSLSGNIPRSLSLLSSLN 532
              + +SSL   + +L  S+ +   D        I+ LNL+ N L+G++ R L     + 
Sbjct: 397 LMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVK 453

Query: 533 ALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRMGGDGAF 581
            L+L  N++  SIP ++  L  L  ++++ NQL  SVP        DG F
Sbjct: 454 VLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP--------DGVF 493

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 74.9 bits (184), Expect = 5e-14
 Identities = 61/403 (15%), Positives = 130/403 (32%), Gaps = 34/403 (8%)

Query: 92  SISALQSLTVLSLPFNVL-SGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
           S   + SL  L L FN      +  E  N + L  L ++         DL  + +L +  
Sbjct: 116 SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--DLLPVAHLHLSC 173

Query: 151 LSINYFT-----GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL----A 201
           + ++  +     G      +  T ++ L    N     ++  S+  L +L    +     
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233

Query: 202 HCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIE---LYANNLTG--- 255
           +C         ++    L  + +   + + +    + +      +E   +Y   +T    
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293

Query: 256 --ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
             E       L  L    + +                + +     ++             
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353

Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF 373
                +   N F+    +       L  + +  N    +F K     + + +L  L  + 
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL 412

Query: 374 ----SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT---GGIS 426
               S     + A  ++I  L +S N L+G +   L   P V +LD  +N        ++
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMSIPKDVT 470

Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNF 469
            L     +L +L + +N+          RLT+L+ + L +N +
Sbjct: 471 HL----QALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  101 bits (253), Expect = 1e-23
 Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 23/171 (13%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR--LDLKKNAGTVAVKQLWKG----DGVKVFAAEME 723
           +D + +    ED  +GSG  G V +    +KK   TVAVK L              AE  
Sbjct: 13  LDRKLL--TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 70

Query: 724 ILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
           ++ ++ +  I+++   C     S  LV+E    G L + L +        +      ++ 
Sbjct: 71  VMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELV 123

Query: 783 LGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
              + G+ YL   +      +HRD+ + N+LL   +  KI+DFG++K    
Sbjct: 124 HQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  102 bits (255), Expect = 2e-23
 Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 25/173 (14%)

Query: 677 NLEEDNLIGSGGTGKVYR-------LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILG 726
            L     +G G  G+V          D  K A TVAVK L        +    +EME++ 
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141

Query: 727 KI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL-----------FQALHKRVKEGKPELD 774
            I +H+NI+ L     + G  ++++EY   GNL            +  +   +  + ++ 
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
           +          A+G+ YL    S   IHRD+ + N+L+ E+   KIADFG+A+
Sbjct: 202 FKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =   99 bits (250), Expect = 2e-23
 Identities = 54/177 (30%), Positives = 77/177 (43%), Gaps = 23/177 (12%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAA---EMEILGKIRHRNILKL 736
            +G G  G+V    L  N  T   VAVK +     V        E+ I   + H N++K 
Sbjct: 14  TLGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY---KIALGAAKGIAYLH 793
           Y    +G   +L LEY   G LF    +   +        +R+    +A     G+ YLH
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMA-----GVVYLH 122

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                 I HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  104 bits (260), Expect = 2e-23
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 12/164 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           I  E +    +   +G G  G+V+          VA+K L  G    + F  E +++ K+
Sbjct: 264 IPRESLRLEVK---LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL 319

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
           RH  +++LYA + +    ++V EYM  G+L   L          L   +   +A   A G
Sbjct: 320 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASG 375

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
           +AY+        +HRD++++NIL+ E+   K+ADFG+A++ E++
Sbjct: 376 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  100 bits (251), Expect = 2e-23
 Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 19/153 (12%)

Query: 684 IGSGGTGKVYRLDLKKNAGT--VAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYA 738
           +G G  G V +   +       VA+K L +G           E +I+ ++ +  I++L  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 739 -CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL--HHD 795
            C     +  LV+E    G L    HK +   + E+      ++    + G+ YL   + 
Sbjct: 78  VCQ--AEALMLVMEMAGGGPL----HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN- 130

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
                +HRD+ + N+LL   +  KI+DFG++K 
Sbjct: 131 ----FVHRDLAARNVLLVNRHYAKISDFGLSKA 159

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  100 bits (252), Expect = 2e-23
 Identities = 53/172 (30%), Positives = 78/172 (45%), Gaps = 24/172 (13%)

Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
            L+    +G G  G+V       +D      TVAVK L +G      +   +E++IL  I
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87

Query: 729 -RHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYK----- 780
             H N++ L  AC   GG   +++E+   GNL   L  KR +    ++     YK     
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 781 -----IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                 +   AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+
Sbjct: 148 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  101 bits (254), Expect = 2e-23
 Identities = 47/180 (26%), Positives = 70/180 (38%), Gaps = 34/180 (18%)

Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAG--TVAVKQLWKGDGVKV---FAAEMEILGKI 728
           N+E    IG G  G+V++     L        VAVK L +     +   F  E  ++ + 
Sbjct: 48  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--------- 779
            + NI+KL      G    L+ EYM  G+L + L          L               
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 780 ----------KIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                      IA   A G+AYL          +HRD+ + N L+ E+   KIADFG+++
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSR 222

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  100 bits (251), Expect = 5e-23
 Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 30/177 (16%)

Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
           NLE   ++GSG  GKV       +     +  VAVK L +       +   +E++++ ++
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105

Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRY------- 779
             H NI+ L       G  +L+ EY   G+L   L  KR K  + E+++  +        
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 780 ----------KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
                       A   AKG+ +L        +HRD+ + N+L+      KI DFG+A
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  100 bits (250), Expect = 5e-23
 Identities = 54/177 (30%), Positives = 77/177 (43%), Gaps = 23/177 (12%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAA---EMEILGKIRHRNILKL 736
            +G G  G+V    L  N  T   VAVK +     V        E+ I   + H N++K 
Sbjct: 14  TLGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY---KIALGAAKGIAYLH 793
           Y    +G   +L LEY   G LF    +   +        +R+    +A     G+ YLH
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMA-----GVVYLH 122

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                 I HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.8 bits (247), Expect = 5e-23
 Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 17/175 (9%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACL 740
           +GSG  G V+ ++ + +     +K + K      ++   AE+E+L  + H NI+K++   
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKP--ELDWFRRYKIALGAAKGIAYLHHDCSP 798
               + ++V+E    G L + +      GK   E       K  + A   +AY H   S 
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFH---SQ 143

Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            ++H+D+K  NIL          KI DFG+A++ ++    ++    AGT  Y+AP
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYMAP 195

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 98.5 bits (246), Expect = 9e-23
 Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 20/175 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
           +G G  G+V +   +      AVK + K             E+E+L K+ H NI+KL+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSP 798
           L    S ++V E    G LF  +   +K  +  E D  R  K        I Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSG---ITYMH---KH 140

Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRD+K  NILL   ++D + KI DFG++   + + K+ D     GT  YIAP
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIAP 192

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  100 bits (250), Expect = 1e-22
 Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 25/178 (14%)

Query: 677 NLEEDNLIGSGGTGKVYR-------LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILG 726
            L     +G G  G+V          D       VAVK L        +    +EME++ 
Sbjct: 70  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129

Query: 727 KI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL-----------FQALHKRVKEGKPELD 774
            I +H+NI+ L     + G  ++++EY   GNL            +  +      + +L 
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
                  A   A+G+ YL    S   IHRD+ + N+L+ ED   KIADFG+A+   + 
Sbjct: 190 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 40/180 (22%), Positives = 70/180 (38%), Gaps = 22/180 (12%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHRNI 733
           +  + +G G  G+V+++  K++    AVK+               AE+    K+ +H   
Sbjct: 60  QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGIA 790
           ++L     +GG  +L  E     +L Q   +      PE     + R           +A
Sbjct: 120 VRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRD------TLLALA 171

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +LH   S  ++H D+K +NI L      K+ DFG+      +          G   Y+AP
Sbjct: 172 HLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAP 225

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (252), Expect = 1e-22
 Identities = 53/188 (28%), Positives = 75/188 (39%), Gaps = 41/188 (21%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
           +GSG  G+V     +K    VA++ + K           D       E+EIL K+ H  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK----- 787
           +K+          ++VLE M  G LF  +   V   +  E                    
Sbjct: 203 IKIKN-FFDAEDYYIVLELMEGGELFDKV---VGNKRLKEAT----------CKLYFYQM 248

Query: 788 --GIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
              + YLH      IIHRD+K  N+LL   +ED   KI DFG +KI   +  +       
Sbjct: 249 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LC 302

Query: 843 GTHGYIAP 850
           GT  Y+AP
Sbjct: 303 GTPTYLAP 310

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 99.7 bits (248), Expect = 1e-22
 Identities = 16/201 (7%), Positives = 38/201 (18%), Gaps = 42/201 (20%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
            +  G    V+ +   +     A+K            ++          ++   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 738 ACL--------------------------LKGGSSFLVLEYMP--NGNLFQALHKRVKEG 769
                                            +  L++         LF  L       
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
             E        +     +  A L       ++H      N+ +  D    + D       
Sbjct: 189 GDEGILALHI-LTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 830 ENSPKVSDYSCFAGTHGYIAP 850
                       +    Y   
Sbjct: 245 GTR-----GPASSVPVTYAPR 260

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  102 bits (256), Expect = 1e-22
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 19/170 (11%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWKGDGVKV---FAAEME 723
           I  E+I        IG G  G V++   +  +  A  VA+K         V   F  E  
Sbjct: 387 IQRERIELGRC---IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443

Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
            + +  H +I+KL   + +    ++++E    G L   L  R    K  LD       A 
Sbjct: 444 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR----KFSLDLASLILYAY 498

Query: 784 GAAKGIAYLH-HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
             +  +AYL         +HRDI + N+L+  +   K+ DFG+++  E+S
Sbjct: 499 QLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 51/173 (29%), Positives = 74/173 (42%), Gaps = 18/173 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLL 741
           IG G  G+V     K      A K++ K   + V  F  E+EI+  + H NI++LY    
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
                +LV+E    G LF+ +   V +    E D  R  K  L A   +AY H      +
Sbjct: 77  DNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSA---VAYCH---KLNV 127

Query: 801 IHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            HRD+K  N L      D   K+ DFG+A   +    +       GT  Y++P
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPYYVSP 177

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  101 bits (254), Expect = 2e-22
 Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 23/210 (10%)

Query: 648 DMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK 707
            +++       +WK      +  +        +  ++G GG G+V    ++      A K
Sbjct: 161 YLDSIYFNRFLQWKWLERQPVTKN-----TFRQYRVLGKGGFGEVCACQVRATGKMYACK 215

Query: 708 QLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL 762
           +L K       G  +   E +IL K+  R ++ L        +  LVL  M  G+L   +
Sbjct: 216 KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI 275

Query: 763 HKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820
           +   + G PE      Y  +I  G    +  LH      I++RD+K  NILLD+    +I
Sbjct: 276 YHMGQAGFPE-ARAVFYAAEICCG----LEDLH---RERIVYRDLKPENILLDDHGHIRI 327

Query: 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +D G+A         +      GT GY+AP
Sbjct: 328 SDLGLAV--HVPEGQTIKG-RVGTVGYMAP 354

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  100 bits (250), Expect = 2e-22
 Identities = 41/179 (22%), Positives = 74/179 (41%), Gaps = 17/179 (9%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLY 737
              +++G G  G +    +  N   VAVK++   +       E+++L +   H N+++ +
Sbjct: 27  CPKDVLGHGAEGTIVYRGMFDN-RDVAVKRILP-ECFSFADREVQLLRESDEHPNVIRYF 84

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    ++ +E      L + + ++       L+      +      G+A+LH   S
Sbjct: 85  CTEKDRQFQYIAIELCA-ATLQEYVEQK-DFAHLGLE---PITLLQQTTSGLAHLH---S 136

Query: 798 PPIIHRDIKSSNILLDEDYE-----PKIADFGVAKIAE-NSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K  NIL+            I+DFG+ K         S  S   GT G+IAP
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  100 bits (251), Expect = 3e-22
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 22/200 (11%)

Query: 659 KWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----D 713
           +WK      +  D        +  ++G GG G+V+   +K      A K+L K       
Sbjct: 173 QWKWLEAQPMGED-----WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227

Query: 714 GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK-EGKPE 772
           G +    E +IL K+  R I+ L           LV+  M  G++   ++   +     +
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287

Query: 773 LDWFRRY--KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
                 Y  +I  G    + +LH      II+RD+K  N+LLD+D   +I+D G+A   E
Sbjct: 288 EPRAIFYTAQIVSG----LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV--E 338

Query: 831 NSPKVSDYSCFAGTHGYIAP 850
                +    +AGT G++AP
Sbjct: 339 LKAGQTKTKGYAGTPGFMAP 358

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 54/188 (28%), Positives = 75/188 (39%), Gaps = 41/188 (21%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
           +GSG  G+V     +K    VA+K + K           D       E+EIL K+ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK----- 787
           +K+          ++VLE M  G LF  +   V   +  E                    
Sbjct: 78  IKIKN-FFDAEDYYIVLELMEGGELFDKV---VGNKRLKEAT----------CKLYFYQM 123

Query: 788 --GIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
              + YLH      IIHRD+K  N+LL   +ED   KI DFG +KI   +  +       
Sbjct: 124 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LC 177

Query: 843 GTHGYIAP 850
           GT  Y+AP
Sbjct: 178 GTPTYLAP 185

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 72/390 (18%), Positives = 130/390 (33%), Gaps = 116/390 (29%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
           ++P+ +    +   L L +  +          L+ L TL +  NKIS   P +   L KL
Sbjct: 45  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG 303
            ++ L  N L  ELP ++     LQE  +  N++  K+ + +                  
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSV------------------ 140

Query: 304 EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKL 363
                F  + ++    +  N               L    I    F G           +
Sbjct: 141 -----FNGLNQMIVVELGTNP--------------LKSSGIENGAFQG-----------M 170

Query: 364 LNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
             L                       +RI+D +++  IP GL                  
Sbjct: 171 KKL---------------------SYIRIADTNIT-TIPQGL----------P------- 191

Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQ 482
                     SL++L L  N+ + ++ +  L  L NL +L L+ N+ S     +L     
Sbjct: 192 ---------PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 241

Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRS-------LSLLSSLNALN 535
           L  LHL  N L   +P  + D   I  + L  N++S  I  +        +  +S + ++
Sbjct: 242 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVS 299

Query: 536 LSGNKLT-GSIPDNLMK--LKLSSIDLSEN 562
           L  N +    I  +  +     +++ L   
Sbjct: 300 LFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 71/312 (22%), Positives = 118/312 (37%), Gaps = 51/312 (16%)

Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
           +L V QC       + P     D   L    +  N+ +     +      L  + +  N+
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNK 87

Query: 349 FS----GSFPKYLCEKRKLLNL--LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP 402
            S    G+F         L+ L  L LS N   E+P      KT+Q LR+ +N ++ K+ 
Sbjct: 88  ISKISPGAF-------APLVKLERLYLSKNQLKELPEKMP--KTLQELRVHENEIT-KVR 137

Query: 403 DGLWA-LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLER 461
             ++  L  + +++ G N               L    ++N  F G        +  L  
Sbjct: 138 KSVFNGLNQMIVVELGTN--------------PLKSSGIENGAFQG--------MKKLSY 175

Query: 462 LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLSGN 520
           + + + N +  IP   G    L+ LHL+ N +T  +          +  L L+ NS+S  
Sbjct: 176 IRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAV 231

Query: 521 IPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGGDG 579
              SL+    L  L+L+ NKL   +P  L   K +  + L  N +S     DF   G + 
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 290

Query: 580 AFAGNEGLCLDQ 591
             A   G+ L  
Sbjct: 291 KKASYSGVSLFS 302

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 58/322 (18%), Positives = 108/322 (33%), Gaps = 61/322 (18%)

Query: 81  DNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD- 139
            +  L  ++   +       +L L  N ++     +  N  NL  L +  N +   +   
Sbjct: 39  SDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPG 94

Query: 140 -LSALKNLEIFDLSINYFT----GRF-----------------PRWVVNLTQLVSLSIGD 177
             + L  LE   LS N                                 L Q++ + +G 
Sbjct: 95  AFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154

Query: 178 NVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236
           N    + I       +K L+Y+ +A  N+   IP+ +     L  L +  NKI+     S
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS 211

Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296
           ++ L  L K+ L  N+++      L N   L+E  +++N++  K+P  + + K + V   
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270

Query: 297 FKNNFS----GEF--PSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS 350
             NN S     +F  P            S++ N               +   +I  + F 
Sbjct: 271 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP--------------VQYWEIQPSTFR 316

Query: 351 GSFPKYLCEKRKLLNLLALSNN 372
                       +   + L N 
Sbjct: 317 CV---------YVRAAVQLGNY 329

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 97.4 bits (243), Expect = 5e-22
 Identities = 59/179 (32%), Positives = 79/179 (44%), Gaps = 30/179 (16%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK 742
            +G G T  VYR   K      A+K L K    K+   E+ +L ++ H NI+KL      
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK-------GIAYLHH 794
                LVLE +  G LF  +   V++G   E D          AA         +AYLH 
Sbjct: 120 PTEISLVLELVTGGELFDRI---VEKGYYSERD----------AADAVKQILEAVAYLH- 165

Query: 795 DCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                I+HRD+K  N+L      D   KIADFG++KI E+   +       GT GY AP
Sbjct: 166 --ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTPGYCAP 219

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  100 bits (249), Expect = 7e-22
 Identities = 43/198 (21%), Positives = 83/198 (41%), Gaps = 22/198 (11%)

Query: 639 SYKNFKLSADMENGEKEVSSKWKLA-SFHHIDIDAEQICNLEEDNLIGSGGTGKVYR--L 695
             K   +  D    E   S   +L      +  D   I ++E    +G G  G V +   
Sbjct: 302 PDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIE----LGCGNFGSVRQGVY 357

Query: 696 DLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752
            ++K    VA+K L +G           E +I+ ++ +  I++L   + +  +  LV+E 
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEM 416

Query: 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNI 810
              G L + L  +    + E+      ++    + G+ YL   +      +HR++ + N+
Sbjct: 417 AGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNV 467

Query: 811 LLDEDYEPKIADFGVAKI 828
           LL   +  KI+DFG++K 
Sbjct: 468 LLVNRHYAKISDFGLSKA 485

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 35/186 (18%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWK------GDGVKVFAAEMEILGKIRHRNI 733
           L+G G  GKV       ++ T    AVK L K       +G      E+++L ++RH+N+
Sbjct: 12  LLGEGSYGKVK---EVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68

Query: 734 LKLYACLLKGGSS--FLVLEYMPNGN--LFQAL-HKRVKEGKPELDWFRRYKIALGAAKG 788
           ++L   L        ++V+EY   G   +  ++  KR    +        Y   L    G
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA-----HGYFCQL--IDG 121

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY----SCFAGT 844
           + YLH      I+H+DIK  N+LL      KI+  GVA+     P  +D     S   G+
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH--PFAADDTCRTSQ--GS 174

Query: 845 HGYIAP 850
             +  P
Sbjct: 175 PAFQPP 180

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 96.1 bits (240), Expect = 8e-22
 Identities = 50/175 (28%), Positives = 75/175 (42%), Gaps = 17/175 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLY 737
           ++G G    V        +   A+K L K   +K         E +++ ++ H   +KLY
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
                    +  L Y  NG L + + K    G  +    R Y  +I       + YLH  
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSA----LEYLH-- 147

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
               IIHRD+K  NILL+ED   +I DFG AK+     K +  + F GT  Y++P
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 95.3 bits (238), Expect = 9e-22
 Identities = 49/182 (26%), Positives = 75/182 (41%), Gaps = 34/182 (18%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
           +G G    V R   K      A K +          +    E  I  K++H NI++L+  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK-------GIAY 791
           + +    +LV + +  G LF+ +   V      E D          A+         IAY
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDI---VAREFYSEAD----------ASHCIQQILESIAY 120

Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
            H   S  I+HR++K  N+LL    +    K+ADFG+A    +S        FAGT GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 174

Query: 849 AP 850
           +P
Sbjct: 175 SP 176

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 96.2 bits (240), Expect = 9e-22
 Identities = 66/295 (22%), Positives = 107/295 (36%), Gaps = 40/295 (13%)

Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
           +L V QC         P     D   L    +  N  S    ++      L  + +  N+
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISPDTTLL---DLQNNDISELRKDDFKGLQHLYALVLVNNK 89

Query: 349 FS----GSFPKYLCEKRKLLNL--LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP 402
            S     +F         L  L  L +S N   E+P +     ++  LRI DN +  K+P
Sbjct: 90  ISKIHEKAF-------SPLRKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIR-KVP 139

Query: 403 DGLWA-LPNVGMLDFGDNDFT-GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE 460
            G+++ L N+  ++ G N     G  P       L+ L +   + +  +P +L     L 
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLN 196

Query: 461 RLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLS 518
            L L +N     I    L    +L  L L  N +   I N        + +L+L  N LS
Sbjct: 197 ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254

Query: 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDN--------LMKLKLSSIDLSENQLS 565
             +P  L  L  L  + L  N +T  +  N        + +   + I L  N + 
Sbjct: 255 -RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 69/358 (19%), Positives = 114/358 (31%), Gaps = 71/358 (19%)

Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
           +L  +  +   L+  +P+ IS   +   LD+  N IS       + LQ L+ + L  N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
           +         L  LQ+  IS N +  ++P  +    +L   +   N         F  +R
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147

Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF 373
            +    + GN               L +       F G            L L       
Sbjct: 148 NMNCIEMGGNP--------------LENSGFEPGAFDG------------LKL------- 174

Query: 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP--LIGL 431
                           LRIS+  L+  IP  L     +  L    N     I    L+  
Sbjct: 175 --------------NYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRY 216

Query: 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491
            + L +L L +N+        L  L  L  L L NN  S ++P+ L  L+ L  ++L  N
Sbjct: 217 -SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274

Query: 492 ALTGSIPNEM--GDCARIVDLNLARNSLSGNIPRSLSL-------LSSLNALNLSGNK 540
            +T  +           +        SL  N      +       ++   A+     K
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 45/213 (21%), Positives = 81/213 (38%), Gaps = 6/213 (2%)

Query: 90  SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIF 149
                 LQ L  L L  N +S       S    L+ L ++ N +V  +P  +   +L   
Sbjct: 71  KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP-NLPSSLVEL 128

Query: 150 DLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI 209
            +  N            L  +  + +G N  + +       +   L YL ++   L   I
Sbjct: 129 RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GI 187

Query: 210 PESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQE 269
           P+ +     L  L +  NKI       + +  KL+++ L  N +       L  L  L+E
Sbjct: 188 PKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245

Query: 270 FDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
             + +N++  ++P  + +LK L V     NN +
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 42/147 (28%), Positives = 67/147 (45%), Gaps = 6/147 (4%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
            +S   + L LQNN  S     +   L +L  L+L NN  S     A   LR+L  L++ 
Sbjct: 51  EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110

Query: 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI--PD 547
           +N L   IP  +   + +V+L +  N +        S L ++N + + GN L  S   P 
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167

Query: 548 NLMKLKLSSIDLSENQLSGSVPLDFLR 574
               LKL+ + +SE +L+  +P D   
Sbjct: 168 AFDGLKLNYLRISEAKLT-GIPKDLPE 193

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.4 bits (240), Expect = 1e-21
 Identities = 45/213 (21%), Positives = 71/213 (33%), Gaps = 49/213 (23%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-------GDGVKVFAAEMEILGKIRHRNILKL 736
           IG G  G V      +     A+K + K          V+    E+ ++ K+ H NI +L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG------------ 784
           Y          LV+E    G+L   L+  + +   +                        
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 785 ----------------AAK-------GIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPK 819
                            +         + YLH   +  I HRDIK  N L   ++ +E K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 820 IADFGVAKIAENSPKVSDYSC--FAGTHGYIAP 850
           + DFG++K          Y     AGT  ++AP
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 50/187 (26%), Positives = 73/187 (39%), Gaps = 39/187 (20%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-----------GDGVKVFAAEMEILGKI-RHR 731
           +G G +  V R   K      AVK +              +  +    E++IL K+  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK--- 787
           NI++L          FLV + M  G LF  L    ++    E +            K   
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKE----------TRKIMR 131

Query: 788 ----GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
                I  LH      I+HRD+K  NILLD+D   K+ DFG +   +   K+ +     G
Sbjct: 132 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCG 185

Query: 844 THGYIAP 850
           T  Y+AP
Sbjct: 186 TPSYLAP 192

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 57/204 (27%), Positives = 79/204 (38%), Gaps = 53/204 (25%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAA------------------- 720
            IG G  G V    L  N       A+K L K   ++                       
Sbjct: 20  EIGKGSYGVVK---LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76

Query: 721 ---------EMEILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQ-ALHKRVKE 768
                    E+ IL K+ H N++KL   L        ++V E +  G + +    K + E
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136

Query: 769 GKPELDWFRRY--KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
                D  R Y   +  G    I YLH      IIHRDIK SN+L+ ED   KIADFGV+
Sbjct: 137 -----DQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 827 KIAENSPKVSDYSCFAGTHGYIAP 850
              + S  +   +   GT  ++AP
Sbjct: 185 NEFKGSDALLSNTV--GTPAFMAP 206

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 57/177 (32%), Positives = 83/177 (46%), Gaps = 27/177 (15%)

Query: 684 IGSGGTGKVYRLDLKKNAGT---VAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILK 735
           IG G   KV    L ++  T   VA+K     QL      K+F  E+ I+  + H NI+K
Sbjct: 23  IGKGNFAKVK---LARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVK 78

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           L+  +    + +L++EY   G +F  L  H R+KE +      R     + +A  + Y H
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----RSKFRQIVSA--VQYCH 131

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                 I+HRD+K+ N+LLD D   KIADFG +       K+    C  G   Y AP
Sbjct: 132 QKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD-AFC--GAPPYAAP 182

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 38/186 (20%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIR-HRN 732
           IG G +  V R   +      AVK +             +  +    E  IL ++  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK---- 787
           I+ L          FLV + M  G LF  L    ++    E +                 
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKE----------TRSIMRS 208

Query: 788 ---GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
               +++LH   +  I+HRD+K  NILLD++ + +++DFG +   E   K+ +     GT
Sbjct: 209 LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGT 262

Query: 845 HGYIAP 850
            GY+AP
Sbjct: 263 PGYLAP 268

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 95.1 bits (237), Expect = 4e-21
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 26/177 (14%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGV--KVFAAEMEILGKIRHRNILKLY 737
            IGSG  G      L ++  T   VAVK + +G  +   V   E+     +RH NI++  
Sbjct: 27  DIGSGNFGVAR---LMRDKLTKELVAVKYIERGAAIDENV-QREIINHRSLRHPNIVRFK 82

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQ--ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
             +L      +++EY   G L++      R  E   E  +F +  ++     G++Y H  
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSE--DEARFFFQQLLS-----GVSYCHSM 135

Query: 796 CSPPIIHRDIKSSNILLDEDYEP--KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
               I HRD+K  N LLD    P  KI DFG +K +    +    +   GT  YIAP
Sbjct: 136 Q---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TV--GTPAYIAP 186

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 94.2 bits (235), Expect = 4e-21
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 19/174 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACL 740
           ++GSG   +V+ +  +      A+K + K           E+ +L KI+H NI+ L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                 +LV++ +  G LF  +   ++ G   E D     +  L A   + YLH      
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSA---VKYLH---ENG 126

Query: 800 IIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           I+HRD+K  N+L    +E+ +  I DFG++K+ +N       S   GT GY+AP
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAP 176

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 28/179 (15%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWK------GDGVKVFAAEMEILGKIRHRNI 733
            +G G  GKV    + ++  T   VAVK L +          K+   E++ L   RH +I
Sbjct: 18  TLGVGTFGKVK---IGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHI 73

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +KLY  +      F+V+EY+  G LF  +  H RV+E   E     +  ++      + Y
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE--MEARRLFQQILS-----AVDY 126

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            H      ++HRD+K  N+LLD     KIADFG++ +  +   +   SC  G+  Y AP
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTSC--GSPNYAAP 179

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 95.9 bits (239), Expect = 7e-21
 Identities = 54/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
           +GSG  G+V     K      A+K + K             E+ +L  + H NI+KLY  
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSP 798
                + +LV+E    G LF  +   +   K  E+D     K  L     + YLH     
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVIIKQVLSG---VTYLH---KH 155

Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRD+K  N+LL   ++D   KI DFG++ + EN  K+ +     GT  YIAP
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLGTAYYIAP 207

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.9 bits (239), Expect = 8e-21
 Identities = 54/176 (30%), Positives = 80/176 (45%), Gaps = 21/176 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYA 738
           +G G  G+V     K      AVK + K         +    E+++L ++ H NI+KLY 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCS 797
                G  +LV E    G LF  +   +   +  E+D  R  +  L     I Y+H +  
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSG---ITYMHKNK- 146

Query: 798 PPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I+HRD+K  N+LL    +D   +I DFG++   E S K+ D     GT  YIAP
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KIGTAYYIAP 197

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 95.2 bits (237), Expect = 8e-21
 Identities = 46/188 (24%), Positives = 79/188 (42%), Gaps = 24/188 (12%)

Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYAC 739
           + ++G G +G V      +    VAVK++       +   E+++L +   H N+++ Y  
Sbjct: 20  EKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCS 77

Query: 740 LLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                  ++ LE   N NL   +       E       +    +    A G+A+LH   S
Sbjct: 78  ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---S 133

Query: 798 PPIIHRDIKSSNILLD-------------EDYEPKIADFGVAKI--AENSPKVSDYSCFA 842
             IIHRD+K  NIL+              E+    I+DFG+ K   +  S   ++ +  +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 843 GTHGYIAP 850
           GT G+ AP
Sbjct: 194 GTSGWRAP 201

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 95.5 bits (238), Expect = 1e-20
 Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 20/175 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
           +G G  G+V +   +      AVK + K             E+E+L K+ H NI+KL+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSP 798
           L    S ++V E    G LF  +   +K  +  E D  R  K        I Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSG---ITYMHKHN-- 141

Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRD+K  NILL   ++D + KI DFG++   + + K+ D     GT  YIAP
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIAP 192

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 45/181 (24%), Positives = 71/181 (39%), Gaps = 24/181 (13%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-------GDGVKVFAAEMEILGKIRHRNILKL 736
           IG G    V R   ++     AVK +         G   +    E  I   ++H +I++L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP--ELDWFRRYKIALGAAKGIAYLH- 793
                  G  ++V E+M   +L   + KR   G    E       +  L A   + Y H 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHD 148

Query: 794 HDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIA 849
           ++    IIHRD+K   +LL   +     K+  FGVA  + E+           GT  ++A
Sbjct: 149 NN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG---RVGTPHFMA 201

Query: 850 P 850
           P
Sbjct: 202 P 202

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 93.9 bits (233), Expect = 1e-20
 Identities = 19/202 (9%), Positives = 52/202 (25%), Gaps = 44/202 (21%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV------------------------- 717
           ++G            ++   +  V   +  +                             
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 718 -----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM----PNGNLFQALHKRVKE 768
                F    +++   + + ++++               Y           + L      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
            K  +   R   + L   + +A LHH     ++H  ++  +I+LD+     +  F     
Sbjct: 200 HKSLVHHARLQ-LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254

Query: 829 AENSPKVSDYSCFAGTHGYIAP 850
                +       + + G+  P
Sbjct: 255 -----RDGARVVSSVSRGFEPP 271

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 49/175 (28%), Positives = 76/175 (43%), Gaps = 20/175 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
           +G G    V R   K      A K +          +    E  I  K++H NI++L+  
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSP 798
           + +    +LV + +  G LF+ +   V      E D     +  L +   IAY H   S 
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILES---IAYCH---SN 147

Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HR++K  N+LL    +    K+ADFG+A    +S        FAGT GY++P
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLSP 199

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 49/285 (17%), Positives = 96/285 (33%), Gaps = 40/285 (14%)

Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
           + T  +C     +   P+G      +L    +  N+          + T LT + +S N 
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63

Query: 349 FSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWAL 408
            S       C  +      +L                  + L +S N +   +      L
Sbjct: 64  LSFKG----CCSQSDFGTTSL------------------KYLDLSFNGVI-TMSSNFLGL 100

Query: 409 PNVGMLDFGDNDFT--GGISPLIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLILT 465
             +  LDF  ++       S  + L  +L  L + +        +     L++LE L + 
Sbjct: 101 EQLEHLDFQHSNLKQMSEFSVFLSL-RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMA 158

Query: 466 NNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPR 523
            N+F           LR L+ L L +  L   +     +  + +  LN++ N+       
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTF 217

Query: 524 SLSLLSSLNALNLSGNKLTGSIPDNL---MKLKLSSIDLSENQLS 565
               L+SL  L+ S N +  +            L+ ++L++N  +
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 56/259 (21%), Positives = 93/259 (35%), Gaps = 15/259 (5%)

Query: 76  TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
           TEI  ++K L+  + + I +  S T L L  N L           + L  L+++ N +  
Sbjct: 10  TEIRCNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 136 ---SVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNL 192
                       +L+  DLS N          + L QL  L    +   +        +L
Sbjct: 67  KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125

Query: 193 KNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSI-RKLQKLWKIELYA 250
           +NL YL ++H + R      I + L  L  L +  N     F   I  +L+ L  ++L  
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184

Query: 251 NNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFPSG 308
             L  +L      +L+ LQ  ++S N     L       L +L V     N+        
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242

Query: 309 FGDM-RKLFAFSIYGNRFS 326
                  L   ++  N F+
Sbjct: 243 LQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 28/150 (18%), Positives = 58/150 (38%), Gaps = 7/150 (4%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGK--IPSALGALRQLSSLH 487
           G+ +S ++L L++N+          +LT L +L L++N  S K     +      L  L 
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 488 LEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL-SLLSSLNALNLSGNKLTGSIP 546
           L  N +  ++ +      ++  L+   ++L      S+   L +L  L++S         
Sbjct: 85  LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAF 142

Query: 547 DN-LMKL-KLSSIDLSENQLSGSVPLDFLR 574
           +     L  L  + ++ N    +   D   
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 47/269 (17%), Positives = 92/269 (34%), Gaps = 34/269 (12%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF--PRSIRKLQ 241
            +P  I    + T L L    L+        +L +L  L +  N +S +    +S     
Sbjct: 21  SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
            L  ++L  N +   + +    L  L+  D   +         +  +   +VF       
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN--------LKQMSEFSVFL------ 123

Query: 302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
                     +R L    I        F       ++L  + ++ N F  +F   +  + 
Sbjct: 124 ---------SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 174

Query: 362 KLLNLLALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDN 419
           + L  L LS     ++   ++    ++Q L +S N+    +       L ++ +LD+  N
Sbjct: 175 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLN 233

Query: 420 DFTGGISP--LIGLSTSLSQLVLQNNRFS 446
                     L    +SL+ L L  N F+
Sbjct: 234 HIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 69.7 bits (171), Expect = 6e-13
 Identities = 54/315 (17%), Positives = 85/315 (26%), Gaps = 86/315 (27%)

Query: 233 FPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK--LPEEIGNLKN 290
            P S  +L+      L +N L          LT L +  +SSN +  K    +      +
Sbjct: 26  IPSSATRLE------LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79

Query: 291 LTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS 350
           L       N       S F  + +L       +                    + +    
Sbjct: 80  LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN-------------------LKQMSEF 119

Query: 351 GSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDG-LWALP 409
             F         L NL                       L IS  H      +G    L 
Sbjct: 120 SVF-------LSLRNL---------------------IYLDISHTHTR-VAFNGIFNGLS 150

Query: 410 NVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLILTN 466
           ++ +L    N F     P     L  +L+ L L   +   +L       L++L+ L +++
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTEL-RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSH 208

Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526
           NNF          L  L  L    N +  +   +                          
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ----------------------H 245

Query: 527 LLSSLNALNLSGNKL 541
             SSL  LNL+ N  
Sbjct: 246 FPSSLAFLNLTQNDF 260

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 93.6 bits (233), Expect = 2e-20
 Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 15/173 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  +  K      A+K L K + +K      F  E +I+       +++L+
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                    ++V+EYMP G+L   +        PE  W R Y   +  A  +  +H   S
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPE-KWARFYTAEVVLA--LDAIH---S 186

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              IHRD+K  N+LLD+    K+ADFG          V   +   GT  YI+P
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 238

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 92.8 bits (231), Expect = 3e-20
 Identities = 43/187 (22%), Positives = 78/187 (41%), Gaps = 32/187 (17%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNIL 734
            + +  ++G G  G+V++ +       +A K +        +    E+ ++ ++ H N++
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP--ELDWFRRYKIALGAAK----- 787
           +LY          LV+EY+  G LF  +   + E     ELD                  
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELD----------TILFMKQI 196

Query: 788 --GIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
             GI ++H      I+H D+K  NIL    +  + KI DFG+A+  +   K+       G
Sbjct: 197 CEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFG 250

Query: 844 THGYIAP 850
           T  ++AP
Sbjct: 251 TPEFLAP 257

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQL---WKGDGVKV--FAAEMEILGKIRHRNILKL 736
           L+G GG G VY   D  +    VA+K +      D V       E    G+++  +++ +
Sbjct: 41  LVGRGGMGDVYEAEDTVRER-IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
           +      G  ++ +  +   +L   L ++   G   L   R   I       +   H   
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQ---GP--LAPPRAVAIVRQIGSALDAAHAA- 153

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                HRD+K  NIL+  D    + DFG+A  A    K++      GT  Y+AP
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAP 204

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.3 bits (232), Expect = 4e-20
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 17/175 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLY 737
           +IG G  G+V  + LK      A+K L K + +K      F  E ++L     + I  L+
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
                  + +LV++Y   G+L   L K   E +   +  R Y  ++ +     I  +H  
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIA----IDSVH-- 192

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                +HRDIK  NIL+D +   ++ADFG          V       GT  YI+P
Sbjct: 193 -QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISP 245

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 92.8 bits (231), Expect = 4e-20
 Identities = 50/171 (29%), Positives = 75/171 (43%), Gaps = 28/171 (16%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA------EMEILGKIRHRNILKLY 737
           IG+G  G VY+  L  +   VA+K        KV         E++I+ K+ H NI++L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIK--------KVLQDKRFKNRELQIMRKLDHCNIVRLR 113

Query: 738 ACLLKGGSSF------LVLEYMPNGNLFQALHKRVKEGKP-ELDWFRRYKIALGAAKGIA 790
                 G         LVL+Y+P   +++      +  +   + + + Y   L   + +A
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLA 170

Query: 791 YLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSC 840
           Y+H   S  I HRDIK  N+LLD D    K+ DFG AK          Y C
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 92.8 bits (230), Expect = 5e-20
 Identities = 27/207 (13%), Positives = 58/207 (28%), Gaps = 39/207 (18%)

Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAE---MEILGKIR 729
           L    ++G            ++   +  V   +       + +K    E   + +L  I+
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 730 HRNILKLYACLLK------------------GGSSFLVLEY---MP-----NGNLFQALH 763
           ++   K++   +                         VL      P          + L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 764 KRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823
                 K  +   R   + L   + +A LHH     ++H  ++  +I+LD+     +  F
Sbjct: 200 SHSSTHKSLVHHARLQ-LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255

Query: 824 GVAKIAENSPKVSDYSCFAGTHGYIAP 850
                 + +  VS            A 
Sbjct: 256 EHLV-RDGASAVSPIGRGFAPPETTAE 281

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 91.5 bits (227), Expect = 5e-20
 Identities = 40/224 (17%), Positives = 74/224 (33%), Gaps = 29/224 (12%)

Query: 641 KNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKN 700
           K  +L       EK +     LA   H  I       LE           +++  D   +
Sbjct: 37  KRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTD 96

Query: 701 AGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
               +   +           ++  +     +N +            ++ ++     NL  
Sbjct: 97  WPLSSPSPMDAPSV------KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150

Query: 761 ALHKRVKEGKPE----LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY 816
            +++R      E    L  F   +IA      + +LH   S  ++HRD+K SNI    D 
Sbjct: 151 WMNRRCSLEDREHGVCLHIFI--QIAEA----VEFLH---SKGLMHRDLKPSNIFFTMDD 201

Query: 817 EPKIADFGVAKIAENS----------PKVSDYSCFAGTHGYIAP 850
             K+ DFG+    +            P  + ++   GT  Y++P
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 50/209 (23%), Positives = 79/209 (37%), Gaps = 21/209 (10%)

Query: 386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNN 443
             QR+ +  N +S        A  N+ +L    N     I      GL   L QL L +N
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGL-ALLEQLDLSDN 90

Query: 444 RFSGELPSE-LGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEM 501
                +       L  L  L L       ++       L  L  L+L++NAL  ++P++ 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148

Query: 502 -GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN-LMKL-KLSSID 558
             D   +  L L  N +S    R+   L SL+ L L  N++   +  +    L +L ++ 
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207

Query: 559 LSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
           L  N LS ++P          A A    L
Sbjct: 208 LFANNLS-ALP--------TEALAPLRAL 227

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 43/162 (26%), Positives = 66/162 (40%), Gaps = 15/162 (9%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
           G+  +  ++ L  NR S    +      NL  L L +N  +    +A   L  L  L L 
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 490 ENALTGSIPNEM-GDCARIVDLNLARNSLSGNIP-RSLSLLSSLNALNLSGNKLTGSIPD 547
           +NA   S+         R+  L+L R  L   +       L++L  L L  N L  ++PD
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPD 146

Query: 548 N-LMKL-KLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
           +    L  L+ + L  N++S SVP        + AF G   L
Sbjct: 147 DTFRDLGNLTHLFLHGNRIS-SVP--------ERAFRGLHSL 179

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 49/206 (23%), Positives = 76/206 (36%), Gaps = 13/206 (6%)

Query: 367 LALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGI 425
           + L  N    VP  S+  C+ +  L +  N L+         L  +  LD  DN     +
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 426 SP--LIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLILTNNNFSGKIPS-ALGALR 481
            P    GL   L  L L       EL       L  L+ L L +N     +P      L 
Sbjct: 97  DPATFHGL-GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLG 153

Query: 482 QLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
            L+ L L  N ++ S+P         +  L L +N ++   P +   L  L  L L  N 
Sbjct: 154 NLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212

Query: 541 LTGSIPDNLMKL--KLSSIDLSENQL 564
           L+ ++P   +     L  + L++N  
Sbjct: 213 LS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 14/227 (6%)

Query: 81  DNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD- 139
             + L   +   I A  +   + L  N +S         C NL +L +  N  +  +   
Sbjct: 19  PQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAA 74

Query: 140 -LSALKNLEIFDLSINY-FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLT 196
             + L  LE  DLS N       P     L +L +L +        E+   +   L  L 
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC--GLQELGPGLFRGLAALQ 132

Query: 197 YLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTG 255
           YL+L    L+  +P+    +L  L  L +  N+IS    R+ R L  L ++ L+ N +  
Sbjct: 133 YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191

Query: 256 ELPAELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
             P    +L  L    + +N +   LP E    L+ L   +   N +
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 55/256 (21%), Positives = 92/256 (35%), Gaps = 50/256 (19%)

Query: 296 CFKNNFSGEFPSGF-GDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS---- 350
           C +       P G     +++F   ++GNR S     +      LT + +  N  +    
Sbjct: 18  CPQQGLQ-AVPVGIPAASQRIF---LHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73

Query: 351 GSFPKYLCEKRKLLNL--LALSNNFSGEV--PNSYADCKTIQRLRISDNHLSGKIPDGLW 406
            +F         L  L  L LS+N       P ++     +  L +    L  ++  GL+
Sbjct: 74  AAF-------TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLF 125

Query: 407 A-LPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463
             L  +  L   DN     +       L  +L+ L L  NR S         L +L+RL+
Sbjct: 126 RGLAALQYLYLQDNALQA-LPDDTFRDL-GNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183

Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
           L  N  +   P A   L +L +L+L  N L+ ++P                         
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALP-----------------------TE 219

Query: 524 SLSLLSSLNALNLSGN 539
           +L+ L +L  L L+ N
Sbjct: 220 ALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 62/296 (20%), Positives = 91/296 (30%), Gaps = 81/296 (27%)

Query: 203 CNLRG--RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE 260
           C  +G   +P  I        + +  N+IS     S R  + L  + L++N L     A 
Sbjct: 18  CPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 261 LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSI 320
              L LL++ D+S N     +                        P+ F  + +L    +
Sbjct: 76  FTGLALLEQLDLSDNAQLRSVD-----------------------PATFHGLGRLHTLHL 112

Query: 321 YGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNS 380
                                 ++    F G           L  L              
Sbjct: 113 DRCGLQ----------------ELGPGLFRG-----------LAAL-------------- 131

Query: 381 YADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISP--LIGLSTSLSQ 437
                  Q L + DN L   +PD  +  L N+  L    N  +  +      GL  SL +
Sbjct: 132 -------QYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGL-HSLDR 181

Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
           L+L  NR +   P     L  L  L L  NN S     AL  LR L  L L +N  
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 40/216 (18%), Positives = 71/216 (32%), Gaps = 9/216 (4%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
            +P  I        +FL    +      S    R L  L +  N ++     +   L  L
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 244 WKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
            +++L  N     +       L  L    +    +  +L   +   L  L       N  
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNAL 141

Query: 302 SGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
               P   F D+  L    ++GNR S           +L  + + +N+ +     +    
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199

Query: 361 RKLLNLLALSNNFSGEVP-NSYADCKTIQRLRISDN 395
              L  L L  N    +P  + A  + +Q LR++DN
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 90.3 bits (224), Expect = 8e-20
 Identities = 49/277 (17%), Positives = 93/277 (33%), Gaps = 22/277 (7%)

Query: 309 FGDMRKLFAFSIYGNRFSGPFP-ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367
           +G  R L       +  +      ++ +  +L  + +   +              +  L 
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 368 ALS---NNFSGEVPNSYADC--KTIQRLRISDNHLSGKIPD----GLWALPNVGMLDFGD 418
            L+      +G  P    +     +  L + +   + +         W  P + +L    
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158

Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE----LGRLTNLERLILTNNNF---SG 471
                     + +  +LS L L +N   GE          +   L+ L L N      SG
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218

Query: 472 KIPSALGALRQLSSLHLEENALTGSIPNEMGD-CARIVDLNLARNSLSGNIPRSLSLLSS 530
              +   A  QL  L L  N+L  +      D  +++  LNL+   L   +P+ L   + 
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AK 275

Query: 531 LNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567
           L+ L+LS N+L    P      ++ ++ L  N    S
Sbjct: 276 LSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 87.6 bits (217), Expect = 6e-19
 Identities = 59/301 (19%), Positives = 104/301 (34%), Gaps = 24/301 (7%)

Query: 263 NLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFP-SGFGDMRKLFAFSI 320
           N +  +    S+    G    E+ G  ++L       +  +     +       L   ++
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75

Query: 321 YGNRFSGPFPENLGR---YTALTDVDISENQFSGSFPKYLCEKRKL-LNLLALSNNFSGE 376
              R          R    + L ++ +   + +G+ P  L E     LN+L L N     
Sbjct: 76  RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135

Query: 377 VPNSYADC-----KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGL 431
                A+        ++ L I+  H      + +   P +  LD  DN   G    +  L
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195

Query: 432 S----TSLSQLVLQNNRF---SGELPSELGRLTNLERLILTNNNFSGKIPSALGA-LRQL 483
                 +L  L L+N      SG   +       L+ L L++N+      +       QL
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255

Query: 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543
           +SL+L    L   +P  +   A++  L+L+ N L    P    L   +  L+L GN    
Sbjct: 256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPSPDEL-PQVGNLSLKGNPFLD 310

Query: 544 S 544
           S
Sbjct: 311 S 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 51/265 (19%), Positives = 96/265 (36%), Gaps = 30/265 (11%)

Query: 324 RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYAD 383
            FS P P+     +A   +  ++ +  G   + L    K ++  A    F+  + +    
Sbjct: 16  NFSDPKPD---WSSAFNCLGAADVELYGG-GRSLEYLLKRVDTEADLGQFTDIIKSL--- 68

Query: 384 CKTIQRLRISDNHLSGKIPDG---LWALPNVGMLDFGDNDFTGGISPLIGLST--SLSQL 438
             +++RL +    +  +I  G   +  +  +  L   + + TG   P +  +T   L+ L
Sbjct: 69  --SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126

Query: 439 VLQNNRFSGELPSELGRL-----TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
            L+N  ++    + L  L       L+ L +   +        +     LS+L L +N  
Sbjct: 127 NLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185

Query: 494 TGSIPNEMGDCAR----IVDLNLARN---SLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
            G        C      +  L L      + SG      +    L  L+LS N L  +  
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 547 DNLMKL--KLSSIDLSENQLSGSVP 569
                   +L+S++LS   L   VP
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVP 269

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 47/290 (16%), Positives = 81/290 (27%), Gaps = 30/290 (10%)

Query: 143 LKNLEIFDLSINYFTGRFP-RWVVNLTQLVSLSIGDNVYDEAEIPE--SIGNLKNLTYLF 199
            ++LE     ++          ++    L  L++         +     +  +  L  L 
Sbjct: 42  GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101

Query: 200 LAHCNLRGRIPESISELRELG--TLDICRNKISGEFPRSIR----KLQKLWKIELYANNL 253
           L +  + G  P  + E        L++     +                L  + +   + 
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161

Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
                 ++     L   D+S N   G+                     S   P  F  ++
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGL-----------------ISALCPLKFPTLQ 204

Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF 373
            L   +      SG           L  +D+S N    +     C+    LN L LS   
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
             +VP        +  L +S N L    P     LP VG L    N F  
Sbjct: 265 LKQVPKGLP--AKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 40/244 (16%), Positives = 67/244 (27%), Gaps = 46/244 (18%)

Query: 74  RVTEISFDNKSLSGEISSSISALQS---LTVLSLPFNVLSGKLP-------------LEL 117
            +  ++     +   I      +     L  L+L    ++G  P             L L
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 118 SNCS-----------------NLKVLNVTGNAM-VGSVPDLSALKNLEIFDLSINYFTGR 159
            N S                  LKVL++        S   +     L   DLS N   G 
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 160 FPRW----VVNLTQLVSLSIGDNVYD--EAEIPESIGNLKNLTYLFLAHCNLRGRIPESI 213
                    +    L  L++ +   +               L  L L+H +LR       
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

Query: 214 -SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI 272
                +L +L++    +         KL  L   +L  N L    P+    L  +    +
Sbjct: 249 CDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL---DLSYNRLD-RNPSPDE-LPQVGNLSL 303

Query: 273 SSNQ 276
             N 
Sbjct: 304 KGNP 307

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 33/193 (17%), Positives = 66/193 (34%), Gaps = 17/193 (8%)

Query: 75  VTEISFDNKSLSGEISS----SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTG 130
           +  ++  N S +   +            L VLS+           ++     L  L+++ 
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182

Query: 131 NAMVGSVP--------DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
           N  +G               L+ L + +  +   +G          QL  L +  N   +
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242

Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
           A    S      L  L L+   L+ ++P+ +    +L  LD+  N++    P S  +L +
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNP-SPDELPQ 297

Query: 243 LWKIELYANNLTG 255
           +  + L  N    
Sbjct: 298 VGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 31/154 (20%), Positives = 59/154 (38%), Gaps = 11/154 (7%)

Query: 428 LIGLSTSLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPS---ALGALRQL 483
           L G   SL  L+ + +  +     +++ +  +L+RL +       +I      +  +  L
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97

Query: 484 SSLHLEENALTGSIPNEMGDCA--RIVDLNLARNSLSGNIPRSLSL----LSSLNALNLS 537
             L LE   +TG+ P  + +     +  LNL   S +        L       L  L+++
Sbjct: 98  QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157

Query: 538 GNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPL 570
                    + +     LS++DLS+N   G   L
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.5 bits (230), Expect = 9e-20
 Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 32/181 (17%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVK-----QLWKGDGVKVFAAEMEILGKIRHRNIL 734
            +G G  GKV    + K+  T   VAVK     ++   D V     E++ L   RH +I+
Sbjct: 23  TLGVGTFGKVK---VGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           KLY  +      F+V+EY+  G LF  +  + R+ E   E     +  ++     G+ Y 
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE--KESRRLFQQILS-----GVDYC 132

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY---SCFAGTHGYIA 849
           H      ++HRD+K  N+LLD     KIADFG++    N     ++   SC  G+  Y A
Sbjct: 133 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLRTSC--GSPNYAA 183

Query: 850 P 850
           P
Sbjct: 184 P 184

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 16/174 (9%)

Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQL---WKGDG--VKVFAAEMEILGKIRHRNILKL 736
            +G GG   VY   D   N   VA+K +    +     +K F  E+    ++ H+NI+ +
Sbjct: 18  KLGGGGMSTVYLAEDTILNI-KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
                +    +LV+EY+    L + +          L              GI + H   
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINFTNQILDGIKHAHDM- 130

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              I+HRDIK  NIL+D +   KI DFG+AK A +   ++  +   GT  Y +P
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSP 181

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 43/182 (23%), Positives = 68/182 (37%), Gaps = 31/182 (17%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHR-NILKLYA 738
           +G G    V +   K      A K L K     D       E+ +L   +    ++ L+ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK-------GIAY 791
                    L+LEY   G +F      + E   E D            +       G+ Y
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND----------VIRLIKQILEGVYY 146

Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           LH      I+H D+K  NILL       + KI DFG+++   ++ ++ +     GT  Y+
Sbjct: 147 LH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYL 200

Query: 849 AP 850
           AP
Sbjct: 201 AP 202

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 26/242 (10%)

Query: 350 SGSFPKYLCEKRKLLNL----------LALSNNFSGEVP-NSYADCKTIQRLRISDNHLS 398
           S  F K +C +R L  +          L L  N    +  +++     ++ L++  N + 
Sbjct: 53  SNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112

Query: 399 GKIPDG-LWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSE-LG 454
            +I  G    L ++  L+  DN  T  I       L + L +L L+NN     +PS    
Sbjct: 113 -QIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYL-SKLRELWLRNNPIE-SIPSYAFN 168

Query: 455 RLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513
           R+ +L RL L        I   A   L  L  L+L    +   +P  +     + +L ++
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226

Query: 514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN-LMKL-KLSSIDLSENQLSGSVPLD 571
            N      P S   LSSL  L +  ++++  I  N    L  L  ++L+ N LS S+P D
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHD 284

Query: 572 FL 573
             
Sbjct: 285 LF 286

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 86.3 bits (214), Expect = 7e-18
 Identities = 60/288 (20%), Positives = 103/288 (35%), Gaps = 53/288 (18%)

Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
             +   C +   S E P G   + R L    +  N       +       L  + +  N 
Sbjct: 55  QFSKVVCTRRGLS-EVPQGIPSNTRYLN---LMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 349 FS----GSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKI 401
                 G+F         L +L  L L +N+   +P  ++     ++ L + +N +   I
Sbjct: 111 IRQIEVGAF-------NGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SI 162

Query: 402 PDGLWA-LPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458
           P   +  +P++  LD G+      IS     GL  +L  L L       ++P+ L  L  
Sbjct: 163 PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL-FNLKYLNLGMCNIK-DMPN-LTPLVG 219

Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
           LE L ++ N+F    P +   L  L  L +  + ++  I                     
Sbjct: 220 LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIE-------------------- 258

Query: 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQL 564
                +   L+SL  LNL+ N L+ S+P +L      L  + L  N  
Sbjct: 259 ---RNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 80.6 bits (199), Expect = 6e-16
 Identities = 45/211 (21%), Positives = 78/211 (36%), Gaps = 7/211 (3%)

Query: 94  SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDL 151
             L  L VL L  N +        +  ++L  L +  N +   +P      L  L    L
Sbjct: 96  RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWL 154

Query: 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE 211
             N            +  L+ L +G+    E     +   L NL YL L  CN++  +P 
Sbjct: 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP- 212

Query: 212 SISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD 271
           +++ L  L  L++  N      P S   L  L K+ +  + ++         L  L E +
Sbjct: 213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272

Query: 272 ISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
           ++ N +   LP ++   L+ L       N +
Sbjct: 273 LAHNNL-SSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 77.1 bits (190), Expect = 6e-15
 Identities = 45/231 (19%), Positives = 85/231 (36%), Gaps = 11/231 (4%)

Query: 98  SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSINY 155
           +   L+L  N +         +  +L+VL +  N  +  +     + L +L   +L  N+
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN-SIRQIEVGAFNGLASLNTLELFDNW 134

Query: 156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPESI- 213
            T         L++L  L + +N      IP      + +L  L L        I E   
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNN--PIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192

Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDI 272
             L  L  L++    I  + P ++  L  L ++E+  N+   E+       L+ L++  +
Sbjct: 193 EGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWV 249

Query: 273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323
            ++Q+          L +L       NN S      F  +R L    ++ N
Sbjct: 250 MNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 55/301 (18%), Positives = 94/301 (31%), Gaps = 67/301 (22%)

Query: 202 HCNLRG--RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPA 259
            C  RG   +P+ I        L++  N I      + R L  L  ++L  N++  ++  
Sbjct: 60  VCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEV 116

Query: 260 E-LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
                L  L   ++  N            L  +                 F  + KL   
Sbjct: 117 GAFNGLASLNTLELFDNW-----------LTVIP-------------SGAFEYLSKLREL 152

Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL----SNNFS 374
            +  N                    I    F+            + +L+ L         
Sbjct: 153 WLRNNPIE----------------SIPSYAFNR-----------VPSLMRLDLGELKKLE 185

Query: 375 GEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP--LIGLS 432
                ++     ++ L +   ++   +P+ L  L  +  L+   N F   I P    GL 
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPE-IRPGSFHGL- 241

Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
           +SL +L + N++ S    +    L +L  L L +NN S         LR L  LHL  N 
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301

Query: 493 L 493
            
Sbjct: 302 W 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 54/247 (21%), Positives = 96/247 (38%), Gaps = 25/247 (10%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
           E+P+ I    N  YL L   N++    ++   L  L  L + RN I      +   L  L
Sbjct: 68  EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125

Query: 244 WKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
             +EL+ N LT  +P+     L+ L+E  + +N +   +P      + +L      +   
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKK 183

Query: 302 SGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS----GSFPKY 356
                 G F  +  L   ++           NL     L ++++S N F     GSF   
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK--DMPNLTPLVGLEELEMSGNHFPEIRPGSF--- 238

Query: 357 LCEKRKLLNL--LALSNNFSGEV-PNSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVG 412
                 L +L  L + N+    +  N++    ++  L ++ N+LS  +P  L+  L  + 
Sbjct: 239 ----HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293

Query: 413 MLDFGDN 419
            L    N
Sbjct: 294 ELHLHHN 300

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 53/175 (30%), Positives = 73/175 (41%), Gaps = 18/175 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
           L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHHD 795
                      V+EY   G LF  L +   E     D  R Y   I       + YLH +
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSA----LDYLHSE 267

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +  +++RD+K  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 318

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 46/187 (24%), Positives = 70/187 (37%), Gaps = 37/187 (19%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA---------AEMEILGKIRHRNIL 734
            G G  G V     K    +VA+K        KV             M+ L  + H NI+
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIK--------KVIQDPRFRNRELQIMQDLAVLHHPNIV 82

Query: 735 KLYACLLKGGSS-------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRR---YKIALG 784
           +L +     G          +V+EY+P+  L +      +          +   +++   
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI-- 139

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
             + I  LH   S  + HRDIK  N+L++  D   K+ DFG AK    S     Y C   
Sbjct: 140 --RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--- 193

Query: 844 THGYIAP 850
           +  Y AP
Sbjct: 194 SRYYRAP 200

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 43/210 (20%), Positives = 76/210 (36%), Gaps = 19/210 (9%)

Query: 648 DMENGEKEVSSKWKLASFHHIDIDAEQICNL-EEDNLIGSGGTGKVYRLDLKKNAGTVAV 706
            + + +K     WK      +++    + +  +    +GSG  G V+R   K        
Sbjct: 22  KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81

Query: 707 KQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK 764
           K +             E+ I+ ++ H  ++ L+          L+LE++  G LF  +  
Sbjct: 82  KFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-- 139

Query: 765 RVKEGKP--ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPKI 820
              E     E +     + A     G+ ++H      I+H DIK  NI+    +    KI
Sbjct: 140 -AAEDYKMSEAEVINYMRQACE---GLKHMH---EHSIVHLDIKPENIMCETKKASSVKI 192

Query: 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            DFG+A        V        T  + AP
Sbjct: 193 IDFGLATKLNPDEIVKV---TTATAEFAAP 219

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.9 bits (226), Expect = 2e-19
 Identities = 47/175 (26%), Positives = 71/175 (40%), Gaps = 17/175 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
           +IG G   +V  + +K+     A+K + K        V  F  E ++L     R I +L+
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
                    +LV+EY   G+L   L K     +   +  R Y  +I +     I  +H  
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMA----IDSVH-- 179

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                +HRDIK  NILLD     ++ADFG          V       GT  Y++P
Sbjct: 180 -RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSP 232

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 91.7 bits (228), Expect = 2e-19
 Identities = 54/188 (28%), Positives = 74/188 (39%), Gaps = 31/188 (16%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---------------GDGVKVFAAEMEILG 726
             +GSG  G+V     K      A+K + K                   +    E+ +L 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 727 KIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGA 785
            + H NI+KL+         +LV E+   G LF+ +   +   K  E D     K  L  
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSG 158

Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
              I YLH      I+HRDIK  NILL   +     KI DFG++       K+ D     
Sbjct: 159 ---ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD---RL 209

Query: 843 GTHGYIAP 850
           GT  YIAP
Sbjct: 210 GTAYYIAP 217

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 91.2 bits (227), Expect = 2e-19
 Identities = 42/175 (24%), Positives = 73/175 (41%), Gaps = 19/175 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
           +G G    V R          A   +          +    E  I   ++H NI++L+  
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSP 798
           + + G  +L+ + +  G LF+ +   V      E D     +  L A   + + H     
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEA---VLHCH---QM 129

Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            ++HR++K  N+LL    +    K+ADFG+A   E   +   +  FAGT GY++P
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSP 182

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 41/183 (22%), Positives = 69/183 (37%), Gaps = 35/183 (19%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYA--- 738
           ++G G  GKV     ++     A+K L+          E++   +     +I+ +     
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYD---SPKARQEVDHHWQASGGPHIVCILDVYE 92

Query: 739 -CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK-------GIA 790
                     +++E M  G LF  + +R  +   E +          AA+        I 
Sbjct: 93  NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----------AAEIMRDIGTAIQ 142

Query: 791 YLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
           +LH   S  I HRD+K  N+L    ++D   K+ DFG AK    +           T  Y
Sbjct: 143 FLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYY 195

Query: 848 IAP 850
           +AP
Sbjct: 196 VAP 198

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 54/186 (29%), Positives = 73/186 (39%), Gaps = 38/186 (20%)

Query: 684 IGSGGTGKVYRLDLKKNAGT---VAVKQLWK-----------GDGVKVFAAEMEILGKIR 729
           +GSG  G V+      +      V VK + K               KV   E+ IL ++ 
Sbjct: 32  LGSGAFGFVW---TAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVE 87

Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGN-LFQ--ALHKRVKEGKPELDWFRRY--KIALG 784
           H NI+K+       G   LV+E   +G  LF     H R+ E  P          ++   
Sbjct: 88  HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE--PLA---SYIFRQLVSA 142

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
               + YL       IIHRDIK  NI++ ED+  K+ DFG A   E         C  GT
Sbjct: 143 ----VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF-YTFC--GT 192

Query: 845 HGYIAP 850
             Y AP
Sbjct: 193 IEYCAP 198

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 46/185 (24%), Positives = 75/185 (40%), Gaps = 31/185 (16%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIR-HRNILKLYAC 739
           ++G G   +V        +   AVK + K  G        E+E+L + + HRN+L+L   
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY------KIALGAAKGIAYLH 793
             +    +LV E M  G++   +HKR           R +       +    A  + +LH
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKR-----------RHFNELEASVVVQDVASALDFLH 128

Query: 794 HDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSC-----FAGTH 845
              +  I HRD+K  NIL    ++    KI DF +    + +   S  S        G+ 
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 846 GYIAP 850
            Y+AP
Sbjct: 186 EYMAP 190

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 46/187 (24%), Positives = 73/187 (39%), Gaps = 39/187 (20%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRNILK 735
           +GSG    V +   K      A K + K        G   +    E+ IL ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK------- 787
           L+          L+LE +  G LF  L    ++    E +          A         
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEE----------ATSFIKQILD 126

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVSDYSCFAG 843
           G+ YLH   +  I H D+K  NI+L +   P    K+ DFG+A   E+  +  +     G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180

Query: 844 THGYIAP 850
           T  ++AP
Sbjct: 181 TPEFVAP 187

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 90.6 bits (225), Expect = 3e-19
 Identities = 65/242 (26%), Positives = 101/242 (41%), Gaps = 26/242 (10%)

Query: 350 SGSFPKYLCEKRKLLNL----------LALSNNFSGEVP-NSYADCKTIQRLRISDNHLS 398
           S  F K +C ++ L  +          L L  N    +  NS+   + ++ L++S NH+ 
Sbjct: 42  SNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101

Query: 399 GKIPDG-LWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSEL-G 454
             I  G    L N+  L+  DN  T  I     + L + L +L L+NN     +PS    
Sbjct: 102 -TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYL-SKLKELWLRNNPIE-SIPSYAFN 157

Query: 455 RLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513
           R+ +L RL L        I   A   L  L  L+L    L   IP  +    ++ +L+L+
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215

Query: 514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN-LMKL-KLSSIDLSENQLSGSVPLD 571
            N LS   P S   L  L  L +  +++   I  N    L  L  I+L+ N L+  +P D
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHD 273

Query: 572 FL 573
             
Sbjct: 274 LF 275

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 82.9 bits (205), Expect = 8e-17
 Identities = 63/288 (21%), Positives = 104/288 (36%), Gaps = 53/288 (18%)

Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
             +   C + N   E P G   + R L    ++ N+       +      L  + +S N 
Sbjct: 44  QFSKVICVRKNLR-EVPDGISTNTRLLN---LHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 349 FS----GSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKI 401
                 G+F         L NL  L L +N    +P  ++     ++ L + +N +   I
Sbjct: 100 IRTIEIGAF-------NGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SI 151

Query: 402 PDGLWA-LPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458
           P   +  +P++  LD G+      IS     GL ++L  L L       E+P+ L  L  
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL-SNLRYLNLAMCNLR-EIPN-LTPLIK 208

Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
           L+ L L+ N+ S   P +   L  L  L + ++ +   I                     
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE-------------------- 247

Query: 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQL 564
                +   L SL  +NL+ N LT  +P +L      L  I L  N  
Sbjct: 248 ---RNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 48/230 (20%), Positives = 89/230 (38%), Gaps = 9/230 (3%)

Query: 98  SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSINY 155
           +  +L+L  N +         +  +L++L ++ N  + ++     + L NL   +L  N 
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN-HIRTIEIGAFNGLANLNTLELFDNR 123

Query: 156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPESI- 213
            T       V L++L  L + +N      IP      + +L  L L        I E   
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNN--PIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181

Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS 273
             L  L  L++    +  E P ++  L KL +++L  N+L+   P     L  LQ+  + 
Sbjct: 182 EGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239

Query: 274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323
            +Q+         NL++L       NN +      F  +  L    ++ N
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 51/247 (20%), Positives = 97/247 (39%), Gaps = 25/247 (10%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
           E+P+ I    N   L L    ++     S   LR L  L + RN I      +   L  L
Sbjct: 57  EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 244 WKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
             +EL+ N LT  +P      L+ L+E  + +N +   +P      + +L      +   
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKR 172

Query: 302 SGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS----GSFPKY 356
                 G F  +  L   ++           NL     L ++D+S N  S    GSF   
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR--EIPNLTPLIKLDELDLSGNHLSAIRPGSF--- 227

Query: 357 LCEKRKLLNL--LALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVG 412
               + L++L  L +  +    +  N++ + +++  + ++ N+L+  +P  L+  L ++ 
Sbjct: 228 ----QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282

Query: 413 MLDFGDN 419
            +    N
Sbjct: 283 RIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 59/298 (19%), Positives = 97/298 (32%), Gaps = 61/298 (20%)

Query: 202 HCNLRG--RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPA 259
            C  +    +P+ IS       L++  N+I      S + L+ L  ++L  N++      
Sbjct: 49  ICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106

Query: 260 ELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFPSG-FGDMRKLFA 317
               L  L   ++  N++   +P      L  L       N      PS  F  +  L  
Sbjct: 107 AFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRR 164

Query: 318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEV 377
                         +LG    L+   ISE  F G           L NL           
Sbjct: 165 L-------------DLGELKRLSY--ISEGAFEG-----------LSNL----------- 187

Query: 378 PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP--LIGLSTSL 435
                     + L ++  +L  +IP+ L  L  +  LD   N  +  I P    GL   L
Sbjct: 188 ----------RYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSA-IRPGSFQGL-MHL 233

Query: 436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
            +L +  ++      +    L +L  + L +NN +         L  L  +HL  N  
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 11/187 (5%)

Query: 94  SALQSLTVLSLPFNVLSGKLPLE-LSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFD 150
           + L +L  L L  N L+  +P       S LK L +  N  + S+P    + + +L   D
Sbjct: 109 NGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNP-IESIPSYAFNRIPSLRRLD 166

Query: 151 LS-INYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI 209
           L  +   +         L+ L  L++      E  IP ++  L  L  L L+  +L    
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IP-NLTPLIKLDELDLSGNHLSAIR 223

Query: 210 PESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQ 268
           P S   L  L  L + +++I      +   LQ L +I L  NNLT  LP +    L  L+
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282

Query: 269 EFDISSN 275
              +  N
Sbjct: 283 RIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 30/167 (17%), Positives = 60/167 (35%), Gaps = 15/167 (8%)

Query: 94  SALQSLTVLSLPFNVLSGKLPLEL-SNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFD 150
             L  L  L L  N +   +P    +   +L+ L++     +  + +     L NL   +
Sbjct: 133 VYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191

Query: 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI----PESIGNLKNLTYLFLAHCNLR 206
           L++       P     L +L  L +  N      +    P S   L +L  L++    ++
Sbjct: 192 LAMCNLR-EIPNLT-PLIKLDELDLSGN-----HLSAIRPGSFQGLMHLQKLWMIQSQIQ 244

Query: 207 GRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
                +   L+ L  +++  N ++         L  L +I L+ N  
Sbjct: 245 VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.9 bits (228), Expect = 3e-19
 Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 26/179 (14%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQLWKG-----DGVKVFAAEMEILGKI---RHRNI 733
           +IG GG G+VY    K + G + A+K L K       G  +   E  +L  +       I
Sbjct: 196 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAY 791
           + +            +L+ M  G+L   L +    G       R Y  +I LG    + +
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILG----LEH 307

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +H   +  +++RD+K +NILLDE    +I+D G+A   + S K        GTHGY+AP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKP--HASVGTHGYMAP 359

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 41/201 (20%), Positives = 73/201 (36%), Gaps = 44/201 (21%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKI-RHRNI 733
            E   IGSG  G V++   + +    A+K+  K     V       E+     + +H ++
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAKG 788
           ++ ++   +     +  EY   G+L  A+ +  +      E    D   +        +G
Sbjct: 74  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ------VGRG 127

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEP-------------------KIADFGVAKIA 829
           + Y+H   S  ++H DIK SNI +     P                   KI D G     
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 830 ENSPKVSDYSCFAGTHGYIAP 850
            +SP+V       G   ++A 
Sbjct: 185 -SSPQV-----EEGDSRFLAN 199

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.9 bits (221), Expect = 5e-19
 Identities = 46/187 (24%), Positives = 71/187 (37%), Gaps = 39/187 (20%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRNILK 735
           +GSG    V +   K      A K + K        G   +    E+ IL ++ H NI+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK------- 787
           L+          L+LE +  G LF  L    ++    E +          A         
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEE----------ATSFIKQILD 126

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
           G+ YLH   +  I H D+K  NI+L          K+ DFG+A   E+  +  +     G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180

Query: 844 THGYIAP 850
           T  ++AP
Sbjct: 181 TPEFVAP 187

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 87.2 bits (217), Expect = 5e-19
 Identities = 49/187 (26%), Positives = 73/187 (39%), Gaps = 39/187 (20%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRNILK 735
           +GSG    V +   K      A K + K        G   +    E+ IL +IRH NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK------- 787
           L+          L+LE +  G LF  L    ++    E +          A +       
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDE----------ATQFLKQILD 119

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
           G+ YLH   S  I H D+K  NI+L      +   K+ DFG+A   E   +  +     G
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFG 173

Query: 844 THGYIAP 850
           T  ++AP
Sbjct: 174 TPEFVAP 180

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 88.9 bits (221), Expect = 5e-19
 Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 20/175 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
            IG G  GKV  +         A+K + K      + V+    E++I+  + H  ++ L+
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
                    F+V++ +  G+L   L +       + +  + +  ++ +     + YL   
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMA----LDYLQ-- 132

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +  IIHRD+K  NILLDE     I DF +A       +    +  AGT  Y+AP
Sbjct: 133 -NQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITT-MAGTKPYMAP 183

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 30/181 (16%), Positives = 71/181 (39%), Gaps = 7/181 (3%)

Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422
               L      S     + A   ++  + +++ +++  +  G+    N+  L   +   T
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHAT 79

Query: 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ 482
              +P+ GL ++L +L +     + +    L  LT+L  L ++++     I + +  L +
Sbjct: 80  N-YNPISGL-SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK 137

Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
           ++S+ L  N     I   +     +  LN+  + +  +  R +     LN L      + 
Sbjct: 138 VNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIG 194

Query: 543 G 543
           G
Sbjct: 195 G 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 31/166 (18%), Positives = 60/166 (36%), Gaps = 11/166 (6%)

Query: 139 DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
            +++L  + + ++++   TG     +     +  L+I +     A     I  L NL  L
Sbjct: 42  QMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNI---HATNYNPISGLSNLERL 93

Query: 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
            +   ++      ++S L  L  LDI  +         I  L K+  I+L  N    ++ 
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153

Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGE 304
             L  L  L+  +I  + +       I +   L     F     G+
Sbjct: 154 P-LKTLPELKSLNIQFDGV-HDY-RGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 34/165 (20%), Positives = 68/165 (41%), Gaps = 7/165 (4%)

Query: 92  SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDL 151
           + + + SLT ++L    ++  L   +    N+K L +       +   +S L NLE   +
Sbjct: 39  TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIH-ATNYNPISGLSNLERLRI 95

Query: 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE 211
                T      +  LT L  L I  + +D++ +   I  L  +  + L++      I  
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL-TKINTLPKVNSIDLSYNGAITDI-M 153

Query: 212 SISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE 256
            +  L EL +L+I  + +     R I    KL ++  ++  + G+
Sbjct: 154 PLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 27/143 (18%), Positives = 54/143 (37%), Gaps = 7/143 (4%)

Query: 91  SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGS-VPDLSALKNLEIF 149
           + I    ++  L++     +   P  +S  SNL+ L + G  +    +P+LS L +L + 
Sbjct: 60  TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117

Query: 150 DLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI 209
           D+S +         +  L ++ S+ +  N          +  L  L  L +    +    
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYN--GAITDIMPLKTLPELKSLNIQFDGVHD-- 173

Query: 210 PESISELRELGTLDICRNKISGE 232
              I +  +L  L      I G+
Sbjct: 174 YRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 24/142 (16%), Positives = 60/142 (42%), Gaps = 6/142 (4%)

Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
            SL+ + L N   + +L + +    N++ L + N + +    + +  L  L  L +    
Sbjct: 44  NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKD 99

Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552
           +T      +     +  L+++ ++   +I   ++ L  +N+++LS N     I   L  L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158

Query: 553 K-LSSIDLSENQLSGSVPLDFL 573
             L S+++  + +     ++  
Sbjct: 159 PELKSLNIQFDGVHDYRGIEDF 180

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 14/103 (13%), Positives = 41/103 (39%), Gaps = 2/103 (1%)

Query: 76  TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
             +    K ++ +   ++S L SLT+L +  +     +  +++    +  ++++ N  + 
Sbjct: 91  ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150

Query: 136 SVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN 178
            +  L  L  L+  ++  +       R + +  +L  L     
Sbjct: 151 DIMPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.0 bits (141), Expect = 8e-10
 Identities = 26/133 (19%), Positives = 54/133 (40%), Gaps = 5/133 (3%)

Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
           ++    +      S        ++ +L  + L N N +  + + +     +  L +    
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77

Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552
            T   P  +   + +  L +    ++ +   +LS L+SL  L++S +    SI   +  L
Sbjct: 78  ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 553 -KLSSIDLSENQL 564
            K++SIDLS N  
Sbjct: 136 PKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 24/210 (11%), Positives = 60/210 (28%), Gaps = 34/210 (16%)

Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS 273
           S  +      + ++  +     +  ++  L  I L   N+T +L   +     +++  I+
Sbjct: 20  STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTIN 74

Query: 274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENL 333
           +          I  L NL   +    + + +       +  L    I  +         +
Sbjct: 75  NIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 334 GRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRIS 393
                +  +D+S N               + +++ L                 ++ L I 
Sbjct: 133 NTLPKVNSIDLSYNG-------------AITDIMPLKTL------------PELKSLNIQ 167

Query: 394 DNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
            + +      G+   P +  L        G
Sbjct: 168 FDGVH-DY-RGIEDFPKLNQLYAFSQTIGG 195

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.1 bits (219), Expect = 6e-19
 Identities = 56/179 (31%), Positives = 83/179 (46%), Gaps = 29/179 (16%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWK------GDGVKVFAAEMEILGKIRHRNI 733
            +G G  GKV    L  +  T   VA+K + +         ++V   E+  L  +RH +I
Sbjct: 16  TLGEGSFGKVK---LATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHI 71

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           +KLY  +       +V+EY   G LF  +   KR+ E   E   F +  I       I Y
Sbjct: 72  IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE--DEGRRFFQQIIC-----AIEY 123

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            H      I+HRD+K  N+LLD++   KIADFG++ I  +   +   SC  G+  Y AP
Sbjct: 124 CHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SC--GSPNYAAP 176

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 88.5 bits (220), Expect = 8e-19
 Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 29/171 (16%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA------EMEILGKIRHRNILKLY 737
           IG+G  G V++  L ++   VA+K        KV         E++I+  ++H N++ L 
Sbjct: 48  IGNGSFGVVFQAKLVES-DEVAIK--------KVLQDKRFKNRELQIMRIVKHPNVVDLK 98

Query: 738 ACLLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKP-ELDWFRRYKIALGAAKGIA 790
           A     G         LVLEY+P   +++A     K  +   +   + Y   L   + +A
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL--LRSLA 155

Query: 791 YLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSC 840
           Y+H   S  I HRDIK  N+LLD      K+ DFG AKI         Y C
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 87.3 bits (217), Expect = 8e-19
 Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 20/179 (11%)

Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQL---WKGDG--VKVFAAEMEILGKIRHRNILKL 736
           ++G GG  +V+   DL+ +   VAVK L      D      F  E +    + H  I+ +
Sbjct: 19  ILGFGGMSEVHLARDLRDHR-DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 737 Y----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           Y    A    G   ++V+EY+    L   +H     G   +   R  ++   A + + + 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GP--MTPKRAIEVIADACQALNFS 132

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
           H +    IIHRD+K +NI++      K+ DFG+A+ IA++   V+  +   GT  Y++P
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 27/213 (12%)

Query: 645 LSADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTV 704
           +   +   +++   KW+  S +   +D       +    +G+G  G+V  +  K++    
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKTLGTGSFGRVMLVKHKESGNHY 69

Query: 705 AVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLF 759
           A+K L K   VK+        E  IL  +    ++KL        + ++V+EY+  G +F
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 760 QALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE 817
             L +    G+      R Y  +I L       YLH   S  +I+RD+K  N+L+D+   
Sbjct: 130 SHLRR---IGRFSEPHARFYAAQIVLT----FEYLH---SLDLIYRDLKPENLLIDQQGY 179

Query: 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            ++ DFG AK  +            GT   +AP
Sbjct: 180 IQVTDFGFAKRVKGRTWT-----LCGTPEALAP 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 38/179 (21%), Positives = 61/179 (34%), Gaps = 31/179 (17%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLK 742
           +G G  G V+R     +  T   K +   G    +   E+ IL   RHRNIL L+     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKP--ELDWFRRYKIALGAAK-------GIAYLH 793
                ++ E++   ++F+ +           E +                     + +LH
Sbjct: 73  MEELVMIFEFISGLDIFERI---NTSAFELNERE----------IVSYVHQVCEALQFLH 119

Query: 794 HDCSPPIIHRDIKSSNILL--DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  I H DI+  NI+         KI +FG A+  +                Y AP
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 42/177 (23%), Positives = 71/177 (40%), Gaps = 27/177 (15%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLK 742
           +G G      +   KK+    AVK + K         E+  L     H NI+KL+     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK-EITALKLCEGHPNIVKLHEVFHD 77

Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY------KIALGAAKGIAYLHHDC 796
              +FLV+E +  G LF+ + K+           + +       I       ++++H   
Sbjct: 78  QLHTFLVMELLNGGELFERIKKK-----------KHFSETEASYIMRKLVSAVSHMH--- 123

Query: 797 SPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              ++HRD+K  N+L    +++ E KI DFG A++     +         T  Y AP
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAP 178

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 54/175 (30%), Positives = 72/175 (41%), Gaps = 19/175 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
           L+G G  GKV  +  K      A+K L K      D V     E  +L   RH  +  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHHD 795
                      V+EY   G LF  L +   E     +  R Y   I       + YLH  
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSA----LEYLH-- 122

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  +++RDIK  N++LD+D   KI DFG+ K  E     +    F GT  Y+AP
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 174

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 42/237 (17%), Positives = 86/237 (36%), Gaps = 18/237 (7%)

Query: 66  ITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKV 125
           I  D       +I+    +++     + + L  +T LS     ++  +   +   +NL  
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIG 67

Query: 126 LNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI 185
           L +  N  +  +  L  L  +   +LS N         +  L  + +L +      +   
Sbjct: 68  LELKDNQ-ITDLAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD--- 121

Query: 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWK 245
              +  L NL  L+L    +       ++ L  L  L I   ++S   P  +  L KL  
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT 177

Query: 246 IELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
           ++   N ++ ++   L +L  L E  + +NQ+       + N  NL +        +
Sbjct: 178 LKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT 230

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 50/256 (19%), Positives = 90/256 (35%), Gaps = 19/256 (7%)

Query: 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176
               +N   +    +  V      + L  +          T      V  L  L+ L + 
Sbjct: 15  DPALANAIKIAAGKSN-VTDTVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELK 71

Query: 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236
           DN   +      + NL  +T L L+   L  +   +I+ L+ + TLD+   +I+   P  
Sbjct: 72  DN---QITDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP-- 124

Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296
           +  L  L  + L  N +T  +   L  LT LQ   I + Q+       + NL  LT  + 
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQV--SDLTPLANLSKLTTLKA 180

Query: 297 FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKY 356
             N  S    S    +  L    +  N+ S      L   + L  V ++    + + P +
Sbjct: 181 DDNKISDI--SPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTIT-NQPVF 235

Query: 357 LCEKRKLLNLLALSNN 372
                 + N++   + 
Sbjct: 236 YNNNLVVPNVVKGPSG 251

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 52/319 (16%), Positives = 107/319 (33%), Gaps = 49/319 (15%)

Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
                L     +   ++ ++     +   L  +  +  +   +T  +   +  L  L   
Sbjct: 13  FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68

Query: 271 DISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP 330
           ++  NQ+       + NL  +T  +   N       S    ++ +    +   + +    
Sbjct: 69  ELKDNQI--TDLAPLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDV-- 122

Query: 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRL 390
             L   + L  + +  NQ +              N+  L+                +Q L
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT--------------NISPLAG------------LTNLQYL 156

Query: 391 RISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP 450
            I +  +S  +   L  L  +  L   DN  +  ISPL  L  +L ++ L+NN+ S    
Sbjct: 157 SIGNAQVS-DL-TPLANLSKLTTLKADDNKISD-ISPLASL-PNLIEVHLKNNQISDV-- 210

Query: 451 SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510
           S L   +NL  + LTN   + +       L   + +     A     P  + D     + 
Sbjct: 211 SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISD-----NG 263

Query: 511 NLARNSLSGNIPRSLSLLS 529
             A  +L+ N+   ++ +S
Sbjct: 264 TYASPNLTWNLTSFINNVS 282

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)

Query: 91  SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
             +  L +L  L L  N ++  L   L N + +  L ++GN  + +V  ++ L++++  D
Sbjct: 57  EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNP-LKNVSAIAGLQSIKTLD 113

Query: 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP 210
           L+    T   P  +  L+ L  L +  N   +      +  L NL YL + +  +     
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLN---QITNISPLAGLTNLQYLSIGNAQVSD--L 166

Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
             ++ L +L TL    NKIS   P  +  L  L ++ L  N ++   P  L N + L   
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222

Query: 271 DISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
            +++  +     + +    NL V    K  
Sbjct: 223 TLTNQTITN---QPVFYNNNLVVPNVVKGP 249

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 57/287 (19%), Positives = 110/287 (38%), Gaps = 43/287 (14%)

Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
            L N       K+N +        D+  +   S +G   +    E +     L  +++ +
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
           NQ +            L  L  L+                I  L +S N L  K    + 
Sbjct: 73  NQIT-----------DLAPLKNLTK---------------ITELELSGNPL--KNVSAIA 104

Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
            L ++  LD      T  ++PL GL ++L  L L  N+ +  + S L  LTNL+ L + N
Sbjct: 105 GLQSIKTLDLTSTQITD-VTPLAGL-SNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGN 160

Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526
              S  + + L  L +L++L  ++N ++  I   +     +++++L  N +S ++   L+
Sbjct: 161 AQVS-DL-TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVS-PLA 214

Query: 527 LLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFL 573
             S+L  + L+   +T + P       +    +     +   P    
Sbjct: 215 NTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGAPIAPATIS 260

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 47/246 (19%), Positives = 81/246 (32%), Gaps = 20/246 (8%)

Query: 127 NVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP 186
           ++T    +  +    AL N        +  T        +L  + +LS            
Sbjct: 2   SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGT---GVTTI 56

Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKI 246
           E +  L NL  L L    +       +  L ++  L++  N +       I  LQ +  +
Sbjct: 57  EGVQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTL 112

Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP 306
           +L +  +T   P  L  L+ LQ   +  NQ+       +  L NL          S    
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDL-- 166

Query: 307 SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL 366
           +   ++ KL       N+ S      L     L +V +  NQ S   P         L +
Sbjct: 167 TPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP---LANTSNLFI 221

Query: 367 LALSNN 372
           + L+N 
Sbjct: 222 VTLTNQ 227

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 50/315 (15%), Positives = 109/315 (34%), Gaps = 50/315 (15%)

Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
            L   + ++ G +   +     +  +L  +T L      +   I E +  L  L  L++ 
Sbjct: 17  ALANAIKIAAGKSNVTD---TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELK 71

Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI 285
            N+I+   P  ++ L K+ ++EL  N L   + A +  L  ++  D++S Q+       +
Sbjct: 72  DNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTPL 125

Query: 286 GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDIS 345
             L NL V     N  +    S    +  L   SI   + S      L   + LT +   
Sbjct: 126 AGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKAD 181

Query: 346 ENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL 405
           +N+ S              ++  L++               +  + + +N +S   P  L
Sbjct: 182 DNKIS--------------DISPLASL------------PNLIEVHLKNNQISDVSP--L 213

Query: 406 WALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT 465
               N+ ++   +   T         +  +  +V   +       + +   T  +     
Sbjct: 214 ANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS------GAPIAPATISDNGTYA 266

Query: 466 NNNFSGKIPSALGAL 480
           + N +  + S +  +
Sbjct: 267 SPNLTWNLTSFINNV 281

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 48/188 (25%), Positives = 81/188 (43%), Gaps = 40/188 (21%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWK---------GDGVKVFAAEMEILGKIRH 730
           L+GSGG G VY             VA+K + K          +G +V   E+ +L K+  
Sbjct: 50  LLGSGGFGSVY---SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSS 105

Query: 731 R--NILKLYACLLKGGSSFLVLEY-MPNGNLFQ--ALHKRVKEGKPELDWFRRY--KIAL 783
               +++L     +  S  L+LE   P  +LF        ++E        R +  ++  
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-----RSFFWQVL- 159

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAENSPKVSDYSCFA 842
              + + + H+     ++HRDIK  NIL+D +  E K+ DFG   + +++     Y+ F 
Sbjct: 160 ---EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFD 209

Query: 843 GTHGYIAP 850
           GT  Y  P
Sbjct: 210 GTRVYSPP 217

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 57/179 (31%), Positives = 84/179 (46%), Gaps = 23/179 (12%)

Query: 683 LIGSGGTGKVY--RLDLKKNAGTV-AVKQLWK------GDGVKVFAAEMEILGKIRHRNI 733
           ++G GG GKV+  R     N G + A+K L K              AE  IL +++H  I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAY 791
           + L      GG  +L+LEY+  G LF  L +   EG    D    Y  +I++     + +
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMA----LGH 136

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           LH      II+RD+K  NI+L+     K+ DFG+ K  E+    +    F GT  Y+AP
Sbjct: 137 LH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAP 190

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 47/187 (25%), Positives = 72/187 (38%), Gaps = 39/187 (20%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRNILK 735
           +GSG    V +   K      A K + K        G   +    E+ IL +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK------- 787
           L+          L+LE +  G LF  L    ++    E +          A +       
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEE----------ATEFLKQILN 125

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
           G+ YLH   S  I H D+K  NI+L          KI DFG+A   +   +  +     G
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFG 179

Query: 844 THGYIAP 850
           T  ++AP
Sbjct: 180 TPEFVAP 186

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 88.0 bits (218), Expect = 3e-18
 Identities = 34/171 (19%), Positives = 65/171 (38%), Gaps = 14/171 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLL 741
           +G+G  G V+R+  +      A K +        +    E++ +  +RH  ++ L+    
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
                 ++ E+M  G LF+ +         E +     +      KG+ ++H       +
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVC---KGLCHMH---ENNYV 277

Query: 802 HRDIKSSNILLDEDYEP--KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H D+K  NI+         K+ DFG+    +    V       GT  + AP
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAP 325

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 85.3 bits (212), Expect = 4e-18
 Identities = 57/178 (32%), Positives = 90/178 (50%), Gaps = 23/178 (12%)

Query: 683 LIGSGGTGKVY--RLDLKKNAGTV-AVKQLWKG-----DGVKVFAAEMEILGKIRHRNIL 734
           ++G G  GKV+  +     +A  + A+K L K      D V+    E +IL ++ H  I+
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIV 89

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYL 792
           KL+      G  +L+L+++  G+LF  L K   E     +  + Y  ++AL     + +L
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALA----LDHL 142

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  II+RD+K  NILLDE+   K+ DFG++K  E+         F GT  Y+AP
Sbjct: 143 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAP 195

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 85.9 bits (213), Expect = 6e-18
 Identities = 42/182 (23%), Positives = 72/182 (39%), Gaps = 34/182 (18%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYA---- 738
           +G G  GKV ++  K+     A+K L      +    E+E+  +  +  +I+++      
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---REVELHWRASQCPHIVRIVDVYEN 126

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA-------KGIAY 791
                    +V+E +  G LF  +  R  +   E +          A+       + I Y
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE----------ASEIMKSIGEAIQY 176

Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           LH   S  I HRD+K  N+L      +   K+ DFG AK   +   ++       T  Y+
Sbjct: 177 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYV 230

Query: 849 AP 850
           AP
Sbjct: 231 AP 232

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 85.0 bits (211), Expect = 6e-18
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 33/180 (18%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGK-IRHRNILKLYACL 740
           IG G      R   K      AVK + K   D  +    E+EIL +  +H NI+ L    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85

Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY------KIALGAAKGIAYLHH 794
             G   ++V E M  G L   + ++             +       +     K + YLH 
Sbjct: 86  DDGKYVYVVTELMKGGELLDKILRQKF-----------FSEREASAVLFTITKTVEYLH- 133

Query: 795 DCSPPIIHRDIKSSNILL---DEDYEP-KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             +  ++HRD+K SNIL      + E  +I DFG AK       +        T  ++AP
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAP 189

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 18/164 (10%), Positives = 46/164 (28%), Gaps = 21/164 (12%)

Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDG-----VKVFAAEMEILGKIRHRNILKL 736
             G     + ++ LD   +   VA+  +          ++   +    L +I    + ++
Sbjct: 38  FHGGVPPLQFWQALDTALDR-QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
              +       +V E++  G+L +                   +     A      H   
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA- 148

Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD-YS 839
              +       S + +  D +  +A        + +P+  D   
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPATM--PDANPQ-DDIRG 187

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 85.5 bits (211), Expect = 3e-17
 Identities = 53/176 (30%), Positives = 80/176 (45%), Gaps = 20/176 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
           ++G G  GKV   + K      AVK L K      D V+    E  +L    +   + +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
           ++C       + V+EY+  G+L   + +    G+ +      Y   IA+G    + +L  
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIG----LFFLQ- 459

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             S  II+RD+K  N++LD +   KIADFG+ K  EN         F GT  YIAP
Sbjct: 460 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAP 511

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.9 bits (205), Expect = 6e-17
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 26/162 (16%)

Query: 684 IGSGGTGKVY--RLDLKKNAGTVAVKQLWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G G  G VY  +    K+    A+KQ+ +G G+ + A  E+ +L +++H N++ L    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACREIALLRELKHPNVISLQKVF 87

Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK--------GIA 790
           L       +L+ +Y         L   +K  +      +  ++  G  K        GI 
Sbjct: 88  LSHADRKVWLLFDYAE-----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKI 828
           YLH +    ++HRD+K +NIL+  +       KIAD G A++
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.9 bits (203), Expect = 6e-17
 Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 11/154 (7%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNI 733
              + + +G G    VY+   K     VA+K+  L   +G    A  E+ +L  ++H NI
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           + L+  +    S  LV EY+      + L + + +    ++            +G+AY H
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                 ++HRD+K  N+L++E  E K+ADFG+A+
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLAR 148

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 82.5 bits (204), Expect = 6e-17
 Identities = 53/263 (20%), Positives = 96/263 (36%), Gaps = 28/263 (10%)

Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFS----GSFPKYLCEKRKLLNL--LALSNN 372
            +  NR +     +L R   L  + ++ N  +     SF         L +L  L LS N
Sbjct: 58  DLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSF-------SSLGSLEHLDLSYN 110

Query: 373 FSGEVPNS-YADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISP--L 428
           +   + +S +    ++  L +  N         L++ L  + +L  G+ D    I     
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 429 IGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHL 488
            GL T L +L +  +      P  L  + N+  LIL        +   +     +  L L
Sbjct: 171 AGL-TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229

Query: 489 EENALTGSIPNEM--GDCARIVDL-NLARNSLSGN----IPRSLSLLSSLNALNLSGNKL 541
            +  L     +E+  G+   ++         ++      + + L+ +S L  L  S N+L
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQL 289

Query: 542 TGSIPDNLMKL--KLSSIDLSEN 562
             S+PD +      L  I L  N
Sbjct: 290 K-SVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 82.1 bits (203), Expect = 7e-17
 Identities = 45/291 (15%), Positives = 91/291 (31%), Gaps = 25/291 (8%)

Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
             IP  +   + +  L L++  +       +     L  L +  N I+     S   L  
Sbjct: 44  NSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101

Query: 243 LWKIELYANNLTGELPAEL-GNLTLLQEFDISSNQMYGKLPEEI--GNLKNLTVFQCFKN 299
           L  ++L  N L+  L +     L+ L   ++  N  Y  L E     +L  L + +    
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNP-YKTLGETSLFSHLTKLQILRVGNM 159

Query: 300 NFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
           +   +     F  +  L    I  +      P++L     ++ + +   Q      +   
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFV 218

Query: 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
           +    +  L L +                       + LS    + L        +   D
Sbjct: 219 DVTSSVECLELRDTDLDTFH---------------FSELSTGETNSLIKKFTFRNVKITD 263

Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNF 469
                 +  L  + + L +L    N+          RLT+L+++ L  N +
Sbjct: 264 ESLFQVMKLLNQI-SGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 79.8 bits (197), Expect = 4e-16
 Identities = 56/309 (18%), Positives = 114/309 (36%), Gaps = 21/309 (6%)

Query: 82  NKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-- 139
           + SL+  I S ++   ++  L L  N ++     +L  C NL+ L +T N +  ++ +  
Sbjct: 40  SGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95

Query: 140 LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLF 199
            S+L +LE  DLS NY +     W   L+ L  L++  N Y          +L  L  L 
Sbjct: 96  FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155

Query: 200 LAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
           + + +   +I     + L  L  L+I  + +    P+S++ +Q +  + L+       L 
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215

Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEI-----GNLKNLTVFQ--CFKNNFSGEFPSGFGD 311
             +   + ++  ++    +      E+      +L     F+     +    +       
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQ 275

Query: 312 MRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSN 371
           +  L       N+          R T+L  + +  N +        C   ++  L    N
Sbjct: 276 ISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD-------CSCPRIDYLSRWLN 328

Query: 372 NFSGEVPNS 380
             S +   S
Sbjct: 329 KNSQKEQGS 337

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 47/309 (15%), Positives = 96/309 (31%), Gaps = 51/309 (16%)

Query: 202 HCNLRGR----IPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
            C         IP  ++E   + +LD+  N+I+      +++   L  + L +N +   +
Sbjct: 35  ICKGSSGSLNSIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TI 91

Query: 258 PAEL-GNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFPSG-FGDMRK 314
             +   +L  L+  D+S N +   L       L +LT      N +     +  F  + K
Sbjct: 92  EEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK 150

Query: 315 LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL---SN 371
           L    +                   T   I    F+G           L  L  L   ++
Sbjct: 151 LQILRVGNMD-------------TFTK--IQRKDFAG-----------LTFLEELEIDAS 184

Query: 372 NFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDND--------FT 422
           +     P S    + +  L +        + +       +V  L+  D D         +
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243

Query: 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ 482
            G +  +    +   + + +     ++   L +++ L  L  + N            L  
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTS 302

Query: 483 LSSLHLEEN 491
           L  + L  N
Sbjct: 303 LQKIWLHTN 311

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.4 bits (202), Expect = 6e-17
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 12/148 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
           IG G  G V++   ++    VA+K++      +GV   A  E+ +L +++H+NI++L+  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           L       LV E+       Q L K       +LD            KG+ + H      
Sbjct: 70  LHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAK 827
           ++HRD+K  N+L++ + E K+A+FG+A+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR 149

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 82.3 bits (204), Expect = 6e-17
 Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 20/176 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
           +IG G   KV  + LKK     A+K + K      + +     E  +  +   H  ++ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
           ++C       F V+EY+  G+L   + +   + K   +  R Y   I+L     + YLH 
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLA----LNYLH- 127

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                II+RD+K  N+LLD +   K+ D+G+ K  E        S F GT  YIAP
Sbjct: 128 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 179

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 6e-17
 Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 8/147 (5%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
           +G+G    VY+   K     VA+K+  L   +G    A  E+ ++ +++H NI++LY  +
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72

Query: 741 LKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
                  LV E+M N +L + +  + V      L+            +G+A+ H +    
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVA 826
           I+HRD+K  N+L+++  + K+ DFG+A
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 7e-17
 Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 21/165 (12%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           IGSG  G V           VA+K+L +    +  A     E+ ++  + H+NI+ L   
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129

Query: 740 LLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                +       +LV+E M   NL Q +   +   +     +  Y++      GI +LH
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS---YLLYQML----CGIKHLH 181

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
              S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 81.4 bits (202), Expect = 7e-17
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 22/175 (12%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLY 737
            +G+G  G+V+ +  + N    A+K L K   V++        E  +L  + H  I++++
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
                    F++++Y+  G LF  L K     +      + Y  ++ L     + YLH  
Sbjct: 73  GTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLA----LEYLH-- 123

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            S  II+RD+K  NILLD++   KI DFG AK   +      Y+   GT  YIAP
Sbjct: 124 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT-LCGTPDYIAP 172

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 81.2 bits (201), Expect = 8e-17
 Identities = 48/190 (25%), Positives = 73/190 (38%), Gaps = 42/190 (22%)

Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWK---------GDGVKVFAAEMEILGKIR- 729
           L+G GG G V+             VA+K + +          D V     E+ +L K+  
Sbjct: 38  LLGKGGFGTVF---AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGA 93

Query: 730 ---HRNILKLYACLLKGGSSFLVLEY-MPNGNLFQ--ALHKRVKEGKPELDWFRRY--KI 781
              H  +++L           LVLE  +P  +LF        + EG       R +  ++
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-----RCFFGQV 148

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAENSPKVSDYSC 840
                  I + H      ++HRDIK  NIL+D      K+ DFG   +  + P    Y+ 
Sbjct: 149 VAA----IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTD 197

Query: 841 FAGTHGYIAP 850
           F GT  Y  P
Sbjct: 198 FDGTRVYSPP 207

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 83.6 bits (206), Expect = 9e-17
 Identities = 41/282 (14%), Positives = 90/282 (31%), Gaps = 42/282 (14%)

Query: 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176
               +     N+   + V      + L +++    + +           ++  +      
Sbjct: 17  DDAFAETIKDNLKKKS-VTDAVTQNELNSIDQIIANNS-----------DIKSV------ 58

Query: 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236
                     + I  L N+T LFL    L   I + ++ L+ LG L +  NKI  +   S
Sbjct: 59  ----------QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLS-S 104

Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296
           ++ L+KL  + L  N ++ ++   L +L  L+   + +N++       +  L  L     
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 160

Query: 297 FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKY 356
             N  S         + KL    +  N  S      L     L  +++   +       +
Sbjct: 161 EDNQISDI--VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINH 216

Query: 357 LCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS 398
                    +     +     P   +D    ++  +  +   
Sbjct: 217 QSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 81.3 bits (200), Expect = 5e-16
 Identities = 61/287 (21%), Positives = 105/287 (36%), Gaps = 18/287 (6%)

Query: 75  VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
           + +I  +N  +   +   I  L ++T L L  N L+   P  L+N  NL  L +  N  +
Sbjct: 45  IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK-I 99

Query: 135 GSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKN 194
             +  L  LK L+   L  N  +      +V+L QL SL +G+N   +      +  L  
Sbjct: 100 KDLSSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNN---KITDITVLSRLTK 154

Query: 195 LTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254
           L  L L    +   I   ++ L +L  L + +N IS    R++  L+ L  +EL++    
Sbjct: 155 LDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECL 210

Query: 255 GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK 314
            +      NL +      +   +    PE I +  +       K +             +
Sbjct: 211 NKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPN-VKWHLPEFTNEVSFIFYQ 267

Query: 315 LFAFSIYGNRFSGPFPENLGR-YTALTDVDISENQFSGSFPKYLCEK 360
                    RF G   + L   YT   DVD +  +        +   
Sbjct: 268 PVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAP 314

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 80.9 bits (199), Expect = 6e-16
 Identities = 43/185 (23%), Positives = 83/185 (44%), Gaps = 15/185 (8%)

Query: 382 ADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQ 441
                  +  +    ++  +      L ++  +   ++D    +  +  L  ++++L L 
Sbjct: 18  DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYL-PNVTKLFLN 73

Query: 442 NNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501
            N+ +      L  L NL  L L  N     + S+L  L++L SL LE N ++  I   +
Sbjct: 74  GNKLTDI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-L 127

Query: 502 GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLS 560
               ++  L L  N ++ +I   LS L+ L+ L+L  N+++  I   L  L KL ++ LS
Sbjct: 128 VHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLS 183

Query: 561 ENQLS 565
           +N +S
Sbjct: 184 KNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 76.7 bits (188), Expect = 1e-14
 Identities = 47/235 (20%), Positives = 99/235 (42%), Gaps = 17/235 (7%)

Query: 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRL 390
                +      ++ +   + +  +        ++ +  +N+    V         + +L
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVTQNELNS---IDQIIANNSDIKSVQG-IQYLPNVTKL 70

Query: 391 RISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP 450
            ++ N L+  I   L  L N+G L   +N     +S L  L   L  L L++N  S ++ 
Sbjct: 71  FLNGNKLT-DIK-PLTNLKNLGWLFLDENKIKD-LSSLKDL-KKLKSLSLEHNGIS-DIN 125

Query: 451 SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510
             L  L  LE L L NN  +    + L  L +L +L LE+N ++  I   +    ++ +L
Sbjct: 126 G-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 180

Query: 511 NLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQL 564
            L++N +S ++  +L+ L +L+ L L   +      ++   L   +++  ++  L
Sbjct: 181 YLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 69.8 bits (170), Expect = 2e-12
 Identities = 53/321 (16%), Positives = 100/321 (31%), Gaps = 44/321 (13%)

Query: 219 LGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY 278
           +G        I   FP       +  K  L   ++T  +      L  + +   +++ + 
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI- 55

Query: 279 GKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338
             + + I  L N+T      N  +   P    +++ L    +  N+       +L     
Sbjct: 56  KSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKK 110

Query: 339 LTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS 398
           L  + +  N  S              ++  L +               ++ L + +N ++
Sbjct: 111 LKSLSLEHNGIS--------------DINGLVH------------LPQLESLYLGNNKIT 144

Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458
                 L  L  +  L   DN  +  I PL GL T L  L L  N  S +L   L  L N
Sbjct: 145 --DITVLSRLTKLDTLSLEDNQISD-IVPLAGL-TKLQNLYLSKNHIS-DL-RALAGLKN 198

Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
           L+ L L +     K  +    L   +++   + +L    P  + D       N+  +   
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256

Query: 519 GNIPRSLSLLSSLNALNLSGN 539
                S      +        
Sbjct: 257 FTNEVSFIFYQPVTIGKAKAR 277

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 69.4 bits (169), Expect = 3e-12
 Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 13/168 (7%)

Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
           A       +      T        L  S+ Q++  N+     +   +  L N+ +L L  
Sbjct: 19  AFAETIKDNLKKKSVTD-AVTQNEL-NSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74

Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526
           N  +  I   L  L+ L  L L+EN +   + + + D  ++  L+L  N +S +I   L 
Sbjct: 75  NKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-GLV 128

Query: 527 LLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL 573
            L  L +L L  NK+T      L +L KL ++ L +NQ+S  VPL  L
Sbjct: 129 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVPLAGL 174

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 20/176 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
           +IG G   KV  + LKK     A++ + K      + +     E  +  +   H  ++ L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
           ++C       F V+EY+  G+L   + +   + K   +  R Y   I+L     + YLH 
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLA----LNYLH- 170

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                II+RD+K  N+LLD +   K+ D+G+ K  E        S F GT  YIAP
Sbjct: 171 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 222

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 52/177 (29%), Positives = 79/177 (44%), Gaps = 24/177 (13%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           IGSG  G V           VA+K+L +    +  A     E+ ++  + H+NI+ L   
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92

Query: 740 LLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                S       ++V+E M   NL Q +   +   +     +  Y++      GI +LH
Sbjct: 93  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS---YLLYQML----CGIKHLH 144

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  IIHRD+K SNI++  D   KI DFG+A+ A  S  ++ Y     T  Y AP
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAP 195

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 80.6 bits (200), Expect = 1e-16
 Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 11/150 (7%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLY 737
             IG G  G VY+   K     VA+K++    + +GV   A  E+ +L ++ H NI+KL 
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
             +      +LV E++   +L + +      G P     + Y   L   +G+A+ H    
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL-PLIKSYLFQL--LQGLAFCHSHR- 123

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             ++HRD+K  N+L++ +   K+ADFG+A+
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 53/176 (30%), Positives = 80/176 (45%), Gaps = 20/176 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
           ++G G  GKV   + K      AVK L K      D V+    E  +L    +   + +L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
           ++C       + V+EY+  G+L   + +    G+ +      Y   IA+G    + +L  
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIG----LFFLQ- 138

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             S  II+RD+K  N++LD +   KIADFG+ K  EN         F GT  YIAP
Sbjct: 139 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAP 190

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 53/176 (30%), Positives = 77/176 (43%), Gaps = 20/176 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
           ++G G  GKV    +K+     AVK L K      D V+    E  IL     H  + +L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
           + C       F V+E++  G+L   + K     + +    R Y   I       + +LH 
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISA----LMFLH- 141

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                II+RD+K  N+LLD +   K+ADFG+ K  E        + F GT  YIAP
Sbjct: 142 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAP 193

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 41/169 (24%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL------WKGDGVKVFAA-EMEILGKIRHR 731
           E+ + +G G    VY+   K     VA+K++         DG+   A  E+++L ++ H 
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELD---WFRRYKIALGAA-- 786
           NI+ L        +  LV ++M                  E D     +   + L  +  
Sbjct: 73  NIIGLLDAFGHKSNISLVFDFM------------------ETDLEVIIKDNSLVLTPSHI 114

Query: 787 --------KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                   +G+ YLH      I+HRD+K +N+LLDE+   K+ADFG+AK
Sbjct: 115 KAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 28/217 (12%)

Query: 646 SADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVY--RLDLKKNAGT 703
              +   + E+ +         + I+     N E   ++G+G  GKV+  R     + G 
Sbjct: 29  GEQLLTVKHELRTANLTGHAEKVGIE-----NFELLKVLGTGAYGKVFLVRKISGHDTGK 83

Query: 704 V-AVKQLWK------GDGVKVFAAEMEILGKIRHRN-ILKLYACLLKGGSSFLVLEYMPN 755
           + A+K L K          +    E ++L  IR    ++ L+          L+L+Y+  
Sbjct: 84  LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 143

Query: 756 GNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813
           G LF  L +     +      + Y  +I L     + +LH      II+RDIK  NILLD
Sbjct: 144 GELFTHLSQ---RERFTEHEVQIYVGEIVLA----LEHLH---KLGIIYRDIKLENILLD 193

Query: 814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            +    + DFG++K          Y  F GT  Y+AP
Sbjct: 194 SNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAP 229

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 57/176 (32%), Positives = 82/176 (46%), Gaps = 20/176 (11%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGK-IRHRNILKL 736
           ++G G  GKV+  + KK     A+K L K      D V+    E  +L     H  +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
           +       + F V+EY+  G+L   +       K +L     Y   I LG    + +LH 
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILG----LQFLH- 135

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             S  I++RD+K  NILLD+D   KIADFG+ K  EN    +  + F GT  YIAP
Sbjct: 136 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAP 187

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 79.5 bits (197), Expect = 3e-16
 Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 12/147 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAA-EMEILGKIRHRNILKLYAC 739
           IG G  G V++   +     VA+K+  +      +K  A  E+ +L +++H N++ L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
             +     LV EY  +  +   L  R + G PE    +         + + + H      
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHL-VKSITWQT--LQAVNFCHKHN--- 122

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVA 826
            IHRD+K  NIL+ +    K+ DFG A
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFA 149

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 58/177 (32%), Positives = 78/177 (44%), Gaps = 22/177 (12%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQLWKG-----DGVKVFAAEMEILGK-IRHRNILK 735
           +IG G  GKV  L   K      AVK L K         K   +E  +L K ++H  ++ 
Sbjct: 45  VIGKGSFGKVL-LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLH 793
           L+         + VL+Y+  G LF  L +   E        R Y  +IA      + YLH
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASA----LGYLH 156

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  I++RD+K  NILLD      + DFG+ K  EN    S  S F GT  Y+AP
Sbjct: 157 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAP 208

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 43/149 (28%), Positives = 66/149 (44%), Gaps = 12/149 (8%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAA-EMEILGKIRHRNILKLY 737
            L+G G  G V +   K     VA+K+  +      VK  A  E+++L ++RH N++ L 
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
               K    +LV E++        +   ++     LD+    K       GI + H    
Sbjct: 91  EVCKKKKRWYLVFEFVD-----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN- 144

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA 826
             IIHRDIK  NIL+ +    K+ DFG A
Sbjct: 145 --IIHRDIKPENILVSQSGVVKLCDFGFA 171

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 78.9 bits (195), Expect = 5e-16
 Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 31/159 (19%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYA---- 738
           +G G  GKV ++  K+     A+K L      +    E+E+  +  +  +I+++      
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---REVELHWRASQCPHIVRIVDVYEN 82

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA-------KGIAY 791
                    +V+E +  G LF  +  R  +   E +          A+       + I Y
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE----------ASEIMKSIGEAIQY 132

Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAK 827
           LH   S  I HRD+K  N+L      +   K+ DFG AK
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 77.7 bits (192), Expect = 8e-16
 Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 34/217 (15%)

Query: 386 TIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFT----GGISPLIGLSTSLSQLVL 440
           + + L +S N L   +    +   P + +LD    +      G    L    + LS L+L
Sbjct: 29  STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL----SHLSTLIL 83

Query: 441 QNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIP 498
             N     L       L++L++L+    N +  + +  +G L+ L  L++  N +  S  
Sbjct: 84  TGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFK 140

Query: 499 NEMGDCARIV---DLNLARN---SLSGNIPRSLSLLSSLNA-LNLSGNKLTGSIPDNL-M 550
                 + +     L+L+ N   S+     R L  +  LN  L+LS N +   I      
Sbjct: 141 -LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198

Query: 551 KLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
           +++L  + L  NQL  SVP        DG F     L
Sbjct: 199 EIRLKELALDTNQLK-SVP--------DGIFDRLTSL 226

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 35/184 (19%), Positives = 59/184 (32%), Gaps = 21/184 (11%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHL 488
            L  S   L L  N               L+ L L+       I   A  +L  LS+L L
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLIL 83

Query: 489 EENALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP- 546
             N +  S+        + +  L     +L+      +  L +L  LN++ N +  S   
Sbjct: 84  TGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKL 141

Query: 547 ----DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLT 602
                NL  L+   +DLS N++  S+                  + L   +  L  + + 
Sbjct: 142 PEYFSNLTNLE--HLDLSSNKIQ-SIY--------CTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 603 ACPA 606
               
Sbjct: 191 FIQP 194

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 46/218 (21%)

Query: 335 RYTALTDVDISENQFS----GSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKTI 387
            +  L  +D+S  +      G++       + L +L  L L+ N    +   +++   ++
Sbjct: 50  SFPELQVLDLSRCEIQTIEDGAY-------QSLSHLSTLILTGNPIQSLALGAFSGLSSL 102

Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF-S 446
           Q+L   + +L+  + +             G             L  +L +L + +N   S
Sbjct: 103 QKLVAVETNLA-SLENFP----------IG------------HL-KTLKELNVAHNLIQS 138

Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL----SSLHLEENALTGSIPNEMG 502
            +LP     LTNLE L L++N       + L  L Q+     SL L  N +   I     
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197

Query: 503 DCARIVDLNLARNSLSGNIPR-SLSLLSSLNALNLSGN 539
              R+ +L L  N L  ++P      L+SL  + L  N
Sbjct: 198 KEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 43/195 (22%), Positives = 77/195 (39%), Gaps = 14/195 (7%)

Query: 90  SSSISALQSLTVLSLPFNVLSGKLPLEL-SNCSNLKVLNVTGNAMVGSVPD--LSALKNL 146
           S S  +   L VL L    +   +      + S+L  L +TGN  + S+     S L +L
Sbjct: 45  SYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN-PIQSLALGAFSGLSSL 102

Query: 147 EIFDLSINYFTGRFPRWV-VNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNL 205
           +               +   +L  L  L++  N+    ++PE   NL NL +L L+   +
Sbjct: 103 QKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

Query: 206 RGRIPESI-SELREL----GTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE 260
           +  I  +    L ++     +LD+  N ++        K  +L ++ L  N L       
Sbjct: 162 Q-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGI 219

Query: 261 LGNLTLLQEFDISSN 275
              LT LQ+  + +N
Sbjct: 220 FDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 40/255 (15%), Positives = 76/255 (29%), Gaps = 53/255 (20%)

Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFK 298
            + L    L  N L         +   LQ  D+S  ++   + +    +L +L+      
Sbjct: 30  TKNLD---LSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTG 85

Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
           N                   S+    FSG         ++L  +   E   + S   +  
Sbjct: 86  NPIQ----------------SLALGAFSGL--------SSLQKLVAVETNLA-SLENFPI 120

Query: 359 EKRKLLNLLALSNNF--SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDF 416
              K L  L +++N   S ++P  +++   ++ L +S N         + ++        
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK--------IQSIYC------ 166

Query: 417 GDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSA 476
              D       L  +      L L  N  +  +     +   L+ L L  N         
Sbjct: 167 --TDLRV----LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGI 219

Query: 477 LGALRQLSSLHLEEN 491
              L  L  + L  N
Sbjct: 220 FDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 47.7 bits (114), Expect = 8e-06
 Identities = 48/247 (19%), Positives = 83/247 (33%), Gaps = 38/247 (15%)

Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
            +IP+++    +   L L+   LR     S     EL  LD+ R +I      + + L  
Sbjct: 20  YKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77

Query: 243 LWKIELYANNLTGELPAEL-GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
           L  + L  N +   L       L+ LQ+                  L +L          
Sbjct: 78  LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETN-----------LASL---------- 115

Query: 302 SGEFPSG-FGDMRKLFAFSIYGNRF-SGPFPENLGRYTALTDVDISENQFS----GSFPK 355
                +   G ++ L   ++  N   S   PE     T L  +D+S N+           
Sbjct: 116 ----ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171

Query: 356 YLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGML 414
            L +   L   L LS N    +         ++ L +  N L   +PDG++  L ++  +
Sbjct: 172 -LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKI 229

Query: 415 DFGDNDF 421
               N +
Sbjct: 230 WLHTNPW 236

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.8 bits (195), Expect = 9e-16
 Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 40/165 (24%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLY-- 737
           IG G  G+V++   +K    VA+K++    + +G  + A  E++IL  ++H N++ L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 738 ------ACLLKGGSSFLVLEYM----------PNGNLFQALHKRVKEGKPELDWFRRYKI 781
                       GS +LV ++                  +  K               ++
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK---------------RV 129

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
                 G+ Y+H +    I+HRD+K++N+L+  D   K+ADFG+A
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 39/200 (19%), Positives = 79/200 (39%), Gaps = 16/200 (8%)

Query: 386 TIQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQN 442
           + Q L++ + HL   IP      LPN+  +    +     +       L + ++ + ++N
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNL-SKVTHIEIRN 89

Query: 443 NRFSGELPSE-LGRLTNLERLILTNNNFSGKIP--SALGALRQLSSLHLEENALTGSIPN 499
            R    +  + L  L  L+ L + N       P  + + +      L + +N    SIP 
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 500 EM--GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNL---MKLKL 554
               G C   + L L  N  + ++       + L+A+ L+ NK    I  +    +    
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207

Query: 555 SSIDLSENQLSGSVPLDFLR 574
           S +D+S+  ++ ++P   L 
Sbjct: 208 SLLDVSQTSVT-ALPSKGLE 226

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 26/161 (16%), Positives = 51/161 (31%), Gaps = 17/161 (10%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHL 488
            L  S   L L               L N+ R+ ++ +    ++ S +   L +++ + +
Sbjct: 28  SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87

Query: 489 EENALTGSIPNEM-GDCARIVDLNLARNSLSGNIP--RSLSLLSSLNALNLSGNKLTGSI 545
                   I  +   +   +  L +    L    P    +        L ++ N    SI
Sbjct: 88  RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146

Query: 546 PDNL---MKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAG 583
           P N    +  +  ++ L  N  + SV           AF G
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFT-SVQ--------GYAFNG 178

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 37/207 (17%), Positives = 77/207 (37%), Gaps = 18/207 (8%)

Query: 364 LNLLALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGL-WALPNVGMLDFGDNDF 421
              L L       +P +++++   I R+ +S +    ++     + L  V  ++  +   
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 422 TGGISP--LIGLSTSLSQLVLQNNRFSGELPSE--LGRLTNLERLILTNNNFSGKIPSAL 477
              I P  L  L   L  L + N       P    +        L +T+N +   IP   
Sbjct: 93  LTYIDPDALKEL-PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

Query: 478 --GALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL--SLLSSLNA 533
             G   +  +L L  N  T S+     +  ++  + L +N     I +     + S  + 
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209

Query: 534 LNLSGNKLTGSIP----DNLMKLKLSS 556
           L++S   +T ++P    ++L +L   +
Sbjct: 210 LDVSQTSVT-ALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 36/219 (16%), Positives = 64/219 (29%), Gaps = 18/219 (8%)

Query: 94  SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDL 151
           S   S   L L    L        SN  N+  + V+ +  +  +       L  +   ++
Sbjct: 28  SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87

Query: 152 SINYFTGRFPRWV-VNLTQLVSLSIGDNVYDEAEIPE--SIGNLKNLTYLFLAHCNLRGR 208
                           L  L  L I +        P+   + +      L +        
Sbjct: 88  RNTRNLTYIDPDALKELPLLKFLGIFNT--GLKMFPDLTKVYSTDIFFILEITDNPYMTS 145

Query: 209 IPE-SISELR-ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL--GNL 264
           IP  +   L  E  TL +  N  +           KL  + L  N     +  +   G  
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204

Query: 265 TLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFS 302
           +     D+S   +   LP +   +LK L      +N ++
Sbjct: 205 SGPSLLDVSQTSV-TALPSKGLEHLKELI----ARNTWT 238

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 77.2 bits (191), Expect = 2e-15
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 15/149 (10%)

Query: 684 IGSGGTGKVYR-LDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYA 738
           +G G  G VY+  D       VA+K++    + +G+   A  E+ +L ++ H NI+ L  
Sbjct: 29  VGEGTYGVVYKAKD--SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
            +       LV E+M      + L K + E K  L   +         +G+A+ H     
Sbjct: 87  VIHSERCLTLVFEFME-----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-- 139

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            I+HRD+K  N+L++ D   K+ADFG+A+
Sbjct: 140 -ILHRDLKPQNLLINSDGALKLADFGLAR 167

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 18/153 (11%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
           +G G  G+VY+        TVA+K++    + +GV   A  E+ +L +++HRNI++L + 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           +       L+ EY         L K+  +  P++              G+ + H      
Sbjct: 102 IHHNHRLHLIFEYAE-----NDL-KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--- 152

Query: 800 IIHRDIKSSNILLDEDYEP-----KIADFGVAK 827
            +HRD+K  N+LL           KI DFG+A+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 13/148 (8%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
           IG G  G VY+        T A+K++    + +G+      E+ IL +++H NI+KLY  
Sbjct: 10  IGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
           +       LV E++      Q L K +   +  L+        L    GIAY H      
Sbjct: 69  IHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAK 827
           ++HRD+K  N+L++ + E KIADFG+A+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR 148

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 37/176 (21%), Positives = 63/176 (35%), Gaps = 33/176 (18%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA-------------EMEILGKIRH 730
           I SG  G V      +    VA+K+++                       E+ +L    H
Sbjct: 30  ISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 731 RNILKLYACLL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPEL-DWFRRYKI--A 782
            NIL L    +     +     LV E M        L + + + +  +     +Y +   
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTD-----LAQVIHDQRIVISPQHIQYFMYHI 143

Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
           L    G+  LH      ++HRD+   NILL ++ +  I DF +A+        + Y
Sbjct: 144 L---LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY 193

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 78.1 bits (193), Expect = 3e-15
 Identities = 85/466 (18%), Positives = 147/466 (31%), Gaps = 91/466 (19%)

Query: 165 VNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR----IPESISELRELG 220
           ++L  + SL I      +A   E +  L+    + L  C L       I  ++     L 
Sbjct: 1   MSLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59

Query: 221 TLDICRNKISGEFPRSI--------RKLQKLWKIELYANNLTGE----LPAELGNLTLLQ 268
            L++  N++       +         K+QKL    L    LTG     L + L  L  LQ
Sbjct: 60  ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLS---LQNCCLTGAGCGVLSSTLRTLPTLQ 116

Query: 269 EFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFS-- 326
           E  +S N         +G+     + +   +              +L    +     S  
Sbjct: 117 ELHLSDNL--------LGDAGLQLLCEGLLDPQC-----------RLEKLQLEYCSLSAA 157

Query: 327 --GPFPENLGRYTALTDVDISENQFSGSFPKYLCE-----KRKLLNLLALSNNFSGEVPN 379
              P    L       ++ +S N  + +  + LC+       +L  L   S   + +   
Sbjct: 158 SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR 217

Query: 380 SYAD----CKTIQRLRISDNHLSGKIPDGLWAL--------PNVGMLDFGDNDFT----G 423
                     +++ L +  N L      G+  L          +  L   +   T    G
Sbjct: 218 DLCGIVASKASLRELALGSNKLGD---VGMAELCPGLLHPSSRLRTLWIWECGITAKGCG 274

Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRL-----TNLERLILTNNNFSGK----IP 474
            +  ++    SL +L L  N    E    L          LE L + + +F+        
Sbjct: 275 DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334

Query: 475 SALGALRQLSSLHLEENALTGSIPNEMGD-----CARIVDLNLARNSLS----GNIPRSL 525
           S L   R L  L +  N L  +   E+        + +  L LA   +S     ++  +L
Sbjct: 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 394

Query: 526 SLLSSLNALNLSGNKLTGSIPDNL------MKLKLSSIDLSENQLS 565
               SL  L+LS N L  +    L          L  + L +   S
Sbjct: 395 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 82/475 (17%), Positives = 158/475 (33%), Gaps = 94/475 (19%)

Query: 75  VTEISFDNKSLSGE-ISSSISALQSLTVLSLPFNVLSGK----LPLELSNCSNLKVLNVT 129
           +  +    + LS    +  +  LQ   V+ L    L+      +   L     L  LN+ 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 130 GNAMVGS-VPDLS-ALKN----LEIFDLSINYFTGR----FPRWVVNLTQLVSLSIGDNV 179
            N +    V  +   L+     ++   L     TG         +  L  L  L + DN+
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 180 YDEAEIPESIGNLKN----LTYLFLAHCNLRGRIPESISEL----RELGTLDICRNKISG 231
             +A +      L +    L  L L +C+L     E ++ +     +   L +  N I+ 
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184

Query: 232 E--------FPRSIRKLQKLWKIELYANNLTGE----LPAELGNLTLLQEFDISSNQMYG 279
                       S  +L+ L    L +  +T +    L   + +   L+E  + SN+   
Sbjct: 185 AGVRVLCQGLKDSPCQLEALK---LESCGVTSDNCRDLCGIVASKASLRELALGSNK--- 238

Query: 280 KLPEEIGN--LKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRY- 336
                +G+  +  L       +              +L    I+    +     +L R  
Sbjct: 239 -----LGDVGMAELCPGLLHPS-------------SRLRTLWIWECGITAKGCGDLCRVL 280

Query: 337 ---TALTDVDISENQFSGSFPKYLCEKRKLLNL----LALSNNFSGE-----VPNSYADC 384
               +L ++ ++ N+      + LCE           L + +            +  A  
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340

Query: 385 KTIQRLRISDNHLSGKIPDGLWAL------PNVGM--LDFGDNDFT----GGISPLIGLS 432
           + +  L+IS+N L      G+  L      P   +  L   D D +      ++  +  +
Sbjct: 341 RFLLELQISNNRLED---AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397

Query: 433 TSLSQLVLQNNRFSGELPSELGRL-----TNLERLILTNNNFSGKIPSALGALRQ 482
            SL +L L NN        +L          LE+L+L +  +S ++   L AL +
Sbjct: 398 HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 452

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 59.2 bits (144), Expect = 3e-09
 Identities = 59/334 (17%), Positives = 102/334 (30%), Gaps = 72/334 (21%)

Query: 267 LQEFDISSNQMYGK-LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325
           +Q  DI   ++      E +  L+   V +      +                       
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------- 51

Query: 326 SGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCK 385
                  L    AL ++++  N+        + +         L                
Sbjct: 52  -------LRVNPALAELNLRSNELGDVGVHCVLQ--------GLQTP-----------SC 85

Query: 386 TIQRLRISDNHLSGK----IPDGLWALPNVGMLDFGDNDFT-GGISPLIGL----STSLS 436
            IQ+L + +  L+G     +   L  LP +  L   DN     G+  L          L 
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 437 QLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGKIPSALG-ALR----QLSSLH 487
           +L L+    S      L S L    + + L ++NN+ +      L   L+    QL +L 
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 488 LEENALT----GSIPNEMGDCARIVDLNLARNSLSGN-----IPRSLSLLSSLNALNLSG 538
           LE   +T      +   +   A + +L L  N L         P  L   S L  L +  
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265

Query: 539 NKLT----GSIPDNLMKLK-LSSIDLSENQLSGS 567
             +T    G +   L   + L  + L+ N+L   
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 41.9 bits (99), Expect = 7e-04
 Identities = 30/147 (20%), Positives = 49/147 (33%), Gaps = 29/147 (19%)

Query: 431 LSTSLSQLVLQNNRFSGELPSELGR-LTNLERLILTNNNFSGK----IPSALGALRQLSS 485
           +S  +  L +Q    S    +EL   L   + + L +   +      I SAL     L+ 
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60

Query: 486 LHLEENALTGSIPNEMGDC-----ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
           L+L  N L     + +         +I  L+L    L+        +LSS     L    
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT---GAGCGVLSST----LRTLP 113

Query: 541 LTGSIPDNLMKLKLSSIDLSENQLSGS 567
                        L  + LS+N L  +
Sbjct: 114 ------------TLQELHLSDNLLGDA 128

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 11/181 (6%)

Query: 386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF 445
               L +S+N L       L     +  L+    + T  +     L   L  L L +N+ 
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTL-PVLGTLDLSHNQL 89

Query: 446 SGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDC 504
              LP     L  L  L ++ N  +  +P  AL  L +L  L+L+ N L  ++P  +   
Sbjct: 90  Q-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146

Query: 505 -ARIVDLNLARNSLSGNIPRSL-SLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSE 561
             ++  L+LA N+L+  +P  L + L +L+ L L  N L  +IP        L    L  
Sbjct: 147 TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204

Query: 562 N 562
           N
Sbjct: 205 N 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 39/159 (24%), Positives = 61/159 (38%), Gaps = 21/159 (13%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
            L    + L L  N       + L   T L +L L     + K+    G L  L +L L 
Sbjct: 28  DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS 85

Query: 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL-SLLSSLNALNLSGNKLTGSIP-- 546
            N L  S+P        +  L+++ N L+ ++P      L  L  L L GN+L  ++P  
Sbjct: 86  HNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPG 142

Query: 547 --DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAG 583
                 KL+   + L+ N L+  +P         G   G
Sbjct: 143 LLTPTPKLE--KLSLANNNLT-ELP--------AGLLNG 170

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 51/226 (22%), Positives = 79/226 (34%), Gaps = 35/226 (15%)

Query: 76  TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
            E++ D ++L+  +   +      T+L L  N+L       L   + L  LN+       
Sbjct: 13  LEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--- 66

Query: 136 SVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNL 195
                  L  L++                  L  L +L +  N      +P     L  L
Sbjct: 67  -------LTKLQVDG---------------TLPVLGTLDLSHN--QLQSLPLLGQTLPAL 102

Query: 196 TYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254
           T L ++   L   +P      L EL  L +  N++    P  +    KL K+ L  NNLT
Sbjct: 103 TVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161

Query: 255 GELPAEL-GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
            ELPA L   L  L    +  N +Y  +P+       L       N
Sbjct: 162 -ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 28/180 (15%)

Query: 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491
             S  ++       +  LP +L    +   L L+ N       + L    +L+ L+L+  
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 492 ALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP----D 547
            LT  +    G    +  L+L+ N L  ++P     L +L  L++S N+LT S+P     
Sbjct: 66  ELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121

Query: 548 NLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKM-LMNSKLTACPA 606
            L +L+   + L  N+L  ++P         G           +  K+ L N+ LT  PA
Sbjct: 122 GLGELQ--ELYLKGNELK-TLP--------PGLLTP-----TPKLEKLSLANNNLTELPA 165

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 53/233 (22%), Positives = 77/233 (33%), Gaps = 39/233 (16%)

Query: 287 NLKNLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDIS 345
            + +     C K N +   P     D   L    +  N         L  YT LT +++ 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 346 ENQFSGSFPKYLCEKRKLLNL--LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403
             + +      L     L  L  L LS+N    +P        +  L +S N L+  +P 
Sbjct: 64  RAELT-----KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPL 117

Query: 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSEL-GRLTNLERL 462
           G                  G           L +L L+ N     LP  L      LE+L
Sbjct: 118 GA---------------LRG--------LGELQELYLKGNELK-TLPPGLLTPTPKLEKL 153

Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARN 515
            L NNN +      L  L  L +L L+EN+L  +IP        +    L  N
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 38/203 (18%), Positives = 63/203 (31%), Gaps = 22/203 (10%)

Query: 225 CRNKISGEFPRSI-RKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPE 283
           C  +     P  + +    L    L  N L     A L   T L + ++   ++  KL  
Sbjct: 17  CDKRNLTALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQV 72

Query: 284 EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD 343
           + G L  L       N      P     +  L    +  NR +      L     L ++ 
Sbjct: 73  D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130

Query: 344 ISENQFS----GSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKTIQRLRISDNH 396
           +  N+      G              L  L+L+NN   E+P       + +  L + +N 
Sbjct: 131 LKGNELKTLPPGLL-------TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183

Query: 397 LSGKIPDGLWALPNVGMLDFGDN 419
           L   IP G +    +       N
Sbjct: 184 LYT-IPKGFFGSHLLPFAFLHGN 205

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 76.3 bits (188), Expect = 8e-15
 Identities = 47/215 (21%), Positives = 79/215 (36%), Gaps = 67/215 (31%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA------EMEILGKIRHRNILKLY 737
           +G+G  G V  +   ++    A+K        KV         E++I+  + H NI+KL 
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALK--------KVLQDPRYKNRELDIMKVLDHVNIIKLV 66

Query: 738 ACLLKGGSSF--------------------------------------LVLEYMPNGNLF 759
                 G                                         +++EY+P+  L 
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125

Query: 760 QALHKRVKEGKP---ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-ED 815
           + L   ++ G+     L     Y++     + + ++H   S  I HRDIK  N+L++ +D
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIH---SLGICHRDIKPQNLLVNSKD 178

Query: 816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              K+ DFG AK    S     Y C   +  Y AP
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC---SRFYRAP 210

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.7 bits (189), Expect = 8e-15
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 22/167 (13%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           IG G  G VY    K     VA+K++ +     +       E+ IL +++   I++LY  
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93

Query: 740 LL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI--ALGAAKGIAYL 792
           ++      F    +VLE   +      L K  K      +   +  +   L    G  ++
Sbjct: 94  IIPDDLLKFDELYIVLEIADSD-----LKKLFKTPIFLTEEHIKTILYNLL---LGENFI 145

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
           H      IIHRD+K +N LL++D   K+ DFG+A+   +    +  +
Sbjct: 146 H---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.8 bits (187), Expect = 9e-15
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 23/165 (13%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V     K++   VA+K+L +    ++FA     E+ +L  ++H N++ L   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91

Query: 740 LLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                S       +LV+ +M   +L + +  +  E K +   +  Y++     KG+ Y+H
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQ---YLVYQML----KGLKYIH 143

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
              S  ++HRD+K  N+ ++ED E KI DFG+A+ A    +++ Y
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGY 183

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 22/162 (13%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           IG+G  G V     K     VA+K++ +     +       E+ IL ++ H +++K+   
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120

Query: 740 LL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI--ALGAAKGIAYL 792
           ++ K    F    +VLE            K  +      +   +  +   L    G+ Y+
Sbjct: 121 VIPKDVEKFDELYVVLEIAD-----SDFKKLFRTPVYLTELHIKTLLYNLL---VGVKYV 172

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
           H   S  I+HRD+K +N L+++D   K+ DFG+A+  +    
Sbjct: 173 H---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 14/202 (6%)

Query: 91  SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
             I  L ++T L L  N L+   P  L+N  NL  L +  N  V  +  L  LK L+   
Sbjct: 62  QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN-KVKDLSSLKDLKKLKSLS 118

Query: 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP 210
           L  N  +      +V+L QL SL +G+N   +      +  L  L  L L    +   I 
Sbjct: 119 LEHNGISDING--LVHLPQLESLYLGNN---KITDITVLSRLTKLDTLSLEDNQIS-DI- 171

Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
             ++ L +L  L + +N IS    R++  L+ L  +EL++     +      NL +    
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229

Query: 271 DISSNQMYGKLPEEIGNLKNLT 292
             +   +    PE I +  +  
Sbjct: 230 KNTDGSL--VTPEIISDDGDYE 249

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 43/185 (23%), Positives = 83/185 (44%), Gaps = 15/185 (8%)

Query: 382 ADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQ 441
                  +  +    ++  +      L ++  +   ++D    +  +  L  ++++L L 
Sbjct: 21  DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYL-PNVTKLFLN 76

Query: 442 NNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501
            N+ +      L  L NL  L L  N     + S+L  L++L SL LE N ++  I   +
Sbjct: 77  GNKLTDI--KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-L 130

Query: 502 GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLS 560
               ++  L L  N ++ +I   LS L+ L+ L+L  N+++  I   L  L KL ++ LS
Sbjct: 131 VHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLS 186

Query: 561 ENQLS 565
           +N +S
Sbjct: 187 KNHIS 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 39/279 (13%), Positives = 88/279 (31%), Gaps = 42/279 (15%)

Query: 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176
               +     N+   + V      + L +++    + +           ++  +      
Sbjct: 20  DDAFAETIKDNLKKKS-VTDAVTQNELNSIDQIIANNS-----------DIKSV------ 61

Query: 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236
                     + I  L N+T LFL    L   I + ++ L+ LG L +  NK+       
Sbjct: 62  ----------QGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSS-- 107

Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296
           ++ L+KL  + L  N ++ ++   L +L  L+   + +N++       +  L  L     
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 163

Query: 297 FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKY 356
             N  S         + KL    +  N  S      L     L  +++   +       +
Sbjct: 164 EDNQISDI--VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINH 219

Query: 357 LCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDN 395
                    +     +     P   +D    ++  +  +
Sbjct: 220 QSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWH 256

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 49/235 (20%), Positives = 102/235 (43%), Gaps = 17/235 (7%)

Query: 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRL 390
            +   +      ++ +   + +  +        ++ +  +N+    V         + +L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVTQNELNS---IDQIIANNSDIKSVQG-IQYLPNVTKL 73

Query: 391 RISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP 450
            ++ N L+  I   L  L N+G L   +N     +S L  L   L  L L++N  S ++ 
Sbjct: 74  FLNGNKLT-DIK-PLANLKNLGWLFLDENKVKD-LSSLKDL-KKLKSLSLEHNGIS-DIN 128

Query: 451 SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510
             L  L  LE L L NN  +  I + L  L +L +L LE+N ++  I   +    ++ +L
Sbjct: 129 G-LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 183

Query: 511 NLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQL 564
            L++N +S ++ R+L+ L +L+ L L   +      ++   L   +++  ++  L
Sbjct: 184 YLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 35/185 (18%), Positives = 73/185 (39%), Gaps = 12/185 (6%)

Query: 91  SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
             ++ L++L  L L  N +   L   L +   LK L++  N  +  +  L  L  LE   
Sbjct: 84  KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNG-ISDINGLVHLPQLESLY 140

Query: 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP 210
           L  N  T      +  LT+L +LS+ DN   +      +  L  L  L+L+  ++     
Sbjct: 141 LGNNKITDITV--LSRLTKLDTLSLEDN---QISDIVPLAGLTKLQNLYLSKNHISD--L 193

Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
            +++ L+ L  L++   +   +       L     ++    +L    P  + +    ++ 
Sbjct: 194 RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKP 251

Query: 271 DISSN 275
           ++  +
Sbjct: 252 NVKWH 256

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 13/171 (7%)

Query: 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463
              A       +      T        L  S+ Q++  N+     +   +  L N+ +L 
Sbjct: 19  SDDAFAETIKDNLKKKSVTD-AVTQNEL-NSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 74

Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
           L  N  +  I   L  L+ L  L L+EN +   + + + D  ++  L+L  N +S +I  
Sbjct: 75  LNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN- 128

Query: 524 SLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL 573
            L  L  L +L L  NK+T  I   L +L KL ++ L +NQ+S  VPL  L
Sbjct: 129 GLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIVPLAGL 177

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 52/294 (17%), Positives = 96/294 (32%), Gaps = 44/294 (14%)

Query: 227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG 286
             I   F        +  K  L   ++T  +      L  + +   +++ +  K  + I 
Sbjct: 12  TPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQ 65

Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
            L N+T      N  +   P    +++ L    +  N+       +L     L  + +  
Sbjct: 66  YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEH 121

Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
           N  S              ++  L +               ++ L + +N ++  I   L 
Sbjct: 122 NGIS--------------DINGLVH------------LPQLESLYLGNNKIT-DI-TVLS 153

Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
            L  +  L   DN  +  I PL GL T L  L L  N  S +L   L  L NL+ L L +
Sbjct: 154 RLTKLDTLSLEDNQISD-IVPLAGL-TKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFS 209

Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGN 520
                K  +    L   +++   + +L    P  + D       N+  +     
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 36/170 (21%)

Query: 679 EEDNLIGSGGTGKVYR-LDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIR---H 730
           E    IG G  GKV++  DLK     VA+K++      +G+ +    E+ +L  +    H
Sbjct: 14  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73

Query: 731 RNILKLY-----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
            N+++L+     +   +     LV E++      Q L          LD      +    
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDL-TTY------LDKVPEPGVPTET 121

Query: 786 AK--------GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
            K        G+ +LH      ++HRD+K  NIL+    + K+ADFG+A+
Sbjct: 122 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.1 bits (180), Expect = 7e-14
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 24/160 (15%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      K    VAVK+L +     + A     E+ +L  ++H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96

Query: 740 LLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI--ALGAAKGIAY 791
                S       +LV   M        L+  + + +   D   ++ I   L   +G+ Y
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGAD-----LN-NIVKCQKLTDDHVQFLIYQIL---RGLKY 147

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
           +H   S  IIHRD+K SN+ ++ED E KI DFG+A+   +
Sbjct: 148 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.1 bits (180), Expect = 8e-14
 Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 26/167 (15%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
           +GSG  G V      +    VA+K+L++    ++FA     E+ +L  +RH N++ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92

Query: 740 LLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRR--YKIALGAAKGIAY 791
                +       +LV+ +M        L K +K  K   D  +   Y++     KG+ Y
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTD-----LGKLMKHEKLGEDRIQFLVYQML----KGLRY 143

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
           +H   +  IIHRD+K  N+ ++ED E KI DFG+A+ A    +++ Y
Sbjct: 144 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGY 185

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 22/164 (13%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVF--AAEMEI-----LGKI 728
           E    IG G  G VY+     +   VA+K +       G      +   E+     L   
Sbjct: 12  EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71

Query: 729 RHRNILKLY-----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
            H N+++L      +   +     LV E++   +L   L K    G P  +  +      
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA-ETIKDLMRQF 129

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
              +G+ +LH +C   I+HRD+K  NIL+      K+ADFG+A+
Sbjct: 130 --LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 34/171 (19%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---------EMEILGKIRHRNIL 734
           IG G  G V       N   VA+K+      +  F           E++IL + RH NI+
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKK------ISPFEHQTYCQRTLREIKILLRFRHENII 88

Query: 735 KLYACLL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFR--RYKIALGAAK 787
            +   +            +V + M        L+K +K      D      Y+I     +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQIL----R 139

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
           G+ Y+H   S  ++HRD+K SN+LL+   + KI DFG+A++A+     + +
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 71.0 bits (173), Expect = 1e-12
 Identities = 104/689 (15%), Positives = 180/689 (26%), Gaps = 240/689 (34%)

Query: 269 EFDISSNQM-YGKLPEEIGNLKNLTVF-QCFKNNF--------------SGEF------P 306
           +F+   +Q  Y  +         L+VF   F +NF                E        
Sbjct: 8   DFETGEHQYQYKDI---------LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK 58

Query: 307 SGFGDMRKLF-AFSIYGNRFSGPFPENLGR--YTALTD-VDISENQFSGSFPKYLCEKRK 362
                  +LF             F E + R  Y  L   +   + Q S     Y+ ++ +
Sbjct: 59  DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118

Query: 363 LLNLLALSNN-FS-GEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNV---GMLDFG 417
           L N     N  F+   V       +   +LR     L    P       NV   G+L  G
Sbjct: 119 LYN----DNQVFAKYNVSRL----QPYLKLR---QALLELRPA-----KNVLIDGVLGSG 162

Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE-----LGRLTNLERLILTNNNFSGK 472
                          T ++  V  + +   ++  +     L    + E ++         
Sbjct: 163 --------------KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL--- 205

Query: 473 IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL---- 528
                  L Q+       +  + +I   +      +   L R   S      L +L    
Sbjct: 206 -------LYQIDPNWTSRSDHSSNIKLRIHS----IQAELRRLLKSKPYENCLLVLLNVQ 254

Query: 529 --SSLNALNL-------SGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDG 579
              + NA NL       +  K    + D L     + I L  + ++              
Sbjct: 255 NAKAWNAFNLSCKILLTTRFK---QVTDFLSAATTTHISLDHHSMT------LTPDEVKS 305

Query: 580 AFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVS 639
                    LD   + L    LT  P              L  IIA ++   LA     +
Sbjct: 306 LLL----KYLDCRPQDLPREVLTTNP------------RRL-SIIAESIRDGLA-----T 343

Query: 640 YKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGK-------V 692
           + N+K             +  KL +     ++      LE           +       V
Sbjct: 344 WDNWKHV-----------NCDKLTTIIESSLN-----VLEPAEY-------RKMFDRLSV 380

Query: 693 YRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF----- 747
           +          +++  +W      + +  M ++ K      L  Y+ + K          
Sbjct: 381 FPPSAHIPTILLSL--IWFD---VIKSDVMVVVNK------LHKYSLVEKQPKESTISIP 429

Query: 748 -LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII----- 801
            + LE         ALH+ + +          Y I         +   D  PP +     
Sbjct: 430 SIYLELKVKLENEYALHRSIVD---------HYNIPK------TFDSDDLIPPYLDQYFY 474

Query: 802 -----H--------RDIKSSNILLDEDY-EPKIADFGVAK-------------------I 828
                H        R      + LD  + E KI     A                    I
Sbjct: 475 SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYI 534

Query: 829 AENSPK----VSDYSCF---AGTHGYIAP 850
            +N PK    V+    F      +   + 
Sbjct: 535 CDNDPKYERLVNAILDFLPKIEENLICSK 563

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 65.6 bits (159), Expect = 5e-11
 Identities = 62/473 (13%), Positives = 147/473 (31%), Gaps = 140/473 (29%)

Query: 7   LCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHG--VLDS-W-KESADSPCG 62
           L + +               L ++     L +        +   VL +    ++ ++   
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA--- 261

Query: 63  FSGITC--------DSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLP 114
           F  ++C          VT  ++  +  + SL    S +++  +  ++L    +     LP
Sbjct: 262 F-NLSCKILLTTRFKQVTDFLSAATTTHISLD-HHSMTLTPDEVKSLLLKYLDCRPQDLP 319

Query: 115 LELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRW----VVNLTQL 170
            E+   +  ++      +++       ++++              +  W       LT +
Sbjct: 320 REVLTTNPRRL------SIIA-----ESIRD----------GLATWDNWKHVNCDKLTTI 358

Query: 171 VSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI-PESISELRELGTLDICRNKI 229
           +  S+  NV + AE        + + +  L+       + P S                I
Sbjct: 359 IESSL--NVLEPAE-------YRKM-FDRLS-------VFPPSA--------------HI 387

Query: 230 SGEFPRSIRKLQKLWKIELYANNLTGELP----AELGNLTLLQ----EFDISSNQMYGKL 281
               P  +  L  +W       ++          +L   +L++    E  IS   +Y +L
Sbjct: 388 ----PTIL--LSLIW------FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLEL 435

Query: 282 PEEIGNLKNL--------TVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENL 333
             ++ N   L         + + F ++   +    + D         Y       F  ++
Sbjct: 436 KVKLENEYALHRSIVDHYNIPKTFDSD---DLIPPYLDQ--------Y-------FYSHI 477

Query: 334 GRYTALTDVDISENQFSGSFPKYLCE----KRKLLNLLALSNNFSGEVPNSYADCKTIQR 389
           G +  L +++  E      F     +    ++K+ +  + + N SG + N+    K  + 
Sbjct: 478 GHH--LKNIEHPER--MTLFRMVFLDFRFLEQKIRH-DSTAWNASGSILNTLQQLKFYKP 532

Query: 390 LRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN 442
             I DN       + L       +    D       + +    T L ++ L  
Sbjct: 533 -YICDND---PKYERL-------VNAILDFLPKIEENLICSKYTDLLRIALMA 574

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.9 bits (144), Expect = 3e-09
 Identities = 93/557 (16%), Positives = 170/557 (30%), Gaps = 163/557 (29%)

Query: 38  QFKSKLKDPHGVLDSWKESADSPCG----FSGITCDSVTGRVTEISFDNKSLSGEISSSI 93
             K++ + P  +   + E  D        F+     +V+ R+         L        
Sbjct: 97  PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK---YNVS-RLQPY----LKL-------R 141

Query: 94  SALQSLTVLSLPFNVL-----SGKLPLELSNCSNLKVLNVTGNAM----VGSV--PD--L 140
            AL  L        ++     SGK  + L  C + KV       +    + +   P+  L
Sbjct: 142 QALLELR--PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199

Query: 141 SALKNLEIFDLSINYFTG---------RFPRWVVNLTQLV-------SLSIGDNVYDEAE 184
             L+ L ++ +  N+ +          R       L +L+        L +  NV + A+
Sbjct: 200 EMLQKL-LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN-AK 257

Query: 185 IPESIGNLKNLTYLFLAHCN--LRGRIPESISELRELGTLDICRNKISGEF-PRSIRKLQ 241
              +          F   C   L  R  +    L    T  I  +  S    P  ++ L 
Sbjct: 258 AWNA----------FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKL----PEEIGNLKNL------ 291
             +      +    +LP E+      +   +S   +  +          N K++      
Sbjct: 308 LKY-----LDCRPQDLPREVLTTNPRR---LS---IIAESIRDGLATWDNWKHVNCDKLT 356

Query: 292 TVFQCFKNNFSGEFPSGFGDMRKLF-AFSIYGNRFSGPFPEN-------LGRY---TALT 340
           T+ +   N      P+   + RK+F   S+        FP +       L         +
Sbjct: 357 TIIESSLNVLE---PA---EYRKMFDRLSV--------FPPSAHIPTILLSLIWFDVIKS 402

Query: 341 DVDISENQFSGSF-----PK---------YLCEKRKLLNLLALSNNF--SGEVPNSYADC 384
           DV +  N+          PK         YL  K KL N  AL  +      +P ++ D 
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF-DS 461

Query: 385 KTIQRLRISDN--------HLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS 436
             +    + D         HL          L  +  LDF    F      +   ST+ +
Sbjct: 462 DDLIPPYL-DQYFYSHIGHHLKNIEHPERMTLFRMVFLDF---RFLE--QKIRHDSTAWN 515

Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNN-FSGKIPSALGALRQLSSLHLEENALTG 495
                    SG + + L +L   +  I  N+  +   + + L  L +     +EEN +  
Sbjct: 516 A--------SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPK-----IEENLI-- 560

Query: 496 SIPNEMGDCARIVDLNL 512
                      ++ + L
Sbjct: 561 -----CSKYTDLLRIAL 572

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.5 bits (125), Expect = 6e-07
 Identities = 108/646 (16%), Positives = 190/646 (29%), Gaps = 202/646 (31%)

Query: 137 VPDL--SALKNLEIFDL--SINYFTG-RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGN 191
           V D+  S L   EI  +  S +  +G     W +       LS  + +  +      +  
Sbjct: 38  VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL-------LSKQEEMVQKF-----VEE 85

Query: 192 LKNLTYLFLAH-CNLRGRIPESISELRELGTLDICRNKISGE---F-PRSIRKLQKLWKI 246
           +  + Y FL        R P  ++ +         R+++  +   F   ++ +LQ   K+
Sbjct: 86  VLRINYKFLMSPIKTEQRQPSMMTRMYIE-----QRDRLYNDNQVFAKYNVSRLQPYLKL 140

Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKN-LTVFQCFKNNFSGEF 305
                 L    PA+  N+ +        + + G      G  K  + +  C       + 
Sbjct: 141 RQALLELR---PAK--NVLI--------DGVLG-----SG--KTWVALDVCLSYKVQCKM 180

Query: 306 PSGFGDMRKLFAFSIY----GNRFS-GPFPENLGRYTALTDVDISENQFSGSFPKYLCE- 359
                       F I+     N  S     E L +     D + +      S  K     
Sbjct: 181 D-----------FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 360 ----KRKLLN-------LLALSNNFSGEVPNSYA-DCKTIQRLRISDNHLSGKIPDGLWA 407
                R+LL        LL L N  + +  N++   CK +   R                
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR---------------- 273

Query: 408 LPNVGMLDFGDNDFTGGIS---PLIGLSTSLS-QLVLQ--NNRFSGELPSE--------- 452
                + DF     T  IS     + L+      L+L+  + R   +LP E         
Sbjct: 274 --FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ-DLPREVLTTNPRRL 330

Query: 453 --LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510
             +     +   + T +N+       L  + + S   LE        P E         L
Sbjct: 331 SIIAES--IRDGLATWDNWKHVNCDKLTTIIESSLNVLE--------PAEYRKMFD--RL 378

Query: 511 NLARNSLSGNIPRS-LSLL------------------SSLNALNLSGNKLTGSIPDNLMK 551
           ++   S   +IP   LSL+                   SL  +     + T SIP   ++
Sbjct: 379 SVFPPSA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--VEKQPKESTISIPSIYLE 434

Query: 552 LKLSSIDLSE---------NQLSGSVPLDFLRMGGDGAFAGNEG---LCLDQSTKMLMNS 599
           LK+   +            N        D +    D  F  + G     ++   +M +  
Sbjct: 435 LKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR 494

Query: 600 KLTACPAIQKQKGGFKD------KLVLFCIIAVALAAFLAGLL-LVSYKNF--------- 643
            +            F D      K+        A  + L  L  L  YK +         
Sbjct: 495 MV------------FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE 542

Query: 644 KLSADMEN-----GEKEVSSKWKLASFHHIDIDAEQICNLEEDNLI 684
           +L   + +      E  + SK       + D+   +I  + ED  I
Sbjct: 543 RLVNAILDFLPKIEENLICSK-------YTDL--LRIALMAEDEAI 579

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 70.6 bits (172), Expect = 1e-12
 Identities = 44/228 (19%), Positives = 72/228 (31%), Gaps = 13/228 (5%)

Query: 329 FPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQ 388
           +  +      L   ++S  + +        E      L  L       +       + + 
Sbjct: 341 WCRDSATDEQLFRCELSVEKST----VLQSELESCKELQELEPENKWCLLTIILLMRALD 396

Query: 389 RLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGE 448
            L      L                LD   + F    S L      +  L L +   +  
Sbjct: 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-- 454

Query: 449 LPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIV 508
           +   L +L  +  L L++N     +P AL ALR L  L   +NAL  ++   + +  R+ 
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQ 511

Query: 509 DLNLARNSLSGNIP--RSLSLLSSLNALNLSGNKLTGSIPDNLMKLKL 554
           +L L  N L       + L     L  LNL GN L         +L  
Sbjct: 512 ELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 557

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 70.2 bits (171), Expect = 1e-12
 Identities = 42/276 (15%), Positives = 78/276 (28%), Gaps = 30/276 (10%)

Query: 222 LDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKL 281
                +++     R I       K  +   +       +      L   ++S  +    L
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364

Query: 282 PEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTD 341
             E+ + K L            E               +          E L  ++ L  
Sbjct: 365 QSELESCKELQ-----------ELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413

Query: 342 VDISENQFSGSFPKYLCEKRKLLN-------LLALSNNFSGEVPNSYADCKTIQRLRISD 394
           VD     +          +  +L        +L L++     + +       +  L +S 
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSH 472

Query: 395 NHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG-ELPSEL 453
           N L   +P  L AL  + +L   DN     +  +  L   L +L+L NNR         L
Sbjct: 473 NRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANL-PRLQELLLCNNRLQQSAAIQPL 529

Query: 454 GRLTNLERLILTNN------NFSGKIPSALGALRQL 483
                L  L L  N          ++   L ++  +
Sbjct: 530 VSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.9 bits (165), Expect = 7e-12
 Identities = 39/206 (18%), Positives = 72/206 (34%), Gaps = 14/206 (6%)

Query: 364 LNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
           L    LS   S  + +    CK +Q L   +      I   +  +  +  L +       
Sbjct: 351 LFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQY 407

Query: 424 GISPLIGL-STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ 482
             S L  +     + L    ++F  E         ++  L L + + +  +   L  L  
Sbjct: 408 -FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLL 464

Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
           ++ L L  N L  ++P  +     +  L  + N+L  N+   ++ L  L  L L  N+L 
Sbjct: 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521

Query: 543 GSIPD--NLMKLK-LSSIDLSENQLS 565
                   L+    L  ++L  N L 
Sbjct: 522 -QSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.2 bits (158), Expect = 5e-11
 Identities = 40/306 (13%), Positives = 82/306 (26%), Gaps = 55/306 (17%)

Query: 83  KSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSA 142
           ++  G    S   L  L   SL   +      +  +   + K   +  +       D + 
Sbjct: 288 RTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSAT 347

Query: 143 LKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI------------PESIG 190
            + L   +LS+   T      + +  +L  L   +       I             E++ 
Sbjct: 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQ 406

Query: 191 NLKNLTYL--------FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
               L  +                        E  ++  L +    ++      + +L  
Sbjct: 407 YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLL 464

Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
           +  ++L  N L   LP  L  L  L+    S N +  +  + + NL  L           
Sbjct: 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQE--------- 512

Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSG-PFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
                            +  NR       + L     L  +++  N            + 
Sbjct: 513 ---------------LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGI---QE 553

Query: 362 KLLNLL 367
           +L  +L
Sbjct: 554 RLAEML 559

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 59.8 bits (144), Expect = 2e-09
 Identities = 29/159 (18%), Positives = 55/159 (34%), Gaps = 14/159 (8%)

Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS 484
           + P          L+++           L   + L+ +      +   + S       + 
Sbjct: 377 LEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL 436

Query: 485 --------SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNL 536
                    LHL    LT  + + +     +  L+L+ N L   +P +L+ L  L  L  
Sbjct: 437 KMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQA 493

Query: 537 SGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR 574
           S N L  ++   +  L +L  + L  N+L  S  +  L 
Sbjct: 494 SDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLV 530

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 53.2 bits (127), Expect = 3e-07
 Identities = 30/140 (21%), Positives = 54/140 (38%), Gaps = 10/140 (7%)

Query: 88  EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLE 147
           E S        + VL L    L+  L   L     +  L+++ N +    P L+AL+ LE
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLE 489

Query: 148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAH----- 202
           +   S N         V NL +L  L + +N   ++   + + +   L  L L       
Sbjct: 490 VLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547

Query: 203 -CNLRGRIPESISELRELGT 221
              ++ R+ E +  +  + T
Sbjct: 548 EEGIQERLAEMLPSVSSILT 567

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 33/188 (17%), Positives = 55/188 (29%), Gaps = 5/188 (2%)

Query: 378 PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQ 437
                           ++ L       +W   +         D              L +
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFR 353

Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI 497
             L   + S  L SEL     L+ L   N      I   +  +R L  L  E+  L    
Sbjct: 354 CELSVEK-STVLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFS 409

Query: 498 PNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSI 557
             +  D  R   L+  R+             + +  L+L+   LT  +      L ++ +
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHL 468

Query: 558 DLSENQLS 565
           DLS N+L 
Sbjct: 469 DLSHNRLR 476

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 42/184 (22%), Positives = 77/184 (41%), Gaps = 36/184 (19%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---------EMEILGKIRHRNIL 734
           +G G  G V     K     VA+K+      ++ F           E++IL   +H NI+
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKK------IEPFDKPLFALRTLREIKILKHFKHENII 72

Query: 735 KLYACLL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI--ALGAAK 787
            ++         +F    ++ E M        LH+ +   +   D   +Y I   L   +
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVIS-TQMLSDDHIQYFIYQTL---R 123

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH-- 845
            +  LH      +IHRD+K SN+L++ + + K+ DFG+A+I + S   +       +   
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 846 GYIA 849
            ++A
Sbjct: 181 EFVA 184

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 43/177 (24%), Positives = 71/177 (40%), Gaps = 21/177 (11%)

Query: 401 IPDGLWALPNVGMLDFGDNDFTGGISP---LIGLSTSLSQLVLQNNRFSGELPSE-LGRL 456
           +P  L       +LD   N+ +  +        L T+L  L+L +N  +  + SE    +
Sbjct: 33  VPQSL--PSYTALLDLSHNNLSR-LRAEWTPTRL-TNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 457 TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARN 515
            NL  L L++N+           L+ L  L L  N +   +      D A++  L L++N
Sbjct: 88  PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146

Query: 516 SLSGNIP----RSLSLLSSLNALNLSGNKLTGSIP----DNLMKLKLSSIDLSENQL 564
            +S   P    +  + L  L  L+LS NKL   +P      L     + + L  N L
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 45/165 (27%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSE--LGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSL 486
            L +  + L L +N  S  L +E    RLTNL  L+L++N+ +  I S A   +  L  L
Sbjct: 36  SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93

Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
            L  N L  ++   +                        S L +L  L L  N +   + 
Sbjct: 94  DLSSNHLH-TLDEFL-----------------------FSDLQALEVLLLYNNHIV-VVD 128

Query: 547 ----DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
               +++ +L+   + LS+NQ+S   P                 L
Sbjct: 129 RNAFEDMAQLQ--KLYLSQNQIS-RFP--------VELIKDGNKL 162

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 29/138 (21%), Positives = 50/138 (36%), Gaps = 11/138 (7%)

Query: 191 NLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSI-RKLQKLWKIEL 248
            L NL  L L+H +L   I       +  L  LD+  N +       +   LQ L  + L
Sbjct: 62  RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119

Query: 249 YANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI----GNLKNLTVFQCFKNNFSG 303
           Y N++   +      ++  LQ+  +S NQ+  + P E+      L  L +     N    
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK 177

Query: 304 EFPSGFGDMRKLFAFSIY 321
              +    +       +Y
Sbjct: 178 LPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 39/175 (22%), Positives = 68/175 (38%), Gaps = 16/175 (9%)

Query: 330 PENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP-NSYADCKTIQ 388
           P++L  YT    +D+S N  S    ++   +   L+ L LS+N    +   ++     ++
Sbjct: 34  PQSLPSYT--ALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLR 91

Query: 389 RLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRF 445
            L +S NHL   + +     L  + +L   +N     +       +   L +L L  N+ 
Sbjct: 92  YLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDM-AQLQKLYLSQNQI 148

Query: 446 SGELPSE----LGRLTNLERLILTNNNFSGKIPSALGALRQLS--SLHLEENALT 494
           S   P E      +L  L  L L++N       + L  L       L+L  N L 
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 35/176 (19%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY-- 737
           +G GG G V+          VA+K++   D           E++I+ ++ H NI+K++  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEI 76

Query: 738 --------ACLLKGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRR--YKIAL 783
                      +   +      +V EYM        L   +++G    +  R   Y++  
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQLL- 130

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDY 838
              +G+ Y+H   S  ++HRD+K +N+ ++ ED   KI DFG+A+I +       +
Sbjct: 131 ---RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 41/192 (21%), Positives = 75/192 (39%), Gaps = 14/192 (7%)

Query: 364 LNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
                L      ++ +   +   +Q     ++++   +  G+    N+  L    N  + 
Sbjct: 21  AVKQNLGKQSVTDLVS-QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISD 77

Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483
            +SPL  L T L +L +  NR              L RL L NN        +L  L+ L
Sbjct: 78  -LSPLKDL-TKLEELSVNRNRLKNLNGIPS---ACLSRLFLDNNELRD--TDSLIHLKNL 130

Query: 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543
             L +  N L  SI   +G  +++  L+L  N ++ N    L+ L  +N ++L+G K   
Sbjct: 131 EILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCVN 186

Query: 544 SIPDNLMKLKLS 555
                  +L ++
Sbjct: 187 EPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 14/167 (8%)

Query: 408 LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN 467
           L N    + G    T  +     L + +      N+       + +   TNL+ L L++N
Sbjct: 18  LANAVKQNLGKQSVTD-LVSQKEL-SGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHN 73

Query: 468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL 527
             S  + S L  L +L  L +  N L  ++       A +  L L  N L      SL  
Sbjct: 74  QIS-DL-SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRD--TDSLIH 126

Query: 528 LSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL 573
           L +L  L++  NKL  SI   L  L KL  +DL  N+++ +  L  L
Sbjct: 127 LKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLTRL 171

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 37/232 (15%), Positives = 73/232 (31%), Gaps = 39/232 (16%)

Query: 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176
               +N    N+   + V  +     L  ++ F+   +           N+  L      
Sbjct: 15  DPGLANAVKQNLGKQS-VTDLVSQKELSGVQNFNGDNS-----------NIQSL------ 56

Query: 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236
                       +    NL  L L+H  +   +   + +L +L  L + RN++       
Sbjct: 57  ----------AGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIP 104

Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296
              L +L+   L  N L       L +L  L+   I +N++  K    +G L  L V   
Sbjct: 105 SACLSRLF---LDNNELRD--TDSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDL 157

Query: 297 FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
             N  +     G   ++K+    + G +      +          V   + +
Sbjct: 158 HGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGR 207

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 34/152 (22%), Positives = 63/152 (41%), Gaps = 17/152 (11%)

Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS 484
           + P  GL  +  +  L     +         L+ ++     N+N    + + +     L 
Sbjct: 12  VFPDPGL-ANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLK 66

Query: 485 SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLN--ALNLSGNKLT 542
            LHL  N ++  +   + D  ++ +L++ RN L      +L+ + S     L L  N+L 
Sbjct: 67  ELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELR 119

Query: 543 GSIPDNLMKLK-LSSIDLSENQLSGSVPLDFL 573
               D+L+ LK L  + +  N+L   V L FL
Sbjct: 120 D--TDSLIHLKNLEILSIRNNKLKSIVMLGFL 149

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 23/137 (16%), Positives = 59/137 (43%), Gaps = 10/137 (7%)

Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGS 496
           + + +    + ++      L N  +  L   + +     +   L  + + + + + +  S
Sbjct: 1   ESIQRPTPIN-QV-FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-S 55

Query: 497 IPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSS 556
           +   M     + +L+L+ N +S ++   L  L+ L  L+++ N+L  ++ + +    LS 
Sbjct: 56  LAG-MQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-NL-NGIPSACLSR 110

Query: 557 IDLSENQLSGSVPLDFL 573
           + L  N+L  +  L  L
Sbjct: 111 LFLDNNELRDTDSLIHL 127

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 35/189 (18%), Positives = 60/189 (31%), Gaps = 39/189 (20%)

Query: 91  SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
           S +  L  L  LS+  N L     L     + L  L +  N  +     L  LKNLEI  
Sbjct: 79  SPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNN-ELRDTDSLIHLKNLEILS 134

Query: 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP 210
           +  N              +L S+               +G L  L  L L    +     
Sbjct: 135 IRNN--------------KLKSIV-------------MLGFLSKLEVLDLHGNEITN--T 165

Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL--PAELGNLTLLQ 268
             ++ L+++  +D+   K   E    ++   +L+ I     +  G    P  + N     
Sbjct: 166 GGLTRLKKVNWIDLTGQKCVNE---PVKYQPELY-ITNTVKDPDGRWISPYYISNGGSYV 221

Query: 269 EFDISSNQM 277
           +  +     
Sbjct: 222 DGCVLWELP 230

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 28/164 (17%), Positives = 57/164 (34%), Gaps = 17/164 (10%)

Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKI 246
                L N     L   ++      S  EL  +   +   + I       ++    L ++
Sbjct: 13  FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKEL 68

Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLK--NLTVFQCFKNNFSGE 304
            L  N ++ +L   L +LT L+E  ++ N++     + +  +    L+      N     
Sbjct: 69  HLSHNQIS-DLSP-LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRD- 120

Query: 305 FPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
                  ++ L   SI  N+        LG  + L  +D+  N+
Sbjct: 121 -TDSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNE 161

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 47.3 bits (113), Expect = 8e-06
 Identities = 39/212 (18%), Positives = 71/212 (33%), Gaps = 15/212 (7%)

Query: 283 EEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDV 342
                L N       K + +        ++  +  F+   +         +  +T L ++
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKEL 68

Query: 343 DISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP 402
            +S NQ S   P  L +  KL   L+++ N    +         + RL + +N L     
Sbjct: 69  HLSHNQISDLSP--LKDLTKL-EELSVNRNRLKNLNGI--PSACLSRLFLDNNELRD--T 121

Query: 403 DGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERL 462
           D L  L N+ +L   +N     I  L  L + L  L L  N  +      L RL  +  +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKS-IVMLGFL-SKLEVLDLHGNEITN--TGGLTRLKKVNWI 177

Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENALT 494
            LT      +       L   +++   +    
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 32/142 (22%), Positives = 61/142 (42%), Gaps = 12/142 (8%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSE--LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLH 487
            +    ++L L NN F+  L +     +L  L ++  +NN  +     A      ++ + 
Sbjct: 29  HIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL 87

Query: 488 LEENALTGSIPNEMGD-CARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
           L  N L  ++ ++M      +  L L  N ++     S   LSS+  L+L  N++T ++ 
Sbjct: 88  LTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVA 145

Query: 547 ----DNLMKLKLSSIDLSENQL 564
               D L    LS+++L  N  
Sbjct: 146 PGAFDTLH--SLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 49.7 bits (119), Expect = 9e-07
 Identities = 20/133 (15%), Positives = 48/133 (36%), Gaps = 8/133 (6%)

Query: 173 LSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISG 231
           L + +N +   E       L  L  +  ++  +   I E        +  + +  N++  
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE- 94

Query: 232 EFPRSI-RKLQKLWKIELYANNLTGELPAEL-GNLTLLQEFDISSNQMYGKLPEEI-GNL 288
                + + L+ L  + L +N +T  +  +    L+ ++   +  NQ+   +       L
Sbjct: 95  NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDTL 152

Query: 289 KNLTVFQCFKNNF 301
            +L+      N F
Sbjct: 153 HSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 34/166 (20%), Positives = 70/166 (42%), Gaps = 29/166 (17%)

Query: 330 PENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP-NSYADCKTIQ 388
           PE++ +YT   ++ ++ N+F+      + +K   L  +  SNN   ++   ++     + 
Sbjct: 27  PEHIPQYT--AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84

Query: 389 RLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGE 448
            + ++ N L          + +  M                GL  SL  L+L++NR +  
Sbjct: 85  EILLTSNRLE--------NVQH-KMFK--------------GL-ESLKTLMLRSNRIT-C 119

Query: 449 LPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
           + ++    L+++  L L +N  +   P A   L  LS+L+L  N  
Sbjct: 120 VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 56/291 (19%), Positives = 100/291 (34%), Gaps = 19/291 (6%)

Query: 121 SNLKVLNVTGNAMVGSVP--DLSALKNLEIFDLSINYFTGRFPRWV-VNLTQLVSLSIGD 177
            N   L       +  +     S   +LE  ++S N         V  NL +L  + I +
Sbjct: 30  RNAIELRFVLT-KLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI-E 87

Query: 178 NVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRN-KISGEFP 234
              +   I      NL NL YL +++  ++  +P+       +   LDI  N  I     
Sbjct: 88  KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146

Query: 235 RSIRKLQKLWK-IELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLT 292
            S   L      + L  N +  E+     N T L E ++S N    +LP ++        
Sbjct: 147 NSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205

Query: 293 VFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGS 352
           +    +         G  +++KL A S Y  +      E L    AL +  ++      +
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL-EKL---VALMEASLTYPSHCCA 261

Query: 353 FPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403
           F  +    R++  L  + N         Y      QR  +++++ S     
Sbjct: 262 FANWR---RQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRG 309

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 24/161 (14%), Positives = 57/161 (35%), Gaps = 18/161 (11%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHL 488
            L  +  +L     +             +LE++ ++ N+    I +     L +L  + +
Sbjct: 27  DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86

Query: 489 EE-NALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSL-LSSLNALNLSGNKLTGSI 545
           E+ N L   I  E   +   +  L ++   +  ++P    +       L++  N    +I
Sbjct: 87  EKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTI 144

Query: 546 PDNL---MKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAG 583
             N    +  +   + L++N +   +         + AF G
Sbjct: 145 ERNSFVGLSFESVILWLNKNGIQ-EIH--------NSAFNG 176

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 48/289 (16%), Positives = 77/289 (26%), Gaps = 60/289 (20%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSI-RKLQK 242
           EIP  +   +N   L      LR     + S   +L  ++I +N +       +   L K
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 243 LWKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
           L +I +   N    +  E   NL  LQ   IS+                +          
Sbjct: 81  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG--------------IKHLP------ 120

Query: 302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENL--GRYTALTDVDISENQFSGSFPKYLCE 359
                       +     I  N        N   G       + +++N            
Sbjct: 121 ----DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFN 175

Query: 360 KRKLLNLLALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
             +L  L    NN   E+P + +        L IS   +   +P                
Sbjct: 176 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE----------- 223

Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN 467
                       L   L      N +   +LP+ L +L  L    LT  
Sbjct: 224 -----------NL-KKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 51/320 (15%), Positives = 95/320 (29%), Gaps = 56/320 (17%)

Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
           +  VF C ++  + E PS    +  +L        +           +  L  ++IS+N 
Sbjct: 10  SNRVFLCQESKVT-EIPSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQND 65

Query: 349 F-----SGSFPKYLCEKRKLLNLLAL----SNNFSGEVPNSYADCKTIQRLRISDNHLSG 399
                 +  F         L  L  +    +NN     P ++ +   +Q L IS+  +  
Sbjct: 66  VLEVIEADVF-------SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK- 117

Query: 400 KIPDGLWA-LPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNR--------FSG- 447
            +PD          +LD  DN     I     +GLS     L L  N         F+G 
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGT 177

Query: 448 --------------ELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
                         ELP++     +    L ++           L  L++L +       
Sbjct: 178 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237

Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552
              ++         +++ +L   S   +     +    ++ L+   NK       + M  
Sbjct: 238 KLPTLEK----LVALMEASLTYPS---HCCAFANWRRQISELHPICNKSILRQEVDYMTQ 290

Query: 553 KLSSIDLSENQLSGSVPLDF 572
                         S    F
Sbjct: 291 ARGQRSSLAEDNESSYSRGF 310

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 44.8 bits (106), Expect = 8e-05
 Identities = 34/184 (18%), Positives = 55/184 (29%), Gaps = 34/184 (18%)

Query: 96  LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSAL-KNLEIFDLS 152
           L +L  L +    +     +   +     +L++  N  + ++       L     I  L+
Sbjct: 103 LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162

Query: 153 INYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPES 212
            N                             EI  S  N   L  L L+  N    +P  
Sbjct: 163 KNGIQ--------------------------EIHNSAFNGTQLDELNLSDNNNLEELPND 196

Query: 213 I-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD 271
           +         LDI R +I       +  L+KL        NL  +LP  L  L  L E  
Sbjct: 197 VFHGASGPVILDISRTRIHSLPSYGLENLKKLR--ARSTYNLK-KLPT-LEKLVALMEAS 252

Query: 272 ISSN 275
           ++  
Sbjct: 253 LTYP 256

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 52/163 (31%), Positives = 69/163 (42%), Gaps = 26/163 (15%)

Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELG---RLTNLERLILTNNNFSGKIPSALGALRQL 483
             I    ++  L L  N+       ++     LTNL  LILT N            L  L
Sbjct: 57  QGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111

Query: 484 SSLHLEENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
             L L EN L  S+P+ + D    +  LNLA N L          L++L  L+LS N+L 
Sbjct: 112 KELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170

Query: 543 GSIP----DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAF 581
            S+P    D L +LK   + L +NQL  SVP        DG F
Sbjct: 171 -SLPEGVFDKLTQLK--DLRLYQNQLK-SVP--------DGVF 201

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 35/167 (20%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIR-HRNILKLYA 738
           +G G  G V++   ++    VAVK+++        A     E+ IL ++  H NI+ L  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76

Query: 739 CLLKGGSSF----LVLEYMP-------NGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
            L     +     LV +YM          N+ + +HK+          +  Y++     K
Sbjct: 77  VLR--ADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ----------YVVYQLI----K 120

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
            I YLH   S  ++HRD+K SNILL+ +   K+ADFG+++   N  +
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 32/114 (28%), Positives = 50/114 (43%), Gaps = 10/114 (8%)

Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
            L+    +G G  G+V       +D      TVAVK L +G      +   +E++IL  I
Sbjct: 23  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82

Query: 729 -RHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
             H N++ L  AC   GG   +++E+   GNL   L  +  E  P      R++
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR 136

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 20/48 (41%), Positives = 27/48 (56%), Gaps = 3/48 (6%)

Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
             +   AKG+ +L    S   IHRD+ + NILL E    KI DFG+A+
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 40/165 (24%), Positives = 69/165 (41%), Gaps = 28/165 (16%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA-----EMEILGKIR-HRNILKLY 737
           +G G   +V+      N   V VK L      K         E++IL  +R   NI+ L 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKIL------KPVKKKKIKREIKILENLRGGPNIITLA 97

Query: 738 ACLLKGGSSF---LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
             ++K   S    LV E++ N +      +  +        F  Y+I     K + Y H 
Sbjct: 98  -DIVKDPVSRTPALVFEHVNNTDF----KQLYQTLTDYDIRFYMYEIL----KALDYCH- 147

Query: 795 DCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDY 838
             S  I+HRD+K  N+++D E  + ++ D+G+A+      + +  
Sbjct: 148 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 52/187 (27%), Positives = 74/187 (39%), Gaps = 42/187 (22%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
            +     +L LQ+N+ S        RLT L  L L +N            L+ L +L + 
Sbjct: 34  NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93

Query: 490 ENALTGSIPNEMGDC-ARIVDLNLARN---SLSGNIPRSL--------------SL---- 527
           +N L  ++P  + D    + +L L RN   SL   +  SL              SL    
Sbjct: 94  DNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGV 152

Query: 528 ---LSSLNALNLSGNKLTGSIP----DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGA 580
              L+SL  L L  N+L   +P    D L +LK  ++ L  NQL   VP        +GA
Sbjct: 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELK--TLKLDNNQLK-RVP--------EGA 200

Query: 581 FAGNEGL 587
           F   E L
Sbjct: 201 FDSLEKL 207

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 46/177 (25%), Positives = 68/177 (38%), Gaps = 14/177 (7%)

Query: 370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISPL 428
           SN  S     ++     ++ L ++DN L   +P G++  L N+  L   DN     +   
Sbjct: 46  SNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIG 103

Query: 429 I--GLSTSLSQLVLQNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPS-ALGALRQLS 484
           +   L  +L++L L  N+    LP  +   LT L  L L  N     +P      L  L 
Sbjct: 104 VFDQL-VNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLK 160

Query: 485 SLHLEENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPR-SLSLLSSLNALNLSGN 539
            L L  N L   +P    D    +  L L  N L   +P  +   L  L  L L  N
Sbjct: 161 ELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 19/202 (9%)

Query: 82  NKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-- 139
           +K L+  I S+I A      L L  N LS          + L++L +  N +  ++P   
Sbjct: 25  SKKLT-AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI 80

Query: 140 LSALKNLEIFDLSINYFT----GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKN 194
              LKNLE   ++ N       G F      L  L  L +  N      +P  +  +L  
Sbjct: 81  FKELKNLETLWVTDNKLQALPIGVF----DQLVNLAELRLDRN--QLKSLPPRVFDSLTK 134

Query: 195 LTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
           LTYL L +  L+  +P+ +  +L  L  L +  N++      +  KL +L  ++L  N L
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL 193

Query: 254 TGELPAELGNLTLLQEFDISSN 275
                    +L  L+   +  N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 8/175 (4%)

Query: 321 YGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP-N 379
             N+ S    +   R T L  + +++N+   + P  + ++ K L  L +++N    +P  
Sbjct: 45  QSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIG 103

Query: 380 SYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISPLI--GLSTSLS 436
            +     +  LR+  N L   +P  ++  L  +  L  G N+    +   +   L TSL 
Sbjct: 104 VFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKL-TSLK 160

Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491
           +L L NN+          +LT L+ L L NN        A  +L +L  L L+EN
Sbjct: 161 ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 61.7 bits (149), Expect = 3e-10
 Identities = 25/130 (19%), Positives = 40/130 (30%), Gaps = 25/130 (19%)

Query: 436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALT 494
           S  +      + +    L    NL  L + N      +    L  L +L +L + ++ L 
Sbjct: 10  SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 495 GSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKL 554
             +                        P +      L+ LNLS N L       +  L L
Sbjct: 70  -FVA-----------------------PDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL 105

Query: 555 SSIDLSENQL 564
             + LS N L
Sbjct: 106 QELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 2/86 (2%)

Query: 433 TSLSQLVLQNNRFSGELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491
            +L++L ++N +    L    L  L  L  L +  +      P A     +LS L+L  N
Sbjct: 31  ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90

Query: 492 ALTGSIPNEMGDCARIVDLNLARNSL 517
           AL  S+  +      + +L L+ N L
Sbjct: 91  ALE-SLSWKTVQGLSLQELVLSGNPL 115

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 36/139 (25%), Positives = 63/139 (45%), Gaps = 11/139 (7%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
            L  +++++ L+ N      P        L R+ L+NN  S   P A   LR L+SL L 
Sbjct: 29  NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY 88

Query: 490 ENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPR-SLSLLSSLNALNLSGNKLTGSIP- 546
            N +T  +P  + +    +  L L  N ++  +   +   L +LN L+L  NKL  +I  
Sbjct: 89  GNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145

Query: 547 ---DNLMKLKLSSIDLSEN 562
                L  ++  ++ L++N
Sbjct: 146 GTFSPLRAIQ--TMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 37/137 (27%), Positives = 57/137 (41%), Gaps = 14/137 (10%)

Query: 386 TIQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFT----GGISPLIGLSTSLSQLVL 440
           TI  +R+  N +   IP G       +  +D  +N  +         L     SL+ LVL
Sbjct: 33  TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL----RSLNSLVL 87

Query: 441 QNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPN 499
             N+ + ELP  L   L +L+ L+L  N  +     A   L  L+ L L +N L  +I  
Sbjct: 88  YGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145

Query: 500 EMGD-CARIVDLNLARN 515
                   I  ++LA+N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 32/143 (22%), Positives = 52/143 (36%), Gaps = 10/143 (6%)

Query: 401 IPDGLWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSEL-GRLT 457
           IP  L     +  +    N     I P         L ++ L NN+ S EL  +    L 
Sbjct: 26  IPTNL--PETITEIRLEQNTIKV-IPPGAFSPY-KKLRRIDLSNNQIS-ELAPDAFQGLR 80

Query: 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC-ARIVDLNLARNS 516
           +L  L+L  N  +    S    L  L  L L  N +   +  +       +  L+L  N 
Sbjct: 81  SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139

Query: 517 LSGNIPRSLSLLSSLNALNLSGN 539
           L      + S L ++  ++L+ N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 30/126 (23%), Positives = 54/126 (42%), Gaps = 8/126 (6%)

Query: 370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL-WALPNVGMLDFGDNDFTGGISPL 428
            N      P +++  K ++R+ +S+N +S ++       L ++  L    N  T  +   
Sbjct: 41  QNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKS 98

Query: 429 I--GLSTSLSQLVLQNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSS 485
           +  GL  SL  L+L  N+ +  L  +    L NL  L L +N            LR + +
Sbjct: 99  LFEGL-FSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT 156

Query: 486 LHLEEN 491
           +HL +N
Sbjct: 157 MHLAQN 162

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 55/359 (15%), Positives = 111/359 (30%), Gaps = 84/359 (23%)

Query: 243 LWKIELYANNLTGE----LPAELGNLTLLQEFDISSNQMYGK-----LPEEIGNLKNLTV 293
           +    L  + +T E    + A L     ++E  +S N + G      L E I + K+L +
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEI 64

Query: 294 FQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSF 353
            + F + F+G       +  +L   ++                  L  V +S+N F  + 
Sbjct: 65  AE-FSDIFTGRVKDEIPEALRLLLQALLKC-------------PKLHTVRLSDNAFGPTA 110

Query: 354 PKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGM 413
            + L +         LS +              ++ L + +N L                
Sbjct: 111 QEPLID--------FLSKH------------TPLEHLYLHNNGLG-----------PQAG 139

Query: 414 LDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNF 469
                      ++     +  L  ++   NR                  L  + +  N  
Sbjct: 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI 199

Query: 470 SGK-----IPSALGALRQLSSLHLEENALTG----SIPNEMGDCARIVDLNLARNSLSGN 520
             +     +   L   ++L  L L++N  T     ++   +     + +L L    LS  
Sbjct: 200 RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259

Query: 521 ----IPRSLSLLS--SLNALNLSGNKLTG--------SIPDNLMKLKLSSIDLSENQLS 565
               +  + S L    L  L L  N++           I + +  L    ++L+ N+ S
Sbjct: 260 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL--FLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 21/145 (14%), Positives = 53/145 (36%), Gaps = 27/145 (18%)

Query: 434 SLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGK----IPSALGALRQLSS 485
           S+    L+ +  + E    + + L    +++ ++L+ N    +    +   + + + L  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 486 LHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI 545
               +   TG + +E+ +  R+             + ++L     L+ + LS N    + 
Sbjct: 65  AEFSDI-FTGRVKDEIPEALRL-------------LLQALLKCPKLHTVRLSDNAFGPTA 110

Query: 546 PDNLMKL-----KLSSIDLSENQLS 565
            + L+        L  + L  N L 
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGLG 135

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 40/254 (15%), Positives = 81/254 (31%), Gaps = 52/254 (20%)

Query: 75  VTEISFDNKSLSGE----ISSSISALQSLTVLSLPFNVLSGKLPLE----------LSNC 120
           V EI     ++  E    +S +I++ + L +                         L  C
Sbjct: 34  VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKC 93

Query: 121 SNLKVLNVTGNA-----MVGSVPDLSALKNLEIFDLSINYFT-------------GRFPR 162
             L  + ++ NA         +  LS    LE   L  N                    +
Sbjct: 94  PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153

Query: 163 WVVNLTQLVSLSIGDNVYDEA---EIPESIGNLKNLTYLFLAHCNLRGR-----IPESIS 214
              N   L S+  G N  +     E  ++  + + L  + +    +R       + E ++
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213

Query: 215 ELRELGTLDICRNKISGE----FPRSIRKLQKLWKIELYANNLT-------GELPAELGN 263
             +EL  LD+  N  +         +++    L ++ L    L+        +  ++L N
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN 273

Query: 264 LTLLQEFDISSNQM 277
           +  LQ   +  N++
Sbjct: 274 IG-LQTLRLQYNEI 286

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 46/157 (29%), Positives = 63/157 (40%), Gaps = 18/157 (11%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
           G+     +L LQ+   +    +    LT L  L L  N            L +L +L L 
Sbjct: 32  GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91

Query: 490 ENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP-- 546
            N L  S+P  + D   ++  L L  N L          L+ L  L L+ N+L  SIP  
Sbjct: 92  NNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAG 149

Query: 547 --DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAF 581
             D L  L+  ++ LS NQL  SVP         GAF
Sbjct: 150 AFDKLTNLQ--TLSLSTNQLQ-SVP--------HGAF 175

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 53/222 (23%), Positives = 76/222 (34%), Gaps = 46/222 (20%)

Query: 67  TCDSVTG-----RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCS 121
           TC++VTG        E+    KSL   + S I A      L L    L+          +
Sbjct: 3   TCETVTGCTCNEGKKEVDCQGKSLDS-VPSGIPA--DTEKLDLQSTGLATLSDATFRGLT 59

Query: 122 NLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV 179
            L  LN+  N +  ++       L  L    L+ N              QL SL +G  V
Sbjct: 60  KLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN--------------QLASLPLG--V 102

Query: 180 YDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKIS----GEFP 234
           +D         +L  L  L+L   N    +P  +   L +L  L +  N++     G F 
Sbjct: 103 FD---------HLTQLDKLYL-GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAF- 151

Query: 235 RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQ 276
               KL  L  + L  N L          L  LQ   +  NQ
Sbjct: 152 ---DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 36/136 (26%), Positives = 56/136 (41%), Gaps = 18/136 (13%)

Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGS 496
           +L         ++ + L  L   + L L+ NN   KI S+L  +  L  L L  N +   
Sbjct: 29  ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-K 84

Query: 497 IPNEMGDCARIVDLNLARN---SLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK 553
           I N       + +L ++ N   SLSG     +  L +L  L +S NK+T      + KL 
Sbjct: 85  IENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITN--WGEIDKLA 137

Query: 554 ----LSSIDLSENQLS 565
               L  + L+ N L 
Sbjct: 138 ALDKLEDLLLAGNPLY 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 27/126 (21%), Positives = 54/126 (42%), Gaps = 9/126 (7%)

Query: 452 ELGRLTNLERLILTNNNFSG--KIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD 509
           +    T  E++ L +       K+ + L  L+    L L  N +   I + +     +  
Sbjct: 18  KSVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRI 74

Query: 510 LNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSV 568
           L+L RN +   I    ++  +L  L +S N++  S+   + KL  L  + +S N+++   
Sbjct: 75  LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWG 131

Query: 569 PLDFLR 574
            +D L 
Sbjct: 132 EIDKLA 137

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 27/120 (22%), Positives = 52/120 (43%), Gaps = 14/120 (11%)

Query: 88  EISSSISALQSLTVLSLPFNVLSGKLPLE-LSNCSNLKVLNVTGNAMVGSVPDLSAL-KN 145
           ++ +++S L++   L+L  N +     +  LS   NL++L++  N ++  + +L A+   
Sbjct: 39  KMDATLSTLKACKHLALSTNNIEK---ISSLSGMENLRILSLGRN-LIKKIENLDAVADT 94

Query: 146 LEIFDLSINYFT---GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAH 202
           LE   +S N      G     +  L  L  L + +N        + +  L  L  L LA 
Sbjct: 95  LEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 32/137 (23%), Positives = 50/137 (36%), Gaps = 9/137 (6%)

Query: 414 LDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKI 473
           L           + L  L  +   L L  N    ++ S L  + NL  L L  N    KI
Sbjct: 30  LHGMIPPIEKMDATLSTL-KACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85

Query: 474 PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS--GNIPRSLSLLSSL 531
            +       L  L +  N +  S+   +     +  L ++ N ++  G I   L+ L  L
Sbjct: 86  ENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKL 142

Query: 532 NALNLSGNKLTGSIPDN 548
             L L+GN L     +N
Sbjct: 143 EDLLLAGNPLYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 31/144 (21%), Positives = 54/144 (37%), Gaps = 27/144 (18%)

Query: 166 NLTQLVSLSIGDNVYDEAEIP--ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLD 223
            L     L++  N      I    S+  ++NL  L L    ++ +I    +    L  L 
Sbjct: 46  TLKACKHLALSTN-----NIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99

Query: 224 ICRNKISGEFPRSIRKLQKLWKIE-LY-ANNLTGELP--AELGNLTLLQEFDISSNQMYG 279
           I  N+I+     S+  ++KL  +  LY +NN         +L  L  L++  ++ N +Y 
Sbjct: 100 ISYNQIA-----SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154

Query: 280 KLPEE----------IGNLKNLTV 293
              E           +  L NL  
Sbjct: 155 DYKENNATSEYRIEVVKRLPNLKK 178

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.6 bits (124), Expect = 6e-08
 Identities = 30/111 (27%), Positives = 51/111 (45%), Gaps = 4/111 (3%)

Query: 434 SLSQLVLQNNRFS-GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
            + +LVL N+R + G+L         LE L   N   +  I + L  L +L  L L +N 
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNR 75

Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSG-NIPRSLSLLSSLNALNLSGNKLT 542
           ++G +      C  +  LNL+ N +   +    L  L +L +L+L   ++T
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 26/115 (22%), Positives = 46/115 (40%), Gaps = 3/115 (2%)

Query: 89  ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEI 148
            + + S ++ L + +   N   GKL         L+ L+      + S+ +L  L  L+ 
Sbjct: 12  RNRTPSDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINV-GLTSIANLPKLNKLKK 68

Query: 149 FDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC 203
            +LS N  +G           L  L++  N   +    E +  L+NL  L L +C
Sbjct: 69  LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 5/111 (4%)

Query: 455 RLTNLERLILTNNNFS-GKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513
             ++++ L+L N+  + GK+        +L  L      LT SI N +    ++  L L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTG-SIPDNLMKLK-LSSIDLSEN 562
            N +SG +        +L  LNLSGNK+   S  + L KL+ L S+DL   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 26/116 (22%), Positives = 43/116 (37%), Gaps = 8/116 (6%)

Query: 383 DCKTIQRLRISDNHLS-GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS--TSLSQLV 439
               ++ L + ++  + GK+         +  L   +     G++ +  L     L +L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV----GLTSIANLPKLNKLKKLE 70

Query: 440 LQNNRFSGELPSELGRLTNLERLILTNNNFSG-KIPSALGALRQLSSLHLEENALT 494
           L +NR SG L     +  NL  L L+ N          L  L  L SL L    +T
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 20/112 (17%), Positives = 45/112 (40%), Gaps = 5/112 (4%)

Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
             + +  L + ++  +E ++       + L +L   +  L   I  ++ +L +L  L++ 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLT--GELPAELGNLTLLQEFDISSN 275
            N++SG       K   L  + L  N +     +   L  L  L+  D+ + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 24/112 (21%), Positives = 42/112 (37%), Gaps = 15/112 (13%)

Query: 191 NLKNLTYLFLAHC-NLRGRIPESISELRELGTLDICRNKIS--GEFPRSIRKLQKLWKIE 247
              ++  L L +  +  G++     E  EL  L      ++     P    KL KL K+E
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70

Query: 248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
           L  N ++G L         L   ++S N+        I +L  +   +  +N
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNK--------IKDLSTIEPLKKLEN 114

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.1 bits (129), Expect = 9e-08
 Identities = 28/193 (14%), Positives = 49/193 (25%), Gaps = 59/193 (30%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK----------QLWKGDGVKVFAAEMEILGKI----- 728
           IG G  G+V++         VA+K                  +    E+ I  ++     
Sbjct: 28  IGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 729 ----RHRNILKLYAC------------------------------LLKGGSSFLVLEYMP 754
               R    + L +                                 K    F+VLE+  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814
            G   + +  ++              I       +A           HRD+   N+LL +
Sbjct: 146 GGIDLEQMRTKL------SSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKK 197

Query: 815 DYEPKIADFGVAK 827
               K+      K
Sbjct: 198 TSLKKLHYTLNGK 210

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 51/168 (30%), Positives = 72/168 (42%), Gaps = 32/168 (19%)

Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIR---------- 729
            +G G    V+   D+  N   VA+K + +GD V   AAE EI  L ++           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNT-HVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 730 -HRNILKLYAC-LLKGGSS---FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG 784
              +ILKL      KG +     +V E +   NL   + K    G P L + ++    L 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIP-LIYVKQISKQL- 140

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP------KIADFGVA 826
              G+ Y+H  C   IIH DIK  N+L++    P      KIAD G A
Sbjct: 141 -LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 13/127 (10%)

Query: 457 TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC-ARIVDLNLARN 515
           TN + L L +N  +   P    +L  L  L+L  N L  ++P  + D   ++  L+L  N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 516 SLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR 574
            L+         L  L  L +  NKLT  +P  + +L  L+ + L +NQL  S+P     
Sbjct: 99  QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP----- 151

Query: 575 MGGDGAF 581
               GAF
Sbjct: 152 ---HGAF 155

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 12/140 (8%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL-GALRQLSSLHL 488
           G+ T+   L L +N+ +   P     L NL+ L L +N     +P  +  +L QL+ L L
Sbjct: 37  GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDL 95

Query: 489 EENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP- 546
             N LT  +P+ + D    + +L +  N L+  +PR +  L+ L  L L  N+L  SIP 
Sbjct: 96  GTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPH 152

Query: 547 ---DNLMKLKLSSIDLSENQ 563
              D L  L      L  N 
Sbjct: 153 GAFDRLSSLT--HAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 30/110 (27%), Positives = 47/110 (42%), Gaps = 3/110 (2%)

Query: 191 NLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELY 249
           +L NL  L+L    L   +P  +   L +L  LD+  N+++        +L  L ++ + 
Sbjct: 62  SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC 120

Query: 250 ANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
            N LT ELP  +  LT L    +  NQ+          L +LT    F N
Sbjct: 121 CNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 39/130 (30%), Positives = 54/130 (41%), Gaps = 18/130 (13%)

Query: 457 TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC-ARIVDLNLARN 515
                L L  N+           L  L+ L+L  N L  S+PN + +    +  LNL+ N
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86

Query: 516 SLSGNIPRSLSLLSSLNALNLSGNKLTGSIP----DNLMKLKLSSIDLSENQLSGSVPLD 571
            L          L+ L  L L+ N+L  S+P    D L +LK   + L +NQL  SVP  
Sbjct: 87  QLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLK--DLRLYQNQLK-SVP-- 140

Query: 572 FLRMGGDGAF 581
                 DG F
Sbjct: 141 ------DGVF 144

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 16/115 (13%), Positives = 42/115 (36%), Gaps = 4/115 (3%)

Query: 90  SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIF 149
           ++  +       L L    +   +    +       ++ + N +   +     L+ L+  
Sbjct: 12  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTL 69

Query: 150 DLSINYFTGRFPRWVVNLTQLVSLSIGDN-VYDEAEIPESIGNLKNLTYLFLAHC 203
            ++ N            L  L  L + +N + +  ++ + + +LK+LTYL +   
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 30/118 (25%), Positives = 46/118 (38%), Gaps = 8/118 (6%)

Query: 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS--TSLSQ 437
            Y +    + L +    +   I +    L     +DF DN+    I  L G      L  
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----IRKLDGFPLLRRLKT 68

Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSG-KIPSALGALRQLSSLHLEENALT 494
           L++ NNR           L +L  LILTNN+         L +L+ L+ L +  N +T
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 26/110 (23%), Positives = 39/110 (35%), Gaps = 7/110 (6%)

Query: 362 KLLNL--LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN 419
             +    L L       + N  A       +  SDN +  K+ DG   L  +  L   +N
Sbjct: 17  NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNN 74

Query: 420 DFTGGISPLIGLSTSLSQLVLQNNRFS--GELPSELGRLTNLERLILTNN 467
                   L      L++L+L NN     G+L   L  L +L  L +  N
Sbjct: 75  RICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 19/116 (16%), Positives = 36/116 (31%), Gaps = 17/116 (14%)

Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR---KLQKL 243
               N      L L    +   I    + L +   +D   N+I     R +     L++L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRL 66

Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
             + +  N +          L  L E  +++N         +  L +L      K+
Sbjct: 67  KTLLVNNNRICRIGEGLDQALPDLTELILTNNS--------LVELGDLDPLASLKS 114

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.6 bits (111), Expect = 5e-06
 Identities = 21/114 (18%), Positives = 36/114 (31%), Gaps = 5/114 (4%)

Query: 451 SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510
           ++         L L        I +    L Q  ++   +N +   +        R+  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69

Query: 511 NLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG-SIPDNLMKLK-LSSIDLSEN 562
            +  N +          L  L  L L+ N L      D L  LK L+ + +  N
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 22/111 (19%), Positives = 41/111 (36%), Gaps = 4/111 (3%)

Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
               +L L+  +    + +    L   + +  ++N    K+      LR+L +L +  N 
Sbjct: 19  VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNR 75

Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSG-NIPRSLSLLSSLNALNLSGNKLT 542
           +             + +L L  NSL        L+ L SL  L +  N +T
Sbjct: 76  ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 21/115 (18%), Positives = 38/115 (33%), Gaps = 12/115 (10%)

Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS--GNI 521
           LT      +         +   L L    +   I N      +   ++ + N +      
Sbjct: 4   LTAELIE-QAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF 60

Query: 522 PRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGSVPLDFLR 574
           P     L  L  L ++ N++   I + L +    L+ + L+ N L     LD L 
Sbjct: 61  PL----LRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLA 110

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.1 bits (121), Expect = 9e-07
 Identities = 26/162 (16%), Positives = 52/162 (32%), Gaps = 22/162 (13%)

Query: 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA--L 480
             +SP++     L+ L +   + +  L        NL+ L + +      +   +    L
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 481 RQLSSLHLEENALTGSIPNEMGDCARIVD---------LNLARNSLSGNIPRSLS---LL 528
             L  L L           +M     +           L +        +        +L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 529 SSLNALNLSGNKLTGS----IPDNLMKL-KLSSIDLSENQLS 565
             L  +++S   LT      + D++ K+  L  I++  N LS
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.6 bits (117), Expect = 2e-06
 Identities = 32/300 (10%), Positives = 85/300 (28%), Gaps = 22/300 (7%)

Query: 282 PEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTD 341
             E        + +  K  +         +M+            +      + +      
Sbjct: 46  AGEAEKAAGKLIAEKTKKGYVETLEEVAKEMKVEAKKYALSYDEAEEGVNLMDKILKDKK 105

Query: 342 VDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKI 401
           +   +    G +     +   + + +  +          +      +   IS        
Sbjct: 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQV--- 162

Query: 402 PDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELG--RLTNL 459
            D    L  + +L+      T  +S       +L  L + +      +  ++    L NL
Sbjct: 163 -DLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221

Query: 460 ERLIL---TNNNFSGKIPSAL------GALRQLSSLHLEENALTGSIPNEMGDC---ARI 507
           E+L+L     +       +             L  L + +      +     +     ++
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281

Query: 508 VDLNLARNSLSGN----IPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQ 563
             ++++   L+      +   +  +  L  +N+  N L+  +   L K     ID+S++Q
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 36/139 (25%), Positives = 58/139 (41%), Gaps = 32/139 (23%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
           G+   +++L L  N+F+  +P EL    +L  + L+NN  S     +   + QL +L L 
Sbjct: 28  GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86

Query: 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP--- 546
            N L   IP                       PR+   L SL  L+L GN ++  +P   
Sbjct: 87  YNRLR-CIP-----------------------PRTFDGLKSLRLLSLHGNDIS-VVPEGA 121

Query: 547 -DNLMKLKLSSIDLSENQL 564
            ++L    LS + +  N L
Sbjct: 122 FNDLS--ALSHLAIGANPL 138

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 22/87 (25%), Positives = 37/87 (42%), Gaps = 1/87 (1%)

Query: 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176
            +   NL+ L++    ++ SV +L  L  L+  +LS N   G        L  L  L++ 
Sbjct: 45  TAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103

Query: 177 DNVYDEAEIPESIGNLKNLTYLFLAHC 203
            N   +    E +  L+ L  L L +C
Sbjct: 104 GNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 34/114 (29%), Positives = 51/114 (44%), Gaps = 5/114 (4%)

Query: 455 RLTNLERLILTNNNFS-GKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513
               +  L+L N   + GKI         L  L L    L  S+ N +    ++  L L+
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTG-SIPDNLMKLK-LSSIDLSENQLS 565
            N + G +      L +L  LNLSGNKL   S  + L KL+ L S+DL   +++
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 28/119 (23%), Positives = 41/119 (34%), Gaps = 8/119 (6%)

Query: 380 SYADCKTIQRLRISDNHLS-GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS--TSLS 436
                  ++ L + +   + GKI        N+  L   +     G+  +  L     L 
Sbjct: 19  RNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV----GLISVSNLPKLPKLK 74

Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSG-KIPSALGALRQLSSLHLEENALT 494
           +L L  NR  G L     +L NL  L L+ N          L  L  L SL L    +T
Sbjct: 75  KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 8e-06
 Identities = 24/113 (21%), Positives = 42/113 (37%), Gaps = 17/113 (15%)

Query: 191 NLKNLTYLFLAHC-NLRGRIPESISELRELGTLDICRNKISGEFPRSI---RKLQKLWKI 246
               +  L L +C +  G+I    +E   L  L +    +      S+    KL KL K+
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKL 76

Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
           EL  N + G L      L  L   ++S N+        + ++  L   +  + 
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNK--------LKDISTLEPLKKLEC 121

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 48.6 bits (116), Expect = 5e-06
 Identities = 23/169 (13%), Positives = 51/169 (30%), Gaps = 34/169 (20%)

Query: 684 IGSGGTGKVY--------RLDLKKNAGTVAVK------------QLWKGDGVKVFAAEME 723
                 G +Y          D        ++K              ++     +   + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 724 ILGKIRHRNILKLYACLLKGGS-SFLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRRYK 780
            L       I       +      FLVL  +  +  +      K V   +  L      +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL------Q 163

Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI--ADFGVAK 827
           +A      + +LH +     +H ++ + NI +D + + ++  A +G A 
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.1 bits (115), Expect = 6e-06
 Identities = 29/155 (18%), Positives = 52/155 (33%), Gaps = 24/155 (15%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLLK 742
           IG G  G ++      N   VA+K   +         E      +     I  +Y    +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77

Query: 743 GGSSFLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRRY---KIALGAAKGIAYLHHDCS 797
           G  + LV++ + P+  +L     ++          F        A      +  +H    
Sbjct: 78  GLHNVLVIDLLGPSLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQSIH---E 124

Query: 798 PPIIHRDIKSSNILLDEDYEPK-----IADFGVAK 827
             +++RDIK  N L+            + DFG+ K
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 36/249 (14%), Positives = 67/249 (26%), Gaps = 47/249 (18%)

Query: 337 TALTDVDISENQFSGSFPKYLCEKRKLLNL----LALSNNFSGEVPNSY------ADCKT 386
             +T +D+  N FS        +    L      L L  N  G   +        A    
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168

Query: 387 IQRLRISDNHLSGKIPDGLWAL--------PNVGMLDFGDNDFT-GGISPLI----GLST 433
           +  L +  N+L+         L         +V  LD   N       + L      +  
Sbjct: 169 VNSLNLRGNNLA---SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN 225

Query: 434 SLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGK-------IPSALGALRQ 482
            +  L L  N   G     L      L +L+ + L  +            + +A   +++
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285

Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNI----------PRSLSLLSSLN 532
           +  +      +  S    + +  R +       SL                 L++   L 
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELR 345

Query: 533 ALNLSGNKL 541
               +   L
Sbjct: 346 ESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 59/295 (20%), Positives = 102/295 (34%), Gaps = 62/295 (21%)

Query: 337 TALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNH 396
             +T +D+S N         L +        A +N  +           ++  L +S N 
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQ--------AFANTPA-----------SVTSLNLSGNS 62

Query: 397 LSGK----IPDGLWALP-NVGMLDFGDNDFTGG-----ISPLIGLSTSLSQLVLQNNRFS 446
           L  K    +   L A+P NV  L+   N  +       +  L  +  +++ L L  N FS
Sbjct: 63  LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122

Query: 447 GELPSELGRL-----TNLERLILTNNNFSGKIPSALG-ALR----QLSSLHLEENALTGS 496
            +  SE  +       ++  L L  N+   K    L   L      ++SL+L  N L   
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182

Query: 497 IPNEMGD-----CARIVDLNLARNSLSGNIPRSLSLL-----SSLNALNLSGNKLTGSIP 546
              E+        A +  L+L+ N L       L+ +     + + +LNL  N L G   
Sbjct: 183 NCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242

Query: 547 DNLMKL-----KLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKML 596
           +NL  L      L ++ L  + +          M  +   A        Q   ++
Sbjct: 243 ENLKLLKDSLKHLQTVYLDYDIVK--------NMSKEQCKALGAAFPNIQKIILV 289

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 39/150 (26%), Positives = 60/150 (40%), Gaps = 16/150 (10%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLLK 742
           IGSG  G +Y          VA+K             E +I   ++    I  +  C  +
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76

Query: 743 GGSSFLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
           G  + +V+E + P+  +LF    ++    K  L       +A      I Y+H   S   
Sbjct: 77  GDYNVMVMELLGPSLEDLFNFCSRKFSL-KTVLL------LADQMISRIEYIH---SKNF 126

Query: 801 IHRDIKSSNILLDEDYEPK---IADFGVAK 827
           IHRD+K  N L+    +     I DFG+AK
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 37/233 (15%), Positives = 85/233 (36%), Gaps = 11/233 (4%)

Query: 53  WKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGK 112
           W+    +           +  +        +S   +  +   +   +  + L  +V+   
Sbjct: 49  WQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 108

Query: 113 -LPLELSNCSNLKVLNVTGNAMV-GSVPDLSALKNLEIFDLSI-NYFTGRFPRWVV-NLT 168
            L   LS CS L+ L++ G  +    V  L+   NL   +LS  + F+    + ++ + +
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 168

Query: 169 QLVSLSIGD--NVYDEAEIPESIGNLKNLTYLFLAHC--NLRGRIPESISE-LRELGTLD 223
           +L  L++    +  ++          + +T L L+    NL+     ++      L  LD
Sbjct: 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228

Query: 224 ICR-NKISGEFPRSIRKLQKLWKIEL-YANNLTGELPAELGNLTLLQEFDISS 274
           +     +  +  +   +L  L  + L    ++  E   ELG +  L+   +  
Sbjct: 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 36/156 (23%), Positives = 58/156 (37%), Gaps = 26/156 (16%)

Query: 684 IGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLL 741
           IG G  G++    +L  N   VA+K             E     ++     I ++Y    
Sbjct: 17  IGCGNFGELRLGKNLYTNE-YVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75

Query: 742 KGGSSFLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRRY---KIALGAAKGIAYLHHDC 796
            G  + +VLE + P+  +LF    +           F       IA+     + Y+H   
Sbjct: 76  CGKYNAMVLELLGPSLEDLFDLCDRT----------FSLKTVLMIAIQLISRMEYVH--- 122

Query: 797 SPPIIHRDIKSSNILLDEDYEPK-----IADFGVAK 827
           S  +I+RD+K  N L+            I DF +AK
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 28/102 (27%), Positives = 42/102 (41%), Gaps = 17/102 (16%)

Query: 485 SLHLEENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543
            L L +N L     + +      +V L L RN L+G  P +    S +  L L  NK+  
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91

Query: 544 SIP----DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAF 581
            I       L +LK   ++L +NQ+S  V          G+F
Sbjct: 92  EISNKMFLGLHQLKT--LNLYDNQIS-CVM--------PGSF 122

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 34/153 (22%), Positives = 59/153 (38%), Gaps = 22/153 (14%)

Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLK 742
           IGSG  G++Y     +    VA+K             E +I   ++    I  +    ++
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74

Query: 743 GGSSFLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRRY---KIALGAAKGIAYLHHDCS 797
           G  + LV++ + P+  +LF    ++                  +A      + ++H   S
Sbjct: 75  GDYNVLVMDLLGPSLEDLFNFCSRK----------LSLKTVLMLADQMINRVEFVH---S 121

Query: 798 PPIIHRDIKSSNILLDEDYEPK---IADFGVAK 827
              +HRDIK  N L+          I DFG+AK
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 70/506 (13%), Positives = 139/506 (27%), Gaps = 82/506 (16%)

Query: 84  SLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSAL 143
            L G+   +   L         +  +        S+ + L+ +                L
Sbjct: 72  ELKGKPHFADFNLVPDGWGGYVYPWIE----AMSSSYTWLEEIR---------------L 112

Query: 144 KNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC 203
           K + + D  +      F     N   L  LS  +    +  +       +NL  L L   
Sbjct: 113 KRMVVTDDCLELIAKSFK----NFKVL-VLSSCEGFSTDG-LAAIAATCRNLKELDLRES 166

Query: 204 NLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE-LPAELG 262
           ++       +S                   P +   L  L  I   A+ ++   L   + 
Sbjct: 167 DVDDVSGHWLSHF-----------------PDTYTSLVSL-NISCLASEVSFSALERLVT 208

Query: 263 NLTLLQEFDISSNQMYGKLPEEIGNLKNLTVF--QCFKNNFSGEFPSGFGDM----RKLF 316
               L+   ++      KL   +     L       +      +  SG        ++L 
Sbjct: 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELR 268

Query: 317 AFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGE 376
             S + +      P      + LT +++S           L  +   L  L + +     
Sbjct: 269 CLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDA 328

Query: 377 VPNSYAD-CKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSL 435
                A  CK ++ LR+                     +   +     G+  +      L
Sbjct: 329 GLEVLASTCKDLRELRVF----------PSEPFVMEPNVALTEQ----GLVSVSMGCPKL 374

Query: 436 SQLVLQNNRFSGELPSELGR-LTNLERLILTNNNFSGKIP-------SALGAL----RQL 483
             ++    + +      + R   N+ R  L                    GA+    + L
Sbjct: 375 ESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDL 434

Query: 484 SSLHLEENALTGSIPNEMGD-CARIVDLNLARNSLSGNIPRSLSL-LSSLNALNLSGNKL 541
             L L    LT  +   +G    ++  L++A    S      +     SL  L +     
Sbjct: 435 RRLSL-SGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493

Query: 542 TG-SIPDNLMKL-KLSSIDLSENQLS 565
              ++  N  KL  + S+ +S   +S
Sbjct: 494 GDKALLANASKLETMRSLWMSSCSVS 519

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 39/158 (24%), Positives = 62/158 (39%), Gaps = 22/158 (13%)

Query: 682 NLIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVFAA---EMEILGKIRHR------ 731
           +LIG G  G+V +  D  +    VA+K +              E+ +L  +         
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQE-WVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
            I+ L    +      LV E + + NL+  L      G   L+  R++   +     + +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVS-LNLTRKFAQQM--CTALLF 172

Query: 792 LH-HDCSPPIIHRDIKSSNILLDEDYEP--KIADFGVA 826
           L   + S  IIH D+K  NILL        KI DFG +
Sbjct: 173 LATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 26/169 (15%)

Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHR------ 731
           +IG G  G+V +  D K +   VA+K +      K F      E+ IL  +R +      
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQ-HVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTM 159

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           N++ +           +  E + + NL++ + K   +G   L   R++  ++   + +  
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFS-LPLVRKFAHSI--LQCLDA 215

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEP--KIADFGVAKIAENSPKVSDY 838
           LH      IIH D+K  NILL +      K+ DFG +       +V  Y
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTY 259

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 39/182 (21%), Positives = 69/182 (37%), Gaps = 27/182 (14%)

Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVF--AA--EMEILGKIRHR------ 731
            +G G  GKV   LD  +    VA+K +     V  +  AA  E+ +L KI+ +      
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII---RNVGKYREAARLEINVLKKIKEKDKENKF 82

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
             + +       G   +  E +   N F+ L +   +  P L   R     L  A  + +
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYP-LPHVRHMAYQLCHA--LRF 138

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP----KVSDY--SCFAGTH 845
           LH +    + H D+K  NIL        + +   +   ++      +V+D+  + F   H
Sbjct: 139 LH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195

Query: 846 GY 847
             
Sbjct: 196 HT 197

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 24/188 (12%), Positives = 57/188 (30%), Gaps = 15/188 (7%)

Query: 89  ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEI 148
              + + L+     SL  ++   +  + L     L  L ++                +  
Sbjct: 238 FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRK 297

Query: 149 FDLS-INYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG 207
            DL      T      +     L  L   + + D   +       K L  L +       
Sbjct: 298 LDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRG-LEVLAQYCKQLKRLRIERGADEQ 356

Query: 208 RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELG-NLTL 266
            + +    + + G + + +           ++L+ +    +Y +++T E    +G  L  
Sbjct: 357 GMEDEEGLVSQRGLIALAQG---------CQELEYM---AVYVSDITNESLESIGTYLKN 404

Query: 267 LQEFDISS 274
           L +F +  
Sbjct: 405 LCDFRLVL 412

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	851
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.98
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.98
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.98
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.96
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.95
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.95
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.95
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.95
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.95
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.95
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.95
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.95
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.95
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.95
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.95
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.95
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.95
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.95
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.95
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.94
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.94
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.94
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.94
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.94
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.94
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.94
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.94
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.94
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.94
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.94
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.94
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.94
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.94
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.94
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.94
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.94
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.94
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.94
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.94
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.94
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
3niz_A	311	Rhodanese family protein; structural genomics, str	99.94
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.94
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.94
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.94
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.94
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.94
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.94
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.94
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.94
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.94
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.94
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.94
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.94
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.94
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.94
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.94
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.94
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.94
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.94
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.94
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.94
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.94
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.94
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.94
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.94
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.94
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.94
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.94
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.94
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.94
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.94
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.94
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.94
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.94
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.93
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.93
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.93
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.93
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.93
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.93
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.93
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.93
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.93
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.93
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.93
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.93
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.93
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.93
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.93
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.93
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.93
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.93
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.93
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.93
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.93
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.93
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.93
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.93
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.93
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.93
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.93
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.93
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.93
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.93
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.93
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.93
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.93
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.93
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.93
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.93
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.93
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.93
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.93
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.93
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.93
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.93
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.93
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.93
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.93
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.93
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.93
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.93
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.93
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.93
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.93
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.93
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.93
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.93
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.93
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.93
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.93
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.93
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.93
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.93
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.93
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.93
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.93
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.92
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.92
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.92
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.92
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.92
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.92
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.92
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.92
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.92
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.92
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.92
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.92
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.92
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.92
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.92
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.92
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.92
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.92
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.92
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.92
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.92
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.92
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.92
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.92
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.92
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.92
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.92
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.92
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.92
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.92
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.92
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.92
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.91
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.91
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.91
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.91
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.91
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.91
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.91
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.9
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.9
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.9
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
3uqc_A	286	Probable conserved transmembrane protein; structur	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.83
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.83
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.8
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.8
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.79
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.75
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.73
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.73
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.7
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.65
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.65
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.65
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.6
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.59
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.58
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.57
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.57
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.57
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.56
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.54
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.53
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.51
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.5
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.47
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.47
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.38
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.32
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.31
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.3
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.28
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.22
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.07
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.0
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.97
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.94
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.93
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.83
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.65
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.54
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.44
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.43
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.42
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.42
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.13
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.03
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.98
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.92
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.64
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.59
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.54
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.44
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.24
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.15
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.08
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.06
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.99
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.92
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.84
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.83
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.78
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.74
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.5
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.32
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.11
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.66
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.23
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.05
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.39

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=9.8e-84  Score=780.97  Aligned_cols=559  Identities=34%  Similarity=0.522  Sum_probs=438.9

Q ss_pred             CCCchhhHHHHHHHHHhcCCCCCCCCCCCCCCCCCcccceeEecCCCCceEEEecccCCccee---cC------------
Q 003065           26 SLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGE---IS------------   90 (851)
Q Consensus        26 ~~~~~~~~~aLl~fk~~~~~~~~~l~sW~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~---i~------------   90 (851)
                      ..+.++|++||++||+++.||. .+++|+.+ +|||+|.||+|+  ++||+.|+|++.+++|.   +|            
T Consensus         7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~~~-~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l   82 (768)
T 3rgz_A            7 SQSLYREIHQLISFKDVLPDKN-LLPDWSSN-KNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL   82 (768)
T ss_dssp             -CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT-SCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred             ccCCHHHHHHHHHHHhhCCCcc-cccCCCCC-CCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence            3457899999999999999998 99999865 789999999999  68999999999999997   54            


Q ss_pred             -----------ccccCCccCcEEeCCCCcccCccCc--ccccCCCCceEecccCcccCCCCC-C-CCCCCCCeEeccCcc
Q 003065           91 -----------SSISALQSLTVLSLPFNVLSGKLPL--ELSNCSNLKVLNVTGNAMVGSVPD-L-SALKNLEIFDLSINY  155 (851)
Q Consensus        91 -----------~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~~~-l-~~l~~L~~L~Ls~N~  155 (851)
                                 +.++.+++|++|||++|.++|.+|.  .|+++++|++|+|++|.+.+..|. + .++++|++|||++|.
T Consensus        83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  162 (768)
T 3rgz_A           83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS  162 (768)
T ss_dssp             ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred             CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence                       4788889999999999999998888  899999999999999888776554 2 445555555544444


Q ss_pred             cCC-------------------------------------------------CCcccccCccccceeecccccCCCCCCc
Q 003065          156 FTG-------------------------------------------------RFPRWVVNLTQLVSLSIGDNVYDEAEIP  186 (851)
Q Consensus       156 l~~-------------------------------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~p  186 (851)
                      +++                                                 .+|. +.++++|++|++++|.+. +.+|
T Consensus       163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~-~~~~  240 (768)
T 3rgz_A          163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLS-GDFS  240 (768)
T ss_dssp             CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCC-SCHH
T ss_pred             cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCC-Cccc
Confidence            433                                                 3333 444444444444444444 3344


Q ss_pred             ccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCC-CcccEEEeeccCccCcCCcCcCCCC
Q 003065          187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKL-QKLWKIELYANNLTGELPAELGNLT  265 (851)
Q Consensus       187 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~  265 (851)
                      ..++++++|++|++++|++++.+|..  .+++|++|++++|++++.+|..+..+ ++|++|+|++|++++.+|..|++++
T Consensus       241 ~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~  318 (768)
T 3rgz_A          241 RAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS  318 (768)
T ss_dssp             HHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCT
T ss_pred             HHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCC
Confidence            44444444444444444444332221  22333333333333333444444443 5555555555555555555555555


Q ss_pred             cccEEecccccccCCCCcc-ccCcCCccEEEccCCccC-------------------------CCCCCCCCC--cccccE
Q 003065          266 LLQEFDISSNQMYGKLPEE-IGNLKNLTVFQCFKNNFS-------------------------GEFPSGFGD--MRKLFA  317 (851)
Q Consensus       266 ~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~l~~N~l~-------------------------~~~p~~~~~--l~~L~~  317 (851)
                      +|++|++++|++++.+|.. +.++++|++|++++|+++                         +.+|..+..  +++|++
T Consensus       319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~  398 (768)
T 3rgz_A          319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE  398 (768)
T ss_dssp             TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCE
T ss_pred             CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccE
Confidence            5555555555555444443 455555555555555544                         444444444  567777


Q ss_pred             EEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCcc
Q 003065          318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHL  397 (851)
Q Consensus       318 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l  397 (851)
                      |++++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++.+|.+.+.+|..+..+++|++|+|++|++
T Consensus       399 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  478 (768)
T 3rgz_A          399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL  478 (768)
T ss_dssp             EECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred             EECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence            88888888878888899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCcccc
Q 003065          398 SGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL  477 (851)
Q Consensus       398 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  477 (851)
                      ++.+|..+..+++|++|++++|++++.+|.+++.+++|++|+|++|+++|.+|..++.+++|++|++++|+++|.+|..+
T Consensus       479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~  558 (768)
T 3rgz_A          479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM  558 (768)
T ss_dssp             CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGG
T ss_pred             cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998877543


Q ss_pred             ----------------------------------------------------------------------ccCCcccEEE
Q 003065          478 ----------------------------------------------------------------------GALRQLSSLH  487 (851)
Q Consensus       478 ----------------------------------------------------------------------~~l~~L~~L~  487 (851)
                                                                                            +.++.|+.||
T Consensus       559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~Ld  638 (768)
T 3rgz_A          559 FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD  638 (768)
T ss_dssp             GTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEE
T ss_pred             hcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEE
Confidence                                                                                  3357799999


Q ss_pred             ecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccc
Q 003065          488 LEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSG  566 (851)
Q Consensus       488 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~  566 (851)
                      |++|+++|.+|.++++++.|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+ .|+.||+++|+++|
T Consensus       639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g  718 (768)
T 3rgz_A          639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG  718 (768)
T ss_dssp             CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred             CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999 89999999999999


Q ss_pred             cCCcccccCCC-CccccCCCCCCCCcc
Q 003065          567 SVPLDFLRMGG-DGAFAGNEGLCLDQS  592 (851)
Q Consensus       567 ~~p~~~~~~~~-~~~~~gn~~lc~~~~  592 (851)
                      .||...++.++ ..+|.||+++||.|.
T Consensus       719 ~iP~~~~~~~~~~~~~~gN~~Lcg~~l  745 (768)
T 3rgz_A          719 PIPEMGQFETFPPAKFLNNPGLCGYPL  745 (768)
T ss_dssp             ECCSSSSGGGSCGGGGCSCTEEESTTS
T ss_pred             cCCCchhhccCCHHHhcCCchhcCCCC
Confidence            99999888777 788999999999873

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.6e-65  Score=619.54  Aligned_cols=493  Identities=28%  Similarity=0.463  Sum_probs=314.2

Q ss_pred             ceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccC
Q 003065           74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI  153 (851)
Q Consensus        74 ~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~  153 (851)
                      +++.|+++++.+++.+|. ++.+++|++|+|++|.+++.+|..|+++++|++|+|++|.+++.+|.. .+++|++|+|++
T Consensus       201 ~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~  278 (768)
T 3rgz_A          201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAE  278 (768)
T ss_dssp             TCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCS
T ss_pred             cCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcC
Confidence            344555555555554444 555555555555555555555555555555555555555555544444 455555555555


Q ss_pred             cccCCCCcccccCc-cccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcc-cccccccCccccccccccc
Q 003065          154 NYFTGRFPRWVVNL-TQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPES-ISELRELGTLDICRNKISG  231 (851)
Q Consensus       154 N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~N~i~~  231 (851)
                      |.+++.+|..+..+ ++|++|++++|.+. +.+|..++++++|++|+|++|++++.+|.. +.++++|++|++++|++++
T Consensus       279 n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~  357 (768)
T 3rgz_A          279 NKFTGEIPDFLSGACDTLTGLDLSGNHFY-GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG  357 (768)
T ss_dssp             SEEEESCCCCSCTTCTTCSEEECCSSEEE-ECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEE
T ss_pred             CccCCccCHHHHhhcCcCCEEECcCCcCC-CccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCc
Confidence            55555555555443 55555555555554 345555555555555555555555555543 5555555555555555555


Q ss_pred             cccccccCCC-cccEEEeeccCccCcCCcCcCC--CCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCC
Q 003065          232 EFPRSIRKLQ-KLWKIELYANNLTGELPAELGN--LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG  308 (851)
Q Consensus       232 ~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~  308 (851)
                      .+|..+.+++ +|++|++++|++++.+|..+..  +++|++|++++|++++.+|..+.++++|++|++++|++++.+|..
T Consensus       358 ~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~  437 (768)
T 3rgz_A          358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS  437 (768)
T ss_dssp             CCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGG
T ss_pred             cccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHH
Confidence            5555555554 5555555555555555555544  555555555555555555555555555555555555555555555


Q ss_pred             CCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccc
Q 003065          309 FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQ  388 (851)
Q Consensus       309 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~  388 (851)
                      ++.+++|+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|++|++.+|++.+.+|.+++.+++|+
T Consensus       438 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  517 (768)
T 3rgz_A          438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA  517 (768)
T ss_dssp             GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred             HhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCC
Confidence            55555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             eeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCC----------------------------------
Q 003065          389 RLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTS----------------------------------  434 (851)
Q Consensus       389 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~----------------------------------  434 (851)
                      +|+|++|+++|.+|..+..+++|+.|++++|+++|.+|..+.....                                  
T Consensus       518 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  597 (768)
T 3rgz_A          518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ  597 (768)
T ss_dssp             EEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECT
T ss_pred             EEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccc
Confidence            5555555555555555555555555555555555555544433221                                  


Q ss_pred             ------------CCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcc
Q 003065          435 ------------LSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMG  502 (851)
Q Consensus       435 ------------L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  502 (851)
                                  +..++++.|.+.|.+|..+..+++|+.|||++|+++|.+|..++.++.|+.|+|++|+++|.+|..++
T Consensus       598 ~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~  677 (768)
T 3rgz_A          598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG  677 (768)
T ss_dssp             TCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred             cccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHh
Confidence                        12223334555556666667778999999999999999999999999999999999999999999999


Q ss_pred             cccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccccceEEeCcCCcccccCC
Q 003065          503 DCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVP  569 (851)
Q Consensus       503 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~L~~l~ls~N~l~~~~p  569 (851)
                      ++++|+.|||++|+++|.+|..+..+++|+.|||++|+|+|.||..-.-..+....+.+|+.-|-.|
T Consensus       678 ~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~  744 (768)
T 3rgz_A          678 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP  744 (768)
T ss_dssp             GCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred             CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence            9999999999999999999999999999999999999999999986322245555677887444333

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.5e-60  Score=562.67  Aligned_cols=506  Identities=18%  Similarity=0.191  Sum_probs=453.6

Q ss_pred             cceeEecCC---------CCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcc
Q 003065           63 FSGITCDSV---------TGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM  133 (851)
Q Consensus        63 w~gv~c~~~---------~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l  133 (851)
                      +.-|.|...         +..++.|+++++.+++..|.+|+.+++|++|+|++|++++..|.+|+++++|++|+|++|++
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            455778532         35789999999999988889999999999999999999988899999999999999999999


Q ss_pred             cCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcc
Q 003065          134 VGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPES  212 (851)
Q Consensus       134 ~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~  212 (851)
                      ++..|. ++++++|++|+|++|.+++..+..+.++++|++|++++|.+.....|..+. +++|++|++++|++++..|..
T Consensus        94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~  172 (606)
T 3t6q_A           94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDFQNNAIHYLSKED  172 (606)
T ss_dssp             SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCC-CTTCCEEECCSSCCCEECHHH
T ss_pred             cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccC-CcccCEEEcccCcccccChhh
Confidence            988775 999999999999999999887889999999999999999998445555554 999999999999999888889


Q ss_pred             cccccccC--ccccccccccccccccccCCCcccEEEeeccCcc--------------------------CcCCcCcCCC
Q 003065          213 ISELRELG--TLDICRNKISGEFPRSIRKLQKLWKIELYANNLT--------------------------GELPAELGNL  264 (851)
Q Consensus       213 ~~~l~~L~--~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~--------------------------~~~p~~~~~l  264 (851)
                      |+.+++|+  +|++++|++++..|..|.. .+|++|++++|...                          ...+..+..+
T Consensus       173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l  251 (606)
T 3t6q_A          173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL  251 (606)
T ss_dssp             HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGG
T ss_pred             hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchh
Confidence            99999999  8999999999877776654 68999999887511                          1112223333


Q ss_pred             C--cccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCcccee
Q 003065          265 T--LLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDV  342 (851)
Q Consensus       265 ~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  342 (851)
                      .  +|+.|++++|++++..+..|.++++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|+.|
T Consensus       252 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  330 (606)
T 3t6q_A          252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL  330 (606)
T ss_dssp             GGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEE
T ss_pred             hcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEE
Confidence            2  7999999999999888888999999999999999999 788899999999999999999998889999999999999


Q ss_pred             eccCCcccccCchh-hhhhcchHHHHhccCCccccc--cccccCccccceeccccCccccccCCcccCccccceEEecCC
Q 003065          343 DISENQFSGSFPKY-LCEKRKLLNLLALSNNFSGEV--PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN  419 (851)
Q Consensus       343 ~Ls~N~l~~~~p~~-~~~~~~L~~l~l~~n~~~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  419 (851)
                      ++++|.+.+.+|.. +..+++|+++++.+|.+.+..  |..+..+++|++|++++|++++..|..+..+++|+.|++++|
T Consensus       331 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  410 (606)
T 3t6q_A          331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT  410 (606)
T ss_dssp             ECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTC
T ss_pred             ECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCC
Confidence            99999999777665 889999999999999999877  888999999999999999999999999999999999999999


Q ss_pred             cCCCCCCc-ccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCC---CccccccCCcccEEEecCCcccC
Q 003065          420 DFTGGISP-LIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGK---IPSALGALRQLSSLHLEENALTG  495 (851)
Q Consensus       420 ~l~~~~~~-~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~  495 (851)
                      ++++..+. .+..+++|+.|++++|.+++..|..+..+++|++|++++|++++.   .+..+..+++|+.|+|++|++++
T Consensus       411 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~  490 (606)
T 3t6q_A          411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS  490 (606)
T ss_dssp             CEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCE
T ss_pred             cCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCc
Confidence            99988665 489999999999999999988999999999999999999999873   34679999999999999999999


Q ss_pred             CCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCccc
Q 003065          496 SIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDF  572 (851)
Q Consensus       496 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~  572 (851)
                      ..|..|+.+++|+.|+|++|++++.+|..+..+++| .|+|++|++++.+|..+..+ .|+.+++++|+|.|.++..+
T Consensus       491 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~  567 (606)
T 3t6q_A          491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY  567 (606)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHH
T ss_pred             cChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHH
Confidence            999999999999999999999999999999999999 99999999998888888888 89999999999999998543

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.9e-61  Score=572.52  Aligned_cols=488  Identities=21%  Similarity=0.302  Sum_probs=312.3

Q ss_pred             CchhhHHHHHHHHHhcCCC-CC-------CCCCCCCCCCCCccc---ceeEecCCCCceEEEecccCCcceecCccccCC
Q 003065           28 SLNVETQALIQFKSKLKDP-HG-------VLDSWKESADSPCGF---SGITCDSVTGRVTEISFDNKSLSGEISSSISAL   96 (851)
Q Consensus        28 ~~~~~~~aLl~fk~~~~~~-~~-------~l~sW~~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l   96 (851)
                      ....|+.||.+||+++.++ +.       ...+|+.+ .|||.|   .||+|+.. |||++|+|++++++|.+|++|++|
T Consensus        27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L  104 (636)
T 4eco_A           27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQL  104 (636)
T ss_dssp             HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGC
T ss_pred             hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcC
Confidence            3457999999999998653 22       34589976 789999   99999865 899999999999999999999999


Q ss_pred             ccCcEEeCCCCcc------cC------ccCcccccCCCCceEecccCcccCCCCC-CCC-CCC-----------------
Q 003065           97 QSLTVLSLPFNVL------SG------KLPLELSNCSNLKVLNVTGNAMVGSVPD-LSA-LKN-----------------  145 (851)
Q Consensus        97 ~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~-l~~-----------------  145 (851)
                      ++|++|+|++|.+      .|      .+|.+.  +.+|+ +++++|.+.+.+|. +.. +.+                 
T Consensus       105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~  181 (636)
T 4eco_A          105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI  181 (636)
T ss_dssp             TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCC
T ss_pred             ccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccccccc
Confidence            9999999999977      33      455544  56777 88888888877665 431 111                 


Q ss_pred             -CCeEecc--CcccCCCCcccccCccccceeecccccCCCCC-----------------Cccccc--CCCCCCeEecccc
Q 003065          146 -LEIFDLS--INYFTGRFPRWVVNLTQLVSLSIGDNVYDEAE-----------------IPESIG--NLKNLTYLFLAHC  203 (851)
Q Consensus       146 -L~~L~Ls--~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----------------~p~~~~--~l~~L~~L~L~~n  203 (851)
                       ++.+.+.  .|++++ +|..++++++|++|+|++|.++ +.                 +|+.++  ++++|++|+|++|
T Consensus       182 ~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~-~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n  259 (636)
T 4eco_A          182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFV-AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC  259 (636)
T ss_dssp             CCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCC-GGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred             chhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccc-cccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence             2222222  456666 6666666777777777766665 32                 666666  6666666666666


Q ss_pred             cccccCCcccccccccCcccccccc-ccc-cccccccCC------CcccEEEeeccCccCcCCc--CcCCCCcccEEecc
Q 003065          204 NLRGRIPESISELRELGTLDICRNK-ISG-EFPRSIRKL------QKLWKIELYANNLTGELPA--ELGNLTLLQEFDIS  273 (851)
Q Consensus       204 ~l~~~~p~~~~~l~~L~~L~L~~N~-i~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls  273 (851)
                      ++.+.+|..|+++++|++|++++|+ +++ .+|..+.++      ++|++|++++|+++ .+|.  .++++++|++|+++
T Consensus       260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~  338 (636)
T 4eco_A          260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECL  338 (636)
T ss_dssp             TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECC
T ss_pred             cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCc
Confidence            6666666666666666666666666 666 566666554      66666666666666 5665  66666666666666


Q ss_pred             cccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCccc-ccEEEeccCcCCCCCCCccCCCC--ccceeeccCCccc
Q 003065          274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK-LFAFSIYGNRFSGPFPENLGRYT--ALTDVDISENQFS  350 (851)
Q Consensus       274 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~  350 (851)
                      +|+++|.+| .+.++++|++|++++|+++ .+|..+..+++ |++|++++|+++ .+|..+....  +|+.|++++|+++
T Consensus       339 ~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~  415 (636)
T 4eco_A          339 YNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIG  415 (636)
T ss_dssp             SCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTT
T ss_pred             CCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCC
Confidence            666666666 6666666666666666666 55666666666 666666666666 5555555433  5666666666665


Q ss_pred             ccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCc-ccCccccceEEecCCcCCCCCCccc
Q 003065          351 GSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFTGGISPLI  429 (851)
Q Consensus       351 ~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~~  429 (851)
                      +.+|..+...                 ......+++|++|+|++|+++ .+|.. +..+++|++|+|++|+++..++..+
T Consensus       416 ~~~p~~l~~~-----------------~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~  477 (636)
T 4eco_A          416 SVDGKNFDPL-----------------DPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSL  477 (636)
T ss_dssp             TTTTCSSCTT-----------------CSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSS
T ss_pred             Ccchhhhccc-----------------ccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHh
Confidence            5444433210                 000113445666666666666 33433 3345666666666666664333333


Q ss_pred             ccCC-------CCCeEecCCCcceeeCCcccc--cCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCC
Q 003065          430 GLST-------SLSQLVLQNNRFSGELPSELG--RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNE  500 (851)
Q Consensus       430 ~~~~-------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  500 (851)
                      ....       +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+        
T Consensus       478 ~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~--------  547 (636)
T 4eco_A          478 KDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR--------  547 (636)
T ss_dssp             EETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB--------
T ss_pred             ccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc--------
Confidence            3222       5555555555555 4555554  55555555555555554 55555555555555554433        


Q ss_pred             cccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccccceEEeCcCCcccc
Q 003065          501 MGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSG  566 (851)
Q Consensus       501 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~L~~l~ls~N~l~~  566 (851)
                                ++++|++.+.+|.++..+++|+.|+|++|++ +.+|..+. -.|+.||+++|++.+
T Consensus       548 ----------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          548 ----------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT-PNISVLDIKDNPNIS  601 (636)
T ss_dssp             ----------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-TTCCEEECCSCTTCE
T ss_pred             ----------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh-CcCCEEECcCCCCcc
Confidence                      2256667777777777777777777777777 46776654 367777777776664

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.2e-59  Score=562.14  Aligned_cols=519  Identities=19%  Similarity=0.181  Sum_probs=397.9

Q ss_pred             CCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEe
Q 003065           72 TGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFD  150 (851)
Q Consensus        72 ~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~  150 (851)
                      ..+++.|+|+++.+++..+..++.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++.++. |+++++|++|+
T Consensus        24 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  103 (680)
T 1ziw_A           24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH  103 (680)
T ss_dssp             CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred             CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence            35899999999999987778899999999999999999999999999999999999999999988875 99999999999


Q ss_pred             ccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccc--cccccCcccccccc
Q 003065          151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESIS--ELRELGTLDICRNK  228 (851)
Q Consensus       151 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L~~N~  228 (851)
                      |++|.+++..|..|.++++|++|++++|.+. +..|..++++++|++|++++|++++..+..+.  .+++|++|++++|+
T Consensus       104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~  182 (680)
T 1ziw_A          104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLS-STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ  182 (680)
T ss_dssp             CCSSCCCCCCSCTTTTCTTCCEEECCSSCCS-CCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCC
T ss_pred             CCCCccCccChhHccccCCCCEEECCCCccc-ccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCc
Confidence            9999999888899999999999999999998 55677889999999999999999977776654  45789999999998


Q ss_pred             ccccccccccCC---------------------------CcccEEEeeccCccCcCCcCcCCCCc--ccEEecccccccC
Q 003065          229 ISGEFPRSIRKL---------------------------QKLWKIELYANNLTGELPAELGNLTL--LQEFDISSNQMYG  279 (851)
Q Consensus       229 i~~~~p~~~~~l---------------------------~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~  279 (851)
                      +++..|..|..+                           ++|+.|++++|.+++..|..|.+++.  |++|++++|++++
T Consensus       183 l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~  262 (680)
T 1ziw_A          183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV  262 (680)
T ss_dssp             CCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCE
T ss_pred             ccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCc
Confidence            887777666544                           34556666666666666666666644  7777777777766


Q ss_pred             CCCccccCcCCccEEEccCCccCCCCCCCCCCcc---------------------------------cccEEEeccCcCC
Q 003065          280 KLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR---------------------------------KLFAFSIYGNRFS  326 (851)
Q Consensus       280 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~---------------------------------~L~~L~l~~N~l~  326 (851)
                      ..|..|.++++|++|++++|++++..|..|.+++                                 +|++|++++|+++
T Consensus       263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~  342 (680)
T 1ziw_A          263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP  342 (680)
T ss_dssp             ECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBC
T ss_pred             cCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccC
Confidence            6666677777777777777776665555555544                                 4555555555555


Q ss_pred             CCCCCccCCCCccceeeccCCccccc-Cc-hhhhh--hcchHHHHhccCCccccccccccCccccceeccccCccccccC
Q 003065          327 GPFPENLGRYTALTDVDISENQFSGS-FP-KYLCE--KRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP  402 (851)
Q Consensus       327 ~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p-~~~~~--~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  402 (851)
                      +..+..|..+++|++|++++|.+++. ++ ..+..  .++|+.+++.+|++.+..|..|..+++|++|+|++|++++.+|
T Consensus       343 ~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  422 (680)
T 1ziw_A          343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT  422 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECC
T ss_pred             CCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccC
Confidence            55555555555555555555543221 11 11111  1345566666677777777888888888888888888877666


Q ss_pred             -CcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcce--eeCCcccccCCCCcEEeccCccccCCCcccccc
Q 003065          403 -DGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS--GELPSELGRLTNLERLILTNNNFSGKIPSALGA  479 (851)
Q Consensus       403 -~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  479 (851)
                       ..+.++++|++|++++|++++..+..|..+++|+.|++++|.++  +.+|..|..+++|++|++++|++++..|..|.+
T Consensus       423 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~  502 (680)
T 1ziw_A          423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG  502 (680)
T ss_dssp             SGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             cccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcc
Confidence             56777888888888888888877888888888888888888876  467888888889999999999998888888888


Q ss_pred             CCcccEEEecCCcccCCCC--------CCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCccccc
Q 003065          480 LRQLSSLHLEENALTGSIP--------NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK  551 (851)
Q Consensus       480 l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~  551 (851)
                      +++|++|+|++|++++..+        ..++.+++|+.|+|++|+++...+..|..+++|+.|+|++|++++..|..+..
T Consensus       503 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~  582 (680)
T 1ziw_A          503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN  582 (680)
T ss_dssp             CTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             ccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCC
Confidence            8999999999998875422        23788888999999999998554457888999999999999999555555677


Q ss_pred             c-cceEEeCcCCcccccCCcccc-c-CCC-CccccCCCCCCCCc
Q 003065          552 L-KLSSIDLSENQLSGSVPLDFL-R-MGG-DGAFAGNEGLCLDQ  591 (851)
Q Consensus       552 l-~L~~l~ls~N~l~~~~p~~~~-~-~~~-~~~~~gn~~lc~~~  591 (851)
                      + .|+.||+++|++++..|..+. . ... .-...+||+.|..+
T Consensus       583 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          583 QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             CTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             CCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            7 899999999999887665432 1 111 34457888888643

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.3e-59  Score=556.53  Aligned_cols=504  Identities=20%  Similarity=0.176  Sum_probs=452.5

Q ss_pred             CCccc----ceeEecC---------CCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCce
Q 003065           59 SPCGF----SGITCDS---------VTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKV  125 (851)
Q Consensus        59 ~~c~w----~gv~c~~---------~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  125 (851)
                      +||.|    ..|.|..         ...+++.|+|+++.+++..+..++.+++|++|+|++|.+++..|.+|+++++|++
T Consensus         5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~   84 (606)
T 3vq2_A            5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN   84 (606)
T ss_dssp             -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred             CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence            45655    2467753         2357999999999999988889999999999999999999888999999999999


Q ss_pred             EecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEeccccc
Q 003065          126 LNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN  204 (851)
Q Consensus       126 L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~  204 (851)
                      |+|++|.+++.+|. ++++++|++|+|++|.+++..+..+.++++|++|++++|.+....+|..++++++|++|++++|+
T Consensus        85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~  164 (606)
T 3vq2_A           85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY  164 (606)
T ss_dssp             EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred             eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence            99999999998776 99999999999999999988888999999999999999999866789999999999999999999


Q ss_pred             ccccCCcccccccccC----ccccccccccccccccccCCCcccEEEeeccCcc-CcCCcCcCCCCcccEEec-------
Q 003065          205 LRGRIPESISELRELG----TLDICRNKISGEFPRSIRKLQKLWKIELYANNLT-GELPAELGNLTLLQEFDI-------  272 (851)
Q Consensus       205 l~~~~p~~~~~l~~L~----~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L-------  272 (851)
                      +++..|..|+.+++|+    +|++++|++++..+..+... +|++|++++|.++ +..|..+.+++.|+.+++       
T Consensus       165 l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~  243 (606)
T 3vq2_A          165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD  243 (606)
T ss_dssp             CCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred             ceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccccc
Confidence            9999899999888876    79999999997666666555 9999999999986 355566666776666655       


Q ss_pred             --------------------------ccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCC
Q 003065          273 --------------------------SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFS  326 (851)
Q Consensus       273 --------------------------s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  326 (851)
                                                ..|.+.+.+|. +..+++|+.|++++|.+. .+| .+..+++|+.|++++|++ 
T Consensus       244 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-  319 (606)
T 3vq2_A          244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-  319 (606)
T ss_dssp             SCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-
T ss_pred             CCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-
Confidence                                      66777777777 889999999999999997 456 899999999999999999 


Q ss_pred             CCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCcccc--ccccccCccccceeccccCccccccCCc
Q 003065          327 GPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGE--VPNSYADCKTIQRLRISDNHLSGKIPDG  404 (851)
Q Consensus       327 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  404 (851)
                      +.+| .+ .+++|+.|++++|+..+.+  .+..+++|+++++++|++.+.  +|..+..+++|++|++++|.++ .+|..
T Consensus       320 ~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~  394 (606)
T 3vq2_A          320 KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSAN  394 (606)
T ss_dssp             SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCC
T ss_pred             cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhh
Confidence            5788 45 9999999999999766544  566889999999999999877  4888999999999999999998 47788


Q ss_pred             ccCccccceEEecCCcCCCCCC-cccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccC-CCccccccCCc
Q 003065          405 LWALPNVGMLDFGDNDFTGGIS-PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSG-KIPSALGALRQ  482 (851)
Q Consensus       405 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~  482 (851)
                      +..+++|+.|++++|++++.++ ..+..+++|+.|++++|++++..|..+..+++|++|++++|.+++ .+|..+..+++
T Consensus       395 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~  474 (606)
T 3vq2_A          395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN  474 (606)
T ss_dssp             CTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred             ccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCC
Confidence            9999999999999999999888 789999999999999999999999999999999999999999998 47899999999


Q ss_pred             ccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc--cceEEeCc
Q 003065          483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLS  560 (851)
Q Consensus       483 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l--~L~~l~ls  560 (851)
                      |+.|+|++|++++..|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|++|+++ .+|..+..+  .|+.|+++
T Consensus       475 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~  553 (606)
T 3vq2_A          475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLT  553 (606)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECC
T ss_pred             CCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEcc
Confidence            999999999999999999999999999999999999999999999999999999999999 789888887  49999999


Q ss_pred             CCcccccCCcccc
Q 003065          561 ENQLSGSVPLDFL  573 (851)
Q Consensus       561 ~N~l~~~~p~~~~  573 (851)
                      +|+|.|.++..|.
T Consensus       554 ~N~~~c~c~~~~~  566 (606)
T 3vq2_A          554 NNSVACICEHQKF  566 (606)
T ss_dssp             SCCCCCSSTTHHH
T ss_pred             CCCcccCCccHHH
Confidence            9999999997654

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.4e-59  Score=562.98  Aligned_cols=505  Identities=20%  Similarity=0.265  Sum_probs=339.3

Q ss_pred             CCCCchhhHHHHHHHHHhcCCCCCCCCCCCCCC----CCC--ccc------------ceeEecCCCCceEEEecccCCcc
Q 003065           25 PSLSLNVETQALIQFKSKLKDPHGVLDSWKESA----DSP--CGF------------SGITCDSVTGRVTEISFDNKSLS   86 (851)
Q Consensus        25 ~~~~~~~~~~aLl~fk~~~~~~~~~l~sW~~~~----~~~--c~w------------~gv~c~~~~~~v~~l~l~~~~l~   86 (851)
                      .+.+..+|++||++||+++.+|     +|+.+.    .+|  |.|            .||+|+. ++||++|+|++++++
T Consensus       263 ~~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~  336 (876)
T 4ecn_A          263 ETAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAK  336 (876)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCE
T ss_pred             ccccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCC
Confidence            3456678999999999999877     887653    356  999            9999987 689999999999999


Q ss_pred             eecCccccCCccCcEEeC-CCCcccCccCcccccC----CC-----CceE------ec-ccCccc-----------CCCC
Q 003065           87 GEISSSISALQSLTVLSL-PFNVLSGKLPLELSNC----SN-----LKVL------NV-TGNAMV-----------GSVP  138 (851)
Q Consensus        87 g~i~~~l~~l~~L~~L~L-~~n~l~~~~p~~~~~l----~~-----L~~L------~L-s~n~l~-----------~~~~  138 (851)
                      |.+|++|++|++|++|+| ++|.++|..|-.-...    +.     ++..      +. ....+.           ...+
T Consensus       337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~  416 (876)
T 4ecn_A          337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP  416 (876)
T ss_dssp             EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred             CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence            999999999999999999 8999988754321111    00     0000      00 000000           0000


Q ss_pred             C-CCCCCCCCeEeccC--cccCCCCcccccCccccceeecccccCCCC----------------CCccccc--CCCCCCe
Q 003065          139 D-LSALKNLEIFDLSI--NYFTGRFPRWVVNLTQLVSLSIGDNVYDEA----------------EIPESIG--NLKNLTY  197 (851)
Q Consensus       139 ~-l~~l~~L~~L~Ls~--N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----------------~~p~~~~--~l~~L~~  197 (851)
                      . ......++.+.++.  |.+++ +|..|.++++|++|+|++|.++..                .+|..++  ++++|++
T Consensus       417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~  495 (876)
T 4ecn_A          417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD  495 (876)
T ss_dssp             CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred             cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence            0 11222333333333  55555 566666666666666666666510                2666655  6666666


Q ss_pred             EecccccccccCCcccccccccCcccccccc-ccc-cccccccCCC-------cccEEEeeccCccCcCCc--CcCCCCc
Q 003065          198 LFLAHCNLRGRIPESISELRELGTLDICRNK-ISG-EFPRSIRKLQ-------KLWKIELYANNLTGELPA--ELGNLTL  266 (851)
Q Consensus       198 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-i~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~~~~l~~  266 (851)
                      |+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..+.+++       +|++|+|++|+++ .+|.  .|+++++
T Consensus       496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~  574 (876)
T 4ecn_A          496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK  574 (876)
T ss_dssp             EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred             EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence            6666666666666666666666666666666 666 5665555444       6666677666666 5666  6666666


Q ss_pred             ccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCccc-ccEEEeccCcCCCCCCCccCCCCc--cceee
Q 003065          267 LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK-LFAFSIYGNRFSGPFPENLGRYTA--LTDVD  343 (851)
Q Consensus       267 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~l~~l~~--L~~L~  343 (851)
                      |++|+|++|+++ .+| .|.++++|+.|++++|+++ .+|..+..+++ |+.|++++|+++ .+|..+..++.  |+.|+
T Consensus       575 L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~  650 (876)
T 4ecn_A          575 LGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVD  650 (876)
T ss_dssp             CCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEE
T ss_pred             CCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEE
Confidence            667777666666 555 6666666666777666666 56666666666 667777766666 55666655543  66677


Q ss_pred             ccCCcccccCchhh---h--hhcchHHHHhccCCcccccccc-ccCccccceeccccCccccccCCcccCc--------c
Q 003065          344 ISENQFSGSFPKYL---C--EKRKLLNLLALSNNFSGEVPNS-YADCKTIQRLRISDNHLSGKIPDGLWAL--------P  409 (851)
Q Consensus       344 Ls~N~l~~~~p~~~---~--~~~~L~~l~l~~n~~~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--------~  409 (851)
                      |++|++.+.+|...   .  ..++|+.|++++|++. .+|.. +..+++|++|+|++|+|+ .+|..+...        +
T Consensus       651 Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~  728 (876)
T 4ecn_A          651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTY  728 (876)
T ss_dssp             CCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGG
T ss_pred             CcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccC
Confidence            77776666554322   1  2235666666666666 34443 457889999999999998 667655442        3


Q ss_pred             ccceEEecCCcCCCCCCcccc--cCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEE
Q 003065          410 NVGMLDFGDNDFTGGISPLIG--LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLH  487 (851)
Q Consensus       410 ~L~~L~Ls~N~l~~~~~~~~~--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  487 (851)
                      +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+                  +
T Consensus       729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~  788 (876)
T 4ecn_A          729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------D  788 (876)
T ss_dssp             GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------C
T ss_pred             CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------------------C
Confidence            8999999999999 5566665  89999999999999997 78889999999999998876                  5


Q ss_pred             ecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccc
Q 003065          488 LEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSG  566 (851)
Q Consensus       488 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~  566 (851)
                      +++|++.+.+|..++.+++|+.|+|++|+| +.+|..+.  ++|+.|||++|++...-+..+... .+..+.+.+|++..
T Consensus       789 ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~  865 (876)
T 4ecn_A          789 AEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD  865 (876)
T ss_dssp             TTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred             cccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccc
Confidence            566777777777777777777777777777 56666654  467777777777764444444443 45555666665543

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4e-59  Score=571.17  Aligned_cols=497  Identities=19%  Similarity=0.219  Sum_probs=426.1

Q ss_pred             cccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCcc-CcccccCCCCceEecccCcccCCCCC
Q 003065           61 CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKL-PLELSNCSNLKVLNVTGNAMVGSVPD  139 (851)
Q Consensus        61 c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~~~  139 (851)
                      |.|..|.+  .+.+++.|||++|.+++..+.+|..+++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+.+..|.
T Consensus        14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            57888877  5568999999999999999999999999999999999777777 77899999999999999999998776


Q ss_pred             -CCCCCCCCeEeccCcccCCCCccc--ccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccc
Q 003065          140 -LSALKNLEIFDLSINYFTGRFPRW--VVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISEL  216 (851)
Q Consensus       140 -l~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l  216 (851)
                       |+++++|++|+|++|.+++..|..  |.++++|++|+|++|.+.....+..|+++++|++|+|++|.+++..|..+..+
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l  171 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL  171 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence             999999999999999999876665  99999999999999999855555789999999999999999999999999988


Q ss_pred             --cccCccccccccccccccccccCCCc------ccEEEeeccCccCcCCcCcCC-------------------------
Q 003065          217 --RELGTLDICRNKISGEFPRSIRKLQK------LWKIELYANNLTGELPAELGN-------------------------  263 (851)
Q Consensus       217 --~~L~~L~L~~N~i~~~~p~~~~~l~~------L~~L~L~~N~l~~~~p~~~~~-------------------------  263 (851)
                        ++|+.|+++.|.+++..|..+..+++      |++|++++|.+++..|..+..                         
T Consensus       172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~  251 (844)
T 3j0a_A          172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN  251 (844)
T ss_dssp             HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred             cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence              89999999999999988888777766      999999999888766654432                         


Q ss_pred             -------------CCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCC
Q 003065          264 -------------LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP  330 (851)
Q Consensus       264 -------------l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  330 (851)
                                   .++|+.|++++|.+.+..|..|.++++|+.|++++|++++..|..|..+++|++|++++|++++..|
T Consensus       252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  331 (844)
T 3j0a_A          252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS  331 (844)
T ss_dssp             STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred             cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence                         2578888888888887778888888888888888888888778888888888888888888888888


Q ss_pred             CccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccc
Q 003065          331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPN  410 (851)
Q Consensus       331 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  410 (851)
                      ..+..+++|+.|++++|++.+..+..+..+++|+.|++++|.+.+.     ..+++|+.|++++|+++ .+|..   ..+
T Consensus       332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~  402 (844)
T 3j0a_A          332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLT  402 (844)
T ss_dssp             CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CTT
T ss_pred             HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---ccc
Confidence            8888888888888888888877777788888888888888887643     23677888888888887 55543   457


Q ss_pred             cceEEecCCcCCCCCC-cccccCCCCCeEecCCCcceeeCCc-ccccCCCCcEEeccCcccc-----CCCccccccCCcc
Q 003065          411 VGMLDFGDNDFTGGIS-PLIGLSTSLSQLVLQNNRFSGELPS-ELGRLTNLERLILTNNNFS-----GKIPSALGALRQL  483 (851)
Q Consensus       411 L~~L~Ls~N~l~~~~~-~~~~~~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L  483 (851)
                      ++.|++++|++++... ..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++     +..|..|.++++|
T Consensus       403 l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L  482 (844)
T 3j0a_A          403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHL  482 (844)
T ss_dssp             CCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCE
T ss_pred             cceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccc
Confidence            8888999998887543 2456789999999999999865543 4566889999999999997     4455678899999


Q ss_pred             cEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccccceEEeCcCCc
Q 003065          484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQ  563 (851)
Q Consensus       484 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~L~~l~ls~N~  563 (851)
                      +.|+|++|+|++.+|..|..+++|+.|+|++|+|++..|..+.  ++|+.|||++|+|++.+|..+.  .|+.+++++|+
T Consensus       483 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~--~L~~l~l~~Np  558 (844)
T 3j0a_A          483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV--SLSVLDITHNK  558 (844)
T ss_dssp             ECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS--SCCEEEEEEEC
T ss_pred             cEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC--CcCEEEecCCC
Confidence            9999999999999999999999999999999999987777766  7899999999999998888765  67889999999


Q ss_pred             ccccCCccc
Q 003065          564 LSGSVPLDF  572 (851)
Q Consensus       564 l~~~~p~~~  572 (851)
                      |.|.|+..+
T Consensus       559 ~~C~c~~~~  567 (844)
T 3j0a_A          559 FICECELST  567 (844)
T ss_dssp             CCCSSSCCS
T ss_pred             cccccccHH
Confidence            999998654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1e-57  Score=547.80  Aligned_cols=499  Identities=21%  Similarity=0.172  Sum_probs=391.0

Q ss_pred             ceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEecc
Q 003065           74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLS  152 (851)
Q Consensus        74 ~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls  152 (851)
                      +++.|+++++.+++..|..++.+++|++|+|++|.+++..+..|+++++|++|+|++|.+++.+|. ++++++|++|||+
T Consensus        50 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  129 (680)
T 1ziw_A           50 QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLS  129 (680)
T ss_dssp             TCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECC
T ss_pred             cCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECC
Confidence            566777777777777777777777777777777777754444677777777777777777766654 7777777777777


Q ss_pred             CcccCCCCcccccCccccceeecccccCCCCCCcccc--cCCCCCCeEecccccccccCCc-------------------
Q 003065          153 INYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI--GNLKNLTYLFLAHCNLRGRIPE-------------------  211 (851)
Q Consensus       153 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~--~~l~~L~~L~L~~n~l~~~~p~-------------------  211 (851)
                      +|.+++..|..+.++++|++|++++|.++ +..|..+  ..+++|++|++++|++++..|.                   
T Consensus       130 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~  208 (680)
T 1ziw_A          130 HNGLSSTKLGTQVQLENLQELLLSNNKIQ-ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG  208 (680)
T ss_dssp             SSCCSCCCCCSSSCCTTCCEEECCSSCCC-CBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCH
T ss_pred             CCcccccCchhhcccccCCEEEccCCccc-ccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccC
Confidence            77777777777777777777777777765 2223332  2345566666666655554444                   


Q ss_pred             --------------------------------ccccccc--cCccccccccccccccccccCCCcccEEEeeccCccCcC
Q 003065          212 --------------------------------SISELRE--LGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL  257 (851)
Q Consensus       212 --------------------------------~~~~l~~--L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~  257 (851)
                                                      .|.+++.  |++|++++|++++..|..|..+++|++|++++|++++..
T Consensus       209 ~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  288 (680)
T 1ziw_A          209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF  288 (680)
T ss_dssp             HHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEEC
T ss_pred             hhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccC
Confidence                                            4444433  566666666665555555666666666666666666555


Q ss_pred             CcCcCCCCcccEEecccccccC-----CCCc----cccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCC
Q 003065          258 PAELGNLTLLQEFDISSNQMYG-----KLPE----EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGP  328 (851)
Q Consensus       258 p~~~~~l~~L~~L~Ls~N~l~~-----~~p~----~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  328 (851)
                      |..|.++++|++|++++|...+     .+|.    .|..+++|++|++++|++++..+..|.++++|++|++++|.++..
T Consensus       289 ~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~  368 (680)
T 1ziw_A          289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR  368 (680)
T ss_dssp             TTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCC
T ss_pred             hhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhh
Confidence            5566666666666666554332     2222    567788999999999999998888999999999999999986533


Q ss_pred             C--CCccCCC--CccceeeccCCcccccCchhhhhhcchHHHHhccCCcccccc-ccccCccccceeccccCccccccCC
Q 003065          329 F--PENLGRY--TALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPD  403 (851)
Q Consensus       329 ~--p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~  403 (851)
                      .  +..+..+  ++|+.|++++|++++..|..+..+++|+.+++++|.+.+.+| ..|.++++|++|++++|++++..+.
T Consensus       369 ~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  448 (680)
T 1ziw_A          369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN  448 (680)
T ss_dssp             EECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTT
T ss_pred             hcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChh
Confidence            2  2333333  589999999999999999999999999999999999998776 6899999999999999999999999


Q ss_pred             cccCccccceEEecCCcCC--CCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCc-------
Q 003065          404 GLWALPNVGMLDFGDNDFT--GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIP-------  474 (851)
Q Consensus       404 ~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-------  474 (851)
                      .|..+++|+.|++++|.++  +..|..+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+       
T Consensus       449 ~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  528 (680)
T 1ziw_A          449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP  528 (680)
T ss_dssp             TTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSC
T ss_pred             hhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCc
Confidence            9999999999999999987  5688899999999999999999998888889999999999999999986532       


Q ss_pred             -cccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccc-cc
Q 003065          475 -SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLM-KL  552 (851)
Q Consensus       475 -~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~-~l  552 (851)
                       ..|.++++|+.|+|++|+++...+..|+++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+. .+
T Consensus       529 ~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  608 (680)
T 1ziw_A          529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF  608 (680)
T ss_dssp             CCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHH
T ss_pred             chhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccc
Confidence             3488999999999999999965556799999999999999999987777889999999999999999987777776 55


Q ss_pred             -cceEEeCcCCcccccCCc-ccc
Q 003065          553 -KLSSIDLSENQLSGSVPL-DFL  573 (851)
Q Consensus       553 -~L~~l~ls~N~l~~~~p~-~~~  573 (851)
                       .|+.+++++|+|.|.++. .|.
T Consensus       609 ~~L~~l~l~~N~~~c~c~~~~~~  631 (680)
T 1ziw_A          609 RNLTELDMRFNPFDCTCESIAWF  631 (680)
T ss_dssp             TTCSEEECTTCCCCBCCCCCSSE
T ss_pred             cccCEEEccCCCcccCCccHHHH
Confidence             899999999999999985 443

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=8.2e-58  Score=541.14  Aligned_cols=506  Identities=19%  Similarity=0.178  Sum_probs=450.4

Q ss_pred             EEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcc
Q 003065           77 EISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINY  155 (851)
Q Consensus        77 ~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~  155 (851)
                      .++.++.+++ .+|..+..  ++++|+|++|.+++..|..|+++++|++|+|++|++.+..|. |+++++|++|+|++|.
T Consensus        16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   92 (606)
T 3t6q_A           16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP   92 (606)
T ss_dssp             EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence            5788888887 67777764  799999999999988899999999999999999999998776 9999999999999999


Q ss_pred             cCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccc
Q 003065          156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPR  235 (851)
Q Consensus       156 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~  235 (851)
                      +++..|..|.++++|++|++++|.+. ...|..++++++|++|++++|++++..+..+..+++|++|++++|++++..|.
T Consensus        93 l~~~~~~~~~~l~~L~~L~L~~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  171 (606)
T 3t6q_A           93 LIFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE  171 (606)
T ss_dssp             CSEECTTTTSSCTTCCEEECTTSCCS-CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred             ccccChhhhcccccccEeeccccCcc-cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence            99999999999999999999999998 22367799999999999999999975545555699999999999999988899


Q ss_pred             cccCCCccc--EEEeeccCccCcCCcCcCCCCcccEEeccccccc--------------------------CCCCccccC
Q 003065          236 SIRKLQKLW--KIELYANNLTGELPAELGNLTLLQEFDISSNQMY--------------------------GKLPEEIGN  287 (851)
Q Consensus       236 ~~~~l~~L~--~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--------------------------~~~p~~l~~  287 (851)
                      .|..+++|+  .|++++|.+++..|..+. ..+|+.|++++|...                          ...+..+..
T Consensus       172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~  250 (606)
T 3t6q_A          172 DMSSLQQATNLSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG  250 (606)
T ss_dssp             HHHTTTTCCSEEEECTTCCCCEECTTTTT-TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGG
T ss_pred             hhhhhcccceeEEecCCCccCccChhHhh-hccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhch
Confidence            999999999  999999999988777765 478999999987510                          111223333


Q ss_pred             cC--CccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHH
Q 003065          288 LK--NLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN  365 (851)
Q Consensus       288 l~--~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~  365 (851)
                      +.  +|+.|++++|++++..+..|+.+++|++|++++|+++ .+|..+..+++|++|++++|++.+..|..+..+++|++
T Consensus       251 l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  329 (606)
T 3t6q_A          251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH  329 (606)
T ss_dssp             GGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSE
T ss_pred             hhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCE
Confidence            33  7999999999999888888999999999999999999 78889999999999999999999888999999999999


Q ss_pred             HHhccCCcccccccc-ccCccccceeccccCcccccc--CCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCC
Q 003065          366 LLALSNNFSGEVPNS-YADCKTIQRLRISDNHLSGKI--PDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN  442 (851)
Q Consensus       366 l~l~~n~~~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~  442 (851)
                      +++.+|.+.+.+|.. +..+++|++|++++|++++..  |..+..+++|++|++++|++++..+..+..+++|+.|++++
T Consensus       330 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  409 (606)
T 3t6q_A          330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF  409 (606)
T ss_dssp             EECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTT
T ss_pred             EECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCC
Confidence            999999999877654 999999999999999999776  78899999999999999999999999999999999999999


Q ss_pred             CcceeeCCcc-cccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCC---CCCCcccccccceeeccCcccc
Q 003065          443 NRFSGELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGS---IPNEMGDCARIVDLNLARNSLS  518 (851)
Q Consensus       443 N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~  518 (851)
                      |++++..|.. +..+++|++|++++|.+++..|..+..+++|++|+|++|++++.   .+..++.+++|+.|++++|+++
T Consensus       410 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~  489 (606)
T 3t6q_A          410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS  489 (606)
T ss_dssp             CCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCC
T ss_pred             CcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccC
Confidence            9999877654 89999999999999999999999999999999999999999873   3467999999999999999999


Q ss_pred             cccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccccCCC--CccccCCCCCCC
Q 003065          519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRMGG--DGAFAGNEGLCL  589 (851)
Q Consensus       519 ~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~~~~~--~~~~~gn~~lc~  589 (851)
                      +.+|..|..+++|+.|+|++|++++.+|..+..+ .| .||+++|++++.+|..+.....  .-...+||..|.
T Consensus       490 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  562 (606)
T 3t6q_A          490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT  562 (606)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred             ccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence            9999999999999999999999999999999998 88 9999999999887765443222  344578887774

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.5e-56  Score=530.23  Aligned_cols=501  Identities=20%  Similarity=0.174  Sum_probs=445.6

Q ss_pred             EEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCc
Q 003065           76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSIN  154 (851)
Q Consensus        76 ~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N  154 (851)
                      +.++.++++++ .+|..+.  +++++|+|++|.+++..|..|+++++|++|+|++|.+++.+|. |+++++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n   90 (606)
T 3vq2_A           14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN   90 (606)
T ss_dssp             TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence            36899999998 6787665  8999999999999988888999999999999999999998776 999999999999999


Q ss_pred             ccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccc-cCCcccccccccCccccccccccccc
Q 003065          155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG-RIPESISELRELGTLDICRNKISGEF  233 (851)
Q Consensus       155 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~i~~~~  233 (851)
                      .+++..|..|.++++|++|++++|.+. ...|..++++++|++|++++|++++ .+|..|+++++|++|++++|++++..
T Consensus        91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~  169 (606)
T 3vq2_A           91 PIQSFSPGSFSGLTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT  169 (606)
T ss_dssp             CCCCCCTTSSTTCTTCCEEECTTSCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred             cccccChhhcCCcccCCEEEccCCccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence            999999999999999999999999997 3334779999999999999999986 57999999999999999999999988


Q ss_pred             cccccCCCccc----EEEeeccCccCcCCcCcCCCCcccEEeccccccc-CCCCccccCcCCccEEEc------------
Q 003065          234 PRSIRKLQKLW----KIELYANNLTGELPAELGNLTLLQEFDISSNQMY-GKLPEEIGNLKNLTVFQC------------  296 (851)
Q Consensus       234 p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~l------------  296 (851)
                      |..|..+++|+    +|++++|.+++..+..+... +|++|++++|.+. +.+|..+.++++|+.+++            
T Consensus       170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~  248 (606)
T 3vq2_A          170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE  248 (606)
T ss_dssp             TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred             hhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccc
Confidence            88888887765    89999999997666666554 9999999999986 355667777777777666            


Q ss_pred             ---------------------cCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCch
Q 003065          297 ---------------------FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPK  355 (851)
Q Consensus       297 ---------------------~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~  355 (851)
                                           ..|.+++.+|. +..+++|+.|++++|.+. .+| .+..+++|++|++++|++ +.+|.
T Consensus       249 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp~  324 (606)
T 3vq2_A          249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFPT  324 (606)
T ss_dssp             CCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCCC
T ss_pred             ccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-ccccc
Confidence                                 66777777776 899999999999999997 456 889999999999999999 68884


Q ss_pred             hhhhhcchHHHHhccCCccccccccccCccccceeccccCccccc--cCCcccCccccceEEecCCcCCCCCCcccccCC
Q 003065          356 YLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGK--IPDGLWALPNVGMLDFGDNDFTGGISPLIGLST  433 (851)
Q Consensus       356 ~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  433 (851)
                      .  .+++|+++++.+|...+.+  .+..+++|++|++++|++++.  +|..+..+++|++|++++|++++.+ ..+..++
T Consensus       325 ~--~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~-~~~~~l~  399 (606)
T 3vq2_A          325 L--DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMS-ANFMGLE  399 (606)
T ss_dssp             C--CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEEC-CCCTTCT
T ss_pred             C--CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccch-hhccCCC
Confidence            4  8999999999999766655  678999999999999999976  3888999999999999999998744 7888999


Q ss_pred             CCCeEecCCCcceeeCC-cccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccC-CCCCCcccccccceee
Q 003065          434 SLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTG-SIPNEMGDCARIVDLN  511 (851)
Q Consensus       434 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~  511 (851)
                      +|+.|++++|++++..| ..+..+++|++|++++|.+++..|..+..+++|++|+|++|++++ .+|..++.+++|+.|+
T Consensus       400 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  479 (606)
T 3vq2_A          400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD  479 (606)
T ss_dssp             TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred             CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEE
Confidence            99999999999998887 689999999999999999999999999999999999999999998 4899999999999999


Q ss_pred             ccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccccCC--C-CccccCCCCC
Q 003065          512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRMG--G-DGAFAGNEGL  587 (851)
Q Consensus       512 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~~~~--~-~~~~~gn~~l  587 (851)
                      |++|++++.+|..+..+++|+.|+|++|++++.+|..+..+ .|+.||+++|+++ .+|..+....  . .-...+|+..
T Consensus       480 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~  558 (606)
T 3vq2_A          480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVA  558 (606)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCC
T ss_pred             CCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcc
Confidence            99999999999999999999999999999999889999998 8999999999999 6776644332  1 2346889988


Q ss_pred             CCCc
Q 003065          588 CLDQ  591 (851)
Q Consensus       588 c~~~  591 (851)
                      |..+
T Consensus       559 c~c~  562 (606)
T 3vq2_A          559 CICE  562 (606)
T ss_dssp             CSST
T ss_pred             cCCc
Confidence            8654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-56  Score=542.15  Aligned_cols=498  Identities=21%  Similarity=0.210  Sum_probs=419.9

Q ss_pred             EEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCC-CC-CCCCCCCCeEeccCc
Q 003065           77 EISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV-PD-LSALKNLEIFDLSIN  154 (851)
Q Consensus        77 ~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-~~-l~~l~~L~~L~Ls~N  154 (851)
                      .+|.++++++ .+|.   ..++|++|||++|.+++..|..|+++++|++|+|++|.+.+.+ |. |+++++|++|+|++|
T Consensus         8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N   83 (844)
T 3j0a_A            8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS   83 (844)
T ss_dssp             EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred             EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence            3455667777 4665   5689999999999999888999999999999999999776654 44 999999999999999


Q ss_pred             ccCCCCcccccCccccceeecccccCCCCCCccc--ccCCCCCCeEecccccccccCC-cccccccccCccccccccccc
Q 003065          155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPES--IGNLKNLTYLFLAHCNLRGRIP-ESISELRELGTLDICRNKISG  231 (851)
Q Consensus       155 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~--~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~i~~  231 (851)
                      .+.+..|.+|.++++|++|+|++|.+. +.+|..  ++++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++
T Consensus        84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~  162 (844)
T 3j0a_A           84 KIYFLHPDAFQGLFHLFELRLYFCGLS-DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL  162 (844)
T ss_dssp             CCCEECTTSSCSCSSCCCEECTTCCCS-SCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred             cCcccCHhHccCCcccCEeeCcCCCCC-cccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence            999999999999999999999999998 445554  8999999999999999997765 579999999999999999999


Q ss_pred             cccccccCC--CcccEEEeeccCccCcCCcCcCCCCc------ccEEecccccccCCCCccccCc---------------
Q 003065          232 EFPRSIRKL--QKLWKIELYANNLTGELPAELGNLTL------LQEFDISSNQMYGKLPEEIGNL---------------  288 (851)
Q Consensus       232 ~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~p~~l~~l---------------  288 (851)
                      ..+..+..+  ++|+.|+++.|.+.+..|..++.+++      |++|++++|++++..|..+...               
T Consensus       163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~  242 (844)
T 3j0a_A          163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI  242 (844)
T ss_dssp             CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred             eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence            999999888  89999999999999999888877776      9999999999887776655432               


Q ss_pred             -----------------------CCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeecc
Q 003065          289 -----------------------KNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDIS  345 (851)
Q Consensus       289 -----------------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls  345 (851)
                                             ++|+.|++++|.+.+..|..|..+++|+.|++++|++++..|..|..+++|+.|+|+
T Consensus       243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls  322 (844)
T 3j0a_A          243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS  322 (844)
T ss_dssp             CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEE
T ss_pred             ccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECC
Confidence                                   578888888888887777788888888888888888888878888888888888888


Q ss_pred             CCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCC
Q 003065          346 ENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGI  425 (851)
Q Consensus       346 ~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  425 (851)
                      +|++++..|..+..+++|+.|++.+|++.+..+..|..+++|++|+|++|.+++ ++    .+++|+.|++++|+++..+
T Consensus       323 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~~N~l~~l~  397 (844)
T 3j0a_A          323 YNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLSGNKLVTLP  397 (844)
T ss_dssp             SCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEESCCCCCCC
T ss_pred             CCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccCCCCccccc
Confidence            888887778888888888888888888887777788888888888888888873 22    2778888888888887543


Q ss_pred             CcccccCCCCCeEecCCCcceeeC-CcccccCCCCcEEeccCccccCCCcc-ccccCCcccEEEecCCccc-----CCCC
Q 003065          426 SPLIGLSTSLSQLVLQNNRFSGEL-PSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALT-----GSIP  498 (851)
Q Consensus       426 ~~~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p  498 (851)
                      . .   ..+++.|++++|++++.. +..+..+++|++|+|++|++++..+. .+..+++|+.|+|++|.++     +..|
T Consensus       398 ~-~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~  473 (844)
T 3j0a_A          398 K-I---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW  473 (844)
T ss_dssp             C-C---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCS
T ss_pred             c-c---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccch
Confidence            2 2   467888999999988542 23456899999999999999976554 5667899999999999997     4556


Q ss_pred             CCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccccceEEeCcCCcccccCCcccccCCCC
Q 003065          499 NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGD  578 (851)
Q Consensus       499 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~L~~l~ls~N~l~~~~p~~~~~~~~~  578 (851)
                      ..|..+++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++..|..+. -.|+.||+++|++++.+|..+.... .
T Consensus       474 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~~~~L~-~  551 (844)
T 3j0a_A          474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDVFVSLS-V  551 (844)
T ss_dssp             SCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCCCSSCC-E
T ss_pred             hhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhHhCCcC-E
Confidence            7799999999999999999999999999999999999999999976665554 5799999999999999997654222 3


Q ss_pred             ccccCCCCCCCC
Q 003065          579 GAFAGNEGLCLD  590 (851)
Q Consensus       579 ~~~~gn~~lc~~  590 (851)
                      -.+.+||..|..
T Consensus       552 l~l~~Np~~C~c  563 (844)
T 3j0a_A          552 LDITHNKFICEC  563 (844)
T ss_dssp             EEEEEECCCCSS
T ss_pred             EEecCCCccccc
Confidence            456889888853

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-54  Score=505.00  Aligned_cols=510  Identities=19%  Similarity=0.177  Sum_probs=418.7

Q ss_pred             CCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEe
Q 003065           72 TGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFD  150 (851)
Q Consensus        72 ~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~  150 (851)
                      ..+++.|+++++.+++..+.++..+++|++|+|++|++++..|..|+++++|++|+|++|.+++.+|. |+++++|++|+
T Consensus        27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (570)
T 2z63_A           27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  106 (570)
T ss_dssp             CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence            34688899999999887778899999999999999999877778889999999999999998887765 88899999999


Q ss_pred             ccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCccccccccc----Ccccccc
Q 003065          151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL----GTLDICR  226 (851)
Q Consensus       151 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L----~~L~L~~  226 (851)
                      +++|.+++..+..+.++++|++|++++|.+....+|..++++++|++|++++|++++..|..++.+++|    ++|++++
T Consensus       107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~  186 (570)
T 2z63_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  186 (570)
T ss_dssp             CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence            999998876666788999999999999988755678889999999999999999988878888888888    7889999


Q ss_pred             ccccccccccccCCCcccEEEeeccCccC-cCCcCcCCCCcccEEeccccccc------CCCCccccCcC--CccEEEcc
Q 003065          227 NKISGEFPRSIRKLQKLWKIELYANNLTG-ELPAELGNLTLLQEFDISSNQMY------GKLPEEIGNLK--NLTVFQCF  297 (851)
Q Consensus       227 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~------~~~p~~l~~l~--~L~~L~l~  297 (851)
                      |.+++..|..|..+ +|++|++++|.... .++..+..+++++.+++..+.+.      ......+..++  .++.++++
T Consensus       187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  265 (570)
T 2z63_A          187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA  265 (570)
T ss_dssp             CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred             CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence            99988777777766 79999998885431 33445556666666655433222      11122233333  25666777


Q ss_pred             CC-ccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCcccc
Q 003065          298 KN-NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGE  376 (851)
Q Consensus       298 ~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~  376 (851)
                      +| .+.+..|..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .+|.  ..+++|+.+.+.+|.+.+.
T Consensus       266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~  340 (570)
T 2z63_A          266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNA  340 (570)
T ss_dssp             ETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCB
T ss_pred             cchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCccccc
Confidence            77 777777888888888888888888887 577777777 8888888888887 5665  3567788888888887776


Q ss_pred             ccccccCccccceeccccCcccccc--CCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCC-ccc
Q 003065          377 VPNSYADCKTIQRLRISDNHLSGKI--PDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP-SEL  453 (851)
Q Consensus       377 ~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p-~~~  453 (851)
                      .+.  ..+++|++|++++|++++..  |..+..+++|++|++++|++++.++. +..+++|+.|++++|++++..| ..+
T Consensus       341 ~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~  417 (570)
T 2z63_A          341 FSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVF  417 (570)
T ss_dssp             CCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTT
T ss_pred             ccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhh
Confidence            665  78899999999999998664  77888999999999999999987666 8899999999999999998766 578


Q ss_pred             ccCCCCcEEeccCccccCCCccccccCCcccEEEecCCccc-CCCCCCcccccccceeeccCcccccccCCCccccccCC
Q 003065          454 GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT-GSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLN  532 (851)
Q Consensus       454 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  532 (851)
                      ..+++|++|++++|.+++..|..+.++++|+.|+|++|+++ +.+|..++.+++|+.|++++|++++..|.++..+++|+
T Consensus       418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  497 (570)
T 2z63_A          418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ  497 (570)
T ss_dssp             TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence            99999999999999999999999999999999999999998 68999999999999999999999999999999999999


Q ss_pred             eEeCCCCccccccCcccccc-cceEEeCcCCcccccCCccccc-CCC---CccccCCCCCCCCc
Q 003065          533 ALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR-MGG---DGAFAGNEGLCLDQ  591 (851)
Q Consensus       533 ~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~~-~~~---~~~~~gn~~lc~~~  591 (851)
                      .|+|++|++++..|..+..+ .|+.|++++|+++|.+|..+.. ...   ...+.+.+ .|..|
T Consensus       498 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~  560 (570)
T 2z63_A          498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS  560 (570)
T ss_dssp             EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred             EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence            99999999998878888888 8999999999999999965432 111   23344444 66654

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.7e-54  Score=504.74  Aligned_cols=486  Identities=19%  Similarity=0.238  Sum_probs=397.8

Q ss_pred             CcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC
Q 003065           60 PCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD  139 (851)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~  139 (851)
                      .|.|.|| ||..          +++++ .+|+.+.  ++|++|+|++|++++..|..|+++++|++|+|++|++++.+|.
T Consensus         3 ~C~~~~~-c~~~----------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   68 (549)
T 2z81_A            3 SCDASGV-CDGR----------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD   68 (549)
T ss_dssp             EECTTSE-EECT----------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred             cCCCCce-EECC----------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence            5999999 9643          34454 5666654  7899999999999887888899999999999999999888765


Q ss_pred             -CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCC-ccccccc
Q 003065          140 -LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP-ESISELR  217 (851)
Q Consensus       140 -l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~  217 (851)
                       ++++++|++|||++|.+++..|.+|.++++|++|++++|.+....+|..++++++|++|++++|++.+.+| ..|.+++
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~  148 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT  148 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred             hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence             88999999999999999988888889999999999999998755667788899999999999998444444 6788999


Q ss_pred             ccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCC--C-ccccCcCCccEE
Q 003065          218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKL--P-EEIGNLKNLTVF  294 (851)
Q Consensus       218 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p-~~l~~l~~L~~L  294 (851)
                      +|++|++++|++++..|..+..+++|++|+++.|.+....+..+..+++|++|++++|++++..  | .....+++|+.|
T Consensus       149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L  228 (549)
T 2z81_A          149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL  228 (549)
T ss_dssp             EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEE
T ss_pred             ccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccce
Confidence            9999999999999888889999999999999999887433333456889999999999988642  2 223457888999


Q ss_pred             EccCCccCCCCC----CCCCCcccccEEEeccCcCCCCC------CCccCCCCccceeeccCCccccc-----Cchhhhh
Q 003065          295 QCFKNNFSGEFP----SGFGDMRKLFAFSIYGNRFSGPF------PENLGRYTALTDVDISENQFSGS-----FPKYLCE  359 (851)
Q Consensus       295 ~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~------p~~l~~l~~L~~L~Ls~N~l~~~-----~p~~~~~  359 (851)
                      ++++|.+++..+    ..+..+++|+.+++++|.+.+..      ...+..+.+|+.|+++++.+...     ++..+..
T Consensus       229 ~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~  308 (549)
T 2z81_A          229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL  308 (549)
T ss_dssp             EEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHH
T ss_pred             eccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhh
Confidence            999998875433    33466788899999998877532      23456678888899888876532     2333445


Q ss_pred             hcchHHHHhccCCccccccccc-cCccccceeccccCccccccC---CcccCccccceEEecCCcCCCCCC--cccccCC
Q 003065          360 KRKLLNLLALSNNFSGEVPNSY-ADCKTIQRLRISDNHLSGKIP---DGLWALPNVGMLDFGDNDFTGGIS--PLIGLST  433 (851)
Q Consensus       360 ~~~L~~l~l~~n~~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~~~  433 (851)
                      ..+++.+++.+|.+. .+|..+ ..+++|++|+|++|++++.+|   ..+..+++|++|++++|++++..+  ..+..++
T Consensus       309 ~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~  387 (549)
T 2z81_A          309 LEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK  387 (549)
T ss_dssp             STTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCT
T ss_pred             cccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCC
Confidence            567888888888875 666665 579999999999999998774   457889999999999999997654  5688999


Q ss_pred             CCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeecc
Q 003065          434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA  513 (851)
Q Consensus       434 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  513 (851)
                      +|++|+|++|+++ .+|..+..+++|++|++++|++++ +|..+.  ++|++|+|++|++++.+    +.+++|+.|+|+
T Consensus       388 ~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls  459 (549)
T 2z81_A          388 NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYIS  459 (549)
T ss_dssp             TCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred             CCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECC
Confidence            9999999999999 788899999999999999999984 444432  58999999999998753    578999999999


Q ss_pred             CcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCc
Q 003065          514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPL  570 (851)
Q Consensus       514 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~  570 (851)
                      +|+|+ .+|. ...+++|+.|+|++|++++.+|..+..+ .|+.||+++|+|.|.+|.
T Consensus       460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            99999 6776 5789999999999999998888889888 899999999999999994

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-52  Score=484.63  Aligned_cols=459  Identities=21%  Similarity=0.254  Sum_probs=386.6

Q ss_pred             EEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCc
Q 003065           76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSIN  154 (851)
Q Consensus        76 ~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N  154 (851)
                      +.+|+++++++ .+|..+.  ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|. ++++++|++|||++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            36899999999 5888777  8999999999999987778999999999999999999988765 899999999999999


Q ss_pred             ccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCccccccccc--Cccccccccc--c
Q 003065          155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL--GTLDICRNKI--S  230 (851)
Q Consensus       155 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~L~~N~i--~  230 (851)
                      +++ .+|..  .+++|++|+|++|.+....+|..++++++|++|++++|++++   ..+..+++|  ++|++++|++  .
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~  153 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE  153 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence            998 56665  899999999999999855788999999999999999999986   457777777  9999999999  7


Q ss_pred             ccccccccCCC-cccEEEeeccCccCcCCc-CcCCCCcccEEeccccc-------ccCCCCccccCcCCccEEEccCCcc
Q 003065          231 GEFPRSIRKLQ-KLWKIELYANNLTGELPA-ELGNLTLLQEFDISSNQ-------MYGKLPEEIGNLKNLTVFQCFKNNF  301 (851)
Q Consensus       231 ~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~-------l~~~~p~~l~~l~~L~~L~l~~N~l  301 (851)
                      +..|..+..+. +...+++++|++.+.++. .+..+++|+.|++++|.       +.+.+| .+..+++|+.|++++|.+
T Consensus       154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l  232 (520)
T 2z7x_B          154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET  232 (520)
T ss_dssp             SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred             ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence            88888888776 455678888988876654 67789999999999997       666665 788899999999999888


Q ss_pred             CCCCCCCCC---CcccccEEEeccCcCCCCCCCcc-----CCCCccceeeccCCcccccCc-hhhhhhcchHHHHhccCC
Q 003065          302 SGEFPSGFG---DMRKLFAFSIYGNRFSGPFPENL-----GRYTALTDVDISENQFSGSFP-KYLCEKRKLLNLLALSNN  372 (851)
Q Consensus       302 ~~~~p~~~~---~l~~L~~L~l~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~L~~l~l~~n~  372 (851)
                      ++..+..+.   ..++|++|++++|+++|.+|..+     +.+++|+.+++++|.+  .+| .+++..            
T Consensus       233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~------------  298 (520)
T 2z7x_B          233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEI------------  298 (520)
T ss_dssp             EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHH------------
T ss_pred             CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcc------------
Confidence            753222111   13588999999999998888888     8889999999999888  455 333322            


Q ss_pred             ccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCccee--eCC
Q 003065          373 FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG--ELP  450 (851)
Q Consensus       373 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~--~~p  450 (851)
                               ....+|+.|++++|++.+..  .+..+++|++|++++|++++.+|..+..+++|++|+|++|++++  .+|
T Consensus       299 ---------~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~  367 (520)
T 2z7x_B          299 ---------FSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA  367 (520)
T ss_dssp             ---------HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHH
T ss_pred             ---------cccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccch
Confidence                     01146889999999886432  12578899999999999999889999999999999999999986  567


Q ss_pred             cccccCCCCcEEeccCccccCCCcc-ccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccc
Q 003065          451 SELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLS  529 (851)
Q Consensus       451 ~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  529 (851)
                      ..+..+++|++|++++|.+++.+|. .+..+++|+.|+|++|++++.+|..+.  ++|+.|++++|+++ .+|..+..++
T Consensus       368 ~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~  444 (520)
T 2z7x_B          368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLE  444 (520)
T ss_dssp             HHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred             HHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCC
Confidence            8899999999999999999985654 588999999999999999988887775  78999999999999 8898888999


Q ss_pred             cCCeEeCCCCccccccCcc-cccc-cceEEeCcCCcccccCCcccc
Q 003065          530 SLNALNLSGNKLTGSIPDN-LMKL-KLSSIDLSENQLSGSVPLDFL  573 (851)
Q Consensus       530 ~L~~L~Ls~N~l~g~ip~~-l~~l-~L~~l~ls~N~l~~~~p~~~~  573 (851)
                      +|+.|+|++|+++ .+|.. +..+ .|+.|++++|+++|.++..|.
T Consensus       445 ~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~  489 (520)
T 2z7x_B          445 ALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY  489 (520)
T ss_dssp             TCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHHHHH
T ss_pred             CCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCchHH
Confidence            9999999999999 67776 7777 899999999999999986544

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=473.90  Aligned_cols=500  Identities=20%  Similarity=0.214  Sum_probs=429.3

Q ss_pred             EecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCccc
Q 003065           78 ISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYF  156 (851)
Q Consensus        78 l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l  156 (851)
                      ++.++.+++ .+|..+.  +++++|+|++|++++..+..|+++++|++|+|++|++++.++. |+++++|++|+|++|.+
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l   88 (570)
T 2z63_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (570)
T ss_dssp             EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence            444445555 4666553  5799999999999988888999999999999999999998776 89999999999999999


Q ss_pred             CCCCcccccCccccceeecccccCCCCCCcc-cccCCCCCCeEecccccccc-cCCcccccccccCcccccccccccccc
Q 003065          157 TGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFLAHCNLRG-RIPESISELRELGTLDICRNKISGEFP  234 (851)
Q Consensus       157 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~-~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~i~~~~p  234 (851)
                      ++..|..|.++++|++|++++|.+.  .+|. .++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|
T Consensus        89 ~~~~~~~~~~l~~L~~L~L~~n~l~--~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~  166 (570)
T 2z63_A           89 QSLALGAFSGLSSLQKLVAVETNLA--SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (570)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCC--CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECG
T ss_pred             CccCHhhhcCccccccccccccccc--cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecH
Confidence            9888899999999999999999997  4444 69999999999999999987 479999999999999999999998888


Q ss_pred             ccccCCCcc----cEEEeeccCccCcCCcCcCCCCcccEEecccccccC-CCCccccCcCCccEEEccCCccC------C
Q 003065          235 RSIRKLQKL----WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG-KLPEEIGNLKNLTVFQCFKNNFS------G  303 (851)
Q Consensus       235 ~~~~~l~~L----~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~------~  303 (851)
                      ..+..+++|    +.|++++|.+++..|..+... +|+.|++++|.... .++..+..+++++.+.+..+.+.      .
T Consensus       167 ~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~  245 (570)
T 2z63_A          167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK  245 (570)
T ss_dssp             GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEE
T ss_pred             HHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhh
Confidence            899999998    899999999998888888766 89999999986542 34566778888888776544332      1


Q ss_pred             CCCCCCCCcc--cccEEEeccC-cCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCcccccccc
Q 003065          304 EFPSGFGDMR--KLFAFSIYGN-RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNS  380 (851)
Q Consensus       304 ~~p~~~~~l~--~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~  380 (851)
                      .....+..+.  .++.+++++| .+.+..|..+..+++|+.|++++|.++ .+|.++... +|+++++.+|.+. .+|. 
T Consensus       246 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~-  321 (570)
T 2z63_A          246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT-  321 (570)
T ss_dssp             CCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB-
T ss_pred             cchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc-
Confidence            2223444444  3567788888 788899999999999999999999998 688888888 9999999999988 5565 


Q ss_pred             ccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCC--CcccccCCCCCeEecCCCcceeeCCcccccCCC
Q 003065          381 YADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGI--SPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN  458 (851)
Q Consensus       381 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~  458 (851)
                       ..+++|++|++++|.+.+..+.  ..+++|++|++++|++++..  +..+..+++|++|++++|.+++..+. +..+++
T Consensus       322 -~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~  397 (570)
T 2z63_A          322 -LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQ  397 (570)
T ss_dssp             -CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTT
T ss_pred             -ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCC
Confidence             5788999999999999877766  68999999999999998765  67788999999999999999966555 999999


Q ss_pred             CcEEeccCccccCCCc-cccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccc-cccCCCccccccCCeEeC
Q 003065          459 LERLILTNNNFSGKIP-SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS-GNIPRSLSLLSSLNALNL  536 (851)
Q Consensus       459 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L  536 (851)
                      |++|++++|.+++..| ..+..+++|++|+|++|++++..|..+..+++|+.|++++|.++ +.+|..+..+++|+.|+|
T Consensus       398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l  477 (570)
T 2z63_A          398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL  477 (570)
T ss_dssp             CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred             CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEEC
Confidence            9999999999998776 57899999999999999999999999999999999999999998 689999999999999999


Q ss_pred             CCCccccccCcccccc-cceEEeCcCCcccccCCcccccCCC--CccccCCCCCCCCc
Q 003065          537 SGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRMGG--DGAFAGNEGLCLDQ  591 (851)
Q Consensus       537 s~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~~~~~--~~~~~gn~~lc~~~  591 (851)
                      ++|++++..|..+..+ .|+.|++++|++++..|..+.....  .-...+|+..|..+
T Consensus       478 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence            9999998889999998 9999999999999987765543332  23457777766543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=7.4e-51  Score=489.21  Aligned_cols=442  Identities=18%  Similarity=0.272  Sum_probs=346.6

Q ss_pred             ccCcEEeCCCCcccCccCcccccCCCCceEec-ccCcccCCCCCC-CCC-CCCCe---Eecc------------CcccCC
Q 003065           97 QSLTVLSLPFNVLSGKLPLELSNCSNLKVLNV-TGNAMVGSVPDL-SAL-KNLEI---FDLS------------INYFTG  158 (851)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~n~l~~~~~~l-~~l-~~L~~---L~Ls------------~N~l~~  158 (851)
                      .+++.|+|++|+++|.+|++|++|++|++|+| ++|.++|..+.- ... ..+..   ..+.            ...+.+
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57899999999999999999999999999999 999998874421 111 00000   0000            000110


Q ss_pred             -----------CCcccccCccccceeeccc--ccCCCCCCcccccCCCCCCeEecccccccc-----------------c
Q 003065          159 -----------RFPRWVVNLTQLVSLSIGD--NVYDEAEIPESIGNLKNLTYLFLAHCNLRG-----------------R  208 (851)
Q Consensus       159 -----------~~~~~~~~l~~L~~L~L~~--N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~  208 (851)
                                 ..+........++.+.++.  |.++ + +|..++++++|++|+|++|++++                 .
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~-~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~  480 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-F-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY  480 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEE-E-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCccc-c-hhHHHhcCCCCCEEECcCCcCCCCccccccccccccccccc
Confidence                       1111112334455555554  8887 3 89999999999999999999998                 3


Q ss_pred             CCcccc--cccccCccccccccccccccccccCCCcccEEEeeccC-ccC-cCCcCcCCCC-------cccEEecccccc
Q 003065          209 IPESIS--ELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN-LTG-ELPAELGNLT-------LLQEFDISSNQM  277 (851)
Q Consensus       209 ~p~~~~--~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l  277 (851)
                      +|+.++  ++++|++|+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..++.++       +|++|+|++|++
T Consensus       481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            899988  99999999999999999999999999999999999998 998 7888666665       999999999999


Q ss_pred             cCCCCc--cccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCc-cceeeccCCcccccCc
Q 003065          278 YGKLPE--EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA-LTDVDISENQFSGSFP  354 (851)
Q Consensus       278 ~~~~p~--~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p  354 (851)
                      + .+|.  .+.++++|+.|++++|+++ .+| .|+.+++|+.|++++|+++ .+|..+..+++ |+.|+|++|+++ .+|
T Consensus       561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp  635 (876)
T 4ecn_A          561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP  635 (876)
T ss_dssp             C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCC
T ss_pred             C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCc
Confidence            9 8888  9999999999999999999 888 8999999999999999999 89999999999 999999999998 555


Q ss_pred             hhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcc---c--CccccceEEecCCcCCCCCCccc
Q 003065          355 KYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL---W--ALPNVGMLDFGDNDFTGGISPLI  429 (851)
Q Consensus       355 ~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~  429 (851)
                      ..+....                      .++|+.|+|++|++++.+|...   .  .+++|+.|+|++|+++..++..+
T Consensus       636 ~~~~~~~----------------------~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~  693 (876)
T 4ecn_A          636 NIFNAKS----------------------VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF  693 (876)
T ss_dssp             SCCCTTC----------------------SSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHH
T ss_pred             hhhhccc----------------------cCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHH
Confidence            4432221                      1237777777777776655322   1  23477777777777775555555


Q ss_pred             ccCCCCCeEecCCCcceeeCCcccccC--------CCCcEEeccCccccCCCccccc--cCCcccEEEecCCcccCCCCC
Q 003065          430 GLSTSLSQLVLQNNRFSGELPSELGRL--------TNLERLILTNNNFSGKIPSALG--ALRQLSSLHLEENALTGSIPN  499 (851)
Q Consensus       430 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~  499 (851)
                      ..+++|+.|+|++|+++ .+|..+...        ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|.
T Consensus       694 ~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~  770 (876)
T 4ecn_A          694 ATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPT  770 (876)
T ss_dssp             HTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCC
T ss_pred             ccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cch
Confidence            56777778888877777 555544332        27888888888887 5666665  77888888888888876 677


Q ss_pred             CcccccccceeeccC------cccccccCCCccccccCCeEeCCCCccccccCcccccccceEEeCcCCcccccCCccc
Q 003065          500 EMGDCARIVDLNLAR------NSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDF  572 (851)
Q Consensus       500 ~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~L~~l~ls~N~l~~~~p~~~  572 (851)
                      .++.+++|+.|+|++      |++.+.+|..+..+++|+.|+|++|++ +.+|..+.. .|+.|||++|++...-+..+
T Consensus       771 ~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~-~L~~LdLs~N~l~~i~~~~~  847 (876)
T 4ecn_A          771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTP-QLYILDIADNPNISIDVTSV  847 (876)
T ss_dssp             GGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCS-SSCEEECCSCTTCEEECGGG
T ss_pred             hhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhcC-CCCEEECCCCCCCccChHHc
Confidence            777888888888765      889999999999999999999999999 699998664 89999999999876555443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.5e-50  Score=473.19  Aligned_cols=474  Identities=18%  Similarity=0.168  Sum_probs=406.0

Q ss_pred             cccceeEecC--CCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCC
Q 003065           61 CGFSGITCDS--VTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP  138 (851)
Q Consensus        61 c~w~gv~c~~--~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~  138 (851)
                      |++.+++.-+  ...+++.|+++++.+++..|.+++.+++|++|+|++|++++..|.+|+++++|++|+|++|++++.++
T Consensus        12 ~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~   91 (549)
T 2z81_A           12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS   91 (549)
T ss_dssp             CTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred             CCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence            5666665532  23589999999999999889999999999999999999998888999999999999999999999988


Q ss_pred             C-CCCCCCCCeEeccCcccCC-CCcccccCccccceeecccccCCCCCCc-ccccCCCCCCeEecccccccccCCccccc
Q 003065          139 D-LSALKNLEIFDLSINYFTG-RFPRWVVNLTQLVSLSIGDNVYDEAEIP-ESIGNLKNLTYLFLAHCNLRGRIPESISE  215 (851)
Q Consensus       139 ~-l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~  215 (851)
                      . ++++++|++|+|++|.+++ ..|..+.++++|++|++++|.+. +.+| ..+.++++|++|++++|++++.+|..+..
T Consensus        92 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~  170 (549)
T 2z81_A           92 SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF-SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS  170 (549)
T ss_dssp             HHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC-CEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred             HHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccc-cccCHhhhhcccccCeeeccCCcccccChhhhhc
Confidence            7 9999999999999999987 46788999999999999999854 3555 57999999999999999999999999999


Q ss_pred             ccccCccccccccccccccccccCCCcccEEEeeccCccCcC--C-cCcCCCCcccEEecccccccCCCCc----cccCc
Q 003065          216 LRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL--P-AELGNLTLLQEFDISSNQMYGKLPE----EIGNL  288 (851)
Q Consensus       216 l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~l~~l  288 (851)
                      +++|++|+++.|.+....+..+..+++|++|++++|++++..  | .....+++|+.|++++|++++..+.    .+..+
T Consensus       171 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~  250 (549)
T 2z81_A          171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI  250 (549)
T ss_dssp             CSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGC
T ss_pred             cccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhh
Confidence            999999999999997443334567999999999999999742  2 2335688999999999999865544    34667


Q ss_pred             CCccEEEccCCccCCCC------CCCCCCcccccEEEeccCcCCCC-----CCCccCCCCccceeeccCCcccccCchhh
Q 003065          289 KNLTVFQCFKNNFSGEF------PSGFGDMRKLFAFSIYGNRFSGP-----FPENLGRYTALTDVDISENQFSGSFPKYL  357 (851)
Q Consensus       289 ~~L~~L~l~~N~l~~~~------p~~~~~l~~L~~L~l~~N~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~  357 (851)
                      ++|+.+++++|.+.+..      ...+..+.+|+.|++.++.+...     ++..+....+|+.|++++|++. .+|..+
T Consensus       251 ~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~  329 (549)
T 2z81_A          251 LELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSF  329 (549)
T ss_dssp             TTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHH
T ss_pred             ccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHH
Confidence            89999999999987642      23457788999999999987632     1222344578999999999997 788877


Q ss_pred             -hhhcchHHHHhccCCcccccc---ccccCccccceeccccCccccccC--CcccCccccceEEecCCcCCCCCCccccc
Q 003065          358 -CEKRKLLNLLALSNNFSGEVP---NSYADCKTIQRLRISDNHLSGKIP--DGLWALPNVGMLDFGDNDFTGGISPLIGL  431 (851)
Q Consensus       358 -~~~~~L~~l~l~~n~~~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  431 (851)
                       ..+++|++|++++|++.+.+|   ..++.+++|++|+|++|++++..+  ..+..+++|++|++++|+++ .+|..+..
T Consensus       330 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~  408 (549)
T 2z81_A          330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW  408 (549)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCC
T ss_pred             HhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcc
Confidence             479999999999999999875   347889999999999999986543  56888999999999999999 46677888


Q ss_pred             CCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceee
Q 003065          432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLN  511 (851)
Q Consensus       432 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  511 (851)
                      +++|++|++++|+++ .+|..+  .++|++|++++|++++.+    ..+++|++|+|++|+|+ .+|. .+.+++|+.|+
T Consensus       409 ~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~  479 (549)
T 2z81_A          409 PEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMK  479 (549)
T ss_dssp             CTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEE
T ss_pred             cccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEe
Confidence            999999999999998 455444  268999999999999753    57899999999999998 6776 57899999999


Q ss_pred             ccCcccccccCCCccccccCCeEeCCCCccccccC
Q 003065          512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP  546 (851)
Q Consensus       512 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip  546 (851)
                      |++|++++.+|..+..+++|+.|+|++|++++..|
T Consensus       480 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             CCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             cCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            99999999999999999999999999999999887

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.5e-51  Score=472.72  Aligned_cols=435  Identities=19%  Similarity=0.204  Sum_probs=379.9

Q ss_pred             CceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEecc
Q 003065           73 GRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLS  152 (851)
Q Consensus        73 ~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls  152 (851)
                      .+++.|+++++.+++..|..+..+++|++|+|++|++++..|..|+++++|++|+|++|++++.++.  .+++|++|||+
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~   98 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLS   98 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEecc
Confidence            5899999999999988888999999999999999999988899999999999999999999975555  89999999999


Q ss_pred             CcccCC-CCcccccCccccceeecccccCCCCCCcccccCCCCC--CeEecccccc--cccCCccccccc-ccCcccccc
Q 003065          153 INYFTG-RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNL--TYLFLAHCNL--RGRIPESISELR-ELGTLDICR  226 (851)
Q Consensus       153 ~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L--~~L~L~~n~l--~~~~p~~~~~l~-~L~~L~L~~  226 (851)
                      +|.+++ .+|..|.++++|++|++++|.+..    ..+..+++|  ++|++++|++  .+..|..+..+. +...+++++
T Consensus        99 ~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~  174 (520)
T 2z7x_B           99 FNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT  174 (520)
T ss_dssp             SSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred             CCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence            999997 578999999999999999999973    457778888  9999999999  888898888776 345678899


Q ss_pred             ccccccccc-cccCCCcccEEEeeccC-------ccCcCCcCcCCCCcccEEecccccccCCCCcccc---CcCCccEEE
Q 003065          227 NKISGEFPR-SIRKLQKLWKIELYANN-------LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG---NLKNLTVFQ  295 (851)
Q Consensus       227 N~i~~~~p~-~~~~l~~L~~L~L~~N~-------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~L~~L~  295 (851)
                      |++.+.++. .+.++++|+.|++++|.       +.+.+| .++.+++|+.|++++|.+++..+..+.   ..++|++|+
T Consensus       175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~  253 (520)
T 2z7x_B          175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS  253 (520)
T ss_dssp             SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEE
T ss_pred             Ccchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEE
Confidence            998876664 68899999999999998       777666 788999999999999998764433322   246899999


Q ss_pred             ccCCccCCCCCCCC-----CCcccccEEEeccCcCCCCCC-CccCCC---CccceeeccCCcccccCchhhhhhcchHHH
Q 003065          296 CFKNNFSGEFPSGF-----GDMRKLFAFSIYGNRFSGPFP-ENLGRY---TALTDVDISENQFSGSFPKYLCEKRKLLNL  366 (851)
Q Consensus       296 l~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~p-~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l  366 (851)
                      +++|+++|.+|..+     +.+++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+.+..             
T Consensus       254 l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~-------------  318 (520)
T 2z7x_B          254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML-------------  318 (520)
T ss_dssp             EEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC-------------
T ss_pred             eecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc-------------
Confidence            99999999999988     9999999999999999  456 445444   67999999999876210             


Q ss_pred             HhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCC--CCCcccccCCCCCeEecCCCc
Q 003065          367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG--GISPLIGLSTSLSQLVLQNNR  444 (851)
Q Consensus       367 ~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~~~~L~~L~Ls~N~  444 (851)
                                   .+..+++|++|++++|++++.+|..+..+++|++|++++|++++  .+|..+..+++|++|+|++|+
T Consensus       319 -------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~  385 (520)
T 2z7x_B          319 -------------CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS  385 (520)
T ss_dssp             -------------CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSC
T ss_pred             -------------chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCc
Confidence                         12567889999999999999899999999999999999999997  455778999999999999999


Q ss_pred             ceeeCCc-ccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCC
Q 003065          445 FSGELPS-ELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR  523 (851)
Q Consensus       445 l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  523 (851)
                      +++.+|. .+..+++|++|++++|++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|.
T Consensus       386 l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~  461 (520)
T 2z7x_B          386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD  461 (520)
T ss_dssp             CBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCT
T ss_pred             CCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCH
Confidence            9985665 488899999999999999988887775  78999999999998 88888889999999999999999 4665


Q ss_pred             C-ccccccCCeEeCCCCccccccC
Q 003065          524 S-LSLLSSLNALNLSGNKLTGSIP  546 (851)
Q Consensus       524 ~-~~~l~~L~~L~Ls~N~l~g~ip  546 (851)
                      . +..+++|+.|+|++|++++..+
T Consensus       462 ~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          462 GIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             TTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             HHhccCCcccEEECcCCCCcccCC
Confidence            5 8999999999999999998665

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=7.3e-51  Score=481.79  Aligned_cols=501  Identities=18%  Similarity=0.275  Sum_probs=361.0

Q ss_pred             hhhHHHHHHHHHhcCCCCCCCCCCCCCC-CC--Ccccc-eeEecCC---CCceEEEecccCCcceecCccccCCccCcEE
Q 003065           30 NVETQALIQFKSKLKDPHGVLDSWKESA-DS--PCGFS-GITCDSV---TGRVTEISFDNKSLSGEISSSISALQSLTVL  102 (851)
Q Consensus        30 ~~~~~aLl~fk~~~~~~~~~l~sW~~~~-~~--~c~w~-gv~c~~~---~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L  102 (851)
                      ..+.+.-.++++-...-.+  .+|.... .+  .|+|. +..|+..   .| |+   .+..             .+++.|
T Consensus        26 ~~~~~d~~aL~~~~~~~~~--~~w~~~~~~~~~~~~W~~~~~~c~w~~~~G-V~---C~~~-------------~~V~~L   86 (636)
T 4eco_A           26 AEYIKDYLALKEIWDALNG--KNWSQQGFGTQPGANWNFNKELDMWGAQPG-VS---LNSN-------------GRVTGL   86 (636)
T ss_dssp             CHHHHHHHHHHHHHHHTTG--GGCCCCC------CCCCCSSCGGGTTCCTT-EE---ECTT-------------CCEEEE
T ss_pred             hhHHHHHHHHHHHHHHcCC--CCcccCCcCCccCCCCCCCCCcccccCCCC-eE---EcCC-------------CCEEEE
Confidence            4445566666655543333  4787442 12  24895 3444444   22 32   1111             468899


Q ss_pred             eCCCCcccCccCcccccCCCCceEecccCccc------C------CCCCCCCCCCCCeEeccCcccCCCCcccccC-ccc
Q 003065          103 SLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV------G------SVPDLSALKNLEIFDLSINYFTGRFPRWVVN-LTQ  169 (851)
Q Consensus       103 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~------~------~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~  169 (851)
                      +|++|.++|.+|.+|++|++|++|+|++|.+.      +      .+|. ..+.+|+ ++++.|.+.+..|..+.. +..
T Consensus        87 ~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~-~~~~~l~-l~l~~~~l~~~~~~~~~~~~~~  164 (636)
T 4eco_A           87 SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD-EQKQKMR-MHYQKTFVDYDPREDFSDLIKD  164 (636)
T ss_dssp             ECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCH-HHHHHHH-THHHHHHTCCCGGGGSCHHHHH
T ss_pred             EecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchH-HHHHHHH-hhHHHhhhccCchhhHHHHHHH
Confidence            99999999999999999999999999999872      2      1221 1145566 888888888888877653 345


Q ss_pred             cceeecccccCCCCCCcccccCCCCCCeEec--ccccccccCCcccccccccCcccccccccccc---------------
Q 003065          170 LVSLSIGDNVYDEAEIPESIGNLKNLTYLFL--AHCNLRGRIPESISELRELGTLDICRNKISGE---------------  232 (851)
Q Consensus       170 L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L--~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~---------------  232 (851)
                      +..+++....+..       .....++.+.+  .+|++++ +|..++++++|++|+|++|++++.               
T Consensus       165 l~~~~l~~~~~~~-------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~  236 (636)
T 4eco_A          165 CINSDPQQKSIKK-------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ  236 (636)
T ss_dssp             HHHHCTTSCCCCC-------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHH
T ss_pred             HhhcCcccccccc-------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhc
Confidence            5555555443321       11223344433  3578887 788888888888888888888875               


Q ss_pred             --cccccc--CCCcccEEEeeccCccCcCCcCcCCCCcccEEeccccc-ccC-CCCccccCc------CCccEEEccCCc
Q 003065          233 --FPRSIR--KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQ-MYG-KLPEEIGNL------KNLTVFQCFKNN  300 (851)
Q Consensus       233 --~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~l~~l------~~L~~L~l~~N~  300 (851)
                        +|..+.  ++++|++|+|++|++.+.+|..|+++++|++|++++|+ +++ .+|..++++      ++|++|++++|+
T Consensus       237 ~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~  316 (636)
T 4eco_A          237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN  316 (636)
T ss_dssp             HHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred             ccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc
Confidence              888887  88888888888888888888888888888888888887 887 788887776      888888888888


Q ss_pred             cCCCCCC--CCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCcccccc
Q 003065          301 FSGEFPS--GFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP  378 (851)
Q Consensus       301 l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p  378 (851)
                      ++ .+|.  .++++++|++|++++|+++|.+| .++.+++|+.|++++|+++ .+                        |
T Consensus       317 l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~l------------------------p  369 (636)
T 4eco_A          317 LK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EI------------------------P  369 (636)
T ss_dssp             CS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-EC------------------------C
T ss_pred             CC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cc------------------------c
Confidence            88 7777  78888888888888888887777 7888888888888888876 44                        4


Q ss_pred             ccccCccc-cceeccccCccccccCCcccCcc--ccceEEecCCcCCCCCCcccc-------cCCCCCeEecCCCcceee
Q 003065          379 NSYADCKT-IQRLRISDNHLSGKIPDGLWALP--NVGMLDFGDNDFTGGISPLIG-------LSTSLSQLVLQNNRFSGE  448 (851)
Q Consensus       379 ~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~~~~L~~L~Ls~N~l~~~  448 (851)
                      ..+..+++ |++|++++|+++ .+|..+..++  +|+.|++++|++++.+|..+.       .+++|+.|+|++|++++.
T Consensus       370 ~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~l  448 (636)
T 4eco_A          370 ANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF  448 (636)
T ss_dssp             TTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSC
T ss_pred             HhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcC
Confidence            45566666 777777777777 6676665544  777777777777777777666       666777888888887743


Q ss_pred             CCcccccCCCCcEEeccCccccCCCccccccCC-------cccEEEecCCcccCCCCCCcc--cccccceeeccCccccc
Q 003065          449 LPSELGRLTNLERLILTNNNFSGKIPSALGALR-------QLSSLHLEENALTGSIPNEMG--DCARIVDLNLARNSLSG  519 (851)
Q Consensus       449 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~  519 (851)
                      .+..+..+++|++|+|++|+++...+..+..+.       +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++
T Consensus       449 p~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~  527 (636)
T 4eco_A          449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK  527 (636)
T ss_dssp             CTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred             CHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC
Confidence            333445577888888888888733333333332       7888888888887 6777776  78888888888888886


Q ss_pred             ccCCCccccccCCeEeC------CCCccccccCcccccc-cceEEeCcCCcccccCCcccccCCCCccccCCCCCCCC
Q 003065          520 NIPRSLSLLSSLNALNL------SGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD  590 (851)
Q Consensus       520 ~~p~~~~~l~~L~~L~L------s~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~gn~~lc~~  590 (851)
                       +|..+..+++|+.|+|      ++|++.+.+|..+..+ .|+.||+++|++ +.+|..+...-..-...+|+..|..
T Consensus       528 -ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~  603 (636)
T 4eco_A          528 -FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISID  603 (636)
T ss_dssp             -CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred             -cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence             7888888888888888      6788999999999999 999999999999 8899764421112334677766644

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.3e-48  Score=461.34  Aligned_cols=492  Identities=18%  Similarity=0.174  Sum_probs=385.9

Q ss_pred             CceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEec
Q 003065           73 GRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDL  151 (851)
Q Consensus        73 ~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~L  151 (851)
                      ..++.|||++|.|++..+.+|..+++|++|||++|+|++..|.+|++|++|++|+|++|++++.++. |.++++|++|+|
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L  131 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  131 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence            4688899999999876667899999999999999999876677889999999999999998887776 888999999999


Q ss_pred             cCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccC----ccccccc
Q 003065          152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELG----TLDICRN  227 (851)
Q Consensus       152 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~L~~N  227 (851)
                      ++|++++..+..|.++++|++|+|++|.+....+|..++.+++|++|+|++|++++..|..|..+.+++    .++++.|
T Consensus       132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n  211 (635)
T 4g8a_A          132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  211 (635)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred             CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence            999998877778889999999999999887667788888899999999999999888888887777655    4677888


Q ss_pred             cccccccccccCCCcccEEEeeccCccCc-CCcCcCCCCcccE------------------------------Eeccccc
Q 003065          228 KISGEFPRSIRKLQKLWKIELYANNLTGE-LPAELGNLTLLQE------------------------------FDISSNQ  276 (851)
Q Consensus       228 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~------------------------------L~Ls~N~  276 (851)
                      .++...+..+ ....+..+++.+|..... .+..+..+..++.                              .++..+.
T Consensus       212 ~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~  290 (635)
T 4g8a_A          212 PMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  290 (635)
T ss_dssp             CCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred             cccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence            8875444433 334566677776654321 1122233333333                              3333222


Q ss_pred             ccC---CCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccC
Q 003065          277 MYG---KLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSF  353 (851)
Q Consensus       277 l~~---~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  353 (851)
                      ...   ..+..+..+.+++.+++.+|.+....  .+.....|+.|++.+|.+....+.   .+..|+.++++.|.+....
T Consensus       291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~~  365 (635)
T 4g8a_A          291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNAF  365 (635)
T ss_dssp             CCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCBC
T ss_pred             hcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCCc
Confidence            211   11223444556667777776665332  245556777788888777654443   3456777777777765432


Q ss_pred             chhhhhhcchHHHHhccCCccc--cccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCC-cccc
Q 003065          354 PKYLCEKRKLLNLLALSNNFSG--EVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS-PLIG  430 (851)
Q Consensus       354 p~~~~~~~~L~~l~l~~n~~~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~  430 (851)
                        ....+++++.++++.|.+..  ..+..+..+.+|++|+++.|.+. ..+..+..+++|+.++++.|+.....+ ..+.
T Consensus       366 --~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~  442 (635)
T 4g8a_A          366 --SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL  442 (635)
T ss_dssp             --CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTT
T ss_pred             --ccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccc
Confidence              23456778888888887753  45566777889999999999987 466678889999999999988766544 5678


Q ss_pred             cCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCcccc-CCCccccccCCcccEEEecCCcccCCCCCCcccccccce
Q 003065          431 LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFS-GKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD  509 (851)
Q Consensus       431 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  509 (851)
                      .+++++.++++.|.+.+..|..+..++.|+.|+|++|.+. +.+|..|..+++|++|+|++|+|++.+|..|+++++|+.
T Consensus       443 ~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~  522 (635)
T 4g8a_A          443 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV  522 (635)
T ss_dssp             TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             cccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCE
Confidence            8999999999999999999999999999999999999854 567889999999999999999999999999999999999


Q ss_pred             eeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc--cceEEeCcCCcccccCCcccc
Q 003065          510 LNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGSVPLDFL  573 (851)
Q Consensus       510 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l--~L~~l~ls~N~l~~~~p~~~~  573 (851)
                      |+|++|+|++..|..|..+++|+.|||++|+|++..|..+..+  +|+.|++++|+|.|+|...|.
T Consensus       523 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~  588 (635)
T 4g8a_A          523 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF  588 (635)
T ss_dssp             EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHH
T ss_pred             EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHH
Confidence            9999999999999999999999999999999999999999887  799999999999999986543

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.9e-48  Score=453.34  Aligned_cols=459  Identities=21%  Similarity=0.239  Sum_probs=381.6

Q ss_pred             EEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCc
Q 003065           76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSIN  154 (851)
Q Consensus        76 ~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N  154 (851)
                      +.+|++++++++ +|..+.  ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|. |.++++|++|||++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            688999999995 888775  8999999999999988888999999999999999999998776 999999999999999


Q ss_pred             ccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCccccccccc--Cccccccccc--c
Q 003065          155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL--GTLDICRNKI--S  230 (851)
Q Consensus       155 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~L~~N~i--~  230 (851)
                      .++ .+|..  .+++|++|++++|.+....+|..++++++|++|++++|++++.   .+..+++|  ++|++++|++  +
T Consensus       111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~  184 (562)
T 3a79_B          111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK  184 (562)
T ss_dssp             CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred             cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence            998 56666  8999999999999998556778999999999999999999863   45555666  9999999999  8


Q ss_pred             ccccccccCCC-cccEEEeeccCccCcCCc-CcCCCCcccEEeccccc-----ccCCCCccccCcCCccEEEccCCccCC
Q 003065          231 GEFPRSIRKLQ-KLWKIELYANNLTGELPA-ELGNLTLLQEFDISSNQ-----MYGKLPEEIGNLKNLTVFQCFKNNFSG  303 (851)
Q Consensus       231 ~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~-----l~~~~p~~l~~l~~L~~L~l~~N~l~~  303 (851)
                      +..|..+..+. ....++++.|.+.+.++. .+..+++|+.|++++|+     +.+ .+..+..+++|+.|+++++.+++
T Consensus       185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~  263 (562)
T 3a79_B          185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTW  263 (562)
T ss_dssp             SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECH
T ss_pred             ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcH
Confidence            88898888765 223678899999876664 56789999999999985     222 23457788899999998887764


Q ss_pred             CCCCC---CCCcccccEEEeccCcCCCCCCCcc-----CCCCccceeeccCCcccccCch-hhhhhcchHHHHhccCCcc
Q 003065          304 EFPSG---FGDMRKLFAFSIYGNRFSGPFPENL-----GRYTALTDVDISENQFSGSFPK-YLCEKRKLLNLLALSNNFS  374 (851)
Q Consensus       304 ~~p~~---~~~l~~L~~L~l~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~~L~~l~l~~n~~~  374 (851)
                      .....   ....++|++|++++|+++|.+|..+     ..++.|+.++++.|.+  .+|. ++...              
T Consensus       264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~--------------  327 (562)
T 3a79_B          264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSV--------------  327 (562)
T ss_dssp             HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHH--------------
T ss_pred             HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhh--------------
Confidence            21110   1123489999999999998899887     7778888888888777  4553 22211              


Q ss_pred             ccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCccee--eCCcc
Q 003065          375 GEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG--ELPSE  452 (851)
Q Consensus       375 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~--~~p~~  452 (851)
                             ....+|++|++++|.+....  ....+++|++|++++|++++.+|..+..+++|+.|+|++|++++  .+|..
T Consensus       328 -------~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  398 (562)
T 3a79_B          328 -------FAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM  398 (562)
T ss_dssp             -------HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHT
T ss_pred             -------hccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhh
Confidence                   01146899999999886322  12678999999999999999899999999999999999999996  34577


Q ss_pred             cccCCCCcEEeccCccccCCCc-cccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccC
Q 003065          453 LGRLTNLERLILTNNNFSGKIP-SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL  531 (851)
Q Consensus       453 ~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  531 (851)
                      +..+++|++|++++|++++.+| ..+..+++|+.|+|++|++++.+|..+.  ++|+.|+|++|+|+ .+|..+..+++|
T Consensus       399 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L  475 (562)
T 3a79_B          399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQAL  475 (562)
T ss_dssp             TTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCC
T ss_pred             hcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCC
Confidence            8999999999999999998455 5688999999999999999988887765  78999999999999 788888899999


Q ss_pred             CeEeCCCCccccccCcc-cccc-cceEEeCcCCcccccCCcccc
Q 003065          532 NALNLSGNKLTGSIPDN-LMKL-KLSSIDLSENQLSGSVPLDFL  573 (851)
Q Consensus       532 ~~L~Ls~N~l~g~ip~~-l~~l-~L~~l~ls~N~l~~~~p~~~~  573 (851)
                      +.|+|++|+|+ .+|.. +..+ .|+.|++++|+|.|.+|..+.
T Consensus       476 ~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~  518 (562)
T 3a79_B          476 QELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRY  518 (562)
T ss_dssp             SEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred             CEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcchHHH
Confidence            99999999999 67776 7777 899999999999999997554

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=3.8e-46  Score=402.26  Aligned_cols=292  Identities=30%  Similarity=0.512  Sum_probs=254.0

Q ss_pred             CCchhhHHHHHHHHHhcCCCCCCCCCCCCCCCCCcc--cceeEecCCC--CceEEEecccCCcce--ecCccccCCccCc
Q 003065           27 LSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCG--FSGITCDSVT--GRVTEISFDNKSLSG--EISSSISALQSLT  100 (851)
Q Consensus        27 ~~~~~~~~aLl~fk~~~~~~~~~l~sW~~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~i~~~l~~l~~L~  100 (851)
                      .|.++|++||++||+++.||. .+++|..+ +|||.  |.||+|+..+  ++|+.|+|++++++|  .+|+.++.+++|+
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~   79 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHhcCCcc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence            599999999999999999887 78999876 78998  9999998765  899999999999999  9999999999999


Q ss_pred             EEeCCC-CcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccc
Q 003065          101 VLSLPF-NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN  178 (851)
Q Consensus       101 ~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  178 (851)
                      +|+|++ |.+++.+|..|+++++|++|+|++|.+++.+|. +..+++|++|||++|.+++.+|..+.++++|++|++++|
T Consensus        80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  159 (313)
T 1ogq_A           80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence            999995 999999999999999999999999999977776 999999999999999999889999999999999999999


Q ss_pred             cCCCCCCcccccCCC-CCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcC
Q 003065          179 VYDEAEIPESIGNLK-NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL  257 (851)
Q Consensus       179 ~l~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~  257 (851)
                      .++ +.+|..++.++ +|++|++++|++++.+|..+..++ |++|++++|++++..|..|..+++|++|+|++|++++.+
T Consensus       160 ~l~-~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  237 (313)
T 1ogq_A          160 RIS-GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL  237 (313)
T ss_dssp             CCE-EECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred             ccc-CcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence            887 67888888887 889999999988888888888887 888888888888888888888888888888888888665


Q ss_pred             CcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCc
Q 003065          258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR  324 (851)
Q Consensus       258 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~  324 (851)
                      |. +..+++|++|+|++|++++.+|..+.++++|++|++++|++++.+|.. ..+++|+.+++++|+
T Consensus       238 ~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          238 GK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             GG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             Cc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence            55 677788888888888888778888888888888888888887777764 666666666666666

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.6e-44  Score=429.54  Aligned_cols=526  Identities=19%  Similarity=0.179  Sum_probs=401.9

Q ss_pred             CCCCCCCCCCCCCCCCcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCc
Q 003065           45 DPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLK  124 (851)
Q Consensus        45 ~~~~~l~sW~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  124 (851)
                      |+...+++|...  -|..|....|....   +.++.++.+|+ .||+.+.  +++++|||++|+|++..|..|.++++|+
T Consensus         8 ~~~~~~~~~~~~--~p~~~~~c~~~~~~---~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~   79 (635)
T 4g8a_A            8 DDDDKLAAANSS--IPESWEPCVEVVPN---ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQ   79 (635)
T ss_dssp             -------------------CCSEEEETT---TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             CCcchhhcccCC--CCCCCCCccccCCC---CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCC
Confidence            455567777764  35566655554222   13567777777 6777664  5899999999999977778899999999


Q ss_pred             eEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCc-ccccCCCCCCeEeccc
Q 003065          125 VLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP-ESIGNLKNLTYLFLAH  202 (851)
Q Consensus       125 ~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p-~~~~~l~~L~~L~L~~  202 (851)
                      +|||++|+|++.++. |.++++|++|+|++|++++..+.+|.++++|++|+|++|+++  .+| ..|+++++|++|+|++
T Consensus        80 ~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~--~l~~~~~~~L~~L~~L~Ls~  157 (635)
T 4g8a_A           80 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA--SLENFPIGHLKTLKELNVAH  157 (635)
T ss_dssp             EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCC--CSTTCCCTTCTTCCEEECCS
T ss_pred             EEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCC--CCChhhhhcCcccCeecccc
Confidence            999999999998886 999999999999999999888889999999999999999997  444 4699999999999999


Q ss_pred             ccccc-cCCcccccccccCccccccccccccccccccCCCccc----EEEeeccCccCcCCcCcCCCCcccEEecccccc
Q 003065          203 CNLRG-RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLW----KIELYANNLTGELPAELGNLTLLQEFDISSNQM  277 (851)
Q Consensus       203 n~l~~-~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  277 (851)
                      |.+++ .+|..+..+++|++|++++|+|++..|..|..+.+++    .++++.|.++...+..+ ....++.+++++|..
T Consensus       158 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~  236 (635)
T 4g8a_A          158 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFD  236 (635)
T ss_dssp             SCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCS
T ss_pred             CccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccc
Confidence            99986 4678899999999999999999998888887766544    78999999996555444 456788899998865


Q ss_pred             cCCC-CccccCcCCccEEEccCCcc------CCC---------------------------CCCCCCCcccccEEEeccC
Q 003065          278 YGKL-PEEIGNLKNLTVFQCFKNNF------SGE---------------------------FPSGFGDMRKLFAFSIYGN  323 (851)
Q Consensus       278 ~~~~-p~~l~~l~~L~~L~l~~N~l------~~~---------------------------~p~~~~~l~~L~~L~l~~N  323 (851)
                      ...+ +..+..+..++...+..+..      ...                           .+..+..+.+++.+.+.+|
T Consensus       237 ~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~  316 (635)
T 4g8a_A          237 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSV  316 (635)
T ss_dssp             SHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESC
T ss_pred             cccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccc
Confidence            5322 23455555555554432221      111                           1223444556666666666


Q ss_pred             cCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCcccc--cc
Q 003065          324 RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSG--KI  401 (851)
Q Consensus       324 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~  401 (851)
                      .+...  ..+.....|+.|++++|.+.+..+..   +..+..+.+..|.....  ..+..+++|+.|++++|.+..  ..
T Consensus       317 ~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~~---l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~  389 (635)
T 4g8a_A          317 TIERV--KDFSYNFGWQHLELVNCKFGQFPTLK---LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCC  389 (635)
T ss_dssp             EEEEC--GGGGSCCCCSEEEEESCEESSCCCCB---CTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEEC
T ss_pred             ccccc--cccccchhhhhhhcccccccCcCccc---chhhhhcccccccCCCC--cccccccccccchhhcccccccccc
Confidence            66532  23455667888888888877544433   34455556666655433  345578899999999999863  44


Q ss_pred             CCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCC-cccccCCCCcEEeccCccccCCCccccccC
Q 003065          402 PDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPSALGAL  480 (851)
Q Consensus       402 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  480 (851)
                      +..+..+.+|+.++++.|.+.... ..+..+++|+.+++++|......+ ..|..+.+++.++++.|.+.+..|..+..+
T Consensus       390 ~~~~~~~~~L~~L~~~~~~~~~~~-~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~  468 (635)
T 4g8a_A          390 SQSDFGTISLKYLDLSFNGVITMS-SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL  468 (635)
T ss_dssp             CHHHHSCSCCCEEECCSCSEEEEC-SCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTC
T ss_pred             ccchhhhhhhhhhhcccccccccc-ccccccccccchhhhhccccccccccccccccccccccccccccccccccccccc
Confidence            556677889999999999887544 456788999999999998876654 567889999999999999999999999999


Q ss_pred             CcccEEEecCCcc-cCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEe
Q 003065          481 RQLSSLHLEENAL-TGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSID  558 (851)
Q Consensus       481 ~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~  558 (851)
                      +.|+.|+|++|++ .+.+|..|..+++|+.|+|++|+|++.+|.+|.++++|+.|+|++|+|++..|..+..+ +|+.||
T Consensus       469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~  548 (635)
T 4g8a_A          469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD  548 (635)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred             hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence            9999999999975 45688999999999999999999999999999999999999999999998888889988 999999


Q ss_pred             CcCCcccccCCcccccC-CC--CccccCCCCCCC
Q 003065          559 LSENQLSGSVPLDFLRM-GG--DGAFAGNEGLCL  589 (851)
Q Consensus       559 ls~N~l~~~~p~~~~~~-~~--~~~~~gn~~lc~  589 (851)
                      +++|++++..|..+... ..  .-...+||..|.
T Consensus       549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            99999999998776543 11  234578998885

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=8.6e-45  Score=425.01  Aligned_cols=451  Identities=19%  Similarity=0.214  Sum_probs=320.6

Q ss_pred             cCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecc
Q 003065           98 SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG  176 (851)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  176 (851)
                      ..+++|+++|++++ +|..+.  ++|++|+|++|.+++.++. +.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus        32 ~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  108 (562)
T 3a79_B           32 LESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS  108 (562)
T ss_dssp             -CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence            34788888888884 777664  7888888888888887764 8888888888888888887777788888888888888


Q ss_pred             cccCCCCCCcccccCCCCCCeEeccccccccc-CCcccccccccCccccccccccccccccccCCCcc--cEEEeeccCc
Q 003065          177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR-IPESISELRELGTLDICRNKISGEFPRSIRKLQKL--WKIELYANNL  253 (851)
Q Consensus       177 ~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L--~~L~L~~N~l  253 (851)
                      +|.++  .+|..  .+++|++|+|++|++++. +|..|+++++|++|++++|++++.   .+..+++|  ++|++++|.+
T Consensus       109 ~N~l~--~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l  181 (562)
T 3a79_B          109 HNRLQ--NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSY  181 (562)
T ss_dssp             TSCCC--EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSC
T ss_pred             CCcCC--ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccc
Confidence            88876  56665  677888888888887752 356777777777777777777643   33334444  7777777777


Q ss_pred             --cCcCCcCcCCCC--cccEEecccccccCCCCc-cccCcCCccEEEccCCcc-----CCCCCCCCCCcccccEEEeccC
Q 003065          254 --TGELPAELGNLT--LLQEFDISSNQMYGKLPE-EIGNLKNLTVFQCFKNNF-----SGEFPSGFGDMRKLFAFSIYGN  323 (851)
Q Consensus       254 --~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~l~~N~l-----~~~~p~~~~~l~~L~~L~l~~N  323 (851)
                        ++..|..+..+.  .+ .+++++|.+.+.++. .+.++++|+.+++++|+.     .+. +..+..+++|+.|++.++
T Consensus       182 ~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~  259 (562)
T 3a79_B          182 HIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHI  259 (562)
T ss_dssp             CCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEE
T ss_pred             cccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCC
Confidence              666666665544  22 446666666655444 344566666666666531     111 112334444444444444


Q ss_pred             cCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccc-----cCccccceeccccCccc
Q 003065          324 RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSY-----ADCKTIQRLRISDNHLS  398 (851)
Q Consensus       324 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~-----~~l~~L~~L~Ls~N~l~  398 (851)
                      .+++..                   +.+ ++..+ ...+|++|++.+|.+.|.+|..+     .+++.|+.++++.|.+ 
T Consensus       260 ~l~~~~-------------------~~~-~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-  317 (562)
T 3a79_B          260 ETTWKC-------------------SVK-LFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-  317 (562)
T ss_dssp             EECHHH-------------------HHH-HHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-
T ss_pred             cCcHHH-------------------HHH-HHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-
Confidence            433210                   000 11111 11244445555555555555554     6777888888888887 


Q ss_pred             cccC-CcccCc---cccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCC--
Q 003065          399 GKIP-DGLWAL---PNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGK--  472 (851)
Q Consensus       399 ~~~p-~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--  472 (851)
                       .+| ..+..+   .+|+.|++++|.+....  ....+++|++|++++|++++.+|..+.++++|++|+|++|++++.  
T Consensus       318 -~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  394 (562)
T 3a79_B          318 -LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK  394 (562)
T ss_dssp             -SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTH
T ss_pred             -ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCccc
Confidence             445 333332   67999999999986543  226789999999999999998999999999999999999999974  


Q ss_pred             CccccccCCcccEEEecCCcccCCCCC-CcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCccccc
Q 003065          473 IPSALGALRQLSSLHLEENALTGSIPN-EMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK  551 (851)
Q Consensus       473 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~  551 (851)
                      +|..+..+++|+.|+|++|++++.+|. .+..+++|+.|++++|++++.+|..+.  ++|+.|+|++|+++ .+|..+..
T Consensus       395 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~  471 (562)
T 3a79_B          395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTH  471 (562)
T ss_dssp             HHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTS
T ss_pred             chhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcC
Confidence            357899999999999999999985665 588999999999999999998887765  78999999999999 89988888


Q ss_pred             c-cceEEeCcCCcccccCCcc-cccCCC--CccccCCCCCCC
Q 003065          552 L-KLSSIDLSENQLSGSVPLD-FLRMGG--DGAFAGNEGLCL  589 (851)
Q Consensus       552 l-~L~~l~ls~N~l~~~~p~~-~~~~~~--~~~~~gn~~lc~  589 (851)
                      + .|+.||+++|+++ .+|.. +.....  .-...+|+..|.
T Consensus       472 l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~  512 (562)
T 3a79_B          472 LQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT  512 (562)
T ss_dssp             SCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred             CCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCC
Confidence            8 9999999999999 57765 332222  233577877764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.9e-45  Score=415.06  Aligned_cols=404  Identities=22%  Similarity=0.291  Sum_probs=216.4

Q ss_pred             ceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccC
Q 003065           74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI  153 (851)
Q Consensus        74 ~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~  153 (851)
                      ++++++++++.+ |.+|++++++++|++|++++|.++|.+|.+++++++|+.+++++|..          +++++|++++
T Consensus        12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~----------~~l~~L~l~~   80 (454)
T 1jl5_A           12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD----------RQAHELELNN   80 (454)
T ss_dssp             -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH----------HTCSEEECTT
T ss_pred             cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc----------cCCCEEEecC
Confidence            344445555555 45555555555555555555555555555555555444444444331          3457888888


Q ss_pred             cccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccc
Q 003065          154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF  233 (851)
Q Consensus       154 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~  233 (851)
                      |.+++ +|..   .++|++|++++|.++  .+|..   +++|++|++++|++++ +|...   ++|++|++++|++++ +
T Consensus        81 ~~l~~-lp~~---~~~L~~L~l~~n~l~--~lp~~---~~~L~~L~l~~n~l~~-l~~~~---~~L~~L~L~~n~l~~-l  146 (454)
T 1jl5_A           81 LGLSS-LPEL---PPHLESLVASCNSLT--ELPEL---PQSLKSLLVDNNNLKA-LSDLP---PLLEYLGVSNNQLEK-L  146 (454)
T ss_dssp             SCCSC-CCSC---CTTCSEEECCSSCCS--SCCCC---CTTCCEEECCSSCCSC-CCSCC---TTCCEEECCSSCCSS-C
T ss_pred             Ccccc-CCCC---cCCCCEEEccCCcCC--ccccc---cCCCcEEECCCCccCc-ccCCC---CCCCEEECcCCCCCC-C
Confidence            88775 3332   367888888888876  36653   3678888888888874 33221   578888888888885 6


Q ss_pred             cccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcc
Q 003065          234 PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR  313 (851)
Q Consensus       234 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~  313 (851)
                      | .|.++++|++|++++|++++ +|..+   ++|++|++++|++++ +| .++++++|+.|++++|++++ +|...   +
T Consensus       147 p-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~  215 (454)
T 1jl5_A          147 P-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---L  215 (454)
T ss_dssp             C-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---T
T ss_pred             c-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---C
Confidence            6 58888888888888888874 55543   578888888888875 55 57888888888888888875 44432   4


Q ss_pred             cccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccc
Q 003065          314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRIS  393 (851)
Q Consensus       314 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls  393 (851)
                      +|++|++++|+++ .+| .++.+++|+.|++++|++++ +|..                           .++|++|+++
T Consensus       216 ~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---------------------------~~~L~~L~l~  265 (454)
T 1jl5_A          216 SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---------------------------PPSLEALNVR  265 (454)
T ss_dssp             TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---------------------------CTTCCEEECC
T ss_pred             cccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---------------------------ccccCEEECC
Confidence            7788888888887 566 37788888888888888773 3321                           1356666666


Q ss_pred             cCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccC-CCCcEEeccCccccCC
Q 003065          394 DNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRL-TNLERLILTNNNFSGK  472 (851)
Q Consensus       394 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~  472 (851)
                      +|++++ +|..   +++|+.|++++|++++...    ..++|+.|++++|++++. +    .+ ++|++|++++|++++ 
T Consensus       266 ~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~----~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-  331 (454)
T 1jl5_A          266 DNYLTD-LPEL---PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-  331 (454)
T ss_dssp             SSCCSC-CCCC---CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-
T ss_pred             CCcccc-cCcc---cCcCCEEECcCCccCcccC----cCCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-
Confidence            666653 4432   2556666666666654211    124566666666666532 1    12 356666666666664 


Q ss_pred             CccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCccccc--ccCCCcccc-------------ccCCeEeCC
Q 003065          473 IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSG--NIPRSLSLL-------------SSLNALNLS  537 (851)
Q Consensus       473 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l-------------~~L~~L~Ls  537 (851)
                      +|..   +++|+.|++++|+++ .+|.   .+++|+.|++++|++++  .+|.++..+             ++|+.||++
T Consensus       332 lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls  404 (454)
T 1jl5_A          332 LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVE  404 (454)
T ss_dssp             CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------
T ss_pred             cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECC
Confidence            3333   355666666666665 3444   34566666666666665  555555443             455555555


Q ss_pred             CCcccc--ccCcccccccceEEeCcCCcccccCC
Q 003065          538 GNKLTG--SIPDNLMKLKLSSIDLSENQLSGSVP  569 (851)
Q Consensus       538 ~N~l~g--~ip~~l~~l~L~~l~ls~N~l~~~~p  569 (851)
                      +|+++|  .+|.++     +.|.+++|.+.+.+|
T Consensus       405 ~N~l~~~~~iP~sl-----~~L~~~~~~~~~~~~  433 (454)
T 1jl5_A          405 TNPLREFPDIPESV-----EDLRMNSERVVDPYE  433 (454)
T ss_dssp             ----------------------------------
T ss_pred             CCcCCccccchhhH-----hheeCcCcccCCccc
Confidence            555554  444432     233445555555444

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=6.7e-44  Score=406.64  Aligned_cols=383  Identities=19%  Similarity=0.175  Sum_probs=240.7

Q ss_pred             eEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccC-CcccccccccCcccccc
Q 003065          148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI-PESISELRELGTLDICR  226 (851)
Q Consensus       148 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~  226 (851)
                      .++.+++.++ .+|. +  .++|++|+|++|.+. ...|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++
T Consensus        14 ~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           14 NAICINRGLH-QVPE-L--PAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             EEECCSSCCS-SCCC-C--CTTCCEEECCSSCCC-EECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             ccCcCCCCcc-cCCC-C--CCccCEEEecCCccC-cCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            4555555554 3333 1  145555555555554 223445555555555555555554333 33455555555555555


Q ss_pred             ccccccccccccCCCcccEEEeeccCccCcCCcC--cCCCCcccEEecccccccCCCCcc-ccCcCCccEEEccCCccCC
Q 003065          227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAE--LGNLTLLQEFDISSNQMYGKLPEE-IGNLKNLTVFQCFKNNFSG  303 (851)
Q Consensus       227 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~l~~N~l~~  303 (851)
                      |++++..|..|.++++|++|+|++|++++..|..  |..+++|++|+|++|++++..|.. +.++++|++|++++|++++
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence            5555544555555555555555555555433322  555555555555555555444443 4455555555555555555


Q ss_pred             CCCCCCCCc--ccccEEEeccCcCCCCCCCcc--------CCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCc
Q 003065          304 EFPSGFGDM--RKLFAFSIYGNRFSGPFPENL--------GRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF  373 (851)
Q Consensus       304 ~~p~~~~~l--~~L~~L~l~~N~l~~~~p~~l--------~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~  373 (851)
                      ..|..+..+  .+|+.|++++|.+.+..+..+        ..+++|++|++++|++++..|..+....            
T Consensus       169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~------------  236 (455)
T 3v47_A          169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAI------------  236 (455)
T ss_dssp             CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHT------------
T ss_pred             cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccc------------
Confidence            444444443  344555555555443333221        1334444444444444443333332210            


Q ss_pred             cccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCccccc--CCCCCeEecCCCcceeeCCc
Q 003065          374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGL--STSLSQLVLQNNRFSGELPS  451 (851)
Q Consensus       374 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--~~~L~~L~Ls~N~l~~~~p~  451 (851)
                               ..++|+.|++++|.+.+...              ..+.+.+..+..+..  .++|+.|++++|++++..|.
T Consensus       237 ---------~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  293 (455)
T 3v47_A          237 ---------AGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKS  293 (455)
T ss_dssp             ---------TTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTT
T ss_pred             ---------cccceeeEeecccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchh
Confidence                     11345555555554432110              111222222222322  36899999999999999999


Q ss_pred             ccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccC
Q 003065          452 ELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL  531 (851)
Q Consensus       452 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  531 (851)
                      .|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..++.+++|+.|+|++|++++..|.++..+++|
T Consensus       294 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  373 (455)
T 3v47_A          294 VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNL  373 (455)
T ss_dssp             TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             hcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccc
Confidence            99999999999999999998889999999999999999999998889999999999999999999999999999999999


Q ss_pred             CeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCc
Q 003065          532 NALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPL  570 (851)
Q Consensus       532 ~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~  570 (851)
                      +.|+|++|++++..+..+..+ .|+.|++++|+++|.+|.
T Consensus       374 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          374 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             cEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence            999999999996555567777 899999999999999994

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=8.9e-44  Score=405.58  Aligned_cols=384  Identities=18%  Similarity=0.165  Sum_probs=245.5

Q ss_pred             cEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccc
Q 003065          100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN  178 (851)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  178 (851)
                      +.++.++++++ .+|. +.  ++|++|+|++|.+++.+|. ++++++|++|+|++|.+.+.++                 
T Consensus        13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~-----------------   71 (455)
T 3v47_A           13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR-----------------   71 (455)
T ss_dssp             TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEEC-----------------
T ss_pred             cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceEC-----------------
Confidence            45666666665 4554 22  5666666666666665444 6666666666666666553331                 


Q ss_pred             cCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccccccccccccc--ccCCCcccEEEeeccCccCc
Q 003065          179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS--IRKLQKLWKIELYANNLTGE  256 (851)
Q Consensus       179 ~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~--~~~l~~L~~L~L~~N~l~~~  256 (851)
                             |..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..  |..+++|++|+|++|++++.
T Consensus        72 -------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~  144 (455)
T 3v47_A           72 -------NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI  144 (455)
T ss_dssp             -------TTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSC
T ss_pred             -------cccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCcc
Confidence                   233444555555555555555444555555555555555555555433332  55555555555555555555


Q ss_pred             CCcC-cCCCCcccEEecccccccCCCCccccCc--CCccEEEccCCccCCCCCCC--------CCCcccccEEEeccCcC
Q 003065          257 LPAE-LGNLTLLQEFDISSNQMYGKLPEEIGNL--KNLTVFQCFKNNFSGEFPSG--------FGDMRKLFAFSIYGNRF  325 (851)
Q Consensus       257 ~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l--~~L~~L~l~~N~l~~~~p~~--------~~~l~~L~~L~l~~N~l  325 (851)
                      .|.. +.++++|++|++++|++++..|..+.++  .+|+.|++++|.+.+..+..        +..+++|++|++++|++
T Consensus       145 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l  224 (455)
T 3v47_A          145 QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF  224 (455)
T ss_dssp             CCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCC
T ss_pred             CcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcc
Confidence            4543 5556666666666666655555555544  45666666666666443332        33567788888888888


Q ss_pred             CCCCCCccCCC---CccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccC
Q 003065          326 SGPFPENLGRY---TALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP  402 (851)
Q Consensus       326 ~~~~p~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  402 (851)
                      ++..|..+...   ++|+.|++++|.+.+...              ..+++.+..+..+..+                  
T Consensus       225 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~------------------  272 (455)
T 3v47_A          225 KESMAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGL------------------  272 (455)
T ss_dssp             CHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGG------------------
T ss_pred             cccchhhhhccccccceeeEeecccccccccc--------------chhhhccCcccccccc------------------
Confidence            77777666543   778888888887654211              1112222222222211                  


Q ss_pred             CcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCc
Q 003065          403 DGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ  482 (851)
Q Consensus       403 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  482 (851)
                          ..++|+.|++++|++++.++..+..+++|+.|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++
T Consensus       273 ----~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  348 (455)
T 3v47_A          273 ----EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK  348 (455)
T ss_dssp             ----TTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTT
T ss_pred             ----cccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCccc
Confidence                1245666666666666666666666677777777777777777777888888888888888887777778888888


Q ss_pred             ccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCc
Q 003065          483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPD  547 (851)
Q Consensus       483 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~  547 (851)
                      |++|+|++|++++..|..++.+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|.
T Consensus       349 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             CCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence            88888888888877788888888888888888888876667788899999999999999988873

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=5.5e-44  Score=404.65  Aligned_cols=388  Identities=23%  Similarity=0.290  Sum_probs=236.5

Q ss_pred             ceEEEecccCCcceecCccccCCccC-------------cEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCC
Q 003065           74 RVTEISFDNKSLSGEISSSISALQSL-------------TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDL  140 (851)
Q Consensus        74 ~v~~l~l~~~~l~g~i~~~l~~l~~L-------------~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l  140 (851)
                      +.+.++++++.++|.+|++++.+++|             ++|++++|.+++ +|..   .++|++|++++|.+++. |. 
T Consensus        35 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~l-p~-  108 (454)
T 1jl5_A           35 SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTEL-PE-  108 (454)
T ss_dssp             CHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSSC-CC-
T ss_pred             chhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCcc-cc-
Confidence            56678899999999999999999986             888888888775 4442   36788888888888774 33 


Q ss_pred             CCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccC
Q 003065          141 SALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELG  220 (851)
Q Consensus       141 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  220 (851)
                       .+++|++|++++|.+++. |..   .++|++|++++|.+.  .+| .++++++|++|++++|++++ +|..+   .+|+
T Consensus       109 -~~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~--~lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~  176 (454)
T 1jl5_A          109 -LPQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLE--KLP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLE  176 (454)
T ss_dssp             -CCTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCS--SCC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCC
T ss_pred             -ccCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCC--CCc-ccCCCCCCCEEECCCCcCcc-cCCCc---cccc
Confidence             236788888888877742 221   157788888888776  366 47777888888888887774 55443   4677


Q ss_pred             ccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCc
Q 003065          221 TLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN  300 (851)
Q Consensus       221 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~  300 (851)
                      +|++++|++++ +| .+.++++|++|++++|++++ +|...   ++|++|++++|+++ .+| .++.+++|++|++++|+
T Consensus       177 ~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~  248 (454)
T 1jl5_A          177 FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNL  248 (454)
T ss_dssp             EEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSC
T ss_pred             EEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCc
Confidence            77777777775 45 57777777777777777774 44332   47777777777777 555 37777777777777777


Q ss_pred             cCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCcccccccc
Q 003065          301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNS  380 (851)
Q Consensus       301 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~  380 (851)
                      +++ +|..   +++|+.|++++|++++ +|..   .++|+.|++++|++++. |                     .+|  
T Consensus       249 l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~---------------------~~~--  296 (454)
T 1jl5_A          249 LKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-S---------------------ELP--  296 (454)
T ss_dssp             CSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-S---------------------CCC--
T ss_pred             CCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-c---------------------CcC--
Confidence            774 4432   3667777777777775 4433   25677777777776631 1                     111  


Q ss_pred             ccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCc
Q 003065          381 YADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE  460 (851)
Q Consensus       381 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  460 (851)
                          ++|++|++++|++++ ++..   .++|+.|++++|++++. |..   +++|+.|++++|+++ .+|.   .+++|+
T Consensus       297 ----~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~l-p~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~  360 (454)
T 1jl5_A          297 ----PNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIEL-PAL---PPRLERLIASFNHLA-EVPE---LPQNLK  360 (454)
T ss_dssp             ----TTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS-CCCC---CCTTCC
T ss_pred             ----CcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCccccc-ccc---CCcCCEEECCCCccc-cccc---hhhhcc
Confidence                468888999998885 3321   25788889998888874 332   478888888888888 4665   467888


Q ss_pred             EEeccCccccC--CCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCccccc--ccCCCccccccCCeEeC
Q 003065          461 RLILTNNNFSG--KIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSG--NIPRSLSLLSSLNALNL  536 (851)
Q Consensus       461 ~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L  536 (851)
                      +|++++|++++  .+|..++.        |+.|.+.|.+|..   +++|+.|++++|++++  .+|.      +++.|.+
T Consensus       361 ~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~  423 (454)
T 1jl5_A          361 QLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE------SVEDLRM  423 (454)
T ss_dssp             EEECCSSCCSSCCCCCTTCCE--------EECCC----------------------------------------------
T ss_pred             EEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchh------hHhheeC
Confidence            88888888887  56666553        3457777777764   4789999999999997  6664      3567788


Q ss_pred             CCCccccccCcccccc
Q 003065          537 SGNKLTGSIPDNLMKL  552 (851)
Q Consensus       537 s~N~l~g~ip~~l~~l  552 (851)
                      .+|.+.+.+|.+....
T Consensus       424 ~~~~~~~~~~~~~~~~  439 (454)
T 1jl5_A          424 NSERVVDPYEFAHETT  439 (454)
T ss_dssp             ----------------
T ss_pred             cCcccCCccccCHHHh
Confidence            9999998887766543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.4e-41  Score=385.33  Aligned_cols=364  Identities=19%  Similarity=0.207  Sum_probs=239.3

Q ss_pred             ceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCccccc
Q 003065           86 SGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVV  165 (851)
Q Consensus        86 ~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  165 (851)
                      .+..+.+++.+++|++|+|++|.+++ +| .|+.+++|++|+|++|++++. | ++.+++|++|++++|.+++. +  +.
T Consensus        31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~~-~--~~  103 (457)
T 3bz5_A           31 QATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTNL-D--VT  103 (457)
T ss_dssp             CTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSCC-C--CT
T ss_pred             CcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCcee-e--cC
Confidence            33444567788888899998888886 45 688888888888888888875 3 78888888888888888864 3  77


Q ss_pred             CccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccE
Q 003065          166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWK  245 (851)
Q Consensus       166 ~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~  245 (851)
                      ++++|++|++++|+++  .+|  ++.+++|++|++++|++++. +  ++++++|++|++++|+..+.+  .+..+++|++
T Consensus       104 ~l~~L~~L~L~~N~l~--~l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~  174 (457)
T 3bz5_A          104 PLTKLTYLNCDTNKLT--KLD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTT  174 (457)
T ss_dssp             TCTTCCEEECCSSCCS--CCC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCE
T ss_pred             CCCcCCEEECCCCcCC--eec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCE
Confidence            8888888888888886  344  77888888888888888763 2  777788888888888554444  4677777888


Q ss_pred             EEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcC
Q 003065          246 IELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF  325 (851)
Q Consensus       246 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  325 (851)
                      |++++|++++ +|  +..+++|+.|++++|++++.   .+..+++|+.|++++|++++ +|  ++.+++|+.|++++|++
T Consensus       175 L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l  245 (457)
T 3bz5_A          175 LDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPL  245 (457)
T ss_dssp             EECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCC
T ss_pred             EECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcC
Confidence            8888887775 34  66777777888877777754   36677777777777777776 44  66777777777777777


Q ss_pred             CCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcc
Q 003065          326 SGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL  405 (851)
Q Consensus       326 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  405 (851)
                      ++..   ++.+++|+.|++++|++                                      +.|++++|.+.+.+|  +
T Consensus       246 ~~~~---~~~l~~L~~L~l~~n~L--------------------------------------~~L~l~~n~~~~~~~--~  282 (457)
T 3bz5_A          246 TELD---VSTLSKLTTLHCIQTDL--------------------------------------LEIDLTHNTQLIYFQ--A  282 (457)
T ss_dssp             SCCC---CTTCTTCCEEECTTCCC--------------------------------------SCCCCTTCTTCCEEE--C
T ss_pred             CCcC---HHHCCCCCEEeccCCCC--------------------------------------CEEECCCCccCCccc--c
Confidence            7643   34456666666665533                                      334444444444443  2


Q ss_pred             cCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccE
Q 003065          406 WALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSS  485 (851)
Q Consensus       406 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  485 (851)
                      +.+++|+.|++++|.+.+.+|.   ..++|+.|++++|             ++|++|++++|++++. +  ++.+++|+.
T Consensus       283 ~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~  343 (457)
T 3bz5_A          283 EGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKS  343 (457)
T ss_dssp             TTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSE
T ss_pred             cccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcE
Confidence            3344444444444443333331   1233444444333             4566666666666653 2  556666666


Q ss_pred             EEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCccc
Q 003065          486 LHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNL  549 (851)
Q Consensus       486 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l  549 (851)
                      |++++|++++        ++.|..|++++|.++|.     ..+..|+.+++++|+++|.||..+
T Consensus       344 L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~  394 (457)
T 3bz5_A          344 LSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDL  394 (457)
T ss_dssp             EECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred             EECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhH
Confidence            6666666654        13455556666666654     344555666666666666666544

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=4e-41  Score=381.51  Aligned_cols=367  Identities=18%  Similarity=0.199  Sum_probs=300.4

Q ss_pred             CcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCc
Q 003065          107 NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP  186 (851)
Q Consensus       107 n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p  186 (851)
                      ....+..+..++++++|++|+|++|.+++. |.++.+++|++|+|++|.+++. |  +..+++|++|++++|.++  .+|
T Consensus        28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~--~~~  101 (457)
T 3bz5_A           28 FEMQATDTISEEQLATLTSLDCHNSSITDM-TGIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLT--NLD  101 (457)
T ss_dssp             TTCCTTSEEEHHHHTTCCEEECCSSCCCCC-TTGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCS--CCC
T ss_pred             cCcCcccccChhHcCCCCEEEccCCCcccC-hhhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCc--eee
Confidence            344556667899999999999999999986 5799999999999999999975 3  889999999999999987  343


Q ss_pred             ccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCc
Q 003065          187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTL  266 (851)
Q Consensus       187 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  266 (851)
                        ++++++|++|++++|++++ +|  ++.+++|++|++++|++++. +  +..+++|++|++++|+..+.+  .+..+++
T Consensus       102 --~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~  171 (457)
T 3bz5_A          102 --VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQ  171 (457)
T ss_dssp             --CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTT
T ss_pred             --cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCc
Confidence              8889999999999999986 44  88889999999999999864 3  788889999999999665555  4778889


Q ss_pred             ccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccC
Q 003065          267 LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE  346 (851)
Q Consensus       267 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~  346 (851)
                      |++|++++|++++ +|  +..+++|+.|++++|++++.   .++.+++|+.|++++|++++ +|  ++.+++|+.|++++
T Consensus       172 L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~  242 (457)
T 3bz5_A          172 LTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSV  242 (457)
T ss_dssp             CCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCS
T ss_pred             CCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeC
Confidence            9999999999886 44  77888889999999988865   37788888888888888887 45  77888888888888


Q ss_pred             CcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCC
Q 003065          347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS  426 (851)
Q Consensus       347 N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  426 (851)
                      |++++.                         |  +..+++|+.|++++|+              |+.|++++|.+.+.+|
T Consensus       243 N~l~~~-------------------------~--~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~  281 (457)
T 3bz5_A          243 NPLTEL-------------------------D--VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ  281 (457)
T ss_dssp             SCCSCC-------------------------C--CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE
T ss_pred             CcCCCc-------------------------C--HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc
Confidence            888742                         1  2345678888887764              4578888888877666


Q ss_pred             cccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccc
Q 003065          427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR  506 (851)
Q Consensus       427 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  506 (851)
                        ++.+++|+.|++++|.+.+.+|.   ...+|+.|++++|             ++|+.|+|++|+|++. +  ++.+++
T Consensus       282 --~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~  340 (457)
T 3bz5_A          282 --AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTK  340 (457)
T ss_dssp             --CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTT
T ss_pred             --ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCc
Confidence              46778899999999988877774   3456777777666             6899999999999984 3  999999


Q ss_pred             cceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccc
Q 003065          507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL  573 (851)
Q Consensus       507 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~  573 (851)
                      |+.|++++|+|++        ++.|..|++++|+++|. +    .+ .+..+|+++|+++|.||..+.
T Consensus       341 L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-~----~~~~l~~l~l~~N~l~g~ip~~~~  395 (457)
T 3bz5_A          341 LKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-G----QTITMPKETLTNNSLTIAVSPDLL  395 (457)
T ss_dssp             CSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-E----EEEECCCBCCBTTBEEEECCTTCB
T ss_pred             CcEEECCCCCCCC--------ccccccccccCCcEEec-c----eeeecCccccccCcEEEEcChhHh
Confidence            9999999999996        24677889999999986 2    33 688899999999999997654

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=9.2e-40  Score=373.12  Aligned_cols=346  Identities=26%  Similarity=0.359  Sum_probs=190.5

Q ss_pred             CCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceee
Q 003065           95 ALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS  174 (851)
Q Consensus        95 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  174 (851)
                      .+++++.|+++++.++. +| .+..+++|++|+|++|.+++.++ +..+++|++|++++|.+++..+  +.++++|++|+
T Consensus        44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  118 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT  118 (466)
T ss_dssp             HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh-hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence            45667777777777653 44 36667777777777777766655 6777777777777777765444  66666666666


Q ss_pred             cccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCcc
Q 003065          175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT  254 (851)
Q Consensus       175 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~  254 (851)
                      +++|.+.  .+|. +.++++|++|++++|.+++ ++ .+..+++|++|+++ |.+.+..+  +.++++|++|++++|.++
T Consensus       119 L~~n~l~--~~~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~  190 (466)
T 1o6v_A          119 LFNNQIT--DIDP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS  190 (466)
T ss_dssp             CCSSCCC--CCGG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCC--CChH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCC
Confidence            6666665  3333 6666666666666666663 22 35666666666664 34433222  556666666666666655


Q ss_pred             CcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccC
Q 003065          255 GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLG  334 (851)
Q Consensus       255 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~  334 (851)
                      +.  ..+..+++|++|++++|++.+..|  ++.+++|+.|++++|++++.  ..+..+++|+.|++++|++++..+  +.
T Consensus       191 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~  262 (466)
T 1o6v_A          191 DI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS  262 (466)
T ss_dssp             CC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred             CC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence            32  235555666666666666554433  44555566666665555532  234445555555555555544333  44


Q ss_pred             CCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceE
Q 003065          335 RYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGML  414 (851)
Q Consensus       335 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  414 (851)
                      .+++|+.|++++|++++..                        +  +..+++|++|++++|++++..|  +..+++|+.|
T Consensus       263 ~l~~L~~L~l~~n~l~~~~------------------------~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L  314 (466)
T 1o6v_A          263 GLTKLTELKLGANQISNIS------------------------P--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL  314 (466)
T ss_dssp             TCTTCSEEECCSSCCCCCG------------------------G--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEE
T ss_pred             cCCCCCEEECCCCccCccc------------------------c--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEE
Confidence            4455555555555444210                        1  3344455555555555554333  4445555555


Q ss_pred             EecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCccc
Q 003065          415 DFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT  494 (851)
Q Consensus       415 ~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  494 (851)
                      ++++|++++..+  +..+++|+.|++++|++++.  ..+..+++|++|++++|++++..|  +..+++|+.|++++|+++
T Consensus       315 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~  388 (466)
T 1o6v_A          315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT  388 (466)
T ss_dssp             ECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred             ECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence            555555554433  34455555555555555432  234455555555555555554444  455555555555555554


Q ss_pred             C
Q 003065          495 G  495 (851)
Q Consensus       495 ~  495 (851)
                      +
T Consensus       389 ~  389 (466)
T 1o6v_A          389 N  389 (466)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.6e-39  Score=371.17  Aligned_cols=355  Identities=27%  Similarity=0.382  Sum_probs=215.4

Q ss_pred             CcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCc
Q 003065          107 NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP  186 (851)
Q Consensus       107 n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p  186 (851)
                      +.+.+.++.  ..+++|+.|++++|.+.. +|.+..+++|++|||++|.+++..+  +.++++|++|++++|.+.  .++
T Consensus        34 ~~~~~~i~~--~~l~~l~~L~l~~~~i~~-l~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~--~~~  106 (466)
T 1o6v_A           34 TNVTDTVSQ--TDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA--DIT  106 (466)
T ss_dssp             SSTTSEECH--HHHHTCCEEECCSSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC--CCG
T ss_pred             cccccccCh--hHhccccEEecCCCCCcc-CcchhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccc--cCh
Confidence            344444432  457789999999999876 4568889999999999999886544  888888888888888886  444


Q ss_pred             ccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCc
Q 003065          187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTL  266 (851)
Q Consensus       187 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  266 (851)
                      . ++++++|++|++++|++++..+  +.++++|++|++++|++++. + .+..+++|++|+++ |.+.+..  .+.++++
T Consensus       107 ~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~  178 (466)
T 1o6v_A          107 P-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTT  178 (466)
T ss_dssp             G-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTT
T ss_pred             h-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCC
Confidence            4 8888888888888888875433  77888888888888888743 3 47777788888875 4454332  2667777


Q ss_pred             ccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccC
Q 003065          267 LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE  346 (851)
Q Consensus       267 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~  346 (851)
                      |++|++++|++++.  ..+..+++|++|++++|.+++..|  ++.+++|+.|++++|++++.  ..+..+++|+.|++++
T Consensus       179 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~  252 (466)
T 1o6v_A          179 LERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN  252 (466)
T ss_dssp             CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred             CCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCC
Confidence            77777777777643  236666677777777766665443  45555566666655555532  2344455555555555


Q ss_pred             CcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCC
Q 003065          347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS  426 (851)
Q Consensus       347 N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  426 (851)
                      |++++..                        |  +..+++|++|++++|++++..|  +..+++|+.|++++|++++..+
T Consensus       253 n~l~~~~------------------------~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~  304 (466)
T 1o6v_A          253 NQISNLA------------------------P--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP  304 (466)
T ss_dssp             SCCCCCG------------------------G--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG
T ss_pred             Cccccch------------------------h--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh
Confidence            5444211                        1  3334455555555555553332  4444555555555555544332


Q ss_pred             cccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccc
Q 003065          427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR  506 (851)
Q Consensus       427 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  506 (851)
                                                +..+++|+.|++++|++++..|  +..+++|+.|++++|++++.  ..+..+++
T Consensus       305 --------------------------~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~  354 (466)
T 1o6v_A          305 --------------------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTN  354 (466)
T ss_dssp             --------------------------GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred             --------------------------hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCC
Confidence                                      4444455555555555544433  44445555555555555433  23444555


Q ss_pred             cceeeccCcccccccCCCccccccCCeEeCCCCccc
Q 003065          507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT  542 (851)
Q Consensus       507 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  542 (851)
                      |+.|++++|++++..|  +..+++|+.|++++|+++
T Consensus       355 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~  388 (466)
T 1o6v_A          355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT  388 (466)
T ss_dssp             CCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred             CCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence            5555555555554444  445555555555555555

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=373.68  Aligned_cols=345  Identities=17%  Similarity=0.176  Sum_probs=290.5

Q ss_pred             CccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCC
Q 003065          220 GTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN  299 (851)
Q Consensus       220 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N  299 (851)
                      +.++.++++++ .+|..+.  +++++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|++++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            45777777777 5666553  57888888888888777788888888888888888888777888888888888888888


Q ss_pred             ccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccc
Q 003065          300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPN  379 (851)
Q Consensus       300 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~  379 (851)
                      ++++..+..|.++++|++|++++|++++..|..|..+++|+.|++++|++++                        ..|.
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~------------------------~~~~  146 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY------------------------ISHR  146 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE------------------------ECTT
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccce------------------------eChh
Confidence            8886666667888888888888888887777788888888888888887764                        3345


Q ss_pred             cccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCC
Q 003065          380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL  459 (851)
Q Consensus       380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L  459 (851)
                      .|..+++|++|+|++|++++..+..+..+++|+.|++++|++.+..+..|..+++|+.|++++|.+.+.+|..+....+|
T Consensus       147 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L  226 (477)
T 2id5_A          147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL  226 (477)
T ss_dssp             SSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred             hccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence            67778889999999999987777778889999999999999998888889999999999999998888888877777899


Q ss_pred             cEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCC
Q 003065          460 ERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN  539 (851)
Q Consensus       460 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  539 (851)
                      +.|+|++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|
T Consensus       227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  306 (477)
T 2id5_A          227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN  306 (477)
T ss_dssp             SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred             cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence            99999999999766678999999999999999999888889999999999999999999999999999999999999999


Q ss_pred             ccccccCcccccc-cceEEeCcCCcccccCCcccccCCC-CccccCCCCCCCCc
Q 003065          540 KLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRMGG-DGAFAGNEGLCLDQ  591 (851)
Q Consensus       540 ~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~~~~~-~~~~~gn~~lc~~~  591 (851)
                      ++++..+..+..+ .|+.|++++|+|.|.++..|..... ...+.++...|..|
T Consensus       307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          307 QLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             CCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             cCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence            9997666677777 8999999999999999877765443 35677888888766

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=367.79  Aligned_cols=350  Identities=17%  Similarity=0.135  Sum_probs=199.9

Q ss_pred             ceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeec
Q 003065          171 VSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYA  250 (851)
Q Consensus       171 ~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~  250 (851)
                      +.++.+++.++  .+|..+.  ++++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        14 ~~v~c~~~~l~--~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           14 RAVLCHRKRFV--AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             TEEECCSCCCS--SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC--cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence            45666666665  5666543  4677777777777766666777777777777777777766666777777777777777


Q ss_pred             cCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCC
Q 003065          251 NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP  330 (851)
Q Consensus       251 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  330 (851)
                      |+++...+..|.++++|++|+|++|++.+..|..|.++++|+.|++++|.+++..+..|.++++|+.|++++|++++..+
T Consensus        90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  169 (477)
T 2id5_A           90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT  169 (477)
T ss_dssp             SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred             CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence            77765555556666777777777776666666666666666666666666665555566666666666666666655444


Q ss_pred             CccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccc
Q 003065          331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPN  410 (851)
Q Consensus       331 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  410 (851)
                      ..+..+++|+.|++++|.+.+                        ..+..|..+++|++|++++|.+.+.+|.......+
T Consensus       170 ~~l~~l~~L~~L~l~~n~i~~------------------------~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~  225 (477)
T 2id5_A          170 EALSHLHGLIVLRLRHLNINA------------------------IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN  225 (477)
T ss_dssp             HHHTTCTTCCEEEEESCCCCE------------------------ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCC
T ss_pred             hHhcccCCCcEEeCCCCcCcE------------------------eChhhcccCcccceeeCCCCccccccCcccccCcc
Confidence            445555555555555555442                        22234455556666666666555555554444445


Q ss_pred             cceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecC
Q 003065          411 VGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE  490 (851)
Q Consensus       411 L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  490 (851)
                      |+.|++++|++++.++..+..+                        ++|+.|+|++|.+++..+..|..+++|+.|+|++
T Consensus       226 L~~L~l~~n~l~~~~~~~~~~l------------------------~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  281 (477)
T 2id5_A          226 LTSLSITHCNLTAVPYLAVRHL------------------------VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG  281 (477)
T ss_dssp             CSEEEEESSCCCSCCHHHHTTC------------------------TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCS
T ss_pred             ccEEECcCCcccccCHHHhcCc------------------------cccCeeECCCCcCCccChhhccccccCCEEECCC
Confidence            5555555555554443444444                        4444444444444444444445555555555555


Q ss_pred             CcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccccceEEeCcCCcccccCCc
Q 003065          491 NALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPL  570 (851)
Q Consensus       491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~L~~l~ls~N~l~~~~p~  570 (851)
                      |++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++.-+.....-....+++..+...|..|.
T Consensus       282 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          282 GQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             SCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             CccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence            55555445555555555555555555554444445555555555555555553322111000122234455666666664


Q ss_pred             cc
Q 003065          571 DF  572 (851)
Q Consensus       571 ~~  572 (851)
                      .+
T Consensus       362 ~~  363 (477)
T 2id5_A          362 FV  363 (477)
T ss_dssp             GG
T ss_pred             HH
Confidence            43

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-37  Score=346.49  Aligned_cols=280  Identities=14%  Similarity=0.132  Sum_probs=184.1

Q ss_pred             CCCCCCCCCCCc-ccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEec
Q 003065           50 LDSWKESADSPC-GFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNV  128 (851)
Q Consensus        50 l~sW~~~~~~~c-~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  128 (851)
                      +++|... .+|| .|.+..|....-+|     ............-..++++++|++++|.++...+..|..+++|++|+|
T Consensus         3 ~~~~~~~-~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L   76 (390)
T 3o6n_A            3 VKPRQPE-YKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL   76 (390)
T ss_dssp             ----CCE-ECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEEC
T ss_pred             cCCCCCc-cceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEEC
Confidence            5789887 4455 55555553222111     222222222233345789999999999998543345789999999999


Q ss_pred             ccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCccc-ccCCCCCCeEeccccccc
Q 003065          129 TGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPES-IGNLKNLTYLFLAHCNLR  206 (851)
Q Consensus       129 s~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~-~~~l~~L~~L~L~~n~l~  206 (851)
                      ++|.+++.++. +..+++|++|+|++|.+++..|..|.++++|++|++++|.+.  .+|.. +.++++|++|++++|+++
T Consensus        77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~l~~~~~~~l~~L~~L~L~~n~l~  154 (390)
T 3o6n_A           77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS--SLPRGIFHNTPKLTTLSMSNNNLE  154 (390)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC--CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC--cCCHHHhcCCCCCcEEECCCCccC
Confidence            99999888774 899999999999999999888888889999999999999886  56655 578888889999888888


Q ss_pred             ccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCcccc
Q 003065          207 GRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG  286 (851)
Q Consensus       207 ~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  286 (851)
                      +..|..|.++++|++|++++|++++.   .+..+++|++|++++|.+++.     ...++|++|++++|++... |..  
T Consensus       155 ~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--  223 (390)
T 3o6n_A          155 RIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--  223 (390)
T ss_dssp             BCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--
T ss_pred             ccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--
Confidence            77777888888888888888888754   356667788888888877632     2345677777777777633 322  


Q ss_pred             CcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCccc
Q 003065          287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS  350 (851)
Q Consensus       287 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  350 (851)
                      ..++|+.|++++|++++.  ..+..+++|++|++++|++++..|..+..+++|+.|+|++|+++
T Consensus       224 ~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  285 (390)
T 3o6n_A          224 VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV  285 (390)
T ss_dssp             CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC
T ss_pred             ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc
Confidence            234566666666666532  23444555555555555554444444444444444444444443

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=4.2e-37  Score=342.92  Aligned_cols=334  Identities=18%  Similarity=0.192  Sum_probs=207.2

Q ss_pred             CCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEe
Q 003065          192 LKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD  271 (851)
Q Consensus       192 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  271 (851)
                      +++++.|++++|.++...+..|..+++|++|++++|++++..+..|..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            46677777777777644444456667777777777777665556666666677777776666666666666666666666


Q ss_pred             cccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccc
Q 003065          272 ISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSG  351 (851)
Q Consensus       272 Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  351 (851)
                      |++|+++...+..|.++++|++|++++|++++..|..|..+++|++|++++|++++.   .+..+++|+.|++++|.+++
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~  200 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST  200 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc
Confidence            666666643333456666666666666666655555566666666666666665543   23344555555555555441


Q ss_pred             cCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCccccc
Q 003065          352 SFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGL  431 (851)
Q Consensus       352 ~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  431 (851)
                      .                             ...++|++|++++|.++.. |..                          .
T Consensus       201 ~-----------------------------~~~~~L~~L~l~~n~l~~~-~~~--------------------------~  224 (390)
T 3o6n_A          201 L-----------------------------AIPIAVEELDASHNSINVV-RGP--------------------------V  224 (390)
T ss_dssp             E-----------------------------ECCSSCSEEECCSSCCCEE-ECC--------------------------C
T ss_pred             c-----------------------------CCCCcceEEECCCCeeeec-ccc--------------------------c
Confidence            0                             1112455555555555422 221                          1


Q ss_pred             CCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceee
Q 003065          432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLN  511 (851)
Q Consensus       432 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  511 (851)
                      .++|+.|++++|++++.  ..+..+++|++|++++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+
T Consensus       225 ~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~  301 (390)
T 3o6n_A          225 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD  301 (390)
T ss_dssp             CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEE
T ss_pred             cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEE
Confidence            24555566666665532  356666666666666666666666666666777777777777663 455556667777777


Q ss_pred             ccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccccCCCCccccCCCCCCCC
Q 003065          512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD  590 (851)
Q Consensus       512 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~gn~~lc~~  590 (851)
                      |++|+++ .+|..+..+++|+.|+|++|+++ .+|  +..+ .|+.|++++|+|.|.....+........+.+++..|..
T Consensus       302 L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~-~~~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~  377 (390)
T 3o6n_A          302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI  377 (390)
T ss_dssp             CCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CCC--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCCT
T ss_pred             CCCCcce-ecCccccccCcCCEEECCCCccc-eeC--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceecc
Confidence            7777777 45666777777888888888877 344  4445 67888888888888776555443335566777777865


Q ss_pred             c
Q 003065          591 Q  591 (851)
Q Consensus       591 ~  591 (851)
                      +
T Consensus       378 ~  378 (390)
T 3o6n_A          378 D  378 (390)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2.9e-37  Score=363.27  Aligned_cols=334  Identities=18%  Similarity=0.175  Sum_probs=240.9

Q ss_pred             CCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEe
Q 003065          192 LKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD  271 (851)
Q Consensus       192 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  271 (851)
                      +++++.|++++|.+....+..|..+++|++|+|++|.|++..|..|..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            57889999999999876666678889999999999999887778888889999999999988888778888888888888


Q ss_pred             cccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccc
Q 003065          272 ISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSG  351 (851)
Q Consensus       272 Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  351 (851)
                      |++|.+++..+..|.++++|++|++++|.+++..|..|+.+++|++|++++|++++..   ++.+++|+.|++++|.+++
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~  206 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST  206 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence            8888888665566788888888888888888777777888888888888888777542   4455667777777776652


Q ss_pred             cCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCccccc
Q 003065          352 SFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGL  431 (851)
Q Consensus       352 ~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  431 (851)
                      .                             ...++|+.|++++|.++...+ .+  .                       
T Consensus       207 l-----------------------------~~~~~L~~L~ls~n~l~~~~~-~~--~-----------------------  231 (597)
T 3oja_B          207 L-----------------------------AIPIAVEELDASHNSINVVRG-PV--N-----------------------  231 (597)
T ss_dssp             E-----------------------------ECCTTCSEEECCSSCCCEEEC-SC--C-----------------------
T ss_pred             c-----------------------------cCCchhheeeccCCccccccc-cc--C-----------------------
Confidence            1                             112346666666666653222 11  1                       


Q ss_pred             CCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceee
Q 003065          432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLN  511 (851)
Q Consensus       432 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  511 (851)
                       ++|+.|+|++|.+++  +..+..+++|+.|+|++|.+++.+|..|+.+++|+.|+|++|++++ +|..++.+++|+.|+
T Consensus       232 -~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~  307 (597)
T 3oja_B          232 -VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD  307 (597)
T ss_dssp             -SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEE
T ss_pred             -CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEE
Confidence             345555555555553  2455666666666666666666666666666667777777776664 455566677777777


Q ss_pred             ccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccccCCCCccccCCCCCCCC
Q 003065          512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD  590 (851)
Q Consensus       512 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~gn~~lc~~  590 (851)
                      |++|.++ .+|..+..+++|+.|+|++|++++ +|  +..+ .|+.|++++|+|.|.++..+........+.+++..|+.
T Consensus       308 Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~-~~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~  383 (597)
T 3oja_B          308 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI  383 (597)
T ss_dssp             CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCT
T ss_pred             CCCCCCC-ccCcccccCCCCCEEECCCCCCCC-cC--hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCc
Confidence            7777777 566677777888888888888874 33  3444 78888888888888876665544335667888889986


Q ss_pred             c
Q 003065          591 Q  591 (851)
Q Consensus       591 ~  591 (851)
                      +
T Consensus       384 ~  384 (597)
T 3oja_B          384 D  384 (597)
T ss_dssp             T
T ss_pred             c
Confidence            4

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.6e-37  Score=328.17  Aligned_cols=168  Identities=28%  Similarity=0.430  Sum_probs=152.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|++++++++|||||+++++|++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4699999999999999999999999999999998643     45677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |||+||+|.+++.+.     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+...
T Consensus       112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            999999999999864     35889999999999999999999   7899999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .........+++||+.|||||
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPE  204 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPE  204 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHH
T ss_pred             CCCCcccccCcccCcccCCHH
Confidence            554444455678999999998

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.1e-36  Score=358.18  Aligned_cols=348  Identities=17%  Similarity=0.221  Sum_probs=225.0

Q ss_pred             CCCCCCCCCCCCCCcc----cceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCC
Q 003065           47 HGVLDSWKESADSPCG----FSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSN  122 (851)
Q Consensus        47 ~~~l~sW~~~~~~~c~----w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  122 (851)
                      ...+++|.++ .+||.    |.++.|+.      .++.......  .+..-..+.+++.|++++|.++...+..|+.+++
T Consensus         6 ~~~l~~~~~~-~~C~~~~~~~~c~~~~~------~i~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~   76 (597)
T 3oja_B            6 RYNVKPRQPE-YKCIDSNLQYDCVFYDV------HIDMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ   76 (597)
T ss_dssp             -----CCCSE-ECCCCC--CCSEEECSC------EECSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCCC
T ss_pred             cccccCCCCC-CcCcccCcCceeEecCc------eecccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCCC
Confidence            3457889887 45552    66666642      1222222221  1122234788999999999998655556889999


Q ss_pred             CceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCccc-ccCCCCCCeEec
Q 003065          123 LKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPES-IGNLKNLTYLFL  200 (851)
Q Consensus       123 L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~-~~~l~~L~~L~L  200 (851)
                      |++|+|++|.+++.++. ++.+++|++|+|++|.+++..|..|.++++|++|+|++|.+.  .+|.. |+++++|++|+|
T Consensus        77 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~l~~~~~~~l~~L~~L~L  154 (597)
T 3oja_B           77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS--SLPRGIFHNTPKLTTLSM  154 (597)
T ss_dssp             CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC--CCCTTTTTTCTTCCEEEC
T ss_pred             CcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC--CCCHHHhccCCCCCEEEe
Confidence            99999999999988774 899999999999999999888888888888888888888886  45554 578888888888


Q ss_pred             ccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCC
Q 003065          201 AHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK  280 (851)
Q Consensus       201 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  280 (851)
                      ++|.+++..|..|.++++|++|+|++|++++.   .+..+++|+.|++++|.+++     +...++|+.|++++|.+...
T Consensus       155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~  226 (597)
T 3oja_B          155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV  226 (597)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEE
T ss_pred             eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccc
Confidence            88888877777788888888888888888754   24556677777777777663     22345666777777666532


Q ss_pred             CCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhh
Q 003065          281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK  360 (851)
Q Consensus       281 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~  360 (851)
                       |..+  .++|+.|++++|.+++                          +..+..+++|+.|+|++|.+++..|      
T Consensus       227 -~~~~--~~~L~~L~L~~n~l~~--------------------------~~~l~~l~~L~~L~Ls~N~l~~~~~------  271 (597)
T 3oja_B          227 -RGPV--NVELTILKLQHNNLTD--------------------------TAWLLNYPGLVEVDLSYNELEKIMY------  271 (597)
T ss_dssp             -ECSC--CSCCCEEECCSSCCCC--------------------------CGGGGGCTTCSEEECCSSCCCEEES------
T ss_pred             -cccc--CCCCCEEECCCCCCCC--------------------------ChhhccCCCCCEEECCCCccCCCCH------
Confidence             2211  1345555555555543                          2344555555555555555543322      


Q ss_pred             cchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEec
Q 003065          361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVL  440 (851)
Q Consensus       361 ~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L  440 (851)
                                        ..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|.+++ +|..+..+++|+.|+|
T Consensus       272 ------------------~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L  331 (597)
T 3oja_B          272 ------------------HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYL  331 (597)
T ss_dssp             ------------------GGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEEC
T ss_pred             ------------------HHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEEC
Confidence                              233444555555555555553 34444555666666666666653 3444555666666666


Q ss_pred             CCCcceeeCCcccccCCCCcEEeccCccccC
Q 003065          441 QNNRFSGELPSELGRLTNLERLILTNNNFSG  471 (851)
Q Consensus       441 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  471 (851)
                      ++|.+++. |  +..+++|+.|++++|++.+
T Consensus       332 ~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~  359 (597)
T 3oja_B          332 DHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  359 (597)
T ss_dssp             CSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             CCCCCCCc-C--hhhcCCCCEEEeeCCCCCC
Confidence            66666533 2  5566777777777777764

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=2.4e-37  Score=335.50  Aligned_cols=280  Identities=17%  Similarity=0.212  Sum_probs=189.7

Q ss_pred             CCCchhhHHHHHHHHHhc-CCCCCCCCCCC---CCCCCCcccceeEecC--------CCCceEEEecccCCcceecCccc
Q 003065           26 SLSLNVETQALIQFKSKL-KDPHGVLDSWK---ESADSPCGFSGITCDS--------VTGRVTEISFDNKSLSGEISSSI   93 (851)
Q Consensus        26 ~~~~~~~~~aLl~fk~~~-~~~~~~l~sW~---~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~g~i~~~l   93 (851)
                      ..+..+|++||++||+++ .|+.+.+.+|.   ....++|.|.|++|+.        ...+|+.|+|+++.++ .+|+.+
T Consensus        22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l  100 (328)
T 4fcg_A           22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA  100 (328)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred             cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence            346789999999999999 57888889994   3347889999999952        3468899999999998 788889


Q ss_pred             cCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCcccccee
Q 003065           94 SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSL  173 (851)
Q Consensus        94 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  173 (851)
                      +.+++|++|+|++|.++ .+|..|+++++|++|+|++|.++..++.++.+++|++|+|++|++.+.+|..+...      
T Consensus       101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~------  173 (328)
T 4fcg_A          101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLAST------  173 (328)
T ss_dssp             GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE------
T ss_pred             hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhc------
Confidence            99999999999999998 88888999999999999999988555558888999999999988888888766540      


Q ss_pred             ecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCc
Q 003065          174 SIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL  253 (851)
Q Consensus       174 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l  253 (851)
                                .++..+.++++|++|+|++|+++ .+|..+.++++|++|+|++|++++ +|..+..+++|++|+|++|++
T Consensus       174 ----------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~  241 (328)
T 4fcg_A          174 ----------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA  241 (328)
T ss_dssp             ----------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTT
T ss_pred             ----------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcc
Confidence                      11122334455555555555555 445555555555555555555552 333455555555555555555


Q ss_pred             cCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcC
Q 003065          254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF  325 (851)
Q Consensus       254 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  325 (851)
                      .+.+|..++.+++|++|+|++|.+.+.+|..+.++++|++|++++|++.+.+|..++.+++|+.+++..|.+
T Consensus       242 ~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          242 LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             CCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             hhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            555555555555555555555555555555555555555555555555555555555555555555554444

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-37  Score=331.64  Aligned_cols=169  Identities=22%  Similarity=0.378  Sum_probs=143.9

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +++|++.+.||+|+||+||+|+++.+++.||||++...    ...+.+.+|++++++++|||||++++++++++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            45899999999999999999999999999999998654    23567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |||+||+|.+++...   ....+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+...
T Consensus       103 Ey~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             ECCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             eCCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            999999999999764   2345788889999999999999999   7899999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ......+||+.|||||
T Consensus       177 ~~~--~~~~~~~GT~~YmAPE  195 (350)
T 4b9d_A          177 STV--ELARACIGTPYYLSPE  195 (350)
T ss_dssp             HHH--HHHHHHHSCCTTCCHH
T ss_pred             CCc--ccccccCCCccccCHH
Confidence            321  1223467999999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-36  Score=325.40  Aligned_cols=165  Identities=27%  Similarity=0.431  Sum_probs=148.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ..|+..+.||+|+||+||+|+++.+++.||||++...  ...+.+.+|++++++++|||||+++++|.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            3688899999999999999999999999999998543  34566889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      +||+|.+++.+.      .+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+......
T Consensus       154 ~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          154 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            999999998652      4889999999999999999999   7899999999999999999999999999998775443


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ...+.+||+.|||||
T Consensus       225 ~--~~~~~~GTp~YmAPE  240 (346)
T 4fih_A          225 P--RRKSLVGTPYWMAPE  240 (346)
T ss_dssp             C--CBCCCCSCGGGCCHH
T ss_pred             C--cccccccCcCcCCHH
Confidence            2  234578999999998

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=5.8e-35  Score=320.25  Aligned_cols=305  Identities=22%  Similarity=0.318  Sum_probs=147.6

Q ss_pred             CCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEE
Q 003065          191 NLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF  270 (851)
Q Consensus       191 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  270 (851)
                      .+++|++|++++|.+.. +| .+..+++|++|++++|++++..+  +..+++|++|++++|.++. + +.+..+++|++|
T Consensus        42 ~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~~L  115 (347)
T 4fmz_A           42 ELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTNLREL  115 (347)
T ss_dssp             HHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCSEE
T ss_pred             hcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-c-hHHcCCCcCCEE
Confidence            34444455555544442 22 24444455555555555543222  4455555555555555543 2 234555555555


Q ss_pred             ecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCccc
Q 003065          271 DISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS  350 (851)
Q Consensus       271 ~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  350 (851)
                      ++++|++.+. +. +..+++|+.|++++|.....++ .+..+++|++|++++|.+.+..+  +..+++|+.|++++|++.
T Consensus       116 ~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~  190 (347)
T 4fmz_A          116 YLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE  190 (347)
T ss_dssp             ECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCC
T ss_pred             ECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccc
Confidence            5555555532 22 4555555555555554332222 24455555555555555543322  445555555555555544


Q ss_pred             ccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccc
Q 003065          351 GSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIG  430 (851)
Q Consensus       351 ~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  430 (851)
                      +. +                        . +..+++|++|++++|.+++..+  +..+++|+.|++++|++++..+  +.
T Consensus       191 ~~-~------------------------~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~  240 (347)
T 4fmz_A          191 DI-S------------------------P-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LA  240 (347)
T ss_dssp             CC-G------------------------G-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GT
T ss_pred             cc-c------------------------c-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hh
Confidence            21 0                        1 3334455555555555553333  4445555555555555554333  44


Q ss_pred             cCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCccccccccee
Q 003065          431 LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL  510 (851)
Q Consensus       431 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  510 (851)
                      .+++|+.|++++|.+++.  ..+..+++|++|++++|++++.  ..+..+++|+.|+|++|++++..|..++.+++|+.|
T Consensus       241 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  316 (347)
T 4fmz_A          241 NLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL  316 (347)
T ss_dssp             TCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred             cCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence            455555555555555432  2345555555555555555533  234555555555555555555555555555555555


Q ss_pred             eccCcccccccCCCccccccCCeEeCCCCccc
Q 003065          511 NLARNSLSGNIPRSLSLLSSLNALNLSGNKLT  542 (851)
Q Consensus       511 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  542 (851)
                      ++++|++++..|  +..+++|+.|++++|+++
T Consensus       317 ~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          317 FLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             ECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EccCCccccccC--hhhhhccceeehhhhccc
Confidence            555555554444  455555555555555543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.4e-36  Score=312.28  Aligned_cols=166  Identities=30%  Similarity=0.440  Sum_probs=135.0

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+++|++.+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|++++++++|||||++++++++++..|+
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            467899999999999999999999999999999998643     335678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+ +|+|.+++.++     ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        91 vmEy~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEeCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence            99999 68999999763     45899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......   ..+.+||+.|||||
T Consensus       162 ~~~~~~---~~~~~GT~~Y~APE  181 (275)
T 3hyh_A          162 MTDGNF---LKTSCGSPNYAAPE  181 (275)
T ss_dssp             ----------------CTTSCHH
T ss_pred             cCCCCc---cCCeeECcccCChh
Confidence            654332   23468999999998

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.5e-36  Score=320.19  Aligned_cols=173  Identities=28%  Similarity=0.405  Sum_probs=146.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|...+.||+|+||+||+|++.     .++..||||++...  ...++|.+|++++++++|||||++++++.+++..|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            36788899999999999999875     35778999999654  345679999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhh--------hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEE
Q 003065          749 VLEYMPNGNLFQALHKRV--------KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI  820 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl  820 (851)
                      |||||++|+|.++++...        ......++|..+.+++.|+|+||+|||   +++||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999998642        123457999999999999999999999   789999999999999999999999


Q ss_pred             eeecCccccCCCCCcccccccccccccccCC
Q 003065          821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|||+|+...............||+.|||||
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE  200 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE  200 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHH
Confidence            9999998765543333333457999999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=327.13  Aligned_cols=165  Identities=27%  Similarity=0.431  Sum_probs=148.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ..|+..+.||+|+||.||+|+++.+++.||||++...  ...+.+.+|+++|++++|||||+++++|.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            4689999999999999999999999999999998643  34566889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      +||+|.++++..      .+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+......
T Consensus       231 ~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          231 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            999999998642      4889999999999999999999   7899999999999999999999999999998775543


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ...+.+||+.|||||
T Consensus       302 ~--~~~~~~GTp~YmAPE  317 (423)
T 4fie_A          302 P--RRKSLVGTPYWMAPE  317 (423)
T ss_dssp             C--CBCCCEECTTTCCHH
T ss_pred             c--cccccccCcCcCCHH
Confidence            2  234578999999998

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.5e-34  Score=317.01  Aligned_cols=307  Identities=23%  Similarity=0.363  Sum_probs=173.6

Q ss_pred             CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCccccccccc
Q 003065          140 LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL  219 (851)
Q Consensus       140 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  219 (851)
                      +..+++|++|++++|.+.. ++ .+..+++|++|++++|.+.  .+|. +..+++|++|++++|++++ + +.+.++++|
T Consensus        40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~--~~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L  112 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQIT--DISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNL  112 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC--CCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC
T ss_pred             chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccc--cchh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcC
Confidence            4456666666776666653 22 2555666666666666554  3333 5555666666666665553 2 235555555


Q ss_pred             CccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCC
Q 003065          220 GTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN  299 (851)
Q Consensus       220 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N  299 (851)
                      ++|++++|++++..+  +..+++|++|++++|.....++ .+..+++|++|++++|.+.                     
T Consensus       113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~---------------------  168 (347)
T 4fmz_A          113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK---------------------  168 (347)
T ss_dssp             SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCC---------------------
T ss_pred             CEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcC---------------------
Confidence            555555555553222  4455555555555553332222 2444455555555555444                     


Q ss_pred             ccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccc
Q 003065          300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPN  379 (851)
Q Consensus       300 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~  379 (851)
                         +..+  +..+++|+.|++++|++.+..+  +..+++|+.|++++|.+.+..+                         
T Consensus       169 ---~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-------------------------  216 (347)
T 4fmz_A          169 ---DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-------------------------  216 (347)
T ss_dssp             ---CCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-------------------------
T ss_pred             ---Cchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch-------------------------
Confidence               3222  4444555555555555543222  4555556666666655542111                         


Q ss_pred             cccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCC
Q 003065          380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL  459 (851)
Q Consensus       380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L  459 (851)
                       +..+++|++|++++|++++..+  +..+++|++|++++|++++.  ..+..+++|+.|++++|++++.  ..+..+++|
T Consensus       217 -~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L  289 (347)
T 4fmz_A          217 -VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQL  289 (347)
T ss_dssp             -GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTC
T ss_pred             -hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCC
Confidence             3344556666666666654333  55566666666666666553  3456666777777777777643  346677777


Q ss_pred             cEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccc
Q 003065          460 ERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS  518 (851)
Q Consensus       460 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  518 (851)
                      +.|++++|.+++..|..+..+++|+.|+|++|++++..|  +..+++|+.|++++|.|+
T Consensus       290 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             SEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            777777777777777777777777777777777776555  677777777777777765

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-35  Score=310.28  Aligned_cols=161  Identities=29%  Similarity=0.359  Sum_probs=140.0

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe----CCeeEEEE
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFLVL  750 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  750 (851)
                      +..+.||+|+||+||+|.++.++..||||++...    ...+.|.+|++++++++|||||+++++|++    ++..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5667899999999999999999999999998643    235678999999999999999999999865    34579999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEEC-CCCceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLD-EDYEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DFGla~  827 (851)
                      |||+||+|.+++.+.     ..+++..+..++.||+.||+|||   +++  ||||||||+|||++ .+|.+||+|||+|+
T Consensus       109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            999999999999864     35889999999999999999999   555  99999999999998 47899999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....    ...+.+||+.|||||
T Consensus       181 ~~~~~----~~~~~~GTp~YmAPE  200 (290)
T 3fpq_A          181 LKRAS----FAKAVIGTPEFMAPE  200 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGG
T ss_pred             eCCCC----ccCCcccCccccCHH
Confidence            64432    233468999999999

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.1e-36  Score=320.33  Aligned_cols=172  Identities=24%  Similarity=0.364  Sum_probs=138.5

Q ss_pred             CCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +|...+.||+|+||+||+|++.     .++..||||++...  ...++|.+|++++++++|||||++++++.+++..|+|
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            5677889999999999999875     35778999999654  3456799999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceE
Q 003065          750 LEYMPNGNLFQALHKRVKE----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPK  819 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  819 (851)
                      ||||++|+|.++++.....          ....++|..+..|+.|||+||+|||   +++||||||||+|||+++++.+|
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEE
Confidence            9999999999999864221          2346899999999999999999999   78999999999999999999999


Q ss_pred             EeeecCccccCCCCCcccccccccccccccCC
Q 003065          820 IADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       820 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|||+|+..............+||+.|||||
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE  230 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE  230 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHH
T ss_pred             EcccccceeccCCCcceecCcccccccccChh
Confidence            99999999775544333334567999999998

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.2e-35  Score=317.90  Aligned_cols=165  Identities=25%  Similarity=0.291  Sum_probs=142.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      ..|+..+.||+|+||+||+|+++.+++.||||++..+..   ..+|++++++++|||||++++++.+++..|+|||||+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  134 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG  134 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence            457788899999999999999999999999999975532   24799999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-ceEEeeecCccccCCCCC
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAENSPK  834 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~  834 (851)
                      |+|.+++++.     ..+++..+..++.||+.||+|||   +++||||||||+|||++.+| .+||+|||+|+.......
T Consensus       135 g~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          135 GSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999864     35899999999999999999999   88999999999999999988 699999999997754322


Q ss_pred             c---ccccccccccccccCC
Q 003065          835 V---SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~---~~~~~~~gt~~Y~APE  851 (851)
                      .   .....++||+.|||||
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE  226 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPE  226 (336)
T ss_dssp             -------CCCCCCGGGCCHH
T ss_pred             ccceecCCccccCccccCHH
Confidence            1   1223467999999998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1e-35  Score=315.99  Aligned_cols=172  Identities=24%  Similarity=0.389  Sum_probs=136.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCC-------
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGG-------  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  744 (851)
                      +.+|++.+.||+|+||+||+|+++.+++.||||++....   ..+.+.+|++++++++|||||+++++|.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            457899999999999999999999999999999986442   3467889999999999999999999987544       


Q ss_pred             -----eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceE
Q 003065          745 -----SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPK  819 (851)
Q Consensus       745 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  819 (851)
                           ..|+|||||++|+|.+++..+.  .....++..+..++.|+++||+|||   +++||||||||+|||++.++.+|
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEE
Confidence                 3699999999999999998642  2234566778899999999999999   78999999999999999999999


Q ss_pred             EeeecCccccCCCCCc----------ccccccccccccccCC
Q 003065          820 IADFGVAKIAENSPKV----------SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       820 l~DFGla~~~~~~~~~----------~~~~~~~gt~~Y~APE  851 (851)
                      |+|||+|+........          ...++.+||+.|||||
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE  200 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE  200 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence            9999999876543221          1223467999999998

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=314.64  Aligned_cols=165  Identities=33%  Similarity=0.510  Sum_probs=136.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +++...+.||+|+||+||+|++.   ..||||+++..    ...+.|.+|++++++++|||||++++++.. +..|+|||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            36778899999999999999874   35999988543    235679999999999999999999998754 56899999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      ||++|+|.++++..    ...+++..+..|+.|||+||+|||   +++||||||||+|||+++++.+||+|||+|+....
T Consensus       112 y~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             CCSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             cCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            99999999999753    456899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..........+||+.|||||
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE  204 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPE  204 (307)
T ss_dssp             ---------CCCCTTSCCHH
T ss_pred             CCcceeecccccCCCccCHH
Confidence            43333345568999999998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-35  Score=316.60  Aligned_cols=172  Identities=22%  Similarity=0.300  Sum_probs=146.0

Q ss_pred             CCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      ++++.+.||+|+||+||+|++.     .+++.||||++...   ...++|.+|+.++++++|||||++++++.+++..|+
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4567889999999999999864     35678999998654   346789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc
Q 003065          749 VLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE  817 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~  817 (851)
                      |||||++|+|.+++..+...           ....++|..+.+|+.|||+||+|||   +++||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            99999999999999764221           1245899999999999999999999   789999999999999999999


Q ss_pred             eEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       818 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +||+|||+|+...............||+.|||||
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE  217 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE  217 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHH
Confidence            9999999998765443333344567999999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.1e-35  Score=314.24  Aligned_cols=166  Identities=31%  Similarity=0.403  Sum_probs=138.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEc---CCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      ++|++.+.||+|+||+||+|++.   .+++.||||++.+.    .....+.+|++++++++|||||++++++++++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            47999999999999999999874   46788999998643    234467899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |||||+||+|.+++.+.     ..+++..+..++.|++.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.
T Consensus       104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            99999999999999864     35889999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  ...+.+||+.|||||
T Consensus       176 ~~~~~~--~~~~~~GT~~YmAPE  196 (304)
T 3ubd_A          176 SIDHEK--KAYSFCGTVEYMAPE  196 (304)
T ss_dssp             -----C--CCCSCCCCGGGCCHH
T ss_pred             ccCCCc--cccccccCcccCCHH
Confidence            544322  233468999999998

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=5.9e-35  Score=314.76  Aligned_cols=249  Identities=27%  Similarity=0.452  Sum_probs=179.1

Q ss_pred             CCccEEEccCCccCC--CCCCCCCCcccccEEEecc-CcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHH
Q 003065          289 KNLTVFQCFKNNFSG--EFPSGFGDMRKLFAFSIYG-NRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN  365 (851)
Q Consensus       289 ~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~  365 (851)
                      .+++.|++++|++++  .+|..|+++++|++|++++ |.+.+.+|..++.+++|++|+|++|++++              
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~--------------  115 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG--------------  115 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEE--------------
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCC--------------
Confidence            356666666666666  5666666666666666663 66666666666666666666666665554              


Q ss_pred             HHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCC-CCCeEecCCCc
Q 003065          366 LLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST-SLSQLVLQNNR  444 (851)
Q Consensus       366 l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~-~L~~L~Ls~N~  444 (851)
                                .+|..|.++++|++|+|++|++++.+|..+..+++|++|++++|++++.+|..+..++ +|+.|+|++|+
T Consensus       116 ----------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~  185 (313)
T 1ogq_A          116 ----------AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR  185 (313)
T ss_dssp             ----------ECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred             ----------cCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCe
Confidence                      3444556667777777777777777777777777777777777777777777777776 77888888888


Q ss_pred             ceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCC
Q 003065          445 FSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRS  524 (851)
Q Consensus       445 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  524 (851)
                      +++.+|..+..++ |++|++++|.+++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|.+
T Consensus       186 l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~  263 (313)
T 1ogq_A          186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG  263 (313)
T ss_dssp             EEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGG
T ss_pred             eeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChH
Confidence            8777777777776 88888888888777777777788888888888887766555 677777888888888887777777


Q ss_pred             ccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcc
Q 003065          525 LSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQL  564 (851)
Q Consensus       525 ~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l  564 (851)
                      +..+++|+.|+|++|+++|.+|.. ..+ .|+.+++++|+.
T Consensus       264 l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~  303 (313)
T 1ogq_A          264 LTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKC  303 (313)
T ss_dssp             GGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSE
T ss_pred             HhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCC
Confidence            777777888888888887777765 445 666666666663

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.2e-33  Score=307.72  Aligned_cols=135  Identities=19%  Similarity=0.221  Sum_probs=67.5

Q ss_pred             ccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEecc
Q 003065          386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT  465 (851)
Q Consensus       386 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  465 (851)
                      +|++|++++|++++..|..+..+++|+.|++++|++++..+..+..+++|+.|+|++|+++ .+|..+..+++|++|+++
T Consensus       194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~  272 (332)
T 2ft3_A          194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH  272 (332)
T ss_dssp             SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECC
T ss_pred             CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECC
Confidence            4555556666555555555555555555555555555555555555555555555555555 445555555555555555


Q ss_pred             CccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccc--cccCCCccccccCCeEeCCCC
Q 003065          466 NNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS--GNIPRSLSLLSSLNALNLSGN  539 (851)
Q Consensus       466 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N  539 (851)
                      +|++++..+..|.....                  -.....|+.|++++|.++  +..|..|..+++|+.+++++|
T Consensus       273 ~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n  330 (332)
T 2ft3_A          273 TNNITKVGVNDFCPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY  330 (332)
T ss_dssp             SSCCCBCCTTSSSCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred             CCCCCccChhHcccccc------------------ccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence            55555444444433200                  000133445555555544  344445555555555555555

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.6e-33  Score=304.94  Aligned_cols=288  Identities=20%  Similarity=0.286  Sum_probs=170.0

Q ss_pred             cCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccC
Q 003065          219 LGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK  298 (851)
Q Consensus       219 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~  298 (851)
                      ++.+++++|.++ .+|..+.  ++|++|++++|.+++..|..|.++++|++|++++|++++..|..|.++++|++|++++
T Consensus        35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  111 (332)
T 2ft3_A           35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK  111 (332)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred             CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence            444444444444 3333332  3455555555555544455555556666666666665555555566666666666666


Q ss_pred             CccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCcccccc
Q 003065          299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP  378 (851)
Q Consensus       299 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p  378 (851)
                      |+++ .+|..+.  ++|++|++++|++++..+..+..+++|+.|++++|+++..                      +..|
T Consensus       112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~----------------------~~~~  166 (332)
T 2ft3_A          112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS----------------------GFEP  166 (332)
T ss_dssp             SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGG----------------------GSCT
T ss_pred             CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccC----------------------CCCc
Confidence            6655 3343332  5566666666666655555566666666666666666420                      1223


Q ss_pred             ccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCC
Q 003065          379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN  458 (851)
Q Consensus       379 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~  458 (851)
                      ..+..+ +|++|++++|++++ +|..+.  +                        +|+.|++++|++++..|..|..+++
T Consensus       167 ~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~------------------------~L~~L~l~~n~i~~~~~~~l~~l~~  218 (332)
T 2ft3_A          167 GAFDGL-KLNYLRISEAKLTG-IPKDLP--E------------------------TLNELHLDHNKIQAIELEDLLRYSK  218 (332)
T ss_dssp             TSSCSC-CCSCCBCCSSBCSS-CCSSSC--S------------------------SCSCCBCCSSCCCCCCTTSSTTCTT
T ss_pred             ccccCC-ccCEEECcCCCCCc-cCcccc--C------------------------CCCEEECCCCcCCccCHHHhcCCCC
Confidence            444444 66667777766663 443322  3                        4555555555555555555556666


Q ss_pred             CcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccc------cccCC
Q 003065          459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL------LSSLN  532 (851)
Q Consensus       459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~  532 (851)
                      |+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|..++.+++|+.|++++|++++..+..|..      ...|+
T Consensus       219 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~  297 (332)
T 2ft3_A          219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN  297 (332)
T ss_dssp             CSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBS
T ss_pred             CCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccccccccccc
Confidence            666666666666555556666666666666666665 55666666666666666666666555555543      36799


Q ss_pred             eEeCCCCccc--cccCcccccc-cceEEeCcCCc
Q 003065          533 ALNLSGNKLT--GSIPDNLMKL-KLSSIDLSENQ  563 (851)
Q Consensus       533 ~L~Ls~N~l~--g~ip~~l~~l-~L~~l~ls~N~  563 (851)
                      .|++++|+++  +..|..+..+ .|+.+++++|+
T Consensus       298 ~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             EEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ceEeecCcccccccCcccccccchhhhhhccccc
Confidence            9999999998  5677778888 89999999985

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=3.7e-33  Score=303.51  Aligned_cols=131  Identities=21%  Similarity=0.240  Sum_probs=65.8

Q ss_pred             cccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEe
Q 003065          409 PNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHL  488 (851)
Q Consensus       409 ~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  488 (851)
                      ++|++|++++|++++..+..+..+++|+.|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|+|
T Consensus       192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l  270 (330)
T 1xku_A          192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL  270 (330)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred             ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence            34444444444444444444444444555555555555444444555555555555555555 44445555555555555


Q ss_pred             cCCcccCCCCCCccc------ccccceeeccCccccc--ccCCCccccccCCeEeCCCCc
Q 003065          489 EENALTGSIPNEMGD------CARIVDLNLARNSLSG--NIPRSLSLLSSLNALNLSGNK  540 (851)
Q Consensus       489 s~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~  540 (851)
                      ++|++++..+..|..      ...++.|++++|.+..  ..|..|..+.+++.++|++|+
T Consensus       271 ~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          271 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             CCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            555555444444432      2455566666666542  444566666667777776664

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.3e-34  Score=303.88  Aligned_cols=167  Identities=32%  Similarity=0.419  Sum_probs=135.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHH-HHHHHHHHHHcCCCCccccEEEEEEeCC----eeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-VFAAEMEILGKIRHRNILKLYACLLKGG----SSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e  751 (851)
                      +|...+.||+|+||+||+|++  +|+.||||++......+ .++.|+..+.+++|||||++++++.+++    ..|+|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            567788999999999999988  58899999986554322 2334566667889999999999987654    5799999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD-----CSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      ||++|+|.++++..      .++|..+.+++.|+++||+|||+.     +.++||||||||+|||++.++.+||+|||+|
T Consensus        82 y~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            99999999999753      588999999999999999999943     1349999999999999999999999999999


Q ss_pred             cccCCCCCcc--cccccccccccccCC
Q 003065          827 KIAENSPKVS--DYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~--~~~~~~gt~~Y~APE  851 (851)
                      +.........  .....+||+.|||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE  182 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPE  182 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHH
T ss_pred             ccccCCCCceeeecccccccccccCHH
Confidence            8775543221  223457999999998

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.3e-32  Score=299.16  Aligned_cols=287  Identities=21%  Similarity=0.278  Sum_probs=202.3

Q ss_pred             ccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEecc
Q 003065          243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYG  322 (851)
Q Consensus       243 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~  322 (851)
                      ++.++++++.++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|++++..|..|+.+++|++|++++
T Consensus        33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (330)
T 1xku_A           33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK  109 (330)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence            344444444444 2333322  3455555555555544444455555555555555555544455555555555555555


Q ss_pred             CcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCcccc--c
Q 003065          323 NRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSG--K  400 (851)
Q Consensus       323 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~--~  400 (851)
                      |+++ .+|..+.  ++|++|++++|++++..+                        ..|.++++|++|++++|.++.  .
T Consensus       110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~------------------------~~~~~l~~L~~L~l~~n~l~~~~~  162 (330)
T 1xku_A          110 NQLK-ELPEKMP--KTLQELRVHENEITKVRK------------------------SVFNGLNQMIVVELGTNPLKSSGI  162 (330)
T ss_dssp             SCCS-BCCSSCC--TTCCEEECCSSCCCBBCH------------------------HHHTTCTTCCEEECCSSCCCGGGB
T ss_pred             CcCC-ccChhhc--ccccEEECCCCcccccCH------------------------hHhcCCccccEEECCCCcCCccCc
Confidence            5555 2333332  566777777766653222                        234556677777777777753  5


Q ss_pred             cCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccC
Q 003065          401 IPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL  480 (851)
Q Consensus       401 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  480 (851)
                      .+..+..+++|++|++++|+++..+...+   ++|+.|++++|++++..|..|..+++|++|+|++|.+++..+..+..+
T Consensus       163 ~~~~~~~l~~L~~L~l~~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  239 (330)
T 1xku_A          163 ENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT  239 (330)
T ss_dssp             CTTGGGGCTTCCEEECCSSCCCSCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred             ChhhccCCCCcCEEECCCCccccCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCC
Confidence            66777788888888888888876544332   789999999999999989999999999999999999998888899999


Q ss_pred             CcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCcccc------ccCCeEeCCCCcccc--ccCcccccc
Q 003065          481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL------SSLNALNLSGNKLTG--SIPDNLMKL  552 (851)
Q Consensus       481 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~g--~ip~~l~~l  552 (851)
                      ++|+.|+|++|+++ .+|..+..+++|+.|++++|+|++..+..|...      ..|+.|++++|++..  ..|..+..+
T Consensus       240 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~  318 (330)
T 1xku_A          240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV  318 (330)
T ss_dssp             TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred             CCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccc
Confidence            99999999999998 889999999999999999999998777777543      789999999999973  456677777


Q ss_pred             -cceEEeCcCCc
Q 003065          553 -KLSSIDLSENQ  563 (851)
Q Consensus       553 -~L~~l~ls~N~  563 (851)
                       .++.+++++|+
T Consensus       319 ~~l~~l~L~~N~  330 (330)
T 1xku_A          319 YVRAAVQLGNYK  330 (330)
T ss_dssp             CCGGGEEC----
T ss_pred             cceeEEEecccC
Confidence             89999999985

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=3e-37  Score=352.27  Aligned_cols=86  Identities=28%  Similarity=0.299  Sum_probs=42.0

Q ss_pred             CCcEEeccCccccCC----CccccccCCcccEEEecCCcccCCCCCCccc-----ccccceeeccCccccc----ccCCC
Q 003065          458 NLERLILTNNNFSGK----IPSALGALRQLSSLHLEENALTGSIPNEMGD-----CARIVDLNLARNSLSG----NIPRS  524 (851)
Q Consensus       458 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~  524 (851)
                      +|++|++++|.+++.    ++..+..+++|+.|+|++|++++..+..+..     .++|+.|+|++|++++    .+|..
T Consensus       314 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~  393 (461)
T 1z7x_W          314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT  393 (461)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             cceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHH
Confidence            444444444444432    2333444455555555555544333332222     3455555555555554    45555


Q ss_pred             ccccccCCeEeCCCCcccc
Q 003065          525 LSLLSSLNALNLSGNKLTG  543 (851)
Q Consensus       525 ~~~l~~L~~L~Ls~N~l~g  543 (851)
                      +..+++|+.|+|++|++++
T Consensus       394 l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          394 LLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             HHHCCCCCEEECCSSSCCH
T ss_pred             HHhCCCccEEECCCCCCCH
Confidence            5555556666666665553

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=4.6e-37  Score=350.69  Aligned_cols=386  Identities=16%  Similarity=0.142  Sum_probs=276.6

Q ss_pred             CCCCeEeccCcccCCCCccc-ccCccccceeecccccCCCC---CCcccccCCCCCCeEecccccccccCCcccc-ccc-
Q 003065          144 KNLEIFDLSINYFTGRFPRW-VVNLTQLVSLSIGDNVYDEA---EIPESIGNLKNLTYLFLAHCNLRGRIPESIS-ELR-  217 (851)
Q Consensus       144 ~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~---~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~-  217 (851)
                      ++|++|||++|.++...... +..+++|++|++++|.+...   .++..+..+++|++|+|++|+++...+..+. .++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            56888999999887544333 67888999999999888632   3466778888999999999988765444433 344 


Q ss_pred             ---ccCccccccccccc----cccccccCCCcccEEEeeccCccCcCCcCc-----CCCCcccEEecccccccCCC----
Q 003065          218 ---ELGTLDICRNKISG----EFPRSIRKLQKLWKIELYANNLTGELPAEL-----GNLTLLQEFDISSNQMYGKL----  281 (851)
Q Consensus       218 ---~L~~L~L~~N~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~----  281 (851)
                         +|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+     ...++|++|++++|++++..    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               68889999988874    457788888888899998888875444332     23567888888888887643    


Q ss_pred             CccccCcCCccEEEccCCccCCCCCCCCC-----CcccccEEEeccCcCCCC----CCCccCCCCccceeeccCCccccc
Q 003065          282 PEEIGNLKNLTVFQCFKNNFSGEFPSGFG-----DMRKLFAFSIYGNRFSGP----FPENLGRYTALTDVDISENQFSGS  352 (851)
Q Consensus       282 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~  352 (851)
                      +..+..+++|+.|++++|.+++..+..+.     .+++|++|++++|.+++.    ++..+..+++|++|++++|++++.
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~  242 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  242 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence            45566678888888888887654333332     245788888888888754    466666778888888888877643


Q ss_pred             CchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccc----cCCcccCccccceEEecCCcCCCCCCcc
Q 003065          353 FPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGK----IPDGLWALPNVGMLDFGDNDFTGGISPL  428 (851)
Q Consensus       353 ~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  428 (851)
                      ....++                   +..+..+++|++|++++|++++.    ++..+..+++|++|++++|++++..+..
T Consensus       243 ~~~~l~-------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~  303 (461)
T 1z7x_W          243 GMAELC-------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL  303 (461)
T ss_dssp             HHHHHH-------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred             HHHHHH-------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHH
Confidence            222111                   12233567899999999998864    5777777889999999999887544433


Q ss_pred             ccc-----CCCCCeEecCCCcceee----CCcccccCCCCcEEeccCccccCCCcccccc-----CCcccEEEecCCccc
Q 003065          429 IGL-----STSLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGKIPSALGA-----LRQLSSLHLEENALT  494 (851)
Q Consensus       429 ~~~-----~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~  494 (851)
                      +..     .++|+.|+|++|.+++.    ++..+..+++|++|++++|.+++..+..+..     .+.|+.|+|++|+++
T Consensus       304 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~  383 (461)
T 1z7x_W          304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS  383 (461)
T ss_dssp             HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             HHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence            332     36899999999998865    4666777899999999999988665554443     678999999999998


Q ss_pred             C----CCCCCcccccccceeeccCcccccccCCCcc-----ccccCCeEeCCCCccccccCcc
Q 003065          495 G----SIPNEMGDCARIVDLNLARNSLSGNIPRSLS-----LLSSLNALNLSGNKLTGSIPDN  548 (851)
Q Consensus       495 ~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~g~ip~~  548 (851)
                      +    .+|..+..+++|++|++++|++++.-...+.     ...+|+.|++.++.+....++.
T Consensus       384 ~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~  446 (461)
T 1z7x_W          384 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR  446 (461)
T ss_dssp             HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred             hhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHH
Confidence            6    7788888889999999999988864222221     1235666777766666444443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-33  Score=306.62  Aligned_cols=173  Identities=31%  Similarity=0.393  Sum_probs=146.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC-----CcEEEEEEecccc---cHHHHHHHHHHHHcCCC-CccccEEEEEEe-CCe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGD---GVKVFAAEMEILGKIRH-RNILKLYACLLK-GGS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h-~niv~l~~~~~~-~~~  745 (851)
                      ++|++.+.||+|+||+||+|++...     ++.||||++....   ..+.|.+|++++++++| ||||++++++.. ++.
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            4688999999999999999998654     3579999986543   34678999999999965 899999999866 456


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE  814 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~  814 (851)
                      .|+|||||++|+|.++++.....           ....+++..+..++.|||+||+|||   +++||||||||+|||+++
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCC
Confidence            89999999999999999864321           1345899999999999999999999   789999999999999999


Q ss_pred             CCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       815 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.+||+|||+|+...............||+.|||||
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE  257 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  257 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred             CCCEEECcchhhhhcccCCCceeeccccccccccCHH
Confidence            9999999999999776554444445567999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.98  E-value=1.4e-32  Score=315.36  Aligned_cols=165  Identities=25%  Similarity=0.336  Sum_probs=144.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHH---HHHHHcCCCCccccEEEEEEeCCee
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAE---MEILGKIRHRNILKLYACLLKGGSS  746 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~  746 (851)
                      +++|++.+.||+|+||+||+|+++.+++.||||++.+.     .......+|   +.+++.++|||||+++++|++.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            46799999999999999999999999999999998543     223334444   5666778999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+|||||+||+|.+++.+.     ..+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|
T Consensus       268 ylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEeccccee
Confidence            9999999999999999864     35889999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +......    ..+.+||+.|||||
T Consensus       340 ~~~~~~~----~~t~~GTp~YmAPE  360 (689)
T 3v5w_A          340 CDFSKKK----PHASVGTHGYMAPE  360 (689)
T ss_dssp             EECSSCC----CCSCCSCGGGCCHH
T ss_pred             eecCCCC----CCCccCCcCccCHH
Confidence            8775443    23468999999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.98  E-value=8.3e-33  Score=305.02  Aligned_cols=166  Identities=31%  Similarity=0.428  Sum_probs=142.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe------CCee
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK------GGSS  746 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  746 (851)
                      +|++.+.||+|+||+||+|+++.+++.||||++...    ...+.+.+|+++|++++|||||++++++..      .+..
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            689999999999999999999999999999999654    234568899999999999999999998764      3578


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+|||||+ |+|.+++..     ...+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|
T Consensus       135 ~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeeccee
Confidence            99999995 689988864     346899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCC--cccccccccccccccCC
Q 003065          827 KIAENSPK--VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~--~~~~~~~~gt~~Y~APE  851 (851)
                      +.......  .....+.+||+.|||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APE  232 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPE  232 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHH
T ss_pred             eecccCccccccccccceeChHhcCHH
Confidence            87644321  22334578999999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.98  E-value=1.7e-32  Score=299.42  Aligned_cols=165  Identities=24%  Similarity=0.362  Sum_probs=142.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEc---CCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +.|++.+.||+|+||+||+|+++   .+++.||||++.+.....++.+|+++++.+ +|||||+++++|.+++..|+|||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            47999999999999999999875   457789999998877778889999999998 69999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-CceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~  830 (851)
                      |+++|+|.+++.        .+++..+..++.|++.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus       101 ~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A          101 YLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             CCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            999999999873        3788899999999999999999   7899999999999999876 799999999998654


Q ss_pred             CCCC--------------------------cccccccccccccccCC
Q 003065          831 NSPK--------------------------VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~--------------------------~~~~~~~~gt~~Y~APE  851 (851)
                      ....                          .......+||++|||||
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE  216 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE  216 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            3321                          01123467999999998

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=2.2e-32  Score=300.33  Aligned_cols=281  Identities=20%  Similarity=0.286  Sum_probs=237.4

Q ss_pred             CCCcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCC
Q 003065           58 DSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV  137 (851)
Q Consensus        58 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~  137 (851)
                      .++|.|.|+ |+-          ++++++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|+|++|.+++.+
T Consensus        27 ~~~C~~~~~-c~~----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~   92 (353)
T 2z80_A           27 SLSCDRNGI-CKG----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE   92 (353)
T ss_dssp             CCEECTTSE-EEC----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred             CCCCCCCeE-eeC----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence            567999998 764          345555 5676655  58999999999999766668999999999999999999987


Q ss_pred             CC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcc--cccCCCCCCeEecccc-cccccCCccc
Q 003065          138 PD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE--SIGNLKNLTYLFLAHC-NLRGRIPESI  213 (851)
Q Consensus       138 ~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~--~~~~l~~L~~L~L~~n-~l~~~~p~~~  213 (851)
                      +. ++++++|++|||++|.+++..+..|.++++|++|++++|.+.  .+|.  .+.++++|++|++++| .+.+..+..|
T Consensus        93 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~  170 (353)
T 2z80_A           93 EDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK--TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF  170 (353)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS--SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTT
T ss_pred             HhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc--ccCchhhhccCCCCcEEECCCCccccccCHHHc
Confidence            76 999999999999999999776777999999999999999997  5665  7899999999999999 5777778889


Q ss_pred             ccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCcccc---CcCC
Q 003065          214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG---NLKN  290 (851)
Q Consensus       214 ~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~  290 (851)
                      .++++|++|++++|++++..|..|..+++|++|++++|+++...+..+..+++|++|++++|++++..+..+.   ..+.
T Consensus       171 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~  250 (353)
T 2z80_A          171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSL  250 (353)
T ss_dssp             TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCC
T ss_pred             cCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccch
Confidence            9999999999999999998899999999999999999999754444455689999999999999976665543   3567


Q ss_pred             ccEEEccCCccCC----CCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCc
Q 003065          291 LTVFQCFKNNFSG----EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFP  354 (851)
Q Consensus       291 L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p  354 (851)
                      ++.++++++.+++    .+|..+..+++|+.|++++|+++...+..|..+++|++|+|++|++.+..|
T Consensus       251 l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          251 IKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             CCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             hhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            8889999998875    356678889999999999999995444446899999999999999986544

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=3.9e-33  Score=302.33  Aligned_cols=289  Identities=17%  Similarity=0.228  Sum_probs=208.2

Q ss_pred             HHhcCCCCCCCCCCCCCC-CCCcccceeEecCCCC--ceEEEecccCCcceecCccc--cCCccCcEEeCCCCcccCccC
Q 003065           40 KSKLKDPHGVLDSWKESA-DSPCGFSGITCDSVTG--RVTEISFDNKSLSGEISSSI--SALQSLTVLSLPFNVLSGKLP  114 (851)
Q Consensus        40 k~~~~~~~~~l~sW~~~~-~~~c~w~gv~c~~~~~--~v~~l~l~~~~l~g~i~~~l--~~l~~L~~L~L~~n~l~~~~p  114 (851)
                      |.++.|+..++..|+..- .|||.|.++.|+....  .+.  ...+.... .++..+  ...+.+++|+|++|.++ .+|
T Consensus        22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~--~~~g~~~~-~~~~~l~~~~~~~l~~L~L~~n~l~-~lp   97 (328)
T 4fcg_A           22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE--TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFP   97 (328)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC--CSHHHHHH-HHHHHHHHHTSTTCCEEEEESSCCS-SCC
T ss_pred             cccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc--ccCCcchh-hhHHHHhcccccceeEEEccCCCch-hcC
Confidence            455566667888897632 5789999998843221  111  11111110 111111  12456677777777776 566


Q ss_pred             cccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCC
Q 003065          115 LELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKN  194 (851)
Q Consensus       115 ~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~  194 (851)
                      ..++++++|++|+|++|.++..+..++.+++|++|+|++|.++ .+|..+.++++|++|++++|.+. +.+|..++.   
T Consensus        98 ~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~-~~~p~~~~~---  172 (328)
T 4fcg_A           98 DQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL-TELPEPLAS---  172 (328)
T ss_dssp             SCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTC-CCCCSCSEE---
T ss_pred             hhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCc-cccChhHhh---
Confidence            6666666666666666666633333666666666666666655 44444545555555555444433 333333221   


Q ss_pred             CCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEeccc
Q 003065          195 LTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISS  274 (851)
Q Consensus       195 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  274 (851)
                         .         ..+..|.++++|++|+|++|+++ .+|..+.++++|++|+|++|++++ +|..+..+++|++|+|++
T Consensus       173 ---~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~  238 (328)
T 4fcg_A          173 ---T---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRG  238 (328)
T ss_dssp             ---E---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTT
T ss_pred             ---c---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcC
Confidence               0         11223456999999999999999 889999999999999999999994 677899999999999999


Q ss_pred             ccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccc
Q 003065          275 NQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSG  351 (851)
Q Consensus       275 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  351 (851)
                      |.+.+.+|..+.++++|++|++++|++.+.+|..+..+++|++|++++|++.+.+|..++.+++|+.+++..|.+..
T Consensus       239 n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~  315 (328)
T 4fcg_A          239 CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ  315 (328)
T ss_dssp             CTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred             CcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999887763

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=1.7e-34  Score=340.33  Aligned_cols=377  Identities=14%  Similarity=0.114  Sum_probs=209.2

Q ss_pred             CCCCCCeEeccCcccCCCCcccccCc--cccceeeccccc-CCCCCCcccccCCCCCCeEeccccccccc----CCcccc
Q 003065          142 ALKNLEIFDLSINYFTGRFPRWVVNL--TQLVSLSIGDNV-YDEAEIPESIGNLKNLTYLFLAHCNLRGR----IPESIS  214 (851)
Q Consensus       142 ~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~-l~~~~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~  214 (851)
                      .+++|++|+|++|.+++..+.++...  .+|++|+|++|. +....++....++++|++|+|++|.+++.    ++..+.
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            45556666666665555445555442  336666666554 22112222334566666666666666544    222334


Q ss_pred             cccccCcccccccccc----ccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEeccccccc---CCCCccccC
Q 003065          215 ELRELGTLDICRNKIS----GEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY---GKLPEEIGN  287 (851)
Q Consensus       215 ~l~~L~~L~L~~N~i~----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~l~~  287 (851)
                      .+++|++|++++|.++    +.++..+.++++|++|++++|.+.+ +|..+..+++|++|+++.+...   +..+..+..
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~  268 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF  268 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence            5566666666666665    2333444556666666666666663 4555666666666666643222   223344555


Q ss_pred             cCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCC-CccCCCCccceeeccCCcccccCchhhhhhcchHHH
Q 003065          288 LKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP-ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL  366 (851)
Q Consensus       288 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l  366 (851)
                      +++|+.|+++++.. +.+|..+..+++|++|++++|.+++... ..+..+++|+.|+++ |.+.+.              
T Consensus       269 ~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~--------------  332 (592)
T 3ogk_B          269 PRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDR--------------  332 (592)
T ss_dssp             CTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHH--------------
T ss_pred             cccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHH--------------
Confidence            66666666665422 2445555566666666666666543222 234566667777776 333321              


Q ss_pred             HhccCCccccccccccCccccceeccc-----------cCccccccC-CcccCccccceEEecCCcCCCCCCccccc-CC
Q 003065          367 LALSNNFSGEVPNSYADCKTIQRLRIS-----------DNHLSGKIP-DGLWALPNVGMLDFGDNDFTGGISPLIGL-ST  433 (851)
Q Consensus       367 ~l~~n~~~~~~p~~~~~l~~L~~L~Ls-----------~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~  433 (851)
                               .++..+..+++|++|+|+           .|.+++... .....+++|++|+++.|++++.....+.. ++
T Consensus       333 ---------~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~  403 (592)
T 3ogk_B          333 ---------GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLK  403 (592)
T ss_dssp             ---------HHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCC
T ss_pred             ---------HHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCC
Confidence                     111222344556666666           245543322 22234566666666666666544444443 66


Q ss_pred             CCCeEecC----CCcceee-----CCcccccCCCCcEEeccCc--cccCCCccccc-cCCcccEEEecCCcccC-CCCCC
Q 003065          434 SLSQLVLQ----NNRFSGE-----LPSELGRLTNLERLILTNN--NFSGKIPSALG-ALRQLSSLHLEENALTG-SIPNE  500 (851)
Q Consensus       434 ~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~  500 (851)
                      +|+.|+++    .|.+++.     ++..+.++++|+.|++++|  .+++..+..+. .+++|+.|+|++|++++ .++..
T Consensus       404 ~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~  483 (592)
T 3ogk_B          404 NLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF  483 (592)
T ss_dssp             SCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHH
T ss_pred             CCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHH
Confidence            66666664    5566542     3334556777777777643  35544444443 36677777777777765 34444


Q ss_pred             cccccccceeeccCcccccc-cCCCccccccCCeEeCCCCccccc
Q 003065          501 MGDCARIVDLNLARNSLSGN-IPRSLSLLSSLNALNLSGNKLTGS  544 (851)
Q Consensus       501 ~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~  544 (851)
                      +..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++.
T Consensus       484 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          484 SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             HhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            56677777777777777654 333345677788888888887754

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=2e-31  Score=286.55  Aligned_cols=286  Identities=20%  Similarity=0.243  Sum_probs=155.6

Q ss_pred             CCcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCC--
Q 003065           59 SPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGS--  136 (851)
Q Consensus        59 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~--  136 (851)
                      +.|.|.+|+|+...            ++ .+|..+.  ++|++|+|++|+++...+..|+++++|++|+|++|.++..  
T Consensus         5 C~C~~~~l~c~~~~------------l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~   69 (306)
T 2z66_A            5 CSCSGTEIRCNSKG------------LT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC   69 (306)
T ss_dssp             CEEETTEEECCSSC------------CS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE
T ss_pred             CeeCCCEEEcCCCC------------cc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC
Confidence            34899999997532            22 3444332  5677777777777743333467777777777777776543  


Q ss_pred             -CCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCccccc
Q 003065          137 -VPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISE  215 (851)
Q Consensus       137 -~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~  215 (851)
                       ++.+..+++|++|+|++|.+. .+|..+..+++|++|++++|.+.....+..+..+++|++|++++|++.+..+..+..
T Consensus        70 ~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  148 (306)
T 2z66_A           70 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG  148 (306)
T ss_dssp             EEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTT
T ss_pred             cccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhccc
Confidence             122445666666666666665 344455555566666666555542111134555555555555555555555555555


Q ss_pred             ccccCccccccccccc-cccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEE
Q 003065          216 LRELGTLDICRNKISG-EFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVF  294 (851)
Q Consensus       216 l~~L~~L~L~~N~i~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  294 (851)
                      +++|++|++++|++++ ..|..+..+++|++|++++|++++..|..|..+++|++|+|++|+                  
T Consensus       149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~------------------  210 (306)
T 2z66_A          149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN------------------  210 (306)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC------------------
T ss_pred             CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCc------------------
Confidence            5555555555555543 344445555555555555555554444444444445555555444                  


Q ss_pred             EccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCC-CccceeeccCCcccccCc--hhhhhhcchHHHHhccC
Q 003065          295 QCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRY-TALTDVDISENQFSGSFP--KYLCEKRKLLNLLALSN  371 (851)
Q Consensus       295 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p--~~~~~~~~L~~l~l~~n  371 (851)
                            +++..+..+..+++|+.|++++|++++..|..+..+ ++|+.|+|++|++++.-+  .....+.....+....+
T Consensus       211 ------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~  284 (306)
T 2z66_A          211 ------FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVE  284 (306)
T ss_dssp             ------CSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGG
T ss_pred             ------cCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhcccc
Confidence                  444333344455555555555555555555555555 366666666666654321  11112223334444556


Q ss_pred             CccccccccccCc
Q 003065          372 NFSGEVPNSYADC  384 (851)
Q Consensus       372 ~~~~~~p~~~~~l  384 (851)
                      .+....|..+.+.
T Consensus       285 ~~~C~~p~~~~g~  297 (306)
T 2z66_A          285 RMECATPSDKQGM  297 (306)
T ss_dssp             GCBEEESGGGTTC
T ss_pred             ccccCCchhhCCc
Confidence            6666666666554

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=2e-34  Score=339.69  Aligned_cols=450  Identities=12%  Similarity=0.046  Sum_probs=320.9

Q ss_pred             CcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcc---cCccCcccc------------cCCCCc
Q 003065           60 PCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVL---SGKLPLELS------------NCSNLK  124 (851)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~L~  124 (851)
                      |++|.++.+..  .+.  +.+. +.+...++..+..+++|++|+|+++..   .+.+|..++            .+++|+
T Consensus        41 ck~W~~~~~~~--~~~--l~~~-~~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~  115 (592)
T 3ogk_B           41 CRRWFKIDSET--REH--VTMA-LCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK  115 (592)
T ss_dssp             CHHHHHHHHHH--CCE--EEES-CGGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             hHHHHHhhhcc--ccE--EEEe-eccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence            45899986532  122  2222 223333445667788999999987532   234554433            789999


Q ss_pred             eEecccCcccCCCCC-CCC-C-CCCCeEeccCcc-cCC-CCcccccCccccceeecccccCCCCC---CcccccCCCCCC
Q 003065          125 VLNVTGNAMVGSVPD-LSA-L-KNLEIFDLSINY-FTG-RFPRWVVNLTQLVSLSIGDNVYDEAE---IPESIGNLKNLT  196 (851)
Q Consensus       125 ~L~Ls~n~l~~~~~~-l~~-l-~~L~~L~Ls~N~-l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~---~p~~~~~l~~L~  196 (851)
                      +|+|++|.+++..+. +.. + ++|++|+|++|. ++. .++....++++|++|+|++|.+....   ++..+.++++|+
T Consensus       116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~  195 (592)
T 3ogk_B          116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE  195 (592)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred             eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence            999999988765443 554 3 349999999987 221 12223357899999999999986322   344567789999


Q ss_pred             eEeccccccc----ccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCcc---CcCCcCcCCCCcccE
Q 003065          197 YLFLAHCNLR----GRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT---GELPAELGNLTLLQE  269 (851)
Q Consensus       197 ~L~L~~n~l~----~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~  269 (851)
                      +|++++|.++    +.++..+.++++|++|++++|.+.+ +|..+.++++|++|+++.....   +..+..+..+++|+.
T Consensus       196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~  274 (592)
T 3ogk_B          196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR  274 (592)
T ss_dssp             EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCE
T ss_pred             EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccc
Confidence            9999999997    3445556788999999999999985 7788999999999999864433   344567788999999


Q ss_pred             EecccccccCCCCccccCcCCccEEEccCCccCCCCC-CCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccC--
Q 003065          270 FDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP-SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE--  346 (851)
Q Consensus       270 L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~--  346 (851)
                      |+++++... .+|..+..+++|++|++++|.+++... ..+..+++|+.|+++++...+.++..+..+++|++|++++  
T Consensus       275 L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~  353 (592)
T 3ogk_B          275 LGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGA  353 (592)
T ss_dssp             EEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCC
T ss_pred             cCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCc
Confidence            999987543 678888999999999999999765433 2357889999999994333333344446788999999993  


Q ss_pred             ---------CcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccC-ccccceEEe
Q 003065          347 ---------NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDF  416 (851)
Q Consensus       347 ---------N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L  416 (851)
                               |.+++...                       +.....+++|++|+++.|.+++..+..+.. +++|+.|++
T Consensus       354 ~~~~~~~~~~~~~~~~~-----------------------~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l  410 (592)
T 3ogk_B          354 DEQGMEDEEGLVSQRGL-----------------------IALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRL  410 (592)
T ss_dssp             CSSTTSSTTCCCCHHHH-----------------------HHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEE
T ss_pred             cccccccccCccCHHHH-----------------------HHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEE
Confidence                     55553211                       111334678888888888888777766665 788888888


Q ss_pred             c----CCcCCCC-----CCcccccCCCCCeEecCCCc--ceeeCCccccc-CCCCcEEeccCccccC-CCccccccCCcc
Q 003065          417 G----DNDFTGG-----ISPLIGLSTSLSQLVLQNNR--FSGELPSELGR-LTNLERLILTNNNFSG-KIPSALGALRQL  483 (851)
Q Consensus       417 s----~N~l~~~-----~~~~~~~~~~L~~L~Ls~N~--l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L  483 (851)
                      +    .|++++.     ++..+..+++|+.|+|++|.  +++..+..+.. +++|++|++++|.+++ .++..+.++++|
T Consensus       411 ~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L  490 (592)
T 3ogk_B          411 VLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNL  490 (592)
T ss_dssp             EECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTC
T ss_pred             eecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCccc
Confidence            6    6777764     33346668889999997543  66555555544 7889999999999875 345566788899


Q ss_pred             cEEEecCCcccCC-CCCCcccccccceeeccCcccccccCCCc-cccccCCeEeCCCC
Q 003065          484 SSLHLEENALTGS-IPNEMGDCARIVDLNLARNSLSGNIPRSL-SLLSSLNALNLSGN  539 (851)
Q Consensus       484 ~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N  539 (851)
                      +.|+|++|.+++. ++..+..+++|+.|+|++|++++.-...+ ..++.+....+..+
T Consensus       491 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          491 QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             CEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             CeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            9999999998654 44445678899999999999886543333 34566665555544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=2.7e-31  Score=307.64  Aligned_cols=167  Identities=20%  Similarity=0.366  Sum_probs=148.8

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +++|++.+.||+|+||.||+|+++.+++.||||++....  ..+.+.+|+++|+.++|||||+++++|.+++..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999999999999999986553  456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC--CceEEeeecCccccC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED--YEPKIADFGVAKIAE  830 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~  830 (851)
                      |+||+|.+++...    ...+++..+..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+...
T Consensus       236 ~~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          236 MSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             CCCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             cCCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999988642    346889999999999999999999   7899999999999999854  899999999999876


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   ....+||+.|||||
T Consensus       309 ~~~~---~~~~~GT~~y~APE  326 (573)
T 3uto_A          309 PKQS---VKVTTGTAEFAAPE  326 (573)
T ss_dssp             TTSE---EEEECSSGGGCCHH
T ss_pred             CCCc---eeeeEECccccCHH
Confidence            5432   23468999999998

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=1.3e-30  Score=280.37  Aligned_cols=283  Identities=18%  Similarity=0.175  Sum_probs=207.2

Q ss_pred             cEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccc
Q 003065          100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN  178 (851)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  178 (851)
                      +.++.+++.++ .+|..+.  ++|++|+|++|+++..++. +.++++|++|+|++|.++...                  
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~------------------   68 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG------------------   68 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE------------------
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc------------------
Confidence            35666777766 4565443  5677777777777655554 566666777777666665211                  


Q ss_pred             cCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccccccccccc-ccccCCCcccEEEeeccCccCcC
Q 003065          179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP-RSIRKLQKLWKIELYANNLTGEL  257 (851)
Q Consensus       179 ~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p-~~~~~l~~L~~L~L~~N~l~~~~  257 (851)
                           ..|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..
T Consensus        69 -----~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~  142 (306)
T 2z66_A           69 -----CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF  142 (306)
T ss_dssp             -----EEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECS
T ss_pred             -----CcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccc
Confidence                 11233444555555555555555 344455556666666666666654433 45677777777777777777777


Q ss_pred             CcCcCCCCcccEEecccccccC-CCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCC
Q 003065          258 PAELGNLTLLQEFDISSNQMYG-KLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRY  336 (851)
Q Consensus       258 p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l  336 (851)
                      +..+..+++|++|++++|++++ .+|..+..+++|++|++++|++++..|..|..+++|+.|++++|++++..+..+..+
T Consensus       143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  222 (306)
T 2z66_A          143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL  222 (306)
T ss_dssp             TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC
T ss_pred             hhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc
Confidence            7778888888888888888876 577888888999999999999988888899999999999999999998888889999


Q ss_pred             CccceeeccCCcccccCchhhhhhc-chHHHHhccCCcccccc--ccccCccccceeccccCccccccCCcccCcc
Q 003065          337 TALTDVDISENQFSGSFPKYLCEKR-KLLNLLALSNNFSGEVP--NSYADCKTIQRLRISDNHLSGKIPDGLWALP  409 (851)
Q Consensus       337 ~~L~~L~Ls~N~l~~~~p~~~~~~~-~L~~l~l~~n~~~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  409 (851)
                      ++|+.|++++|++++..|..+..++ +|+++++.+|.+.+..+  .....+...+.+....+.+....|..+.+.+
T Consensus       223 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~~  298 (306)
T 2z66_A          223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP  298 (306)
T ss_dssp             TTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTTCB
T ss_pred             ccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCCce
Confidence            9999999999999999999998884 89999999999987643  1123345566777888888888888876644

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=3.4e-30  Score=282.85  Aligned_cols=178  Identities=15%  Similarity=0.117  Sum_probs=88.6

Q ss_pred             cccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEE
Q 003065          168 TQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIE  247 (851)
Q Consensus       168 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~  247 (851)
                      +.....++++|.++  .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|++++..|..|.++++|++|+
T Consensus        31 ~~~~~c~~~~~~l~--~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (353)
T 2z80_A           31 DRNGICKGSSGSLN--SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD  106 (353)
T ss_dssp             CTTSEEECCSTTCS--SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCeEeeCCCCCcc--ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence            33344555555554  4554443  3555555555555544444555555555555555555554455555555555555


Q ss_pred             eeccCccCcCCcCcCCCCcccEEecccccccCCCC-ccccCcCCccEEEccCCc-cCCCCCCCCCCcccccEEEeccCcC
Q 003065          248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKLP-EEIGNLKNLTVFQCFKNN-FSGEFPSGFGDMRKLFAFSIYGNRF  325 (851)
Q Consensus       248 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l  325 (851)
                      |++|++++..+..|.++++|++|++++|++++..+ ..+.++++|++|++++|+ +.+..+..|.++++|++|++++|++
T Consensus       107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l  186 (353)
T 2z80_A          107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL  186 (353)
T ss_dssp             CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence            55555553333335555555555555555553222 244455555555555552 3333334444444555555554444


Q ss_pred             CCCCCCccCCCCccceeeccCCcc
Q 003065          326 SGPFPENLGRYTALTDVDISENQF  349 (851)
Q Consensus       326 ~~~~p~~l~~l~~L~~L~Ls~N~l  349 (851)
                      ++..|..+..+++|++|++++|++
T Consensus       187 ~~~~~~~l~~l~~L~~L~l~~n~l  210 (353)
T 2z80_A          187 QSYEPKSLKSIQNVSHLILHMKQH  210 (353)
T ss_dssp             CEECTTTTTTCSEEEEEEEECSCS
T ss_pred             CccCHHHHhccccCCeecCCCCcc
Confidence            444444444444444444444444

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=2.6e-31  Score=286.32  Aligned_cols=271  Identities=18%  Similarity=0.223  Sum_probs=134.4

Q ss_pred             CCCCCCCCCCCcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcc-cCccCcccc-------cCC
Q 003065           50 LDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVL-SGKLPLELS-------NCS  121 (851)
Q Consensus        50 l~sW~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~  121 (851)
                      ..+|... ..|+.|..+.......+++.++++++.+  .+|..+...  |++|+|++|.+ .+.+|..+.       +++
T Consensus        21 ~~~~~~~-~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~   95 (312)
T 1wwl_A           21 KPDWSSA-FNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGIS   95 (312)
T ss_dssp             SCCGGGG-GGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTS
T ss_pred             ccchHHH-hhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcC
Confidence            3455543 3444554443222222344555555555  445444433  55555555555 334444443       455


Q ss_pred             CCceEecccCcccCCCCC-C--CCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeE
Q 003065          122 NLKVLNVTGNAMVGSVPD-L--SALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL  198 (851)
Q Consensus       122 ~L~~L~Ls~n~l~~~~~~-l--~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L  198 (851)
                      +|++|+|++|++++..|. +  ..+++|++|+|++|.+++. |..+..+..                    ..+++|++|
T Consensus        96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~--------------------~~~~~L~~L  154 (312)
T 1wwl_A           96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQ--------------------WLKPGLKVL  154 (312)
T ss_dssp             CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHT--------------------TCCTTCCEE
T ss_pred             CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHH--------------------hhcCCCcEE
Confidence            555555555555544443 2  4555555555555555544 444444400                    000455555


Q ss_pred             ecccccccccCCcccccccccCcccccccccccc--ccccc--cCCCcccEEEeeccCccC--cCC-cCcCCCCcccEEe
Q 003065          199 FLAHCNLRGRIPESISELRELGTLDICRNKISGE--FPRSI--RKLQKLWKIELYANNLTG--ELP-AELGNLTLLQEFD  271 (851)
Q Consensus       199 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~--~p~~~--~~l~~L~~L~L~~N~l~~--~~p-~~~~~l~~L~~L~  271 (851)
                      +|++|++++..|..|+++++|++|+|++|++.+.  .|..+  ..+++|++|+|++|++++  .++ ..+.++++|++|+
T Consensus       155 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~  234 (312)
T 1wwl_A          155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLD  234 (312)
T ss_dssp             EEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEE
T ss_pred             EeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEE
Confidence            5555555544444555555555555555554433  12222  455555555555555542  111 2233455555555


Q ss_pred             cccccccCCCC-ccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCccc
Q 003065          272 ISSNQMYGKLP-EEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS  350 (851)
Q Consensus       272 Ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  350 (851)
                      +++|++++..| ..+..+++|++|++++|+++ .+|..+.  ++|++|++++|++++. |. +..+++|++|++++|+++
T Consensus       235 Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             CTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             CCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            55555555443 23444555666666666655 4455444  5666666666666644 44 566666666666666665


Q ss_pred             c
Q 003065          351 G  351 (851)
Q Consensus       351 ~  351 (851)
                      +
T Consensus       310 ~  310 (312)
T 1wwl_A          310 D  310 (312)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=6.1e-30  Score=298.15  Aligned_cols=293  Identities=22%  Similarity=0.305  Sum_probs=155.0

Q ss_pred             CCCCCCCCCCCCCCcccceeEec------CCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccC
Q 003065           47 HGVLDSWKESADSPCGFSGITCD------SVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNC  120 (851)
Q Consensus        47 ~~~l~sW~~~~~~~c~w~gv~c~------~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l  120 (851)
                      ...+++|... .+||.|.|..|.      .....++.|++++++|+ .+|..+.  ++|++|+|++|.++ .+|.   .+
T Consensus         9 ~~~w~~W~~~-~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l   80 (622)
T 3g06_A            9 DAVWSAWRRA-APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LP   80 (622)
T ss_dssp             -CHHHHHHHT-CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CC
T ss_pred             HHHHHHHHhc-CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cC
Confidence            4456778776 678999775321      11123566777777766 5666554  56666666666666 3554   45


Q ss_pred             CCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEec
Q 003065          121 SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL  200 (851)
Q Consensus       121 ~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L  200 (851)
                      ++|++|+|++|++++.++   .+++|++|+|++|.+++. |.   .+++|++|++++|+++  .+|..   +++|++|+|
T Consensus        81 ~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~--~lp~~---l~~L~~L~L  148 (622)
T 3g06_A           81 PELRTLEVSGNQLTSLPV---LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLT--SLPVL---PPGLQELSV  148 (622)
T ss_dssp             TTCCEEEECSCCCSCCCC---CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCS--CCCCC---CTTCCEEEC
T ss_pred             CCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCC--cCCCC---CCCCCEEEC
Confidence            666666666666665433   456666666666666532 22   3455555555555554  34432   245555555


Q ss_pred             ccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCC
Q 003065          201 AHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK  280 (851)
Q Consensus       201 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  280 (851)
                      ++|++++ +|..                           +++|+.|++++|.+++ +|   ..+++|+.|++++|++++ 
T Consensus       149 s~N~l~~-l~~~---------------------------~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-  195 (622)
T 3g06_A          149 SDNQLAS-LPAL---------------------------PSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-  195 (622)
T ss_dssp             CSSCCSC-CCCC---------------------------CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-
T ss_pred             cCCcCCC-cCCc---------------------------cCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-
Confidence            5555542 2221                           2344444455554442 33   223445555555555542 


Q ss_pred             CCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhh
Q 003065          281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK  360 (851)
Q Consensus       281 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~  360 (851)
                      +|..   +++|+.|++++|.++ .+|..   +++|+.|++++|++++ +|   ..+++|+.|+|++|+|+ .+|      
T Consensus       196 l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp------  257 (622)
T 3g06_A          196 LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLP------  257 (622)
T ss_dssp             CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCC------
T ss_pred             CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCC------
Confidence            2221   244555555555555 23322   2455555555555553 33   23455666666666655 122      


Q ss_pred             cchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccC
Q 003065          361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS  432 (851)
Q Consensus       361 ~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  432 (851)
                                        .   .+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+++.++..+..+
T Consensus       258 ------------------~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          258 ------------------M---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  307 (622)
T ss_dssp             ------------------C---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred             ------------------c---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence                              1   2244566666666665 455556666666666666666665555544433

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=4e-31  Score=284.82  Aligned_cols=249  Identities=17%  Similarity=0.184  Sum_probs=191.5

Q ss_pred             ccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCccc-CCCCccccc-------CccccceeecccccCCCCCCcccc
Q 003065          118 SNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYF-TGRFPRWVV-------NLTQLVSLSIGDNVYDEAEIPESI  189 (851)
Q Consensus       118 ~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l-~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~p~~~  189 (851)
                      +..++|++|++++|.+ ..++.+...  |+.|+|++|.+ ...+|..+.       ++++|++|+|++|.++ +.+|..+
T Consensus        40 ~~~~~L~~l~l~~n~l-~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~  115 (312)
T 1wwl_A           40 GGGRSLEYLLKRVDTE-ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT-GTAPPPL  115 (312)
T ss_dssp             EEEEECTTHHHHCCTT-CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCB-SCCCCCS
T ss_pred             ccCCCceeEeeccccc-ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCccc-chhHHHH
Confidence            3344444444444444 211112222  44455555555 223444433       5666666667666665 4566665


Q ss_pred             --cCCCCCCeEecccccccccCCcccccc-----cccCccccccccccccccccccCCCcccEEEeeccCccCc--CCcC
Q 003065          190 --GNLKNLTYLFLAHCNLRGRIPESISEL-----RELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE--LPAE  260 (851)
Q Consensus       190 --~~l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~  260 (851)
                        ..+++|++|+|++|++++. |..+..+     ++|++|+|++|++++..|..|.++++|++|+|++|++.+.  .|..
T Consensus       116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  194 (312)
T 1wwl_A          116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA  194 (312)
T ss_dssp             SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred             HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence              7888999999999999876 8888887     8999999999999988889999999999999999998765  2334


Q ss_pred             c--CCCCcccEEecccccccCC--CC-ccccCcCCccEEEccCCccCCCCC-CCCCCcccccEEEeccCcCCCCCCCccC
Q 003065          261 L--GNLTLLQEFDISSNQMYGK--LP-EEIGNLKNLTVFQCFKNNFSGEFP-SGFGDMRKLFAFSIYGNRFSGPFPENLG  334 (851)
Q Consensus       261 ~--~~l~~L~~L~Ls~N~l~~~--~p-~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~l~  334 (851)
                      +  ..+++|++|++++|++++.  ++ ..+.++++|++|++++|++++..| ..+..+++|++|++++|+++ .+|..+.
T Consensus       195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~  273 (312)
T 1wwl_A          195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP  273 (312)
T ss_dssp             SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred             HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence            4  8899999999999999832  22 345688999999999999998875 46778999999999999999 7788776


Q ss_pred             CCCccceeeccCCcccccCchhhhhhcchHHHHhccCCcccc
Q 003065          335 RYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGE  376 (851)
Q Consensus       335 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~  376 (851)
                        ++|++|||++|+|++. |. +..+++|+++++.+|.+++.
T Consensus       274 --~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~  311 (312)
T 1wwl_A          274 --AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS  311 (312)
T ss_dssp             --SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred             --CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence              8999999999999976 76 88999999999999998763

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=7.1e-29  Score=281.81  Aligned_cols=255  Identities=19%  Similarity=0.200  Sum_probs=218.3

Q ss_pred             CccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhc
Q 003065          290 NLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL  369 (851)
Q Consensus       290 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~  369 (851)
                      ....++++++.++ .+|..+.  +++++|++++|++++..|..|..+++|+.|+|++|+|++                  
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------------------  113 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ------------------  113 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE------------------
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCC------------------
Confidence            4567888888887 5666553  578888888888887778888888888888888887764                  


Q ss_pred             cCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCC-Ccceee
Q 003065          370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN-NRFSGE  448 (851)
Q Consensus       370 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~-N~l~~~  448 (851)
                            ..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++.++..|..+++|+.|+|++ |.+...
T Consensus       114 ------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i  187 (452)
T 3zyi_A          114 ------IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYI  187 (452)
T ss_dssp             ------ECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred             ------cChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCcccc
Confidence                  3345677888999999999999977777788899999999999999988888899999999999998 556655


Q ss_pred             CCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCcccc
Q 003065          449 LPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL  528 (851)
Q Consensus       449 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  528 (851)
                      .+..|.++++|++|+|++|++++. | .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+
T Consensus       188 ~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  265 (452)
T 3zyi_A          188 SEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL  265 (452)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             ChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCC
Confidence            556799999999999999999864 4 58889999999999999999999999999999999999999999999999999


Q ss_pred             ccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccc
Q 003065          529 SSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL  573 (851)
Q Consensus       529 ~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~  573 (851)
                      ++|+.|+|++|+|++..+..+..+ .|+.|++++|+|.|.+...|.
T Consensus       266 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~~l  311 (452)
T 3zyi_A          266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWL  311 (452)
T ss_dssp             TTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTHHH
T ss_pred             CCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCchHH
Confidence            999999999999997666777777 899999999999999986654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=9.2e-29  Score=279.90  Aligned_cols=255  Identities=22%  Similarity=0.239  Sum_probs=221.7

Q ss_pred             CccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhc
Q 003065          290 NLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL  369 (851)
Q Consensus       290 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~  369 (851)
                      ..+.++++++.++ .+|..+.  ++++.|+|++|++++..+..|..+++|++|+|++|+|++.                 
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i-----------------  103 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTI-----------------  103 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEE-----------------
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCcc-----------------
Confidence            4568888888888 5676554  6788889999998888888888888999999988888743                 


Q ss_pred             cCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCC-Ccceee
Q 003065          370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN-NRFSGE  448 (851)
Q Consensus       370 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~-N~l~~~  448 (851)
                             .+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++ |.+...
T Consensus       104 -------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i  176 (440)
T 3zyj_A          104 -------EIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYI  176 (440)
T ss_dssp             -------CGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred             -------ChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCccee
Confidence                   335677788999999999999977777889999999999999999988888899999999999998 456655


Q ss_pred             CCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCcccc
Q 003065          449 LPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL  528 (851)
Q Consensus       449 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  528 (851)
                      .+..|.++++|++|+|++|.++. +| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+
T Consensus       177 ~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  254 (440)
T 3zyj_A          177 SEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL  254 (440)
T ss_dssp             CTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred             CcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence            56689999999999999999984 45 48899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccc
Q 003065          529 SSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL  573 (851)
Q Consensus       529 ~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~  573 (851)
                      ++|+.|+|++|+|++..+..+..+ .|+.|++++|+|.|++...|.
T Consensus       255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l  300 (440)
T 3zyj_A          255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWL  300 (440)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHH
T ss_pred             CCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHH
Confidence            999999999999997666777888 899999999999999986654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=6.2e-29  Score=264.18  Aligned_cols=223  Identities=21%  Similarity=0.223  Sum_probs=106.4

Q ss_pred             EEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCc
Q 003065          245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR  324 (851)
Q Consensus       245 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~  324 (851)
                      .++.+++.++ .+|..+  .++|++|++++|++++..+..|.++++|++|++++|.+++..|..|..+++|++|++++|+
T Consensus        15 ~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~   91 (285)
T 1ozn_A           15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (285)
T ss_dssp             EEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence            3444444444 333322  2445555555555554444445555555555555555544444444444555555554444


Q ss_pred             -CCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCC
Q 003065          325 -FSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD  403 (851)
Q Consensus       325 -l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  403 (851)
                       ++...|..+..+++|++|++++|++++.                        .|..|..+++|++|++++|++++..+.
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------~~~~~~~l~~L~~L~l~~n~l~~~~~~  147 (285)
T 1ozn_A           92 QLRSVDPATFHGLGRLHTLHLDRCGLQEL------------------------GPGLFRGLAALQYLYLQDNALQALPDD  147 (285)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCCCC------------------------CTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             CccccCHHHhcCCcCCCEEECCCCcCCEE------------------------CHhHhhCCcCCCEEECCCCcccccCHh
Confidence             4433344444444444444444444321                        122233344444555555544433333


Q ss_pred             cccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcc
Q 003065          404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL  483 (851)
Q Consensus       404 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  483 (851)
                      .+..+++|++|++++|++++.++..+..+++|+.|+|++|++++..|..|..+++|+.|++++|++++..+..+..+++|
T Consensus       148 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  227 (285)
T 1ozn_A          148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL  227 (285)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred             HhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCccc
Confidence            44444444444444444444444444444555555555555554545555555555555555555554444445555555


Q ss_pred             cEEEecCCccc
Q 003065          484 SSLHLEENALT  494 (851)
Q Consensus       484 ~~L~Ls~N~l~  494 (851)
                      +.|+|++|.+.
T Consensus       228 ~~L~l~~N~~~  238 (285)
T 1ozn_A          228 QYLRLNDNPWV  238 (285)
T ss_dssp             CEEECCSSCEE
T ss_pred             CEEeccCCCcc
Confidence            55555555554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=1.2e-28  Score=262.05  Aligned_cols=225  Identities=21%  Similarity=0.269  Sum_probs=137.6

Q ss_pred             cEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccc
Q 003065          100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN  178 (851)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  178 (851)
                      ++++.+++.++ .+|..+  .++|++|+|++|.+++.++. +..+++|++|+|++|.+++..|..|.++++|++|++++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            56777777776 456544  35777777777777776654 677777777777777776555555666666666666555


Q ss_pred             c-CCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcC
Q 003065          179 V-YDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL  257 (851)
Q Consensus       179 ~-l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~  257 (851)
                      . +. ...|..+..+++|++|++++|++++..|                        ..|.++++|++|++++|++++..
T Consensus        91 ~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~------------------------~~~~~l~~L~~L~l~~n~l~~~~  145 (285)
T 1ozn_A           91 AQLR-SVDPATFHGLGRLHTLHLDRCGLQELGP------------------------GLFRGLAALQYLYLQDNALQALP  145 (285)
T ss_dssp             TTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCT------------------------TTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCcc-ccCHHHhcCCcCCCEEECCCCcCCEECH------------------------hHhhCCcCCCEEECCCCcccccC
Confidence            4 33 1224445555555555555555554444                        44444555555555555555444


Q ss_pred             CcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCC
Q 003065          258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYT  337 (851)
Q Consensus       258 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~  337 (851)
                      +..|..+++|++|++++|++++..+..|.++++|+.|++++|++++..|..|..+++|+.|++++|++++..+..+..++
T Consensus       146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  225 (285)
T 1ozn_A          146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR  225 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred             HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence            44455555555666666655544444555666666666666666655566666666666777777777665556677777


Q ss_pred             ccceeeccCCccccc
Q 003065          338 ALTDVDISENQFSGS  352 (851)
Q Consensus       338 ~L~~L~Ls~N~l~~~  352 (851)
                      +|+.|++++|++...
T Consensus       226 ~L~~L~l~~N~~~c~  240 (285)
T 1ozn_A          226 ALQYLRLNDNPWVCD  240 (285)
T ss_dssp             TCCEEECCSSCEECS
T ss_pred             ccCEEeccCCCccCC
Confidence            777788888877643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=4.4e-29  Score=270.38  Aligned_cols=166  Identities=29%  Similarity=0.414  Sum_probs=148.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +.+|++.+.||+|+||.||+|++..+++.||||++...    ...+.+.+|+++++.++||||+++++++...+..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35799999999999999999999999999999998654    23456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus        94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            999999999999764     34788999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   ....+||+.|+|||
T Consensus       166 ~~~~---~~~~~gt~~y~aPE  183 (328)
T 3fe3_A          166 VGGK---LDAFCGAPPYAAPE  183 (328)
T ss_dssp             SSCG---GGTTSSSGGGCCHH
T ss_pred             CCCc---cccccCCcceeCcc
Confidence            4432   23467999999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=1e-28  Score=268.17  Aligned_cols=167  Identities=30%  Similarity=0.400  Sum_probs=148.0

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +++|+..+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|+++++.++||||+++++++...+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            35789999999999999999999999999999998643     3466788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++.+.     ..+++..+..++.|++.||+|||   +++|+||||||+||+++.+|.+||+|||+|+..
T Consensus        84 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            9999999999998764     35788899999999999999999   789999999999999999999999999999864


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  .....+||+.|+|||
T Consensus       156 ~~~~~--~~~~~~gt~~y~aPE  175 (337)
T 1o6l_A          156 ISDGA--TMKTFCGTPEYLAPE  175 (337)
T ss_dssp             CCTTC--CBCCCEECGGGCCGG
T ss_pred             ccCCC--cccccccChhhCChh
Confidence            33222  233467999999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=7.2e-29  Score=271.24  Aligned_cols=168  Identities=33%  Similarity=0.460  Sum_probs=143.7

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  747 (851)
                      .+++|++.+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|.++++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            456899999999999999999999999999999998643     3456678999999988 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++|+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       101 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEcccccee
Confidence            999999999999999764     35889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  .....+||+.|+|||
T Consensus       173 ~~~~~~~--~~~~~~gt~~y~aPE  194 (353)
T 3txo_A          173 EGICNGV--TTATFCGTPDYIAPE  194 (353)
T ss_dssp             CSCC-----------CCGGGCCHH
T ss_pred             ecccCCc--cccccCCCcCeEChh
Confidence            6443322  233467999999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.96  E-value=1.8e-28  Score=262.23  Aligned_cols=166  Identities=27%  Similarity=0.387  Sum_probs=148.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ..+|+..+.||+|+||.||+|.+..+++.||||++...  ...+.+.+|+.++++++||||+++++++..++..|+||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            35899999999999999999999999999999998543  4567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++|+|.+++...      .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus        99 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            9999999998753      4788899999999999999999   789999999999999999999999999999876544


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  .....||+.|+|||
T Consensus       170 ~~~--~~~~~gt~~y~aPE  186 (297)
T 3fxz_A          170 QSK--RSTMVGTPYWMAPE  186 (297)
T ss_dssp             TCC--BCCCCSCGGGCCHH
T ss_pred             ccc--cCCccCCcCccChh
Confidence            322  23457999999998

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.96  E-value=5.7e-29  Score=278.92  Aligned_cols=168  Identities=28%  Similarity=0.337  Sum_probs=147.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ++|+..+.||+|+||+||+|+++.+++.||||++.+..     ....+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            57999999999999999999999999999999986532     2234789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++.+.    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       154 Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             CCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence            999999999999753    346889999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..... .....+||+.|||||
T Consensus       227 ~~~~~-~~~~~~GT~~Y~APE  246 (437)
T 4aw2_A          227 EDGTV-QSSVAVGTPDYISPE  246 (437)
T ss_dssp             TTSCE-ECCSCCSCGGGCCHH
T ss_pred             cCCCc-ccccccCCcCeeChH
Confidence            54332 223467999999998

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=3.8e-28  Score=274.83  Aligned_cols=241  Identities=20%  Similarity=0.222  Sum_probs=155.6

Q ss_pred             cccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCC
Q 003065           80 FDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTG  158 (851)
Q Consensus        80 l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~  158 (851)
                      .++.+++ .+|..+.  ++++.|+|++|++++..+..|+++++|++|+|++|.+++..+. |.++++|++|+|++|+++.
T Consensus        50 c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~  126 (440)
T 3zyj_A           50 CVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT  126 (440)
T ss_dssp             CCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSS
T ss_pred             eCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCe
Confidence            3344444 4555444  5667777777777665556666666666666666666554443 5555556666665555554


Q ss_pred             CCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccc-cccccccccc
Q 003065          159 RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRN-KISGEFPRSI  237 (851)
Q Consensus       159 ~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~i~~~~p~~~  237 (851)
                      ..+..                         |..+++|++|+|++|++++..+..|.++++|++|+|++| .++...+..|
T Consensus       127 ~~~~~-------------------------~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~  181 (440)
T 3zyj_A          127 IPNGA-------------------------FVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAF  181 (440)
T ss_dssp             CCTTT-------------------------SCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTT
T ss_pred             eCHhH-------------------------hhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchh
Confidence            33334                         445555555555555555444445555555666666553 3333333456


Q ss_pred             cCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccE
Q 003065          238 RKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFA  317 (851)
Q Consensus       238 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  317 (851)
                      .++++|++|+|++|+++ .+| .+..+++|++|+|++|++++..|..|.++++|+.|++++|++++..+..|.++++|+.
T Consensus       182 ~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  259 (440)
T 3zyj_A          182 EGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE  259 (440)
T ss_dssp             TTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCE
T ss_pred             hcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCE
Confidence            66666666666666666 344 3666777777777777777766777777777777777777777777777777888888


Q ss_pred             EEeccCcCCCCCCCccCCCCccceeeccCCccc
Q 003065          318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFS  350 (851)
Q Consensus       318 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  350 (851)
                      |+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus       260 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          260 INLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             EECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             EECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            888888888777777788888888888888876

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=3.8e-28  Score=275.86  Aligned_cols=238  Identities=19%  Similarity=0.210  Sum_probs=161.8

Q ss_pred             CCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCc
Q 003065           83 KSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFP  161 (851)
Q Consensus        83 ~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~  161 (851)
                      .+++ .+|..+.  +++++|+|++|++++..|..|+++++|++|+|++|.+++..+. |.++++|++|+|++|.+++..+
T Consensus        64 ~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  140 (452)
T 3zyi_A           64 RGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPS  140 (452)
T ss_dssp             SCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCT
T ss_pred             CCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccCh
Confidence            3444 3555444  5778888888888777777777778888887777777766654 6677777777777777665444


Q ss_pred             ccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccc-ccccccccccccCC
Q 003065          162 RWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICR-NKISGEFPRSIRKL  240 (851)
Q Consensus       162 ~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~i~~~~p~~~~~l  240 (851)
                      ..|.++++|++|+|++|                         ++++..+..|.++++|++|++++ |.+....+..|.++
T Consensus       141 ~~~~~l~~L~~L~L~~N-------------------------~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l  195 (452)
T 3zyi_A          141 GAFEYLSKLRELWLRNN-------------------------PIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL  195 (452)
T ss_dssp             TTSSSCTTCCEEECCSC-------------------------CCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTC
T ss_pred             hhhcccCCCCEEECCCC-------------------------CcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCC
Confidence            44555555555555555                         44444344455555555555555 23332333356666


Q ss_pred             CcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEe
Q 003065          241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSI  320 (851)
Q Consensus       241 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  320 (851)
                      ++|++|+|++|++++ +| .+..+++|++|+|++|++++..|..|.++++|+.|++++|++++..|..|..+++|+.|++
T Consensus       196 ~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  273 (452)
T 3zyi_A          196 FNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL  273 (452)
T ss_dssp             TTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEEC
Confidence            666666666666663 33 3667777777777777777777777777888888888888887777777888888888888


Q ss_pred             ccCcCCCCCCCccCCCCccceeeccCCccc
Q 003065          321 YGNRFSGPFPENLGRYTALTDVDISENQFS  350 (851)
Q Consensus       321 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  350 (851)
                      ++|++++..+..+..+++|+.|+|++|.+.
T Consensus       274 ~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          274 AHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             CSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             CCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            888888777777888888888888888876

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=5.7e-29  Score=276.81  Aligned_cols=166  Identities=26%  Similarity=0.356  Sum_probs=146.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|+..+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999998653     23345789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||++||+|.+++...      .+++..+..++.|++.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+...
T Consensus       149 E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          149 EYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             CCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             eCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            999999999998652      4788889999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .... ......+||+.|+|||
T Consensus       220 ~~~~-~~~~~~~gt~~Y~APE  239 (410)
T 3v8s_A          220 KEGM-VRCDTAVGTPDYISPE  239 (410)
T ss_dssp             TTSE-EECCSCCSCGGGCCHH
T ss_pred             cCCc-ccccCCcCCccccCHH
Confidence            4432 1233468999999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.96  E-value=1.1e-28  Score=272.04  Aligned_cols=172  Identities=21%  Similarity=0.235  Sum_probs=147.9

Q ss_pred             cCCccCCeecccCcEEEEEEE-----EcCCCcEEEEEEecccccHHHHHHHHHHHHcCC---CCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLD-----LKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR---HRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  747 (851)
                      .+|.+.+.||+|+||.||+|.     ...+++.||||++... ....+.+|++++++++   |+||+++++++..++..|
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~  143 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV  143 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence            468899999999999999994     5678889999998654 4567888999998887   999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-----------CC
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-----------DY  816 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-----------~~  816 (851)
                      +||||+++|+|.+++..........+++..++.++.|++.||+|||   +.+|+||||||+|||++.           ++
T Consensus       144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccC
Confidence            9999999999999998765545667999999999999999999999   789999999999999998           89


Q ss_pred             ceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       817 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+||+|||+|+..............+||+.|||||
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE  255 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE  255 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHH
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChH
Confidence            99999999998665333333345568999999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.95  E-value=1.2e-28  Score=271.65  Aligned_cols=166  Identities=27%  Similarity=0.396  Sum_probs=148.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +++|++.+.||+|+||.||+|++..+++.||||++...     ...+.+.+|+++++.++|||||++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            35789999999999999999999999999999998543     3456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++..     ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.+|.+||+|||+|+..
T Consensus        94 ~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             ECCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            999999999999875     245889999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   ....+||+.|+|||
T Consensus       166 ~~~~~---~~~~~gt~~Y~aPE  184 (384)
T 4fr4_A          166 PRETQ---ITTMAGTKPYMAPE  184 (384)
T ss_dssp             CTTCC---BCCCCSCGGGCCGG
T ss_pred             cCCCc---eeccCCCccccCCe
Confidence            54332   23467999999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.95  E-value=1.2e-28  Score=274.27  Aligned_cols=168  Identities=27%  Similarity=0.316  Sum_probs=148.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ++|+..+.||+|+||+||+|+++.+++.||||++.+..     ..+.+.+|++++..++||||+++++++.+.+..|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            57999999999999999999999999999999986532     2344788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++|+|.+++.+.    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       141 E~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             cCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            999999999999864    235888999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..... .....+||+.|+|||
T Consensus       214 ~~~~~-~~~~~~Gt~~Y~APE  233 (412)
T 2vd5_A          214 ADGTV-RSLVAVGTPDYLSPE  233 (412)
T ss_dssp             TTSCE-ECSSCCSCGGGCCHH
T ss_pred             CCCcc-ccceeccccCcCCHH
Confidence            54322 223457999999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.95  E-value=1.9e-28  Score=264.11  Aligned_cols=164  Identities=30%  Similarity=0.442  Sum_probs=147.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +.+|++.+.||+|+||.||+|+++.+++.||||++.+.     ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            45789999999999999999999999999999998653     3456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.+|.+||+|||+|+..
T Consensus        85 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             ECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             EeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence            9999999999999763     35788899999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...     ....+||+.|+|||
T Consensus       157 ~~~-----~~~~~gt~~y~aPE  173 (318)
T 1fot_A          157 PDV-----TYTLCGTPDYIAPE  173 (318)
T ss_dssp             SSC-----BCCCCSCTTTCCHH
T ss_pred             CCc-----cccccCCccccCHh
Confidence            432     22357999999998

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=6e-30  Score=276.29  Aligned_cols=247  Identities=19%  Similarity=0.196  Sum_probs=168.0

Q ss_pred             cCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHH
Q 003065          286 GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN  365 (851)
Q Consensus       286 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~  365 (851)
                      ..+++|++|++++|++++..|..|..+++|++|++++|++++..+  +..+++|++|++++|++++..            
T Consensus        31 ~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~------------   96 (317)
T 3o53_A           31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL------------   96 (317)
T ss_dssp             TTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE------------
T ss_pred             ccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc------------
Confidence            334444444444444444333444444444444555554443332  555666666666666665210            


Q ss_pred             HHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcc
Q 003065          366 LLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF  445 (851)
Q Consensus       366 l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l  445 (851)
                                       ..++|++|++++|++++..+..   +++|+.|++++|++++..+..+..+++|++|+|++|++
T Consensus        97 -----------------~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  156 (317)
T 3o53_A           97 -----------------VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI  156 (317)
T ss_dssp             -----------------ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCC
T ss_pred             -----------------CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCC
Confidence                             1246777777777776554443   46677777777777777776777777788888888888


Q ss_pred             eeeCCcccc-cCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCC
Q 003065          446 SGELPSELG-RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRS  524 (851)
Q Consensus       446 ~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  524 (851)
                      ++..|..+. .+++|++|+|++|.+++. |. ...+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..
T Consensus       157 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~  232 (317)
T 3o53_A          157 DTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKA  232 (317)
T ss_dssp             CEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTT
T ss_pred             CcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhH
Confidence            777666664 678888888888888755 32 2347888888888888875 4455888888888999998888 57788


Q ss_pred             ccccccCCeEeCCCCccc-cccCcccccc-cceEEeCc-CCcccccCCc
Q 003065          525 LSLLSSLNALNLSGNKLT-GSIPDNLMKL-KLSSIDLS-ENQLSGSVPL  570 (851)
Q Consensus       525 ~~~l~~L~~L~Ls~N~l~-g~ip~~l~~l-~L~~l~ls-~N~l~~~~p~  570 (851)
                      +..+++|+.|+|++|+++ +.+|.++..+ .|+.++++ .+.+.|..|.
T Consensus       233 ~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             CCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             hhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            888889999999999998 7788888877 78888888 4457776654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.95  E-value=2.4e-28  Score=263.07  Aligned_cols=169  Identities=27%  Similarity=0.478  Sum_probs=146.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ++|...+.||+|+||.||+|++..+++.||+|++...  ...+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            4788999999999999999999999999999988553  34567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++|+|.+++...    ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           90 KGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             TTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             CCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999763    346899999999999999999999   7899999999999999999999999999998765432


Q ss_pred             Ccc------------cccccccccccccCC
Q 003065          834 KVS------------DYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~------------~~~~~~gt~~Y~APE  851 (851)
                      ...            ......||+.|+|||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  192 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPE  192 (310)
T ss_dssp             -----------------CCCCSCGGGCCHH
T ss_pred             ccccccccccccccccccccCCCcceeCHH
Confidence            211            111457999999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.95  E-value=1.3e-28  Score=272.30  Aligned_cols=167  Identities=27%  Similarity=0.419  Sum_probs=146.1

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  748 (851)
                      +.+|++.+.||+|+||+||+|+++.+++.||||++.+..     ..+.+.+|..+++++ +|||||++++++.+.+..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            457999999999999999999999999999999986542     234578899999887 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++|+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+.
T Consensus       131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            99999999999999864     35889999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  .....+||+.|+|||
T Consensus       203 ~~~~~~--~~~~~~gt~~Y~aPE  223 (396)
T 4dc2_A          203 GLRPGD--TTSTFCGTPNYIAPE  223 (396)
T ss_dssp             CCCTTC--CBCCCCBCGGGCCHH
T ss_pred             cccCCC--ccccccCCcccCCch
Confidence            433221  234468999999998

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=1.6e-27  Score=277.69  Aligned_cols=267  Identities=28%  Similarity=0.405  Sum_probs=153.6

Q ss_pred             CCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecc
Q 003065          194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS  273 (851)
Q Consensus       194 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  273 (851)
                      +++.|++++|+++ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|+|+ .+|.   .+++|++|+|+
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls  109 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF  109 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence            4666666666666 5555444  56666666666665 3333   3455555566655555 2333   34555555555


Q ss_pred             cccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccC
Q 003065          274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSF  353 (851)
Q Consensus       274 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  353 (851)
                      +|++++ +|.   .+++|+.|++++|++++ +|.                        .   +++|+.|+|++|++++ +
T Consensus       110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~------------------------~---l~~L~~L~Ls~N~l~~-l  156 (622)
T 3g06_A          110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPV------------------------L---PPGLQELSVSDNQLAS-L  156 (622)
T ss_dssp             SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCC------------------------C---CTTCCEEECCSSCCSC-C
T ss_pred             CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCC------------------------C---CCCCCEEECcCCcCCC-c
Confidence            555553 222   33445555555555442 222                        1   2445555555555442 1


Q ss_pred             chhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCC
Q 003065          354 PKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST  433 (851)
Q Consensus       354 p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  433 (851)
                      |                        .   ..++|+.|++++|.|++ +|   ..+++|+.|++++|++++.++    .++
T Consensus       157 ~------------------------~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~----~~~  201 (622)
T 3g06_A          157 P------------------------A---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT----LPS  201 (622)
T ss_dssp             C------------------------C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCT
T ss_pred             C------------------------C---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC----ccc
Confidence            1                        1   11345555555555552 33   234556666666666654332    135


Q ss_pred             CCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeecc
Q 003065          434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA  513 (851)
Q Consensus       434 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  513 (851)
                      +|+.|++++|.++ .+|..   +++|+.|+|++|.|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|+
T Consensus       202 ~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls  269 (622)
T 3g06_A          202 ELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVY  269 (622)
T ss_dssp             TCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECC
T ss_pred             hhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCC
Confidence            6666677777666 34432   3667777777777775 44   34467777777777776 4554   45677777888


Q ss_pred             CcccccccCCCccccccCCeEeCCCCccccccCcccccc
Q 003065          514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL  552 (851)
Q Consensus       514 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l  552 (851)
                      +|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus       270 ~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  307 (622)
T ss_dssp             SSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred             CCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence            88777 667777777888888888888887777766544

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.95  E-value=1.9e-28  Score=266.81  Aligned_cols=168  Identities=32%  Similarity=0.482  Sum_probs=147.5

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  747 (851)
                      .+.+|+..+.||+|+||.||+|+++.+++.||||++.+.     ...+.+..|.++++.+ +||||+++++++.+.+..|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            346899999999999999999999999999999998653     3456778899999887 9999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.+|.+||+|||+|+
T Consensus        95 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999764     35788999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  .....+||+.|+|||
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE  188 (345)
T 1xjd_A          167 ENMLGDA--KTNTFCGTPDYIAPE  188 (345)
T ss_dssp             CCCCTTC--CBCCCCSCGGGCCHH
T ss_pred             hcccCCC--cccCCCCCcccCChh
Confidence            6433222  233468999999998

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=2.1e-29  Score=272.07  Aligned_cols=268  Identities=16%  Similarity=0.204  Sum_probs=151.3

Q ss_pred             ceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccC
Q 003065           74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI  153 (851)
Q Consensus        74 ~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~  153 (851)
                      +..-.+++.+.+...+...+..+++|++|+|++|++++..|..|+++++|++|+|++|.+++.++ +..+++|++|+|++
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCS
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcC
Confidence            34445566666655444555566677777777777776666667777777777777777766544 66667777777777


Q ss_pred             cccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccc
Q 003065          154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF  233 (851)
Q Consensus       154 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~  233 (851)
                      |.+++..     ..++|++|++++|.+.  .++.  ..+++|++|++++|++++..+..+..+++|++|++++|++++..
T Consensus        90 n~l~~l~-----~~~~L~~L~l~~n~l~--~~~~--~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  160 (317)
T 3o53_A           90 NYVQELL-----VGPSIETLHAANNNIS--RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN  160 (317)
T ss_dssp             SEEEEEE-----ECTTCCEEECCSSCCS--EEEE--CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred             Ccccccc-----CCCCcCEEECCCCccC--CcCc--cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence            7665321     2255555555555554  1111  12344555555555555444444555555555555555554444


Q ss_pred             cccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcc
Q 003065          234 PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR  313 (851)
Q Consensus       234 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~  313 (851)
                      +..+.                       ..+++|++|+|++|++++. |. ...+++|++|++++|++++ +|..+..++
T Consensus       161 ~~~~~-----------------------~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~  214 (317)
T 3o53_A          161 FAELA-----------------------ASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAA  214 (317)
T ss_dssp             GGGGG-----------------------GGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGT
T ss_pred             HHHHh-----------------------hccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccC
Confidence            43332                       2344455555555544422 11 1224555555555555553 233355555


Q ss_pred             cccEEEeccCcCCCCCCCccCCCCccceeeccCCccc-ccCchhhhhhcchHHHHhccC-Ccccccc
Q 003065          314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS-GSFPKYLCEKRKLLNLLALSN-NFSGEVP  378 (851)
Q Consensus       314 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~~~~L~~l~l~~n-~~~~~~p  378 (851)
                      +|+.|++++|+++ .+|..+..+++|+.|++++|++. +.+|.++..+++|+.+.+.++ .+.+..|
T Consensus       215 ~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            5666666666665 35556667777777777777777 666777777777777776633 3444433

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.95  E-value=3.1e-28  Score=265.62  Aligned_cols=167  Identities=28%  Similarity=0.433  Sum_probs=146.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  748 (851)
                      +.+|+..+.||+|+||.||+|+++.+++.||||++.+.     ...+.+.+|+.+++++ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            45789999999999999999999999999999998654     2345678899999988 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++|+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        88 v~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence            99999999999999764     35889999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  .....+||+.|+|||
T Consensus       160 ~~~~~~--~~~~~~gt~~y~aPE  180 (345)
T 3a8x_A          160 GLRPGD--TTSTFCGTPNYIAPE  180 (345)
T ss_dssp             SCCTTC--CBCCCCSCGGGCCHH
T ss_pred             ccCCCC--cccccCCCccccCcc
Confidence            433221  233468999999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.95  E-value=3.6e-28  Score=266.43  Aligned_cols=165  Identities=27%  Similarity=0.357  Sum_probs=146.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      +.|++.+.||+|+||.||+|+++.+++.||||++....        ..+.+.+|+.++++++||||+++++++.+.+..|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            46899999999999999999999999999999986542        3577899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC----ceEEeee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIADF  823 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DF  823 (851)
                      +||||+++|+|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+||
T Consensus        92 lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           92 LILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999864     346899999999999999999999   78999999999999998776    7999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++.......   .....||+.|+|||
T Consensus       164 G~a~~~~~~~~---~~~~~gt~~y~aPE  188 (361)
T 2yab_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPE  188 (361)
T ss_dssp             SSCEECCTTCC---CCCCCSCGGGCCHH
T ss_pred             CCceEcCCCCc---cccCCCCccEECch
Confidence            99987765432   23467999999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.95  E-value=2.9e-28  Score=266.26  Aligned_cols=168  Identities=29%  Similarity=0.384  Sum_probs=147.6

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  747 (851)
                      .+.+|+..+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|.++++.+ +||+|+++++++...+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            346899999999999999999999989999999998643     3456788999999988 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||++||+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+
T Consensus        98 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            999999999999999864     35888999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  .....+||+.|+|||
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE  191 (353)
T 2i0e_A          170 ENIWDGV--TTKTFCGTPDYIAPE  191 (353)
T ss_dssp             CCCCTTC--CBCCCCSCGGGCCHH
T ss_pred             ccccCCc--ccccccCCccccChh
Confidence            6433222  233468999999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.95  E-value=3.2e-28  Score=265.91  Aligned_cols=164  Identities=25%  Similarity=0.362  Sum_probs=147.6

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +.+|+..+.||+|+||.||+|++..+++.||||++.+.     ...+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            45899999999999999999999999999999998543     3456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.+|.+||+|||+|+..
T Consensus       120 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceec
Confidence            9999999999999864     34788999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...     ....+||+.|+|||
T Consensus       192 ~~~-----~~~~~gt~~y~aPE  208 (350)
T 1rdq_E          192 KGR-----TWTLCGTPEALAPE  208 (350)
T ss_dssp             SSC-----BCCCEECGGGCCHH
T ss_pred             cCC-----cccccCCccccCHH
Confidence            543     22357999999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.95  E-value=2.9e-28  Score=268.82  Aligned_cols=173  Identities=29%  Similarity=0.417  Sum_probs=147.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-------CCCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-------KNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGG  744 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  744 (851)
                      ++|++.+.||+|+||.||+|++.       .++..||||++....   ..+.+.+|+++++++ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            47889999999999999999874       245579999986543   345688999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      ..|+||||+++|+|.+++......           ....+++..++.++.|++.||+|||   +++|+||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEEC
Confidence            999999999999999999875211           1245789999999999999999999   78999999999999999


Q ss_pred             CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++.+||+|||+|+...............||+.|+|||
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE  275 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE  275 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHh
Confidence            99999999999998766544333334456889999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=4.1e-28  Score=265.79  Aligned_cols=170  Identities=25%  Similarity=0.275  Sum_probs=147.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-------ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      +.|++.+.||+|+||.||+|+++.+++.||||++...       ...+.+.+|+++++.++||||+++++++..++..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4689999999999999999999999999999998532       246778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc---eEEeeecC
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGV  825 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGl  825 (851)
                      ||||+++++|.+++..... ....+++..+..++.|++.||+|||   +++|+||||||+||+++.++.   +||+|||+
T Consensus       104 v~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999998876533 2345789999999999999999999   789999999999999986654   99999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++........  ....+||+.|+|||
T Consensus       180 a~~~~~~~~~--~~~~~gt~~y~aPE  203 (351)
T 3c0i_A          180 AIQLGESGLV--AGGRVGTPHFMAPE  203 (351)
T ss_dssp             CEECCTTSCB--CCCCCSCGGGCCHH
T ss_pred             eeEecCCCee--ecCCcCCcCccCHH
Confidence            9877654321  23457999999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.95  E-value=1.1e-28  Score=267.03  Aligned_cols=169  Identities=28%  Similarity=0.397  Sum_probs=147.0

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +++|++.+.||+|+||.||+|++..+++.||||++....   ..+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999999999999999986442   24568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++|+|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           86 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            9999999888753     345889999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...........||+.|+|||
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE  177 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPE  177 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHH
T ss_pred             CCcccccCCCccCcCccCcH
Confidence            43333334567999999998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.95  E-value=3.5e-28  Score=264.29  Aligned_cols=173  Identities=23%  Similarity=0.371  Sum_probs=144.1

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC------
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------  744 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  744 (851)
                      .+.+|++.+.||+|+||.||+|+++.+++.||||++...   ...+.+.+|++++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            356799999999999999999999999999999998643   34577899999999999999999999986543      


Q ss_pred             ---------------------------------------------------eeEEEEeccCCCCHHHHHHHhhhCCCCCC
Q 003065          745 ---------------------------------------------------SSFLVLEYMPNGNLFQALHKRVKEGKPEL  773 (851)
Q Consensus       745 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l  773 (851)
                                                                         ..|+||||+++++|.+++....  .....
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~  161 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDR  161 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGS
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccch
Confidence                                                               3799999999999999998642  23345


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc----------cccccccc
Q 003065          774 DWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV----------SDYSCFAG  843 (851)
Q Consensus       774 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~g  843 (851)
                      .+..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+........          .......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            77778899999999999999   789999999999999999999999999999877654211          11234579


Q ss_pred             ccccccCC
Q 003065          844 THGYIAPG  851 (851)
Q Consensus       844 t~~Y~APE  851 (851)
                      |+.|+|||
T Consensus       239 t~~y~aPE  246 (332)
T 3qd2_B          239 TKLYMSPE  246 (332)
T ss_dssp             CGGGSCHH
T ss_pred             CcCccChH
Confidence            99999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.7e-28  Score=262.56  Aligned_cols=166  Identities=23%  Similarity=0.286  Sum_probs=147.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+++++.++||||+++++++.+.+..|+||||++
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   84 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence            4789999999999999999999999999999998654 345568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC--CCceEEeeecCccccCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE--DYEPKIADFGVAKIAENS  832 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~  832 (851)
                      +|+|.+++...    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.  ++.+||+|||+++.....
T Consensus        85 g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           85 GLDIFERINTS----AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            99999988642    346889999999999999999999   789999999999999987  789999999999877554


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..   .....||+.|+|||
T Consensus       158 ~~---~~~~~gt~~y~aPE  173 (321)
T 1tki_A          158 DN---FRLLFTAPEYYAPE  173 (321)
T ss_dssp             CE---EEEEESCGGGSCHH
T ss_pred             Cc---cccccCChhhcCcH
Confidence            32   23357999999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.95  E-value=4.3e-28  Score=258.90  Aligned_cols=167  Identities=26%  Similarity=0.375  Sum_probs=141.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...     ...+.+.+|++++++++||||+++++++..++..|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            4689999999999999999999999999999988442     23467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        91 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           91 EYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             ECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999764     35889999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..... ......||+.|+|||
T Consensus       163 ~~~~~-~~~~~~gt~~y~aPE  182 (294)
T 4eqm_A          163 ETSLT-QTNHVLGTVQYFSPE  182 (294)
T ss_dssp             -------------CCSSCCHH
T ss_pred             ccccc-ccCccccCccccCHh
Confidence            43221 223457999999998

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.95  E-value=4.3e-28  Score=263.07  Aligned_cols=165  Identities=29%  Similarity=0.423  Sum_probs=146.6

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +.+|.+.+.||+|+||.||+|++..+++.||||++...     ...+.+.+|+++++.++||||+++++++...+..|+|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999999999999999998543     2345788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+ +|+|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        88 ~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             EECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence            9999 78999998764     35889999999999999999999   679999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   ....+||+.|+|||
T Consensus       159 ~~~~~---~~~~~gt~~y~aPE  177 (336)
T 3h4j_B          159 TDGNF---LKTSCGSPNYAAPE  177 (336)
T ss_dssp             TTSBT---TCCCTTSTTTSCGG
T ss_pred             cCCcc---cccccCCcCcCCHH
Confidence            54432   23357999999998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=5.7e-28  Score=277.21  Aligned_cols=167  Identities=28%  Similarity=0.374  Sum_probs=148.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|+..+.||+|+||.||+|+++.+++.||||++.+.     .....+.+|+++++.++|||||++++++.+.+..|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            4688999999999999999999999999999998543     34566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||++||+|.+++...   ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+...
T Consensus       264 Ey~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          264 TLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             CCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999999998753   2345899999999999999999999   7899999999999999999999999999998775


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   ....+||+.|+|||
T Consensus       338 ~~~~---~~~~~GT~~Y~APE  355 (576)
T 2acx_A          338 EGQT---IKGRVGTVGYMAPE  355 (576)
T ss_dssp             TTCC---EECCCSCGGGCCHH
T ss_pred             cCcc---ccccCCCccccCHH
Confidence            5432   23357999999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.95  E-value=1.3e-27  Score=257.37  Aligned_cols=176  Identities=22%  Similarity=0.250  Sum_probs=143.5

Q ss_pred             cccccccHHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcC-CCCccccEEEE
Q 003065          665 FHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKI-RHRNILKLYAC  739 (851)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~  739 (851)
                      +.+........++|+..+.||+|+||+||+|++..+++.||||++...    ........|+..+.++ +||||++++++
T Consensus        46 ~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~  125 (311)
T 3p1a_A           46 YDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA  125 (311)
T ss_dssp             CCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence            333333333446799999999999999999999999999999987543    2233445566666555 89999999999


Q ss_pred             EEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceE
Q 003065          740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPK  819 (851)
Q Consensus       740 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  819 (851)
                      +.+++..|+||||+ +++|.+++...    ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~k  197 (311)
T 3p1a_A          126 WEEGGILYLQTELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCK  197 (311)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEE
T ss_pred             EEeCCEEEEEEecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEE
Confidence            99999999999999 77999998765    346899999999999999999999   67999999999999999999999


Q ss_pred             EeeecCccccCCCCCcccccccccccccccCC
Q 003065          820 IADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       820 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|||+|+.......   .....||+.|+|||
T Consensus       198 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE  226 (311)
T 3p1a_A          198 LGDFGLLVELGTAGA---GEVQEGDPRYMAPE  226 (311)
T ss_dssp             ECCCTTCEECC---------CCCCCGGGCCGG
T ss_pred             EccceeeeecccCCC---CcccCCCccccCHh
Confidence            999999987654332   23356999999998

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=1.1e-28  Score=281.79  Aligned_cols=233  Identities=20%  Similarity=0.191  Sum_probs=156.1

Q ss_pred             CccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhc
Q 003065          290 NLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL  369 (851)
Q Consensus       290 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~  369 (851)
                      +|+.|++++|.+++..|..|+.+++|++|+|++|.+++..|  +..+++|+.|+|++|.|++..                
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~----------------   96 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL----------------   96 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE----------------
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC----------------
Confidence            45555555555554444445555555555555555544333  556666666666666665211                


Q ss_pred             cCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeC
Q 003065          370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGEL  449 (851)
Q Consensus       370 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~  449 (851)
                                   ..++|++|++++|.+++..+..   +++|+.|+|++|++++.+|..++.+++|+.|+|++|.+++..
T Consensus        97 -------------~~~~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  160 (487)
T 3oja_A           97 -------------VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN  160 (487)
T ss_dssp             -------------ECTTCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEE
T ss_pred             -------------CCCCcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcC
Confidence                         1156777777777777655543   466777777777777777777777777777777778777777


Q ss_pred             Ccccc-cCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCcccc
Q 003065          450 PSELG-RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL  528 (851)
Q Consensus       450 p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  528 (851)
                      |..+. .+++|+.|+|++|.+++..+  +..+++|+.|+|++|+|++. |..++.+++|+.|+|++|.|++ +|..+..+
T Consensus       161 ~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l  236 (487)
T 3oja_A          161 FAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFS  236 (487)
T ss_dssp             GGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCC
T ss_pred             hHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccC
Confidence            77765 67788888888888876532  33477888888888888754 4447778888888888888884 67778888


Q ss_pred             ccCCeEeCCCCccc-cccCcccccc-cceEEeCc
Q 003065          529 SSLNALNLSGNKLT-GSIPDNLMKL-KLSSIDLS  560 (851)
Q Consensus       529 ~~L~~L~Ls~N~l~-g~ip~~l~~l-~L~~l~ls  560 (851)
                      ++|+.|++++|+++ +.+|.++..+ .++.++++
T Consensus       237 ~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             TTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            88888888888887 6677777666 66666654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=3.2e-27  Score=248.76  Aligned_cols=216  Identities=22%  Similarity=0.275  Sum_probs=135.4

Q ss_pred             CCCcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCC
Q 003065           58 DSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV  137 (851)
Q Consensus        58 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~  137 (851)
                      .++|.|.|+.|+-. +.++.+++++++++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|+|++|.+++.+
T Consensus         2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP   77 (270)
T ss_dssp             CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence            46899999998643 35667888888888 4666554  57788888888887665667777888888888887777666


Q ss_pred             CC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccc
Q 003065          138 PD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISEL  216 (851)
Q Consensus       138 ~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l  216 (851)
                      +. +..+++|++|+|++|.+++..+..|.++++|++|++++|.+                         ++..+..|..+
T Consensus        78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l-------------------------~~~~~~~~~~l  132 (270)
T 2o6q_A           78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQL-------------------------KSLPPRVFDSL  132 (270)
T ss_dssp             TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCC-------------------------CCCCTTTTTTC
T ss_pred             hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCcc-------------------------CeeCHHHhCcC
Confidence            55 56777777777777777655444555555555555555555                         44444444444


Q ss_pred             cccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEc
Q 003065          217 RELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC  296 (851)
Q Consensus       217 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l  296 (851)
                      ++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++
T Consensus       133 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  212 (270)
T 2o6q_A          133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL  212 (270)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence            45555555555554433344555555555555555555444445555566666666666665444445555666666666


Q ss_pred             cCCccC
Q 003065          297 FKNNFS  302 (851)
Q Consensus       297 ~~N~l~  302 (851)
                      ++|.+.
T Consensus       213 ~~N~~~  218 (270)
T 2o6q_A          213 QENPWD  218 (270)
T ss_dssp             CSSCBC
T ss_pred             cCCCee
Confidence            666554

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.95  E-value=5.9e-28  Score=261.40  Aligned_cols=165  Identities=32%  Similarity=0.422  Sum_probs=142.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCCCCccccEEEEEEeCC----eeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLKGG----SSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  750 (851)
                      .+|+..+.||+|+||.||+|++.  ++.||||++.... ......+|+.++++++||||+++++++....    ..|+||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            47899999999999999999884  7899999986543 3345667899999999999999999998754    369999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC----------CcEEeCCCCCCEEECCCCceEE
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP----------PIIHRDIKSSNILLDEDYEPKI  820 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivHrDlkp~NILl~~~~~~kl  820 (851)
                      ||+++|+|.++++..      .+++..+..++.|++.||+|||   +.          +|+||||||+||+++.++.+||
T Consensus       102 e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             ECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             ecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            999999999999753      4889999999999999999999   77          9999999999999999999999


Q ss_pred             eeecCccccCCCCCcccccccccccccccCC
Q 003065          821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|||+|+...............||+.|+|||
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE  203 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPE  203 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHh
Confidence            9999998776554433344467999999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.2e-27  Score=259.45  Aligned_cols=165  Identities=28%  Similarity=0.362  Sum_probs=146.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ..|+..+.||+|+||.||+|++..+++.||||++....        ..+.+.+|++++++++||||+++++++...+..|
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            36889999999999999999999999999999986432        3677999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC----ceEEeee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIADF  823 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DF  823 (851)
                      +||||+++++|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+||
T Consensus        91 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999864     345889999999999999999999   78999999999999999887    7999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+.......   .....||+.|+|||
T Consensus       163 g~a~~~~~~~~---~~~~~gt~~y~aPE  187 (326)
T 2y0a_A          163 GLAHKIDFGNE---FKNIFGTPEFVAPE  187 (326)
T ss_dssp             TTCEECCTTSC---CCCCCSCTTTCCHH
T ss_pred             CCCeECCCCCc---cccccCCcCcCCce
Confidence            99987754332   23357999999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=9.4e-28  Score=263.78  Aligned_cols=166  Identities=28%  Similarity=0.403  Sum_probs=145.8

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ..+|++.+.||+|+||.||+|.++.+++.||||++...    ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            35799999999999999999999999999999998654    23466889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC---CceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~  827 (851)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.+   +.+||+|||+|+
T Consensus       108 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          108 DLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             CCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999998864     245889999999999999999999   7899999999999999865   459999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......   .....||+.|+|||
T Consensus       180 ~~~~~~~---~~~~~gt~~y~aPE  200 (362)
T 2bdw_A          180 EVNDSEA---WHGFAGTPGYLSPE  200 (362)
T ss_dssp             CCTTCCS---CCCSCSCTTTCCHH
T ss_pred             EecCCcc---cccCCCCccccCHH
Confidence            7664432   23467999999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.95  E-value=1.3e-27  Score=255.07  Aligned_cols=166  Identities=26%  Similarity=0.363  Sum_probs=144.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|+..+.||+|+||.||+|++..+++.||||++...    ...+.+.+|++++++++||||+++++++..++..|+|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5789999999999999999999999999999998643    234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++ ++.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus        82 ~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             cCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            9964 777766543    346899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ......||+.|+|||
T Consensus       154 ~~~--~~~~~~~t~~y~aPE  171 (292)
T 3o0g_A          154 PVR--CYSAEVVTLWYRPPD  171 (292)
T ss_dssp             CCS--CCCSCCSCGGGCCHH
T ss_pred             ccc--cccCCccccCCcChH
Confidence            322  223457899999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.95  E-value=1.1e-27  Score=269.45  Aligned_cols=167  Identities=23%  Similarity=0.335  Sum_probs=145.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    ..+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            357999999999999999999999999999999986542    3456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC---CCCceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~  827 (851)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++   .++.+||+|||+|+
T Consensus        90 E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           90 DLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             CCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999998763     35889999999999999999999   78999999999999998   46789999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  ......||+.|+|||
T Consensus       162 ~~~~~~~--~~~~~~gt~~Y~APE  183 (444)
T 3soa_A          162 EVEGEQQ--AWFGFAGTPGYLSPE  183 (444)
T ss_dssp             CCCTTCC--BCCCSCSCGGGCCHH
T ss_pred             EecCCCc--eeecccCCcccCCHH
Confidence            7654432  223467999999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=6e-28  Score=265.69  Aligned_cols=167  Identities=31%  Similarity=0.392  Sum_probs=138.3

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHH-HHcCCCCccccEEEEEEeCCeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEI-LGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      ..+|+..+.||+|+||+||+|+++.+++.||||++.+..     ..+.+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357899999999999999999999999999999986542     23456677776 567899999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++|+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+.
T Consensus       117 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            99999999999999764     35788888999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  .....+||+.|+|||
T Consensus       189 ~~~~~~--~~~~~~gt~~y~aPE  209 (373)
T 2r5t_A          189 NIEHNS--TTSTFCGTPEYLAPE  209 (373)
T ss_dssp             GBCCCC--CCCSBSCCCCCCCHH
T ss_pred             cccCCC--ccccccCCccccCHH
Confidence            443322  233468999999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=1.3e-27  Score=273.76  Aligned_cols=170  Identities=28%  Similarity=0.385  Sum_probs=149.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|...+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|++++++++||||+++++++...+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            5788899999999999999999999999999998543     34567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||++||+|.+++.... .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+...
T Consensus       265 E~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             CCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999987642 22446899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  ....+||+.|+|||
T Consensus       341 ~~~~~--~~~~~GT~~Y~APE  359 (543)
T 3c4z_A          341 AGQTK--TKGYAGTPGFMAPE  359 (543)
T ss_dssp             TTCCC--BCCCCSCTTTSCHH
T ss_pred             CCCcc--cccccCCccccChh
Confidence            44322  23457999999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=2e-27  Score=256.64  Aligned_cols=171  Identities=24%  Similarity=0.348  Sum_probs=134.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ..+|+..+.||+|+||.||+|++..+++.||||++...   ...+.+.+|++++++++||||+++++++..++..|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            35799999999999999999999999999999998643   234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |++ |+|.+++...... ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 6999999875432 2245889999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  ......||+.|+|||
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE  178 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPD  178 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHH
T ss_pred             CCcc--cCCCCcccccccCch
Confidence            4322  123357899999998

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=2.5e-28  Score=279.03  Aligned_cols=250  Identities=18%  Similarity=0.188  Sum_probs=157.2

Q ss_pred             cCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCc
Q 003065           82 NKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFP  161 (851)
Q Consensus        82 ~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~  161 (851)
                      ..++...+......+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.+| ++.+++|++|||++|.+++.. 
T Consensus        19 ~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~-   96 (487)
T 3oja_A           19 DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELL-   96 (487)
T ss_dssp             TTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEE-
T ss_pred             hhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCC-
Confidence            333433333334445588888888888888777888888888888888888887665 788888888888888876432 


Q ss_pred             ccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccccccccccccccc-CC
Q 003065          162 RWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR-KL  240 (851)
Q Consensus       162 ~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~-~l  240 (851)
                          ..++|++|++++|.+.  .+|.  ..+++|+.|+|++|++++..|..++.+++|++|+|++|++++..|..+. .+
T Consensus        97 ----~~~~L~~L~L~~N~l~--~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l  168 (487)
T 3oja_A           97 ----VGPSIETLHAANNNIS--RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS  168 (487)
T ss_dssp             ----ECTTCCEEECCSSCCC--CEEE--CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGT
T ss_pred             ----CCCCcCEEECcCCcCC--CCCc--cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhC
Confidence                2266777777777665  2222  2345666666666666666666666666666666666666665555554 56


Q ss_pred             CcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEe
Q 003065          241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSI  320 (851)
Q Consensus       241 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  320 (851)
                      ++|++|+|++|.+++..+  +..+++|++|+|++|++++. |..+..+++|+.|++++|.++                  
T Consensus       169 ~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~------------------  227 (487)
T 3oja_A          169 DTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV------------------  227 (487)
T ss_dssp             TTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC------------------
T ss_pred             CcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCc------------------
Confidence            666666666666654421  22355555555555555532 223555555555555555554                  


Q ss_pred             ccCcCCCCCCCccCCCCccceeeccCCccc-ccCchhhhhhcchHHHHhc
Q 003065          321 YGNRFSGPFPENLGRYTALTDVDISENQFS-GSFPKYLCEKRKLLNLLAL  369 (851)
Q Consensus       321 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~~~~L~~l~l~  369 (851)
                            + +|..+..+++|+.|++++|.+. +.+|.++..++.+..+.+.
T Consensus       228 ------~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          228 ------L-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             ------E-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             ------c-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence                  2 3444555566666666666665 5566667777777776665

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=1.5e-27  Score=258.59  Aligned_cols=166  Identities=30%  Similarity=0.426  Sum_probs=136.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEc---CCCcEEEEEEeccc------ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  746 (851)
                      ++|+..+.||+|+||.||+|++.   .+++.||||++.+.      .....+.+|+++++.++||||+++++++..++..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            47899999999999999999985   67889999998654      2345577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+++++|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           97 YLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            9999999999999999764     34788889999999999999999   779999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.......  ......||+.|+|||
T Consensus       169 ~~~~~~~~--~~~~~~gt~~y~aPE  191 (327)
T 3a62_A          169 KESIHDGT--VTHTFCGTIEYMAPE  191 (327)
T ss_dssp             ------------CTTSSCCTTSCHH
T ss_pred             cccccCCc--cccccCCCcCccCHh
Confidence            86543322  123457999999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.95  E-value=8.6e-28  Score=261.14  Aligned_cols=168  Identities=21%  Similarity=0.219  Sum_probs=147.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+|++.+.||+|+||.||+|++..+++.||||++......+.+.+|+++++++ +||||+++++++..++..|+||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            46899999999999999999999999999999987666566788999999999 9999999999999999999999999 


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc-----eEEeeecCcccc
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-----PKIADFGVAKIA  829 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~  829 (851)
                      +++|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||+|+..
T Consensus        88 ~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           88 GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99999999863    346899999999999999999999   789999999999999998887     999999999876


Q ss_pred             CCCCCcc-----cccccccccccccCC
Q 003065          830 ENSPKVS-----DYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~-----~~~~~~gt~~Y~APE  851 (851)
                      .......     ......||+.|+|||
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE  187 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSIN  187 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred             ecCCCCccccccccCCcCCCccccChH
Confidence            5443211     123567999999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.95  E-value=2.5e-27  Score=256.17  Aligned_cols=163  Identities=28%  Similarity=0.419  Sum_probs=144.5

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      |+..+.||+|+||.||+|++..+++.||||++...  ...+.+.+|+.++++++||||+++++++..++..|+||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            56677899999999999999889999999998643  4567789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      ++|.+++..      ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       127 ~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          127 GALTDIVSQ------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             CBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence            999998753      35889999999999999999999   789999999999999999999999999999876543222


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                        .....||+.|+|||
T Consensus       198 --~~~~~gt~~y~aPE  211 (321)
T 2c30_A          198 --RKSLVGTPYWMAPE  211 (321)
T ss_dssp             --BCCCCSCGGGCCHH
T ss_pred             --cccccCCccccCHh
Confidence              23457999999998

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.95  E-value=6.3e-28  Score=258.22  Aligned_cols=166  Identities=32%  Similarity=0.396  Sum_probs=140.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----------------------------cHHHHHHHHHHHH
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------------------------GVKVFAAEMEILG  726 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~E~~~l~  726 (851)
                      +++|++.+.||+|+||.||+|++..+++.||||++....                            ..+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            357999999999999999999999999999999985432                            1245789999999


Q ss_pred             cCCCCccccEEEEEEe--CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeC
Q 003065          727 KIRHRNILKLYACLLK--GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRD  804 (851)
Q Consensus       727 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrD  804 (851)
                      +++||||+++++++..  .+..|+||||+++++|.+++.      ...+++..+..++.|+++||+|||   +.+|+|||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D  162 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRD  162 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence            9999999999999986  567899999999999876432      346899999999999999999999   77999999


Q ss_pred             CCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          805 IKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       805 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |||+||+++.++.+||+|||+++........  .....||+.|+|||
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE  207 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPE  207 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGG
T ss_pred             CCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChh
Confidence            9999999999999999999999876544322  23357999999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.95  E-value=2.3e-27  Score=256.55  Aligned_cols=168  Identities=29%  Similarity=0.419  Sum_probs=146.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC--eeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGG--SSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  750 (851)
                      .+|.+.+.||+|+||.||+|++..+++.||||++...   ...+.+.+|++++++++||||+++++++...+  ..|+||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            3688999999999999999999999999999998653   34677889999999999999999999988765  779999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE----CCCCceEEeeecCc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVA  826 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla  826 (851)
                      ||+++++|.+++.....  ...+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+|
T Consensus        89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             eCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            99999999999986522  234899999999999999999999   7899999999999999    77888999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +........   ....||+.|+|||
T Consensus       164 ~~~~~~~~~---~~~~gt~~y~aPE  185 (319)
T 4euu_A          164 RELEDDEQF---VSLYGTEEYLHPD  185 (319)
T ss_dssp             EECCTTCCB---CCCCSCGGGCCHH
T ss_pred             eecCCCCce---eecccCCCccCHH
Confidence            877654332   2357999999998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.94  E-value=6.2e-28  Score=267.07  Aligned_cols=169  Identities=26%  Similarity=0.338  Sum_probs=144.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ++|...+.||+|+||.||+|++..+++.||||++....   ..+.+.+|++++++++||||+++++++..++..|+||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            36888999999999999999998899999999986542   234678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++|+|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       194 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          194 VQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             CCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            9999999999864    235788999999999999999999   789999999999999999999999999999865443


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..........+++.|+|||
T Consensus       267 ~~~~~~~~~~~~~~y~aPE  285 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPE  285 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHH
T ss_pred             ceeecCCCCCCCcCcCCHh
Confidence            2111111234678899998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.94  E-value=1e-27  Score=262.24  Aligned_cols=165  Identities=33%  Similarity=0.440  Sum_probs=130.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++......+.+.+|++++++++||||+++++++..++..|+||||+++
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            46889999999999999999999999999999998776677888999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---CCceEEeeecCccccCCC
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVAKIAENS  832 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~  832 (851)
                      |+|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++.....
T Consensus       133 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          133 GELFDRIVE-----KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999998864     245889999999999999999999   779999999999999975   889999999999876543


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..   .....||+.|+|||
T Consensus       205 ~~---~~~~~gt~~y~aPE  220 (349)
T 2w4o_A          205 VL---MKTVCGTPGYCAPE  220 (349)
T ss_dssp             -----------CGGGSCHH
T ss_pred             cc---cccccCCCCccCHH
Confidence            22   23357999999998

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.94  E-value=1.6e-27  Score=258.14  Aligned_cols=169  Identities=28%  Similarity=0.477  Sum_probs=142.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc---EEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|++.+.||+|+||.||+|++..+++   .||||++...   ...+.+.+|++++++++||||+++++++..++..|+|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            468899999999999999999975554   4999998754   2356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       129 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             eeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999998653    346899999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCc-ccccccccccccccCC
Q 003065          830 ENSPKV-SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~-~~~~~~~gt~~Y~APE  851 (851)
                      ...... .......||+.|+|||
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE  224 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPE  224 (325)
T ss_dssp             C----CCEECC---CCGGGSCHH
T ss_pred             ccCccceeeccCCCCcccccCHh
Confidence            554322 1222345688999998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.94  E-value=1.5e-27  Score=262.28  Aligned_cols=165  Identities=28%  Similarity=0.331  Sum_probs=138.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+|++.+.||+|+||.||+|++..+++.||||++... ...+.+.+|+.+++.++||||+++++++..++..|+||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            4799999999999999999999999999999998654 334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc--eEEeeecCccccCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE--PKIADFGVAKIAENS  832 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~~~  832 (851)
                      +|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.  +||+|||+|+.....
T Consensus       100 ~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A          100 GGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999764     35889999999999999999999   789999999999999987765  999999999754332


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..   .....||+.|+|||
T Consensus       172 ~~---~~~~~gt~~y~aPE  187 (361)
T 3uc3_A          172 SQ---PKSTVGTPAYIAPE  187 (361)
T ss_dssp             ------------CTTSCHH
T ss_pred             CC---CCCCcCCCCcCChh
Confidence            22   23357999999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.94  E-value=1.5e-27  Score=270.26  Aligned_cols=166  Identities=31%  Similarity=0.471  Sum_probs=148.1

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +.+|.+.+.||+|+||.||+|++..+++.||||++...     ...+.+.+|+++++.++||||+++++++...+..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35789999999999999999999999999999998643     2356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++.+     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus        95 ~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           95 MEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            999999999998864     345899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   ....+||+.|+|||
T Consensus       167 ~~~~~---~~~~~gt~~y~aPE  185 (476)
T 2y94_A          167 SDGEF---LRTSCGSPNYAAPE  185 (476)
T ss_dssp             CTTCC---BCCCCSCSTTCCHH
T ss_pred             ccccc---ccccCCCcCeEChh
Confidence            55432   23357999999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.94  E-value=2.6e-27  Score=261.97  Aligned_cols=166  Identities=23%  Similarity=0.312  Sum_probs=146.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+|+++++.++||||+++++++.+.+..|+||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            57999999999999999999999999999999986543  3456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC--CCceEEeeecCccccCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE--DYEPKIADFGVAKIAEN  831 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~  831 (851)
                      ++|+|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.  ++.+||+|||+|+....
T Consensus       131 ~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          131 SGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999988642    345899999999999999999999   789999999999999974  47899999999987755


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   ....||+.|+|||
T Consensus       204 ~~~~---~~~~gt~~y~aPE  220 (387)
T 1kob_A          204 DEIV---KVTTATAEFAAPE  220 (387)
T ss_dssp             TSCE---EEECSSGGGCCHH
T ss_pred             Ccce---eeeccCCCccCch
Confidence            4322   2347999999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.94  E-value=1.2e-27  Score=271.06  Aligned_cols=167  Identities=30%  Similarity=0.386  Sum_probs=137.9

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +++|+..+.||+|+||.||+|++..+++.||||++...     .....+.+|+++++.++||||+++++++...+..|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            35799999999999999999999999999999998643     2345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |||+++|+|.+++...     ..+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+|+.
T Consensus       227 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             ECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            9999999999998764     35889999999999999999999   5 7999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  .....+||+.|+|||
T Consensus       299 ~~~~~~--~~~~~~gt~~y~aPE  319 (446)
T 4ejn_A          299 GIKDGA--TMKTFCGTPEYLAPE  319 (446)
T ss_dssp             TCC-------CCSSSCGGGCCHH
T ss_pred             ccCCCc--ccccccCCccccCHh
Confidence            443322  233468999999998

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.94  E-value=1.3e-27  Score=258.67  Aligned_cols=171  Identities=38%  Similarity=0.612  Sum_probs=147.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|+..+.||+|+||.||+|++ .+++.||||++...  ...+.+.+|++++++++||||+++++++..++..|+||||+
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  117 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM  117 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred             hccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence            5899999999999999999997 46889999988654  34677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++|+|.+++.... .....+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus       118 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          118 ENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD  193 (321)
T ss_dssp             TTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred             CCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9999998886431 12345899999999999999999999   7899999999999999999999999999998755433


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .........||+.|+|||
T Consensus       194 ~~~~~~~~~gt~~y~aPE  211 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPE  211 (321)
T ss_dssp             CCCCBCCCEEETTTCCHH
T ss_pred             ccccccccCCCccccCHH
Confidence            222233456999999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.94  E-value=1.3e-27  Score=271.95  Aligned_cols=167  Identities=25%  Similarity=0.394  Sum_probs=131.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC-----Cee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  746 (851)
                      ++|++.+.||+|+||.||+|+++.+++.||||++...    ...+++.+|++++++++|||||++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            4799999999999999999999999999999998653    2456788999999999999999999998443     568


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+ +++|.+++..     ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       133 ~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccc
Confidence            9999998 5799988864     345899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCc-------------------------ccccccccccccccCC
Q 003065          827 KIAENSPKV-------------------------SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~-------------------------~~~~~~~gt~~Y~APE  851 (851)
                      +........                         ......+||++|+|||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE  253 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE  253 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHH
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChH
Confidence            876532210                         1234567999999998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.94  E-value=6.6e-28  Score=265.78  Aligned_cols=173  Identities=28%  Similarity=0.337  Sum_probs=144.3

Q ss_pred             cCCccCCeecccCcEEEEEEEE-----cCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      .+|++.+.||+|+||.||+|++     ..+++.||||++...   .....+.+|+.++++++||||+++++++...+..|
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            4688999999999999999994     456778999998643   33456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC---ceEEee
Q 003065          748 LVLEYMPNGNLFQALHKRVKE--GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---EPKIAD  822 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~D  822 (851)
                      +||||+++|+|.+++......  ....+++..++.++.|+++||+|||   +++|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            999999999999999875321  2245899999999999999999999   78999999999999999555   599999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|+...............||+.|+|||
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE  256 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPE  256 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHH
T ss_pred             CccccccccccccccCCCcCCcccEECHH
Confidence            99998654333223334457899999998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=3e-27  Score=262.93  Aligned_cols=171  Identities=29%  Similarity=0.442  Sum_probs=136.2

Q ss_pred             cHHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCC-CCccccEEEEEEeCC-
Q 003065          671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIR-HRNILKLYACLLKGG-  744 (851)
Q Consensus       671 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-  744 (851)
                      +.....+|++.+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|+.+++++. ||||+++++++...+ 
T Consensus         4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            445667999999999999999999999999999999998543    34566789999999997 999999999997644 


Q ss_pred             -eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          745 -SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       745 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                       ..|+||||++ ++|.+++...      .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DF  153 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADF  153 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CEEEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCC
Confidence             6899999996 6899888752      5788889999999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCC-------------------cccccccccccccccCC
Q 003065          824 GVAKIAENSPK-------------------VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~-------------------~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+.......                   .......+||++|+|||
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  200 (388)
T 3oz6_A          154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPE  200 (388)
T ss_dssp             TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHH
T ss_pred             cccccccccccccccccccccccccccccccccccCCcccCCcCCHH
Confidence            99986543111                   11223468999999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.94  E-value=4.5e-27  Score=261.60  Aligned_cols=170  Identities=18%  Similarity=0.205  Sum_probs=146.6

Q ss_pred             cCCccCCeeccc--CcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSG--GTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|++.+.||+|  +||.||+|++..+++.||||++...    ...+.+.+|+++++.++|||||++++++..++..|+|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            479999999999  9999999999999999999998654    2345678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.+...
T Consensus       105 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          105 TSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999764   2345889999999999999999999   789999999999999999999999999998654


Q ss_pred             CCCCCc-----ccccccccccccccCC
Q 003065          830 ENSPKV-----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~-----~~~~~~~gt~~Y~APE  851 (851)
                      ......     .......||+.|+|||
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE  205 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPE  205 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHH
T ss_pred             ccccccccccccccccccccccccCHH
Confidence            322111     1112347999999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.94  E-value=7.6e-27  Score=246.93  Aligned_cols=165  Identities=28%  Similarity=0.394  Sum_probs=147.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ++|++.+.||+|+||.||+|++..++..||+|++...  ...+.+.+|++++++++||||+++++++..++..|+||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            4689999999999999999999999999999998653  45678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE---CCCCceEEeeecCccccC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~  830 (851)
                      ++++|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||++   +.++.+||+|||++....
T Consensus        89 ~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           89 TGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999998764     34789999999999999999999   7899999999999999   788899999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   ....||+.|+|||
T Consensus       161 ~~~~~---~~~~~t~~y~aPE  178 (277)
T 3f3z_A          161 PGKMM---RTKVGTPYYVSPQ  178 (277)
T ss_dssp             TTSCB---CCCCSCTTTCCHH
T ss_pred             Cccch---hccCCCCCccChH
Confidence            44322   2357999999998

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.94  E-value=1.5e-27  Score=260.71  Aligned_cols=173  Identities=29%  Similarity=0.381  Sum_probs=145.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|+..+.||+|+||.||+|++.     .+++.||||++....   ..+.+.+|++++++++||||+++++++..++..|
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            47899999999999999999986     345789999987543   3467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC
Q 003065          748 LVLEYMPNGNLFQALHKRVKE-------------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSS  808 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~  808 (851)
                      +||||+++|+|.+++......                   ....+++..++.++.|+++||+|||   +.+|+||||||+
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~  203 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATR  203 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcc
Confidence            999999999999999864211                   1256899999999999999999999   789999999999


Q ss_pred             CEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          809 NILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       809 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++.++.+||+|||+++...............||+.|+|||
T Consensus       204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  246 (343)
T 1luf_A          204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE  246 (343)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred             eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChh
Confidence            9999999999999999998765433222233456899999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.94  E-value=2.6e-27  Score=266.93  Aligned_cols=167  Identities=28%  Similarity=0.388  Sum_probs=141.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC-----Cee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  746 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++...    ...+.+.+|++++++++||||+++++++...     +..
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            4799999999999999999999999999999998653    2356788999999999999999999999766     568


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||++ ++|.+++..     ...+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       106 ~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            99999995 699998864     345899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCc--------------------ccccccccccccccCC
Q 003065          827 KIAENSPKV--------------------SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~--------------------~~~~~~~gt~~Y~APE  851 (851)
                      +........                    ......+||++|+|||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  221 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE  221 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHH
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence            876543211                    1234578999999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.94  E-value=6.1e-27  Score=253.58  Aligned_cols=160  Identities=27%  Similarity=0.356  Sum_probs=127.6

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEeccCCCCHH
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEYMPNGNLF  759 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  759 (851)
                      .+.||+|+||.||+|++..+++.||||++... ....+.+|+++++.+. ||||+++++++.+++..|+||||+++|+|.
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            47899999999999999999999999998544 4566789999999997 999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC---ceEEeeecCccccCCCCCcc
Q 003065          760 QALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---EPKIADFGVAKIAENSPKVS  836 (851)
Q Consensus       760 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~  836 (851)
                      +++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++   .+||+|||+++........ 
T Consensus        95 ~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-  165 (325)
T 3kn6_A           95 ERIKKK-----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-  165 (325)
T ss_dssp             HHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence            999763     45899999999999999999999   78999999999999998765   7999999999866543222 


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                       .....||+.|+|||
T Consensus       166 -~~~~~~t~~y~aPE  179 (325)
T 3kn6_A          166 -LKTPCFTLHYAAPE  179 (325)
T ss_dssp             ---------------
T ss_pred             -ccccCCCcCccCHH
Confidence             23457899999998

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.94  E-value=3.1e-27  Score=260.66  Aligned_cols=163  Identities=25%  Similarity=0.410  Sum_probs=138.1

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      ...+.||+|+||.||+|++..+++.||+|++...  ...+.+.+|++++++++||||+++++++...+..|+||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            3467899999999999999999999999998765  34567899999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE--CCCCceEEeeecCccccCCCCC
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|.+++...    ...+++..+..++.|+++||+|||   +.+|+||||||+|||+  +.++.+||+|||+++.......
T Consensus       172 ~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          172 ELFDRIIDE----SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             EEHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            999998753    235788999999999999999999   7899999999999999  5678999999999987755432


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .   ....||+.|+|||
T Consensus       245 ~---~~~~gt~~y~aPE  258 (373)
T 2x4f_A          245 L---KVNFGTPEFLAPE  258 (373)
T ss_dssp             C---CCCCSSCTTCCHH
T ss_pred             c---ccccCCCcEeChh
Confidence            2   2356999999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.94  E-value=1.7e-27  Score=255.94  Aligned_cols=167  Identities=35%  Similarity=0.610  Sum_probs=134.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .+|++.+.||+|+||.||+|++  +++.||||++....    ..+.+.+|++++++++||||+++++++...+..|+|||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            4788999999999999999987  57889999986542    34568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |+++|+|.+++.....  ...+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+|||+++..
T Consensus       115 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             CCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             cCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            9999999999975311  123889999999999999999999   678  999999999999999999999999999865


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  ......||+.|+|||
T Consensus       190 ~~~~~--~~~~~~gt~~y~aPE  209 (309)
T 3p86_A          190 ASTFL--SSKSAAGTPEWMAPE  209 (309)
T ss_dssp             --------------CCTTSCHH
T ss_pred             ccccc--ccccCCCCccccChh
Confidence            44322  123457999999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.94  E-value=1.2e-27  Score=257.81  Aligned_cols=168  Identities=24%  Similarity=0.365  Sum_probs=136.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCe----e
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGS----S  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~  746 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++....     ..+.+.+|++++++++||||+++++++...+.    .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            47999999999999999999999999999999986541     23568899999999999999999999876543    4


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+++++|.+++...     ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            9999999999999999764     35889999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCc-ccccccccccccccCC
Q 003065          827 KIAENSPKV-SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~-~~~~~~~gt~~Y~APE  851 (851)
                      +........ .......||+.|+|||
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE  189 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPE  189 (311)
T ss_dssp             ------------------CCTTCCHH
T ss_pred             ccccccccccccccccCcCcccCCHH
Confidence            876543221 2233457999999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.94  E-value=1.7e-27  Score=261.97  Aligned_cols=173  Identities=31%  Similarity=0.390  Sum_probs=144.7

Q ss_pred             cCCccCCeecccCcEEEEEEE-----EcCCCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCCe-
Q 003065          676 CNLEEDNLIGSGGTGKVYRLD-----LKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGGS-  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-  745 (851)
                      ++|++.+.||+|+||.||+|+     ...+++.||||++....   ..+.+.+|+++++++ +||||+++++++...+. 
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            478999999999999999998     44566889999997643   345688999999999 79999999999887554 


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCC--------------------------------------------------------
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEG--------------------------------------------------------  769 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------  769 (851)
                      .|+||||+++|+|.+++.......                                                        
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            899999999999999998653210                                                        


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccc
Q 003065          770 -----KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT  844 (851)
Q Consensus       770 -----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt  844 (851)
                           ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+...............||
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence                 112888999999999999999999   789999999999999999999999999999876554443334456789


Q ss_pred             cccccCC
Q 003065          845 HGYIAPG  851 (851)
Q Consensus       845 ~~Y~APE  851 (851)
                      +.|+|||
T Consensus       259 ~~y~aPE  265 (359)
T 3vhe_A          259 LKWMAPE  265 (359)
T ss_dssp             GGGCCHH
T ss_pred             ceeEChh
Confidence            9999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.94  E-value=4.4e-27  Score=249.87  Aligned_cols=169  Identities=25%  Similarity=0.364  Sum_probs=143.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ++|.+.+.||+|+||.||+|++..++..||+|++...   ...+.+.+|++++++++||||+++++++...+..|+||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            4789999999999999999999999999999998654   3467889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE---CCCCceEEeeecCcccc
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIA  829 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~  829 (851)
                      +++|+|.+++..... ....+++..+..++.|+++||+|||   +.+|+||||||+||++   +.++.+||+|||+++..
T Consensus       102 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          102 CEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            999999999976432 2346889999999999999999999   7899999999999999   45678999999999866


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   .....||+.|+|||
T Consensus       178 ~~~~~---~~~~~~t~~y~aPE  196 (285)
T 3is5_A          178 KSDEH---STNAAGTALYMAPE  196 (285)
T ss_dssp             ------------CTTGGGCCHH
T ss_pred             CCccc---CcCcccccCcCChH
Confidence            54322   23357999999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.94  E-value=7.1e-27  Score=245.86  Aligned_cols=167  Identities=28%  Similarity=0.364  Sum_probs=145.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|++. ++..||||++... ...+.+.+|++++++++||||+++++++..++..|+||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            47889999999999999999885 5678999998665 356778999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...    ...+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        87 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           87 NGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             TCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             CCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            99999999775    235889999999999999999999   78999999999999999999999999999987655432


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .. .....||+.|+|||
T Consensus       160 ~~-~~~~~~~~~y~aPE  175 (268)
T 3sxs_A          160 VS-SVGTKFPVKWSAPE  175 (268)
T ss_dssp             EE-CCSCCCCGGGCCHH
T ss_pred             hc-ccCCCcCcccCCHH
Confidence            22 23345788899998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=1.7e-27  Score=259.06  Aligned_cols=167  Identities=32%  Similarity=0.429  Sum_probs=146.8

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----------cHHHHHHHHHHHHcCCCCccccEEEEEEeC
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIRHRNILKLYACLLKG  743 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  743 (851)
                      ...+|++.+.||+|+||.||+|++..+++.||||++....          ..+.+.+|++++++++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4467999999999999999999999999999999986542          233567899999999999999999999999


Q ss_pred             CeeEEEEeccCCC-CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          744 GSSFLVLEYMPNG-NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       744 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      +..++||||+.+| +|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred             CEEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEee
Confidence            9999999999776 99998875     345899999999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++.......   .....||+.|+|||
T Consensus       174 fg~a~~~~~~~~---~~~~~gt~~y~aPE  199 (335)
T 3dls_A          174 FGSAAYLERGKL---FYTFCGTIEYCAPE  199 (335)
T ss_dssp             CTTCEECCTTCC---BCEECSCGGGCCHH
T ss_pred             cccceECCCCCc---eeccCCCccccChh
Confidence            999987765432   23357999999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.94  E-value=4.8e-27  Score=252.83  Aligned_cols=166  Identities=27%  Similarity=0.352  Sum_probs=141.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .++|++.+.||+|+||.||+|++. +++.||||++....    ..+.+.+|++++++++||||+++++++..++..|+||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            357899999999999999999994 58899999986432    2467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||++ +++.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus        99 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           99 EFME-KDLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             ECCS-EEHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             cCCC-CCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            9997 5888887653    345889999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  .....||+.|+|||
T Consensus       171 ~~~~~--~~~~~~t~~y~aPE  189 (311)
T 3niz_A          171 IPVRS--YTHEVVTLWYRAPD  189 (311)
T ss_dssp             SCCC-----CCCCCCTTCCHH
T ss_pred             CCccc--ccCCcccCCcCCHH
Confidence            43222  23357899999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.94  E-value=3.5e-27  Score=254.36  Aligned_cols=173  Identities=27%  Similarity=0.356  Sum_probs=147.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      .+|.+.+.||+|+||.||+|++.     .++..||||++....   ..+.+.+|++++++++||||+++++++...+..|
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            46889999999999999999983     445789999986543   3467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC
Q 003065          748 LVLEYMPNGNLFQALHKRVKE-------------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSS  808 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~  808 (851)
                      +||||+++++|.+++......                   ....+++..++.++.|+++||+|||   +.+|+||||||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~  179 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAAR  179 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGG
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchh
Confidence            999999999999999875321                   1234789999999999999999999   789999999999


Q ss_pred             CEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          809 NILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       809 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++.++.+||+|||+++...............||+.|+|||
T Consensus       180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  222 (314)
T 2ivs_A          180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE  222 (314)
T ss_dssp             GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChh
Confidence            9999999999999999998776544333334456889999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.94  E-value=2.5e-27  Score=252.21  Aligned_cols=165  Identities=30%  Similarity=0.398  Sum_probs=139.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|+..+.||+|+||.||+|++ .+++.||||++....    ..+.+.+|++++++++||||+++++++..++..|+|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            4789999999999999999998 678999999985432    24678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++ +|.+++...    ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus        81 ~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             CCSE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             ecCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            9974 999888753    345888999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ......||+.|+|||
T Consensus       153 ~~~--~~~~~~~t~~y~aPE  170 (288)
T 1ob3_A          153 PVR--KYTHEIVTLWYRAPD  170 (288)
T ss_dssp             -----------CCCTTCCHH
T ss_pred             ccc--ccccccccccccCch
Confidence            322  123356899999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.94  E-value=6e-27  Score=259.72  Aligned_cols=173  Identities=29%  Similarity=0.388  Sum_probs=147.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC-------CcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN-------AGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGG  744 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  744 (851)
                      ++|.+.+.||+|+||.||+|++...       +..||||++....   ..+.+.+|+++++++ +||||+++++++..++
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            4688899999999999999997533       3579999986653   346688999999999 9999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      ..|+||||+++|+|.+++......           ....+++..++.++.|++.||+|||   +.+|+||||||+||+++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEc
Confidence            999999999999999999875321           1245899999999999999999999   78999999999999999


Q ss_pred             CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++.+||+|||+|+...............||+.|+|||
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE  263 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE  263 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHH
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHH
Confidence            99999999999998776544333344456899999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.94  E-value=7.5e-27  Score=247.28  Aligned_cols=165  Identities=35%  Similarity=0.519  Sum_probs=143.3

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +++|++.+.||+|+||.||+|++..++..||||++...     ...+.+.+|++++++++||||+++++++...+..|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            35789999999999999999999999999999998543     2356688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            9999999999999764     34788999999999999999999   789999999999999999999999999998655


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....    .....||+.|+|||
T Consensus       160 ~~~~----~~~~~~~~~y~aPE  177 (279)
T 3fdn_A          160 PSSR----RTDLCGTLDYLPPE  177 (279)
T ss_dssp             ------------CCCCTTCCHH
T ss_pred             Cccc----ccccCCCCCccCHh
Confidence            4332    22357899999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.94  E-value=3e-27  Score=248.86  Aligned_cols=167  Identities=26%  Similarity=0.374  Sum_probs=145.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|++. +++.||+|++... ...+++.+|++++++++||||+++++++.+++..|+||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            36889999999999999999985 5778999998765 356789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...    ...+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        89 ~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           89 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             TCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            99999999753    345889999999999999999999   78999999999999999999999999999986654321


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                       .......||+.|+|||
T Consensus       162 -~~~~~~~~~~~y~aPE  177 (269)
T 4hcu_A          162 -TSSTGTKFPVKWASPE  177 (269)
T ss_dssp             -HSTTSTTCCGGGCCHH
T ss_pred             -ccccCcccccccCCHH
Confidence             1222345788999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.94  E-value=2.7e-27  Score=261.28  Aligned_cols=169  Identities=30%  Similarity=0.480  Sum_probs=133.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEc---CCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|++.+.||+|+||.||+|++.   .++..||||++...   ...+.+.+|++++++++||||+++++++..++..|+|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47899999999999999999986   45677999998654   2346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++...    ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       125 ~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          125 TEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999753    346899999999999999999999   779999999999999999999999999999876


Q ss_pred             CCCCCcc-cccccccccccccCC
Q 003065          830 ENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ....... ......+|+.|+|||
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE  220 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPE  220 (373)
T ss_dssp             ----------------CTTSCHH
T ss_pred             ccCCccceeccCCCcCCCccChh
Confidence            5442211 122234678899998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.94  E-value=7.9e-27  Score=246.94  Aligned_cols=168  Identities=32%  Similarity=0.452  Sum_probs=135.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +++|++.+.||+|+||.||+|++..+++.||||++...     ...+.+.+|++++++++||||+++++++...+..|+|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            45789999999999999999999989999999998543     2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|.+++...    ...+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             EECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            9999999999998753    346889999999999999999999   779999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  .....||+.|+|||
T Consensus       163 ~~~~~~--~~~~~~~~~y~aPE  182 (278)
T 3cok_A          163 KMPHEK--HYTLCGTPNYISPE  182 (278)
T ss_dssp             C---------------------
T ss_pred             cCCCCc--ceeccCCCCcCCcc
Confidence            543221  22356999999998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.94  E-value=2.7e-27  Score=257.61  Aligned_cols=173  Identities=27%  Similarity=0.381  Sum_probs=146.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc-----EEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG-----TVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      .+|+..+.||+|+||.||+|.+..+++     .||+|++....   ..+.+.+|+++++++ +||||+++++++..++..
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            478899999999999999999876554     79999986553   356788999999999 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKE---------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE  817 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~  817 (851)
                      |+||||+++|+|.+++......         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCe
Confidence            9999999999999999865321         1235789999999999999999999   779999999999999999999


Q ss_pred             eEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       818 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +||+|||+++...............||+.|+|||
T Consensus       203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  236 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE  236 (333)
T ss_dssp             EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHH
T ss_pred             EEECccccccccccccceeecCCCCCCccccCHH
Confidence            9999999998765443333333456788999998

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=4.6e-31  Score=311.11  Aligned_cols=457  Identities=11%  Similarity=0.082  Sum_probs=275.8

Q ss_pred             CcccceeEecCCCCceEEEecccCCcceecC-ccccCCccCcEEeCCCCcccC---ccC------------cccccCCCC
Q 003065           60 PCGFSGITCDSVTGRVTEISFDNKSLSGEIS-SSISALQSLTVLSLPFNVLSG---KLP------------LELSNCSNL  123 (851)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~-~~l~~l~~L~~L~L~~n~l~~---~~p------------~~~~~l~~L  123 (851)
                      |++|.++...    ....+++....  +..+ ..+..+++|++|+|+++....   ..|            .....+++|
T Consensus        34 ck~W~~~~~~----~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L  107 (594)
T 2p1m_B           34 CKSWYEIERW----CRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL  107 (594)
T ss_dssp             CHHHHHHHHH----HCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HHHHHHhhhh----hceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence            5688887221    23344444322  1122 345667888888888865321   111            123467788


Q ss_pred             ceEecccCcccCCCCC-CC-CCCCCCeEeccCc-ccCCC-CcccccCccccceeecccccCCCCC---CcccccCCCCCC
Q 003065          124 KVLNVTGNAMVGSVPD-LS-ALKNLEIFDLSIN-YFTGR-FPRWVVNLTQLVSLSIGDNVYDEAE---IPESIGNLKNLT  196 (851)
Q Consensus       124 ~~L~Ls~n~l~~~~~~-l~-~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~---~p~~~~~l~~L~  196 (851)
                      ++|+|++|.+++..+. +. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.++...   ++.....+++|+
T Consensus       108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~  187 (594)
T 2p1m_B          108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV  187 (594)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred             CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence            8888888877654433 43 5778888888877 44432 3333446778888888877765211   222233566788


Q ss_pred             eEeccccc--cccc-CCcccccccccCccccccc-cccccccccccCCCcccEEEeecc-------CccCcCCcCcCCCC
Q 003065          197 YLFLAHCN--LRGR-IPESISELRELGTLDICRN-KISGEFPRSIRKLQKLWKIELYAN-------NLTGELPAELGNLT  265 (851)
Q Consensus       197 ~L~L~~n~--l~~~-~p~~~~~l~~L~~L~L~~N-~i~~~~p~~~~~l~~L~~L~L~~N-------~l~~~~p~~~~~l~  265 (851)
                      +|++++|.  +... ++..+..+++|++|++++| .+.+ +|..+..+++|++|+++.+       .+.+ ++..+.+++
T Consensus       188 ~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~  265 (594)
T 2p1m_B          188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCK  265 (594)
T ss_dssp             EEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCT
T ss_pred             EEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCC
Confidence            88887776  2211 1111234577777777777 4443 6667777777777774433       3332 233556666


Q ss_pred             cccEE-ecccccccCCCCccccCcCCccEEEccCCccCCCCCC-CCCCcccccEEEeccCcCCCC-CCCccCCCCcccee
Q 003065          266 LLQEF-DISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPS-GFGDMRKLFAFSIYGNRFSGP-FPENLGRYTALTDV  342 (851)
Q Consensus       266 ~L~~L-~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L  342 (851)
                      +|+.| ++.+... +.++..+..+++|+.|++++|.+++.... .+..+++|+.|++++| ++.. ++.....+++|++|
T Consensus       266 ~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L  343 (594)
T 2p1m_B          266 ELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLREL  343 (594)
T ss_dssp             TCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEE
T ss_pred             CcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEE
Confidence            67666 3333322 23444444566777777777665432111 1345566666666665 3211 11112235566666


Q ss_pred             eccCCcccccCchhhhhhcchHHHHhccCCccccccccc-cCccccceeccccCccccccCCccc-CccccceEEec--C
Q 003065          343 DISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSY-ADCKTIQRLRISDNHLSGKIPDGLW-ALPNVGMLDFG--D  418 (851)
Q Consensus       343 ~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~  418 (851)
                      +++++.-.|               ....+.+++.....+ ..+++|++|+++.|.+++..+..+. .+++|+.|+++  +
T Consensus       344 ~L~~~~~~g---------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~  408 (594)
T 2p1m_B          344 RVFPSEPFV---------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIE  408 (594)
T ss_dssp             EEECSCTTC---------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESS
T ss_pred             EEecCcccc---------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeeccc
Confidence            663321000               001122222211222 2467899999988998877666665 48899999998  4


Q ss_pred             ----CcCCCCCC-----cccccCCCCCeEecCCCcceeeCCccccc-CCCCcEEeccCccccCCCcccc-ccCCcccEEE
Q 003065          419 ----NDFTGGIS-----PLIGLSTSLSQLVLQNNRFSGELPSELGR-LTNLERLILTNNNFSGKIPSAL-GALRQLSSLH  487 (851)
Q Consensus       419 ----N~l~~~~~-----~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~  487 (851)
                          |++++.+.     ..+..+++|+.|+|++ .+++..+..+.. +++|++|+|++|.+++..+..+ ..+++|+.|+
T Consensus       409 ~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~  487 (594)
T 2p1m_B          409 PKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLE  487 (594)
T ss_dssp             TTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEE
T ss_pred             CCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEE
Confidence                56664322     2356788999999987 777666666665 8999999999999976555555 6789999999


Q ss_pred             ecCCcccCCCCC-CcccccccceeeccCcccccccCCCc-cccccCCeEeCCCCccc
Q 003065          488 LEENALTGSIPN-EMGDCARIVDLNLARNSLSGNIPRSL-SLLSSLNALNLSGNKLT  542 (851)
Q Consensus       488 Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~  542 (851)
                      |++|.+++..+. .+..+++|+.|++++|.++......+ ..+++|+...+..+.-.
T Consensus       488 L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~  544 (594)
T 2p1m_B          488 IRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP  544 (594)
T ss_dssp             EESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred             CcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence            999999654443 44568999999999999865544444 45778877777776544

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.94  E-value=1.2e-26  Score=247.82  Aligned_cols=170  Identities=26%  Similarity=0.372  Sum_probs=148.8

Q ss_pred             HHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCee
Q 003065          672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS  746 (851)
Q Consensus       672 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  746 (851)
                      .....+|...+.||+|+||.||+|++..+++.||+|++...     ...+.+.+|+++++.++||||+++++++..++..
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            34456799999999999999999999999999999998543     2356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+++++|.+++...     ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  162 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA  162 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCc
Confidence            9999999999999988764     35889999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +........  .....||+.|+|||
T Consensus       163 ~~~~~~~~~--~~~~~~~~~y~aPE  185 (294)
T 2rku_A          163 TKVEYDGER--KKVLCGTPNYIAPE  185 (294)
T ss_dssp             EECCSTTCC--BCCCCSCCSSCCHH
T ss_pred             eecccCccc--cccccCCCCcCCcc
Confidence            876543222  23357999999998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.94  E-value=9e-27  Score=252.03  Aligned_cols=165  Identities=27%  Similarity=0.363  Sum_probs=146.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++....        ..+.+.+|++++++++||||+++++++...+..|
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46899999999999999999999999999999986532        3677999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC----ceEEeee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIADF  823 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DF  823 (851)
                      +||||+++++|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+||
T Consensus        92 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999875     245789999999999999999999   78999999999999999887    7999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++.......   .....||+.|+|||
T Consensus       164 g~~~~~~~~~~---~~~~~gt~~y~aPE  188 (321)
T 2a2a_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPE  188 (321)
T ss_dssp             TTCEECCTTCC---CCCCCSCGGGCCHH
T ss_pred             ccceecCcccc---ccccCCCCCccCcc
Confidence            99987665432   23357999999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.94  E-value=1e-26  Score=248.75  Aligned_cols=168  Identities=18%  Similarity=0.220  Sum_probs=147.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+|++.+.||+|+||.||+|++..+++.||||++......+.+.+|+++++++ +|++++++++++..+...|+||||+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            36899999999999999999999999999999987766666788999999999 7999999999999999999999999 


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc-----eEEeeecCcccc
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-----PKIADFGVAKIA  829 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~  829 (851)
                      +++|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||+|+..
T Consensus        89 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           89 GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99999999764    335899999999999999999999   889999999999999987776     999999999876


Q ss_pred             CCCCCc-----ccccccccccccccCC
Q 003065          830 ENSPKV-----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~-----~~~~~~~gt~~Y~APE  851 (851)
                      ......     .......||+.|+|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE  188 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSIN  188 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred             ccccccccccccCccCCCCCcccCCch
Confidence            654321     1223467999999998

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=2.5e-30  Score=304.90  Aligned_cols=434  Identities=15%  Similarity=0.161  Sum_probs=294.7

Q ss_pred             cEEeCCCCcccCccC-cccccCCCCceEecccCcccC---CCC------------C-CCCCCCCCeEeccCcccCCCCcc
Q 003065          100 TVLSLPFNVLSGKLP-LELSNCSNLKVLNVTGNAMVG---SVP------------D-LSALKNLEIFDLSINYFTGRFPR  162 (851)
Q Consensus       100 ~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~---~~~------------~-l~~l~~L~~L~Ls~N~l~~~~~~  162 (851)
                      +.+++++...  ..| ..+..+++|++|+|+++....   ..|            . ...+++|++|+|++|.+++..+.
T Consensus        46 ~~l~~~~~~~--~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~  123 (594)
T 2p1m_B           46 RKVFIGNCYA--VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLE  123 (594)
T ss_dssp             CEEEESSTTS--SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHH
T ss_pred             eEEeeccccc--cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHH
Confidence            3555554332  223 346788999999999986432   111            1 23678999999999998877777


Q ss_pred             ccc-Cccccceeecccc-cCCCCCCcccccCCCCCCeEecccccccccCCcccc----cccccCcccccccc--cccc-c
Q 003065          163 WVV-NLTQLVSLSIGDN-VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESIS----ELRELGTLDICRNK--ISGE-F  233 (851)
Q Consensus       163 ~~~-~l~~L~~L~L~~N-~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~L~~L~L~~N~--i~~~-~  233 (851)
                      .+. .+++|++|+|++| .+....++..+.++++|++|+|++|.+++..+..+.    .+++|++|++++|.  ++.. +
T Consensus       124 ~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l  203 (594)
T 2p1m_B          124 LIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSAL  203 (594)
T ss_dssp             HHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHH
T ss_pred             HHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHH
Confidence            775 6889999999888 454223455556789999999999998766555444    56689999998886  3211 2


Q ss_pred             cccccCCCcccEEEeecc-CccCcCCcCcCCCCcccEEecccc-------cccCCCCccccCcCCccEE-EccCCccCCC
Q 003065          234 PRSIRKLQKLWKIELYAN-NLTGELPAELGNLTLLQEFDISSN-------QMYGKLPEEIGNLKNLTVF-QCFKNNFSGE  304 (851)
Q Consensus       234 p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N-------~l~~~~p~~l~~l~~L~~L-~l~~N~l~~~  304 (851)
                      +..+.++++|++|++++| .+. .+|..+..+++|++|+++.+       .+.+ ++..+.++++|+.| .+.+... +.
T Consensus       204 ~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~  280 (594)
T 2p1m_B          204 ERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AY  280 (594)
T ss_dssp             HHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GG
T ss_pred             HHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hh
Confidence            223355688999999888 444 36777778888888885443       3443 34467778888887 3333222 23


Q ss_pred             CCCCCCCcccccEEEeccCcCCCCCC-CccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccC
Q 003065          305 FPSGFGDMRKLFAFSIYGNRFSGPFP-ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYAD  383 (851)
Q Consensus       305 ~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~  383 (851)
                      ++..+..+++|+.|++++|.+++... ..+..+++|+.|++++| +.+.                       .++.....
T Consensus       281 l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~-----------------------~l~~l~~~  336 (594)
T 2p1m_B          281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDA-----------------------GLEVLAST  336 (594)
T ss_dssp             GGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHH-----------------------HHHHHHHH
T ss_pred             HHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHH-----------------------HHHHHHHh
Confidence            33334456778888888777653322 22456777777777776 3311                       11112234


Q ss_pred             ccccceecc---------ccCccccccCCccc-CccccceEEecCCcCCCCCCcccc-cCCCCCeEecC--C----Ccce
Q 003065          384 CKTIQRLRI---------SDNHLSGKIPDGLW-ALPNVGMLDFGDNDFTGGISPLIG-LSTSLSQLVLQ--N----NRFS  446 (851)
Q Consensus       384 l~~L~~L~L---------s~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~-~~~~L~~L~Ls--~----N~l~  446 (851)
                      +++|++|++         +.|.+++.....+. ++++|+.|+++.|++++.....+. .+++|+.|+|+  +    |.++
T Consensus       337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~  416 (594)
T 2p1m_B          337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT  416 (594)
T ss_dssp             CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT
T ss_pred             CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc
Confidence            678899988         44566654444443 489999999999999876555554 58999999999  4    6666


Q ss_pred             ee-----CCcccccCCCCcEEeccCccccCCCcccccc-CCcccEEEecCCcccCCCCCCc-ccccccceeeccCccccc
Q 003065          447 GE-----LPSELGRLTNLERLILTNNNFSGKIPSALGA-LRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLSG  519 (851)
Q Consensus       447 ~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~  519 (851)
                      +.     ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++
T Consensus       417 ~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~  495 (594)
T 2p1m_B          417 LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD  495 (594)
T ss_dssp             CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred             CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence            22     223367789999999988 777655556655 8999999999999976655555 678999999999999976


Q ss_pred             ccCC-CccccccCCeEeCCCCccccccCccc-ccc-cceEEeCcCCc
Q 003065          520 NIPR-SLSLLSSLNALNLSGNKLTGSIPDNL-MKL-KLSSIDLSENQ  563 (851)
Q Consensus       520 ~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~l-~~l-~L~~l~ls~N~  563 (851)
                      ..+. ....+++|+.|++++|+++......+ ..+ .++...+..+.
T Consensus       496 ~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~  542 (594)
T 2p1m_B          496 KALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG  542 (594)
T ss_dssp             HHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred             HHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence            5544 44568999999999999965443334 223 45555555554

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.94  E-value=5e-27  Score=254.69  Aligned_cols=173  Identities=43%  Similarity=0.739  Sum_probs=147.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ++|+..+.||+|+||.||+|++ .+++.||||++....   ....+.+|+++++.++||||+++++++...+..++||||
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            5799999999999999999986 468899999986543   223688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++|+|.+++.... .....+++..+..++.|++.||+|||..+..+|+||||||+||+++.++.+||+|||+|+.....
T Consensus       109 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  187 (326)
T 3uim_A          109 MANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK  187 (326)
T ss_dssp             CTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred             ccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence            99999999998642 23445899999999999999999999543349999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ... ......||+.|+|||
T Consensus       188 ~~~-~~~~~~gt~~y~aPE  205 (326)
T 3uim_A          188 DTH-VTTAVRGTIGHIAPE  205 (326)
T ss_dssp             SSC-EECCCCSCGGGCCHH
T ss_pred             ccc-ccccccCCcCccCHH
Confidence            322 223456999999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.94  E-value=8.9e-27  Score=250.89  Aligned_cols=167  Identities=23%  Similarity=0.374  Sum_probs=140.3

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc----HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +++|+..+.||+|+||.||+|++..+++.||||++.....    .+.+.+|++++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            3579999999999999999999999999999998865432    456789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||++++++.+++..     ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus        82 e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           82 EYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             ECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            99999998887754     245889999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  .....||+.|+|||
T Consensus       154 ~~~~~--~~~~~~~~~y~aPE  172 (311)
T 4agu_A          154 GPSDY--YDDEVATRWYRSPE  172 (311)
T ss_dssp             --------------GGGCCHH
T ss_pred             Ccccc--cCCCcCCccccChH
Confidence            43322  23357899999998

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.94  E-value=3.6e-27  Score=255.76  Aligned_cols=168  Identities=23%  Similarity=0.344  Sum_probs=137.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcE----EEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|+..+.||+|+||.||+|++..+++.    ||+|.+...   ...+.+.+|++++++++||||+++++++..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            4688999999999999999998777665    577776433   34577899999999999999999999998754 789


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+||+++|+|.+++...    ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        94 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            99999999999999763    346889999999999999999999   77999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..............||+.|+|||
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE  189 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALE  189 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHH
T ss_pred             ccCCcccccccCCCccccccChH
Confidence            76554443334456788999998

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.94  E-value=4.5e-27  Score=254.64  Aligned_cols=173  Identities=24%  Similarity=0.346  Sum_probs=129.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc---EEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCee--
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS--  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  746 (851)
                      .+|+..+.||+|+||.||+|++..++.   .||||++...    ...+.+.+|++++++++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            378999999999999999999877665   7999998643    3457789999999999999999999999876655  


Q ss_pred             ----EEEEeccCCCCHHHHHHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEe
Q 003065          747 ----FLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA  821 (851)
Q Consensus       747 ----~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~  821 (851)
                          |+||||+++|+|.+++...... ....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEe
Confidence                9999999999999999765432 2235899999999999999999999   7899999999999999999999999


Q ss_pred             eecCccccCCCCCcccccccccccccccCC
Q 003065          822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       822 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |||+|+...............+|+.|+|||
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  209 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALE  209 (323)
T ss_dssp             CCCC-----------------CCGGGCCHH
T ss_pred             eccccccccccccccccccccCcccccCch
Confidence            999998765544333333446788999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.94  E-value=1.2e-26  Score=252.62  Aligned_cols=171  Identities=26%  Similarity=0.379  Sum_probs=149.7

Q ss_pred             cHHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCe
Q 003065          671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS  745 (851)
Q Consensus       671 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  745 (851)
                      +.....+|.+.+.||+|+||.||+|++..+++.||+|++...     ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  115 (335)
T 2owb_A           36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF  115 (335)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            334456899999999999999999999999999999998643     245678899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+||||+++++|.+++...     ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  187 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGL  187 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccC
Confidence            99999999999999988764     35889999999999999999999   77999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++........  .....||+.|+|||
T Consensus       188 ~~~~~~~~~~--~~~~~gt~~y~aPE  211 (335)
T 2owb_A          188 ATKVEYDGER--KKVLCGTPNYIAPE  211 (335)
T ss_dssp             CEECCSTTCC--BCCCCSCCSSCCHH
T ss_pred             ceecccCccc--ccccCCCccccCHH
Confidence            9876543222  23357999999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.94  E-value=1.8e-26  Score=245.03  Aligned_cols=165  Identities=28%  Similarity=0.417  Sum_probs=145.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    ..+.+.+|++++++++||||+++++++..++..|+|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            47899999999999999999999999999999986542    34668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc---eEEeeecCccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAKI  828 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~  828 (851)
                      |+++++|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.   +||+|||.+..
T Consensus        86 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           86 LVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             cCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999988764     35889999999999999999999   789999999999999986655   99999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......   .....||+.|+|||
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE  177 (284)
T 3kk8_A          158 VNDSEA---WHGFAGTPGYLSPE  177 (284)
T ss_dssp             CCSSCB---CCCSCSCGGGCCHH
T ss_pred             cccCcc---ccCCCCCcCCcCch
Confidence            654432   23357999999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.94  E-value=2.8e-27  Score=252.81  Aligned_cols=169  Identities=28%  Similarity=0.422  Sum_probs=139.0

Q ss_pred             cCCccCCeecccCcEEEEEEE----EcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLD----LKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  747 (851)
                      .+|++.+.||+|+||.||+|+    +..+++.||||++....  ..+.+.+|++++++++||||+++++++...  ...|
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            478899999999999999998    45678899999986543  346788999999999999999999998653  5589


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++|+|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        90 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            999999999999999764    235889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCc-ccccccccccccccCC
Q 003065          828 IAENSPKV-SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~-~~~~~~~gt~~Y~APE  851 (851)
                      ........ .......||+.|+|||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE  187 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPE  187 (295)
T ss_dssp             -------------CTTCGGGGCCHH
T ss_pred             cccCCcceeeeccCCCCccceeCcH
Confidence            76543321 1122345788899998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.94  E-value=1e-26  Score=254.15  Aligned_cols=161  Identities=34%  Similarity=0.516  Sum_probs=142.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .|+..+.||+|+||.||+|++..+++.||||++...     ...+.+.+|++++++++||||+++++++..++..|+|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            588889999999999999999999999999998643     223568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |++ |++.+++...    ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       135 ~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          135 YCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             CCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             cCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            996 6888888654    346889999999999999999999   67999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .      ....||+.|+|||
T Consensus       207 ~------~~~~gt~~y~aPE  220 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPE  220 (348)
T ss_dssp             B------CCCCSCGGGCCHH
T ss_pred             C------CcccCCcceeCHh
Confidence            2      2357999999998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.94  E-value=7.1e-27  Score=260.26  Aligned_cols=165  Identities=26%  Similarity=0.359  Sum_probs=133.5

Q ss_pred             HcCCccC-CeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHH-cCCCCccccEEEEEEe----CCeeEE
Q 003065          675 ICNLEED-NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILG-KIRHRNILKLYACLLK----GGSSFL  748 (851)
Q Consensus       675 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~l  748 (851)
                      +.+|.+. +.||+|+||+||+|.+..+++.||||++...   ..+.+|++++. ..+||||+++++++..    .+..|+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            3567765 6899999999999999999999999998643   45678998874 4589999999998875    567899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---CCceEEeeecC
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGV  825 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGl  825 (851)
                      ||||+++|+|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+
T Consensus       137 v~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            99999999999999753   2345899999999999999999999   789999999999999997   78999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+.......   ....+||+.|+|||
T Consensus       211 a~~~~~~~~---~~~~~gt~~y~aPE  233 (400)
T 1nxk_A          211 AKETTSHNS---LTTPCYTPYYVAPE  233 (400)
T ss_dssp             CEECC--------------CTTCCGG
T ss_pred             ccccCCCCc---cccCCCCCCccCHh
Confidence            987654322   23457999999998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.94  E-value=7.9e-27  Score=276.25  Aligned_cols=168  Identities=29%  Similarity=0.384  Sum_probs=147.7

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  747 (851)
                      .+.+|++.+.||+|+||+||+|+++.+++.||||++.+.     ...+.+..|.+++..+ +||+|+++++++++.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            346899999999999999999999999999999998643     3456678899999988 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++|+|.+++...     ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence            999999999999999864     35889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  .....+||+.|||||
T Consensus       491 ~~~~~~~--~~~~~~GT~~Y~APE  512 (674)
T 3pfq_A          491 ENIWDGV--TTKTFCGTPDYIAPE  512 (674)
T ss_dssp             ECCCTTC--CBCCCCSCSSSCCHH
T ss_pred             ccccCCc--ccccccCCCcccCHh
Confidence            6443322  234468999999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=8.1e-27  Score=254.08  Aligned_cols=165  Identities=27%  Similarity=0.336  Sum_probs=141.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEecc
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .++|+..+.||+|+||.||+|+++.+++.||||++.+...  ...+|++++.++ +||||+++++++.+++..|+||||+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            3478999999999999999999999999999999865432  235788888888 7999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC----CceEEeeecCcccc
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED----YEPKIADFGVAKIA  829 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~  829 (851)
                      ++|+|.+++.+.     ..+++..+..++.|++.||+|||   +.+|+||||||+||++.++    +.+||+|||+|+..
T Consensus        99 ~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           99 KGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999998753     35889999999999999999999   7899999999999998533    35999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  ....+||+.|+|||
T Consensus       171 ~~~~~~--~~~~~gt~~y~aPE  190 (342)
T 2qr7_A          171 RAENGL--LMTPCYTANFVAPE  190 (342)
T ss_dssp             BCTTCC--BCCSSCCSSCCCHH
T ss_pred             cCCCCc--eeccCCCccccCHH
Confidence            544322  23457999999998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.94  E-value=4.8e-27  Score=269.08  Aligned_cols=169  Identities=25%  Similarity=0.391  Sum_probs=148.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+|+..+.||+|+||.||+|++..++..||||++... ...+.+.+|++++++++||||+++++++...+..|+||||++
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            3678889999999999999999888999999998654 457789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++...   ....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus       300 ~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          300 YGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             TCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             CCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999763   3346889999999999999999999   78999999999999999999999999999987654322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                       .......+++.|+|||
T Consensus       374 -~~~~~~~~~~~y~aPE  389 (495)
T 1opk_A          374 -TAHAGAKFPIKWTAPE  389 (495)
T ss_dssp             -ECCTTCCCCGGGCCHH
T ss_pred             -eecCCCcCCcceeCHh
Confidence             2223345678999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.94  E-value=6e-27  Score=247.52  Aligned_cols=170  Identities=29%  Similarity=0.400  Sum_probs=148.5

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+++|++.+.||+|+||.||+|++..+++.||||++...   ...+.+.+|+++++.++||||+++++++..++..|+||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            356899999999999999999999989999999998543   34577889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.++...
T Consensus        85 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           85 EYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             ECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            99999999887753     345889999999999999999999   7899999999999999999999999999998665


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ............||+.|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE  177 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPE  177 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGG
T ss_pred             CCcchhcccCCccccCccChH
Confidence            433222234467999999998

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.94  E-value=1.5e-26  Score=247.85  Aligned_cols=169  Identities=28%  Similarity=0.395  Sum_probs=144.0

Q ss_pred             cCCccCCeecccCcEEEEEEE----EcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeC--Cee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLD----LKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  746 (851)
                      ..|+..+.||+|+||.||+|+    +..+++.||||++...   ...+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            358899999999999999999    4568889999998654   3457789999999999999999999999876  668


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+++|+|.+++...    ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence            9999999999999999764    345889999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCc-ccccccccccccccCC
Q 003065          827 KIAENSPKV-SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~-~~~~~~~gt~~Y~APE  851 (851)
                      +........ .......||+.|+|||
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE  199 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPE  199 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCe
Confidence            877654322 1223456899999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.94  E-value=1.7e-26  Score=245.56  Aligned_cols=168  Identities=21%  Similarity=0.296  Sum_probs=145.2

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  748 (851)
                      ...+|++.+.||+|+||.||+|++..+++.||||++...    .....+.+|+..+..+ +||||+++++++..++..|+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            345799999999999999999999989999999998653    3456788999999999 99999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-------------
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-------------  815 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-------------  815 (851)
                      ||||+++++|.+++..... ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.+             
T Consensus        89 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC---------------
T ss_pred             EEEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            9999999999999987532 2245889999999999999999999   7899999999999999844             


Q ss_pred             ------CceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          816 ------YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       816 ------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                            ..+||+|||.++.......      ..||+.|+|||
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE  200 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANE  200 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSCC------CCCCGGGCCHH
T ss_pred             cccCCceEEEEcccccccccCCccc------cCCCccccChh
Confidence                  4799999999987654322      35899999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.94  E-value=2.1e-26  Score=253.36  Aligned_cols=164  Identities=24%  Similarity=0.299  Sum_probs=144.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCC-----CCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIR-----HRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv  749 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++... ...+.+..|+++++.++     ||||+++++++...+..|+|
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv  114 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI  114 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence            4799999999999999999999999999999998653 34566788999999986     99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---------------
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---------------  814 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---------------  814 (851)
                      |||+ +++|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.               
T Consensus       115 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          115 FEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             ECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             EcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcccc
Confidence            9999 99999999864   2345889999999999999999999   789999999999999975               


Q ss_pred             ----------CCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          815 ----------DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       815 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                                ++.+||+|||+|+......     ....||+.|+|||
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE  229 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPE  229 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHH
T ss_pred             cccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcH
Confidence                      7899999999998654332     2357999999998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=2.1e-26  Score=264.94  Aligned_cols=165  Identities=32%  Similarity=0.435  Sum_probs=144.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---------------ccHHHHHHHHHHHHcCCCCccccEEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---------------DGVKVFAAEMEILGKIRHRNILKLYACL  740 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---------------~~~~~~~~E~~~l~~l~h~niv~l~~~~  740 (851)
                      .+|.+.+.||+|+||.||+|+++.+++.||||++...               ...+.+.+|++++++++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            5799999999999999999999999999999998643               2346788999999999999999999999


Q ss_pred             EeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC---c
Q 003065          741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---E  817 (851)
Q Consensus       741 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~---~  817 (851)
                      ..++..|+||||+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++   .
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSS
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999998764     35889999999999999999999   78999999999999998776   6


Q ss_pred             eEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       818 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +||+|||+|+.......   .....||+.|+|||
T Consensus       188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE  218 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE  218 (504)
T ss_dssp             EEECCCTTCEECCTTSC---BCCCCSCTTTCCHH
T ss_pred             EEEEECCCCEEcCCCCc---cccccCCcCCCCHH
Confidence            99999999987765432   23357999999998

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.94  E-value=5.5e-27  Score=252.66  Aligned_cols=173  Identities=29%  Similarity=0.412  Sum_probs=147.5

Q ss_pred             cCCccCCeecccCcEEEEEEEE-----cCCCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      .+|+..+.||+|+||.||+|++     ..+++.||||++....   ..+.+.+|+++++++ +||||+++++++..++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            4788999999999999999985     3567789999987553   346788999999999 999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          747 FLVLEYMPNGNLFQALHKRVK-------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      |+||||+++|+|.+++.....             .....+++..++.++.|+++||+|||   +.+|+||||||+||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEc
Confidence            999999999999999987521             11235899999999999999999999   78999999999999999


Q ss_pred             CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++.+||+|||+++...............||+.|+|||
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  217 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE  217 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChH
Confidence            99999999999998776554433333456889999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=6.5e-27  Score=255.82  Aligned_cols=173  Identities=26%  Similarity=0.368  Sum_probs=144.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      .+|+..+.||+|+||.||+|++.     .++..||||++...   ...+.+.+|+++++++ +||||+++++++...+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            47889999999999999999973     35667999998654   2346788999999999 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC
Q 003065          747 FLVLEYMPNGNLFQALHKRVKE------------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSS  808 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~  808 (851)
                      |+||||+++|+|.+++......                  ....+++..++.++.|++.||+|||   +.+|+||||||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~  201 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  201 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChh
Confidence            9999999999999999864211                  0124789999999999999999999   789999999999


Q ss_pred             CEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          809 NILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       809 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++.++.+||+|||+++...............||+.|+|||
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  244 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  244 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence            9999999999999999998765544333333456889999998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.94  E-value=6.5e-27  Score=260.71  Aligned_cols=168  Identities=29%  Similarity=0.429  Sum_probs=145.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC--eeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGG--SSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  750 (851)
                      .+|.+.+.||+|+||.||+|++..+++.||||++...   ...+.+.+|++++++++||||+++++++...+  ..|+||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            3688999999999999999999999999999998653   34677889999999999999999999998755  679999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE----CCCCceEEeeecCc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVA  826 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla  826 (851)
                      ||+++|+|.+++.....  ...+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+|
T Consensus        89 e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             CCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             ecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            99999999999876422  234899999999999999999999   7899999999999999    77788999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.......   .....||+.|+|||
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE  185 (396)
T 4eut_A          164 RELEDDEQ---FVSLYGTEEYLHPD  185 (396)
T ss_dssp             EECCCGGG---SSCSSSCCTTCCHH
T ss_pred             eEccCCCc---cccccCCccccCHH
Confidence            87654322   23457999999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.94  E-value=3.1e-28  Score=265.32  Aligned_cols=159  Identities=18%  Similarity=0.214  Sum_probs=133.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----------cHHHHHHHHHHHHcCC---------CCccccE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIR---------HRNILKL  736 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~---------h~niv~l  736 (851)
                      .+|++.+.||+|+||+||+|++  +++.||||++....          ..+.+.+|++++++++         |||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5789999999999999999998  67899999986542          2377899999999885         7777777


Q ss_pred             EEEEE------------------------------eCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 003065          737 YACLL------------------------------KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA  786 (851)
Q Consensus       737 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~  786 (851)
                      .+.+.                              ..+..|+||||+++|++.+.+.+      ..+++..+..++.|++
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence            76543                              26789999999999977666532      3578999999999999


Q ss_pred             HHHHHHHhCCCCCcEEeCCCCCCEEECCCC--------------------ceEEeeecCccccCCCCCcccccccccccc
Q 003065          787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDY--------------------EPKIADFGVAKIAENSPKVSDYSCFAGTHG  846 (851)
Q Consensus       787 ~~l~~LH~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  846 (851)
                      .||+|||+  +.+|+||||||+|||++.++                    .+||+|||+|+.....       ..+||+.
T Consensus       172 ~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred             HHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence            99999993  25899999999999999887                    8999999999876532       2479999


Q ss_pred             cccCC
Q 003065          847 YIAPG  851 (851)
Q Consensus       847 Y~APE  851 (851)
                      |||||
T Consensus       243 y~aPE  247 (336)
T 2vuw_A          243 SMDED  247 (336)
T ss_dssp             TTCSG
T ss_pred             ccChh
Confidence            99998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.94  E-value=1.6e-26  Score=261.75  Aligned_cols=163  Identities=29%  Similarity=0.462  Sum_probs=141.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCC-eeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGG-SSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~  754 (851)
                      .+|+..+.||+|+||.||+|++.  ++.||||+++.....+.+.+|++++++++||||+++++++...+ ..|+||||++
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~  270 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA  270 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence            46888999999999999999884  67999999987777788999999999999999999999987654 7899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++...   ....+++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus       271 ~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          271 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             TCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            99999999875   2334788899999999999999999   7899999999999999999999999999998654321 


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                          ....+++.|+|||
T Consensus       344 ----~~~~~~~~y~aPE  356 (450)
T 1k9a_A          344 ----DTGKLPVKWTAPE  356 (450)
T ss_dssp             -------CCCTTTSCHH
T ss_pred             ----cCCCCCcceeCHH
Confidence                1235788999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.94  E-value=1.4e-26  Score=265.41  Aligned_cols=166  Identities=32%  Similarity=0.475  Sum_probs=145.8

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecc----cccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ..+|++.+.||+|+||.||+|++..+++.||||++..    ......+.+|++++++++||||+++++++...+..|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            4579999999999999999999999999999999853    245678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC---CCCceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~  827 (851)
                      ||+++|+|.+++...     ..+++..+..++.|++.||.|||   +.+|+||||||+||+++   .++.+||+|||+|+
T Consensus       101 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999998764     35889999999999999999999   78999999999999995   45679999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......   ....+||+.|+|||
T Consensus       173 ~~~~~~~---~~~~~gt~~y~aPE  193 (486)
T 3mwu_A          173 CFQQNTK---MKDRIGTAYYIAPE  193 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGG
T ss_pred             ECCCCCc---cCCCcCCCCCCCHH
Confidence            7654432   23357999999998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.94  E-value=2.7e-26  Score=246.60  Aligned_cols=166  Identities=43%  Similarity=0.651  Sum_probs=143.2

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc------ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ...+.||+|+||.||+|++  +++.||||++...      ...+.+.+|++++++++||||+++++++..++..|+||||
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  111 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY  111 (307)
T ss_dssp             TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence            3448999999999999986  5789999998542      2356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++....  ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       112 ~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          112 MPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             CTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             cCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence            99999999997642  2346899999999999999999999   789999999999999999999999999999876554


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..........||+.|+|||
T Consensus       187 ~~~~~~~~~~g~~~y~aPE  205 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPE  205 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHH
T ss_pred             cccccccccCCCcCcCChH
Confidence            3332333457999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.94  E-value=2.5e-26  Score=247.92  Aligned_cols=168  Identities=25%  Similarity=0.353  Sum_probs=139.2

Q ss_pred             cCCccC-CeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEED-NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ..|.+. +.||+|+||.||+|++..+++.||||++...  ...+.+.+|++++.++ +||||+++++++..++..|+|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            367774 7899999999999999999999999998654  3467889999999985 79999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc---eEEeeecCccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAKI  828 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~  828 (851)
                      |+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||+++.
T Consensus        92 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           92 KMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             cCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            99999999999864     35788999999999999999999   779999999999999998776   99999999976


Q ss_pred             cCCCCC-----cccccccccccccccCC
Q 003065          829 AENSPK-----VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~-----~~~~~~~~gt~~Y~APE  851 (851)
                      ......     ........||+.|+|||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE  191 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPE  191 (316)
T ss_dssp             ------------------CCSGGGCCHH
T ss_pred             cccCCccccccccccccccCCcCccChH
Confidence            543211     11122356999999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.94  E-value=2e-26  Score=248.47  Aligned_cols=169  Identities=28%  Similarity=0.404  Sum_probs=145.6

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++......+.+.+|++++++++||||+++++++...+..|+||||+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            34579999999999999999999998999999999987777788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++...    ...+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||.++......
T Consensus       107 ~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          107 GAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             TTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            999999998753    346889999999999999999999   7899999999999999999999999999998765432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .  ......||+.|+|||
T Consensus       180 ~--~~~~~~~~~~y~aPE  195 (314)
T 3com_A          180 A--KRNTVIGTPFWMAPE  195 (314)
T ss_dssp             S--CBCCCCSCGGGCCHH
T ss_pred             c--ccCccCCCCCccChh
Confidence            2  123357999999998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.94  E-value=1.4e-26  Score=252.06  Aligned_cols=173  Identities=29%  Similarity=0.422  Sum_probs=145.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-------CCCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-------KNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGG  744 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  744 (851)
                      ++|++.+.||+|+||.||+|++.       .++..||||++....   ..+.+.+|+++++++ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            47889999999999999999985       356789999986543   345688999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      ..|+||||+++|+|.+++......           ....+++..++.++.|+++||+|||   +.+|+||||||+||+++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEc
Confidence            999999999999999999864221           1234889999999999999999999   78999999999999999


Q ss_pred             CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++.+||+|||+++...............||+.|+|||
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  229 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE  229 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHH
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChH
Confidence            99999999999998776544333334456789999998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.94  E-value=2.7e-26  Score=252.67  Aligned_cols=167  Identities=28%  Similarity=0.422  Sum_probs=147.1

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----------cHHHHHHHHHHHHcC-CCCccccEEEEEEe
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKI-RHRNILKLYACLLK  742 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  742 (851)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++....          ..+.+.+|+++++++ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            3457999999999999999999998899999999885432          135678999999999 79999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      .+..|+||||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEe
Confidence            99999999999999999999764     35889999999999999999999   67999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||++........   .....||+.|+|||
T Consensus       244 fG~~~~~~~~~~---~~~~~gt~~y~aPE  269 (365)
T 2y7j_A          244 FGFSCHLEPGEK---LRELCGTPGYLAPE  269 (365)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred             cCcccccCCCcc---cccCCCCCCccChh
Confidence            999987765432   23367999999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.94  E-value=2.7e-26  Score=243.67  Aligned_cols=165  Identities=33%  Similarity=0.508  Sum_probs=146.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +++|++.+.||+|+||.||+|++..+++.||||++...     ...+.+.+|++++++++||||+++++++..++..|+|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            35789999999999999999999989999999998543     2356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            9999999999999764     25788999999999999999999   789999999999999999999999999999765


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....    ....||+.|+|||
T Consensus       165 ~~~~~----~~~~~~~~y~aPE  182 (284)
T 2vgo_A          165 PSLRR----RTMCGTLDYLPPE  182 (284)
T ss_dssp             SSSCB----CCCCSCGGGCCHH
T ss_pred             ccccc----ccccCCCCcCCHH
Confidence            44321    2357999999998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.94  E-value=1.6e-26  Score=248.63  Aligned_cols=167  Identities=27%  Similarity=0.326  Sum_probs=140.8

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-------cHHHHHHHHHHHHcCC---CCccccEEEEEEeCC
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------GVKVFAAEMEILGKIR---HRNILKLYACLLKGG  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  744 (851)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....       ....+.+|++++++++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            358999999999999999999999999999999985321       2346678888887775   999999999998755


Q ss_pred             -----eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceE
Q 003065          745 -----SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPK  819 (851)
Q Consensus       745 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  819 (851)
                           ..++||||++ ++|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEE
Confidence                 4799999996 6999998763   2334899999999999999999999   78999999999999999999999


Q ss_pred             EeeecCccccCCCCCcccccccccccccccCC
Q 003065          820 IADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       820 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|||+|+.......   .....||+.|+|||
T Consensus       161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE  189 (308)
T 3g33_A          161 LADFGLARIYSYQMA---LTPVVVTLWYRAPE  189 (308)
T ss_dssp             ECSCSCTTTSTTCCC---SGGGGCCCSSCCHH
T ss_pred             EeeCccccccCCCcc---cCCccccccccCch
Confidence            999999987654332   23457999999998

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.94  E-value=8.9e-27  Score=247.23  Aligned_cols=167  Identities=22%  Similarity=0.347  Sum_probs=142.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|++. ++..||||++... ...+++.+|++++++++||||+++++++..++..|+||||++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            47889999999999999999885 6778999998765 356789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       103 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          103 NGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             TCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999999763    235889999999999999999999   78999999999999999999999999999986654321


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                       .......||+.|+|||
T Consensus       176 -~~~~~~~~~~~y~aPE  191 (283)
T 3gen_A          176 -TSSVGSKFPVRWSPPE  191 (283)
T ss_dssp             -HSTTSTTSCGGGCCHH
T ss_pred             -ccccCCccCcccCCHH
Confidence             1122345788999998

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=5.1e-26  Score=240.48  Aligned_cols=212  Identities=22%  Similarity=0.236  Sum_probs=152.8

Q ss_pred             ecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccC
Q 003065           88 EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVN  166 (851)
Q Consensus        88 ~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~  166 (851)
                      .+|..+.  ++|++|+|++|++++..+..|+++++|++|+|++|++++.++. +..+++|++|+|++|.+++..+..|.+
T Consensus        21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (276)
T 2z62_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (276)
T ss_dssp             SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence            3555443  5789999999999876667888999999999999988887764 888889999999999888777778888


Q ss_pred             ccccceeecccccCCCCCCcccccCCCCCCeEeccccccccc-CCcccccccccCccccccccccccccccccCCCccc-
Q 003065          167 LTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR-IPESISELRELGTLDICRNKISGEFPRSIRKLQKLW-  244 (851)
Q Consensus       167 l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~-  244 (851)
                      +++|++|++++|.+. ...+..++.+++|++|++++|++++. +|..+.++++|++|++++|++++..+..|..+++|+ 
T Consensus        99 l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  177 (276)
T 2z62_A           99 LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL  177 (276)
T ss_dssp             CTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTT
T ss_pred             CccccEEECCCCCcc-ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccc
Confidence            888888888888876 22233577788888888888888753 577777777788888887777766666666666665 


Q ss_pred             ---EEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCC
Q 003065          245 ---KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG  303 (851)
Q Consensus       245 ---~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~  303 (851)
                         .|++++|.+++..+..+. ..+|++|++++|++++..+..|.++++|+.|++++|.+.+
T Consensus       178 l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          178 LNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             CCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             cceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence               667777777644444333 3356666666666665444445556666666666665553

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=1.7e-26  Score=265.14  Aligned_cols=165  Identities=32%  Similarity=0.440  Sum_probs=142.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .+|++.+.||+|+||.||+|+++.++..||||++...    .....+.+|+++++.++||||+++++++...+..|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4689999999999999999999999999999998653    335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---CCceEEeeecCccc
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVAKI  828 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~  828 (851)
                      |+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+|+.
T Consensus       117 ~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          117 CYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999988764     35788899999999999999999   789999999999999976   45599999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......   ....+||+.|+|||
T Consensus       189 ~~~~~~---~~~~~gt~~y~aPE  208 (494)
T 3lij_A          189 FENQKK---MKERLGTAYYIAPE  208 (494)
T ss_dssp             CBTTBC---BCCCCSCTTTCCHH
T ss_pred             CCCCcc---ccccCCCcCeeCHH
Confidence            765432   23357999999998

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=6.3e-27  Score=249.06  Aligned_cols=169  Identities=26%  Similarity=0.399  Sum_probs=148.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+|+..+.||+|+||.||+|.+..++..||+|++.... ..+.+.+|++++++++||||+++++++..++..|+||||++
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   92 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   92 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            46889999999999999999999999999999986553 45778999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...   ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        93 ~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           93 YGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             TEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             CCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999999763   3456899999999999999999999   67999999999999999999999999999987664432


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......||+.|+|||
T Consensus       167 ~-~~~~~~~~~~y~aPE  182 (288)
T 3kfa_A          167 T-AHAGAKFPIKWTAPE  182 (288)
T ss_dssp             E-EETTEEECGGGCCHH
T ss_pred             c-cccCCccccCcCChh
Confidence            2 223345788999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.94  E-value=3.8e-27  Score=255.44  Aligned_cols=168  Identities=25%  Similarity=0.368  Sum_probs=139.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcE----EEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|+..+.||+|+||.||+|++..+++.    ||+|.+...   ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            4788999999999999999999877765    777776433   22345678999999999999999999886 456899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++|+|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            99999999999998753    235778889999999999999999   77999999999999999999999999999998


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..............||+.|+|||
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE  187 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALE  187 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHH
T ss_pred             cCcccccccccCCCCcccccChH
Confidence            76554443344567888999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.93  E-value=3.1e-26  Score=242.98  Aligned_cols=165  Identities=29%  Similarity=0.395  Sum_probs=143.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++....        ..+.+.+|++++++++||||+++++++..++..|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            36889999999999999999999899999999885431        3678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC----ceEEeee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIADF  823 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DF  823 (851)
                      +||||+++++|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            999999999999999763     35789999999999999999999   78999999999999998877    7999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |.++.......   .....||+.|+|||
T Consensus       157 g~~~~~~~~~~---~~~~~~~~~y~aPE  181 (283)
T 3bhy_A          157 GIAHKIEAGNE---FKNIFGTPEFVAPE  181 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHH
T ss_pred             ccceeccCCCc---ccccCCCcCccCcc
Confidence            99987654332   22356999999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.93  E-value=2.2e-26  Score=246.51  Aligned_cols=167  Identities=32%  Similarity=0.450  Sum_probs=138.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHc--CCCCccccEEEEEEe----CCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLLK----GGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~lv  749 (851)
                      ++|++.+.||+|+||.||+|++  +++.||||++... ..+.+.+|.+++..  ++||||+++++++..    ....|+|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv   84 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI   84 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence            4789999999999999999988  6889999998654 44556677777766  799999999998654    3457999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD-----CSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      |||+++|+|.++++.      ..+++..+++++.|++.|++|||..     ++++|+||||||+||+++.++.+||+|||
T Consensus        85 ~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           85 THYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             ECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             hhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            999999999999853      3589999999999999999999932     14699999999999999999999999999


Q ss_pred             CccccCCCCCcc--cccccccccccccCC
Q 003065          825 VAKIAENSPKVS--DYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~--~~~~~~gt~~Y~APE  851 (851)
                      +|+.........  ......||+.|+|||
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  187 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPE  187 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHH
T ss_pred             CeeecccccccccccccccccccceeChh
Confidence            998765543321  122347999999998

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.93  E-value=6.6e-27  Score=249.05  Aligned_cols=163  Identities=21%  Similarity=0.325  Sum_probs=142.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC-------cEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA-------GTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  746 (851)
                      ++|.+.+.||+|+||.||+|++..++       ..||+|++...  ...+.+.+|++++++++||||+++++++..++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            47889999999999999999998766       46999998543  4567789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc--------e
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE--------P  818 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~  818 (851)
                      |+||||+++|+|.+++...    ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.        +
T Consensus        88 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999864    234788899999999999999999   789999999999999998877        9


Q ss_pred             EEeeecCccccCCCCCcccccccccccccccCC
Q 003065          819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       819 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|||+++.....      ....||+.|+|||
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE  187 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPE  187 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHH
T ss_pred             eeccCcccccccCc------cccCCcCcccCHH
Confidence            99999999755332      2245899999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.93  E-value=5.7e-27  Score=253.85  Aligned_cols=166  Identities=27%  Similarity=0.359  Sum_probs=137.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccH---HHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV---KVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ++|.+.+.||+|+||.||+|++..+++.||||++......   ..+.+|++++++++||||+++++++..++..|+||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5789999999999999999999999999999998654322   1345799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++ |+|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus        82 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            96 6999988764    345888999999999999999999   789999999999999999999999999999865533


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ......||+.|+|||
T Consensus       154 ~~--~~~~~~~t~~y~aPE  170 (324)
T 3mtl_A          154 TK--TYDNEVVTLWYRPPD  170 (324)
T ss_dssp             -----------CGGGCCHH
T ss_pred             cc--ccccccCcccccChh
Confidence            22  223357899999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.93  E-value=5.5e-27  Score=265.98  Aligned_cols=163  Identities=33%  Similarity=0.402  Sum_probs=134.9

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC------C
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------G  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  744 (851)
                      .++|+..+.||+|+||.||+|++..+++.||||++...    ...+.+.+|+++++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            45899999999999999999999999999999998643    3456788999999999999999999999654      3


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      ..|+||||+++ ++.+.+..       .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence            57999999965 56666532       3788899999999999999999   7899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|+.......   ....+||++|+|||
T Consensus       210 ~a~~~~~~~~---~~~~~gt~~y~aPE  233 (464)
T 3ttj_A          210 LARTAGTSFM---MTPYVVTRYYRAPE  233 (464)
T ss_dssp             CC-----CCC---C----CCCTTCCHH
T ss_pred             eeeecCCCcc---cCCCcccccccCHH
Confidence            9987654322   23467999999998

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.93  E-value=1.4e-26  Score=245.76  Aligned_cols=168  Identities=30%  Similarity=0.463  Sum_probs=145.2

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEe----------
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK----------  742 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  742 (851)
                      ....+|+..+.||+|+||.||+|++..+++.||||++....  +.+.+|++++++++||||+++++++..          
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            34467999999999999999999998899999999986543  356789999999999999999998854          


Q ss_pred             ------CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC
Q 003065          743 ------GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY  816 (851)
Q Consensus       743 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~  816 (851)
                            ....|+||||+++++|.+++....   ...+++..++.++.|++.|+.|||   +.+|+||||||+||+++.++
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCC
Confidence                  445799999999999999998642   346889999999999999999999   77999999999999999999


Q ss_pred             ceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       817 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+||+|||+++........   ....||+.|+|||
T Consensus       160 ~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE  191 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPE  191 (284)
T ss_dssp             EEEECCCTTCEESSCCSCC---CCCCSCCTTSCHH
T ss_pred             CEEECcchhheeccccccc---cccCCcccccChh
Confidence            9999999999877654322   2346999999998

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=5.4e-27  Score=256.55  Aligned_cols=174  Identities=26%  Similarity=0.312  Sum_probs=142.1

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-------ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...       ...+.+.+|++++++++||||+++++++.+.+..|
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            45799999999999999999999999999999998542       34567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCC-----------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 003065          748 LVLEYMPNGNLFQALHKRVKEG-----------------------------------KPELDWFRRYKIALGAAKGIAYL  792 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~-----------------------------------~~~l~~~~~~~i~~~i~~~l~~L  792 (851)
                      +||||+++|+|.+++.......                                   ...+++..+..++.|++.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            9999999999999885321110                                   11235667788999999999999


Q ss_pred             HhCCCCCcEEeCCCCCCEEECCCC--ceEEeeecCccccCCCCC--cccccccccccccccCC
Q 003065          793 HHDCSPPIIHRDIKSSNILLDEDY--EPKIADFGVAKIAENSPK--VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       793 H~~~~~~ivHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE  851 (851)
                      |   +.+|+||||||+||+++.++  .+||+|||+|+.......  ........||+.|+|||
T Consensus       185 H---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  244 (345)
T 3hko_A          185 H---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE  244 (345)
T ss_dssp             H---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred             H---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence            9   77999999999999998776  899999999986543221  11223457999999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.93  E-value=3.3e-26  Score=245.61  Aligned_cols=170  Identities=26%  Similarity=0.384  Sum_probs=143.6

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc------ccHHHHHHHHHHHHcCCCCccccEEEEEE--eCCee
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKLYACLL--KGGSS  746 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  746 (851)
                      +++|++.+.||+|+||.||+|.+..+++.||||++...      ...+.+.+|++++++++||||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999999999999999998643      34567899999999999999999999984  45678


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||++++ +.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+
T Consensus        84 ~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccc
Confidence            9999999866 77777653   3456889999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +...............||+.|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE  181 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPE  181 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHH
T ss_pred             cccCccccccccccCCCCCCCcChh
Confidence            8765433333333457999999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.93  E-value=3.6e-26  Score=241.55  Aligned_cols=165  Identities=29%  Similarity=0.455  Sum_probs=139.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|.+.+.||+|+||.||+|++..+++.||||++...     ...+.+.+|+++++.++||||+++++++...+..|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            4789999999999999999999889999999998543     34567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        91 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           91 EYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             ECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             eccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            999999999999764     34788999999999999999999   6799999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   .....||+.|+|||
T Consensus       163 ~~~~---~~~~~~~~~y~aPE  180 (276)
T 2h6d_A          163 DGEF---LRTSCGSPNYAAPE  180 (276)
T ss_dssp             C----------------CCTG
T ss_pred             CCcc---eecccCCccccCHH
Confidence            4322   22346899999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=7.8e-27  Score=256.03  Aligned_cols=168  Identities=28%  Similarity=0.352  Sum_probs=145.1

Q ss_pred             HcCCccCCeecccCcEEEEEEEEc---CCCcEEEEEEeccc------ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCC
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKI-RHRNILKLYACLLKGG  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  744 (851)
                      +.+|++.+.||+|+||.||+|++.   .+++.||||++...      ...+.+.+|+++++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            357999999999999999999984   47889999998543      2345677899999999 6999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      ..|+||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence            999999999999999999764     35788999999999999999999   7799999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +++........ ......||+.|+|||
T Consensus       205 ~a~~~~~~~~~-~~~~~~gt~~y~aPE  230 (355)
T 1vzo_A          205 LSKEFVADETE-RAYDFCGTIEYMAPD  230 (355)
T ss_dssp             EEEECCGGGGG-GGCGGGSCCTTCCHH
T ss_pred             CCeecccCCCC-cccCcccCcCccChh
Confidence            99865433221 223457999999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.93  E-value=1e-26  Score=251.75  Aligned_cols=173  Identities=21%  Similarity=0.316  Sum_probs=146.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|+..+.||+|+||.||+|++.     .+++.||||++....   ....+.+|++++++++||||+++++++..++..|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            47899999999999999999886     356789999986543   3456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhh-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          748 LVLEYMPNGNLFQALHKRVK-----EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      +||||+++|+|.+++.....     .....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~D  181 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  181 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECc
Confidence            99999999999999986432     11245688999999999999999999   77999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++...............||+.|+|||
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE  210 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPE  210 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred             CccccccccccccccccCCCCCCCccChh
Confidence            99998665443322333446789999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.93  E-value=1.4e-26  Score=265.27  Aligned_cols=165  Identities=32%  Similarity=0.461  Sum_probs=146.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|+..+.||+|+||.||+|++..+++.||||++...     ...+.+.+|++++++++||||+++++++...+..|+||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            4689999999999999999999999999999998543     35678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE---CCCCceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~  827 (851)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+|+
T Consensus       106 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          106 EVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             CCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999988753     45889999999999999999999   7899999999999999   467899999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......   ....+||+.|+|||
T Consensus       178 ~~~~~~~---~~~~~gt~~y~aPE  198 (484)
T 3nyv_A          178 HFEASKK---MKDKIGTAYYIAPE  198 (484)
T ss_dssp             HBCCCCS---HHHHTTGGGTCCHH
T ss_pred             Ecccccc---cccCCCCccccCce
Confidence            7765433   23357999999998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.93  E-value=3.1e-26  Score=246.35  Aligned_cols=170  Identities=22%  Similarity=0.291  Sum_probs=140.1

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ..+++|++.+.||+|+||.||+|++..+++.||||++....     ..+.+.+|++++++++||||+++++++..++..|
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            34678999999999999999999999899999999986542     2367889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++++|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       111 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             EEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             EEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            999999999999999864     35889999999999999999999   7799999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....... .......||+.|+|||
T Consensus       183 ~~~~~~~-~~~~~~~~~~~y~aPE  205 (309)
T 2h34_A          183 ATTDEKL-TQLGNTVGTLYYMAPE  205 (309)
T ss_dssp             ---------------CCGGGCCGG
T ss_pred             ccccccc-ccccccCCCcCccCHH
Confidence            6654322 1223457999999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.93  E-value=2.5e-26  Score=255.08  Aligned_cols=164  Identities=24%  Similarity=0.358  Sum_probs=137.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCC--CCccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIR--HRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .|++.+.||+|+||.||+|.+.. ++.||||++...    ...+.+.+|++++++++  ||||+++++++..++..|+||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            58999999999999999999854 889999998643    23467889999999996  599999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      | +.+++|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+|+...
T Consensus       136 E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             E-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             e-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            9 5588999999763     35788889999999999999999   88999999999999996 5799999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...........+||+.|+|||
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE  226 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPE  226 (390)
T ss_dssp             --------CCSCCCGGGCCHH
T ss_pred             CCCccccCCCCCcCCCccChH
Confidence            443322233467999999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.6e-26  Score=254.66  Aligned_cols=161  Identities=29%  Similarity=0.441  Sum_probs=135.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC------e
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------S  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  745 (851)
                      .+|+..+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|+++++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4789999999999999999999999999999998543    23466889999999999999999999997653      4


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+||||+ +++|.+++..      ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       105 ~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence            59999999 8899999875      24788899999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+.....     ....+||++|+|||
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE  195 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPE  195 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTH
T ss_pred             ccccccc-----cCcCcCCCCcCCHH
Confidence            9876432     23357899999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.93  E-value=2.5e-26  Score=247.30  Aligned_cols=173  Identities=23%  Similarity=0.369  Sum_probs=138.3

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ..+.+|++.+.||+|+||.||+|.+..+++.||||++...     ...+.+.+|++++++++||||+++++++...+..+
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            3456899999999999999999999999999999998642     23567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++++|.+++..... ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       109 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             EEEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            99999999999999976533 3456889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ........  .....||+.|+|||
T Consensus       185 ~~~~~~~~--~~~~~~~~~y~aPE  206 (310)
T 2wqm_A          185 FFSSKTTA--AHSLVGTPYYMSPE  206 (310)
T ss_dssp             ----------------CCSSCCHH
T ss_pred             eecCCCcc--ccccCCCeeEeChH
Confidence            66543221  22356899999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.93  E-value=9.4e-27  Score=261.11  Aligned_cols=166  Identities=30%  Similarity=0.389  Sum_probs=135.2

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----------cHHHHHHHHHHHHcCCCCccccEEEEEEeC
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIRHRNILKLYACLLKG  743 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  743 (851)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++....          ....+.+|++++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            3468999999999999999999999999999999986431          12247899999999999999999999754 


Q ss_pred             CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC---CceEE
Q 003065          744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKI  820 (851)
Q Consensus       744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl  820 (851)
                      +..|+||||+++|+|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             CceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEE
Confidence            568999999999999887753     346899999999999999999999   7799999999999999754   45999


Q ss_pred             eeecCccccCCCCCcccccccccccccccCC
Q 003065          821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|||+|+.......   ....+||+.|+|||
T Consensus       284 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE  311 (419)
T 3i6u_A          284 TDFGHSKILGETSL---MRTLCGTPTYLAPE  311 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTT
T ss_pred             eecccceecCCCcc---ccccCCCCCccCce
Confidence            99999987654322   23467999999999

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.93  E-value=1e-26  Score=252.43  Aligned_cols=168  Identities=26%  Similarity=0.360  Sum_probs=137.3

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      ..+++|++.+.||+|+||.||+|++..+++.||||++....    ..+.+.+|++++++++||||+++++++..++..|+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34568999999999999999999999999999999986542    23457799999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC-----CCCceEEeee
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-----EDYEPKIADF  823 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~-----~~~~~kl~DF  823 (851)
                      ||||++ |+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++     ..+.+||+||
T Consensus       111 v~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            999997 5999998763     35889999999999999999999   78999999999999994     4556999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+.......  ......||+.|+|||
T Consensus       182 g~a~~~~~~~~--~~~~~~~t~~y~aPE  207 (329)
T 3gbz_A          182 GLARAFGIPIR--QFTHEIITLWYRPPE  207 (329)
T ss_dssp             THHHHHC-------------CCTTCCHH
T ss_pred             CCccccCCccc--ccCCCcCCccccCHH
Confidence            99987654322  223356899999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.5e-26  Score=252.96  Aligned_cols=167  Identities=29%  Similarity=0.397  Sum_probs=139.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc-------HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-------VKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ..+|+..+.||+|+||.||+|++..+++.||||++.....       .+.+.+|++++++++||||+++++++...+..|
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            4689999999999999999999999999999999864321       235789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++ +|.+++...    ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus        89 lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             EEEECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             EEEEcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            99999975 888887642    345777888999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  ......||+.|+|||
T Consensus       161 ~~~~~~~--~~~~~~~t~~y~aPE  182 (346)
T 1ua2_A          161 SFGSPNR--AYTHQVVTRWYRAPE  182 (346)
T ss_dssp             TTTSCCC--CCCCSCCCCTTCCHH
T ss_pred             eccCCcc--cCCcccccccccCch
Confidence            7654322  223357899999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.93  E-value=6.7e-26  Score=242.36  Aligned_cols=166  Identities=32%  Similarity=0.405  Sum_probs=146.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----------cHHHHHHHHHHHHcCC-CCccccEEEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----------GVKVFAAEMEILGKIR-HRNILKLYACLLK  742 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  742 (851)
                      ..+|+..+.||+|+||.||+|++..+++.||||++....           ..+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            458999999999999999999999999999999985432           2356789999999995 9999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      ++..|+||||+++++|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEec
Confidence            99999999999999999999764     35788999999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++.......   .....||+.|+|||
T Consensus       168 fg~~~~~~~~~~---~~~~~~~~~y~aPE  193 (298)
T 1phk_A          168 FGFSCQLDPGEK---LREVCGTPSYLAPE  193 (298)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred             ccchhhcCCCcc---cccccCCccccCHH
Confidence            999987654432   22357899999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.93  E-value=3e-26  Score=243.67  Aligned_cols=162  Identities=34%  Similarity=0.604  Sum_probs=140.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc---------HHHHHHHHHHHHcCCCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---------VKVFAAEMEILGKIRHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  746 (851)
                      .+|+..+.||+|+||.||+|++..+++.||||++.....         .+.+.+|++++++++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            478999999999999999999999999999999854321         167889999999999999999999986654  


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEECCCCc-----eE
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLDEDYE-----PK  819 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDlkp~NILl~~~~~-----~k  819 (851)
                      ++||||+++|+|.+++...    ...+++..+..++.|++.|++|||   +.+  |+||||||+||+++.++.     +|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence            7999999999999988653    346899999999999999999999   677  999999999999988776     99


Q ss_pred             EeeecCccccCCCCCcccccccccccccccCC
Q 003065          820 IADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       820 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|||+|+.....     .....||+.|+|||
T Consensus       170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE  196 (287)
T 4f0f_A          170 VADFGLSQQSVHS-----VSGLLGNFQWMAPE  196 (287)
T ss_dssp             ECCCTTCBCCSSC-----EECCCCCCTTSCGG
T ss_pred             eCCCCcccccccc-----ccccCCCccccCch
Confidence            9999999854432     23357999999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.93  E-value=2.6e-26  Score=251.75  Aligned_cols=169  Identities=25%  Similarity=0.374  Sum_probs=143.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe--------
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK--------  742 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  742 (851)
                      +.+|++.+.||+|+||.||+|++..+++.||||++...    .....+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999999999999999988543    234567899999999999999999999876        


Q ss_pred             CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      .+..|+||||++ +++.+.+...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             CceEEEEEeccC-CCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence            456899999996 5888877653    345899999999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCC--cccccccccccccccCC
Q 003065          823 FGVAKIAENSPK--VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~--~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|+.......  ........||+.|+|||
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  198 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPE  198 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHH
T ss_pred             chhcccccccccccccccCCcccccCccCch
Confidence            999987653321  12234467899999998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.93  E-value=2.1e-26  Score=251.50  Aligned_cols=164  Identities=24%  Similarity=0.360  Sum_probs=136.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCC--CccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRH--RNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~  750 (851)
                      +|++.+.||+|+||.||+|.+ .+++.||||++...    ...+.+.+|++++++++|  |||+++++++..++..|+||
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            588999999999999999998 56889999998643    234678899999999976  99999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |+ .+++|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+|+...
T Consensus        89 e~-~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           89 EC-GNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             CC-CSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             eC-CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            95 588999999763     45888999999999999999999   78999999999999997 5789999999998776


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...........+||+.|+|||
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE  179 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPE  179 (343)
T ss_dssp             -----------CCCCSSCCHH
T ss_pred             cccccccCCCCcCCcCcCCHH
Confidence            544333334467999999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.93  E-value=2.3e-26  Score=246.34  Aligned_cols=170  Identities=27%  Similarity=0.486  Sum_probs=139.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEe-----------
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLK-----------  742 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----------  742 (851)
                      .++|+..+.||+|+||.||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++..           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            35789999999999999999999999999999998654 345678899999999999999999998765           


Q ss_pred             --CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEE
Q 003065          743 --GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI  820 (851)
Q Consensus       743 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl  820 (851)
                        .+..|+||||+++|+|.+++...    ...+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEE
Confidence              35679999999999999999763    345678888999999999999999   779999999999999999999999


Q ss_pred             eeecCccccCCCCC------------cccccccccccccccCC
Q 003065          821 ADFGVAKIAENSPK------------VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~------------~~~~~~~~gt~~Y~APE  851 (851)
                      +|||+++.......            ........||+.|+|||
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  200 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE  200 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcc
Confidence            99999986643211            11223457999999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.93  E-value=7.9e-26  Score=240.84  Aligned_cols=163  Identities=29%  Similarity=0.358  Sum_probs=141.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe----CCeeEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFL  748 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  748 (851)
                      .|.+.+.||+|+||.||+|.+..++..||+|++...    ...+.+.+|++++++++||||+++++++..    ....|+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            467888999999999999999999999999998643    235678899999999999999999999875    355899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEEC-CCCceEEeeecC
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLD-EDYEPKIADFGV  825 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DFGl  825 (851)
                      ||||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+  |+||||||+||+++ .++.+||+|||+
T Consensus       107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            99999999999999764     35788999999999999999999   667  99999999999998 789999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++......    .....||+.|+|||
T Consensus       179 ~~~~~~~~----~~~~~~t~~y~aPE  200 (290)
T 1t4h_A          179 ATLKRASF----AKAVIGTPEFMAPE  200 (290)
T ss_dssp             GGGCCTTS----BEESCSSCCCCCGG
T ss_pred             cccccccc----cccccCCcCcCCHH
Confidence            97654432    22357999999998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.93  E-value=1.5e-26  Score=251.46  Aligned_cols=168  Identities=30%  Similarity=0.414  Sum_probs=140.8

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+++|+..+.||+|+||.||+|++..+++.||||++....    ..+.+.+|++++++++||||+++++++...+..|+|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            4568999999999999999999999999999999985442    245577999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||++++++.++...     ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       103 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A          103 FEFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            999999888877553     235889999999999999999999   789999999999999999999999999999866


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......  .....||+.|+|||
T Consensus       175 ~~~~~~--~~~~~~t~~y~aPE  194 (331)
T 4aaa_A          175 AAPGEV--YDDEVATRWYRAPE  194 (331)
T ss_dssp             -----------CCCCCTTCCHH
T ss_pred             cCCccc--cCCCcCCccccCcc
Confidence            543222  23356899999998

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.93  E-value=2e-26  Score=249.86  Aligned_cols=168  Identities=23%  Similarity=0.344  Sum_probs=135.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEE----EEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTV----AVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|+..+.||+|+||.||+|++..+++.|    |+|.+...   ...+.+.+|+.++++++||||+++++++..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            47899999999999999999998777654    66666432   35678999999999999999999999998765 789


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      |+||+++|+|.+++...    ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        94 v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            99999999999999864    345889999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..............||+.|+|||
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE  189 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALE  189 (327)
T ss_dssp             -------------CCCGGGSCHH
T ss_pred             ccCccccccccCCCccccccCHH
Confidence            75544333334456788999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.93  E-value=1.8e-26  Score=244.72  Aligned_cols=167  Identities=26%  Similarity=0.308  Sum_probs=130.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC---CcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|++.+.||+|+||.||+|++..+   +..||+|++....   ..+.+.+|+.++++++||||+++++++. ++..|+|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            4788999999999999999998653   4569999886542   3456889999999999999999999984 5678999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        94 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           94 MELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999999763    345889999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...... ......+|+.|+|||
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE  187 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPE  187 (281)
T ss_dssp             -------------CCGGGCCHH
T ss_pred             Cccccc-ccccCCCcccccChh
Confidence            543322 122345788999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=6.5e-26  Score=247.01  Aligned_cols=165  Identities=31%  Similarity=0.450  Sum_probs=136.9

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC--CCCccccEEEEEEeC----CeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--RHRNILKLYACLLKG----GSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~~l  748 (851)
                      .++|++.+.||+|+||.||+|++.  ++.||||++.... ...+.+|.+++...  +||||+++++++...    ...|+
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            457999999999999999999884  8899999985543 34455666666655  899999999999887    78899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--------CcEEeCCCCCCEEECCCCceEE
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP--------PIIHRDIKSSNILLDEDYEPKI  820 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivHrDlkp~NILl~~~~~~kl  820 (851)
                      ||||+++|+|.++++..      .+++..++.++.|++.||+|||   +.        +|+||||||+||+++.++.+||
T Consensus       113 v~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             EECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             EEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            99999999999999652      5889999999999999999999   66        9999999999999999999999


Q ss_pred             eeecCccccCCCCCcc--cccccccccccccCC
Q 003065          821 ADFGVAKIAENSPKVS--DYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE  851 (851)
                      +|||+|+.........  ......||+.|+|||
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  216 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE  216 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHH
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChh
Confidence            9999997665433221  122457999999998

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=5.9e-26  Score=239.98  Aligned_cols=226  Identities=20%  Similarity=0.222  Sum_probs=184.2

Q ss_pred             EEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCc
Q 003065          317 AFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNH  396 (851)
Q Consensus       317 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~  396 (851)
                      .++..+..++ .+|..+.  ++|++|++++|++++.                        .+..|.++++|++|+|++|+
T Consensus        11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~------------------------~~~~~~~l~~L~~L~l~~n~   63 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHL------------------------GSYSFFSFPELQVLDLSRCE   63 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEE------------------------CTTTTTTCTTCSEEECTTCC
T ss_pred             eEEecCCCcc-ccCCCCC--CCccEEECCCCccccc------------------------CHhHhccccCCcEEECCCCc
Confidence            3455555555 4565543  4688888888887743                        23456777888999999999


Q ss_pred             cccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCC-Ccc
Q 003065          397 LSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGK-IPS  475 (851)
Q Consensus       397 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~  475 (851)
                      +++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|.+++. +|.
T Consensus        64 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~  143 (276)
T 2z62_A           64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE  143 (276)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred             CCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCch
Confidence            8877777888889999999999999888888888889999999999999877777888999999999999999864 588


Q ss_pred             ccccCCcccEEEecCCcccCCCCCCcccccccc----eeeccCcccccccCCCccccccCCeEeCCCCccccccCccccc
Q 003065          476 ALGALRQLSSLHLEENALTGSIPNEMGDCARIV----DLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK  551 (851)
Q Consensus       476 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~  551 (851)
                      .+..+++|+.|+|++|++++..+..+..+.+|+    .|++++|.+++..+..+.. .+|+.|+|++|++++..+..+..
T Consensus       144 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~  222 (276)
T 2z62_A          144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDR  222 (276)
T ss_dssp             GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTT
T ss_pred             hhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcc
Confidence            899999999999999999888888888888877    8999999999766655554 48999999999999655556677


Q ss_pred             c-cceEEeCcCCcccccCCc
Q 003065          552 L-KLSSIDLSENQLSGSVPL  570 (851)
Q Consensus       552 l-~L~~l~ls~N~l~~~~p~  570 (851)
                      + .|+.|++++|+|.|.+|.
T Consensus       223 l~~L~~L~l~~N~~~c~c~~  242 (276)
T 2z62_A          223 LTSLQKIWLHTNPWDCSCPR  242 (276)
T ss_dssp             CCSCCEEECCSSCBCCCTTT
T ss_pred             cccccEEEccCCcccccCCc
Confidence            7 899999999999999983

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.93  E-value=5.9e-26  Score=243.48  Aligned_cols=165  Identities=31%  Similarity=0.441  Sum_probs=146.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ..|+..+.||+|+||.||+|++..+++.||||++...   ...+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            4689999999999999999999999999999998643   3467889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      +++++|.+++..      ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       102 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          102 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999998853      35889999999999999999999   779999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ......||+.|+|||
T Consensus       173 ~~--~~~~~~~~~~y~aPE  189 (303)
T 3a7i_A          173 QI--KRNTFVGTPFWMAPE  189 (303)
T ss_dssp             BC--CBCCCCSCGGGCCHH
T ss_pred             cc--ccCccCCCcCccCHH
Confidence            22  123457999999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.93  E-value=4.4e-26  Score=247.35  Aligned_cols=169  Identities=30%  Similarity=0.343  Sum_probs=144.6

Q ss_pred             cCCccCCeecccCcEEEEEEE----EcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEE--eCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLD----LKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLL--KGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  747 (851)
                      .+|+..+.||+|+||.||+|+    ...+++.||||++....  ..+.+.+|++++++++||||+++++++.  .....|
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            478899999999999999999    45678899999986553  3456899999999999999999999886  456689


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++++|.+++....    ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       103 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence            9999999999999998642    25889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcc-cccccccccccccCC
Q 003065          828 IAENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ......... ......||+.|+|||
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE  200 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPE  200 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHH
T ss_pred             ecccCCccceeeccCCccccccCHH
Confidence            775443221 223346899999998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=3.3e-26  Score=253.95  Aligned_cols=166  Identities=23%  Similarity=0.341  Sum_probs=139.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeC------------
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG------------  743 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------------  743 (851)
                      .+|+..+.||+|+||.||+|++..+++.||||++....  ....+|+++++.++||||+++++++...            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            47899999999999999999999999999999986542  2234799999999999999999998543            


Q ss_pred             --------------------------CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 003065          744 --------------------------GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS  797 (851)
Q Consensus       744 --------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  797 (851)
                                                ...++||||++ |+|.+.+..... ....+++..+..++.|+++||+|||   +
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~  159 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIH---S  159 (383)
T ss_dssp             -------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence                                      34789999997 689888876433 3456899999999999999999999   8


Q ss_pred             CCcEEeCCCCCCEEEC-CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          798 PPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       798 ~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+|+||||||+||+++ .++.+||+|||+|+........   ....||+.|+|||
T Consensus       160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE  211 (383)
T 3eb0_A          160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPE  211 (383)
T ss_dssp             TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHH
T ss_pred             CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHH
Confidence            8999999999999998 6889999999999876544322   2357899999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.93  E-value=5.5e-26  Score=243.82  Aligned_cols=164  Identities=27%  Similarity=0.431  Sum_probs=143.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++....  ..+.+.+|++++++++||||+++++++...+..|+||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            47899999999999999999999999999999986542  3456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE---CCCCceEEeeecCccccC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~  830 (851)
                      ++++|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||++   +.++.+||+|||+++...
T Consensus        89 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           89 SGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999998764     35788999999999999999999   7899999999999999   778899999999997654


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...    .....||+.|+|||
T Consensus       161 ~~~----~~~~~~~~~y~aPE  177 (304)
T 2jam_A          161 NGI----MSTACGTPGYVAPE  177 (304)
T ss_dssp             CBT----THHHHSCCCBCCTT
T ss_pred             CCc----cccccCCCCccChH
Confidence            321    22346999999999

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.93  E-value=1.1e-25  Score=240.32  Aligned_cols=168  Identities=26%  Similarity=0.372  Sum_probs=142.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      +|.....||+|+||.||+|++..+++.||||++...  ...+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            456667999999999999999999999999998654  335678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-CCceEEeeecCccccCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~  833 (851)
                      +++|.+++...  ......++..+..++.|++.||+|||   +.+|+||||||+||+++. ++.+||+|||+++......
T Consensus       103 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          103 GGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999764  22345678888899999999999999   789999999999999987 8999999999998765432


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  .....||+.|+|||
T Consensus       178 ~~--~~~~~~~~~y~aPE  193 (295)
T 2clq_A          178 PC--TETFTGTLQYMAPE  193 (295)
T ss_dssp             -----CCCCCCGGGCCHH
T ss_pred             Cc--ccccCCCccccChh
Confidence            21  22357999999998

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.93  E-value=2e-26  Score=253.59  Aligned_cols=164  Identities=28%  Similarity=0.426  Sum_probs=143.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      .+|+..+.||+|+||.||+|++..+++.||+|++...   ...+.+.+|++++++++||||+++++++..++..|+||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            4789999999999999999999999999999998654   2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      +++++|.+++...     ..+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||+++....
T Consensus       113 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          113 MDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            9999999999764     25788899999999999999999   54 899999999999999999999999999976533


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..    .....||+.|+|||
T Consensus       185 ~~----~~~~~gt~~y~aPE  200 (360)
T 3eqc_A          185 SM----ANSFVGTRSYMSPE  200 (360)
T ss_dssp             HC--------CCCCTTCCHH
T ss_pred             cc----ccCCCCCCCeECHH
Confidence            21    22357999999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.93  E-value=1.5e-26  Score=247.95  Aligned_cols=169  Identities=26%  Similarity=0.402  Sum_probs=142.8

Q ss_pred             HHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       674 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...  ...+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            345899999999999999999999989999999998543  456788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++++|.+++...    ...+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        97 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             CCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             eCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999998764    345889999999999999999999   77999999999999999999999999999764322


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  .......||+.|+|||
T Consensus       170 ~~--~~~~~~~~~~~y~aPE  187 (302)
T 2j7t_A          170 TL--QKRDSFIGTPYWMAPE  187 (302)
T ss_dssp             HH--HC-----CCGGGCCHH
T ss_pred             cc--cccccccCChhhcCCe
Confidence            11  1112356899999998

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.93  E-value=4.3e-26  Score=243.99  Aligned_cols=168  Identities=26%  Similarity=0.380  Sum_probs=144.3

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +++|+..+.||+|+||.||+|++..+++.||||++....    ..+.+.+|++++++++||||+++++++..++..|+||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   81 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence            468999999999999999999999899999999986442    2356889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||++ ++|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.++...
T Consensus        82 e~~~-~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  154 (299)
T 2r3i_A           82 EFLH-QDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  154 (299)
T ss_dssp             ECCS-EEHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             Eccc-CCHHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhcc
Confidence            9997 6999998764   2345788899999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  ......||+.|+|||
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE  173 (299)
T 2r3i_A          155 VPVR--TYTHEVVTLWYRAPE  173 (299)
T ss_dssp             CCSB--CTTSCBCCCTTCCHH
T ss_pred             CCcc--ccCcccccccccCcH
Confidence            4322  122346899999998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=3.5e-26  Score=240.36  Aligned_cols=167  Identities=26%  Similarity=0.369  Sum_probs=144.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|++. +++.||+|++... ...+.+.+|++++++++||||+++++++..++..|+||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            46889999999999999999985 6778999998765 356788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++...    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++...... 
T Consensus        87 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-  158 (267)
T 3t9t_A           87 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-  158 (267)
T ss_dssp             TCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred             CCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence            99999999763    345789999999999999999999   7899999999999999999999999999998664321 


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      ........||+.|+|||
T Consensus       159 ~~~~~~~~~~~~y~aPE  175 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPE  175 (267)
T ss_dssp             HHSTTSTTCCGGGCCHH
T ss_pred             ccccccccccccccChh
Confidence            11122345788999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.93  E-value=2.1e-26  Score=247.37  Aligned_cols=165  Identities=33%  Similarity=0.506  Sum_probs=135.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      ++|++.+.||+|+||.||+|++  .++.||||++......+.+.+|++++++++||||+++++++.  +..|+||||+++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~   83 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG   83 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence            4788999999999999999988  467899999987777788999999999999999999999876  347999999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc-eEEeeecCccccCCCCC
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-PKIADFGVAKIAENSPK  834 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~~  834 (851)
                      |+|.+++...  .....+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||+++...... 
T Consensus        84 ~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-  160 (307)
T 2eva_A           84 GSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-  160 (307)
T ss_dssp             CBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence            9999999753  12234788889999999999999999432279999999999999998886 7999999997654322 


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                          ....||+.|+|||
T Consensus       161 ----~~~~gt~~y~aPE  173 (307)
T 2eva_A          161 ----TNNKGSAAWMAPE  173 (307)
T ss_dssp             --------CCTTSSCHH
T ss_pred             ----ccCCCCCceEChh
Confidence                2246899999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.93  E-value=8.3e-26  Score=245.47  Aligned_cols=161  Identities=24%  Similarity=0.322  Sum_probs=141.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCC-CCccccEEEEEEe--CCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLK--GGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~  752 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++.. ...+.+.+|++++++++ ||||+++++++..  ....++||||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~  114 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  114 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence            579999999999999999999999999999999864 44677899999999997 9999999999987  6678999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-ceEEeeecCccccCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAEN  831 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~  831 (851)
                      +++++|.+++.        .++...+..++.|++.||+|||   +.+|+||||||+||+++.++ .+||+|||+|+....
T Consensus       115 ~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          115 VNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             cCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999988764        2678889999999999999999   78999999999999999776 899999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...   .....||+.|+|||
T Consensus       184 ~~~---~~~~~~~~~y~aPE  200 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPE  200 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHH
T ss_pred             CCc---cccccccccccChh
Confidence            432   23357899999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.93  E-value=1.9e-26  Score=261.55  Aligned_cols=167  Identities=26%  Similarity=0.429  Sum_probs=141.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .+|+..+.||+|+||.||+|++. .+..||||++... ...+.+.+|++++++++||||+++++++. .+..|+||||++
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            36788999999999999999984 5678999998754 45788999999999999999999999986 567899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.++++...   ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus       266 ~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          266 KGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             TCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            999999997542   124678889999999999999999   78999999999999999999999999999987654321


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                       .......+|+.|+|||
T Consensus       340 -~~~~~~~~~~~y~aPE  355 (454)
T 1qcf_A          340 -TAREGAKFPIKWTAPE  355 (454)
T ss_dssp             -HTTCSSSSCGGGSCHH
T ss_pred             -eccCCCcccccccCHH
Confidence             1122335688999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.93  E-value=8.1e-27  Score=258.27  Aligned_cols=166  Identities=15%  Similarity=0.187  Sum_probs=135.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHH---HHHcCCCCccccEE-------EEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEME---ILGKIRHRNILKLY-------ACL  740 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~---~l~~l~h~niv~l~-------~~~  740 (851)
                      ++|+..+.||+|+||.||+|++..+++.||||++...     ...+.+.+|++   .+++++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            4688899999999999999999889999999998532     34577889994   55556899999988       776


Q ss_pred             EeCCe-----------------eEEEEeccCCCCHHHHHHHhhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 003065          741 LKGGS-----------------SFLVLEYMPNGNLFQALHKRVKEGK--PELDWFRRYKIALGAAKGIAYLHHDCSPPII  801 (851)
Q Consensus       741 ~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  801 (851)
                      ...+.                 .|+||||+ +|+|.+++........  ..+++..++.++.|++.||+|||   +.+|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            65542                 78999999 6899999987533221  23446778889999999999999   78999


Q ss_pred             EeCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       802 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||||||+|||++.++.+||+|||+|+....     ......| +.|+|||
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE  272 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPE  272 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChh
Confidence            999999999999999999999999986432     1233568 9999998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.93  E-value=3.7e-26  Score=246.78  Aligned_cols=172  Identities=23%  Similarity=0.308  Sum_probs=143.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEe----CCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  749 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++...  ...+.+.+|+++++.++||||+++++++..    ....|+|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            4789999999999999999999999999999988544  345678899999999999999999998862    3478999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++..... ....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       109 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            999999999999987532 3456899999999999999999999   779999999999999999999999999998765


Q ss_pred             CCCCCc-------ccccccccccccccCC
Q 003065          830 ENSPKV-------SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~-------~~~~~~~gt~~Y~APE  851 (851)
                      ......       .......||+.|+|||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  213 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPE  213 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGG
T ss_pred             ccccccccccccccccccccCCcccCCHh
Confidence            422111       0112345799999998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.93  E-value=3.5e-26  Score=243.47  Aligned_cols=168  Identities=23%  Similarity=0.316  Sum_probs=132.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc----HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|+..+.||+|+||.||+|++..+++.||||++.....    .+.+.++...++.++||||+++++++..++..|+|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            478999999999999999999999999999999865422    2234445555788899999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |++ |+|.+++..... ....+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||+|+...
T Consensus        87 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           87 LMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             CCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             hhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            996 599888876433 3456899999999999999999999   66 99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   ....||+.|+|||
T Consensus       162 ~~~~~---~~~~~t~~y~aPE  179 (290)
T 3fme_A          162 DDVAK---DIDAGCKPYMAPE  179 (290)
T ss_dssp             -----------CCCCCCSCHH
T ss_pred             ccccc---cccCCCccccChh
Confidence            44322   2246999999998

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=6.4e-25  Score=231.11  Aligned_cols=205  Identities=21%  Similarity=0.288  Sum_probs=180.0

Q ss_pred             ccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEec
Q 003065          338 ALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG  417 (851)
Q Consensus       338 ~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  417 (851)
                      +.+.+++++|.++ .+|.                        .+.  +++++|+|++|++++..+..|..+++|++|+++
T Consensus        17 ~~~~l~~~~~~l~-~ip~------------------------~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   69 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPS------------------------NIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN   69 (270)
T ss_dssp             TTTEEECTTSCCS-SCCS------------------------CCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCC------------------------CCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECC
Confidence            4667888888877 2332                        222  468999999999997777789999999999999


Q ss_pred             CCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCC
Q 003065          418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI  497 (851)
Q Consensus       418 ~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  497 (851)
                      +|+++...+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++|++++..
T Consensus        70 ~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  149 (270)
T 2o6q_A           70 DNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP  149 (270)
T ss_dssp             SSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence            99999888888899999999999999999777788899999999999999999888888999999999999999999877


Q ss_pred             CCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCC
Q 003065          498 PNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVP  569 (851)
Q Consensus       498 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p  569 (851)
                      +..|+.+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+ .|+.|++++|+|.|.++
T Consensus       150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            7779999999999999999998877889999999999999999996555567777 89999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.93  E-value=2e-26  Score=248.71  Aligned_cols=173  Identities=31%  Similarity=0.392  Sum_probs=144.4

Q ss_pred             cCCccCCeecccCcEEEEEEEE-----cCCCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCC-e
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGG-S  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~  745 (851)
                      ++|++.+.||+|+||.||+|++     ..+++.||||++....   ..+.+.+|+++++++ +||||+++++++...+ .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            4789999999999999999985     3466789999987653   345688999999999 7999999999987654 5


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE  814 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~  814 (851)
                      .|+||||+++|+|.+++.......           ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE  183 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECC
Confidence            899999999999999998642210           122788999999999999999999   789999999999999999


Q ss_pred             CCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       815 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.+||+|||+++...............||+.|+|||
T Consensus       184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  220 (316)
T 2xir_A          184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  220 (316)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred             CCCEEECCCccccccccCccceeccCCCcceeecCch
Confidence            9999999999998765544333334456899999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.93  E-value=3e-26  Score=248.62  Aligned_cols=173  Identities=27%  Similarity=0.335  Sum_probs=139.3

Q ss_pred             cCCccCCeecccCcEEEEEEE-----EcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLD-----LKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      .+|++.+.||+|+||.||+|+     ...++..||||++...   ....++.+|+.++++++||||+++++++...+..|
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            579999999999999999998     4467788999998643   33457889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---CCceEEee
Q 003065          748 LVLEYMPNGNLFQALHKRVKE--GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIAD  822 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~D  822 (851)
                      +||||+++++|.+++......  ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.   +..+||+|
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECc
Confidence            999999999999999875321  1245889999999999999999999   789999999999999984   44699999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++...............||+.|+|||
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE  215 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPE  215 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHH
T ss_pred             cccccccccccccccCCCcCCCcceeCHh
Confidence            99998665443333333456899999998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.93  E-value=2e-26  Score=247.09  Aligned_cols=173  Identities=28%  Similarity=0.420  Sum_probs=129.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      .+|++.+.||+|+||.||+|.+..+++.||||++...   ...+.+.+|++++++++||||+++++++...+..|+||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            4799999999999999999999889999999988543   3356688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          753 MPNGNLFQALHKRVKE---GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      +++++|.+++......   ....+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            9999999999764322   2345899999999999999999999   779999999999999999999999999999766


Q ss_pred             CCCCCc---ccccccccccccccCC
Q 003065          830 ENSPKV---SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~---~~~~~~~gt~~Y~APE  851 (851)
                      ......   .......||+.|+|||
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE  196 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPE  196 (303)
T ss_dssp             C---------------CCCTTCCHH
T ss_pred             ccCCCccchhhhcccCCCccccCHH
Confidence            543211   1123457999999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.93  E-value=2.4e-26  Score=243.36  Aligned_cols=171  Identities=25%  Similarity=0.453  Sum_probs=144.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe--CCeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  748 (851)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...    ...+.+.+|++++++++||||+++++++..  ++..|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            45789999999999999999999999999999998643    235668899999999999999999998754  578899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----cEEeCCCCCCEEECCCCceEEeee
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP-----IIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      ||||+++++|.+++..... ....+++..++.++.|++.||+|||   +.+     |+||||||+||+++.++.+||+||
T Consensus        85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            9999999999999987533 3445899999999999999999999   556     999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |.++........  .....||+.|+|||
T Consensus       161 g~~~~~~~~~~~--~~~~~~~~~y~aPE  186 (279)
T 2w5a_A          161 GLARILNHDTSF--AKTFVGTPYYMSPE  186 (279)
T ss_dssp             CHHHHC---CHH--HHHHHSCCTTCCHH
T ss_pred             chheeecccccc--ccccCCCccccChH
Confidence            999876543221  22356899999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.93  E-value=5.9e-26  Score=244.72  Aligned_cols=173  Identities=23%  Similarity=0.327  Sum_probs=133.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC---CCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC----
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG----  744 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  744 (851)
                      .+|.+.+.||+|+||.||+|++..   ++..||||++...    ...+.+.+|++++++++||||+++++++...+    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            468899999999999999998865   4558999998643    23466889999999999999999999987654    


Q ss_pred             -eeEEEEeccCCCCHHHHHHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          745 -SSFLVLEYMPNGNLFQALHKRVK-EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       745 -~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                       ..|+||||+++|+|.+++..... .....+++..++.++.|+++||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEee
Confidence             34999999999999999965432 23456899999999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++...............|++.|+|||
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE  219 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIE  219 (313)
T ss_dssp             CSCC----------------CCGGGSCHH
T ss_pred             cCcceecccccccCcccccCCCccccCch
Confidence            99998765443222233346788999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.93  E-value=5.6e-26  Score=246.48  Aligned_cols=171  Identities=32%  Similarity=0.481  Sum_probs=142.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEE--EEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTV--AVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  748 (851)
                      .++|+..+.||+|+||.||+|++..++..+  |||.+...   ...+.+.+|+++++++ +||||+++++++...+..|+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            357999999999999999999998888765  99988643   3445688999999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhh-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc
Q 003065          749 VLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE  817 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~  817 (851)
                      ||||+++|+|.+++.....           .....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence            9999999999999976420           12346899999999999999999999   789999999999999999999


Q ss_pred             eEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       818 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +||+|||+++.......   .....+|+.|+|||
T Consensus       181 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE  211 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIE  211 (327)
T ss_dssp             EEECCTTCEESSCEECC---C----CCTTTCCHH
T ss_pred             EEEcccCcCcccccccc---ccCCCCCccccChh
Confidence            99999999974432211   12245788999998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.93  E-value=7.6e-26  Score=245.30  Aligned_cols=168  Identities=30%  Similarity=0.432  Sum_probs=140.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcC-CCCccccEEEEEEe------CCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLLK------GGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~  747 (851)
                      .+|++.+.||+|+||.||+|++..+++.||||++... ...+.+.+|+++++++ +||||+++++++..      .+..|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            5789999999999999999999999999999998654 4457788999999999 89999999999976      46789


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++|+|.+++....   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       104 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             EEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             EEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence            9999999999999998642   245788899999999999999999   7799999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......  ......||+.|+|||
T Consensus       178 ~~~~~~~--~~~~~~~~~~y~aPE  199 (326)
T 2x7f_A          178 QLDRTVG--RRNTFIGTPYWMAPE  199 (326)
T ss_dssp             ---------------CCGGGCCHH
T ss_pred             ecCcCcc--ccccccCCccccChh
Confidence            7654321  123357999999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=6e-26  Score=246.77  Aligned_cols=169  Identities=30%  Similarity=0.470  Sum_probs=135.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC----cEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA----GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|+..+.||+|+||.||+|++..++    ..||||++....   ....+.+|++++++++||||+++++++...+..|+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            36778899999999999999986543    359999986542   34568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++|+|.+++...    ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       124 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999763    346889999999999999999999   77999999999999999999999999999987


Q ss_pred             cCCCCCcc-cccccccccccccCC
Q 003065          829 AENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ........ ......+|+.|+|||
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE  220 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPE  220 (333)
T ss_dssp             --------------CCCGGGSCHH
T ss_pred             hccccccccccCCCCccccccCch
Confidence            65432211 122335688999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.93  E-value=3.1e-26  Score=243.92  Aligned_cols=165  Identities=33%  Similarity=0.509  Sum_probs=128.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .+|++.+.||+|+||.||+|++.   ..||||++...    ...+.+.+|++++++++||||++++++. ..+..++|||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            37899999999999999999863   35999988643    2346788999999999999999999965 5566899999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++++|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A          100 WCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999988642    346889999999999999999999   78999999999999999999999999999986654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...........||+.|+|||
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE  192 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPE  192 (289)
T ss_dssp             -----------CCCTTCCHH
T ss_pred             ccccccccccCCCccccCch
Confidence            33333334467999999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.93  E-value=4.2e-26  Score=251.31  Aligned_cols=168  Identities=19%  Similarity=0.277  Sum_probs=135.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC-----CcEEEEEEeccccc-------------HHHHHHHHHHHHcCCCCccccEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGDG-------------VKVFAAEMEILGKIRHRNILKLY  737 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-------------~~~~~~E~~~l~~l~h~niv~l~  737 (851)
                      .+|++.+.||+|+||.||+|.+..+     ++.||||++.....             ...+.+|+..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4789999999999999999998664     47899999865431             11234456667778899999999


Q ss_pred             EEEEeC----CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          738 ACLLKG----GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       738 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      +++...    ...|+||||+ +++|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEE
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEe
Confidence            998764    4579999999 99999999763    346899999999999999999999   77999999999999998


Q ss_pred             --CCCceEEeeecCccccCCCCCc-----ccccccccccccccCC
Q 003065          814 --EDYEPKIADFGVAKIAENSPKV-----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 --~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE  851 (851)
                        .++.+||+|||+|+........     .......||+.|+|||
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  231 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSID  231 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHH
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHH
Confidence              8899999999999876433211     1123456999999998

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=7.3e-26  Score=242.03  Aligned_cols=168  Identities=27%  Similarity=0.382  Sum_probs=140.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCc---EEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCee-EEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSS-FLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  749 (851)
                      .|...+.||+|+||.||+|++..++.   .||+|++....   ..+.+.+|++++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46677899999999999999765544   79999986543   346788999999999999999999999776555 999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+.+|+|.+++...    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       102 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             ECCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            9999999999998752    346788999999999999999999   779999999999999999999999999999865


Q ss_pred             CCCCC--cccccccccccccccCC
Q 003065          830 ENSPK--VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~--~~~~~~~~gt~~Y~APE  851 (851)
                      .....  ........||+.|+|||
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE  198 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALE  198 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHH
T ss_pred             cCCcccccccCcCCCCCccccChh
Confidence            44321  11223356899999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.93  E-value=8.4e-26  Score=248.90  Aligned_cols=166  Identities=27%  Similarity=0.392  Sum_probs=142.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeC-----CeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  747 (851)
                      .+|+..+.||+|+||.||+|++..+++.||||++....   ..+.+.+|++++++++||||+++++++...     ...|
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            37999999999999999999999999999999986542   346788999999999999999999998754     3689


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||++ |+|.+++...      .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus       107 iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            9999996 6999988652      4889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcc-cccccccccccccCC
Q 003065          828 IAENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ......... ......||+.|+|||
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE  201 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPE  201 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHH
T ss_pred             ecCCCCCccccccccccccCCCCCH
Confidence            765432211 123457999999998

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.93  E-value=5.1e-26  Score=255.22  Aligned_cols=165  Identities=29%  Similarity=0.443  Sum_probs=136.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeC----C--eeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG----G--SSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~~lv~  750 (851)
                      +|+..+.||+|+||.||+|++..+++.||||++....  ....+|++++++++|||||++++++...    +  ..++||
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  132 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL  132 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence            5888999999999999999999999999999986542  2234799999999999999999988542    2  367999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-CceEEeeecCcccc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIA  829 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~  829 (851)
                      ||+++ ++.+.+..... ....+++..+..++.|+++||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+..
T Consensus       133 e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          133 DYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             ECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            99964 77777665322 3456899999999999999999999   8899999999999999965 57899999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......   ...+||+.|+|||
T Consensus       208 ~~~~~~---~~~~~t~~y~aPE  226 (420)
T 1j1b_A          208 VRGEPN---VSYICSRYYRAPE  226 (420)
T ss_dssp             CTTCCC---CSCCSCTTSCCHH
T ss_pred             ccCCCc---eeeeeCCCcCCHH
Confidence            544322   2357899999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=2.2e-26  Score=266.54  Aligned_cols=156  Identities=17%  Similarity=0.115  Sum_probs=124.0

Q ss_pred             eecccCcEEEEEEEEcCCCcEEEEEEeccc------------ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEE
Q 003065          683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------------DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       683 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ..+.|+.|.+..++....|+.||||++.+.            ...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            356677777777777778899999998543            2345689999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||++|++|.+++.+.     ..++..   +|+.||+.||+|+|   ++|||||||||+|||++++|.+||+|||+|+..
T Consensus       321 MEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            9999999999999763     234543   58999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  ...+.+||++|||||
T Consensus       390 ~~~~~--~~~t~vGTp~YmAPE  409 (569)
T 4azs_A          390 PQDCS--WPTNLVQSFFVFVNE  409 (569)
T ss_dssp             C---C--CSHHHHHHHHHHHHH
T ss_pred             CCCCc--cccCceechhhccHH
Confidence            55432  234568999999998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.93  E-value=6.3e-26  Score=250.48  Aligned_cols=163  Identities=33%  Similarity=0.398  Sum_probs=132.1

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC------
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  744 (851)
                      .++|+..+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            35899999999999999999999999999999998653    23456889999999999999999999997654      


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      ..|+||||++ ++|.+++..       .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEee
Confidence            7899999996 578887752       3788899999999999999999   7899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|+.......   .....||+.|+|||
T Consensus       173 ~a~~~~~~~~---~~~~~gt~~y~aPE  196 (371)
T 2xrw_A          173 LARTAGTSFM---MTPYVVTRYYRAPE  196 (371)
T ss_dssp             C-------------------CTTCCHH
T ss_pred             cccccccccc---cCCceecCCccCHH
Confidence            9987654321   23357999999998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.93  E-value=1.1e-25  Score=245.04  Aligned_cols=165  Identities=33%  Similarity=0.485  Sum_probs=133.0

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHH--HHcCCCCccccEEEEEEe-----CCeeE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIRHRNILKLYACLLK-----GGSSF  747 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~~  747 (851)
                      +++|++.+.||+|+||.||+|++  +++.||||++.... ...+..|.++  +..++||||+++++++..     ....|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            45899999999999999999977  67899999986443 3444455555  445899999999986542     23568


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC---------CcEEeCCCCCCEEECCCCce
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP---------PIIHRDIKSSNILLDEDYEP  818 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivHrDlkp~NILl~~~~~~  818 (851)
                      +||||+++|+|.+++...      ..++..+..++.|+++||+|||   +.         +|+||||||+|||++.++.+
T Consensus        89 lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             EEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcE
Confidence            999999999999999753      3478889999999999999999   66         99999999999999999999


Q ss_pred             EEeeecCccccCCCCC------cccccccccccccccCC
Q 003065          819 KIADFGVAKIAENSPK------VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       819 kl~DFGla~~~~~~~~------~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|||+|+.......      ........||+.|+|||
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  198 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE  198 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHH
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCch
Confidence            9999999987654321      11223457999999998

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=4.2e-25  Score=234.63  Aligned_cols=207  Identities=23%  Similarity=0.250  Sum_probs=181.4

Q ss_pred             cCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccc
Q 003065          333 LGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVG  412 (851)
Q Consensus       333 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  412 (851)
                      +..+++++++++++|.++ .+|                        ..+.  +++++|+|++|++++..|..|..+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip------------------------~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~   58 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALP------------------------PDLP--KDTTILHLSENLLYTFSLATLMPYTRLT   58 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCC------------------------SCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCC------------------------CCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCC
Confidence            556778888898888887 333                        2222  5688999999999988888899999999


Q ss_pred             eEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCc
Q 003065          413 MLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA  492 (851)
Q Consensus       413 ~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  492 (851)
                      +|+|++|++++..+.  ..+++|+.|+|++|+++ .+|..+..+++|++|+|++|++++..|..|..+++|+.|+|++|+
T Consensus        59 ~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~  135 (290)
T 1p9a_G           59 QLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE  135 (290)
T ss_dssp             EEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence            999999999876543  67899999999999998 788889999999999999999998888999999999999999999


Q ss_pred             ccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCc
Q 003065          493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPL  570 (851)
Q Consensus       493 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~  570 (851)
                      +++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+... .|+.+++++|+|.|.+..
T Consensus       136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~~  213 (290)
T 1p9a_G          136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI  213 (290)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred             CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCcc
Confidence            99888888899999999999999999777777899999999999999999 788888777 899999999999998854

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.93  E-value=1.5e-25  Score=252.04  Aligned_cols=164  Identities=24%  Similarity=0.285  Sum_probs=142.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcC------CCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI------RHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+++++.+      +|+||+++++++...+..|+
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            46999999999999999999999999999999997653 345677899888877      57799999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc--eEEeeecCc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE--PKIADFGVA  826 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla  826 (851)
                      ||||++ ++|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||+|
T Consensus       177 v~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999995 6999998864   2345899999999999999999999   679999999999999999887  999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +......     ...+||+.|+|||
T Consensus       250 ~~~~~~~-----~~~~gt~~y~aPE  269 (429)
T 3kvw_A          250 CYEHQRV-----YTYIQSRFYRAPE  269 (429)
T ss_dssp             EETTCCC-----CSSCSCGGGCCHH
T ss_pred             eecCCcc-----cccCCCCCccChH
Confidence            7654332     2357999999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.93  E-value=4.4e-26  Score=246.72  Aligned_cols=165  Identities=31%  Similarity=0.403  Sum_probs=139.8

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----------cHHHHHHHHHHHHcCCCCccccEEEEEEeCC
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIRHRNILKLYACLLKGG  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  744 (851)
                      .++|.+.+.||+|+||.||+|++..+++.||||++....          ....+.+|++++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357999999999999999999999999999999985431          2235789999999999999999999987655


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc---eEEe
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIA  821 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~  821 (851)
                       .|+||||+++++|.+++..     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             -eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence             8999999999999998854     346889999999999999999999   789999999999999987654   9999


Q ss_pred             eecCccccCCCCCcccccccccccccccCC
Q 003065          822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       822 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |||+++.......   .....||+.|+|||
T Consensus       160 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE  186 (322)
T 2ycf_A          160 DFGHSKILGETSL---MRTLCGTPTYLAPE  186 (322)
T ss_dssp             CCTTCEECCCCHH---HHHHHSCCTTCCHH
T ss_pred             cCccceecccccc---cccccCCcCccCch
Confidence            9999987654321   22356899999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.93  E-value=6.2e-26  Score=242.69  Aligned_cols=169  Identities=30%  Similarity=0.381  Sum_probs=138.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC---cEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEE-EeCCeeEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA---GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACL-LKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l  748 (851)
                      ..|+..+.||+|+||.||+|++..++   ..||+|.+....   ..+.+.+|++++++++||||+++++++ ..++..|+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            36888999999999999999975433   358999886543   346688999999999999999999985 45667899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++|+|.+++...    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus       105 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccc
Confidence            99999999999999753    345788999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCC--cccccccccccccccCC
Q 003065          829 AENSPK--VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~--~~~~~~~~gt~~Y~APE  851 (851)
                      ......  ........||+.|+|||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE  202 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALE  202 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHH
T ss_pred             ccccchhccccccCCCCCccccChH
Confidence            654321  11223456889999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.93  E-value=7e-26  Score=238.48  Aligned_cols=161  Identities=22%  Similarity=0.319  Sum_probs=140.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  749 (851)
                      ++|+..+.||+|+||.||+|++  .++.||||++...    ...+.+.+|++++++++||||+++++++...  +..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            5789999999999999999998  4788999998654    2346788999999999999999999999876  778999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      |||+++|+|.+++...   ....+++..+..++.|++.|++|||   +.+  |+||||||+||+++.++.+||+|||++.
T Consensus        88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             ecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            9999999999999753   2335899999999999999999999   667  9999999999999999999999999876


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....       ...||+.|+|||
T Consensus       162 ~~~~~-------~~~~t~~y~aPE  178 (271)
T 3kmu_A          162 SFQSP-------GRMYAPAWVAPE  178 (271)
T ss_dssp             TTSCT-------TCBSCGGGSCHH
T ss_pred             eeccc-------CccCCccccChh
Confidence            43322       246899999998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.93  E-value=6.6e-26  Score=238.86  Aligned_cols=164  Identities=34%  Similarity=0.493  Sum_probs=129.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc------ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|+..+.||+|+||.||+|++  .+..||||++...      ...+.+.+|+++++.++||||+++++++..++..|+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            5789999999999999999998  4788999988543      2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC--------CCceEEe
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE--------DYEPKIA  821 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~--------~~~~kl~  821 (851)
                      |||+++++|.+++..      ..+++..++.++.|+++|++|||.....+|+||||||+||+++.        ++.+||+
T Consensus        85 ~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            999999999988742      35889999999999999999999431122999999999999986        6789999


Q ss_pred             eecCccccCCCCCcccccccccccccccCC
Q 003065          822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       822 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |||+++........    ...||+.|+|||
T Consensus       159 Dfg~~~~~~~~~~~----~~~~~~~y~aPE  184 (271)
T 3dtc_A          159 DFGLAREWHRTTKM----SAAGAYAWMAPE  184 (271)
T ss_dssp             CCCC-----------------CCGGGSCHH
T ss_pred             cCCccccccccccc----CCCCccceeCHH
Confidence            99999866543322    346899999998

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.93  E-value=4.9e-26  Score=254.57  Aligned_cols=170  Identities=27%  Similarity=0.388  Sum_probs=128.5

Q ss_pred             Ccc-CCeecccCcEEEEEEEEc--CCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEe--CCeeEEEEec
Q 003065          678 LEE-DNLIGSGGTGKVYRLDLK--KNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLVLEY  752 (851)
Q Consensus       678 ~~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  752 (851)
                      |++ .++||+|+||.||+|+++  .+++.||||++......+.+.+|++++++++||||+++++++..  ....|+||||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~  101 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY  101 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence            554 568999999999999976  46788999999776666778899999999999999999999954  6788999999


Q ss_pred             cCCCCHHHHHHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE----CCCCceEEeeec
Q 003065          753 MPNGNLFQALHKRVKE----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFG  824 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFG  824 (851)
                      ++ ++|.+++......    ....+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||
T Consensus       102 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A          102 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             CS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             CC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            95 6898888754321    1224889999999999999999999   7899999999999999    677899999999


Q ss_pred             CccccCCCCC-cccccccccccccccCC
Q 003065          825 VAKIAENSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      +|+....... .......+||+.|+|||
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE  205 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPE  205 (405)
T ss_dssp             CCC----------------CCCTTCCHH
T ss_pred             CceecCCCCcccccCCCceecCcccCch
Confidence            9987654322 12233467999999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.93  E-value=8.2e-26  Score=239.25  Aligned_cols=167  Identities=28%  Similarity=0.447  Sum_probs=142.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|++. ++..||||++... ...+.+.+|++++++++||||+++++++. .+..|+||||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence            46889999999999999999984 5678999998654 35678999999999999999999999886 456899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +++|.+++....   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        91 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           91 NGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             TCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999986532   125788999999999999999999   78999999999999999999999999999987654432


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......||+.|+|||
T Consensus       165 ~-~~~~~~~~~~y~aPE  180 (279)
T 1qpc_A          165 T-AREGAKFPIKWTAPE  180 (279)
T ss_dssp             E-CCTTCCCCTTTSCHH
T ss_pred             c-cccCCCCccCccChh
Confidence            1 223345788999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.92  E-value=5.8e-26  Score=246.26  Aligned_cols=167  Identities=24%  Similarity=0.280  Sum_probs=140.4

Q ss_pred             cCCccC-CeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEED-NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ..|.+. +.||+|+||.||+|++..+++.||||++...    .....+.+|+.+++.+ +||||+++++++...+..|+|
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            346665 8899999999999999999999999998653    3467889999999999 469999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---CCceEEeeecCc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVA  826 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla  826 (851)
                      |||+++|+|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus       108 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             EECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             EEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            9999999998887532   2356899999999999999999999   789999999999999987   789999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.......   .....||+.|+|||
T Consensus       182 ~~~~~~~~---~~~~~gt~~y~aPE  203 (327)
T 3lm5_A          182 RKIGHACE---LREIMGTPEYLAPE  203 (327)
T ss_dssp             EEC------------CCCGGGCCHH
T ss_pred             cccCCccc---cccccCCcCccCCe
Confidence            87654432   22357999999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.92  E-value=4.5e-26  Score=258.21  Aligned_cols=167  Identities=28%  Similarity=0.443  Sum_probs=136.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|.+.. +..||||++... ...+.+.+|++++++++||||+++++++.. +..|+||||++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            367889999999999999999954 567999998754 356789999999999999999999999866 67899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++....   ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       262 ~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          262 KGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             TCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            999999997542   234788999999999999999999   78999999999999999999999999999987654322


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......+|+.|+|||
T Consensus       336 ~-~~~~~~~~~~y~aPE  351 (452)
T 1fmk_A          336 T-ARQGAKFPIKWTAPE  351 (452)
T ss_dssp             --------CCGGGSCHH
T ss_pred             e-cccCCcccccccCHh
Confidence            1 122345788999998

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.92  E-value=6.7e-26  Score=252.84  Aligned_cols=181  Identities=23%  Similarity=0.255  Sum_probs=146.2

Q ss_pred             cceeeecccccccHHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCC--------
Q 003065          659 KWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIR--------  729 (851)
Q Consensus       659 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~--------  729 (851)
                      .+....++.+.+......+|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++++.++        
T Consensus        20 ~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~   99 (397)
T 1wak_A           20 DYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPN   99 (397)
T ss_dssp             --CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGG
T ss_pred             cCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCC
Confidence            3333444444444333468999999999999999999999999999999997553 3567889999999985        


Q ss_pred             CCccccEEEEEE----eCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CcEEeC
Q 003065          730 HRNILKLYACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRD  804 (851)
Q Consensus       730 h~niv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrD  804 (851)
                      |+||+++++++.    .+...|+||||+ ++++.+++...   ....+++..+..++.|++.||+|||   ++ +|+|||
T Consensus       100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrD  172 (397)
T 1wak_A          100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTD  172 (397)
T ss_dssp             GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCC
T ss_pred             cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCC
Confidence            788999999987    455789999999 67887777653   2346899999999999999999999   66 999999


Q ss_pred             CCCCCEEECCCC-------------------------------------------------ceEEeeecCccccCCCCCc
Q 003065          805 IKSSNILLDEDY-------------------------------------------------EPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       805 lkp~NILl~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~  835 (851)
                      |||+|||++.++                                                 .+||+|||+|+.....   
T Consensus       173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---  249 (397)
T 1wak_A          173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---  249 (397)
T ss_dssp             CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---
T ss_pred             CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---
Confidence            999999999775                                                 7999999999876543   


Q ss_pred             ccccccccccccccCC
Q 003065          836 SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~~~~~~~gt~~Y~APE  851 (851)
                        .....||+.|+|||
T Consensus       250 --~~~~~gt~~y~aPE  263 (397)
T 1wak_A          250 --FTEDIQTRQYRSLE  263 (397)
T ss_dssp             --SCSCCSCGGGCCHH
T ss_pred             --CccCCCCCcccCCh
Confidence              22347999999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.92  E-value=1.3e-25  Score=239.85  Aligned_cols=168  Identities=22%  Similarity=0.255  Sum_probs=140.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEE-EEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYA-CLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|++..+++.||||++......+.+.+|+++++.++|++++..+. ++..++..++||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence            579999999999999999999999999999998766655566889999999999888776554 557788889999999 


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE---CCCCceEEeeecCccccCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~  831 (851)
                      +++|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+|+....
T Consensus        88 ~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           88 GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            99999998753    345899999999999999999999   7899999999999999   7889999999999987655


Q ss_pred             CCCc-----ccccccccccccccCC
Q 003065          832 SPKV-----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~-----~~~~~~~gt~~Y~APE  851 (851)
                      ....     .......||+.|+|||
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE  185 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASIN  185 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHH
T ss_pred             cccCccCCCCcccccCCCccccchH
Confidence            4321     1223467999999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.92  E-value=2.2e-25  Score=238.06  Aligned_cols=168  Identities=22%  Similarity=0.255  Sum_probs=143.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEE-EEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYA-CLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|++..+++.||||++......+.+.+|+++++.++|++++..+. ++..++..++||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            478999999999999999999999999999999877666667899999999999888766544 556778889999999 


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE---CCCCceEEeeecCccccCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~  831 (851)
                      +++|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++....
T Consensus        88 ~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           88 GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            99999999753    345899999999999999999999   7899999999999999   4788999999999987665


Q ss_pred             CCCcc-----cccccccccccccCC
Q 003065          832 SPKVS-----DYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~-----~~~~~~gt~~Y~APE  851 (851)
                      .....     ......||+.|+|||
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE  185 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASIN  185 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHH
T ss_pred             cccccccccccccccccccccCChh
Confidence            43211     123467999999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.92  E-value=4e-26  Score=241.51  Aligned_cols=164  Identities=29%  Similarity=0.454  Sum_probs=134.8

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeC-CeeEEEEecc
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG-GSSFLVLEYM  753 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  753 (851)
                      .++|+..+.||+|+||.||+|++  +++.||||++......+.+.+|++++++++||||+++++++... +..|+||||+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            35789999999999999999987  47899999998777778899999999999999999999987544 5789999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++++|.+++....   ...+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        98 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  171 (278)
T 1byg_A           98 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  171 (278)
T ss_dssp             TTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             CCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence            9999999997652   123678889999999999999999   7899999999999999999999999999998654332


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      .     ...+++.|+|||
T Consensus       172 ~-----~~~~~~~y~aPE  184 (278)
T 1byg_A          172 D-----TGKLPVKWTAPE  184 (278)
T ss_dssp             ---------CCTTTSCHH
T ss_pred             c-----CCCccccccCHH
Confidence            1     235789999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.92  E-value=1.6e-25  Score=242.70  Aligned_cols=169  Identities=29%  Similarity=0.433  Sum_probs=142.7

Q ss_pred             cCCccCCeecccCcEEEEEEEE----cCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCC--eeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDL----KKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGG--SSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  747 (851)
                      .+|++.+.||+|+||.||+|++    ..+++.||||++....  ..+.+.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4688999999999999999984    5678899999986543  3567899999999999999999999886543  689


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++++|.+++...    ...+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       121 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            999999999999999763    345889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcc-cccccccccccccCC
Q 003065          828 IAENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ......... ......||..|+|||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE  218 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPE  218 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHH
T ss_pred             hccccccccccccCCCCceeEECch
Confidence            776543221 122345788899998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.92  E-value=2.9e-25  Score=242.42  Aligned_cols=171  Identities=32%  Similarity=0.427  Sum_probs=144.3

Q ss_pred             HHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHc--CCCCccccEEEEEEeCC----e
Q 003065          672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLLKGG----S  745 (851)
Q Consensus       672 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~  745 (851)
                      ....++|++.+.||+|+||.||+|++  +++.||||++... ..+.+.+|+++++.  ++||||+++++++...+    .
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            34456899999999999999999998  5889999998644 45667889999887  78999999999998775    7


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEeCCCCCCEEECCCCceEE
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD-----CSPPIIHRDIKSSNILLDEDYEPKI  820 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl  820 (851)
                      .|+||||+++|+|.+++.+.      .+++..++.++.|++.|++|||..     ++.+|+||||||+||+++.++.+||
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             eEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence            89999999999999999752      488999999999999999999932     1368999999999999999999999


Q ss_pred             eeecCccccCCCCCcc--cccccccccccccCC
Q 003065          821 ADFGVAKIAENSPKVS--DYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE  851 (851)
                      +|||+++.........  ......||+.|+|||
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  221 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE  221 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHH
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHh
Confidence            9999998765543221  123457999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.92  E-value=2.4e-25  Score=241.56  Aligned_cols=169  Identities=27%  Similarity=0.352  Sum_probs=129.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHH-HHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEME-ILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|+..+.||+|+||.||+|.+..+++.||||++....   ....+.+|+. +++.++||||+++++++..++..|+|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            57899999999999999999999999999999986542   2344556666 6777899999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |++ ++|.+++..........+++..+..++.|++.|+.|||   +. +|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            997 58888887654444567899999999999999999999   66 99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   ....||+.|+|||
T Consensus       178 ~~~~~---~~~~gt~~y~aPE  195 (327)
T 3aln_A          178 DSIAK---TRDAGCRPYMAPE  195 (327)
T ss_dssp             ---------------------
T ss_pred             ccccc---ccCCCCccccCce
Confidence            43221   2246999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.92  E-value=1.7e-25  Score=243.66  Aligned_cols=169  Identities=25%  Similarity=0.340  Sum_probs=131.1

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCC-CCccccEEEEEE--------eCCe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIR-HRNILKLYACLL--------KGGS  745 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~~  745 (851)
                      +|++.+.||+|+||.||+|++..+++.||||++....  ..+.+.+|+.+++++. ||||+++++++.        ....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            6889999999999999999999999999999885543  3566889999999996 999999999984        3345


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEECCCCceEEeee
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      .++||||++ |+|.+++....  ....+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+||
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             EEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            799999995 79999987643  2346899999999999999999999   677  999999999999999999999999


Q ss_pred             cCccccCCCCCcc----------cccccccccccccCC
Q 003065          824 GVAKIAENSPKVS----------DYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~----------~~~~~~gt~~Y~APE  851 (851)
                      |+++.........          ......||+.|+|||
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE  220 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE  220 (337)
T ss_dssp             TTCBCCSSCC----------------------------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChh
Confidence            9998765432211          111346999999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.92  E-value=2.4e-25  Score=252.54  Aligned_cols=168  Identities=21%  Similarity=0.264  Sum_probs=144.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCC-CccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++......+.+.+|+++++.++| ++|+.+..++...+..|+||||+ 
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            4799999999999999999999999999999998766656678899999999987 55556777778888999999999 


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE---CCCCceEEeeecCccccCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~  831 (851)
                      +++|.+++...    ...+++..++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+|+....
T Consensus        86 g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           86 GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99999999753    346899999999999999999999   7899999999999999   6888999999999987765


Q ss_pred             CCCcc-----cccccccccccccCC
Q 003065          832 SPKVS-----DYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~-----~~~~~~gt~~Y~APE  851 (851)
                      .....     ......||+.|+|||
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE  183 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVN  183 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred             CccccccccccccccCCCccccCHH
Confidence            43221     122567999999998

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1.2e-25  Score=237.00  Aligned_cols=163  Identities=21%  Similarity=0.233  Sum_probs=79.8

Q ss_pred             cccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcc
Q 003065          188 SIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLL  267 (851)
Q Consensus       188 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  267 (851)
                      .+..+++|++|+|++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|
T Consensus        80 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  159 (272)
T 3rfs_A           80 ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNL  159 (272)
T ss_dssp             GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccC
Confidence            34444555555555555554444444555555555555555554444444555555555555555554444444555555


Q ss_pred             cEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCC
Q 003065          268 QEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISEN  347 (851)
Q Consensus       268 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N  347 (851)
                      ++|++++|++++..+..+.++++|++|++++|++++..|..|..+++|+.|++++|.+.+.       +++|+.|+++.|
T Consensus       160 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n  232 (272)
T 3rfs_A          160 TELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWIN  232 (272)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHH
T ss_pred             CEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHH
Confidence            5555555555544444445555555555555555544444444445555555554444422       223444444444


Q ss_pred             cccccCchhh
Q 003065          348 QFSGSFPKYL  357 (851)
Q Consensus       348 ~l~~~~p~~~  357 (851)
                      +++|.+|.++
T Consensus       233 ~~~g~ip~~~  242 (272)
T 3rfs_A          233 KHSGVVRNSA  242 (272)
T ss_dssp             HTGGGBBCTT
T ss_pred             hCCCcccCcc
Confidence            4444444443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.92  E-value=2.2e-25  Score=237.46  Aligned_cols=167  Identities=25%  Similarity=0.287  Sum_probs=138.4

Q ss_pred             cCCccCC-eecccCcEEEEEEEE--cCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          676 CNLEEDN-LIGSGGTGKVYRLDL--KKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       676 ~~~~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+|.+.+ .||+|+||.||+|.+  ..+++.||||++....    ..+.+.+|+++++.++||||+++++++ ..+..|+
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            3677777 999999999999954  4567889999986542    256788999999999999999999998 5667899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++++|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        95 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            99999999999999763     35888999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCcc-cccccccccccccCC
Q 003065          829 AENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ........ ......||+.|+|||
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE  190 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPE  190 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHH
T ss_pred             eccCCCcccccccCCCCceeeChH
Confidence            65543321 122335678999998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.8e-25  Score=237.66  Aligned_cols=167  Identities=25%  Similarity=0.336  Sum_probs=139.6

Q ss_pred             CCccCC-eecccCcEEEEEEEEc--CCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDN-LIGSGGTGKVYRLDLK--KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +|.+.+ .||+|+||.||+|.+.  .++..||||++...   ...+.+.+|++++++++||||+++++++ ..+..|+||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            455555 8999999999999864  46778999998764   2456788999999999999999999999 456689999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      ||+++++|.+++...    ...+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        89 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           89 EMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             ECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            999999999998642    346899999999999999999999   7899999999999999999999999999998775


Q ss_pred             CCCCc-ccccccccccccccCC
Q 003065          831 NSPKV-SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~-~~~~~~~gt~~Y~APE  851 (851)
                      ..... .......||+.|+|||
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE  183 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPE  183 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHH
T ss_pred             cCcceeeccccccccccccCHH
Confidence            44322 1122345789999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.92  E-value=3.3e-25  Score=235.72  Aligned_cols=168  Identities=31%  Similarity=0.457  Sum_probs=146.5

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      ...++|++.+.||+|+||.||+|++..+++.||||++...    ...+.+.+|++++++++||||+++++++...+..|+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            3446899999999999999999999989999999998543    356788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC---CceEEeeecC
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKIADFGV  825 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGl  825 (851)
                      ||||+++++|.+++...     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.+   +.+||+|||+
T Consensus        99 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           99 VGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            99999999999988764     25789999999999999999999   7799999999999999754   4699999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++........   ....||+.|+|||
T Consensus       171 ~~~~~~~~~~---~~~~~~~~y~aPE  193 (287)
T 2wei_A          171 STCFQQNTKM---KDRIGTAYYIAPE  193 (287)
T ss_dssp             GGTBCCCSSC---SCHHHHHTTCCHH
T ss_pred             ceeecCCCcc---ccccCcccccChH
Confidence            9876544322   2346899999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=5.3e-26  Score=250.61  Aligned_cols=168  Identities=29%  Similarity=0.378  Sum_probs=129.9

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCC---cEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEE-eCCeeEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNA---GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLL-KGGSSFLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  749 (851)
                      .|+..+.||+|+||.||+|++..++   ..||||.+...   ...+.+.+|+.++++++||||+++++++. .++..|+|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999975433   35899988543   34567899999999999999999999864 45678999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++...    ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       170 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccc
Confidence            9999999999999753    345788899999999999999999   789999999999999999999999999999866


Q ss_pred             CCCCCc--ccccccccccccccCC
Q 003065          830 ENSPKV--SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~--~~~~~~~gt~~Y~APE  851 (851)
                      ......  .......||+.|+|||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE  266 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALE  266 (373)
T ss_dssp             ---------------CCGGGSCHH
T ss_pred             cccccccccccCCCCCcccccChH
Confidence            443211  1122346788999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.92  E-value=2.3e-25  Score=244.43  Aligned_cols=166  Identities=25%  Similarity=0.397  Sum_probs=140.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeC-----CeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  747 (851)
                      ++|+..+.||+|+||.||+|++..+++.||||++....   ....+.+|++++++++||||+++++++...     ...|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            47899999999999999999999999999999986443   345678999999999999999999987654     6789


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||++ ++|.+++..      ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus        91 lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            9999996 699998875      25889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcc--------cccccccccccccCC
Q 003065          828 IAENSPKVS--------DYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~--------~~~~~~gt~~Y~APE  851 (851)
                      .........        ......||+.|+|||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  192 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPE  192 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHH
T ss_pred             ccccccccccCccccccchhhccccccccCCe
Confidence            765432111        122357899999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.92  E-value=1.6e-25  Score=237.31  Aligned_cols=167  Identities=27%  Similarity=0.381  Sum_probs=138.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC---CcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|+..+.||+|+||.||+|++...   +..||||++...   ...+.+.+|++++++++||||+++++++.. +..|+|
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence            4788999999999999999987543   345999998654   245678899999999999999999999865 456899


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++++|.+++...    ...+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        91 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           91 MELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            9999999999999764    345789999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...... ......||+.|+|||
T Consensus       164 ~~~~~~-~~~~~~~~~~y~aPE  184 (281)
T 3cc6_A          164 EDEDYY-KASVTRLPIKWMSPE  184 (281)
T ss_dssp             ----------CCCCCGGGCCHH
T ss_pred             cccccc-ccccCCCCcceeCch
Confidence            543321 122345788999998

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.92  E-value=7.3e-26  Score=247.47  Aligned_cols=167  Identities=19%  Similarity=0.225  Sum_probs=134.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC---CCcEEEEEEeccccc-------------HHHHHHHHHHHHcCCCCccccEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKGDG-------------VKVFAAEMEILGKIRHRNILKLYAC  739 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-------------~~~~~~E~~~l~~l~h~niv~l~~~  739 (851)
                      .+|++.+.||+|+||.||+|++..   ++..||||++.....             .+.+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            468999999999999999999976   778899999865421             1235678889999999999999999


Q ss_pred             EEe----CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC
Q 003065          740 LLK----GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED  815 (851)
Q Consensus       740 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~  815 (851)
                      +..    ....|+||||+ +++|.+++...     ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccC
Confidence            987    67889999999 99999998753     26899999999999999999999   7799999999999999887


Q ss_pred             C--ceEEeeecCccccCCCCCc-----ccccccccccccccCC
Q 003065          816 Y--EPKIADFGVAKIAENSPKV-----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       816 ~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE  851 (851)
                      +  .+||+|||+|+........     .......||+.|+|||
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  230 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLD  230 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHH
Confidence            7  9999999999876432211     1123457999999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.92  E-value=4.7e-26  Score=250.59  Aligned_cols=161  Identities=29%  Similarity=0.402  Sum_probs=124.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC------Ce
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------GS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  745 (851)
                      .+|+..+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|+++++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4799999999999999999999999999999998543    2356788999999999999999999998654      56


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+|+||+ +++|.+++..      ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       109 ~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             EEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            79999999 7899888754      35889999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+.....     ....+||++|+|||
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE  199 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPE  199 (367)
T ss_dssp             -----------------CCCTTCCHH
T ss_pred             ccccccc-----CCCcCcCcCccChH
Confidence            9865432     23357999999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.92  E-value=3.3e-25  Score=243.85  Aligned_cols=174  Identities=25%  Similarity=0.302  Sum_probs=133.5

Q ss_pred             HHHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCe-----
Q 003065          672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS-----  745 (851)
Q Consensus       672 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  745 (851)
                      ...+++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|++.++.++||||+++++++...+.     
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            45678999999999999999999999999999999988544 234456788888999999999999999876443     


Q ss_pred             --eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-CCceEEee
Q 003065          746 --SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIAD  822 (851)
Q Consensus       746 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~D  822 (851)
                        .++||||+++ ++.+.+.... .....+++..+..++.|++.|+.|||.. +.+|+||||||+||+++. ++.+||+|
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             eeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEee
Confidence              7899999975 6666665432 2345678889999999999999999943 579999999999999996 89999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|+........   ....||+.|+|||
T Consensus       176 fg~a~~~~~~~~~---~~~~gt~~y~aPE  201 (360)
T 3e3p_A          176 FGSAKKLSPSEPN---VAYICSRYYRAPE  201 (360)
T ss_dssp             CTTCBCCCTTSCC---CSTTSCGGGCCHH
T ss_pred             CCCceecCCCCCc---ccccCCcceeCHH
Confidence            9999876644322   2357899999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.92  E-value=2.1e-25  Score=240.96  Aligned_cols=165  Identities=31%  Similarity=0.403  Sum_probs=139.0

Q ss_pred             CccCCeecccCcEEEEEEEE----cCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeC--CeeEE
Q 003065          678 LEEDNLIGSGGTGKVYRLDL----KKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFL  748 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  748 (851)
                      |+..+.||+|+||.||+|..    ..+++.||||++....   ..+.+.+|++++++++||||+++++++...  ...|+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48899999999999988764    3477889999997653   345688999999999999999999999874  57899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++|+|.+++...      .+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            99999999999998652      3889999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCc-ccccccccccccccCC
Q 003065          829 AENSPKV-SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~-~~~~~~~gt~~Y~APE  851 (851)
                      ....... .......||+.|+|||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE  207 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPE  207 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHH
T ss_pred             ccccccccccccCCCCCceeeChH
Confidence            7654322 1123356889999998

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1e-24  Score=229.75  Aligned_cols=226  Identities=20%  Similarity=0.204  Sum_probs=184.2

Q ss_pred             CeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccc
Q 003065          147 EIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICR  226 (851)
Q Consensus       147 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~  226 (851)
                      ..++++.+.+...  ..+..+++|++|++++|.+.  .+ ..+..+++|++|++++|++++.  ..+.++++|++|++++
T Consensus        22 ~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~--~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~   94 (272)
T 3rfs_A           22 IKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK--SV-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTG   94 (272)
T ss_dssp             HHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC--CC-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT
T ss_pred             HHHHhcCcccccc--cccccccceeeeeeCCCCcc--cc-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC
Confidence            3344444444322  23456677777777777765  33 3578889999999999999863  4788999999999999


Q ss_pred             ccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCC
Q 003065          227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP  306 (851)
Q Consensus       227 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p  306 (851)
                      |++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..+..+.++++|+.|++++|++++..+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  174 (272)
T 3rfs_A           95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE  174 (272)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence            99998888889999999999999999998888889999999999999999998777788999999999999999998877


Q ss_pred             CCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccc
Q 003065          307 SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKT  386 (851)
Q Consensus       307 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~  386 (851)
                      ..|+.+++|++|++++|++++..|..+..+++|+.|++++|.+.+..       +.+..+.+..|++.|.+|.+++.+..
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~-------~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC-------PGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT-------TTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC-------cHHHHHHHHHHhCCCcccCcccccCC
Confidence            78899999999999999999988888999999999999999887543       34566666666666666666655543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.92  E-value=6.6e-26  Score=248.19  Aligned_cols=168  Identities=21%  Similarity=0.266  Sum_probs=144.0

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc-------------------HHHHHHHHHHHHcCCCCcccc
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-------------------VKVFAAEMEILGKIRHRNILK  735 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~E~~~l~~l~h~niv~  735 (851)
                      +++|++.+.||+|+||.||+|++  +++.||||++.....                   .+.+.+|++++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            35899999999999999999998  889999999854311                   178999999999999999999


Q ss_pred             EEEEEEeCCeeEEEEeccCCCCHHHHHHHh---hhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCcEEeCCCCCCEE
Q 003065          736 LYACLLKGGSSFLVLEYMPNGNLFQALHKR---VKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNIL  811 (851)
Q Consensus       736 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrDlkp~NIL  811 (851)
                      +++++...+..|+||||+++|+|.+++...   .......+++..+..++.|++.|+.|||   + .+|+||||||+||+
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL  184 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence            999999999999999999999998873211   0112456899999999999999999999   5 89999999999999


Q ss_pred             ECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          812 LDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       812 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.++.+||+|||.++.....    ......||+.|+|||
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE  220 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPE  220 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGG
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCch
Confidence            999999999999999876543    123357999999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.92  E-value=1.5e-25  Score=249.38  Aligned_cols=165  Identities=30%  Similarity=0.438  Sum_probs=133.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeCCe------eEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGS------SFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv  749 (851)
                      .+|+..+.||+|+||.||+|++..+++ ||+|++.....  ...+|+++++.++||||+++++++...+.      .|+|
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            368899999999999999999976654 88888754422  22479999999999999999999865443      7899


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC-CCCceEEeeecCccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKI  828 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~  828 (851)
                      |||+++ ++.+.+..... ....+++..+..++.|+++||+|||   +.+|+||||||+||+++ .++.+||+|||+|+.
T Consensus       117 ~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          117 LEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            999975 55554443322 2456889999999999999999999   78999999999999999 789999999999987


Q ss_pred             cCCCCCcccccccccccccccCC
Q 003065          829 AENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .......   ....||+.|+|||
T Consensus       192 ~~~~~~~---~~~~~t~~y~aPE  211 (394)
T 4e7w_A          192 LIAGEPN---VSYICSRYYRAPE  211 (394)
T ss_dssp             CCTTCCC---CSSCSCGGGCCHH
T ss_pred             ccCCCCC---cccccCcCccCHH
Confidence            6544322   2357899999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.92  E-value=5.4e-25  Score=239.77  Aligned_cols=164  Identities=24%  Similarity=0.352  Sum_probs=141.4

Q ss_pred             cCCccCCeecccCcEEEEEEEE-cCCCcEEEEEEecccc-cHHHHHHHHHHHHcCCCCc------cccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDL-KKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRN------ILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~  747 (851)
                      .+|++.+.||+|+||.||+|.+ ..+++.||||++.... ..+.+.+|+++++.++|++      ++++++++...+..|
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            4789999999999999999998 5678899999986543 3567889999999987665      999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-------------
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-------------  814 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-------------  814 (851)
                      +||||+ +++|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.             
T Consensus        94 lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999 89999999764   2345789999999999999999999   789999999999999987             


Q ss_pred             ------CCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          815 ------DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       815 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                            ++.+||+|||+++......     ....||+.|+|||
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE  204 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPE  204 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHH
T ss_pred             ccccccCCCceEeeCcccccCcccc-----ccccCCccccChH
Confidence                  6689999999998654332     2357999999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.92  E-value=1.1e-25  Score=260.36  Aligned_cols=167  Identities=28%  Similarity=0.448  Sum_probs=141.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|++.. +..||||++... ...+.|.+|++++++++||||+++++++.. +..|+||||++
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            367889999999999999999954 567999998754 356789999999999999999999999866 67899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++....   ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus       345 ~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  417 (535)
T 2h8h_A          345 KGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  417 (535)
T ss_dssp             TEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred             CCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence            999999997542   234788999999999999999999   7899999999999999999999999999998765321 


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      ........++..|+|||
T Consensus       418 ~~~~~~~~~~~~y~aPE  434 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPE  434 (535)
T ss_dssp             HHTTCSTTSCGGGSCHH
T ss_pred             eecccCCcCcccccCHH
Confidence            11122345788999998

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.92  E-value=1.4e-25  Score=247.73  Aligned_cols=162  Identities=10%  Similarity=0.032  Sum_probs=121.6

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcC--CCCccccEE-------EEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKI--RHRNILKLY-------ACLLK  742 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~  742 (851)
                      .|+..+.||+|+||.||+|++..+++.||||++....     ..+.+.+|+++++.+  +||||++++       +++..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            5889999999999999999999999999999997643     345567785544444  699988855       45543


Q ss_pred             CC-----------------eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 003065          743 GG-----------------SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRR------YKIALGAAKGIAYLHHDCSPP  799 (851)
Q Consensus       743 ~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~  799 (851)
                      .+                 ..|+||||++ |+|.+++......    +.+..+      ..++.|++.||+|||   +++
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~  214 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV----YVFRGDEGILALHILTAQLIRLAANLQ---SKG  214 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc----cchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence            32                 3799999998 8999999875322    233334      677899999999999   789


Q ss_pred             cEEeCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       800 ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+||||||+|||++.++.+||+|||+|+......     ....||+.|+|||
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE  261 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPRE  261 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHH
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChh
Confidence            9999999999999999999999999998664321     1245779999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.92  E-value=2e-25  Score=245.85  Aligned_cols=164  Identities=24%  Similarity=0.330  Sum_probs=131.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-------------cHHHHHHHHHHHHcCCCCccccEEEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------------GVKVFAAEMEILGKIRHRNILKLYACLLK  742 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~~~~~~  742 (851)
                      .+|...+.||+|+||.||+|.+.. ++.||||++....             ..+.+.+|++++++++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            579999999999999999999854 8899999885421             13678999999999999999999999854


Q ss_pred             -----CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc
Q 003065          743 -----GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE  817 (851)
Q Consensus       743 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~  817 (851)
                           ....|+||||++ |++.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~  172 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNND  172 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCC
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCC
Confidence                 236799999997 6898888742    346899999999999999999999   779999999999999999999


Q ss_pred             eEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       818 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +||+|||+++.......   .....||+.|+|||
T Consensus       173 ~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE  203 (362)
T 3pg1_A          173 ITICDFNLAREDTADAN---KTHYVTHRWYRAPE  203 (362)
T ss_dssp             EEECCTTC------------------CGGGCCHH
T ss_pred             EEEEecCcccccccccc---cceecccceecCcH
Confidence            99999999985544322   22357899999998

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.92  E-value=6.7e-27  Score=254.82  Aligned_cols=266  Identities=15%  Similarity=0.223  Sum_probs=180.3

Q ss_pred             CCcccceeEecCCCCceEEEecccCCcceecCccccCC--ccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCC
Q 003065           59 SPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISAL--QSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGS  136 (851)
Q Consensus        59 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~  136 (851)
                      -|..|.++.|++.  .++.+|++++.+.   +..+..+  ++++.|++++|.+++..|. +..+++|++|+|++|.+++.
T Consensus        35 vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~  108 (336)
T 2ast_B           35 VCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS  108 (336)
T ss_dssp             SCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred             HHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence            3568999998743  5778888888776   3456666  7888888888888766554 55788888888888887654


Q ss_pred             -CCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccc-cCCCCCCcccccCCCCCCeEecccc-ccccc-CCc
Q 003065          137 -VPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN-VYDEAEIPESIGNLKNLTYLFLAHC-NLRGR-IPE  211 (851)
Q Consensus       137 -~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~  211 (851)
                       .+. +..+++|++|+|++|.+++..+..+..+++|++|++++| .++...+|..+.++++|++|++++| .+++. ++.
T Consensus       109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~  188 (336)
T 2ast_B          109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV  188 (336)
T ss_dssp             HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHH
T ss_pred             HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHH
Confidence             444 677888888888888877777777777888888888887 5553235666777778888888888 77654 456


Q ss_pred             cccccc-ccCccccccc--ccc-ccccccccCCCcccEEEeeccC-ccCcCCcCcCCCCcccEEeccccc-ccCCCCccc
Q 003065          212 SISELR-ELGTLDICRN--KIS-GEFPRSIRKLQKLWKIELYANN-LTGELPAELGNLTLLQEFDISSNQ-MYGKLPEEI  285 (851)
Q Consensus       212 ~~~~l~-~L~~L~L~~N--~i~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l  285 (851)
                      .+..++ +|++|++++|  .++ +.+|..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......+
T Consensus       189 ~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l  268 (336)
T 2ast_B          189 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL  268 (336)
T ss_dssp             HHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGG
T ss_pred             HHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHH
Confidence            677777 7777787777  444 4456666777777777777777 665666677777777777777774 221111245


Q ss_pred             cCcCCccEEEccCCccCCCCCCCCCCcc-cccEEEeccCcCCCCCCCccC
Q 003065          286 GNLKNLTVFQCFKNNFSGEFPSGFGDMR-KLFAFSIYGNRFSGPFPENLG  334 (851)
Q Consensus       286 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~l~  334 (851)
                      .++++|+.|++++| ++   ...+..+. ++..|++++|++++..|..++
T Consensus       269 ~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          269 GEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             GGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             hcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence            66677777777766 22   11233332 255555566666655555544

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=2.1e-24  Score=229.25  Aligned_cols=180  Identities=22%  Similarity=0.258  Sum_probs=92.0

Q ss_pred             cccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCC
Q 003065          117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLT  196 (851)
Q Consensus       117 ~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~  196 (851)
                      ++++++|+++++++|.++..++.+.  ++++.|+|++|.+++..+..|.++++|++|+|++|.++  .+|.. +.+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~-~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVD-GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC--EEECC-SCCTTCC
T ss_pred             ccccCCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC--cccCC-CCCCcCC
Confidence            4555566666666666655544443  45666666666666555555555566666666555554  22222 4555566


Q ss_pred             eEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEeccccc
Q 003065          197 YLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQ  276 (851)
Q Consensus       197 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  276 (851)
                      +|+|++|+++ .+|..+..+++|++|++++|+|++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            6666666555 444445555555555555555554444444444445555555554444433444444444444444444


Q ss_pred             ccCCCCccccCcCCccEEEccCCccC
Q 003065          277 MYGKLPEEIGNLKNLTVFQCFKNNFS  302 (851)
Q Consensus       277 l~~~~p~~l~~l~~L~~L~l~~N~l~  302 (851)
                      +++..+..|.++++|+.|++++|+++
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~  185 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY  185 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC
Confidence            44333333344444444444444444

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.92  E-value=9.6e-26  Score=247.28  Aligned_cols=166  Identities=17%  Similarity=0.180  Sum_probs=138.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC--------CCcEEEEEEecccccHHHHHHHHHHHHcCCCCcccc------------
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK--------NAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILK------------  735 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~------------  735 (851)
                      ++|++.+.||+|+||.||+|++..        .++.||||++...   +.+.+|++++++++||||++            
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            478999999999999999999977        3788999998655   45779999999999999987            


Q ss_pred             ---EEEEEEe-CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 003065          736 ---LYACLLK-GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL  811 (851)
Q Consensus       736 ---l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NIL  811 (851)
                         +++++.. ++..|+||||+ +++|.+++...   ....+++..++.++.|++.||+|||   +.+|+||||||+||+
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence               6777766 67889999999 99999999863   1246899999999999999999999   779999999999999


Q ss_pred             ECCCC--ceEEeeecCccccCCCCCc-----ccccccccccccccCC
Q 003065          812 LDEDY--EPKIADFGVAKIAENSPKV-----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       812 l~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE  851 (851)
                      ++.++  .+||+|||+|+........     .......||+.|+|||
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  238 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMD  238 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHH
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHH
Confidence            99998  8999999999866533211     1123357999999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.92  E-value=3.4e-25  Score=239.30  Aligned_cols=166  Identities=29%  Similarity=0.417  Sum_probs=133.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEE------------
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLL------------  741 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~------------  741 (851)
                      .+|+..+.||+|+||.||+|++..+++.||||++....  ..+.+.+|++++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            47899999999999999999999999999999886543  4567889999999999999999999873            


Q ss_pred             --eCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC-CCCce
Q 003065          742 --KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEP  818 (851)
Q Consensus       742 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~-~~~~~  818 (851)
                        ..+..|+||||++ |+|.+++..      ..+++..+..++.|++.||+|||   +.+|+||||||+||+++ +++.+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeE
Confidence              3467899999997 699988753      35788899999999999999999   78999999999999997 56799


Q ss_pred             EEeeecCccccCCCCC-cccccccccccccccCC
Q 003065          819 KIADFGVAKIAENSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       819 kl~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|||+++....... ........||+.|+|||
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  194 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR  194 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcH
Confidence            9999999987653321 11223356899999998

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.92  E-value=3.3e-25  Score=260.56  Aligned_cols=161  Identities=25%  Similarity=0.293  Sum_probs=132.3

Q ss_pred             CeecccCcEEEEEEEE--cCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDL--KKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||.||+|.+  ..+++.||||+++..    ...+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999965  456678999998653    235789999999999999999999999864 558899999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+........
T Consensus       454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            9999999752     45889999999999999999999   789999999999999999999999999999876544321


Q ss_pred             -ccccccccccccccCC
Q 003065          836 -SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 -~~~~~~~gt~~Y~APE  851 (851)
                       .......||+.|+|||
T Consensus       526 ~~~~~~~~~t~~y~APE  542 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPE  542 (635)
T ss_dssp             ---------CGGGSCHH
T ss_pred             cccccCCCCceeeeChh
Confidence             1222345788999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.92  E-value=8.7e-25  Score=237.87  Aligned_cols=164  Identities=24%  Similarity=0.338  Sum_probs=122.3

Q ss_pred             cCCccC-CeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEe----CCeeEEEE
Q 003065          676 CNLEED-NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  750 (851)
                      ++|.+. +.||+|+||.||+|++..+++.||||++....  +...+....++.++||||+++++++..    +...|+||
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  105 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM  105 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence            478885 46999999999999999999999999986542  222233344667799999999999876    44589999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---CCceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~  827 (851)
                      ||+++|+|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++
T Consensus       106 e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          106 ECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             ECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             eccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            999999999999864   2346899999999999999999999   779999999999999976   4559999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......    .....||+.|+|||
T Consensus       180 ~~~~~~----~~~~~~t~~y~aPE  199 (336)
T 3fhr_A          180 ETTQNA----LQTPCYTPYYVAPE  199 (336)
T ss_dssp             EC----------------------
T ss_pred             eccccc----cccCCCCcCccChh
Confidence            665432    22356899999998

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.92  E-value=3e-25  Score=260.33  Aligned_cols=161  Identities=23%  Similarity=0.317  Sum_probs=132.4

Q ss_pred             eecccCcEEEEEEEEcC--CCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCCCC
Q 003065          683 LIGSGGTGKVYRLDLKK--NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGN  757 (851)
Q Consensus       683 ~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  757 (851)
                      .||+|+||.||+|.++.  ++..||||+++..   ...+.+.+|++++++++|||||++++++.. +..|+||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            79999999999998753  4567999998653   356789999999999999999999999876 56899999999999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc-c
Q 003065          758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV-S  836 (851)
Q Consensus       758 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~  836 (851)
                      |.+++...    ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+........ .
T Consensus       422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred             HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence            99998642    346899999999999999999999   789999999999999999999999999999876543221 1


Q ss_pred             cccccccccccccCC
Q 003065          837 DYSCFAGTHGYIAPG  851 (851)
Q Consensus       837 ~~~~~~gt~~Y~APE  851 (851)
                      ......+|+.|+|||
T Consensus       495 ~~~~~~~~~~y~APE  509 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPE  509 (613)
T ss_dssp             -------CCTTSCHH
T ss_pred             eccCCCCccceeCHh
Confidence            112234678999998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.92  E-value=2.2e-25  Score=246.10  Aligned_cols=160  Identities=29%  Similarity=0.419  Sum_probs=135.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCee-----
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS-----  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  746 (851)
                      ++|...+.||+|+||.||+|.+..+++.||||++...    ...+.+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4789999999999999999999999999999998653    2246788999999999999999999999876654     


Q ss_pred             -EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          747 -FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       747 -~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                       |+||||++ ++|.+++.       ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       122 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             EEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence             99999996 68877653       24889999999999999999999   77999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+.....     .....||+.|+|||
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE  211 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPE  211 (371)
T ss_dssp             C-------------CTTCCCTTSCHH
T ss_pred             ccccccC-----cCCcccCccccCHH
Confidence            9865433     22357899999998

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.92  E-value=2.8e-25  Score=240.06  Aligned_cols=164  Identities=27%  Similarity=0.384  Sum_probs=143.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------cHHHHHHHHHHHHcCC--CCccccEEEEEEeCCe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIR--HRNILKLYACLLKGGS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  745 (851)
                      .+|++.+.||+|+||.||+|++..+++.||||++....        ..+.+.+|++++++++  |+||+++++++..++.
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            47899999999999999999999999999999986542        2245678999999996  5999999999999999


Q ss_pred             eEEEEeccCC-CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC-CCCceEEeee
Q 003065          746 SFLVLEYMPN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADF  823 (851)
Q Consensus       746 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DF  823 (851)
                      .++||||+.+ ++|.+++...     ..+++..+..++.|+++||+|||   +.+|+||||||+||+++ +++.+||+||
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            9999999976 8999999764     35788999999999999999999   78999999999999999 7889999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+++......    .....||+.|+|||
T Consensus       195 g~~~~~~~~~----~~~~~gt~~y~aPE  218 (320)
T 3a99_A          195 GSGALLKDTV----YTDFDGTRVYSPPE  218 (320)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHH
T ss_pred             cccccccccc----ccCCCCCccCCChH
Confidence            9998765432    22356999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.91  E-value=2e-25  Score=240.34  Aligned_cols=164  Identities=27%  Similarity=0.399  Sum_probs=137.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------cHHHHHHHHHHHHcC----CCCccccEEEEEEeC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKI----RHRNILKLYACLLKG  743 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l----~h~niv~l~~~~~~~  743 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++....        ....+.+|+++++++    +||||+++++++...
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            57999999999999999999999999999999986542        223356799999998    899999999999999


Q ss_pred             CeeEEEEec-cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC-CCCceEEe
Q 003065          744 GSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIA  821 (851)
Q Consensus       744 ~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~  821 (851)
                      +..++|||| +++++|.+++...     ..+++..++.++.|+++||+|||   +.+|+||||||+||+++ .++.+||+
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             CeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEE
Confidence            999999999 7899999999864     25889999999999999999999   67999999999999999 88999999


Q ss_pred             eecCccccCCCCCcccccccccccccccCC
Q 003065          822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       822 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |||+++......    .....||+.|+|||
T Consensus       183 dfg~~~~~~~~~----~~~~~~~~~y~aPE  208 (312)
T 2iwi_A          183 DFGSGALLHDEP----YTDFDGTRVYSPPE  208 (312)
T ss_dssp             CCSSCEECCSSC----BCCCCSCTTTSCHH
T ss_pred             EcchhhhcccCc----ccccCCcccccCce
Confidence            999998765432    23356999999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.91  E-value=3.4e-25  Score=264.04  Aligned_cols=159  Identities=25%  Similarity=0.392  Sum_probs=137.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCe-----e
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGS-----S  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~  746 (851)
                      .+|++.+.||+|+||.||+|++.. +++.||||++....   ..+.+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            579999999999999999999976 68899999886542   34567899999999999999999999987665     6


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||+++++|.+++..       .+++..++.++.|++.||.|||   +.+|+||||||+||+++.+ .+||+|||++
T Consensus       160 ~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccc
Confidence            999999999999876542       5889999999999999999999   7899999999999999986 8999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.....      ....||+.|+|||
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE  247 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPE  247 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTT
T ss_pred             hhcccC------CccCCCccccCHH
Confidence            876543      2356999999999

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.91  E-value=5.8e-25  Score=238.33  Aligned_cols=166  Identities=27%  Similarity=0.346  Sum_probs=138.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-CCCcEEEEEEecccc----cHHHHHHHHHHHHcC---CCCccccEEEEEE-----e
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-KNAGTVAVKQLWKGD----GVKVFAAEMEILGKI---RHRNILKLYACLL-----K  742 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  742 (851)
                      .+|++.+.||+|+||.||+|++. .+++.||||++....    ....+.+|+++++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            57999999999999999999995 677889999885432    223566788877766   8999999999987     4


Q ss_pred             CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      ....++||||++ |+|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence            567899999997 6999998764   2345889999999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++......   ......||+.|+|||
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE  189 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPE  189 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHH
T ss_pred             CcccccccCCC---CccccccccceeCHH
Confidence            99998654322   223457899999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.91  E-value=1.5e-24  Score=240.42  Aligned_cols=167  Identities=25%  Similarity=0.282  Sum_probs=141.6

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCC-CC-----ccccEEEEEEeCCeeE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIR-HR-----NILKLYACLLKGGSSF  747 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~  747 (851)
                      ..+|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++++.++ |+     +|+++++++...+..|
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            468999999999999999999999999999999997553 3466778999988875 44     4999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC--CCCceEEeeecC
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD--EDYEPKIADFGV  825 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGl  825 (851)
                      +||||++ ++|.+++...   ....+++..+..++.|++.||.|||.. +.+|+||||||+|||++  .++.+||+|||+
T Consensus       133 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            9999995 6999999864   234588999999999999999999942 46899999999999995  477899999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+......     ....||+.|+|||
T Consensus       208 a~~~~~~~-----~~~~~t~~y~aPE  228 (382)
T 2vx3_A          208 SCQLGQRI-----YQYIQSRFYRSPE  228 (382)
T ss_dssp             CEETTCCC-----CSSCSCGGGCCHH
T ss_pred             ceeccccc-----ccccCCccccChH
Confidence            98765432     2357999999998

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=3e-26  Score=252.13  Aligned_cols=260  Identities=16%  Similarity=0.167  Sum_probs=138.0

Q ss_pred             ecccCCcceecCccccCCccCcEEeCCCCcccCccC----cccccCC-CCceEecccCcccCCCCC-CCCC-----CCCC
Q 003065           79 SFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLP----LELSNCS-NLKVLNVTGNAMVGSVPD-LSAL-----KNLE  147 (851)
Q Consensus        79 ~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~n~l~~~~~~-l~~l-----~~L~  147 (851)
                      +++.++++|.+|..+...++|++|||++|.+++..+    ..|..++ +|++|+|++|.+.+..+. +..+     ++|+
T Consensus         4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~   83 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT   83 (362)
T ss_dssp             ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred             ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence            445555555555555555555555555555554443    4444555 555555555555544332 2222     4555


Q ss_pred             eEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCC-CCCCeEecccccccccCCccccc-----ccccCc
Q 003065          148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNL-KNLTYLFLAHCNLRGRIPESISE-----LRELGT  221 (851)
Q Consensus       148 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~-----l~~L~~  221 (851)
                      +|||++|.+++..+..+...                     +..+ ++|++|+|++|++++..+..+..     .++|++
T Consensus        84 ~L~Ls~n~l~~~~~~~l~~~---------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~  142 (362)
T 3goz_A           84 SLNLSGNFLSYKSSDELVKT---------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS  142 (362)
T ss_dssp             EEECCSSCGGGSCHHHHHHH---------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCE
T ss_pred             EEECcCCcCChHHHHHHHHH---------------------HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeE
Confidence            55555555544444332222                     2222 45555555555554433333222     135555


Q ss_pred             cccccccccccc----cccccCCC-cccEEEeeccCccCcCCcCcC----CC-CcccEEecccccccCC----CCccccC
Q 003065          222 LDICRNKISGEF----PRSIRKLQ-KLWKIELYANNLTGELPAELG----NL-TLLQEFDISSNQMYGK----LPEEIGN  287 (851)
Q Consensus       222 L~L~~N~i~~~~----p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~l~~  287 (851)
                      |+|++|++++..    +..+..++ +|++|+|++|++++..+..+.    .. ++|++|||++|++++.    ++..+..
T Consensus       143 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~  222 (362)
T 3goz_A          143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS  222 (362)
T ss_dssp             EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred             EEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence            555555555322    22333343 566666666666544443322    22 4666666666666542    2333433


Q ss_pred             -cCCccEEEccCCccCCCCC----CCCCCcccccEEEeccCcCCCCC-------CCccCCCCccceeeccCCcccccCch
Q 003065          288 -LKNLTVFQCFKNNFSGEFP----SGFGDMRKLFAFSIYGNRFSGPF-------PENLGRYTALTDVDISENQFSGSFPK  355 (851)
Q Consensus       288 -l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~-------p~~l~~l~~L~~L~Ls~N~l~~~~p~  355 (851)
                       .++|+.|++++|.+++..+    ..+..+++|+.|++++|.+.+..       +..+..+++|+.||+++|++.+..+.
T Consensus       223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~  302 (362)
T 3goz_A          223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI  302 (362)
T ss_dssp             SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred             CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence             2466677777776665433    23456667777777777744332       34677888999999999999877665


Q ss_pred             hhhh
Q 003065          356 YLCE  359 (851)
Q Consensus       356 ~~~~  359 (851)
                      .+.+
T Consensus       303 ~~~~  306 (362)
T 3goz_A          303 PISN  306 (362)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            5543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.91  E-value=4.3e-25  Score=235.14  Aligned_cols=168  Identities=27%  Similarity=0.380  Sum_probs=132.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-CCc--EEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-NAG--TVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~--~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|++.+.||+|+||.||+|++.. +++  .||||++...     ...+.+.+|++++++++||||+++++++..+. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            478999999999999999998643 333  5899988643     34567889999999999999999999998765 89


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++++|.+++...    ...+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        97 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccc
Confidence            999999999999999864    235788999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCcc-cccccccccccccCC
Q 003065          828 IAENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ......... ......||+.|+|||
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE  194 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPE  194 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHH
T ss_pred             cccccccchhhhccCCCCceeeCch
Confidence            775543221 222346788999998

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=4.5e-26  Score=250.74  Aligned_cols=261  Identities=17%  Similarity=0.182  Sum_probs=135.7

Q ss_pred             cccccccccccccccccCCCcccEEEeeccCccCcCC----cCcCCCC-cccEEecccccccCCCCccccCc-----CCc
Q 003065          222 LDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP----AELGNLT-LLQEFDISSNQMYGKLPEEIGNL-----KNL  291 (851)
Q Consensus       222 L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~L  291 (851)
                      ++++.|.+++.+|..+...++|++|+|++|.+++..+    ..|..++ +|++|+|++|++++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4567777777777666666667777777777775554    5556666 67777777777766655555554     566


Q ss_pred             cEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCC-CccceeeccCCcccccCchhhhhhcchHHHHhcc
Q 003065          292 TVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRY-TALTDVDISENQFSGSFPKYLCEKRKLLNLLALS  370 (851)
Q Consensus       292 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~  370 (851)
                      ++|++++|++++..+..+...                    +..+ ++|++|+|++|++++..+..++.           
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~-----------  131 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKT--------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQ-----------  131 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECCSSCGGGSCHHHHHH-----------
T ss_pred             cEEECcCCcCChHHHHHHHHH--------------------HHhCCCCccEEECcCCcCCcHHHHHHHH-----------
Confidence            666666666654443322221                    1111 34444555555444333322211           


Q ss_pred             CCccccccccccC-ccccceeccccCcccccc----CCcccCcc-ccceEEecCCcCCCCCCcccc----cC-CCCCeEe
Q 003065          371 NNFSGEVPNSYAD-CKTIQRLRISDNHLSGKI----PDGLWALP-NVGMLDFGDNDFTGGISPLIG----LS-TSLSQLV  439 (851)
Q Consensus       371 n~~~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~----p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~----~~-~~L~~L~  439 (851)
                               .+.. .++|++|+|++|++++..    +..+..++ +|++|+|++|++++..+..+.    .. ++|+.|+
T Consensus       132 ---------~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~  202 (362)
T 3goz_A          132 ---------AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLD  202 (362)
T ss_dssp             ---------HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEE
T ss_pred             ---------HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEE
Confidence                     1112 124555555555554322    22222232 455555555555444433222    22 3566666


Q ss_pred             cCCCcceee----CCcccccC-CCCcEEeccCccccCCCc----cccccCCcccEEEecCCcccCC-------CCCCccc
Q 003065          440 LQNNRFSGE----LPSELGRL-TNLERLILTNNNFSGKIP----SALGALRQLSSLHLEENALTGS-------IPNEMGD  503 (851)
Q Consensus       440 Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~  503 (851)
                      |++|++++.    ++..+... ++|++|+|++|.+++..+    ..+..+++|+.|+|++|.+.+.       ++..+..
T Consensus       203 Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~  282 (362)
T 3goz_A          203 LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPN  282 (362)
T ss_dssp             CTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTT
T ss_pred             CCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhcc
Confidence            666666532    33344442 366666666666665433    2345556666666666664322       2234555


Q ss_pred             ccccceeeccCcccccccC
Q 003065          504 CARIVDLNLARNSLSGNIP  522 (851)
Q Consensus       504 l~~L~~L~Ls~N~l~~~~p  522 (851)
                      +++|+.||+++|++.+..+
T Consensus       283 l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          283 IQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             CCEEEEECTTSCBCCGGGC
T ss_pred             CCceEEEecCCCcCCCcch
Confidence            5566666666666655433

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.91  E-value=2.1e-24  Score=236.76  Aligned_cols=164  Identities=21%  Similarity=0.294  Sum_probs=140.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC-cEEEEEEeccc-ccHHHHHHHHHHHHcCCCCc------cccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA-GTVAVKQLWKG-DGVKVFAAEMEILGKIRHRN------ILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~  747 (851)
                      ++|++.+.||+|+||.||+|.+..++ +.||||++... ...+.+.+|++++++++|++      ++.+++++...+..|
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            57999999999999999999998776 68999998654 34566888999999997766      899999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEE---------------
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---------------  812 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl---------------  812 (851)
                      +||||+ ++++.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+||++               
T Consensus        99 lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence            999999 67888887763   2346889999999999999999999   8899999999999999               


Q ss_pred             ----CCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          813 ----DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       813 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                          +.++.+||+|||+++......     ....||+.|+|||
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE  209 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPE  209 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHH
T ss_pred             cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCe
Confidence                567899999999998654332     2357999999998

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=3.9e-24  Score=222.47  Aligned_cols=191  Identities=22%  Similarity=0.226  Sum_probs=120.2

Q ss_pred             CCcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCC
Q 003065           59 SPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP  138 (851)
Q Consensus        59 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~  138 (851)
                      +||.|.|++|...   .+.+++++++++ .+|..+.  +++++|+|++|.+++..|..|+++++|++|+|++|.+++.++
T Consensus         3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   76 (251)
T 3m19_A            3 TCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA   76 (251)
T ss_dssp             -CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             cCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence            5889999999532   336788888887 5666555  577788888888877777777777777777777777777666


Q ss_pred             C-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCccccccc
Q 003065          139 D-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELR  217 (851)
Q Consensus       139 ~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  217 (851)
                      . +..+++|++|+|++|.+++..+..|..+++|++|+|++|.+                         ++..+..|..++
T Consensus        77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l-------------------------~~~~~~~~~~l~  131 (251)
T 3m19_A           77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQL-------------------------KSLPSGVFDRLT  131 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCC-------------------------CCCCTTTTTTCT
T ss_pred             hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcC-------------------------CCcChhHhccCC
Confidence            5 67777777777777777655555555555555555555555                         433333344445


Q ss_pred             ccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCC
Q 003065          218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK  280 (851)
Q Consensus       218 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  280 (851)
                      +|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+.+.
T Consensus       132 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          132 KLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             cccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            555555555555544444455555555555555555555455555566666666666666543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.91  E-value=1.2e-24  Score=234.49  Aligned_cols=165  Identities=24%  Similarity=0.346  Sum_probs=134.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCC--CCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIR--HRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv  749 (851)
                      ++|++.+.||+|+||.||+|++. +++.||||++...    ...+.+.+|++++++++  ||||+++++++..++..|+|
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            36899999999999999999985 5889999998543    23467889999999997  59999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      || +.+++|.+++...     ..+++..+..++.|+++||+|||   +.+|+||||||+||++++ +.+||+|||+++..
T Consensus       107 ~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             Ee-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            99 5588999999763     35788899999999999999999   779999999999999965 79999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .............||+.|+|||
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE  198 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPE  198 (313)
T ss_dssp             -------------CCGGGCCHH
T ss_pred             cCccccccccCCCCCCCcCCHH
Confidence            5443322223457999999998

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=3.8e-24  Score=220.87  Aligned_cols=201  Identities=18%  Similarity=0.149  Sum_probs=127.4

Q ss_pred             ecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCc-ccCCCCC-CCCCCCCCeEeccC-cccCCCCcccc
Q 003065           88 EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNA-MVGSVPD-LSALKNLEIFDLSI-NYFTGRFPRWV  164 (851)
Q Consensus        88 ~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~~~-l~~l~~L~~L~Ls~-N~l~~~~~~~~  164 (851)
                      .+|. +.  ++|++|+|++|++++..+..|+++++|++|+|++|+ +++.++. +..+++|++|++++ |.+++..+..|
T Consensus        25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f  101 (239)
T 2xwt_C           25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL  101 (239)
T ss_dssp             SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred             ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence            3555 33  378888888888886666678888888888888886 7766664 77888888888887 88876666677


Q ss_pred             cCccccceeecccccCCCCCCcccccCCCCCC---eEecccc-cccccCCcccccccccC-ccccccccccccccccccC
Q 003065          165 VNLTQLVSLSIGDNVYDEAEIPESIGNLKNLT---YLFLAHC-NLRGRIPESISELRELG-TLDICRNKISGEFPRSIRK  239 (851)
Q Consensus       165 ~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~---~L~L~~n-~l~~~~p~~~~~l~~L~-~L~L~~N~i~~~~p~~~~~  239 (851)
                      .++++|++|++++|.++  .+|. +..+++|+   +|++++| ++++..+..|.++++|+ +|++++|+++...+..|..
T Consensus       102 ~~l~~L~~L~l~~n~l~--~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~  178 (239)
T 2xwt_C          102 KELPLLKFLGIFNTGLK--MFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG  178 (239)
T ss_dssp             ECCTTCCEEEEEEECCC--SCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT
T ss_pred             CCCCCCCEEeCCCCCCc--cccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC
Confidence            77777777777777775  3555 66666666   6666666 66655555566666666 6666666665222223333


Q ss_pred             CCcccEEEeeccC-ccCcCCcCcCCC-CcccEEecccccccCCCCccccCcCCccEEEccC
Q 003065          240 LQKLWKIELYANN-LTGELPAELGNL-TLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK  298 (851)
Q Consensus       240 l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~  298 (851)
                       ++|++|++++|+ +++..+..|..+ ++|++|++++|++++ +|..  .+++|+.|++++
T Consensus       179 -~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~  235 (239)
T 2xwt_C          179 -TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARN  235 (239)
T ss_dssp             -CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTT
T ss_pred             -CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccC
Confidence             555556665553 554444455555 555555555555553 2222  334444444443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.91  E-value=1.1e-24  Score=256.93  Aligned_cols=167  Identities=26%  Similarity=0.308  Sum_probs=137.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC---CcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .+|+..+.||+|+||.||+|.+..+   +..||||++....   ..+.+.+|+.++++++||||+++++++. .+..|+|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            4688999999999999999998643   4569999886532   3467889999999999999999999985 4568999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|+|.+++...    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       469 ~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          469 MELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            9999999999999763    345889999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...... ......||+.|+|||
T Consensus       542 ~~~~~~-~~~~~~~t~~y~aPE  562 (656)
T 2j0j_A          542 EDSTYY-KASKGKLPIKWMAPE  562 (656)
T ss_dssp             CC-----------CCGGGCCHH
T ss_pred             CCCcce-eccCCCCCcceeCHH
Confidence            544322 122345788999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.91  E-value=4.4e-25  Score=242.13  Aligned_cols=160  Identities=28%  Similarity=0.411  Sum_probs=135.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCe------
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGS------  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  745 (851)
                      .+|...+.||+|+||.||+|++..+++.||||++....    ..+.+.+|+.+++.++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            47889999999999999999999999999999986532    24568899999999999999999999987654      


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+||||++ ++|.+++.       ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       104 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             EEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence            499999996 68766552       24889999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.....     .....||+.|+|||
T Consensus       173 ~~~~~~~-----~~~~~~t~~y~aPE  193 (353)
T 3coi_A          173 ARHADAE-----MTGYVVTRWYRAPE  193 (353)
T ss_dssp             TTC-------------CCSBCCSCHH
T ss_pred             ccCCCCC-----ccccccCcCcCCHH
Confidence            9865432     22357899999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.91  E-value=4.1e-25  Score=255.83  Aligned_cols=171  Identities=27%  Similarity=0.373  Sum_probs=142.2

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEe------C
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLK------G  743 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~  743 (851)
                      ..+++|++.+.||+|+||.||+|.+..+++.||||++...   ...+.+.+|++++++++||||+++++++..      +
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            3457899999999999999999999999999999998654   235668899999999999999999998755      6


Q ss_pred             CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCc---eEE
Q 003065          744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKI  820 (851)
Q Consensus       744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl  820 (851)
                      +..|+||||+++|+|.+++....  ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.   +||
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEE
Confidence            67899999999999999997632  2235777888999999999999999   789999999999999997665   999


Q ss_pred             eeecCccccCCCCCcccccccccccccccCC
Q 003065          821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       821 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|||.++........   ....||+.|+|||
T Consensus       166 ~DFG~a~~~~~~~~~---~~~~gt~~Y~APE  193 (676)
T 3qa8_A          166 IDLGYAKELDQGELC---TEFVGTLQYLAPE  193 (676)
T ss_dssp             CSCCCCCBTTSCCCC---CCCCSCCTTCSSC
T ss_pred             ccccccccccccccc---ccccCCcccCChH
Confidence            999999876554322   3357999999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.91  E-value=1.2e-24  Score=240.58  Aligned_cols=164  Identities=24%  Similarity=0.304  Sum_probs=140.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCC-----------CCccccEEEEEEeC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIR-----------HRNILKLYACLLKG  743 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~  743 (851)
                      .+|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|++++++++           ||||+++++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            47999999999999999999999999999999987543 4566789999999886           89999999998765


Q ss_pred             C----eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CcEEeCCCCCCEEEC-----
Q 003065          744 G----SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLD-----  813 (851)
Q Consensus       744 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrDlkp~NILl~-----  813 (851)
                      +    ..++||||+ +++|.+++...   ....+++..+..++.|++.||+|||   ++ +|+||||||+||+++     
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence            4    789999999 89999999864   2345889999999999999999999   66 999999999999994     


Q ss_pred             -CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          814 -EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                       ..+.+||+|||+|+......     ....||+.|+|||
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE  205 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPE  205 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHH
T ss_pred             cCcceEEEcccccccccCCCC-----CCCCCCccccCcH
Confidence             44579999999998765432     2347899999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.91  E-value=2e-24  Score=233.18  Aligned_cols=166  Identities=26%  Similarity=0.402  Sum_probs=124.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc----HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +.+|+..+.||+|+||.||+|++..+++.||||++.....    .+.+.++..+++.++||||+++++++..++..|+||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            4578999999999999999999998999999999865432    223444556788889999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ||+ ++.+..+....    ...+++..+..++.|+++||.|||   +. +|+||||||+||+++.++.+||+|||+++..
T Consensus       104 e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             CCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             ecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            999 55555554432    345889999999999999999999   54 9999999999999999999999999999766


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......   ....||+.|+|||
T Consensus       176 ~~~~~~---~~~~~~~~y~aPE  194 (318)
T 2dyl_A          176 VDDKAK---DRSAGCAAYMAPE  194 (318)
T ss_dssp             --------------CCTTCCHH
T ss_pred             cCCccc---cccCCCccccChh
Confidence            543222   2346899999998

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=8e-24  Score=227.53  Aligned_cols=222  Identities=16%  Similarity=0.138  Sum_probs=130.4

Q ss_pred             cCcEEeCCCCcccCcc-Cc--ccccCCCCceEecccCcccCCCCC-C--CCCCCCCeEeccCcccCCCCc----ccccCc
Q 003065           98 SLTVLSLPFNVLSGKL-PL--ELSNCSNLKVLNVTGNAMVGSVPD-L--SALKNLEIFDLSINYFTGRFP----RWVVNL  167 (851)
Q Consensus        98 ~L~~L~L~~n~l~~~~-p~--~~~~l~~L~~L~Ls~n~l~~~~~~-l--~~l~~L~~L~Ls~N~l~~~~~----~~~~~l  167 (851)
                      .++.|.++++.++... ..  .+..+++|++|+|++|.+.+..|. +  ..+++|++|+|++|.+++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            4566777776664321 11  123446688888888887776665 4  777778888888877776544    334456


Q ss_pred             cccceeecccccCCCCCCcccccCCCCCCeEeccccccccc--C--CcccccccccCccccccccccccccc----cccC
Q 003065          168 TQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR--I--PESISELRELGTLDICRNKISGEFPR----SIRK  239 (851)
Q Consensus       168 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~--~--p~~~~~l~~L~~L~L~~N~i~~~~p~----~~~~  239 (851)
                      ++|++|+|++|.+. ...|..++.+++|++|+|++|++.+.  +  +..+..+++|++|+|++|+++. ++.    .+..
T Consensus       145 ~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~  222 (310)
T 4glp_A          145 PGLKVLSIAQAHSP-AFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA  222 (310)
T ss_dssp             SCCCEEEEECCSSC-CCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred             cCCCEEEeeCCCcc-hhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence            77777777777775 34445666777777777777776542  1  2223566677777777777752 222    2455


Q ss_pred             CCcccEEEeeccCccCcCCcCcCCC---CcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCccccc
Q 003065          240 LQKLWKIELYANNLTGELPAELGNL---TLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLF  316 (851)
Q Consensus       240 l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~  316 (851)
                      +++|++|+|++|++++..|..+..+   ++|++|+|++|+++ .+|..+.  ++|+.|++++|++++. |. +..+++|+
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~  297 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD  297 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence            6666666666666666555555554   46666666666665 4444443  4555555555555532 21 34444444


Q ss_pred             EEEeccCcCC
Q 003065          317 AFSIYGNRFS  326 (851)
Q Consensus       317 ~L~l~~N~l~  326 (851)
                      .|++++|+++
T Consensus       298 ~L~L~~N~l~  307 (310)
T 4glp_A          298 NLTLDGNPFL  307 (310)
T ss_dssp             CEECSSTTTS
T ss_pred             EEECcCCCCC
Confidence            4444444443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=1.2e-23  Score=218.73  Aligned_cols=179  Identities=24%  Similarity=0.271  Sum_probs=110.6

Q ss_pred             ccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEecc
Q 003065          386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT  465 (851)
Q Consensus       386 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  465 (851)
                      +.++++++++.++ .+|..+.  ++++.|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            3455566666655 4444432  456666666666666666566666666666666666665555556666666666666


Q ss_pred             CccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCcccccc
Q 003065          466 NNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI  545 (851)
Q Consensus       466 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i  545 (851)
                      +|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..
T Consensus        92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  171 (251)
T 3m19_A           92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP  171 (251)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence            66666555566666666666666666666555555666666666666666666555556666666666666666666554


Q ss_pred             Ccccccc-cceEEeCcCCccccc
Q 003065          546 PDNLMKL-KLSSIDLSENQLSGS  567 (851)
Q Consensus       546 p~~l~~l-~L~~l~ls~N~l~~~  567 (851)
                      |..+..+ .|+.|++++|+|.|.
T Consensus       172 ~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          172 HGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTTTCTTCCEEECCSCCBCTT
T ss_pred             HHHHhCCCCCCEEEeeCCceeCC
Confidence            5555555 666666666666665

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.90  E-value=1.5e-25  Score=243.99  Aligned_cols=252  Identities=15%  Similarity=0.178  Sum_probs=187.4

Q ss_pred             cCcEEeCCCCcccCccCcccccC--CCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCC-CcccccCccccceee
Q 003065           98 SLTVLSLPFNVLSGKLPLELSNC--SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGR-FPRWVVNLTQLVSLS  174 (851)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~  174 (851)
                      .++.+++++|.+.   |..+..+  +++++|++++|.+.+.++.+..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            4789999999887   5677888  899999999999999988888899999999999998866 777888889999999


Q ss_pred             cccccCCCCCCcccccCCCCCCeEecccc-ccccc-CCcccccccccCccccccc-ccccc-ccccccCCC-cccEEEee
Q 003065          175 IGDNVYDEAEIPESIGNLKNLTYLFLAHC-NLRGR-IPESISELRELGTLDICRN-KISGE-FPRSIRKLQ-KLWKIELY  249 (851)
Q Consensus       175 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L~~N-~i~~~-~p~~~~~l~-~L~~L~L~  249 (851)
                      +++|.++ ...|..++.+++|++|++++| .+++. ++..+.++++|++|++++| ++++. ++..+..++ +|++|+++
T Consensus       125 L~~~~l~-~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~  203 (336)
T 2ast_B          125 LEGLRLS-DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS  203 (336)
T ss_dssp             CTTCBCC-HHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred             CcCcccC-HHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence            9998876 456777888899999999988 67753 5666778888888888888 88754 566778888 88888888


Q ss_pred             cc--Ccc-CcCCcCcCCCCcccEEeccccc-ccCCCCccccCcCCccEEEccCCc-cCCCCCCCCCCcccccEEEeccCc
Q 003065          250 AN--NLT-GELPAELGNLTLLQEFDISSNQ-MYGKLPEEIGNLKNLTVFQCFKNN-FSGEFPSGFGDMRKLFAFSIYGNR  324 (851)
Q Consensus       250 ~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~  324 (851)
                      +|  .++ +.+|..+..+++|++|++++|. +++..+..+.++++|+.|++++|. +.......++.+++|+.|++++| 
T Consensus       204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-  282 (336)
T 2ast_B          204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-  282 (336)
T ss_dssp             SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred             CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence            88  454 3556666778888888888887 666667777778888888888875 22111114566666777777666 


Q ss_pred             CCCCCCCccCCC-CccceeeccCCcccccCchhh
Q 003065          325 FSGPFPENLGRY-TALTDVDISENQFSGSFPKYL  357 (851)
Q Consensus       325 l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~  357 (851)
                      ++   ...+..+ .+++.|++++|++++..|..+
T Consensus       283 i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~  313 (336)
T 2ast_B          283 VP---DGTLQLLKEALPHLQINCSHFTTIARPTI  313 (336)
T ss_dssp             SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred             cC---HHHHHHHHhhCcceEEecccCccccCCcc
Confidence            22   1223333 235555566666665555444

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.90  E-value=6.4e-25  Score=237.23  Aligned_cols=165  Identities=27%  Similarity=0.385  Sum_probs=135.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|++.+.||+|+||.||+|++..   .||+|++...    ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            478999999999999999998843   4999988543    234557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+++++|.+++...    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++ ++.+||+|||+++....
T Consensus       110 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          110 LCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             cccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            99999999998642    345888899999999999999999   78999999999999998 67999999999876532


Q ss_pred             CC---CcccccccccccccccCC
Q 003065          832 SP---KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~---~~~~~~~~~gt~~Y~APE  851 (851)
                      ..   .........||+.|+|||
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE  204 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPE  204 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHH
T ss_pred             ccccccccccccCCCcccccChH
Confidence            21   111223356999999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.90  E-value=2.5e-24  Score=242.55  Aligned_cols=168  Identities=25%  Similarity=0.358  Sum_probs=126.4

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCCC
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  756 (851)
                      |...+.||+|+||+||.+.. .+++.||||++... ..+.+.+|+++++++ +|||||++++++..++..|+||||++ |
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g   93 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L   93 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred             eeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence            45568899999999987544 67899999998654 345678999999886 89999999999999999999999995 6


Q ss_pred             CHHHHHHHhhhCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC-------------CceEEe
Q 003065          757 NLFQALHKRVKEGKP--ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-------------YEPKIA  821 (851)
Q Consensus       757 sL~~~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~-------------~~~kl~  821 (851)
                      +|.+++.........  ...+..++.++.|++.||+|||   +.+|+||||||+|||++.+             +.+||+
T Consensus        94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             EHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            999999764221111  1123345679999999999999   7899999999999999754             489999


Q ss_pred             eecCccccCCCCCcc--cccccccccccccCC
Q 003065          822 DFGVAKIAENSPKVS--DYSCFAGTHGYIAPG  851 (851)
Q Consensus       822 DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE  851 (851)
                      |||+|+.........  ......||+.|+|||
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  202 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE  202 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHH
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHH
Confidence            999998776543211  123457999999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.90  E-value=1.7e-24  Score=243.26  Aligned_cols=165  Identities=24%  Similarity=0.357  Sum_probs=127.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +|...+.||+|+||+||.. ...+++.||||++.... .+.+.+|+++++++ +|||||++++++.+.+..|+||||++ 
T Consensus        25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            5788899999999997643 33578899999986542 22356899999999 79999999999999999999999995 


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-----CCceEEeeecCccccC
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-----DYEPKIADFGVAKIAE  830 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~  830 (851)
                      |+|.+++....    .......+..++.|++.||+|||   +.+|+||||||+||+++.     ...+||+|||+|+...
T Consensus       102 g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          102 ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            69999987642    22333345689999999999999   789999999999999953     2358899999998765


Q ss_pred             CCCC-cccccccccccccccCC
Q 003065          831 NSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      .... ........||+.|+|||
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE  196 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPE  196 (432)
T ss_dssp             -----------CCSCTTSCCGG
T ss_pred             CCCcceeeccccCCCcCccChh
Confidence            4321 12233467999999998

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=6.2e-24  Score=228.37  Aligned_cols=200  Identities=22%  Similarity=0.294  Sum_probs=161.3

Q ss_pred             cchHHHHhccCCccccccccc--cCccccceeccccCccccccC----CcccCccccceEEecCCcCCCCCCcccccCCC
Q 003065          361 RKLLNLLALSNNFSGEVPNSY--ADCKTIQRLRISDNHLSGKIP----DGLWALPNVGMLDFGDNDFTGGISPLIGLSTS  434 (851)
Q Consensus       361 ~~L~~l~l~~n~~~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  434 (851)
                      ++|++|++.+|.+.+..|..+  ..+++|++|+|++|++++..|    ..++.+++|++|++++|++++.++..+..+++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            446666666677777777777  788899999999999987655    34567889999999999999888889999999


Q ss_pred             CCeEecCCCcceee--C--CcccccCCCCcEEeccCccccCCCcc----ccccCCcccEEEecCCcccCCCCCCcccc--
Q 003065          435 LSQLVLQNNRFSGE--L--PSELGRLTNLERLILTNNNFSGKIPS----ALGALRQLSSLHLEENALTGSIPNEMGDC--  504 (851)
Q Consensus       435 L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--  504 (851)
                      |++|+|++|++.+.  +  +..+..+++|++|+|++|+++. +|.    .+..+++|++|+|++|++++..|..++.+  
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  249 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW  249 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence            99999999998653  2  2334788999999999999973 333    35778999999999999998888888877  


Q ss_pred             -cccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccc
Q 003065          505 -ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSG  566 (851)
Q Consensus       505 -~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~  566 (851)
                       ++|+.|+|++|+|+ .+|..+.  ++|+.|||++|+|++ +|. +..+ .|+.|++++|+++.
T Consensus       250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR-APQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred             cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence             58999999999999 6787775  789999999999995 444 4555 78999999999874

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=2e-24  Score=248.78  Aligned_cols=153  Identities=21%  Similarity=0.245  Sum_probs=118.2

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----------cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEE
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  748 (851)
                      ...+.||+|+||.||+|+.  .++.+|+|+.....          ..+++.+|++++++++||||+++..++...+..|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            4567899999999999954  57789999764321          13457899999999999999966555557777899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ||||+++++|.+++..             +..++.|+++||+|||   +++|+||||||+|||++.  .+||+|||+|+.
T Consensus       417 VmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~  478 (540)
T 3en9_A          417 MMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKI  478 (540)
T ss_dssp             EEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred             EEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence            9999999999998764             3478999999999999   789999999999999998  999999999998


Q ss_pred             cCCCCCcc-----cccccccccccccCC
Q 003065          829 AENSPKVS-----DYSCFAGTHGYIAPG  851 (851)
Q Consensus       829 ~~~~~~~~-----~~~~~~gt~~Y~APE  851 (851)
                      ........     ....+.||+.|||||
T Consensus       479 ~~~~~~~~~~~~~~~~~~~GT~~y~APE  506 (540)
T 3en9_A          479 SNLDEDKAVDLIVFKKAVLSTHHEKFDE  506 (540)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHCGGGHHH
T ss_pred             CCCccccccchhhhhhhhcCCCCcCCHH
Confidence            75532211     123568999999998

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=8.3e-26  Score=251.09  Aligned_cols=189  Identities=20%  Similarity=0.280  Sum_probs=118.1

Q ss_pred             ccCccccceeccccCcccc----ccCCcccCccccceEEecCCcCCCCCCcccc----cC---------CCCCeEecCCC
Q 003065          381 YADCKTIQRLRISDNHLSG----KIPDGLWALPNVGMLDFGDNDFTGGISPLIG----LS---------TSLSQLVLQNN  443 (851)
Q Consensus       381 ~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~~---------~~L~~L~Ls~N  443 (851)
                      +..+++|++|+|++|++++    .+|..+..+++|++|+|++|++++..+..+.    .+         ++|++|+|++|
T Consensus        90 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n  169 (386)
T 2ca6_A           90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN  169 (386)
T ss_dssp             HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred             HhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCC
Confidence            3445556666666666554    3455555556666666666655433222222    22         66777777777


Q ss_pred             cce-eeCC---cccccCCCCcEEeccCcccc--C---CCccccccCCcccEEEecCCccc----CCCCCCccccccccee
Q 003065          444 RFS-GELP---SELGRLTNLERLILTNNNFS--G---KIPSALGALRQLSSLHLEENALT----GSIPNEMGDCARIVDL  510 (851)
Q Consensus       444 ~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L  510 (851)
                      +++ +.+|   ..+..+++|++|+|++|.++  |   ..|..+..+++|+.|+|++|+++    +.+|..+..+++|+.|
T Consensus       170 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L  249 (386)
T 2ca6_A          170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL  249 (386)
T ss_dssp             CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred             CCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEE
Confidence            765 3333   35556677777777777776  2   34446667777777777777775    4566667777777777


Q ss_pred             eccCcccccc----cCCCcc--ccccCCeEeCCCCcccc----ccCccc-ccc-cceEEeCcCCcccccCC
Q 003065          511 NLARNSLSGN----IPRSLS--LLSSLNALNLSGNKLTG----SIPDNL-MKL-KLSSIDLSENQLSGSVP  569 (851)
Q Consensus       511 ~Ls~N~l~~~----~p~~~~--~l~~L~~L~Ls~N~l~g----~ip~~l-~~l-~L~~l~ls~N~l~~~~p  569 (851)
                      +|++|.+++.    +|..+.  .+++|+.|+|++|++++    .+|..+ ..+ .|+.|++++|++++..|
T Consensus       250 ~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             ECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            7777777765    455553  36777777777777776    367666 444 67777777777776554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.89  E-value=2.2e-23  Score=221.06  Aligned_cols=142  Identities=10%  Similarity=0.003  Sum_probs=126.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      .+|++.+.||+|+||.||+|++..+++.||||++....     ..+.+.+|++++++++||||+++++++..++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            46999999999999999999999889999999986542     2367889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      ||++|++|.++++..       .....+.+++.|++.||+|||   +.+|+||||||+||+++.+|.+||+++|...
T Consensus       111 e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence            999999999998431       245567889999999999999   7899999999999999999999999887653

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=6e-23  Score=211.88  Aligned_cols=85  Identities=24%  Similarity=0.228  Sum_probs=45.0

Q ss_pred             CCCeEecccccccccCCcccccccccCcccccccc-ccccccccccCCCcccEEEeec-cCccCcCCcCcCCCCcccEEe
Q 003065          194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNK-ISGEFPRSIRKLQKLWKIELYA-NNLTGELPAELGNLTLLQEFD  271 (851)
Q Consensus       194 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-i~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~  271 (851)
                      +|++|++++|++++..+..|.++++|++|++++|+ +++..+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            55566666666654444455555555555555554 5544444555555555555554 555544444445555555555


Q ss_pred             ccccccc
Q 003065          272 ISSNQMY  278 (851)
Q Consensus       272 Ls~N~l~  278 (851)
                      +++|+++
T Consensus       112 l~~n~l~  118 (239)
T 2xwt_C          112 IFNTGLK  118 (239)
T ss_dssp             EEEECCC
T ss_pred             CCCCCCc
Confidence            5555554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=2.2e-25  Score=247.69  Aligned_cols=256  Identities=20%  Similarity=0.249  Sum_probs=155.5

Q ss_pred             cCCcCcCCCCcccEEecccccccCCCC----ccccCcCCccEEEccCCc---cCCCCCCCC-------CCcccccEEEec
Q 003065          256 ELPAELGNLTLLQEFDISSNQMYGKLP----EEIGNLKNLTVFQCFKNN---FSGEFPSGF-------GDMRKLFAFSIY  321 (851)
Q Consensus       256 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~l~~N~---l~~~~p~~~-------~~l~~L~~L~l~  321 (851)
                      .++..+..+++|++|+|++|++++..+    ..+..+++|++|++++|.   +++.+|..+       ..+++|++|+++
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            455566667777777777777765433    335567777777777753   333334333       345555555555


Q ss_pred             cCcCCC----CCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCcc
Q 003065          322 GNRFSG----PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHL  397 (851)
Q Consensus       322 ~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l  397 (851)
                      +|++++    .+|..+..+++|+.|+|++|.+++..+..+...  +..+  ..|++.+.       .             
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~~l--~~~~~~~~-------~-------------  158 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQEL--AVNKKAKN-------A-------------  158 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHHH--HHHHHHHT-------C-------------
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--HHHH--hhhhhccc-------C-------------
Confidence            555554    234444455555555555555543322222211  0000  00000000       0             


Q ss_pred             ccccCCcccCccccceEEecCCcCC-CCCC---cccccCCCCCeEecCCCcce--e---eCCcccccCCCCcEEeccCcc
Q 003065          398 SGKIPDGLWALPNVGMLDFGDNDFT-GGIS---PLIGLSTSLSQLVLQNNRFS--G---ELPSELGRLTNLERLILTNNN  468 (851)
Q Consensus       398 ~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~---~~~~~~~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~  468 (851)
                                 ++|++|++++|+++ +..+   ..+..+++|+.|+|++|+++  |   ..|..+..+++|+.|+|++|.
T Consensus       159 -----------~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~  227 (386)
T 2ca6_A          159 -----------PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT  227 (386)
T ss_dssp             -----------CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSC
T ss_pred             -----------CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCC
Confidence                       45555555555554 2222   23445666777777777765  2   344467777888888888888


Q ss_pred             cc----CCCccccccCCcccEEEecCCcccCC----CCCCc--ccccccceeeccCccccc----ccCCCc-cccccCCe
Q 003065          469 FS----GKIPSALGALRQLSSLHLEENALTGS----IPNEM--GDCARIVDLNLARNSLSG----NIPRSL-SLLSSLNA  533 (851)
Q Consensus       469 l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~  533 (851)
                      ++    +.+|..+..+++|+.|+|++|++++.    +|..+  +.+++|+.|+|++|.+++    .+|..+ .++++|+.
T Consensus       228 l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~  307 (386)
T 2ca6_A          228 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF  307 (386)
T ss_dssp             CHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCE
T ss_pred             CCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceE
Confidence            75    56677778888888888888888755    45555  347888999999999887    477777 66899999


Q ss_pred             EeCCCCccccccC
Q 003065          534 LNLSGNKLTGSIP  546 (851)
Q Consensus       534 L~Ls~N~l~g~ip  546 (851)
                      |+|++|++++..|
T Consensus       308 L~l~~N~l~~~~~  320 (386)
T 2ca6_A          308 LELNGNRFSEEDD  320 (386)
T ss_dssp             EECTTSBSCTTSH
T ss_pred             EEccCCcCCcchh
Confidence            9999999997664

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.89  E-value=6.4e-23  Score=219.35  Aligned_cols=148  Identities=26%  Similarity=0.383  Sum_probs=129.8

Q ss_pred             HcCCccC-CeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHH-HcCCCCccccEEEEEEe----CCeeEE
Q 003065          675 ICNLEED-NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEIL-GKIRHRNILKLYACLLK----GGSSFL  748 (851)
Q Consensus       675 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~l  748 (851)
                      +.+|.+. +.||+|+||.||+|.+..+++.||||++...   ..+.+|++++ +..+||||+++++++..    ....|+
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l   92 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   92 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence            4577776 7899999999999999999999999998543   4567899988 56699999999999876    677899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---CCceEEeeecC
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGV  825 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGl  825 (851)
                      ||||+++|+|.+++...   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+
T Consensus        93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            99999999999999864   2346899999999999999999999   789999999999999997   78899999999


Q ss_pred             ccccCC
Q 003065          826 AKIAEN  831 (851)
Q Consensus       826 a~~~~~  831 (851)
                      |+....
T Consensus       167 a~~~~~  172 (299)
T 3m2w_A          167 AKETTG  172 (299)
T ss_dssp             CEECTT
T ss_pred             cccccc
Confidence            986654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=6e-23  Score=220.19  Aligned_cols=194  Identities=22%  Similarity=0.300  Sum_probs=108.9

Q ss_pred             ccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccce
Q 003065           93 ISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVS  172 (851)
Q Consensus        93 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  172 (851)
                      +.++++|++|++++|.++. +| .+..+++|++|+|++|.+++.++ +..+++|++|+|++|.+++.  ..+..+++|++
T Consensus        37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~  111 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKT  111 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred             HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence            3456667777777777663 44 46667777777777777666555 66666677777776666542  24556666666


Q ss_pred             eecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccC
Q 003065          173 LSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN  252 (851)
Q Consensus       173 L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~  252 (851)
                      |++++|.+.  .+|. +..+++|++|++++|++++..+  +..+++|++|++++|++++..+  +..+++|++|++++|+
T Consensus       112 L~l~~n~l~--~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~  184 (308)
T 1h6u_A          112 LDLTSTQIT--DVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK  184 (308)
T ss_dssp             EECTTSCCC--CCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EECCCCCCC--Cchh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence            666666654  2332 5556666666666666654322  5555555555555555553222  5555555555555555


Q ss_pred             ccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccC
Q 003065          253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS  302 (851)
Q Consensus       253 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~  302 (851)
                      +++..+  +..+++|++|++++|++++..  .+..+++|+.|++++|.++
T Consensus       185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          185 ISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             CCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred             cCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence            553222  444555555555555554332  1444555555555555544

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.89  E-value=1.2e-23  Score=241.97  Aligned_cols=208  Identities=22%  Similarity=0.346  Sum_probs=135.1

Q ss_pred             CCCCCCCCCCCCc-----cccee-EecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCC
Q 003065           49 VLDSWKESADSPC-----GFSGI-TCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSN  122 (851)
Q Consensus        49 ~l~sW~~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  122 (851)
                      .+.+|..+ .++|     .|.|+ .|..  ++++.|++++++|++ +|+.+.  ++|++|+|++|+|+ .+|   ..+++
T Consensus        32 ~l~~W~~~-~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~  101 (571)
T 3cvr_A           32 AWDKWEKQ-ALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPAS  101 (571)
T ss_dssp             HHHHHHTT-CCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTT
T ss_pred             HHHHHhcc-CCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCC
Confidence            35567654 5678     79999 7863  378889999988887 777664  78888888888888 677   45688


Q ss_pred             CceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEeccc
Q 003065          123 LKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAH  202 (851)
Q Consensus       123 L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~  202 (851)
                      |++|+|++|.|++.++ +..  +|++|+|++|.+++ +|.   .+++|++|+|++|.++  .+|.   .+++|++|+|++
T Consensus       102 L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~--~lp~---~l~~L~~L~Ls~  169 (571)
T 3cvr_A          102 LEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLT--MLPE---LPTSLEVLSVRN  169 (571)
T ss_dssp             CCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS--CCCC---CCTTCCEEECCS
T ss_pred             CCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccC--cCCC---cCCCcCEEECCC
Confidence            8888888888887444 554  78888888888775 444   5677777777777775  3554   456677777777


Q ss_pred             ccccccCCcccccccccCccccccccccccccccccCCCcc-------cEEEeeccCccCcCCcCcCCCCcccEEecccc
Q 003065          203 CNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL-------WKIELYANNLTGELPAELGNLTLLQEFDISSN  275 (851)
Q Consensus       203 n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  275 (851)
                      |+|++ +|. |.  ++|++|+|++|+|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus       170 N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N  240 (571)
T 3cvr_A          170 NQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN  240 (571)
T ss_dssp             SCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSS
T ss_pred             CCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCC
Confidence            77764 454 44  56666666666666 4444 332  44       55555555555 34444444555555555555


Q ss_pred             cccCCCCccccC
Q 003065          276 QMYGKLPEEIGN  287 (851)
Q Consensus       276 ~l~~~~p~~l~~  287 (851)
                      .+++.+|..+..
T Consensus       241 ~l~~~~p~~l~~  252 (571)
T 3cvr_A          241 PLSSRIRESLSQ  252 (571)
T ss_dssp             SCCHHHHHHHHH
T ss_pred             cCCCcCHHHHHH
Confidence            555444444443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=3.7e-23  Score=221.89  Aligned_cols=210  Identities=20%  Similarity=0.293  Sum_probs=136.1

Q ss_pred             CcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccc
Q 003065           99 LTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN  178 (851)
Q Consensus        99 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  178 (851)
                      +..+.+..+.+++.+  .+.++++|++|++++|.+... +.+..+++|++|+|++|.+++..+  +..+++|++|++++|
T Consensus        21 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n   95 (308)
T 1h6u_A           21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN   95 (308)
T ss_dssp             HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred             HHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-hhhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCC
Confidence            344456666665433  356788899999999988764 468888888888888888885544  778888888888888


Q ss_pred             cCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCC
Q 003065          179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP  258 (851)
Q Consensus       179 ~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  258 (851)
                      .+.  .+| .+..+++|++|++++|++++. + .+..+++|++|++++|++++..+  +..+++|++|++++|++++..+
T Consensus        96 ~l~--~~~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~  168 (308)
T 1h6u_A           96 PLK--NVS-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP  168 (308)
T ss_dssp             CCS--CCG-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG
T ss_pred             cCC--Cch-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh
Confidence            876  333 577777777888777777743 3 26677777777777777764433  6666666666666666664322


Q ss_pred             cCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCC
Q 003065          259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFS  326 (851)
Q Consensus       259 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  326 (851)
                        +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|+++
T Consensus       169 --l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          169 --LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             --GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred             --hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence              5566666666666666654322  5555556666666655553321  444444444444444443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=1.5e-22  Score=221.32  Aligned_cols=243  Identities=18%  Similarity=0.147  Sum_probs=133.6

Q ss_pred             cccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-
Q 003065           61 CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-  139 (851)
Q Consensus        61 c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-  139 (851)
                      |+|..|.|+.            ++|+ +||..+  .+++++|+|++|+|+..-+.+|.++++|++|+|++|++.+.+|. 
T Consensus         9 C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~   73 (350)
T 4ay9_X            9 CSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD   73 (350)
T ss_dssp             EETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred             eeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence            7787777753            3444 456655  35778888888888743334677888888888888877665443 


Q ss_pred             -CCCCCCCCe-EeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCccccccc
Q 003065          140 -LSALKNLEI-FDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELR  217 (851)
Q Consensus       140 -l~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  217 (851)
                       |.++++|+. ++++.|+++...|..|.++++|++|++++|.+.                         +..+..+....
T Consensus        74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-------------------------~~~~~~~~~~~  128 (350)
T 4ay9_X           74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-------------------------HLPDVHKIHSL  128 (350)
T ss_dssp             SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCS-------------------------SCCCCTTCCBS
T ss_pred             HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccc-------------------------cCCchhhcccc
Confidence             667766654 455556666555555555555555555555554                         33333333333


Q ss_pred             ccCcccccc-ccccccccccccCCC-cccEEEeeccCccCcCCcCcCCCCcccEEeccc-ccccCCCCccccCcCCccEE
Q 003065          218 ELGTLDICR-NKISGEFPRSIRKLQ-KLWKIELYANNLTGELPAELGNLTLLQEFDISS-NQMYGKLPEEIGNLKNLTVF  294 (851)
Q Consensus       218 ~L~~L~L~~-N~i~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L  294 (851)
                      ++..|++.+ |++....+..|..+. .++.|+|++|+|+. +|......++|++|++++ |.++...++.|.++++|++|
T Consensus       129 ~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~L  207 (350)
T 4ay9_X          129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL  207 (350)
T ss_dssp             SCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEE
T ss_pred             hhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchh
Confidence            344444432 334333333444432 35555555555553 333333445566666653 44443333345666666666


Q ss_pred             EccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCc
Q 003065          295 QCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ  348 (851)
Q Consensus       295 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~  348 (851)
                      ++++|+|+...+..|.++++|+.+++  +.++ .+| .+..+++|+.++++++.
T Consensus       208 dLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          208 DISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             ECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             hcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCCc
Confidence            66666666433334444444433332  2222 444 36677778888776543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=4.8e-22  Score=200.36  Aligned_cols=185  Identities=19%  Similarity=0.196  Sum_probs=112.4

Q ss_pred             CCcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCC
Q 003065           59 SPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP  138 (851)
Q Consensus        59 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~  138 (851)
                      +.|.|.+|.|+...            ++ .+|..+  .++|++|+|++|++++..+..|+.+++|++|+|++|++++.++
T Consensus         5 C~C~~~~v~c~~~~------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~   69 (208)
T 2o6s_A            5 CSCSGTTVECYSQG------------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPN   69 (208)
T ss_dssp             CEEETTEEECCSSC------------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred             CEECCCEEEecCCC------------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccCh
Confidence            45899999997532            22 234333  3578888888888876555667777888888888887776665


Q ss_pred             C-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCccccccc
Q 003065          139 D-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELR  217 (851)
Q Consensus       139 ~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  217 (851)
                      . +..+++|++|+|++|.+++..+..|.++++|++|++++|.+                         ++..+..|.+++
T Consensus        70 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l-------------------------~~~~~~~~~~l~  124 (208)
T 2o6s_A           70 GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQL-------------------------QSLPDGVFDKLT  124 (208)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC-------------------------CCCCTTTTTTCT
T ss_pred             hhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcC-------------------------cccCHhHhccCC
Confidence            5 56777777777777777654444445555555555555544                         433333444455


Q ss_pred             ccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCC
Q 003065          218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKN  290 (851)
Q Consensus       218 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  290 (851)
                      +|++|++++|++++..+..|..+++|++|++++|.+.+       .+++|++|+++.|+++|.+|..++.++.
T Consensus       125 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          125 QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             cCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            55555555555554444445555555555555555442       2345666666666666666666665543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.87  E-value=7.5e-23  Score=228.91  Aligned_cols=165  Identities=18%  Similarity=0.202  Sum_probs=125.7

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCC-Ccc----------cc-----
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRH-RNI----------LK-----  735 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h-~ni----------v~-----  735 (851)
                      .|...+.||+|+||.||+|++..+++.||||++...     ...+.+.+|+.+++.++| ++.          +.     
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            467788999999999999999999999999998633     224678899999999977 211          11     


Q ss_pred             ------EEEEEEe-----CCeeEEEEeccCCCCHHHHHHHhh--hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEE
Q 003065          736 ------LYACLLK-----GGSSFLVLEYMPNGNLFQALHKRV--KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH  802 (851)
Q Consensus       736 ------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  802 (851)
                            +..++..     ....+++|+++ +++|.+++....  ......+++..++.++.|+++||+|||   +++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence                  1111111     22357778766 689999886432  122335678888999999999999999   789999


Q ss_pred             eCCCCCCEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       803 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |||||+|||++.++.+||+|||+|+.....     ....+| +.|+|||
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE  277 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPE  277 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCch
Confidence            999999999999999999999999865433     233568 9999998

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=1.9e-21  Score=212.63  Aligned_cols=241  Identities=14%  Similarity=0.048  Sum_probs=154.4

Q ss_pred             ceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCc-ccccCCCCCCe-Eecc
Q 003065          124 KVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP-ESIGNLKNLTY-LFLA  201 (851)
Q Consensus       124 ~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p-~~~~~l~~L~~-L~L~  201 (851)
                      ++++.++++++..|.++  .+++++|+|++|+|+...+..|.++++|++|+|++|++. ..+| ..|.+++++++ +.++
T Consensus        12 ~~v~C~~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~-~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL-EVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTC-CEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCC-CccChhHhhcchhhhhhhccc
Confidence            34555555555544434  245666666666666444445666666666666666654 2333 34667777665 5666


Q ss_pred             cccccccCCcccccccccCccccccccccccccccccCCCcccEEEeec-cCccCcCCcCcCCCC-cccEEecccccccC
Q 003065          202 HCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYA-NNLTGELPAELGNLT-LLQEFDISSNQMYG  279 (851)
Q Consensus       202 ~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~  279 (851)
                      .|+++...|..|..+++|++|++++|++++..+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+ 
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-  167 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-  167 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-
Confidence            7888877778888888888888888888876666777777788888865 566655555666654 5778888888887 


Q ss_pred             CCCccccCcCCccEEEccC-CccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhh
Q 003065          280 KLPEEIGNLKNLTVFQCFK-NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC  358 (851)
Q Consensus       280 ~~p~~l~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  358 (851)
                      .+|.......+|+.|++++ |.++...+..|..+++|++|++++|+|+...+..+.++++|+.+++.  .+         
T Consensus       168 ~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~--~l---------  236 (350)
T 4ay9_X          168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NL---------  236 (350)
T ss_dssp             EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--TC---------
T ss_pred             CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC--Cc---------
Confidence            4455444556788888875 44543333457778888888888888775555455554444443321  12         


Q ss_pred             hhcchHHHHhccCCccccccccccCccccceeccccCc
Q 003065          359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNH  396 (851)
Q Consensus       359 ~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~  396 (851)
                                      ..+| .+.++++|+.++++++.
T Consensus       237 ----------------~~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          237 ----------------KKLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             ----------------CCCC-CTTTCCSCCEEECSCHH
T ss_pred             ----------------CcCC-CchhCcChhhCcCCCCc
Confidence                            2344 36677888888887654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=1.4e-20  Score=189.67  Aligned_cols=179  Identities=22%  Similarity=0.240  Sum_probs=89.1

Q ss_pred             ceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeec
Q 003065          171 VSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYA  250 (851)
Q Consensus       171 ~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~  250 (851)
                      +.++++++.+.  ++|..+  .++|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++
T Consensus        10 ~~v~c~~~~l~--~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A           10 TTVECYSQGRT--SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             TEEECCSSCCS--SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEecCCCcc--CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            34555555554  444433  24566666666666544444455555555555555555544444445555555555555


Q ss_pred             cCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCC
Q 003065          251 NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP  330 (851)
Q Consensus       251 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  330 (851)
                      |++++..+..|..+++|++|++++|++++..+                        ..|..+++|++|++++|++++..+
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------------------------~~~~~l~~L~~L~l~~N~l~~~~~  141 (208)
T 2o6s_A           86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPD------------------------GVFDKLTQLKDLRLYQNQLKSVPD  141 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT------------------------TTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcCCccCHhHhcCccCCCEEEcCCCcCcccCH------------------------hHhccCCcCCEEECCCCccceeCH
Confidence            55554433444445555555555555544333                        344444555555555555554444


Q ss_pred             CccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCc
Q 003065          331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADC  384 (851)
Q Consensus       331 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l  384 (851)
                      ..+..+++|+.|++++|.+.+.       .+.++.+.+..|+++|.+|.+++.+
T Consensus       142 ~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~ip~~~~~l  188 (208)
T 2o6s_A          142 GVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV  188 (208)
T ss_dssp             TTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred             HHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCceeeccCccc
Confidence            4455555555555555554422       2234444444444444444444443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=5.2e-22  Score=209.41  Aligned_cols=133  Identities=17%  Similarity=0.194  Sum_probs=108.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------------------cHHHHHHHHHHHHcCCCCccccE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------------------GVKVFAAEMEILGKIRHRNILKL  736 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------------~~~~~~~E~~~l~~l~h~niv~l  736 (851)
                      .|.+.+.||+|+||.||+|.+ .+++.||||++....                    ....+.+|++++++++|   +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence            356679999999999999999 889999999985421                    24568899999999994   555


Q ss_pred             EEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC
Q 003065          737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY  816 (851)
Q Consensus       737 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~  816 (851)
                      .+++.. +..|+||||++|++|.+ +..           .....++.|++.|++|||   +.+|+||||||+|||++ ++
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~  229 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EE  229 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TT
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CC
Confidence            554433 45699999999999977 311           123468999999999999   78999999999999999 99


Q ss_pred             ceEEeeecCccccC
Q 003065          817 EPKIADFGVAKIAE  830 (851)
Q Consensus       817 ~~kl~DFGla~~~~  830 (851)
                      .+||+|||+|+...
T Consensus       230 ~vkl~DFG~a~~~~  243 (282)
T 1zar_A          230 GIWIIDFPQSVEVG  243 (282)
T ss_dssp             EEEECCCTTCEETT
T ss_pred             cEEEEECCCCeECC
Confidence            99999999997554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.84  E-value=3.3e-21  Score=195.78  Aligned_cols=140  Identities=23%  Similarity=0.270  Sum_probs=99.8

Q ss_pred             CCCeEecCCCcceeeCC-cccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeec
Q 003065          434 SLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL  512 (851)
Q Consensus       434 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  512 (851)
                      .++.|+|++|+|++..| ..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|+.+++|++|+|
T Consensus        33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  112 (220)
T 2v70_A           33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML  112 (220)
T ss_dssp             TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred             CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence            34566666666665543 34666777777777777777666666777777777777777777666666777777777777


Q ss_pred             cCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccc
Q 003065          513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL  573 (851)
Q Consensus       513 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~  573 (851)
                      ++|+|++..|..|..+++|+.|+|++|++++..|..+..+ .|+.|++++|+|.|.++..+.
T Consensus       113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~l  174 (220)
T 2v70_A          113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWL  174 (220)
T ss_dssp             TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGGHHH
T ss_pred             CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCchHHH
Confidence            7777777777777777777777777777776667777777 778888888888888776544

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=9e-21  Score=218.13  Aligned_cols=188  Identities=22%  Similarity=0.308  Sum_probs=113.3

Q ss_pred             CCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecc
Q 003065          122 NLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLA  201 (851)
Q Consensus       122 ~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~  201 (851)
                      +|++|+|++|.+++.++.+.  ++|++|+|++|.|+ .+|   ..+++|++|+|++|.+                     
T Consensus        60 ~L~~L~Ls~n~L~~lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l---------------------  112 (571)
T 3cvr_A           60 QFSELQLNRLNLSSLPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRL---------------------  112 (571)
T ss_dssp             TCSEEECCSSCCSCCCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCC---------------------
T ss_pred             CccEEEeCCCCCCccCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCC---------------------
Confidence            67777777777766444342  56666666666665 333   2344455555555544                     


Q ss_pred             cccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCC
Q 003065          202 HCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKL  281 (851)
Q Consensus       202 ~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  281 (851)
                          ++ +|. +.+  +|++|+|++|+|++ +|.   .+++|++|+|++|+|++ +|.   .+++|++|+|++|++++ +
T Consensus       113 ----~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-l  175 (571)
T 3cvr_A          113 ----ST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-L  175 (571)
T ss_dssp             ----SC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred             ----CC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-c
Confidence                43 333 332  45555555555543 333   34555555555555553 343   34566666666666664 4


Q ss_pred             CccccCcCCccEEEccCCccCCCCCCCCCCcccc-------cEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCc
Q 003065          282 PEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKL-------FAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFP  354 (851)
Q Consensus       282 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L-------~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p  354 (851)
                      |. |.  ++|+.|++++|+|+ .+|. |..  +|       +.|++++|+|+ .+|..+..+++|+.|+|++|++++.+|
T Consensus       176 p~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p  247 (571)
T 3cvr_A          176 PE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR  247 (571)
T ss_dssp             CC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred             ch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence            44 44  56666666666666 4444 443  55       88888888888 578777889999999999999998888


Q ss_pred             hhhhhhc
Q 003065          355 KYLCEKR  361 (851)
Q Consensus       355 ~~~~~~~  361 (851)
                      ..++.+.
T Consensus       248 ~~l~~l~  254 (571)
T 3cvr_A          248 ESLSQQT  254 (571)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHhh
Confidence            8776654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.84  E-value=2.4e-22  Score=239.95  Aligned_cols=230  Identities=15%  Similarity=0.166  Sum_probs=110.2

Q ss_pred             CchhhHHHHHHHHHhcCC-CCCCCCCCCCCCCCCcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCC
Q 003065           28 SLNVETQALIQFKSKLKD-PHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPF  106 (851)
Q Consensus        28 ~~~~~~~aLl~fk~~~~~-~~~~l~sW~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~  106 (851)
                      ....++++|+++..+... .+..-..|....+.++.|.+++++.  ++|+.++|.++++.+ ++..+.     +.++|+.
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~l-----~~l~Ls~  200 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQALL-----QHKKLSQ  200 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhHh-----hcCccCc
Confidence            456789999999887743 2333457766656668999998875  589999999999886 344333     3344444


Q ss_pred             CcccC---------ccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeeccc
Q 003065          107 NVLSG---------KLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGD  177 (851)
Q Consensus       107 n~l~~---------~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  177 (851)
                      |.+++         ..|..|..+++|++|+|++|.+...++.+..+++|++|+|++|.|+ .+|..|.++++|++|+|++
T Consensus       201 ~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~  279 (727)
T 4b8c_D          201 YSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSH  279 (727)
T ss_dssp             ---------------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTT
T ss_pred             ccccCccccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcC
Confidence            44332         3466677777777777777777755555667777777777777777 6677777777777777777


Q ss_pred             ccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCc-ccEEEeeccCccCc
Q 003065          178 NVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK-LWKIELYANNLTGE  256 (851)
Q Consensus       178 N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~-L~~L~L~~N~l~~~  256 (851)
                      |.++  .+|..|++|++|++|+|++|.|+ .+|..|+++++|++|+|++|+|++.+|..+..+.. +..|+|++|.+++.
T Consensus       280 N~l~--~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~  356 (727)
T 4b8c_D          280 NRLT--SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIP  356 (727)
T ss_dssp             SCCS--SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred             CcCC--ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCc
Confidence            7776  56777777777777777777776 56666777777777777777777777666654322 22356666666665


Q ss_pred             CCcCcCCCCcccEEecccc
Q 003065          257 LPAELGNLTLLQEFDISSN  275 (851)
Q Consensus       257 ~p~~~~~l~~L~~L~Ls~N  275 (851)
                      +|..      |+.|+++.|
T Consensus       357 ~p~~------l~~l~l~~n  369 (727)
T 4b8c_D          357 LPHE------RRFIEINTD  369 (727)
T ss_dssp             CCCC---------------
T ss_pred             Cccc------cceeEeecc
Confidence            5543      344555555

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=8.7e-21  Score=192.69  Aligned_cols=141  Identities=25%  Similarity=0.301  Sum_probs=96.7

Q ss_pred             CCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeec
Q 003065          433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL  512 (851)
Q Consensus       433 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  512 (851)
                      ++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            45666666666666555556666666666666666666666666667777777777777776555555666777777777


Q ss_pred             cCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccc
Q 003065          513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL  573 (851)
Q Consensus       513 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~  573 (851)
                      ++|+|++..|..|..+++|+.|+|++|+|++..|..+..+ .|+.|++++|+|.|.++..|.
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l~~l  173 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHLKWL  173 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGGHHH
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCccHHH
Confidence            7777776667777777777777777777775555566666 677778888888777765554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=2.2e-20  Score=191.06  Aligned_cols=162  Identities=23%  Similarity=0.235  Sum_probs=125.7

Q ss_pred             CCCCCCCCcccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCc
Q 003065           53 WKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNA  132 (851)
Q Consensus        53 W~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~  132 (851)
                      |... .+.|+|.+|.|+...            ++ .+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|+
T Consensus        12 ~~~~-~~~Cs~~~v~c~~~~------------l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~   75 (229)
T 3e6j_A           12 ACPS-QCSCSGTTVDCRSKR------------HA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ   75 (229)
T ss_dssp             CCCT-TCEEETTEEECTTSC------------CS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cCCC-CCEEeCCEeEccCCC------------cC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCC
Confidence            4433 567999999997432            22 4555444  889999999999998888899999999999999999


Q ss_pred             ccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCc
Q 003065          133 MVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE  211 (851)
Q Consensus       133 l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~  211 (851)
                      +.+.++. +..+++|++|+|++|.+++..+..|..+++|++|+|++|++.  .+|..+..+++|++|+|++|+|++..+.
T Consensus        76 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~~~~~  153 (229)
T 3e6j_A           76 LGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT--ELPRGIERLTHLTHLALDQNQLKSIPHG  153 (229)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC--SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred             CCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc--ccCcccccCCCCCEEECCCCcCCccCHH
Confidence            9877766 788999999999999998777777778888888888888776  6777777777777777777777765556


Q ss_pred             ccccccccCcccccccccccc
Q 003065          212 SISELRELGTLDICRNKISGE  232 (851)
Q Consensus       212 ~~~~l~~L~~L~L~~N~i~~~  232 (851)
                      .|..+++|++|+|++|.+...
T Consensus       154 ~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A          154 AFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             TTTTCTTCCEEECTTSCBCTT
T ss_pred             HHhCCCCCCEEEeeCCCccCC
Confidence            666777777777777766543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=1.6e-20  Score=190.79  Aligned_cols=157  Identities=20%  Similarity=0.262  Sum_probs=144.1

Q ss_pred             cceeccccCccccccCCcccCccccceEEecCCcCCCCCC-cccccCCCCCeEecCCCcceeeCCcccccCCCCcEEecc
Q 003065          387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS-PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT  465 (851)
Q Consensus       387 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  465 (851)
                      -+.+++++|.++ .+|..+  .+.+++|+|++|++++.++ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus        13 ~~~l~~s~n~l~-~iP~~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   89 (220)
T 2v70_A           13 GTTVDCSNQKLN-KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT   89 (220)
T ss_dssp             TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEeEeCCCCcc-cCccCC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence            368999999998 577765  3467899999999998855 568999999999999999998888899999999999999


Q ss_pred             CccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCcccccc
Q 003065          466 NNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI  545 (851)
Q Consensus       466 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i  545 (851)
                      +|++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..
T Consensus        90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  169 (220)
T 2v70_A           90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC  169 (220)
T ss_dssp             SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred             CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence            99999998999999999999999999999999999999999999999999999999999999999999999999999765


Q ss_pred             C
Q 003065          546 P  546 (851)
Q Consensus       546 p  546 (851)
                      +
T Consensus       170 ~  170 (220)
T 2v70_A          170 Y  170 (220)
T ss_dssp             G
T ss_pred             c
Confidence            5

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.83  E-value=1e-20  Score=220.26  Aligned_cols=197  Identities=22%  Similarity=0.285  Sum_probs=124.0

Q ss_pred             cCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeeccc
Q 003065           98 SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGD  177 (851)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  177 (851)
                      .+..+.++.+.+++.++  +..|++|+.|+|++|.+... +.+..+++|+.|+|++|.+++..|  +..+++|++|+|++
T Consensus        22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~   96 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE   96 (605)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence            34445555555554333  45566666666666666543 346666666666666666665443  66666666666666


Q ss_pred             ccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcC
Q 003065          178 NVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL  257 (851)
Q Consensus       178 N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~  257 (851)
                      |.+.  .+| .+..+++|++|+|++|++++.  ..+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|.+++..
T Consensus        97 N~l~--~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~  169 (605)
T 1m9s_A           97 NKIK--DLS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV  169 (605)
T ss_dssp             SCCC--CCT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred             CCCC--CCh-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence            6665  233 566677777777777777642  3466677777777777777654  45667777777777777777554


Q ss_pred             CcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCC
Q 003065          258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFG  310 (851)
Q Consensus       258 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~  310 (851)
                      |  +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++++.....+.
T Consensus       170 ~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~  218 (605)
T 1m9s_A          170 P--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS  218 (605)
T ss_dssp             G--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCS
T ss_pred             h--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccc
Confidence            4  66777777777777777643  3466777777777777777654333333

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.83  E-value=6.2e-21  Score=202.67  Aligned_cols=172  Identities=26%  Similarity=0.356  Sum_probs=90.9

Q ss_pred             ccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCe
Q 003065          118 SNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTY  197 (851)
Q Consensus       118 ~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~  197 (851)
                      ..+++|++|++++|.+... +.+..+++|++|+|++|.+++..+  +.++++|++|++++|.+.  .+ +.+..+++|++
T Consensus        43 ~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~--~~-~~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK--DL-SSLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC--CG-GGGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC--CC-hhhccCCCCCE
Confidence            3444555555555554433 334455555555555555554332  455555555555555554  22 23555556666


Q ss_pred             EecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccc
Q 003065          198 LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQM  277 (851)
Q Consensus       198 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  277 (851)
                      |++++|++++.  ..+..+++|++|++++|++++.  ..+..+++|++|++++|++++..|  +..+++|++|++++|++
T Consensus       117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i  190 (291)
T 1h6t_A          117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  190 (291)
T ss_dssp             EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence            66666655532  3455555566666666655543  345555666666666666654333  55566666666666666


Q ss_pred             cCCCCccccCcCCccEEEccCCccCC
Q 003065          278 YGKLPEEIGNLKNLTVFQCFKNNFSG  303 (851)
Q Consensus       278 ~~~~p~~l~~l~~L~~L~l~~N~l~~  303 (851)
                      ++ +| .+..+++|+.|++++|+++.
T Consensus       191 ~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          191 SD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             CC-Ch-hhccCCCCCEEECcCCcccC
Confidence            53 22 25556666666666665553

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.83  E-value=1.2e-20  Score=207.22  Aligned_cols=182  Identities=25%  Similarity=0.244  Sum_probs=157.6

Q ss_pred             cceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccc-cCCCCCeEecCCCcceeeCCcccccCCCCcEEecc
Q 003065          387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIG-LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT  465 (851)
Q Consensus       387 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  465 (851)
                      -+.+++++|+++ .+|..+.  +.++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..|..|..+++|++|+|+
T Consensus        20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            368999999998 5777553  4689999999999998888887 89999999999999998888899999999999999


Q ss_pred             CccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCc---cccccCCeEeCCCCccc
Q 003065          466 NNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL---SLLSSLNALNLSGNKLT  542 (851)
Q Consensus       466 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~  542 (851)
                      +|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|   ..+++|+.|||++|+|+
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            999998888889999999999999999998889999999999999999999996544445   67999999999999999


Q ss_pred             cccCcccccc-c--ceEEeCcCCcccccCCcc
Q 003065          543 GSIPDNLMKL-K--LSSIDLSENQLSGSVPLD  571 (851)
Q Consensus       543 g~ip~~l~~l-~--L~~l~ls~N~l~~~~p~~  571 (851)
                      +..+..+..+ .  ++.|++++|+|.|.+...
T Consensus       177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l~  208 (361)
T 2xot_A          177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCKLY  208 (361)
T ss_dssp             CCCHHHHHHSCHHHHTTEECCSSCEECCHHHH
T ss_pred             ccCHHHhhhccHhhcceEEecCCCccCCcCcH
Confidence            5444556655 3  588999999999998743

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=8.3e-20  Score=185.44  Aligned_cols=153  Identities=20%  Similarity=0.218  Sum_probs=142.4

Q ss_pred             ceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCc
Q 003065          388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN  467 (851)
Q Consensus       388 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  467 (851)
                      +.+++++|+++ .+|..+.  ++++.|++++|++++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            67899999998 6777654  78999999999999988889999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCcccc
Q 003065          468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG  543 (851)
Q Consensus       468 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g  543 (851)
                      +|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            9998777889999999999999999999999999999999999999999998888889999999999999999975

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=3.7e-20  Score=215.51  Aligned_cols=196  Identities=24%  Similarity=0.320  Sum_probs=159.1

Q ss_pred             EEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCccc
Q 003065           77 EISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYF  156 (851)
Q Consensus        77 ~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l  156 (851)
                      .+.+..+.+.+.++  +..|++|+.|+|++|.++. +| .|+.|++|+.|+|++|++.+.++ +..+++|+.|+|++|.+
T Consensus        25 ~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l   99 (605)
T 1m9s_A           25 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKI   99 (605)
T ss_dssp             HHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCC
T ss_pred             HHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCC
Confidence            34445555554332  5678889999999999874 44 58899999999999999988766 88999999999999998


Q ss_pred             CCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccccccccccccc
Q 003065          157 TGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS  236 (851)
Q Consensus       157 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~  236 (851)
                      ++.  ..+..+++|++|+|++|.+.  .+ +.+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|+|++..|  
T Consensus       100 ~~l--~~l~~l~~L~~L~Ls~N~l~--~l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--  170 (605)
T 1m9s_A          100 KDL--SSLKDLKKLKSLSLEHNGIS--DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--  170 (605)
T ss_dssp             CCC--TTSTTCTTCCEEECTTSCCC--CC-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--
T ss_pred             CCC--hhhccCCCCCEEEecCCCCC--CC-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--
Confidence            853  37888999999999999987  34 4688899999999999999865  678899999999999999997766  


Q ss_pred             ccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCc
Q 003065          237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNL  288 (851)
Q Consensus       237 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  288 (851)
                      +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++.+.....+..+
T Consensus       171 l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l  220 (605)
T 1m9s_A          171 LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNL  220 (605)
T ss_dssp             GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred             hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccE
Confidence            89999999999999999864  468899999999999999986544444333

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=4.3e-20  Score=196.12  Aligned_cols=186  Identities=25%  Similarity=0.354  Sum_probs=156.7

Q ss_pred             ecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCC
Q 003065           79 SFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTG  158 (851)
Q Consensus        79 ~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~  158 (851)
                      .+....+++.+  .+..+++|++|++++|.++. +| .++.+++|++|+|++|++++.++ +..+++|++|+|++|.+++
T Consensus        30 ~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~  104 (291)
T 1h6t_A           30 NLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD  104 (291)
T ss_dssp             HTTCSCTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred             HhcCCCccccc--chhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC
Confidence            34444444332  34578899999999999974 44 48899999999999999998776 9999999999999999986


Q ss_pred             CCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccccccccccccccc
Q 003065          159 RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR  238 (851)
Q Consensus       159 ~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~  238 (851)
                       + ..+..+++|++|++++|.+.  .+ +.+..+++|++|++++|++++.  ..+..+++|++|++++|++++..|  +.
T Consensus       105 -~-~~l~~l~~L~~L~L~~n~i~--~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~  175 (291)
T 1h6t_A          105 -L-SSLKDLKKLKSLSLEHNGIS--DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LA  175 (291)
T ss_dssp             -G-GGGTTCTTCCEEECTTSCCC--CC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred             -C-hhhccCCCCCEEECCCCcCC--CC-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hc
Confidence             3 34899999999999999997  34 5688999999999999999865  678999999999999999997655  89


Q ss_pred             CCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCC
Q 003065          239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK  280 (851)
Q Consensus       239 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  280 (851)
                      .+++|++|++++|.+++ +| .+..+++|+.|++++|+++..
T Consensus       176 ~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          176 GLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             TCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred             CCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence            99999999999999995 44 488999999999999999853

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.80  E-value=3.4e-19  Score=182.18  Aligned_cols=136  Identities=25%  Similarity=0.308  Sum_probs=73.5

Q ss_pred             CCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeec
Q 003065          433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL  512 (851)
Q Consensus       433 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  512 (851)
                      ++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus        40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L  119 (229)
T 3e6j_A           40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM  119 (229)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence            34444455555554444445555555555555555554444444555555555555555555444444555555555555


Q ss_pred             cCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCC
Q 003065          513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVP  569 (851)
Q Consensus       513 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p  569 (851)
                      ++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+ .|+.|++++|+|.|.++
T Consensus       120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            555555 455555555566666666666654333445555 56666666666666554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.80  E-value=1.9e-21  Score=225.00  Aligned_cols=202  Identities=20%  Similarity=0.211  Sum_probs=117.7

Q ss_pred             CCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccce
Q 003065          310 GDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQR  389 (851)
Q Consensus       310 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~  389 (851)
                      ...++|+.|+|++|+++ .+|..++.+++|+.|++++|......|           ..+..++..+..|..++.+++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~-----------~ll~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII-----------LLMRALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHH-----------HHHHHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHH-----------HHHHhcccccCCHHHHHHHHhccc
Confidence            34455555555555554 455555555555555554443110000           001112345666777777777777


Q ss_pred             ec-cccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCcc
Q 003065          390 LR-ISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNN  468 (851)
Q Consensus       390 L~-Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  468 (851)
                      |+ ++.|.+.           +|..+.+++|.+++..+      ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|.
T Consensus       414 L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~  474 (567)
T 1dce_A          414 VDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR  474 (567)
T ss_dssp             HCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred             Ccchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence            77 6665543           33444555555443222      136666666666664 454 6666666777777766


Q ss_pred             ccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCccccccc-CCCccccccCCeEeCCCCcccccc
Q 003065          469 FSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNI-PRSLSLLSSLNALNLSGNKLTGSI  545 (851)
Q Consensus       469 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~i  545 (851)
                      |+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..++.+++|+.|+|++|+|++.+
T Consensus       475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~  549 (567)
T 1dce_A          475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE  549 (567)
T ss_dssp             CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence            66 556666666677777777776664 45 6666667777777777776665 666677777777777777776443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.80  E-value=3.7e-21  Score=222.57  Aligned_cols=217  Identities=18%  Similarity=0.130  Sum_probs=173.2

Q ss_pred             cCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHH
Q 003065          286 GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN  365 (851)
Q Consensus       286 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~  365 (851)
                      ..+++|+.|+|++|+++ .+|..++++++|+.|++++|......|          . .+..+.+.+..|..+..+++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~----------~-ll~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII----------L-LMRALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHH----------H-HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHH----------H-HHHhcccccCCHHHHHHHHhccc
Confidence            56889999999999998 789999999999999997765311111          1 11223345577888888888888


Q ss_pred             HH-hccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCc
Q 003065          366 LL-ALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNR  444 (851)
Q Consensus       366 l~-l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~  444 (851)
                      |+ +..|.           +.+|+.+.+++|.+++..+      ..|+.|+|++|+|++. |. ++.+++|+.|+|++|+
T Consensus       414 L~~l~~n~-----------~~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~  474 (567)
T 1dce_A          414 VDPMRAAY-----------LDDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNR  474 (567)
T ss_dssp             HCGGGHHH-----------HHHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSC
T ss_pred             Ccchhhcc-----------cchhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCccc
Confidence            87 44432           2467788888888875433      2488899999999885 44 8889999999999999


Q ss_pred             ceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCC-CCCcccccccceeeccCcccccccCC
Q 003065          445 FSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI-PNEMGDCARIVDLNLARNSLSGNIPR  523 (851)
Q Consensus       445 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~  523 (851)
                      |+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..++.+++|+.|+|++|.|++.+|.
T Consensus       475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            98 889999999999999999999996 56 8999999999999999999887 99999999999999999999977664


Q ss_pred             C---ccccccCCeEeC
Q 003065          524 S---LSLLSSLNALNL  536 (851)
Q Consensus       524 ~---~~~l~~L~~L~L  536 (851)
                      .   +..+++|+.||+
T Consensus       552 ~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          552 QERLAEMLPSVSSILT  567 (567)
T ss_dssp             TTHHHHHCTTCSEEEC
T ss_pred             HHHHHHHCcccCccCC
Confidence            3   234788988875

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.79  E-value=1.4e-19  Score=198.65  Aligned_cols=158  Identities=24%  Similarity=0.169  Sum_probs=137.3

Q ss_pred             ccceeccccCccccccCCccc-CccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEec
Q 003065          386 TIQRLRISDNHLSGKIPDGLW-ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLIL  464 (851)
Q Consensus       386 ~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  464 (851)
                      .++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  119 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL  119 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence            478899999999987777777 8999999999999999888888999999999999999999888888999999999999


Q ss_pred             cCccccCCCccccccCCcccEEEecCCcccCCCCCCc---ccccccceeeccCcccccccCCCcccccc--CCeEeCCCC
Q 003065          465 TNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM---GDCARIVDLNLARNSLSGNIPRSLSLLSS--LNALNLSGN  539 (851)
Q Consensus       465 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N  539 (851)
                      ++|+|++..|..|..+++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|++..+..+..++.  |+.|+|++|
T Consensus       120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N  199 (361)
T 2xot_A          120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN  199 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSS
T ss_pred             CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCC
Confidence            9999998888999999999999999999986555555   57899999999999999766667788877  488999999


Q ss_pred             cccc
Q 003065          540 KLTG  543 (851)
Q Consensus       540 ~l~g  543 (851)
                      ++..
T Consensus       200 ~~~C  203 (361)
T 2xot_A          200 PLEC  203 (361)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            9974

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.77  E-value=4.4e-19  Score=176.00  Aligned_cols=130  Identities=25%  Similarity=0.330  Sum_probs=60.7

Q ss_pred             ceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCc-ccccCCCCcEEeccCccccCCCccccccCCcccEEEecC
Q 003065          412 GMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPS-ELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE  490 (851)
Q Consensus       412 ~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  490 (851)
                      +.+++++|+++..+. .+.  .+|+.|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~~ip~-~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPR-DIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSSCCS-CCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCcCcc-CCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            455555555543322 111  1455555555555433332 244445555555555555444444444444455555555


Q ss_pred             CcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccc
Q 003065          491 NALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGS  544 (851)
Q Consensus       491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~  544 (851)
                      |+|++..|..|+.+++|+.|+|++|+|++.+|..+..+++|+.|+|++|++++.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            544444444444444444444444444444444444444444444444444443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=1.9e-19  Score=188.08  Aligned_cols=171  Identities=23%  Similarity=0.286  Sum_probs=116.6

Q ss_pred             CCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceee
Q 003065           95 ALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS  174 (851)
Q Consensus        95 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  174 (851)
                      .+..++.++++.|.+++ ++ .+..+++|++|++++|.++.. +.+..+++|++|+|++|.+++..+  +.++++|++|+
T Consensus        17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~   91 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred             HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcccc-hHHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence            45566667777777764 33 567777777777777777654 367777777777777777775444  67777777777


Q ss_pred             cccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCcc
Q 003065          175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT  254 (851)
Q Consensus       175 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~  254 (851)
                      +++|++.  .+|....  ++|++|+|++|++++.  +.+..+++|++|++++|+|++. + .+..+++|++|+|++|+++
T Consensus        92 L~~N~l~--~l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~  163 (263)
T 1xeu_A           92 VNRNRLK--NLNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT  163 (263)
T ss_dssp             CCSSCCS--CCTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred             CCCCccC--CcCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence            7777775  3443322  7777777777777743  3467777777777777777753 3 5677777777777777777


Q ss_pred             CcCCcCcCCCCcccEEecccccccCC
Q 003065          255 GELPAELGNLTLLQEFDISSNQMYGK  280 (851)
Q Consensus       255 ~~~p~~~~~l~~L~~L~Ls~N~l~~~  280 (851)
                      +.  ..+..+++|+.|++++|.+++.
T Consensus       164 ~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          164 NT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             ch--HHhccCCCCCEEeCCCCcccCC
Confidence            54  5566777777777777777644

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=9.6e-19  Score=182.73  Aligned_cols=170  Identities=21%  Similarity=0.282  Sum_probs=105.8

Q ss_pred             hhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeE
Q 003065          359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQL  438 (851)
Q Consensus       359 ~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L  438 (851)
                      .+.++..+.+..|.+.+..  .+..+++|++|++++|+++ .+| .+..+++|+.|++++|++++..+  +..+++|+.|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            4455666666666665433  4666777777777777776 344 56667777777777777776554  6666677777


Q ss_pred             ecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccc
Q 003065          439 VLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS  518 (851)
Q Consensus       439 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  518 (851)
                      +|++|++++ +|.. .. ++|++|+|++|++++. + .+..+++|+.|+|++|++++. | .++.+++|+.|+|++|+++
T Consensus        91 ~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~  163 (263)
T 1xeu_A           91 SVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT  163 (263)
T ss_dssp             ECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred             ECCCCccCC-cCcc-cc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence            777777664 3322 22 6666666666666643 2 466666666666666666543 2 4566666666666666666


Q ss_pred             cccCCCccccccCCeEeCCCCcccc
Q 003065          519 GNIPRSLSLLSSLNALNLSGNKLTG  543 (851)
Q Consensus       519 ~~~p~~~~~l~~L~~L~Ls~N~l~g  543 (851)
                      +.  ..+..+++|+.|++++|++++
T Consensus       164 ~~--~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          164 NT--GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             BC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred             ch--HHhccCCCCCEEeCCCCcccC
Confidence            54  455666666666666666653

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=1.3e-18  Score=173.37  Aligned_cols=157  Identities=16%  Similarity=0.230  Sum_probs=125.5

Q ss_pred             cccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCC
Q 003065          380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL  459 (851)
Q Consensus       380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L  459 (851)
                      ..+.+++|++|++++|.++ .+| .+..+++|++|++++|.++.  +..+..+++|++|++++|++++..|..++.+++|
T Consensus        39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L  114 (197)
T 4ezg_A           39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL  114 (197)
T ss_dssp             BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred             ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence            4477888999999999998 566 68888999999999997653  3467788889999999999887778888888889


Q ss_pred             cEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCC
Q 003065          460 ERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN  539 (851)
Q Consensus       460 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  539 (851)
                      ++|++++|.+++..|..+..+++|++|+|++|++.+.+| .+..+++|+.|++++|.+++ ++ .+..+++|+.|++++|
T Consensus       115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N  191 (197)
T 4ezg_A          115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ  191 (197)
T ss_dssp             CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred             CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence            999999998888778888888888899998887333555 68888888888888888885 44 6788888888888888


Q ss_pred             cccc
Q 003065          540 KLTG  543 (851)
Q Consensus       540 ~l~g  543 (851)
                      ++.+
T Consensus       192 ~i~~  195 (197)
T 4ezg_A          192 TIGG  195 (197)
T ss_dssp             ----
T ss_pred             ccCC
Confidence            8763

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=2.5e-18  Score=170.55  Aligned_cols=153  Identities=23%  Similarity=0.377  Sum_probs=96.4

Q ss_pred             CeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCcc-ccccCCcccEEEecCCcccCCCCCCcccccccceeeccC
Q 003065          436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLAR  514 (851)
Q Consensus       436 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  514 (851)
                      +.+++++|+++ .+|..+..  +|++|++++|++++..+. .|+.+++|++|+|++|+|++..|..|+.+++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56667777665 55554433  667777777777655553 366677777777777777666666677777777777777


Q ss_pred             cccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccccCCC-CccccCCCCCCCCc
Q 003065          515 NSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRMGG-DGAFAGNEGLCLDQ  591 (851)
Q Consensus       515 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~~~~~-~~~~~gn~~lc~~~  591 (851)
                      |+|++..|..|..+++|+.|+|++|+|++.+|..+..+ .|+.|++++|+|.|.++..+..... ...+.++...|+.|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            77776666666667777777777777776666666666 6777777777777766654432211 12233444556554

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.75  E-value=1.1e-18  Score=208.23  Aligned_cols=163  Identities=22%  Similarity=0.290  Sum_probs=124.7

Q ss_pred             cccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCcc
Q 003065          222 LDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF  301 (851)
Q Consensus       222 L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l  301 (851)
                      ++++.|++. ..|..|..+++|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|+++++|++|+|++|+|
T Consensus       206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l  282 (727)
T 4b8c_D          206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL  282 (727)
T ss_dssp             -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred             cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence            345556665 66788999999999999999998 77877889999999999999999 8899999999999999999999


Q ss_pred             CCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhc-chHHHHhccCCcccccccc
Q 003065          302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR-KLLNLLALSNNFSGEVPNS  380 (851)
Q Consensus       302 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-~L~~l~l~~n~~~~~~p~~  380 (851)
                      + .+|..|+.+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+.... ....+++.+|.+.+.+|..
T Consensus       283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~  360 (727)
T 4b8c_D          283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE  360 (727)
T ss_dssp             S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred             C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence            9 78999999999999999999998 7788899999999999999999999999887654 3345788899999888864


Q ss_pred             ccCccccceeccccC
Q 003065          381 YADCKTIQRLRISDN  395 (851)
Q Consensus       381 ~~~l~~L~~L~Ls~N  395 (851)
                            |+.|++++|
T Consensus       361 ------l~~l~l~~n  369 (727)
T 4b8c_D          361 ------RRFIEINTD  369 (727)
T ss_dssp             ---------------
T ss_pred             ------cceeEeecc
Confidence                  566777777

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=1.2e-18  Score=181.45  Aligned_cols=139  Identities=17%  Similarity=0.205  Sum_probs=106.9

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcE--EEEEEecccc-c-------------------------HHHHHHHHHHHHcCC
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGT--VAVKQLWKGD-G-------------------------VKVFAAEMEILGKIR  729 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~-~-------------------------~~~~~~E~~~l~~l~  729 (851)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++... .                         ...+.+|++++++++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998778888  9999864321 0                         135789999999998


Q ss_pred             CCcc--ccEEEEEEeCCeeEEEEeccCC-C----CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEE
Q 003065          730 HRNI--LKLYACLLKGGSSFLVLEYMPN-G----NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH  802 (851)
Q Consensus       730 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  802 (851)
                      |+++  +..+++    +..++||||+.+ |    +|.++...        .++..+..++.|++.|+.|||.  +.+|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~--~~givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ--EAELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH--TSCEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence            8864  444443    356899999942 3    66655322        1123456789999999999994  359999


Q ss_pred             eCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          803 RDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       803 rDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      |||||+|||++.  .++|+|||+|.....+
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence            999999999998  9999999999876443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=3.2e-18  Score=170.63  Aligned_cols=105  Identities=21%  Similarity=0.199  Sum_probs=39.5

Q ss_pred             CCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCc
Q 003065          142 ALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGT  221 (851)
Q Consensus       142 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  221 (851)
                      .+++|++|++++|.++ .+| .+..+++|++|++++|.+.   .+..+..+++|++|++++|++++..|..+..+++|++
T Consensus        42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~---~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT---NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS---CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC---cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            3344444444444443 222 2333444444444444322   1123333334444444444433333333333333333


Q ss_pred             cccccccccccccccccCCCcccEEEeecc
Q 003065          222 LDICRNKISGEFPRSIRKLQKLWKIELYAN  251 (851)
Q Consensus       222 L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N  251 (851)
                      |++++|++++..|..+..+++|++|++++|
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n  146 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYN  146 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSC
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCC
Confidence            333333333333333333333333333333

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.73  E-value=3.1e-18  Score=185.47  Aligned_cols=102  Identities=10%  Similarity=0.047  Sum_probs=68.7

Q ss_pred             CCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCccc-EEEecCCcccCCCCCCccccccccee
Q 003065          432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS-SLHLEENALTGSIPNEMGDCARIVDL  510 (851)
Q Consensus       432 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L  510 (851)
                      +++|+.++|++|+++.+.+.+|.++.+|+.|+|.+| ++...+.+|.++++|+ .|++.+ .++.+.+..|.++.+|+.+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            566677777766666555566777777777777766 5555556677777776 777766 5655556667777777777


Q ss_pred             eccCcccccccCCCccccccCCeEe
Q 003065          511 NLARNSLSGNIPRSLSLLSSLNALN  535 (851)
Q Consensus       511 ~Ls~N~l~~~~p~~~~~l~~L~~L~  535 (851)
                      +++.|+++...+.+|.++++|+.++
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             EeCCCccCccchhhhcCCcchhhhc
Confidence            7777777766666777777777665

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.73  E-value=1.2e-18  Score=188.68  Aligned_cols=103  Identities=15%  Similarity=0.052  Sum_probs=74.7

Q ss_pred             ccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCc-EEeccCccccCCCccccccCCcccEE
Q 003065          408 LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE-RLILTNNNFSGKIPSALGALRQLSSL  486 (851)
Q Consensus       408 l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L  486 (851)
                      +++|+.|+|++|+++.+.+..|..+++|+.++|++| ++.+.+.+|.++.+|+ .+++.+ .++...+.+|.++++|+.|
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            566777777776676666667777777777777776 6656667777777777 777777 6665666777777788888


Q ss_pred             EecCCcccCCCCCCcccccccceeec
Q 003065          487 HLEENALTGSIPNEMGDCARIVDLNL  512 (851)
Q Consensus       487 ~Ls~N~l~~~~p~~~~~l~~L~~L~L  512 (851)
                      ++++|+++...+..|.++++|+.++.
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EeCCCccCccchhhhcCCcchhhhcc
Confidence            88777777666677777777777653

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.70  E-value=2.1e-17  Score=163.86  Aligned_cols=133  Identities=23%  Similarity=0.379  Sum_probs=87.1

Q ss_pred             eEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcc
Q 003065          437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS  516 (851)
Q Consensus       437 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  516 (851)
                      .+++++|.++ .+|..+.  ++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4555555554 3444332  35666666666665 455666666666667777776666666666677777777777777


Q ss_pred             cccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcccc
Q 003065          517 LSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL  573 (851)
Q Consensus       517 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~~  573 (851)
                      |++..|..|..+++|+.|+|++|+|++..+..+..+ .|+.|++++|+|.|.+...|.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l  147 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWL  147 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHH
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHH
Confidence            776666677777777777777777774444456666 777888888888887775543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.69  E-value=5e-17  Score=157.42  Aligned_cols=135  Identities=21%  Similarity=0.232  Sum_probs=102.2

Q ss_pred             CCccCcEEeCCCCccc-CccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCcccccee
Q 003065           95 ALQSLTVLSLPFNVLS-GKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSL  173 (851)
Q Consensus        95 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  173 (851)
                      ..++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. +.+..+++|++|+|++|.+++.+|..+.++++|++|
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            3477889999999887 78888888889999999999988877 668888888888888888887677777778888888


Q ss_pred             ecccccCCCCCCcccccCCCCCCeEecccccccccCC---cccccccccCcccccccccc
Q 003065          174 SIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP---ESISELRELGTLDICRNKIS  230 (851)
Q Consensus       174 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~L~~N~i~  230 (851)
                      ++++|.++....+..+..+++|++|++++|.+++..+   ..+..+++|++|++++|.+.
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            8888877622222567777777777777777774433   35666666777776666665

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.68  E-value=1.1e-16  Score=154.98  Aligned_cols=132  Identities=20%  Similarity=0.178  Sum_probs=92.4

Q ss_pred             cccceeccccCccc-cccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEe
Q 003065          385 KTIQRLRISDNHLS-GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI  463 (851)
Q Consensus       385 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  463 (851)
                      ++|++|++++|+++ +.+|..+..+++|++|++++|++++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            67888888888887 67787778888888888888888765  5666777777777777777766666666677777777


Q ss_pred             ccCccccCCCc-cccccCCcccEEEecCCcccCCCC---CCcccccccceeeccCcccc
Q 003065          464 LTNNNFSGKIP-SALGALRQLSSLHLEENALTGSIP---NEMGDCARIVDLNLARNSLS  518 (851)
Q Consensus       464 Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~  518 (851)
                      +++|++++..+ ..+..+++|+.|+|++|++++..+   ..+..+++|+.|++++|.++
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            77777765422 566666677777777776664433   25555666666666666555

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.67  E-value=6.8e-17  Score=153.11  Aligned_cols=130  Identities=22%  Similarity=0.242  Sum_probs=100.9

Q ss_pred             CCccCcEEeCCCCccc-CccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCcccccee
Q 003065           95 ALQSLTVLSLPFNVLS-GKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSL  173 (851)
Q Consensus        95 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  173 (851)
                      ..++|++|++++|.++ +.+|..++.+++|++|++++|.+++. +.++.+++|++|+|++|.+++.+|..+..+++|++|
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            3477889999999988 78888888999999999999988877 668888889999999988887777777778888888


Q ss_pred             ecccccCCCCCCcccccCCCCCCeEecccccccccCC---cccccccccCccccc
Q 003065          174 SIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP---ESISELRELGTLDIC  225 (851)
Q Consensus       174 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~L~  225 (851)
                      ++++|.++....|..+..+++|++|++++|++++..+   ..+..+++|++||++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            8888887632233667777777777777777775544   356667777777665

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.65  E-value=7.1e-16  Score=152.79  Aligned_cols=128  Identities=23%  Similarity=0.272  Sum_probs=101.1

Q ss_pred             eEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCc
Q 003065          413 MLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA  492 (851)
Q Consensus       413 ~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  492 (851)
                      .+++++|+++..+...   .++|+.|+|++|+|+ .+|..|.++++|++|+|++|.|++..+..|.++++|+.|+|++|+
T Consensus        14 ~l~~~~~~l~~ip~~~---~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLKVLPKGI---PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCSSCCSCC---CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCCcCCCCC---CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4455555554333221   246777888888877 667788888888888888888888878888888889999999999


Q ss_pred             ccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccc
Q 003065          493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGS  544 (851)
Q Consensus       493 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~  544 (851)
                      |++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            8888888888889999999999999877667788899999999999998753

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.65  E-value=5.3e-16  Score=151.61  Aligned_cols=113  Identities=24%  Similarity=0.270  Sum_probs=58.3

Q ss_pred             CCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeC
Q 003065          457 TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNL  536 (851)
Q Consensus       457 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  536 (851)
                      ++|+.|++++|++++..+..|..+++|++|+|++|++++..+..++.+++|+.|++++|+|++..+..+..+++|+.|+|
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            34555555555555444444455555555555555555444444455555555555555555444444555555555555


Q ss_pred             CCCccccccCcccccc-cceEEeCcCCcccccCC
Q 003065          537 SGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVP  569 (851)
Q Consensus       537 s~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p  569 (851)
                      ++|++++..+..+..+ .|+.|++++|++.|.+|
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            5555553333333444 55555555555555555

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.65  E-value=7.4e-16  Score=150.56  Aligned_cols=132  Identities=22%  Similarity=0.267  Sum_probs=98.9

Q ss_pred             ceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCC
Q 003065          412 GMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN  491 (851)
Q Consensus       412 ~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  491 (851)
                      +.+++++|+++..+...   .++|+.|++++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|
T Consensus        10 ~~l~~~~~~l~~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLTSVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCSSCCTTC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCccCCCCC---CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            34455555554433221   246777777777777666666777788888888888888776777788888888888888


Q ss_pred             cccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccC
Q 003065          492 ALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP  546 (851)
Q Consensus       492 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip  546 (851)
                      ++++..+..++.+++|+.|++++|++++..+..+..+++|+.|+|++|++++..|
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            8887777778888888888888888886666667888999999999999997665

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.64  E-value=2.4e-16  Score=149.31  Aligned_cols=127  Identities=21%  Similarity=0.195  Sum_probs=75.7

Q ss_pred             cccceeccccCccc-cccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEe
Q 003065          385 KTIQRLRISDNHLS-GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI  463 (851)
Q Consensus       385 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  463 (851)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|++++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            56777777777777 66777667777777777777776655  4455566666666666666654555555556666666


Q ss_pred             ccCccccCC-CccccccCCcccEEEecCCcccCCCC---CCcccccccceeecc
Q 003065          464 LTNNNFSGK-IPSALGALRQLSSLHLEENALTGSIP---NEMGDCARIVDLNLA  513 (851)
Q Consensus       464 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls  513 (851)
                      +++|++++. .+..+..+++|++|++++|++++..+   ..++.+++|+.|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            666665542 23455555555555555555554333   234444445544443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.60  E-value=1.3e-14  Score=160.52  Aligned_cols=227  Identities=11%  Similarity=0.094  Sum_probs=92.8

Q ss_pred             CccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhc
Q 003065          290 NLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL  369 (851)
Q Consensus       290 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~  369 (851)
                      +|+.+.+..| ++......|.+. +|+.+.+.. .++...+.+|..+++|+.+++++|+++. +|...+...+|+.+.+.
T Consensus       136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~-I~~~aF~~~~L~~l~lp  211 (401)
T 4fdw_A          136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITK-LPASTFVYAGIEEVLLP  211 (401)
T ss_dssp             CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSE-ECTTTTTTCCCSEEECC
T ss_pred             CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceE-echhhEeecccCEEEeC
Confidence            4444444433 332333344442 355555543 3443444555555555555555555542 22211111222222221


Q ss_pred             cCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcce---
Q 003065          370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS---  446 (851)
Q Consensus       370 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~---  446 (851)
                       +++...-..+|.++++|+.+++..| ++.....+|.+ .+|+.+++ .|.++.+....|..+++|+.+++.+|.+.   
T Consensus       212 -~~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~  287 (401)
T 4fdw_A          212 -VTLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDP  287 (401)
T ss_dssp             -TTCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCT
T ss_pred             -CchheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCc
Confidence             1122222344555555555555543 33233333333 44455544 23344334444444444444444444332   


Q ss_pred             --eeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCC
Q 003065          447 --GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRS  524 (851)
Q Consensus       447 --~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  524 (851)
                        ...+.+|.++++|+.++|. |.++.....+|.++++|+.++|..| ++..-+..|.++ +|+.+++++|.+....+..
T Consensus       288 ~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~  364 (401)
T 4fdw_A          288 EAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKV  364 (401)
T ss_dssp             TCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSS
T ss_pred             ccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccccccc
Confidence              2333344444444444444 2233333334444444444444322 332333344444 4444444444443333333


Q ss_pred             ccc
Q 003065          525 LSL  527 (851)
Q Consensus       525 ~~~  527 (851)
                      |.+
T Consensus       365 F~~  367 (401)
T 4fdw_A          365 WYG  367 (401)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            333

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.59  E-value=2.7e-14  Score=157.94  Aligned_cols=265  Identities=10%  Similarity=0.079  Sum_probs=145.4

Q ss_pred             CCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEec
Q 003065          193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI  272 (851)
Q Consensus       193 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  272 (851)
                      ..++.+.+.+ .++.+...+|.+. +|+.+++..| ++.+...+|.+. +|+.+.+.. .++...+.+|.++++|+.+++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l  187 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL  187 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence            4455555532 3443444455552 4666665544 444444455552 455555553 444344445555555555555


Q ss_pred             ccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCccccc
Q 003065          273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGS  352 (851)
Q Consensus       273 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  352 (851)
                      ++|+++......|. .++|+.+                        .+..+ ++.....+|..+++|+.+++..| ++. 
T Consensus       188 ~~n~l~~I~~~aF~-~~~L~~l------------------------~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~-  239 (401)
T 4fdw_A          188 SKTKITKLPASTFV-YAGIEEV------------------------LLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VST-  239 (401)
T ss_dssp             TTSCCSEECTTTTT-TCCCSEE------------------------ECCTT-CCEECTTTTTTCTTCCCEECCTT-CCE-
T ss_pred             CCCcceEechhhEe-ecccCEE------------------------EeCCc-hheehhhHhhCCCCCCEEecCCC-ccC-
Confidence            55555432222333 3444444                        44422 33334445555555555555443 221 


Q ss_pred             CchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCC-----CCCCc
Q 003065          353 FPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT-----GGISP  427 (851)
Q Consensus       353 ~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~~~  427 (851)
                                             .-..+|.+ .+|+.+++ .|.++...+.+|.++++|+.+++.+|.+.     .+.+.
T Consensus       240 -----------------------I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~  294 (401)
T 4fdw_A          240 -----------------------IGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPY  294 (401)
T ss_dssp             -----------------------ECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTT
T ss_pred             -----------------------cccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHH
Confidence                                   11123333 34555555 33444344455556666666666655544     34555


Q ss_pred             ccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCccccc-c
Q 003065          428 LIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA-R  506 (851)
Q Consensus       428 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~  506 (851)
                      .|..+++|+.++|. +.++.+...+|.++++|+.++|.+| ++...+.+|.++ +|+.|++++|.+....+..|.+++ .
T Consensus       295 aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~  371 (401)
T 4fdw_A          295 CLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDD  371 (401)
T ss_dssp             TTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTT
T ss_pred             HhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCC
Confidence            67777777777777 3466566677777888888888554 555556777777 788888888877766666676663 5


Q ss_pred             cceeeccCcccc
Q 003065          507 IVDLNLARNSLS  518 (851)
Q Consensus       507 L~~L~Ls~N~l~  518 (851)
                      ++.|++..|.+.
T Consensus       372 l~~l~vp~~~~~  383 (401)
T 4fdw_A          372 ITVIRVPAESVE  383 (401)
T ss_dssp             CCEEEECGGGHH
T ss_pred             ccEEEeCHHHHH
Confidence            667777666544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.58  E-value=1.5e-15  Score=163.80  Aligned_cols=134  Identities=16%  Similarity=0.135  Sum_probs=98.3

Q ss_pred             CccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----------------ccHH--------HHHHHHHHHHcCCCCcc
Q 003065          678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----------------DGVK--------VFAAEMEILGKIRHRNI  733 (851)
Q Consensus       678 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----------------~~~~--------~~~~E~~~l~~l~h~ni  733 (851)
                      |.+.+.||+|+||.||+|.+ .+|+.||||+++..                ....        ...+|...+.++.+..+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            88999999999999999998 46899999986421                0011        12457777777765554


Q ss_pred             cc--EEEEEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 003065          734 LK--LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL  811 (851)
Q Consensus       734 v~--l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NIL  811 (851)
                      ..  .+++  .  ..++||||++|+++.++..         .+  ....++.|++.++.|||   +.|||||||||.|||
T Consensus       176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~---------~~--~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSS---------VP--DPASLYADLIALILRLA---KHGLIHGDFNEFNIL  237 (397)
T ss_dssp             SCCCEEEE--E--TTEEEEECCSCEEGGGCCC---------CS--CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred             CCCeeeec--c--CceEEEEecCCccHhhhcc---------cH--HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEE
Confidence            32  2322  2  2479999999888743211         11  23467899999999999   679999999999999


Q ss_pred             ECCCC----------ceEEeeecCccccC
Q 003065          812 LDEDY----------EPKIADFGVAKIAE  830 (851)
Q Consensus       812 l~~~~----------~~kl~DFGla~~~~  830 (851)
                      +++++          .+.|+||+-+....
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EeCCCCcccccccccceEEEEeCCcccCC
Confidence            98776          38999999876543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.57  E-value=2.4e-17  Score=164.35  Aligned_cols=106  Identities=24%  Similarity=0.285  Sum_probs=49.9

Q ss_pred             CccCcEEeCCCCcccCccCc------ccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccc
Q 003065           96 LQSLTVLSLPFNVLSGKLPL------ELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQ  169 (851)
Q Consensus        96 l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  169 (851)
                      ...++.++++.+.++|.+|.      .|+.+++|++|+|++|.+++. |.+..+++|++|++++|.++ .+|..+..+++
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~   94 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADT   94 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-CCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-cccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence            34444455555555544444      555555555555555555542 24455555555555555554 33444444444


Q ss_pred             cceeecccccCCCCCCcccccCCCCCCeEeccccccc
Q 003065          170 LVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLR  206 (851)
Q Consensus       170 L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~  206 (851)
                      |++|++++|+++  .+| .+..+++|++|++++|+++
T Consensus        95 L~~L~L~~N~l~--~l~-~~~~l~~L~~L~l~~N~i~  128 (198)
T 1ds9_A           95 LEELWISYNQIA--SLS-GIEKLVNLRVLYMSNNKIT  128 (198)
T ss_dssp             CSEEEEEEEECC--CHH-HHHHHHHSSEEEESEEECC
T ss_pred             CCEEECcCCcCC--cCC-ccccCCCCCEEECCCCcCC
Confidence            444444444443  122 2333444444444444443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.57  E-value=3e-17  Score=163.65  Aligned_cols=138  Identities=22%  Similarity=0.278  Sum_probs=75.9

Q ss_pred             ccCccccceeccccCccccccCC------cccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccc
Q 003065          381 YADCKTIQRLRISDNHLSGKIPD------GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELG  454 (851)
Q Consensus       381 ~~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~  454 (851)
                      +.....++.++++.|.++|.+|.      .+..+++|++|++++|++++ +| .+..+++|+.|++++|+++ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            34455677778888888777665      55556666666666666555 22 4555555555555555555 4444455


Q ss_pred             cCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCC-CCcccccccceeeccCcccccccCC
Q 003065          455 RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP-NEMGDCARIVDLNLARNSLSGNIPR  523 (851)
Q Consensus       455 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~  523 (851)
                      .+++|++|++++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.+++.+|.
T Consensus        91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A           91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred             cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence            55555555555555553 23 35555555555555555543211 2444555555555555555544443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.57  E-value=2.7e-15  Score=146.43  Aligned_cols=134  Identities=16%  Similarity=0.180  Sum_probs=101.7

Q ss_pred             ccccCCccCcEEeCCCCcccCccCcccccCC-CCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccc
Q 003065           91 SSISALQSLTVLSLPFNVLSGKLPLELSNCS-NLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQ  169 (851)
Q Consensus        91 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  169 (851)
                      +.+.++.+|++|+|++|+++. +|. +..+. +|++|+|++|.+++. +.++.+++|++|+|++|.+++..+..+..+++
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            356677888888888888884 454 55554 888888888888876 66888888888888888888655555678888


Q ss_pred             cceeecccccCCCCCCcc--cccCCCCCCeEecccccccccCCcc----cccccccCcccccccccc
Q 003065          170 LVSLSIGDNVYDEAEIPE--SIGNLKNLTYLFLAHCNLRGRIPES----ISELRELGTLDICRNKIS  230 (851)
Q Consensus       170 L~~L~L~~N~l~~~~~p~--~~~~l~~L~~L~L~~n~l~~~~p~~----~~~l~~L~~L~L~~N~i~  230 (851)
                      |++|++++|.+.  .+|.  .+..+++|++|++++|.++ .+|..    +..+++|++||++.|.+.
T Consensus        90 L~~L~L~~N~i~--~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           90 LTELILTNNSLV--ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCEEECCSCCCC--CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCEEECCCCcCC--cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            888888888885  5565  6777888888888888887 45553    777777777777777765

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.56  E-value=3.4e-15  Score=145.62  Aligned_cols=105  Identities=19%  Similarity=0.265  Sum_probs=48.6

Q ss_pred             CCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCC--Ccccccccceee
Q 003065          434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPN--EMGDCARIVDLN  511 (851)
Q Consensus       434 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~  511 (851)
                      +|+.|+|++|++++.  ..|..+++|++|+|++|.+++..|..+..+++|++|+|++|+++ .+|.  .++.+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            444444444444432  33444445555555555554333333344555555555555553 2332  344444444444


Q ss_pred             ccCcccccccCCC----ccccccCCeEeCCCCccc
Q 003065          512 LARNSLSGNIPRS----LSLLSSLNALNLSGNKLT  542 (851)
Q Consensus       512 Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~  542 (851)
                      +++|.++ .+|..    +..+++|+.||+++|.+.
T Consensus       120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            4444444 23332    445555555555555543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.54  E-value=7.7e-14  Score=154.79  Aligned_cols=333  Identities=10%  Similarity=0.026  Sum_probs=170.1

Q ss_pred             cCCCCcccccCccccceeecccccCCCCCC-cccccCCCCCCeEecccccccccCCcccccccccCcccccccccccccc
Q 003065          156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEI-PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP  234 (851)
Q Consensus       156 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p  234 (851)
                      ++.+...+|.++++|+++.+..+ ++  .| ...|.++++|+.+++..+ ++.....+|.++++|+.+.+..+ +.....
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~--~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~  133 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VR--EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGV  133 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CC--EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-cc--CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecc
Confidence            33344567777888888888644 33  23 235777778888877644 55455566777777777666543 333444


Q ss_pred             ccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCccc
Q 003065          235 RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK  314 (851)
Q Consensus       235 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  314 (851)
                      .+|.+...+......  .+......+|.++++|+.+.+..+... .....|.++.+|+.+++..| ++......|.++..
T Consensus       134 ~aF~~~~~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~  209 (394)
T 4fs7_A          134 EAFKGCDFKEITIPE--GVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECIL  209 (394)
T ss_dssp             TTTTTCCCSEEECCT--TCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTT
T ss_pred             eeeecccccccccCc--cccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccc
Confidence            556555433322221  122223345666666666666544322 33334555555555555443 22222334444444


Q ss_pred             ccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceecccc
Q 003065          315 LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISD  394 (851)
Q Consensus       315 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~  394 (851)
                      |+.+.+..+...  +.+......+|+.+.+..                         .....-...|..+..|+.+.+..
T Consensus       210 L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~-------------------------~~~~i~~~~f~~~~~l~~~~~~~  262 (394)
T 4fs7_A          210 LENMEFPNSLYY--LGDFALSKTGVKNIIIPD-------------------------SFTELGKSVFYGCTDLESISIQN  262 (394)
T ss_dssp             CCBCCCCTTCCE--ECTTTTTTCCCCEEEECT-------------------------TCCEECSSTTTTCSSCCEEEECC
T ss_pred             cceeecCCCceE--eehhhcccCCCceEEECC-------------------------CceecccccccccccceeEEcCC
Confidence            444444333221  111112222333333221                         11112234456666666666665


Q ss_pred             CccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCc
Q 003065          395 NHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIP  474 (851)
Q Consensus       395 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  474 (851)
                      +... .....|.....++.+....+.+   ....|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++....
T Consensus       263 ~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~  336 (394)
T 4fs7_A          263 NKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGK  336 (394)
T ss_dssp             TTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECT
T ss_pred             Ccce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhH
Confidence            5443 4445566666666666655432   2234555666666666544 44444556666666666666533 443444


Q ss_pred             cccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCe
Q 003065          475 SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNA  533 (851)
Q Consensus       475 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  533 (851)
                      .+|.++.+|+.+++..| ++..-..+|.++.+|+.+++..+ ++ .+..+|.+.++|+.
T Consensus       337 ~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~  392 (394)
T 4fs7_A          337 RSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW  392 (394)
T ss_dssp             TTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred             HhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence            56666666666666555 44444455666666666666543 22 22344555555543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.53  E-value=1.7e-13  Score=151.96  Aligned_cols=122  Identities=11%  Similarity=0.087  Sum_probs=69.2

Q ss_pred             ccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCc
Q 003065          381 YADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE  460 (851)
Q Consensus       381 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  460 (851)
                      |..+..++.+....+.+   ....|..+.+|+.+.+.++ ++.+....|.++++|+.++|.++ ++.+-..+|.++.+|+
T Consensus       272 F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~  346 (394)
T 4fs7_A          272 FYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLS  346 (394)
T ss_dssp             TTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCC
T ss_pred             cccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCC
Confidence            44444444444443322   1224445555555555443 44444555666666666666543 5545566777777777


Q ss_pred             EEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCccccccccee
Q 003065          461 RLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL  510 (851)
Q Consensus       461 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  510 (851)
                      .+++..| ++.....+|.++++|+.+++..+ ++ .+...|.++.+|+.+
T Consensus       347 ~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          347 NINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             EECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             EEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            7777665 55455567777777777777654 22 234566666666553

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.51  E-value=4.8e-14  Score=136.46  Aligned_cols=105  Identities=22%  Similarity=0.272  Sum_probs=56.5

Q ss_pred             CCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccC
Q 003065          435 LSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLAR  514 (851)
Q Consensus       435 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  514 (851)
                      .+.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            345666666665 3444332  4555555555555555555555555555555555555544444455555555555555


Q ss_pred             cccccccCCCccccccCCeEeCCCCccc
Q 003065          515 NSLSGNIPRSLSLLSSLNALNLSGNKLT  542 (851)
Q Consensus       515 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  542 (851)
                      |+|++..+..|..+++|+.|+|++|+++
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            5555444444555555555555555554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.50  E-value=6.8e-14  Score=135.42  Aligned_cols=108  Identities=19%  Similarity=0.240  Sum_probs=86.3

Q ss_pred             CcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCC
Q 003065          459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG  538 (851)
Q Consensus       459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  538 (851)
                      .+.+++++|.++. +|..+.  +.|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            4678888888874 555553  6788888888888887788888888888888888888877777778888888888888


Q ss_pred             CccccccCcccccc-cceEEeCcCCcccccCC
Q 003065          539 NKLTGSIPDNLMKL-KLSSIDLSENQLSGSVP  569 (851)
Q Consensus       539 N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p  569 (851)
                      |+|++..|..+..+ .|+.|+|++|+|.|.++
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            88886555567777 78888888888888876

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.47  E-value=1.2e-13  Score=134.09  Aligned_cols=104  Identities=25%  Similarity=0.325  Sum_probs=61.4

Q ss_pred             CeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCc
Q 003065          436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARN  515 (851)
Q Consensus       436 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  515 (851)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            44555555554 4444432  55666666666666555666666666666666666666544444556666666666666


Q ss_pred             ccccccCCCccccccCCeEeCCCCccc
Q 003065          516 SLSGNIPRSLSLLSSLNALNLSGNKLT  542 (851)
Q Consensus       516 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~  542 (851)
                      +|++..+..|..+++|+.|+|++|++.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            666544445666666666666666666

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.47  E-value=1.4e-13  Score=133.69  Aligned_cols=108  Identities=19%  Similarity=0.240  Sum_probs=97.3

Q ss_pred             CcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCC
Q 003065          459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG  538 (851)
Q Consensus       459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  538 (851)
                      -+.+++++|.++ .+|..+.  ++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            478999999997 6676665  7999999999999999999999999999999999999987777789999999999999


Q ss_pred             CccccccCcccccc-cceEEeCcCCcccccCC
Q 003065          539 NKLTGSIPDNLMKL-KLSSIDLSENQLSGSVP  569 (851)
Q Consensus       539 N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p  569 (851)
                      |+|++..|..+..+ .|+.|++++|+|.|.++
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            99996555568888 99999999999999886

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.38  E-value=5.8e-13  Score=145.09  Aligned_cols=108  Identities=23%  Similarity=0.266  Sum_probs=63.5

Q ss_pred             EeccCc-cccCCCccccccCCcccEEEecC-CcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCC
Q 003065          462 LILTNN-NFSGKIPSALGALRQLSSLHLEE-NALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN  539 (851)
Q Consensus       462 L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  539 (851)
                      ++++++ .|++ +|. +..+++|+.|+|++ |+|++..|..|+++++|+.|+|++|+|++..|..|..+++|+.|||++|
T Consensus        13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            455555 5552 444 55555666666664 6665555555666666666666666666666666666666666666666


Q ss_pred             ccccccCcccccccceEEeCcCCcccccCCcc
Q 003065          540 KLTGSIPDNLMKLKLSSIDLSENQLSGSVPLD  571 (851)
Q Consensus       540 ~l~g~ip~~l~~l~L~~l~ls~N~l~~~~p~~  571 (851)
                      +|++..|..+..+.|+.|+|++|+|.|.+...
T Consensus        91 ~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~l~  122 (347)
T 2ifg_A           91 ALESLSWKTVQGLSLQELVLSGNPLHCSCALR  122 (347)
T ss_dssp             CCSCCCSTTTCSCCCCEEECCSSCCCCCGGGH
T ss_pred             ccceeCHHHcccCCceEEEeeCCCccCCCccH
Confidence            66643333444445666666666666666543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.32  E-value=1.9e-14  Score=157.63  Aligned_cols=166  Identities=17%  Similarity=0.192  Sum_probs=110.3

Q ss_pred             ccccceeccccCccccccCCcccCc-----cccceEEecCCcCCCCCCcc-cccCCCCCeEecCCCcceeeCCcccc---
Q 003065          384 CKTIQRLRISDNHLSGKIPDGLWAL-----PNVGMLDFGDNDFTGGISPL-IGLSTSLSQLVLQNNRFSGELPSELG---  454 (851)
Q Consensus       384 l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~~~~-~~~~~~L~~L~Ls~N~l~~~~p~~~~---  454 (851)
                      ++.|++|+|++|.++......+...     ++|+.|+|++|+++...... ...+++|+.|+|++|.++......++   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            3568888999998875544443332     67888888888876432222 23356788888888888755444442   


Q ss_pred             --cCCCCcEEeccCccccCC----CccccccCCcccEEEecCCcccCC----CCCCcccccccceeeccCcccccc----
Q 003065          455 --RLTNLERLILTNNNFSGK----IPSALGALRQLSSLHLEENALTGS----IPNEMGDCARIVDLNLARNSLSGN----  520 (851)
Q Consensus       455 --~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----  520 (851)
                        ..++|++|+|++|.|+..    ++..+...+.|++|+|++|+|+..    ++..+...+.|+.|+|++|.|+..    
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence              356788888888888642    334456677888888888887642    244556667788888888888753    


Q ss_pred             cCCCccccccCCeEeCCCCccccccCccc
Q 003065          521 IPRSLSLLSSLNALNLSGNKLTGSIPDNL  549 (851)
Q Consensus       521 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l  549 (851)
                      ++..+...++|+.|||++|.|+..-...+
T Consensus       231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L  259 (372)
T 3un9_A          231 LARAAREHPSLELLHLYFNELSSEGRQVL  259 (372)
T ss_dssp             HHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence            33344456778888888888875444444

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.31  E-value=1.6e-12  Score=141.47  Aligned_cols=130  Identities=25%  Similarity=0.227  Sum_probs=65.7

Q ss_pred             EecCCC-cceeeCCcccccCCCCcEEeccC-ccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCc
Q 003065          438 LVLQNN-RFSGELPSELGRLTNLERLILTN-NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARN  515 (851)
Q Consensus       438 L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  515 (851)
                      ++++++ +++ .+|. +..+++|+.|+|++ |.|++..|..|.++++|+.|+|++|+|++..|..|+++++|+.|+|++|
T Consensus        13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            344444 444 3444 55555555555553 5555555555555555555555555555555555555555555555555


Q ss_pred             ccccccCCCccccccCCeEeCCCCccccccC-cccccc-cceEEeCcCCcccccCCc
Q 003065          516 SLSGNIPRSLSLLSSLNALNLSGNKLTGSIP-DNLMKL-KLSSIDLSENQLSGSVPL  570 (851)
Q Consensus       516 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip-~~l~~l-~L~~l~ls~N~l~~~~p~  570 (851)
                      +|++..+..|..++ |+.|+|++|+|...-. .++..+ ......+..+++.|..|.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            55544444444443 6666666666653211 112111 122223344566666654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.30  E-value=2.8e-11  Score=134.11  Aligned_cols=158  Identities=13%  Similarity=0.069  Sum_probs=99.5

Q ss_pred             CCcccccCcc-ccceeecccccCCCCCC-cccccCCCCCCeEeccccc---ccccCCcccccccccCccccccccccccc
Q 003065          159 RFPRWVVNLT-QLVSLSIGDNVYDEAEI-PESIGNLKNLTYLFLAHCN---LRGRIPESISELRELGTLDICRNKISGEF  233 (851)
Q Consensus       159 ~~~~~~~~l~-~L~~L~L~~N~l~~~~~-p~~~~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~L~L~~N~i~~~~  233 (851)
                      +...+|.+.. .|+++.+..+ ++  .| ...|.++++|+.+.+..|.   ++.....+|.+..+|+.+.+..+ ++...
T Consensus        54 Ig~~aF~~~~~~L~sI~iP~s-vt--~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~  129 (394)
T 4gt6_A           54 IGDRVFCNYKYVLTSVQIPDT-VT--EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEID  129 (394)
T ss_dssp             ECTTTTTTCCSCCCEEEECTT-CC--EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEEC
T ss_pred             cCHhhccCCCCcCEEEEECCC-ee--EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceeh
Confidence            3455677764 5888888654 32  22 3467888899999888764   65555667888888888877654 44455


Q ss_pred             cccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcc
Q 003065          234 PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR  313 (851)
Q Consensus       234 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~  313 (851)
                      ..+|..+.+|+.+.+..+ +.......|....+|+.+.+..+ ++..-...|.+ .+|+.+.+..+-.. .....|.++.
T Consensus       130 ~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~  205 (394)
T 4gt6_A          130 SEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECF  205 (394)
T ss_dssp             TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCT
T ss_pred             hhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcc
Confidence            667888888888888654 33355567777888888877655 33233334433 56777766544322 3344566666


Q ss_pred             cccEEEeccCc
Q 003065          314 KLFAFSIYGNR  324 (851)
Q Consensus       314 ~L~~L~l~~N~  324 (851)
                      .+.......+.
T Consensus       206 ~l~~~~~~~~~  216 (394)
T 4gt6_A          206 ALSTITSDSES  216 (394)
T ss_dssp             TCCEEEECCSS
T ss_pred             ccceecccccc
Confidence            66655554443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.28  E-value=5.9e-14  Score=153.63  Aligned_cols=61  Identities=20%  Similarity=0.132  Sum_probs=29.1

Q ss_pred             CCCceEecccCcccCCCCC-----CC-CCCCCCeEeccCcccCCCCcccc-cCccccceeecccccCC
Q 003065          121 SNLKVLNVTGNAMVGSVPD-----LS-ALKNLEIFDLSINYFTGRFPRWV-VNLTQLVSLSIGDNVYD  181 (851)
Q Consensus       121 ~~L~~L~Ls~n~l~~~~~~-----l~-~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~  181 (851)
                      ++|++|+|++|.++.....     +. ..++|++|||++|.++......+ ..+++|++|+|++|.+.
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~  139 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG  139 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC
Confidence            4566666666666542211     11 22456666666665543322222 22344555555555443

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.22  E-value=1.8e-10  Score=127.63  Aligned_cols=328  Identities=12%  Similarity=0.090  Sum_probs=157.7

Q ss_pred             cccCCC-CCCeEecccccccccCCcccccccccCcccccccc---ccccccccccCCCcccEEEeeccCccCcCCcCcCC
Q 003065          188 SIGNLK-NLTYLFLAHCNLRGRIPESISELRELGTLDICRNK---ISGEFPRSIRKLQKLWKIELYANNLTGELPAELGN  263 (851)
Q Consensus       188 ~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~---i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  263 (851)
                      .|.+.+ .|+.+.+..+ ++.+-..+|.++++|+.+.+..|.   ++.+...+|..+.+|+.+.+..+ ++.....+|..
T Consensus        58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~  135 (394)
T 4gt6_A           58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHH  135 (394)
T ss_dssp             TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred             hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhh
Confidence            344553 4777777543 665566677777778777777653   55455567777777777666544 44345566777


Q ss_pred             CCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceee
Q 003065          264 LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD  343 (851)
Q Consensus       264 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~  343 (851)
                      +.+|+.+.+..+. .......|.++.+|+.+.+..+ ++......|.+ ..|+.+.+..+-.. ....+|..+.+++...
T Consensus       136 c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~  211 (394)
T 4gt6_A          136 CEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTIT  211 (394)
T ss_dssp             CTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEE
T ss_pred             hccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceec
Confidence            7777777776443 2244456667777777776554 33233334543 45666666554332 3445566666666665


Q ss_pred             ccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCC
Q 003065          344 ISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG  423 (851)
Q Consensus       344 Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  423 (851)
                      ...+.... +...+....          .........+.....+..+.+. +.++..-..+|.++.+|+.+.+.++. ..
T Consensus       212 ~~~~~~~~-~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~-~~  278 (394)
T 4gt6_A          212 SDSESYPA-IDNVLYEKS----------ANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSV-VS  278 (394)
T ss_dssp             ECCSSSCB-SSSCEEEEC----------TTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTC-CE
T ss_pred             cccccccc-ccceeeccc----------ccccccccccccccccceEEcC-CcceEcccceeeecccccEEeccccc-ce
Confidence            55444331 111110000          0000000001111222223222 22222333445555555555554332 22


Q ss_pred             CCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCccc
Q 003065          424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGD  503 (851)
Q Consensus       424 ~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  503 (851)
                      .....|.++++|+.+.+. +.++.....+|.++.+|+.++|..+ ++.....+|.++.+|+.+.|..+ ++..-...|.+
T Consensus       279 I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~  355 (394)
T 4gt6_A          279 IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSN  355 (394)
T ss_dssp             ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTT
T ss_pred             ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhC
Confidence            333444555555555554 2333344445555555555555433 33333445555555555555433 33333445555


Q ss_pred             ccccceeeccCcccccccCCCccccccCCeEeCCCCc
Q 003065          504 CARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK  540 (851)
Q Consensus       504 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  540 (851)
                      +.+|+.+++.+|....   ..+....+|+.+.+..|.
T Consensus       356 C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~  389 (394)
T 4gt6_A          356 CTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGS  389 (394)
T ss_dssp             CTTCCEEEESSCHHHH---HTCBCCCCC---------
T ss_pred             CCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence            5555555555554321   234444455555544443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.21  E-value=2.1e-11  Score=126.96  Aligned_cols=144  Identities=17%  Similarity=0.059  Sum_probs=112.3

Q ss_pred             HHHcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEE
Q 003065          673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       673 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  749 (851)
                      ..+.+|+.....+.|+.+.||++..  .++.+++|+....  .....+.+|+++++.+. |..++++++++...+..|+|
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            3466888888888899999999975  3678999988642  23346889999999984 67788899999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD----------------------------------  795 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------  795 (851)
                      |||++|.++.+.+..       .   .....++.++++++..||..                                  
T Consensus        89 ~e~i~G~~l~~~~~~-------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           89 MSEADGVLCSEEYED-------E---QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EECCSSEEHHHHCCT-------T---TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEecCCeehhhccCC-------c---ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            999999988764210       1   11236788999999999961                                  


Q ss_pred             ----------------------CCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          796 ----------------------CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       796 ----------------------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                                            ....++|+|++|.||+++++..+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                  014589999999999998765667999998853

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.07  E-value=1.7e-11  Score=132.90  Aligned_cols=202  Identities=14%  Similarity=0.137  Sum_probs=103.6

Q ss_pred             CceEEEecccCCcce-e-------cCccccCCccCcEEeCCCCccc---------CccCcccccCCCCceEecccCcccC
Q 003065           73 GRVTEISFDNKSLSG-E-------ISSSISALQSLTVLSLPFNVLS---------GKLPLELSNCSNLKVLNVTGNAMVG  135 (851)
Q Consensus        73 ~~v~~l~l~~~~l~g-~-------i~~~l~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~n~l~~  135 (851)
                      .+|++|.+....+.| .       +.+++..+++|+.|.+..+...         +.++..+..+++|+.|+|++|.-..
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~  186 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS  186 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence            478888887666553 2       2455677888888888665331         1234445667788888887763111


Q ss_pred             CCCCCCCCCCCCeEeccCcccCCCCccccc--Cccccceeeccc--ccCCCC----CCcccccCCCCCCeEecccccccc
Q 003065          136 SVPDLSALKNLEIFDLSINYFTGRFPRWVV--NLTQLVSLSIGD--NVYDEA----EIPESIGNLKNLTYLFLAHCNLRG  207 (851)
Q Consensus       136 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~--N~l~~~----~~p~~~~~l~~L~~L~L~~n~l~~  207 (851)
                       .+.+. +++|+.|+|..|.++......+.  .+++|++|+|+.  |.....    .+...+.                 
T Consensus       187 -l~~~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~-----------------  247 (362)
T 2ra8_A          187 -IGKKP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS-----------------  247 (362)
T ss_dssp             -CCSCB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC-----------------
T ss_pred             -ecccc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh-----------------
Confidence             12232 67777777777766533333332  566666666642  211100    0001111                 


Q ss_pred             cCCcccccccccCcccccccccccccccccc---CCCcccEEEeeccCccCc----CCcCcCCCCcccEEecccccccCC
Q 003065          208 RIPESISELRELGTLDICRNKISGEFPRSIR---KLQKLWKIELYANNLTGE----LPAELGNLTLLQEFDISSNQMYGK  280 (851)
Q Consensus       208 ~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~---~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~  280 (851)
                           -..+++|++|+|++|.+.+..+..+.   .+++|++|+|+.|.+++.    ++..+.++++|+.|+|++|.++..
T Consensus       248 -----~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~  322 (362)
T 2ra8_A          248 -----KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE  322 (362)
T ss_dssp             -----TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred             -----cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence                 01234445555544444432222221   345566666666665542    223334556677777776666532


Q ss_pred             CCccccC-cCCccEEEccCCc
Q 003065          281 LPEEIGN-LKNLTVFQCFKNN  300 (851)
Q Consensus       281 ~p~~l~~-l~~L~~L~l~~N~  300 (851)
                      .-..+.. +  ...++++.++
T Consensus       323 ~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          323 MKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHHC--CSEEECCSBC
T ss_pred             HHHHHHHHc--CCEEEecCCc
Confidence            2222222 1  2446666665

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.06  E-value=9.4e-11  Score=121.80  Aligned_cols=138  Identities=17%  Similarity=0.190  Sum_probs=98.5

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCc--cccEEEEEEeCCeeEEEEeccC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN--ILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      +|......+.|..+.||++.. .++..+++|+.... ....+.+|+++++.+.+.+  +++++++...++..|+||||++
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~   98 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   98 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence            344433334566699999965 45678999987544 3345778999999986544  5568888888888999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC--------------------------------------  796 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------  796 (851)
                      |.++.  ..        ...   ...++.++++.+..||...                                      
T Consensus        99 G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           99 GQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             SEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             CcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            98773  11        011   1245677777777777421                                      


Q ss_pred             -----------------CCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          797 -----------------SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       797 -----------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                                       ...++|+|++|+||++++++.++|+|||.|...
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                             123999999999999987766779999998643

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.00  E-value=2.2e-08  Score=110.02  Aligned_cols=107  Identities=13%  Similarity=0.134  Sum_probs=52.1

Q ss_pred             ccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCccccccc
Q 003065          428 LIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARI  507 (851)
Q Consensus       428 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  507 (851)
                      .|..+..|+.+.+..+ ++..-..+|.++.+|+.+.+..+ ++.....+|.++++|+.+++.++.++..-...|.++.+|
T Consensus       235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L  312 (379)
T 4h09_A          235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL  312 (379)
T ss_dssp             TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred             cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCC
Confidence            3444444555554443 33333444555555555555432 332333445555555555555555544444455555555


Q ss_pred             ceeeccCcccccccCCCccccccCCeEeCC
Q 003065          508 VDLNLARNSLSGNIPRSLSLLSSLNALNLS  537 (851)
Q Consensus       508 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  537 (851)
                      +.++|..+ ++..-..+|.++++|+.+.+.
T Consensus       313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          313 SSVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             CEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             CEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence            55555433 443334455555555555554

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.97  E-value=2.4e-08  Score=109.73  Aligned_cols=144  Identities=13%  Similarity=0.156  Sum_probs=82.9

Q ss_pred             ccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCC
Q 003065          379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN  458 (851)
Q Consensus       379 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~  458 (851)
                      ..+..+.+|+.+.+..+ +......+|.++..|+.+.+..+ ++.+....|..+.+|+.+.+..+ +......+|.++.+
T Consensus       211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~  287 (379)
T 4h09_A          211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN  287 (379)
T ss_dssp             TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred             cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence            34555566666666543 33244445566666666666554 44445556666666666666543 44344556666667


Q ss_pred             CcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccc
Q 003065          459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL  527 (851)
Q Consensus       459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  527 (851)
                      |+.+++.++.++...+.+|.++.+|+.++|..+ ++.+-..+|.++.+|+.+.+..+ ++..-..+|.+
T Consensus       288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~  354 (379)
T 4h09_A          288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEG  354 (379)
T ss_dssp             CCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred             cccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhC
Confidence            777777666666555566666666777766543 44344556666666666666543 44333344443

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.94  E-value=8.1e-12  Score=128.37  Aligned_cols=120  Identities=17%  Similarity=0.154  Sum_probs=60.5

Q ss_pred             CcccceeEecCCCCceEEEeccc---CCcceecCc-cccCCccCcEEeCCCCcccCccCcc-cccCCCCce--EecccCc
Q 003065           60 PCGFSGITCDSVTGRVTEISFDN---KSLSGEISS-SISALQSLTVLSLPFNVLSGKLPLE-LSNCSNLKV--LNVTGNA  132 (851)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~l~~---~~l~g~i~~-~l~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~--L~Ls~n~  132 (851)
                      .|.|.|+.|+....+|+.+-..+   ..+.|.+.+ .+..++.  .|+.++|.-++.++-. |...+.|+.  ++++.|.
T Consensus        77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~  154 (267)
T 3rw6_A           77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR  154 (267)
T ss_dssp             HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred             HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence            48999999997766776665544   344455542 3333333  3333444444333322 444445554  5555553


Q ss_pred             ccCC---CCC-CCCCCCCCeEeccCcccCC--CCcccccCccccceeecccccCC
Q 003065          133 MVGS---VPD-LSALKNLEIFDLSINYFTG--RFPRWVVNLTQLVSLSIGDNVYD  181 (851)
Q Consensus       133 l~~~---~~~-l~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~  181 (851)
                      ....   .+. ..++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|++.
T Consensus       155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~  209 (267)
T 3rw6_A          155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK  209 (267)
T ss_dssp             HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred             HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence            2211   111 1345566666666666654  22334444555555555555544

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.93  E-value=1.6e-09  Score=118.26  Aligned_cols=140  Identities=16%  Similarity=0.274  Sum_probs=104.6

Q ss_pred             cCCeecccCcEEEEEEEEcCCCcEEEEEEec--ccc---cHHHHHHHHHHHHcCC--CCccccEEEEEEeC---CeeEEE
Q 003065          680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW--KGD---GVKVFAAEMEILGKIR--HRNILKLYACLLKG---GSSFLV  749 (851)
Q Consensus       680 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~---~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv  749 (851)
                      ..+.++.|.++.||++...  +..+++|+..  ...   ....+.+|+++++.+.  +..+++++.++.+.   +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3567899999999998863  4688899875  332   2356789999999997  45578888888766   458999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC---------------------------------  796 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------  796 (851)
                      |||++|..+.+.       ....++...+..++.+++++|..||...                                 
T Consensus       120 me~v~G~~l~~~-------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          120 MEFVSGRVLWDQ-------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EECCCCBCCCCT-------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEecCCeecCCC-------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            999998766321       1224567777888999999999999620                                 


Q ss_pred             ----------------------CCCcEEeCCCCCCEEECCCCc--eEEeeecCccc
Q 003065          797 ----------------------SPPIIHRDIKSSNILLDEDYE--PKIADFGVAKI  828 (851)
Q Consensus       797 ----------------------~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~  828 (851)
                                            ...++|+|++|.||+++.++.  +.|+||+.|..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  257999999999999997753  68999999864

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.83  E-value=7e-10  Score=120.19  Aligned_cols=180  Identities=16%  Similarity=0.205  Sum_probs=112.9

Q ss_pred             ccCccccceeccccCccc---------cccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCc
Q 003065          381 YADCKTIQRLRISDNHLS---------GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPS  451 (851)
Q Consensus       381 ~~~l~~L~~L~Ls~N~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~  451 (851)
                      ...+++|+.|.+.++...         +.++..+..+|+|+.|++++|.-.. .+. + .+++|+.|+|..+.++.....
T Consensus       135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~-l~~-~-~~~~L~~L~L~~~~l~~~~l~  211 (362)
T 2ra8_A          135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS-IGK-K-PRPNLKSLEIISGGLPDSVVE  211 (362)
T ss_dssp             HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-CCS-C-BCTTCSEEEEECSBCCHHHHH
T ss_pred             hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-ecc-c-cCCCCcEEEEecCCCChHHHH
Confidence            344556666666554321         1233444567888888888773111 222 3 267899999988887654444


Q ss_pred             ccc--cCCCCcEEeccC--ccccCC-----Ccccc--ccCCcccEEEecCCcccCCCCCCc---ccccccceeeccCccc
Q 003065          452 ELG--RLTNLERLILTN--NNFSGK-----IPSAL--GALRQLSSLHLEENALTGSIPNEM---GDCARIVDLNLARNSL  517 (851)
Q Consensus       452 ~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l  517 (851)
                      .++  .+++|+.|+|+.  |...+.     +...+  ..+++|+.|+|++|.+....+..+   ..+++|+.|+|+.|.|
T Consensus       212 ~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L  291 (362)
T 2ra8_A          212 DILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL  291 (362)
T ss_dssp             HHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred             HHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence            454  688999998863  222211     11122  247889999999988864333333   2478899999999998


Q ss_pred             ccc----cCCCccccccCCeEeCCCCccccccCcccccccceEEeCcCCc
Q 003065          518 SGN----IPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQ  563 (851)
Q Consensus       518 ~~~----~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~L~~l~ls~N~  563 (851)
                      ++.    ++..+..+++|+.|+|++|.++...-..+...-...+|+++|+
T Consensus       292 ~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~alg~~~~~~~~~  341 (362)
T 2ra8_A          292 TDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ  341 (362)
T ss_dssp             BHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHCCSEEECCSBC
T ss_pred             ChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHcCCEEEecCCc
Confidence            873    4555567888999999999887543333332112457888776

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.54  E-value=1.4e-07  Score=100.27  Aligned_cols=137  Identities=24%  Similarity=0.250  Sum_probs=97.2

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCC-CCc--cccEEEEEEeCC---eeEEEEeccC
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRN--ILKLYACLLKGG---SSFLVLEYMP  754 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~  754 (851)
                      .+.++.|....||++.     ..+++|+.........+.+|+++++.+. +..  +++.+......+   ..|+||||++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999863     4688998655445677889999998883 333  344555443332   3489999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD---------------------------------------  795 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------  795 (851)
                      |.++.+....       .++...+..++.++++.+..||..                                       
T Consensus       100 G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A          100 GVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9887643221       245556666777777777777741                                       


Q ss_pred             ----------------CCCCcEEeCCCCCCEEECC--CCceEEeeecCcccc
Q 003065          796 ----------------CSPPIIHRDIKSSNILLDE--DYEPKIADFGVAKIA  829 (851)
Q Consensus       796 ----------------~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~  829 (851)
                                      ....++|+|++|.||++++  ...+.|+||+.+...
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                            1245899999999999998  456899999998653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.44  E-value=1e-06  Score=91.61  Aligned_cols=143  Identities=20%  Similarity=0.162  Sum_probs=101.0

Q ss_pred             HcCCccCCeecccCcE-EEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEec
Q 003065          675 ICNLEEDNLIGSGGTG-KVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +.+|+. +.+..|..| .||+......+..+++|+-.. .....+.+|.+.++.+. +--+.+++.++.+.+..|+|||+
T Consensus        24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~  101 (272)
T 4gkh_A           24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA  101 (272)
T ss_dssp             HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET-HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC-CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence            344443 234455554 699988776777899997543 34566889999998884 33367788999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD-------------------------------------  795 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------  795 (851)
                      ++|.++.+.....         ......++.++++.+..||..                                     
T Consensus       102 l~G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A          102 IPGKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             CCSEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             eCCccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            9998887665431         011234556666666666631                                     


Q ss_pred             ------------------CCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          796 ------------------CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       796 ------------------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                                        ....++|+|+.|.||+++.++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              012379999999999999877778999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.43  E-value=9.2e-07  Score=93.83  Aligned_cols=137  Identities=20%  Similarity=0.171  Sum_probs=90.8

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCC---ccccEEEEEE-eCCeeEEEEeccCCC
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHR---NILKLYACLL-KGGSSFLVLEYMPNG  756 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g  756 (851)
                      .+.++.|....||+.     +..+++|+.........+.+|.++++.+.+.   .+++.+.+.. ..+..|+||||++|.
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            456788888999987     4678899864434456788999999999652   3556676664 456678999999998


Q ss_pred             CHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 003065          757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD-----------------------------------------  795 (851)
Q Consensus       757 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----------------------------------------  795 (851)
                      .+.+....       .++......++.++++.+..||..                                         
T Consensus        99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            77652110       112222222333333333333311                                         


Q ss_pred             ----------------CCCCcEEeCCCCCCEEECC---CCc-eEEeeecCcccc
Q 003065          796 ----------------CSPPIIHRDIKSSNILLDE---DYE-PKIADFGVAKIA  829 (851)
Q Consensus       796 ----------------~~~~ivHrDlkp~NILl~~---~~~-~kl~DFGla~~~  829 (851)
                                      ....++|+|++|.||+++.   ++. +.|+||+.+...
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                            2456799999999999987   455 489999988643

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.42  E-value=4.5e-08  Score=100.48  Aligned_cols=104  Identities=17%  Similarity=0.205  Sum_probs=52.0

Q ss_pred             hccCCccccccc-cccCccccce--eccccCccc---cccCCcccCccccceEEecCCcCCCC--CCcccccCCCCCeEe
Q 003065          368 ALSNNFSGEVPN-SYADCKTIQR--LRISDNHLS---GKIPDGLWALPNVGMLDFGDNDFTGG--ISPLIGLSTSLSQLV  439 (851)
Q Consensus       368 l~~n~~~~~~p~-~~~~l~~L~~--L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~~~~L~~L~  439 (851)
                      ..+|...+.++- .|...+.|..  ++++.|+..   +.++....++++|+.|+|++|+|++.  ++..+..+++|+.|+
T Consensus       123 ~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~  202 (267)
T 3rw6_A          123 KRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN  202 (267)
T ss_dssp             HTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEE
T ss_pred             hccchhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEE
Confidence            334444444443 2555666666  677777543   11121223456666666666666653  234444555555555


Q ss_pred             cCCCcceeeCCcccccCC--CCcEEeccCccccCCC
Q 003065          440 LQNNRFSGELPSELGRLT--NLERLILTNNNFSGKI  473 (851)
Q Consensus       440 Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~  473 (851)
                      |++|+|++.  ..+..+.  +|++|+|++|.+.+.+
T Consensus       203 Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~  236 (267)
T 3rw6_A          203 LSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTF  236 (267)
T ss_dssp             CTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGC
T ss_pred             CCCCccCCc--hhhhhcccCCcceEEccCCcCcccc
Confidence            555555533  2222222  5555555555554433

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.42  E-value=8.9e-09  Score=100.64  Aligned_cols=122  Identities=13%  Similarity=0.103  Sum_probs=63.5

Q ss_pred             ecCccccCCccCcEEeCCCC-cccCc----cCcccccCCCCceEecccCcccCCC-----CCCCCCCCCCeEeccCcccC
Q 003065           88 EISSSISALQSLTVLSLPFN-VLSGK----LPLELSNCSNLKVLNVTGNAMVGSV-----PDLSALKNLEIFDLSINYFT  157 (851)
Q Consensus        88 ~i~~~l~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~~-----~~l~~l~~L~~L~Ls~N~l~  157 (851)
                      .+...+...+.|++|+|++| .+...    +...+...++|++|+|++|.+...-     ..+...++|++|+|++|.|.
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            34455666777788888777 77532    3334555566777777777664311     11334455666666666554


Q ss_pred             CCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEec--cccccccc----CCcccccccccCcccccccccc
Q 003065          158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL--AHCNLRGR----IPESISELRELGTLDICRNKIS  230 (851)
Q Consensus       158 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L--~~n~l~~~----~p~~~~~l~~L~~L~L~~N~i~  230 (851)
                      .....                     .+...+...++|++|+|  ++|.+...    +.+.+...++|++|+|++|.+.
T Consensus       107 ~~g~~---------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          107 GSGIL---------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHH---------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHH---------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            32111                     11223344445555555  55555432    1223334455666666666654

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.37  E-value=4e-08  Score=95.92  Aligned_cols=88  Identities=17%  Similarity=0.267  Sum_probs=41.6

Q ss_pred             cCCCCcEEeccCccccCC----CccccccCCcccEEEecCCcccCC----CCCCcccccccceeec--cCcccccc----
Q 003065          455 RLTNLERLILTNNNFSGK----IPSALGALRQLSSLHLEENALTGS----IPNEMGDCARIVDLNL--ARNSLSGN----  520 (851)
Q Consensus       455 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~----  520 (851)
                      ..++|++|+|++|.|...    +...+...+.|++|+|++|.|+..    +...+...+.|+.|+|  ++|.|+..    
T Consensus        63 ~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~  142 (185)
T 1io0_A           63 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME  142 (185)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred             hCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHH
Confidence            334555555555555421    122233334555555555555421    2333444445555555  45555432    


Q ss_pred             cCCCccccccCCeEeCCCCccc
Q 003065          521 IPRSLSLLSSLNALNLSGNKLT  542 (851)
Q Consensus       521 ~p~~~~~l~~L~~L~Ls~N~l~  542 (851)
                      +...+...++|+.|+|++|.+.
T Consensus       143 l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          143 IANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHhCCCcCEEeccCCCCC
Confidence            2223334456666666666664

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.03  E-value=4.1e-06  Score=90.96  Aligned_cols=78  Identities=9%  Similarity=0.183  Sum_probs=54.8

Q ss_pred             CCee-cccCcEEEEEEEEc--C----CCcEEEEEEecccc-----cHHHHHHHHHHHHcCCC---CccccEEEEEEeC--
Q 003065          681 DNLI-GSGGTGKVYRLDLK--K----NAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRH---RNILKLYACLLKG--  743 (851)
Q Consensus       681 ~~~l-g~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--  743 (851)
                      .+.| +.|....+|+....  .    +++.+++|+.....     ....+.+|+++++.+..   -.+++++.+...+  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78889999998763  1    15678899764432     12457789999988853   3467788877654  


Q ss_pred             -CeeEEEEeccCCCCH
Q 003065          744 -GSSFLVLEYMPNGNL  758 (851)
Q Consensus       744 -~~~~lv~e~~~~gsL  758 (851)
                       +..|+||||++|..+
T Consensus       105 ~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TSSCEEEEECCCCBCC
T ss_pred             cCCceEEEEecCCCCh
Confidence             457899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.98  E-value=3.9e-05  Score=82.53  Aligned_cols=143  Identities=16%  Similarity=0.219  Sum_probs=81.5

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCC--CccccEEE------EEEeCCeeEEEEecc
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH--RNILKLYA------CLLKGGSSFLVLEYM  753 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~~  753 (851)
                      +.++.|..+.||++...  +..+++|+....  ...+..|.++++.+..  -.+++++.      +....+..|+||||+
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            34566778899998762  345899988653  3444556666665531  12333332      123467789999999


Q ss_pred             CCCCHH--------------HHHHHhhhCC--C-------CCCCHHHHH-------------------------------
Q 003065          754 PNGNLF--------------QALHKRVKEG--K-------PELDWFRRY-------------------------------  779 (851)
Q Consensus       754 ~~gsL~--------------~~l~~~~~~~--~-------~~l~~~~~~-------------------------------  779 (851)
                      +|..+.              ..++.....-  .       ....|...+                               
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986431              1122221110  0       011232110                               


Q ss_pred             HHHHHHHHHHHHHHh----------CCCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          780 KIALGAAKGIAYLHH----------DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       780 ~i~~~i~~~l~~LH~----------~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      .+...+..++++++.          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            111123345666652          0257899999999999998888999999998853

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.92  E-value=2.7e-05  Score=85.78  Aligned_cols=74  Identities=14%  Similarity=0.119  Sum_probs=49.4

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEecccc---------cHHHHHHHHHHHHcCCC--C-ccccEEEEEEeCCeeEE
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---------GVKVFAAEMEILGKIRH--R-NILKLYACLLKGGSSFL  748 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  748 (851)
                      .+.+|.|..+.||+++...+++.|+||......         ..+++..|.++++.+..  + .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999765567789999764321         23456789999887742  3 34456644  3445689


Q ss_pred             EEeccCCC
Q 003065          749 VLEYMPNG  756 (851)
Q Consensus       749 v~e~~~~g  756 (851)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.64  E-value=1.3e-05  Score=76.24  Aligned_cols=82  Identities=11%  Similarity=0.164  Sum_probs=34.4

Q ss_pred             CCCeEecccccccccCCcccccccccCcccccccc-ccccccccccCC----CcccEEEeeccC-ccCcCCcCcCCCCcc
Q 003065          194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNK-ISGEFPRSIRKL----QKLWKIELYANN-LTGELPAELGNLTLL  267 (851)
Q Consensus       194 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-i~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L  267 (851)
                      +|++||+++|.++...-..+..+++|++|+|++|. |+...-..+..+    ++|++|+|++|. |+...-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            34445555444443333334444444444444442 333222233332    234555555442 443222333444455


Q ss_pred             cEEecccc
Q 003065          268 QEFDISSN  275 (851)
Q Consensus       268 ~~L~Ls~N  275 (851)
                      ++|+|+++
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            55555444

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.59  E-value=0.001  Score=70.11  Aligned_cols=140  Identities=21%  Similarity=0.260  Sum_probs=92.3

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCC---CCccccEEEEEEeCCeeEEEEeccCCCC
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR---HRNILKLYACLLKGGSSFLVLEYMPNGN  757 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gs  757 (851)
                      .+.|+.|....+|+...  ++..+++|+.... ....+.+|.+.++.+.   ...+++.+.+....+..|+||||+++..
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            45689999999999875  4678889976543 4667889999998884   3567888888888888999999999875


Q ss_pred             HH--------HH---HHHhhhCCC-----------------CCCCHHHHH---HHHHH----------------HHHH-H
Q 003065          758 LF--------QA---LHKRVKEGK-----------------PELDWFRRY---KIALG----------------AAKG-I  789 (851)
Q Consensus       758 L~--------~~---l~~~~~~~~-----------------~~l~~~~~~---~i~~~----------------i~~~-l  789 (851)
                      +.        +.   ++.......                 -.-+|....   ++..+                +++. .
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            41        22   222111000                 012454332   11111                1111 1


Q ss_pred             HHHH-hCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          790 AYLH-HDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       790 ~~LH-~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      ..|. ....+.++|+|+.+.|++++.++ +.|+||+
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2332 12246899999999999999887 9999984

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.54  E-value=1.7e-05  Score=75.35  Aligned_cols=83  Identities=18%  Similarity=0.111  Sum_probs=46.5

Q ss_pred             cccCccccccccccccccccccCCCcccEEEeeccC-ccCcCCcCcCCC----CcccEEeccccc-ccCCCCccccCcCC
Q 003065          217 RELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN-LTGELPAELGNL----TLLQEFDISSNQ-MYGKLPEEIGNLKN  290 (851)
Q Consensus       217 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~l~~l~~  290 (851)
                      .+|+.||++++.|+...-..+.++++|++|+|++|. |++..-..+..+    ++|++|+|++|. ++..--..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            356777777777665555556666677777777663 554333333333    256666666653 54333334445555


Q ss_pred             ccEEEccCC
Q 003065          291 LTVFQCFKN  299 (851)
Q Consensus       291 L~~L~l~~N  299 (851)
                      |+.|+++++
T Consensus       141 L~~L~L~~c  149 (176)
T 3e4g_A          141 LKYLFLSDL  149 (176)
T ss_dssp             CCEEEEESC
T ss_pred             CCEEECCCC
Confidence            555555554

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.44  E-value=0.00047  Score=76.41  Aligned_cols=71  Identities=15%  Similarity=0.238  Sum_probs=45.0

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEec-------cc-c---cHHHHHHHHHHHHc-CCCCccccEEEEEEeCCeeEE
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLW-------KG-D---GVKVFAAEMEILGK-IRHRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-------~~-~---~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~l  748 (851)
                      .+.+|.|..+.||++..  +++.++||...       .. .   ....++.|+..+.. ..+..+++++.+.  .+..++
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            45688999999999964  56789999321       11 1   23334444433322 2334566777765  566799


Q ss_pred             EEecc-CC
Q 003065          749 VLEYM-PN  755 (851)
Q Consensus       749 v~e~~-~~  755 (851)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.24  E-value=0.00056  Score=72.70  Aligned_cols=145  Identities=14%  Similarity=0.132  Sum_probs=80.3

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCc--cccEEEE------EEeCCeeEEEEecc
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN--ILKLYAC------LLKGGSSFLVLEYM  753 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~  753 (851)
                      +.++.|....+|++...  +..+++|+.........+..|+++++.+....  +++++..      ....+..++||||+
T Consensus        28 ~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             eccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            45677888899998763  33688998765333345667888887774222  2333321      22346779999999


Q ss_pred             CCCCHH-----------H---HHHHhhhC-CCC---CC---CHHHHHH------------HHHHHHHHHHHHHhC----C
Q 003065          754 PNGNLF-----------Q---ALHKRVKE-GKP---EL---DWFRRYK------------IALGAAKGIAYLHHD----C  796 (851)
Q Consensus       754 ~~gsL~-----------~---~l~~~~~~-~~~---~l---~~~~~~~------------i~~~i~~~l~~LH~~----~  796 (851)
                      +|..+.           +   .++..... ..+   ..   .|.....            +...+.+.+++++..    .
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            875431           1   12221110 001   01   1221110            001134445555531    1


Q ss_pred             CCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       797 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ..+++|+|+++.||+++.++.+.++||+.+..
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            35799999999999999876668999998753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.15  E-value=0.00093  Score=69.77  Aligned_cols=75  Identities=17%  Similarity=0.154  Sum_probs=53.4

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCC---CccccEEEEEEeCCeeEEEEecc
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRH---RNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ...+.+|.|..+.||+.+. .+|+.|.||+....  .....|.+|++.|+.+.-   --+++.+++    +..++||||+
T Consensus        18 ~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l   92 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred             EEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence            3456789999999999987 57889999986433  223467899999998842   234455553    2347899999


Q ss_pred             CCCCH
Q 003065          754 PNGNL  758 (851)
Q Consensus       754 ~~gsL  758 (851)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.08  E-value=0.0008  Score=74.53  Aligned_cols=72  Identities=19%  Similarity=0.283  Sum_probs=49.6

Q ss_pred             CCeecccCcEEEEEEEEcC-------CCcEEEEEEecccccHHHHHHHHHHHHcCCCCcc-ccEEEEEEeCCeeEEEEec
Q 003065          681 DNLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNI-LKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  752 (851)
                      .+.|+.|-...||++....       .++.+++|+.........+.+|..+++.+...++ +++++.+..    .+|+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            3467888889999998743       2467899987442222566689999988854344 567766542    389999


Q ss_pred             cCCC
Q 003065          753 MPNG  756 (851)
Q Consensus       753 ~~~g  756 (851)
                      ++|.
T Consensus       154 l~G~  157 (429)
T 1nw1_A          154 IPSR  157 (429)
T ss_dssp             CCEE
T ss_pred             eCCc
Confidence            9863

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.06  E-value=0.002  Score=68.61  Aligned_cols=143  Identities=17%  Similarity=0.188  Sum_probs=82.1

Q ss_pred             CeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCc--cccEEEE-----EEeCCeeEEEEecc
Q 003065          682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRN--ILKLYAC-----LLKGGSSFLVLEYM  753 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~  753 (851)
                      +.++ |....||++.. .+|+.+++|+.... .....+..|..+++.+....  +++++..     ...++..++||||+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4466 77789998765 34567999988643 34567778888888774222  3333332     23356778999999


Q ss_pred             CCCCHH-----H------H---HHHhhhC----CCCCCCHHHHH----HH---------------HHHHHHHHHHHHhC-
Q 003065          754 PNGNLF-----Q------A---LHKRVKE----GKPELDWFRRY----KI---------------ALGAAKGIAYLHHD-  795 (851)
Q Consensus       754 ~~gsL~-----~------~---l~~~~~~----~~~~l~~~~~~----~i---------------~~~i~~~l~~LH~~-  795 (851)
                      +|..+.     .      .   ++.....    .....++....    .+               ...+.+.++.+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            874321     1      1   1211111    01122222110    00               01111223333211 


Q ss_pred             ---CCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          796 ---CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       796 ---~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                         ....++|+|+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               245689999999999999 4 899999988754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.99  E-value=0.0012  Score=69.36  Aligned_cols=71  Identities=15%  Similarity=0.111  Sum_probs=45.3

Q ss_pred             cCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc-HHHHHHHHHHHHcCCCCcc-ccEEEEEEeCCeeEEEEecc-CCC
Q 003065          680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-VKVFAAEMEILGKIRHRNI-LKLYACLLKGGSSFLVLEYM-PNG  756 (851)
Q Consensus       680 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g  756 (851)
                      -.+.|+.|....+|++      ..+++|+...... .....+|+.+++.+....+ +++++..  .+.-++|+||+ +|.
T Consensus        22 ~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             SCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             ceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            3678889999999998      4688887654311 1123568888887753333 4566543  33357899999 654


Q ss_pred             CH
Q 003065          757 NL  758 (851)
Q Consensus       757 sL  758 (851)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.92  E-value=0.00016  Score=69.89  Aligned_cols=61  Identities=15%  Similarity=0.134  Sum_probs=27.9

Q ss_pred             CCCCeEecCCCcceeeCC----cccccCCCCcEEeccCcc---ccC----CCccccccCCcccEEEecCCcc
Q 003065          433 TSLSQLVLQNNRFSGELP----SELGRLTNLERLILTNNN---FSG----KIPSALGALRQLSSLHLEENAL  493 (851)
Q Consensus       433 ~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~---l~~----~~p~~~~~l~~L~~L~Ls~N~l  493 (851)
                      +.|+.|+|++|+|+..--    +.+..-+.|++|+|++|.   +..    .+...+..-+.|+.|+++.|.+
T Consensus        98 ~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A           98 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             CccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            445555555555543221    222233456666665442   221    1222334445666666665554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.84  E-value=0.0042  Score=66.24  Aligned_cols=144  Identities=14%  Similarity=0.137  Sum_probs=74.3

Q ss_pred             CeecccCcEE-EEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCC--CccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          682 NLIGSGGTGK-VYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH--RNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       682 ~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      +.++.|+... +|+... .+++.+++|...... ...+..|+++++.+..  -.+++++.+....+  ++|||++.+..+
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l   99 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF   99 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence            3455554444 667653 235677777653321 1334567777777642  23556676543333  789999977777


Q ss_pred             HHHHHHhhh------------------C---CCCCCCHHHHH---------H-----------HHHHHHHHHHHHHh---
Q 003065          759 FQALHKRVK------------------E---GKPELDWFRRY---------K-----------IALGAAKGIAYLHH---  794 (851)
Q Consensus       759 ~~~l~~~~~------------------~---~~~~l~~~~~~---------~-----------i~~~i~~~l~~LH~---  794 (851)
                      .+++.....                  .   ..+.++.....         .           ....+...++.+..   
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~  179 (333)
T 3csv_A          100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL  179 (333)
T ss_dssp             HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence            655432100                  0   01112211100         0           00111122233311   


Q ss_pred             CCCCCcEEeCCCCCCEEECCC----CceEEeeecCcccc
Q 003065          795 DCSPPIIHRDIKSSNILLDED----YEPKIADFGVAKIA  829 (851)
Q Consensus       795 ~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~  829 (851)
                      .....++|+|+.+.||+++.+    +.+.|+||+.+...
T Consensus       180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            124689999999999999874    67999999988643

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.83  E-value=0.0015  Score=58.89  Aligned_cols=62  Identities=26%  Similarity=0.326  Sum_probs=38.8

Q ss_pred             eeeccCcccc-cccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCccc
Q 003065          509 DLNLARNSLS-GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDF  572 (851)
Q Consensus       509 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~~  572 (851)
                      .++.+++.|+ ..+|..+.  .+|+.|+|++|+|+..-+..|..+ .|+.|+|++|+|.|++-..|
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~   75 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVP   75 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHH
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHH
Confidence            4555555554 23443322  257778888888874333445666 78888888888888876543

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.78  E-value=0.00029  Score=68.17  Aligned_cols=89  Identities=10%  Similarity=0.156  Sum_probs=60.1

Q ss_pred             ccCCCCCeEecCCCcceeeCCcc----cccCCCCcEEeccCccccCC----CccccccCCcccEEEecCC---cccC---
Q 003065          430 GLSTSLSQLVLQNNRFSGELPSE----LGRLTNLERLILTNNNFSGK----IPSALGALRQLSSLHLEEN---ALTG---  495 (851)
Q Consensus       430 ~~~~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~---  495 (851)
                      ..-+.|+.|+|++|+|.......    +..-+.|+.|+|++|.|+..    +-.++..-+.|+.|+|++|   .+..   
T Consensus        67 ~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~  146 (197)
T 1pgv_A           67 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE  146 (197)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred             hhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHH
Confidence            34467888888888886443333    34458899999999999743    2334555677999999865   3332   


Q ss_pred             -CCCCCcccccccceeeccCcccc
Q 003065          496 -SIPNEMGDCARIVDLNLARNSLS  518 (851)
Q Consensus       496 -~~p~~~~~l~~L~~L~Ls~N~l~  518 (851)
                       .+...+..-+.|+.|+++.|.+.
T Consensus       147 ~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          147 MDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHHHhCCCcCeEeccCCCcc
Confidence             13334455678999999888654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.74  E-value=0.0031  Score=68.23  Aligned_cols=144  Identities=17%  Similarity=0.184  Sum_probs=82.4

Q ss_pred             CCeecccCcEEEEEEEEcC-------CCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCc-cccEEEEEEeCCeeEEEEe
Q 003065          681 DNLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRN-ILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  751 (851)
                      .+.+..|-...+|++....       +++.|++|+.-.. .......+|.++++.+.... .+++++++..    .+|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            3456678788899988742       3467999985322 24566779999998885333 3557766543    28999


Q ss_pred             ccCCCCHH--------------HHHHHhhhCC---CCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 003065          752 YMPNGNLF--------------QALHKRVKEG---KPELD--WFRRYKIALGAA-------------------KGIAYLH  793 (851)
Q Consensus       752 ~~~~gsL~--------------~~l~~~~~~~---~~~l~--~~~~~~i~~~i~-------------------~~l~~LH  793 (851)
                      |++|..+.              +.+.+-....   .....  +.++.++..++.                   ..+.++.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            99875432              1111111100   11122  333333333321                   1233332


Q ss_pred             h-----CCCCCcEEeCCCCCCEEECCC----CceEEeeecCccc
Q 003065          794 H-----DCSPPIIHRDIKSSNILLDED----YEPKIADFGVAKI  828 (851)
Q Consensus       794 ~-----~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~  828 (851)
                      .     .....++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            1     123479999999999999876    7899999998863

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.50  E-value=0.0038  Score=56.30  Aligned_cols=56  Identities=25%  Similarity=0.340  Sum_probs=35.9

Q ss_pred             EEEecCCccc-CCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccc
Q 003065          485 SLHLEENALT-GSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT  542 (851)
Q Consensus       485 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  542 (851)
                      .++.+++.|+ ..+|..+.  .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5566666664 24443332  34667777777777555566777777888888888775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.32  E-value=0.0075  Score=67.03  Aligned_cols=73  Identities=15%  Similarity=0.123  Sum_probs=47.1

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCCCCcc-ccEEEEEEeCCeeEEEEeccCCCC
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNI-LKLYACLLKGGSSFLVLEYMPNGN  757 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs  757 (851)
                      .+.|+.|-...+|++.....+..+++|+..... ..-+..+|..+++.+...++ +++++++.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            456788888999999875435778899764321 11112589999998865445 45777763  2  25999998743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.11  E-value=0.005  Score=66.70  Aligned_cols=72  Identities=17%  Similarity=0.147  Sum_probs=43.2

Q ss_pred             CeecccCcEEEEEEEEcC--------CCcEEEEEEeccccc-HHHHHHHHHHHHcCCCCc-cccEEEEEEeCCeeEEEEe
Q 003065          682 NLIGSGGTGKVYRLDLKK--------NAGTVAVKQLWKGDG-VKVFAAEMEILGKIRHRN-ILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  751 (851)
                      +.++.|....+|++....        .++.+++|+...... ......|.++++.+.... ++++++.+  .  -++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            456778888999998643        126788887643311 112357888888875333 44676554  2  268999


Q ss_pred             ccCCCC
Q 003065          752 YMPNGN  757 (851)
Q Consensus       752 ~~~~gs  757 (851)
                      |++|..
T Consensus       115 ~i~G~~  120 (369)
T 3c5i_A          115 WLYGDP  120 (369)
T ss_dssp             CCCSEE
T ss_pred             EecCCc
Confidence            998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.66  E-value=0.037  Score=58.99  Aligned_cols=32  Identities=22%  Similarity=0.357  Sum_probs=28.2

Q ss_pred             CCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       797 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                      ...++|+|+.+.||+++.++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35799999999999999888899999988754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.05  E-value=0.09  Score=57.55  Aligned_cols=72  Identities=13%  Similarity=0.098  Sum_probs=46.0

Q ss_pred             CeecccCcEEEEEEEEcCC-------CcEEEEEEecccc-cHHHHHHHHHHHHcCCCCc-cccEEEEEEeCCeeEEEEec
Q 003065          682 NLIGSGGTGKVYRLDLKKN-------AGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRN-ILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~  752 (851)
                      +.+..|-...+|++.....       ++.|++|+..... ..-+..+|.++++.+.... .+++++.+  .  -++||||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence            4566677788999887421       5778898764321 1112357888888885333 34566533  2  2789999


Q ss_pred             cCCCC
Q 003065          753 MPNGN  757 (851)
Q Consensus       753 ~~~gs  757 (851)
                      ++|..
T Consensus       152 I~G~~  156 (424)
T 3mes_A          152 IDGEP  156 (424)
T ss_dssp             CCSEE
T ss_pred             eCCcc
Confidence            98865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=90.39  E-value=0.42  Score=51.99  Aligned_cols=30  Identities=30%  Similarity=0.430  Sum_probs=25.0

Q ss_pred             CcEEeCCCCCCEEE------CCCCceEEeeecCccc
Q 003065          799 PIIHRDIKSSNILL------DEDYEPKIADFGVAKI  828 (851)
Q Consensus       799 ~ivHrDlkp~NILl------~~~~~~kl~DFGla~~  828 (851)
                      .++|+|+.+.||++      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4456799999998853

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	851
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-42
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-41
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-40
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-40
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-40
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-39
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-39
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-38
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-38
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-37
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-37
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-37
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-37
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-37
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-36
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-35
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-33
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-31
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-31
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-31
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-29
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-29
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-28
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-26
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-25
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-25
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-25
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-14
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-23
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.001
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-08
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-10
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-16
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.001
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	8e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	6e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 5e-44
 Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 15/178 (8%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRN 732
            +     IGSG  G VY+       G VAVK L         ++ F  E+ +L K RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           IL             +V ++    +L+  LH      + + +  +   IA   A+G+ YL
Sbjct: 66  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYL 120

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H      IIHRD+KS+NI L ED   KI DFG+A +         +   +G+  ++AP
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 7e-42
 Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 14/177 (7%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNI 733
           + E+ + +G+G  G V+++  K +   +A K +              E+++L +     I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           +  Y      G   + +E+M  G+L Q L K  +     +      K+++   KG+ YL 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLR 121

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                 I+HRD+K SNIL++   E K+ DFGV+    +S   S    F GT  Y++P
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSP 172

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 6e-41
 Identities = 45/182 (24%), Positives = 87/182 (47%), Gaps = 11/182 (6%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRN 732
           + E    IG+G  G+  ++  K +   +  K+L  G       ++  +E+ +L +++H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 733 ILKLYACLL--KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
           I++ Y  ++     + ++V+EY   G+L   + K  KE +  LD     ++       + 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALK 123

Query: 791 YLH--HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
             H   D    ++HRD+K +N+ LD     K+ DFG+A+I  +    +    F GT  Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYM 181

Query: 849 AP 850
           +P
Sbjct: 182 SP 183

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-40
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 14/175 (8%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKL 736
            L+    IG G  G V   D + N   VAVK +      + F AE  ++ ++RH N+++L
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 737 Y-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
               + + G  ++V EYM  G+L   L  R   G+  L      K +L   + + YL   
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                +HRD+ + N+L+ ED   K++DFG+ K A      S          + AP
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAP 169

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 3e-40
 Identities = 47/175 (26%), Positives = 90/175 (51%), Gaps = 10/175 (5%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILK 735
            L+    +G+G  G+V+      +   VAVK L +G      F AE  ++ +++H+ +++
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           LYA + +    +++ EYM NG+L   L         +L   +   +A   A+G+A++   
Sbjct: 73  LYAVVTQEPI-YIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIE-- 126

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                IHRD++++NIL+ +    KIADFG+A++ E++ + +          + AP
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAP 179

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 9e-40
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 19/177 (10%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNI 733
            +   IG G  G VY     +N+  VA+K++        +  +    E+  L K+RH N 
Sbjct: 18  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           ++   C L+  +++LV+EY            +       L       +  GA +G+AYLH
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLH 132

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              S  +IHRD+K+ NILL E    K+ DFG A I   +      + F GT  ++AP
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAP 180

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 15/190 (7%)

Query: 665 FHHI--DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAA 720
           + H+  D++ E    +     +G G  GKVY+   K+ +   A K +       ++ +  
Sbjct: 1   YEHVTRDLNPEDFWEIIG--ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV 58

Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
           E++IL    H NI+KL        + ++++E+   G +   + +     +  L   +   
Sbjct: 59  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTESQIQV 114

Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
           +       + YLH      IIHRD+K+ NIL   D + K+ADFGV+     +  +     
Sbjct: 115 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDS 169

Query: 841 FAGTHGYIAP 850
           F GT  ++AP
Sbjct: 170 FIGTPYWMAP 179

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-39
 Identities = 49/177 (27%), Positives = 75/177 (42%), Gaps = 11/177 (6%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNI 733
           + +    +G G  G+V     +     VAVK +      D  +    E+ I   + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           +K Y    +G   +L LEY   G LF  +   +      +      +       G+ YLH
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 120

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                 I HRDIK  N+LLDE    KI+DFG+A +   + +    +   GT  Y+AP
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 5e-39
 Identities = 58/179 (32%), Positives = 81/179 (45%), Gaps = 17/179 (9%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHR 731
           + E    +G G  G VY    K++   +A+K L+K              E+EI   +RH 
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           NIL+LY         +L+LEY P G +++ L K  K      D  R        A  ++Y
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSY 121

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            H   S  +IHRDIK  N+LL    E KIADFG +  A +S      +   GT  Y+ P
Sbjct: 122 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 173

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (363), Expect = 8e-39
 Identities = 46/186 (24%), Positives = 83/186 (44%), Gaps = 16/186 (8%)

Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG---DGVKVFAAEMEILGK 727
            I  ++ + +IG+G  G+V    LK        VA+K L  G      + F +E  I+G+
Sbjct: 24  DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83

Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
             H N++ L   + K     ++ E+M NG+L   L +   +        +   +  G A 
Sbjct: 84  FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAA 139

Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS---CFAGT 844
           G+ YL        +HRD+ + NIL++ +   K++DFG+++  E+      Y+        
Sbjct: 140 GMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 845 HGYIAP 850
             + AP
Sbjct: 197 IRWTAP 202

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (360), Expect = 2e-38
 Identities = 44/175 (25%), Positives = 84/175 (48%), Gaps = 8/175 (4%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-VKVFAAEMEILGKIRHRNILK 735
           ++   + +G G  G+VY    KK + TVAVK L +    V+ F  E  ++ +I+H N+++
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           L     +    +++ E+M  GNL   L +     + E+       +A   +  + YL   
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE-- 132

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                IHRD+ + N L+ E++  K+ADFG++++       + ++       + AP
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAP 185

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-38
 Identities = 58/185 (31%), Positives = 87/185 (47%), Gaps = 22/185 (11%)

Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA-AEMEILGKIRHRNILKL 736
           L+E   IG G  G+V+R   +     VAVK     +    F  AE+     +RH NIL  
Sbjct: 7   LQE--SIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 62

Query: 737 YACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
            A   K   +    +LV +Y  +G+LF  L++        +      K+AL  A G+A+L
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHL 116

Query: 793 HHDC-----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC--FAGTH 845
           H +       P I HRD+KS NIL+ ++    IAD G+A   +++    D +     GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 846 GYIAP 850
            Y+AP
Sbjct: 177 RYMAP 181

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 5e-38
 Identities = 49/182 (26%), Positives = 70/182 (38%), Gaps = 19/182 (10%)

Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNI 733
           L+ D  IG G    VY+    +    VA  +L          + F  E E+L  ++H NI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 734 LKLYACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
           ++ Y              LV E M +G L   L +        +             KG+
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGL 125

Query: 790 AYLHHDCSPPIIHRDIKSSNILL-DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
            +LH    PPIIHRD+K  NI +       KI D G+A +   S          GT  ++
Sbjct: 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFM 180

Query: 849 AP 850
           AP
Sbjct: 181 AP 182

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 7e-38
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 28/203 (13%)

Query: 665 FHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG--TVAVKQLWKG---DGVKVFA 719
           +  +D +     +++  ++IG G  G+V +  +KK+      A+K++ +    D  + FA
Sbjct: 4   YPVLDWN-----DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58

Query: 720 AEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----------VK 767
            E+E+L K+  H NI+ L       G  +L +EY P+GNL   L K              
Sbjct: 59  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118

Query: 768 EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
                L   +    A   A+G   + +      IHRD+ + NIL+ E+Y  KIADFG+++
Sbjct: 119 STASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 175

Query: 828 IAENSPKVSDYSCFAGTHGYIAP 850
             E   K    +       ++A 
Sbjct: 176 GQEVYVK---KTMGRLPVRWMAI 195

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-37
 Identities = 47/201 (23%), Positives = 78/201 (38%), Gaps = 30/201 (14%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT-----VAVKQLWKG---DGVKVFAAEMEILGKI 728
           NLE   ++GSG  GKV        + T     VAVK L +       +   +E++++ ++
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK------------------EG 769
             H NI+ L       G  +L+ EY   G+L   L  + +                  E 
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
              L +      A   AKG+ +L        +HRD+ + N+L+      KI DFG+A+  
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 830 ENSPKVSDYSCFAGTHGYIAP 850
            +               ++AP
Sbjct: 215 MSDSNYVVRGNARLPVKWMAP 235

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-37
 Identities = 52/196 (26%), Positives = 81/196 (41%), Gaps = 25/196 (12%)

Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
            L     +G+G  GKV       L     A TVAVK L         +   +E+++L  +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-------------VKEGKPELD 774
             H NI+ L      GG + ++ EY   G+L   L ++             +++ +  LD
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
                  +   AKG+A+L    S   IHRD+ + NILL      KI DFG+A+  +N   
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 835 VSDYSCFAGTHGYIAP 850
                       ++AP
Sbjct: 201 YVVKGNARLPVKWMAP 216

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-37
 Identities = 40/177 (22%), Positives = 77/177 (43%), Gaps = 14/177 (7%)

Query: 680 EDNLIGSGGTGKVYR--LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNIL 734
            D  +G G  G V +    ++K    VA+K L +G      +    E +I+ ++ +  I+
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
           +L     +  +  LV+E    G L + L  +    + E+      ++    + G+ YL  
Sbjct: 73  RLIGVC-QAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE 127

Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
                 +HRD+ + N+LL   +  KI+DFG++K +  +    +  S       + AP
Sbjct: 128 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-37
 Identities = 38/182 (20%), Positives = 75/182 (41%), Gaps = 13/182 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID +   +L     +G+G  G V     +     VA+K + +G      F  E +++  +
Sbjct: 1   IDPK---DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNL 56

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY    K    F++ EYM NG L   L +     +      +  ++     + 
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEA 112

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           + YL        +HRD+ + N L+++    K++DFG+++   +    S          + 
Sbjct: 113 MEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWS 168

Query: 849 AP 850
            P
Sbjct: 169 PP 170

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-37
 Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 13/182 (7%)

Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
           ID      L     IGSG  G V+          VA+K + +G    + F  E E++ K+
Sbjct: 2   IDPS---ELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIEEAEVMMKL 57

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            H  +++LY   L+     LV E+M +G L   L  +    +          + L   +G
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEG 113

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
              + +     +IHRD+ + N L+ E+   K++DFG+ +   +  + +  +       + 
Sbjct: 114 ---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWA 169

Query: 849 AP 850
           +P
Sbjct: 170 SP 171

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (351), Expect = 4e-37
 Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 30/201 (14%)

Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKI 728
           N+E    IG G  G+V++     L   +    VAVK L +    D    F  E  ++ + 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-------------------VKEG 769
            + NI+KL      G    L+ EYM  G+L + L                         G
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
            P L    +  IA   A G+AYL        +HRD+ + N L+ E+   KIADFG+++  
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 830 ENSPKVSDYSCFAGTHGYIAP 850
            ++         A    ++ P
Sbjct: 191 YSADYYKADGNDAIPIRWMPP 211

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-37
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 10/175 (5%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILK 735
           +L  +  +G G  G+V+          VA+K L  G    + F  E +++ K+RH  +++
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
           LYA +      ++V EYM  G+L   L          L   +   +A   A G+AY+   
Sbjct: 77  LYAVV-SEEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
                +HRD++++NIL+ E+   K+ADFG+A++ E++ + +          + AP
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAP 183

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 8e-37
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 13/179 (7%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHR 731
           + +   ++G G    V        +   A+K L K      + V     E +++ ++ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
             +KLY         +  L Y  NG L + + K    G  +    R Y      A+ ++ 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFY-----TAEIVSA 120

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           L +     IIHRD+K  NILL+ED   +I DFG AK+     K +  + F GT  Y++P
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 4e-36
 Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 16/178 (8%)

Query: 680 EDNLIGSGGTGKVYR--LDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNI 733
           ED  +GSG  G V +    +KK   TVAVK L              AE  ++ ++ +  I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
           +++     +  S  LV+E    G L + L +        +      ++    + G+ YL 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLE 124

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
                  +HRD+ + N+LL   +  KI+DFG++K +  +       +       + AP
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 9e-36
 Identities = 53/198 (26%), Positives = 81/198 (40%), Gaps = 17/198 (8%)

Query: 662 LASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG---DGV 715
           + +  H+ I    +  +  + +IG G  G VY   L  N G     AVK L +      V
Sbjct: 14  VQAVQHVVIGPSSL-IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 72

Query: 716 KVFAAEMEILGKIRHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELD 774
             F  E  I+    H N+L L   CL   GS  +VL YM +G+L   +            
Sbjct: 73  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPT 128

Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
                   L  AKG   +    S   +HRD+ + N +LDE +  K+ADFG+A+   +   
Sbjct: 129 VKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185

Query: 835 VSDYSC--FAGTHGYIAP 850
            S ++         ++A 
Sbjct: 186 DSVHNKTGAKLPVKWMAL 203

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-35
 Identities = 49/190 (25%), Positives = 90/190 (47%), Gaps = 18/190 (9%)

Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKG---DGVKVFAAE 721
           +I    +       +IG+G  G+VY+  LK ++G     VA+K L  G        F  E
Sbjct: 3   EIHPSCV---TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59

Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
             I+G+  H NI++L   + K     ++ EYM NG L + L ++      E    +   +
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGM 115

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC- 840
             G A G+    +  +   +HRD+ + NIL++ +   K++DFG++++ E+ P+ +  +  
Sbjct: 116 LRGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 841 FAGTHGYIAP 850
                 + AP
Sbjct: 173 GKIPIRWTAP 182

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  131 bits (331), Expect = 5e-34
 Identities = 37/203 (18%), Positives = 77/203 (37%), Gaps = 15/203 (7%)

Query: 653 EKEVSSKWKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK 711
           +  V   WK      ++I  + + +  +    +G+G  G V+R+  +      A K +  
Sbjct: 2   DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61

Query: 712 GD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG 769
                 +    E++ +  +RH  ++ L+          ++ E+M  G LF+ +       
Sbjct: 62  PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---- 117

Query: 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPKIADFGVAK 827
             ++      +      KG+ ++H +     +H D+K  NI+       E K+ DFG+  
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 174

Query: 828 IAENSPKVSDYSCFAGTHGYIAP 850
             +            GT  + AP
Sbjct: 175 HLDPKQS---VKVTTGTAEFAAP 194

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-33
 Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 13/171 (7%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYAC 739
             IG G +G VY          VA++Q+        ++   E+ ++ + ++ NI+     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
            L G   ++V+EY+  G+L   + +         D  +   +     + + +LH   S  
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLH---SNQ 136

Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +IHRDIKS NILL  D   K+ DFG     + +P+ S  S   GT  ++AP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 185

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-33
 Identities = 40/179 (22%), Positives = 75/179 (41%), Gaps = 15/179 (8%)

Query: 679 EEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHR 731
           ++  ++GSG  G VY+     + +K    VA+K+L +       K    E  ++  + + 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           ++ +L    L   +  L+ + MP G L   + +     K  +         +  AKG+ Y
Sbjct: 72  HVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNY 126

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           L       ++HRD+ + N+L+      KI DFG+AK+     K            ++A 
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  130 bits (327), Expect = 2e-33
 Identities = 40/207 (19%), Positives = 75/207 (36%), Gaps = 15/207 (7%)

Query: 649 MENGEKEVSSKWKLASFHHIDIDAEQICNL-EEDNLIGSGGTGKVYRLDLKKNAGTVAVK 707
           + + +K     WK      +++    + +  +    +GSG  G V+R   K        K
Sbjct: 1   INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60

Query: 708 QLWKGDGV--KVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR 765
            +     +       E+ I+ ++ H  ++ L+          L+LE++  G LF  +   
Sbjct: 61  FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE 120

Query: 766 VKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP--KIADF 823
                 ++           A +G+ ++H      I+H DIK  NI+ +       KI DF
Sbjct: 121 ----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDF 173

Query: 824 GVAKIAENSPKVSDYSCFAGTHGYIAP 850
           G+A                 T  + AP
Sbjct: 174 GLATKLNPD---EIVKVTTATAEFAAP 197

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 4e-33
 Identities = 52/183 (28%), Positives = 79/183 (43%), Gaps = 17/183 (9%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWK-----GDGVKVFAAEMEILGKI 728
           +L     +G G  G V R +    +G    VAVK L        + +  F  E+  +  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
            HRN+++LY  +L      +V E  P G+L   L K   +G   L    RY  A+  A+G
Sbjct: 69  DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRY--AVQVAEG 123

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGY 847
           + YL    S   IHRD+ + N+LL      KI DFG+ + + +N               +
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 848 IAP 850
            AP
Sbjct: 181 CAP 183

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-33
 Identities = 36/187 (19%), Positives = 73/187 (39%), Gaps = 16/187 (8%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
            +     +G G  G VY    K     +    VA+K + +         F  E  ++ + 
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK-----EGKPELDWFRRYKIAL 783
              ++++L   + +G  + +++E M  G+L   L                   +  ++A 
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
             A G+AYL    +   +HRD+ + N ++ ED+  KI DFG+ +    +           
Sbjct: 141 EIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 844 THGYIAP 850
              +++P
Sbjct: 198 PVRWMSP 204

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 1e-32
 Identities = 56/215 (26%), Positives = 83/215 (38%), Gaps = 35/215 (16%)

Query: 657 SSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWK 711
           +SKW        +   +    L+    +G G  G+V       +D      TVAVK L +
Sbjct: 5   ASKW--------EFPRD---RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE 53

Query: 712 G---DGVKVFAAEMEILGKIRHRNILKLY--ACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
           G      +   +E++IL  I H   +     AC   GG   +++E+   GNL   L  + 
Sbjct: 54  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 113

Query: 767 KEGKPE-----------LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED 815
            E  P            L        +   AKG+ +L    S   IHRD+ + NILL E 
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 170

Query: 816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
              KI DFG+A+     P             ++AP
Sbjct: 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 205

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  122 bits (308), Expect = 1e-31
 Identities = 54/186 (29%), Positives = 74/186 (39%), Gaps = 23/186 (12%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----------FAAEMEIL 725
           N E   ++G G +  V R   K      AVK +    G                 E++IL
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 726 GKIR-HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG 784
            K+  H NI++L          FLV + M  G LF  L ++V      L      KI   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRA 118

Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
             + I  LH      I+HRD+K  NILLD+D   K+ DFG +   +            GT
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGT 172

Query: 845 HGYIAP 850
             Y+AP
Sbjct: 173 PSYLAP 178

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 15/179 (8%)

Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRH 730
            +E    IG G  G V++   +  +  A  VA+K           + F  E   + +  H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
            +I+KL   + +    ++++E    G L   L  R       LD       A   +  +A
Sbjct: 68  PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALA 122

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
           YL    S   +HRDI + N+L+  +   K+ DFG+++  E+S      S       ++A
Sbjct: 123 YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMA 177

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  124 bits (312), Expect = 2e-31
 Identities = 40/181 (22%), Positives = 72/181 (39%), Gaps = 20/181 (11%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAE---MEILGKI 728
           +     +IG GG G+VY           A+K L K       G  +   E   + ++   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
               I+ +            +L+ M  G+L   L +     + ++ ++           G
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-----IILG 119

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
           + ++H   +  +++RD+K +NILLDE    +I+D G+A                GTHGY+
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYM 172

Query: 849 A 849
           A
Sbjct: 173 A 173

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 6e-31
 Identities = 50/196 (25%), Positives = 80/196 (40%), Gaps = 25/196 (12%)

Query: 677 NLEEDNLIGSGGTGKVYR-------LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILG 726
            L     +G G  G+V          D       VAVK L        +    +EME++ 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 727 KI-RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELD 774
            I +H+NI+ L     + G  ++++EY   GNL + L  R   G           + +L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
                  A   A+G   + +  S   IHRD+ + N+L+ ED   KIADFG+A+   +   
Sbjct: 134 SKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 835 VSDYSCFAGTHGYIAP 850
               +       ++AP
Sbjct: 191 YKKTTNGRLPVKWMAP 206

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (303), Expect = 9e-31
 Identities = 41/172 (23%), Positives = 73/172 (42%), Gaps = 11/172 (6%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYA 738
           +++G+G   +V   + K+    VA+K + K            E+ +L KI+H NI+ L  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
               GG  +L+++ +  G LF  + ++              ++       + YLH     
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKGF-----YTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
               +        LDED +  I+DFG++K+ +        S   GT GY+AP
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP 178

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 1e-30
 Identities = 40/171 (23%), Positives = 67/171 (39%), Gaps = 13/171 (7%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
            +G G  G V+R     +  T   K +  KG    +   E+ IL   RHRNIL L+    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
                 ++ E++   ++F+ ++        EL+            + + +LH   S  I 
Sbjct: 72  SMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLH---SHNIG 124

Query: 802 HRDIKSSNILLD--EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H DI+  NI+         KI +FG A+  +      ++        Y AP
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAP 172

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 1e-30
 Identities = 55/180 (30%), Positives = 80/180 (44%), Gaps = 16/180 (8%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGK-IRH 730
           +     ++G G  GKV+  + KK     A+K L K      D V+    E  +L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
             +  ++       + F V+EY+  G+L   +    K      D  R    A     G+ 
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQ 117

Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           +L    S  I++RD+K  NILLD+D   KIADFG+ K  EN    +  + F GT  YIAP
Sbjct: 118 FL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAP 172

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (301), Expect = 2e-30
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 18/179 (10%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHR 731
           + +    +G+G  G+V+ +  + N    A+K L K        V+    E  +L  + H 
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
            I++++         F++++Y+  G LF  L K  +         + Y   +        
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEV-----CLA 116

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           L +  S  II+RD+K  NILLD++   KI DFG AK   +           GT  YIAP
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAP 170

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-30
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 9/173 (5%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYA 738
           + IG G  G V       N   VA+K++   +     +    E++IL + RH NI+ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
            +       +   Y+    +   L+K +K     L             +G+ Y+H   S 
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SA 128

Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIA-ENSPKVSDYSCFAGTHGYIAP 850
            ++HRD+K SN+LL+   + KI DFG+A++A  +       + +  T  Y AP
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 17/179 (9%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHR 731
           E+ + +G G    VY+   K     VA+K++  G          +    E+++L ++ H 
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
           NI+ L        +  LV ++M                       + Y +       +  
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMT-----LQG 112

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           L +     I+HRD+K +N+LLDE+   K+ADFG+AK   +  +   Y+    T  Y AP
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAP 169

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-29
 Identities = 52/179 (29%), Positives = 76/179 (42%), Gaps = 17/179 (9%)

Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYA 738
            +  +IG+G  G VY+  L  +   VA+K++ +    +    E++I+ K+ H NI++L  
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRY 80

Query: 739 CLLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
                G         LVL+Y+P      A H    +    L             + +AY+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMYQLFRSLAYI 138

Query: 793 HHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  I HRDIK  N+LLD D    K+ DFG AK          Y C      Y AP
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYRAP 191

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 5e-29
 Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 15/179 (8%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHR 731
           + +   L+G G  GKV  +  K      A+K L K      D V     E  +L   RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
            +  L            V+EY   G LF  L +     +    ++         A+ ++ 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--------GAEIVSA 117

Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           L +  S  +++RDIK  N++LD+D   KI DFG+ K   +        C  GT  Y+AP
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAP 174

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  114 bits (286), Expect = 9e-29
 Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 18/178 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
           ++G GG  +V+     +    VAVK L             F  E +    + H  I+ +Y
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 738 ACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
                    G   ++V+EY+    L   +H         +   R  ++   A + + +  
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFS- 127

Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAP 850
                 IIHRD+K +NI++      K+ DFG+A+ IA++   V+  +   GT  Y++P
Sbjct: 128 --HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-28
 Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 23/180 (12%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRNIL 734
            +GSG    V +   K      A K + K        G   +    E+ IL +I+H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
            L+          L+LE +  G LF  L ++        +    +       + +  +++
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEF-----LKQILNGVYY 128

Query: 795 DCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             S  I H D+K  NI+L +   P    KI DFG+A   +     +++    GT  ++AP
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAP 185

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 4e-28
 Identities = 38/173 (21%), Positives = 65/173 (37%), Gaps = 14/173 (8%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACL- 740
           ++G G  GKV ++  K+     A+K L           E+E+  +  +  +I+++     
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML---QDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 741 ---LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
                     +V+E +  G LF  +  R   G          +I     + I YLH   S
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---S 129

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             I HRD+K  N+L        I        A+ +   +  +    T  Y+AP
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-26
 Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 13/178 (7%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRN 732
           N ++   IG G  G VY+   K     VA+K++               E+ +L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           I+KL   +      +LV E++ + +L + +      G   +             +G+A+ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC 118

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
               S  ++HRD+K  N+L++ +   K+ADFG+A+       V  Y+    T  Y AP
Sbjct: 119 ---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-26
 Identities = 42/183 (22%), Positives = 77/183 (42%), Gaps = 22/183 (12%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLY 737
             IG G  G+V++   +K    VA+K++               E++IL  ++H N++ L 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 738 AC--------LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
                         GS +LV ++  +       +      K  L   +R    L     +
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQML-----L 127

Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI--AENSPKVSDYSCFAGTHGY 847
             L++     I+HRD+K++N+L+  D   K+ADFG+A+      + + + Y+    T  Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 848 IAP 850
             P
Sbjct: 188 RPP 190

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-26
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 22/179 (12%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--------DGVKVFAAEMEILGKIR--HRN 732
           L+GSGG G VY      +   VA+K + K                 E+ +L K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
           +++L     +  S  L+LE                  +  L             + + + 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC 126

Query: 793 HHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
               +  ++HRDIK  NIL+D +  E K+ DFG   + +++     Y+ F GT  Y  P
Sbjct: 127 ---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPP 178

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 7e-26
 Identities = 44/189 (23%), Positives = 77/189 (40%), Gaps = 19/189 (10%)

Query: 675 ICNLEED----NLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKGDGVKVFA-------AEM 722
           +C  ++       IG G  GKV++    KN G  VA+K++    G +          A +
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKI 781
             L    H N+++L+       +       +   ++ Q       K  +P +       +
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
                +G+ +LH   S  ++HRD+K  NIL+    + K+ADFG+A+I          +  
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSV 175

Query: 842 AGTHGYIAP 850
             T  Y AP
Sbjct: 176 VVTLWYRAP 184

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  104 bits (259), Expect = 4e-25
 Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 13/164 (7%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLY 737
             IG G  G VY+        T A+K++               E+ IL +++H NI+KLY
Sbjct: 8   EKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
             +       LV E++                +  L+        L    GIAY H    
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCH---D 118

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
             ++HRD+K  N+L++ + E KIADFG+A+      +   +   
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  104 bits (259), Expect = 4e-25
 Identities = 29/179 (16%), Positives = 55/179 (30%), Gaps = 19/179 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN-ILKLYACLL 741
            IG G  G ++      N   VA+K   +         E      +     I  +Y    
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +G  + LV++ +            +     +         A      +  +H      ++
Sbjct: 72  EGLHNVLVIDLLGPSL-----EDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123

Query: 802 HRDIKSSNILLDEDYEP-----KIADFGVAKIAENSPKVS-----DYSCFAGTHGYIAP 850
           +RDIK  N L+            + DFG+ K   +          +    +GT  Y++ 
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  104 bits (259), Expect = 5e-25
 Identities = 36/177 (20%), Positives = 57/177 (32%), Gaps = 17/177 (9%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILK-LYACLL 741
            IGSG  G +Y          VA+K             E +I   ++    +  +  C  
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73

Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
           +G  + +V+E +                  +        +A      I Y+H   S   I
Sbjct: 74  EGDYNVMVMELLGPSLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIH---SKNFI 125

Query: 802 HRDIKSSNIL---LDEDYEPKIADFGVAKIAENSPKVSDY-----SCFAGTHGYIAP 850
           HRD+K  N L     +     I DFG+AK   ++               GT  Y + 
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 8e-25
 Identities = 40/173 (23%), Positives = 74/173 (42%), Gaps = 14/173 (8%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLY 737
             IG G  G V++   ++    VA+K++   D           E+ +L +++H+NI++L+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
             L       LV E+                G  + +  + +       + +  L    S
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSF-----LFQLLKGLGFCHS 119

Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
             ++HRD+K  N+L++ + E K+A+FG+A+       V  YS    T  Y  P
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPP 170

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  103 bits (257), Expect = 9e-25
 Identities = 71/306 (23%), Positives = 114/306 (37%), Gaps = 35/306 (11%)

Query: 32  ETQALIQFKSKLKDPHGVLDSWKESADSPCGFS--GITCD--SVTGRVTEISFDNKSLSG 87
           + QAL+Q K  L +P   L SW  + D  C  +  G+ CD  + T RV  +     +L  
Sbjct: 7   DKQALLQIKKDLGNPT-TLSSWLPTTD-CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64

Query: 88  --EISSSISALQSLTVLSLPFNV-LSGKLPLELSNCSNLKVLNVTGNAMVGSVPDL-SAL 143
              I SS++ L  L  L +     L G +P  ++  + L  L +T   + G++PD  S +
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124

Query: 144 KNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC 203
           K L   D S N  +G  P  + +L  LV ++   N      IP+S G+   L        
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN-RISGAIPDSYGSFSKLFTSMTISR 183

Query: 204 N-----------------------LRGRIPESISELRELGTLDICRNKISGEFPRSIRKL 240
           N                       +       +    +                  +   
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243

Query: 241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
           + L  ++L  N + G LP  L  L  L   ++S N + G++P + GNL+   V     N 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302

Query: 301 FSGEFP 306
                P
Sbjct: 303 CLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 94.4 bits (233), Expect = 1e-21
 Identities = 61/279 (21%), Positives = 94/279 (33%), Gaps = 5/279 (1%)

Query: 223 DICRNKISGEFPRSIRKLQKLWKIELYANNLTG--ELPAELGNLTLLQEFDISSN-QMYG 279
           D C     G    +  +  ++  ++L   NL     +P+ L NL  L    I     + G
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91

Query: 280 KLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTAL 339
            +P  I  L  L        N SG  P     ++ L       N  SG  P ++     L
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151

Query: 340 TDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSG 399
             +    N+ SG+ P       KL   + +S N              +  + +S N L G
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG 211

Query: 400 KIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459
                  +  N   +    N     +  +           L+NNR  G LP  L +L  L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLD-LRNNRIYGTLPQGLTQLKFL 270

Query: 460 ERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
             L ++ NN  G+IP   G L++        N      P
Sbjct: 271 HSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.9 bits (172), Expect = 7e-14
 Identities = 54/279 (19%), Positives = 94/279 (33%), Gaps = 6/279 (2%)

Query: 296 CFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPF--PENLGRYTALTDVDISENQFSGSF 353
           C    + G          ++    + G     P+  P +L     L  + I         
Sbjct: 33  CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92

Query: 354 PKYLCEKRKLLNLLALSNNFSGEVPNS-YADCKTIQRLRISDNHLSGKIPDGLWALPNVG 412
                 K   L+ L +++           +  KT+  L  S N LSG +P  + +LPN+ 
Sbjct: 93  IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152

Query: 413 MLDFGDNDFTGGISPLIGLSTSLSQ-LVLQNNRFSGELPSELGRLTNLERLILTNNNFSG 471
            + F  N  +G I    G  + L   + +  NR +G++P     L      +  N     
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD 212

Query: 472 KIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL 531
                            + +         +      +DL    N + G +P+ L+ L  L
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFL 270

Query: 532 NALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPL 570
           ++LN+S N L G IP      +      + N+     PL
Sbjct: 271 HSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  102 bits (256), Expect = 3e-24
 Identities = 47/207 (22%), Positives = 83/207 (40%), Gaps = 23/207 (11%)

Query: 649 MENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ 708
           +   +++   KW+  S +   +D       +    +G+G  G+V  +  K++    A+K 
Sbjct: 19  LAKAKEDFLKKWETPSQNTAQLD-----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73

Query: 709 LWKGDGVKV-----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH 763
           L K   VK+        E  IL  +    ++KL        + ++V+EY+  G +F  L 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133

Query: 764 KRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823
           +  +              A        YLH   S  +I+RD+K  N+L+D+    ++ DF
Sbjct: 134 RIGR-----FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185

Query: 824 GVAKIAENSPKVSDYSCFAGTHGYIAP 850
           G AK               GT   +AP
Sbjct: 186 GFAK-----RVKGRTWTLCGTPEALAP 207

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 3e-23
 Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 19/183 (10%)

Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG------DGVKVFAAEMEILGK 727
           N E   ++G+G  GKV+ +       T    A+K L K          +    E ++L  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 728 IRHR-NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
           IR    ++ L+          L+L+Y+  G LF  L +R +    E +            
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIY------VG 136

Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
           + +  L H     II+RDIK  NILLD +    + DFG++K    + +      F GT  
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIE 195

Query: 847 YIA 849
           Y+A
Sbjct: 196 YMA 198

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.9 bits (248), Expect = 3e-23
 Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 25/178 (14%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYA 738
            +GSG  G V      +    VA+K+L++        K    E+ +L  +RH N++ L  
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 739 CLLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
                 +       +LV+ +M  G     L K  K     L   R   +     KG+ Y+
Sbjct: 85  VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYI 137

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   +  IIHRD+K  N+ ++ED E KI DFG+A+ A+     S+ + +  T  Y AP
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWYRAP 187

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 98.8 bits (245), Expect = 5e-23
 Identities = 39/173 (22%), Positives = 67/173 (38%), Gaps = 19/173 (10%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACL 740
             +G G   +V+      N   V VK L      K    E++IL  +R   NI+ L   +
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVK-KKKIKREIKILENLRGGPNIITLADIV 99

Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
               S    LV E++ N +  Q            L  +          K + Y H     
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG-- 149

Query: 799 PIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
            I+HRD+K  N+++D E  + ++ D+G+A+         +Y+    +  +  P
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGP 198

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 99.7 bits (247), Expect = 6e-23
 Identities = 94/399 (23%), Positives = 146/399 (36%), Gaps = 33/399 (8%)

Query: 94  SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153
           +AL       L    ++  +    ++   +  L       + S+  +  L NL   + S 
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLG-IKSIDGVEYLNNLTQINFSN 75

Query: 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESI 213
           N  T   P  + NLT+LV + + +N   +     ++ NL  LT       ++      + 
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS 273
                    ++  N IS     S     +         +        L NLT L+  DIS
Sbjct: 134 LNRL-----ELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDIS 183

Query: 274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENL 333
           SN++       +  L NL       N  S   P G   +  L   S+ GN+        L
Sbjct: 184 SNKVSD--ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTL 237

Query: 334 GRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRIS 393
              T LTD+D++ NQ S   P  L    KL  L   +N  S   P +     T   L  +
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295

Query: 394 DNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSEL 453
                      +  L N+  L    N+ +  ISP+  L T L +L   NN+ S    S L
Sbjct: 296 QLE----DISPISNLKNLTYLTLYFNNIS-DISPVSSL-TKLQRLFFANNKVSD--VSSL 347

Query: 454 GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
             LTN+  L   +N  S   P  L  L +++ L L + A
Sbjct: 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.5 bits (236), Expect = 2e-21
 Identities = 78/402 (19%), Positives = 137/402 (34%), Gaps = 35/402 (8%)

Query: 138 PDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTY 197
            D +AL       L     T    +   +L Q+ +L          +  + +  L NLT 
Sbjct: 17  TD-TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRL---GIKSIDGVEYLNNLTQ 70

Query: 198 LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
           +  ++  L    P  +  L +L  + +  N+I+   P +         +          L
Sbjct: 71  INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128

Query: 258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFA 317
                        +++  ++      +I  L  LT  Q               ++  L  
Sbjct: 129 K---------NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEV 377
             I  N+        L + T L  +  + NQ S   P  +      L+L    N      
Sbjct: 180 LDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSL--NGNQLKD-- 233

Query: 378 PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQ 437
             + A    +  L +++N +S   P  L  L  +  L  G N  +  ISPL GL+   + 
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS-NISPLAGLTALTNL 290

Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI 497
            + +N        S L  LT L    L  NN S   P  + +L +L  L    N ++   
Sbjct: 291 ELNENQLEDISPISNLKNLTYLT---LYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343

Query: 498 PNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN 539
            + + +   I  L+   N +S   P  L+ L+ +  L L+  
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 94.7 bits (234), Expect = 3e-21
 Identities = 68/368 (18%), Positives = 115/368 (31%), Gaps = 50/368 (13%)

Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
           L +  K  L   N+T  +     +L  +         +  K  + +  L NLT      N
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 76

Query: 300 NFSGEFPSGFGDMRKL--FAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYL 357
             +   P    ++ KL     +        P              +   +         L
Sbjct: 77  QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134

Query: 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA---------- 407
                  N ++  +  SG                    +L+      + +          
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194

Query: 408 -LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
            L N+  L   +N  +      I   T+L +L L  N+        L  LTNL  L L N
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250

Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIP--------------------NEMGDCAR 506
           N  S   P  L  L +L+ L L  N ++   P                    + + +   
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308

Query: 507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLS 565
           +  L L  N++S   P  +S L+ L  L  + NK++     +L  L  ++ +    NQ+S
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS 364

Query: 566 GSVPLDFL 573
              PL  L
Sbjct: 365 DLTPLANL 372

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 92.0 bits (227), Expect = 2e-20
 Identities = 78/397 (19%), Positives = 144/397 (36%), Gaps = 33/397 (8%)

Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
            L + +   +G     +     S  +L  +T L      ++    + +  L  L  ++  
Sbjct: 20  ALAEKMKTVLGKTNVTD---TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 74

Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI 285
            N+++   P  ++ L KL  I +  N +    P              +   +     +  
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITP---------LANLTNLTGLTLFNNQIT 123

Query: 286 GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDIS 345
                  +    +   S    S    +  L +             + L   T L  +DIS
Sbjct: 124 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS 183

Query: 346 ENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL 405
            N+ S           + L   A +N  S   P        +  L ++ N L       L
Sbjct: 184 SNKVSDISVLAKLTNLESLI--ATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTL 237

Query: 406 WALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT 465
            +L N+  LD  +N  +  ++PL GL T L++L L  N+ S   P  L  LT L  L L 
Sbjct: 238 ASLTNLTDLDLANNQISN-LAPLSGL-TKLTELKLGANQISNISP--LAGLTALTNLELN 293

Query: 466 NNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL 525
            N      P     L+ L+ L L  N ++   P  +    ++  L  A N +S     SL
Sbjct: 294 ENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347

Query: 526 SLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSEN 562
           + L+++N L+   N+++   P   +  +++ + L++ 
Sbjct: 348 ANLTNINWLSAGHNQISDLTPLANLT-RITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 63.1 bits (152), Expect = 5e-11
 Identities = 43/202 (21%), Positives = 72/202 (35%), Gaps = 32/202 (15%)

Query: 47  HGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPF 106
              L + +    +    S IT   +   + E+S +   L      ++++L +LT L L  
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250

Query: 107 NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLS---------------------ALKN 145
           N +S   PL  S  + L  L +  N +    P                         LKN
Sbjct: 251 NQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308

Query: 146 LEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNL 205
           L    L  N  +   P  V +LT+L  L   +N   +     S+ NL N+ +L   H  +
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANN---KVSDVSSLANLTNINWLSAGHNQI 363

Query: 206 RGRIPESISELRELGTLDICRN 227
               P  ++ L  +  L +   
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 0.001
 Identities = 18/71 (25%), Positives = 31/71 (43%), Gaps = 5/71 (7%)

Query: 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQ 563
           A  +   L + +++  +  S + L  +  L      +  SI D +  L  L+ I+ S NQ
Sbjct: 22  AEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77

Query: 564 LSGSVPLDFLR 574
           L+   PL  L 
Sbjct: 78  LTDITPLKNLT 88

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.1 bits (230), Expect = 5e-21
 Identities = 50/199 (25%), Positives = 77/199 (38%), Gaps = 27/199 (13%)

Query: 665 FHHIDIDAEQICNL---EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKV 717
           F+ +++       L   +    IGSG  G V           VA+K+L +        K 
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62

Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKP 771
              E+ ++  + H+NI+ L        +       +LV+E M          +       
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------ 116

Query: 772 ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
             D  R   +      GI +LH      IIHRD+K SNI++  D   KI DFG+A+ A  
Sbjct: 117 --DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171

Query: 832 SPKVSDYSCFAGTHGYIAP 850
           S      + +  T  Y AP
Sbjct: 172 SFM---MTPYVVTRYYRAP 187

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 88.6 bits (218), Expect = 1e-19
 Identities = 47/290 (16%), Positives = 91/290 (31%), Gaps = 16/290 (5%)

Query: 225 CRNKISGEFPRSI-RKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPE 283
           C +    + P+ +      L    L  N +T     +  NL  L    + +N++    P 
Sbjct: 17  CSDLGLEKVPKDLPPDTALLD---LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73

Query: 284 EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD 343
               L  L      KN            +++L        +        L +   + ++ 
Sbjct: 74  AFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELG 132

Query: 344 ISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403
            +  + SG         +K L+ + +++     +P       ++  L +  N ++     
Sbjct: 133 TNPLKSSGIENGAFQGMKK-LSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAA 189

Query: 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463
            L  L N+  L    N  +   +  +  +  L +L L NN+     P  L     ++ + 
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVY 248

Query: 464 LTNNNFSG------KIPSALGALRQLSSLHLEENALT-GSIPNEMGDCAR 506
           L NNN S         P         S + L  N +    I      C  
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 84.3 bits (207), Expect = 3e-18
 Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 41/318 (12%)

Query: 251 NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFG 310
             L  ++P +L         D+ +N++      +  NLKNL       N  S   P  F 
Sbjct: 20  LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 76

Query: 311 DMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALS 370
            + KL    +  N+      +       L   +    +   S    L  +  ++ L    
Sbjct: 77  PLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNP 135

Query: 371 NNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIG 430
              SG    ++   K +  +RI+D +++  IP GL                         
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP------------------------ 170

Query: 431 LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE 490
              SL++L L  N+ +    + L  L NL +L L+ N+ S     +L     L  LHL  
Sbjct: 171 --PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228

Query: 491 NALTGSIPNEMGDCARIVDLNLARNSLSG------NIPRSLSLLSSLNALNLSGNKLT-G 543
           N L   +P  + D   I  + L  N++S         P   +  +S + ++L  N +   
Sbjct: 229 NKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287

Query: 544 SIPDNLMKL--KLSSIDL 559
            I  +  +     +++ L
Sbjct: 288 EIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 80.5 bits (197), Expect = 5e-17
 Identities = 50/306 (16%), Positives = 101/306 (33%), Gaps = 49/306 (16%)

Query: 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLW 244
                 NLKNL  L L +  +    P + + L +L  L + +N++     +  + LQ+L 
Sbjct: 47  KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELR 106

Query: 245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGE 304
             E     +   +   L  + +++                                 SG 
Sbjct: 107 VHENEITKVRKSVFNGLNQMIVVE-------------------------LGTNPLKSSGI 141

Query: 305 FPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLL 364
               F  M+KL    I     +           +LT++ +  N+ +      L     L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 365 NLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGG 424
            L    N+ S     S A+   ++ L +++N L  K+P GL     + ++   +N+ +  
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA- 256

Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN--NFSGKIPSALGALRQ 482
                          + +N F    P    +  +   + L +N   +    PS    +  
Sbjct: 257 ---------------IGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299

Query: 483 LSSLHL 488
            +++ L
Sbjct: 300 RAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 78.9 bits (193), Expect = 2e-16
 Identities = 50/286 (17%), Positives = 96/286 (33%), Gaps = 21/286 (7%)

Query: 290 NLTVFQCFKNNFSGEFPSGFG-DMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
           +L V QC       + P     D   L    +  N+ +     +      L  + +  N+
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNK 66

Query: 349 FSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWAL 408
            S   P       KL  L    N                Q LR+ +N ++         L
Sbjct: 67  ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTL---QELRVHENEITKVRKSVFNGL 123

Query: 409 PNVGMLDFGD--NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
             + +++ G      +G  +        LS + + +   +  +P  L    +L  L L  
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 180

Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526
           N  +    ++L  L  L+ L L  N+++      + +   + +L+L  N L   +P  L+
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239

Query: 527 LLSSLNALNLSGNKLTGSIPD-------NLMKLKLSSIDLSENQLS 565
               +  + L  N ++    +       N  K   S + L  N + 
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 78.2 bits (191), Expect = 3e-16
 Identities = 55/264 (20%), Positives = 100/264 (37%), Gaps = 10/264 (3%)

Query: 329 FPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQ 388
            P++L        +D+  N+ +          + L  L+ ++N  S   P ++A    ++
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 389 RLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN--NRFS 446
           RL +S N L   +P+ +     +  L   +N+ T     +      +  + L     + S
Sbjct: 83  RLYLSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139

Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR 506
           G        +  L  + + + N +  IP   G    L+ LHL+ N +T      +     
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNN 196

Query: 507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSG 566
           +  L L+ NS+S     SL+    L  L+L+ NKL            +  + L  N +S 
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256

Query: 567 SVPLDFLRMGGDGAFAGNEGLCLD 590
               DF   G +   A   G+ L 
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLF 280

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.4 bits (189), Expect = 5e-16
 Identities = 46/282 (16%), Positives = 86/282 (30%), Gaps = 16/282 (5%)

Query: 76  TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
             +   +  L  ++   +       +L L  N ++     +  N  NL  L +  N +  
Sbjct: 13  RVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 136 SVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKN 194
             P   + L  LE   LS N       +    L +L           ++    +  N   
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF--NGLNQMI 127

Query: 195 LTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254
           +  L        G    +   +++L  + I    I+         L +L    L  N +T
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH---LDGNKIT 184

Query: 255 GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK 314
               A L  L  L +  +S N +       + N  +L       N    + P G  D + 
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243

Query: 315 LFAFSIYGNRFSG------PFPENLGRYTALTDVDISENQFS 350
           +    ++ N  S         P    +  + + V +  N   
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.3 bits (129), Expect = 2e-08
 Identities = 25/128 (19%), Positives = 48/128 (37%), Gaps = 2/128 (1%)

Query: 448 ELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARI 507
           ++P +L    +   L L NN  +         L+ L +L L  N ++   P       ++
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567
             L L++N L     +    L  L        K+  S+ + L ++ +  +  +  + SG 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 568 VPLDFLRM 575
               F  M
Sbjct: 142 ENGAFQGM 149

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.9 bits (214), Expect = 6e-19
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 23/178 (12%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLY 737
           + +GSG  G V      K    VAVK+L +        K    E+ +L  ++H N++ L 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 738 ACL-----LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
                   L+  +   ++ ++   +L   +  +      +L       +     +G+ Y+
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYI 137

Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
           H   S  IIHRD+K SN+ ++ED E KI DFG+A+  ++     + + +  T  Y AP
Sbjct: 138 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 187

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 85.9 bits (211), Expect = 2e-18
 Identities = 35/183 (19%), Positives = 65/183 (35%), Gaps = 19/183 (10%)

Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV-KVFAAEMEILGKIRHRNILKLYACLL 741
            +G G    V+      N   VA+K +       +    E+++L ++   +  K  +   
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 742 KG-------------GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
                              +V+ +   G    AL K+ +     L + ++    L    G
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL--LLG 137

Query: 789 IAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
           + Y+H  C   IIH DIK  N+L++  D    +    +A +         Y+    T  Y
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 848 IAP 850
            +P
Sbjct: 196 RSP 198

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (200), Expect = 1e-17
 Identities = 54/264 (20%), Positives = 87/264 (32%), Gaps = 7/264 (2%)

Query: 113 LPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLV 171
           +P+ +   +  + + + GN +         A +NL I  L  N            L  L 
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 172 SLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISG 231
            L + DN    +  P +   L  L  L L  C L+   P     L  L  L +  N +  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 232 EFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNL 291
               + R L  L  + L+ N ++         L  L    +  N++    P    +L  L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 292 TVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSG 351
                F NN S         +R L    +  N +          +  L     S ++   
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPC 262

Query: 352 SFPKYLCEKRKLLNLLALSNNFSG 375
           S P+ L   R L  L   +N+  G
Sbjct: 263 SLPQRL-AGRDLKRL--AANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (181), Expect = 4e-15
 Identities = 52/245 (21%), Positives = 83/245 (33%), Gaps = 3/245 (1%)

Query: 329 FPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQ 388
            P  +   +    + +  N+ S          R L  L   SN  +     ++     ++
Sbjct: 26  VPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 389 RLRISDNHLSGKI-PDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG 447
           +L +SDN     + P     L  +  L             L     +L  L LQ+N    
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 448 ELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARI 507
                   L NL  L L  N  S     A   L  L  L L +N +    P+   D  R+
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567
           + L L  N+LS     +L+ L +L  L L+ N          +   L     S +++  S
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263

Query: 568 VPLDF 572
           +P   
Sbjct: 264 LPQRL 268

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.8 bits (143), Expect = 3e-10
 Identities = 44/216 (20%), Positives = 66/216 (30%), Gaps = 26/216 (12%)

Query: 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNR 444
              QR+ +  N +S        A  N+ +L    N      +        L QL L +N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 445 FSGEL-PSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGD 503
               + P+    L  L  L L         P     L  L  L+L++NAL     +   D
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 504 CARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL----------- 552
              +  L L  N +S    R+   L SL+ L L  N++    P     L           
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 553 --------------KLSSIDLSENQLSGSVPLDFLR 574
                          L  + L++N          L 
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.4 bits (182), Expect = 8e-16
 Identities = 25/166 (15%), Positives = 51/166 (30%), Gaps = 33/166 (19%)

Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQL------------WKGDGVKVFAAEMEILGKIR 729
            L+G G    V+    +K  G   VK               +  G   F+       +  
Sbjct: 6   KLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 730 HRNILKLY----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
            R + KL       +     + +++E +    L++                   ++    
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMI 112

Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
            + +A  +H     I+H D+   N+L+  +    I DF  +     
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (143), Expect = 3e-10
 Identities = 40/264 (15%), Positives = 81/264 (30%), Gaps = 17/264 (6%)

Query: 186 PESIGNL--KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGE-FPRSIRKLQK 242
           P+  G L  + +         +   + E  S  R +  +D+  + I        + +  K
Sbjct: 14  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSK 72

Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISS--NQMYGKLPEEIGNLKNLTVF------ 294
           L  + L    L+  +   L   + L   ++S         L   + +   L         
Sbjct: 73  LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132

Query: 295 QCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFP 354
              + +           + +L       N         + R   L  +D+S++    +  
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192

Query: 355 KYLCEKRKLLNLLALSN--NFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVG 412
                +   L  L+LS   +   E      +  T++ L++      G +     ALP+  
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH-- 250

Query: 413 MLDFGDNDFTGGISPLIGLSTSLS 436
            L    + FT    P IG   +  
Sbjct: 251 -LQINCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (127), Expect = 3e-08
 Identities = 34/271 (12%), Positives = 78/271 (28%), Gaps = 14/271 (5%)

Query: 126 LNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI 185
           L++TG  +   V      + +  F    ++          +  ++  + + ++V + + +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL 63

Query: 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDI--CRNKISGEFPRSIRKLQKL 243
              +     L  L L    L   I  ++++   L  L++  C           +    +L
Sbjct: 64  HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123

Query: 244 WKIELYANNLTG------ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF 297
            ++ L              +      +T L       N     L   +    NL      
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183

Query: 298 KN-NFSGEFPSGFGDMRKLFAFSIYG-NRFSGPFPENLGRYTALTDVDISENQFSGSFPK 355
            +     +    F  +  L   S+             LG    L  + +      G+   
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243

Query: 356 YLCEKRKLLNLLALSNNFSGEVPNSYADCKT 386
               K  L +L    ++F+     +  + K 
Sbjct: 244 ---LKEALPHLQINCSHFTTIARPTIGNKKN 271

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.6 bits (114), Expect = 2e-06
 Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 5/102 (4%)

Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFG-DNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
           Q L ++  +L    PD    L + G++ F     F             +  + L N+   
Sbjct: 3   QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59

Query: 447 GE-LPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLH 487
              L   L + + L+ L L     S  I + L     L  L+
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 1e-05
 Identities = 41/272 (15%), Positives = 82/272 (30%), Gaps = 23/272 (8%)

Query: 69  DSVTGRVTEISFDNKSLSG----EISSSISALQSLTVLSLPFNVLSGK-LPLELSNCSNL 123
             VTGR+                +  +   +   +  + L  +V+    L   LS CS L
Sbjct: 14  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73

Query: 124 KVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
           + L++ G  +   + + L+   NL   +LS       F      L+    L   +  +  
Sbjct: 74  QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA-LQTLLSSCSRLDELNLSWCF 132

Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRN---------KISGEF 233
               + +          +   NL G                              +  + 
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192

Query: 234 PRSIRKLQKLWKIEL-YANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLT 292
            +   +L  L  + L    ++  E   ELG +  L+   +      G L      L +L 
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252

Query: 293 VFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324
           +     ++F+       G+ +      I+G +
Sbjct: 253 I---NCSHFTTIARPTIGNKKNQ---EIWGIK 278

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 0.001
 Identities = 11/65 (16%), Positives = 26/65 (40%), Gaps = 1/65 (1%)

Query: 510 LNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVP 569
           L+L   +L  ++   L L   + A     + +   + ++    ++  +DLS + +  S  
Sbjct: 5   LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63

Query: 570 LDFLR 574
              L 
Sbjct: 64  HGILS 68

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.9 bits (133), Expect = 5e-09
 Identities = 45/211 (21%), Positives = 70/211 (33%), Gaps = 9/211 (4%)

Query: 284 EIGNLKNLTVFQCFKNNFSGEFPSGFG-DMRKLFAFSIYGNRFSGPFPENLGRYTALTDV 342
           E+  + +     C K N +   P     D   L    +  N         L  YT LT +
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQL 60

Query: 343 DISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP 402
           ++   +        +     +L  L LS+N    +P        +  L +S N L+    
Sbjct: 61  NLDRAEL---TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 403 DGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERL 462
             L  L  +  L    N+       L+  +  L +L L NN  +      L  L NL+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
           +L  N+    IP        L    L  N  
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.9 bits (133), Expect = 5e-09
 Identities = 45/235 (19%), Positives = 73/235 (31%), Gaps = 32/235 (13%)

Query: 67  TCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVL 126
               V   + E++ D ++L+  +   +      T+L L  N+L       L   + L  L
Sbjct: 5   EVSKVASHL-EVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 127 NVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP 186
           N+   A +  +     L  L   DLS N                                
Sbjct: 61  NL-DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL----------------- 102

Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKI 246
                    T L ++   L      ++  L EL  L +  N++    P  +    KL K+
Sbjct: 103 ---------TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153

Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
            L  NNLT      L  L  L    +  N +Y  +P+       L       N +
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.1 bits (131), Expect = 1e-08
 Identities = 37/210 (17%), Positives = 79/210 (37%), Gaps = 7/210 (3%)

Query: 116 ELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSI 175
           E+S  ++   +N     +  ++P     K+  I  LS N         ++  T+L  L++
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 176 GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPR 235
                 + ++  ++  L  L        +L        +        D+  N+++     
Sbjct: 63  DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL----DVSFNRLTSLPLG 118

Query: 236 SIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQ 295
           ++R L +L ++ L  N L    P  L     L++  +++N +       +  L+NL    
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 296 CFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325
             +N+     P GF     L    ++GN +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 5e-08
 Identities = 31/208 (14%), Positives = 63/208 (30%), Gaps = 7/208 (3%)

Query: 188 SIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIE 247
            +  + +   +     NL   +P  +   ++   L +  N +      ++    +L   +
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLT--Q 59

Query: 248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPS 307
           L  +          G L +L   D+S NQ+              TV     N  +     
Sbjct: 60  LNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLG 118

Query: 308 GFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367
               + +L    + GN      P  L     L  + ++ N  +      L    + L+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN-GLENLDTL 177

Query: 368 ALSNNFSGEVPNSYADCKTIQRLRISDN 395
            L  N    +P  +     +    +  N
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 6e-08
 Identities = 37/189 (19%), Positives = 59/189 (31%), Gaps = 7/189 (3%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
            +P  +   K+ T L L+   L      ++     L  L++ R ++     +    L  L
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVL 79

Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG 303
             ++L  N L          L  L   D+S N++       +  L  L       N    
Sbjct: 80  GTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 304 EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKL 363
             P       KL   S+  N  +      L     L  + + EN    + PK       L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF-GSHL 196

Query: 364 LNLLALSNN 372
           L    L  N
Sbjct: 197 LPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.2 bits (108), Expect = 7e-06
 Identities = 36/191 (18%), Positives = 56/191 (29%), Gaps = 47/191 (24%)

Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNN--------------------- 468
            L    + L L  N       + L   T L +L L                         
Sbjct: 28  DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHN 87

Query: 469 ------------------------FSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC 504
                                    +     AL  L +L  L+L+ N L    P  +   
Sbjct: 88  QLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147

Query: 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQ 563
            ++  L+LA N+L+      L+ L +L+ L L  N L  +IP        L    L  N 
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206

Query: 564 LSGSVPLDFLR 574
              +  + + R
Sbjct: 207 WLCNCEILYFR 217

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.0 bits (133), Expect = 8e-09
 Identities = 50/321 (15%), Positives = 91/321 (28%), Gaps = 25/321 (7%)

Query: 193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN 252
           +    L L +  L   +PE    L  L       N ++ E P   + L+ L         
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
           L+   P          + +           + I    N                +G   +
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 313 RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNN 372
            +L          +     N  +      + +       +  + L E + L  L  +  +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 373 FSGEVPNSYADCKTIQRLRISDNHLS-----------GKIPDGLWALPNVGMLDFGDNDF 421
            +                   +                   +    L  +    +  N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALR 481
           +  I  L  L  SL +L + NN+   ELP+       LERLI + N+ + ++P     L+
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLK 327

Query: 482 QLSSLHLEENALTGSIPNEMG 502
               LH+E N L    P+   
Sbjct: 328 ---QLHVEYNPLR-EFPDIPE 344

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.2 bits (131), Expect = 1e-08
 Identities = 53/366 (14%), Positives = 102/366 (27%), Gaps = 55/366 (15%)

Query: 120 CSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV 179
                 L +    +  S+P+L    +LE    S N  T                      
Sbjct: 37  DRQAHELELNNLGL-SSLPEL--PPHLESLVASCNSLT---------------------- 71

Query: 180 YDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRK 239
               E+PE   +LK+L         L    P             +    +S      + +
Sbjct: 72  ----ELPELPQSLKSLLVDNNNLKALSDLPPL------------LEYLGVSNNQLEKLPE 115

Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
           LQ    +++   +       +           I++     +   E+ NL  LT      N
Sbjct: 116 LQNSSFLKIIDVD---NNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNN 172

Query: 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
           +              +   +I            L    A  ++  +      S       
Sbjct: 173 SLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVR 232

Query: 360 KRKLLNLLALSNNFSGEVPN--SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417
              L +L  L  + +    +   ++    +       N  S +I       P++  L+  
Sbjct: 233 DNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVS 292

Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL 477
           +N        L  L   L +L+   N  + E+P       NL++L +  N    + P   
Sbjct: 293 NNKLIE----LPALPPRLERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIP 343

Query: 478 GALRQL 483
            ++  L
Sbjct: 344 ESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.8 bits (117), Expect = 8e-07
 Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 10/95 (10%)

Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
              N  S +I S       L  L++  N L   +P       R+  L  + N L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP- 320

Query: 524 SLSLLSSLNALNLSGNKLTG--SIPDNLMKLKLSS 556
              L  +L  L++  N L     IP+++  L+++S
Sbjct: 321 --ELPQNLKQLHVEYNPLREFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 19/80 (23%), Positives = 31/80 (38%), Gaps = 7/80 (8%)

Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
               NA +  I +       + +LN++ N L   +P   +L   L  L  S N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVP 320

Query: 547 DNLMKLKLSSIDLSENQLSG 566
           +    LK   + +  N L  
Sbjct: 321 ELPQNLK--QLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.3 bits (95), Expect = 4e-04
 Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 33/116 (28%)

Query: 104 LPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRW 163
              N  S ++        +L+ LNV+ N ++  +P L     LE    S N+        
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL--PPRLERLIASFNHLA------ 317

Query: 164 VVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL 219
                               E+PE   NLK    L + +  LR   P+    + +L
Sbjct: 318 --------------------EVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 51/326 (15%), Positives = 92/326 (28%), Gaps = 29/326 (8%)

Query: 98  SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFT 157
               L L    LS  LP    +   L+ L  + N++   +P+L   ++L+   +  N   
Sbjct: 39  QAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPEL--PQSLKSLLVDNNNLK 91

Query: 158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISE-- 215
                  +     VS +  + + +            +   L             +     
Sbjct: 92  ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151

Query: 216 ---LRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI 272
              L EL  L       +            L    + A N   E   EL NL  L     
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211

Query: 273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG--------EFPSGFGDMRKLFAFSIYGNR 324
            +N +                     +               + F  + +L     Y N 
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271

Query: 325 FSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADC 384
            S           +L ++++S N+     P         L  L  S N   EVP      
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR----LERLIASFNHLAEVPEL---P 323

Query: 385 KTIQRLRISDNHLSGKIPDGLWALPN 410
           + +++L +  N L  + PD   ++ +
Sbjct: 324 QNLKQLHVEYNPLR-EFPDIPESVED 348

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.6 bits (123), Expect = 1e-08
 Identities = 30/118 (25%), Positives = 47/118 (39%), Gaps = 8/118 (6%)

Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI 497
           L L +   +      L +L  +  L L++N      P+ L ALR L  L   +N      
Sbjct: 3   LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDN--ALEN 57

Query: 498 PNEMGDCARIVDLNLARNSL-SGNIPRSLSLLSSLNALNLSGNKLTG--SIPDNLMKL 552
            + + +  R+ +L L  N L      + L     L  LNL GN L     I + L ++
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.3 bits (117), Expect = 8e-08
 Identities = 24/119 (20%), Positives = 43/119 (36%), Gaps = 5/119 (4%)

Query: 101 VLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRF 160
           VL L    L+      L     +  L+++ N +    P L+AL+ LE+   S N      
Sbjct: 2   VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 161 PRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL 219
               +   Q + L   +N   ++   + + +   L  L L   +L          L E+
Sbjct: 60  GVANLPRLQELLLC--NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.9 bits (103), Expect = 6e-06
 Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 5/109 (4%)

Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
            +   +  L  +T+L L+H  LR   P +++ LR L  L    N +  E    +  L +L
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL--ENVDGVANLPRL 67

Query: 244 WKIELYANNLTG-ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNL 291
            ++ L  N L        L +   L   ++  N +          L  +
Sbjct: 68  QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 27/124 (21%), Positives = 41/124 (33%), Gaps = 8/124 (6%)

Query: 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
           L L++     + +       +  L +S N L    P  L AL  + +L   DN       
Sbjct: 3   LHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDG 60

Query: 427 PLIGLSTSLSQLVLQNNRF-SGELPSELGRLTNLERLILTNNNFSGK---IPSALGALRQ 482
                   L +L+L NNR         L     L  L L  N+   +          L  
Sbjct: 61  VAN--LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118

Query: 483 LSSL 486
           +SS+
Sbjct: 119 VSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.9 bits (90), Expect = 3e-04
 Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 7/107 (6%)

Query: 462 LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNI 521
           L L + + +  +   L  L  ++ L L  N L    P  +     +  L  + N+     
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57

Query: 522 PRSLSLLSSLNALNLSGNKLTG-SIPDNLMKL-KLSSIDLSENQLSG 566
              ++ L  L  L L  N+L   +    L+   +L  ++L  N L  
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.8 bits (87), Expect = 0.001
 Identities = 20/109 (18%), Positives = 42/109 (38%), Gaps = 6/109 (5%)

Query: 197 YLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE 256
            L LAH +L   +   + +L  +  LD+  N++    P ++  L+ L  ++   N L   
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 257 LPAELGNLTLLQEFDISSNQM-YGKLPEEIGNLKNLTVFQCFKNNFSGE 304
                      QE  + +N++      + + +   L +     N+   E
Sbjct: 59  DGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.2 bits (83), Expect = 0.003
 Identities = 24/112 (21%), Positives = 45/112 (40%), Gaps = 5/112 (4%)

Query: 91  SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
             +  L  +T L L  N L    P  L+    L+VL  + N  + +V  ++ L  L+   
Sbjct: 14  CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN-ALENVDGVANLPRLQELL 71

Query: 151 LSINYFTG-RFPRWVVNLTQLVSLSIGDN--VYDEAEIPESIGNLKNLTYLF 199
           L  N        + +V+  +LV L++  N    +E         L +++ + 
Sbjct: 72  LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.0 bits (123), Expect = 6e-08
 Identities = 41/227 (18%), Positives = 70/227 (30%), Gaps = 18/227 (7%)

Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
           L    KI    +N+T  +     +L  +         +     E +  L NL   +   N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDN 73

Query: 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
             +   P            S    +                 +D++  Q +   P     
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIK----TLDLTSTQITDVTPLAGLS 129

Query: 360 KRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN 419
             ++L           ++ N            +S  +        L  L  +  L   DN
Sbjct: 130 NLQVLY------LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 420 DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
             +  ISPL  L  +L ++ L+NN+ S   P  L   +NL  + LTN
Sbjct: 184 KISD-ISPLASL-PNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 28/215 (13%), Positives = 57/215 (26%), Gaps = 21/215 (9%)

Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
            L   + ++ G +   +     +  +L  +T L      +     E +  L  L  L++ 
Sbjct: 17  ALANAIKIAAGKSNVTD---TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELK 71

Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI 285
            N+I+   P          ++          +       TL       ++         +
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 286 GNLKNLTVFQCFKNNF--------------SGEFPSGFGDMRKLFAFSIYGNRFSGPFPE 331
             L          +                     +   ++ KL       N+ S   P 
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190

Query: 332 NLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL 366
            L     L +V +  NQ S   P        ++ L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 5e-05
 Identities = 29/212 (13%), Positives = 72/212 (33%), Gaps = 20/212 (9%)

Query: 95  ALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSIN 154
           AL +   ++   + ++  +    ++   +  L+  G  +  ++  +  L NL   +L  N
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDN 73

Query: 155 YFT------GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR 208
             T             + L+     ++      ++     + + +      LA  +    
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 209 IPESISELRELGTLDIC-------RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL 261
           +   ++++  +  L                     +  L KL  ++   N ++   P  L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191

Query: 262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTV 293
            +L  L E  + +NQ+    P  + N  NL +
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 8e-04
 Identities = 38/226 (16%), Positives = 71/226 (31%), Gaps = 18/226 (7%)

Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
            L N       K+N +        D+  +   S +G   +    E +     L  +++ +
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
           NQ             K L  +         + N  A         +            L 
Sbjct: 73  NQI------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
            L N+ +L    N     I+ +  L+   +   L          + L  L+ L  L   +
Sbjct: 127 GLSNLQVLYLDLNQ----ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512
           N  S   P  L +L  L  +HL+ N ++   P  + + + +  + L
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (124), Expect = 1e-07
 Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 5/94 (5%)

Query: 432 STSLSQLVLQNNRFSGELPSEL-GRLTNLERLILTNNNFSGK----IPSALGALRQLSSL 486
           S  +  L +Q    S    +EL   L   + + L +   +      I SAL     L+ L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGN 520
           +L  N L     + +    +     + + SL   
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 1e-06
 Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 22/111 (19%)

Query: 458 NLERLILTNNNFSGK-IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS 516
           +++ L +     S       L  L+Q   + L++  LT +                    
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC------------------ 44

Query: 517 LSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK-LKLSSIDLSENQLSG 566
              +I  +L +  +L  LNL  N+L       +++ L+  S  + +  L  
Sbjct: 45  --KDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 14/97 (14%), Positives = 30/97 (30%), Gaps = 5/97 (5%)

Query: 410 NVGMLDFGDNDFT-GGISPLIGLSTSLSQLVLQNNRFSGE----LPSELGRLTNLERLIL 464
           ++  LD    + +    + L+ L      + L +   +      + S L     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 465 TNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501
            +N         +    Q  S  +++ +L        
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 14/90 (15%), Positives = 31/90 (34%), Gaps = 4/90 (4%)

Query: 170 LVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR----IPESISELRELGTLDIC 225
           + SL I      +A   E +  L+    + L  C L       I  ++     L  L++ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTG 255
            N++       + +  +    ++   +L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 18/78 (23%), Positives = 32/78 (41%), Gaps = 9/78 (11%)

Query: 414 LDFGDNDFTG----GISPLIGLSTSLSQLVLQNNRFSGELPSELGR-----LTNLERLIL 464
           L   D D +      ++  +  + SL +L L NN        +L          LE+L+L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433

Query: 465 TNNNFSGKIPSALGALRQ 482
            +  +S ++   L AL +
Sbjct: 434 YDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 17/80 (21%), Positives = 29/80 (36%), Gaps = 9/80 (11%)

Query: 433 TSLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGKIPSALG-ALRQ----L 483
           + L  L L +   S      L + L    +L  L L+NN         L  ++RQ    L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 484 SSLHLEENALTGSIPNEMGD 503
             L L +   +  + + +  
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 4e-05
 Identities = 16/70 (22%), Positives = 27/70 (38%), Gaps = 10/70 (14%)

Query: 510 LNLARNSLSGN----IPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL------KLSSIDL 559
           L LA   +S +    +  +L    SL  L+LS N L  +    L++        L  + L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433

Query: 560 SENQLSGSVP 569
            +   S  + 
Sbjct: 434 YDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 6e-05
 Identities = 18/103 (17%), Positives = 30/103 (29%), Gaps = 23/103 (22%)

Query: 457 TNLERLILTNNNFSGK----IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512
           + L  L L + + S      + + L A   L  L L  N L  +   ++ +  R      
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR------ 422

Query: 513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLS 555
                             L  L L     +  + D L  L+  
Sbjct: 423 -------------QPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 9e-05
 Identities = 14/76 (18%), Positives = 30/76 (39%), Gaps = 5/76 (6%)

Query: 218 ELGTLDICRNKISGE-FPRSIRKLQKLWKIELYANNLTGE----LPAELGNLTLLQEFDI 272
           ++ +LDI   ++S   +   +  LQ+   + L    LT      + + L     L E ++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 273 SSNQMYGKLPEEIGNL 288
            SN++       +   
Sbjct: 63  RSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 13/64 (20%), Positives = 23/64 (35%), Gaps = 6/64 (9%)

Query: 510 LNLARNSLSGN-IPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-----KLSSIDLSENQ 563
           L++    LS       L LL     + L    LT +   ++         L+ ++L  N+
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 564 LSGS 567
           L   
Sbjct: 67  LGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 2e-04
 Identities = 15/88 (17%), Positives = 32/88 (36%), Gaps = 8/88 (9%)

Query: 163 WVVNLTQLVSLSIGDNVYDEA---EIPESIGNLKNLTYLFLAHCNLRGRIPESISE-LRE 218
                + L  L + D    ++    +  ++    +L  L L++  L       + E +R+
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423

Query: 219 ----LGTLDICRNKISGEFPRSIRKLQK 242
               L  L +     S E    ++ L+K
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 16/119 (13%), Positives = 32/119 (26%), Gaps = 23/119 (19%)

Query: 294 FQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG----PFPENLGRYTALTDVDISENQF 349
            +                   L    +     S          L    +L ++D+S N  
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409

Query: 350 SGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWAL 408
             +    L E        ++                 +++L + D + S ++ D L AL
Sbjct: 410 GDAGILQLVE--------SVRQPGC-----------LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 10/110 (9%), Positives = 27/110 (24%), Gaps = 21/110 (19%)

Query: 267 LQEFDISSNQMYGK-LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325
           +Q  DI   ++      E +  L+   V +      +                       
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------- 50

Query: 326 SGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSG 375
                  L    AL ++++  N+        + +  +  +      +   
Sbjct: 51  -------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.3 bits (105), Expect = 2e-05
 Identities = 51/375 (13%), Positives = 92/375 (24%), Gaps = 53/375 (14%)

Query: 122 NLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYD 181
           +LK+  +T          L    +++   LS N       RW                  
Sbjct: 9   SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARW------------------ 50

Query: 182 EAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQ 241
              + E+I + K+L     +         E    LR L                ++ K  
Sbjct: 51  ---LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ--------------ALLKCP 93

Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
           KL  + L  N         L +                 L  + G      + +   N  
Sbjct: 94  KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK 153

Query: 302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
           +   P     +           +      ++              +           E  
Sbjct: 154 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL----------HTVKMVQNGIRPEGI 203

Query: 362 KLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDF 421
           + L L  L+     +V +   +  T          L          L +  +   G    
Sbjct: 204 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 263

Query: 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSEL-----GRLTNLERLILTNNNFSGKIPSA 476
               S L   +  L  L LQ N    +    L      ++ +L  L L  N F  +    
Sbjct: 264 VDAFSKLE--NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDV 320

Query: 477 LGALRQLSSLHLEEN 491
           +  +R++ S      
Sbjct: 321 VDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.8 bits (96), Expect = 2e-04
 Identities = 51/338 (15%), Positives = 92/338 (27%), Gaps = 46/338 (13%)

Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG-------NLKNLTVF 294
           K  K++         + A L     ++E  +S N +  +    +        +L+     
Sbjct: 8   KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 295 QCFKNNFSGEFP-------SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISEN 347
             F      E P              KL    +  N F     E L  + +         
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 348 QFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA 407
             +         K          N  +   P   +      RL         K       
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187

Query: 408 LPNV------GMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLER 461
           L  V         +  ++    G++    L     Q     +  S  L   L    NL  
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247

Query: 462 LILTNNNFSGKIPSALG-ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGN 520
           L L +   S +  +A+  A  +L ++ L+                    L L  N +  +
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQT-------------------LRLQYNEIELD 288

Query: 521 IPRSL-----SLLSSLNALNLSGNKLTGSIPDNLMKLK 553
             R+L       +  L  L L+GN+      D + +++
Sbjct: 289 AVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIR 325

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.8 bits (96), Expect = 2e-04
 Identities = 32/304 (10%), Positives = 65/304 (21%), Gaps = 29/304 (9%)

Query: 209 IPESISELRELGTLDICRNKISGE----FPRSIRKLQKLWKIELYAN---NLTGELPAEL 261
           +   + E   +  + +  N I  E       +I   + L   E        +  E+P  L
Sbjct: 23  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82

Query: 262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIY 321
             L          + +           +   +    K+            +       I 
Sbjct: 83  RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142

Query: 322 GNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSY 381
                    +       L  +    N+      K   +  +   LL         +    
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202

Query: 382 ADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQ 441
            +   ++ L          + D  +       L      +                  L 
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL-----------GLN 251

Query: 442 NNRFSGELPSELGR------LTNLERLILTNNNFSGKIPSALGA-----LRQLSSLHLEE 490
           +   S    + +           L+ L L  N         L       +  L  L L  
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311

Query: 491 NALT 494
           N  +
Sbjct: 312 NRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 7/66 (10%), Positives = 25/66 (37%), Gaps = 8/66 (12%)

Query: 434 SLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGK----IPSALGALRQLSS 485
           S+    L+ +  + E    + + L    +++ ++L+ N    +    +   + + + L  
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 486 LHLEEN 491
               + 
Sbjct: 64  AEFSDI 69

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (96), Expect = 8e-05
 Identities = 21/137 (15%), Positives = 48/137 (35%), Gaps = 5/137 (3%)

Query: 90  SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIF 149
           ++  +       L L    +   +    +       ++ + N  +  +     L+ L+  
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN-EIRKLDGFPLLRRLKTL 68

Query: 150 DLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAH---CNLR 206
            ++ N            L  L  L + +N   E    + + +LK+LTYL +      N +
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 207 GRIPESISELRELGTLD 223
                 I ++ ++  LD
Sbjct: 129 HYRLYVIYKVPQVRVLD 145

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (95), Expect = 1e-04
 Identities = 16/138 (11%), Positives = 32/138 (23%), Gaps = 3/138 (2%)

Query: 225 CRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL-GNLTLLQEFDISSNQMYGKLPE 283
           C    + +    +   + L ++ +        L       L  L+   I  + +    P+
Sbjct: 15  CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74

Query: 284 EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPF-PENLGRYTALTDV 342
                  L+      N               L    + GN          L R+      
Sbjct: 75  AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLG 133

Query: 343 DISENQFSGSFPKYLCEK 360
            + E +        L   
Sbjct: 134 GVPEQKLQCHGQGPLAHM 151

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.002
 Identities = 17/151 (11%), Positives = 40/151 (26%), Gaps = 4/151 (2%)

Query: 120 CSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVV-NLTQLVSLSIGDN 178
                 L  T +  + S+  L   +NL    +             +  L +L +L+I  +
Sbjct: 7   PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKIS-GEFPRSI 237
                         +          N    +     +   L  L +  N +      R +
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNL--SFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124

Query: 238 RKLQKLWKIELYANNLTGELPAELGNLTLLQ 268
           ++ ++     +    L       L ++    
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.003
 Identities = 29/140 (20%), Positives = 50/140 (35%), Gaps = 5/140 (3%)

Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEEN 491
              S L    +    +    L    NL  L + N      +    L  L +L +L + ++
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 492 ALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKL--TGSIPDNL 549
            L    P+      R+  LNL+ N+L  ++        SL  L LSGN L  + ++    
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125

Query: 550 MKLKLSSIDLSENQLSGSVP 569
              +     + E +L     
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQ 145

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.9 bits (94), Expect = 2e-04
 Identities = 29/160 (18%), Positives = 52/160 (32%), Gaps = 28/160 (17%)

Query: 430 GLSTSLSQLVLQNNRFSGEL-PSELGRLTNLERLI------------------------L 464
            +    ++L+L +N           GRL +L +L                         L
Sbjct: 26  DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85

Query: 465 TNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRS 524
             N            L QL +L+L +N ++  +P        +  LNLA N  + N    
Sbjct: 86  GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-L 144

Query: 525 LSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQL 564
                 L   +L+G       P  +  +++   DL  ++ 
Sbjct: 145 AWFAEWLRKKSLNGGAARCGAPSKVRDVQIK--DLPHSEF 182

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 2e-04
 Identities = 23/124 (18%), Positives = 47/124 (37%), Gaps = 3/124 (2%)

Query: 112 KLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLV 171
           +L L +S   +     +    +  S PDL A     + +   +           N+ +L+
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGL-RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELL 68

Query: 172 SLSI-GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKIS 230
           SL++  + +Y   ++   +    NL  L L+   L+        +  +L  L +  N +S
Sbjct: 69  SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128

Query: 231 GEFP 234
             F 
Sbjct: 129 DTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 6e-04
 Identities = 24/113 (21%), Positives = 40/113 (35%), Gaps = 7/113 (6%)

Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTG-- 495
           L L+  R   +L         L R     ++ +  +      + +L SL+L  N L    
Sbjct: 27  LDLKGLRSDPDL-VAQNIDVVLNRR----SSMAATLRIIEENIPELLSLNLSNNRLYRLD 81

Query: 496 SIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN 548
            + + +     +  LNL+ N L             L  L L GN L+ +  D 
Sbjct: 82  DMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 3e-04
 Identities = 39/200 (19%), Positives = 67/200 (33%), Gaps = 16/200 (8%)

Query: 94  SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153
           +AL       L    ++    +  ++   +  L       + S+  +  L NL   + S 
Sbjct: 15  TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRL-GIKSIDGVEYLNNLTQINFSN 71

Query: 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESI 213
           N  T   P   +           D + +  +I +            L   N +    + +
Sbjct: 72  NQLTDITPLKNLTKLV-------DILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124

Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS 273
             L  L  L++  N IS     S     +       +N +T   P  L NLT L+  DIS
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLNF--SSNQVTDLKP--LANLTTLERLDIS 180

Query: 274 SNQMYGKLPEEIGNLKNLTV 293
           SN++       +  L NL  
Sbjct: 181 SNKVSD--ISVLAKLTNLES 198

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 6e-04
 Identities = 32/223 (14%), Positives = 55/223 (24%), Gaps = 40/223 (17%)

Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
           L +  K  L   N+T  +     +L  +         +  K  + +  L NLT      N
Sbjct: 17  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 72

Query: 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
             +   P            +        P                               
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTG---------------------- 110

Query: 360 KRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN 419
                                    K +  L   +   +        +           +
Sbjct: 111 -----------LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSS 159

Query: 420 DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERL 462
           +    + PL  L T+L +L + +N+ S    S L +LTNLE L
Sbjct: 160 NQVTDLKPLANL-TTLERLDISSNKVSD--ISVLAKLTNLESL 199

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 23/202 (11%), Positives = 53/202 (26%), Gaps = 16/202 (7%)

Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
                      K + +        ++  +       +         +     +T + ++ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNG 77

Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
           N+ +   P         L  L        +              ++    L       + 
Sbjct: 78  NKLTDIKP---------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128

Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
            L ++  L+             +    +    +   +    ++   L  LT L+ L L+ 
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSK 187

Query: 467 NNFSGKIPSALGALRQLSSLHL 488
           N+ S     AL  L+ L  L L
Sbjct: 188 NHISD--LRALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 28/213 (13%), Positives = 65/213 (30%), Gaps = 22/213 (10%)

Query: 209 IPESISE------LRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELG 262
           +P  I +        E    ++ +  ++    ++  +L  + +I    +++       + 
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65

Query: 263 NLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYG 322
            L  + +  ++ N++       I  L NL        + +           K        
Sbjct: 66  YLPNVTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120

Query: 323 NRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYA 382
           +         L     L  + +  N+ +         K   L+      +         A
Sbjct: 121 HNGI-SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS----LEDNQISDIVPLA 175

Query: 383 DCKTIQRLRISDNHLSGKIPDGLWALPNVGMLD 415
               +Q L +S NH+S      L  L N+ +L+
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLE 206

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	851
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.98
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.98
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.98
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.98
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.98
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.97
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.96
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.96
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.96
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.96
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.96
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.95
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.95
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.95
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.95
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.94
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.89
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.82
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.8
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.57
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.54
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.52
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.51
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.5
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.5
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.47
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.47
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.37
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.36
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.34
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.31
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.47
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.47
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.18
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.82
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.54
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.41
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.39
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.54
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.5
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.44
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.35
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.63

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.6e-45  Score=395.36  Aligned_cols=292  Identities=30%  Similarity=0.495  Sum_probs=248.5

Q ss_pred             CCchhhHHHHHHHHHhcCCCCCCCCCCCCCCCCCc--ccceeEecCCC--CceEEEecccCCcce--ecCccccCCccCc
Q 003065           27 LSLNVETQALIQFKSKLKDPHGVLDSWKESADSPC--GFSGITCDSVT--GRVTEISFDNKSLSG--EISSSISALQSLT  100 (851)
Q Consensus        27 ~~~~~~~~aLl~fk~~~~~~~~~l~sW~~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~g--~i~~~l~~l~~L~  100 (851)
                      .|.++|++||++||+++.||. .+++|..+ +|||  .|.||+|++.+  +||++|||++++++|  .+|++|++|++|+
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~   79 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHHCCCCC-cCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence            599999999999999999885 68999876 7899  59999999755  499999999999998  5889999999999


Q ss_pred             EEeCCC-CcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeecccc
Q 003065          101 VLSLPF-NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN  178 (851)
Q Consensus       101 ~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  178 (851)
                      +|+|++ |+++|.+|.+|++|++|++|+|++|++.+.++. +..+.+|+.+++++|.+.+.+|..+.++++|+++++++|
T Consensus        80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n  159 (313)
T d1ogqa_          80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence            999987 899999999999999999999999999998877 888999999999999999888888999999999999888


Q ss_pred             cCCCCCCcccccCCCCC-CeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcC
Q 003065          179 VYDEAEIPESIGNLKNL-TYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL  257 (851)
Q Consensus       179 ~l~~~~~p~~~~~l~~L-~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~  257 (851)
                      .+. +.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|.+.+.+|..+..+++++.+++++|.+++.+
T Consensus       160 ~l~-~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~  237 (313)
T d1ogqa_         160 RIS-GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL  237 (313)
T ss_dssp             CCE-EECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred             ccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence            887 6788888887776 778888888888888887776544 6888888888888888888888888888888887655


Q ss_pred             CcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCc
Q 003065          258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR  324 (851)
Q Consensus       258 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~  324 (851)
                      | .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus       238 ~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         238 G-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             G-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             c-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence            4 577778888888888888888888888888888888888888877764 5666677666666665

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-36  Score=315.24  Aligned_cols=169  Identities=28%  Similarity=0.397  Sum_probs=148.7

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +++|++.+.||+|+||+||+|+++.+++.||||++....   ..+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357999999999999999999999999999999986542   34568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      ||++|+|.+++..     ...+++..+..++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+|+....
T Consensus        84 y~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          84 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             ccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            9999999998854     346899999999999999999999   78999999999999999999999999999997765


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..........+||+.|||||
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE  175 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPE  175 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTH
T ss_pred             CCccccccceeeCcCccCHh
Confidence            44333345578999999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-35  Score=302.06  Aligned_cols=165  Identities=35%  Similarity=0.525  Sum_probs=148.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +++|++.+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|++++++++|||||++++++.+++..|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            35789999999999999999999999999999998542     3456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ||||++|+|.+++.+.     ..+++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        85 mEy~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~  156 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  156 (263)
T ss_dssp             EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred             EeecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeec
Confidence            9999999999999864     35889999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....    .....||+.|||||
T Consensus       157 ~~~~----~~~~~Gt~~Y~APE  174 (263)
T d2j4za1         157 PSSR----RTTLCGTLDYLPPE  174 (263)
T ss_dssp             CCCC----CEETTEEGGGCCHH
T ss_pred             CCCc----ccccCCCCcccCHH
Confidence            5432    23467999999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=304.44  Aligned_cols=165  Identities=27%  Similarity=0.394  Sum_probs=148.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      .+|+..+.||+|+||+||+|+++.+++.||||++...  ...+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            3699999999999999999999999999999998643  45677999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++|+|.+++.+.      .+++..+..++.|++.||+|||   +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus       100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1         100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            999999887642      4889999999999999999999   7899999999999999999999999999998775443


Q ss_pred             CcccccccccccccccCC
Q 003065          834 KVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~~~~~~~~gt~~Y~APE  851 (851)
                      ..  ....+||+.|||||
T Consensus       171 ~~--~~~~~gt~~Y~aPE  186 (293)
T d1yhwa1         171 SK--RSTMVGTPYWMAPE  186 (293)
T ss_dssp             CC--BCCCCSCGGGCCHH
T ss_pred             cc--ccccccCCCccChh
Confidence            22  23467999999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-35  Score=305.93  Aligned_cols=168  Identities=28%  Similarity=0.430  Sum_probs=146.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            3689999999999999999999999999999998542     34567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |||++|+|.+++...     ..+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+...
T Consensus        88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence            999999999998764     35889999999999999999999   7899999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...........+||+.|||||
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE  180 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPE  180 (288)
T ss_dssp             ----------CCCCGGGCCHH
T ss_pred             cCCcccccccccCCccccCce
Confidence            554444445568999999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-35  Score=305.81  Aligned_cols=166  Identities=27%  Similarity=0.406  Sum_probs=147.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      .|++.+.||+|+||+||+|+++.+++.||||++...  ...+.+.+|++++++++|||||++++++.+++..|+|||||+
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            688999999999999999999999999999998654  445678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++.+.    ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        93 ~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          93 GGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             TEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            99999998764    245899999999999999999999   7899999999999999999999999999997654321 


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                       .......||+.|||||
T Consensus       165 -~~~~~~~Gt~~y~APE  180 (288)
T d2jfla1         165 -QRRDSFIGTPYWMAPE  180 (288)
T ss_dssp             -HHHTCCCSCCTTCCHH
T ss_pred             -ccccccccccccCCHH
Confidence             1223467999999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-35  Score=305.90  Aligned_cols=169  Identities=26%  Similarity=0.393  Sum_probs=150.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||+||+|+++.+++.||||++... ...++|.+|++++++++|||||++++++.+++..|+|||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            3688899999999999999999999999999998654 456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++.+.   ....+++..+..++.|+|+||+|||   +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus        97 ~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          97 YGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             TCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             CcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999763   3457899999999999999999999   68999999999999999999999999999987765433


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......||+.|||||
T Consensus       171 ~-~~~~~~g~~~y~aPE  186 (287)
T d1opja_         171 T-AHAGAKFPIKWTAPE  186 (287)
T ss_dssp             E-EETTEEECGGGCCHH
T ss_pred             e-eeccccccccccChH
Confidence            2 223446899999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=300.54  Aligned_cols=173  Identities=25%  Similarity=0.452  Sum_probs=135.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe--CCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  749 (851)
                      ++|++.+.||+|+||+||+|+++.+++.||||++...    ...+.+.+|++++++++|||||++++++.+  ++..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            4789999999999999999999999999999998654    234568899999999999999999998864  4568999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC--SPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      ||||++|+|.+++.+... ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        84 mEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999976533 2456899999999999999999999531  2359999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ........  ....+||+.|||||
T Consensus       163 ~~~~~~~~--~~~~~gt~~Y~APE  184 (269)
T d2java1         163 ILNHDTSF--AKAFVGTPYYMSPE  184 (269)
T ss_dssp             HC-------------CCCSCCCHH
T ss_pred             ecccCCCc--cccCCCCcccCCHH
Confidence            87654322  23468999999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=303.02  Aligned_cols=167  Identities=30%  Similarity=0.400  Sum_probs=149.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +++|++.+.||+|+||.||+|+++.+++.||||++.+.     ...+.+.+|++++++++|||||++++++++++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            45799999999999999999999999999999998643     3567788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ||||+||+|.+++.+.     ..+++..+..++.|++.||+|||   +++|+||||||+|||++.+|.+||+|||+|+..
T Consensus        84 ~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eeccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence            9999999999998874     35788889999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  .....+||+.|||||
T Consensus       156 ~~~~~--~~~~~~GT~~Y~aPE  175 (337)
T d1o6la_         156 ISDGA--TMKTFCGTPEYLAPE  175 (337)
T ss_dssp             CCTTC--CBCCCEECGGGCCGG
T ss_pred             ccCCc--ccccceeCHHHhhhh
Confidence            54332  233468999999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-34  Score=309.69  Aligned_cols=165  Identities=28%  Similarity=0.423  Sum_probs=145.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ++|++.+.||+|+||+||+|+++.+++.||||++...   ...+.+.+|++++++++|||||+++++|.+++..|+||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4689999999999999999999999999999998644   3356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      |++|+|.+++.+.     ..+++..+..++.|++.||+|||+  ..+|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        86 ~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          86 MDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            9999999999864     358899999999999999999993  148999999999999999999999999999876432


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      .    ..+.+||++|||||
T Consensus       159 ~----~~~~~GT~~Y~APE  173 (322)
T d1s9ja_         159 M----ANSFVGTRSYMSPE  173 (322)
T ss_dssp             T----C---CCSSCCCCHH
T ss_pred             c----cccccCCccccCch
Confidence            2    23468999999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=292.08  Aligned_cols=161  Identities=29%  Similarity=0.360  Sum_probs=139.1

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe----CCeeEEEE
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFLVL  750 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  750 (851)
                      +..+.||+|+||+||+|+++.+++.||+|++...    ...+.+.+|++++++++|||||++++++.+    +...|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            5567899999999999999999999999998654    234578899999999999999999999865    34579999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEEC-CCCceEEeeecCcc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLD-EDYEPKIADFGVAK  827 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DFGla~  827 (851)
                      ||+++|+|.+++.+.     ..+++..+..++.|+++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+
T Consensus        92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            999999999999764     35788999999999999999999   556  99999999999996 57899999999998


Q ss_pred             ccCCCCCcccccccccccccccCC
Q 003065          828 IAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......    ....+||+.|||||
T Consensus       164 ~~~~~~----~~~~~GT~~Y~aPE  183 (270)
T d1t4ha_         164 LKRASF----AKAVIGTPEFMAPE  183 (270)
T ss_dssp             GCCTTS----BEESCSSCCCCCGG
T ss_pred             eccCCc----cCCcccCccccCHH
Confidence            654332    23468999999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-33  Score=299.56  Aligned_cols=164  Identities=30%  Similarity=0.447  Sum_probs=147.5

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +++|++.+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            45799999999999999999999999999999998643     3467789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ||||+||++.+++...     ..+++..+..++.|++.|++|||   +++|+||||||+|||++.+|.+||+|||+|+..
T Consensus        83 mE~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~  154 (316)
T d1fota_          83 MDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  154 (316)
T ss_dssp             ECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             eeecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence            9999999999988763     35677888899999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....     ...+||+.|||||
T Consensus       155 ~~~~-----~~~~Gt~~Y~APE  171 (316)
T d1fota_         155 PDVT-----YTLCGTPDYIAPE  171 (316)
T ss_dssp             SSCB-----CCCCSCTTTCCHH
T ss_pred             cccc-----ccccCcccccCHH
Confidence            5432     2367999999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-34  Score=297.06  Aligned_cols=165  Identities=33%  Similarity=0.517  Sum_probs=137.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|++.+.||+|+||+||+|+..   ..||||+++..    ...+.|.+|++++++++|||||++++++.. +..|+|||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            47899999999999999999863   36999998543    346789999999999999999999998754 56899999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      ||++|+|.+++...    ...+++..+..++.|+|+||+|||   +++||||||||+|||++.++.+||+|||+|+....
T Consensus        84 y~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          84 WCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             CCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             cCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            99999999999753    346899999999999999999999   78999999999999999999999999999987665


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...........||+.|||||
T Consensus       157 ~~~~~~~~~~~gt~~y~APE  176 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPE  176 (276)
T ss_dssp             ---------CCCCGGGCCHH
T ss_pred             cCCcccccccccCcccCCHH
Confidence            44333445568999999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-34  Score=300.78  Aligned_cols=161  Identities=33%  Similarity=0.470  Sum_probs=143.3

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      .|+..+.||+|+||+||+|++..+++.||||++....     ..+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4889999999999999999999999999999986542     23568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      ||++|++..++..     ...+++..+..++.||+.||+|||   +++||||||||+|||++.++.+||+|||+|+....
T Consensus        96 ~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          96 YCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             CCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999988766554     246899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .      ....||+.|||||
T Consensus       168 ~------~~~~GT~~Y~APE  181 (309)
T d1u5ra_         168 A------NSFVGTPYWMAPE  181 (309)
T ss_dssp             B------CCCCSCGGGCCHH
T ss_pred             C------CccccCccccCHH
Confidence            2      2357999999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-33  Score=303.26  Aligned_cols=167  Identities=20%  Similarity=0.367  Sum_probs=148.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +++|++.+.||+|+||.||+|+++.+|+.||||++....  ..+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999999999999999986553  356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC--CCCceEEeeecCccccC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD--EDYEPKIADFGVAKIAE  830 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~  830 (851)
                      |+||+|.+++.+.    ...+++..+..++.||+.||+|||   +++||||||||+|||++  .++.+||+|||+|+...
T Consensus       105 ~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         105 MSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             CCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999988642    345899999999999999999999   78999999999999996  45789999999998776


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   .....||+.|||||
T Consensus       178 ~~~~---~~~~~gT~~Y~aPE  195 (350)
T d1koaa2         178 PKQS---VKVTTGTAEFAAPE  195 (350)
T ss_dssp             TTSC---EEEECSCTTTCCHH
T ss_pred             cccc---cceecCcccccCHH
Confidence            5432   23467999999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-33  Score=299.40  Aligned_cols=165  Identities=28%  Similarity=0.456  Sum_probs=131.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      +.|++.+.||+|+||+||+|+++.+++.||||++...   ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            3589999999999999999999999999999998654   2345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC---CCCceEEeeecCcccc
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAKIA  829 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~  829 (851)
                      |+||+|.+++.+     ...+++..+..++.|++.||+|||   +++|+||||||+||++.   +++.+||+|||+|+..
T Consensus        89 ~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          89 VSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             cCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            999999999975     346899999999999999999999   78999999999999994   5789999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....   ....+||+.|||||
T Consensus       161 ~~~~~---~~~~~GT~~y~APE  179 (307)
T d1a06a_         161 DPGSV---LSTACGTPGYVAPE  179 (307)
T ss_dssp             ---------------CTTSCHH
T ss_pred             cCCCe---eeeeeeCccccCcH
Confidence            54432   23467999999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-33  Score=292.44  Aligned_cols=167  Identities=27%  Similarity=0.374  Sum_probs=136.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|++. +++.||||++... ...++|.+|++++++++|||||++++++..++..|+||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            36888999999999999999985 5678999998654 456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++...    ...+++..+..++.|+|+||+|+|   +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus        84 ~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          84 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             TCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             CCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            99999998753    456889999999999999999999   78999999999999999999999999999987655432


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      .. .....||+.|||||
T Consensus       157 ~~-~~~~~gt~~y~aPE  172 (263)
T d1sm2a_         157 TS-STGTKFPVKWASPE  172 (263)
T ss_dssp             ---------CTTSCCHH
T ss_pred             ee-ecceecCcccCChH
Confidence            22 23357999999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.98  E-value=5.1e-33  Score=299.82  Aligned_cols=166  Identities=22%  Similarity=0.305  Sum_probs=147.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEecc
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  753 (851)
                      ++|++.+.||+|+||.||+|+++.+++.||||++....  ..+.+.+|++++++++|||||+++++|.+++..|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47999999999999999999999999999999986653  3456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC--CCCceEEeeecCccccCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD--EDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~  831 (851)
                      +||+|.+++...    ...+++..+..++.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+|+....
T Consensus       109 ~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         109 SGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            999998876542    346899999999999999999999   78999999999999998  578999999999998765


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...   .....||+.|||||
T Consensus       182 ~~~---~~~~~gt~~y~aPE  198 (352)
T d1koba_         182 DEI---VKVTTATAEFAAPE  198 (352)
T ss_dssp             TSC---EEEECSSGGGCCHH
T ss_pred             CCc---eeeccCcccccCHH
Confidence            432   23357999999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.2e-33  Score=291.46  Aligned_cols=167  Identities=28%  Similarity=0.452  Sum_probs=143.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||.||+|+++ ++..||||++... ...+.|.+|++++++++|||||++++++.+ +..|+||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            36888999999999999999984 5678999998654 456789999999999999999999998754 56799999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++....   ...+++..+.+|+.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus        91 ~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          91 NGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             TCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            999999876542   235899999999999999999999   78999999999999999999999999999998765432


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......||+.|||||
T Consensus       165 ~-~~~~~~gt~~y~APE  180 (272)
T d1qpca_         165 T-AREGAKFPIKWTAPE  180 (272)
T ss_dssp             E-CCTTCCCCTTTSCHH
T ss_pred             c-cccccCCcccccChH
Confidence            2 233457999999998

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.4e-32  Score=290.09  Aligned_cols=165  Identities=27%  Similarity=0.356  Sum_probs=147.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc--------ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      +.|++.+.||+|+||+||+|+++.+++.||||++.+.        ...+.+.+|++++++++|||||++++++.+++..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3689999999999999999999999999999998543        23578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC----ceEEeee
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIADF  823 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DF  823 (851)
                      +|||||++|+|.+++.+.     ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++    .+|++||
T Consensus        90 iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecch
Confidence            999999999999999764     35899999999999999999999   78999999999999998776    4999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+.......   .....||+.|||||
T Consensus       162 G~a~~~~~~~~---~~~~~~t~~y~APE  186 (293)
T d1jksa_         162 GLAHKIDFGNE---FKNIFGTPEFVAPE  186 (293)
T ss_dssp             TTCEECTTSCB---CSCCCCCGGGCCHH
T ss_pred             hhhhhcCCCcc---ccccCCCCcccCHH
Confidence            99987765432   23357999999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.98  E-value=2.5e-33  Score=296.10  Aligned_cols=169  Identities=26%  Similarity=0.411  Sum_probs=132.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc---EEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ++|+..+.||+|+||+||+|+++.+++   .||||++...   ...+.|.+|++++++++|||||++++++..++..|+|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            467888999999999999999976654   5899988654   2346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ||||++|+|.+++...    ...+++..+..++.|+|+||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus       106 ~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEc
Confidence            9999999999988753    346899999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcc---cccccccccccccCC
Q 003065          830 ENSPKVS---DYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~---~~~~~~gt~~Y~APE  851 (851)
                      .......   ......||+.|||||
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE  203 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPE  203 (299)
T ss_dssp             -----------------CGGGSCHH
T ss_pred             cCCCCcceeeecccccCCccccCHH
Confidence            5543221   122346899999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.7e-32  Score=282.93  Aligned_cols=167  Identities=22%  Similarity=0.344  Sum_probs=147.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||+||+|++ .+++.||||+++.. ...++|.+|++++++++|||||++++++.+++..|+||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            4789999999999999999998 46788999998764 456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|++.+++...    ...+++..+.+++.|+|+||+|||   +.+|+||||||+||++++++.+||+|||+|+.......
T Consensus        83 ~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          83 NGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            99999987654    345788999999999999999999   78999999999999999999999999999987655433


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......||+.|+|||
T Consensus       156 ~-~~~~~~~t~~y~aPE  171 (258)
T d1k2pa_         156 T-SSVGSKFPVRWSPPE  171 (258)
T ss_dssp             C-CCCCSCCCGGGCCHH
T ss_pred             e-eecccCCCCCcCCcH
Confidence            2 233457999999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.1e-33  Score=297.14  Aligned_cols=173  Identities=26%  Similarity=0.374  Sum_probs=145.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCc-----EEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAG-----TVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      ++|++.+.||+|+||+||+|++...++     .||||++...   .....+.+|+.+++++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            368899999999999999999865543     6999988543   2345688999999998 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC
Q 003065          747 FLVLEYMPNGNLFQALHKRVKE------------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSS  808 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~  808 (851)
                      |+|||||++|+|.++++.....                  ....+++..++.++.|+++||+|||   +++||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            9999999999999999764211                  1235789999999999999999999   789999999999


Q ss_pred             CEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          809 NILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       809 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++.++.+||+|||+|+...............||+.|||||
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  236 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  236 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence            9999999999999999998776554443344567899999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=1.3e-32  Score=296.58  Aligned_cols=164  Identities=25%  Similarity=0.366  Sum_probs=148.3

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +++|++.+.||+|+||.||+|+++.+++.||||++.+.     ...+.+.+|+++++.++|||||++++++.+.+..|+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            45899999999999999999999999999999998543     3456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+.+|++.+++.+.     ..+++..+..++.||+.||.|||   +++||||||||+|||++.+|.+||+|||+|+..
T Consensus       120 ~e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence            9999999999999764     35889999999999999999999   789999999999999999999999999999877


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....     ....||+.|||||
T Consensus       192 ~~~~-----~~~~Gt~~Y~APE  208 (350)
T d1rdqe_         192 KGRT-----WTLCGTPEALAPE  208 (350)
T ss_dssp             SSCB-----CCCEECGGGCCHH
T ss_pred             cccc-----ccccCccccCCHH
Confidence            5432     2357999999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=3e-32  Score=284.06  Aligned_cols=165  Identities=32%  Similarity=0.412  Sum_probs=147.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-----------cHHHHHHHHHHHHcCC-CCccccEEEEEEeC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----------GVKVFAAEMEILGKIR-HRNILKLYACLLKG  743 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  743 (851)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.+..           ..+.+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            47899999999999999999999999999999986531           1235789999999997 99999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeee
Q 003065          744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF  823 (851)
Q Consensus       744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF  823 (851)
                      +..|+|||||++|+|.++++..     ..+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccc
Confidence            9999999999999999999764     35899999999999999999999   789999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+........   ...+||+.|+|||
T Consensus       155 G~a~~~~~~~~~---~~~~gt~~y~~PE  179 (277)
T d1phka_         155 GFSCQLDPGEKL---REVCGTPSYLAPE  179 (277)
T ss_dssp             TTCEECCTTCCB---CCCCSCGGGCCHH
T ss_pred             hheeEccCCCce---eeeeccCCCCCHH
Confidence            999887654332   3367999999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=2.2e-32  Score=296.53  Aligned_cols=165  Identities=25%  Similarity=0.329  Sum_probs=143.3

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHH---HHHHHHcCCCCccccEEEEEEeCCee
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAA---EMEILGKIRHRNILKLYACLLKGGSS  746 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~  746 (851)
                      +++|++.+.||+|+||.||+|+++.+++.||||++.+.     .....+.+   |+++++.++|||||++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            45899999999999999999999999999999998543     22333444   46677778899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+|||||+||+|.+++.+.     ..+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             EEEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeecee
Confidence            9999999999999999764     35778899999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +.......    ...+||+.|||||
T Consensus       155 ~~~~~~~~----~~~~GT~~y~APE  175 (364)
T d1omwa3         155 CDFSKKKP----HASVGTHGYMAPE  175 (364)
T ss_dssp             EECSSSCC----CSCCSCGGGCCHH
T ss_pred             eecCCCcc----cccccccccchhH
Confidence            87665432    3357999999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-32  Score=288.08  Aligned_cols=168  Identities=30%  Similarity=0.473  Sum_probs=136.2

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCC----cEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNA----GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      .|+..++||+|+||.||+|+++.++    ..||||++....   ..++|.+|++++++++|||||++++++.+.+..++|
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v   87 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII   87 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence            5788899999999999999987554    469999986542   345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||++++++.+++...    ...+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        88 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          88 TEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999887653    456899999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcc-cccccccccccccCC
Q 003065          830 ENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ....... ......||+.|||||
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE  183 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPE  183 (283)
T ss_dssp             -------------CCCGGGSCHH
T ss_pred             cCCCccceEeccCCCCccccCHH
Confidence            5543222 223356899999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.9e-32  Score=285.37  Aligned_cols=167  Identities=24%  Similarity=0.330  Sum_probs=139.7

Q ss_pred             CCccCCe-ecccCcEEEEEEEEcC--CCcEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEE
Q 003065          677 NLEEDNL-IGSGGTGKVYRLDLKK--NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  750 (851)
                      +|...+. ||+|+||.||+|.++.  ++..||||++...   ...++|.+|++++++++|||||++++++.. +..|+||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            4555564 9999999999998754  3447999998654   235678999999999999999999999865 4689999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccC
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE  830 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~  830 (851)
                      |||++|+|.+++...    ...+++..+..++.|+|+||+|||   +++|+||||||+||+++.++.+||+|||+|+...
T Consensus        88 E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          88 EMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             ECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            999999999987542    356899999999999999999999   7899999999999999999999999999999776


Q ss_pred             CCCCc-ccccccccccccccCC
Q 003065          831 NSPKV-SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~-~~~~~~~gt~~Y~APE  851 (851)
                      ..... .......||+.|||||
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE  182 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPE  182 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHH
T ss_pred             ccccccccccccccCccccChH
Confidence            54322 2223456899999998

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=2.6e-32  Score=291.89  Aligned_cols=248  Identities=24%  Similarity=0.406  Sum_probs=130.0

Q ss_pred             cccEEecccccccC--CCCccccCcCCccEEEccC-CccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCcccee
Q 003065          266 LLQEFDISSNQMYG--KLPEEIGNLKNLTVFQCFK-NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDV  342 (851)
Q Consensus       266 ~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  342 (851)
                      .++.|||++|.++|  .+|..+++|++|++|++++ |+++|.+|..|+++++|++|++++|++.+..+..+..+..|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            56777777777766  3566677777777777765 66666666666666666666666666665555555555555555


Q ss_pred             eccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCcccc-ceEEecCCcC
Q 003065          343 DISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNV-GMLDFGDNDF  421 (851)
Q Consensus       343 ~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l  421 (851)
                      ++++|++.+.+                        |..+.+++.|+++++++|.+++.+|..+..+..+ +.+++++|++
T Consensus       131 ~l~~N~~~~~~------------------------p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l  186 (313)
T d1ogqa_         131 DFSYNALSGTL------------------------PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL  186 (313)
T ss_dssp             ECCSSEEESCC------------------------CGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred             ccccccccccC------------------------chhhccCcccceeeccccccccccccccccccccccccccccccc
Confidence            55555554333                        3334445556666666666666666555554443 4444444444


Q ss_pred             CCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCc
Q 003065          422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM  501 (851)
Q Consensus       422 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  501 (851)
                      ++..+..+..+.. ..+++++|.+.+.+|..+..+++|+.+++++|.+.+.+| .++.+++|+.|+|++|+++|.+|.++
T Consensus       187 ~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l  264 (313)
T d1ogqa_         187 TGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL  264 (313)
T ss_dssp             EEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred             ccccccccccccc-ccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHH
Confidence            4444444443322 234444444444444444444444444444444443332 34444444444444444444444444


Q ss_pred             ccccccceeeccCcccccccCCCccccccCCeEeCCCCc
Q 003065          502 GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK  540 (851)
Q Consensus       502 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  540 (851)
                      +++++|++|+|++|+|+|.+|. ++.+++|+.+++++|+
T Consensus       265 ~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         265 TQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             GGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             hCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence            4444444444444444444442 3344444444444443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.9e-32  Score=288.91  Aligned_cols=166  Identities=23%  Similarity=0.285  Sum_probs=146.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||+||+|.++.+++.||||++.... ....+.+|++++++++|||||++++++++++..|+|||||+
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            57999999999999999999999999999999997654 34567899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCC--CceEEeeecCccccCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED--YEPKIADFGVAKIAENS  832 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~  832 (851)
                      ||+|.+++...    ...+++..+..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+++.....
T Consensus        85 gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          85 GLDIFERINTS----AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            99999998653    335899999999999999999999   7899999999999999854  47999999999876544


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ..   .....||++|+|||
T Consensus       158 ~~---~~~~~~t~~y~ape  173 (321)
T d1tkia_         158 DN---FRLLFTAPEYYAPE  173 (321)
T ss_dssp             CE---EEEEESCGGGSCHH
T ss_pred             Cc---ccccccccccccch
Confidence            32   23357899999997

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.3e-32  Score=282.58  Aligned_cols=161  Identities=24%  Similarity=0.276  Sum_probs=134.9

Q ss_pred             CeecccCcEEEEEEEEcC--CCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccCC
Q 003065          682 NLIGSGGTGKVYRLDLKK--NAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +.||+|+||+||+|.++.  +++.||||++...    ...+++.+|++++++++|||||++++++.. +..|+||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998653  4567999998543    234679999999999999999999999865 457899999999


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCCc
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV  835 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~  835 (851)
                      |+|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+........
T Consensus        92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            9999998753     45899999999999999999999   789999999999999999999999999999876554332


Q ss_pred             c-cccccccccccccCC
Q 003065          836 S-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       836 ~-~~~~~~gt~~Y~APE  851 (851)
                      . ......||+.|||||
T Consensus       164 ~~~~~~~~gt~~y~APE  180 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPE  180 (277)
T ss_dssp             EEC----CCCGGGCCHH
T ss_pred             cccccccCCCceecCch
Confidence            2 223457999999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.4e-32  Score=286.77  Aligned_cols=166  Identities=32%  Similarity=0.479  Sum_probs=145.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHH-cCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILG-KIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.+.     ...+.+.+|+.++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999999999999999998642     34556777877765 68999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ||||++|+|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+..
T Consensus        82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence            9999999999999864     34788899999999999999999   789999999999999999999999999999866


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  ......||+.|||||
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE  173 (320)
T d1xjda_         154 MLGDA--KTNTFCGTPDYIAPE  173 (320)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHH
T ss_pred             ccccc--cccccCCCCCcCCHH
Confidence            54332  233467999999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.4e-32  Score=284.61  Aligned_cols=167  Identities=28%  Similarity=0.443  Sum_probs=137.6

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||+||+|+++.+ +.||||++... ...+.|.+|+.++++++|||||++++++.+ +..|+||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            4789999999999999999999654 57999998654 356789999999999999999999999854 56899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|++.+++....   ...+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.......
T Consensus        95 ~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          95 KGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             TCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            999999887642   235899999999999999999999   77999999999999999999999999999987654432


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                      . ......||+.|+|||
T Consensus       169 ~-~~~~~~gt~~y~aPE  184 (285)
T d1fmka3         169 T-ARQGAKFPIKWTAPE  184 (285)
T ss_dssp             --------CCGGGSCHH
T ss_pred             e-eeccccccccccChH
Confidence            2 223457999999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.5e-32  Score=286.95  Aligned_cols=167  Identities=23%  Similarity=0.352  Sum_probs=139.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCc----EEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      +|++.+.||+|+||+||+|++..+++    +||||++...   ...+.+.+|++++++++|||||++++++.++ ..+++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v   88 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   88 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence            68999999999999999999987775    5888887543   3467899999999999999999999999865 56788


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      +||+.+|+|.+++...    ...+++..+.+++.|||.||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        89 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          89 TQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            9999999999988763    456899999999999999999999   789999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .............||+.|||||
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE  183 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALE  183 (317)
T ss_dssp             TTTCC--------CCTTTSCHH
T ss_pred             ccccccccccccccCccccChH
Confidence            6655444444567999999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-31  Score=287.02  Aligned_cols=165  Identities=26%  Similarity=0.371  Sum_probs=141.0

Q ss_pred             HcCCccCC-eecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcC-CCCccccEEEEEEe----CCeeEE
Q 003065          675 ICNLEEDN-LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLK----GGSSFL  748 (851)
Q Consensus       675 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~l  748 (851)
                      +++|++.+ .||+|+||.||+|++..+++.||||++...   +.+.+|++++.++ +|||||+++++|++    +...|+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i   86 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   86 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence            45788764 699999999999999999999999998543   4567899987655 89999999999875    456899


Q ss_pred             EEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---CCceEEeeecC
Q 003065          749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGV  825 (851)
Q Consensus       749 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGl  825 (851)
                      |||||+||+|.+++.++   +...+++..+..++.|++.||+|||   +++|+||||||+|||++.   .+.+||+|||+
T Consensus        87 vmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          87 VMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccce
Confidence            99999999999999753   3346899999999999999999999   789999999999999985   56799999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+........   ...+||+.|||||
T Consensus       161 a~~~~~~~~~---~~~~gt~~y~aPE  183 (335)
T d2ozaa1         161 AKETTSHNSL---TTPCYTPYYVAPE  183 (335)
T ss_dssp             CEECCCCCCC---CCCSCCCSSCCCC
T ss_pred             eeeccCCCcc---ccccCCcccCCcH
Confidence            9877654332   3357999999999

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-31  Score=283.56  Aligned_cols=167  Identities=26%  Similarity=0.381  Sum_probs=143.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc----cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|++.+.||+|+||+||+|++..+++.||||++....    ..+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999999999999999985432    34678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+.+ ++.+++...   ....+++..+..++.|++.||+|||   +++||||||||+|||++.++.+||+|||.|+....
T Consensus        82 ~~~~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          82 FLHQ-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             CCSE-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ecCC-chhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC
Confidence            9964 555555443   3456899999999999999999999   78999999999999999999999999999987765


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  .....||+.|+|||
T Consensus       155 ~~~~--~~~~~gt~~y~apE  172 (298)
T d1gz8a_         155 PVRT--YTHEVVTLWYRAPE  172 (298)
T ss_dssp             CSBC--TTCCBCCCTTCCHH
T ss_pred             Cccc--ceeecccceeeehh
Confidence            4322  23357999999998

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.8e-29  Score=277.71  Aligned_cols=356  Identities=25%  Similarity=0.315  Sum_probs=185.1

Q ss_pred             ecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCC
Q 003065           79 SFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTG  158 (851)
Q Consensus        79 ~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~  158 (851)
                      .+...++++.++  ..++.+|++|++++++++. + +.+..|++|++|+|++|+|++.+ .++++++|++|++++|.+.+
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~-~l~~L~~L~~L~L~~n~i~~  102 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIAD  102 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC
T ss_pred             HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc-cccCCccccccccccccccc
Confidence            344444555443  2355667777777776653 2 34666777777777777766643 36666777777777776664


Q ss_pred             CCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCcccccccccccccccccc
Q 003065          159 RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR  238 (851)
Q Consensus       159 ~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~  238 (851)
                      ..+  ++++++|+.|++++|.+.  .++ .......+..+....|.+....+....                        
T Consensus       103 i~~--l~~l~~L~~L~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~------------------------  153 (384)
T d2omza2         103 ITP--LANLTNLTGLTLFNNQIT--DID-PLKNLTNLNRLELSSNTISDISALSGL------------------------  153 (384)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCC--CCG-GGTTCTTCSEEEEEEEEECCCGGGTTC------------------------
T ss_pred             ccc--cccccccccccccccccc--ccc-ccccccccccccccccccccccccccc------------------------
Confidence            322  556666666666666554  221 233344555555555555432221111                        


Q ss_pred             CCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEE
Q 003065          239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF  318 (851)
Q Consensus       239 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  318 (851)
                      ..............     ...+...+.........|...  ....+..+++++.+++++|.+++..|  +..+++|+.|
T Consensus       154 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L  224 (384)
T d2omza2         154 TSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL  224 (384)
T ss_dssp             TTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred             ccccccccccccch-----hhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEE
Confidence            11111111111111     111222233333333333322  22333444444555555554443322  2334445555


Q ss_pred             EeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccc
Q 003065          319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS  398 (851)
Q Consensus       319 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~  398 (851)
                      ++++|+++.  +..+..+++|+.|++++|++++..                          .+..+++|++|++++|+++
T Consensus       225 ~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~--------------------------~~~~~~~L~~L~l~~~~l~  276 (384)
T d2omza2         225 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA--------------------------PLSGLTKLTELKLGANQIS  276 (384)
T ss_dssp             ECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--------------------------GGTTCTTCSEEECCSSCCC
T ss_pred             ECCCCCCCC--cchhhcccccchhccccCccCCCC--------------------------cccccccCCEeeccCcccC
Confidence            555555542  123455555566666655554211                          1334455556666666555


Q ss_pred             cccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccc
Q 003065          399 GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALG  478 (851)
Q Consensus       399 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  478 (851)
                      +..+  +..++.++.++++.|++++.  ..+..+++++.|++++|++++..  .+..+++|++|++++|++++ ++ .+.
T Consensus       277 ~~~~--~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~  348 (384)
T d2omza2         277 NISP--LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLA  348 (384)
T ss_dssp             CCGG--GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGG
T ss_pred             CCCc--cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHc
Confidence            3322  44555566666666666542  23455666666666666666432  26666777777777777664 23 466


Q ss_pred             cCCcccEEEecCCcccCCCCCCcccccccceeeccCc
Q 003065          479 ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARN  515 (851)
Q Consensus       479 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  515 (851)
                      ++++|++|+|++|++++..|  ++++++|+.|+|++|
T Consensus       349 ~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            67777777777777765544  666777777777766

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=2.3e-31  Score=278.57  Aligned_cols=168  Identities=25%  Similarity=0.367  Sum_probs=137.4

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC----ee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG----SS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  746 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++...     ...+.+.+|++++++++|||||++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            3699999999999999999999999999999998643     22456889999999999999999999987654    37


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      |+||||++|++|.+++...     ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++..+++|||.+
T Consensus        87 ~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhh
Confidence            9999999999999988764     35889999999999999999999   789999999999999999999999999998


Q ss_pred             cccCCCCC-cccccccccccccccCC
Q 003065          827 KIAENSPK-VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~-~~~~~~~~gt~~Y~APE  851 (851)
                      +....... .......+||+.|||||
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE  184 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPE  184 (277)
T ss_dssp             EECC----------------TTCCHH
T ss_pred             hhhccccccccccccccCcccccCHH
Confidence            76543322 22234567999999998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.2e-31  Score=284.04  Aligned_cols=173  Identities=29%  Similarity=0.375  Sum_probs=145.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|++.+.||+|+||.||+|+++.     +++.||||++....   ..++|.+|++++++++||||+++++++...+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            368999999999999999999753     45789999986542   3567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhh-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC
Q 003065          748 LVLEYMPNGNLFQALHKRVK-------------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSS  808 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~  808 (851)
                      +||||+++|+|.+++.....                   .....+++..+..++.|++.||+|||   +++||||||||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~  169 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATR  169 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEccc
Confidence            99999999999999975321                   12235789999999999999999999   789999999999


Q ss_pred             CEEECCCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          809 NILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       809 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |||++.++.+||+|||+|+...............||+.|||||
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE  212 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE  212 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHH
Confidence            9999999999999999998765544333444567999999998

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=2.9e-29  Score=276.06  Aligned_cols=358  Identities=23%  Similarity=0.303  Sum_probs=254.7

Q ss_pred             EeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCC
Q 003065          102 LSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYD  181 (851)
Q Consensus       102 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  181 (851)
                      ..++.+.+++.++  ...+.+|++|++++|.|+.. +.+..+++|++|||++|++++..+  +.++++|++|++++|.  
T Consensus        27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~--   99 (384)
T d2omza2          27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ--   99 (384)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC--
T ss_pred             HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc-cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccc--
Confidence            3555666665544  34666777777777777643 456667777777777777664321  4455555555555554  


Q ss_pred             CCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCc
Q 003065          182 EAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL  261 (851)
Q Consensus       182 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  261 (851)
                                             +.+..  .++++++|+.|++++|.+++..+  ......+..+....|.+....+...
T Consensus       100 -----------------------i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~  152 (384)
T d2omza2         100 -----------------------IADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSG  152 (384)
T ss_dssp             -----------------------CCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTT
T ss_pred             -----------------------ccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccc
Confidence                                   44321  24455555555555555543322  2334455666666666664433333


Q ss_pred             CCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccce
Q 003065          262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTD  341 (851)
Q Consensus       262 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~  341 (851)
                      ..............     ....+...+.........|...  ....+..+++++.+++++|.+++..|  +...++|++
T Consensus       153 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~  223 (384)
T d2omza2         153 LTSLQQLSFGNQVT-----DLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDE  223 (384)
T ss_dssp             CTTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred             cccccccccccccc-----hhhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCE
Confidence            33333333322222     2234555666666777776654  34567888999999999999997655  466789999


Q ss_pred             eeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcC
Q 003065          342 VDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDF  421 (851)
Q Consensus       342 L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  421 (851)
                      |++++|++++.                          ..+..+++|+.|++++|++++..+  +..+++|+.|++++|++
T Consensus       224 L~l~~n~l~~~--------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l  275 (384)
T d2omza2         224 LSLNGNQLKDI--------------------------GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI  275 (384)
T ss_dssp             EECCSSCCCCC--------------------------GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCC
T ss_pred             EECCCCCCCCc--------------------------chhhcccccchhccccCccCCCCc--ccccccCCEeeccCccc
Confidence            99999998731                          235667889999999999996554  77899999999999999


Q ss_pred             CCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCc
Q 003065          422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM  501 (851)
Q Consensus       422 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  501 (851)
                      ++..+  +..++.++.+++++|++++  ...+..+++++.|++++|++++..|  +..+++|+.|+|++|+|++ ++ .+
T Consensus       276 ~~~~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l  347 (384)
T d2omza2         276 SNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SL  347 (384)
T ss_dssp             CCCGG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GG
T ss_pred             CCCCc--ccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hH
Confidence            87654  6788899999999999985  3458889999999999999997643  8899999999999999985 44 69


Q ss_pred             ccccccceeeccCcccccccCCCccccccCCeEeCCCCc
Q 003065          502 GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK  540 (851)
Q Consensus       502 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  540 (851)
                      +++++|++|++++|+|++.+|  +.++++|+.|+|++|.
T Consensus       348 ~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             GGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             cCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            999999999999999998765  8999999999999984

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-31  Score=283.44  Aligned_cols=162  Identities=28%  Similarity=0.381  Sum_probs=136.3

Q ss_pred             cCCeecccCcEEEEEEEEcCCCcEEEEEEeccccc-------HHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEec
Q 003065          680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-------VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY  752 (851)
Q Consensus       680 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  752 (851)
                      ..++||+|+||+||+|+++.+++.||||++.....       .+.+.+|++++++++|||||++++++..++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            35789999999999999999999999999854321       24578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCC
Q 003065          753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS  832 (851)
Q Consensus       753 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~  832 (851)
                      ++++++..+..     ....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          82 METDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             CSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             hcchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC
Confidence            98876654432     2345777888999999999999999   789999999999999999999999999999876554


Q ss_pred             CCcccccccccccccccCC
Q 003065          833 PKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...  ....+||+.|||||
T Consensus       154 ~~~--~~~~~gt~~y~aPE  170 (299)
T d1ua2a_         154 NRA--YTHQVVTRWYRAPE  170 (299)
T ss_dssp             CCC--CCCSCCCCTTCCHH
T ss_pred             ccc--ccceecChhhccHH
Confidence            322  23357999999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.8e-31  Score=281.35  Aligned_cols=173  Identities=31%  Similarity=0.388  Sum_probs=136.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeC-Ce
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKG-GS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  745 (851)
                      ++|++.+.||+|+||+||+|++..     +++.||||++...   ...+.+.+|..++.++ +|+|||.+++++... +.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            468899999999999999999754     3467999998654   2345677888888777 689999999987654 56


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE  814 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~  814 (851)
                      .|+|||||++|+|.++++.....           ....+++..+..++.|+++||+|||   +++||||||||+|||++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence            89999999999999999865321           1235889999999999999999999   789999999999999999


Q ss_pred             CCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       815 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.+||+|||+|+...............||+.|||||
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE  206 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  206 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchh
Confidence            9999999999998776554444445568999999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-31  Score=275.83  Aligned_cols=163  Identities=29%  Similarity=0.452  Sum_probs=134.9

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEe-CCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  754 (851)
                      ++|+..+.||+|+||.||+|++  .+.+||||+++.....+.+.+|++++++++|||||++++++.+ .+..|+||||++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            3678889999999999999998  4678999999888778889999999999999999999998854 466899999999


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCCC
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK  834 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~  834 (851)
                      +|+|.+++..+.   ...+++..+.+++.||+.|++|||   +.+|+||||||+||+++.++.+|++|||+++...... 
T Consensus        85 ~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-  157 (262)
T d1byga_          85 KGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  157 (262)
T ss_dssp             TEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence            999999997652   224789999999999999999999   7899999999999999999999999999998654432 


Q ss_pred             cccccccccccccccCC
Q 003065          835 VSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       835 ~~~~~~~~gt~~Y~APE  851 (851)
                          ....+|+.|+|||
T Consensus       158 ----~~~~~~~~y~aPE  170 (262)
T d1byga_         158 ----DTGKLPVKWTAPE  170 (262)
T ss_dssp             --------CCTTTSCHH
T ss_pred             ----ccccccccCCChH
Confidence                2246899999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.7e-31  Score=276.01  Aligned_cols=164  Identities=27%  Similarity=0.376  Sum_probs=141.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------cHHHHHHHHHHHHcCC--CCccccEEEEEEeCCe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIR--HRNILKLYACLLKGGS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  745 (851)
                      ++|++.+.||+|+||.||+|++..+++.||||++.+..        ...++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            47899999999999999999999999999999986431        1234678999999986  8999999999999999


Q ss_pred             eEEEEeccCC-CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-CCceEEeee
Q 003065          746 SFLVLEYMPN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADF  823 (851)
Q Consensus       746 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DF  823 (851)
                      .|+||||+++ +++.+++...     ..+++..+..++.|+++||+|||   +++|+||||||+|||++. ++.+||+||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcc
Confidence            9999999976 6788887764     35889999999999999999999   789999999999999985 579999999


Q ss_pred             cCccccCCCCCcccccccccccccccCC
Q 003065          824 GVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       824 Gla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+|+......    .....||+.|||||
T Consensus       156 G~a~~~~~~~----~~~~~GT~~y~aPE  179 (273)
T d1xwsa_         156 GSGALLKDTV----YTDFDGTRVYSPPE  179 (273)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHH
T ss_pred             ccceeccccc----ccccccCCCcCCHH
Confidence            9998754432    23467999999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.4e-31  Score=276.94  Aligned_cols=167  Identities=32%  Similarity=0.422  Sum_probs=136.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHH--HHHHHcCCCCccccEEEEEEeCC----eeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAE--MEILGKIRHRNILKLYACLLKGG----SSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~~~----~~~lv  749 (851)
                      ++|...+.||+|+||.||+|++  +++.||||++.... .+.+.+|  +..+.+++|||||++++++.+.+    ..|+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            3577788999999999999987  67899999986543 3344444  44556789999999999987654    57999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD-----CSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      ||||++|+|.+++++.      .++|..+.+++.|+|.|++|+|..     .+++||||||||+|||++.++.+||+|||
T Consensus        80 ~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            9999999999999753      588999999999999999999942     13699999999999999999999999999


Q ss_pred             CccccCCCCCcc--cccccccccccccCC
Q 003065          825 VAKIAENSPKVS--DYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~--~~~~~~gt~~Y~APE  851 (851)
                      +++.........  .....+||+.|||||
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE  182 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPE  182 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHH
T ss_pred             ccccccCCCcceeccccceecccCcCChh
Confidence            998775543221  233467999999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.8e-31  Score=274.27  Aligned_cols=167  Identities=26%  Similarity=0.304  Sum_probs=130.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC---cEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA---GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ++|+..+.||+|+||.||+|++..++   ..||||++...   ...+.+.+|++++++++|||||++++++. .+..|+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            36889999999999999999986543   46899988643   23467899999999999999999999986 4678999


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      |||+++|++.+++...    ...+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+|+..
T Consensus        86 ~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          86 MELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999987653    346899999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ...... ......||+.|+|||
T Consensus       159 ~~~~~~-~~~~~~gt~~y~apE  179 (273)
T d1mp8a_         159 EDSTYY-KASKGKLPIKWMAPE  179 (273)
T ss_dssp             -------------CCGGGCCHH
T ss_pred             cCCcce-eccceecCcccchhh
Confidence            543322 223456899999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.6e-31  Score=277.73  Aligned_cols=173  Identities=21%  Similarity=0.312  Sum_probs=147.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcC-----CCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|+..+.||+|+||.||+|.+..     ++..||||++....   ....+.+|++++++++|||||++++++..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            467889999999999999998853     34679999996543   3346889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhhh-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          748 LVLEYMPNGNLFQALHKRVK-----EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      +||||+++|+|.+++.....     .....+++..+.+++.|+|+||.|||   +++|+||||||+|||++.++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence            99999999999999876421     22345789999999999999999999   67999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|+...............||+.|+|||
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe  205 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPE  205 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred             cccceeccCCcceeeccceecccccCCHH
Confidence            99998776554444444557999999997

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-30  Score=277.31  Aligned_cols=170  Identities=32%  Similarity=0.489  Sum_probs=142.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcE--EEEEEeccc---ccHHHHHHHHHHHHcC-CCCccccEEEEEEeCCeeEEE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGT--VAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLV  749 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  749 (851)
                      ++|+..+.||+|+||.||+|+++.++..  ||||++...   ...+.+.+|+++++++ +|||||++++++.+++..|+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            4788899999999999999999888764  778877533   3455789999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhh-----------hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCce
Q 003065          750 LEYMPNGNLFQALHKRV-----------KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP  818 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~  818 (851)
                      |||+++|+|.++++...           ......+++..+.+++.|||+|+.|+|   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            99999999999997541           123457899999999999999999999   7899999999999999999999


Q ss_pred             EEeeecCccccCCCCCcccccccccccccccCC
Q 003065          819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       819 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+|||+|+.......   .....||+.|+|||
T Consensus       167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE  196 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIE  196 (309)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHH
T ss_pred             EEcccccccccccccc---ccceecCCcccchH
Confidence            9999999986543322   22346899999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.7e-30  Score=276.42  Aligned_cols=173  Identities=29%  Similarity=0.408  Sum_probs=148.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEc-----CCCcEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCCee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  746 (851)
                      ++|+..+.||+|+||.||+|++.     .+++.||||+++...   ....+.+|+.+++++ +|||||++++++.+++..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            36888999999999999999863     456789999996543   345688999999999 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhhh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          747 FLVLEYMPNGNLFQALHKRVK-------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      |+|||||++|+|.+++++...             .....+++..+..++.||++|++|||   ++++|||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence            999999999999999987532             12335889999999999999999999   78999999999999999


Q ss_pred             CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++.+|++|||.++...............||+.|+|||
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE  217 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE  217 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHH
Confidence            99999999999999876655444445568999999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.7e-30  Score=274.68  Aligned_cols=173  Identities=29%  Similarity=0.389  Sum_probs=143.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCC-------cEEEEEEecccc---cHHHHHHHHHHHHcC-CCCccccEEEEEEeCC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNA-------GTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGG  744 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  744 (851)
                      ++|++.+.||+|+||.||+|+...++       ..||||++....   ....+.+|+..+.++ +|||||++++++.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            37888999999999999999976544       369999986553   346678899999888 8999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhh-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEEC
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD  813 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~  813 (851)
                      ..|+||||+++|+|.+++..+..           .....+++..++.++.|++.||+|||   +.+||||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            99999999999999999976532           12346899999999999999999999   78999999999999999


Q ss_pred             CCCceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       814 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .++.+||+|||+++...............||+.|+|||
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  207 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE  207 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhh
Confidence            99999999999999776655444445567999999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.3e-30  Score=269.40  Aligned_cols=168  Identities=27%  Similarity=0.376  Sum_probs=133.2

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC-C--cEEEEEEeccc-----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeE
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN-A--GTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF  747 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~--~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  747 (851)
                      ++|++.+.||+|+||.||+|++... +  ..||||++.+.     ...++|.+|++++++++|||||++++++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            4688999999999999999987533 2  36899988543     235678999999999999999999999965 4678


Q ss_pred             EEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       748 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      +||||+++|++.+++..+    ...+++..+..++.|+|+||+|||   +++|+||||||+||+++.++.+||+|||+|+
T Consensus        87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhh
Confidence            999999999999988765    235899999999999999999999   7899999999999999999999999999999


Q ss_pred             ccCCCCCcc-cccccccccccccCC
Q 003065          828 IAENSPKVS-DYSCFAGTHGYIAPG  851 (851)
Q Consensus       828 ~~~~~~~~~-~~~~~~gt~~Y~APE  851 (851)
                      ......... ......||+.|+|||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE  184 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPE  184 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHH
T ss_pred             hcccCCCcceecCccccCcccCCHH
Confidence            876554322 223346788999998

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.96  E-value=9.6e-30  Score=268.10  Aligned_cols=168  Identities=18%  Similarity=0.217  Sum_probs=145.3

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCC-CccccEEEEEEeCCeeEEEEeccC
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLLKGGSSFLVLEYMP  754 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~  754 (851)
                      ++|++.+.||+|+||+||+|++..+++.||||++......+.+.+|+++++.++| +|++.+++++.+++..|+||||+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            3689999999999999999999999999999998666555667899999999975 89999999999999999999999 


Q ss_pred             CCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC-----CCceEEeeecCcccc
Q 003065          755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-----DYEPKIADFGVAKIA  829 (851)
Q Consensus       755 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~  829 (851)
                      +++|.+++...    ...++...+..++.|++.|++|||   +++|+||||||+||+++.     ++.+||+|||+|+..
T Consensus        84 ~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          84 GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            78999988753    345889999999999999999999   889999999999999974     578999999999876


Q ss_pred             CCCCCc-----ccccccccccccccCC
Q 003065          830 ENSPKV-----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~-----~~~~~~~gt~~Y~APE  851 (851)
                      ......     ......+||+.|||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE  183 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSIN  183 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred             ccCccccceeecccCceEEchhhcCHH
Confidence            543221     1233568999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-29  Score=269.36  Aligned_cols=164  Identities=30%  Similarity=0.402  Sum_probs=137.7

Q ss_pred             CCeecccCcEEEEEEEEcCCC---cEEEEEEeccc---ccHHHHHHHHHHHHcCCCCccccEEEEEEe-CCeeEEEEecc
Q 003065          681 DNLIGSGGTGKVYRLDLKKNA---GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSSFLVLEYM  753 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  753 (851)
                      .++||+|+||+||+|++..++   ..||||++...   ...++|.+|++++++++|||||++++++.. ++..|+|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            578999999999999986543   35999998643   345679999999999999999999998765 56889999999


Q ss_pred             CCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCCCC
Q 003065          754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP  833 (851)
Q Consensus       754 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~  833 (851)
                      ++|+|.+++...    ....++..+.+++.|+++||.|+|   +++|+||||||+|||+++++.+||+|||+++......
T Consensus       112 ~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            999999988753    445778888999999999999999   7899999999999999999999999999998765443


Q ss_pred             Cc--ccccccccccccccCC
Q 003065          834 KV--SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       834 ~~--~~~~~~~gt~~Y~APE  851 (851)
                      ..  .......||+.|+|||
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE  204 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALE  204 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHH
T ss_pred             cccceecccccccccccChH
Confidence            22  2223457999999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.96  E-value=3.9e-30  Score=270.72  Aligned_cols=165  Identities=28%  Similarity=0.346  Sum_probs=138.8

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|+..+.||+|+||+||+|+++ +++.||||++...    ...+.+.+|+.++++++|||||++++++..++..|++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            57999999999999999999985 7899999998553    235678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      |+.++.+..+..     ....++...+..++.||+.||+|||   +.+||||||||+|||++.++.+|++|||.|.....
T Consensus        81 ~~~~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          81 HLDQDLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             CCSEEHHHHHHT-----STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             eehhhhHHHHHh-----hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            997665554433     2456899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....  .....||+.|+|||
T Consensus       153 ~~~~--~~~~~~~~~y~~pE  170 (286)
T d1ob3a_         153 PVRK--YTHEIVTLWYRAPD  170 (286)
T ss_dssp             -----------CCCTTCCHH
T ss_pred             Cccc--cceecccchhhhHH
Confidence            4322  23356899999997

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-29  Score=275.03  Aligned_cols=165  Identities=29%  Similarity=0.422  Sum_probs=136.8

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccccEEEEEEeC------CeeEEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG------GSSFLVL  750 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  750 (851)
                      +|+..++||+|+||+||+|++..+++.||||++.....  ...+|++++++++|||||+++++|...      .+.|+||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            57888999999999999999999999999999865432  234799999999999999999998543      3478999


Q ss_pred             eccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-ceEEeeecCcccc
Q 003065          751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIA  829 (851)
Q Consensus       751 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~  829 (851)
                      |||+++ +.+.+.... .....+++..+..++.|++.||+|||   +++|+||||||+|||++.++ .+||+|||+|+..
T Consensus        99 Ey~~~~-~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          99 DYVPET-VYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             ECCSEE-HHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             eccCCc-cHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999755 444444322 23456899999999999999999999   88999999999999999775 8999999999877


Q ss_pred             CCCCCcccccccccccccccCC
Q 003065          830 ENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......   ...+||+.|+|||
T Consensus       174 ~~~~~~---~~~~gt~~y~aPE  192 (350)
T d1q5ka_         174 VRGEPN---VSYICSRYYRAPE  192 (350)
T ss_dssp             CTTSCC---CSCCSCTTSCCHH
T ss_pred             cCCccc---ccccccccccChH
Confidence            554322   3357999999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=1e-29  Score=273.13  Aligned_cols=162  Identities=23%  Similarity=0.308  Sum_probs=140.2

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCC-CCccccEEEEEEeC--CeeEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLKG--GSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  751 (851)
                      .++|++.+.||+|+||+||+|+++.+++.||||++... ..+++.+|++++++++ ||||+++++++...  ...|+|||
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            35799999999999999999999999999999998654 4577889999999995 99999999999754  56899999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC-ceEEeeecCccccC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAE  830 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~  830 (851)
                      |+++++|.++.        ..++...+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+...
T Consensus       113 ~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         113 HVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             CCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             ecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceecc
Confidence            99999986542        25888999999999999999999   78999999999999998655 69999999998776


Q ss_pred             CCCCcccccccccccccccCC
Q 003065          831 NSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       831 ~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ....   ....+||+.|+|||
T Consensus       182 ~~~~---~~~~~~t~~y~aPE  199 (328)
T d3bqca1         182 PGQE---YNVRVASRYFKGPE  199 (328)
T ss_dssp             TTCC---CCSCCSCGGGCCHH
T ss_pred             CCCc---ccccccCccccCcc
Confidence            5433   23357999999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-29  Score=273.25  Aligned_cols=166  Identities=25%  Similarity=0.374  Sum_probs=137.4

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc---cHHHHHHHHHHHHcCCCCccccEEEEEEeCC----eeEEE
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGG----SSFLV  749 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  749 (851)
                      +|++.+.||+|+||+||+|++..+++.||||++.+..   ..+.+.+|++++++++||||+++++++....    ..+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            6899999999999999999999999999999986543   3457889999999999999999999986543    23445


Q ss_pred             EeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCcccc
Q 003065          750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA  829 (851)
Q Consensus       750 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~  829 (851)
                      ++|+.+|+|.+++...      .+++..+..++.|++.||+|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus        89 ~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          89 VTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            5566799999999752      5889999999999999999999   789999999999999999999999999999865


Q ss_pred             CCCCCc-ccccccccccccccCC
Q 003065          830 ENSPKV-SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       830 ~~~~~~-~~~~~~~gt~~Y~APE  851 (851)
                      ...... ......+||+.|+|||
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE  182 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPE  182 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGG
T ss_pred             cCCCccceeeccccccceechHH
Confidence            443221 1234467999999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.4e-29  Score=272.14  Aligned_cols=161  Identities=29%  Similarity=0.436  Sum_probs=135.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCC------e
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------S  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  745 (851)
                      .+|++.+.||+|+||+||+|+++.+++.||||++...    ...+.+.+|++++++++|||||+++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            4789999999999999999999999999999998653    23457889999999999999999999997654      4


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+||||+ +.++.++.+.      ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+|++|||+
T Consensus        98 ~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccc
Confidence            69999999 6678777654      25899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      |+......     +..+||+.|+|||
T Consensus       168 a~~~~~~~-----~~~~~t~~y~aPE  188 (346)
T d1cm8a_         168 ARQADSEM-----TGYVVTRWYRAPE  188 (346)
T ss_dssp             CEECCSSC-----CSSCSCGGGCCTH
T ss_pred             eeccCCcc-----ccccccccccCHH
Confidence            98765432     3357999999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.6e-29  Score=267.69  Aligned_cols=169  Identities=24%  Similarity=0.339  Sum_probs=137.8

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe--------
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK--------  742 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  742 (851)
                      +++|++.+.||+|+||+||+|++..+++.||||++...    ...+++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            57899999999999999999999999999999998543    234678899999999999999999998754        


Q ss_pred             CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      .+..|+||||++++.+..+. .    ....++...+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~----~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-N----VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-C----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEEeccCCCccchhh-h----cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeee
Confidence            34679999999776554332 2    3456788889999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCc--ccccccccccccccCC
Q 003065          823 FGVAKIAENSPKV--SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~--~~~~~~~gt~~Y~APE  851 (851)
                      ||+|+........  ......+||+.|+|||
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE  191 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPE  191 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHH
T ss_pred             cceeeecccccccccccccceecCHHHhhHH
Confidence            9999876543221  1223457999999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.4e-29  Score=267.48  Aligned_cols=166  Identities=26%  Similarity=0.309  Sum_probs=135.1

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCC-CcEEEEEEeccc----ccHHHHHHHHHHHHcC---CCCccccEEEEEEe-----
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKN-AGTVAVKQLWKG----DGVKVFAAEMEILGKI---RHRNILKLYACLLK-----  742 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  742 (851)
                      ++|++.+.||+|+||+||+|++..+ ++.||||++...    .....+.+|+++++.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            5799999999999999999999765 567999998543    2233466788877766   79999999998853     


Q ss_pred             CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEee
Q 003065          743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD  822 (851)
Q Consensus       743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D  822 (851)
                      ....|++|||++++.+......    ....+++..+..++.|++.||+|||   +++||||||||+|||++.++.+||+|
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecc
Confidence            3467999999987765443332    3456889999999999999999999   78999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccccCC
Q 003065          823 FGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       823 FGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ||+++......   ......||+.|||||
T Consensus       160 fg~~~~~~~~~---~~~~~~gT~~Y~APE  185 (305)
T d1blxa_         160 FGLARIYSFQM---ALTSVVVTLWYRAPE  185 (305)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHH
T ss_pred             hhhhhhhcccc---cCCCcccChhhcCcc
Confidence            99998654332   234468999999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1e-28  Score=260.87  Aligned_cols=166  Identities=25%  Similarity=0.306  Sum_probs=145.0

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeCCeeEEEEe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..    ...+++.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999999999999999998543    235778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCccccCC
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN  831 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~  831 (851)
                      ++.++++..++..     ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.|+....
T Consensus        82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence            9999888777654     345788899999999999999999   78999999999999999999999999999987765


Q ss_pred             CCCcccccccccccccccCC
Q 003065          832 SPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       832 ~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .....  ....+++.|+|||
T Consensus       154 ~~~~~--~~~~~~~~~~~pe  171 (292)
T d1unla_         154 PVRCY--SAEVVTLWYRPPD  171 (292)
T ss_dssp             CCSCC--CSCCSCGGGCCHH
T ss_pred             CCccc--eeeccccchhhhh
Confidence            43322  2345788888886

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=9.5e-29  Score=261.80  Aligned_cols=167  Identities=22%  Similarity=0.252  Sum_probs=140.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccc-cEEEEEEeCCeeEEEEeccCC
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNIL-KLYACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  755 (851)
                      +|++.+.||+|+||+||+|++..+++.||||++......+++.+|+++++.++|++++ .+.+++.+++..++||||+ +
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~   86 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G   86 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence            5899999999999999999999999999999987665556788999999999877655 5667778888999999999 6


Q ss_pred             CCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECC---CCceEEeeecCccccCCC
Q 003065          756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVAKIAENS  832 (851)
Q Consensus       756 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~  832 (851)
                      +++.+.+...    ...+++..+..++.|++.||+|||   +++|+||||||+|||++.   +..+|++|||+|+.....
T Consensus        87 ~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          87 PSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Cchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            6777766543    346899999999999999999999   789999999999999864   457999999999987654


Q ss_pred             CCc-----ccccccccccccccCC
Q 003065          833 PKV-----SDYSCFAGTHGYIAPG  851 (851)
Q Consensus       833 ~~~-----~~~~~~~gt~~Y~APE  851 (851)
                      ...     .......||+.|||||
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE  183 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASIN  183 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHH
T ss_pred             ccccceeccccCCcCCCccccCHH
Confidence            322     1234568999999998

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.1e-29  Score=264.93  Aligned_cols=168  Identities=29%  Similarity=0.361  Sum_probs=144.4

Q ss_pred             HcCCccCCeecccCcEEEEEEEEc---CCCcEEEEEEeccc------ccHHHHHHHHHHHHcCCC-CccccEEEEEEeCC
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRH-RNILKLYACLLKGG  744 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~  744 (851)
                      +++|++.+.||+|+||+||+|++.   .+++.||||++.+.      ...+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            467999999999999999999874   46889999988543      234567899999999976 89999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeec
Q 003065          745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG  824 (851)
Q Consensus       745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  824 (851)
                      ..|+||||+.+|+|.+++...     .......+..++.|++.|++|+|   +.+|+||||||+||+++.++.+||+|||
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             ceeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeecc
Confidence            999999999999999999865     24567788889999999999999   7899999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccccCC
Q 003065          825 VAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       825 la~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      +|+........ ......||+.|+|||
T Consensus       175 ~a~~~~~~~~~-~~~~~~g~~~~~~pe  200 (322)
T d1vzoa_         175 LSKEFVADETE-RAYDFCGTIEYMAPD  200 (322)
T ss_dssp             EEEECCGGGGG-GGCGGGSCCTTCCHH
T ss_pred             chhhhcccccc-cccccccccccchhH
Confidence            99876543322 233457999999997

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=3.3e-26  Score=243.13  Aligned_cols=273  Identities=19%  Similarity=0.267  Sum_probs=161.6

Q ss_pred             cccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-
Q 003065           61 CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-  139 (851)
Q Consensus        61 c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-  139 (851)
                      |.|.+|.|++            ++|+ .+|+.+.  +++++|+|++|+|+...+..|.++++|++|++++|.+....|. 
T Consensus        10 c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~   74 (305)
T d1xkua_          10 CHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA   74 (305)
T ss_dssp             EETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred             ecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence            7888888864            2344 4565553  5677777777777643334566777777777777766665554 


Q ss_pred             CCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCccccccccc
Q 003065          140 LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL  219 (851)
Q Consensus       140 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  219 (851)
                      |.++++|++|++++|+++.                          +|..+  ...++.|++++|.+.+..+..+.....+
T Consensus        75 f~~l~~L~~L~l~~n~l~~--------------------------l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~  126 (305)
T d1xkua_          75 FAPLVKLERLYLSKNQLKE--------------------------LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQM  126 (305)
T ss_dssp             TTTCTTCCEEECCSSCCSB--------------------------CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTC
T ss_pred             hhCCCccCEecccCCccCc--------------------------Cccch--hhhhhhhhccccchhhhhhhhhhccccc
Confidence            6666666666666666652                          22221  1344445555555544333334444444


Q ss_pred             Ccccccccccc--ccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEcc
Q 003065          220 GTLDICRNKIS--GEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF  297 (851)
Q Consensus       220 ~~L~L~~N~i~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~  297 (851)
                      ..++...|...  ...+..+..+++|+++++++|.++ .+|..+  .++|+.|++++|.+.+..+..|.+++.++.|+++
T Consensus       127 ~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s  203 (305)
T d1xkua_         127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS  203 (305)
T ss_dssp             CEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECC
T ss_pred             cccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccc
Confidence            44555444322  223345566666666666666666 344332  4566777777777666666666677777777777


Q ss_pred             CCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccc
Q 003065          298 KNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEV  377 (851)
Q Consensus       298 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~  377 (851)
                      +|.+++..+..|.++++|++|+|++|+|+ .+|.++..+++|+.|+|++|+|+..-...|..                  
T Consensus       204 ~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~------------------  264 (305)
T d1xkua_         204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP------------------  264 (305)
T ss_dssp             SSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC------------------
T ss_pred             cccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccC------------------
Confidence            77776666666667777777777777776 44666777777777777777776322222211                  


Q ss_pred             cccccCccccceeccccCccc
Q 003065          378 PNSYADCKTIQRLRISDNHLS  398 (851)
Q Consensus       378 p~~~~~l~~L~~L~Ls~N~l~  398 (851)
                      +..+....+|+.|+|++|.++
T Consensus       265 ~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         265 PGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             SSCCTTSCCCSEEECCSSSSC
T ss_pred             cchhcccCCCCEEECCCCcCc
Confidence            123344556777777777664

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=3.4e-26  Score=242.98  Aligned_cols=109  Identities=27%  Similarity=0.312  Sum_probs=58.4

Q ss_pred             CCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeec
Q 003065          433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL  512 (851)
Q Consensus       433 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  512 (851)
                      ++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.++..+++|+.|+|
T Consensus       171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L  249 (305)
T d1xkua_         171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL  249 (305)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred             CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence            34445555555554444555555555555555555555444555555555555555555554 34445555555555555


Q ss_pred             cCcccccccCC------CccccccCCeEeCCCCccc
Q 003065          513 ARNSLSGNIPR------SLSLLSSLNALNLSGNKLT  542 (851)
Q Consensus       513 s~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~  542 (851)
                      ++|+|+.....      .+..+.+|+.|+|++|+++
T Consensus       250 s~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             CCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            55555532222      2334567888888888775

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.6e-28  Score=262.66  Aligned_cols=162  Identities=33%  Similarity=0.388  Sum_probs=128.5

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEe------CCe
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK------GGS  745 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  745 (851)
                      ++|++.+.||+|+||+||+|+++.+++.||||++...    ...+++.+|+.++++++|||||+++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999999999999999998654    234568899999999999999999999964      367


Q ss_pred             eEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecC
Q 003065          746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV  825 (851)
Q Consensus       746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl  825 (851)
                      .|+||||+.+ ++.+.+.       ..+++..+..++.|++.||+|||   ++||+||||||+|||++.++.+|++|||+
T Consensus        97 ~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhh
Confidence            8999999965 4544442       24788999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccCC
Q 003065          826 AKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       826 a~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ++.......   ....+||+.|+|||
T Consensus       166 ~~~~~~~~~---~~~~~~t~~y~aPE  188 (355)
T d2b1pa1         166 ARTAGTSFM---MTPYVVTRYYRAPE  188 (355)
T ss_dssp             ------------------CCTTCCHH
T ss_pred             hhccccccc---cccccccccccChh
Confidence            987655432   23457999999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.5e-28  Score=264.58  Aligned_cols=162  Identities=27%  Similarity=0.368  Sum_probs=135.7

Q ss_pred             cCCccCCeecccCcEEEEEEEEcCCCcEEEEEEeccc----ccHHHHHHHHHHHHcCCCCccccEEEEEEeC-----Cee
Q 003065          676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSS  746 (851)
Q Consensus       676 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  746 (851)
                      ++|++.+.||+|+||+||+|++..+++.||||++.+.    ...+++.+|++++++++|||||++++++...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            3699999999999999999999999999999998654    2345688999999999999999999998643     334


Q ss_pred             EEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCceEEeeecCc
Q 003065          747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA  826 (851)
Q Consensus       747 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla  826 (851)
                      ++++||+.+|+|.+++..      ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+|++|||.|
T Consensus        98 ~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             EEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchh
Confidence            666777889999998853      35899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCC
Q 003065          827 KIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       827 ~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      ......     ..+..||+.|+|||
T Consensus       169 ~~~~~~-----~~~~~g~~~y~apE  188 (348)
T d2gfsa1         169 RHTDDE-----MTGYVATRWYRAPE  188 (348)
T ss_dssp             -CCTGG-----GSSSCHHHHTSCHH
T ss_pred             cccCcc-----cccccccccccCch
Confidence            755432     23357999999998

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.9e-26  Score=240.75  Aligned_cols=223  Identities=19%  Similarity=0.206  Sum_probs=111.1

Q ss_pred             EecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccCCcc
Q 003065          270 FDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQF  349 (851)
Q Consensus       270 L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  349 (851)
                      ++.++++++ .+|..+.  +++++|+|++|+|+...+..|.++++|++|++++|++....+..+..+..++.++.+.+  
T Consensus        16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~--   90 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN--   90 (284)
T ss_dssp             EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC--
T ss_pred             EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc--
Confidence            344555554 4444332  34555555555555433334555555555555555554444444444444444433211  


Q ss_pred             cccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCccc
Q 003065          350 SGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLI  429 (851)
Q Consensus       350 ~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~  429 (851)
                                           |.+....|..|.++++|++|++++|.+.+..+..+...++|+.+++++|+++++++..|
T Consensus        91 ---------------------~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f  149 (284)
T d1ozna_          91 ---------------------AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF  149 (284)
T ss_dssp             ---------------------TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             ---------------------cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHh
Confidence                                 11222224445555566666666666554444455555555555555555555555555


Q ss_pred             ccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccce
Q 003065          430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD  509 (851)
Q Consensus       430 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  509 (851)
                      ..+++|+.|++++|++++..+.+|.++++|+++++++|++++..|..|..+++|++||+++|++++..|..|+.+.+|++
T Consensus       150 ~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~  229 (284)
T d1ozna_         150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY  229 (284)
T ss_dssp             TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred             ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence            55555555555555555444555555555555555555555544555555555555555555555444444445555555


Q ss_pred             eeccCcccc
Q 003065          510 LNLARNSLS  518 (851)
Q Consensus       510 L~Ls~N~l~  518 (851)
                      |+|++|.+.
T Consensus       230 L~l~~N~l~  238 (284)
T d1ozna_         230 LRLNDNPWV  238 (284)
T ss_dssp             EECCSSCEE
T ss_pred             EEecCCCCC
Confidence            555555444

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.3e-25  Score=233.80  Aligned_cols=224  Identities=21%  Similarity=0.263  Sum_probs=141.3

Q ss_pred             EEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-CCCCCCCCeEeccCcccCCCCcccccCccccceeeccccc
Q 003065          101 VLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV  179 (851)
Q Consensus       101 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  179 (851)
                      .++.++++++ .+|..+.  +++++|+|++|+|++.++. |.++++|++||+++|.+....+..+.+++.++.++...  
T Consensus        15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~--   89 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD--   89 (284)
T ss_dssp             EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS--
T ss_pred             EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccc--
Confidence            4566677776 5676554  5677777777777766654 77777777777777777655555555555555554432  


Q ss_pred             CCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCc
Q 003065          180 YDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPA  259 (851)
Q Consensus       180 l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  259 (851)
                                            .|.++...|..|.++++|++|++++|.+....+..+...++|+.+++++|++++..+.
T Consensus        90 ----------------------~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~  147 (284)
T d1ozna_          90 ----------------------NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD  147 (284)
T ss_dssp             ----------------------CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             ----------------------ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChh
Confidence                                  3333333344455555555555555555444444555555566666666666655555


Q ss_pred             CcCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCcc
Q 003065          260 ELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTAL  339 (851)
Q Consensus       260 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L  339 (851)
                      .|..+++|+.|++++|++++..+..|.++++|+.+++++|++++..|..|..+++|++|++++|++.+..+..|..+++|
T Consensus       148 ~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L  227 (284)
T d1ozna_         148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL  227 (284)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred             HhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccccc
Confidence            56666666666666666665555666666666666666666666666666777777777777777776666777777777


Q ss_pred             ceeeccCCcccc
Q 003065          340 TDVDISENQFSG  351 (851)
Q Consensus       340 ~~L~Ls~N~l~~  351 (851)
                      +.|++++|++..
T Consensus       228 ~~L~l~~N~l~C  239 (284)
T d1ozna_         228 QYLRLNDNPWVC  239 (284)
T ss_dssp             CEEECCSSCEEC
T ss_pred             CEEEecCCCCCC
Confidence            888888887764

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.6e-24  Score=223.23  Aligned_cols=206  Identities=23%  Similarity=0.241  Sum_probs=178.4

Q ss_pred             CCCccceeeccCCcccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceE
Q 003065          335 RYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGML  414 (851)
Q Consensus       335 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  414 (851)
                      ....+.++|.+++.++ .+|.                        .+.  +++++|+|++|+|++..+..|.++++|++|
T Consensus         8 ~~~~~~~v~C~~~~L~-~iP~------------------------~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L   60 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT-ALPP------------------------DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL   60 (266)
T ss_dssp             CSTTCCEEECTTSCCS-SCCS------------------------CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEE
T ss_pred             ccCCCeEEEccCCCCC-eeCc------------------------CcC--cCCCEEECcCCcCCCcCHHHhhcccccccc
Confidence            3455666788887777 3443                        221  468999999999997777788999999999


Q ss_pred             EecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCccc
Q 003065          415 DFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT  494 (851)
Q Consensus       415 ~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  494 (851)
                      +|++|+|+...  .++.+++|+.|+|++|+++ ..+..+..+++|++|++++|.+.+..+..+..+.+++.|++++|.++
T Consensus        61 ~L~~N~l~~l~--~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~  137 (266)
T d1p9ag_          61 NLDRAELTKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK  137 (266)
T ss_dssp             ECTTSCCCEEE--CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred             ccccccccccc--ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccc
Confidence            99999998543  3567899999999999998 55778999999999999999999888889999999999999999999


Q ss_pred             CCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEEeCcCCcccccCCcc
Q 003065          495 GSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLD  571 (851)
Q Consensus       495 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l~ls~N~l~~~~p~~  571 (851)
                      +..+..+..++.++.+++++|+|++..+..|..+++|+.|||++|+|+ .+|+.+..+ .|+.|+|++|+|.|++...
T Consensus       138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~  214 (266)
T d1p9ag_         138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEIL  214 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGH
T ss_pred             eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcchH
Confidence            888888899999999999999999888889999999999999999999 899988888 8999999999999988644

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.2e-23  Score=216.10  Aligned_cols=177  Identities=22%  Similarity=0.247  Sum_probs=83.6

Q ss_pred             CCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEe
Q 003065          120 CSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLF  199 (851)
Q Consensus       120 l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~  199 (851)
                      .+.+...|.+++.++..|+.+.  ++|++|||++|+|++..+..|.++++|++|+|++|+++  .+| .++.+++|++|+
T Consensus         9 ~~~~~~v~C~~~~L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~--~l~-~~~~l~~L~~L~   83 (266)
T d1p9ag_           9 VASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQ-VDGTLPVLGTLD   83 (266)
T ss_dssp             STTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC--EEE-CCSCCTTCCEEE
T ss_pred             cCCCeEEEccCCCCCeeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc--ccc-cccccccccccc
Confidence            3344444555555554433332  34555555555555444445555555555555555553  222 234455555555


Q ss_pred             cccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccC
Q 003065          200 LAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG  279 (851)
Q Consensus       200 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  279 (851)
                      |++|+++ ..+..+.++++|++|++++|++....+..+..+.++++|++++|.++...+..+..+++|+.|++++|++++
T Consensus        84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~  162 (266)
T d1p9ag_          84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (266)
T ss_dssp             CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             ccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence            5555555 234444445555555555555444444444444444444444444443333344444444444444444443


Q ss_pred             CCCccccCcCCccEEEccCCccC
Q 003065          280 KLPEEIGNLKNLTVFQCFKNNFS  302 (851)
Q Consensus       280 ~~p~~l~~l~~L~~L~l~~N~l~  302 (851)
                      ..+..|..+++|++|+|++|+|+
T Consensus       163 ~~~~~~~~l~~L~~L~Ls~N~L~  185 (266)
T d1p9ag_         163 LPAGLLNGLENLDTLLLQENSLY  185 (266)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cCccccccccccceeecccCCCc
Confidence            33334444444444444444444

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.89  E-value=6.7e-24  Score=230.91  Aligned_cols=166  Identities=23%  Similarity=0.255  Sum_probs=132.0

Q ss_pred             CCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCC-----------CCccccEEEEEEe--
Q 003065          677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIR-----------HRNILKLYACLLK--  742 (851)
Q Consensus       677 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~--  742 (851)
                      +|++.+.||+|+||+||+|+++.+++.||||++.... ..+.+.+|+++++.++           |+||+++++++..  
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            5999999999999999999999999999999997653 3466788999988875           5789999888754  


Q ss_pred             CCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCC------
Q 003065          743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY------  816 (851)
Q Consensus       743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~------  816 (851)
                      ....+++++++..+.........  ......+...+..++.|++.|++|||+  ..+|+||||||+|||++.++      
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence            35566777776555443333322  234567888999999999999999995  37999999999999998655      


Q ss_pred             ceEEeeecCccccCCCCCcccccccccccccccCC
Q 003065          817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPG  851 (851)
Q Consensus       817 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE  851 (851)
                      .+|++|||.|+......     ...+||+.|+|||
T Consensus       170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE  199 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPE  199 (362)
T ss_dssp             EEEECCCTTCEETTBCC-----CSCCSCGGGCCHH
T ss_pred             eeeEeeccccccccccc-----ccccccccccChh
Confidence            39999999998654332     2357999999998

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=8e-20  Score=197.08  Aligned_cols=96  Identities=21%  Similarity=0.282  Sum_probs=49.4

Q ss_pred             CCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEec
Q 003065          121 SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL  200 (851)
Q Consensus       121 ~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L  200 (851)
                      .+|++|||++|.++..+ +  .+++|++|+|++|+|+ .+|..   +.+|++|++++|+++  .++..   .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~~lp-~--~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~--~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLSSLP-E--LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK--ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCSCCC-S--CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS--CCCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCCCCC-C--CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc--hhhhh---ccccccccc
Confidence            35777777777776543 3  2356677777777766 44443   234555555555554  22211   123555555


Q ss_pred             ccccccccCCcccccccccCcccccccccc
Q 003065          201 AHCNLRGRIPESISELRELGTLDICRNKIS  230 (851)
Q Consensus       201 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~  230 (851)
                      ++|.++ .+|. ++.+++|++|++++|.++
T Consensus       106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~  133 (353)
T d1jl5a_         106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLK  133 (353)
T ss_dssp             CSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred             cccccc-cccc-hhhhccceeecccccccc
Confidence            555554 2332 344444444444444443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=1.1e-19  Score=196.00  Aligned_cols=138  Identities=20%  Similarity=0.186  Sum_probs=98.3

Q ss_pred             ccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecc
Q 003065           97 QSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG  176 (851)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  176 (851)
                      .++++|||++|.++ .+|+.   +++|++|+|++|+|+..+..   +.+|+.|++++|.++. ++..   .+.|++|+++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~  106 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS  106 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccch-hhhh---cccccccccc
Confidence            46889999999998 68864   46899999999999965433   4589999999999873 3321   1469999999


Q ss_pred             cccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCcc
Q 003065          177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT  254 (851)
Q Consensus       177 ~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~  254 (851)
                      +|.+.  .+|. ++.+++|++|++++|.+.. .+...   ..+..+.+..+...  .+..+..++.++.|++++|.+.
T Consensus       107 ~n~l~--~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         107 NNQLE--KLPE-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             SSCCS--SCCC-CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred             ccccc--cccc-hhhhccceeeccccccccc-ccccc---ccccchhhcccccc--ccccccccccceeccccccccc
Confidence            99986  6664 6889999999999999874 33333   34445555544443  2334555566666666666555

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.82  E-value=7.1e-21  Score=186.39  Aligned_cols=132  Identities=20%  Similarity=0.258  Sum_probs=103.7

Q ss_pred             ccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--------------------cHHHHHHHHHHHHcCCCCccccEEE
Q 003065          679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------------------GVKVFAAEMEILGKIRHRNILKLYA  738 (851)
Q Consensus       679 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------------~~~~~~~E~~~l~~l~h~niv~l~~  738 (851)
                      .+.+.||+|+||.||+|++ .+|+.||||+++...                    ......+|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            4678999999999999998 468899999864210                    0123457889999999999998876


Q ss_pred             EEEeCCeeEEEEeccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEECCCCce
Q 003065          739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP  818 (851)
Q Consensus       739 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~NILl~~~~~~  818 (851)
                      +.    ..++||||+++....+            ++......++.|+++|++|||   +.+|+||||||+|||++++ .+
T Consensus        82 ~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~  141 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GI  141 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EE
T ss_pred             ec----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CE
Confidence            53    2379999998754321            222334578999999999999   7899999999999999975 58


Q ss_pred             EEeeecCccccCC
Q 003065          819 KIADFGVAKIAEN  831 (851)
Q Consensus       819 kl~DFGla~~~~~  831 (851)
                      +++|||.|+....
T Consensus       142 ~liDFG~a~~~~~  154 (191)
T d1zara2         142 WIIDFPQSVEVGE  154 (191)
T ss_dssp             EECCCTTCEETTS
T ss_pred             EEEECCCcccCCC
Confidence            9999999976643

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=5.7e-20  Score=187.38  Aligned_cols=222  Identities=17%  Similarity=0.165  Sum_probs=125.8

Q ss_pred             cccceeEecCCCCceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCC-
Q 003065           61 CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-  139 (851)
Q Consensus        61 c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~-  139 (851)
                      |++..|.|.            +.+++ .+|+.+.  +++++|+|++|.++...+..|.++++|++|+|++|.+...++. 
T Consensus         8 C~~~~i~c~------------~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~   72 (242)
T d1xwdc1           8 CSNRVFLCQ------------ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD   72 (242)
T ss_dssp             ECSSEEEEE------------SCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSS
T ss_pred             CcCCEEEEe------------CCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecc
Confidence            566666664            34455 5666553  5788888888888744444688888888888888887765443 


Q ss_pred             -CCCCCCCCeEeccC-cccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCccccccc
Q 003065          140 -LSALKNLEIFDLSI-NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELR  217 (851)
Q Consensus       140 -l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  217 (851)
                       +.++++++++++.. |.+....+..|.++++|++|++++|.+........+..+..++.+...++++....+..|..++
T Consensus        73 ~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~  152 (242)
T d1xwdc1          73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS  152 (242)
T ss_dssp             SEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccc
Confidence             67777888877654 5666555666666666666666666664222222233344444444444444433333333332


Q ss_pred             ccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcCCCCcccEE-ecccccccCCCCccccCcCCccEEEc
Q 003065          218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF-DISSNQMYGKLPEEIGNLKNLTVFQC  296 (851)
Q Consensus       218 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L-~Ls~N~l~~~~p~~l~~l~~L~~L~l  296 (851)
                                             ..++.|++++|+++...+..+ ..++++++ ++++|+++...+..|.++++|++|++
T Consensus       153 -----------------------~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~L  208 (242)
T d1xwdc1         153 -----------------------FESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI  208 (242)
T ss_dssp             -----------------------SSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEEC
T ss_pred             -----------------------ccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEEC
Confidence                                   245555555555553322222 23333333 44555555333344566666666666


Q ss_pred             cCCccCCCCCCCCCCcccccEEEec
Q 003065          297 FKNNFSGEFPSGFGDMRKLFAFSIY  321 (851)
Q Consensus       297 ~~N~l~~~~p~~~~~l~~L~~L~l~  321 (851)
                      ++|+++...+..|.++++|+++++.
T Consensus       209 s~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         209 SRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             TTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             CCCcCCccCHHHHcCCcccccCcCC
Confidence            6666664434456666666665554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=1.2e-19  Score=182.87  Aligned_cols=202  Identities=18%  Similarity=0.271  Sum_probs=98.0

Q ss_pred             EEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccC
Q 003065          101 VLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVY  180 (851)
Q Consensus       101 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  180 (851)
                      .++++.+++++.+  .+..+++|++|++++|.++.. +.+..+++|++|++++|.+++..|  +..+++|+++++++|.+
T Consensus        23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~   97 (227)
T d1h6ua2          23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL   97 (227)
T ss_dssp             HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred             HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence            3444444444322  234455555555555555433 335555555555555555543322  45555555555555554


Q ss_pred             CCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcC
Q 003065          181 DEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE  260 (851)
Q Consensus       181 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  260 (851)
                      +  .+ +.+..+++|+.+++++|...+.  ..+...+.++.++++.+.+...  ..+.++++|++|++++|.+++.  ..
T Consensus        98 ~--~i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~  168 (227)
T d1h6ua2          98 K--NV-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TP  168 (227)
T ss_dssp             S--CC-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GG
T ss_pred             c--cc-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hh
Confidence            3  22 2345555566666655555432  2233444555555555555422  2244455555555555555432  12


Q ss_pred             cCCCCcccEEecccccccCCCCccccCcCCccEEEccCCccCCCCCCCCCCcccccEEEe
Q 003065          261 LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSI  320 (851)
Q Consensus       261 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  320 (851)
                      ++++++|++|+|++|++++ ++ .+.++++|++|++++|++++..  .++++++|+.|++
T Consensus       169 l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~l  224 (227)
T d1h6ua2         169 LANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTL  224 (227)
T ss_dssp             GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEE
T ss_pred             hcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEe
Confidence            4555555555555555553 22 2455555555555555554321  1444444444444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=1.3e-19  Score=177.30  Aligned_cols=177  Identities=21%  Similarity=0.286  Sum_probs=118.6

Q ss_pred             cceeccccCccccccCCcccCccccceEEecCCcCCC-CCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEEecc
Q 003065          387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG-GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT  465 (851)
Q Consensus       387 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  465 (851)
                      .+.++.++|+++ .+|..+  .+++++|+|++|+|++ ..+..|..+++|+.|+|++|++.+..+..|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            456788888887 667655  2567777777777765 345566777777777777777777777777777777777777


Q ss_pred             CccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCcccccc
Q 003065          466 NNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI  545 (851)
Q Consensus       466 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i  545 (851)
                      +|+|++..|.+|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+. ..-...++.+.+..|.++...
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~  165 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCC
Confidence            7777766667777777777777777777766666777777777777777776643321 111233556666677776666


Q ss_pred             CcccccccceEEeCcCCcccccCC
Q 003065          546 PDNLMKLKLSSIDLSENQLSGSVP  569 (851)
Q Consensus       546 p~~l~~l~L~~l~ls~N~l~~~~p  569 (851)
                      |..+..+  +.+||+.|.+.|..+
T Consensus       166 p~~l~~~--~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         166 PSKVRDV--QIKDLPHSEFKCSSE  187 (192)
T ss_dssp             STTTTTS--BGGGSCTTTCCCCCC
T ss_pred             ChhhcCC--EeeecCHhhCcCCCC
Confidence            6655443  345667777766544

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=2.6e-19  Score=180.42  Aligned_cols=207  Identities=19%  Similarity=0.278  Sum_probs=171.5

Q ss_pred             ceEEEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccC
Q 003065           74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI  153 (851)
Q Consensus        74 ~v~~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~  153 (851)
                      .|+.++++.+.+++.+  .+.+|.+|++|++.+|+++. ++ .+.++++|++|++++|.+++..| +..+++|+++++++
T Consensus        20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~   94 (227)
T d1h6ua2          20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSG   94 (227)
T ss_dssp             HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCS
T ss_pred             HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc-cccccccccccccc
Confidence            3455667777777654  56778999999999999984 54 68999999999999999987654 89999999999999


Q ss_pred             cccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccc
Q 003065          154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF  233 (851)
Q Consensus       154 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~  233 (851)
                      |.++. + ..+.++++|++++++++...  . ...+...+.++.+.++.+.+...  ..+...++|++|++++|+++...
T Consensus        95 n~~~~-i-~~l~~l~~L~~l~l~~~~~~--~-~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~  167 (227)
T d1h6ua2          95 NPLKN-V-SAIAGLQSIKTLDLTSTQIT--D-VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT  167 (227)
T ss_dssp             CCCSC-C-GGGTTCTTCCEEECTTSCCC--C-CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG
T ss_pred             ccccc-c-cccccccccccccccccccc--c-cchhccccchhhhhchhhhhchh--hhhccccccccccccccccccch
Confidence            99874 3 46889999999999999875  2 24567789999999999998744  34778899999999999997543


Q ss_pred             cccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccCCCCccccCcCCccEEEccC
Q 003065          234 PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK  298 (851)
Q Consensus       234 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~  298 (851)
                        .+.++++|++|+|++|++++ ++ .+.++++|++|+|++|++++. + .+.++++|++|++++
T Consensus       168 --~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         168 --PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLTN  226 (227)
T ss_dssp             --GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEEE
T ss_pred             --hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEeeC
Confidence              48899999999999999985 33 488999999999999999954 3 388999999999874

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=7.3e-23  Score=229.61  Aligned_cols=187  Identities=22%  Similarity=0.202  Sum_probs=106.6

Q ss_pred             CccccceeccccCcccc-----ccCCcccCccccceEEecCCcCCCCC----CcccccCCCCCeEecCCCcceeeCCccc
Q 003065          383 DCKTIQRLRISDNHLSG-----KIPDGLWALPNVGMLDFGDNDFTGGI----SPLIGLSTSLSQLVLQNNRFSGELPSEL  453 (851)
Q Consensus       383 ~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~~~~L~~L~Ls~N~l~~~~p~~~  453 (851)
                      ..+.++.+++++|++..     ..+........++.+++++|.+....    ...+...+.++.+++++|.++......+
T Consensus       224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l  303 (460)
T d1z7xw1         224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL  303 (460)
T ss_dssp             HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred             ccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence            34556666666665532     12222333456666777766665321    1223445667777777777653322222


Q ss_pred             -----ccCCCCcEEeccCccccCCCcc----ccccCCcccEEEecCCcccCC----CCCCcc-cccccceeeccCccccc
Q 003065          454 -----GRLTNLERLILTNNNFSGKIPS----ALGALRQLSSLHLEENALTGS----IPNEMG-DCARIVDLNLARNSLSG  519 (851)
Q Consensus       454 -----~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~  519 (851)
                           .....|+.+++++|.++.....    .+...++|++|+|++|+++..    ++..+. ....|+.|+|++|+|+.
T Consensus       304 ~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~  383 (460)
T d1z7xw1         304 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD  383 (460)
T ss_dssp             HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred             hccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence                 1234677777777777644322    233445677777777777532    222232 34567778888887764


Q ss_pred             c----cCCCccccccCCeEeCCCCccccccCcccc----c-c-cceEEeCcCCcccccCC
Q 003065          520 N----IPRSLSLLSSLNALNLSGNKLTGSIPDNLM----K-L-KLSSIDLSENQLSGSVP  569 (851)
Q Consensus       520 ~----~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~----~-l-~L~~l~ls~N~l~~~~p  569 (851)
                      .    ++..+...++|++|||++|+++......+.    . . .|+.|++++|++....+
T Consensus       384 ~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~  443 (460)
T d1z7xw1         384 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME  443 (460)
T ss_dssp             HHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHH
Confidence            2    444455667788888888887754333332    1 1 47788888887775444

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=1.1e-18  Score=177.63  Aligned_cols=220  Identities=16%  Similarity=0.046  Sum_probs=145.6

Q ss_pred             ceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEeccc-
Q 003065          124 KVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAH-  202 (851)
Q Consensus       124 ~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~-  202 (851)
                      ++++.+++.++..++.+.  +++++|||++|+++...+..|.++++|++|++++|.+....-+..|.+++++++|.+.. 
T Consensus        11 ~~i~c~~~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          11 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             SEEEEESCSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             CEEEEeCCCCCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence            445555555554333332  35556666666655444445556666666666666554211133566677777776653 


Q ss_pred             ccccccCCcccccccccCcccccccccccccc-ccccCCCcccEEEeeccCccCcCCcCcCCCC-cccEEecccccccCC
Q 003065          203 CNLRGRIPESISELRELGTLDICRNKISGEFP-RSIRKLQKLWKIELYANNLTGELPAELGNLT-LLQEFDISSNQMYGK  280 (851)
Q Consensus       203 n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~  280 (851)
                      |++....+..|.++++|++|++++|++....+ ..+..+..+..+..+++.+....+..|..++ .++.|++++|+++..
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i  168 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI  168 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred             ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence            56666666777777788888888877764333 2345567777777788888866667777664 788999999999854


Q ss_pred             CCccccCcCCccEE-EccCCccCCCCCCCCCCcccccEEEeccCcCCCCCCCccCCCCccceeeccC
Q 003065          281 LPEEIGNLKNLTVF-QCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE  346 (851)
Q Consensus       281 ~p~~l~~l~~L~~L-~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~  346 (851)
                       +....+.++++.+ ++++|+++...+..|.++++|++|++++|+++...+..|.++++|+.+++.+
T Consensus       169 -~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         169 -HNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             -CTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             -ccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence             4444455555554 5677888855555789999999999999999976667788888888887754

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=1.2e-21  Score=219.46  Aligned_cols=94  Identities=23%  Similarity=0.208  Sum_probs=51.2

Q ss_pred             cCCCCCeEecCCCcceee----CCcccc-cCCCCcEEeccCccccCC----CccccccCCcccEEEecCCcccCCCCCCc
Q 003065          431 LSTSLSQLVLQNNRFSGE----LPSELG-RLTNLERLILTNNNFSGK----IPSALGALRQLSSLHLEENALTGSIPNEM  501 (851)
Q Consensus       431 ~~~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  501 (851)
                      ..++|++|+|++|+++..    ++..+. ..+.|++|+|++|+|+..    ++..+...++|++|+|++|+|+......+
T Consensus       338 ~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l  417 (460)
T d1z7xw1         338 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL  417 (460)
T ss_dssp             HCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHH
T ss_pred             cccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHH
Confidence            344566666666666532    222222 245567777777776532    33345555677777777777653222222


Q ss_pred             ----c-cccccceeeccCcccccccCCC
Q 003065          502 ----G-DCARIVDLNLARNSLSGNIPRS  524 (851)
Q Consensus       502 ----~-~l~~L~~L~Ls~N~l~~~~p~~  524 (851)
                          . +...|+.|++++|.+....+..
T Consensus       418 ~~~l~~~~~~L~~l~l~~~~~~~~~~~~  445 (460)
T d1z7xw1         418 VESVRQPGCLLEQLVLYDIYWSEEMEDR  445 (460)
T ss_dssp             HHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred             HHHHHhCCCccCEEECCCCCCCHHHHHH
Confidence                1 2235777777777776544433

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=3e-18  Score=170.05  Aligned_cols=179  Identities=24%  Similarity=0.307  Sum_probs=91.8

Q ss_pred             eCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCC
Q 003065          103 SLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE  182 (851)
Q Consensus       103 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  182 (851)
                      .++.+.+++.++.  ..+.+|++|++++|.+... +.+..+++|++|+|++|++++..  .+.++++|++|++++|+++ 
T Consensus        30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-  103 (210)
T d1h6ta2          30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-  103 (210)
T ss_dssp             HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-
T ss_pred             HhCcCccCCccCH--HHhcCccEEECcCCCCCCc-hhHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc-
Confidence            4444444443332  2345555555555555442 23555555666666666555322  2445555555555555554 


Q ss_pred             CCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcCcC
Q 003065          183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELG  262 (851)
Q Consensus       183 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  262 (851)
                       .+| .+..+++|+.|++++|.+..  ...+..+++|+.+++++|.+++  +..+..+++|+++++++|++++. + .+.
T Consensus       104 -~l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~  175 (210)
T d1h6ta2         104 -DLS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLA  175 (210)
T ss_dssp             -CGG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGT
T ss_pred             -ccc-cccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-ccc
Confidence             233 35555666666666665542  1235555555555555555542  22344555555555555555532 2 255


Q ss_pred             CCCcccEEecccccccCCCCccccCcCCccEEEcc
Q 003065          263 NLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF  297 (851)
Q Consensus       263 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~  297 (851)
                      ++++|++|+|++|+++. +| .+.++++|++|+++
T Consensus       176 ~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         176 GLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             TCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             CCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence            55556666666555552 33 35555555555554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=3.4e-18  Score=169.67  Aligned_cols=181  Identities=24%  Similarity=0.314  Sum_probs=148.3

Q ss_pred             EecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccC
Q 003065           78 ISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFT  157 (851)
Q Consensus        78 l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~  157 (851)
                      .++..+.+++.++.  ..|..|++|++++|.+++. + .+..+++|++|+|++|++++.. .++.+++|++|++++|+++
T Consensus        29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~  103 (210)
T d1h6ta2          29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVK  103 (210)
T ss_dssp             HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC
T ss_pred             HHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc-ccccCcccccccccccccc
Confidence            34555556655543  3578899999999999753 3 4888999999999999998754 5788999999999999998


Q ss_pred             CCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccc
Q 003065          158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSI  237 (851)
Q Consensus       158 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~  237 (851)
                      + +| .+.++++|+.|++++|.+.  .+ ..+..+++++.+++++|.+++  +..+..+++|+++++++|++++. + .+
T Consensus       104 ~-l~-~l~~l~~L~~L~l~~~~~~--~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l  174 (210)
T d1h6ta2         104 D-LS-SLKDLKKLKSLSLEHNGIS--DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PL  174 (210)
T ss_dssp             C-GG-GGTTCTTCCEEECTTSCCC--CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GG
T ss_pred             c-cc-ccccccccccccccccccc--cc-ccccccccccccccccccccc--ccccccccccccccccccccccc-c-cc
Confidence            5 34 5888999999999999886  33 468889999999999999974  34678899999999999999864 3 38


Q ss_pred             cCCCcccEEEeeccCccCcCCcCcCCCCcccEEeccc
Q 003065          238 RKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISS  274 (851)
Q Consensus       238 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  274 (851)
                      .++++|++|+|++|+++. +| .+.++++|++|+|++
T Consensus       175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            899999999999999984 54 589999999999974

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.75  E-value=2.8e-18  Score=167.81  Aligned_cols=159  Identities=22%  Similarity=0.264  Sum_probs=131.7

Q ss_pred             cceEEecCCcCCCCCCcccccCCCCCeEecCCCcceee-CCcccccCCCCcEEeccCccccCCCccccccCCcccEEEec
Q 003065          411 VGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGE-LPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE  489 (851)
Q Consensus       411 L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  489 (851)
                      .+.++.++|+++.+++..   .+++++|+|++|+|++. .+..|.++++|+.|+|++|.+.+..+..|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~~iP~~l---p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLKEIPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCSSCCSCC---CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcCccCCCC---CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            457899999999665433   36799999999999864 46678899999999999999998889999999999999999


Q ss_pred             CCcccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccccceEEeCcCCcccccCC
Q 003065          490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVP  569 (851)
Q Consensus       490 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~L~~l~ls~N~l~~~~p  569 (851)
                      +|+|++..|..|.++++|+.|+|++|+|++..|.+|..+++|++|+|++|++.+..+.......++.+++..|.+.|..|
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence            99999888888999999999999999999888889999999999999999998544332211145666778888888888


Q ss_pred             ccc
Q 003065          570 LDF  572 (851)
Q Consensus       570 ~~~  572 (851)
                      ...
T Consensus       167 ~~l  169 (192)
T d1w8aa_         167 SKV  169 (192)
T ss_dssp             TTT
T ss_pred             hhh
Confidence            654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=1.8e-18  Score=170.21  Aligned_cols=178  Identities=26%  Similarity=0.379  Sum_probs=103.8

Q ss_pred             EEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccC
Q 003065          101 VLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVY  180 (851)
Q Consensus       101 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  180 (851)
                      .+.++.+.+++.++  ...+.++++|++++|.+.. ++.+..+++|++|++++|++++..|  +.++++|++|++++|.+
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~   96 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI   96 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-ccccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence            34455555554332  2355666666666666654 2346666666666666666664332  56666666666666665


Q ss_pred             CCCCCcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCccCcCCcC
Q 003065          181 DEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE  260 (851)
Q Consensus       181 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  260 (851)
                      .  .++ .+.++++|+.|++++|.+...  ..+..+++|+.|++++|++.. + ..+..+++|++|++++|++++. + .
T Consensus        97 ~--~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~  167 (199)
T d2omxa2          97 A--DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-P  167 (199)
T ss_dssp             C--CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-G
T ss_pred             c--ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-c
Confidence            4  333 366667777777776666532  235566666666666666652 2 2456666666666666666642 2 3


Q ss_pred             cCCCCcccEEecccccccCCCCccccCcCCccEE
Q 003065          261 LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVF  294 (851)
Q Consensus       261 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  294 (851)
                      ++++++|++|++++|++++ ++ .++++++|+.|
T Consensus       168 l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         168 LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            5566666666666666653 22 35555555543

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=9.1e-18  Score=165.07  Aligned_cols=191  Identities=26%  Similarity=0.383  Sum_probs=148.5

Q ss_pred             ccccCchhhhhhcchHHHHhccCCccccccccccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcc
Q 003065          349 FSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPL  428 (851)
Q Consensus       349 l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  428 (851)
                      +...+|+.  .+.+.....+..+++++.++  ...+.++++|++++|.++. + +.+..+++|++|++++|++++..+  
T Consensus         8 i~~if~d~--~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--   79 (199)
T d2omxa2           8 INQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--   79 (199)
T ss_dssp             HHHHSCSH--HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--
T ss_pred             cCccccCH--HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--
Confidence            33345542  34455566677777776553  3467889999999999984 3 357789999999999999987654  


Q ss_pred             cccCCCCCeEecCCCcceeeCCcccccCCCCcEEeccCccccCCCccccccCCcccEEEecCCcccCCCCCCcccccccc
Q 003065          429 IGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIV  508 (851)
Q Consensus       429 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  508 (851)
                      ++.+++|+.|++++|.+.. ++ .+.+++.|+.|++++|.+....  .+..+++|+.|++++|++.. ++ .+..+++|+
T Consensus        80 l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~  153 (199)
T d2omxa2          80 LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQ  153 (199)
T ss_dssp             GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred             ccCCccccccccccccccc-cc-cccccccccccccccccccccc--ccchhhhhHHhhhhhhhhcc-cc-ccccccccc
Confidence            7889999999999999873 44 4889999999999999987543  47788999999999999874 33 588899999


Q ss_pred             eeeccCcccccccCCCccccccCCeEeCCCCccccccCcccccc-cceEE
Q 003065          509 DLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSI  557 (851)
Q Consensus       509 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~L~~l  557 (851)
                      .|++++|++++..  .+.++++|+.|++++|+++ .+| .+..+ +|+.|
T Consensus       154 ~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~L  199 (199)
T d2omxa2         154 QLNFSSNQVTDLK--PLANLTTLERLDISSNKVS-DIS-VLAKLTNLESL  199 (199)
T ss_dssp             EEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred             ccccccccccCCc--cccCCCCCCEEECCCCCCC-CCc-cccCCCCCCcC
Confidence            9999999998643  3889999999999999998 455 45555 56544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=9e-17  Score=167.18  Aligned_cols=221  Identities=15%  Similarity=0.250  Sum_probs=122.8

Q ss_pred             EEecccCCcceecCccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCC-CC-CCCCCCCCeEeccCc
Q 003065           77 EISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV-PD-LSALKNLEIFDLSIN  154 (851)
Q Consensus        77 ~l~l~~~~l~g~i~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-~~-l~~l~~L~~L~Ls~N  154 (851)
                      .+||+++.+.+.+...+.. ..+..+.++...+...+. ......+|++|||+++.+.... +. +..+++|++|+|++|
T Consensus         4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~   81 (284)
T d2astb2           4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL   81 (284)
T ss_dssp             EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             EEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence            5667766665443332221 234455555555443222 2334457777777777665432 22 566777777777777


Q ss_pred             ccCCCCcccccCccccceeecccc-cCCCCCCcccccCCCCCCeEeccccc-cccc-CCccccc-ccccCccccccc--c
Q 003065          155 YFTGRFPRWVVNLTQLVSLSIGDN-VYDEAEIPESIGNLKNLTYLFLAHCN-LRGR-IPESISE-LRELGTLDICRN--K  228 (851)
Q Consensus       155 ~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~p~~~~~l~~L~~L~L~~n~-l~~~-~p~~~~~-l~~L~~L~L~~N--~  228 (851)
                      .+++..+..+..+++|++|+++++ .++...+.....++++|++|++++|. ++.. +...+.. .++|+.|+++++  .
T Consensus        82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~  161 (284)
T d2astb2          82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN  161 (284)
T ss_dssp             BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred             CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccc
Confidence            776666666777777777777763 44422222233456777777777753 3321 1122222 245677776643  3


Q ss_pred             cccc-ccccccCCCcccEEEeecc-CccCcCCcCcCCCCcccEEecccc-cccCCCCccccCcCCccEEEccCC
Q 003065          229 ISGE-FPRSIRKLQKLWKIELYAN-NLTGELPAELGNLTLLQEFDISSN-QMYGKLPEEIGNLKNLTVFQCFKN  299 (851)
Q Consensus       229 i~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~l~~N  299 (851)
                      ++.. +...+.++++|++|++++| .+++.....+..+++|++|+|+++ .+++.....++++++|+.|+++++
T Consensus       162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            3322 2223345666777777664 455555556666667777777663 455444455666666666666654

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=3.5e-15  Score=140.49  Aligned_cols=130  Identities=15%  Similarity=0.135  Sum_probs=91.0

Q ss_pred             ccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCcccc
Q 003065           91 SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQL  170 (851)
Q Consensus        91 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  170 (851)
                      +.+.+...+++|||++|+|+ .+|..+..+++|++|||++|+|+.. +.+..+++|++|++++|.++...+..+..+++|
T Consensus        12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCcccccccccc
Confidence            34567778888888888887 4576677788888888888888754 567888888888888888876555556677788


Q ss_pred             ceeecccccCCCCCCcccccCCCCCCeEecccccccccCCc----ccccccccCccc
Q 003065          171 VSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE----SISELRELGTLD  223 (851)
Q Consensus       171 ~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~  223 (851)
                      ++|++++|++....-...+..+++|++|++++|.++. .|.    .+..+++|++||
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             ccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            8888888877522111356667777777777777763 332    345556666555

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=6.1e-16  Score=160.78  Aligned_cols=222  Identities=15%  Similarity=0.171  Sum_probs=120.9

Q ss_pred             cEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCC-cccccCccccceeecccc
Q 003065          100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRF-PRWVVNLTQLVSLSIGDN  178 (851)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N  178 (851)
                      ++|||+++.+.......+.. .....+.++...+...........+|++|||++|.++... +..+..+++|++|+|+++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~   81 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL   81 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence            47899988875333222221 2456677777666655444556678888888888876442 344567777888888777


Q ss_pred             cCCCCCCcccccCCCCCCeEecccc-ccccc-CCcccccccccCccccccc-ccccc-ccccccC-CCcccEEEeecc--
Q 003065          179 VYDEAEIPESIGNLKNLTYLFLAHC-NLRGR-IPESISELRELGTLDICRN-KISGE-FPRSIRK-LQKLWKIELYAN--  251 (851)
Q Consensus       179 ~l~~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L~~N-~i~~~-~p~~~~~-l~~L~~L~L~~N--  251 (851)
                      .++ ...+..++.+++|++|++++| .++.. +...+..+++|++|+++++ .++.. +...+.. .++|+.|+++++  
T Consensus        82 ~l~-~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~  160 (284)
T d2astb2          82 RLS-DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK  160 (284)
T ss_dssp             BCC-HHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred             CCC-cHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence            765 344566777777777777775 44421 1112345666777777664 34321 1122322 345666666643  


Q ss_pred             CccCc-CCcCcCCCCcccEEecccc-cccCCCCccccCcCCccEEEccCC-ccCCCCCCCCCCcccccEEEeccC
Q 003065          252 NLTGE-LPAELGNLTLLQEFDISSN-QMYGKLPEEIGNLKNLTVFQCFKN-NFSGEFPSGFGDMRKLFAFSIYGN  323 (851)
Q Consensus       252 ~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N  323 (851)
                      .++.. +...+.++++|++|++++| .+++..+..+.++++|++|+++++ .+++.....++++++|+.|+++++
T Consensus       161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            23211 1112234556666666554 344444455555555555555552 344333333344444444444433

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=1.8e-14  Score=128.81  Aligned_cols=103  Identities=25%  Similarity=0.261  Sum_probs=55.4

Q ss_pred             cEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeeccccc
Q 003065          100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV  179 (851)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  179 (851)
                      |+|||++|+++ .+| .++++++|++|++++|++++.++.++.+++|++|++++|.+++. | .+.++++|++|++++|+
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence            45666666665 333 35666666666666666665444455666666666666666532 2 24555555555555555


Q ss_pred             CCCCCCcccccCCCCCCeEeccccccc
Q 003065          180 YDEAEIPESIGNLKNLTYLFLAHCNLR  206 (851)
Q Consensus       180 l~~~~~p~~~~~l~~L~~L~L~~n~l~  206 (851)
                      +...+.+..+..+++|++|++++|.++
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            542222234445555555555555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=1.5e-14  Score=136.10  Aligned_cols=111  Identities=25%  Similarity=0.281  Sum_probs=66.3

Q ss_pred             ccCccccceeccccCccccccCCcccCccccceEEecCCcCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCc
Q 003065          381 YADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE  460 (851)
Q Consensus       381 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  460 (851)
                      |.++.++++|||++|+|+ .+|..+..+++|+.|+|++|+|+..  +.+..+++|++|++++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            556667777777777777 4455556666777777777766643  2355566666666666666644444445566666


Q ss_pred             EEeccCccccCCCc-cccccCCcccEEEecCCccc
Q 003065          461 RLILTNNNFSGKIP-SALGALRQLSSLHLEENALT  494 (851)
Q Consensus       461 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~  494 (851)
                      .|++++|+++.... ..+..+++|++|++++|.++
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cceeccccccccccccccccccccchhhcCCCccc
Confidence            66666666653221 34555555555555555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.50  E-value=2.4e-14  Score=127.99  Aligned_cols=102  Identities=23%  Similarity=0.293  Sum_probs=68.3

Q ss_pred             ceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCCCcccccCCCCCCeEecccc
Q 003065          124 KVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC  203 (851)
Q Consensus       124 ~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n  203 (851)
                      |+|+|++|+++.. +.+..+++|++||+++|.++ .+|..+..+++|++|++++|.++  .+| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~--~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC--CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCCC-cccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc--ccC-ccccccccCeEECCCC
Confidence            5678888888744 45777777778888777776 45666777777777777777775  343 4667777777777777


Q ss_pred             cccccC-CcccccccccCcccccccccc
Q 003065          204 NLRGRI-PESISELRELGTLDICRNKIS  230 (851)
Q Consensus       204 ~l~~~~-p~~~~~l~~L~~L~L~~N~i~  230 (851)
                      +++... ...+..+++|++|++++|+++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            776332 134566666666666666665

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.47  E-value=9.1e-16  Score=164.54  Aligned_cols=243  Identities=15%  Similarity=0.140  Sum_probs=122.8

Q ss_pred             cCccccCCccCcEEeCCCCcccCc----cCcccccCCCCceEecccCcccCCCC-----------CCCCCCCCCeEeccC
Q 003065           89 ISSSISALQSLTVLSLPFNVLSGK----LPLELSNCSNLKVLNVTGNAMVGSVP-----------DLSALKNLEIFDLSI  153 (851)
Q Consensus        89 i~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~~~-----------~l~~l~~L~~L~Ls~  153 (851)
                      +..++.....|+.|+|++|.++..    +-..+...++|+.|+++++.......           .+...++|+.|||++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence            345566777888888888877543    23345666788888887765432211           134566677777777


Q ss_pred             cccCCCCc----ccccCccccceeecccccCCCCCC---cc---------cccCCCCCCeEecccccccccCCccccccc
Q 003065          154 NYFTGRFP----RWVVNLTQLVSLSIGDNVYDEAEI---PE---------SIGNLKNLTYLFLAHCNLRGRIPESISELR  217 (851)
Q Consensus       154 N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~---p~---------~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  217 (851)
                      |.++....    ..+...++|++|++++|.+.....   ..         .....+.|+.|++++|+++.....      
T Consensus       103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~------  176 (344)
T d2ca6a1         103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK------  176 (344)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHH------
T ss_pred             cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccc------
Confidence            77664322    223345566666666665531000   00         012334455555555544321111      


Q ss_pred             ccCccccccccccccccccccCCCcccEEEeeccCccCc-----CCcCcCCCCcccEEecccccccCC----CCccccCc
Q 003065          218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE-----LPAELGNLTLLQEFDISSNQMYGK----LPEEIGNL  288 (851)
Q Consensus       218 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l  288 (851)
                                    .+...+...+.|+.|+|++|.++..     +...+...++|+.|+|++|.++..    +...+..+
T Consensus       177 --------------~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~  242 (344)
T d2ca6a1         177 --------------EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW  242 (344)
T ss_dssp             --------------HHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred             --------------cccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccccc
Confidence                          1112233344445555555444321     122334445555555555554321    22334445


Q ss_pred             CCccEEEccCCccCCCCCCCC----C--CcccccEEEeccCcCCCC----CCCcc-CCCCccceeeccCCcccc
Q 003065          289 KNLTVFQCFKNNFSGEFPSGF----G--DMRKLFAFSIYGNRFSGP----FPENL-GRYTALTDVDISENQFSG  351 (851)
Q Consensus       289 ~~L~~L~l~~N~l~~~~p~~~----~--~l~~L~~L~l~~N~l~~~----~p~~l-~~l~~L~~L~Ls~N~l~~  351 (851)
                      ++|++|++++|.+++.....+    .  ..+.|++|++++|+|+..    +...+ .++++|+.|+|++|++..
T Consensus       243 ~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             ccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            555555555555543211111    1  124566677777766532    12223 246778899999998863

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.47  E-value=7.7e-16  Score=165.13  Aligned_cols=254  Identities=17%  Similarity=0.204  Sum_probs=159.2

Q ss_pred             ccCcccccCCCCceEecccCcccCC-----CCCCCCCCCCCeEeccCcccCCCC---c-------ccccCccccceeecc
Q 003065          112 KLPLELSNCSNLKVLNVTGNAMVGS-----VPDLSALKNLEIFDLSINYFTGRF---P-------RWVVNLTQLVSLSIG  176 (851)
Q Consensus       112 ~~p~~~~~l~~L~~L~Ls~n~l~~~-----~~~l~~l~~L~~L~Ls~N~l~~~~---~-------~~~~~l~~L~~L~L~  176 (851)
                      .+...+.+.++|+.|+|++|.+...     ...+...++|+.|+++++......   +       ..+...++|++|+|+
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~  101 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  101 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence            3455677788899999999887432     123667788888888877654221   1       122334556666666


Q ss_pred             cccCCCCC---CcccccCCCCCCeEecccccccccCCcccccccccCccccccccccccccccccCCCcccEEEeeccCc
Q 003065          177 DNVYDEAE---IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL  253 (851)
Q Consensus       177 ~N~l~~~~---~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l  253 (851)
                      +|.+....   +...+...++|++|++++|.+.......++.  .|..+.         ........+.|+.+++++|.+
T Consensus       102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~---------~~~~~~~~~~L~~l~l~~n~i  170 (344)
T d2ca6a1         102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELA---------VNKKAKNAPPLRSIICGRNRL  170 (344)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHH---------HHHHHHTCCCCCEEECCSSCC
T ss_pred             ccccccccccchhhhhcccccchheecccccccccccccccc--cccccc---------cccccccCcccceeecccccc
Confidence            55554211   1122334455555555555543211111110  011000         011123456888999999988


Q ss_pred             cCc----CCcCcCCCCcccEEecccccccCC-----CCccccCcCCccEEEccCCccCCC----CCCCCCCcccccEEEe
Q 003065          254 TGE----LPAELGNLTLLQEFDISSNQMYGK-----LPEEIGNLKNLTVFQCFKNNFSGE----FPSGFGDMRKLFAFSI  320 (851)
Q Consensus       254 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l  320 (851)
                      +..    +...+...+.|++|+|++|++...     +...+..+++|+.|++++|.++..    +...+..+++|++|++
T Consensus       171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~L  250 (344)
T d2ca6a1         171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL  250 (344)
T ss_dssp             TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred             cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhh
Confidence            632    223355678999999999998642     334567789999999999998633    3345678899999999


Q ss_pred             ccCcCCCCCCCcc----C--CCCccceeeccCCcccccC----chhhh-hhcchHHHHhccCCcccc
Q 003065          321 YGNRFSGPFPENL----G--RYTALTDVDISENQFSGSF----PKYLC-EKRKLLNLLALSNNFSGE  376 (851)
Q Consensus       321 ~~N~l~~~~p~~l----~--~l~~L~~L~Ls~N~l~~~~----p~~~~-~~~~L~~l~l~~n~~~~~  376 (851)
                      ++|.+++.....+    .  ....|++||+++|+|+...    ...+. +.+.|+.+++.+|.+...
T Consensus       251 s~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~  317 (344)
T d2ca6a1         251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  317 (344)
T ss_dssp             TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             hcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence            9999985433332    2  3467999999999997643    33332 456789999999988643

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.37  E-value=6.1e-15  Score=143.91  Aligned_cols=86  Identities=22%  Similarity=0.236  Sum_probs=35.7

Q ss_pred             ccccCCccCcEEeCCCCcccCccCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCcccc
Q 003065           91 SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQL  170 (851)
Q Consensus        91 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  170 (851)
                      .+++.|++|++|+|++|+|+. ++ .|..+++|++|+|++|.++..++....+++|+.|++++|.++..  ..+..+++|
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L  117 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL--SGIEKLVNL  117 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHS
T ss_pred             hHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccccccccccccccccccccccccccc--ccccccccc
Confidence            344445555555555555442 22 24444444444444444443221122233344444444444321  123334444


Q ss_pred             ceeecccccC
Q 003065          171 VSLSIGDNVY  180 (851)
Q Consensus       171 ~~L~L~~N~l  180 (851)
                      ++|++++|++
T Consensus       118 ~~L~L~~N~i  127 (198)
T d1m9la_         118 RVLYMSNNKI  127 (198)
T ss_dssp             SEEEESEEEC
T ss_pred             cccccccchh
Confidence            4444444443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=8.3e-13  Score=123.05  Aligned_cols=114  Identities=23%  Similarity=0.242  Sum_probs=85.3

Q ss_pred             CCCcEEeccCccccCCCccccccCCcccEEEecCC-cccCCCCCCcccccccceeeccCcccccccCCCccccccCCeEe
Q 003065          457 TNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN-ALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALN  535 (851)
Q Consensus       457 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  535 (851)
                      ...+.++.+++.+. ..|..+..+++|+.|++++| .|+...+..|.++++|+.|+|++|+|+...|.+|..+++|+.|+
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            34456777777776 45666777778888888665 47766667788888888888888888877777888888888888


Q ss_pred             CCCCccccccCcc-cccccceEEeCcCCcccccCCccc
Q 003065          536 LSGNKLTGSIPDN-LMKLKLSSIDLSENQLSGSVPLDF  572 (851)
Q Consensus       536 Ls~N~l~g~ip~~-l~~l~L~~l~ls~N~l~~~~p~~~  572 (851)
                      |++|+|+ .+|.. +..+.++.|+|++|+|.|.+-..|
T Consensus        87 Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~  123 (156)
T d2ifga3          87 LSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW  123 (156)
T ss_dssp             CCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGGGHH
T ss_pred             ccCCCCc-ccChhhhccccccccccCCCcccCCchHHH
Confidence            8888888 55554 444488899999999988775443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.34  E-value=1.3e-14  Score=141.47  Aligned_cols=44  Identities=27%  Similarity=0.348  Sum_probs=22.4

Q ss_pred             cCcccccCCCCceEecccCcccCCCCCCCCCCCCCeEeccCcccC
Q 003065          113 LPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFT  157 (851)
Q Consensus       113 ~p~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~  157 (851)
                      +|..++.+++|++|+|++|+|+.. +.+..+++|++|+|++|.++
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~   83 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK   83 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEEC
T ss_pred             hhhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccc
Confidence            344455555555555555555432 33445555555555555544

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.31  E-value=2.9e-12  Score=119.30  Aligned_cols=109  Identities=17%  Similarity=0.074  Sum_probs=71.6

Q ss_pred             ccccceeccccCccccccCCcccCccccceEEecCC-cCCCCCCcccccCCCCCeEecCCCcceeeCCcccccCCCCcEE
Q 003065          384 CKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN-DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERL  462 (851)
Q Consensus       384 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  462 (851)
                      +...+.++.+++.+. ..|..+.++++|++|++++| .++.+.+..|..+++|+.|+|++|+|+...|.+|..+++|++|
T Consensus         7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L   85 (156)
T d2ifga3           7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL   85 (156)
T ss_dssp             CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred             cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence            344556777777776 55666767777777777655 3666666666777777777777777776666667777777777


Q ss_pred             eccCccccCCCccccccCCcccEEEecCCccc
Q 003065          463 ILTNNNFSGKIPSALGALRQLSSLHLEENALT  494 (851)
Q Consensus       463 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  494 (851)
                      +|++|+|+...+..|..+ .|+.|+|++|.+.
T Consensus        86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             eccCCCCcccChhhhccc-cccccccCCCccc
Confidence            777777764444444443 5667777777663

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.47  E-value=5.5e-09  Score=97.30  Aligned_cols=66  Identities=20%  Similarity=0.200  Sum_probs=28.6

Q ss_pred             ccccccCccccccccccccc--cccccCCCcccEEEeeccCccCcCCcCcCCCCcccEEecccccccC
Q 003065          214 SELRELGTLDICRNKISGEF--PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG  279 (851)
Q Consensus       214 ~~l~~L~~L~L~~N~i~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  279 (851)
                      .++++|++|+|++|+|+..-  +..+..+++|+.|+|++|.|+...+-.+.....|+.|++++|.+..
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~  129 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD  129 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence            34445555555555554321  2233444445555555554442222112222345555555555543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.47  E-value=7.9e-09  Score=96.24  Aligned_cols=105  Identities=19%  Similarity=0.175  Sum_probs=46.7

Q ss_pred             CceEecccCcccCCCCCCCCCCCCCeEeccCcccCCCCcccccCccccceeecccccCCCCC-CcccccCCCCCCeEecc
Q 003065          123 LKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAE-IPESIGNLKNLTYLFLA  201 (851)
Q Consensus       123 L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~p~~~~~l~~L~~L~L~  201 (851)
                      .+.||+++++.   .+.+..+..+..++...+... .++..+..+++|++|+|++|+++... ++..+..+++|+.|+|+
T Consensus        24 ~~~Ldls~l~~---~~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls   99 (162)
T d1koha1          24 QQALDLKGLRS---DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS   99 (162)
T ss_dssp             SCCBCCCCCSS---CTTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCT
T ss_pred             hCeeecccCCC---CchhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccc
Confidence            34455544332   122333334444444433322 22223344555555555555554211 12334455566666666


Q ss_pred             cccccccCCcccccccccCccccccccccc
Q 003065          202 HCNLRGRIPESISELRELGTLDICRNKISG  231 (851)
Q Consensus       202 ~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~  231 (851)
                      +|+|+...+-.+....+|+.|++++|.++.
T Consensus       100 ~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~  129 (162)
T d1koha1         100 GNELKSERELDKIKGLKLEELWLDGNSLSD  129 (162)
T ss_dssp             TSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred             cCccccchhhhhhhccccceeecCCCCcCc
Confidence            666553222122233345555555555543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.18  E-value=2e-06  Score=86.47  Aligned_cols=142  Identities=17%  Similarity=0.058  Sum_probs=94.0

Q ss_pred             HcCCccCCeecccCcEEEEEEEEcCCCcEEEEEEecccc--cHHHHHHHHHHHHcCC-CCccccEEEEEEeCCeeEEEEe
Q 003065          675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLE  751 (851)
Q Consensus       675 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  751 (851)
                      +..|...+..+-++.+.||+...  +++.+++|+.....  ....+.+|...++.+. +--+.+++.+...++..|+||+
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            34555544433344568998763  56678888875432  2345678888888774 4346778888888899999999


Q ss_pred             ccCCCCHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 003065          752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD------------------------------------  795 (851)
Q Consensus       752 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------  795 (851)
                      +++|.++.+....       ...   ...++.++++.+..||..                                    
T Consensus        91 ~l~G~~~~~~~~~-------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          91 EADGVLCSEEYED-------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             CCSSEEHHHHTTT-------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             ecccccccccccc-------ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            9998877543211       011   123344555555555531                                    


Q ss_pred             --------------------CCCCcEEeCCCCCCEEECCCCceEEeeecCccc
Q 003065          796 --------------------CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI  828 (851)
Q Consensus       796 --------------------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~  828 (851)
                                          ....++|+|+.|.||++++++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                012379999999999999876677999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.82  E-value=1.3e-05  Score=79.93  Aligned_cols=73  Identities=19%  Similarity=0.282  Sum_probs=51.1

Q ss_pred             ecccCc-EEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCC--CccccEEEEEEeCCeeEEEEeccCCCCH
Q 003065          684 IGSGGT-GKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH--RNILKLYACLLKGGSSFLVLEYMPNGNL  758 (851)
Q Consensus       684 lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL  758 (851)
                      +..|.. +.||+... +.+..+++|..... ....+..|.+.++.+..  -.+++++.+..+++..|+||||++|.++
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344443 67898876 45666888875433 33456788888887743  3356688888888889999999987554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.54  E-value=0.00013  Score=77.22  Aligned_cols=75  Identities=13%  Similarity=0.105  Sum_probs=48.7

Q ss_pred             CCeecccCcEEEEEEEEcCCCcEEEEEEeccc---------ccHHHHHHHHHHHHcCC---CCccccEEEEEEeCCeeEE
Q 003065          681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---------DGVKVFAAEMEILGKIR---HRNILKLYACLLKGGSSFL  748 (851)
Q Consensus       681 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  748 (851)
                      .+.||.|....||+++...+++.|+||.....         ...++...|.+.++.+.   ...+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            34679999999999998777888999965321         12344567888887662   2345566654  4455689


Q ss_pred             EEeccCCCC
Q 003065          749 VLEYMPNGN  757 (851)
Q Consensus       749 v~e~~~~gs  757 (851)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.41  E-value=2.4e-05  Score=72.27  Aligned_cols=64  Identities=16%  Similarity=0.273  Sum_probs=30.4

Q ss_pred             CccccceeccccC-ccccc----cCCcccCccccceEEecCCcCCCC----CCcccccCCCCCeEecCCCcce
Q 003065          383 DCKTIQRLRISDN-HLSGK----IPDGLWALPNVGMLDFGDNDFTGG----ISPLIGLSTSLSQLVLQNNRFS  446 (851)
Q Consensus       383 ~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~~~~L~~L~Ls~N~l~  446 (851)
                      +.++|++|+|+++ .++..    +-..+...+.|+.|+|++|.+...    +...+...+.|+.|+|++|.++
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            3466777777763 45422    112233344555555555555421    1122233344555555555544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.39  E-value=2e-05  Score=72.81  Aligned_cols=40  Identities=25%  Similarity=0.346  Sum_probs=17.3

Q ss_pred             cCCCCcEEeccCccccCC----CccccccCCcccEEEecCCccc
Q 003065          455 RLTNLERLILTNNNFSGK----IPSALGALRQLSSLHLEENALT  494 (851)
Q Consensus       455 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  494 (851)
                      ..+.|+.|+|++|.+...    +...+...+.|+.|+|++|.++
T Consensus        42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            334455555555544321    1122233344555555555544

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.54  E-value=0.00018  Score=66.12  Aligned_cols=12  Identities=25%  Similarity=0.412  Sum_probs=6.5

Q ss_pred             cCCCCceEeccc
Q 003065          119 NCSNLKVLNVTG  130 (851)
Q Consensus       119 ~l~~L~~L~Ls~  130 (851)
                      +.++|++|+|++
T Consensus        15 ~~~~L~~L~L~~   26 (166)
T d1io0a_          15 NDPDLEEVNLNN   26 (166)
T ss_dssp             TCTTCCEEECTT
T ss_pred             cCCCCcEEEcCC
Confidence            345555555554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.50  E-value=0.00019  Score=65.84  Aligned_cols=88  Identities=15%  Similarity=0.237  Sum_probs=40.9

Q ss_pred             ccCCCCcEEeccCccccCC----CccccccCCcccEEEecCCcccCC----CCCCcccccccce--eeccCccccc----
Q 003065          454 GRLTNLERLILTNNNFSGK----IPSALGALRQLSSLHLEENALTGS----IPNEMGDCARIVD--LNLARNSLSG----  519 (851)
Q Consensus       454 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~--L~Ls~N~l~~----  519 (851)
                      ...++|++|+|++|.++..    +-..+...+.++.+++++|.+...    +-..+...+.|+.  |++++|.+..    
T Consensus        43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~  122 (166)
T d1io0a_          43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM  122 (166)
T ss_dssp             TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred             hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH
Confidence            3445555566665555422    112333445566666666655421    1123334444443  3333444432    


Q ss_pred             ccCCCccccccCCeEeCCCCcc
Q 003065          520 NIPRSLSLLSSLNALNLSGNKL  541 (851)
Q Consensus       520 ~~p~~~~~l~~L~~L~Ls~N~l  541 (851)
                      .+...+...++|+.|+++.|..
T Consensus       123 ~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_         123 EIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHHhCCCcCEEeCcCCCC
Confidence            2333344556666666665543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.44  E-value=0.0035  Score=65.96  Aligned_cols=72  Identities=19%  Similarity=0.296  Sum_probs=49.6

Q ss_pred             CeecccCcEEEEEEEEcC-------CCcEEEEEEecccccHHHHHHHHHHHHcCCCCcc-ccEEEEEEeCCeeEEEEecc
Q 003065          682 NLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNI-LKLYACLLKGGSSFLVLEYM  753 (851)
Q Consensus       682 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~  753 (851)
                      +.|+.|-.-.+|++....       ..+.|.+++.-.........+|..+++.+.-.++ +++++++..    .+|+||+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi  123 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  123 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence            567778888999998743       2345777766544444556789999998853344 567777643    5899999


Q ss_pred             CCCC
Q 003065          754 PNGN  757 (851)
Q Consensus       754 ~~gs  757 (851)
                      +|..
T Consensus       124 ~g~~  127 (395)
T d1nw1a_         124 PSRP  127 (395)
T ss_dssp             CEEE
T ss_pred             cccc
Confidence            8643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.35  E-value=0.0048  Score=62.94  Aligned_cols=66  Identities=14%  Similarity=0.148  Sum_probs=45.6

Q ss_pred             EEEEEEEEcCCCcEEEEEEecccc-cHHHHHHHHHHHHcCCCCccc-----cE--EEEEEeCCeeEEEEeccCCC
Q 003065          690 GKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNIL-----KL--YACLLKGGSSFLVLEYMPNG  756 (851)
Q Consensus       690 g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv-----~l--~~~~~~~~~~~lv~e~~~~g  756 (851)
                      -.||+++. ++|..|++|+.++.. ..+++..|.+.+..+....+.     ..  -..+...+..+.++++++|.
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            47999987 567889999887653 567788899988887432221     11  11234567789999999763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.63  E-value=0.0068  Score=61.44  Aligned_cols=142  Identities=14%  Similarity=0.072  Sum_probs=72.3

Q ss_pred             ecccCcEEEEEEEEcCCCcEEEEEEecccccHHHHHHHHHHHHcCCCCccc--cEE------EEEEeCCeeEEEEeccCC
Q 003065          684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNIL--KLY------ACLLKGGSSFLVLEYMPN  755 (851)
Q Consensus       684 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~------~~~~~~~~~~lv~e~~~~  755 (851)
                      |..|---+.|+.+..  +..+++|+.......+++..|++++..+...++.  ...      ......+..+.++.+..+
T Consensus        26 i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g  103 (316)
T d2ppqa1          26 IAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG  103 (316)
T ss_dssp             ECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred             CCCCcccCeEEEEEC--CCcEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeeccc
Confidence            445666778998763  3468999886544445566778888777432221  111      012334566677777765


Q ss_pred             CCHH-----H---------HHHHhhhCC--C--CCCCH------------------HHHHHHHHHHHHHHHHHH-hCCCC
Q 003065          756 GNLF-----Q---------ALHKRVKEG--K--PELDW------------------FRRYKIALGAAKGIAYLH-HDCSP  798 (851)
Q Consensus       756 gsL~-----~---------~l~~~~~~~--~--~~l~~------------------~~~~~i~~~i~~~l~~LH-~~~~~  798 (851)
                      ....     .         .++......  .  .....                  ......+......+.-.+ .....
T Consensus       104 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~  183 (316)
T d2ppqa1         104 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA  183 (316)
T ss_dssp             BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred             ccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccccc
Confidence            3221     0         111000000  0  00000                  001111112222222222 12246


Q ss_pred             CcEEeCCCCCCEEECCCCceEEeeecCcc
Q 003065          799 PIIHRDIKSSNILLDEDYEPKIADFGVAK  827 (851)
Q Consensus       799 ~ivHrDlkp~NILl~~~~~~kl~DFGla~  827 (851)
                      ++||+|+.++||+++.+...-|+||+.|.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            89999999999999988777899999885